PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, HL; Krieger, IV; Parai, MK; Gawandi, VB; Sacchettini, JC				Huang, Hsiao-Ling; Krieger, Inna V.; Parai, Maloy K.; Gawandi, Vijay B.; Sacchettini, James C.			Mycobacterium tuberculosis Malate Synthase Structures with Fragments Reveal a Portal for Substrate/Product Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG DISCOVERY; ESCHERICHIA-COLI; LEAD DISCOVERY; INHIBITORS; DECONSTRUCTION; MACROPHAGES; GLYOXYLATE; RESOLUTION; INFECTION; DESIGN	Fragment screening and high throughput screening are complementary approaches that combine with structural biology to explore the binding capabilities of an active site. We have used a fragment-based approach on malate synthase (GlcB) from Mycobacterium tuberculosis and discovered several novel binding chemotypes. In addition, the crystal structures of GlcB in complex with these fragments indicated conformational changes in the active site that represent the enzyme conformations during catalysis. Additional structures of the complex with malate and of the apo form of GlcB supported that hypothesis. Comparative analysis of GlcB structures in complex with 18 fragments allowed us to characterize the preferred chemotypes and their binding modes. The fragment structures showed a hydrogen bond to the backbone carbonyl of Met-631. We successfully incorporated an indole group from a fragment into an existing phenyl-diketo acid series. The resulting indole-containing inhibitor was 100-fold more potent than the parent phenyl- diketo acid with an IC50 value of 20 nM.	[Huang, Hsiao-Ling; Sacchettini, James C.] Texas A&M Univ, Dept Chem, College Stn, TX 77845 USA; [Krieger, Inna V.; Parai, Maloy K.; Gawandi, Vijay B.; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	sacchett@tamu.edu	Parai, Maloy K/J-1393-2014		Welch Foundation [A-0015]; National Institutes of Health [P01 AI095208]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Welch Foundation Grant A-0015 and National Institutes of Health Grant P01 AI095208 (to J. C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anstrom DM, 2006, PROTEIN SCI, V15, P2002, DOI 10.1110/ps.062300206; Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381; Chen HJ, 2015, DRUG DISCOV TODAY, V20, P105, DOI 10.1016/j.drudis.2014.09.015; Ciulli A, 2007, CURR OPIN BIOTECH, V18, P489, DOI 10.1016/j.copbio.2007.09.003; CLARK JD, 1988, BIOCHEMISTRY-US, V27, P5961, DOI 10.1021/bi00416a020; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hartshorn MJ, 2005, J MED CHEM, V48, P403, DOI 10.1021/jm0495778; Howard BR, 2000, BIOCHEMISTRY-US, V39, P3156, DOI 10.1021/bi992519h; Howard N, 2006, J MED CHEM, V49, P1346, DOI 10.1021/jm050850v; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Karumudi B., 2012, 244 ACS NAT M EXP PH; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-1; Kozakov D, 2015, P NATL ACAD SCI USA, V112, pE2585, DOI 10.1073/pnas.1501567112; Krieger IV, 2012, CHEM BIOL, V19, P1556, DOI 10.1016/j.chembiol.2012.09.018; Lohman JR, 2008, PROTEIN SCI, V17, P1935, DOI 10.1110/ps.036269.108; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Murray CW, 2010, J MED CHEM, V53, P5942, DOI 10.1021/jm100059d; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quartararo CE, 2011, BIOCHEMISTRY-US, V50, P6879, DOI 10.1021/bi2007299; Rhee KY, 2011, TRENDS MICROBIOL, V19, P307, DOI 10.1016/j.tim.2011.03.008; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Saxty G, 2007, J MED CHEM, V50, P2293, DOI 10.1021/jm070091b; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200	35	18	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27421	27432		10.1074/jbc.M116.750877	http://dx.doi.org/10.1074/jbc.M116.750877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27738104	hybrid, Green Published			2022-12-28	WOS:000391576300037
J	Seifert, EL; Gal, A; Acoba, MG; Li, QP; Anderson-Pullinger, L; Golenar, T; Moffat, C; Sondheimer, N; Claypool, SM; Hajnoczky, G				Seifert, Erin L.; Gal, Aniko; Acoba, Michelle G.; Li, Qipei; Anderson-Pullinger, Lauren; Golenar, Tunde; Moffat, Cynthia; Sondheimer, Neal; Claypool, Steven M.; Hajnoczky, Gyorgy			Natural and Induced Mitochondrial Phosphate Carrier Loss DIFFERENTIAL DEPENDENCE OF MITOCHONDRIAL METABOLISM AND DYNAMICS AND CELL SURVIVAL ON THE EXTENT OF DEPLETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; RAT-LIVER MITOCHONDRIA; ATP SYNTHASOME; YEAST MITOCHONDRIA; P-I; FUSION; DEFICIENCY; EXPRESSION; MYOPATHY; CARDIOMYOPATHY	The relevance of mitochondrial phosphate carrier (PiC), encoded by SLC25A3, in bioenergetics is well accepted. However, little is known about the mechanisms mediating the cellular impairments induced by pathological SLC25A3 variants. To this end, we investigated the pathogenicity of a novel compound heterozygous mutation in SLC25A3. First, each variant was modeled in yeast, revealing that substituting GSSAS for QIP within the fifth matrix loop is incompatible with survival on non-fermentable substrate, whereas the L200W variant is functionally neutral. Next, using skin fibroblasts from an individual expressing these variants and HeLa cells with varying degrees of PiC depletion, PiC loss of similar to 60% was still compatible with uncompromised maximal oxidative phosphorylation (oxphos), whereas lower maximal oxphos was evident at similar to 85% PiC depletion. Furthermore, intact mutant fibroblasts displayed suppressed mitochondrial bioenergetics consistent with a lower substrate availability rather than phosphate limitation. This was accompanied by slowed proliferation in glucose-replete medium; however, proliferation ceased when only mitochondrial substrate was provided. Both mutant fibroblasts and HeLa cells with 60% PiC loss showed a less interconnected mitochondrial network and a mitochondrial fusion defect that is not explained by altered abundance of OPA1 or MFN1/2 or relative amount of different OPA1 forms. Altogether these results indicate that PiC depletion may need to be profound (>85%) to substantially affect maximal oxphos and that pathogenesis associated with PiC depletion or loss of function may be independent of phosphate limitation when ATP requirements are not high.	[Seifert, Erin L.; Gal, Aniko; Li, Qipei; Anderson-Pullinger, Lauren; Golenar, Tunde; Moffat, Cynthia; Hajnoczky, Gyorgy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Imaging Res & Diagnost, Philadelphia, PA 19107 USA; [Acoba, Michelle G.; Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Sondheimer, Neal] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Sondheimer, Neal] Univ Toronto, Dept Paediat, Toronto, ON M5G 1X8, Canada	Jefferson University; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Seifert, EL; Hajnoczky, G (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Imaging Res & Diagnost, Philadelphia, PA 19107 USA.	erin.seifert@jefferson.edu; gyorgy.hajnoczky@jefferson.edu	Sondheimer, Neal/X-7846-2019; Acoba, Michelle Grace/S-4973-2016	Acoba, Michelle Grace/0000-0002-0768-069X; Claypool, Steven/0000-0001-5316-1623; Sondheimer, Neal/0000-0001-9982-5712	United Mitochondrial Disease Foundation [14-145R]; National Institutes of Health [R01HL108882]; Hungarian-American Enterprise Scholarship Fund international research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051526] Funding Source: NIH RePORTER	United Mitochondrial Disease Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian-American Enterprise Scholarship Fund international research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by United Mitochondrial Disease Foundation Grant 14-145R (to E. L. S.) and National Institutes of Health Grant R01HL108882 (to S. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a Hungarian-American Enterprise Scholarship Fund international research fellowship.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; Bhoj EJ, 2015, JIMD REP, V19, P59, DOI 10.1007/8904_2014_364; Burelle Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120767; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Cotticelli MG, 2015, J BIOMOL SCREEN, V20, P1084, DOI 10.1177/1087057115600433; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; DOLCE V, 1994, J BIOL CHEM, V269, P10451; Dolce V, 1996, FEBS LETT, V399, P95, DOI 10.1016/S0014-5793(96)01294-X; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Guillery O, 2008, NEUROMUSCULAR DISORD, V18, P319, DOI 10.1016/j.nmd.2007.12.008; Gutierrez-Aguilar M, 2014, J MOL CELL CARDIOL, V72, P316, DOI 10.1016/j.yjmcc.2014.04.008; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUCKRIEDE A, 1995, VIRCHOWS ARCH, V427, P159; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; LIGETI E, 1985, BIOCHEMISTRY-US, V24, P4423, DOI 10.1021/bi00337a025; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Moffat C, 2014, J LIPID RES, V55, P2458, DOI 10.1194/jlr.M046961; Nuskova H, 2015, BIOCHEM BIOPH RES CO, V464, P787, DOI 10.1016/j.bbrc.2015.07.034; PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; RIEZMAN H, 1983, EMBO J, V2, P1105, DOI 10.1002/j.1460-2075.1983.tb01553.x; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240; Seifert EL, 2015, BIOCHEM BIOPH RES CO, V464, P369, DOI 10.1016/j.bbrc.2015.06.031; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Zara V, 1996, MOL CELL BIOL, V16, P6524	38	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26126	26137		10.1074/jbc.M116.744714	http://dx.doi.org/10.1074/jbc.M116.744714			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780865	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000390345200030
J	Memmer, S; Weil, S; Beyer, S; Zoller, T; Peters, E; Hartmann, J; Steinle, A; Koch, J				Memmer, Stefanie; Weil, Sandra; Beyer, Steffen; Zoeller, Tobias; Peters, Eike; Hartmann, Jessica; Steinle, Alexander; Koch, Joachim			The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cell surface receptor; membrane protein; natural killer cells (NK cells); protein-protein interaction; receptor modification; receptor regulation	NATURAL-KILLER-CELLS; N-GLYCOSYLATION MUTAGENESIS; CYTOTOXICITY RECEPTOR NKP30; T-CELLS; SURFACE EXPRESSION; IMMUNOGLOBULIN SUPERFAMILY; INHIBITORY LIGAND; ANION-EXCHANGER; TCR/CD3 COMPLEX; TUMOR-CELLS	The natural cytotoxicity receptor (NCR) NKp30 (CD337) is a key player for NK cell immunosurveillance of infections and cancer. The molecular details of ligand recognition and its connection to CD3 signaling remain unsolved. Here, we show that the stalk domain ((129)KEHPQLGAGTVLLLR(143)) of NKp30 is very sensitive to sequence alterations, as mutations lead to impaired ligand binding and/or signaling capacity. Surprisingly, the stalk domains of NKp30 and NKp46, another NCR employing CD3 for signaling, were not exchangeable without drastic deficiencies in folding, plasma membrane targeting, and/or ligand-induced receptor signaling. Further mutational studies, N-glycosylation mapping, and plasma membrane targeting studies in the absence and presence of CD3 suggest two interconvertible types of NCR-CD3 assemblies: 1) a signaling incompetent structural NKp30-CD3 complex and 2) a ligand-induced signaling competent NKp30-CD3 complex. Moreover, we propose that ligand binding triggers translocation of Arg-143 from the membrane interface into the membrane to enable alignment with oppositely charged aspartate residues within CD3 and activation of CD3-signaling.	[Memmer, Stefanie; Weil, Sandra; Koch, Joachim] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Med Ctr, D-55131 Mainz, Germany; [Memmer, Stefanie; Weil, Sandra; Beyer, Steffen; Peters, Eike; Koch, Joachim] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany; [Zoeller, Tobias; Steinle, Alexander] Goethe Univ Frankfurt Main, Inst Mol Med, D-60528 Frankfurt, Germany; [Peters, Eike] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Hartmann, Jessica] Paul Ehrlich Inst, Div Mol Biotechnol & Gene Therapy, D-63225 Langen, Germany; [Koch, Joachim] LOEWE Excellence Ctr Cell & Gene Therapy, D-60590 Frankfurt, Germany	Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Swiss Federal Institutes of Technology Domain; ETH Zurich; Paul Ehrlich Institute	Koch, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Med Ctr, D-55131 Mainz, Germany.; Koch, J (corresponding author), Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany.; Koch, J (corresponding author), LOEWE Excellence Ctr Cell & Gene Therapy, D-60590 Frankfurt, Germany.	joachim.koch@uni-mainz.de	Hartmann, Jessica/AAL-8849-2021	Hartmann, Jessica/0000-0001-9372-8954; Steinle, Alexander/0000-0001-5081-8503	Deutsche Forschungsgemeinschaft [KO 4368/3-1]; Hessisches Ministerium fur Wissenschaft und Kunst (HMWK) [III L 4-518/17.004]; Alfons und Gertrud Kassel-Stiftung; Research Support Foundation (Vaduz, Switzerland); Uniscientia Stiftung (Vaduz, Switzerland)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hessisches Ministerium fur Wissenschaft und Kunst (HMWK); Alfons und Gertrud Kassel-Stiftung; Research Support Foundation (Vaduz, Switzerland); Uniscientia Stiftung (Vaduz, Switzerland)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (KO 4368/3-1), the LOEWE Center for Cell and Gene Therapy Frankfurt supported by Hessisches Ministerium fur Wissenschaft und Kunst (HMWK) funding reference number III L 4-518/17.004 (2010), the Alfons und Gertrud Kassel-Stiftung, the Research Support Foundation (Vaduz, Switzerland), and the Uniscientia Stiftung (Vaduz, Switzerland). The authors declare that they have no conflicts of interest with the contents of this article.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Arnaud J, 1996, J IMMUNOL, V156, P2155; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Baychelier F, 2013, BLOOD, V122, P2935, DOI 10.1182/blood-2013-03-489054; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Binici J, 2013, J BIOL CHEM, V288, P34295, DOI 10.1074/jbc.M113.483602; Bolliger L, 1997, MOL IMMUNOL, V34, P819, DOI 10.1016/S0161-5890(97)00122-3; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Cheung JC, 2005, MOL MEMBR BIOL, V22, P203, DOI 10.1080/09687860500093115; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Herrmann J, 2014, J BIOL CHEM, V289, P765, DOI 10.1074/jbc.M113.514786; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; JOHN S, 1989, EUR J IMMUNOL, V19, P335, DOI 10.1002/eji.1830190218; Joyce MG, 2011, P NATL ACAD SCI USA, V108, P6223, DOI 10.1073/pnas.1100622108; KAPPES DJ, 1991, P NATL ACAD SCI USA, V88, P10619, DOI 10.1073/pnas.88.23.10619; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li YL, 2011, J EXP MED, V208, P703, DOI 10.1084/jem.20102548; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Popov M, 1999, BIOCHEM J, V339, P269, DOI 10.1042/0264-6021:3390269; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wang W, 2014, J BIOL CHEM, V289, P33311, DOI 10.1074/jbc.M114.603464	41	6	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25427	25438		10.1074/jbc.M116.742981	http://dx.doi.org/10.1074/jbc.M116.742981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27754869	Green Published, hybrid			2022-12-28	WOS:000390095300013
J	Wang, J; Zhao, SS; Wei, Y; Zhou, Y; Shore, P; Deng, WS				Wang, Juan; Zhao, Shasha; Wei, Yun; Zhou, Ying; Shore, Paul; Deng, Wensheng			Cytoskeletal Filamin A Differentially Modulates RNA Polymerase III Gene Transcription in Transformed Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGEN RECEPTOR; PROSTATE-CANCER; CORE PROMOTER; TRNASCAN-SE; EXPRESSION; LOCALIZATION; ACTIVATION; CYTOPLASM; TUMORS	Cytoskeletal filamin A (FLNA) is an important protein involved in multiple cellular processes. Previous studies have shown that FLNA can promote or inhibit cancer growth and development; however, the mechanisms underlying these events are not fully understood. Here we show that, in both 293T and SaOS2 cells, knockdown of FLNA significantly enhanced transcription of RNA polymerase (pol) III-transcribed genes except for a subset of tRNA genes. In contrast, re-expression of FLNA in an FLNA-deficient melanoma cell line (A7) repressed transcription of all pol III-transcribed genes, suggesting that FLNA inhibits pol III transcription in a cell type-specific manner. Chromatin immunoprecipitation assays revealed that the repression of pol III gene transcription by FLNA correlates with the decreased occupancy of the RNA pol III transcription machinery at promoters. Immunofluorescence microscopy and coimmunoprecipitation assays revealed that FLNA can associate with the RNA pol III transcription machinery through its actin-binding domain within nuclei. Mechanistic analysis revealed that FLNA suppresses pol III gene transcription by confining the recruitment of the RNA pol III transcription machinery at the promoters of the genes that are sensitive to the alteration of FLNA expression. These findings not only extend the understanding of FLNA function in cells but also provide novel insights into the mechanism by which FLNA represses cell proliferation.	[Wang, Juan; Zhao, Shasha; Wei, Yun; Zhou, Ying; Deng, Wensheng] Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 430065, Hubei Province, Peoples R China; [Shore, Paul] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Wuhan University of Science & Technology; University of Manchester	Deng, WS (corresponding author), Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 430065, Hubei Province, Peoples R China.; Shore, P (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	paul.shore@manchester.ac.u; dengwensheng@wust.edu.cn		Shore, Paul/0000-0002-1832-5976	National Natural Science Foundation of China [31271395]; WorldWide Cancer Research Project [09-0208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); WorldWide Cancer Research Project	This work was supported by National Natural Science Foundation of China Project 31271395 (to W. D.) and WorldWide Cancer Research Project 09-0208 (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrass CK, 2010, J BIOL CHEM, V285, P12925, DOI 10.1074/jbc.M109.061754; Berry FB, 2005, MOL CELL BIOL, V25, P1415, DOI 10.1128/MCB.25.4.1415-1424.2005; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Chen W, 1997, J PATHOL, V183, P345, DOI 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8; Deng WS, 2012, P NATL ACAD SCI USA, V109, P1524, DOI 10.1073/pnas.1107879109; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Grewal SS, 2015, BBA-GENE REGUL MECH, V1849, P898, DOI 10.1016/j.bbagrm.2014.12.005; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Jacquemet G, 2013, J CELL SCI, V126, P4121, DOI 10.1242/jcs.121988; Kim EJ, 2007, BIOCHEM BIOPH RES CO, V362, P1101, DOI 10.1016/j.bbrc.2007.08.148; Nguyen LXT, 2014, BLOOD, V124, P579, DOI 10.1182/blood-2013-12-544726; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Ma BC, 2002, MOL CELL BIOL, V22, P8067, DOI 10.1128/MCB.22.22.8067-8078.2002; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Mooso BA, 2012, ENDOCR-RELAT CANCER, V19, P759, DOI 10.1530/ERC-12-0171; Qiu H, 2011, BIOSCI BIOTECH BIOCH, V75, P145, DOI 10.1271/bbb.100567; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Savoy RM, 2015, ENDOCR-RELAT CANCER, V22, P369, DOI 10.1530/ERC-15-0021; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shivaswamy S, 2004, MOL CELL BIOL, V24, P3596, DOI 10.1128/MCB.24.9.3596-3606.2004; Uramoto H, 2010, ANTICANCER RES, V30, P3939; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Yuan Y, 2001, J BIOL CHEM, V276, P48318, DOI 10.1074/jbc.M102557200; Zhang J. Q., 2013, ADV MATER SCI ENG, V2013, P2, DOI DOI 10.1371/J0URNAL.P0NE.0057251; Zhang K, 2014, J CANCER RES CLIN, V140, P1913, DOI 10.1007/s00432-014-1722-3; Zheng XW, 2014, P NATL ACAD SCI USA, V111, P2560, DOI 10.1073/pnas.1320815111; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	36	9	10	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25239	25246		10.1074/jbc.M116.735886	http://dx.doi.org/10.1074/jbc.M116.735886			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27738102	Green Published, hybrid			2022-12-28	WOS:000388880100037
J	Zhang, HM; Hua, Y; Li, R; Kong, DC				Zhang, Huimin; Hua, Yu; Li, Rui; Kong, Daochun			Cdc24 Is Essential for Long-range End Resection in the Repair of Double-stranded DNA Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; STALLED REPLICATION FORKS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; S-PHASE; GENE CONVERSION; RECOMBINATION; MRE11-RAD50-XRS2; NUCLEASES; MECHANISM	Double-stranded DNA breaks (DSBs) are highly detrimental DNA lesions, which may be repaired by the homologous recombination-mediated repair pathway. The 5' to 3' direction of long-range end resection on one DNA strand, in which 3'-single-stranded DNA overhangs are created from broken DNA ends, is an essential step in this pathway. Dna2 has been demonstrated as an essential nuclease in this event, but the molecular mechanism of how Dna2 is recruited to DNA break sites in vivo has not been elucidated. In this study, a novel recombination factor called Cdc24 was identified in fission yeast. We demonstrated that Cdc24 localizes to DNA break sites during the repair of DNA breaks and is an essential factor in long-range end resection. We also determined that Cdc24 plays a direct role in recruiting Dna2 to DNA break sites through its interaction with Dna2 and replication protein A (RPA). Further, this study revealed that RPA acts as the foundation for assembling the machinery for long-range end resection by its essential role in recruiting Cdc24 and Dna2 to DNA break sites. These results define Cdc24 as an essential factor for long-range end resection in the repair of DSBs, opening the door for further investigations into the enzymes involved in long-range end resection for DSB repair.	[Zhang, Huimin; Hua, Yu; Li, Rui; Kong, Daochun] Peking Univ, Coll Life Sci, Natl Lab Prot & Plant Gene Res, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University	Kong, DC (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Prot & Plant Gene Res, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	kongdc@pku.edu.cn			National Natural Science Foundation of China [31230021]; Ministry of Science and Technology of China [2013CB911000]; Peking-Tsinghua Center for Life Sciences; National Key Laboratory of Protein and Plant Gene Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Peking-Tsinghua Center for Life Sciences; National Key Laboratory of Protein and Plant Gene Research	This work was supported by Grant 31230021 from the National Natural Science Foundation of China and Grant 2013CB911000 from the Ministry of Science and Technology of China. This work also was supported by grants from the Peking-Tsinghua Center for Life Sciences and the National Key Laboratory of Protein and Plant Gene Research. The authors declare that they have no conflicts of interest with the contents of this article.	Andres SN, 2015, NAT STRUCT MOL BIOL, V22, P158, DOI 10.1038/nsmb.2945; Blackwood JK, 2013, BIOCHEM SOC T, V41, P314, DOI 10.1042/BST20120307; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka P, 2015, J BIOL CHEM, V290, P22931, DOI 10.1074/jbc.R115.675942; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Chiruvella K. K., 2013, COLD SPRING HARB PER, V5; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Davies OR, 2015, NAT STRUCT MOL BIOL, V22, P150, DOI 10.1038/nsmb.2937; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gould KL, 1998, GENETICS, V149, P1221; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nanbu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140456; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Osman F, 2016, SCI REP-UK, V6, DOI 10.1038/srep22837; Prakash Aishwarya, 2012, Subcell Biochem, V62, P171, DOI 10.1007/978-94-007-4572-8_10; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; STRATHERN JN, 1995, GENETICS, V140, P965; Symington LS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016436; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tanaka H, 2004, NUCLEIC ACIDS RES, V32, P6367, DOI 10.1093/nar/gkh963; Tanaka H, 1999, MOL CELL BIOL, V19, P1038; Tinline-Purvis H, 2009, EMBO J, V28, P3400, DOI 10.1038/emboj.2009.265; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yu Y, 2013, DNA REPAIR, V12, P433, DOI 10.1016/j.dnarep.2013.04.001; Zhang J, 2014, ELECTRON J DIFFER EQ; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	41	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24961	24973		10.1074/jbc.M116.755991	http://dx.doi.org/10.1074/jbc.M116.755991			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27729451	Green Published, hybrid			2022-12-28	WOS:000388880100015
J	Harris, DT; Wang, NY; Riley, TP; Anderson, SD; Singh, NK; Procko, E; Baker, BM; Kranz, DM				Harris, Daniel T.; Wang, Ningyan; Riley, Timothy P.; Anderson, Scott D.; Singh, Nishant K.; Procko, Erik; Baker, Brian M.; Kranz, David M.			Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SURFACE-DISPLAY; DIRECTED EVOLUTION; IN-VITRO; COMPUTATIONAL DESIGN; THERMAL-STABILITY; PROTEIN FUNCTION; SPECIFICITY; EXPRESSION; INTERFACE; BINDING	Proteins are often engineered to have higher affinity for their ligands to achieve therapeutic benefit. For example, many studies have used phage or yeast display libraries of mutants within complementarity-determining regions to affinity mature antibodies and T cell receptors (TCRs). However, these approaches do not allow rapid assessment or evolution across the entire interface. By combining directed evolution with deep sequencing, it is now possible to generate sequence fitness landscapes that survey the impact of every amino acid substitution across the entire protein-protein interface. Here we used the results of deep mutational scans of a TCR-peptide-MHC interaction to guide mutational strategies. The approach yielded stable TCRs with affinity increases of >200-fold. The substitutions with the greatest enrichments based on the deep sequencing were validated to have higher affinity and could be combined to yield additional improvements. We also conducted in silico binding analyses for every substitution to compare them with the fitness landscape. Computational modeling did not effectively predict the impacts of mutations distal to the interface and did not account for yeast display results that depended on combinations of affinity and protein stability. However, computation accurately predicted affinity changes for mutations within or near the interface, highlighting the complementary strengths of computational modeling and yeast surface display coupled with deep mutational scanning for engineering high affinity TCRs.	[Harris, Daniel T.; Wang, Ningyan; Anderson, Scott D.; Procko, Erik; Kranz, David M.] Univ Illinois, Dept Biochem, 600 S Matthews Ave, Urbana, IL 61801 USA; [Riley, Timothy P.; Singh, Nishant K.; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46557 USA; [Riley, Timothy P.; Singh, Nishant K.; Baker, Brian M.] Univ Notre Dame, Harper Canc Res Inst, South Bend, IN 46557 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame; University of Notre Dame	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, 600 S Matthews Ave, Urbana, IL 61801 USA.	d-kranz@illinois.edu	Singh, Nishant/ABB-3749-2020	Procko, Erik/0000-0002-0028-490X	National Institutes of Health [CA178844, CA187592, GM118166, CA180723]; Indiana CTSI - National Institutes of Health [UL1TR001108]; NATIONAL CANCER INSTITUTE [R01CA178844, R21CA187592, F30CA180723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana CTSI - National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA178844 and CA187592 (to D. M. K.), GM118166 (to B. M. B.), and CA180723 (to D. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a fellowship from the Indiana CTSI, funded in part by National Institutes of Health Grant UL1TR001108.	Aggen DH, 2011, PROTEIN ENG DES SEL, V24, P361, DOI 10.1093/protein/gzq113; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Harris DT, 2016, STRUCTURE, V24, P1142, DOI 10.1016/j.str.2016.04.011; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Honegger A, 2009, PROTEIN ENG DES SEL, V22, P121, DOI 10.1093/protein/gzn077; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kieke MC, 2001, J MOL BIOL, V307, P1305, DOI 10.1006/jmbi.2001.4560; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Li ZX, 2013, ANNU REV BIOPHYS, V42, P315, DOI 10.1146/annurev-biophys-083012-130315; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Nielsen JE, 2011, PROTEINS, V79, P3249, DOI 10.1002/prot.23194; Orr BA, 2003, BIOTECHNOL PROGR, V19, P631, DOI 10.1021/bp0200797; Park S, 2006, PROTEIN ENG DES SEL, V19, P211, DOI 10.1093/protein/gzl003; Pierce BG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003478; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; REYNOLDS JA, 1974, P NATL ACAD SCI USA, V71, P2925, DOI 10.1073/pnas.71.8.2925; Riley TP, 2016, PROTEIN ENG DES SEL, V29, P595, DOI 10.1093/protein/gzw050; Riley TP, 2016, METHODS MOL BIOL, V1414, P319, DOI 10.1007/978-1-4939-3569-7_19; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Schmitt TM, 2013, BLOOD, V122, P348, DOI 10.1182/blood-2013-01-478164; Schreiber G, 2013, CURR OPIN STRUC BIOL, V23, P903, DOI 10.1016/j.sbi.2013.08.003; Shultzaberger RK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001042; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Smith SN, 2015, METHODS MOL BIOL, V1319, P95, DOI 10.1007/978-1-4939-2748-7_6; Smith SN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6223; Smith SN, 2013, J MOL BIOL, V425, P4496, DOI 10.1016/j.jmb.2013.08.007; Starwalt SE, 2003, PROTEIN ENG, V16, P147, DOI 10.1093/proeng/gzg018; Stone JD, 2011, J IMMUNOL, V187, P6281, DOI 10.4049/jimmunol.1101734; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Thiltgen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046084; Traxlmayr MW, 2012, J MOL BIOL, V423, P397, DOI 10.1016/j.jmb.2012.07.017; Traxlmayr MW, 2012, ARCH BIOCHEM BIOPHYS, V526, P174, DOI 10.1016/j.abb.2012.04.022; Van Deventer JA, 2014, METHODS MOL BIOL, V1131, P151, DOI 10.1007/978-1-62703-992-5_10; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102	62	30	31	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24566	24578		10.1074/jbc.M116.748681	http://dx.doi.org/10.1074/jbc.M116.748681			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27681597	Green Published, hybrid			2022-12-28	WOS:000388875500019
J	Liu, SS; Long, JY; Yuan, B; Zheng, MJ; Xiao, M; Xu, JM; Lin, X; Feng, XH				Liu, Sisi; Long, Jianyin; Yuan, Bo; Zheng, Mingjie; Xiao, Mu; Xu, Jianming; Lin, Xia; Feng, Xin-Hua			SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-beta Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; BONE METASTASIS; SIGNAL-TRANSDUCTION; CELL-CYCLE; CANCER; SNIP1; SUMOYLATION; GROWTH; DOMAIN; LUNG	SNIP1 (Smad nuclear interacting protein 1) is a transcription repressor for the TGE-beta and NE-kappa B signaling pathways through disrupting the recruitment of co-activator p300. However, it is unclear how the functions of SNIP1 in the TGE-beta signaling pathway are controlled. Our present studies show that SNIP1 is covalently modified by small ubiquitin-like modifier (SUMO) in vitro and in vivo at three lysine sites: Lys(5), Lys(30), and Lys(108), with Lys(30) being the major SUMO modification site. SUMOylation of SNIP! is enhanced by SUMO E3 ligase PIAS proteins and inhibited by SUMO proteases SENP1/2. Furthermore, we find that SUMOylation of SNIP1 attenuates its inhibitory effect in TGE-beta signaling because the SUMO-conjugated form of SNIP1 exhibits impaired ability to disrupt the formation of Smad complex and the interaction between p300 and Smads. Subsequently, SUMOylation of SNIP1 leads to the loss of SNIP1-mediated inhibition on expression of the TGF-beta target genes PAI-1 and MMP2 and eventually enhances TGE-beta-regulated cell migration and invasion.	[Liu, Sisi; Yuan, Bo; Zheng, Mingjie; Xiao, Mu; Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Sisi; Long, Jianyin; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Liu, Sisi; Xu, Jianming; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Long, Jianyin] Univ Texas MD Anderson Canc Ctr, Nephrol Sect, Dept Emergency Med, Houston, TX 77030 USA	Zhejiang University; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Feng, XH (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	fenglab@zju.edu.cn		Zheng, Mingjie/0000-0003-0735-3995; Xiao, Mu/0000-0003-3058-2905	Key Program of the Ministry of Sciences and Technology [2012CB966600]; National Natural Science Foundation of China [91540205, 31571447]; Major Program of the National Natural Science Foundation of China [31090360]; Fundamental Research Funds for the Central Universities; Department of Defense [DAMD W81XWH-15-1-0650]; National Institutes of Health [R21CA209007, R01GM63773, R01AR053591, R01CA108454, R01DK073932]; NATIONAL CANCER INSTITUTE [R21CA209007, R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	Key Program of the Ministry of Sciences and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Key Program of the Ministry of Sciences and Technology Grant 2012CB966600, National Natural Science Foundation of China Grants 91540205 and 31571447, Major Program of the National Natural Science Foundation of China Grant 31090360, the Fundamental Research Funds for the Central Universities, Department of Defense Grant DAMD W81XWH-15-1-0650, and National Institutes of Health Grants R21CA209007, R01GM63773, R01AR053591, R01CA108454, and R01DK073932. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bonacci T, 2014, J PROTEOME RES, V13, P2478, DOI 10.1021/pr401258d; Chan HM, 2001, J CELL SCI, V114, P2363; Choi SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10384; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Fang YZ, 2013, JNCI-J NATL CANCER I, V105, P47, DOI 10.1093/jnci/djs485; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng YL, 2014, J BIOL CHEM, V289, P2072, DOI 10.1074/jbc.M113.526905; Fujii M, 2006, MOL CELL, V24, P771, DOI 10.1016/j.molcel.2006.11.006; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kim RH, 2001, J BIOL CHEM, V276, P46297, DOI 10.1074/jbc.M103819200; Kim RH, 2000, GENE DEV, V14, P1605; Li JS, 2015, ONCOTARGET, V6, P6749, DOI 10.18632/oncotarget.3155; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li Z, 2012, CURR MOL MED, V12, P967, DOI 10.2174/156652412802480871; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Lin Y, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-15; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Roche KC, 2007, ONCOGENE, V26, P4523, DOI 10.1038/sj.onc.1210233; Roche KC, 2004, ONCOGENE, V23, P8185, DOI 10.1038/sj.onc.1208025; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zheng C, 2014, J MED CHEM, V57, P600, DOI 10.1021/jm401117t	38	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24418	24430		10.1074/jbc.M116.755850	http://dx.doi.org/10.1074/jbc.M116.755850			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703003	hybrid, Green Published			2022-12-28	WOS:000388875500008
J	Ratha, BN; Ghosh, A; Brender, JR; Gayen, N; Ilyas, H; Neeraja, C; Das, KP; Mandal, AK; Bhunia, A				Ratha, Bhisma N.; Ghosh, Anirban; Brender, Jeffrey R.; Gayen, Nilanjan; Ilyas, Humaira; Neeraja, Chilukoti; Das, Kali P.; Mandal, Atin K.; Bhunia, Anirban			Inhibition of Insulin Amyloid Fibrillation by a Novel Amphipathic Heptapeptide: MECHANISTIC DETAILS STUDIED BY SPECTROSCOPY IN COMBINATION WITH MICROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; atomic force microscopy (AFM); fluorescence anisotropy; inhibitor; insulin	TRANSFER DIFFERENCE NMR; AGGREGATION PATHWAYS; BETA FIBRILS; PROTEINS; BINDING; LIGAND; FIBRILLIZATION; STABILIZATION; ASSIGNMENT; DYNAMICS	The aggregation of insulin into amyloid fibers has been a limiting factor in the development of fast acting insulin analogues, creating a demand for excipients that limit aggregation. Despite the potential demand, inhibitors specifically targeting insulin have been few in number. Here we report a non-toxic and serum stable-designed heptapeptide, KR7 (KPWWPRR-NH2), that differs significantly from the primarily hydrophobic sequences that have been previously used to interfere with insulin amyloid fibrillation. Thioflavin T fluorescence assays, circular dichroism spectroscopy, and one-dimensional proton NMR experiments suggest KR7 primarily targets the fiber elongation step with little effect on the early oligomerization steps in the lag time period. From confocal fluorescence and atomic force microscopy experiments, the net result appears to be the arrest of aggregation in an early, non-fibrillar aggregation stage. This mechanism is noticeably different from previous peptide-based inhibitors, which have primarily shifted the lag time with little effect on later stages of aggregation. As insulin is an important model system for understanding protein aggregation, the new peptide may be an important tool for understanding peptide-based inhibition of amyloid formation.	[Ratha, Bhisma N.; Ghosh, Anirban; Ilyas, Humaira; Bhunia, Anirban] Bose Inst, Dept Biophys, P 1-12 CIT Scheme 7 M, Kolkata 700054, India; [Gayen, Nilanjan; Mandal, Atin K.] Bose Inst, Dept Mol Med, P 1-12 CIT Scheme 7 M, Kolkata 700054, India; [Brender, Jeffrey R.] NIH, Radiat Biol Branch, Bethesda, MD 20814 USA; [Neeraja, Chilukoti] TIFR Ctr Interdisciplinary Sci TCIS, Hyderabad 500075, Andhra Pradesh, India; [Das, Kali P.] Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; National Institutes of Health (NIH) - USA; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad; Department of Science & Technology (India); Bose Institute	Bhunia, A (corresponding author), Bose Inst, Dept Biophys, P 1-12 CIT Scheme 7 M, Kolkata 700054, India.	anirbanbhunia@gmail.com	Ghosh, Anirban/S-9315-2017; RATHA, BHISMA NARAYAN/ABF-1767-2020	Ghosh, Anirban/0000-0001-9837-3339; RATHA, BHISMA NARAYAN/0000-0002-0829-1637; Ilyas, Humaira/0000-0002-5784-9086; Bhunia, Anirban/0000-0002-8752-2842; brender, jeffrey/0000-0001-7487-6169; Das, Kali/0000-0001-7686-9077	DBT, Government of India [BT/PR3106/INF/22/138/2011]	DBT, Government of India(Department of Biotechnology (DBT) India)	A. B. acknowledges DBT, Government of India, for infrastructure development Fund BT/PR3106/INF/22/138/2011 to the Bose Institute for procuring a 700-MHz NMR spectrometer with cryoprobe. Central Instrument Facility (CIF) of Bose Institute is greatly acknowledged.	Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Brender JR, 2013, CHEM COMMUN, V49, P3339, DOI 10.1039/c3cc40383a; Choudhary S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17599; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Crespo R, 2016, J BIOL CHEM, V291, P2018, DOI 10.1074/jbc.M115.699348; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Erlkamp M, 2014, J PHYS CHEM B, V118, P3310, DOI 10.1021/jp500530h; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghosh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135976; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Goddard T. D., 2014, SPARKY LINUX 2 6 18, V3, P115; Gong H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05648; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Guilhem I, 2006, DIABETES METAB, V32, P279, DOI 10.1016/S1262-3636(07)70281-1; Gupta Yashdeep, 2015, Indian J Endocrinol Metab, V19, P174, DOI 10.4103/2230-8210.146879; Hackl EV, 2015, EUR BIOPHYS J BIOPHY, V44, P249, DOI 10.1007/s00249-015-1019-8; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, 1990, BIOCHEMISTRY-US, V29, P10545, DOI 10.1021/bi00498a018; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Jakhria T, 2014, J BIOL CHEM, V289, P35781, DOI 10.1074/jbc.M114.586222; Javid N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.028101; Jenssen H., 2008, SERUM STABILITY PEPT, V494, P171; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kar RK, 2016, BIOMACROMOLECULES, V17, P1998, DOI 10.1021/acs.biomac.6b00165; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kurouski D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036989; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Lorenzen K, 2012, J CHEM THEORY COMPUT, V8, P3628, DOI 10.1021/ct300080n; Viet MH, 2015, J PHYS CHEM B, V119, P5145, DOI 10.1021/acs.jpcb.5b00006; Marti-Aluja I, 2013, CHEMOMETR INTELL LAB, V127, P49, DOI 10.1016/j.chemolab.2013.05.015; Matthes D, 2014, J MOL BIOL, V426, P362, DOI 10.1016/j.jmb.2013.10.020; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Mishra NK, 2015, J PHYS CHEM B, V119, P15395, DOI 10.1021/acs.jpcb.5b08215; Murray B, 2015, LANGMUIR, V31, P4246, DOI 10.1021/acs.langmuir.5b00254; Nagase T, 2014, AM J MED, V127, P450, DOI 10.1016/j.amjmed.2013.10.029; Olsen HB, 1998, J MOL BIOL, V284, P477, DOI 10.1006/jmbi.1998.2175; Patel HR, 2014, J PHYS CHEM LETT, V5, P1864, DOI 10.1021/jz5001775; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; Selivanova OM, 2014, J PHYS CHEM B, V118, P1198, DOI 10.1021/jp4083568; Smirnovas V, 2008, BIOPHYS J, V94, P3241, DOI 10.1529/biophysj.107.123133; Smirnovas V, 2006, CHEMPHYSCHEM, V7, P1046, DOI 10.1002/cphc.200500717; Smith RAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132309; Tu LH, 2015, BIOCHEMISTRY-US, V54, P666, DOI 10.1021/bi501016r; Valipour M, 2015, INT J BIOL MACROMOL, V80, P610, DOI 10.1016/j.ijbiomac.2015.07.030; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wang JB, 2011, BIOCHEM BIOPH RES CO, V415, P675, DOI 10.1016/j.bbrc.2011.10.135; Wang SH, 2012, BIOCHEM ENG J, V63, P38, DOI 10.1016/j.bej.2012.02.002; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Woods R Jeremy, 2012, J Diabetes Sci Technol, V6, P265; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Yesuvadian R, 2014, BIOCHEM BIOPH RES CO, V447, P590, DOI 10.1016/j.bbrc.2014.04.041	66	46	46	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23545	23556		10.1074/jbc.M116.742460	http://dx.doi.org/10.1074/jbc.M116.742460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27679488	hybrid, Green Published			2022-12-28	WOS:000387884400016
J	Tillgren, V; Morgelin, M; Onnerfjord, P; Kalamajski, S; Aspberg, A				Tillgren, Viveka; Morgelin, Matthias; Onnerfjord, Patrik; Kalamajski, Sebastian; Aspberg, Anders			The Tyrosine Sulfate Domain of Fibromodulin Binds Collagen and Enhances Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix; fibromodulin; post-translational modification (PTM); protein assembly; tyrosine sulfation; fibrillogenesis	RICH REPEAT PROTEIN; MATRIX PROTEIN; EXTRACELLULAR-MATRIX; DEFICIENT MICE; I COLLAGEN; ELECTRON-MICROSCOPY; CONNECTIVE TISSUES; CROSS-LINKING; PRELP BINDS; LUMICAN	Small leucine-rich proteoglycans interact with other extracellular matrix proteins and are important regulators of matrix assembly. Fibromodulin has a key role in connective tissues, binding collagen through two identified binding sites in its leucine-rich repeat domain and regulating collagen fibril formation in vitro and in vivo. Some nine tyrosine residues in the fibromodulin N-terminal domain are O-sulfated, a posttranslational modification often involved in protein interactions. The N-terminal domain mimics heparin, binding proteins with clustered basic amino acid residues. Because heparin affects collagen fibril formation, we investigated whether tyrosine sulfate is involved in fibromodulin interactions with collagen. Using full-length fibromodulin and its N-terminal tyrosine-sulfated domain purified from tissue, as well as recombinant fibromodulin fragments, we found that the N-terminal domain binds collagen. The tyrosine-sulfated domain and the leucine-rich repeat domain both bound to three specific sites along the collagen type I molecule, at the N terminus and at 100 and 220 nm from the N terminus. The N-terminal domain shortened the collagen fibril formation lag phase and tyrosine sulfation was required for this effect. The isolated leucine-rich repeat domain inhibited the fibril formation rate, and full-length fibromodulin showed a combination of these effects. The fibrils formed in the presence of fibromodulin or its fragments showed more organized structure. Fibromodulin and its tyrosine sulfate domain remained bound on the formed fiber. Taken together, this suggests a novel, regulatory function for tyrosine sulfation in collagen interaction and control of fibril formation.	[Tillgren, Viveka; Onnerfjord, Patrik; Kalamajski, Sebastian; Aspberg, Anders] Lund Univ, Dept Clin Sci Lund Rheumatol & Mol Skeletal Biol, SE-22184 Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci Lund, Div Infect Med BMC BMC B14, SE-22184 Lund, Sweden; [Kalamajski, Sebastian] Lund Univ, Div Translat Canc Res, Dept Lab Med, Medicon Village 406-3, SE-22363 Lund, Sweden	Lund University; Lund University; Lund University	Aspberg, A (corresponding author), Lund Univ, Dept Clin Sci Lund Rheumatol & Mol Skeletal Biol, SE-22184 Lund, Sweden.	Anders.Aspberg@med.lu.se	Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937; Kalamajski, Sebastian/0000-0002-6600-9302; Aspberg, Anders/0000-0002-6588-6944; Tillgren, Viveka/0000-0003-2869-9477	Swedish Research Council; King Gustaf V's 80-years fund; Crafoord Foundation; Swedish Rheumatism association; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V's 80-years fund; Crafoord Foundation; Swedish Rheumatism association; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	This work was supported by grants from the Swedish Research Council, King Gustaf V's 80-years fund, the Crafoord Foundation, the Swedish Rheumatism association, the Greta and Johan Kock Foundation, and the Alfred Osterlund Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	ANTONSSON P, 1991, J BIOL CHEM, V266, P16859; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Day JM, 2004, J BIOL CHEM, V279, P12511, DOI 10.1074/jbc.M400242200; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; FORBES EG, 1994, FEBS LETT, V351, P433, DOI 10.1016/0014-5793(94)00907-4; FREIBERGER H, 1980, J INVEST DERMATOL, V75, P425, DOI 10.1111/1523-1747.ep12524080; Geng H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4022; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; MACBEATH JRE, 1993, J BIOL CHEM, V268, P19826; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Muller C, 2014, MATRIX BIOL, V40, P34, DOI 10.1016/j.matbio.2014.08.013; OBRINK B, 1973, EUR J BIOCHEM, V34, P129, DOI 10.1111/j.1432-1033.1973.tb02739.x; OLSEN BR, 1963, Z ZELLFORSCH MIK ANA, V59, P199, DOI 10.1007/BF00320445; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Park H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-599; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; SANANTONIO JD, 1994, GLYCOBIOLOGY, V4, P327; SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; Viola M, 2007, CONNECT TISSUE RES, V48, P141, DOI 10.1080/03008200701276133	47	15	15	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23744	23755		10.1074/jbc.M116.730325	http://dx.doi.org/10.1074/jbc.M116.730325			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634037	Green Published, hybrid			2022-12-28	WOS:000387884400034
J	Zeituni, EM; Wilson, MH; Zheng, XB; Iglesias, PA; Sepanski, MA; Siddiqi, MA; Anderson, JL; Zheng, YX; Farber, SA				Zeituni, Erin M.; Wilson, Meredith H.; Zheng, Xiaobin; Iglesias, Pablo A.; Sepanski, Michael A.; Siddiqi, Mahmud A.; Anderson, Jennifer L.; Zheng, Yixian; Farber, Steven A.			Endoplasmic Reticulum Lipid Flux Influences Enterocyte Nuclear Morphology and Lipid-dependent Transcriptional Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intestine; lipid droplet; lipoprotein; mitochondria; nucleus; apoA-IV; creb3l3; enterocyte; plin2	ELEMENT-BINDING PROTEIN; TRIGLYCERIDE TRANSFER PROTEIN; SMALL INTESTINAL ENTEROCYTES; FATTY-ACID-COMPOSITION; GENE-EXPRESSION DATA; A-IV EXPRESSION; EGG-YOLK; CHOLESTEROL ABSORPTION; MORPHOMETRIC ANALYSIS; APOA-IV	Responding to a high-fat meal requires an interplay between multiple digestive tissues, sympathetic response pathways, and the gut microbiome. The epithelial enterocytes of the intestine are responsible for absorbing dietary nutrients and preparing them for circulation to distal tissues, which requires significant changes in cellular activity, including both morphological and transcriptional responses. Following a high-fat meal, we observe morphological changes in the enterocytes of larval zebrafish, including elongation of mitochondria, formation and expansion of lipid droplets, and the rapid and transient ruffling of the nuclear periphery. Dietary and pharmacological manipulation of zebrafish larvae demonstrated that these subcellular changes are specific to triglyceride absorption. The transcriptional changes that occur simultaneously with these morphological changes were determined using RNA sequencing, revealing a cohort of up-regulated genes associated with lipid droplet formation and lipid transport via lipoprotein particles. Using a microsomal triglyceride transfer protein (MTP) inhibitor to block -lipoprotein particle formation, we demonstrate that the transcriptional response to a high-fat meal is associated with the transfer of ER triglyceride to nascent -lipoproteins, possibly through the activation of Creb3l3/cyclic AMP-responsive element-binding protein. These data suggest that a transient increase in ER lipids is the likely mediator of the initial physiological response of intestinal enterocytes to dietary lipid.	[Zeituni, Erin M.; Wilson, Meredith H.; Zheng, Xiaobin; Sepanski, Michael A.; Siddiqi, Mahmud A.; Anderson, Jennifer L.; Zheng, Yixian; Farber, Steven A.] Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA; [Iglesias, Pablo A.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Carnegie Institution for Science; Johns Hopkins University	Farber, SA (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	farber@ciwemb.edu	Iglesias, Pablo A/A-5202-2008; Farber, Steven A/G-5851-2012; Zheng, Xiaobin/AAD-7564-2019	Iglesias, Pablo A/0000-0002-0840-155X; Farber, Steven A/0000-0002-8037-7312; Wilson, Meredith/0000-0002-6152-7127	NIDDK, National Institutes of Health [F32DK109592, RO1DK093399]; NIGMS, National Institutes of Health [RO1GM63904]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK109592, R01DK093399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIDDK, National Institutes of Health, Grants F32DK109592 (to M. H. W.) and RO1DK093399 (to S. A. F.) and NIGMS, National Institutes of Health, Grant RO1GM63904 to the Zebrafish Functional Genomics Consortium (to S. Ekker and S. A. F.). This work was also supported by the G. Harold and Leila Y. Mathers Charitable Foundation (to the laboratory of S. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anderson JL, 2011, METHOD CELL BIOL, V101, P111, DOI 10.1016/B978-0-12-387036-0.00005-0; Asaoka Y, 2013, DIS MODEL MECH, V6, P905, DOI 10.1242/dmm.011981; Baek JS, 2012, CHOLESTEROL, DOI 10.1155/2012/564705; Barbosa S, 2013, TRAFFIC, V14, P382, DOI 10.1111/tra.12038; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; BOUMA ME, 1990, J LIPID RES, V31, P1; Brown R., 2007, FITCIRCLE M MATLAB C; BUSCHMANN RJ, 1981, J ULTRA MOL STRUCT R, V76, P15, DOI 10.1016/S0022-5320(81)80047-0; BUSCHMANN RJ, 1981, J ULTRA MOL STRUCT R, V76, P1, DOI 10.1016/S0022-5320(81)80046-9; CARDELL RR, 1967, J CELL BIOL, V34, P123, DOI 10.1083/jcb.34.1.123; Carten JD, 2011, DEV BIOL, V360, P276, DOI 10.1016/j.ydbio.2011.09.010; Chakraborty RD, 2007, J AGR FOOD CHEM, V55, P4043, DOI 10.1021/jf063654l; Cheng DM, 2016, J BIOL CHEM, V291, P23793, DOI 10.1074/jbc.M116.749283; Clifton JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012386; Creamer B, 1974, Biomembranes, V4A, P1; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; ELSHOURBAGY NA, 1986, J BIOL CHEM, V261, P1998; Fang LH, 2014, TRANSL RES, V163, P99, DOI 10.1016/j.trsl.2013.09.004; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; GANDER W, 1994, BIT, V34, P558, DOI 10.1007/BF01934268; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Hama K, 2009, AM J PHYSIOL-GASTR L, V296, pG445, DOI 10.1152/ajpgi.90513.2008; Hamilton RL, 1998, J LIPID RES, V39, P1543; HOGAN S, 1987, INT J OBESITY, V11, P35; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; HUSBANDS DR, 1970, BIOCHEM J, V120, P365, DOI 10.1042/bj1200365; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; JASPER DK, 1968, J CELL BIOL, V38, P277, DOI 10.1083/jcb.38.2.277; JERSILD RA, 1966, AM J ANAT, V118, P135, DOI 10.1002/aja.1001180108; JONES D, 1969, NATURE, V221, P780, DOI 10.1038/221780a0; KARATHANASIS SK, 1986, BIOCHEMISTRY-US, V25, P3962, DOI 10.1021/bi00361a034; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Otis JP, 2015, DIS MODEL MECH, V8, P295, DOI 10.1242/dmm.018754; PALAY SL, 1959, J BIOPHYS BIOCHEM CY, V5, P373, DOI 10.1083/jcb.5.3.373; Queisser G, 2011, NUCLEUS-PHILA, V2, P98, DOI 10.4161/nucl.2.2.15116; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robl JA, 2001, J MED CHEM, V44, P851, DOI 10.1021/jm000494a; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; SKELLON JH, 1962, J SCI FOOD AGR, V13, P300, DOI 10.1002/jsfa.2740130506; STOECKENIUS W, 1965, LAB INVEST, V14, P1196; Sturley SL, 2012, J LIPID RES, V53, P1800, DOI 10.1194/jlr.R028290; Thisse B, 2004, ZFIN DIRECT DATA SUB; van Heek M, 2001, DIABETES, V50, P1330, DOI 10.2337/diabetes.50.6.1330; VerHague MA, 2013, ARTERIOSCL THROM VAS, V33, P2501, DOI 10.1161/ATVBAHA.113.301948; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	60	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23804	23816		10.1074/jbc.M116.749358	http://dx.doi.org/10.1074/jbc.M116.749358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27655916	Green Published, hybrid			2022-12-28	WOS:000387884400039
J	Albracht, CD; Guzik-Lendrum, S; Rayment, I; Gilbert, SP				Albracht, Clayton D.; Guzik-Lendrum, Stephanie; Rayment, Ivan; Gilbert, Susan P.			Heterodimerization of Kinesin-2 KIF3AB Modulates Entry into the Processive Run	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATPASE PATHWAY; INTRAFLAGELLAR TRANSPORT; INTRACELLULAR-TRANSPORT; CONVENTIONAL KINESIN; SUPERFAMILY PROTEIN; MICROTUBULE MOTOR; ACCESSORY SUBUNIT; AXONAL-TRANSPORT; COILED-COIL; NECK-LINKER	Mammalian KIF3AB is an N-terminal processive kinesin-2 that is best known for its roles in intracellular transport. There has been significant interest in KIF3AB to define the key principles that underlie its processivity but also to define the mechanistic basis of its sensitivity to force. In this study, the kinetics for entry into the processive run were quantified. The results show for KIF3AB that the kinetics of microtubule association at 7 mu M-1 s(-1) is less than the rates observed for KIF3AA at 13 mu M-1 s(-1) or KIF3BB at 11.9 mu M-1 s(-1). ADP release after microtubule association for KIF3AB is 33 s(-1) and is significantly slower than ADP release from homodimeric KIF3AA and KIF3BB, which reach 80-90 s(-1). To explore the interhead communication implied by the rate differences at these first steps, we compared the kinetics of KIF3AB microtubule association followed by ADP release with the kinetics for mixtures of KIF3AA plus KIF3BB. Surprisingly, the kinetics of KIF3AB are not equivalent to any of the mixtures of KIF3AA + KIF3BB. In fact, the transients for each of the mixtures overlay the transients for KIF3AA and KIF3BB. These results reveal that intermolecular communication within the KIF3AB heterodimer modulates entry into the processive run, and the results suggest that it is the high rate of microtubule association that drives rebinding to the microtubule after force-dependent motor detachment.	[Albracht, Clayton D.; Guzik-Lendrum, Stephanie; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Albracht, Clayton D.; Guzik-Lendrum, Stephanie; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Albracht, Clayton D.] NIH, Lab Mol Physiol, Bldg 50,Rm 3523, Bethesda, MD 20814 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.; Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	sgilbert@rpi.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [R37-GM054141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141, R01GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37-GM054141 (to S. P. G). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Arpag G, 2014, BIOPHYS J, V107, P1896, DOI 10.1016/j.bpj.2014.09.009; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Carpenter BS, 2015, J CELL SCI, V128, P1034, DOI 10.1242/jcs.162552; Chen CJ, 2012, J BIOL CHEM, V287, P36673, DOI 10.1074/jbc.M112.395590; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Dogan MY, 2015, CELL REP, V10, P1967, DOI 10.1016/j.celrep.2015.02.061; Doodhi H, 2009, BIOCHEMISTRY-US, V48, P2248, DOI 10.1021/bi8018338; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gindhart JG, 1996, TRENDS CELL BIOL, V6, P415, DOI 10.1016/S0962-8924(96)20037-6; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P2175, DOI 10.1073/pnas.0610939104; Kallipolitou A, 2001, EMBO J, V20, P6226, DOI 10.1093/emboj/20.22.6226; Komaki S, 2010, J CELL SCI, V123, P451, DOI 10.1242/jcs.062703; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; LOCKHART A, 1995, FEBS LETT, V368, P531, DOI 10.1016/0014-5793(95)00723-M; Lockhart A, 1996, BIOCHEMISTRY-US, V35, P2365, DOI 10.1021/bi952318n; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; PESAVENTO PA, 1994, J CELL BIOL, V127, P1041, DOI 10.1083/jcb.127.4.1041; Phillips RK, 2016, J BIOL CHEM, V291, P20372, DOI 10.1074/jbc.M116.737577; Prevo B, 2015, NAT CELL BIOL, V17, P1536, DOI 10.1038/ncb3263; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2002, J BIOL CHEM, V277, P36731, DOI 10.1074/jbc.M205261200; Rosenfeld SS, 2009, J BIOL CHEM, V284, P32858, DOI 10.1074/jbc.M109.041210; SADHU A, 1992, J BIOL CHEM, V267, P11352; Sardar HS, 2012, J BIOL CHEM, V287, P24894, DOI 10.1074/jbc.M112.376830; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Sen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074448; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Zhang PW, 2016, J BIOL CHEM, V291, P4407, DOI 10.1074/jbc.M115.705970; Zhang PW, 2015, P NATL ACAD SCI USA, V112, P6359, DOI 10.1073/pnas.1505531112	74	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23248	23256		10.1074/jbc.M116.752196	http://dx.doi.org/10.1074/jbc.M116.752196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27637334	Green Published, hybrid			2022-12-28	WOS:000387224800033
J	Oza, J; Ganguly, B; Kulkarni, A; Ginjala, V; Yao, M; Ganesan, S				Oza, Jay; Ganguly, Bratati; Kulkarni, Atul; Ginjala, Vasudeva; Yao, Ming; Ganesan, Shridar			A Novel Role of Chromodomain Protein CBX8 in DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CHROMATIN DYNAMICS; STEM-CELLS; POLYCOMB; REPAIR; COMPLEXES; CANCER; POLY(ADP-RIBOSYL)ATION; RECRUITMENT; FAMILY	Induction of DNA damage induces a dynamic repair process involving DNA repair factors and epigenetic regulators. Chromatin alterations must occur for DNA repair factors to gain access to DNA lesions and restore original chromatin configuration to preserve the gene expression profile. We characterize the novel role of CBX8, a chromodomain-containing protein with established roles in epigenetic regulation in DNA damage response. CBX8 protein rapidly accumulates at the sites of DNA damage within 30 s and progresses to accumulate until 4 min before gradually dispersing back to its predamage distribution by 15 min. CBX8 recruitment to the sites of DNA damage is dependent upon PARP1 activation and not dependent on ATM activation. CBX8 biochemically interacts with TRIM33, and its recruitment to DNA damage is also dependent on the presence of TRIM33. Knockdown of CBX8 using siRNA significantly reduces the efficiency of both homologous and the other non-homologous recombination, as well as increases sensitivity of cells to ionizing radiation. These findings demonstrate that CBX8 functions in the PARP-dependent DNA damage response partly through interaction with TRIM33 and is required for efficient DNA repair.	[Oza, Jay] Rutgers Robert Wood Johnson Med Sch, MD PhD Program, New Brunswick, NJ 08903 USA; [Oza, Jay; Ganesan, Shridar] Rutgers Grad Sch Biomed Sci, Dept Cellular & Mol Pharmacol, Piscataway, NJ 08854 USA; [Oza, Jay; Ganguly, Bratati; Kulkarni, Atul; Ginjala, Vasudeva; Yao, Ming; Ganesan, Shridar] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Oza, Jay] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Dartmouth College	Ganesan, S (corresponding author), Rutgers Grad Sch Biomed Sci, Dept Cellular & Mol Pharmacol, Piscataway, NJ 08854 USA.; Ganesan, S (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	ganesash@cinj.rutgers.edu	Oza, Jay/ABG-8272-2021; Ginjala, Vasudeva/E-5869-2019	Oza, Jay/0000-0001-6050-1913	New Jersey State Commission on Cancer Research [808057]; Department of Defense Breast Cancer Research Program Award [W81XWH-10-BCRP-PREDOC]; NCI; National Institutes of Health; Val Skinner Foundation; Hugs for Brady Foundation; Triple Negative Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA169182, P30CA072720] Funding Source: NIH RePORTER	New Jersey State Commission on Cancer Research; Department of Defense Breast Cancer Research Program Award(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Val Skinner Foundation; Hugs for Brady Foundation; Triple Negative Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Fellowship 808057 from the New Jersey State Commission on Cancer Research (to J. O.), Department of Defense Breast Cancer Research Program Award W81XWH-10-BCRP-PREDOC (to J. O.), and funding from the NCI, National Institutes of Health, the Val Skinner Foundation, Hugs for Brady Foundation and the Triple Negative Breast Cancer Foundation (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Bardos JI, 2000, J BIOL CHEM, V275, P28785, DOI 10.1074/jbc.M001835200; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Camahort R, 2012, CELL STEM CELL, V10, P4, DOI 10.1016/j.stem.2011.12.011; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Ganguly Bratati, 2016, Biomark Cancer, V8, P15, DOI 10.4137/BIC.S36679; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hemenway CS, 2001, ONCOGENE, V20, P3798, DOI 10.1038/sj.onc.1204478; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Huertas D, 2009, EPIGENETICS-US, V4, P31, DOI 10.4161/epi.4.1.7733; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; JONES GDD, 1995, INT J RADIAT BIOL, V67, P647, DOI 10.1080/09553009514550761; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Kulkarni A, 2013, J BIOL CHEM, V288, P32357, DOI 10.1074/jbc.M113.459164; Lafon-Hughes L, 2008, MUTAT RES-REV MUTAT, V658, P191, DOI 10.1016/j.mrrev.2008.01.008; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Moding EJ, 2013, NAT REV DRUG DISCOV, V12, P526, DOI 10.1038/nrd4003; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nakayama T, 2009, SEMIN IMMUNOL, V21, P78, DOI 10.1016/j.smim.2009.02.001; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Reliene R, 2007, ADV GENET, V58, P67, DOI 10.1016/S0065-2660(06)58003-4; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Senthilkumar R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-549; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sinha M, 2009, EPIGENOMICS-UK, V1, P371, DOI 10.2217/epi.09.22; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xiao WF, 2014, INT J CLIN EXP PATHO, V7, P4817; Xu Bo, 2004, Methods Mol Biol, V281, P283; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yan KP, 2004, GENE, V334, P3, DOI 10.1016/j.gene.2004.02.056	62	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22881	22893		10.1074/jbc.M116.725879	http://dx.doi.org/10.1074/jbc.M116.725879			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27555324	hybrid, Green Published			2022-12-28	WOS:000387224800003
J	Zhu, S; Lu, YC; Sinno, T; Diamond, SL				Zhu, Shu; Lu, Yichen; Sinno, Talid; Diamond, Scott L.			Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; PROTHROMBINASE COMPLEX; PLATELET DEPOSITION; TISSUE FACTOR; FACTOR-XI; SYSTEMS-APPROACH; COMPUTATIONAL SIMULATION; HEALTHY-INDIVIDUALS; MICROFLUIDIC ASSAY; FIBRIN DEPOSITION	Coagulation kinetics are well established for purified blood proteases or human plasma clotting isotropically. However, less is known about thrombin generation kinetics and transport within blood clots formed under hemodynamic flow. Using microfluidic perfusion (wall shear rate, 200 s(-1)) of corn trypsin inhibitor-treated whole blood over a 250-mu m long patch of type I fibrillar collagen/lipidated tissue factor (TF; similar to 1 TF molecule/mu m(2)), we measured thrombin released from clots using thrombin-antithrombin immunoassay. The majority (>85%) of generated thrombin was captured by intrathrombus fibrin as thrombin-antithrombin was largely undetectable in the effluent unless Gly-Pro-Arg-Pro (GPRP) was added to block fibrin polymerization. With GPRP present, the flux of thrombin increased to similar to 0.5 x 10(-12) nmol/mu m(2)-s over the first 500 s of perfusion and then further increased by similar to 2-3-fold over the next 300 s. The increased thrombin flux after 500 s was blocked by anti-FXIa antibody (O1A6), consistent with thrombin-feedback activation of FXI. Over the first 500 s, similar to 92,000 molecules of thrombin were generated per surface TF molecule for the 250-mu m-long coating. A single layer of platelets (obtained with alpha(IIb)beta(3) antagonism preventing continued platelet deposition) was largely sufficient for thrombin production. Also, the overall thrombin-generating potential of a 1000-mu m-long coating became less efficient on a per mu m(2) basis, likely due to distal boundary layer depletion of platelets. Overall, thrombin is robustly generated within clots by the extrinsic pathway followed by late-stage FXIa contributions, with fibrin localizing thrombin via its antithrombin-I activity as a potentially self-limiting hemostatic mechanism.	[Zhu, Shu; Lu, Yichen; Sinno, Talid; Diamond, Scott L.] Univ Penn, Inst Med & Engn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Diamond, SL (corresponding author), Univ Penn, Inst Med & Engn, Vagelos Res Labs 1024, 3340 Smith Walk, Philadelphia, PA 19104 USA.	sld@seas.upenn.edu			National Institutes of Health [R01 HL103419, U01-HL131053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL131053, R01HL103419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL103419 and U01-HL131053 (to S. L. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bird R. B., 2006, TRANSPORT PHENOMENA, P543; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029178; Bungay SD, 2003, MATH MED BIOL, V20, P105, DOI 10.1093/imammb20.1.105; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Chandler WL, 2003, BLOOD, V101, P4355, DOI 10.1182/blood-2002-08-2400; Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000950; Choi SH, 2015, THROMB HAEMOSTASIS, V113, P599, DOI 10.1160/TH14-06-0515; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Colace TV, 2014, J THROMB HAEMOST, V12, P147, DOI 10.1111/jth.12457; Colace TV, 2013, ARTERIOSCL THROM VAS, V33, P105, DOI 10.1161/ATVBAHA.112.300522; Colace TV, 2012, ARTERIOSCL THROM VAS, V32, P1466, DOI 10.1161/ATVBAHA.112.249789; Colace TV, 2011, BIOCONJUGATE CHEM, V22, P2104, DOI 10.1021/bc200326v; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DOWNING MR, 1978, BIOCHEMISTRY-US, V17, P2649, DOI 10.1021/bi00606a030; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; Fogelson AL, 2012, BIOPHYS J, V102, P10, DOI 10.1016/j.bpj.2011.10.048; FOLIE BJ, 1989, BIOPHYS J, V56, P1121, DOI 10.1016/S0006-3495(89)82760-2; Fredenburgh JC, 2004, BIOPHYS CHEM, V112, P277, DOI 10.1016/j.bpc.2004.07.031; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Hoffman M, 2003, DM-DIS MON, V49, P14, DOI 10.1053/shem.2001.29504; HORNYAK TJ, 1989, BIOCHEMISTRY-US, V28, P7326, DOI 10.1021/bi00444a027; Kim OV, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003095; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Leiderman K, 2013, B MATH BIOL, V75, P1255, DOI 10.1007/s11538-012-9784-3; Li R, 2015, HAEMOPHILIA, V21, P266, DOI 10.1111/hae.12558; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Maloney SF, 2010, INTEGR BIOL-UK, V2, P183, DOI 10.1039/b919728a; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Muthard RW, 2015, ARTERIOSCL THROM VAS, V35, P645, DOI 10.1161/ATVBAHA.114.305054; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Rivard GE, 2005, J THROMB HAEMOST, V3, P2039, DOI 10.1111/j.1538-7836.2005.01513.x; Ruhl H, 2012, THROMB HAEMOSTASIS, V107, P848, DOI 10.1160/TH11-10-0719; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Sorensen EN, 1999, ANN BIOMED ENG, V27, P436, DOI 10.1114/1.200; Sorensen EN, 1999, ANN BIOMED ENG, V27, P449, DOI 10.1114/1.201; Stalker TJ, 2014, BLOOD, V124, P1824, DOI 10.1182/blood-2014-01-550319; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; SWORDS NA, 1993, ARTERIOSCLER THROMB, V13, P1602, DOI 10.1161/01.ATV.13.11.1602; Tomaiuolo M, 2014, BLOOD, V124, P1816, DOI 10.1182/blood-2014-01-550343; TRACY PB, 1983, P NATL ACAD SCI-BIOL, V80, P2380, DOI 10.1073/pnas.80.8.2380; Voronov RS, 2013, ANN BIOMED ENG, V41, P1297, DOI 10.1007/s10439-013-0764-z; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Welsh JD, 2012, J THROMB HAEMOST, V10, P2344, DOI 10.1111/j.1538-7836.2012.04928.x; Welsh JD, 2014, BLOOD, V124, P1808, DOI 10.1182/blood-2014-01-550335; WILLEMS GM, 1991, HAEMOSTASIS, V21, P197; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Xu ZL, 2010, BIOPHYS J, V98, P1723, DOI 10.1016/j.bpj.2009.12.4331; Yeh CH, 2012, CIRC RES, V111, P1069, DOI 10.1161/CIRCRESAHA.112.276741; Zhu S, 2016, J THROMB HAEMOST, V14, P1070, DOI 10.1111/jth.13245; Zhu S, 2016, INTEGR BIOL-UK, V8, P813, DOI 10.1039/c6ib00077k; Zhu S, 2015, BLOOD, V126, P1494, DOI 10.1182/blood-2015-04-641472; Zhu S, 2014, THROMB RES, V134, P1335, DOI 10.1016/j.thromres.2014.09.030; Zilberman-Rudenko J, 2016, ARTERIOSCL THROM VAS, V36, P510, DOI 10.1161/ATVBAHA.115.307034	63	25	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23027	23035		10.1074/jbc.M116.754671	http://dx.doi.org/10.1074/jbc.M116.754671			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605669	Green Published, hybrid			2022-12-28	WOS:000387224800015
J	Kaur, S; Coulombe, Y; Ramdzan, ZM; Leduy, L; Masson, JY; Nepveu, A				Kaur, Simran; Coulombe, Yan; Ramdzan, Zubaidah M.; Leduy, Lam; Masson, Jean-Yves; Nepveu, Alain			Special AT-rich Sequence-binding Protein 1 (SATB1) Functions as an Accessory Factor in Base Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-oxoguanine (8-oxoG); 8-oxoguanine glycosylase (OGG1); base excision repair (BER); DNA damage; oxidative stress; Cut domains; Cut repeats; SATB1	MATRIX ATTACHMENT REGION; DOMAIN-MEDIATED DIMERIZATION; TRANSCRIPTION FACTOR SATB1; DNA GLYCOSYLASE ACTIVITY; AP-ENDONUCLEASE; GASTRIC-CANCER; DAMAGE REPAIR; CUT REPEATS; STIMULATION; HOMEODOMAIN	Base excision repair is initiated by DNA glycosylases that recognize specific altered bases. DNA glycosylases for oxidized bases carry both a glycosylase activity that removes the faulty base and an apyrimidinic/apurinic lyase activity that introduces a single-strand DNA incision. In particular, the CUT domains within the CUX1 and CUX2 proteins were recently shown to interact with the 8-oxoguanine (8-oxoG) DNA glycosylase and stimulate its enzymatic activities. SATB1, which contains two CUT domains, was originally characterized as a T cell-specific genome organizer whose aberrant overexpression in breast cancer can promote tumor progression. Here we investigated the involvement of SATB1 in DNA repair. SATB1 knockdown caused a delay in DNA repair following exposure to H2O2, an increase in OGG1-sensitive oxidized bases within genomic DNA, and a decrease in 8-oxoG cleavage activity in cell extracts. In parallel, we observed an increase in phospho-CHK1 and -H2AX levels and a decrease in DNA synthesis. Conversely, ectopic expression of SATB1 accelerated DNA repair and reduced the levels of oxidized bases in genomic DNA. Moreover, an enhanced GFP-SATB1 fusion protein was rapidly recruited to laser microirradiation-induced DNA damage. Using purified proteins, we showed that SATB1 interacts directly with OGG1, increases its binding to 8-oxoG-containing DNA, promotes Schiff base formation, and stimulates its glycosylase and apyrimidinic/apurinic lyase enzymatic activities. Structure/function analysis demonstrated that CUT domains, but not the homeodomain, are responsible for the stimulation of OGG1. Together, these results identify another CUT domain protein that functions both as a transcription factor and an accessory factor in base excision repair.	[Kaur, Simran; Ramdzan, Zubaidah M.; Leduy, Lam; Nepveu, Alain] Goodman Canc Res Ctr, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada; [Kaur, Simran; Nepveu, Alain] McGill Univ, Dept Biochem, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Oncol, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Med, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada; [Coulombe, Yan; Masson, Jean-Yves] CHU Quebec Res Ctr, Genome Stabil Lab, Quebec City, PQ G1R 2J6, Canada; [Coulombe, Yan; Masson, Jean-Yves] Univ Laval, Canc Res Ctr, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1V 0A6, Canada	McGill University; McGill University; McGill University; Laval University	Nepveu, A (corresponding author), Goodman Canc Res Ctr, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada.; Nepveu, A (corresponding author), McGill Univ, Dept Biochem, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada.; Nepveu, A (corresponding author), McGill Univ, Dept Oncol, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada.; Nepveu, A (corresponding author), McGill Univ, Dept Med, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020	Masson, Jean Yves/0000-0002-4403-7169; Kaur, Simran/0000-0003-1510-928X	Canadian Institutes of Health Research [MOP-130524, MOP-326694]; National Science and Engineering Council [RGPIN-2016-05155]; Maysie MacSporran graduate studentship; CIHR/Fonds de la recherche du Quebec en sante (FRQS) Training Grant in Cancer Research of the McGill Integrated Cancer Research Training Program [FRN53888]; FRQS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Maysie MacSporran graduate studentship; CIHR/Fonds de la recherche du Quebec en sante (FRQS) Training Grant in Cancer Research of the McGill Integrated Cancer Research Training Program; FRQS	This research was supported by Canadian Institutes of Health Research Grants MOP-130524 (to J.-Y.M.) and MOP-326694 (to A. N.) and National Science and Engineering Council Grant RGPIN-2016-05155 (to A. N.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Maysie MacSporran graduate studentship and CIHR/Fonds de la recherche du Quebec en sante (FRQS) Training Grant in Cancer Research FRN53888 of the McGill Integrated Cancer Research Training Program.r Supported by a fellowship from the FRQS.	Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Alvarez JD, 2000, GENE DEV, V14, P521; ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; Banath JP, 1999, RADIAT RES, V151, P550, DOI 10.2307/3580031; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Campalans A, 2007, J CELL SCI, V120, P23, DOI 10.1242/jcs.03312; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Egecioglu D, 2011, CURR OPIN CELL BIOL, V23, P338, DOI 10.1016/j.ceb.2011.01.001; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P169; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Gingras N, 2005, GENE, V344, P273, DOI 10.1016/j.gene.2004.11.008; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; Kondo M, 2016, J IMMUNOL, V196, P563, DOI 10.4049/jimmunol.1501429; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li Z, 2015, NUCLEIC ACIDS RES, V43, P3986, DOI 10.1093/nar/gkv283; Liu JQ, 1999, MOL CELL BIOL, V19, P4918; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Marenstein DR, 2001, J BIOL CHEM, V276, P21242, DOI 10.1074/jbc.M101594200; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Mir R, 2016, ONCOGENE, V35, P1679, DOI 10.1038/onc.2015.232; Mokkapati SK, 2004, BIOCHEMISTRY-US, V43, P11596, DOI 10.1021/bi049097i; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Noren Hooten N, 2012, AGING-US, V4, P674, DOI 10.18632/aging.100492; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Pal R, 2015, J BIOL CHEM, V290, P22520, DOI 10.1074/jbc.M115.651042; Paz-Elizur T, 2007, DNA REPAIR, V6, P45, DOI 10.1016/j.dnarep.2006.08.003; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Purbey PK, 2008, NUCLEIC ACIDS RES, V36, P2107, DOI 10.1093/nar/gkm1151; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramdzan ZM, 2015, ONCOTARGET, V6, P3613, DOI 10.18632/oncotarget.2919; Ramdzan ZM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001807; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Svilar D, 2012, JOVE-J VIS EXP, DOI 10.3791/4168; Vadnais C, 2012, NUCLEIC ACIDS RES, V40, P4483, DOI 10.1093/nar/gks041; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; WANG BC, 1995, J BIOL CHEM, V270, P23239, DOI 10.1074/jbc.270.40.23239; Wang FF, 2015, P NATL ACAD SCI USA, V112, pE4995, DOI 10.1073/pnas.1513780112; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Yamaguchi H, 2006, J BIOL CHEM, V281, P5319, DOI 10.1074/jbc.M510933200; Yamasaki K, 2007, NUCLEIC ACIDS RES, V35, P5073, DOI 10.1093/nar/gkm504; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	69	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22769	22780		10.1074/jbc.M116.735696	http://dx.doi.org/10.1074/jbc.M116.735696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27590341	Green Published, hybrid			2022-12-28	WOS:000386760600034
J	Chen, YC; Semenova, S; Rozov, S; Sundvik, M; Bonkowsky, JL; Panula, P				Chen, Yu-Chia; Semenova, Svetlana; Rozov, Stanislav; Sundvik, Maria; Bonkowsky, Joshua L.; Panula, Pertti			A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine; dopamine receptor; histamine; hypothalamus; zebrafish; morpholino; orexin	PRECURSOR CELL-PROLIFERATION; IN-SITU HYBRIDIZATION; TYROSINE-HYDROXYLASE; NEURON DEVELOPMENT; ZEBRAFISH BRAIN; VENTRAL TELENCEPHALON; SUBVENTRICULAR ZONE; SUBSTANTIA-NIGRA; HISTAMINE; SYSTEM	Hypothalamic neurons expressing histamine and orexin/hypocretin (hcrt) are necessary for normal regulation of wakefulness. In Parkinson's disease, the loss of dopaminergic neurons is associated with elevated histamine levels and disrupted sleep/wake cycles, but the mechanism is not understood. To characterize the role of dopamine in the development of histamine neurons, we inhibited the translation of the two non-allelic forms of tyrosine hydroxylase (th1 and th2) in zebrafish larvae. We found that dopamine levels were reduced in both th1 and th2 knockdown, but the serotonin level and number of serotonin neurons remained unchanged. Further, we demonstrated that th2 knockdown increased histamine neuron number and histamine levels, whereas increased dopaminergic signaling using the dopamine precursor l-DOPA (l-3,4-dihydroxyphenylalanine) or dopamine receptor agonists reduced the number of histaminergic neurons. Increases in the number of histaminergic neurons were paralleled by matching increases in the numbers of hcrt neurons, supporting observations that histamine regulates hcrt neuron development. Finally, we show that histaminergic neurons surround th2-expressing neurons in the hypothalamus, and we suggest that dopamine regulates the terminal differentiation of histamine neurons via paracrine actions or direct synaptic neurotransmission. These results reveal a role for dopaminergic signaling in the regulation of neurotransmitter identity and a potential mechanism contributing to sleep disturbances in Parkinson's disease.	[Chen, Yu-Chia; Semenova, Svetlana; Rozov, Stanislav; Sundvik, Maria; Panula, Pertti] Univ Helsinki, Neurosci Ctr, FIN-00290 Helsinki, Finland; [Chen, Yu-Chia; Semenova, Svetlana; Rozov, Stanislav; Sundvik, Maria; Panula, Pertti] Univ Helsinki, Dept Anat, Helsinki 00290, Finland; [Bonkowsky, Joshua L.] Univ Utah, Dept Pediat, Sch Med, Salt Lake City, UT 84113 USA	University of Helsinki; University of Helsinki; Utah System of Higher Education; University of Utah	Panula, P (corresponding author), Univ Helsinki, Neurosci Ctr, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.; Panula, P (corresponding author), Univ Helsinki, Dept Anat, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	pertti.panula@helsinki.fi		Panula, Pertti/0000-0002-1189-5132; Rozov, Stanislav/0000-0002-0352-5502	Academy of Finland; Sigrid Juselius Foundation;  [DP2 MH100008]; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH100008] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Academy of Finland and Sigrid Juselius Foundation (to P. P.) and DP2 MH100008 (to J. L. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Anichtchik OV, 2000, EXP NEUROL, V163, P20, DOI 10.1006/exnr.2000.7362; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Candy J, 2005, BBA-GENE STRUCT EXPR, V1727, P35, DOI 10.1016/j.bbaexp.2004.11.005; Chen YC, 2012, DEV BIOL, V370, P237, DOI 10.1016/j.ydbio.2012.07.030; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Eiden LE, 2011, ANN NY ACAD SCI, V1216, P86, DOI 10.1111/j.1749-6632.2010.05906.x; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Fink M, 2006, DEV DYNAM, V235, P3370, DOI 10.1002/dvdy.20995; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Fujimoto E, 2011, DEV BIOL, V352, P393, DOI 10.1016/j.ydbio.2011.01.023; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Irons TD, 2013, PHARMACOL BIOCHEM BE, V103, P792, DOI 10.1016/j.pbb.2012.12.010; John J, 2013, ANN NEUROL, V74, P786, DOI 10.1002/ana.23968; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kukko-Lukjanov TK, 2003, J CHEM NEUROANAT, V25, P279, DOI 10.1016/S0891-0618(03)00043-7; Lauter G, 2014, METHODS MOL BIOL, V1082, P175, DOI 10.1007/978-1-62703-655-9_12; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machluf Y, 2011, ANN NY ACAD SCI, V1220, P93, DOI 10.1111/j.1749-6632.2010.05945.x; Maggi R, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00440; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; McPherson AD, 2016, CURR BIOL, V26, P263, DOI 10.1016/j.cub.2015.11.064; Mu Y, 2012, NEURON, V75, P688, DOI 10.1016/j.neuron.2012.05.035; Nyholm MK, 2007, DEVELOPMENT, V134, P735, DOI 10.1242/dev.02756; O'Keeffe GC, 2009, CELL CYCLE, V8, P2888, DOI 10.4161/cc.8.18.9512; PANULA P, 1990, NEUROSCIENCE, V34, P127, DOI 10.1016/0306-4522(90)90307-P; Panula P, 2014, TRENDS NEUROSCI, V37, P159, DOI 10.1016/j.tins.2014.01.001; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Popolo M, 2004, DEV NEUROSCI-BASEL, V26, P229, DOI 10.1159/000082140; PRELL GD, 1995, SCHIZOPHR RES, V14, P93, DOI 10.1016/0920-9964(94)00034-6; Reimer MM, 2013, DEV CELL, V25, P478, DOI 10.1016/j.devcel.2013.04.012; Ren GQ, 2013, J BIOL CHEM, V288, P22451, DOI 10.1074/jbc.M113.485227; Rink E, 2004, BRAIN RES, V1011, P206, DOI 10.1016/j.brainres.2004.03.027; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rinne JO, 2002, J NEUROCHEM, V81, P954, DOI 10.1046/j.1471-4159.2002.00871.x; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2010, NEUROBIOL DIS, V40, P93, DOI 10.1016/j.nbd.2010.06.001; Sallinen V, 2009, J NEUROCHEM, V109, P403, DOI 10.1111/j.1471-4159.2009.05986.x; Schmidt U, 1996, NEUROSCIENCE, V74, P453, DOI 10.1016/0306-4522(96)00201-1; Schweitzer J, 2009, ADV EXP MED BIOL, V651, P1; Semenova SA, 2014, HISTOCHEM CELL BIOL, V142, P619, DOI 10.1007/s00418-014-1240-z; Sundvik M, 2015, ACTA PHYSIOL, V213, P321, DOI 10.1111/apha.12432; Sundvik M, 2013, J NEUROSCI, V33, P1589, DOI 10.1523/JNEUROSCI.1802-12.2013; Sundvik M, 2011, FASEB J, V25, P4338, DOI 10.1096/fj.11-188268; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; TODD RD, 1992, BIOL PSYCHIAT, V31, P794, DOI 10.1016/0006-3223(92)90311-M; Valko PO, 2013, ANN NEUROL, V74, P794, DOI 10.1002/ana.24019; Wang X, 2012, DEV CELL, V23, P624, DOI 10.1016/j.devcel.2012.07.012; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006; Yanovsky Y, 2011, J PHYSIOL-LONDON, V589, P1349, DOI 10.1113/jphysiol.2010.203257; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	61	17	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21880	21892		10.1074/jbc.M115.697466	http://dx.doi.org/10.1074/jbc.M115.697466			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27539857	hybrid, Green Published			2022-12-28	WOS:000386332600005
J	Lakhter, AJ; Hamilton, J; Konger, RL; Brustovetsky, N; Broxmeyer, HE; Naidu, SR				Lakhter, Alexander J.; Hamilton, James; Konger, Raymond L.; Brustovetsky, Nickolay; Broxmeyer, Hal E.; Naidu, Samisubbu R.			Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl-CoA synthetase; bioenergetics; glucose metabolism; glutamine; glycolysis; melanoma; mitochondria; acetate metabolism; glycolysis; melanoma; ACSS1; ACSS2	MITOCHONDRIAL PYRUVATE CARRIER; OXIDATIVE-METABOLISM; CANCER-CELLS; SYNTHETASE; BRAF; EXPRESSION; COLON; SUPPLEMENTATION; PROLIFERATION; CONTRIBUTES	Tumors rely on multiple nutrients to meet cellular bioenergetics and macromolecular synthesis demands of rapidly dividing cells. Although the role of glucose and glutamine in cancer metabolism is well understood, the relative contribution of acetate metabolism remains to be clarified. We show that glutamine supplementation is not sufficient to prevent loss of cell viability in a subset of glucose-deprived melanoma cells, but synergizes with acetate to support cell survival. Glucose-deprived melanoma cells depend on both oxidative phosphorylation and acetate metabolism for cell survival. Acetate supplementation significantly contributed to maintenance of ATP levels in glucose-starved cells. Unlike acetate, short chain fatty acids such as butyrate and propionate failed to prevent loss of cell viability from glucose deprivation. In vivo studies revealed that in addition to nucleo-cytoplasmic acetate assimilating enzyme ACSS2, mitochondrial ACSS1 was critical for melanoma tumor growth in mice. Our data indicate that acetate metabolism may be a potential therapeutic target for BRAF mutant melanoma.	[Lakhter, Alexander J.; Broxmeyer, Hal E.; Naidu, Samisubbu R.] Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA; [Hamilton, James; Brustovetsky, Nickolay] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Konger, Raymond L.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Naidu, SR (corresponding author), Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA.	naidus@iu.edu		Naidu, Samisubbu/0000-0001-9411-660X	Indiana CTSI Independent Scientist Award; Indiana CTSI Core awards; Showalter award; National Institutes of Health [NS078008]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078008] Funding Source: NIH RePORTER	Indiana CTSI Independent Scientist Award; Indiana CTSI Core awards; Showalter award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Indiana CTSI Independent Scientist Award, Indiana CTSI Core awards, and the Showalter award (to S. R. N.) and National Institutes of Health Grant NS078008 (to N. B.). Hal Broxmeyer committed significant financial resources for completion of this project. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balsa-Martinez E, 2015, MOL CELL, V60, P509, DOI 10.1016/j.molcel.2015.11.005; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bjornson E, 2015, CELL REP, V13, P2014, DOI 10.1016/j.celrep.2015.10.045; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brogsitter C, 2013, EUR J NUCL MED MOL I, V40, pS18, DOI 10.1007/s00259-013-2358-2; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Cresci GA, 2014, ALCOHOL CLIN EXP RES, V38, P1489, DOI 10.1111/acer.12428; Fedorenko IV, 2015, BRIT J CANCER, V112, P217, DOI 10.1038/bjc.2014.476; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hill EW, 2010, ANIM GENET, V41, P56, DOI 10.1111/j.1365-2052.2010.02104.x; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kluza J, 2012, CANCER RES, V72, P5035, DOI 10.1158/0008-5472.CAN-12-0979; Lakhter AJ, 2014, ONCOTARGET, V5, P12694, DOI 10.18632/oncotarget.3031; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liang XY, 2012, CANCER RES, V72, P2791, DOI 10.1158/0008-5472.CAN-12-0320; MARAGOS CM, 1993, CANCER RES, V53, P564; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Miller MA, 2016, VET PATHOL, V53, P390, DOI 10.1177/0300985815608674; NUUTINEN H, 1985, ALCOHOL, V2, P623, DOI 10.1016/0741-8329(85)90090-4; Olson KA, 2016, TRENDS BIOCHEM SCI, V41, P219, DOI 10.1016/j.tibs.2016.01.002; Oyama N, 2002, J NUCL MED, V43, P181; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Phillips JC, 2013, VET CLIN N AM-EQUINE, V29, P673, DOI 10.1016/j.cveq.2013.08.008; Pollak M, 2013, CANCER CELL, V23, P263, DOI 10.1016/j.ccr.2013.02.015; POMARE EW, 1985, J CLIN INVEST, V75, P1448, DOI 10.1172/JCI111847; Reijnders D, 2016, CELL METAB, V24, P63, DOI [10.1016/j.cmet.2016.06.016, 10.1016/j.cmet.2016.07.008]; Richards R H, 1976, Proc Clin Dial Transplant Forum, V6, P73; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Sakakibara I, 2009, CELL METAB, V9, P191, DOI 10.1016/j.cmet.2008.12.008; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Segel R, 2011, MOL GENET METAB, V103, P203, DOI 10.1016/j.ymgme.2011.03.012; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Trajkovski M, 2016, NATURE, V534, P185, DOI 10.1038/534185a; Tsen AR, 2014, INT J CANCER, V134, P1300, DOI 10.1002/ijc.28465; Tsuchida T, 2008, NUCL MED BIOL, V35, P171, DOI 10.1016/j.nucmedbio.2007.11.004; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yu Y, 2015, J DRUGS DERMATOL, V14, P461; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Yun M, 2009, J NUCL MED, V50, P1222, DOI 10.2967/jnumed.109.062703; ZAKUT R, 1993, CANCER RES, V53, P5; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	59	37	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21869	21879		10.1074/jbc.M115.712166	http://dx.doi.org/10.1074/jbc.M115.712166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27539851	Green Published, hybrid			2022-12-28	WOS:000386332600004
J	Dukel, M; Streitfeld, WS; Tang, TCC; Backman, LRF; Ai, LB; May, WS; Brown, KD				Dukel, Muzaffer; Streitfeld, W. Scott; Tang, Tsz Ching Chloe; Backman, Lindsey R. F.; Ai, Lingbao; May, W. Stratford; Brown, Kevin D.			The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cell signaling; hypoxia; hypoxia-inducible factor (HIF); tumor suppressor gene	UBIQUITIN-PROTEASOME PATHWAY; DOUBLE-STRAND BREAKS; NF-KAPPA-B; ATAXIA-TELANGIECTASIA; GENE-EXPRESSION; INDUCIBLE FACTOR-1; OXIDATIVE STRESS; PANCREATIC-CANCER; FACTOR 1-ALPHA; DNA-DAMAGE	Reduced ATM function has been linked to breast cancer risk, and the TRIM29 protein is an emerging breast cancer tumor suppressor. Here we show that, in cultured breast tumor and non-tumorigenic mammary epithelial cells, TRIM29 is up-regulated in response to hypoxic stress but not DNA damage. Hypoxia-induced up-regulation of TRIM29 is dependent upon ATM and HIF1 and occurs through increased transcription of the TRIM29 gene. Basal expression of TRIM29 is also down-regulated in cells expressing diminished levels of ATM, and findings suggest that this occurs through basal NF-B activity as knockdown of the NF-B subunit RelA suppresses TRIM29 abundance. We have previously shown that the activity of the TWIST1 oncogene is antagonized by TRIM29 and now show that TRIM29 is necessary to block the up-regulation of TWIST1 that occurs in response to hypoxic stress. This study establishes TRIM29 as a hypoxia-induced tumor suppressor gene and provides a novel molecular mechanism for ATM-dependent breast cancer suppression.	[Dukel, Muzaffer; Backman, Lindsey R. F.; Ai, Lingbao; Brown, Kevin D.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, 1200 Newell Dr,Box 1000245, Gainesville, FL 32610 USA; [Streitfeld, W. Scott; Tang, Tsz Ching Chloe; May, W. Stratford] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brown, KD (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, 1200 Newell Dr,Box 1000245, Gainesville, FL 32610 USA.	kdbrown1@ufl.edu			National Institutes of Health [R03 CA12582]; Florida Department of Health; Violet Brownhill Trust; Scientific and Technological Research Council of Turkey (TUBITAK); NATIONAL CANCER INSTITUTE [P01CA012582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; Violet Brownhill Trust; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R03 CA12582 and funds from the Florida Department of Health and the Violet Brownhill Trust (to K. D. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a research fellowship from the Scientific and Technological Research Council of Turkey (TUBITAK). Present address: Dept. of Biology, Mehmet Akif Ersoy University, Burdur, Turkey.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Ai LB, 2014, CANCER RES, V74, P4875, DOI 10.1158/0008-5472.CAN-13-3579; Ai LB, 2012, J BIOL CHEM, V287, P18330, DOI 10.1074/jbc.M112.339317; Alpay M, 2015, BREAST CANCER RES TR, V151, P75, DOI 10.1007/s10549-015-3368-5; Angele S, 2000, CLIN CANCER RES, V6, P3536; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bebb DG, 1999, BRIT J CANCER, V80, P1979, DOI 10.1038/sj.bjc.6690630; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Bernstein JL, 2006, HUM MUTAT, V27, P1122, DOI 10.1002/humu.20415; Bernstein JL, 2003, BRIT J CANCER, V89, P1513, DOI 10.1038/sj.bjc.6601289; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Buchler P, 2003, PANCREAS, V26, P56, DOI 10.1097/00006676-200301000-00010; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; CORTESSIS V, 1993, CANCER RES, V53, P5083; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Freiberg RA, 2006, MOL CELL BIOL, V26, P1598, DOI 10.1128/MCB.26.5.1598-1609.2006; Fristrup N, 2013, AM J PATHOL, V182, P339, DOI 10.1016/j.ajpath.2012.10.017; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gibson SL, 2005, CANCER RES, V65, P10734, DOI 10.1158/0008-5472.CAN-05-1160; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/FON.13.92, 10.2217/fon.13.92]; Glebov OK, 2006, CANCER EPIDEM BIOMAR, V15, P2253, DOI 10.1158/1055-9965.EPI-05-0694; Golding SE, 2011, CELL CYCLE, V10, P3227, DOI 10.4161/cc.10.19.17048; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hosoi Y, 2006, BIOCHEM BIOPH RES CO, V348, P728, DOI 10.1016/j.bbrc.2006.07.115; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kairouz R, 1999, J CLIN PATHOL-MOL PA, V52, P252, DOI 10.1136/mp.52.5.252; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Langholz B, 2006, INT J CANCER, V119, P724, DOI 10.1002/ijc.21876; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Masuda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8299; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; PIPPARD EC, 1988, CANCER RES, V48, P2929; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shafman TD, 2000, GENE CHROMOSOME CANC, V27, P124, DOI 10.1002/(SICI)1098-2264(200002)27:2<124::AID-GCC2>3.0.CO;2-M; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Tang ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063676; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Veuger SJ, 2011, DNA REPAIR, V10, P235, DOI 10.1016/j.dnarep.2010.11.005; Vo QN, 2004, ONCOGENE, V23, P9432, DOI 10.1038/sj.onc.1208092; Wang LD, 2015, GENE DEV, V29, P171, DOI 10.1101/gad.253591.114; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; WOOSTER R, 1993, HUM GENET, V92, P91, DOI 10.1007/BF00216153; Xiao ZX, 2013, CANCER CELL, V23, P527, DOI 10.1016/j.ccr.2013.03.009; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zundel W, 2000, GENE DEV, V14, P391	73	15	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21541	21552		10.1074/jbc.M116.730960	http://dx.doi.org/10.1074/jbc.M116.730960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27535224	Green Published, hybrid			2022-12-28	WOS:000385999200021
J	Hegazy, AM; Yamada, D; Kobayashi, M; Kohno, S; Ueno, M; Ali, MAE; Ohta, K; Tadokoro, Y; Ino, Y; Todo, T; Soga, T; Takahashi, C; Hirao, A				Hegazy, Ahmed M.; Yamada, Daisuke; Kobayashi, Masahiko; Kohno, Susumu; Ueno, Masaya; Ali, Mohamed A. E.; Ohta, Kumiko; Tadokoro, Yuko; Ino, Yasushi; Todo, Tomoki; Soga, Tomoyoshi; Takahashi, Chiaki; Hirao, Atsushi			Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; brain tumor; drug screening; mammalian target of rapamycin (mTOR); mitochondria	CANCER-CELLS; INITIATING CELLS; STEM-CELLS; MITOCHONDRIAL; TUMORIGENICITY; IDENTIFICATION; BIOGENESIS; ACTIVATION; GROWTH; MTORC1	Although abnormal metabolic regulation is a critical determinant of cancer cell behavior, it is still unclear how an altered balance between ATP production and consumption contributes to malignancy. Here we show that disruption of this energy balance efficiently suppresses aggressive malignant gliomas driven by mammalian target of rapamycin complex 1 (mTORC1) hyperactivation. In a mouse glioma model, mTORC1 hyperactivation induced by conditional Tsc1 deletion increased numbers of glioma-initiating cells (GICs) in vitro and in vivo. Metabolic analysis revealed that mTORC1 hyperactivation enhanced mitochondrial biogenesis, as evidenced by elevations in oxygen consumption rate and ATP production. Inhibition of mitochondrial ATP synthetase was more effective in repressing sphere formation by Tsc1-deficient glioma cells than that by Tsc1-competent glioma cells, indicating a crucial function for mitochondrial bioenergetic capacity in GIC expansion. To translate this observation into the development of novel therapeutics targeting malignant gliomas, we screened drug libraries for small molecule compounds showing greater efficacy in inhibiting the proliferation/survival of Tsc1-deficient cells compared with controls. We identified several compounds able to preferentially inhibit mitochondrial activity, dramatically reducing ATP levels and blocking glioma sphere formation. In human patient-derived glioma cells, nigericin, which reportedly suppresses cancer stem cell properties, induced AMPK phosphorylation that was associated with mTORC1 inactivation and induction of autophagy and led to a marked decrease in sphere formation with loss of GIC marker expression. Furthermore, malignant characteristics of human glioma cells were markedly suppressed by nigericin treatment in vivo. Thus, targeting mTORC1-driven processes, particularly those involved in maintaining a cancer cell's energy balance, may be an effective therapeutic strategy for glioma patients.	[Hegazy, Ahmed M.; Yamada, Daisuke; Kobayashi, Masahiko; Ueno, Masaya; Ali, Mohamed A. E.; Ohta, Kumiko; Tadokoro, Yuko; Hirao, Atsushi] Kanazawa Univ, Canc Res Inst, Div Mol Genet, Kanazawa, Ishikawa 9200934, Japan; [Kohno, Susumu; Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Canc & Stem Cell Res Program, Kanazawa, Ishikawa 9200934, Japan; [Ino, Yasushi; Todo, Tomoki] Univ Tokyo, Inst Med Sci, Lab Innovat Canc Therapy, Minato Ku, Tokyo 1088639, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Yamada, Daisuke] Niigata Univ Pharm & Appl Sci, Div Pharmacol, Niigata, Niigata 9568603, Japan	Kanazawa University; Kanazawa University; University of Tokyo; Keio University; Niigata University	Hirao, A (corresponding author), Kanazawa Univ, Div Mol Genet, Canc & Stem Cell Res Program, Canc Res Inst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	ahirao@staff.kanazawa-u.ac.jp	UENO, Masaya/D-8464-2015	UENO, Masaya/0000-0001-9177-8640; Ahmed, Mohamed/0000-0002-8789-8567	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)/Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED); Egyptian Ministry of Higher Education and Mission Sector; Japan Society for the Promotion of Science (JSPS) KAKENHI [JP25340028]; Grants-in-Aid for Scientific Research [15H01509] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)/Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Egyptian Ministry of Higher Education and Mission Sector; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)/Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from the Egyptian Ministry of Higher Education and Mission Sector.; Supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant JP25340028.	Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Cavalli LR, 1997, CELL GROWTH DIFFER, V8, P1189; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Deng CC, 2013, INT J BIOCHEM CELL B, V45, P1997, DOI 10.1016/j.biocel.2013.06.023; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoshii T, 2014, J BIOCHEM, V156, P73, DOI 10.1093/jb/mvu037; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Korkolopoulou P, 2012, HISTOPATHOLOGY, V61, P293, DOI 10.1111/j.1365-2559.2012.04236.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Manago A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.263; MORAIS R, 1994, CANCER RES, V54, P3889; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Rigobello MP, 2002, BRIT J PHARMACOL, V136, P1162, DOI 10.1038/sj.bjp.0704823; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Tanaka S, 2015, J NEURO-ONCOL, V121, P239, DOI 10.1007/s11060-014-1630-z; The WHO, 2020, CLASSIFICATION TUMOU; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada D, 2014, J BIOCHEM, V155, P227, DOI 10.1093/jb/mvt112; Yang JF, 2011, J SURG RES, V168, P97, DOI 10.1016/j.jss.2009.06.025; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935	42	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21496	21509		10.1074/jbc.M116.734756	http://dx.doi.org/10.1074/jbc.M116.734756			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27519418	hybrid, Green Published			2022-12-28	WOS:000385999200017
J	Liu, LK; Abdelwahab, H; Del Campo, JSM; Mehra-Chaudhary, R; Sobrado, P; Tanner, JJ				Liu, Li-Kai; Abdelwahab, Heba; Campo, Julia S. Martin Del; Mehra-Chaudhary, Ritcha; Sobrado, Pablo; Tanner, John J.			The Structure of the Antibiotic Deactivating, N-hydroxylating Rifampicin Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme structure; flavoprotein; small-angle X-ray scattering (SAXS); x-ray crystallography	SMALL-ANGLE SCATTERING; FLAVOPROTEIN MONOOXYGENASES; SUBSTRATE RECOGNITION; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; RNA-POLYMERASE; BETA-SUBUNIT; RESISTANCE; BIOSYNTHESIS; GENE	Rifampicin monooxygenase (RIFMO) catalyzes the N-hydroxylation of the natural product antibiotic rifampicin (RIF) to 2-N-hydroxy-4-oxo-rifampicin, a metabolite with much lower antimicrobial activity. RIFMO shares moderate sequence similarity with well characterized flavoprotein monooxygenases, but the protein has not been isolated and characterized at the molecular level. Herein, we report crystal structures of RIFMO from Nocardia farcinica, the determination of the oligomeric state in solution with small angle x-ray scattering, and the spectrophotometric characterization of substrate binding. The structure identifies RIFMO as a class A flavoprotein monooxygenase and is similar in fold and quaternary structure to MtmOIV and OxyS, which are enzymes in the mithramycin and oxytetracycline biosynthetic pathways, respectively. RIFMO is distinguished from other class A flavoprotein monooxygenases by its unique middle domain, which is involved in binding RIF. Small angle x-ray scattering analysis shows that RIFMO dimerizes via the FAD-binding domain to form a bell-shaped homodimer in solution with a maximal dimension of 110 . RIF binding was monitored using absorbance at 525 nm to determine a dissociation constant of 13 m. Steady-state oxygen consumption assays show that NADPH efficiently reduces the FAD only when RIF is present, implying that RIF binds before NADPH in the catalytic scheme. The 1.8 resolution structure of RIFMO complexed with RIF represents the precatalytic conformation that occurs before formation of the ternary E-RIF-NADPH complex. The RIF naphthoquinone blocks access to the FAD N5 atom, implying that large conformational changes are required for NADPH to reduce the FAD. A model for these conformational changes is proposed.	[Liu, Li-Kai; Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Mehra-Chaudhary, Ritcha] Univ Missouri, Struct Biol Core, Columbia, MO 65211 USA; [Abdelwahab, Heba; Campo, Julia S. Martin Del; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Abdelwahab, Heba] Damietta Univ, Dept Chem, Fac Sci, Dumyat 34517, Egypt	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Virginia Polytechnic Institute & State University; Egyptian Knowledge Bank (EKB); Damietta University	Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.; Sobrado, P (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	psobrado@vt.edu; tannerjj@missouri.edu		S. Martin del Campo, Julia/0000-0001-8914-2504; abdelwahab, heba/0000-0002-4005-464X; Tanner, John/0000-0001-8314-113X	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; National Institute of Health project MINOS [R01GM105404]; Direct For Biological Sciences [1021384] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); National Institute of Health project MINOS; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jay Nix for help with x-ray diffraction data collection and Kathryn Burnett for collecting the SAXS data through the SIBYLS mail-in program at the Advanced Light Source. We thank Dr. Nicholas Noinaj for providing the model of MtmOIV complexed with NADPH. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. Additional support for the SYBILS beamline comes from the National Institute of Health project MINOS (R01GM105404).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen SJ, 1997, ANTIMICROB AGENTS CH, V41, P218, DOI 10.1128/AAC.41.1.218; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; Bosserman MA, 2013, ACS CHEM BIOL, V8, P2466, DOI 10.1021/cb400399b; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enroth C, 1998, STRUCTURE, V6, P605, DOI 10.1016/S0969-2126(98)00062-8; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Floss HG, 2005, CHEM REV, V105, P621, DOI 10.1021/cr030112j; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; Hoshino Y, 2010, J ANTIBIOT, V63, P23, DOI 10.1038/ja.2009.116; Ishikawa J, 2006, ANTIMICROB AGENTS CH, V50, P1342, DOI 10.1128/AAC.50.4.1342-1346.2006; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindqvist Y, 2009, J MOL BIOL, V393, P966, DOI 10.1016/j.jmb.2009.09.003; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Qi XF, 2016, P NATL ACAD SCI USA, V113, P3803, DOI 10.1073/pnas.1523614113; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; SEVERINOV K, 1993, J BIOL CHEM, V268, P14820; Spanogiannopoulos P, 2014, P NATL ACAD SCI USA, V111, P7102, DOI 10.1073/pnas.1402358111; Spanogiannopoulos P, 2012, ANTIMICROB AGENTS CH, V56, P5061, DOI 10.1128/AAC.01166-12; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stogios PJ, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms11343; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tupin A, 2010, INT J ANTIMICROB AG, V35, P519, DOI 10.1016/j.ijantimicag.2009.12.017; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang P, 2013, J AM CHEM SOC, V135, P7138, DOI 10.1021/ja403516u; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; YAZAWA K, 1993, ANTIMICROB AGENTS CH, V37, P1313, DOI 10.1128/AAC.37.6.1313	44	30	31	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21553	21562		10.1074/jbc.M116.745315	http://dx.doi.org/10.1074/jbc.M116.745315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27557658	Green Published, hybrid			2022-12-28	WOS:000385999200022
J	Nawaz, MS; Vik, ES; Berges, N; Fladeby, C; Bjoras, M; Dalhus, B; Alseth, I				Nawaz, Meh Sameen; Vik, Erik Sebastian; Berges, Natalia; Fladeby, Cathrine; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun			Regulation of Human Endonuclease V Activity and Relocalization to Cytoplasmic Stress Granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; nitrosative stress; ribonuclease; RNA; RNA processing; stress granule; endonuclease V; PABPC1; deamination; inosine	ESCHERICHIA-COLI; ENDORIBONUCLEASE G3BP; ADENOSINE-DEAMINASE; MESSENGER-RNA; ATP DEPLETION; TUDOR-SN; DNA; PROTEINS; CELLS; PHOSPHORYLATION	Endonuclease V (EndoV) is an enzyme with specificity for inosines in nucleic acids. Whereas the bacterial homologs are active on both DNA and RNA, the mammalian variants only cleave RNA, at least when assayed with recombinant proteins. Here we show that ectopically expressed, as well as endogenously expressed human (h)EndoV, share the same enzymatic properties as the recombinant protein and cleaves RNA with inosine but not DNA. In search for proteins interacting with hEndoV, polyadenylate-binding protein C1 (PABPC1) was identified. The association between PABPC1 and hEndoV is RNA dependent and furthermore, PABPC1 stimulates hEndoV activity and affinity for inosine-containing RNA. Upon cellular stress, PABPC1 relocates to cytoplasmic stress granules that are multimolecular aggregates of stalled translation initiation complexes formed to aid cell recovery. Arsenite, as well as other agents, triggered relocalization also of hEndoV to cytoplasmic stress granules. As inosines in RNA are highly abundant, hEndoV activity is likely regulated in cells to avoid aberrant cleavage of inosine-containing transcripts. Indeed, we find that hEndoV cleavage is inhibited by normal intracellular ATP concentrations. The ATP stores inside a cell do not overlay stress granules and we suggest that hEndoV is redistributed to stress granules as a strategy to create a local environment low in ATP to permit hEndoV activity.	[Nawaz, Meh Sameen; Vik, Erik Sebastian; Berges, Natalia; Fladeby, Cathrine; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun] Natl Hosp Norway, Dept Microbiol, Oslo Univ Hosp HF, NO-0424 Oslo, Norway; [Nawaz, Meh Sameen; Vik, Erik Sebastian; Berges, Natalia; Fladeby, Cathrine; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun] Univ Oslo, NO-0424 Oslo, Norway; [Bjoras, Magnar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway; [Dalhus, Bjorn] Univ Oslo, Inst Clin Med, Dept Med Biochem, NO-0424 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo	Alseth, I (corresponding author), Natl Hosp Norway, Dept Microbiol, Oslo Univ Hosp HF, NO-0424 Oslo, Norway.; Alseth, I (corresponding author), Univ Oslo, NO-0424 Oslo, Norway.	ingrun.alseth@rr-research.no	Dalhus, Bjørn/AAK-2895-2020; Bjørås, Magnar/N-9286-2017		Norwegian Cancer Society [5739724]; Research Council of Norway [250474]; South-Eastern Norway Regional Health Authorities [2014034, 2015095]; Erasmus+ program/EU; Molecular Life Science program at UiO	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authorities; Erasmus+ program/EU; Molecular Life Science program at UiO	This work was supported by Norwegian Cancer Society Grant 5739724 (to E. S. V.), The Research Council of Norway Grant 250474 (to N. B.), South-Eastern Norway Regional Health Authorities Grants 2014034 and 2015095 (to B. D.), grants from the Erasmus+ program/EU (to N. B.) and the Molecular Life Science program at UiO (to M. S. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Alseth I, 2014, CURR OPIN GENET DEV, V26, P116, DOI 10.1016/j.gde.2014.07.008; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; FIELD AK, 1972, MEDICINE, V51, P169, DOI 10.1097/00005792-197205000-00002; Fladeby C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047466; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; GRESSER MJ, 1981, J BIOL CHEM, V256, P5981; Guo GM, 1997, J BACTERIOL, V179, P310, DOI 10.1128/jb.179.2.310-316.1997; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Kawahara Y, 2003, J NEUROCHEM, V85, P680, DOI 10.1046/j.1471-4159.2003.01703.x; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Mayeda A, 1999, METH MOL B, V118, P309; Mi RJ, 2012, MUTAT RES-FUND MOL M, V735, P12, DOI 10.1016/j.mrfmmm.2012.05.003; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; Osenbroch PO, 2009, FEBS J, V276, P2811, DOI 10.1111/j.1742-4658.2009.07004.x; Pang B, 2012, P NATL ACAD SCI USA, V109, P2319, DOI 10.1073/pnas.1118455109; Prestwich EG, 2013, CHEM RES TOXICOL, V26, P538, DOI 10.1021/tx300473n; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Scadden ADJ, 2001, EMBO J, V20, P4243, DOI 10.1093/emboj/20.15.4243; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vik ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3271; Weissbach R, 2012, RNA, V18, P462, DOI 10.1261/rna.027656.111; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Xie JW, 2014, BBA-GENE REGUL MECH, V1839, P1062, DOI 10.1016/j.bbagrm.2014.08.001; YAO M, 1994, J BIOL CHEM, V269, P16260; Yasui M, 2008, J MOL BIOL, V377, P1015, DOI 10.1016/j.jmb.2008.01.033; YIH LH, 1991, CELL BIOL INT REP, V15, P253, DOI 10.1016/0309-1651(91)90157-E	46	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21786	21801		10.1074/jbc.M116.730911	http://dx.doi.org/10.1074/jbc.M116.730911			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27573237	Green Published, hybrid			2022-12-28	WOS:000385999200042
J	Hashimoto, M; Ozono, M; Furuyashiki, M; Baba, R; Hashiguchi, S; Suda, Y; Fukase, K; Fujimoto, Y				Hashimoto, Masahito; Ozono, Mami; Furuyashiki, Maiko; Baba, Risako; Hashiguchi, Shuhei; Suda, Yasuo; Fukase, Koichi; Fujimoto, Yukari			Characterization of a Novel D-Glycero-D-talo-oct-2-ulosonic acid-substituted Lipid A Moiety in the Lipopolysaccharide Produced by the Acetic Acid Bacterium Acetobacter pasteurianus NBRC 3283	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; PROTON COUPLING-CONSTANTS; CALCOACETICUS NCTC 10305; MASS-SPECTROMETRY; STRUCTURAL-CHARACTERIZATION; CARBOHYDRATE BACKBONE; FATTY-ACIDS; MESORHIZOBIUM; CHROMATOGRAPHY; SEPARATION	Acetobacter pasteurianus is an aerobic Gram-negative rod that is used in the fermentation process used to produce the traditional Japanese black rice vinegar kurozu. Previously, we found that a hydrophobic fraction derived from kurozu stimulates Toll-like receptors to produce cytokines. LPSs, particularly LPS from A. pasteurianus, are strong candidates for the immunostimulatory component of kurozu. The LPS of A. pasteurianus remains stable in acidic conditions during the 2 years of the abovementioned fermentation process. Thus, we hypothesized that its stability results from its structure. In this study, we isolated the LPS produced by A. pasteurianus NBRC 3283 bacterial cells and characterized the structure of its lipid A component. The lipid A moiety was obtained by standard weak acid hydrolysis of the LPS. However, the hydrolysis was incomplete because a certain proportion of the LPS contained acid-stable D-glycero-D-talo-oct-2-ulosonic acid (Ko) residues instead of the acid-labile 3-deoxy-D-manno-oct-2-ulosonic acid residues that are normally found in typical LPS. Even so, we obtained a Ko-substituted lipid A with a novel sugar backbone, alpha-Man(14)[alpha-Ko(2-6)]beta-GlcN3N(1-6)alpha-GlcN(1-1)alpha-GlcA. Its reducing end GlcN(1-1) GlcA bond was also found to be quite acid-stable. Six fatty acids were attached to the backbone. Both the whole LPS and the lipid A moiety induced TNF-alpha production in murine cells via Toll-like receptor 4, although their activity was weaker than those of Escherichia coli LPS and lipid A. These results suggest that the structurally atypical A. pasteurianus lipid A found in this study remains stable and, hence, retains its immunostimulatory activity during acetic acid fermentation.	[Hashimoto, Masahito; Ozono, Mami; Furuyashiki, Maiko; Baba, Risako; Hashiguchi, Shuhei; Suda, Yasuo] Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, Korimoto 1-21-40, Kagoshima 8900065, Japan; [Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; [Fujimoto, Yukari] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan	Kagoshima University; Osaka University; Keio University	Hashimoto, M (corresponding author), Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, Korimoto 1-21-40, Kagoshima 8900065, Japan.	hassy@eng.kagoshima-u.ac.jp	Fujimoto, Yukari/M-7282-2014	Fujimoto, Yukari/0000-0001-5320-3192	Adaptable and Seamless Technology Transfer Program through Japan Science and Technology Agency [AS2111291E]; Japan Society for the Promotion of Science [23510259, 26350961]; Grants-in-Aid for Scientific Research [15H05836] Funding Source: KAKEN	Adaptable and Seamless Technology Transfer Program through Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through Grant AS2111291E from the Japan Science and Technology Agency and Grants-in-Aid for Scientific Research 23510259 and 26350961 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	ALTONA C, 1980, ORG MAGN RESONANCE, V13, P417, DOI 10.1002/mrc.1270130606; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Azuma Y, 2009, NUCLEIC ACIDS RES, V37, P5768, DOI 10.1093/nar/gkp612; Choma A, 2004, EUR J BIOCHEM, V271, P1310, DOI 10.1111/j.1432-1033.2004.04038.x; Choma A, 2012, CARBOHYD RES, V352, P126, DOI 10.1016/j.carres.2012.03.003; Chung HS, 2011, P NATL ACAD SCI USA, V108, P510, DOI 10.1073/pnas.1016462108; El-Samalouti VT, 2000, METH MOL B, V145, P287; FISCHER W, 1990, EUR J BIOCHEM, V194, P655, DOI 10.1111/j.1432-1033.1990.tb15665.x; Fujimoto Y, 2005, J ENDOTOXIN RES, V11, P340, DOI 10.1179/096805105X76841; Fukase Y, 2001, SYNLETT, P1693; GASS J, 1993, CARBOHYD RES, V244, P69, DOI 10.1016/0008-6215(93)80005-Y; GERWIG GJ, 1978, CARBOHYD RES, V62, P349, DOI 10.1016/S0008-6215(00)80881-2; GRADOWSKA W, 1994, J MICROBIOL METH, V20, P55, DOI 10.1016/0167-7012(94)90064-7; HAISHIMA Y, 1992, EUR J BIOCHEM, V203, P127, DOI 10.1111/j.1432-1033.1992.tb19837.x; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2004, INT IMMUNOL, V16, P1431, DOI 10.1093/intimm/dxh146; Hashimoto M, 2013, J BIOSCI BIOENG, V116, P688, DOI 10.1016/j.jbiosc.2013.05.029; Hashimoto M, 2012, MICROBES ENVIRON, V27, P490, DOI 10.1264/jsme2.ME12103; Holst O, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P21, DOI 10.1007/978-3-7091-0733-1_2; IKEMOTO S, 1978, J GEN APPL MICROBIOL, V24, P41, DOI 10.2323/jgam.24.41; Kabanov DS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P383, DOI 10.1134/S0006297910040012; Kato H, 1998, J BACTERIOL, V180, P3891, DOI 10.1128/JB.180.15.3891-3899.1998; Komaniecka I, 2010, MICROBIOL IMMUNOL, V54, P717, DOI 10.1111/j.1348-0421.2010.00269.x; Komaniecka I, 2010, CHEM-EUR J, V16, P2922, DOI 10.1002/chem.200902390; Kussak A, 2002, ANAL BIOCHEM, V307, P131, DOI 10.1016/S0003-2697(02)00004-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mayer H., 1985, METH MICROBIOL, V18, P157, DOI [10.1016/S0580-9517(08)70475-6, DOI 10.1016/S0580-9517(08)70475-6]; Murooka Yoshikatsu, 2009, P121, DOI 10.1007/978-88-470-0866-3_7; Nanda K, 2001, APPL ENVIRON MICROB, V67, P986, DOI 10.1128/AEM.67.2.986-990.2001; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Seydel U, 2005, FEBS J, V272, P327, DOI 10.1111/j.1742-4658.2004.04471.x; Shaffer SA, 2007, J AM SOC MASS SPECTR, V18, P1080, DOI 10.1016/j.jasms.2007.03.008; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Silipo A, 2005, CARBOHYD RES, V340, P2540, DOI 10.1016/j.carres.2005.08.021; Taniguchi Y, 2006, ANTICANCER RES, V26, P3997; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tsukushi Y, 2004, J ENDOTOXIN RES, V10, P25, DOI 10.1179/096805104225003799; Tvaroska I, 1995, ADV CARBOHYD CHEM BI, V51, P15, DOI 10.1016/S0065-2318(08)60191-2; Velasco J, 1998, CARBOHYD RES, V306, P283, DOI 10.1016/S0008-6215(97)10029-5; Vinogradov EV, 1998, J BIOL CHEM, V273, P28122, DOI 10.1074/jbc.273.43.28122; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Yasuno S, 1999, BIOSCI BIOTECH BIOCH, V63, P1353, DOI 10.1271/bbb.63.1353; Zahringer U, 2013, CARBOHYD RES, V378, P63, DOI 10.1016/j.carres.2013.05.003	43	17	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21184	21194		10.1074/jbc.M116.751271	http://dx.doi.org/10.1074/jbc.M116.751271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27539854	Green Published, hybrid			2022-12-28	WOS:000385406200032
J	Wang, HB; Lu, J; Edmunds, LR; Kulkarni, S; Dolezal, J; Tao, JY; Ranganathan, S; Jackson, L; Fromherz, M; Beer-Stolz, D; Uppala, R; Bharathi, S; Monga, SP; Goetzman, ES; Prochownik, EV				Wang, Huabo; Lu, Jie; Edmunds, Lia R.; Kulkarni, Sucheta; Dolezal, James; Tao, Junyan; Ranganathan, Sarangarajan; Jackson, Laura; Fromherz, Marc; Beer-Stolz, Donna; Uppala, Radha; Bharathi, Sivakama; Monga, Satdarshan P.; Goetzman, Eric S.; Prochownik, Edward V.			Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO SIGNALING PATHWAY; BETA-CATENIN; MOUSE MODELS; CANCER; METABOLISM; GENES; CELL; PROLIFERATION; ACTIVATION; BIOGENESIS	Hepatoblastoma (HB) is associated with aberrant activation of the beta-catenin and Hippo/YAP signaling pathways. Overexpression of mutant beta-catenin and YAP in mice induces HBs that express high levels of c-Myc (Myc). In light of recent observations that Myc is unnecessary for long-term hepatocyte proliferation, we have now examined its role in HB pathogenesis using the above model. Although Myc was found to be dispensable for in vivo HB initiation, it was necessary to sustain rapid tumor growth. Gene expression profiling identified key molecular differences between myc(+/+) (WT) and myc(-/-) (KO) hepatocytes and HBs that explain these behaviors. In HBs, these included both Myc-dependent and Myc-independent increases in families of transcripts encoding ribosomal proteins, non-structural factors affecting ribosome assembly and function, and enzymes catalyzing glycolysis and lipid bio-synthesis. In contrast, transcripts encoding enzymes involved in fatty acid beta-oxidation were mostly down-regulated. Myc-independent metabolic changes associated with HBs included dramatic reductions in mitochondrial mass and oxidative function, increases in ATP content and pyruvate dehydrogenase activity, and marked inhibition of fatty acid beta-oxidation (FAO). Myc-dependent metabolic changes included higher levels of neutral lipid and acetylCoA in WT tumors. The latter correlated with higher histone H3 acetylation. Collectively, our results indicate that the role of Myc in HB pathogenesis is to impose mutually dependent changes in gene expression and metabolic reprogramming that are unattainable in non-transformed cells and that cooperate to maximize tumor growth.	[Wang, Huabo; Lu, Jie; Edmunds, Lia R.; Kulkarni, Sucheta; Dolezal, James; Fromherz, Marc; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15224 USA; [Tao, Junyan; Monga, Satdarshan P.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15237 USA; [Ranganathan, Sarangarajan] UPMC, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA 15224 USA; [Jackson, Laura] UPMC, Childrens Hosp Pittsburgh, Div Neonatol, Pittsburgh, PA 15224 USA; [Beer-Stolz, Donna] Univ Pittsburgh, Med Ctr, Dept Cell Biol, Pittsburgh, PA 15237 USA; [Uppala, Radha; Bharathi, Sivakama; Goetzman, Eric S.] UPMC, Childrens Hosp Pittsburgh, Div Med Genet, Pittsburgh, PA 15224 USA; [Monga, Satdarshan P.] Univ Pittsburgh, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15237 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA 15237 USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Rangos Res Ctr, Rm 5124,4401 Penn Ave, Pittsburgh, PA 15224 USA.	procev@chp.edu		Ranganathan, Sarangarajan/0000-0001-6214-9167; Dolezal, James/0000-0002-6788-7203; Jackson, Laura/0000-0001-9088-576X; Monga, Satdarshan/0000-0002-8437-3378	National Institutes of Health [5RO1 CA174713, 1R01 CA204586, 1R01 DK100287]; Children's Hospital of Pittsburgh of UPMC Research Advisory Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD071834] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA174713, R01CA204586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007052, R01DK090242, R01DK100287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh of UPMC Research Advisory Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants 5RO1 CA174713 (to E. V. P.) and 1R01 CA204586 and 1R01 DK100287 (to S. P. M.). This work was also supported by a predoctoral research award from The Children's Hospital of Pittsburgh of UPMC Research Advisory Committee (to L. R. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armengol C, 2011, INT J BIOCHEM CELL B, V43, P265, DOI 10.1016/j.biocel.2009.07.012; BARRETT J, 1992, MOL CELL BIOL, V12, P3130, DOI 10.1128/MCB.12.7.3130; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Cairo Stefano, 2012, Front Biosci (Elite Ed), V4, P480; Campbell KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018408; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; De Ioris M, 2008, EUR J CANCER, V44, P545, DOI 10.1016/j.ejca.2007.11.022; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Edmunds LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134049; Edmunds LR, 2014, J BIOL CHEM, V289, P25382, DOI 10.1074/jbc.M114.580662; Eigentler A., 2020, MITOCHONDR PHYSL NET, V17, P1; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Hamada Y, 2003, PEDIATR SURG INT, V19, P112, DOI 10.1007/s00383-002-0734-2; Heck JE, 2013, CANCER EPIDEMIOL, V37, P390, DOI 10.1016/j.canep.2013.03.004; Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Landay M, 2000, CELL DEATH DIFFER, V7, P697, DOI 10.1038/sj.cdd.4400701; Leprivier G, 2015, BBA-GENE REGUL MECH, V1849, P845, DOI 10.1016/j.bbagrm.2014.11.002; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ranganathan S, 2005, PEDIATR DEVEL PATHOL, V8, P435, DOI 10.1007/s10024-005-0028-5; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Spector LG, 2012, PEDIATR BLOOD CANCER, V59, P776, DOI 10.1002/pbc.24215; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Sylvester KG, 2014, GASTROENTEROLOGY, V147, P562, DOI 10.1053/j.gastro.2014.07.026; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Trinei M, 2006, BBA-BIOENERGETICS, V1757, P624, DOI 10.1016/j.bbabio.2006.05.029; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vivanco I, 2014, BRIT J CANCER, V111, P2033, DOI 10.1038/bjc.2014.461; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	50	30	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26241	26251		10.1074/jbc.M116.754218	http://dx.doi.org/10.1074/jbc.M116.754218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27738108	Green Published, hybrid			2022-12-28	WOS:000391568200001
J	Bracher, S; Schmidt, CC; Dittmer, SI; Jung, H				Bracher, Susanne; Schmidt, Claudia C.; Dittmer, Sophie I.; Jung, Heinrich			Core Transmembrane Domain 6 Plays a Pivotal Role in the Transport Cycle of the Sodium/Proline Symporter PutP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-BINDING SITES; ESCHERICHIA-COLI; NA+/PROLINE TRANSPORTER; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; LIGAND-BINDING; OUTWARD-OPEN; LOOP 4; MECHANISM; NA+	Crystal structures of transporters with a LeuT-type structural fold assign core transmembrane domain 6 (TM6') a central role in substrate binding and translocation. Here, the function of TM6' in the sodium/proline symporter PutP, a member of the solute/sodium symporter family, was investigated. A complete scan of TM6' identified eight amino acids as particularly important for PutP function. Of these residues, Tyr-248, His-253, and Arg-257 impact sodium binding, whereas Arg-257 and Ala-260 may participate in interactions leading to closure of the inner gate. Furthermore, the previous suggestion of an involvement of Trp-244, Tyr-248, and Pro-252 in proline binding is further supported. In addition, substitution of Gly-245, Gly-247, and Gly250 affects the amount of PutP in the membrane. A Cys accessibility analysis suggests an involvement of the inner half of TM6' in the formation of a hydrophilic pathway that is open to the inside in the absence of ligands and closed in the presence of sodium and proline. In conclusion, the results demonstrate that TM6' plays a central role in substrate binding and release on the inner side of the membrane also in PutP and extend the knowledge on functionally relevant amino acids in transporters with a LeuT-type structural fold.	[Bracher, Susanne; Schmidt, Claudia C.; Dittmer, Sophie I.; Jung, Heinrich] Ludwig Maximilians Univ Munchen, Dept Biol 1, Div Microbiol, D-82152 Martinsried, Germany	University of Munich	Jung, H (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 1, Div Microbiol, D-82152 Martinsried, Germany.	hjung@lmu.de	Jung, Heinrich/K-3790-2014	Jung, Heinrich/0000-0002-5450-3063; Schmidt, Claudia/0000-0002-7642-7081	Deutsche Forschungsgemeinschaft [JU 333/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Project JU 333/4-2. The authors declare that they have no conflicts of interest with the contents of this article.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Bracher S, 2016, J BIOL CHEM, V291, P4998, DOI 10.1074/jbc.M115.675306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Jung H, 2012, FRONT BIOSCI-LANDMRK, V17, P745, DOI 10.2741/3955; Khafizov K, 2012, P NATL ACAD SCI USA, V109, pE3035, DOI 10.1073/pnas.1209039109; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Li Z, 2015, J BIOL CHEM, V290, P127, DOI 10.1074/jbc.M114.584383; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Olkhova E, 2011, J MOL BIOL, V406, P59, DOI 10.1016/j.jmb.2010.11.045; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Perez C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5231; Perez C, 2013, BIOL CHEM, V394, P641, DOI 10.1515/hsz-2012-0336; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Portulano C, 2014, ENDOCR REV, V35, P106, DOI 10.1210/er.2012-1036; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2015, VITAM HORM, V98, P63, DOI 10.1016/bs.vh.2014.12.003; Raba M, 2008, J MOL BIOL, V382, P884, DOI 10.1016/j.jmb.2008.07.070; Raba M, 2014, STRUCTURE, V22, P769, DOI 10.1016/j.str.2014.03.011; REIZER J, 1994, BBA-REV BIOMEMBRANES, V1197, P133, DOI 10.1016/0304-4157(94)90003-5; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STALMACH ME, 1983, J BACTERIOL, V156, P481, DOI 10.1128/JB.156.2.481-486.1983; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yamato I., 1993, ALKALI CATION TRANSP, P53; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	47	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26208	26215		10.1074/jbc.M116.753103	http://dx.doi.org/10.1074/jbc.M116.753103			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27793991	Green Published, hybrid			2022-12-28	WOS:000390345200036
J	Dong, L; Yuan, C; Orlando, BJ; Malkowski, MG; Smith, WL				Dong, Liang; Yuan, Chong; Orlando, Benjamin J.; Malkowski, Michael G.; Smith, William L.			Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); cyclooxygenase (COX); eicosanoid; fatty acid; prostaglandin; eicosapentaenoic acid; half-site; naproxen; oleic acid; palmitic acid	ENDOPEROXIDE-H SYNTHASE-1; ENDOCANNABINOID OXYGENATION; ARACHIDONIC-ACID; STRUCTURAL BASIS; SELECTIVE-INHIBITION; CRYSTAL-STRUCTURE; ARGININE 120; ACTIVE-SITE; CROSS-TALK; PROSTAGLANDIN	Prostaglandin endoperoxide H synthase-2 (PGHS-2), also called cyclooxygenase-2 (COX-2), converts arachidonic acid to PGH(2). PGHS-2 is a conformational heterodimer composed of allosteric (E-allo) and catalytic (E-cat) subunits. Fatty acids (FAs) bind to Arg-120 of E-allo increasing to different degrees, depending on the FA, the V-max of its E-cat partner. We report here that movement of helical residues 120-122 and loop residues 123-129 of E-allo underlies the allosteric effects of FAs and allosteric COX-2 inhibitors, including naproxen and flurbiprofen. An S121P substitution in both PGHS-2 monomers yields a variant (S121P/S121P PGHS-2) that has 1.7-1.8 times the V-max of native PGHS-2 and is relatively insensitive to activation by FAs or inhibition by allosteric inhibitors. The S121P substitution in E-allo is primarily responsible for these effects. In X-ray crystal structures, the C atoms of helical residues 119-122 of S121P/S121P PGHS-2 are displaced from their normal positions. Additionally, the S121P/S121P PGHS-2 variants in which Pro-127 and Ser-541 are replaced by cysteines spontaneously forms Cys-127 to Cys-541 cross-links between monomers. This is unlike the corresponding native PGHS-2 variant and suggests that S121P substitutions also unhinge the loop involving residues 123-129. We conclude the following: (a) the region involving residues 120-129 of unoccupied E-allo tonically inhibits E-cat; (b) binding of an activating FA (e.g. arachidonic, palmitic, or oleic acid) to E-allo or an S121P substitution in E-allo repositions this region to increase E-cat activity; and (c) allosteric COX inhibitors act by preventing FA binding to E-allo and additionally by relocating E-allo residues to inhibit E-cat.	[Dong, Liang; Yuan, Chong; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA; [Orlando, Benjamin J.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Orlando, Benjamin J.; Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute	Malkowski, MG; Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	malkowski@hwi.buffalo.edu; smithww@umich.edu		Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health from NIGMS [GM077176, GM115386, GM68848]; NCI [CA130810]; NHLBI [HL117798]; NATIONAL CANCER INSTITUTE [P50CA130810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848, R01GM077176, R01GM115386] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM077176 (to M. G. M,), GM115386 (to M. G. M.), and GM68848 (to W. L. S.) from NIGMS, Grant CA130810 (to W. L. S.) from NCI, and Grant HL117798 (to W. L. S.) from NHLBI. William L. Smith has served as a consultant for Cayman Chemical Company, products from which were used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong L, 2016, J LIPID RES, V57, P1043, DOI 10.1194/jlr.M067512; Dong L, 2016, J BIOL CHEM, V291, P4069, DOI 10.1074/jbc.M115.698001; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EJ, 2006, J BIOL CHEM, V281, P29309, DOI 10.1074/jbc.M601314200; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Greig GM, 1997, MOL PHARMACOL, V52, P829, DOI 10.1124/mol.52.5.829; Jiang Y, 2014, CANCER PREV RES, V7, P1011, DOI 10.1158/1940-6207.CAPR-14-0134; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Liu Y, 2016, J BIOL CHEM, V291, P948, DOI 10.1074/jbc.M115.668038; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Malkowski MG, 2000, ARCH BIOCHEM BIOPHYS, V380, P39, DOI 10.1006/abbi.2000.1906; MANCINI JA, 1995, J BIOL CHEM, V270, P29372, DOI 10.1074/jbc.270.49.29372; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Orlando BJ, 2016, J BIOL CHEM, V291, P15069, DOI 10.1074/jbc.M116.725713; Orlando BJ, 2015, J STRUCT BIOL, V189, P62, DOI 10.1016/j.jsb.2014.11.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wang JL, 2010, BIOORG MED CHEM LETT, V20, P7159, DOI 10.1016/j.bmcl.2010.07.054; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	57	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25641	25655		10.1074/jbc.M116.757310	http://dx.doi.org/10.1074/jbc.M116.757310			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756840	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000390095300030
J	Sielaff, H; Martin, J; Singh, D; Biukovic, G; Gruber, G; Frasch, WD				Sielaff, Hendrik; Martin, James; Singh, Dhirendra; Biukovic, Goran; Gruber, Gerhard; Frasch, Wayne D.			Power Stroke Angular Velocity Profiles of Archaeal A-ATP Synthase Versus Thermophilic and Mesophilic F-ATP Synthase Molecular Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; bioenergetics; F1FO-ATPase; molecular motor; single molecule biophysics; A-ATP synthase; F-ATP synthase; angular velocity; power stroke; single molecule rotation	ENTEROCOCCUS-HIRAE V-1-ATPASE; METHANOSARCINA-MAZEI GO1; EUKARYOTIC V-ATPASE; TORQUE GENERATION; CRYSTAL-STRUCTURES; SUBUNIT-F; F-1-ATPASE; ROTATION; RESOLUTION; MECHANISM	The angular velocities of ATPase-dependent power strokes as a function of the rotational position for the A-type molecular motor A(3)B(3)DF, from the Methanosarcina mazei Go1 A-ATP synthase, and the thermophilic motor (33), from Geobacillus stearothermophilus (formerly known as Bacillus PS3) F-ATP synthase, are resolved at 5 s resolution for the first time. Unexpectedly, the angular velocity profile of the A-type was closely similar in the angular positions of accelerations and decelerations to the profiles of the evolutionarily distant F-type motors of thermophilic and mesophilic origins, and they differ only in the magnitude of their velocities. M. mazei A(3)B(3)DF power strokes occurred in 120 degrees steps at saturating ATP concentrations like the F-type motors. However, because ATP-binding dwells did not interrupt the 120 degrees steps at limiting ATP, ATP binding to A(3)B(3)DF must occur during the catalytic dwell. Elevated concentrations of ADP did not increase dwells occurring 40 degrees after the catalytic dwell. In F-type motors, elevated ADP induces dwells 40 degrees after the catalytic dwell and slows the overall velocity. The similarities in these power stroke profiles are consistent with a common rotational mechanism for A-type and F-type rotary motors, in which the angular velocity is limited by the rotary position at which ATP binding occurs and by the drag imposed on the axle as it rotates within the ring of stator subunits.	[Martin, James; Frasch, Wayne D.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Sielaff, Hendrik; Singh, Dhirendra; Biukovic, Goran; Gruber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Arizona State University; Arizona State University-Tempe; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Frasch, WD (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.; Gruber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg; frasch@asu.edu	RAHI, DEEPALI/GMW-8189-2022	RAHI, DEEPALI/0000-0002-4818-5572; Singh, Dhirendra/0000-0002-5576-7052; Sielaff, Hendrik/0000-0001-5231-7286	National Institutes of Health [R01GM097510]; Ministry of Education (Singapore) [MOE2011-T2-2-156]; ARC [18/12]; Ministry of Health (Singapore) Grant National Medical Research Council [CBRG12nov049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education (Singapore)(Ministry of Education, Singapore); ARC(Australian Research Council); Ministry of Health (Singapore) Grant National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM097510 (to W. D. F.), Ministry of Education (Singapore) Grant MOE2011-T2-2-156, ARC 18/12, and Ministry of Health (Singapore) Grant National Medical Research Council, CBRG12nov049 (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Adachi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2026; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Deppenmeier Uwe, 2008, V45, P123, DOI 10.1007/400_2006_026; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Gayen S, 2007, BIOCHEMISTRY-US, V46, P11684, DOI 10.1021/bi701102n; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gruber G, 2014, BBA-BIOENERGETICS, V1837, P940, DOI 10.1016/j.bbabio.2014.03.004; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Ho J, 2015, J MOL BIOL, V427, P1866, DOI 10.1016/j.jmb.2015.01.024; Hornung T, 2008, BBA-BIOENERGETICS, V1777, P579, DOI 10.1016/j.bbabio.2008.04.016; Hornung T, 2011, METHODS MOL BIOL, V778, P273, DOI 10.1007/978-1-61779-261-8_18; Iino R, 2015, CURR OPIN STRUC BIOL, V31, P49, DOI 10.1016/j.sbi.2015.02.013; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kishikawa J, 2014, EUR BIOPHYS J BIOPHY, V43, P415, DOI 10.1007/s00249-014-0973-x; Kishikawa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064695; Kumar A, 2010, J MOL BIOL, V396, P301, DOI 10.1016/j.jmb.2009.11.046; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemker T, 2003, FEBS LETT, V544, P206, DOI 10.1016/S0014-5793(03)00496-4; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; Singh D, 2016, BBA-BIOENERGETICS, V1857, P177, DOI 10.1016/j.bbabio.2015.12.003; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Spetzler D, 2012, ADV PHOTOSYNTH RESP, V34, P561, DOI 10.1007/978-94-007-1579-0_22; Spetzler D, 2009, BIOCHEMISTRY-US, V48, P7979, DOI 10.1021/bi9008215; Stewart Alastair G, 2013, Bioarchitecture, V3, P2, DOI 10.4161/bioa.23301; Suzuki T, 2014, NAT CHEM BIOL, V10, P930, DOI [10.1038/nchembio.1635, 10.1038/NCHEMBIO.1635]; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	40	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25351	25363		10.1074/jbc.M116.745240	http://dx.doi.org/10.1074/jbc.M116.745240			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27729450	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000390095300007
J	Wakabayashi, S; Sawamura, N; Voelzmann, A; Broemer, M; Asahi, T; Hoch, M				Wakabayashi, Satoru; Sawamura, Naoya; Voelzmann, Andre; Broemer, Meike; Asahi, Toru; Hoch, Michael			Ohgata, the Single Drosophila Ortholog of Human Cereblon, Regulates Insulin Signaling-dependent Organismic Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; BAYESIAN PHYLOGENETIC INFERENCE; DNA-BINDING PROTEIN-1; POTASSIUM CHANNEL; CELLS; LENALIDOMIDE; COMPLEX; DEGRADATION; PROMOTES; SYSTEM	Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that is highly conserved in animals and plants. CRBN proteins have been implicated in various biological processes such as development, metabolism, learning, and memory formation, and their impairment has been linked to autosomal recessive non-syndromic intellectual disability and cancer. Furthermore, human CRBN was identified as the primary target of thalidomide teratogenicity. Data on functional analysis of CRBN family members in vivo, however, are still scarce. Here we identify Ohgata (OHGT), the Drosophila ortholog of CRBN, as a regulator of insulin signaling-mediated growth. Using ohgt mutants that we generated by targeted mutagenesis, we show that its loss results in increased body weight and organ size without changes of the body proportions. We demonstrate that ohgt knockdown in the fat body, an organ analogous to mammalian liver and adipose tissue, phenocopies the growth phenotypes. We further show that overgrowth is due to an elevation of insulin signaling in ohgt mutants and to the down-regulation of inhibitory cofactors of circulating Drosophila insulin-like peptides (DILPs), named acid-labile subunit and imaginal morphogenesis protein-late 2. The two inhibitory proteins were previously shown to be components of a heterotrimeric complex with growth-promoting DILP2 and DILP5. Our study reveals OHGT as a novel regulator of insulin-dependent organismic growth in Drosophila.	[Wakabayashi, Satoru; Sawamura, Naoya; Asahi, Toru] Waseda Univ, Fac Sci & Engn, TWIns, Shinjuku Ku, 2-2 Wakamatsu, Tokyo 1628480, Japan; [Sawamura, Naoya; Asahi, Toru] Waseda Univ, Res Org Nanolife Innovat, Shinjuku Ku, Tokyo 1620041, Japan; [Voelzmann, Andre] Univ Manchester, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Broemer, Meike] German Ctr Neurodegenerat Dis DZNE, Life & Med Sci LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany; [Hoch, Michael] Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Lab Mol Dev Biol, Carl Troll Str 31, D-53115 Bonn, Germany	Waseda University; Waseda University; University of Manchester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Sawamura, N; Asahi, T (corresponding author), Waseda Univ, Fac Sci & Engn, TWIns, Shinjuku Ku, 2-2 Wakamatsu, Tokyo 1628480, Japan.; Hoch, M (corresponding author), Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Lab Mol Dev Biol, Carl Troll Str 31, D-53115 Bonn, Germany.	naoya.sawamura@gmail.com; tasahi@waseda.jp; m.hoch@uni-bonn.de	Sawamura, Naoya/K-1663-2018	Sawamura, Naoya/0000-0003-4753-1119; Voelzmann, Andre/0000-0002-7682-5637	Leading Graduate Program in Science and Engineering, Waseda University from MEXT, Japan; European Union Institute in Japan at Waseda University (EUIJ Waseda); Deutsche Forschungsgemeinschaft (DFG) [VO 2071/1-1]; DFG [SFB 645, TRR83]; Helmholtz cross program topic "Metabolic Dysfunction"; DFG Excellence Cluster ImmunoSensation	Leading Graduate Program in Science and Engineering, Waseda University from MEXT, Japan; European Union Institute in Japan at Waseda University (EUIJ Waseda); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Helmholtz cross program topic "Metabolic Dysfunction"; DFG Excellence Cluster ImmunoSensation(German Research Foundation (DFG))	This work was supported by the Leading Graduate Program in Science and Engineering, Waseda University from MEXT, Japan; the European Union Institute in Japan at Waseda University (EUIJ Waseda); Deutsche Forschungsgemeinschaft (DFG) Grant VO 2071/1-1 (to A. V.); and DFG Grants SFB 645 and TRR83, the Helmholtz cross program topic "Metabolic Dysfunction," and the DFG Excellence Cluster ImmunoSensation (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal N, 2016, CELL METAB, V23, P675, DOI 10.1016/j.cmet.2016.03.003; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bauer R, 2006, CELL COMMUN ADHES, V13, P103, DOI 10.1080/15419060600631839; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10667; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Eichner R, 2016, NAT MED, V22, P735, DOI 10.1038/nm.4128; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; GARBE JC, 1993, DEVELOPMENT, V119, P1237; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gundner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097332; Hahn I, 2013, J CELL SCI, V126, P2470, DOI 10.1242/jcs.120964; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kang JA, 2016, P NATL ACAD SCI USA, V113, P8771, DOI 10.1073/pnas.1502166113; Kataoka K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29986; Kim HK, 2016, PFLUG ARCH EUR J PHY, V468, P1299, DOI 10.1007/s00424-016-1854-1; Koyama T, 2016, PLOS BIOL, V14, DOI [10.1371/journal.pbio.1002392, 10.1371/journal.pbio.1002551]; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kwon Y, 2015, DEV CELL, V33, P36, DOI 10.1016/j.devcel.2015.02.012; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pignoni F, 1997, DEVELOPMENT, V124, P271; Qiu WR, 2015, J BIOMOL STRUCT DYN, V33, P1731, DOI 10.1080/07391102.2014.968875; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodenfels J, 2014, GENE DEV, V28, P2636, DOI 10.1101/gad.249763.114; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sano H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005209; Sawamura N, 2015, BIOCHEM BIOPH RES CO, V464, P1054, DOI 10.1016/j.bbrc.2015.07.068; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Shimanouchi K, 2006, J BIOCHEM, V139, P51, DOI 10.1093/jb/mvj006; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wada T, 2016, BIOCHEM BIOPH RES CO, V477, P388, DOI 10.1016/j.bbrc.2016.06.091; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	72	7	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25120	25132		10.1074/jbc.M116.757823	http://dx.doi.org/10.1074/jbc.M116.757823			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27702999	Green Published, hybrid			2022-12-28	WOS:000388880100027
J	Dudakovic, A; Camilleri, ET; Riester, SM; Paradise, CR; Gluscevic, M; O'Toole, TM; Thaler, R; Evans, JM; Yan, H; Subramaniam, M; Hawse, JR; Stein, GS; Montecino, MA; Mcgee-Lawrence, ME; Westendorf', JJ; van Wijnen, AJ				Dudakovic, Amel; Camilleri, Emily T.; Riester, Scott M.; Paradise, Christopher R.; Gluscevic, Martina; O'Toole, Thomas M.; Thaler, Roman; Evans, Jared M.; Yan, Huihuang; Subramaniam, Malayannan; Hawse, John R.; Stein, Gary S.; Montecino, Martin A.; Mcgee-Lawrence, Meghan E.; Westendorf', Jennifer J.; van Wijnen, Andre J.			Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; HISTONE METHYLTRANSFERASE EZH2; CHIP-SEQ DATA; MUSCLE DIFFERENTIATION; INTEGRATIVE ANALYSIS; DEVELOPMENTAL GENES; DNA-METHYLATION; TARGETING EZH2; SELF-RENEWAL; OSTEOPOROSIS	Perturbations in skeletal development and bone degeneration may result in reduced bone mass and quality, leading to greater fracture risk. Bone loss is mitigated by bone protective therapies, but there is a clinical need for new bone-anabolic agents. Previous work has demonstrated that Ezh2 (enhancer of zeste homolog 2), a histone 3 lysine 27 (H3K27) methyltransferase, suppressed differentiation of osteogenic progenitors. Here, we investigated whether inhibition of Ezh2 can be leveraged for bone stimulatory applications. Pharmacologic inhibition and siRNA knockdown of Ezh2 enhanced osteogenic commitment of MC3T3 preosteoblasts. Next generation RNA sequencing of mRNAs and real time quantitative PCR profiling established that Ezh2 inactivation promotes expression of bone-related gene regulators and extracellular matrix proteins. Mechanistically, enhanced gene expression was linked to decreased H3K27 trimethylation (H3K27me3) near transcriptional start sites in genome-wide sequencing of chromatin immunoprecipitations assays. Administration of an Ezh2 inhibitor modestly increases bone density parameters of adult mice. Furthermore, Ezh2 inhibition also alleviated bone loss in an estrogen-deficient mammalian model for osteoporosis. Ezh2 inhibition enhanced expression of Wnt10B and Pth1r and increased the BMP-dependent phosphorylation of Smad1/5. Thus, these data suggest that inhibition of Ezh2 promotes paracrine signaling in osteoblasts and has bone anabolic and osteoprotective potential in adults.	[Dudakovic, Amel; Camilleri, Emily T.; Riester, Scott M.; Paradise, Christopher R.; O'Toole, Thomas M.; Thaler, Roman; Westendorf', Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA; [Subramaniam, Malayannan; Hawse, John R.; Westendorf', Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [Gluscevic, Martina] Mayo Clin, Initiat Maximum Student Dev, Rochester, MN 55905 USA; [Evans, Jared M.; Yan, Huihuang] Mayo Clin, Stat & Informat, Rochester, MN 55905 USA; [Stein, Gary S.] Univ Vermont, Dept Biochem, Sch Med, Burlington, VT 05405 USA; [Montecino, Martin A.] Univ Andres Bello, Ctr Invest Biomed, Santiago 8370146, Chile; [Montecino, Martin A.] Univ Andres Bello, FONDAP Ctr Genome Regulat, Santiago 8370146, Chile; [Mcgee-Lawrence, Meghan E.] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Vermont; Universidad Andres Bello; Universidad Andres Bello; University System of Georgia; Augusta University	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.; van Wijnen, AJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Dudakovic, Amel/0000-0002-8850-3977; Camilleri, Emily/0000-0001-8982-6770	National Institutes of Health [F32 AR066508, R01 AR049069, R01 AR068103, R01 DE020194]; Fondo de Financiamiento de Centros de Investigation en Areas Prioritarias [15090007]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR068103, F32AR066508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo de Financiamiento de Centros de Investigation en Areas Prioritarias; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AR066508 (to A. D.), R01 AR049069 (to A. J. v. W.), R01 AR068103 (to J. J. W.), and R01 DE020194 (to J. J. W.), Fondo de Financiamiento de Centros de Investigation en Areas Prioritarias 15090007 (to M. A. M.), and generous philanthropic support from William H. and Karen J. Eby and the charitable foundation in their names. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Bellido T, 2013, BONE, V54, P250, DOI 10.1016/j.bone.2012.09.016; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Canalis E, 2013, NAT REV ENDOCRINOL, V9, P575, DOI 10.1038/nrendo.2013.154; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chou RH, 2015, CELL TRANSPLANT, V24, P313, DOI 10.3727/096368915X686823; de Gorter D.J.J., 2013, PRIMER METABOLIC BON, P15, DOI DOI 10.1002/9781118453926.CH2; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000053299; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Ge K., 2012, BIOCHIM BIOPHYS ACTA, V7, P727; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Huang D, 2016, ONCOL REP, V35, P1083, DOI 10.3892/or.2015.4467; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui TQ, 2014, J ENDODONT, V40, P1132, DOI 10.1016/j.joen.2014.01.031; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Marchesi I, 2014, CELL CYCLE, V13, P516, DOI 10.4161/cc.27921; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; PECK WA, 1993, AM J MED, V94, P646; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Pike JW, 2011, J BONE MINER RES, V26, P1155, DOI 10.1002/jbmr.317; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Sanchez-Duffhues G, 2015, BONE, V80, P43, DOI 10.1016/j.bone.2015.05.025; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Yan HH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-280; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhu L, 2013, BIOCHEM BIOPH RES CO, V432, P612, DOI 10.1016/j.bbrc.2013.02.036	52	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24594	24606		10.1074/jbc.M116.740571	http://dx.doi.org/10.1074/jbc.M116.740571			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27758858	Green Published, hybrid			2022-12-28	WOS:000388875500021
J	Libby, AE; Bales, E; Orlicky, DJ; McManaman, JL				Libby, Andrew E.; Bales, Elise; Orlicky, David J.; McManaman, James L.			Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); gene knockout; lipid droplet; lipid metabolism; lipogenesis; liver metabolism; mass spectrometry (MS); membrane lipid; metabolic disease; perilipin-2	FATTY LIVER-DISEASE; DIFFERENTIATION-RELATED PROTEIN; STEAROYL-COA DESATURASE; ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; ACID SYNTHESIS; ANTISENSE OLIGONUCLEOTIDE; PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTOR	Perilipin-2 (PLIN2) is a constitutively associated cytoplasmic lipid droplet coat protein that has been implicated in fatty liver formation in non-alcoholic fatty liver disease. Mice with or without whole-body deletion of perilipin-2 (Plin2-null) were fed either Western or control diets for 30 weeks. Perilipin-2 deletion prevents obesity and insulin resistance in Western diet-fed mice and dramatically reduces hepatic triglyceride and cholesterol levels in mice fed Western or control diets. Gene and protein expression studies reveal that PLIN2 deletion suppressed SREBP-1 and SREBP-2 target genes involved in de novo lipogenesis and cholesterol biosynthetic pathways in livers of mice on either diet. GC-MS lipidomics demonstrate that this reduction correlated with profound alterations in the hepatic lipidome with significant reductions in both desaturation and elongation of hepatic neutral lipid species. To examine the possibility that lipidomic actions of PLIN2 deletion contribute to suppression of SREBP activation, we isolated endoplasmic reticulum membrane fractions from long-term Western diet-fed wild type (WT) and Plin2-null mice. Lipidomic analyses reveal that endoplasmic reticulum membranes from Plin2-null mice are markedly enriched in -3 and -6 long-chain polyunsaturated fatty acids, which others have shown inhibit SREBP activation and de novo lipogenesis. Our results identify PLIN2 as a determinant of global changes in the hepatic lipidome and suggest the hypothesis that these actions contribute to SREBP-regulated de novo lipogenesis involved in non-alcoholic fatty liver disease.	[Libby, Andrew E.; McManaman, James L.] Univ Colorado, Integrated Physiol Grad Program, Anschutz Med Campus, Aurora, CO 80045 USA; [Bales, Elise; McManaman, James L.] Univ Colorado, Div Reprod Sci, Anschutz Med Campus,12700 E 19th Ave,Rm 3013, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Div Reprod Sci, Anschutz Med Campus,12700 E 19th Ave,Rm 3013, Aurora, CO 80045 USA.	jim.mcmanaman@ucdenver.edu			National Institutes of Health [2RO1-HD045965]; University of Colorado CCTSI/National Institutes of Health [TL1-TR001081]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129, R01HD045965, R01HD075285] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado CCTSI/National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant 2RO1-HD045965 (to J.L.M.) and University of Colorado CCTSI/National Institutes of Health Grant TL1-TR001081 (to A.E.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Carr RM, 2016, EXP CELL RES, V340, P187, DOI 10.1016/j.yexcr.2015.10.021; Catenacci VA, 2009, CLIN CHEST MED, V30, P415, DOI 10.1016/j.ccm.2009.05.001; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; GARG ML, 1988, J NUTR, V118, P661, DOI 10.1093/jn/118.6.661; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Imai Y, 2012, PHYSIOL GENOMICS, V44, P1125, DOI 10.1152/physiolgenomics.00045.2012; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Langhi C, 2014, J HEPATOL, V61, P358, DOI 10.1016/j.jhep.2014.04.009; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu XJ, 2014, BIOCHEM BIOPH RES CO, V450, P117, DOI 10.1016/j.bbrc.2014.05.072; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712; Manrique C, 2013, ENDOCRINOLOGY, V154, P3632, DOI 10.1210/en.2013-1256; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Scorletti E, 2013, ANNU REV NUTR, V33, P231, DOI 10.1146/annurev-nutr-071812-161230; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Takahashi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20975; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; Torres DM, 2012, SEMIN LIVER DIS, V32, P30, DOI 10.1055/s-0032-1306424; Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062; Tripathy S, 2013, J LIPID RES, V54, P71, DOI 10.1194/jlr.M028787; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Yamada K, 2015, LIVER INT, V35, P582, DOI 10.1111/liv.12685; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zhang SB, 2005, BIOCHEM J, V388, P135, DOI 10.1042/BJ20041554	68	51	56	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24231	24246		10.1074/jbc.M116.759795	http://dx.doi.org/10.1074/jbc.M116.759795			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679530	hybrid, Green Published			2022-12-28	WOS:000388498100036
J	Zhang, DM; Marlin, MC; Liang, ZM; Ahmad, M; Ashpole, NM; Sonntag, WE; Zhao, ZJ; Li, GP				Zhang, Dongmei; Marlin, M. Caleb; Liang, Zhimin; Ahmad, Mohiuddin; Ashpole, Nicole M.; Sonntag, William E.; Zhao, Zhizhuang Joe; Li, Guangpu			The Protein Tyrosine Phosphatase MEG2 Regulates the Transport and Signal Transduction of Tropomyosin Receptor Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophosphorylation; membrane trafficking; neuron; receptor tyrosine kinase; tyrosine-protein phosphatase (tyrosine phosphatase); PTP-MEG2; PTPN9; TrkA	NERVE GROWTH-FACTOR; T-CELLS; ACTIVATION; POLYPHOSPHOINOSITIDES; TRAFFICKING; EXPRESSION; HOMOLOGY; PTP-MEG2; SEC14P	Protein tyrosine phosphatase MEG2 (PTP-MEG2) is a unique nonreceptor tyrosine phosphatase associated with transport vesicles, where it facilitates membrane trafficking by dephosphorylation of the N-ethylmaleimide-sensitive fusion factor. In this study, we identify the neurotrophin receptor TrkA as a novel cargo whose transport to the cell surface requires PTP-MEG2 activity. In addition, TrkA is also a novel substrate of PTP-MEG2, which dephosphorylates both Tyr-490 and Tyr-674/Tyr-675 of TrkA. As a result, overexpression of PTP-MEG2 down-regulates NGF/TrkA signaling and blocks neurite outgrowth and differentiation in PC12 cells and cortical neurons.	[Zhang, Dongmei] Fujian Agr & Forestry Univ, Coll Plant Protect, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China; [Zhang, Dongmei; Marlin, M. Caleb; Liang, Zhimin; Li, Guangpu] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Ahmad, Mohiuddin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Zhao, Zhizhuang Joe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Ashpole, Nicole M.; Sonntag, William E.] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK 73104 USA; [Zhao, Zhizhuang Joe; Li, Guangpu] Univ Oklahoma Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA	Fujian Agriculture & Forestry University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Li, GP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	guangpu-li@ouhsc.edu	Li, Guangpu/GRS-5397-2022	Ahmad, Mohiuddin/0000-0001-9123-0618; sonntag, William/0000-0003-1850-2407; Marlin, M. Caleb/0000-0003-0453-5355	Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR15-089]; National Institutes of Health [R01GM074692]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038747] Funding Source: NIH RePORTER	Oklahoma Center for the Advancement of Science and Technology (OCAST); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Oklahoma Center for the Advancement of Science and Technology (OCAST) Grant HR15-089 and National Institutes of Health Grant R01GM074692 (to G. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad M, 2012, NEURON, V73, P260, DOI 10.1016/j.neuron.2011.11.020; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GU MX, 1992, P NATL ACAD SCI USA, V89, P2980, DOI 10.1073/pnas.89.7.2980; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Huynh H, 2003, J IMMUNOL, V171, P6661, DOI 10.4049/jimmunol.171.12.6661; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kruger JM, 2002, J BIOL CHEM, V277, P2620, DOI 10.1074/jbc.M104550200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Saito K, 2007, J BIOL CHEM, V282, P15170, DOI 10.1074/jbc.M608682200; Wang XD, 2002, J IMMUNOL, V168, P4612, DOI 10.4049/jimmunol.168.9.4612; Wang YC, 2005, J EXP MED, V202, P1587, DOI 10.1084/jem.20051108; Xu MJ, 2003, BLOOD, V102, P4354, DOI 10.1182/blood-2003-04-1308; Zhao RX, 2003, J BIOL CHEM, V278, P22609, DOI 10.1074/jbc.M301560200; ZHOU J, 1995, J NEUROCHEM, V65, P1146	17	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23895	23905		10.1074/jbc.M116.728550	http://dx.doi.org/10.1074/jbc.M116.728550			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27655914	hybrid, Green Published			2022-12-28	WOS:000388498100005
J	Cheng, DM; Xu, X; Simon, T; Boudyguina, E; Deng, ZY; VerHague, M; Lee, AH; Shelness, GS; Weinberg, RB; Parks, JS				Cheng, Dongmei; Xu, Xu; Simon, Trang; Boudyguina, Elena; Deng, Zhiyong; VerHague, Melissa; Lee, Ann-Hwee; Shelness, Gregory S.; Weinberg, Richard B.; Parks, John S.			Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; cAMP response element-binding protein (CREB); lipoprotein; lipoprotein secretion; liver; secretion; microsomal triglyceride transfer protein; hepatosteatosis; very low density lipoproteins	TRIGLYCERIDE TRANSFER PROTEIN; FATTY LIVER-DISEASE; LIPID-METABOLISM; MESSENGER-RNA; APO-B; SECRETION; TISSUE; CELLS; OVEREXPRESSION; STEATOSIS	Hepatic apolipoprotein A-IV (apoA-IV) expression is correlated with hepatic triglyceride (TG) content in mouse models of chronic hepatosteatosis, and steatosis-induced hepatic apoA-IV gene expression is regulated by nuclear transcription factor cAMP-responsive element-binding protein H (CREBH) processing. To define what aspects of TG homeostasis regulate hepatic CREBH processing and apoA-IV gene expression, several mouse models of attenuated VLDL particle assembly were subjected to acute hepatosteatosis induced by an overnight fast or short term ketogenic diet feeding. Compared with chow-fed C57BL/6 mice, fasted or ketogenic diet-fed mice displayed increased hepatic TG content, which was highly correlated (r(2) = 0.95) with apoA-IV gene expression, and secretion of larger, TG-enriched VLDL, despite a lower rate of TG secretion and a similar or reduced rate of apoB100 secretion. When VLDL particle assembly and secretion was inhibited by hepatic shRNA-induced apoB silencing or genetic or pharmacologic reduction in microsomal triglyceride transfer protein (MTP) activity, hepatic TG content increased dramatically; however, CREBH processing and apoA-IV gene expression were attenuated compared with controls. Adenovirus-mediated reconstitution of MTP expression proportionately restored CREBH processing and apoA-IV expression in liver-specific MTP knock-out mice. These results reveal that hepatic TG content, per se, does not regulate CREBH processing. Instead, TG mobilization into the endoplasmic reticulum for nascent VLDL particle assembly activates CREBH processing and enhances apoA-IV gene expression in the setting of acute steatosis. We conclude that VLDL assembly and CREBH activation play key roles in the response to hepatic steatosis by up-regulating apoA-IV and promoting assembly and secretion of larger, more TG-enriched VLDL particles.	[Cheng, Dongmei; Boudyguina, Elena; VerHague, Melissa; Shelness, Gregory S.; Parks, John S.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Simon, Trang; Weinberg, Richard B.] Wake Forest Sch Med, Dept Internal Med, Gastroenterol Sect, Winston Salem, NC 27157 USA; [Deng, Zhiyong] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Parks, John S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Xu, Xu; Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Cornell University	Parks, JS (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jparks@wakehealth.edu			National Institutes of Health [R01 HL119983, R01 DK089211]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119983, R01HL119962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01 HL119983 (to J. S. P.) and R01 DK089211 (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Black DD, 2007, AM J PHYSIOL-GASTR L, V293, pG519, DOI 10.1152/ajpgi.00189.2007; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Cheng DM, 2010, J LIPID RES, V51, P849, DOI 10.1194/jlr.D002709; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cromwell WC, 2007, J CLIN LIPIDOL, V1, P583, DOI 10.1016/j.jacl.2007.10.001; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; ELSHOURBAGY NA, 1986, J BIOL CHEM, V261, P1998; Evert M, 2003, PATHOL RES PRACT, V199, P373, DOI 10.1078/0344-0338-00433; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Gallagher JW, 2004, J LIPID RES, V45, P1826, DOI 10.1194/jlr.M400188-JLR200; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hamilton RL, 1998, J LIPID RES, V39, P1543; Hanniman EA, 2006, J LIPID RES, V47, P2503, DOI 10.1194/jlr.M600303-JLR200; Kalogeris TJ, 1997, J NUTR, V127, pS537, DOI 10.1093/jn/127.3.537S; KARATHANASIS SK, 1986, BIOCHEMISTRY-US, V25, P3962, DOI 10.1021/bi00361a034; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Liang Y, 2004, MOL ENDOCRINOL, V18, P2000, DOI 10.1210/me.2003-0477; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Lu S, 2002, J BIOL CHEM, V277, P31929, DOI 10.1074/jbc.M201418200; Nguyen AT, 2006, BBA-MOL CELL BIOL L, V1761, P182, DOI 10.1016/j.bbalip.2006.02.004; Otvos JD, 2011, J CLIN LIPIDOL, V5, P105, DOI 10.1016/j.jacl.2011.02.001; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Robl JA, 2001, J MED CHEM, V44, P851, DOI 10.1021/jm000494a; Sanecka A, 2012, MOL IMMUNOL, V50, P66, DOI 10.1016/j.molimm.2011.12.003; Shelness GS, 2005, CURR OPIN LIPIDOL, V16, P325, DOI 10.1097/01.mol.0000169353.12772.eb; Sozio MS, 2010, SEMIN LIVER DIS, V30, P378, DOI 10.1055/s-0030-1267538; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; SWANEY JB, 1977, BIOCHEMISTRY-US, V16, P271, DOI 10.1021/bi00621a018; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; VerHague MA, 2013, ARTERIOSCL THROM VAS, V33, P2501, DOI 10.1161/ATVBAHA.113.301948; Wang F, 2015, J LIPID RES, V56, P1403, DOI 10.1194/jlr.R052753; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Weinberg RB, 2000, J LIPID RES, V41, P1419; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; WEISGRABER KH, 1978, BIOCHEM BIOPH RES CO, V85, P287, DOI 10.1016/S0006-291X(78)80041-2; WU AL, 1978, J BIOL CHEM, V253, P2525; Xu X, 2014, J LIPID RES, V55, P850, DOI 10.1194/jlr.M045104	46	15	15	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23793	23803		10.1074/jbc.M116.749283	http://dx.doi.org/10.1074/jbc.M116.749283			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27655915	Green Published, hybrid			2022-12-28	WOS:000387884400038
J	Rompler, K; Muller, T; Juris, L; Wissel, M; Vukotic, M; Hofmann, K; Deckers, M				Roempler, Katharina; Mueller, Tobias; Juris, Lisa; Wissel, Mirjam; Vukotic, Milena; Hofmann, Kay; Deckers, Markus			Overlapping Role of Respiratory Supercomplex Factor Rcf2 and Its N-terminal Homolog Rcf3 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c oxidase (complex IV); membrane protein; mitochondria; protein assembly; respiratory chain	CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-MEMBRANE PROTEIN; OXIDATIVE-PHOSPHORYLATION; CHAIN SUPERCOMPLEXES; YEAST; COMPLEX; ORGANIZATION; CARDIOLIPIN; BIOGENESIS; COMPONENTS	The mitochondrial electron transport chain consists of individual protein complexes arranged into large macromolecular structures, termed respiratory chain supercomplexes or respirasomes. In the yeast Saccharomyces cerevisiae, respiratory chain supercomplexes form by association of the bc(1) complex with the cytochrome c oxidase. Formation and maintenance of these assemblies are promoted by specific respiratory supercomplex factors, the Rcf proteins. For these proteins a regulatory function in bridging the electron transfer within supercomplexes has been proposed. Here we report on the maturation of Rcf2 into an N- and C-terminal peptide. We show that the previously uncharacterized Rcf3 (YBR255c-A) is a homolog of the N-terminal Rcf2 peptide, whereas Rcf1 is homologous to the C-terminal portion. Both Rcf3 and the C-terminal fragment of Rcf2 associate with monomeric cytochrome c oxidase and respiratory chain supercomplexes. A lack of Rcf2 and Rcf3 increases oxygen flux through the respiratory chain by up-regulation of the cytochrome c oxidase activity. A double gene deletion of RCF2 and RCF3 affects cellular survival under non-fermentable growth conditions, suggesting an overlapping role for both proteins in the regulation of the OXPHOS activity. Furthermore, our data suggest an association of all three Rcf proteins with the bc(1) complex in the absence of a functional cytochrome c oxidase and identify a supercomplex independent interaction network of the Rcf proteins.	[Roempler, Katharina; Mueller, Tobias; Juris, Lisa; Wissel, Mirjam; Vukotic, Milena; Deckers, Markus] Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Gottingen; University of Cologne	Deckers, M (corresponding author), Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany.	markus.deckers@medizin.uni-goettingen.de			Deutsche Forschungsgemeinschaft [DE 2277/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DE 2277/1-1. The authors declare that they have no conflicts of interest with the contents of this article.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Deckers M, 2014, FEBS LETT, V588, P2985, DOI 10.1016/j.febslet.2014.06.006; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Helbig AO, 2009, PROTEOMICS, V9, P4787, DOI 10.1002/pmic.200800951; HORAZDOVSKY BF, 1993, J BIOL CHEM, V268, P4953; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Levchenko M, 2016, BBA-MOL CELL RES, V1863, P1624, DOI 10.1016/j.bbamcr.2016.04.007; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lundin CR, 2016, P NATL ACAD SCI USA, V113, pE4476, DOI 10.1073/pnas.1601196113; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; ONISHI T, 1967, EUR J BIOCHEM, V1, P301, DOI 10.1111/j.1432-1033.1967.tb00074.x; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Reinhold R, 2011, HUM MOL GENET, V20, P2379, DOI 10.1093/hmg/ddr145; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Ryan M. T., 2001, PROTEIN TRANSLOCATIO; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; TAANMAN JW, 1993, J BIOL CHEM, V268, P18754; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200	35	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23769	23778		10.1074/jbc.M116.734665	http://dx.doi.org/10.1074/jbc.M116.734665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27662906	Green Published, hybrid			2022-12-28	WOS:000387884400036
J	Wickramaratne, S; Ji, SF; Mukherjee, S; Su, Y; Pence, MG; Lior-Hoffmann, L; Fu, I; Broyde, S; Guengerich, FP; Distefano, M; Scharer, OD; Sham, YY; Tretyakova, N				Wickramaratne, Susith; Ji, Shaofei; Mukherjee, Shivam; Su, Yan; Pence, Matthew G.; Lior-Hoffmann, Lee; Fu, Iwen; Broyde, Suse; Guengerich, F. Peter; Distefano, Mark; Scharer, Orlando D.; Sham, Yuk Yin; Tretyakova, Natalia			Bypass of DNA-Protein Cross-links Conjugated to the 7-Deazaguanine Position of DNA by Translesion Synthesis Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; gel electrophoresis; mass spectrometry (MS); molecular dynamics; DNA-protein conjugates; reductive amination; steady-state kinetics; translesion synthesis	NUCLEOTIDE EXCISION-REPAIR; ANTITUMOR NITROGEN MUSTARDS; FIBROSARCOMA HT1080 CELLS; Y-FAMILY; MAMMALIAN-CELLS; MAJOR GROOVE; REDUCTIVE AMINATION; REPLICATION; ADDUCT; KAPPA	DNA-protein cross-links (DPCs) are bulky DNA lesions that form both endogenously and following exposure to bis-electrophiles such as common antitumor agents. The structural and biological consequences of DPCs have not been fully elucidated due to the complexity of these adducts. The most common site of DPC formation in DNA following treatment with bis-electrophiles such as nitrogen mustards and cisplatin is the N7 position of guanine, but the resulting conjugates are hydrolytically labile and thus are not suitable for structural and biological studies. In this report, hydrolytically stable structural mimics of N7-guanine-conjugated DPCs were generated by reductive amination reactions between the Lys and Arg side chains of proteins/peptides and aldehyde groups linked to 7-deazaguanine residues in DNA. These model DPCs were subjected to in vitro replication in the presence of human translesion synthesis DNA polymerases. DPCs containing full-length proteins (11-28 kDa) or a 23-mer peptide blocked human polymerases and . DPC conjugates to a 10-mer peptide were bypassed with nucleotide insertion efficiency 50-100-fold lower than for native G. Both human polymerase (hPol) and hPol inserted the correct base (C) opposite the 10-mer peptide cross-link, although small amounts of T were added by hPol . Molecular dynamics simulation of an hPol ternary complex containing a template-primer DNA with dCTP opposite the 10-mer peptide DPC revealed that this bulky lesion can be accommodated in the polymerase active site by aligning with the major groove of the adducted DNA within the ternary complex of polymerase and dCTP.	[Wickramaratne, Susith; Ji, Shaofei; Tretyakova, Natalia] Univ Minnesota, Mason Canc Ctr, 2231 6th St SE,2-147 CCRB, Minneapolis, MN 55455 USA; [Wickramaratne, Susith; Ji, Shaofei; Distefano, Mark] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Sham, Yuk Yin] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA; [Tretyakova, Natalia] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Scharer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Mukherjee, Shivam; Scharer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Lior-Hoffmann, Lee; Fu, Iwen; Broyde, Suse] NYU, Dept Biol, New York, NY 10003 USA; [Su, Yan; Pence, Matthew G.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; Vanderbilt University	Tretyakova, N (corresponding author), Univ Minnesota, Mason Canc Ctr, 2231 6th St SE,2-147 CCRB, Minneapolis, MN 55455 USA.; Tretyakova, N (corresponding author), Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.	trety001@umn.edu	Pence, Matthew/J-1379-2012; Ji, Shaofei/K-3555-2019; Scharer, Orlando/B-8908-2008; Pence, Matthew/C-9171-2013; Schärer, Orlando D./AAF-8613-2021; Sham, Yuk Y/A-6472-2011	Pence, Matthew/0000-0003-2271-789X; Ji, Shaofei/0000-0003-0013-0617; Scharer, Orlando/0000-0003-2425-2715; Pence, Matthew/0000-0003-2271-789X; Sham, Yuk Y/0000-0003-2601-8930	National Institutes of Health NIEHS [R01 ES023350, R01 ES010546, R01 ES025987]; National Institutes of Health [R01 CA100670, R01 CA75449]; NIGMS, National Institutes of Health [R01 GM084152]; Brainstorm Award from the University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE [R01CA165911, R01CA075449, R01CA100670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025987, R01ES023350, R01ES010546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084152] Funding Source: NIH RePORTER	National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brainstorm Award from the University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIEHS Grants R01 ES023350 (to N. T.), R01 ES010546 (to F. P. G.), and R01 ES025987 (to S. B.); NCI, National Institutes of Health Grants R01 CA100670 (to N. T.) and R01 CA75449 (to S. B.); and NIGMS, National Institutes of Health Grant R01 GM084152 (to M. D.) and a Brainstorm Award from the University of Minnesota Masonic Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bau DT, 2002, ENVIRON HEALTH PERSP, V110, P753, DOI 10.1289/ehp.02110s5753; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Chakrabarti SK, 1999, TOXICOL APPL PHARM, V154, P245, DOI 10.1006/taap.1998.8584; Cho SH, 2013, CHEM RES TOXICOL, V26, P1005, DOI 10.1021/tx400145e; Chung JA, 2009, ANAL BIOCHEM, V386, P1, DOI 10.1016/j.ab.2008.09.007; DIZDAROGLU M, 1989, CANCER RES, V49, P3463; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Enoiu Milica, 2012, Methods Mol Biol, V920, P203, DOI 10.1007/978-1-61779-998-3_15; FEDTKE N, 1990, CARCINOGENESIS, V11, P1287, DOI 10.1093/carcin/11.8.1287; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P977, DOI 10.1021/bi00456a020; Ganguly M, 2007, NUCLEIC ACIDS RES, V35, P6181, DOI 10.1093/nar/gkm670; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; Geacintov N, 2010, CHEM BIOL DNA DAMAGE; Gherezghiher TB, 2013, J PROTEOME RES, V12, P2151, DOI 10.1021/pr3011974; GILMAN A, 1946, SCIENCE, V103, P409, DOI 10.1126/science.103.2675.409; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Groehler A, 2016, CHEM RES TOXICOL, V29, P190, DOI 10.1021/acs.chemrestox.5b00430; Gueranger Q, 2011, NUCLEIC ACIDS RES, V39, P5057, DOI 10.1093/nar/gkr112; HALL AG, 1992, BLOOD REV, V6, P163, DOI 10.1016/0268-960X(92)90028-O; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kotapati S, 2012, J BIOL CHEM, V287, P38800, DOI 10.1074/jbc.M112.396788; Kowal EA, 2011, J PHYS CHEM B, V115, P13925, DOI 10.1021/jp207104w; Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Lior-Hoffmann L, 2014, BIOCHEMISTRY-US, V53, P5683, DOI 10.1021/bi5007964; Loeber R, 2008, CHEM RES TOXICOL, V21, P787, DOI 10.1021/tx7004508; Loeber RL, 2009, CHEM RES TOXICOL, V22, P1151, DOI 10.1021/tx900078y; Loecken EM, 2008, CHEM RES TOXICOL, V21, P453, DOI 10.1021/tx7003618; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Maddukuri L, 2010, BIOCHEMISTRY-US, V49, P8415, DOI 10.1021/bi1009024; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Michaelson-Richie ED, 2011, J PROTEOME RES, V10, P2785, DOI 10.1021/pr200042u; Michaelson-Richie ED, 2010, J PROTEOME RES, V9, P4356, DOI 10.1021/pr1000835; Ming X. I., 2011, THESIS; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Nakano T, 2003, J BIOL CHEM, V278, P25264, DOI 10.1074/jbc.M212847200; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; OCONNOR PM, 1989, J BIOL CHEM, V264, P6391; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Rechkoblit O, 2002, J BIOL CHEM, V277, P30488, DOI 10.1074/jbc.M201167200; Roy U, 2016, DNA REPAIR, V44, P33, DOI 10.1016/j.dnarep.2016.05.004; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Singer B., 1983, MOL BIOL MUTAGENS CA; Stingele J, 2015, TRENDS BIOCHEM SCI, V40, P67, DOI 10.1016/j.tibs.2014.10.012; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Ho TV, 2011, NUCLEIC ACIDS RES, V39, P7455, DOI 10.1093/nar/gkr448; Tretyakova NY, 2015, ACCOUNTS CHEM RES, V48, P1631, DOI 10.1021/acs.accounts.5b00056; Tretyakova NY, 2013, BIOCHEMISTRY-US, V52, P3171, DOI 10.1021/bi400273m; Wang CH, 1999, J CONTROL RELEASE, V61, P21, DOI 10.1016/S0168-3659(99)00098-X; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638; Wickramaratne S, 2013, BIOCONJUGATE CHEM, V24, P1496, DOI 10.1021/bc400018u; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yang W, 2005, FEBS LETT, V579, P868, DOI 10.1016/j.febslet.2004.11.047; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao LL, 2012, J BIOL CHEM, V287, P35516, DOI 10.1074/jbc.M112.403253; Zhitkovich A, 1998, ENVIRON HEALTH PERSP, V106, P969, DOI 10.2307/3434139	86	25	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23589	23603		10.1074/jbc.M116.745257	http://dx.doi.org/10.1074/jbc.M116.745257			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621316	Green Published, hybrid			2022-12-28	WOS:000387884400020
J	Stolwijk, JA; Zhang, XX; Gueguinou, M; Zhang, W; Matrougui, K; Renken, C; Trebak, M				Stolwijk, Judith A.; Zhang, Xuexin; Gueguinou, Maxime; Zhang, Wei; Matrougui, Khalid; Renken, Christian; Trebak, Mohamed			Calcium Signaling Is Dispensable for Receptor Regulation of Endothelial Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CA2+ CHANNELS; LIGHT-CHAIN KINASE; 2-AMINOETHYLDIPHENYL BORATE; ENTRY; CELLS; STIM1; ORAI1; THROMBIN; MYOSIN; CRAC	Endothelial barrier function is tightly regulated by plasma membrane receptors and is crucial for tissue fluid homeostasis; its dysfunction causes disease, including sepsis and inflammation. The ubiquitous activation of Ca2+ signaling upon phospholipase C-coupled receptor ligation leads quite naturally to the assumption that Ca2+ signaling is required for receptor-regulated endothelial barrier function. This widespread hypothesis draws analogy from smooth muscle and proposes the requirement of G protein-coupled receptor (GPCR)-generated Ca2+ signaling in activating the endothelial contractile apparatus and generating interendothelial gaps. Notwithstanding endothelia being non-excitable in nature, the hypothesis of Ca2+-induced endothelial contraction has been invoked to explain actions of GPCR agonists that either disrupt or stabilize endothelial barrier function. Here, we challenge this correlative hypothesis by showing a lack of causal link between GPCR-generated Ca2+ signaling and changes in human microvascular endothelial barrier function. We used three endogenous GPCR agonists: thrombin and histamine, which disrupt endothelial barrier function, and sphingosine-1-phosphate, which stabilizes barrier function. The qualitatively different effects of these three agonists on endothelial barrier function occur independently of Ca2+ entry through the ubiquitous store-operated Ca2+ entry channel Orai1, global Ca2+ entry across the plasma membrane, and Ca2+ release from internal stores. However, disruption of endothelial barrier function by thrombin and histamine requires the Ca2+ sensor stromal interacting molecule-1 (STIM1), whereas sphingosine-1-phosphate-mediated enhancement of endothelial barrier function occurs independently of STIM1. We conclude that although STIM1 is required for GPCR-mediated disruption of barrier function, a causal link between GPCR-induced cytoplasmic Ca2+ increases and acute changes in barrier function is missing. Thus, the cytosolic Ca2+ induced endothelial contraction is a cum hoc fallacy that should be abandoned.	[Stolwijk, Judith A.; Zhang, Xuexin; Gueguinou, Maxime; Zhang, Wei; Trebak, Mohamed] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Matrougui, Khalid] East Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; [Stolwijk, Judith A.; Renken, Christian] Appl Biophys Inc, Troy, NY 12180 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Eastern Virginia Medical School	Trebak, M (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	mtrebak@hmc.psu.edu	张学新, XUEXIN ZHANG/AAD-7645-2019	张学新, XUEXIN ZHANG/0000-0001-8276-3885; Gueguinou, Maxime/0000-0002-5793-2082	American Heart Association [14GRNT18880008]; National Institutes of Health [R01HL097111, R01HL123364, R01HL095566]; Applied Biophysics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL123364, R01HL095566] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Applied Biophysics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 14GRNT18880008, National Institutes of Health Grants R01HL097111 and R01HL123364 (to M. T.) and R01HL095566 (to K. M.), and in part by a post-doctoral fellowship from Applied Biophysics Inc. (to J. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Borbiev T, 2001, AM J PHYSIOL-LUNG C, V280, pL983, DOI 10.1152/ajplung.2001.280.5.L983; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI 10.1089/ARS.2008.2221; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Fahrner M, 2013, CHANNELS, V7, P330, DOI 10.4161/chan.26742; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gonzalez-Cobos JC, 2013, CIRC RES, V112, P1013, DOI 10.1161/CIRCRESAHA.111.300220; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Kassan M, 2015, PFLUG ARCH EUR J PHY, V467, P1195, DOI 10.1007/s00424-014-1556-5; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003; Law M, 2011, INT J BIOCHEM CELL B, V43, P1228, DOI 10.1016/j.biocel.2011.04.016; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Mehta D, 2005, J BIOL CHEM, V280, P17320, DOI 10.1074/jbc.M411674200; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Moccia F, 2014, CURR MOL MED, V14, P457, DOI 10.2174/1566524013666131118113410; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Motiani RK, 2013, FASEB J, V27, P63, DOI 10.1096/fj.12-213801; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Norwood N, 2000, AM J PHYSIOL-LUNG C, V279, pL815, DOI 10.1152/ajplung.2000.279.5.L815; Ohga K, 2008, INT IMMUNOPHARMACOL, V8, P1787, DOI 10.1016/j.intimp.2008.08.016; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rosado JA, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00325; Sandoval R, 2001, AM J PHYSIOL-LUNG C, V280, pL239, DOI 10.1152/ajplung.2001.280.2.L239; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Stolwijk JA, 2015, PFLUG ARCH EUR J PHY, V467, P2193, DOI 10.1007/s00424-014-1674-0; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Takezawa R, 2006, MOL PHARMACOL, V69, P1413, DOI 10.1124/mol.105.021154; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285, DOI 10.1152/ajpcell.2000.279.4.C1285; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2012, J PHYSIOL-LONDON, V590, P4201, DOI 10.1113/jphysiol.2012.233353; Trebak M, 2009, CIRC RES, V104, pE56, DOI 10.1161/CIRCRESAHA.109.196105; Amerongen GPV, 2008, AM J PHYSIOL-CELL PH, V294, pC1234, DOI 10.1152/ajpcell.00551.2007; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Yuan D, 2014, AM J PHYSIOL-HEART C, V307, pH44, DOI 10.1152/ajpheart.00929.2013; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492; Zhou XP, 2011, AM J PHYSIOL-HEART C, V301, pH1788, DOI 10.1152/ajpheart.00599.2011; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH2869, DOI 10.1152/ajpheart.01080.2004; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	62	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22894	22912		10.1074/jbc.M116.756114	http://dx.doi.org/10.1074/jbc.M116.756114			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27624938	Green Published, hybrid			2022-12-28	WOS:000387224800004
J	Banuelos, CA; Tavakoli, I; Tien, AH; Caley, DP; Mawji, NR; Li, ZZ; Wang, J; Yang, YC; Imamura, Y; Yan, LP; Wen, JG; Andersen, RJ; Sadar, MD				Banuelos, Carmen A.; Tavakoli, Iran; Tien, Amy H.; Caley, Daniel P.; Mawji, Nasrin R.; Li, Zhenzhen; Wang, Jun; Yang, Yu Chi; Imamura, Yusuke; Yan, Luping; Wen, Jian Guo; Andersen, Raymond J.; Sadar, Marianne D.			Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; drug development; intrinsically disordered protein; prostate cancer; steroid hormone receptor; transcription factor	RESISTANT PROSTATE-CANCER; SIGNAL-TRANSDUCTION PATHWAYS; SPLICE VARIANTS; TRANSCRIPTIONAL ACTIVATION; ENZALUTAMIDE; ABIRATERONE; ANTIANDROGEN; PROGRESSION; INDUCTION; MDV3100	Androgen receptor (AR) is a validated drug target for all stages of prostate cancer including metastatic castration-resistant prostate cancer (CRPC). All current hormone therapies for CRPC target the C-terminal ligand-binding domain of AR and ultimately all fail with resumed AR transcriptional activity. Within the AR N-terminal domain (NTD) is activation function-1 (AF-1) that is essential for AR transcriptional activity. Inhibitors of AR AF-1 would potentially block most AR mechanisms of resistance including constitutively active AR splice variants that lack the ligand-binding domain. Here we provide evidence that sintokamide A (SINT1) binds AR AF-1 region to specifically inhibit transactivation of AR NTD. Consistent with SINT1 targeting AR AF-1, it attenuated transcriptional activities of both full-length AR and constitutively active AR splice variants, which correlated with inhibition of growth of enzalutamide-resistant prostate cancer cells expressing AR splice variants. In vivo, SINT1 caused regression of CRPC xenografts and reduced expression of prostate-specific antigen, a gene transcriptionally regulated by AR. Inhibition of AR activity by SINT1 was additive to EPI-002, a known AR AF-1 inhibitor that is in clinical trials (NCT02606123). This implies that SINT1 binds to a site on AF-1 that is unique from EPI. Consistent with this suggestion, these two compounds showed differences in blocking AR interaction with STAT3. This work provides evidence that the intrinsically disordered NTD of AR is druggable and that SINT1 analogs may provide a novel scaffold for drug development for the treatment of prostate cancer or other diseases of the AR axis.	[Banuelos, Carmen A.; Tavakoli, Iran; Tien, Amy H.; Caley, Daniel P.; Mawji, Nasrin R.; Li, Zhenzhen; Wang, Jun; Yang, Yu Chi; Imamura, Yusuke; Sadar, Marianne D.] British Columbia Canc Agcy, Dept Genome Sci Ctr, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Li, Zhenzhen] Zhengzhou Univ, Inst Clin Med, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Yan, Luping; Andersen, Raymond J.] Univ British Columbia, Chem & Earth & Ocean Sci, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada; [Wen, Jian Guo] Zhengzhou Univ Hosp, Affiliated Hosp Zhengzhou 1, Urodynam Ctr, Zhengzhou 450052, Henan, Peoples R China	British Columbia Cancer Agency; Zhengzhou University; University of British Columbia; Zhengzhou University	Sadar, MD (corresponding author), British Columbia Canc Agcy, Dept Genome Sci Ctr, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	msadar@bcgsc.ca	Sadar, Marianne/E-9136-2012	Sadar, Marianne/0000-0003-0599-9215; Yang, Yu Chi/0000-0001-8318-1174	NCI, National Institutes of Health [2R01CA105304]; Canadian Institutes of Health Research Grant [MOP79308]; Country Meadows Senior Men's Golf Charity Classic; NATIONAL CANCER INSTITUTE [R01CA105304] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Country Meadows Senior Men's Golf Charity Classic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant 2R01CA105304 (to M. D. S.), Canadian Institutes of Health Research Grant MOP79308 (to M. D. S.), and Country Meadows Senior Men's Golf Charity Classic. C. A. B., N. R. M., J. W., R. J. A., and M. D. S. are shareholders of ESSA Pharma Inc. M. D. S. and R. J. A. receive compensation as consultants. M. D. S. and R. J. A. are Directors and Officers of ESSA Pharma Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; De Mol E, 2016, ACS CHEM BIOL, V11, P2499, DOI 10.1021/acschembio.6b00182; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Imamura Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87850; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Kato M, 2016, CLIN CANCER RES, V22, P2744, DOI 10.1158/1078-0432.CCR-15-2119; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Malik Z, 2013, ADV THER, V30, P1041, DOI 10.1007/s12325-013-0070-z; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; Payne H, 2012, BJU INT, V110, P658, DOI 10.1111/j.1464-410X.2011.10886.x; Poujol N, 2000, J BIOL CHEM, V275, P24022, DOI 10.1074/jbc.M001999200; Rathkopf DE, 2014, EUR UROL, V66, P815, DOI 10.1016/j.eururo.2014.02.056; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; Sadar MD, 2011, CANCER RES, V71, P1208, DOI 10.1158/0008-5472.CAN_10-3398; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Scher HI, 2016, JAMA ONCOL, V2, P1441, DOI 10.1001/jamaoncol.2016.1828; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Yang YC, 2016, CLIN CANCER RES, V22, P4466, DOI 10.1158/1078-0432.CCR-15-2901; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	37	35	40	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22231	22243		10.1074/jbc.M116.734475	http://dx.doi.org/10.1074/jbc.M116.734475			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27576691	Green Published, hybrid			2022-12-28	WOS:000386332600034
J	Beraldo, FH; Ostapchenko, VG; Caetano, FA; Guimaraes, ALS; Ferretti, GDS; Daude, N; Bertram, L; Nogueira, KOPC; Silva, JL; Westaway, D; Cashman, NR; Martins, VR; Prado, VF; Prado, MAM				Beraldo, Flavio H.; Ostapchenko, Valeriy G.; Caetano, Fabiana A.; Guimaraes, Andre L. S.; Ferretti, Giulia D. S.; Daude, Nathalie; Bertram, Lisa; Nogueira, Katiane O. P. C.; Silva, Jerson L.; Westaway, David; Cashman, Neil R.; Martins, Vilma R.; Prado, Vania F.; Prado, Marco A. M.			Regulation of Amyloid Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; calcium; laminin; metabotropic glutamate receptor (mGluR); prion; Protein trafficking; metabotropic glutamate receptor 5	STRESS-INDUCIBLE PROTEIN-1; GLUTAMATE-RECEPTOR 5; NICOTINIC ACETYLCHOLINE-RECEPTOR; CLATHRIN-COATED PITS; CELLULAR PRION; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; SIGNALING PATHWAYS; NEURITE OUTGROWTH	The prion protein (PrPC) has been suggested to operate as a scaffold/receptor protein in neurons, participating in both physiological and pathological associated events. PrPC, laminin, and metabotropic glutamate receptor 5 (mGluR5) form a protein complex on the plasma membrane that can trigger signaling pathways involved in neuronal differentiation. PrPC and mGluR5 are co-receptors also for -amyloid oligomers (AOs) and have been shown to modulate toxicity and neuronal death in Alzheimer's disease. In the present work, we addressed the potential crosstalk between these two signaling pathways, laminin-PrPC-mGluR5 or AO-PrPC-mGluR5, as well as their interplay. Herein, we demonstrated that an existing complex containing PrPC-mGluR5 has an important role in AO binding and activity in neurons. A peptide mimicking the binding site of laminin onto PrPC (Ln-1) binds to PrPC and induces intracellular Ca2+ increase in neurons via the complex PrPC-mGluR5. Ln-1 promotes internalization of PrPC and mGluR5 and transiently decreases AO biding to neurons; however, the peptide does not impact AO toxicity. Given that mGluR5 is critical for toxic signaling by AOs and in prion diseases, we tested whether mGlur5 knock-out mice would be susceptible to prion infection. Our results show mild, but significant, effects on disease progression, without affecting survival of mice after infection. These results suggest that PrPC-mGluR5 form a functional response unit by which multiple ligands can trigger signaling. We propose that trafficking of PrPC-mGluR5 may modulate signaling intensity by different PrPC ligands.	[Beraldo, Flavio H.; Ostapchenko, Valeriy G.; Caetano, Fabiana A.; Guimaraes, Andre L. S.; Ferretti, Giulia D. S.; Nogueira, Katiane O. P. C.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5B7, Canada; [Caetano, Fabiana A.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5B7, Canada; [Guimaraes, Andre L. S.] Univ Estadual Montes Claros, BR-39401089 Montes Claros, MG, Brazil; [Ferretti, Giulia D. S.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Inst Nacl Biol Estrutural & Bioimagem, Ctr Nacl Ressonacia Magnet Nucl Jiri Jonas,Progra, BR-21941901 Rio De Janeiro, Brazil; [Nogueira, Katiane O. P. C.] Univ Fed Ouro Preto, Dept Ciencias Biol, Inst Ciencias Exatas & Biol, Campus Morro Cruzeiro S-N, BR-35400000 Ouro Preto, MG, Brazil; [Daude, Nathalie; Westaway, David] Univ Alberta, Ctr Pr & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada; [Bertram, Lisa; Cashman, Neil R.] Univ British Columbia, Ctr Brain Hlth, Vancouver, BC V6T 1Z3, Canada; [Martins, Vilma R.] AC Camargo Canc Ctr, Int Ctr Res & Educ, BR-01509010 Sao Paulo, SP, Brazil; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade Estadual de Montes Claros; Universidade Federal do Rio de Janeiro; Universidade Federal de Ouro Preto; University of Alberta; University of British Columbia; A.C.Camargo Cancer Center; Western University (University of Western Ontario)	Prado, MAM (corresponding author), 1151 Richmond St N, London, ON N6A 5B7, Canada.	mprado@robarts.ca	Martins, Vilma/N-5446-2019; Prado, Marco Antonio Maximo/K-7638-2013; Silva, Jerson/J-8984-2014; Guimarães, André Luiz Sena/D-8122-2011; Prado, Vania Ferreira/K-7630-2013; SILVA, JERSON Lima/GRF-1442-2022	Prado, Marco Antonio Maximo/0000-0002-3028-5778; Silva, Jerson/0000-0001-9523-9441; Guimarães, André Luiz Sena/0000-0002-3162-3206; Prado, Vania Ferreira/0000-0003-4994-6393; SILVA, JERSON Lima/0000-0001-9523-9441; Ostapchenko, Valeriy/0000-0002-3629-7702; Diniz da Silva Ferretti, Giulia/0000-0002-1205-6090	PrioNet-Canada; Canadian Institutes of Health Research [MOP 93651, MOP 136930, MOP 126000, MOP 89919]; Alzheimer's Association; Canadian Foundation for Innovation; Ontario Research Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP	PrioNet-Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Association(Alzheimer's Association); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by PrioNet-Canada, Canadian Institutes of Health Research (Grants MOP 93651, MOP 136930, MOP 126000, and MOP 89919), The Alzheimer's Association, the Canadian Foundation for Innovation, and the Ontario Research Fund (to M. A. M. P. and V. F. P.). This work was also supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (to V. R. M) The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Valles A, 2015, J NEUROSCI, V35, P11125, DOI 10.1523/JNEUROSCI.4615-14.2015; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Beland M, 2014, NEUROBIOL AGING, V35, P1537, DOI 10.1016/j.neurobiolaging.2014.02.001; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Carneiro MV, 2016, BIOCHEM BIOPH RES CO, V472, P293, DOI 10.1016/j.bbrc.2016.02.122; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; D'Antoni S, 2014, NEUROSCI BIOBEHAV R, V46, P228, DOI 10.1016/j.neubiorev.2014.02.003; de Esch CEF, 2015, NEUROBIOL DIS, V75, P31, DOI 10.1016/j.nbd.2014.12.021; Fatemi SH, 2015, SCHIZOPHR RES, V167, P42, DOI 10.1016/j.schres.2014.10.010; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Guo WR, 2016, J NEUROSCI, V36, P2131, DOI 10.1523/JNEUROSCI.2921-15.2016; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Hamilton A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-40; Hirsch TZ, 2014, BIOCHIMIE, V104, P2, DOI 10.1016/j.biochi.2014.06.009; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Hunt DL, 2013, NAT NEUROSCI, V16, P1049, DOI 10.1038/nn.3461; Jeong JK, 2015, ONCOTARGET, V6, P24660, DOI 10.18632/oncotarget.4953; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kang YS, 2009, J CELL SCI, V122, P4062, DOI 10.1242/jcs.046292; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Loubet D, 2012, FASEB J, V26, P678, DOI 10.1096/fj.11-185579; Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003; Lu YM, 1997, J NEUROSCI, V17, P5196; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Martins VR, 2016, J NEUROCHEM, V137, P9, DOI 10.1111/jnc.13541; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Matosin N, 2015, SCHIZOPHR RES, V166, P212, DOI 10.1016/j.schres.2015.05.001; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Ostapchenko VG, 2013, J NEUROCHEM, V127, P415, DOI 10.1111/jnc.12296; Ostapchenko VG, 2013, J NEUROSCI, V33, P16552, DOI 10.1523/JNEUROSCI.3214-13.2013; Petratos S, 2008, BRAIN, V131, P90, DOI 10.1093/brain/awm260; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Santos TG, 2013, J NEUROCHEM, V124, P210, DOI 10.1111/jnc.12091; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tsutsui S, 2008, AM J PATHOL, V173, P1029, DOI 10.2353/ajpath.2008.071062; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Yim YI, 2015, J CELL SCI, V128, P1434, DOI 10.1242/jcs.165472; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	81	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21945	21955		10.1074/jbc.M116.738286	http://dx.doi.org/10.1074/jbc.M116.738286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27563063	hybrid, Green Published			2022-12-28	WOS:000386332600010
J	Anazco, C; Lopez-Jimenez, AJ; Rafi, M; Vega-Montoto, L; Zhang, MZ; Hudson, BG; Vanacore, RM				Anazco, Carolina; Lopez-Jimenez, Alberto J.; Rafi, Mohamed; Vega-Montoto, Lorenzo; Zhang, Ming-Zhi; Hudson, Billy G.; Vanacore, Roberto M.			Lysyl Oxidase-like-2 Cross-links Collagen IV of Glomerular Basement Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGION 7S DOMAIN; ENZYMATIC-ACTIVITY; KIDNEY GLOMERULI; 7-S COLLAGEN; EXPRESSION; NETWORK; HYPOXIA; ORGANIZATION; IDENTIFICATION; STABILIZATION	The 7S dodecamer is recognized as an important structural cross-linking domain of collagen IV networks that provide mechanical stability to basement membranes, a specialized form of extracellular matrix essential for the development and maintenance of tissue architecture. Although the 7S dodecamer is stabilized by covalent cross-linking, the molecular mechanism by which such cross-links are formed has not been revealed. Here, we aimed to identify the enzyme(s) that crosslinks the 7S dodecamer and characterize its expression in the kidney glomerulus. Pharmacological inhibition of candidate extracellular matrix enzymes revealed that lysyl oxidase activity is required for cross-linking of 7S polypeptides. Among all lysyl oxidase family members, lysyl oxidase-like-2 (LOXL2) was identified as the isoform cross-linking collagen IV in mouse embryonal PFHR-9 cells. Biochemical analyses revealed that LOXL2 readily promoted the formation of lysyl-derived cross-links in the 7S dodecamer but not in the NC1 domain. We also established that LOXL2 is the main lysyl oxidase family member present in the glomerular extracellular matrix. Altogether, we demonstrate that LOXL2 is a novel component of the molecular machinery that forms cross-linked collagen IV networks, which are essential for glomerular basement membrane stability and molecular ultrafiltration function.	[Anazco, Carolina; Lopez-Jimenez, Alberto J.; Rafi, Mohamed; Vega-Montoto, Lorenzo; Zhang, Ming-Zhi; Hudson, Billy G.; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Dept Med, Nashville, TN 37232 USA; [Anazco, Carolina; Lopez-Jimenez, Alberto J.; Vega-Montoto, Lorenzo; Hudson, Billy G.; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Vega-Montoto, Lorenzo] Idaho Natl Lab, Idaho Falls, ID 83415 USA	Vanderbilt University; Vanderbilt University; United States Department of Energy (DOE); Idaho National Laboratory	Vanacore, RM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, 1161 21st Ave S,B-3113 Med Ctr N, Nashville, TN 37232 USA.	roberto.vanacore@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020; Vega-Montoto, Lorenzo/B-9035-2017; Lopez, Alberto/GWC-5652-2022	Vanacore, Roberto/0000-0002-2886-0606; Vega-Montoto, Lorenzo/0000-0002-4096-1100; Lopez Jimenez, Alberto Jose/0000-0002-4992-631X; Anazco, Carolina/0000-0003-1311-9492; Hudson, Billy/0000-0002-5420-4100	NIDDK, National Institutes of Health [R01 DK099467, R01 DK18381, R01 DK051265]; Vanderbilt Division of Nephrology; Chilean Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051265, R01DK018381, R01DK099467] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Vanderbilt Division of Nephrology; Chilean Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the NIDDK, National Institutes of Health Grants R01 DK099467, R01 DK18381, and R01 DK051265 and Vanderbilt Division of Nephrology faculty development funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported in part by "Becas-Chile" scholarship provided by the Chilean Government.	BAILEY AJ, 1984, BIOCHEM J, V218, P713, DOI 10.1042/bj2180713; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Brukamp K, 2007, AM J PHYSIOL-RENAL, V293, pF1397, DOI 10.1152/ajprenal.00133.2007; CARLSON EC, 1978, J ULTRA MOL STRUCT R, V62, P26, DOI 10.1016/S0022-5320(78)80028-8; Cummings CF, 2016, J CELL BIOL, V213, P479, DOI 10.1083/jcb.201510065; DiDonato A, 1997, NEPHRON, V76, P192, DOI 10.1159/000190168; DUNCAN KG, 1983, J BIOL CHEM, V258, P5869; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; GLANVILLE RW, 1985, EUR J BIOCHEM, V152, P213, DOI 10.1111/j.1432-1033.1985.tb09186.x; Grau-Bove X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10568; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Kagan HM, 2011, BIOL EXTRACELL MATR, P303, DOI 10.1007/978-3-642-16555-9_9; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorz C, 2008, J AM SOC NEPHROL, V19, P904, DOI 10.1681/ASN.2007050581; Lugassy J, 2012, J BIOL CHEM, V287, P3541, DOI 10.1074/jbc.M111.261016; Martin A, 2015, EMBO J, V34, P1090, DOI 10.15252/embj.201489975; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Moon HJ, 2013, J BIOL CHEM, V288, P30000, DOI 10.1074/jbc.C113.502310; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Polgar N, 2007, J BIOL CHEM, V282, P3262, DOI 10.1074/jbc.M609407200; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; Robertson WE, 2014, J BIOL CHEM, V289, P25601, DOI 10.1074/jbc.M114.571844; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SIEBOLD B, 1987, EUR J BIOCHEM, V168, P569, DOI 10.1111/j.1432-1033.1987.tb13455.x; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANZER ML, 1967, BIOCHIM BIOPHYS ACTA, V133, P584, DOI 10.1016/0005-2795(67)90564-8; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TIMPL R, 1979, FEBS LETT, V101, P265, DOI 10.1016/0014-5793(79)81022-4; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Vanacore R, 2011, CLIN EXP IMMUNOL, V164, P4, DOI 10.1111/j.1365-2249.2011.04356.x; Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang MZ, 2012, AM J PHYSIOL-RENAL, V302, pF433, DOI 10.1152/ajprenal.00292.2011; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	62	40	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25999	26012		10.1074/jbc.M116.738856	http://dx.doi.org/10.1074/jbc.M116.738856			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27770022	Green Published, hybrid			2022-12-28	WOS:000390345200020
J	Glab, B; Beganovic, M; Anaokar, S; Hao, MS; Rasmusson, AG; Patton-Vogt, J; Banas, A; Stymne, S; Lager, I				Glab, Bartosz; Beganovic, Mirela; Anaokar, Sanket; Hao, Meng-Shu; Rasmusson, Allan G.; Patton-Vogt, Jana; Banas, Antoni; Stymne, Sten; Lager, Ida			Cloning of Glycerophosphocholine Acyltransferase (GPCAT) from Fungi and Plants A NOVEL ENZYME IN PHOSPHATIDYLCHOLINE SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL PREPARATIONS; BIOSYNTHESIS; GLYCEROPHOSPHOINOSITOL	Glycero-3-phosphocholine (GPC), the product of the complete deacylation of phosphatidylcholine (PC), was long thought to not be a substrate for reacylation. However, it was recently shown that cell-free extracts from yeast and plants could acylate GPC with acyl groups from acyl-CoA. By screening enzyme activities of extracts derived from a yeast knock-out collection, we were able to identify and clone the yeast gene (GPC1) encoding the enzyme, named glycerophosphocholine acyltransferase (GPCAT). By homology search, we also identified and cloned GPCAT genes from three plant species. All enzymes utilize acyl-CoA to acylate GPC, forming lyso-PC, and they show broad acyl specificities in both yeast and plants. In addition to acyl-CoA, GPCAT efficiently utilizes LPC and lysophosphatidylethanolamine as acyl donors in the acylation of GPC. GPCAT homologues were found in the major eukaryotic organism groups but not in prokaryotes or chordates. The enzyme forms its own protein family and does not contain any of the acyl binding or lipase motifs that are present in other studied acyltransferases and transacylases. In vivo labeling studies confirm a role for Gpc1p in PC biosynthesis in yeast. It is postulated that GPCATs contribute to the maintenance of PC homeostasis and also have specific functions in acyl editing of PC (e.g. in transferring acyl groups modified at the sn-2 position of PC to the sn-1 position of this molecule in plant cells).	[Glab, Bartosz; Banas, Antoni] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Glab, Bartosz; Banas, Antoni] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Beganovic, Mirela; Stymne, Sten; Lager, Ida] Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden; [Anaokar, Sanket; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Hao, Meng-Shu; Rasmusson, Allan G.] Lund Univ, Dept Biol, Biol Bldg A,Solvegatan 35, S-22362 Lund, Sweden	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Swedish University of Agricultural Sciences; Duquesne University; Lund University	Lager, I (corresponding author), Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden.	ida.lager@slu.se		Lager, Ida/0000-0001-9755-8534; Glab, Bartosz/0000-0001-6562-5608; Banas, Antoni/0000-0001-9397-7627	PlantLink, the Strategic Research Area project "Trees and Crops for the Future"; Foundation for Strategic research (SSF) project "Oil Crops for the Future"; National Institutes of Health [R15 GM104876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104876] Funding Source: NIH RePORTER	PlantLink, the Strategic Research Area project "Trees and Crops for the Future"; Foundation for Strategic research (SSF) project "Oil Crops for the Future"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from PlantLink, the Strategic Research Area project "Trees and Crops for the Future," and the Foundation for Strategic research (SSF) project "Oil Crops for the Future" and by National Institutes of Health Grant R15 GM104876 (to J. P.-V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almaguer C, 2004, J BIOL CHEM, V279, P31937, DOI 10.1074/jbc.M403648200; BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; Bishop AC, 2013, J BIOL CHEM, V288, P33939, DOI 10.1074/jbc.M113.505735; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen GQ, 2015, LIPIDS, V50, P1057, DOI 10.1007/s11745-015-4069-x; Cheng LY, 2011, PLANT PHYSIOL, V156, P1131, DOI 10.1104/pp.111.173724; DAWSON RMC, 1955, BIOCHEM J, V59, P5, DOI 10.1042/bj0590005; De Smet CH, 2013, BBA-MOL CELL BIOL L, V1831, P1167, DOI 10.1016/j.bbalip.2013.03.002; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Guan R, 2014, PLANT BIOTECHNOL J, V12, P193, DOI 10.1111/pbi.12128; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Jones AM, 2014, SCIENCE, V344, P711, DOI 10.1126/science.1251358; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Lager I, 2015, PLANTA, V241, P347, DOI 10.1007/s00425-014-2184-1; Lager I, 2013, J BIOL CHEM, V288, P36902, DOI 10.1074/jbc.M113.521815; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Liu YF, 2015, J NANOMATER, V2015, DOI 10.1155/2015/792095; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patton-Vogt JL, 1998, GENETICS, V149, P1707; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; SANCHEZ M, 1973, BIOCHEM J, V132, P697, DOI 10.1042/bj1320697; Siltberg-Liberles J, 2011, GENES-BASEL, V2, P748, DOI 10.3390/genes2040748; Stalberg K, 2008, J LIPID RES, V49, P1794, DOI 10.1194/jlr.M800129-JLR200; Surlow BA, 2014, J BIOL CHEM, V289, P31591, DOI 10.1074/jbc.M114.581157; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	27	15	18	2	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25066	25076		10.1074/jbc.M116.743062	http://dx.doi.org/10.1074/jbc.M116.743062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758859	Green Published, hybrid			2022-12-28	WOS:000388880100022
J	Koh, EH; Chen, Y; Bader, DA; Hamilton, MP; He, B; York, B; Kajimura, S; McGuire, SE; Hartig, SM				Koh, Eun Hee; Chen, Yong; Bader, David A.; Hamilton, Mark P.; He, Bin; York, Brian; Kajimura, Shingo; McGuire, Sean E.; Hartig, Sean M.			Mitochondrial Activity in Human White Adipocytes Is Regulated by the Ubiquitin Carrier Protein 9/microRNA-30a Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; GLUCOSE-HOMEOSTASIS; HUMAN ADIPOGENESIS; BEIGE FAT; EXPRESSION; MICRORNA; PRDM16; CELLS; ACTIVATION; PROGRAM	The acquisition of beige adipocyte features by white fat cells corresponds to protection against obesity-induced metabolic diseases in humans and animal models of type 2 diabetes. In adipose tissue, expression of the F2 small ubiquitin-like modifier ligase ubiquitin carrier protein 9 (Ubc9) is positively correlated with markers of insulin resistance and corresponds with impaired browning of human white adipocytes. However, the molecular regulation of Ubc9 expression in adipocytes and other cells remains unclear. In this study, we demonstrate that the mRNA and protein expression of Ubc9 are regulated by the microRNA miRNA-30a (milk-30a) in human subcutaneous adipocytes. Ubc9 and miR-30a exhibit inverse expression in adipose tissue, with miR-30a robustly elevated in brown fat. Depletion of Ubc9 by siRNA or enforced expression of a miR-30a mimic augments mitochondrial volume and respiration in human white adipocytes, reflecting features of brown fat cells. Furthermore, Ubc9 depletion induces a brown fat gene program in human subcutaneous adipocytes. Induction of the beige-selective gene program corresponds to stabilization of the PR domain-containing 16 (PRDM16) protein, an obligate transcriptional regulator of the brown/beige fat metabolic program in white adipocytes that interacts with Ubc9. Taken together, our data demonstrate a previously unappreciated molecular axis that controls browning of human white adipocytes.	[Koh, Eun Hee; Bader, David A.; Hamilton, Mark P.; He, Bin; York, Brian; McGuire, Sean E.; Hartig, Sean M.] Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,BCM130, Houston, TX 77030 USA; [He, Bin] Baylor Coll Med, Dept Med, Div Hematol & Oncol, Houston, TX 77030 USA; [Koh, Eun Hee] Asan Med Ctr, Dept Internal Med, Seoul 138736, South Korea; [Chen, Yong; Kajimura, Shingo] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Chen, Yong; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [McGuire, Sean E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Ulsan; Asan Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center	Hartig, SM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza,BCM130, Houston, TX 77030 USA.	hartig@bcm.edu	Kajimura, Shingo/AAC-5090-2019	Kajimura, Shingo/0000-0003-0672-5910	National Institutes of Health [K01DK096093, R03DK105006, R21CA205257, F30CA196108, R01GM033976, K01DK081446, R01DK97441]; American Heart Association [15BGIA25850025]; Baylor College of Medicine Bridge to Independence program; Alkek Center for Molecular Discovery; Caroline Weiss Law Foundation; Prostate Cancer Research Foundation; American Cancer Society [RSG-13-061-01-TBE]; Baylor College of Medicine Diabetes and Endocrinology Research Center [P30-DK079638]; NATIONAL CANCER INSTITUTE [R21CA205257, F30CA196108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, K01DK096093, K01DK081446, P30DK079638, R03DK105006, R01DK097441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baylor College of Medicine Bridge to Independence program; Alkek Center for Molecular Discovery; Caroline Weiss Law Foundation; Prostate Cancer Research Foundation; American Cancer Society(American Cancer Society); Baylor College of Medicine Diabetes and Endocrinology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants K01DK096093 and R03DK105006, American Heart Association Beginning Grant-in-Aid 15BGIA25850025, the Baylor College of Medicine Bridge to Independence program, and the Alkek Center for Molecular Discovery (to S. M. H.). This work was also supported by the Caroline Weiss Law Foundation, National Institutes of Health Grant R21CA205257, and the Prostate Cancer Research Foundation (to S. E. M.). Additional support was provided by National Institutes of Health Grants F30CA196108 (to D. A. B.), R01GM033976 (to A. R. M.), K01DK081446 (to B. H.), and R01DK97441 (to S.K.); American Cancer Society Grant RSG-13-061-01-TBE (to B. H.), and Baylor College of Medicine Diabetes and Endocrinology Research Center Grant P30-DK079638. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Allgood VE, 1997, BIOCHEMISTRY-US, V36, P224, DOI 10.1021/bi961125c; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Civelek M, 2013, HUM MOL GENET, V22, P3023, DOI 10.1093/hmg/ddt159; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Forini F, 2014, ENDOCRINOLOGY, V155, P4581, DOI 10.1210/en.2014-1106; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hamilton MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3730; Harms MJ, 2015, GENE DEV, V29, P298, DOI 10.1101/gad.252734.114; Hartig SM, 2015, MOL ENDOCRINOL, V29, P1320, DOI 10.1210/me.2015-1084; Hartig SM, 2012, CHEM BIOL, V19, P1126, DOI 10.1016/j.chembiol.2012.07.020; Hu F, 2015, DIABETES, V64, P2056, DOI 10.2337/db14-1117; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Keuper M, 2014, FASEB J, V28, P761, DOI 10.1096/fj.13-238725; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nishikata I, 2011, ONCOGENE, V30, P4194, DOI 10.1038/onc.2011.132; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Preusse M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151771; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2015, DIABETES, V64, P2369, DOI 10.2337/db15-0203; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Yehuda-Shnaidman E, 2010, DIABETES, V59, P2474, DOI 10.2337/db10-0245; Ying SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075695; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	47	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24747	24755		10.1074/jbc.M116.749408	http://dx.doi.org/10.1074/jbc.M116.749408			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27758866	Green Published, hybrid			2022-12-28	WOS:000388875500032
J	Watanabe, T; Kametani, K; Koyama, Y; Suzuki, D; Imamura, Y; Takehana, K; Hiramatsu, K				Watanabe, Takafumi; Kametani, Kiyokazu; Koyama, Yoh-ichi; Suzuki, Daisuke; Imamura, Yasutada; Takehana, Kazushige; Hiramatsu, Kohzy			Ring-Mesh Model of Proteoglycan Glycosaminoglycan Chains in Tendon based on Three-dimensional Reconstruction by Focused Ion Beam Scanning Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; collagen; decorin; dermatan sulfate; proteoglycan structure; tendon; focused ion beam scanning electron microscope; ring mesh	COLLAGEN FIBRIL MORPHOLOGY; MECHANICAL-PROPERTIES; IN-VITRO; DECORIN; ORGANIZATION; FORCE; LIGAMENT; TISSUE	Tendons are composed of collagen fibrils and proteoglycan predominantly consisting of decorin. Decorin is located on the d-band of collagen fibrils, and its glycosaminoglycan (GAG) chains have been observed between collagen fibrils with transmission electron microscopy. GAG chains have been proposed to interact with each other or with collagen fibrils, but its three-dimensional organization remains unclear. In this report, we used focused ion beam scanning electron microscopy to examine the three-dimensional organization of the GAG chain in the Achilles tendon of mature rats embedded in epoxy resin after staining with Cupromeronic blue, which specifically stains GAG chains. We used 250 serial back-scattered electron images of longitudinal sections with a 10-nm interval for reconstruction. Three-dimensional images revealed that GAG chains form a ring mesh-like structure with each ring surrounding a collagen fibril at the d-band and fusing with adjacent rings to form the planar network. This ring mesh model of GAG chains suggests that more than two GAG chains may interact with each other around collagen fibrils, which could provide new insights into the roles of GAG chains.	[Watanabe, Takafumi; Hiramatsu, Kohzy] Shinshu Univ, Fac Agr, Nagano 3994598, Japan; [Kametani, Kiyokazu] Shinshu Univ, Dept Instrumental Anal, Res Ctr Human & Environm Sci, Matsumoto, Nagano 3908621, Japan; [Koyama, Yoh-ichi] Nippi Inc, Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan; [Suzuki, Daisuke] Sapporo Med Univ, Sch Med, Dept Musculoskeletal Biomech & Surg Dev, Sapporo, Hokkaido 0608556, Japan; [Imamura, Yasutada] Kogakuin Univ, Sch Adv Engn, Dept Chem & Life Sci, Hachioji, Tokyo 1920015, Japan; [Takehana, Kazushige] Rakuno Gakuen Univ, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan	Shinshu University; Shinshu University; Sapporo Medical University; Kogakuin University; Rakuno Gakuen University	Watanabe, T (corresponding author), Shinshu Univ, Fac Agr, Nagano 3994598, Japan.	yosenabe@shinshu-u.ac.jp	Imamura, Yasutada/AAI-3078-2020	Imamura, Yasutada/0000-0001-6264-1709				Ahmadzadeh H, 2013, J BIOMECH, V46, P2497, DOI 10.1016/j.jbiomech.2013.07.008; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Connizzo BK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023234; CRIBB AM, 1995, J ANAT, V187, P423; Dahl R, 2015, ACTA PHYSIOL, V213, P145, DOI 10.1111/apha.12289; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Feitosa VLC, 2006, MICRON, V37, P518, DOI 10.1016/j.micron.2006.01.010; Fessel G, 2012, J SHOULDER ELB SURG, V21, P209, DOI 10.1016/j.jse.2011.10.002; Fessel G, 2011, J THEOR BIOL, V268, P77, DOI 10.1016/j.jtbi.2010.10.007; Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002; Franchi M, 2010, J ANAT, V216, P301, DOI 10.1111/j.1469-7580.2009.01188.x; Kalson NS, 2015, ELIFE, V4, DOI 10.7554/eLife.05958; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02422; Liu XH, 2005, BIOCHEM BIOPH RES CO, V338, P1342, DOI 10.1016/j.bbrc.2005.10.096; Lujan TJ, 2007, J ORTHOP RES, V25, P894, DOI 10.1002/jor.20351; Nomura Y, 2006, CONNECT TISSUE RES, V47, P249, DOI 10.1080/03008200600846606; Ohta K, 2012, MICRON, V43, P612, DOI 10.1016/j.micron.2011.11.001; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Raspanti M, 2008, J STRUCT BIOL, V164, P134, DOI 10.1016/j.jsb.2008.07.001; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287; SCOTT JE, 1992, J ANAT, V180, P155; Vesentini S, 2005, J BIOMECH, V38, P433, DOI 10.1016/j.jbiomech.2004.04.032; Watanabe T, 2012, J ANAT, V220, P156, DOI 10.1111/j.1469-7580.2011.01456.x; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	31	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23704	23708		10.1074/jbc.M116.733857	http://dx.doi.org/10.1074/jbc.M116.733857			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27624935	Green Published, hybrid			2022-12-28	WOS:000387884400030
J	Medina, J; Nakagawa, Y; Nagasawa, M; Fernandez, A; Sakaguchi, K; Kitaguchi, T; Kojima, I				Medina, Johan; Nakagawa, Yuko; Nagasawa, Masahiro; Fernandez, Anny; Sakaguchi, Kazushige; Kitaguchi, Tetsuya; Kojima, Itaru			Positive Allosteric Modulation of the Calcium-sensing Receptor by Physiological Concentrations of Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWEET TASTE RECEPTOR; EXTRACELLULAR CA2+-SENSING RECEPTOR; SIGNALING SYSTEMS; CELL-SURFACE; SECRETION; PROTEIN; CA2+; ANTAGONISTS	The calcium-sensing receptor (CaSR) is activated by various cations, cationic compounds, and amino acids. In the present study we investigated the effect of glucose on CaSR in HEK293 cells stably expressing human CaSR (HEK-CaSR cells). When glucose concentration in the buffer was raised from 3 to 25 mM, a rapid elevation of cytoplasmic Ca2+ concentration ([Ca2+](c)) was observed. This elevation was immediate and transient and was followed by a sustained decrease in [Ca2+](c). The effect of glucose was detected at a concentration of 4 mM and reached its maximum at 5 mM. 3-O-Methylglucose, a non-metabolizable analogue of glucose, reproduced the effect of glucose. Sucrose also induced an elevation of [Ca2+](c) in HEK-CaSR cells. Similarly, sucralose was nearly as effective as glucose in inducing elevation of [Ca2+](c). Glucose was not able to increase [Ca2+](c) in the absence of extracellular Ca2+. The effect of glucose on [Ca2+](c) was inhibited by NPS-2143, an allosteric inhibitor of CaSR. In addition, NPS-2143 also inhibited the [Ca2+](c) responses to sucralose and sucrose. Glucose as well as sucralose decreased cytoplasmic cAMP concentration in HEK-CaSR cells. The reduction of cAMP induced by glucose was blocked by pertussis toxin. Likewise, sucralose reduced [cAMP](c). Finally, glucose increased [Ca2+](c) in PT-r parathyroid cells and in Madin-Darby canine kidney cells, both of which express endogenous CaSR. These results indicate that glucose acts as a positive allosteric modulator of CaSR.	[Medina, Johan; Nakagawa, Yuko; Nagasawa, Masahiro; Fernandez, Anny; Kojima, Itaru] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma 3718512, Japan; [Sakaguchi, Kazushige] Wakayama Med Univ, Inst Adv Med, Wakayama 6418509, Japan; [Kitaguchi, Tetsuya] Waseda Biosci Res Inst Singapore, Singapore 138667, Singapore; [Kitaguchi, Tetsuya] Waseda Univ, Org Univ Res Initiat, Tokyo 1620041, Japan	Gunma University; Wakayama Medical University; Waseda University	Kojima, I (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma 3718512, Japan.	ikojima@gunma-u.ac.jp	KITAGUCHI, TETSUYA/AAR-1895-2021; Kitaguchi, Tetsuya/F-5260-2017	KITAGUCHI, TETSUYA/0000-0001-6701-1933; Kitaguchi, Tetsuya/0000-0001-6701-1933	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1990, CELL CALCIUM, V11, P333, DOI 10.1016/0143-4160(90)90035-S; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2002, EUR J CLIN NUTR, V56, P1072, DOI 10.1038/sj.ejcn.1601463; Conigrave AD, 2013, BEST PRACT RES CL EN, V27, P315, DOI 10.1016/j.beem.2013.05.010; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jouret F, 2013, J CELL SCI, V126, P5132, DOI 10.1242/jcs.127555; Kojima I, 2015, J DIABETES INVEST, V6, P256, DOI 10.1111/jdi.12304; Malaisse WJ, 1999, ENDOCRINE, V11, P293, DOI 10.1385/ENDO:11:3:293; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; Mamillapalli R, 2010, J ENDOCRINOL, V204, P287, DOI 10.1677/JOE-09-0183; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034489; Nagano N, 2005, J PHARMACOL SCI, V97, P355, DOI 10.1254/jphs.FMJ04007X6; Nakagawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144053; Nakagawa Y, 2014, ENDOCR J, V61, P119, DOI 10.1507/endocrj.EJ13-0431; Nakagawa Y, 2013, ENDOCR J, V60, P1191, DOI 10.1507/endocrj.EJ13-0282; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290015; Odaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100252; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; Ohtsu Y, 2014, MOL CELL ENDOCRINOL, V394, P70, DOI 10.1016/j.mce.2014.07.004; Quinn SJ, 1998, J BIOL CHEM, V273, P19579, DOI 10.1074/jbc.273.31.19579; Rasschaert J, 1999, BIOCHEM BIOPH RES CO, V264, P615, DOI 10.1006/bbrc.1999.1577; Riccardi D, 2002, EXP PHYSIOL, V87, P403, DOI 10.1111/j.1469-445X.2002.tb00053.x; Rogachevskaja OA, 2011, BIOCHEM BIOPH RES CO, V416, P433, DOI 10.1016/j.bbrc.2011.11.095; SAKAGUCHI K, 1987, P NATL ACAD SCI USA, V84, P3269, DOI 10.1073/pnas.84.10.3269; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Temussi P, 2007, ADV FOOD NUTR RES, V53, P199, DOI 10.1016/S1043-4526(07)53006-8; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501	33	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23126	23135		10.1074/jbc.M116.729863	http://dx.doi.org/10.1074/jbc.M116.729863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613866	Green Published, hybrid			2022-12-28	WOS:000387224800023
J	Forny, P; Schumann, A; Mustedanagic, M; Mathis, D; Wulf, MA; Nagele, N; Langhans, CD; Zhakupova, A; Heeren, J; Scheja, L; Fingerhut, R; Peters, HL; Hornemann, T; Thony, B; Kolker, S; Burda, P; Froese, DS; Devuyst, O; Baumgartner, MR				Forny, Patrick; Schumann, Anke; Mustedanagic, Merima; Mathis, Deborah; Wulf, Marie-Angela; Nagele, Nadine; Langhans, Claus-Dieter; Zhakupova, Assem; Heeren, Joerg; Scheja, Ludger; Fingerhut, Ralph; Peters, Heidi L.; Hornemann, Thorsten; Thony, Beat; Koelker, Stefan; Burda, Patricie; Froese, D. Sean; Devuyst, Olivier; Baumgartner, Matthias R.			Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; ammonia; enzyme mutation; inborn error of metabolism; metabolic disease; mitochondrial disease; genotype-phenotype correlation; knock-in mouse model; methylmalonic aciduria; vitamin B12 metabolism	CHAIN FATTY-ACIDS; MITOCHONDRIAL DYSFUNCTION; PROPIONIC ACIDURIA; ORGANIC ACIDURIAS; LIPOCALIN 2; ACIDEMIA; DISEASE; MUT; IDENTIFICATION; METABOLISM	Methylmalonic aciduria (MMAuria), caused by deficiency of methylmalonyl-CoA mutase (MUT), usually presents in the newborn period with failure to thrive and metabolic crisis leading to coma or even death. Survivors remain at risk of metabolic decompensations and severe long term complications, notably renal failure and neurological impairment. We generated clinically relevant mouse models of MMAuria using a constitutive Mut knock-in (KI) allele based on the p.Met700Lys patient mutation, used homozygously (KI/KI) or combined with a knockout allele (KO/KI), to study biochemical and clinical MMAuria disease aspects. Transgenic Mut(ki/ki) and Mut(ko/ki) mice survive post-weaning, show failure to thrive, and show increased methylmalonic acid, propionylcarnitine, odd chain fatty acids, and sphingoid bases, a new potential biomarker of MMAuria. Consistent with genetic dosage, Mut(ko/ki) mice have lower Mut activity, are smaller, and show higher metabolite levels than Mut(ki/ki) mice. Further, Mut(ko/ki) mice exhibit manifestations of kidney and brain damage, including increased plasma urea, impaired diuresis, elevated biomarkers, and changes in brain weight. On a high protein diet, mutant mice display disease exacerbation, including elevated blood ammonia, and catastrophic weight loss, which, in Mut(ki/ki) mice, is rescued by hydroxocobalamin treatment. This study expands knowledge of MMAuria, introduces the discovery of new biomarkers, and constitutes the first in vivo proof of principle of cobalamin treatment in mut-type MMAuria.	[Forny, Patrick; Schumann, Anke; Mustedanagic, Merima; Thony, Beat; Burda, Patricie; Froese, D. Sean; Baumgartner, Matthias R.] Univ Childrens Hosp Zurich, Div Metab, CH-8032 Zurich, Switzerland; [Forny, Patrick; Schumann, Anke; Fingerhut, Ralph; Thony, Beat; Burda, Patricie; Froese, D. Sean; Baumgartner, Matthias R.] Univ Childrens Hosp Zurich, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Mathis, Deborah] Univ Childrens Hosp Zurich, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland; [Fingerhut, Ralph] Univ Childrens Hosp Zurich, Swiss Newborn Screening Lab, CH-8032 Zurich, Switzerland; [Forny, Patrick; Schumann, Anke; Hornemann, Thorsten; Froese, D. Sean; Devuyst, Olivier; Baumgartner, Matthias R.] Univ Zurich, Clin Res Prior Program Rare Dis, Radiz Rare Dis Initiat Zurich, CH-8006 Zurich, Switzerland; [Forny, Patrick; Devuyst, Olivier; Baumgartner, Matthias R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Schumann, Anke; Nagele, Nadine; Devuyst, Olivier] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Wulf, Marie-Angela] Univ Zurich Hosp, Inst Neuropathol, CH-8006 Zurich, Switzerland; [Zhakupova, Assem; Hornemann, Thorsten] Univ Zurich Hosp, Inst Clin Chem, CH-8006 Zurich, Switzerland; [Langhans, Claus-Dieter; Koelker, Stefan] Univ Childrens Hosp, Div Child Neurol & Inherited Metab Dis, D-69120 Heidelberg, Germany; [Heeren, Joerg; Scheja, Ludger] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Peters, Heidi L.] Murdoch Childrens Res Inst, Metab Res, Parkville, Vic 3052, Australia	University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Murdoch Children's Research Institute	Baumgartner, MR (corresponding author), Univ Childrens Hosp Zurich, Div Metab, CH-8032 Zurich, Switzerland.	matthias.baumgartner@kispi.uzh.ch	Forny, Patrick/I-8387-2016; Froese, Sean/J-6665-2017; peters, heidi/GWD-0358-2022; Fingerhut, Ralph/AAY-5061-2021; Froese, D. Sean Sean/AAW-6899-2021; Baumgartner, Matthias/Q-2855-2017	Forny, Patrick/0000-0003-1877-2976; Froese, Sean/0000-0003-1557-3517; Fingerhut, Ralph/0000-0002-9674-8931; Froese, D. Sean Sean/0000-0003-1557-3517; Baumgartner, Matthias/0000-0002-9270-0826; Thony, Beat/0000-0002-8420-4769; Devuyst, Olivier/0000-0003-3744-4767; Peters, Heidi/0000-0001-7189-5874; Mathis, Deborah/0000-0002-2326-7782	Rare Disease Initiative Zurich; clinical research priority program for rare diseases of the University of Zurich; Swiss National Science Foundation [31003A_138521, 310030-146490]; Wolferman-Nageli Foundation; European Community [305608]; Swiss National Science Foundation MD-PhD fellowship (Swiss National Science Foundation) [323530_145248]	Rare Disease Initiative Zurich; clinical research priority program for rare diseases of the University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wolferman-Nageli Foundation; European Community(European Commission); Swiss National Science Foundation MD-PhD fellowship (Swiss National Science Foundation)	This work was supported by the Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich; the Swiss National Science Foundation Grant 31003A_138521; the Wolferman-Nageli Foundation; the European Community's Seventh Framework Programme FP7/2007-2013 Grant 305608 (EURenOmics) (to O. D.); the Swiss National Science Foundation Project Grant 310030-146490 (to O. D.); and a Swiss National Science Foundation MD-PhD fellowship (Swiss National Science Foundation Grant 323530_145248; to P. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Acquaviva C, 2005, HUM MUTAT, V25, P167, DOI 10.1002/humu.20128; Ballhausen D, 2009, NEUROSCIENCE, V164, P578, DOI 10.1016/j.neuroscience.2009.08.028; Baumgartner MR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0130-8; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Buck NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044974; Chandler RJ, 2008, HUM GENE THER, V19, P53, DOI 10.1089/hum.2007.0118; Chandler RJ, 2010, MOL THER, V18, P11, DOI 10.1038/mt.2009.247; Chandler RJ, 2009, FASEB J, V23, P1252, DOI 10.1096/fj.08-121848; Coker M, 1996, J INHERIT METAB DIS, V19, P743, DOI 10.1007/BF01799166; Cosson MA, 2009, MOL GENET METAB, V97, P172, DOI 10.1016/j.ymgme.2009.03.006; de Keyzer Y, 2009, PEDIATR RES, V66, P91, DOI 10.1203/PDR.0b013e3181a7c270; Ferreira AC, 2015, PROG NEUROBIOL, V131, P120, DOI 10.1016/j.pneurobio.2015.06.005; Forny P, 2016, HUM MUTAT, V37, P745, DOI 10.1002/humu.23013; Forny P, 2014, HUM MUTAT, V35, P1449, DOI 10.1002/humu.22633; Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; HILLMAN RE, 1974, PEDIATR RES, V8, P941, DOI 10.1203/00006450-197412000-00005; Horster F, 2009, J INHERIT METAB DIS, V32, P630, DOI 10.1007/s10545-009-1189-6; Horster F, 2007, PEDIATR RES, V62, P225; Kolker S, 2015, J INHERIT METAB DIS, V38, P1041, DOI 10.1007/s10545-015-9839-3; Kolker S, 2013, J INHERIT METAB DIS, V36, P635, DOI 10.1007/s10545-013-9600-8; Kolker S, 2005, CELL MOL LIFE SCI, V62, P621, DOI 10.1007/s00018-005-4463-2; Kolker S, 2003, J BIOL CHEM, V278, P47388, DOI 10.1074/jbc.M308861200; Lempp TJ, 2007, MOL GENET METAB, V90, P284, DOI 10.1016/j.ymgme.2006.10.002; Malvagia S, 2015, CLIN CHIM ACTA, V450, P342, DOI 10.1016/j.cca.2015.09.012; Malyszko J, 2008, RENAL FAILURE, V30, P625, DOI 10.1080/08860220802134607; Manoli I, 2013, P NATL ACAD SCI USA, V110, P13552, DOI 10.1073/pnas.1302764110; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; Merinero B, 2008, J INHERIT METAB DIS, V31, P55, DOI 10.1007/s10545-007-0667-y; Morath MA, 2008, J INHERIT METAB DIS, V31, P35, DOI 10.1007/s10545-007-0571-5; Naude PJW, 2012, FASEB J, V26, P2811, DOI 10.1096/fj.11-202457; Nicolaides P, 1998, ARCH DIS CHILD, V78, P508, DOI 10.1136/adc.78.6.508; OBERHOLZ.VG, 1967, ARCH DIS CHILD, V42, P492, DOI 10.1136/adc.42.225.492; Okun JG, 2002, J BIOL CHEM, V277, P14674, DOI 10.1074/jbc.M200997200; Othman A, 2015, ATHEROSCLEROSIS, V240, P216, DOI 10.1016/j.atherosclerosis.2015.03.011; PERRY TL, 1977, PEDIATR RES, V11, P1192, DOI 10.1203/00006450-197712000-00005; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Peters HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040609; Scheja L, 2008, LIPIDS, V43, P1039, DOI 10.1007/s11745-008-3220-3; Schwab MA, 2006, BIOCHEM J, V398, P107, DOI 10.1042/BJ20060221; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Turgeon CT, 2010, CLIN CHEM, V56, P1686, DOI 10.1373/clinchem.2010.148957; WENDEL U, 1991, PEDIATR RES, V29, P403, DOI 10.1203/00006450-199104000-00015; Ziesch B, 2012, J INHERIT METAB DIS, V35, P983, DOI 10.1007/s10545-012-9458-1	44	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20563	20573		10.1074/jbc.M116.747717	http://dx.doi.org/10.1074/jbc.M116.747717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27519416	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000384574800022
J	Myers, CL; Li, FKK; Koo, BM; El-Halfawy, OM; French, S; Gross, CA; Strynadka, NCJ; Brown, ED				Myers, Cullen L.; Li, Franco K. K.; Koo, Byoung-Mo; El-Halfawy, Omar M.; French, Shawn; Gross, Carol A.; Strynadka, Natalie C. J.; Brown, Eric D.			Identification of Two Phosphate Starvation-induced Wall Teichoic Acid Hydrolases Provides First Insights into the Degradative Pathway of a Key Bacterial Cell Wall Component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE GDPD; BACILLUS-SUBTILIS CELLS; GRAM-POSITIVE BACTERIA; L-ALANINE AMIDASE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSCRIPTIONAL ANALYSIS; TEICHURONIC ACID; ACTIVE-SITE	The cell wall of most Gram-positive bacteria contains equal amounts of peptidoglycan and the phosphate-rich glycopolymer wall teichoic acid (WTA). During phosphate-limited growth of the Gram-positive model organism Bacillus subtilis 168, WTA is lost from the cell wall in a response mediated by the PhoPR two-component system, which regulates genes involved in phosphate conservation and acquisition. It has been thought that WTA provides a phosphate source to sustain growth during starvation conditions; however, WTA degradative pathways have not been described for this or any condition of bacterial growth. Here, we uncover roles for the Bacillus subtilis PhoP regulon genes glpQ and phoD as encoding secreted phosphodiesterases that function in WTA metabolism during phosphate starvation. Unlike the parent 168 strain, Delta glpQ or Delta phoD mutants retained WTA and ceased growth upon phosphate limitation. Characterization of GlpQ and PhoD enzymatic activities, in addition to X-ray crystal structures of GlpQ, revealed distinct mechanisms of WTA depolymerization for the two enzymes; GlpQ catalyzes exolytic cleavage of individual monomer units, and PhoD catalyzes endo-hydrolysis at nonspecific sites throughout the polymer. The combination of these activities appears requisite for the utilization of WTA as a phosphate reserve. Phenotypic characterization of the Delta glpQ and Delta phoD mutants revealed altered cell morphologies and effects on autolytic activity and antibiotic susceptibilities that, unexpectedly, also occurred in phosphate-replete conditions. Our findings offer novel insight into the B. subtilis phosphate starvation response and implicate WTA hydrolase activity as a determinant of functional properties of the Gram-positive cell envelope.	[Myers, Cullen L.; El-Halfawy, Omar M.; French, Shawn; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Myers, Cullen L.; El-Halfawy, Omar M.; French, Shawn; Brown, Eric D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Li, Franco K. K.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; [Li, Franco K. K.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Koo, Byoung-Mo; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [El-Halfawy, Omar M.] Univ Alexandria, Fac Pharm, Dept Microbiol & Immunol, Alexandria 21521, Egypt	McMaster University; McMaster University; University of British Columbia; University of British Columbia; University of California System; University of California San Francisco; Egyptian Knowledge Bank (EKB); Alexandria University	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca	El-Halfawy, Omar/AAE-2491-2020	El-Halfawy, Omar/0000-0003-2829-5851; Li, Franco/0000-0001-7318-9754; Koo, Byoung-Mo/0000-0003-1001-6367; Myers, Cullen/0000-0002-5789-2260	Canadian Institutes of Health Research Foundation [FRN-143215]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Canadian Institutes of Health Research; Howard Hughes Medical Institute; Canada Foundation for Innovation; British Columbia; National Institutes of Health [R01 GM102790, R35 GM118061]	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Canadian Institutes of Health Research Foundation Grant FRN-143215, a Natural Sciences and Engineering Research Council of Canada Discovery Grant (to E. D. B.), the Canada Research Chairs Program (to E. D. B. and N. C. J. S.), the Canadian Institutes of Health Research, the Howard Hughes Medical Institute International Scholar Program, Canada Foundation for Innovation, British Columbia Knowledge Development Fund, and National Institutes of Health Grants R01 GM102790 and R35 GM118061 (to C. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allenby NEE, 2005, J BACTERIOL, V187, P8063, DOI 10.1128/JB.187.23.8063-8080.2005; Allenby NEE, 2004, MICROBIOL-SGM, V150, P2619, DOI 10.1099/mic.0.27126-0; Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; Antelmann H, 2000, J BACTERIOL, V182, P4478, DOI 10.1128/JB.182.16.4478-4490.2000; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Bhavsar AP, 2001, APPL ENVIRON MICROB, V67, P403, DOI 10.1128/AEM.67.1.403-410.2001; Bisicchia P, 2010, MOL MICROBIOL, V75, P972, DOI 10.1111/j.1365-2958.2009.07036.x; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Botella E, 2014, MOL MICROBIOL, V94, P1242, DOI 10.1111/mmi.12833; Botella E, 2011, MICROBIOL-SGM, V157, P2470, DOI 10.1099/mic.0.049205-0; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; Cutting S., 1990, MOL BIOL METHODS BAC; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; D'Elia MA, 2009, CHEM BIOL, V16, P548, DOI 10.1016/j.chembiol.2009.04.009; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Eder S, 1996, MICROBIOL-SGM, V142, P2041, DOI 10.1099/13500872-142-8-2041; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; GRANT WD, 1979, J BACTERIOL, V137, P35, DOI 10.1128/JB.137.1.35-43.1979; HERBOLD DR, 1975, J BIOL CHEM, V250, P7231; Hulett F. M, 2002, BACILLUS SUBTILIS IT, P193, DOI [10.1128/9781555817992.ch15, DOI 10.1128/9781555817992.CH15]; HULETT FM, 1994, J BACTERIOL, V176, P1348, DOI 10.1128/jb.176.5.1348-1358.1994; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JENKINSON HF, 1983, J GEN MICROBIOL, V129, P1945; Kasahara J, 2016, J BACTERIOL, V198, P1585, DOI 10.1128/JB.00003-16; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; KUSSER W, 1983, J BACTERIOL, V155, P302, DOI 10.1128/JB.155.1.302-310.1983; Lee SH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7364; LINDSAY B, 1976, J BACTERIOL, V127, P803, DOI 10.1128/JB.127.2.803-811.1976; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maria JPS, 2014, P NATL ACAD SCI USA, V111, P12510, DOI 10.1073/pnas.1404099111; MAUCK J, 1971, J BIOL CHEM, V246, P1820; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Muller JP, 1999, FEMS MICROBIOL LETT, V180, P287; MUNSON RS, 1993, J BACTERIOL, V175, P4569, DOI 10.1128/JB.175.14.4569-4571.1993; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nicholson W. L, 1991, MOL BIOL METHODS BAC, P391; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Pragai Z, 2004, J BACTERIOL, V186, P1182, DOI 10.1128/JB.186.4.1182-1190.2004; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Rodriguez F, 2014, J BIOL CHEM, V289, P30889, DOI 10.1074/jbc.M114.604892; Sambrook J, 2012, MOL CLONING, V4; Santelli E, 2004, PROTEINS, V56, P167, DOI 10.1002/prot.20120; Schenk G, 2013, COORDIN CHEM REV, V257, P473, DOI 10.1016/j.ccr.2012.03.020; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sewell EWC, 2014, J ANTIBIOT, V67, P43, DOI 10.1038/ja.2013.100; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; Soldo B, 1999, MOL MICROBIOL, V31, P795, DOI 10.1046/j.1365-2958.1999.01218.x; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Vuitika L, 2016, BBA-MOL CELL BIOL L, V1861, P970, DOI 10.1016/j.bbalip.2016.05.009; Wecke J, 1997, MICROBIOL-UK, V143, P2953, DOI 10.1099/00221287-143-9-2953; Winstel V, 2015, MBIO, V6, DOI 10.1128/mBio.00632-15; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; WISE EM, 1972, P NATL ACAD SCI USA, V69, P233, DOI 10.1073/pnas.69.1.233; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009; Yamamoto H, 2003, J BACTERIOL, V185, P6666, DOI 10.1128/JB.185.22.6666-6677.2003	65	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26066	26082		10.1074/jbc.M116.760447	http://dx.doi.org/10.1074/jbc.M116.760447			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780866	hybrid, Green Published			2022-12-28	WOS:000390345200026
J	Gleyzer, N; Scarpulla, RC				Gleyzer, Natalie; Scarpulla, Richard C.			Concerted Action of PGC-1-related Coactivator (PRC) and c-MYC in the Stress Response to Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; metabolism; mitochondria; signaling; stress	ALLOSTERIC AKT INHIBITOR; PHOSPHORYLATION; TRANSCRIPTION; EXPRESSION; RESPIRATION; ACTIVATION; TRANSFORMATION; DEGRADATION; INTEGRATION; BIOGENESIS	PGC-1-related coactivator (PRC) has a dual function in growth-regulated mitochondrial biogenesis and as a sensor of metabolic stress. PRC induction by mitochondrial inhibitors, intracellular ROS, or topoisomerase I inhibition orchestrates an inflammatory program associated with the adaptation to cellular stress. Activation of this program is accompanied by the coordinate expression of c-MYC, which is linked kinetically to that of PRC in response to multiple stress inducers. Here, we show that the c-MYC inhibitor 10058-F4 blocks the induction of c-MYC, PRC, and representative PRC-dependent stress genes by the respiratory chain uncoupler, carbonyl cyanide m-chlorophenyl hydrazine (CCCP). This result, confirmed by the suppression of PRC induction by c-MYC siRNA silencing, demonstrates a requirement for c-MYC in orchestrating the stress program. PRC steady-state expression was markedly increased upon mutation of two GSK-3 serine phosphorylation sites within the carboxyl-terminal domain. The negative control of PRC expression by GSK-3 was consistent with the phosphor-inactivation of GSK-3 by CCCP and by the induction of PRC by the GSK-3 inhibitor AZD2858. Unlike PRC, which was induced post-translationally through increased protein half-life, c-MYC was induced predominantly at the mRNA level. Moreover, suppression of Akt activation by the Akt inhibitor MK-2206 blocked the CCCP induction of PRC, c-MYC, and representative PRC stress genes, demonstrating a requirement for Akt signaling. MK-2206 also inhibited the phosphor-inactivation of GSK-3 by CCCP, a result consistent with the ability of Akt to phosphorylate, and thereby suppress GSK-3 activity. Thus, PRC and c-MYC can act in concert through Akt-GSK-3 signaling to reprogram gene expression in response to mitochondrial stress.	[Gleyzer, Natalie; Scarpulla, Richard C.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 East Chicago Ave, Chicago, IL 60611 USA	Northwestern University	Scarpulla, RC (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 East Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			National Institutes of General Medical Sciences [GM 32525]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM032525, R01GM032525] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of General Medical Sciences Grant GM 32525. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campaner S, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-6; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Dey S, 2013, AUTOPHAGY, V9, P612, DOI 10.4161/auto.23486; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Flick K, 2012, SEMIN CELL DEV BIOL, V23, P515, DOI 10.1016/j.semcdb.2012.01.019; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Gleyzer N, 2013, J BIOL CHEM, V288, P8004, DOI 10.1074/jbc.M112.426841; Gleyzer N, 2011, J BIOL CHEM, V286, P39715, DOI 10.1074/jbc.M111.291575; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; He X, 2012, DEV DYNAM, V241, P975, DOI 10.1002/dvdy.23769; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hudis C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3577; Idan C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14756; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsell R, 2012, BONE, V50, P619, DOI 10.1016/j.bone.2011.11.007; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Molife LR, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-1; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rohban S, 2015, BBA-GENE REGUL MECH, V1849, P517, DOI 10.1016/j.bbagrm.2014.04.008; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scarpulla RC, 2012, BBA-GENE REGUL MECH, V1819, P1088, DOI 10.1016/j.bbagrm.2011.10.011; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; Wang H, 1997, BBA-GENE STRUCT EXPR, V1352, P325, DOI 10.1016/S0167-4781(97)00035-3; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Whitfield JR, 2012, CELL MOL LIFE SCI, V69, P931, DOI 10.1007/s00018-011-0860-x; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Yoon JC, 2014, P NATL ACAD SCI USA, V111, P3781, DOI 10.1073/pnas.1400705111	59	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25529	25541		10.1074/jbc.M116.719682	http://dx.doi.org/10.1074/jbc.M116.719682			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27789709	Green Published, hybrid			2022-12-28	WOS:000390095300021
J	Lander, N; Chiurillo, MA; Storey, M; Vercesi, AE; Docampo, R				Lander, Noelia; Chiurillo, Miguel A.; Storey, Melissa; Vercesi, Anibal E.; Docampo, Roberto			CRISPR/Cas9-mediated endogenous C-terminal Tagging of Trypanosoma cruzi Genes Reveals the Acidocalcisome Localization of the Inositol 1,4,5-Trisphosphate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; inositol 1; 4; 5-trisphosphate (IP3); mitochondria; Trypanosoma cruzi; vacuolar acidification; acidocalcisome; flagellum	SECRETORY GRANULES; CA-2+ TRANSPORT; CA2+; BRUCEI; EXPRESSION; MEMBRANE; RELEASE; PROTEIN; GROWTH; PYROPHOSPHATASE	Methods for genetic manipulation of Trypanosoma cruzi, the etiologic agent of Chagas disease, have been highly inefficient, and no endogenous tagging of genes has been reported to date. We report here the use of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated gene 9) system for endogenously tagging genes in this parasite. The utility of the method was established by tagging genes encoding proteins of known localization such as TcFCaBP (flagellar calcium binding protein) and TcVP1 (vacuolar proton pyrophosphatase), and two proteins of undefined or disputed localization, the TcMCU (mitochondrial calcium uniporter) and TcIP3R (inositol 1,4,5-trisphosphate receptor). We confirmed the flagellar and acidocalcisome localization of TcFCaBP and TcVP1 by co-localization with antibodies to the flagellum and acidocalcisomes, respectively. As expected, TcMCU was co-localized with the voltage-dependent anion channel to the mitochondria. However, in contrast to previous reports and our own results using overexpressed TcIP3R, endogenously tagged TcIP3R showed co-localization with antibodies against VP1 to acidocalcisomes. These results are also in agreement with our previous reports on the localization of this channel to acidocalcisomes of Trypanosoma brucei and suggest that caution should be exercised when overexpression of tagged genes is done to localize proteins in T. cruzi.	[Lander, Noelia; Chiurillo, Miguel A.; Vercesi, Anibal E.; Docampo, Roberto] Univ Estadual Campinas, Dept Patol Clin, Fac Ciencias Med, BR-13083 Campinas, SP, Brazil; [Storey, Melissa; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Storey, Melissa; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Universidade Estadual de Campinas; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lander, N; Docampo, R (corresponding author), Univ Estadual Campinas, Dept Patol Clin, Fac Ciencias Med, BR-13083 Campinas, SP, Brazil.; Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	noelia@uga.edu; rdocampo@uga.edu	Vercesi, Aníbal E/C-8767-2012; Docampo, Roberto/X-9424-2019	Docampo, Roberto/0000-0003-4229-8784; Vercesi, Anibal Eugenio/0000-0001-6671-7125; Chiurillo, Miguel A./0000-0002-5581-9027; Lander, Noelia/0000-0003-2178-381X	Sao Paulo Research Foundation [2013/ 50624-0, 2014/08995-4, 2014/13148-9]; National Institutes of Health [AI107663]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI107663, R01AI107663] Funding Source: NIH RePORTER	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Sao Paulo Research Foundation Grant 2013/ 50624-0, and National Institutes of Health Grant AI107663, and Sao Paulo Research Foundation Postdoctoral Fellowships 2014/08995-4 (to N. L.) and 2014/13148-9 (to M. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez J, 2012, CELL CALCIUM, V51, P331, DOI 10.1016/j.ceca.2011.12.002; Alzayady KJ, 2015, MOL BIOL EVOL, V32, P2236, DOI 10.1093/molbev/msv098; BANGS JD, 1993, J CELL SCI, V105, P1101; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; DOCAMPO R, 1989, ARCH BIOCHEM BIOPHYS, V272, P122, DOI 10.1016/0003-9861(89)90202-6; Docampo R, 2015, CELL CALCIUM, V57, P194, DOI 10.1016/j.ceca.2014.10.015; Docampo R, 2014, MOL BIOCHEM PARASIT, V196, P108, DOI 10.1016/j.molbiopara.2014.09.001; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Docampo R, 2011, ESSAYS BIOCHEM, V51, P1, DOI [10.1042/BSE0510001, 10.1042/bse0510001]; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; ENGMAN DM, 1989, J BIOL CHEM, V264, P18627; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; Hashimoto M, 2013, MOL MICROBIOL, V87, P1133, DOI 10.1111/mmi.12155; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Huang GZ, 2013, P NATL ACAD SCI USA, V110, P1887, DOI 10.1073/pnas.1216955110; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Lander N, 2016, J EUKARYOT MICROBIOL, V63, P679, DOI 10.1111/jeu.12338; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Lu HG, 1998, MOL CELL BIOL, V18, P2309, DOI 10.1128/MCB.18.4.2309; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Quesada I, 2001, BIOPHYS J, V80, P2133, DOI 10.1016/S0006-3495(01)76186-3; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Yoo SH, 2010, FASEB J, V24, P653, DOI 10.1096/fj.09-132456; YOO SH, 1994, J BIOL CHEM, V269, P12001; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096908; Zhang WG, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/765362	43	54	54	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25505	25515		10.1074/jbc.M116.749655	http://dx.doi.org/10.1074/jbc.M116.749655			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27793988	Green Published, hybrid			2022-12-28	WOS:000390095300019
J	Fujiwara, Y; Piemontese, M; Liu, Y; Thostenson, JD; Xiong, JH; O'Brien, CA				Fujiwara, Yuko; Piemontese, Marilina; Liu, Yu; Thostenson, Jeff D.; Xiong, Jinhu; O'Brien, Charles A.			RANKL (Receptor Activator of NF kappa B Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTMENOPAUSAL WOMEN; OSTEOCLAST FORMATION; LYMPHOPOIESIS; EXPRESSION; LYMPHOCYTE; RESORPTION; DIFFERENTIATION; IDENTIFICATION; INTERLEUKIN-7; PROGENITORS	The cytokine receptor activator of NF kappa B ligand (RANKL) produced by osteocytes is essential for osteoclast formation in cancellous bone under physiological conditions, and RANKL production by B lymphocytes is required for the bone loss caused by estrogen deficiency. Here, we examined whether RANKL produced by osteocytes is also required for the bone loss caused by estrogen deficiency. Mice lacking RANKL in osteocytes were protected from the increase in osteoclast number and the bone loss caused by ovariectomy. Moreover, these mice did not exhibit the increase in bone marrow B lymphocytes caused by ovariectomy that occurred in control littermates. Deletion of estrogen receptor alpha from B cells did not alter B cell number or bone mass and did not alter the response to ovariectomy. In addition, lineage-tracing studies demonstrated that B cells do not act as osteoclast progenitors in estrogen-replete or estrogen-deficient mice. Taken together, these results demonstrate that RANKL expressed by osteocytes is required for the bone loss as well as the increase in B cell number caused by estrogen deficiency. Moreover, they suggest that estrogen control of B cell number is indirect via osteocytes and that the increase in bone marrow B cells may be a necessary component of the cascade of events that lead to cancellous bone loss during estrogen deficiency. However, the role of B cells is not to act as osteoclast progenitors but may be to act as osteoclast support cells.	[Fujiwara, Yuko; Piemontese, Marilina; Liu, Yu; Xiong, Jinhu; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Thostenson, Jeff D.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Fujiwara, Yuko; Piemontese, Marilina; Liu, Yu; Xiong, Jinhu; O'Brien, Charles A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, 4301 W Markham St, Little Rock, AR 72205 USA.	caobrien@uams.edu	O'Brien, Charles A./AAL-5078-2020; xiong, jinhu/E-1849-2011	Piemontese, Marilina/0000-0002-9296-1348	National Institutes of Health [P01 AG13918, R01 AR49794]; University of Arkansas for Medical Sciences Translational Research Institute (NIH) [UL1TR000039]; Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant [I01 BX000294]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Sciences Translational Research Institute (NIH); Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG13918 and R01 AR49794 and the University of Arkansas for Medical Sciences Translational Research Institute (NIH UL1TR000039). This work was also supported by the Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant I01 BX000294 and by tobacco settlement funds. C. A. O'Brien owns stock in Radius Health Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blin-Wakkach C, 2004, J BONE MINER RES, V19, P1137, DOI 10.1359/JBMR.040318; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Katavic V, 2003, BONE, V32, P581, DOI 10.1016/S8756-3282(03)00097-8; KINCADE PW, 1994, IMMUNOL REV, V137, P119, DOI 10.1111/j.1600-065X.1994.tb00661.x; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Li XD, 2009, BONE, V45, P669, DOI 10.1016/j.bone.2009.06.011; Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manabe N, 2001, J IMMUNOL, V167, P2625, DOI 10.4049/jimmunol.167.5.2625; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Mansour A, 2011, CELL RES, V21, P1102, DOI 10.1038/cr.2011.21; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Onal M, 2012, J BIOL CHEM, V287, P29851, DOI 10.1074/jbc.M112.377945; PARFITT AM, 1982, METAB BONE DIS RELAT, V4, P1, DOI 10.1016/0221-8747(82)90002-9; Perlot T, 2012, J IMMUNOL, V188, P1201, DOI 10.4049/jimmunol.1102063; Proell V, 2009, BONE, V45, P677, DOI 10.1016/j.bone.2009.05.024; Pugliese LS, 2012, IMMUNOBIOLOGY, V217, P336, DOI 10.1016/j.imbio.2011.07.014; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sato T, 2001, J BONE MINER RES, V16, P2215, DOI 10.1359/jbmr.2001.16.12.2215; Sato T, 2007, J BONE MINER METAB, V25, P19, DOI 10.1007/s00774-006-0723-y; SMITHSON G, 1995, J IMMUNOL, V155, P3409; SMITHSON G, 1994, J EXP MED, V180, P717, DOI 10.1084/jem.180.2.717; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Taxel P, 2008, OSTEOPOROSIS INT, V19, P193, DOI 10.1007/s00198-007-0452-7; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Terashima A, 2016, IMMUNITY, V44, P1434, DOI 10.1016/j.immuni.2016.05.012; Teufel S, 2014, J IMMUNOL, V193, P223, DOI 10.4049/jimmunol.1302713; Weitzmann MN, 2002, J CLIN INVEST, V110, P1643, DOI 10.1172/JCI200215687; Windahl SH, 2013, P NATL ACAD SCI USA, V110, P2294, DOI 10.1073/pnas.1220811110; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Xiong JH, 2014, BONE, V66, P146, DOI 10.1016/j.bone.2014.06.006; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Xu S, 2016, J BONE MINER RES, V31, P1320, DOI 10.1002/jbmr.2800; Yasui T, 2009, EUR J ENDOCRINOL, V161, P267, DOI 10.1530/EJE-09-0063; Yasui T, 2009, ATHEROSCLEROSIS, V204, P471, DOI 10.1016/j.atherosclerosis.2008.09.014; Zhang JZ, 2016, J BONE MINER RES, V31, P2001, DOI 10.1002/jbmr.2877; Zhou J, 2013, J BIOL CHEM, V288, P30064, DOI 10.1074/jbc.M113.478750; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	54	51	55	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24838	24850		10.1074/jbc.M116.742452	http://dx.doi.org/10.1074/jbc.M116.742452			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27733688	Green Published, hybrid			2022-12-28	WOS:000388880100004
J	Premchandar, A; Mucke, N; Poznanski, J; Wedig, T; Kaus-Drobek, M; Herrmann, H; Dadlez, M				Premchandar, Aiswarya; Mucke, Norbert; Poznanski, Jaroslaw; Wedig, Tatjana; Kaus-Drobek, Magdalena; Herrmann, Harald; Dadlez, Michal			Structural Dynamics of the Vimentin Coiled-coil Contact Regions Involved in Filament Assembly as Revealed by Hydrogen-Deuterium Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; KERATIN INTERMEDIATE-FILAMENTS; IN-VITRO; ATOMIC-STRUCTURE; 2B; DOMAINS; DESMIN; DIMER; ROD; ARCHITECTURE	Intermediate filaments (IF) are major constituents of the cytoskeleton of metazoan cells. They are not only responsible for the mechanical properties but also for various physiological activities in different cells and tissues. The building blocks of IFs are extended coiled-coil-forming proteins exhibiting a characteristic central alpha-helical domain ("rod"). The fundamental principles of the filament assembly mechanism and the network formation have been widely elucidated for the cytoplasmic IF protein vimentin. Also, a comprehensive structural model for the tetrameric complex of vimentin has been obtained by X-ray crystallography in combination with various biochemical and biophysical techniques. To extend these static data and to investigate the dynamic properties of the full-length proteins in solution during the various assembly steps, we analyzed the patterns of hydrogen-deuterium exchange in vimentin and in four variants carrying point mutations in the IF consensus motifs present at either end of the alpha-helical rod that cause an assembly arrest at the unit-length filament (ULF) stage. The results yielded unique insights into the structural properties of subdomains within the full-length vimentin, in particular in regions of contact in alpha-helical and linker segments that stabilize different oligomeric forms such as tetramers, ULFs, and mature filaments. Moreover, hydrogen-deuterium exchange analysis of the point-mutated variants directly demonstrated the active role of the IF consensus motifs in the oligomerization mechanism of tetramers during ULF formation. Ultimately, using molecular dynamics simulation procedures, we provide a structural model for the subdomain-mediated tetramer/tetramer interaction via "cross-coiling" as the first step of the assembly process.	[Premchandar, Aiswarya; Poznanski, Jaroslaw; Kaus-Drobek, Magdalena; Dadlez, Michal] Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland; [Dadlez, Michal] Univ Warsaw, Inst Genet & Biotechnol, Dept Biol, Miecznikowa 3, PL-02106 Warsaw, Poland; [Mucke, Norbert; Wedig, Tatjana] German Canc Res Ctr, Biophys Macromol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Herrmann, Harald] Univ Hosp Erlangen, Inst Neuropathol, D-91054 Erlangen, Germany	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg	Herrmann, H (corresponding author), Univ Hosp Erlangen, Inst Neuropathol, D-91054 Erlangen, Germany.; Dadlez, M (corresponding author), Inst Biochem & Biophys, Dept Biophys, PL-02106 Warsaw, Poland.	harald.herrmann@uk-erlangen.de; michald@ibb.waw.pl	Poznanski, Jaroslaw/F-7705-2014; Premchandar, Aiswarya/AAD-1077-2019	Poznanski, Jaroslaw/0000-0003-2684-1775; Premchandar, Aiswarya/0000-0002-5664-496X; Mucke, Norbert/0000-0002-0683-4386; Dadlez, Michal/0000-0001-8811-5176; Kaus-Drobek, Magdalena/0000-0001-6202-4567	Foundation for Polish Science Grant [TEAM/2011-7/1]; European Union Centre for Preclinical Research and Technology (CePT) Grant [POIG.02.02.00-14-024/08-00]; NanoFun Program [POIGT.02.02.00-00-025/09-00]; German Research Foundation (DFG) [HE1853/11-1]; MAESTRO Grant from the National Science Centre, Poland [2014/14/A/NZ1/0030]	Foundation for Polish Science Grant; European Union Centre for Preclinical Research and Technology (CePT) Grant; NanoFun Program; German Research Foundation (DFG)(German Research Foundation (DFG)); MAESTRO Grant from the National Science Centre, Poland	This work was supported by Foundation for Polish Science Grant TEAM/2011-7/1, European Union Centre for Preclinical Research and Technology (CePT) Grant POIG.02.02.00-14-024/08-00, and NanoFun Program Grant POIGT.02.02.00-00-025/09-00. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by German Research Foundation (DFG) Grant HE1853/11-1. To whom correspondence may be addressed: Institute of Neuropathology, University Hospital Erlangen, D-91054 Erlangen, Germany. Tel.: 49-9131-85-34782; Fax: 49-9131-85-26033; E-mail: harald.herrmann@uk-erlangen.de.r Supported by MAESTRO Grant 2014/14/A/NZ1/0030 from the National Science Centre, Poland. To whom correspondence may be addressed: Institute of Biochemistry and Biophysics, Dept. of Biophysics, 02-106 Warsaw, Poland. Tel.: 48-22-5923-471; Fax: 48-22-658-4766; E-mail: michald@ibb.waw.pl.	Aziz A, 2012, J BIOL CHEM, V287, P28349, DOI 10.1074/jbc.M111.334011; Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Chernyatina AA, 2015, CURR OPIN CELL BIOL, V32, P65, DOI 10.1016/j.ceb.2014.12.007; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Colas J, 2012, HUM MOL GENET, V21, P623, DOI 10.1093/hmg/ddr496; GEISLER N, 1982, CELL, V30, P277, DOI 10.1016/0092-8674(82)90033-2; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kapinos LE, 2010, J MOL BIOL, V396, P719, DOI 10.1016/j.jmb.2009.12.001; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Koster S, 2015, CURR OPIN CELL BIOL, V32, P82, DOI 10.1016/j.ceb.2015.01.001; Kowlessur D, 2012, J BIOL CHEM, V287, P42299, DOI 10.1074/jbc.M112.423459; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; Noding B, 2014, BIOPHYS J, V107, P2914, DOI 10.1016/j.bpj.2014.09.050; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; PARRY DAD, 1995, INTERMEDIATE FILAMEN; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Parry DAD, 2006, J STRUCT BIOL, V155, P370, DOI 10.1016/j.jsb.2006.03.017; Premchandar A, 2015, J STRUCT BIOL, V192, P426, DOI 10.1016/j.jsb.2015.10.001; Quinlan RA, 1999, EYE, V13, P409, DOI 10.1038/eye.1999.115; Richter MM, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150238; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; STEINERT PM, 1993, J BIOL CHEM, V268, P24916; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Vijayaraj P, 2009, J CELL BIOL, V187, P175, DOI 10.1083/jcb.200906094; Winheim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019202; Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539	51	28	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24931	24950		10.1074/jbc.M116.748145	http://dx.doi.org/10.1074/jbc.M116.748145			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27694444	Green Published, hybrid			2022-12-28	WOS:000388880100013
J	Bround, MJ; Wambolt, R; Cen, HN; Asghari, P; Albu, RF; Han, J; McAfee, D; Pourrier, M; Scott, NE; Bohunek, L; Kulpa, JE; Chen, SRW; Fedida, D; Brownsey, RW; Borchers, CH; Foster, LJ; Mayor, T; Moore, EDW; Allard, MF; Johnson, JD				Bround, Michael J.; Wambolt, Rich; Cen, Haoning; Asghari, Parisa; Albu, Razvan F.; Han, Jun; McAfee, Donald; Pourrier, Marc; Scott, Nichollas E.; Bohunek, Lubos; Kulpa, Jerzy E.; Chen, S. R. Wayne; Fedida, David; Brownsey, Roger W.; Borchers, Christoph H.; Foster, Leonard J.; Mayor, Thibault; Moore, Edwin D. W.; Allard, Michael F.; Johnson, James D.			Cardiac Ryanodine Receptor (Ryr2)-mediated Calcium Signals Specifically Promote Glucose Oxidation via Pyruvate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium intracellular release; cardiac metabolism; cardiomyocyte; heart failure; metabolomics; mitochondrial metabolism; proteomics; ryanodine receptor; transcriptomics; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); metabolism; calcium; mitochondria; intracellular calcium release	SARCOPLASMIC-RETICULUM; PRESSURE-OVERLOAD; ATP PRODUCTION; VENTRICULAR-ARRHYTHMIAS; MITOCHONDRIAL CA2+; HEART-FAILURE; METABOLISM; HYPERTROPHY; UNIPORTER; MICE	Cardiac ryanodine receptor (Ryr2) Ca2+ release channels and cellular metabolism are both disrupted in heart disease. Recently, we demonstrated that total loss of Ryr2 leads to cardiomyocyte contractile dysfunction, arrhythmia, and reduced heart rate. Acute total Ryr2 ablation also impaired metabolism, but it was not clear whether this was a cause or consequence of heart failure. Previous in vitro studies revealed that Ca2+ flux into the mitochondria helps pace oxidative metabolism, but there is limited in vivo evidence supporting this concept. Here, we studied heart-specific, inducible Ryr2 haploinsufficient (cRyr250) mice with a stable 50% reduction in Ryr2 protein. This manipulation decreased the amplitude and frequency of cytosolic and mitochondrial Ca2+ signals in isolated cardiomyocytes, without changes in cardiomyocyte contraction. Remarkably, in the context of well preserved contractile function in perfused hearts, we observed decreased glucose oxidation, but not fat oxidation, with increased glycolysis. cRyr250 hearts exhibited hyperphosphorylation and inhibition of pyruvate dehydrogenase, the key Ca2+-sensitive gatekeeper to glucose oxidation. Metabolomic, proteomic, and transcriptomic analyses revealed additional functional networks associated with altered metabolism in this model. These results demonstrate that Ryr2 controls mitochondrial Ca2+ dynamics and plays a specific, critical role in promoting glucose oxidation in cardiomyocytes. Our findings indicate that partial RYR2 loss is sufficient to cause metabolic abnormalities seen in heart disease.	[Bround, Michael J.; Wambolt, Rich; Cen, Haoning; Asghari, Parisa; McAfee, Donald; Pourrier, Marc; Fedida, David; Moore, Edwin D. W.; Allard, Michael F.; Johnson, James D.] Univ British Columbia, Cardiovasc Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Bround, Michael J.; Cen, Haoning; Asghari, Parisa; Moore, Edwin D. W.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Albu, Razvan F.; Scott, Nichollas E.; Kulpa, Jerzy E.; Brownsey, Roger W.; Foster, Leonard J.; Mayor, Thibault] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [McAfee, Donald; Pourrier, Marc; Fedida, David] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Wambolt, Rich; Bohunek, Lubos; Allard, Michael F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6Z 1Y6, Canada; [Wambolt, Rich; Bohunek, Lubos; Allard, Michael F.] St Pauls Hosp, Ctr Heart & Lung Innovat, Vancouver, BC V6T 1Z4, Canada; [Albu, Razvan F.; Scott, Nichollas E.; Foster, Leonard J.; Mayor, Thibault] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Han, Jun; Borchers, Christoph H.] Univ Victoria, Genome British Columbia Prote Ctr, Victoria, BC V8Z 7X8, Canada; [Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 2T9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Victoria; Libin Cardiovascular Institute Of Alberta; University of Calgary	Johnson, JD (corresponding author), Univ British Columbia, Cardiovasc Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.; Johnson, JD (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada.; Johnson, JD (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, 5358,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	james.d.johnson@ubc.ca	BORCHERS, Christoph/U-5964-2019; Cen, Haoning Howard/GSN-3597-2022	Cen, Haoning Howard/0000-0001-8045-1335; Asghari, Parisa/0000-0003-2285-3242; Scott, Nichollas/0000-0003-2556-8316; Moore, Edwin DW/0000-0001-7519-5592	University of British Columbia Start-Up Funds; Canadian Institutes of Health Research (CIHR) [MOP-77688, MOP 115158]; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research	University of British Columbia Start-Up Funds; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research	This work was supported by University of British Columbia Start-Up Funds (to J. D. J.), funding from the Canadian Institutes of Health Research (CIHR) (MOP-77688) (to L. J. F.) and (MOP 115158) (to E. D. W. M.), a scholarship from CIHR (to M. J. B.), a scholarship from the Michael Smith Foundation for Health Research (to N. E. S.), and Natural Sciences and Engineering Research Council of Canada (NSERC) and the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research (to S. R. W. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Albu RF, 2015, J PROTEOMICS, V118, P21, DOI 10.1016/j.jprot.2014.10.011; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Allard MF, 2007, AM J PHYSIOL-HEART C, V292, pH140, DOI 10.1152/ajpheart.00424.2006; Bidasse KR, 2001, MOL PHARMACOL, V60, P1356, DOI 10.1124/mol.60.6.1356; Bround MJ, 2013, J BIOL CHEM, V288, P18975, DOI 10.1074/jbc.M112.427062; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; de Haas HJ, 2014, CIRC RES, V114, P903, DOI 10.1161/CIRCRESAHA.113.302680; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Fernando V., 2006, CARDIOVASCULAR PROTE, DOI [10.1385/1597452149, DOI 10.1385/1597452149]; Garcia-Perez C, 2011, AM J PHYSIOL-HEART C, V301, pH1907, DOI 10.1152/ajpheart.00397.2011; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gomez AM, 2004, CARDIOVASC RES, V64, P3, DOI 10.1016/j.cardiores.2004.07.018; Gong GH, 2014, J MOL CELL CARDIOL, V76, P235, DOI 10.1016/j.yjmcc.2014.09.012; Han J, 2013, ELECTROPHORESIS, V34, P2891, DOI 10.1002/elps.201200601; Han J, 2013, ANAL CHEM, V85, P5965, DOI 10.1021/ac400769g; Hernandez OM, 2007, AM J PHYSIOL-HEART C, V292, pH1643, DOI 10.1152/ajpheart.00931.2006; Herrer I, 2014, LAB INVEST, V94, P645, DOI 10.1038/labinvest.2014.54; Hiess F, 2015, J BIOL CHEM, V290, P20477, DOI 10.1074/jbc.M115.650531; Hoerter J, 2004, CIRCULATION, V110, P528, DOI 10.1161/01.CIR.0000137824.30476.0E; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kandilci HB, 2011, J PHYSIOL BIOCHEM, V67, P317, DOI 10.1007/s13105-011-0077-3; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Lu D, 2014, INT J CARDIOL, V173, P146, DOI 10.1016/j.ijcard.2014.02.032; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; MATSUI H, 1995, AM J PHYSIOL-CELL PH, V268, pC252, DOI 10.1152/ajpcell.1995.268.1.C252; Milnes JT, 2001, J MOL CELL CARDIOL, V33, P473, DOI 10.1006/jmcc.2000.1320; Min CK, 2012, BIOCHEM J, V447, P371, DOI 10.1042/BJ20120705; Monfredi O, 2013, PHYSIOLOGY, V28, P74, DOI 10.1152/physiol.00054.2012; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Pouliquin P, 2009, PFLUG ARCH EUR J PHY, V458, P723, DOI 10.1007/s00424-009-0664-0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Scriven DRL, 2013, CARDIOVASC RES, V98, P169, DOI 10.1093/cvr/cvt025; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; Song W, 2015, GENE, V569, P1, DOI 10.1016/j.gene.2015.06.029; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Williams S, 2014, AM J PHYSIOL-HEART C, V306, pH867, DOI 10.1152/ajpheart.00704.2013; Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; Zanivan S, 2011, METHODS MOL BIOL, V757, P435, DOI 10.1007/978-1-61779-166-6_25; Zou YZ, 2011, HYPERTENSION, V58, P1099, DOI 10.1161/HYPERTENSIONAHA.111.173500	55	17	17	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23490	23505		10.1074/jbc.M116.756973	http://dx.doi.org/10.1074/jbc.M116.756973			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621312	hybrid, Green Published			2022-12-28	WOS:000387884400012
J	Brutsch, SH; Rademacher, M; Roth, SR; Muller, K; Eder, S; Viertel, D; Franz, C; Kuhn, H; Borchert, A				Bruetsch, Simone Hanna; Rademacher, Marlena; Roth, Sophia Regina; Mueller, Karin; Eder, Susanne; Viertel, Dagmar; Franz, Christiane; Kuhn, Hartmut; Borchert, Astrid			Male Subfertility Induced by Heterozygous Expression of Catalytically Inactive Glutathione Peroxidase 4 Is Rescued in Vivo by Systemic Inactivation of the Alox15 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eicosanoid; lipoxygenase pathway; mitochondria; oxidative stress; sperm	OXIDATIVE STRESS; EMBRYONIC LETHALITY; REDOX HOMEOSTASIS; RAT TESTIS; 15-LIPOXYGENASE; LIPOXYGENASE; PHGPX; ACID; SPECIFICITY; MUTATIONS	Glutathione peroxidase 4 (GPX4) and arachidonic acid 15-lipoxygenase (ALOX15) are antagonizing enzymes in the metabolism of hydroperoxy lipids. In spermatoid cells and/or in the male reproductive system both enzymes are apparently expressed, and GPX4 serves as anti-oxidative enzyme but also as a structural protein. In this study we explored whether germ line inactivation of the Alox15 gene might rescue male subfertility induced by heterozygous expression of catalytically silent Gpx4. To address this question we employed Gpx4 knock-in mice expressing the Sec46Ala-Gpx4 mutant, in which the catalytic selenocysteine was replaced by a redox inactive alanine. Because homozygous Gpx4 knock-in mice (Sec46Ala-Gpx4(+/+)) are not viable we created heterozygous animals (Sec46Ala-Gpx4(+/-)) and crossed them with Alox15 knock-out mice (Alox15(-/-)). Male Sec46Ala-Gpx4(+/-) mice, but not their female littermates, were subfertile. Sperm extracted from the epididymal cauda showed strongly impaired motility characteristics and severe structural midpiece alterations (swollen mitochondria, intramitochondrial vacuoles, disordered mitochondrial capsule). Despite these structural alterations, they exhibited similar respiration characteristics than wild-type sperm. When Sec46Ala-Gpx4(+/-) mice were crossed with Alox15-deficient animals, the resulting males (Sec46Ala-Gpx4(+/-)+Alox15(-/-)) showed normalized fertility, and sperm motility was reimproved to wild-type levels. Taken together these data suggest that systemic inactivation of the Alox15 gene normalizes the reduced fertility of male Sec46Ala-Gpx4(+/-) mice by improving the motility of their sperm. If these data can be confirmed in humans, ALOX15 inhibitors might counteract male infertility related to GPX4 deficiency.	[Bruetsch, Simone Hanna; Rademacher, Marlena; Roth, Sophia Regina; Kuhn, Hartmut; Borchert, Astrid] Charite, Inst Biochem, Virchowweg 6,Chariteplatz 1, D-10117 Berlin, Germany; [Mueller, Karin; Eder, Susanne; Viertel, Dagmar; Franz, Christiane] Leibniz Inst Zoo & Wildlife Res, Alfred Kowalke Str 17, D-10315 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Zoo und Wildtierforschung	Kuhn, H (corresponding author), Charite, Inst Biochem, Virchowweg 6,Chariteplatz 1, D-10117 Berlin, Germany.	hartmut.kuehn@charite.de		Borchert, Astrid/0000-0003-3551-5592	Deutsche Forschungsgemeinschaft (DFG) [GRK1673, Ku961/11-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants GRK1673 (to H. K.) and Ku961/11-1(to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bocci V, 2013, CURR MED CHEM, V20, P3397, DOI 10.2174/0929867311320270005; Borchert A, 2006, J BIOL CHEM, V281, P19655, DOI 10.1074/jbc.M601195200; Borchert A, 2010, IMMUNOL LETT, V133, P85, DOI 10.1016/j.imlet.2010.07.006; Brault C, 2016, GUT, V65, P144, DOI 10.1136/gutjnl-2014-307904; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Brutsch SH, 2015, ANTIOXID REDOX SIGN, V22, P281, DOI 10.1089/ars.2014.5967; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Canli O, 2016, BLOOD, V127, P139, DOI 10.1182/blood-2015-06-654194; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; De Marchi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/564961; de Oliveira MF, 2012, INT J CELL BIOL, V2012; Diaconu M, 2006, ANDROLOGIA, V38, P152, DOI 10.1111/j.1439-0272.2006.00729.x; Dreher I, 1997, J TRACE ELEM MED BIO, V11, P83, DOI 10.1016/S0946-672X(97)80031-4; Fischer KA, 2005, REPRODUCTION, V130, P213, DOI 10.1530/rep.1.00646; Flohe L, 2008, ANTIOXID REDOX SIGN, V10, P1485, DOI 10.1089/ars.2008.2059; Forman HJ, 2014, J MOL CELL CARDIOL, V73, P2, DOI 10.1016/j.yjmcc.2014.01.018; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gregus AM, 2013, FASEB J, V27, P1939, DOI 10.1096/fj.12-217414; GROSSMAN S, 1979, BIOCHIM BIOPHYS ACTA, V572, P293, DOI 10.1016/0005-2760(79)90044-4; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Ingold I, 2015, J BIOL CHEM, V290, P14668, DOI 10.1074/jbc.M115.656363; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Karunakaran U, 2013, DIABETES METAB J, V37, P106, DOI 10.4093/dmj.2013.37.2.106; KUHN H, 1990, EUR J BIOCHEM, V191, P221, DOI 10.1111/j.1432-1033.1990.tb19113.x; KUHN H, 1990, J BIOL CHEM, V265, P18351; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Moore K, 2010, CELL TISSUE RES, V340, P569, DOI 10.1007/s00441-010-0972-x; Olsen LF, 2013, REDOX REP, V18, P245, DOI 10.1179/1351000213Y.0000000059; Passaia G, 2015, PLANT SCI, V234, P22, DOI 10.1016/j.plantsci.2015.01.017; Pekarova M, 2015, ARCH BIOCHEM BIOPHYS, V571, P50, DOI 10.1016/j.abb.2015.02.029; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; REDDY GP, 1992, PROSTAG OTH LIPID M, V44, P497, DOI 10.1016/0090-6980(92)90020-T; ROVERI A, 1992, J BIOL CHEM, V267, P6142; Roveri A, 2001, BIOFACTORS, V14, P213, DOI 10.1002/biof.5520140127; Schneider M, 2010, NEOPLASIA, V12, P254, DOI 10.1593/neo.91782; Schnurr K, 1999, FASEB J, V13, P143, DOI 10.1096/fasebj.13.1.143; Schnurr K, 1996, J BIOL CHEM, V271, P4653; SCHON I, 1989, INT J BIOCHEM, V21, P7, DOI 10.1016/0020-711X(89)90021-9; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; SLOANE DL, 1991, ADV PROSTAG THROMB L, V21, P25; Smith AC, 2014, J MED GENET, V51, P470, DOI 10.1136/jmedgenet-2013-102218; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Tourmente M, 2015, J BIOL CHEM, V290, P20613, DOI 10.1074/jbc.M115.664813; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	53	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23578	23588		10.1074/jbc.M116.738930	http://dx.doi.org/10.1074/jbc.M116.738930			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634046	Green Published, hybrid			2022-12-28	WOS:000387884400019
J	Gravina, HD; Goes, AM; Murta, SMF; Ropert, C				Gravina, Humberto Doriguetto; Goes, Alfredo Miranda; Fonseca Murta, Silvane Maria; Ropert, Catherine			MyD88 Adapter-like (Mal)/TIRAP Is Required for Cytokine Production by Splenic Ly6C(lo)TLR2(hi) but Not by Ly6C(hi)TLR2(hi) Monocytes during Trypanosoma cruzi Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; flow cytometry; infection; inflammation; innate immunity; MAL; TIRAP; monocyte; Toll-like receptor (TLR)	TOLL-LIKE RECEPTOR-2; DENDRITIC CELLS; SIGNAL-TRANSDUCTION; CUTTING EDGE; TLR2; ACTIVATION; EXPRESSION; INFLAMMATION; MACROPHAGES; RECOGNITION	This study continues to explore the plasticity of Toll-like receptor 2 (TLR2) previously described in immune response during Trypanosoma cruzi infection. Here, we have shown that Ly6C(hi)TLR2(hi) monocytes were involved in TNF- and IL-12 production, whereas Ly6C(lo)TLR2(hi) monocytes were mainly committed to IL-10 and TNF- production during T. cruzi infection independently of TLR agonist used (i.e. TLR2 or TLR9 agonists). Another difference between the monocyte populations is that the adapter Mal (encoded by TIRAP) has appeared crucial for the cytokine production by Ly6C(lo) but not by Ly6C(hi) monocytes. The protein Mal was necessary to induce cytokine synthesis by Ly6C(lo) monocytes after triggering TLR2 or TLR9. Finally, our data have suggested that TLR2, TLR9, and Mal/TIRAP controlled differentially the emergence of the different TLR2(hi) monocyte populations in the spleen. In summary, this study highlights the central role of the TLR2/Mal tandem in the distinct activity among the monocyte subsets during T. cruzi infection. Such findings provide a basis for understanding the challenge posed by the use of TLR2 agonist in immunotherapy.	[Gravina, Humberto Doriguetto; Goes, Alfredo Miranda; Ropert, Catherine] Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270910 Belo Horizonte, MG, Brazil; [Fonseca Murta, Silvane Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Ropert, C (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270910 Belo Horizonte, MG, Brazil.; Ropert, C (corresponding author), Inst Ciencias Biol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	ropertcatherine@gmail.com	Ropert, Catherine/G-2463-2012; Gravina, H D/F-2831-2016; Murta, Silvane Fonseca Murta/ABE-9410-2021; Ropert, Catherine/AAL-7302-2021	Gravina, H D/0000-0002-5006-8869; Murta, Silvane Fonseca Murta/0000-0002-8523-2155; Ropert, Catherine/0000-0002-3077-714X				Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Aviello G, 2014, AM J PHYSIOL-GASTR L, V306, pG769, DOI 10.1152/ajpgi.00399.2013; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bartholomeu DC, 2008, J IMMUNOL, V181, P1333, DOI 10.4049/jimmunol.181.2.1333; Bernard NJ, 2013, IUBMB LIFE, V65, P777, DOI 10.1002/iub.1201; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Cheallaigh CN, 2016, IMMUNITY, V44, P368, DOI 10.1016/j.immuni.2016.01.019; Choi YJ, 2013, FASEB J, V27, P243, DOI 10.1096/fj.12-217596; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gravina HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063100; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Ladhani SN, 2010, CLIN INFECT DIS, V51, P761, DOI 10.1086/656236; Lin IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038635; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Mukherjee R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13886; Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688; Richards DM, 2013, CANCER MICROENVIRON, V6, P179, DOI 10.1007/s12307-012-0123-x; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Ropert C, 2004, J ENDOTOXIN RES, V10, P425, DOI 10.1179/096805104225006507; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Shmuel-Galia L, 2016, EMBO J, V35, P685, DOI 10.15252/embj.201592649; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Bergenhenegouwen J, 2013, J LEUKOCYTE BIOL, V94, P885, DOI 10.1189/jlb.0113003; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	44	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23832	23841		10.1074/jbc.M116.729509	http://dx.doi.org/10.1074/jbc.M116.729509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27646001	hybrid, Green Published			2022-12-28	WOS:000387884400042
J	Rosenberg, MM; Redfield, AG; Roberts, MF; Hedstrom, L				Rosenberg, Masha M.; Redfield, Alfred G.; Roberts, Mary F.; Hedstrom, Lizbeth			Substrate and Cofactor Dynamics on Guanosine Monophosphate Reductase Probed by High Resolution Field Cycling P-31 NMR Relaxometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARREL ENZYMES; BINDING SITES; RELAXATION; PROTEINS; LIGAND	Guanosine-5'-monophosphate reductase (GMPR) catalyzes the reduction of GMP to IMP and ammonia with concomitant oxidation of NADPH. Here we investigated the structure and dynamics of enzyme-bound substrates and cofactors by measuring P-31 relaxation rates over a large magnetic field range using high resolution field cycling NMR relaxometry. Surprisingly, these experiments reveal differences in the low field relaxation profiles for the monophosphate of GMP compared with IMP in their respective NADP(+) complexes. These complexes undergo partial reactions that mimic different steps in the overall catalytic cycle. The relaxation profiles indicate that the substrate monophosphates have distinct interactions in E.IMP.NADP(+) and E.GMP.NADP(+) complexes. These findings were not anticipated by x-ray crystal structures, which show identical interactions for the monophosphates of GMP and IMP in several inert complexes. In addition, the motion of the cofactor is enhanced in the E.GMP.NADP(+) complex. Last, the motions of the substrate and cofactor are coordinately regulated; the cofactor has faster local motions than GMP in the deamination complex but is more constrained than IMP in that complex, leading to hydride transfer. These results show that field cycling can be used to investigate the dynamics of protein-bound ligands and provide new insights into how portions of the substrate remote from the site of chemical transformation promote catalysis.	[Rosenberg, Masha M.; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, MS009,415 South St, Waltham, MA 02453 USA; [Redfield, Alfred G.] Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02453 USA; [Roberts, Mary F.] Boston Coll, Dept Chem, 140 Commonwealth Ave, Chestnut Hill, MA 02467 USA	Brandeis University; Brandeis University; Brandeis University; Boston College	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biol, MS009,415 South St, Waltham, MA 02453 USA.; Roberts, MF (corresponding author), Boston Coll, Dept Chem, 140 Commonwealth Ave, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu; hedstrom@brandeis.edu			National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jerome Fung and Seth Fraden for help with the DLS experiments. Molecular graphics images were produced using the UCSF Chimera package from the Computer Graphics Laboratory, University of California, San Francisco (supported by National Institutes of Health Grant P41 RR-01081).	Bloustine J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.087803; BURBAUM JJ, 1989, BIOCHEMISTRY-US, V28, P9293, DOI 10.1021/bi00450a009; Charlier C, 2013, J AM CHEM SOC, V135, P18665, DOI 10.1021/ja409820g; Clarkson MW, 2009, J BIOMOL NMR, V45, P217, DOI 10.1007/s10858-009-9347-6; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gradziel CS, 2014, BIOCHEMISTRY-US, V53, P462, DOI 10.1021/bi401720v; Grebenkov DS, 2009, J PHYS CHEM B, V113, P13347, DOI 10.1021/jp9048082; Hsieh CJ, 2013, PHYS CHEM CHEM PHYS, V15, P16634, DOI 10.1039/c3cp51739j; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; KAYE W, 1973, APPL OPTICS, V12, P541, DOI 10.1364/AO.12.000541; Li JX, 2006, J MOL BIOL, V355, P980, DOI 10.1016/j.jmb.2005.11.047; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mayer M, 2004, J AM CHEM SOC, V126, P4453, DOI 10.1021/ja0398870; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Patton GC, 2011, NAT CHEM BIOL, V7, P950, DOI [10.1038/NCHEMBIO.693, 10.1038/nchembio.693]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pravdivtsev AN, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897336; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P8282, DOI 10.1021/bi901190j; Redfield AG, 2012, J BIOMOL NMR, V52, P159, DOI 10.1007/s10858-011-9594-1; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Steele RM, 2016, MAGN RESON CHEM, V54, P502, DOI 10.1002/mrc.4220; Wei Y, 2015, J BIOL CHEM, V290, P1592, DOI 10.1074/jbc.M114.588590; WILMANNS M, 1991, BIOCHEMISTRY-US, V30, P9161, DOI 10.1021/bi00102a006	27	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22988	22998		10.1074/jbc.M116.739516	http://dx.doi.org/10.1074/jbc.M116.739516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613871	Green Published, hybrid			2022-12-28	WOS:000387224800012
J	Caceres, PS; Mendez, M; Haque, MZ; Ortiz, PA				Caceres, Paulo S.; Mendez, Mariela; Haque, Mohammed Z.; Ortiz, Pablo A.			Vesicle-associated Membrane Protein 3 (VAMP3) Mediates Constitutive Trafficking of the Renal Co-transporter NKCC2 in Thick Ascending Limbs ROLE IN RENAL FUNCTION AND BLOOD PRESSURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial cell; exocytosis; kidney; membrane transport; Na-K-Cl cotransporter (NKCC); renal physiology; SNARE proteins; apical surface; blood pressure; urine excretion	NA-K-2CL COTRANSPORTER; BARTTERS-SYNDROME; COLLECTING DUCT; NA+-K+-2CL(-) COTRANSPORTER; SYNAPTIC VESICLES; TETANUS-TOXIN; HYPOKALEMIC ALKALOSIS; RECYCLING ENDOSOMES; SURFACE EXPRESSION; V-SNARES	Renal cells of the thick ascending limb (TAL) reabsorb NaCl via the apical Na+/K+/2Cl(-) co-transporter NKCC2. Trafficking of NKCC2 to the apical surface regulates NKCC2-mediated NaCl absorption and blood pressure. The molecular mechanisms by which NKCC2 reaches the apical surface and their role in renal function and maintenance of blood pressure are poorly characterized. Here we report that NKCC2 interacts with the vesicle fusion protein VAMP3, and they co-localize at the TAL apical surface. We observed that silencing VAMP3 in vivo blocks constitutive NKCC2 exocytic delivery, decreasing the amount of NKCC2 at the TAL apical surface. VAMP3 is not required for cAMP-stimulated NKCC2 exocytic delivery. Additionally, genetic deletion of VAMP3 in mice decreased total expression of NKCC2 in the TAL and lowered blood pressure. Consistent with these results, urinary excretion of water and electrolytes was higher in VAMP3 knock-out mice, which produced more diluted urine. We conclude that VAMP3 interacts with NKCC2 and mediates its constitutive exocytic delivery to the apical surface. Additionally, VAMP3 is required for normal NKCC2 expression, renal function, and blood pressure.	[Caceres, Paulo S.; Mendez, Mariela; Haque, Mohammed Z.; Ortiz, Pablo A.] Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, 2799 W Grand Blvd,E&R 7044, Detroit, MI 48202 USA; [Caceres, Paulo S.; Ortiz, Pablo A.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [Haque, Mohammed Z.] Hamad Med Corp, Acad Hlth Syst, Interim Translat Res Inst, Doha 16060, Qatar	Henry Ford Health System; Henry Ford Hospital; Wayne State University; Hamad Medical Corporation	Ortiz, PA (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, 2799 W Grand Blvd,E&R 7044, Detroit, MI 48202 USA.	portiz1@hfhs.org	Mendez, Mariela/D-7033-2019	Mendez, Mariela/0000-0002-2537-7272; Ortiz, Pablo/0000-0002-7512-7255; Caceres, Paulo/0000-0003-0197-8177	National Institutes of Health [RO1 HL080409]; NRSA [F32 HL096346-01]; American Heart Association [13IRG14770033, 10PRE3710001, 12PRE12070224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080409, F32HL096346, R01HL070985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO1 HL080409 (to P. A. O.) and NRSA F32 HL096346-01 (to M. M.), American Heart Association Grant 13IRG14770033 (to P. A. O.), and American Heart Association predoctoral fellowships 10PRE3710001 and 12PRE12070224 (to P. S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acuna R, 2011, J HYPERTENS, V29, P475, DOI 10.1097/HJH.0b013e328341d0fd; Adachi M, 2007, ENDOCR J, V54, P1003, DOI 10.1507/endocrj.K06-204; Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Allen LAH, 2002, J LEUKOCYTE BIOL, V72, P217; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bettinelli A, 2000, PEDIATR NEPHROL, V14, P940, DOI 10.1007/PL00013418; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Caceres PS, 2014, J BIOL CHEM, V289, P23951, DOI 10.1074/jbc.M114.589333; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; FRANKI N, 1995, AM J PHYSIOL-CELL PH, V269, pC797, DOI 10.1152/ajpcell.1995.269.3.C797; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Fukuyama S, 2003, KIDNEY INT, V64, P808, DOI 10.1046/j.1523-1755.2003.00163.x; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Gouraud S, 2002, J CELL SCI, V115, P3667, DOI 10.1242/jcs.00053; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Haque MZ, 2011, AM J PHYSIOL-RENAL, V300, pF1096, DOI 10.1152/ajprenal.00600.2010; Hua YF, 2010, NAT NEUROSCI, V13, P1451, DOI 10.1038/nn.2695; Jaykumar AB, 2016, AM J PHYSIOL-RENAL, V310, pF183, DOI 10.1152/ajprenal.00104.2015; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Kurtz CL, 1997, J AM SOC NEPHROL, V8, P1706; LINK E, 1993, J BIOL CHEM, V268, P18423; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MATSUMOTO J, 1989, AM J ROENTGENOL, V152, P1251, DOI 10.2214/ajr.152.6.1251; MCCREDIE DA, 1974, AUST PAEDIATR J, V10, P286; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Mendez M, 2011, J BIOL CHEM, V286, P28608, DOI 10.1074/jbc.M111.225839; Millar CA, 1999, MOL BIOL CELL, V10, P3675, DOI 10.1091/mbc.10.11.3675; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Paredes A, 2006, AM J PHYSIOL-RENAL, V290, pF1094, DOI 10.1152/ajprenal.00071.2005; Procino G, 2008, J CELL SCI, V121, P2097, DOI 10.1242/jcs.022210; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; REIF MC, 1986, J CLIN INVEST, V77, P1291, DOI 10.1172/JCI112433; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schraw TD, 2003, BLOOD, V102, P1716, DOI 10.1182/blood-2003-01-0331; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Sevilla L, 1997, ENDOCRINOLOGY, V138, P3006, DOI 10.1210/en.138.7.3006; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Wang CC, 2010, MOL CELL BIOL, V30, P333, DOI 10.1128/MCB.00814-09; Wilhelm BG, 2010, NAT NEUROSCI, V13, P1454, DOI 10.1038/nn.2690; Yamazaki Y, 2013, EMBO J, V32, P524, DOI 10.1038/emboj.2013.1; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449	64	13	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22063	22073		10.1074/jbc.M116.735167	http://dx.doi.org/10.1074/jbc.M116.735167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27551042	Green Published, hybrid			2022-12-28	WOS:000386332600021
J	Kim, G; Cole, NB; Lim, JC; Zhao, H; Levine, RL				Kim, Geumsoo; Cole, Nelson B.; Lim, Jung Chae; Zhao, Hang; Levine, Rodney L.			Dual sites of protein initiation control the localization and myristoylation of methionine sulfoxide reductase A (vol 285, pg 18085, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701	1	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22338	22338		10.1074/jbc.A110.119701	http://dx.doi.org/10.1074/jbc.A110.119701			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27742876	hybrid, Green Published			2022-12-28	WOS:000386332600043
J	Cheng, YF; Tong, MJ; Edge, ASB				Cheng, Yen-Fu; Tong, Mingjie; Edge, Albert S. B.			Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN INNER-EAR; BETA-CATENIN; NEURAL DIFFERENTIATION; PROGENITOR CELLS; STEM-CELLS; NULL MICE; PROLIFERATION; DEGRADATION; EPITHELIA; PROTEIN	Proneural basic helix-loop-helix transcription factor, Atoh1, plays a key role in the development of sensory hair cells. We show here that the level of Atoh1 must be accurately controlled by degradation of the protein in addition to the regulation of Atoh1 gene expression to achieve normal cellular patterning during development of the cochlear sensory epithelium. The stability of Atoh1 was regulated by the ubiquitin proteasome system through the action of Huwe1, a HECT-domain, E3 ubiquitin ligase. An interaction between Huwe1 and Atoh1 could be visualized by a proximity ligation assay and was confirmed by co-immunoprecipitation and mass spectrometry. Transfer of a lysine 48-linked polyubiquitin chain to Atoh1 by Huwe1 could be demonstrated both in intact cells and in a cell-free system, and proteasome inhibition or Huwe1 silencing increased Atoh1 levels. The interaction with Huwe1 and polyubiquitylation were blocked by disruption of casein kinase 1 (CK1) activity, and mass spectrometry and mutational analysis identified serine 334 as an important phosphorylation site for Atoh1 ubiquitylation and subsequent degradation. Phosphorylation by CK1 thus targeted the protein for degradation. Development of an extra row of inner hair cells in the cochlea and an approximate doubling in the number of afferent synapses was observed after embryonic or early postnatal deletion of Huwe1 in cochlear-supporting cells, and hair cells died in the early postnatal period when Huwe1 was knocked out in the developing cochlea. These data indicate that the regulation of Atoh1 by the ubiquitin proteasome pathway is necessary for hair cell fate determination and survival.	[Cheng, Yen-Fu; Edge, Albert S. B.] Harvard Univ, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02138 USA; [Cheng, Yen-Fu; Edge, Albert S. B.] MIT, Cambridge, MA 02138 USA; [Cheng, Yen-Fu; Tong, Mingjie; Edge, Albert S. B.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Cheng, Yen-Fu; Tong, Mingjie; Edge, Albert S. B.] Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Edge, ASB (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, 243 Charles St, Boston, MA 02114 USA.	albert_edge@meei.harvard.edu	Edge, Albert/Q-5448-2019	Cheng, Yen-Fu/0000-0003-1995-5854	National Institutes of Health [RO1 DC007174, P30 DC005209]; American Hearing Research Foundation; Yen Tjing Ling Medical Foundation (Taiwan); Amelia-Peabody Foundation; Shulsky Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005209, R01DC007174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearing Research Foundation; Yen Tjing Ling Medical Foundation (Taiwan); Amelia-Peabody Foundation; Shulsky Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DC007174 and P30 DC005209 (NIDCD). This work was also supported by the American Hearing Research Foundation, the Yen Tjing Ling Medical Foundation (Taiwan), the Amelia-Peabody Foundation, the Shulsky Foundation, David H. Koch, and Robert Boucai. The authors declare that they have no conflicts of interest with the contents of this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bossuyt W, 2009, PLOS BIOL, V7, P301, DOI 10.1371/journal.pbio.1000040; Bramhall NF, 2014, STEM CELL REP, V2, P311, DOI 10.1016/j.stemcr.2014.01.008; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen P, 2002, DEVELOPMENT, V129, P2495; de Groot REA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004985; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Forget A, 2014, DEV CELL, V29, P649, DOI 10.1016/j.devcel.2014.05.014; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Hao ZY, 2012, J EXP MED, V209, P173, DOI 10.1084/jem.20111363; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Parker MA, 2014, HUM GENE THER METHOD, V25, P1, DOI 10.1089/hgtb.2013.014; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Shi FX, 2010, J BIOL CHEM, V285, P392, DOI 10.1074/jbc.M109.059055; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmuller Judith, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-38; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Tsuchiya K, 2007, GASTROENTEROLOGY, V132, P208, DOI 10.1053/j.gastro.2006.10.031; van Noort M, 2007, BLOOD, V110, P2778, DOI 10.1182/blood-2007-05-092445; Wang XZ, 2014, BIOCHEM BIOPH RES CO, V444, P549, DOI 10.1016/j.bbrc.2014.01.075; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7; Zhang J, 2011, GENE DEV, V25, P2610, DOI 10.1101/gad.170605.111; Zhang XX, 2013, STEM CELLS, V31, P2667, DOI 10.1002/stem.1371; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	51	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21096	21109		10.1074/jbc.M116.722124	http://dx.doi.org/10.1074/jbc.M116.722124			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542412	Green Published, hybrid			2022-12-28	WOS:000385406200025
J	Liu, QY; Liu, F; Yu, KL; Tas, R; Grigoriev, I; Remmelzwaal, S; Serra-Marques, A; Kapitein, LC; Heck, AJR; Akhmanova, A				Liu, Qingyang; Liu, Fan; Yu, Ka Lou; Tas, Roderick; Grigoriev, Ilya; Remmelzwaal, Sanne; Serra-Marques, Andrea; Kapitein, Lukas C.; Heck, Albert J. R.; Akhmanova, Anna			MICAL3 Flavoprotein Monooxygenase Forms a Complex with Centralspindlin and Regulates Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cytokinesis; mass spectrometry (MS); microtubule; protein cross-linking; centralspindlin; flavoprotein monooxygenase; midbody; vesicle transport	RAB8; MEMBRANE; MIDBODY; TRANSPORT; ABSCISSION; GTPASE; ACTIN; CELLS; MICROTUBULES; SPECTRIN	During cytokinesis, the antiparallel array of microtubules forming the central spindle organizes the midbody, a structure that anchors the ingressed cleavage furrow and guides the assembly of abscission machinery. Here, we identified a role for the flavoprotein monooxygenase MICAL3, an actin disassembly factor, in organizing midbody-associated protein complexes. By combining cell biological assays with cross-linking mass spectrometry, we show that MICAL3 is recruited to the central spindle and the midbody through a direct interaction with the centralspindlin component MKLP1. Knock-out of MICAL3 leads to an increased frequency of cytokinetic failure and a delayed abscission. In a mechanism independent of its enzymatic activity, MICAL3 targets the adaptor protein ELKS and Rab8A-positive vesicles to the midbody, and the depletion of ELKS and Rab8A also leads to cytokinesis defects. We propose that MICAL3 acts as a midbody-associated scaffold for vesicle targeting, which promotes maturation of the intercellular bridge and abscission.	[Liu, Qingyang; Yu, Ka Lou; Tas, Roderick; Grigoriev, Ilya; Remmelzwaal, Sanne; Serra-Marques, Andrea; Kapitein, Lukas C.; Akhmanova, Anna] Univ Utrecht, Fac Sci, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Liu, Fan; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Liu, Fan; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Yu, Ka Lou] Agcy Sci Technol & Res, Inst Med Biol, 8a Biomed Grove,06-06 Immunos, Singapore 138648, Singapore; [Serra-Marques, Andrea] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	Utrecht University; Utrecht University; Utrecht University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of California System; University of California San Francisco	Akhmanova, A (corresponding author), Univ Utrecht, Fac Sci, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.akhmanova@uu.nl	Kapitein, Lukas C/J-4776-2016; Heck, Albert/D-7098-2011	Kapitein, Lukas C/0000-0001-9418-6739; Heck, Albert/0000-0002-2405-4404; Liu, Fan/0000-0002-2358-549X; Yu, Ka Lou (Carol)/0000-0002-4960-5399; Tas, Roderick/0000-0003-3111-8784	Netherlands Organization for Scientific Research Grant CW ECHO [711.011.005]; Proteins@Work, a program of the Netherlands Proteomics Centre - Netherlands Organization for Scientific Research (NWO) [184.032.201]	Netherlands Organization for Scientific Research Grant CW ECHO; Proteins@Work, a program of the Netherlands Proteomics Centre - Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research Grant CW ECHO 711.011.005 (to A. A. and A. J. R. H.) and Proteins@Work, a program of the Netherlands Proteomics Centre financed by the Netherlands Organization for Scientific Research (NWO) as part of the National Roadmap Large-scale Research Facilities of the Netherlands Project Number 184.032.201. The authors declare that they have no conflicts of interest with the contents of this article.	Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bassi ZI, 2013, P NATL ACAD SCI USA, V110, P9782, DOI 10.1073/pnas.1301328110; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Giridharan SSP, 2014, ANTIOXID REDOX SIGN, V20, P2059, DOI 10.1089/ars.2013.5487; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Gould GW, 2016, SEMIN CELL DEV BIOL, V53, P64, DOI 10.1016/j.semcdb.2015.12.012; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; Hida Y, 2010, J BIOCHEM, V148, P131, DOI 10.1093/jb/mvq065; Joseph N, 2012, EMBO J, V31, P2604, DOI 10.1038/emboj.2012.139; Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212; Kaplan A, 2011, J CELL SCI, V124, P3989, DOI 10.1242/jcs.085407; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kolk SM, 2007, ADV EXP MED BIOL, V600, P38; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; Makyio H, 2012, EMBO J, V31, P2590, DOI 10.1038/emboj.2012.89; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reinecke JB, 2015, TRAFFIC, V16, P48, DOI 10.1111/tra.12234; Schiel JA, 2013, CURR OPIN CELL BIOL, V25, P92, DOI 10.1016/j.ceb.2012.10.012; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Schmidt EF, 2008, J NEUROSCI, V28, P2287, DOI 10.1523/JNEUROSCI.5646-07.2008; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	41	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20617	20629		10.1074/jbc.M116.748186	http://dx.doi.org/10.1074/jbc.M116.748186			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27528609	Green Published, hybrid			2022-12-28	WOS:000384574800026
J	Littler, DR; Bullen, HE; Harvey, KL; Beddoe, T; Crabb, BS; Rossjohn, J; Gilson, PR				Littler, Dene R.; Bullen, Hayley E.; Harvey, Katherine L.; Beddoe, Travis; Crabb, Brendan S.; Rossjohn, Jamie; Gilson, Paul R.			Disrupting the Allosteric Interaction between the Plasmodium falciparum cAMP-dependent Kinase and Its Regulatory Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); malaria; plasmodium; protein kinase A (PKA); protein structure	PROTEIN-KINASE; STRUCTURE REVEALS; RI-ALPHA; PKA; BINDING; INHIBITORS	The ubiquitous second messenger cAMP mediates signal transduction processes in the malarial parasite that regulate host erythrocyte invasion and the proliferation of merozoites. In Plasmodium falciparum, the central receptor for cAMP is the single regulatory subunit (R) of protein kinase A (PKA). To aid the development of compounds that can selectively dysregulate parasite PKA signaling, we solved the structure of the PKA regulatory subunit in complex with cAMP and a related analogue that displays antimalarial activity, (S-p)-2-Cl-cAMPS. Prior to signaling, PKA-R holds the kinase's catalytic subunit (C) in an inactive state by exerting an allosteric inhibitory effect. When two cAMP molecules bind to PKA-R, they stabilize a structural conformation that facilitates its dissociation, freeing PKA-C to phosphorylate downstream substrates such as apical membrane antigen 1. Although PKA activity was known to be necessary for erythrocytic proliferation, we show that uncontrolled induction of PKA activity using membrane-permeable agonists is equally disruptive to growth.	[Littler, Dene R.; Crabb, Brendan S.; Rossjohn, Jamie; Gilson, Paul R.] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Littler, Dene R.; Crabb, Brendan S.; Rossjohn, Jamie; Gilson, Paul R.] Monash Univ, Dept Biochem & Mol Biol, Biomedicine Discovery Inst, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Bullen, Hayley E.; Harvey, Katherine L.; Crabb, Brendan S.; Gilson, Paul R.] Burnet Inst, Melbourne, Vic 3004, Australia; [Harvey, Katherine L.; Crabb, Brendan S.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Beddoe, Travis] La Trobe Univ, Ctr AgriBiosci, Bundoora, Vic 3086, Australia; [Rossjohn, Jamie] Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; Monash University; Burnet Institute; University of Melbourne; La Trobe University	Gilson, PR (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia.; Gilson, PR (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomedicine Discovery Inst, Clayton, Vic 3800, Australia.; Gilson, PR (corresponding author), Burnet Inst, Melbourne, Vic 3004, Australia.	paul.gilson@burnet.edu.au	Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013	Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Bullen, Hayley/0000-0003-4923-3019; Littler, Dene/0000-0001-5904-1905	National Health and Medical Research Council of Australia Project [APP1068287]; Victorian Operational Infrastructure Support Program	National Health and Medical Research Council of Australia Project(National Health and Medical Research Council (NHMRC) of Australia); Victorian Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council of Australia Project Grant APP1068287 and funding from the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akimoto M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002305; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Badireddy S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.110.004390; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brautigam CA, 2015, METHODS, V76, P124, DOI 10.1016/j.ymeth.2014.11.018; Brown SHJ, 2013, ACS CHEM BIOL, V8, P2164, DOI 10.1021/cb400247t; Bruystens JGH, 2014, STRUCTURE, V22, P59, DOI 10.1016/j.str.2013.10.012; Buskes MJ, 2016, ORG BIOMOL CHEM, V14, P4617, DOI [10.1039/c5ob02517f, 10.1039/C5OB02517F]; Dawn A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004520; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Haste NM, 2012, MICROBES INFECT, V14, P838, DOI 10.1016/j.micinf.2012.05.004; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Howard BL, 2015, ACS CHEM BIOL, V10, P1145, DOI 10.1021/cb501004q; Ilouz R, 2012, P NATL ACAD SCI USA, V109, P12443, DOI 10.1073/pnas.1209538109; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Lasonder E, 2015, PROTEOMICS, V15, P2716, DOI 10.1002/pmic.201400508; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merckx A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040019; Moll D, 2007, BIOL CHEM, V388, P163, DOI 10.1515/BC.2007.018; Ramdani G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004815; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; Rinaldi J, 2010, STRUCTURE, V18, P1471, DOI 10.1016/j.str.2010.08.013; Soberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060935; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Syin C, 2001, EUR J BIOCHEM, V268, P4842, DOI 10.1046/j.1432-1327.2001.02403.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2013, ANNU REV MICROBIOL, V67, P271, DOI 10.1146/annurev-micro-092412-155741; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO Malaria Policy Advisory Comm, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1169-x; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	40	11	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25375	25386		10.1074/jbc.M116.750174	http://dx.doi.org/10.1074/jbc.M116.750174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27738107	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000390095300009
J	Banerji, S; Lawrance, W; Metcalfe, C; Briggs, DC; Yamauchi, A; Dushek, O; van der Merwe, PA; Day, AJ; Jackson, DG				Banerji, Suneale; Lawrance, William; Metcalfe, Clive; Briggs, David C.; Yamauchi, Akira; Dushek, Omer; van der Merwe, P. Anton; Day, Anthony J.; Jackson, David G.			Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL-MIGRATION; LINK MODULE; DOMAIN; CD44; TRAFFICKING; EXPRESSION; MECHANISM; CYSTEINE; COMPLEX; GROWTH	The lymphatic vessel endothelial receptor LYVE-1 is implicated in the uptake of hyaluronan (HA) and trafficking of leukocytes to draining lymph nodes. Yet LYVE-1 has only weak affinity for hyaluronan and depends on receptor clustering and higher order ligand organization for durable binding in lymphatic endothelium. An unusual feature of LYVE-1 not found in other HA receptors is the potential to form disulfide-linked homodimers. However, their influence on function has not been investigated. Here we show LYVE-1 homodimers are the predominant configuration in lymphatic endothelium in vitro and in vivo, and formation solely requires the unpaired cysteine residue Cys-201 within the membrane-proximal domain, yielding a 15-fold higher HA binding affinity and an similar to 67-fold slower off-rate than the monomer. Moreover, we show non-dimerizing LYVE-1 mutants fail to bind HA even when expressed at high densities in lymphatic endothelial cells or artificially crosslinked with antibody. Consistent with these findings, small angle X-ray scattering (SAXS) indicates the Cys-201 inter-chain disulfide forms a hinge that maintains the homodimer in an "open scissors" conformation, likely allowing arrangement of the two HA binding domains for mutual engagement with ligand. Finally, we demonstrate the Cys-201 inter-chain disulfide is highly labile, and selective reduction with TCEP-HCl disrupts LYVE-1 homodimers, ablating HA binding. These findings reveal binding is dependent not just on clustering but also on the biochemical properties of LYVE-1 homodimers. They also mark LYVE-1 as the first Link protein superfamily member requiring covalent homodimerization for function and suggest the interchain disulfide acts as a redox switch in vivo.	[Banerji, Suneale; Lawrance, William; Metcalfe, Clive; Jackson, David G.] John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England; [Metcalfe, Clive; Dushek, Omer; van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Yamauchi, Akira] Kawasaki Med Sch, Dept Biochem, 577 Matsushima, Kurashiki, Okayama 7010192, Japan; [Briggs, David C.; Day, Anthony J.] Univ Manchester, Fac Biol Med & Hlth, Wellcome Trust Ctr Cell Matrix Res, Oxford Rd, Manchester M13 9PT, Lancs, England	University of Oxford; University of Oxford; Kawasaki Medical School; University of Manchester	Jackson, DG (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DS, England.	david.jackson@imm.ox.ac.uk	Day, Anthony/O-1658-2015; Yamauchi, Akira/F-2202-2010	Day, Anthony/0000-0002-1415-3134; Yamauchi, Akira/0000-0001-9205-6922; Briggs, David/0000-0002-9793-7339; banerji, suneale/0000-0002-1179-3152; , david/0000-0002-4133-9364; Metcalfe, Clive/0000-0002-7856-8574	UK Medical Research Council; MRC Research Grant [G9826026]; Arthritis Research UK [19489]; Medical Research Council [MC_U137884182, MC_UU_12010/2, G9826026, G9722488, G19/31] Funding Source: researchfish; Versus Arthritis [19489] Funding Source: researchfish; Wellcome Trust [101799/Z/13/Z] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K10201] Funding Source: KAKEN; MRC [G9722488, G19/31, MC_UU_12010/2, MC_U137884182, G9826026] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in whole or in part by the UK Medical Research Council through funding to the MRC Human Immunology Unit (to D. G. J.), MRC Research Grant G9826026 (to C. M.), and by Arthritis Research UK Grant 19489 (to A. J. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armstrong SE, 2002, AM J PHYSIOL-HEART C, V283, pH2485, DOI 10.1152/ajpheart.00385.2002; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Huang SS, 2003, J BIOL CHEM, V278, P43855, DOI 10.1074/jbc.M306411200; Jackson David G, 2014, J Clin Cell Immunol, V5; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Kellett-Clarke H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138137; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lawrance W, 2016, J BIOL CHEM, V291, P8014, DOI 10.1074/jbc.M115.708305; Liu D, 1996, J EXP MED, V183, P1987, DOI 10.1084/jem.183.5.1987; Liu DC, 1997, J IMMUNOL, V159, P2702; Lynskey NN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005137; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Metcalfe C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110036; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Nishida-Fukuda H, 2016, J BIOL CHEM, V291, P10490, DOI 10.1074/jbc.M115.683201; Ohki I, 2011, BBA-PROTEINS PROTEOM, V1814, P345, DOI 10.1016/j.bbapap.2010.10.006; Platt AM, 2013, ADV IMMUNOL, V120, P51, DOI 10.1016/B978-0-12-417028-5.00002-8; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Su HP, 2010, J VIROL, V84, P2502, DOI 10.1128/JVI.02247-09; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Teijeira A, 2014, SEMIN IMMUNOPATHOL, V36, P261, DOI 10.1007/s00281-013-0410-8; TENGBLAD A, 1986, BIOCHEM J, V236, P521, DOI 10.1042/bj2360521; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yan ZH, 2010, BIOCHEMISTRY-US, V49, P1059, DOI 10.1021/bi902022n; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; YANG BH, 1995, ANAL BIOCHEM, V228, P299, DOI 10.1006/abio.1995.1354; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	46	24	24	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25004	25018		10.1074/jbc.M116.736926	http://dx.doi.org/10.1074/jbc.M116.736926			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27733683	Green Published, hybrid			2022-12-28	WOS:000388880100018
J	Ben-Hail, D; Begas-Shvartz, R; Shalev, M; Shteinfer-Kuzmine, A; Gruzman, A; Reina, S; De Pinto, V; Shoshan-Barmatz, V				Ben-Hail, Danya; Begas-Shvartz, Racheli; Shalev, Moran; Shteinfer-Kuzmine, Anna; Gruzman, Arie; Reina, Simona; De Pinto, Vito; Shoshan-Barmatz, Varda			Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; ARSENIC TRIOXIDE AS2O3; CELL-DEATH; ALZHEIMERS-DISEASE; HEXOKINASE-II; ATRIAL-FIBRILLATION; TRANSGENIC MICE; IN-VITRO	Apoptosis is thought to play a critical role in several pathological processes, such as neurodegenerative diseases (i.e. Parkinson's and Alzheimer's diseases) and various cardiovascular diseases. Despite the fact that apoptotic mechanisms are well defined, there is still no substantial therapeutic strategy to stop or even slow this process. Thus, there is an unmet need for therapeutic agents that are able to block or slow apoptosis in neurodegenerative and cardiovascular diseases. The outer mitochondrial membrane protein voltage-dependent anion channel 1 (VDAC1) is a convergence point for a variety of cell survival and death signals, including apoptosis. Recently, we demonstrated that VDAC1 oligomerization is involved in mitochondrion-mediated apoptosis. Thus, VDAC1 oligomerization represents a prime target for agents designed to modulate apoptosis. Here, high-throughput compound screening and medicinal chemistry were employed to develop compounds that directly interact with VDAC1 and prevent VDAC1 oligomerization, concomitant with an inhibition of apoptosis as induced by various means and in various cell lines. The compounds protected against apoptosis-associated mitochondrial dysfunction, restoring dissipated mitochondrial membrane potential, and thus cell energy and metabolism, decreasing reactive oxidative species production, and preventing detachment of hexokinase bound to mitochondria and disruption of intracellular Ca2+ levels. Thus, this study describes novel drug candidates with a defined mechanism of action that involves inhibition of VDAC1 oligomerization, apoptosis, and mitochondrial dysfunction. The compounds VBIT-3 and VBIT-4 offer a therapeutic strategy for treating different diseases associated with enhanced apoptosis and point to VDAC1 as a promising target for therapeutic intervention.	[Ben-Hail, Danya; Begas-Shvartz, Racheli; Shalev, Moran; Shteinfer-Kuzmine, Anna; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ben-Hail, Danya; Begas-Shvartz, Racheli; Shalev, Moran; Shteinfer-Kuzmine, Anna; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Gruzman, Arie] Bar Ilan Univ, Dept Chem, IL-5290002 Ramat Gan, Israel; [Reina, Simona; De Pinto, Vito] Univ Catania, Natl Inst Biomembranes & Biosyst, Sect Catania, Dept Biomed & Biotechnol, Viale A Doria 6, I-95125 Catania, Italy; [Reina, Simona] Univ Catania, Natl Inst Biomembranes & Biosyst, Sect Catania, Dept Chem Sci, Viale A Doria 6, I-95125 Catania, Italy	Ben Gurion University; Ben Gurion University; Bar Ilan University; University of Catania; University of Catania	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.; Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il	De Pinto, Vito/AAC-2634-2019	Ben-Hail, Danya/0000-0002-8210-3446	Israel Science Foundation [307/13]; Sima and Philip Needleman research funds	Israel Science Foundation(Israel Science Foundation); Sima and Philip Needleman research funds	This work was supported Israel Science Foundation Grant 307/13 and by Sima and Philip Needleman research funds. The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Ahmed M, 2010, ISLETS, V2, P283, DOI 10.4161/isl.2.5.12639; Aiello R, 2004, J BIOL CHEM, V279, P25364, DOI 10.1074/jbc.M310572200; Anis Y, 2006, PATHWAYS, V2, P2; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Ben-Hail D, 2016, BBA-MOL CELL RES, V1863, P1612, DOI 10.1016/j.bbamcr.2016.04.002; Ben-Hail Danya, 2014, Cold Spring Harb Protoc, V2014, P94, DOI 10.1101/pdb.prot073130; Ben-Hail Danya, 2014, Cold Spring Harb Protoc, V2014, P100, DOI 10.1101/pdb.prot073148; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bertrand L, 2002, J RECEPT SIGNAL TR R, V22, P533, DOI 10.1081/RRS-120014619; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Branco AF, 2011, CARDIOVASC TOXICOL, V11, P191, DOI 10.1007/s12012-011-9111-5; Carney DA, 2008, LEUKEMIA LYMPHOMA, V49, P1846, DOI 10.1080/10428190802464745; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Chen GQ, 1996, BLOOD, V88, P1052; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cuadrado-Tejedor M, 2011, J ALZHEIMERS DIS, V23, P195, DOI 10.3233/JAD-2010-100966; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; De Pinto V, 2016, BBA-BIOENERGETICS, V1857, P1219, DOI 10.1016/j.bbabio.2016.02.020; Deedwania PC, 2010, AM J MED, V123, P198, DOI 10.1016/j.amjmed.2009.06.033; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Ghosh T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001170; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Goldin N, 2008, ONCOGENE, V27, P4636, DOI 10.1038/onc.2008.108; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073; Huang L, 2015, J BIOL CHEM, V290, P23563, DOI 10.1074/jbc.M115.648774; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Keeble JA, 2007, CELL RES, V17, P976, DOI 10.1038/cr.2007.101; Keinan N, 2013, BBA-MOL CELL RES, V1833, P1745, DOI 10.1016/j.bbamcr.2013.03.017; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P681, DOI 10.1517/14728222.2013.775253; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Martinou JC, 2000, NAT CELL BIOL, V2, pE41, DOI 10.1038/35004069; Marunouchi T, 2015, BIOL PHARM BULL, V38, P1094, DOI 10.1248/bpb.b15-00288; Muller P, 2013, J CARDIOVASC ELECTR, V24, P1110, DOI 10.1111/jce.12191; Obulesu M, 2014, NEUROCHEM RES, V39, P2301, DOI 10.1007/s11064-014-1454-4; Okatsu K, 2012, BIOCHEM BIOPH RES CO, V428, P197, DOI 10.1016/j.bbrc.2012.10.041; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Perez-Gracia E, 2008, ACTA NEUROPATHOL, V116, P261, DOI 10.1007/s00401-008-0370-6; Radi E, 2014, J ALZHEIMERS DIS, V42, pS125, DOI 10.3233/JAD-132738; Regenold WT, 2012, J PSYCHIATR RES, V46, P95, DOI 10.1016/j.jpsychires.2011.09.018; Reina S, 2016, ONCOTARGET, V7, P2249, DOI 10.18632/oncotarget.6850; Reina S, 2013, BBA-BIOENERGETICS, V1827, P793, DOI 10.1016/j.bbabio.2013.03.007; Rohn TT, 2009, INT J CLIN EXP MED, V2, P300; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Shan D, 2014, SCHIZOPHR RES, V154, P1, DOI 10.1016/j.schres.2014.01.028; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V., 2008, CELL SCI, V4, P74; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; Shoshan-Barmatz V, 2013, PROG MOL BIOL TRANSL, V117, P303, DOI 10.1016/B978-0-12-386931-9.00011-8; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; Sureda FX, 2011, CURR PHARM DESIGN, V17, P230; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Ujwal R, 2009, CHANNELS, V3, P167, DOI 10.4161/chan.3.3.9196; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weisthal S, 2014, BBA-MOL CELL RES, V1843, P2270, DOI 10.1016/j.bbamcr.2014.03.021; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Yu J, 2007, CANCER BIOL THER, V6, P580, DOI 10.4161/cbt.6.4.3887; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zeth K, 2008, J BIOENERG BIOMEMBR, V40, P127, DOI 10.1007/s10863-008-9144-z; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	92	59	62	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24986	25003		10.1074/jbc.M116.744284	http://dx.doi.org/10.1074/jbc.M116.744284			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27738100	hybrid, Green Published			2022-12-28	WOS:000388880100017
J	Hinds, TD; Burns, KA; Hosick, PA; McBeth, L; Nestor-Kalinoski, A; Drummond, HA; AlAmodi, AA; Hankins, MW; Heuvel, JPV; Stec, DE				Hinds, Terry D., Jr.; Burns, Katherine A.; Hosick, Peter A.; McBeth, Lucien; Nestor-Kalinoski, Andrea; Drummond, Heather A.; AlAmodi, Abdulhadi A.; Hankins, Michael W.; Heuvel, John P. Vanden; Stec, David E.			Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3 beta Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-RECEPTOR; DEFICIENT MICE; INSULIN-RECEPTOR; LIPID-METABOLISM; SKELETAL-MUSCLE; FATTY LIVER; BILIRUBIN; INACTIVATION; ATHEROSCLEROSIS; STEATOHEPATITIS	Non-alcoholic fatty liver disease is the most rapidly growing form of liver disease and if left untreated can result in non-alcoholic steatohepatitis, ultimately resulting in liver cirrhosis and failure. Biliverdin reductase A (BVRA) is a multifunctioning protein primarily responsible for the reduction of biliverdin to bilirubin. Also, BVRA functions as a kinase and transcription factor, regulating several cellular functions. We report here that liver BVRA protects against hepatic steatosis by inhibiting glycogen synthase kinase 3 beta (GSK3 beta) by enhancing serine 9 phosphorylation, which inhibits its activity. We show that GSK3 beta phosphorylates serine 73 (Ser(P)(73)) of the peroxisome proliferator-activated receptor alpha (PPAR alpha), which in turn increased ubiquitination and protein turnover, as well as decreased activity. Interestingly, liver-specific BVRA KO mice had increased GSK3 beta activity and Ser(P)(73) of PPAR alpha, which resulted in decreased PPAR alpha protein and activity. Furthermore, the liver-specific BVRA KO mice exhibited increased plasma glucose and insulin levels and decreased glycogen storage, which may be due to the manifestation of hepatic steatosis observed in the mice. These findings reveal a novel BVRA-GSK beta-PPAR alpha axis that regulates hepatic lipid metabolism and may provide unique targets for the treatment of non-alcoholic fatty liver disease.	[Hosick, Peter A.; Drummond, Heather A.; AlAmodi, Abdulhadi A.; Hankins, Michael W.; Stec, David E.] Univ Mississippi, Med Ctr, Mississippi Ctr Obes Res, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Hosick, Peter A.] Montclair State Univ, Dept Exercise Sci & Phys Educ, Montclair, NJ 07043 USA; [Hinds, Terry D., Jr.; McBeth, Lucien] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43614 USA; [Nestor-Kalinoski, Andrea] Univ Toledo, Coll Med & Life Sci, Dept Surg, Adv Microscopy & Imaging Ctr, Toledo, OH 43614 USA; [Burns, Katherine A.; Heuvel, John P. Vanden] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Burns, Katherine A.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Environm Genet & Mol Toxicol, Cincinnati, OH 45267 USA	University of Mississippi; University of Mississippi Medical Center; Montclair State University; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; University of Cincinnati	Hinds, TD (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 3000 Arlington Ave,Mailstop 1008, Toledo, OH 43614 USA.; Stec, DE (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, 2500 North State St, Jackson, MS 39216 USA.	Terry.Hinds@utoledo.edu; dstec@umc.edu	Hinds, Terry/B-8495-2015	Hinds, Terry/0000-0002-7599-1529	University of Toledo deArce-Memorial Endowment Fund; National Institutes of Health [L32MD009154]; National Heart, Lung and Blood Institute [K01HL-125445, PO1HL-051971, HL088421]; National Institute of General Medical Sciences [P20GM-104357]; National Institute of Environmental Health Sciences [ES07799]; Bristol Myers Squibb; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125445, P01HL051971, R01HL088421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES021737, R01ES007799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	University of Toledo deArce-Memorial Endowment Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Bristol Myers Squibb(Bristol-Myers Squibb); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Toledo deArce-Memorial Endowment Fund (T.D.H). Research reported in this publication was also supported, in whole or part, by the National Institutes of Health [L32MD009154] (T.D.H.), the National Heart, Lung and Blood Institute [K01HL-125445] (T.D.H.) and [PO1HL-051971], [HL088421] (D.E.S.), the National Institute of General Medical Sciences [P20GM-104357] (D.E.S.), the National Institute of Environmental Health Sciences [ES07799] (J.P.V.H.), and graduate student fellowship from Bristol Myers Squibb (K.A.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Banko NS, 2014, AM J PATHOL, V184, P3394, DOI 10.1016/j.ajpath.2014.07.028; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bowes AJ, 2009, AM J PATHOL, V174, P330, DOI 10.2353/ajpath.2009.080385; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chang YS, 2011, J CELL BIOCHEM, V112, P881, DOI 10.1002/jcb.22996; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Csongradi E, 2012, INT J OBESITY, V36, P244, DOI 10.1038/ijo.2011.78; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Gibbs PEM, 2014, FASEB J, V28, P2478, DOI 10.1096/fj.13-247015; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Habets DDJ, 2009, BBA-MOL CELL BIOL L, V1791, P212, DOI 10.1016/j.bbalip.2008.12.009; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Hinds Jr T.D., 2013, OBESITY SILVER SPRIN, V22, P705; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Huang T. J., 2002, CURR PROTOC TOXICOL, V9; Ibrahim SH, 2011, J HEPATOL, V54, P765, DOI 10.1016/j.jhep.2010.09.039; IMAZU M, 1984, J BIOL CHEM, V259, P1813; Jang BK, 2012, CLIN MOL HEPATOL, V18, P357, DOI 10.3350/cmh.2012.18.4.357; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Kwak MS, 2012, CLIN MOL HEPATOL, V18, P383, DOI 10.3350/cmh.2012.18.4.383; Lebrun V, 2013, CLIN SCI, V125, P501, DOI 10.1042/CS20130064; Lee S, 2013, BIOCHEM PHARMACOL, V85, P965, DOI 10.1016/j.bcp.2012.12.023; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Liu J, 2015, DIABETES, V64, P1564, DOI 10.2337/db14-1391; Lu KH, 2013, J NAT PROD, V76, P672, DOI 10.1021/np300889y; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Miralem T, 2016, FASEB J, V30, P2926, DOI 10.1096/fj.201600330RR; Murgia M, 2009, J PHYSIOL-LONDON, V587, P4319, DOI 10.1113/jphysiol.2009.174888; O'Brien L, 2015, TRENDS ENDOCRIN MET, V26, P212, DOI 10.1016/j.tem.2015.02.001; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; Puri K, 2013, J PEDIATR GASTR NUTR, V57, P114, DOI 10.1097/MPG.0b013e318291fefe; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stec DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153427; Stienstra R, 2007, ENDOCRINOLOGY, V148, P2753, DOI 10.1210/en.2007-0014; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Yang Y, 2014, ACTA PHARMACOL SIN, V35, P1285, DOI 10.1038/aps.2014.64; Zeng R, 2008, J AM SOC NEPHROL, V19, P380, DOI 10.1681/ASN.2006111194	49	77	78	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25179	25191		10.1074/jbc.M116.731703	http://dx.doi.org/10.1074/jbc.M116.731703			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27738106	Green Published, hybrid			2022-12-28	WOS:000388880100032
J	Sekihara, S; Shibata, T; Hyakkendani, M; Kawabata, S				Sekihara, Sanae; Shibata, Toshio; Hyakkendani, Mai; Kawabata, Shun-ichiro			RNA Interference Directed against the Transglutaminase Gene Triggers Dysbiosis of Gut Microbiota in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-SYSTEM; HOST; MELANOGASTER; HOMEOSTASIS; PROVIDENCIA; BACTERIA; PROTEIN; MODEL; MUTUALISM; DUOX	We recently reported that transglutaminase (TG) suppresses immune deficiency pathway-controlled antimicrobial peptides (IMD-AMPs), thereby conferring immune tolerance to gut microbes, and that RNAi of the TG gene in flies decreases the lifespan compared with non-TG-RNAi flies. Here, analysis of the bacterial composition of the Drosophila gut by next-generation sequencing revealed that gut microbiota comprising one dominant genus of Acetobacter in non-TG-RNAi flies was shifted to that comprising two dominant genera of Acetobacter and Providencia in TG-RNAi flies. Four bacterial strains, including Acetobacter persici SK1 and Acetobacter indonesiensis SK2, Lactobacillus pentosus SK3, and Providencia rettgeri SK4, were isolated from the midgut of TG-RNAi flies. SK1 exhibited the highest resistance to the IMD-AMPs Cecropin A1 and Diptericin among the isolated bacteria. In contrast, SK4 exhibited considerably lower resistance against Cecropin A1, whereas SK4 exhibited high resistance to hypochlorous acid. The resistance of strains SK1-4 against IMD-AMPs in in vitro assays could not explain the shift of the microbiota in the gut of TG-RNAi flies. The lifespan was reduced in gnotobiotic flies that ingested both SK4 and SK1, concomitant with the production of reactive oxygen species and apoptosis in the midgut, whereas the survival rate was not altered in gnotobiotic flies that mono-ingested either SK4 or SK1. Interestingly, significant amounts of reactive oxygen species were detected in the midgut of gnotobiotic flies that ingested SK4 and SK2, concomitant with no significant apoptosis in the midgut. In gnotobiotic flies that co-ingested SK4 and SK1, an additional unknown factor(s) may be required to cause midgut apoptosis.	[Sekihara, Sanae; Shibata, Toshio; Kawabata, Shun-ichiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8190395, Japan; [Hyakkendani, Mai; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8190395, Japan	Kyushu University; Kyushu University; Kyushu University	Kawabata, S (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan.	skawascb@kyudai.jp		Shibata, Toshio/0000-0003-0211-5525	Uehara Memorial Foundation; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund (TT type) [26701];  [24570164];  [15H04353];  [24117712];  [26860333]	Uehara Memorial Foundation(Uehara Memorial Foundation); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund (TT type); ; ; ; 	This work was supported by Grant-in-Aid for Scientific Research (C) 24570164 (to S. K.); Grant-in-Aid for Scientific Research (B) 15H04353 (to S. K.); Grant-in-Aid for Scientific Research on Innovative Areas 24117712 (to S. K.); the Uehara Memorial Foundation (to S. K.); Grant-in-Aid for Young Scientists (B) 26860333 (to T. S.); and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development Fund (TT type) (Grant 26701) (to T. S.). The authors declare that they have no conflicts of interest regarding the content of this article.	Amir A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1070; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Beninati S, 2004, AMINO ACIDS, V26, P367, DOI 10.1007/s00726-004-0091-7; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Capo F, 2016, DEV COMP IMMUNOL, V64, P11, DOI 10.1016/j.dci.2016.01.001; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chambers MC, 2014, INFECT IMMUN, V82, P4380, DOI 10.1128/IAI.02415-14; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Conn H. J., 1957, MANUAL MICROBIOLOGIC, P99; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; Fukuzaki S., 2007, J SURF FINISH SOC JP, V58, P465, DOI [10.4139/sfj.58.465, DOI 10.4139/SFJ.58.465]; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hertig M, 1924, J MED RES, V44, P329; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Kawabata S, 1996, J BIOCHEM-TOKYO, V120, P1253; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Kim SH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00116; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Kuraishi T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00375; Lee KA, 2015, CELL HOST MICROBE, V17, P191, DOI 10.1016/j.chom.2014.12.012; Lee KA, 2014, DEV COMP IMMUNOL, V42, P102, DOI 10.1016/j.dci.2013.05.005; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Ma D, 2015, BIOMED J, V38, P285, DOI 10.4103/2319-4170.158620; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Senior BW, 1997, J MED MICROBIOL, V46, P524, DOI 10.1099/00222615-46-6-524; Shibata T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005244; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Somvanshi VS, 2006, INT J SYST EVOL MICR, V56, P629, DOI 10.1099/ijs.0.63973-0; Spasova DS, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00318; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Urano H, 2006, J BIOSCI BIOENG, V102, P457, DOI 10.1263/jbb.102.457; Wong ACN, 2015, APPL ENVIRON MICROB, V81, P6232, DOI 10.1128/AEM.01442-15; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Yoh M, 2005, J MED MICROBIOL, V54, P1077, DOI 10.1099/jmm.0.45846-0	57	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25077	25087		10.1074/jbc.M116.761791	http://dx.doi.org/10.1074/jbc.M116.761791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27760824	Green Published, hybrid			2022-12-28	WOS:000388880100023
J	Boubakri, M; Chaya, T; Hirata, H; Kajimura, N; Kuwahara, R; Ueno, A; Malicki, J; Furukawa, T; Omori, Y				Boubakri, Meriam; Chaya, Taro; Hirata, Hiromi; Kajimura, Naoko; Kuwahara, Ryusuke; Ueno, Akiko; Malicki, Jarema; Furukawa, Takahisa; Omori, Yoshihiro			Loss of ift122, a Retrograde Intraflagellar Transport (IFT) Complex Component, Leads to Slow, Progressive Photoreceptor Degeneration Due to Inefficient Opsin Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINITIS-PIGMENTOSA; VERTEBRATE PHOTORECEPTOR; ZEBRAFISH RETINA; KUPFFERS VESICLE; CILIARY LENGTH; KINASE MAK; GENE; MUTATIONS; CILIOGENESIS; TRAFFICKING	In the retina, aberrant opsin transport from cell bodies to outer segments leads to retinal degenerative diseases such as retinitis pigmentosa. Opsin transport is facilitated by the intra-flagellar transport (LET) system that mediates the bidirectional movement of proteins within cilia. In contrast to functions of the anterograde transport executed by IFT complex B (IFT-B), the precise functions of the retrograde transport mediated by LET complex A (IFT-A) have not been well studied in photoreceptor cilia. Here, we analyzed developing zebrafish larvae carrying a null mutation in ift122 encoding a component of IFT-A. ift122 mutant larvae show unexpectedly mild phenotypes, compared with those of mutants defective in IFT-B. ift122 mutants exhibit a slow onset of progressive photoreceptor degeneration mainly after 7 days post-fertilization. ift122 mutant larvae also develop cystic kidney but not curly body, both of which are typically observed in various ciliary mutants. ift122 mutants display a loss of cilia in the inner ear hair cells and nasal pit epithelia. Loss of ift122 causes disorganization of outer segment discs. Ectopic accumulation of an IFT-B component, ift88, is observed in the ift122 mutant photoreceptor cilia. In addition, pulse chase experiments using GFP-opsin fusion proteins revealed that ift122 is required for the efficient transport of opsin and the distal elongation of outer segments. These results show that IFT-A is essential for the efficient transport of outer segment proteins, including opsin, and for the survival of retinal photo-receptor cells, rendering the ift122 mutant a unique model for human retinal degenerative diseases.	[Boubakri, Meriam; Chaya, Taro; Ueno, Akiko; Furukawa, Takahisa; Omori, Yoshihiro] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Chaya, Taro; Omori, Yoshihiro] Japan Sci & Technol Agcy JST, PRESTO, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Hirata, Hiromi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan; [Kajimura, Naoko; Kuwahara, Ryusuke] Osaka Univ, Res Ctr Ultrahigh Voltage Electron Microscopy, 7-1 Mihogaoka, Osaka 5670047, Japan; [Malicki, Jarema] Univ Sheffield, Dept Biomed Sci, Bateson Ctr, Firth Court Western Bank, Sheffield S10 2TN, S Yorkshire, England	Osaka University; Japan Science & Technology Agency (JST); Aoyama Gakuin University; Osaka University; University of Sheffield	Omori, Y (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yoshihiro.omori@protein.osaka-u.ac.jp	malicki, jarema/G-8611-2014; Kajimura, Naoko/R-9267-2019; Kuwahara, Ryusuke/J-5024-2015	malicki, jarema/0000-0002-5947-8805; Kuwahara, Ryusuke/0000-0002-7041-0828; Hirata, Hiromi/0000-0002-3769-7441	Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [JP25113519, JP15H04669, JP25293070, JP16K08583, JP15K18955]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [12024046]; Takeda Science Foundation; Uehara Memorial Foundation; Novartis Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Send Life Science Foundation; Kato Memorial Bioscience Foundation; Daiichi-Sankyo Foundation of Life Science; Suzuken Memorial Foundation; Osaka Community Foundation; NIG Collaborative Research Program [201685]; National Institutes of Health from the NEI [EY018176]; Medical Research Council [MR/N000714/1] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY018176] Funding Source: NIH RePORTER; MRC [MR/N000714/1] Funding Source: UKRI	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Novartis Foundation(Novartis); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Send Life Science Foundation; Kato Memorial Bioscience Foundation; Daiichi-Sankyo Foundation of Life Science; Suzuken Memorial Foundation; Osaka Community Foundation; NIG Collaborative Research Program; National Institutes of Health from the NEI; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by PRESTO from the Japan Science and Technology Agency (JST); Grant-in-aid for Scientific Research on Innovative Areas JP25113519, Grants-in-aid for Scientific Research (B) JP15H04669 and JP25293070; Grant-in-aid for Scientific Research (C) JP16K08583; Young Scientists (B) Grant JP15K18955 from Japan Society for the Promotion of Science (JSPS); Nanotechnology Platform Grant 12024046 from The Ministry of Education, Culture, Sports, Science and Technology (MEXT); The Takeda Science Foundation; The Uehara Memorial Foundation; The Novartis Foundation; The Mochida Memorial Foundation for Medical and Pharmaceutical Research; The Naito Foundation; The Send Life Science Foundation; The Kato Memorial Bioscience Foundation; The Daiichi-Sankyo Foundation of Life Science; The Suzuken Memorial Foundation; The Osaka Community Foundation; NIG Collaborative Research Program Grant 201685; the initial stages of this project were supported by National Institutes of Health RO1 Award EY018176 from the NEI (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Cao Y, 2010, J AM SOC NEPHROL, V21, P1326, DOI 10.1681/ASN.2009091001; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Doerre G, 2002, MECH DEVELOP, V110, P125, DOI 10.1016/S0925-4773(01)00571-8; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hartong Dyonne T, 2006, Lancet, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; KANE DA, 1993, DEVELOPMENT, V119, P447; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Krock BL, 2009, INVEST OPHTH VIS SCI, V50, P5463, DOI 10.1167/iovs.09-3828; Li JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027365; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; TOKUYASU K, 1959, J BIOPHYS BIOCHEM CY, V6, P225, DOI 10.1083/jcb.6.2.225; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	45	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24465	24474		10.1074/jbc.M116.738658	http://dx.doi.org/10.1074/jbc.M116.738658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27681595	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000388875500011
J	Liu, B; Kong, L; Han, KP; Hong, H; Marcus, WD; Chen, XY; Jeng, EK; Alter, S; Zhu, XY; Rubinstein, MP; Shi, SX; Rhode, PR; Cai, WB; Wong, HC				Liu, Bai; Kong, Lin; Han, Kaiping; Hong, Hao; Marcus, Warren D.; Chen, Xiaoyue; Jeng, Emily K.; Alter, Sarah; Zhu, Xiaoyun; Rubinstein, Mark P.; Shi, Sixiang; Rhode, Peter R.; Cai, Weibo; Wong, Hing C.			A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; fusion protein; immunotherapy; interleukin; scaffold protein	IMMUNE-RESPONSE; MONOCLONAL-ANTIBODIES; FAB FRAGMENT; FC-RECEPTOR; CELLS; COMPLEX; IMMUNOTHERAPY; CHLORAMBUCIL; PROTECTION; RITUXIMAB	IL-15 and its receptor (IL-15R) are co-expressed on antigen-presenting cells, allowing transpresentation of IL-15 to immune cells bearing IL-2R(C) and stimulation of effector immune responses. We reported previously that the high-affinity interactions between an IL-15 superagonist (IL-15N72D) and the extracellular IL-15R sushi domain (IL-15RSu) could be exploited to create a functional scaffold for the design of multivalent disease-targeted complexes. The IL-15N72DIL-15RSuFc complex, also known as ALT-803, is a multimeric complex constructed by fusing IL-15N72DIL-15RSu to the Fc domain of IgG1. ALT-803 is an IL-15 superagonist complex that has been developed as a potent antitumor immunotherapeutic agent and is in clinical trials. Here we describe the creation of a novel fusion molecule, 2B8T2M, using the ALT-803 scaffold fused to four single chains of the tumor-targeting monoclonal antibody rituximab. This molecule displays trispecific binding activity through its recognition of the CD20 molecule on tumor cells, stimulation via IL-2R(C) displayed on immune effector cells, and binding to Fc receptors on natural killer cells and macrophages. 2B8T2M activates natural killer cells to enhance antibody-dependent cellular cytotoxicity, mediates complement-dependent cytotoxicity, and induces apoptosis of B-lymphoma cells. Compared with rituximab, 2B8T2M exhibits significantly stronger antitumor activity in a xenograft SCID mouse model and depletes B cells in cynomolgus monkeys more efficiently. Thus, ALT-803 can be modified as a functional scaffold for creating multispecific, targeted IL-15-based immunotherapeutic agents and may serve as a novel platform to improve the antitumor activity and clinical efficacy of therapeutic antibodies.	[Liu, Bai; Kong, Lin; Han, Kaiping; Marcus, Warren D.; Chen, Xiaoyue; Jeng, Emily K.; Alter, Sarah; Zhu, Xiaoyun; Rhode, Peter R.; Wong, Hing C.] Altor BioSci Corp, 2810 N Commerce Pkwy, Miramar, FL 33025 USA; [Hong, Hao; Shi, Sixiang; Cai, Weibo] Univ Wisconsin, Dept Radiol & Med Phys, Madison, WI 53706 USA; [Rubinstein, Mark P.] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Rubinstein, Mark P.] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	University of Wisconsin System; University of Wisconsin Madison; Medical University of South Carolina; Medical University of South Carolina	Wong, HC (corresponding author), Altor BioSci Corp, 2810 N Commerce Pkwy, Miramar, FL 33025 USA.	hingwong@altorbioscience.com		Shi, Sixiang/0000-0002-8354-7620; Wong, Hing C./0000-0002-6865-4313	National Institute of Health [1R43CA174091-01]; American Cancer Society [125246-RSG-13-099-01-CCE]; NATIONAL CANCER INSTITUTE [R43CA174091] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or in part by National Institute of Health Grant 1R43CA174091-01 (to H.C.W.) and American Cancer Society Grant 125246-RSG-13-099-01-CCE (to W.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Beers SA, 2010, SEMIN HEMATOL, V47, P107, DOI 10.1053/j.seminhematol.2010.01.001; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Ghetie MA, 2001, BLOOD, V97, P1392, DOI 10.1182/blood.V97.5.1392; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hilchey SP, 2009, BLOOD, V113, P3809, DOI 10.1182/blood-2008-10-185280; Hillmen P, 2015, LANCET, V385, P1873, DOI 10.1016/S0140-6736(15)60027-7; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Li BH, 2008, CANCER RES, V68, P2400, DOI 10.1158/0008-5472.CAN-07-6663; Mathios D, 2016, INT J CANCER, V138, P187, DOI 10.1002/ijc.29686; Nishida M, 2007, INT J ONCOL, V31, P29; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Rhode PR, 2016, CANCER IMMUNOL RES, V4, P49, DOI 10.1158/2326-6066.CIR-15-0093-T; Rosario M, 2016, CLIN CANCER RES, V22, P596, DOI 10.1158/1078-0432.CCR-15-1419; Seay K, 2015, J VIROL, V89, P6264, DOI 10.1128/JVI.00563-15; Shi SX, 2015, EUR J NUCL MED MOL I, V42, P1295, DOI 10.1007/s00259-015-3038-1; Shi SX, 2015, J NUCL MED, V56, P927, DOI 10.2967/jnumed.114.153098; Sips M, 2016, MUCOSAL IMMUNOL, V9, P1584, DOI 10.1038/mi.2016.12; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; van Meerten T, 2010, SEMIN HEMATOL, V47, P199, DOI 10.1053/j.seminhematol.2010.01.007; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang W, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00368; Wong HC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26442; Wong RL, 2011, PROTEIN ENG DES SEL, V24, P373, DOI 10.1093/protein/gzq116; Xu WX, 2013, CANCER RES, V73, P3075, DOI 10.1158/0008-5472.CAN-12-2357; Zhu EF, 2015, CANCER CELL, V27, P489, DOI 10.1016/j.ccell.2015.03.004; Zhu XY, 2009, J IMMUNOL, V183, P3598, DOI 10.4049/jimmunol.0901244	30	45	53	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23869	23881		10.1074/jbc.M116.733600	http://dx.doi.org/10.1074/jbc.M116.733600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27650494	hybrid, Green Published			2022-12-28	WOS:000388498100003
J	Lee, SH; Sud, N; Lee, N; Subramaniyam, S; Chung, CY				Lee, Sang-Hyun; Sud, Neetu; Lee, Narae; Subramaniyam, Selvaraj; Chung, Chang Y.			Regulation of Integrin 6 Recycling by Calcium-independent Phospholipase A(2) (iPLA(2)) to Promote Microglia Chemotaxis on Laminin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemotaxis; focal adhesion; integrin; microglia; phospholipase A	HUMAN MONOCYTE CHEMOTAXIS; EXTRACELLULAR-MATRIX; CELL-ADHESION; BRAIN-INJURY; EXPRESSION; TRAFFICKING; CYTOKINES; TRANSPORT; KINESIN; ACCUMULATION	Microglia are the immune effector cells that are activated in response to pathological changes in the central nervous system. Microglial activation is accompanied by the alteration of integrin expression on the microglia surface. However, changes of integrin expression upon chemoattractant (ADP) stimulation still remain unknown. In this study, we investigated whether ADP induces the alteration of integrin species on the cell surface, leading to changes in chemotactic ability on different extracellular matrix proteins. Flow cytometry scans and on-cell Western assays showed that ADP stimulation induced a significant increase of 6 integrin-GFP, but not 5, on the surface of microglia cells. Microglia also showed a greater motility increase on laminin than fibronectin after ADP stimulation. Time lapse microscopy and integrin endocytosis assay revealed the essential role of calcium-independent phospholipase A(2) activity for the recycling of 6 integrin-GFP from the endosomal recycling complex to the plasma membrane. Lack of calcium-independent phospholipase A(2) activity caused a reduced rate of focal adhesion formation on laminin at the leading edge. Our results suggest that the alteration of integrin-mediated adhesion may regulate the extent of microglial infiltration into the site of damage by controlling their chemotactic ability.	[Lee, Sang-Hyun; Sud, Neetu; Lee, Narae; Chung, Chang Y.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, 468 Robinson Res Bldg MRB 1, Nashville, TN 37232 USA; [Lee, Sang-Hyun] Korea Res Inst Biosci & Biotechnol, Biotherapeut Translat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Subramaniyam, Selvaraj; Chung, Chang Y.] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China	Vanderbilt University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Tianjin University	Chung, CY (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Ctr, 468 Robinson Res Bldg MRB 1, Nashville, TN 37232 USA.	chang.chung@vanderbilt.edu	Chung, Chang Y/G-7522-2012	Min, Jeong-Ki/0000-0003-4924-8739; Lee, Sang-Hyun/0000-0002-9682-1473	National Institutes of Health [GM68097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM68097 (to C. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Boddeke EWGH, 1999, EUR J PHARMACOL, V374, P309, DOI 10.1016/S0014-2999(99)00307-6; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; CHAMAK B, 1991, NEUROSCIENCE, V45, P513, DOI 10.1016/0306-4522(91)90267-R; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jucker M, 1996, MOL CHEM NEUROPATHOL, V28, P209, DOI 10.1007/BF02815224; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee S, 2009, MOL CELL NEUROSCI, V42, P382, DOI 10.1016/j.mcn.2009.08.010; Lee SH, 2011, TRAFFIC, V12, P878, DOI 10.1111/j.1600-0854.2011.01195.x; LIESI P, 1984, EMBO J, V3, P683, DOI 10.1002/j.1460-2075.1984.tb01867.x; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Milner R, 2006, MOL CELL NEUROSCI, V33, P429, DOI 10.1016/j.mcn.2006.09.004; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MONNING U, 1995, J BIOL CHEM, V270, P7104, DOI 10.1074/jbc.270.13.7104; Pechoux C, 2005, BBA-MOL CELL RES, V1743, P317, DOI 10.1016/j.bbamcr.2005.01.006; Schmidt D, 2003, ROFO-FORTSCHR RONTG, V175, P967; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Tran H, 2002, J CELL SCI, V115, P2031; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; Yanaka K, 1997, J CEREBR BLOOD F MET, V17, P605; Yu NC, 1998, NEUROIMMUNOMODULAT, V5, P42, DOI 10.1159/000026325	35	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23645	23653		10.1074/jbc.M116.732610	http://dx.doi.org/10.1074/jbc.M116.732610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27655917	Green Published, hybrid			2022-12-28	WOS:000387884400024
J	De La Fuente, S; Fernandez-Sanz, C; Vail, C; Agra, EJ; Holmstrom, K; Sun, JH; Mishra, J; Williams, D; Finkel, T; Murphy, E; Joseph, SK; Sheu, SS; Csordas, G				De La Fuente, Sergio; Fernandez-Sanz, Celia; Vail, Caitlin; Agra, Elorm J.; Holmstrom, Kira; Sun, Junhui; Mishra, Jyotsna; Williams, Dewight; Finkel, Toren; Murphy, Elizabeth; Joseph, Suresh K.; Sheu, Shey-Shing; Csordas, Gyoergy			Strategic Positioning and Biased Activity of the Mitochondrial Calcium Uniporter in Cardiac Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CA2+ UPTAKE; MICU1; MCU; STRESS; COMMUNICATION; HOMEOSTASIS; GATEKEEPER; TRANSPORT; RESPONSES	Control of myocardial energetics by Ca2+ signal propagation to the mitochondrial matrix includes local Ca2+ delivery from sarcoplasmic reticulum (SR) ryanodine receptors (RyR2) to the inner mitochondrial membrane (IMM) Ca2+ uniporter (mtCU). mtCU activity in cardiac mitochondria is relatively low, whereas the IMM surface is large, due to extensive cristae folding. Hence, stochastically distributed mtCU may not suffice to support local Ca2+ transfer. We hypothesized that mtCU concentrated at mitochondria-SR associations would promote the effective Ca2+ transfer. mtCU distribution was determined by tracking MCU and EMRE, the proteins essential for channel formation. Both proteins were enriched in the IMM-outer mitochondrial membrane (OMM) contact point submitochondrial fraction and, as super-resolution microscopy revealed, located more to the mitochondrial periphery (inner boundary membrane) than inside the cristae, indicating high accessibility to cytosol-derived Ca2+ inputs. Furthermore, MCU immunofluorescence distribution was biased toward the mitochondria-SR interface (RyR2), and this bias was promoted by Ca2+ signaling activity in intact cardiomyocytes. The SR fraction of heart homogenate contains mitochondria with extensive SR associations, and these mitochondria are highly enriched in EMRE. Size exclusion chromatography suggested for EMRE- and MCU-containing complexes a wide size range and also revealed MCU-containing complexes devoid of EMRE (thus disabled) in the mitochondrial but not the SR fraction. Functional measurements suggested more effective mtCU-mediated Ca2+ uptake activity by the mitochondria of the SR than of the mitochondrial fraction. Thus, mtCU "hot spots" can be formed at the cardiac muscle mitochondria-SR associations via localization and assembly bias, serving local Ca2+ signaling and the excitation-energetics coupling.	[De La Fuente, Sergio; Vail, Caitlin; Agra, Elorm J.; Joseph, Suresh K.; Csordas, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Mitochondrial Imaging Res & Diagnost, 527J Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA; [Holmstrom, Kira; Finkel, Toren] NHLBI, Ctr Mol Med, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Sun, Junhui; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, Lab Cardiac Physiol, NIH, Bethesda, MD 20892 USA; [Mishra, Jyotsna; Sheu, Shey-Shing] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Williams, Dewight] Univ Penn, Penn EM Resource Lab, Philadelphia, PA 19104 USA	Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Jefferson University; University of Pennsylvania	Csordas, G (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Mitochondrial Imaging Res & Diagnost, 527J Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	Gyorgy.Csordas@jefferson.edu	Sheu, Shey-Shing/Y-4009-2019	Sheu, Shey-Shing/0000-0003-3838-3601; Fernandez-Sanz, Celia/0000-0002-3437-7792; Holmstrom, Kira/0000-0001-6434-7909; De la Fuente, Sergio/0000-0001-7823-063X; , Sergio/0000-0002-8021-2390; Mishra, Jyotsna/0000-0002-7798-4891; Csordas, Gyorgy/0000-0003-3156-1460; Fernandez Sanz, Celia/0000-0002-0809-0675	NHLBI, National Institutes of Health [RO1 HL122124]; American Heart Association Postdoctoral Fellowship [16POST27770032]; National Institutes of Health [RO1 DK103558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122124, ZIGHL006020, ZIAHL002066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103558] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Postdoctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NHLBI, National Institutes of Health, Grant RO1 HL122124 (to G. C. and S. S. S.), by American Heart Association Postdoctoral Fellowship 16POST27770032 (to S. F.), and National Institutes of Health Grant RO1 DK103558 (to S. K. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antony AN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10955; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Boyman L, 2014, BIOPHYS J, V107, P1289, DOI 10.1016/j.bpj.2014.07.045; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Cosson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046293; Csordas G, 2001, TRENDS CARDIOVAS MED, V11, P269, DOI 10.1016/S1050-1738(01)00123-2; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Despa S, 2014, CIRC RES, V115, P339, DOI 10.1161/CIRCRESAHA.115.303582; Fernandez-Sanz C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.526; Fieni F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2325; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; Fulop L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025199; Garcia-Perez C, 2008, J BIOL CHEM, V283, P32771, DOI 10.1074/jbc.M803385200; Garcia-Perez C, 2011, AM J PHYSIOL-HEART C, V301, pH1907, DOI 10.1152/ajpheart.00397.2011; Holmstrom KM, 2015, J MOL CELL CARDIOL, V85, P178, DOI 10.1016/j.yjmcc.2015.05.022; Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kovacs-Bogdan E, 2014, P NATL ACAD SCI USA, V111, P8985, DOI 10.1073/pnas.1400514111; Kushnareva YE, 2013, CELL DEATH DIFFER, V20, P353, DOI 10.1038/cdd.2012.128; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011; Lu XY, 2013, CIRC RES, V112, P424, DOI 10.1161/CIRCRESAHA.111.300501; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mammucari C, 2016, BBA-MOL CELL RES, V1863, P2457, DOI 10.1016/j.bbamcr.2016.03.006; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oxenoid K, 2016, NATURE, V533, P269, DOI 10.1038/nature17656; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Parfenov AS, 2006, BIOPHYS J, V90, P1107, DOI 10.1529/biophysj.105.071787; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Tsai MF, 2016, ELIFE, V5, DOI 10.7554/eLife.15545; Vais H, 2016, CELL REP, V14, P403, DOI 10.1016/j.celrep.2015.12.054; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yamamoto T, 2016, BBA-BIOENERGETICS, V1857, P831, DOI 10.1016/j.bbabio.2016.03.019	47	40	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23343	23362		10.1074/jbc.M116.755496	http://dx.doi.org/10.1074/jbc.M116.755496			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27637331	hybrid, Green Published			2022-12-28	WOS:000387224800041
J	Reifschneider, O; Marx, C; Jacobs, J; Kollipara, L; Sickmann, A; Wolters, D; Kuck, U				Reifschneider, Olga; Marx, Christina; Jacobs, Jessica; Kollipara, Laxmikanth; Sickmann, Albert; Wolters, Dirk; Kueck, Ulrich			A Ribonucleoprotein Supercomplex Involved in trans-Splicing of Organelle Group II Introns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN PROTEIN FUNCTIONS; CHLAMYDOMONAS-REINHARDTII; MAIZE CHLOROPLASTS; CRYSTAL-STRUCTURE; REPEAT PROTEIN; RNA; COMPLEX; IDENTIFICATION; GENES; TRANSFORMATION	In the chloroplast of the green alga Chlamydomonas reinhardtii, two discontinuous group II introns, psaA-i1 and psaA-i2, splice in trans, and thus their excision process resembles the nuclear spliceosomal splicing pathway. Here, we address the question whether fragmentation of trans-acting RNAs is accompanied by the formation of a chloroplast spliceosome-like machinery. Using a combination of liquid chromatographymass spectrometry (LC-MS), size exclusion chromatography, and quantitative RT-PCR, we provide the first characterization of a high molecular weight ribonucleoprotein apparatus participating in psaA mRNA splicing. This supercomplex contains two subcomplexes (I and II) that are responsible for trans-splicing of either psaA-i1 or psaA-i2. We further demonstrate that both subcomplexes are associated with intron RNA, which is a prerequisite for the correct assembly of subcomplex I. This study contributes further to our view of how the eukaryotic nuclear spliceosome evolved after bacterial endosymbiosis through fragmentation of self-splicing group II introns into a dynamic, protein-rich RNP machinery.	[Reifschneider, Olga; Marx, Christina; Jacobs, Jessica; Kueck, Ulrich] Ruhr Univ Bochum, Lehrstuhl Allgemeine & Mol Bot, Univ Str 150, D-44801 Bochum, Germany; [Sickmann, Albert] Ruhr Univ Bochum, Med Fak, MPC, Univ Str 150, D-44801 Bochum, Germany; [Wolters, Dirk] Ruhr Univ Bochum, Dept Analyt Chem, Univ Str 150, D-44801 Bochum, Germany; [Kollipara, Laxmikanth; Sickmann, Albert] Leibniz Inst Analyt Wissensch ISAS eV, Otto Hahn Str 6b, D-44227 Dortmund, Germany; [Sickmann, Albert] Univ Aberdeen, Sch Nat & Comp Sci, Meston Bldg, Meston Walk AB24 3UE, Old Aberdeen, Scotland; [Marx, Christina] WFG Herne, Westring 303, D-44629 Herne, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Aberdeen	Kuck, U (corresponding author), Ruhr Univ Bochum, Dept Gen & Mol Bot, Univ Str 150, D-44801 Bochum, Germany.	ulrich.kueck@rub.de	Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265; Marx, Christina/0000-0002-0698-0674; Laxmikanth, Kollipara/0000-0002-2673-0488; Kuck, Ulrich/0000-0002-2998-8230	Deutsche Forschungsgemeinschaft (Bonn Bad-Godesberg, Germany) [KU 517/13-1, JA 2296/1-1]	Deutsche Forschungsgemeinschaft (Bonn Bad-Godesberg, Germany)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Bonn Bad-Godesberg, Germany) Grants KU 517/13-1 (to U.K.) and JA 2296/1-1 (to J.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Balczun C, 2005, PLANT J, V43, P636, DOI 10.1111/j.1365-313X.2005.02478.x; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Brown GG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00035; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Chen WJ, 2015, CURR BIOL, V25, pR181, DOI 10.1016/j.cub.2014.11.059; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; Dlakic M, 2011, RNA, V17, P799, DOI 10.1261/rna.2396011; Eberhard S, 2011, PLANT J, V67, P1055, DOI 10.1111/j.1365-313X.2011.04657.x; Germain A, 2013, WIRES RNA, V4, P295, DOI 10.1002/wrna.1161; Glanz S, 2012, PLANT J, V69, P421, DOI 10.1111/j.1365-313X.2011.04801.x; Glanz S, 2009, BIOESSAYS, V31, P921, DOI 10.1002/bies.200900036; GOLDSCHMIDTCLERMONT M, 1991, CELL, V65, P135, DOI 10.1016/0092-8674(91)90415-U; Hammani K, 2014, NUCLEIC ACIDS RES, V42, P5033, DOI 10.1093/nar/gku112; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hsu Y. W., 2014, PLOS ONE, V11; Jacobs J, 2013, MOL CELL PROTEOMICS, V12, P1912, DOI 10.1074/mcp.M112.026583; James P, 1996, GENETICS, V144, P1425; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Klein R M, 1992, Biotechnology, V24, P384; Kleinknecht L, 2014, PLANT CELL, V26, P777, DOI 10.1105/tpc.114.122853; Kotzer-Nevo H, 2014, INT J MOL SCI, V15, P11637, DOI 10.3390/ijms150711637; Kroeger TS, 2009, P NATL ACAD SCI USA, V106, P4537, DOI 10.1073/pnas.0812503106; KUCK U, 1987, EMBO J, V6, P2185, DOI 10.1002/j.1460-2075.1987.tb02489.x; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; Lefebvre-Legendre L, 2016, PLANT J, V85, P57, DOI 10.1111/tpj.13089; Lemieux C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-857; Marx C, 2015, EUKARYOT CELL, V14, P998, DOI 10.1128/EC.00096-15; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merendino L, 2006, NUCLEIC ACIDS RES, V34, P262, DOI 10.1093/nar/gkj429; NEWMAN SM, 1990, GENETICS, V126, P875; Perron K, 1999, EMBO J, V18, P6481, DOI 10.1093/emboj/18.22.6481; Perron K, 2004, RNA, V10, P704, DOI 10.1261/rna.5237804; Rahire M, 2012, PLANT J, V72, P652, DOI 10.1111/j.1365-313X.2012.05111.x; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; Robart AR, 2014, NATURE, V514, P193, DOI 10.1038/nature13790; Shahheydari H, 2014, MOL BIOL REP, V41, P4565, DOI 10.1007/s11033-014-3327-y; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Smith DR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-83; Smith DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-132; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Teichert I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004582; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Watkins KP, 2007, PLANT CELL, V19, P2606, DOI 10.1105/tpc.107.053736; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Zimmerly S, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0037-5	53	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23330	23342		10.1074/jbc.M116.750570	http://dx.doi.org/10.1074/jbc.M116.750570			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27645995	Green Published, hybrid			2022-12-28	WOS:000387224800040
J	Koch, S; de Wit, JG; Vos, I; Birkner, JP; Gordiichuk, P; Herrmann, A; van Oijen, AM; Driessen, AJM				Koch, Sabrina; de Wit, Janny G.; Vos, Iuliia; Birkner, Jan Peter; Gordiichuk, Pavlo; Herrmann, Andreas; van Oijen, Antoine M.; Driessen, Arnold J. M.			Lipids Activate SecA for High Affinity Binding to the SecYEG Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; lipid bilayer; membrane biophysics; membrane function; membrane protein; protein-lipid interaction; scaffold protein; SecA; SecYEG; nanodiscs	COLI PLASMA-MEMBRANE; ESCHERICHIA-COLI; PROTEIN-TRANSLOCATION; IN-VIVO; NANOLIPOPROTEIN PARTICLES; PREPROTEIN TRANSLOCASE; PHOSPHOLIPID-BILAYER; ACIDIC PHOSPHOLIPIDS; DEPENDENT MANNER; ATPASE	Protein translocation across the bacterial cytoplasmic membrane is an essential process catalyzed predominantly by the Sec translocase. This system consists of the membrane-embedded protein-conducting channel SecYEG, the motor ATPase SecA, and the heterotrimeric SecDFyajC membrane protein complex. Previous studies suggest that anionic lipids are essential for SecA activity and that the N terminus of SecA is capable of penetrating the lipid bilayer. The role of lipid binding, however, has remained elusive. By employing differently sized nanodiscs reconstituted with single SecYEG complexes and comprising varying amounts of lipids, we establish that SecA gains access to the SecYEG complex via a lipid-bound intermediate state, whereas acidic phospholipids allosterically activate SecA for ATP-dependent protein translocation.	[Koch, Sabrina; de Wit, Janny G.; Vos, Iuliia; Driessen, Arnold J. M.] Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Koch, Sabrina; de Wit, Janny G.; Vos, Iuliia; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Birkner, Jan Peter; van Oijen, Antoine M.] Univ Groningen, Single Mol Biophys, Zernike Inst Adv Mat, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Gordiichuk, Pavlo; Herrmann, Andreas] Univ Groningen, Zernike Inst Adv Mat, Polymer Chem & Bioengn, NL-9747 AG Groningen, Netherlands; [van Oijen, Antoine M.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Gordiichuk, Pavlo] Northwestern Univ, Dept Chem, Evanston, IL USA	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Wollongong; Northwestern University	Driessen, AJM (corresponding author), Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.; Driessen, AJM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Birkner, Jan Peter/E-8316-2014; Driessen, Arnold J.M./D-1876-2012; Institute, Zernike/W-7033-2019; van Oijen, Antoine/I-3167-2014; Herrmann, Andreas/F-3189-2016	van Oijen, Antoine/0000-0002-1794-5161; Herrmann, Andreas/0000-0002-8886-0894; Gordiichuk, Pavlo/0000-0003-4152-7186; Driessen, Arnold J.M./0000-0001-9258-9104; Birkner, Jan Peter/0000-0002-5536-2274	Stichting voor Fundamenteel Onderzoek der Materie (FOM)	Stichting voor Fundamenteel Onderzoek der Materie (FOM)(FOM (The Netherlands))	This work was supported by the Stichting voor Fundamenteel Onderzoek der Materie (FOM). The authors declare that they have no conflicts of interest with the contents of this article.	Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Bello OD, 2016, LANGMUIR, V32, P3015, DOI 10.1021/acs.langmuir.6b00245; Blanchette CD, 2008, J LIPID RES, V49, P1420, DOI 10.1194/jlr.M700586-JLR200; Blanchette CD, 2009, BBA-BIOMEMBRANES, V1788, P724, DOI 10.1016/j.bbamem.2008.11.019; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; CUNNINGHAM K, 1989, EMBO J, V8, P955, DOI 10.1002/j.1460-2075.1989.tb03457.x; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Dickey A, 2008, BIOPHYS J, V95, P2636, DOI 10.1529/biophysj.107.128074; Dong J, 2001, BIOCHEMISTRY-US, V40, P2826, DOI 10.1021/bi002417n; Driessen AJM, 2001, TRENDS MICROBIOL, V9, P193, DOI 10.1016/S0966-842X(01)01980-1; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Floyd JH, 2014, BIOCHEM BIOPH RES CO, V453, P138, DOI 10.1016/j.bbrc.2014.09.080; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gari RRS, 2013, J BIOL CHEM, V288, P16848, DOI 10.1074/jbc.M113.471870; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; KELLER RCA, 1995, FEBS LETT, V358, P251, DOI 10.1016/0014-5793(94)01439-8; KLOSE M, 1993, J BIOL CHEM, V268, P4504; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Prabudiansyah I, 2015, BBA-BIOMEMBRANES, V1848, P2050, DOI 10.1016/j.bbamem.2015.06.024; Prabudiansyah I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128788; Ramadurai S, 2010, BIOPHYS J, V99, P1482, DOI 10.1016/j.bpj.2010.06.036; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tafvizi A, 2011, CHEMPHYSCHEM, V12, P1481, DOI 10.1002/cphc.201100112; Taufik I, 2013, J MOL BIOL, V425, P4145, DOI 10.1016/j.jmb.2013.08.012; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Wang HY, 2008, J BACTERIOL, V190, P1413, DOI 10.1128/JB.01633-07; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	44	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22534	22543		10.1074/jbc.M116.743831	http://dx.doi.org/10.1074/jbc.M116.743831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27613865	Green Published, hybrid			2022-12-28	WOS:000386760600015
J	Marty, L; Vigouroux, A; Aumont-Nicaise, M; Dessaux, Y; Faure, D; Morera, S				Marty, Loic; Vigouroux, Armelle; Aumont-Nicaise, Magali; Dessaux, Yves; Faure, Denis; Morera, Solange			Structural Basis for High Specificity of Amadori Compound and Mannopine Opine Binding in Bacterial Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; crystal structure; host-pathogen interaction; isothermal titration calorimetry (ITC); x-ray crystallography; DFG; mannopine; opine; periplasmic binding protein; plant pathogen	AGROBACTERIUM-TUMEFACIENS; TI-PLASMID; PLANT TRANSFORMATION; OCTOPINE SYNTHASE; CATABOLISM GENES; GABA BINDING; AMINO-ACID; PROTEIN; POPULATIONS; SUBSTRATE	Agrobacterium tumefaciens pathogens genetically modify their host plants to drive the synthesis of opines in plant tumors. Opines are either sugar phosphodiesters or the products of condensed amino acids with ketoacids or sugars. They are Agrobacterium nutrients and imported into the bacterial cell via periplasmic-binding proteins (PBPs) and ABC-transporters. Mannopine, an opine from the mannityl-opine family, is synthesized from an intermediate named deoxy-fructosyl-glutamine (DFG), which is also an opine and abundant Amadori compound (a name used for any derivative of aminodeoxysugars) present in decaying plant materials. The PBP MotA is responsible for mannopine import in mannopine-assimilating agrobacteria. In the nopaline-opine type agrobacteria strain, SocA protein was proposed as a putative mannopine binding PBP, and AttC protein was annotated as a mannopine binding-like PBP. Structural data on mannityl-opine-PBP complexes is currently lacking. By combining affinity data with analysis of seven x-ray structures at high resolution, we investigated the molecular basis of MotA, SocA, and AttC interactions with mannopine and its DFG precursor. Our work demonstrates that AttC is not a mannopine-binding protein and reveals a specific binding pocket for DFG in SocA with an affinity in nanomolar range. Hence, mannopine would not be imported into nopaline-type agrobacteria strains. In contrast, MotA binds both mannopine and DFG. We thus defined one mannopine and two DFG binding signatures. Unlike mannopine-PBPs, selective DFG-PBPs are present in a wide diversity of bacteria, including Actinobacteria, -,-, and -proteobacteria, revealing a common role of this Amadori compound in pathogenic, symbiotic, and opportunistic bacteria.	[Marty, Loic; Vigouroux, Armelle; Aumont-Nicaise, Magali; Dessaux, Yves; Faure, Denis; Morera, Solange] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, Ave Terrasse, F-91198 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Morera, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, Ave Terrasse, F-91198 Gif Sur Yvette, France.	solange.morera@i2bc.paris-saclay.fr		morera, solange/0000-0001-7781-0448	FRISBI [ANR-10-INSB-05-01]	FRISBI	This work has benefited from the I2BC crystallization platform and @ TOME-2, both supported by FRISBI ANR-10-INSB-05-01. We acknowledge SOLEIL for provision of synchrotron radiation facilities (proposals ID 20130869 and 20140774) in using Proxima beamlines. We are grateful to Gavin Fox for critical reading of the manuscript.	Baek CH, 2005, FEMS MICROBIOL ECOL, V53, P221, DOI 10.1016/j.femsec.2004.12.008; Baek CH, 2003, J BACTERIOL, V185, P513, DOI 10.1128/JB.185.2.513-524.2003; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; CHILTON WS, 1995, PHYTOCHEMISTRY, V40, P619, DOI 10.1016/0031-9422(93)00283-L; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; DESSAUX Y, 1987, MOL GEN GENET, V208, P301, DOI 10.1007/BF00330457; DESSAUX Y, 1993, PHYTOCHEMISTRY, V34, P31, DOI 10.1016/S0031-9422(00)90778-7; Dessaux Y., 1998, RHIZOBIACEAE MOL BIO, P173, DOI DOI 10.1007/978-94-011-5060-6_9; El Sahili A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005071; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flores-Mireles AL, 2012, MOL MICROBIOL, V84, P845, DOI 10.1111/j.1365-2958.2012.08061.x; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; GUYON P, 1993, MOL PLANT MICROBE IN, V6, P92, DOI 10.1094/MPMI-6-092; HACK E, 1980, PLANT PHYSIOL, V65, P949, DOI 10.1104/pp.65.5.949; Hong SB, 1997, J BACTERIOL, V179, P4831, DOI 10.1128/jb.179.15.4831-4840.1997; HONG SB, 1994, J BACTERIOL, V176, P3576, DOI 10.1128/JB.176.12.3576-3583.1994; HONG SB, 1993, J BACTERIOL, V175, P401, DOI 10.1128/JB.175.2.401-410.1993; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim H, 1997, J BACTERIOL, V179, P7559, DOI 10.1128/jb.179.23.7559-7572.1997; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004444; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oger P, 1998, MOL MICROBIOL, V27, P277, DOI 10.1046/j.1365-2958.1998.00671.x; Oger P, 1997, NAT BIOTECHNOL, V15, P369, DOI 10.1038/nbt0497-369; Oger PM, 2004, MICROB ECOL, V47, P96, DOI 10.1007/s00248-003-2012-9; OH BH, 1993, J BIOL CHEM, V268, P11348; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Planamente S, 2012, MOL MICROBIOL, V86, P1085, DOI 10.1111/mmi.12043; Planamente S, 2010, J BIOL CHEM, V285, P30294, DOI 10.1074/jbc.M110.140715; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Sakaguchi A, 2005, BIOCHEM BIOPH RES CO, V336, P1074, DOI 10.1016/j.bbrc.2005.08.230; Savka MA, 1997, NAT BIOTECHNOL, V15, P363, DOI 10.1038/nbt0497-363; SCHARDL CL, 1983, MOL GEN GENET, V191, P10, DOI 10.1007/BF00330882; SCHELL J, 1979, PROC R SOC SER B-BIO, V204, P251, DOI 10.1098/rspb.1979.0026; Stamp AL, 2011, PROTEINS, V79, P2352, DOI 10.1002/prot.23060; TATE ME, 1982, CARBOHYD RES, V104, P105, DOI 10.1016/S0008-6215(00)82224-7; Tempe J., 1983, Molecular genetics of the bacteria-plant interaction., P14; WILSON M, 1995, APPL ENVIRON MICROB, V61, P2151, DOI 10.1128/AEM.61.6.2151-2158.1995; Yu J, 2015, P NATL ACAD SCI USA, V112, P5243, DOI 10.1073/pnas.1415037112; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000	41	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22638	22649		10.1074/jbc.M116.745562	http://dx.doi.org/10.1074/jbc.M116.745562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609514	Green Published, hybrid			2022-12-28	WOS:000386760600024
J	Vergnolle, O; Xu, H; Tufariello, JM; Favrot, L; Malek, AA; Jacobs, WR; Blanchard, JS				Vergnolle, Olivia; Xu, Hua; Tufariello, JoAnn M.; Favrot, Lorenza; Malek, Adel A.; Jacobs, William R., Jr.; Blanchard, John S.			Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; enzyme structure; iron; Mycobacterium tuberculosis; post-translational modification (PTM); MbtA; mycobactin	CRYSTAL-STRUCTURE; IRON ACQUISITION; COA SYNTHETASE; TUBERCULOSIS; GENE; BINDING; IDER; METABOLISM; EXPRESSION; INHIBITORS	Iron is an essential element for life, but its soluble form is scarce in the environment and is rarer in the human body. Mtb (Mycobacterium tuberculosis) produces two aryl-capped siderophores, mycobactin (MBT) and carboxymycobactin (cMBT), to chelate intracellular iron. The adenylating enzyme MbtA catalyzes the first step of mycobactin biosynthesis in two half-reactions: activation of the salicylic acid as an acyl-adenylate and ligation onto the acyl carrier protein (ACP) domain of MbtB to form covalently salicylated MbtB-ACP. We report the first apo-MbtA structure from Mycobacterium smegmatis at 2.3 . We demonstrate here that MbtA activity can be reversibly, post-translationally regulated by acetylation. Indeed the mycobacterial Pat (protein lysine acetyltransferase), Rv0998, specifically acetylates MbtA on lysine 546, in a cAMP-dependent manner, leading to enzyme inhibition. MbtA acetylation can be reversed by the NAD(+)-dependent DAc (deacetyltransferase), Rv1151c. Deletion of Pat and DAc genes in Mtb revealed distinct phenotypes for strains lacking one or the other gene at low pH and limiting iron conditions. This study establishes a direct connection between the reversible acetylation system Pat/DAc and the ability of Mtb to adapt in limited iron conditions, which is critical for mycobacterial infection.	[Vergnolle, Olivia; Xu, Hua; Favrot, Lorenza; Blanchard, John S.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Biochem, Bronx, NY 10461 USA; [Tufariello, JoAnn M.; Malek, Adel A.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	john.blanchard@einstein.yu.edu	Malek, Adel/ABF-9944-2021	Jacobs, William/0000-0003-3321-3080	National Institutes of Health [AI60899, AI26170, AI098925, P01AI63537]; Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026170, R01AI026170, R01AI098925, P01AI063537, R01AI060899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI60899 (to J. S. B.) and AI26170, AI098925, and P01AI63537 (to W. R. J.). This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team Beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; Chavadi SS, 2011, J BACTERIOL, V193, P5905, DOI 10.1128/JB.05811-11; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Drake EJ, 2010, BIOCHEMISTRY-US, V49, P9292, DOI 10.1021/bi101226n; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favrot L, 2016, BIOCHEMISTRY-US, V55, P989, DOI 10.1021/acs.biochem.5b01269; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Gobin J, 1996, J EXP MED, V183, P1527, DOI 10.1084/jem.183.4.1527; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krithika R, 2006, P NATL ACAD SCI USA, V103, P2069, DOI 10.1073/pnas.0507924103; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; Lun S, 2013, ANTIMICROB AGENTS CH, V57, P5138, DOI 10.1128/AAC.00918-13; Luo MK, 2005, NAT CHEM BIOL, V1, P149, DOI 10.1038/nchembio717; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Nelson KM, 2015, J MED CHEM, V58, P5459, DOI 10.1021/acs.jmedchem.5b00391; Pandey R, 2014, MOL MICROBIOL, V91, P98, DOI 10.1111/mmi.12441; Pandey SD, 2014, J BACTERIOL, V196, P1853, DOI 10.1128/JB.01483-13; PFLEIDERER G, 1960, BIOCHEM Z, V333, P308; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rodriguez GM, 2006, TRENDS MICROBIOL, V14, P320, DOI 10.1016/j.tim.2006.05.006; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Ryndak MB, 2010, J BACTERIOL, V192, P861, DOI 10.1128/JB.00223-09; SCHMITT MP, 1995, INFECT IMMUN, V63, P4284, DOI 10.1128/IAI.63.11.4284-4289.1995; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tufariello JM, 2014, MBIO, V5, DOI 10.1128/mBio.01179-14; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Vergnolle O, 2013, J BIOL CHEM, V288, P28116, DOI 10.1074/jbc.M113.495549; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Zheng RJ, 2001, BIOCHEMISTRY-US, V40, P12904, DOI 10.1021/bi011522+	47	19	20	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22315	22326		10.1074/jbc.M116.744532	http://dx.doi.org/10.1074/jbc.M116.744532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27566542	Green Published, hybrid			2022-12-28	WOS:000386332600041
J	Liu, YF; Wei, JY; Shi, MH; Jiang, H; Zhou, J				Liu, Yu-Feng; Wei, Jian-Yang; Shi, Mao-Hua; Jiang, Hua; Zhou, Jie			Glucocorticoid Induces Hepatic Steatosis by Inhibiting Activating Transcription Factor 3 (ATF3)/S100A9 Protein Signaling in Granulocytic Myeloid-derived Suppressor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cAMP response element-binding protein; glucocorticoid; immunosuppression; liver metabolism; S100 proteins	IMMUNE SUPPRESSION; LIVER-DISEASE; FATTY LIVER; ATF3; INFLAMMATION; DIFFERENTIATION; ACCUMULATION; REGULATOR; EXPANSION; MICE	Glucocorticoids (GCs) used as inflammation suppressors have harmful side effects, including induction of hepatic steatosis. The underlying mechanisms of GC-promoted dysregulation of lipid metabolism, however, are not fully understood. GCs could facilitate the accumulation of myeloid-derived suppressor cells (MDSC) in the liver of animals, and the potential role of MDSCs in GC-induced hepatic steatosis was therefore investigated in this study. We demonstrated that granulocytic (G)-MDSC accumulation mediated the effects of GCs on the fatty liver, in which activating transcription factor 3 (ATF3)/S100A9 signaling plays an important role. ATF3-deficient mice developed hepatic steatosis and displayed expansion of G-MDSCs in the liver and multiple immune organs, which shared high similarity with the phenotype observed in GC-treated wild-type littermates. Adoptive transfer of GC-induced or ATF3-deficient G-MDSCs promoted lipid accumulation in the liver, whereas depletion of G-MDSCs alleviated these effects. Mechanistic studies showed that in MDSCs, ATF3 was transrepressed by the GC receptor GR through direct binding to the negative GR-response element. S100A9 is the major transcriptional target of ATF3 in G-MDSCs. Silencing S100A9 clearly alleviated G-MDSCs expansion and hepatic steatosis caused by ATF3 deficiency or GC treatment. Our study uncovers an important role of G-MDSCs in GC-induced hepatic steatosis, in which ATF3 may have potential therapeutic implications.	[Liu, Yu-Feng; Jiang, Hua; Zhou, Jie] Zhongshan Sch Med, Affiliated Guangzhou Women & Childrens Med Ctr, Program Immunol, 9th Jin Sui Rd, Guangzhou 510623, Guangdong, Peoples R China; [Liu, Yu-Feng; Wei, Jian-Yang; Shi, Mao-Hua; Zhou, Jie] Sun Yat Sen Univ, Inst Human Virol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Zhou, Jie] Sun Yat Sen Univ, Chinese Minist Educ, Key Lab Trop Dis Control, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Yu-Feng; Jiang, Hua] Guangzhou Med Univ, Dept Hematol Oncol, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Zhou, J (corresponding author), 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	zhouj72@mail.sysu.edu.cn			National Key Basic Research Program of China [2012CB524900]; Guangdong Innovative Research Team Program Grant [2009010058]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); Programme for the 12th Five-year Plan [2012ZX10001003]; National Natural Science Foundation of China [91542112, 81571520, 31270921]; Fundamental Research Funds for the Central Universities; Provincial Talents Cultivated by "Thousand-Hundred-Ten" Programme of Guangdong Province; 111 Project [B12003]; China Postdoctoral Science Foundation [2015M582365]; Natural Science Foundation of Guangdong Province [2016A030310252]	National Key Basic Research Program of China(National Basic Research Program of China); Guangdong Innovative Research Team Program Grant; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); Programme for the 12th Five-year Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Provincial Talents Cultivated by "Thousand-Hundred-Ten" Programme of Guangdong Province; 111 Project(Ministry of Education, China - 111 Project); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Key Basic Research Program of China Grant 2012CB524900; Guangdong Innovative Research Team Program Grant 2009010058; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS, 2014); Programme for the 12th Five-year Plan 2012ZX10001003; National Natural Science Foundation of China Grants 91542112, 81571520, 31270921; Fundamental Research Funds for the Central Universities; the Provincial Talents Cultivated by "Thousand-Hundred-Ten" Programme of Guangdong Province; 111 Project B12003; China Postdoctoral Science Foundation Grant 2015M582365, and Natural Science Foundation of Guangdong Province Grant 2016A030310252. The authors declare that they have no conflicts of interest with the contents of this article.	Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chou HS, 2011, HEPATOLOGY, V53, P1007, DOI 10.1002/hep.24162; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Gustot T, 2006, HEPATOLOGY, V43, P989, DOI 10.1002/hep.21138; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Hu CE, 2011, SCAND J GASTROENTERO, V46, P156, DOI 10.3109/00365521.2010.516450; Huang A, 2014, J IMMUNOL, V193, P5461, DOI 10.4049/jimmunol.1400849; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Kim JY, 2014, J BIOL CHEM, V289, P27065, DOI 10.1074/jbc.M114.585653; Liao JB, 2014, J LEUKOCYTE BIOL, V96, P675, DOI 10.1189/jlb.2HI1113-611RR; Liu GW, 2014, J IMMUNOL, V192, P3068, DOI 10.4049/jimmunol.1301193; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Miura K, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/362847; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Oakley RH, 2012, P NATL ACAD SCI USA, V109, P17591, DOI 10.1073/pnas.1209411109; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Patel R, 2011, J CLIN INVEST, V121, P431, DOI 10.1172/JCI41681; Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12; Sade H, 2003, EUR J IMMUNOL, V33, P913, DOI 10.1002/eji.200323782; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Shi MH, 2014, J ALLERGY CLIN IMMUN, V134, P1163, DOI 10.1016/j.jaci.2014.04.035; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; van der Goes MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4686; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Varga G, 2014, J IMMUNOL, V193, P1090, DOI 10.4049/jimmunol.1300891; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Yan DH, 2013, EUR J IMMUNOL, V43, P2943, DOI 10.1002/eji.201343472; Yang Q, 2014, BLOOD, V124, P1610, DOI 10.1182/blood-2014-03-559658; Zhang K, 2012, INT J MOL MED, V30, P277, DOI 10.3892/ijmm.2012.1014	44	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21771	21785		10.1074/jbc.M116.726364	http://dx.doi.org/10.1074/jbc.M116.726364			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27573240	Green Published, hybrid			2022-12-28	WOS:000385999200041
J	Garantziotis, S; Li, ZW; Potts, EN; Kimata, K; Zhuo, LS; Morgan, DL; Savani, RC; Noble, PW; Foster, WM; Schwartz, DA; Hollingsworth, JW				Garantziotis, Stavros; Li, Zhuowei; Potts, Erin N.; Kimata, Koji; Zhuo, Lisheng; Morgan, Daniel L.; Savani, Rashmin C.; Noble, Paul W.; Foster, W. Michael; Schwartz, David A.; Hollingsworth, John W.			Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice (vol 284, pg 11309, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction							ASTHMA						Garantziotis, Stavros/A-6903-2009	Garantziotis, Stavros/0000-0003-4007-375X				Bauer RN, 2015, AM J RESP CELL MOL, V52, P285, DOI 10.1165/rcmb.2014-0035OC; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Hernandez ML, 2010, J ALLERGY CLIN IMMUN, V126, P537, DOI 10.1016/j.jaci.2010.06.043; Lazrak A, 2015, AM J PHYSIOL-LUNG C, V308, pL891, DOI 10.1152/ajplung.00377.2014; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Williams AS, 2015, AM J PHYSIOL-LUNG C, V308, pL1168, DOI 10.1152/ajplung.00393.2014; Yue W, 2012, CARBOHYD POLYM, V89, P709, DOI 10.1016/j.carbpol.2012.03.081	7	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19257	19258		10.1074/jbc.A116.802400	http://dx.doi.org/10.1074/jbc.A116.802400			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27613954	Green Published, hybrid			2022-12-28	WOS:000383242800005
J	Yin, T; Wang, GP; He, SS; Shen, GB; Su, C; Zhang, Y; Wei, XW; Ye, TH; Li, L; Yang, SY; Li, D; Guo, FC; Mo, ZM; Wan, Y; Ai, P; Zhou, XJ; Liu, YT; Wang, YS; Wei, YQ				Yin, Tao; Wang, Guoping; He, Sisi; Shen, Guobo; Su, Chao; Zhang, Yan; Wei, Xiawei; Ye, Tinghong; Li, Ling; Yang, Shengyong; Li, Dan; Guo, Fuchun; Mo, Zeming; Wan, Yang; Ai, Ping; Zhou, Xiaojuan; Liu, Yantong; Wang, Yongsheng; Wei, Yuquan			Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER; LUNG-CANCER; SELF-RENEWAL; THERAPY; BEVACIZUMAB; METASTASIS; DISSEMINATION; PROGRESSION; ACTIVATION; EXPRESSION	Malignant pleural effusion (PE) and ascites, common clinical manifestations in advanced cancer patients, are associated with a poor prognosis. However, the biological characteristics of malignant PE and ascites are not clarified. Here we report that malignant PE and ascites can induce a frequent epithelial-mesenchymal transition program and endow tumor cells with stem cell properties with high efficiency, which promotes tumor growth, chemoresistance, and immune evasion. We determine that this epithelial-mesenchymal transition process is mainly dependent on VEGF, one initiator of the PI3K/Akt/mechanistic target of rapamycin (mTOR) pathway. From the clinical observation, we define a therapeutic option with VEGF antibody for malignant PE and ascites. Taken together, our findings clarify a novel biological characteristic of malignant PE and ascites in cancer progression and provide a promising and available strategy for cancer patients with recurrent/refractory malignant PE and ascites.	[Wang, Yongsheng] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Thorac Oncol, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China; [Wang, Yongsheng] Sichuan Univ, West China Hosp, Ctr Canc, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China; [Wang, Yongsheng] Collaborat Innovat Ctr Biotherapy, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Wang, YS (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Thorac Oncol, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China.; Wang, YS (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China.; Wang, YS (corresponding author), Collaborat Innovat Ctr Biotherapy, 17,Sect 3 Peoples South Rd, Chengdu 610041, Peoples R China.	wangys75@gmail.com			National Natural Science Foundation of China [81272523, 81501609]; National Basic Research Program of China [2010CB529900]; Chinese Postdoctoral Special Funds [2016T90856]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Postdoctoral Special Funds	This work was supported by National Natural Science Foundation of China Grants 81272523 and 81501609, National Basic Research Program of China Grant 2010CB529900, and Chinese Postdoctoral Special Funds Grant 2016T90856. The authors declare that they have no conflicts of interest with the contents of this article.	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0056380]; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Du N, 2013, ONCOL REP, V29, P2332, DOI 10.3892/or.2013.2349; Duysinx BC, 2008, RESP MED, V102, P1708, DOI 10.1016/j.rmed.2008.07.008; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Giarnieri E, 2015, J CELL PHYSIOL, V230, P272, DOI 10.1002/jcp.24806; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jewett A, 2012, CURR DRUG DELIV, V9, P5, DOI 10.2174/156720112798375989; Kobold S, 2009, ONCOLOGIST, V14, P1242, DOI 10.1634/theoncologist.2009-0109; Kolomainen DF, 2003, J CLIN ONCOL, V21, P3113, DOI 10.1200/JCO.2003.06.119; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Latifi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046858; Lee JY, 2011, AM J PHYSIOL-RENAL, V300, pF1214, DOI 10.1152/ajprenal.00710.2010; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Okano J, 2003, BIOCHEM BIOPH RES CO, V309, P298, DOI 10.1016/j.bbrc.2003.04.002; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; PLANTE M, 1994, CANCER, V73, P1882, DOI 10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rafehi S, 2016, ENDOCR-RELAT CANCER, V23, P147, DOI 10.1530/ERC-15-0383; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ricci A, 2013, CELL CYCLE, V12, P1696, DOI 10.4161/cc.24759; RUNYON BA, 1994, NEW ENGL J MED, V330, P337, DOI 10.1056/NEJM199402033300508; Ryu JS, 2014, J CLIN ONCOL, V32, P960, DOI 10.1200/JCO.2013.50.5453; Sakr L, 2011, J THORAC ONCOL, V6, P592, DOI 10.1097/JTO.0b013e318208c7c1; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shen-Gunther J, 2002, GYNECOL ONCOL, V87, P77, DOI 10.1006/gyno.2002.6800; Shiota M, 2012, CANCER RES, V72, P5261, DOI 10.1158/0008-5472.CAN-12-0254; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Zebrowski BK, 1999, ANN SURG ONCOL, V6, P373, DOI 10.1007/s10434-999-0373-0; Zhao H, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0292-1	49	20	22	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26750	26761		10.1074/jbc.M116.753236	http://dx.doi.org/10.1074/jbc.M116.753236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27756837	Green Published, hybrid			2022-12-28	WOS:000391571400014
J	Gerarduzzi, C; de Polo, A; Liu, XS; El Kharbili, M; Little, JB; Yuan, ZM				Gerarduzzi, Casimiro; de Polo, Anna; Liu, Xue-Song; El Kharbili, Manale; Little, John B.; Yuan, Zhi-Min			Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ERBB4 ISOFORM; LIGASE ACTIVITY; EXPRESSION; MDM2; DOMAIN; PROLIFERATION; DEGRADATION; CARCINOMA; SURVIVAL	Deregulated receptor tyrosine kinase (RTK) signaling is frequently associated with tumorigenesis and therapy resistance, but its underlying mechanisms still need to be elucidated. In this study, we have shown that the RTK human epidermal growth factor receptor 4 (Her4, also known as Erbb4) can inhibit the tumor suppressor p53 by regulating MDMX-mouse double minute 2 homolog (MDM2) complex stability. Upon activation by either overexpression of a constitutively active vector or ligand binding (Neuregulin-1), Her4 was able to stabilize the MDMX-MDM2 complex, resulting in suppression of p53 transcriptional activity, as shown by p53-responsive element-driven luciferase assay and mRNA levels of p53 target genes. Using a phospho-proteomics approach, we functionally identified a novel Her4-induced posttranslational modification on MDMX at Ser-314, a putative phosphorylation site for the CDK4/6 kinase. Remarkably, inhibition of Ser-314 phosphorylation either with Ser-to-Ala substitution or with a specific inhibitor of CDK4/6 kinase blocked Her4-induced stabilization of MDMX-MDM2 and rescued p53 activity. Our study offers insights into the mechanisms of deregulated RTK-induced carcinogenesis and provides the basis for the use of inhibitors targeting RTK-mediated signals for p53 restoration.	[Gerarduzzi, Casimiro; de Polo, Anna; Liu, Xue-Song; El Kharbili, Manale; Little, John B.; Yuan, Zhi-Min] Harvard TH Chan Sch Publ Hlth, John B Little Ctr Radiat Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Yuan, ZM (corresponding author), Harvard TH Chan Sch Publ Hlth, John B Little Ctr Radiat Sci, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu		de Polo, Anna/0000-0002-5607-8048; Gerarduzzi, Casimiro/0000-0001-7098-1455	Morningside Foundation; Zhu fund; NCI, National Institutes of Health [R01CA085679, RO1CA167814, RO1CA183074]	Morningside Foundation; Zhu fund; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Morningside Foundation, the Zhu fund, and NCI, National Institutes of Health Grants R01CA085679, RO1CA167814, and RO1CA183074. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Barnes NLP, 2005, CLIN CANCER RES, V11, P2163, DOI 10.1158/1078-0432.CCR-04-1633; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Feng SM, 2007, MOL ENDOCRINOL, V21, P1861, DOI 10.1210/me.2006-0101; Forslund A, 2008, MOL CANCER RES, V6, P205, DOI 10.1158/1541-7786.MCR-07-0239; Fujiwara S, 2014, ONCOTARGET, V5, P3919, DOI 10.18632/oncotarget.2002; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Gilkes DM, 2008, MOL CELL BIOL, V28, P1999, DOI 10.1128/MCB.01633-07; Gu JJ, 2001, ONCOGENE, V20, P3519, DOI 10.1038/sj.onc.1204454; Haskins JW, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5124; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito M, 2011, CLIN CANCER RES, V17, P416, DOI 10.1158/1078-0432.CCR-10-2050; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lopez-Pajares V, 2008, J BIOL CHEM, V283, P13707, DOI 10.1074/jbc.M710030200; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Mejia-Guerrero S, 2010, GENE CHROMOSOME CANC, V49, P518, DOI 10.1002/gcc.20761; Mohd N., 2014, INT J EDUC RES, V2, P2; Myklebust MP, 2012, BRIT J CANCER, V107, P1684, DOI 10.1038/bjc.2012.463; Nakamura Y, 2013, PROSTATE, V73, P590, DOI 10.1002/pros.22599; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okazaki S, 2016, BIOCHEM BIOPH RES CO, V470, P239, DOI 10.1016/j.bbrc.2016.01.045; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Pentassuglia L, 2016, AM J PHYSIOL-ENDOC M, V310, pE782, DOI 10.1152/ajpendo.00259.2015; Portier BP, 2013, ONCOTARGET, V4, P1662, DOI 10.18632/oncotarget.1232; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Shadfan M, 2012, TRANSL CANCER RES, V1, P88, DOI 10.3978/j.issn.2218-676X.2012.04.02; Shibagaki I, 1995, CLIN CANCER RES, V1, P769; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Suo Z, 2002, J PATHOL, V196, P17, DOI 10.1002/path.1003; Thor AD, 2009, AM J PATHOL, V175, P1802, DOI 10.2353/ajpath.2009.090204; Tovey SM, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1394; Tovey SM, 2004, BREAST CANCER RES, V6, pR246, DOI 10.1186/bcr783; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020	45	11	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25937	25949		10.1074/jbc.M116.752303	http://dx.doi.org/10.1074/jbc.M116.752303			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777309	Green Published, hybrid			2022-12-28	WOS:000390345200016
J	Hasenhuetl, PS; Freissmuth, M; Sandtner, W				Hasenhuetl, Peter S.; Freissmuth, Michael; Sandtner, Walter			Electrogenic Binding of Intracellular Cations Defines a Kinetic Decision Point in the Transport Cycle of the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DOPAMINE TRANSPORTER; MEMBRANE-TRANSPORT; CONDUCTING STATES; SODIUM SYMPORTERS; CHLORIDE-ION; MECHANISM; NA+; NEUROTRANSMITTER; AMPHETAMINE; CURRENTS	The plasmalemmal monoamine transporters clear the extracellular space from their cognate substrates and sustain cellular monoamine stores even during neuronal activity. In some instances, however, the transporters enter a substrate-exchange mode, which results in release of intracellular substrate. Understanding what determines the switch between these two transport modes demands time-resolved measurements of intracellular (co-) substrate binding and release. Here, we report an electrophysiological investigation of intracellular solute-binding to the human serotonin transporter (SERT) expressed in HEK-293 cells. We measured currents induced by rapid application of serotonin employing varying intracellular (co-) substrate concentrations and interpreted the data using kinetic modeling. Our measurements revealed that the induction of the substrate-exchange mode depends on both voltage and intracellular Na+ concentrations because intracellular Na+ release occurs before serotonin release and is highly electrogenic. This voltage dependence was blunted by electrogenic binding of intracellular K+ and, notably, also H+. In addition, our data suggest that Cl- is bound to SERT during the entire catalytic cycle. Our experiments, therefore, document an essential role of electrogenic binding of K+ or of H+ to the inward-facing conformation of SERT in (i) cancelling out the electrogenic nature of intracellular Na+ release and (ii) in selecting the forward-transport over the substrate-exchange mode. Finally, the kinetics of intracellular Na+ release and K+ (or H+) binding result in a voltage-independent rate-limiting step where SERT may return to the outward-facing state in a KCl- or HCl-bound form.	[Hasenhuetl, Peter S.; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria	Medical University of Vienna	Sandtner, W (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.	walter.sandtner@meduniwien.ac.at		Freissmuth, Michael/0000-0001-9398-1765; Hasenhuetl, Peter/0000-0002-3121-9502	Austrian Science Fund/FWF [P28090, SFB35 (F3510)]; Medical University of Vienna	Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Medical University of Vienna	This work was supported by the Austrian Science Fund/FWF Project P28090 (to W. S.), Project Program Grant SFB35 (F3510 to M. F.), and the MD/Ph.D. program of the Medical University of Vienna (to P. S. H.). This work is part of a dissertation submitted in partial fulfillment of the requirements of the Ph.D. degree. The authors declare that they have no conflicts of interest with the contents of this article.	Bicho A, 2005, BIOPHYS J, V89, P211, DOI 10.1529/biophysj.105.061002; Billesbolle CB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12755; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Cheng MH, 2015, STRUCTURE, V23, P2171, DOI 10.1016/j.str.2015.09.001; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Grewer C, 2013, ANNU REV BIOPHYS, V42, P95, DOI 10.1146/annurev-biophys-083012-130312; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; KEYES SR, 1982, J BIOL CHEM, V257, P1172; Khelashvili G, 2016, J BIOL CHEM, V291, P19786, DOI 10.1074/jbc.M116.731455; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Koldso H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063635; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lauger P., 1991, ELECTROGENIC ION PUM; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; NELSON PJ, 1979, J BIOL CHEM, V254, P84; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	43	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25864	25876		10.1074/jbc.M116.753319	http://dx.doi.org/10.1074/jbc.M116.753319			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27756841	Green Published, hybrid			2022-12-28	WOS:000390345200010
J	Bouche, L; Panico, M; Hitchen, P; Binet, D; Sastre, F; Faulds-Pain, A; Valiente, E; Vinogradov, E; Aubry, A; Fulton, K; Twine, S; Logan, SM; Wren, BW; Dell, A; Morris, HR				Bouche, Laura; Panico, Maria; Hitchen, Paul; Binet, Daniel; Sastre, Federico; Faulds-Pain, Alexandra; Valiente, Esmeralda; Vinogradov, Evgeny; Aubry, Annie; Fulton, Kelly; Twine, Susan; Logan, Susan M.; Wren, Brendan W.; Dell, Anne; Morris, Howard R.			The Type B Flagellin of Hypervirulent Clostridium difficile Is Modified with Novel Sulfonated Peptidylamido-glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; glycosylation; Gram-positive bacteria; mass spectrometry (MS); nuclear magnetic resonance (NMR); Clostridium difficile; flagellin; modification; sulfonated	TANDEM MASS-SPECTROMETRY; TYROBUTYRICUM ATCC 25755; PROTEIN GLYCOSYLATION; POSTTRANSLATIONAL MODIFICATION; IDENTIFICATION; MOTILITY; VIRULENCE; GENOME	Glycosylation of flagellins is a well recognized property of many bacterial species. In this study, we describe the structural characterization of novel flagellar glycans from a number of hypervirulent strains of C. difficile. We used mass spectrometry (nano-LC-MS and MS/MS analysis) to identify a number of putative glycopeptides that carried a variety of glycoform substitutions, each of which was linked through an initial N-acetylhexosamine residue to Ser or Thr. Detailed analysis of a LLDGSSTEIR glycopeptide released by tryptic digestion, which carried two variant structures, revealed that the glycopeptide contained, in addition to carbohydrate moieties, a novel structural entity. A variety of electrospray-MS strategies using Q-TOF technology were used to define this entity, including positive and negative ion collisionally activated decomposition MS/MS, which produced unique fragmentation patterns, and high resolution accurate mass measurement to allow derivation of atomic compositions, leading to the suggestion of a taurine-containing peptidylamido-glycan structure. Finally, NMR analysis of flagellin glycopeptides provided complementary information. The glycan portion of the modification was assigned as -Fuc3N-(13)--Rha-(12)--Rha3OMe-(13)--GlcNAc-(1)Ser, and the novel capping moiety was shown to be comprised of taurine, alanine, and glycine. This is the first report of a novel O-linked sulfonated peptidylamido-glycan moiety decorating a flagellin protein.	[Bouche, Laura; Panico, Maria; Hitchen, Paul; Sastre, Federico; Dell, Anne; Morris, Howard R.] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Faulds-Pain, Alexandra; Valiente, Esmeralda; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England; [Vinogradov, Evgeny; Aubry, Annie; Fulton, Kelly; Twine, Susan; Logan, Susan M.] CNR, Vaccine Program, Human Hlth Therapeut Portfolio, Ottawa, ON K1A 0R6, Canada; [Binet, Daniel; Morris, Howard R.] BioPharmaSpec, Suite 3-1 Lido Med Ctr,St Saviours Rd, Jersey JE2 7LA, England; [Sastre, Federico] Pontificia Univ Catolica Chile PUC, Escuela Ingn, Dept Ingn Quim & Bioproc, Av Vicuna Mackenna 4860, Santiago 7820436, Chile	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; National Research Council Canada; Pontificia Universidad Catolica de Chile	Dell, A (corresponding author), Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England.	a.dell@imperial.ac.uk		Dell, Anne/0000-0003-1380-2347	Wellcome Trust [102979/Z/13/Z]; Medical Research Council [MR/K000551/1]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-252207-CDI]; Biotechnology and Biological Sciences Research Council [BB/D521849/1] Funding Source: researchfish; Medical Research Council [G1000214] Funding Source: researchfish; BBSRC [BB/D521849/1, BB/F008309/1, BB/K016164/1] Funding Source: UKRI; MRC [MR/K000551/1, G1000214] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Intra-European Fellowship(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 102979/Z/13/Z, Medical Research Council Grant MR/K000551/1, and Biotechnology and Biological Sciences Research Council Grants BB/K016164/1 and BB/F008309/1. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Marie Curie Intra-European Fellowship for career development (PIEF-GA-2009-252207-CDI).	Alemka A, 2013, INFECT IMMUN, V81, P1674, DOI 10.1128/IAI.01370-12; Arnold F, 1998, MICROBIOL IMMUNOL, V42, P23, DOI 10.1111/j.1348-0421.1998.tb01965.x; Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; Barketi-Klai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096876; Bedouet L, 1998, MICROBIOS, V94, P183; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Cairns MD, 2012, FUTURE MICROBIOL, V7, P945, DOI [10.2217/FMB.12.73, 10.2217/fmb.12.73]; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Faulds-Pain A, 2014, MOL MICROBIOL, V94, P272, DOI 10.1111/mmi.12755; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; HUNT E, 1973, BIOCHEM J, V135, P833, DOI 10.1042/bj1350833; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Janesch B, 2016, GLYCOBIOLOGY, V26, P74, DOI 10.1093/glycob/cwv087; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Lyristis M, 2000, ANAEROBE, V6, P69, DOI 10.1006/anae.1999.0311; Merino S, 2014, INT J MOL SCI, V15, P2840, DOI 10.3390/ijms15022840; Miao JF, 2012, CYTOKINE, V59, P35, DOI 10.1016/j.cyto.2012.04.009; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; Morris HR, 1997, J PROTEIN CHEM, V16, P469, DOI 10.1023/A:1026309410737; Naundorf A, 1996, CARBOHYD RES, V285, P141, DOI 10.1016/S0008-6215(96)90180-9; Ni Eidhin D, 2006, J MED MICROBIOL, V55, P69, DOI 10.1099/jmm.0.46204-0; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Schirm M, 2005, ANAL CHEM, V77, P7774, DOI 10.1021/ac051316y; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Valiente E, 2016, J BIOL CHEM, V291, P25450, DOI 10.1074/jbc.M116.749523	35	12	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25439	25449		10.1074/jbc.M116.749481	http://dx.doi.org/10.1074/jbc.M116.749481			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27758867	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-28	WOS:000390095300014
J	Murray, B; Pearson, CS; Aranjo, A; Cherupalla, D; Belfort, G				Murray, Brian; Pearson, C. Seth; Aranjo, Alexa; Cherupalla, Dinesh; Belfort, Georges			Mechanism of Four de Novo Designed Antimicrobial Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); cell-penetrating peptide (CPP); lipid bilayer; peptide interaction; peptides	QUARTZ-CRYSTAL MICROBALANCE; PORE FORMATION; ANTIBACTERIAL PEPTIDES; BETA-SHEET; INDOLICIDIN; BINDING	As pathogenic bacteria become resistant to traditional antibiotics, alternate approaches such as designing and testing new potent selective antimicrobial peptides (AMP) are increasingly attractive. However, whereas much is known regarding the relationship between the AMP sequence and potency, less research has focused on developing links between AMP properties, such as design and structure, with mechanisms. Here we use four natural AMPs of varying known secondary structures and mechanisms of lipid bilayer disruption as controls to determine the mechanisms of four rationally designed AMPs with similar secondary structures and rearranged amino acid sequences. Using a Quartz Crystal Microbalance with Dissipation, we were able to differentiate between molecular models of AMP actions such as barrel-stave pore formation, toroidal pore formation, and peptide insertion mechanisms by quantifying differential frequencies throughout an oscillating supported lipid bilayer. Barrel-stave pores were identified by uniform frequency modulation, whereas toroidal pores possessed characteristic changes in oscillation frequency throughout the bilayer. The resulting modes of action demonstrate that rearrangement of an amino acid sequence of the AMP resulted in identical overall mechanisms, and that a given secondary structure did not necessarily predict mechanism. Also, increased mass addition to Gram-positive mimetic membranes from AMP disruption corresponded with lower minimum inhibitory concentrations against the Gram-positive Staphylococcus aureus.	Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Belfort, G (corresponding author), 110 8th St, Troy, NY 12180 USA.	belfog@rpi.edu			United States National Science Foundation; National Science Foundation [CBET-125071]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067545] Funding Source: NIH RePORTER	United States National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Science Foundation and National Science Foundation Grant CBET-125071. The authors declare that they have no conflicts of interest with the contents of this article.	Briand E, 2010, ANALYST, V135, P343, DOI 10.1039/b918288h; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cho NJ, 2010, NAT PROTOC, V5, P1096, DOI 10.1038/nprot.2010.65; Christ K, 2007, BBA-BIOMEMBRANES, V1768, P694, DOI 10.1016/j.bbamem.2006.12.003; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3; Friedrich CL, 2001, J BIOL CHEM, V276, P24015, DOI 10.1074/jbc.M009691200; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gu MH, 2013, ACTA BIOMATER, V9, P5201, DOI 10.1016/j.actbio.2012.10.013; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hilpert K, 2006, CHEM BIOL, V13, P1101, DOI 10.1016/j.chembiol.2006.08.014; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; Koczulla AR, 2003, DRUGS, V63, P389, DOI 10.2165/00003495-200363040-00005; Ladokhin AS, 1997, BIOPHYS J, V72, P794, DOI 10.1016/S0006-3495(97)78713-7; Lee BW, 2004, FLUID PHASE EQUILIBR, V225, P63, DOI DOI 10.1016/J.FLUID.2004.07.008); Liu YF, 2011, INT J PEPT RES THER, V17, P175, DOI 10.1007/s10989-011-9255-y; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; Mechler A, 2007, BIOPHYS J, V93, P3907, DOI 10.1529/biophysj.107.116525; Miteva M, 1999, FEBS LETT, V462, P155, DOI 10.1016/S0014-5793(99)01520-3; Mowery BP, 2007, J AM CHEM SOC, V129, P15474, DOI 10.1021/ja077288d; Neale C, 2014, BIOPHYS J, V106, pL29, DOI 10.1016/j.bpj.2014.02.031; Pearson CS, 2016, ANTIMICROB AGENTS CH, V60, P2757, DOI 10.1128/AAC.00940-15; Piantavigna S, 2009, INT J PEPT RES THER, V15, P139, DOI 10.1007/s10989-009-9175-2; Pokorny A, 2002, BIOCHEMISTRY-US, V41, P11044, DOI 10.1021/bi020244r; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Rausch JM, 2007, BIOCHEMISTRY-US, V46, P12124, DOI 10.1021/bi700978h; Sherman PJ, 2009, BIOCHEMISTRY-US, V48, P11892, DOI 10.1021/bi901668y; Tamba Y, 2010, J PHYS CHEM B, V114, P12018, DOI 10.1021/jp104527y; Tang M, 2009, MOL BIOSYST, V5, P317, DOI 10.1039/b820398a; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; Wang KF, 2015, BIOPHYS CHEM, V196, P53, DOI 10.1016/j.bpc.2014.09.003; Wang KF, 2011, J PHYS CHEM B, V115, P15228, DOI 10.1021/jp209658y; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	37	12	13	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25706	25715		10.1074/jbc.M116.733816	http://dx.doi.org/10.1074/jbc.M116.733816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27738105	hybrid, Green Published			2022-12-28	WOS:000390095300035
J	Van Aelst, B; Devloo, R; Zachee, P; t'Kindt, R; Sandra, K; Vandekerckhove, P; Compernolle, V; Feys, HB				Van Aelst, Britt; Devloo, Rosalie; Zachee, Pierre; t'Kindt, Ruben; Sandra, Koen; Vandekerckhove, Philippe; Compernolle, Veerle; Feys, Hendrik B.			Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET ACTIVATION; LIPID PACKING; EXTRACORPOREAL PHOTOPHERESIS; PHOTOCHEMICAL INACTIVATION; IMMUNE SUPPRESSION; THROMBUS FORMATION; MASS-SPECTROMETRY; NUCLEIC-ACID; PUVA THERAPY; IN-VITRO	Psoralen and ultraviolet A light (PUNTA) are used to kill pathogens in blood products and as a treatment of aberrant cell proliferation in dermatitis, cutaneous T-cell lymphoma, and graft versus-host disease. DNA damage is well described, but the direct effects of PUVA on cell signal transduction are poorly understood. Because platelets are anucleate and contain archetypal signal transduction machinery, they are ideally suited to address this. Lipidomics on platelet membrane extracts showed that psoralen forms adducts with unsaturated carbon bonds of fatty acyls in all major phospholipid classes after PUVA. Such adducts increased lipid packing as measured by a blue shift of an environment-sensitive fluorescent probe in model liposomes. Furthermore, the interaction of these liposomes with lipid order-sensitive proteins like amphipathic lipid-packing sensor and a-synuclein was inhibited by PUVA. In platelets, PUVA caused poor membrane binding of Akt and Bruton's tyrosine kinase effectors following activation of the collagen glycoprotein VI and thrombin protease-activated receptor (PAR) 1. This resulted in defective Akt phosphorylation despite unaltered phosphatidylinositol 3,4,5-trisphosphate levels. Downstream integrin activation was furthermore affected similarly by PUVA following PAR1 (effective half-maximal concentration (EC), 8.4 +/- 1.1 versus 4.3 +/- 1.1 mu M) and glycoprotein VI (EC50, 1.61 +/- 0.85 versus 0.26 +/- 0.21 mu g/ml) but not PAR4 (EC50, 50 +/- 1 versus 58 +/- 1 mu m) signal transduction. Our findings were confirmed in T-cells ftom graft-versus-host disease patients treated with extracorporeal photopheresis, a form of systemic PUVA. In conclusion, PUVA increases the order of lipid phases by covalent modification of phospholipids, thereby inhibiting membrane recruitment of effector kinases.	[Van Aelst, Britt; Devloo, Rosalie; Compernolle, Veerle; Feys, Hendrik B.] Belgian Red Cross Flanders, Transfus Res Ctr, Ottergemsesteenweg 413, B-9000 Ghent, Belgium; [Zachee, Pierre] Hosp Network Antwerp, Dept Hematol, B-2000 Antwerp, Belgium; [t'Kindt, Ruben; Sandra, Koen] Res Inst Chromatog, B-8500 Kortrijk, Belgium; [Vandekerckhove, Philippe; Compernolle, Veerle] Belgian Red Cross Flanders, Blood Serv, B-2800 Mechelen, Belgium; [Vandekerckhove, Philippe] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, B-3000 Leuven, Belgium; [Vandekerckhove, Philippe; Compernolle, Veerle] Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	KU Leuven; Ghent University	Feys, HB (corresponding author), Belgian Red Cross Flanders, Transfus Res Ctr, Ottergemsesteenweg 413, B-9000 Ghent, Belgium.	hendrik.feys@rodekruis.be	Zachee, Pierre/B-5391-2018	Zachee, Pierre/0000-0002-2275-5143; Feys, Hendrik/0000-0003-0052-8852	Foundation for Research and Development of the Belgian Red Cross-Flanders Blood Service	Foundation for Research and Development of the Belgian Red Cross-Flanders Blood Service	This work was supported by the Foundation for Research and Development of the Belgian Red Cross-Flanders Blood Service. The authors declare that they have no conflicts of interest with the contents of this article.	Anthony FA, 1997, PHOTODERMATOL PHOTO, V13, P9, DOI 10.1111/j.1600-0781.1997.tb00101.x; Badolia R, 2015, BLOOD, V125, P175, DOI 10.1182/blood-2014-05-576306; Bernal-Perez LF, 2012, ANAL BIOCHEM, V428, P13, DOI 10.1016/j.ab.2012.05.026; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; BOHM F, 1986, ARCH DERMATOL RES, V279, P16, DOI 10.1007/BF00404352; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Caffieri S, 1996, ACTA BIOCHIM POL, V43, P241; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Cazenave Jean-Pierre, 2004, Methods Mol Biol, V272, P13; Chen X, 2013, BLOOD, V121, P3718, DOI 10.1182/blood-2012-10-461897; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Dardare N, 2002, PHOTOCHEM PHOTOBIOL, V75, P561, DOI 10.1562/0031-8655(2002)075<0561:BAOCES>2.0.CO;2; Darwich Z, 2012, BBA-BIOMEMBRANES, V1818, P3048, DOI 10.1016/j.bbamem.2012.07.017; Del Fante C, 2016, BONE MARROW TRANSPL, V51, P728, DOI 10.1038/bmt.2015.324; dos Santos DJVA, 2011, PHYS CHEM CHEM PHYS, V13, P10174, DOI 10.1039/c0cp02245d; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Flesch FM, 2005, BIOCHEM J, V389, P435, DOI 10.1042/BJ20041721; Frank S, 1998, J PHOTOCH PHOTOBIO B, V44, P39, DOI 10.1016/S1011-1344(98)00103-1; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Goodall Alison H, 2004, Methods Mol Biol, V272, P225; Greinix HT, 2012, EXTRACORPOREAL PHOTOPHERESIS: CELLULAR PHOTOIMMUNOTHERAPY, P1, DOI 10.1515/9783110276138; Hardwick J, 2008, ISBT SCI SER, V3, P148, DOI 10.1111/j.1751-2824.2008.00195.x; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Knutson F, 2000, VOX SANG, V78, P209, DOI 10.1159/000031183; Lai CF, 2008, ANAL CHEM, V80, P8790, DOI 10.1021/ac801520m; LASKIN JD, 1985, P NATL ACAD SCI USA, V82, P6158, DOI 10.1073/pnas.82.18.6158; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li XY, 2005, PHOTOCHEM PHOTOBIOL, V81, P1153, DOI 10.1562/2005-03-21-RA-467; Lin L, 1997, TRANSFUSION, V37, P423, DOI 10.1046/j.1537-2995.1997.37497265344.x; Ling TC, 2016, BRIT J DERMATOL, V174, P24, DOI 10.1111/bjd.14317; Locke D, 2002, J BIOL CHEM, V277, P18801, DOI 10.1074/jbc.M111520200; Lumb CN, 2011, STRUCTURE, V19, P1338, DOI 10.1016/j.str.2011.04.010; Mischnik M, 2013, MOL BIOSYST, V9, P1326, DOI 10.1039/c3mb25597b; Pathak MA, 1992, AD J PHOTOCHEM PHO B, V14, P3, DOI DOI 10.1016/1011-1344(92)85080-E; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Riehle RD, 2013, ADV EXP MED BIOL, V991, P105, DOI 10.1007/978-94-007-6331-9_7; Sandra K, 2010, J CHROMATOGR A, V1217, P4087, DOI 10.1016/j.chroma.2010.02.039; Sanford KW, 2012, J CLIN APHERESIS, V27, P126, DOI 10.1002/jca.21217; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; t'kindt R, 2015, ANAL CHEM, V87, P4957, DOI 10.1021/acs.analchem.5b00732; Van Aelst B, 2015, VOX SANG, V108, P328, DOI 10.1111/vox.12231; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANHENEGOUWEN GMJB, 1989, J PHOTOCH PHOTOBIO B, V3, P631, DOI 10.1016/1011-1344(89)80086-7; vanIperen HP, 1996, PHOTOCHEM PHOTOBIOL, V63, P577, DOI 10.1111/j.1751-1097.1996.tb05659.x; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; WAKSVIK H, 1977, HUM GENET, V38, P195, DOI 10.1007/BF00527403; Wolf P, 2016, BRIT J DERMATOL, V174, P11, DOI 10.1111/bjd.14341; Wolf P, 2006, AM J PATHOL, V169, P795, DOI 10.2353/ajpath.2006.060079; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; ZAREBSKA Z, 1994, J PHOTOCH PHOTOBIO B, V23, P101, DOI 10.1016/1011-1344(94)06944-1	57	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24364	24376		10.1074/jbc.M116.735126	http://dx.doi.org/10.1074/jbc.M116.735126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27687726	Green Published, hybrid			2022-12-28	WOS:000388875500004
J	Yu, RR; Liu, WM; Li, DQ; Zhao, XM; Ding, GW; Zhang, M; Ma, E; Zhu, K; Li, S; Moussian, B; Zhang, JZ				Yu, Rongrong; Liu, Weimin; Li, Daqi; Zhao, Xiaoming; Ding, Guowei; Zhang, Min; Ma, Enbo; Zhu, KunYan; Li, Sheng; Moussian, Bernard; Zhang, Jianzhen			Helicoidal Organization of Chitin in the Cuticle of the Migratory Locust Requires the Function of the Chitin Deacetylase2 Enzyme (LmCDA2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERITROPHIC MATRIX; DROSOPHILA-MELANOGASTER; PROTEINS; EXPRESSION; BINDING	In the three-dimensional extracellular matrix of the insect cuticle, horizontally aligned microfibrils composed of the polysaccharide chitin and associated proteins are stacked either parallel to each other or helicoidally. The underlying molecular mechanisms that implement differential chitin organization are largely unknown. To learn more about cuticle organization, we sought to study the role of chitin deacetylases (CDA) in this process. In the body cuticle of nymphs of the migratory locust Locusta migratoria, helicoidal chitin organization is changed to an organization with unidirectional microfibril orientation when LmCDA2 expression is knocked down by RNA interference. In addition, the buCDA2-deficient cuticle is less compact suggesting that LmCDA2 is needed for chitin packaging. Animals with reduced LmCDA2 activity die at molting, underlining that correct chitin organization is essential for survival. Interestingly, we find that LmCDA2 localizes only to the initially produced chitin microfibrils that constitute the apical site of the chitin stack. Based on our data, we hypothesize that LmCDA2-mediated chitin deacetylation at the beginning of chitin production is a decisive reaction that triggers helicoidal arrangement of subsequently assembled chitin-protein microfibrils.	[Yu, Rongrong; Liu, Weimin; Li, Daqi; Zhao, Xiaoming; Ding, Guowei; Zhang, Min; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China; [Yu, Rongrong; Liu, Weimin; Li, Daqi; Zhao, Xiaoming; Ding, Guowei; Zhang, Min; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China; [Zhu, KunYan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, ThelKey Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Moussian, Bernard] Tech Univ Dresden, Chair Appl Zool, Inst Zool, D-01217 Dresden, Germany	Shanxi University; Shanxi University; Kansas State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Technische Universitat Dresden	Zhang, JZ (corresponding author), Shanxi Univ, Res Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China.; Zhang, JZ (corresponding author), Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China.; Moussian, B (corresponding author), Univ Nice, Inst Biol Valrose, Nice, France.	bernard.moussian@tu-dresden.de; zjz@sxu.edu.cn	zhao, xiaoming/GNM-5551-2022	Zhao, Xiaoming/0000-0003-2237-3417; Zhu, Kun Yan/0000-0001-9372-8030	National Natural Science Foundation of China [31272380, 31672364]; National Basic Research Program of China [2012CB114102]; Natural Science Foundation of Shanxi Province, China [2015011070]; Shanxi Scholarship Council of China [2015-007]; German Science Foundation (DFG) [MO1714/7-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Shanxi Province, China(Natural Science Foundation of Shanxi Province); Shanxi Scholarship Council of China; German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by National Natural Science Foundation of China Grants 31272380 and 31672364, National Basic Research Program of China Grant 2012CB114102, Natural Science Foundation of Shanxi Province, China, Grant 2015011070, and Shanxi Scholarship Council of China Grant 2015-007. The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by German Science Foundation (DFG) Grant MO1714/7-1. To whom correspondence may be addressed: Institute of Biology Valrose, University of Nice, Nice, France. E-mail: bernard.moussian@tu-dresden.de.	Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; BOULIGAND Y, 1965, CR HEBD ACAD SCI, V261, P4864; Campbell PM, 2008, INSECT BIOCHEM MOLEC, V38, P950, DOI 10.1016/j.ibmb.2008.07.009; Chen Yong-Lin, 2000, Entomological Knowledge, V37, P50; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Gangishetti U, 2012, INSECT MOL BIOL, V21, P283, DOI 10.1111/j.1365-2583.2012.01134.x; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; Guo YQ, 2012, INSECT SCI, V19, P75, DOI 10.1111/j.1744-7917.2011.01450.x; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Liu WM, 2009, J INVERTEBR PATHOL, V101, P96, DOI 10.1016/j.jip.2009.03.002; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; NEVILLE A C, 1969, Tissue and Cell, V1, P183, DOI 10.1016/S0040-8166(69)80011-X; NEVILLE A C, 1969, Tissue and Cell, V1, P689, DOI 10.1016/S0040-8166(69)80041-8; Neville A. C., 1975, BIOL ARTHROPOD CUTIC, P71; NEVILLE AC, 1965, Q J MICROSC SCI, V106, P315; NEVILLE AC, 1965, Q J MICROSC SCI, V106, P269; Noh MY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004963; Noh MY, 2014, INSECT BIOCHEM MOLEC, V53, P22, DOI 10.1016/j.ibmb.2014.07.005; Quan GX, 2013, INSECT BIOCHEM MOLEC, V43, P683, DOI 10.1016/j.ibmb.2013.04.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toprak U, 2008, INSECT MOL BIOL, V17, P573, DOI 10.1111/j.1365-2583.2008.00829.x; Toprak U, 2010, INSECT MOL BIOL, V19, P163, DOI 10.1111/j.1365-2583.2009.00966.x; Toprak U, 2014, INSECT BIOCHEM MOLEC, V54, P89, DOI 10.1016/j.ibmb.2014.09.002; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wang YW, 2014, APIDOLOGIE, V45, P733, DOI 10.1007/s13592-014-0292-3; Yang M.L., 2009, Archives of Insect Biochemistry and Physiology, V71, P3, DOI 10.1002/arch.20254; Zhang JZ, 2006, INSECT BIOCHEM MOLEC, V36, P712, DOI 10.1016/j.ibmb.2006.06.002; Zhang JZ, 2010, INSECT BIOCHEM MOLEC, V40, P824, DOI 10.1016/j.ibmb.2010.08.001; Zhong XW, 2014, INT J MOL SCI, V15, P1946, DOI 10.3390/ijms15021946; Zhu Q, 2008, INSECT BIOCHEM MOLEC, V38, P467, DOI 10.1016/j.ibmb.2007.06.011	36	51	63	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24352	24363		10.1074/jbc.M116.720581	http://dx.doi.org/10.1074/jbc.M116.720581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27637332	Green Published, hybrid			2022-12-28	WOS:000388875500003
J	Ackermann, KL; Florke, RR; Reyes, SS; Tader, BR; Hamann, MJ				Ackermann, Karly L.; Florke, Rebecca R.; Reyes, Shannon S.; Tader, Brooke R.; Hamann, Michael J.			TCL/RhoJ Plasma Membrane Localization and Nucleotide Exchange Is Coordinately Regulated by Amino Acids within the N Terminus and a Distal Loop Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; CDC42; cell biology; GTPase; membrane trafficking; Rho (Rho GTPase); small GTPase; vesicles; RhoJ; TCL	RHO-FAMILY GTPASES; MULTIPLE SEQUENCE ALIGNMENT; CELL-MIGRATION; RAS ISOFORMS; H-RAS; CDC42; PROTEINS; PALMITOYLATION; ACTIVATION; ANGIOGENESIS	TCL/RhoJ is a Cdc42-related Rho GTPase with reported activities in endothelial cell biology and angiogenesis, metastatic melanoma, and corneal epithelial cells; however, less is known about how it is inherently regulated in comparison to its closest homologues TC10 and Cdc42. TCL has an N-terminal extension of 18 amino acids in comparison to Cdc42, but the function of this amino acid sequence has not been elucidated. A truncation mutant lacking the N terminus (N) was found to alter TCL plasma membrane localization and nucleotide binding, and additional truncation and point mutants mapped the alterations of TCL biochemistry to amino acids 17-20. Interestingly, whereas the TCL N mutant clearly influenced nucleotide exchange, deletion of the N terminus from its closest homologue, TC10, did not have a similar effect. Chimeras of TCL and TC10 revealed amino acids 121-129 of TCL contributed to the differences in nucleotide loading. Together, these results identify amino acids within the N terminus and a loop region distal to the nucleotide binding pocket of TCL capable of allosterically regulating nucleotide exchange and thus influence membrane association of the protein.	[Ackermann, Karly L.; Florke, Rebecca R.; Reyes, Shannon S.; Tader, Brooke R.; Hamann, Michael J.] Bemidji State Univ, Dept Biol, Bemidji, MN 56601 USA	Minnesota State Colleges & Universities; Bemidji State University	Hamann, MJ (corresponding author), Bemidji State Univ, 1500 Birchmont Dr NE 27, Bemidji, MN 56601 USA.	mhamann@bemidjistate.edu		Gee, Rebecca/0000-0002-4736-3154	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences, National Institutes of Health [1P30GM103329]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Dan Billadeau (Mayo Clinic, Rochester, MN) for providing the pCI2.F.YFP and pGEX constructs, as well as constitutively active and dominant-negative TCL mutants, Dr. Bryon Grove and Sarah Abrahamson (UND, Grand Forks, ND) for their assistance with the confocal microscopy, and Dr. Holly LaFerriere for editorial comments. We also acknowledge use of the Edward C. Carlson Imaging and Image Analysis Core Facility, which is supported in part by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences, National Institutes of Health Grant 1P30GM103329.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Anderson EL, 2012, BIOCHEM J, V441, P869, DOI 10.1042/BJ20111111; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Benard V, 2002, METHOD ENZYMOL, V345, P349; Braun AC, 2015, CELL SIGNAL, V27, P1643, DOI 10.1016/j.cellsig.2015.04.003; Bridges D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042451; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Ho H, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12058; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; Hou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077107; Hou JCQ, 2003, MOL BIOL CELL, V14, P3578, DOI 10.1091/mbc.E03-02-0012; Jack ER, 2008, MOL MEMBR BIOL, V25, P14, DOI 10.1080/09687680701494007; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kim C, 2014, CANCER CELL, V25, P102, DOI 10.1016/j.ccr.2013.12.010; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kusuhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045858; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Leszczynska K, 2011, BIOCHEM SOC T, V39, P1606, DOI 10.1042/BST20110702; Lin WC, 2014, P NATL ACAD SCI USA, V111, P2996, DOI 10.1073/pnas.1321155111; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Marcus K, 2015, CLIN CANCER RES, V21, P1810, DOI 10.1158/1078-0432.CCR-14-2148; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Shutes A, 2006, METHOD ENZYMOL, V406, P11, DOI 10.1016/S0076-6879(06)06002-2; Shutes A, 2004, CURR BIOL, V14, P2052, DOI 10.1016/j.cub.2004.11.011; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; Vignal E, 2000, J BIOL CHEM, V275, P36457, DOI 10.1074/jbc.M003487200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wilson E, 2014, J CELL SCI, V127, P3039, DOI 10.1242/jcs.140434; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zhang JS, 2011, MOL BIOL CELL, V22, P2119, DOI 10.1091/mbc.E10-12-0969	47	4	4	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23604	23617		10.1074/jbc.M116.750026	http://dx.doi.org/10.1074/jbc.M116.750026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27660391	Green Published, hybrid			2022-12-28	WOS:000387884400021
J	Sehanobish, E; Williamson, HR; Davidson, VL				Sehanobish, Esha; Williamson, Heather R.; Davidson, Victor L.			Roles of Conserved Residues of the Glycine Oxidase GoxA in Controlling Activity, Cooperativity, Subunit Composition, and Cysteine Tryptophylquinone Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-EPSILON-OXIDASE; MARINOMONAS-MEDITERRANEA; METHYLAMINE DEHYDROGENASE; AMINE DEHYDROGENASE; STEADY-STATE; LODA; QUINOPROTEINS; COFACTORS; GENES	GoxA is a glycine oxidase that possesses a cysteine tryptophylquinone (CTQ) cofactor that is formed by posttranslational modifications that are catalyzed by a modifying enzyme GoxB. It is the second known tryptophylquinone enzyme to function as an oxidase, the other being the lysine epsilon-oxidase, LodA. All other enzymes containing CTQ or tryptophan tryptophylquinone (TTQ) cofactors are dehydrogenases. Kinetic analysis of GoxA revealed allosteric cooperativity for its glycine substrate, but not O-2. This is the first CTQ-or TTQ-dependent enzyme to exhibit cooperativity. Here, we show that cooperativity and homodimer stabilization are strongly dependent on the presence of Phe-237. Conversion of this residue, which is a Tyr in LodA, to Tyr or Ala eliminates the cooperativity and destabilizes the dimer. These mutations also significantly affect the k(cat) and K-m values for the substrates. On the basis of structural and modeling studies, a mechanism by which Phe-237 exerts this influence is presented. Two active site residues, Asp-547 and His-466, were also examined and shown by site-directed mutagenesis to be critical for CTQbiogenesis. This result is compared with the results of similar studies of mutagenesis of structurally conserved residues of other tryptophylquinone enzymes. These results provide insight into the roles of specific active-site residues in catalysis and CTQ biogenesis, as well as describing an interesting mechanism by which a single residue can dictate whether or not an enzyme exhibits cooperative allosteric behavior toward a substrate.	[Sehanobish, Esha; Williamson, Heather R.; Davidson, Victor L.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Davidson, VL (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	victor.davidson@ucf.edu		Williamson, Heather/0000-0002-2413-659X	Burnett School of Biomedical Sciences; NIGMS, National Institutes of Health [R37GM41574]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041574] Funding Source: NIH RePORTER	Burnett School of Biomedical Sciences; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by internal funds from the Burnett School of Biomedical Sciences and in part by the NIGMS, National Institutes of Health Grant R37GM41574 (to V. L. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Campillo-Brocal JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1455-y; Chen LY, 1998, J MOL BIOL, V276, P131, DOI 10.1006/jmbi.1997.1511; Campillo-Brocal JC, 2013, MICROBIOLOGYOPEN, V2, P684, DOI 10.1002/mbo3.107; Datta S, 2001, P NATL ACAD SCI USA, V98, P14268, DOI 10.1073/pnas.241429098; Davidson VL, 2007, BIOCHEMISTRY-US, V46, P5283, DOI 10.1021/bi700468t; Davidson VL, 2011, MOL BIOSYST, V7, P29, DOI 10.1039/c005311b; Chacon-Verdu MD, 2015, BBA-PROTEINS PROTEOM, V1854, P1123, DOI 10.1016/j.bbapap.2014.12.018; Chacon-Verdu MD, 2014, APPL MICROBIOL BIOT, V98, P2981, DOI 10.1007/s00253-013-5168-3; Gomez D, 2006, BBA-PROTEINS PROTEOM, V1764, P1577, DOI 10.1016/j.bbapap.2006.08.014; Gomez D, 2010, MOL MICROBIOL, V75, P462, DOI 10.1111/j.1365-2958.2009.07000.x; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Hossain GS, 2014, APPL MICROBIOL BIOT, V98, P1507, DOI 10.1007/s00253-013-5444-2; Jones LH, 2005, J BIOL CHEM, V280, P17392, DOI 10.1074/jbc.M500943200; Klinman JP, 2014, CHEM REV, V114, P4343, DOI 10.1021/cr400475g; Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08; Okazaki S, 2013, J BIOCHEM, V154, P233, DOI 10.1093/jb/mvt070; PAZ MA, 1991, J BIOL CHEM, V266, P689; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Roujeinikova A, 2006, J BIOL CHEM, V281, P40264, DOI 10.1074/jbc.M605559200; Sehanobish E, 2016, BIOCHEMISTRY-US, V55, P2305, DOI 10.1021/acs.biochem.6b00274; Sehanobish E, 2015, ARCH BIOCHEM BIOPHYS, V579, P26, DOI 10.1016/j.abb.2015.05.013; Sehanobish E, 2014, FEBS LETT, V588, P752, DOI 10.1016/j.febslet.2014.01.021; WALSH K, 1984, J BIOL CHEM, V259, P9646	24	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23199	23207		10.1074/jbc.M116.741835	http://dx.doi.org/10.1074/jbc.M116.741835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27637328	Green Published, hybrid			2022-12-28	WOS:000387224800029
J	Raval, MH; Quintero, OA; Weck, ML; Unrath, WC; Gallagher, JW; Cui, RJ; Kachar, B; Tyska, MJ; Yengo, CM				Raval, Manmeet H.; Quintero, Omar A.; Weck, Meredith L.; Unrath, William C.; Gallagher, James W.; Cui, Runjia; Kachar, Bechara; Tyska, Matthew J.; Yengo, Christopher M.			Impact of the Motor and Tail Domains of Class III Myosins on Regulating the Formation and Elongation of Actin Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cytoskeleton; hair cell; molecular motor; myosin	DROSOPHILA-NINAC KINASE; HAIR-CELL STEREOCILIA; MOLECULAR TREADMILL; FILOPODIA FORMATION; DENDRITIC NETWORK; HEARING-LOSS; BUNDLES; LOCALIZATION; PROTEINS; BINDING	Class III myosins (MYO3A and MYO3B) are proposed to function as transporters as well as length and ultrastructure regulators within stable actin-based protrusions such as stereocilia and calycal processes. MYO3A differs from MYO3B in that it contains an extended tail domain with an additional actin-binding motif. We examined how the properties of the motor and tail domains of human class III myosins impact their ability to enhance the formation and elongation of actin protrusions. Direct examination of the motor and enzymatic properties of human MYO3A and MYO3B revealed that MYO3A is a 2-fold faster motor with enhanced ATPase activity and actin affinity. A chimera in which the MYO3A tail was fused to the MYO3B motor demonstrated that motor activity correlates with formation and elongation of actin protrusions. We demonstrate that removal of individual exons (30-34) in the MYO3A tail does not prevent filopodia tip localization but abolishes the ability to enhance actin protrusion formation and elongation in COS7 cells. Interestingly, our results demonstrate that MYO3A slows filopodia dynamics and enhances filopodia lifetime in COS7 cells. We also demonstrate that MYO3A is more efficient than MYO3B at increasing formation and elongation of stable microvilli on the surface of cultured epithelial cells. We propose that the unique features of MYO3A, enhanced motor activity, and an extended tail with tail actin-binding motif, allow it to play an important role in stable actin protrusion length and ultrastructure maintenance.	[Raval, Manmeet H.; Unrath, William C.; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Quintero, Omar A.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA; [Weck, Meredith L.; Tyska, Matthew J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Gallagher, James W.] Lincoln Univ, Dept Biol, Philadelphia, PA 19104 USA; [Cui, Runjia; Kachar, Bechara] NIDCD, Lab Cell Struct & Dynam, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Richmond; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Lincoln University - Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Yengo, CM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cmy11@psu.edu	Raval, Manmeet H./J-5093-2019	Quintero-Carmona, Omar/0000-0002-9314-1704; Raval, Manmeet/0000-0002-7792-2375	National Institutes of Health [EYE018141, DK075555, R01-DK095811, CA160667, DK095811]; Pennsylvania Lions Hearing Research Foundation; National Institutes of Health Vanderbilt University Medical Center Developmental Biology Training Grant [T32-HD007502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK108528, R01DK095811, P30DK058404, R01DK075555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000002] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Lions Hearing Research Foundation; National Institutes of Health Vanderbilt University Medical Center Developmental Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grant EYE018141, Pennsylvania Lions Hearing Research Foundation (to C. M. Y.), and National Institutes of Health Grants DK075555 and R01-DK095811 (to M. J. T.). This work was authored, in whole or in part, by National Institutes of Health staff. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant CA160667.r Supported by National Institutes of Health Vanderbilt University Medical Center Developmental Biology Training Grant T32-HD007502.r Supported by National Institutes of Health Grants DK075555 and DK095811.r Supported by National Institutes of Health Grant EYE018141 and the Pennsylvania Lions Hearing Research Foundation.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; Courson DS, 2015, EXP CELL RES, V334, P10, DOI 10.1016/j.yexcr.2015.03.014; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Ebrahim S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10833; Erickson FL, 2003, MOL BIOL CELL, V14, P4173, DOI 10.1091/mbc.e02-10-0656; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Grati M, 2016, HUM MUTAT, V37, P481, DOI 10.1002/humu.22961; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grega-Larson NE, 2015, MOL BIOL CELL, V26, P3803, DOI 10.1091/mbc.E15-06-0443; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lelli A, 2016, J CELL BIOL, V212, P231, DOI 10.1083/jcb.201509017; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Lin-Jones J, 2004, J CELL SCI, V117, P5825, DOI 10.1242/jcs.01512; Liu HY, 2016, ELIFE, V5, DOI 10.7554/eLife.12856; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Manor Uri, 2012, Bioarchitecture, V2, P171, DOI 10.4161/bioa.21733; Mecklenburg KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122502; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Merritt RC, 2012, CURR BIOL, V22, P320, DOI 10.1016/j.cub.2011.12.053; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Nal N, 2007, HUM MUTAT, V28, P1014, DOI 10.1002/humu.20556; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Quintero OA, 2013, J BIOL CHEM, V288, P37126, DOI 10.1074/jbc.M113.511014; Quintero OA, 2010, J BIOL CHEM, V285, P35770, DOI 10.1074/jbc.M110.144360; Revenu C, 2012, MOL BIOL CELL, V23, P324, DOI 10.1091/mbc.E11-09-0765; ROSE GG, 1958, J BIOPHYS BIOCHEM CY, V4, P761, DOI 10.1083/jcb.4.6.761; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Sekerkova G, 2006, CELL MOL LIFE SCI, V63, P2329, DOI 10.1007/s00018-006-6148-x; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Shifrin DA, 2014, GUT MICROBES, V5, P504, DOI 10.4161/gmic.32084; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tilney LG, 2004, J CELL SCI, V117, P3531, DOI 10.1242/jcs.01215; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Trivedi DV, 2013, BIOCHEMISTRY-US, V52, P4710, DOI 10.1021/bi4004364; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Walsh VL, 2011, MAMM GENOME, V22, P170, DOI 10.1007/s00335-010-9310-6; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Yengo CM, 2012, J MUSCLE RES CELL M, V33, P385, DOI 10.1007/s10974-012-9316-7; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	66	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22781	22792		10.1074/jbc.M116.733741	http://dx.doi.org/10.1074/jbc.M116.733741			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27582493	Green Published, hybrid			2022-12-28	WOS:000386760600035
J	Labourel, A; Crouch, LI; Bras, JLA; Jackson, A; Rogowski, A; Gray, J; Yadav, MP; Henrissat, B; Fontes, CMGA; Gilbert, HJ; Najmudin, S; Basle, A; Cuskin, F				Labourel, Aurore; Crouch, Lucy I.; Bras, Joana L. A.; Jackson, Adam; Rogowski, Artur; Gray, Joseph; Yadav, Madhav P.; Henrissat, Bernard; Fontes, Carlos M. G. A.; Gilbert, Harry J.; Najmudin, Shabir; Basle, Arnaud; Cuskin, Fiona			The Mechanism by Which Arabinoxylanases Can Recognize Highly Decorated Xylans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulosome; crystallography; enzyme kinetics; enzyme mechanism; glycoside hydrolase	CARBOHYDRATE-BINDING MODULES; CLOSTRIDIUM-THERMOCELLUM; POLYSACCHARIDE RECOGNITION; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURES; DEGRADATION; DECONSTRUCTION; CELLULOSOMES; BIOCHEMISTRY; REFINEMENT	The enzymatic degradation of plant cell walls is an important biological process of increasing environmental and industrial significance. Xylan, a major component of the plant cell wall, consists of a backbone of -1,4-xylose (Xylp) units that are often decorated with arabinofuranose (Araf) side chains. A large penta-modular enzyme, CtXyl5A, was shown previously to specifically target arabinoxylans. The mechanism of substrate recognition displayed by the enzyme, however, remains unclear. Here we report the crystal structure of the arabinoxylanase and the enzyme in complex with ligands. The data showed that four of the protein modules adopt a rigid structure, which stabilizes the catalytic domain. The C-terminal non-catalytic carbohydrate binding module could not be observed in the crystal structure, suggesting positional flexibility. The structure of the enzyme in complex with Xylp--1,4-Xylp--1,4-Xylp-[-1,3-Araf]--1,4-Xylp showed that the Araf decoration linked O-3 to the xylose in the active site is located in the pocket (-2* subsite) that abuts onto the catalytic center. The -2* subsite can also bind to Xylp and Arap, explaining why the enzyme can utilize xylose and arabinose as specificity determinants. Alanine substitution of Glu(68), Tyr(92), or Asn(139), which interact with arabinose and xylose side chains at the -2* subsite, abrogates catalytic activity. Distal to the active site, the xylan backbone makes limited apolar contacts with the enzyme, and the hydroxyls are solvent-exposed. This explains why CtXyl5A is capable of hydrolyzing xylans that are extensively decorated and that are recalcitrant to classic endo-xylanase attack.	[Labourel, Aurore; Crouch, Lucy I.; Jackson, Adam; Rogowski, Artur; Gray, Joseph; Gilbert, Harry J.; Basle, Arnaud; Cuskin, Fiona] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bras, Joana L. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir] Univ Lisbon, CIISA Fac Med Vet, Polo Univ Alto Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal; [Bras, Joana L. A.; Fontes, Carlos M. G. A.] NZYTech Genes & Enzymes, P-1649038 Lisbon, Portugal; [Yadav, Madhav P.] ARS, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA; [Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR7857, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] INRA, Architecture & Fonct Macromol Biol USC1408, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jedda 21589, Saudi Arabia	Newcastle University - UK; Universidade de Lisboa; United States Department of Agriculture (USDA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; King Abdulaziz University	Basle, A; Cuskin, F (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Najmudin, S (corresponding author), Univ Lisbon, CIISA Fac Med Vet, Polo Univ Alto Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	shabir@fmv.ulosboa.pt; arnaud.basle@ncl.uk; Fiona.cuskin@newcastle.ac.uk	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Bras, Joana/0000-0002-1141-5530; Labourel, Aurore/0000-0002-4762-5804; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454; Basle, Arnaud/0000-0002-4899-3086; Gray, Joseph/0000-0003-2338-0301; Cuskin, Fiona/0000-0003-4287-4921	European Research Council [322820]; Biotechnology and Biological Research Council [BB/K020358/1, BB/K001949/1]; Wellcome Trust [RES/0120/7613]; Agence Nationale de la Recherche [ANR 12-BIME-0006-01]; Fundacao para a Ciencia e Tecnologia [PTDC/BIAPRO/103980/2008, PTDC/BIAMIC/5947/2014]; BBSRC [BB/K001949/1, BB/K020358/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K020358/1, BB/K001949/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by European Research Council Grant 322820 (to H. J. G. and B. H.), Biotechnology and Biological Research Council Grants BB/K020358/1 and BB/K001949/1 (to H. J. G.), Wellcome Trust Grant RES/0120/7613 (to H. J. G.), Agence Nationale de la Recherche Grant ANR 12-BIME-0006-01 (to B. H.), and Fundacao para a Ciencia e Tecnologia Grants PTDC/BIAPRO/103980/2008 and PTDC/BIAMIC/5947/2014 (to C. M. G. A. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Agger J, 2010, J AGR FOOD CHEM, V58, P6141, DOI 10.1021/jf100633f; Alahuhta M, 2010, ACTA CRYSTALLOGR F, V66, P878, DOI 10.1107/S1744309110022529; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bras JLA, 2011, ACTA CRYSTALLOGR F, V67, P833, DOI 10.1107/S1744309111020823; Brett CT, 1996, PHYSL BIOCH PLANT CE; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Cartmell A, 2011, J BIOL CHEM, V286, P15483, DOI 10.1074/jbc.M110.215962; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2011, J BIOL CHEM, V286, P22510, DOI 10.1074/jbc.M110.217315; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Fujimoto Z, 2000, J MOL BIOL, V300, P575, DOI 10.1006/jmbi.2000.3877; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; Jiang DH, 2012, J STRUCT BIOL, V180, P447, DOI 10.1016/j.jsb.2012.08.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leslie A. G. W., 2007, EVOLVING METHODS MAC; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montanier CY, 2011, J BIOL CHEM, V286, P22499, DOI 10.1074/jbc.M110.217372; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notenboom V, 2002, BIOCHEMISTRY-US, V41, P4246, DOI 10.1021/bi015865j; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Poon DKY, 2007, J BIOL CHEM, V282, P2091, DOI 10.1074/jbc.M609670200; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vardakou M, 2008, J MOL BIOL, V375, P1293, DOI 10.1016/j.jmb.2007.11.007; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x	49	21	21	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22149	22159		10.1074/jbc.M116.743948	http://dx.doi.org/10.1074/jbc.M116.743948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27531750	Green Published, hybrid			2022-12-28	WOS:000386332600028
J	Paschkowsky, S; Hamze, M; Oestereich, F; Munter, LM				Paschkowsky, Sandra; Hamze, Mehdi; Oestereich, Felix; Munter, Lisa Marie			Alternative Processing of the Amyloid Precursor Protein Family by Rhomboid Protease RHBDL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein (APP); amyloid (A); endoplasmic reticulum (ER); lysosome; rhomboid protease; APLP1; APLP2; APP fragments	INTRAMEMBRANE PROTEASE; ALZHEIMERS-DISEASE; TERMINAL FRAGMENTS; NEURONAL-ACTIVITY; EGF RECEPTOR; ALPHA; APP; TRAFFICKING; SECRETION; CLEAVAGE	The amyloid precursor protein (APP) is an ubiquitously expressed cell surface protein and a key molecule in the etiology of Alzheimer disease. Amyloidogenic processing of APP through secretases leads to the generation of toxic amyloid (A) peptides, which are regarded as the molecular cause of the disease. We report here an alternative processing pathway of APP through the mammalian intramembrane rhomboid protease RHBDL4. RHBDL4 efficiently cleaves APP inside the cell, thus bypassing APP from amyloidogenic processing, leading to reduced A levels. RHBDL4 cleaves APP multiple times in the ectodomain, resulting in several N- and C-terminal fragments that are not further degraded by classical APP secretases. Knockdown of endogenous RHBDL4 results in decreased levels of C-terminal fragments derived from endogenous APP. Similarly, we found the APP family members APLP1 and APLP2 to be substrates of RHBDL4. We conclude that RHBDL4-mediated APP processing provides insight into APP and rhomboid physiology and qualifies for further investigations to elaborate its impact on Alzheimer disease pathology.	[Paschkowsky, Sandra; Hamze, Mehdi; Oestereich, Felix; Munter, Lisa Marie] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 0B1, Canada; [Oestereich, Felix] McGill Univ, Integrated Program Neurosci, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Munter, LM (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 0B1, Canada.	lisa.munter@mcgill.ca		Munter, Lisa/0000-0001-5736-1462	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-04645]; Canada Foundation of Innovation Leaders Opportunity Fund Grant [32565]; Alzheimer Society of Canada Young Investigator Award [PT-58872]; Fonds d'innovation Pfizer-Fonds de recherche Sante Quebec (FRQS) sur la maladie d'Alzheimer et les maladies apparentees [31288]; McGill University; McGill Faculty of Medicine	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation of Innovation Leaders Opportunity Fund Grant(Canada Foundation for Innovation); Alzheimer Society of Canada Young Investigator Award; Fonds d'innovation Pfizer-Fonds de recherche Sante Quebec (FRQS) sur la maladie d'Alzheimer et les maladies apparentees; McGill University; McGill Faculty of Medicine	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2015-04645, the Canada Foundation of Innovation Leaders Opportunity Fund Grant 32565, Alzheimer Society of Canada Young Investigator Award PT-58872, Fonds d'innovation Pfizer-Fonds de recherche Sante Quebec (FRQS) sur la maladie d'Alzheimer et les maladies apparentees 31288, McGill University Startup funding, and McGill Faculty of Medicine Incentive funding. The authors declare that they have no conflicts of interest with the contents of this article.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Bergbold N, 2013, BBA-BIOMEMBRANES, V1828, P2840, DOI 10.1016/j.bbamem.2013.03.025; Blaydon DC, 2012, AM J HUM GENET, V90, P340, DOI 10.1016/j.ajhg.2011.12.008; Christova Y, 2013, EMBO REP, V14, P884, DOI 10.1038/embor.2013.128; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Fleck D, 2016, J BIOL CHEM, V291, P318, DOI 10.1074/jbc.M115.697995; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Heber S, 2000, J NEUROSCI, V20, P7951; Hosur V, 2014, P NATL ACAD SCI USA, V111, pE2200, DOI 10.1073/pnas.1323908111; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kinch LN, 2013, BBA-BIOMEMBRANES, V1828, P2937, DOI 10.1016/j.bbamem.2013.06.031; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lazareno-Saez C, 2013, J MOL BIOL, V425, P1127, DOI 10.1016/j.jmb.2013.01.019; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Liao HJ, 2012, TRAFFIC, V13, P1106, DOI 10.1111/j.1600-0854.2012.01371.x; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Placido AI, 2014, BBA-MOL BASIS DIS, V1842, P1444, DOI 10.1016/j.bbadis.2014.05.003; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Puig KL, 2013, EXP GERONTOL, V48, P608, DOI 10.1016/j.exger.2012.07.009; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Song W, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/213534; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Vella LJ, 2012, FASEB J, V26, P2930, DOI 10.1096/fj.11-200295; Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3; Wang HZ, 2015, BIOCHEMISTRY-US, V54, P2806, DOI 10.1021/acs.biochem.5b00329; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	46	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21903	21912		10.1074/jbc.M116.753582	http://dx.doi.org/10.1074/jbc.M116.753582			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27563067	Green Published, hybrid			2022-12-28	WOS:000386332600007
J	Yao, WL; Oh, YT; Deng, JS; Yue, P; Deng, L; Huang, H; Zhou, W; Sun, SY				Yao, Weilong; Oh, You-Take; Deng, Jiusheng; Yue, Ping; Deng, Liang; Huang, Henry; Zhou, Wei; Sun, Shi-Yong			Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); apoptosis; cancer biology; gene expression; Trail; DR4; MEK	TRAIL-INDUCED APOPTOSIS; LUNG-CANCER CELLS; NF-KAPPA-B; C-JUN; DR4; ACTIVATION; INDUCTION; JNK; ERK; DIFFERENTIATION	Death receptor 4 (DR4) is a cell surface receptor for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and triggers apoptosis upon ligation with TRAIL or aggregation. MEK/ERK signaling is a well known and the best-studied effector pathway downstream of Ras and Raf. This study focuses on determining the impact of pharmacological MEK inhibition on DR4 expression and elucidating the underlying mechanism. We found that several MEK inhibitors including MEK162, AZD6244, and PD0325901 effectively decreased DR4 protein levels including cell surface DR4 in different cancer cell lines. Accordingly, pre-treatment of TRAIL-sensitive cancer cell lines with a MEK inhibitor desensitized them to TRAIL-induced apoptosis. These results indicate that MEK inhibition negatively regulates DR4 expression and cell response to TRAIL-induced apoptosis. MEK inhibitors did not alter DR4 protein stability, rather decreased its mRNA levels, suggesting a transcriptional regulation. In contrast, enforced activation of MEK/ERK signaling by expressing ectopic B-Raf (V600E) or constitutively activated MEK1 (MEK1-CA) or MEK2 (MEK2-CA) activated ERK and increased DR4 expression; these effects were inhibited when a MEK inhibitor was present. Promoter analysis through deletion and mutation identified the AP-1 binding site as an essential response element for enhancing DR4 transactivation by MEK1-CA. Furthermore, inhibition of AP-1 by c-Jun knockdown abrogated the ability of MEK1-CA to increase DR4 promoter activity and DR4 expression. These results suggest an essential role of AP-1 in mediating MEK/ERK activation-induced DR4 expression. Our findings together highlight a previously undiscovered mechanism that positively regulates DR4 expression through activation of the MEK/ERK/AP-1 signaling pathway.	[Yao, Weilong; Deng, Liang] Cent S Univ, Xiangya Sch Med, Changsha 410008, Hunan, Peoples R China; [Yao, Weilong; Oh, You-Take; Deng, Jiusheng; Yue, Ping; Deng, Liang; Huang, Henry; Zhou, Wei; Sun, Shi-Yong] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Central South University; Emory University	Sun, SY (corresponding author), 1365-C Clifton Rd NE,Suite C3088, Atlanta, GA 30322 USA.	ssun@emory.edu			National Institutes of Health NCI [CA140571, CA160522, CA118450]; Emory Winship Cancer Institute Robbins Scholar awards; Halpern Research Scholar award; Anise McDaniel Brock Scholar award; NATIONAL CANCER INSTITUTE [R01CA160522, R01CA140571, R01CA118450] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Emory Winship Cancer Institute Robbins Scholar awards; Halpern Research Scholar award; Anise McDaniel Brock Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI Grants R01s CA140571 (to W. Z.), CA160522 (to S. Y. S.), and CA118450 (to S. Y. S.) and Emory Winship Cancer Institute Robbins Scholar awards (to Y. T. O. and J. D.), Halpern Research Scholar award (to S. Y. S.), and Anise McDaniel Brock Scholar award (to W. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Buchsbaum Donald J, 2007, Future Oncol, V3, P405, DOI 10.2217/14796694.3.4.405; Chen SZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-23; den Hollander MW, 2013, CANCER LETT, V332, P194, DOI 10.1016/j.canlet.2012.04.007; Deng ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036739; Dhandapani L, 2011, CANCER RES, V71, P5245, DOI 10.1158/0008-5472.CAN-10-4180; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Falschlehner C, 2009, ADV EXP MED BIOL, V647, P195, DOI 10.1007/978-0-387-89520-8_14; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fu L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-315; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Guan BX, 2001, J CELL PHYSIOL, V188, P98, DOI 10.1002/jcp.1101; Hersey P, 2009, CANCER IMMUNOL IMMUN, V58, P1751, DOI 10.1007/s00262-009-0732-5; Holland PM, 2014, CYTOKINE GROWTH F R, V25, P185, DOI 10.1016/j.cytogfr.2013.12.009; Huang TG, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-30; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lemke J, 2010, J MOL MED, V88, P729, DOI 10.1007/s00109-010-0619-0; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Martinez-Lostao L, 2015, IMMUNOTHERAPY-UK, V7, P883, DOI 10.2217/imt.15.56; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Oh YT, 2016, ONCOGENE, V35, P459, DOI 10.1038/onc.2015.97; Oh YT, 2015, ONCOTARGET, V6, P41324, DOI 10.18632/oncotarget.5847; Oh YT, 2012, J BIOL CHEM, V287, P257, DOI 10.1074/jbc.M111.304006; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Sun SY, 2005, APOPTOSIS, V10, P1203, DOI 10.1007/s10495-005-2274-4; Sun SY, 1997, CANCER RES, V57, P4931; Sussman RT, 2007, CANCER BIOL THER, V6, P1490, DOI 10.4161/cbt.6.9.4905; van Roosmalen IAM, 2014, BIOCHEM PHARMACOL, V91, P447, DOI 10.1016/j.bcp.2014.08.010; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yao WL, 2015, ONCOTARGET, V6, P34669, DOI 10.18632/oncotarget.5785; Yao WL, 2015, CANCER LETT, V364, P70, DOI 10.1016/j.canlet.2015.04.028; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	40	21	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21694	21702		10.1074/jbc.M116.738302	http://dx.doi.org/10.1074/jbc.M116.738302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27576686	Green Published, hybrid			2022-12-28	WOS:000385999200034
J	Han, YF; Shewan, AM; Thorn, P				Han, Yanfeng; Shewan, Annette M.; Thorn, Peter			HCO(3)(-)Transport through Anoctamin/Transmembrane Protein ANO1/TMEM16A in Pancreatic Acinar Cells Regulates Luminal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bicarbonate; epithelial cell; exocytosis; ion channel; pancreas; secretion; transporter	CYTOSOLIC CA2+; TMEM16A; EXOCYTOSIS; SECRETION; CHANNEL; BICARBONATE; EXPRESSION	The identification of ANO1/TMEM16A as the likely calcium-dependent chloride channel of exocrine glands has led to a more detailed understanding of its biophysical properties. This includes a calcium-dependent change in channel selectivity and evidence that HCO3-permeability can be significant. Here we use freshly isolated pancreatic acini that preserve the luminal structure to measure intraluminal pH and test the idea that ANO1/TMEM16A contributes to luminal pH balance. Our data show that, under physiologically relevant stimulation with 10 pm cholesystokinin, the luminal acid load that results from the exocytic fusion of zymogen granules is significantly blunted by HCO3-buffer in comparison with HEPES, and that this is blocked by the specific TMEM16A inhibitor T16inh-A01. Furthermore, in a model of acute pancreatitis, we observed substantive luminal acidification and provide evidence that ANO1/TMEM16A acts to attenuate this pH shift. We conclude that ANO1/TMEM16A is a significant pathway in pancreatic acinar cells for HCO3-secretion into the lumen.	[Han, Yanfeng; Thorn, Peter] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Shewan, Annette M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Thorn, Peter] Univ Sydney, Charles Perkins Ctr, John Hopkins Dr, Sydney, NSW 2050, Australia	University of Queensland; University of Queensland; University of Sydney	Thorn, P (corresponding author), Univ Sydney, Charles Perkins Ctr, John Hopkins Dr, Sydney, NSW 2050, Australia.	p.thorn@sydney.edu.au	Shewan, Annette/B-3251-2011; Thorn, peter/F-7030-2010	Shewan, Annette/0000-0003-4936-9207; Thorn, peter/0000-0002-3228-770X; Han, Yanfeng/0000-0001-8423-0409	Australian Research Council [DP110100642]; National Health and Medical Research Council [APP1021764, APP1059426]; National Breast Cancer Foundation	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported by Australian Research Council Grant DP110100642 (to P. T.) and National Health and Medical Research Council Grants APP1021764 and APP1059426 (to P. T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a National Breast Cancer Foundation Early Career Researcher fellowship.	Behrendorff N, 2010, GASTROENTEROLOGY, V139, P1711, DOI 10.1053/j.gastro.2010.07.051; Boedtkjer DMB, 2015, BRIT J PHARMACOL, V172, P4158, DOI 10.1111/bph.13201; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; DUTTA SK, 1979, DIGEST DIS SCI, V24, P529, DOI 10.1007/BF01489321; Freedman SD, 2001, GASTROENTEROLOGY, V121, P950, DOI 10.1053/gast.2001.27992; GILLESPIE JI, 1989, Q J EXP PHYSIOL CMS, V74, P883, DOI 10.1113/expphysiol.1989.sp003359; Hegyi P, 2011, GUT, V60, P544, DOI 10.1136/gut.2010.218461; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Ishikawa T, 1996, J MEMBRANE BIOL, V153, P147, DOI 10.1007/s002329900118; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Kidd JF, 2001, PFLUG ARCH EUR J PHY, V441, P489, DOI 10.1007/s004240000451; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Low JT, 2010, J CELL SCI, V123, P3201, DOI 10.1242/jcs.071225; MUALLEM S, 1990, J BIOL CHEM, V265, P12806; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Ni YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086734; Novak I, 2013, FRONT PHYSIOL, V4, P1; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pena-Munzenmayer G, 2015, J BIOL CHEM, V290, P10677, DOI 10.1074/jbc.M114.612895; Peters CJ, 2015, P NATL ACAD SCI USA, V112, P3547, DOI 10.1073/pnas.1502291112; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sohma Y, 2001, JOP, V2, P198; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Thorn P, 2005, J PHYSIOL-LONDON, V563, P433, DOI 10.1113/jphysiol.2004.077230; THORN P, 1992, J GEN PHYSIOL, V100, P11, DOI 10.1085/jgp.100.1.11; Thorn P, 2004, P NATL ACAD SCI USA, V101, P6774, DOI 10.1073/pnas.0400336101; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu YW, 2014, J GEN PHYSIOL, V144, P113, DOI 10.1085/jgp.201411179; ZHANG GH, 1992, J MEMBRANE BIOL, V129, P311	32	17	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20345	20352		10.1074/jbc.M116.750224	http://dx.doi.org/10.1074/jbc.M116.750224			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27510033	hybrid, Green Published			2022-12-28	WOS:000384574800006
J	Cheng, B; Meng, YW; Cui, YB; Li, CF; Tao, F; Yin, HJ; Yang, CY; Xu, P				Cheng, Bin; Meng, Yiwei; Cui, Yanbing; Li, Chunfang; Tao, Fei; Yin, Huijia; Yang, Chunyu; Xu, Ping			Alkaline Response of a Halotolerant Alkaliphilic Halomonas Strain and Functional Diversity of Its Na+ (K+)/H+ Antiporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CATION/PROTON ANTIPORTERS; VIBRIO-PARAHAEMOLYTICUS; ALKALIMONAS-AMYLOLYTICA; BACILLUS-SUBTILIS; BLACK LIQUOR; GENE; CLONING; EXPRESSION; SYSTEM	Halomonas sp. Y2 is a halotolerant alkaliphilic strain from Na+-rich pulp mill wastewater with high alkalinity (pH > 11.0). Transcriptome analysis of this isolate revealed this strain may use various transport systems for pH homeostasis. In particular, the genes encoding four putative Na+/H+ antiporters were differentially expressed upon acidic or alkaline conditions. Further evidence, from heterologous expression and mutant studies, suggested that Halomonas sp. Y2 employs its Na+/H+ antiporters in a labor division way to deal with saline and alkaline environments. Ha-NhaD2 displayed robust Na+(Li+) resistance and high transport activities in Escherichia coli; a Delta Ha-nhaD2 mutant exhibited growth inhibition at high Na+(Li+) concentrations at pH values of 6.2, 8.0, and 10.0, suggesting its physiological role in osmotic homeostasis. In contrast, Ha-NhaD1 showed much weaker activities in ion exporting and pH homeostasis. Ha-Mrp displayed a combination of properties similar to those of Mrp transporters from some Bacillus alkaliphiles and neutrophiles. This conferred obvious Na+(Li+, K+) resistance in E. coli-deficient strains, as those ion transport spectra of some neutrophil Mrp antiporters. Conversely, similar to the Bacillus alkaliphiles, Ha-Mrp showed central roles in the pH homeostasis of Halomonas sp. Y2. An Ha-mrp-disrupted mutant was seriously inhibited by high concentrations of Na+(Li+, K+) but only under alkaline conditions. Ha-NhaP was determined to be a K+/H+ antiporter and shown to confer strong K+ resistance both at acidic and alkaline stresses.	[Cheng, Bin; Meng, Yiwei; Cui, Yanbing; Li, Chunfang; Yin, Huijia; Yang, Chunyu; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Tao, Fei; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Tao, Fei; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, CY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	ycy21th@sdu.edu.cn	Liu, Wenjun/L-5256-2016	Liu, Wenjun/0000-0001-9380-2990; Xu, Ping/0000-0002-4418-9680	National Natural Science Foundation of China [31370153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31370153. The authors declare that they have no conflicts of interest with the contents of this article.	Banciu HL, 2015, CURR OPIN MICROBIOL, V25, P73, DOI 10.1016/j.mib.2015.05.003; Chanroj S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00025; Dzioba J, 2002, MOL CELL BIOCHEM, V229, P119, DOI 10.1023/A:1017932829927; EPSTEIN W, 1993, BIOCHEM SOC T, V21, P1006, DOI 10.1042/bst0211006; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Grant WD, 2011, EXTREMOPHILES HDB, P27, DOI DOI 10.1007/978-4-431-53898-1_3; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Huang GL, 2007, BIORESOURCE TECHNOL, V98, P2829, DOI 10.1016/j.biortech.2006.09.029; Ito M, 2001, FEBS LETT, V496, P117, DOI 10.1016/S0014-5793(01)02417-6; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Janto B, 2011, ENVIRON MICROBIOL, V13, P3289, DOI 10.1111/j.1462-2920.2011.02591.x; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Krulwich TA, 2009, MOL MICROBIOL, V74, P257, DOI 10.1111/j.1365-2958.2009.06842.x; Kurz Matthias, 2006, Saline Syst, V2, P10, DOI 10.1186/1746-1448-2-10; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu J, 2005, J BACTERIOL, V187, P7589, DOI 10.1128/JB.187.22.7589-7595.2005; Meng L, 2014, EXTREMOPHILES, V18, P963, DOI 10.1007/s00792-014-0666-5; Mesbah NM, 2009, MOL MICROBIOL, V74, P270, DOI 10.1111/j.1365-2958.2009.06845.x; Nozaki K, 1998, BBA-BIOMEMBRANES, V1369, P213, DOI 10.1016/S0005-2736(97)00223-X; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; PINNER E, 1992, J BIOL CHEM, V267, P11064; Putnoky P, 1998, MOL MICROBIOL, V28, P1091, DOI 10.1046/j.1365-2958.1998.00868.x; Radchenko MV, 2006, MOL MICROBIOL, V59, P651, DOI 10.1111/j.1365-2958.2005.04966.x; Resch CT, 2010, BIOCHEMISTRY-US, V49, P2520, DOI 10.1021/bi902173y; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Takami H., 2011, EXTREMOPHILES HDB, P184; Wei Y, 2007, MICROBIOL-SGM, V153, P2168, DOI 10.1099/mic.0.2007/007450-0; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Yang CY, 2010, BIORESOURCE TECHNOL, V101, P6778, DOI 10.1016/j.biortech.2010.03.108; Yang CY, 2010, BIORESOURCE TECHNOL, V101, P1737, DOI 10.1016/j.biortech.2009.09.092; Yang LF, 2006, FEMS MICROBIOL LETT, V255, P89, DOI 10.1111/j.1574-6968.2005.00055.x; Zou YJ, 2008, J MICROBIOL, V46, P415, DOI 10.1007/s12275-008-0009-2	42	30	34	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26056	26065		10.1074/jbc.M116.751016	http://dx.doi.org/10.1074/jbc.M116.751016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777302	Green Published, hybrid			2022-12-28	WOS:000390345200025
J	Lertkiatmongkol, P; Paddock, C; Newman, DK; Zhu, JQ; Thomas, MJ; Newman, PJ				Lertkiatmongkol, Panida; Paddock, Cathy; Newman, Debra K.; Zhu, Jieqing; Thomas, Michael J.; Newman, Peter J.			The Role of Sialylated Glycans in Human Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1)-mediated Trans Homophilic Interactions and Endothelial Cell Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSYLATION; BINDING SPECIFICITIES; HEMOPHILIC BINDING; INFLUENZA-VIRUSES; PECAM-1; ACID; INFLAMMATION; DOMAINS; SIALOADHESIN; MIGRATION	Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) is a major component of the endothelial cell intercellular junction. Previous studies have shown that PECAM-1 homophilic interactions, mediated by amino-terminal immunoglobulin homology domain 1, contribute to maintenance of the vascular permeability barrier and to its re-establishment following inflammatory or thrombotic insult. PECAM-1 glycans account for similar to 30% of its molecular mass, and the newly solved crystal structure of human PECAM-1 immunoglobulin homology domain 1 reveals that a glycan emanating from the asparagine residue at position 25 (Asn-25) is located within the trans homophilic-binding interface, suggesting a role for an Asn-25-associated glycan in PECAM-1 homophilic interactions. In support of this possibility, unbiased molecular docking studies revealed that negatively charged alpha 2,3 sialic acid moieties bind tightly to a groove within the PECAM-1 homophilic interface in an orientation that favors the formation of an electrostatic bridge with positively charged Lys-89, mutation of which has been shown previously to disrupt PECAM-1-mediated homophilic binding. To verify the contribution of the Asn-25 glycan to endothelial barrier function, we generated an N25Q mutant form of PECAM-1 that is not glycosylated at this position and examined its ability to contribute to vascular integrity in endothelial cell-like REN cells. Confocal microscopy showed that although N25Q PECAM-1 concentrates normally at cell-cell junctions, the ability of this mutant form of PECAM-1 to support re-establishment of a permeability barrier following disruption with thrombin was significantly compromised. Taken together, these data suggest that a sialic acid-containing glycan emanating from Asn-25 reinforces dynamic endothelial cell-cell interactions by stabilizing the PECAM-1 homophilic binding interface.	[Lertkiatmongkol, Panida; Paddock, Cathy; Newman, Debra K.; Zhu, Jieqing; Newman, Peter J.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53201 USA; [Lertkiatmongkol, Panida; Newman, Debra K.; Thomas, Michael J.; Newman, Peter J.] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA; [Zhu, Jieqing] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Newman, Peter J.] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Newman, PJ (corresponding author), BloodCtr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	peter.newman@bcw.edu			NHLBI, National Institutes of Health [HL-40926]; Midwest Affiliate of the American Heart Association [16PRE30400012]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Midwest Affiliate of the American Heart Association(American Heart Association)	This work was supported by Grant HL-40926 from the NHLBI, National Institutes of Health (to P. J. N.) and Predoctoral Fellowship Award 16PRE30400012 (to P. L.) from the Midwest Affiliate of the American Heart Association. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe Y, 1999, J IMMUNOL, V163, P2867; ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Bird IN, 1999, J CELL SCI, V112, P1989; Carvalho S, 2016, ONCOGENE, V35, P1619, DOI 10.1038/onc.2015.225; Cioffi DL, 2012, AM J PHYSIOL-LUNG C, V302, pL1067, DOI 10.1152/ajplung.00190.2011; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; CUNNINGHAM BA, 1983, P NATL ACAD SCI-BIOL, V80, P3116, DOI 10.1073/pnas.80.10.3116; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Farooq MM, 2001, J VASC SURG, V34, P555, DOI 10.1067/mva.2001.115813; FERRERO E, 1995, FEBS LETT, V374, P323, DOI 10.1016/0014-5793(95)01110-Z; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kaufman DA, 2004, BIOCHEM BIOPH RES CO, V320, P1076, DOI 10.1016/j.bbrc.2004.06.055; Kitazume S, 2014, J BIOL CHEM, V289, P27604, DOI 10.1074/jbc.M114.563585; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Maas M, 2005, AM J PHYSIOL-HEART C, V288, pH159, DOI 10.1152/ajpheart.00500.2004; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; MCEVER RP, 1991, THROMB HAEMOSTASIS, V65, P223; Mei H, 2014, J BIOL CHEM, V289, P20836, DOI 10.1074/jbc.M114.557454; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Newman PJ, 1999, J CLIN INVEST, V103, P5, DOI 10.1172/JCI5928; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Newton JP, 1999, BIOCHEM BIOPH RES CO, V261, P283, DOI 10.1006/bbrc.1999.1018; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Nourshargh S, 2006, J LEUKOCYTE BIOL, V80, P714, DOI 10.1189/jlb.1105645; O'Brien CD, 2004, AM J PHYSIOL-CELL PH, V287, pC1103, DOI 10.1152/ajpcell.00573.2003; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Paddock C, 2016, BLOOD, V127, P1052, DOI 10.1182/blood-2015-07-660092; POWELL LD, 1994, J BIOL CHEM, V269, P10628; Privratsky JR, 2011, J CELL SCI, V124, P1477, DOI 10.1242/jcs.082271; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rombouts Y, 2016, GLYCOCONJUGATE J, V33, P457, DOI 10.1007/s10719-015-9648-9; Sabri S, 1995, BIOCHEM CELL BIOL, V73, P411, DOI 10.1139/o95-048; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott DW, 2015, MOL BIOL CELL, V26, P3205, DOI 10.1091/mbc.E14-12-1604; Scott DW, 2013, AM J PHYSIOL-CELL PH, V305, pC228, DOI 10.1152/ajpcell.00116.2013; Scott DW, 2013, GLYCOBIOLOGY, V23, P622, DOI 10.1093/glycob/cwt014; Shi WX, 1996, J BIOL CHEM, V271, P15130, DOI 10.1074/jbc.271.25.15130; SMYTHE WR, 1994, CANCER RES, V54, P2055; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Sun J, 2000, J CELL SCI, V113, P1459; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608	61	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26216	26225		10.1074/jbc.M116.756502	http://dx.doi.org/10.1074/jbc.M116.756502			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27793989	Green Published, hybrid			2022-12-28	WOS:000390345200037
J	Jung, JY; Czabany, T; Wilding, B; Klempier, N; Nidetzky, B				Jung, Jihye; Czabany, Tibor; Wilding, Birgit; Klempier, Norbert; Nidetzky, Bernd			Kinetic Analysis and Probing with Substrate Analogues of the Reaction Pathway of the Nitrile Reductase QueF from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; isothermal titration calorimetry (ITC); isotope effect; pre-steady-state kinetics; reductase; thermodynamics; NADPH; catalytic reaction pathway; nitrile reductase	ADENINE-DINUCLEOTIDE PHOSPHATE; RNA-GUANINE TRANSGLYCOSYLASE; UDP-GLUCOSE DEHYDROGENASE; CATALYTIC MECHANISM; BIOSYNTHESIS; BINDING; ENZYME; OXIDOREDUCTASE; SEQUENCES; INSIGHT	The enzyme QueF catalyzes a four-electron reduction of a nitrile group into an amine, the only reaction of this kind known in biology. In nature, QueF converts 7-cyano-7-deazaguanine (preQ(0)) into 7-aminomethyl-7-deazaguanine (preQ(1)) for the biosynthesis of the tRNA-inserted nucleoside queuosine. The proposed QueF mechanism involves a covalent thioimide adduct between preQ(0) and a cysteine nucleophile in the enzyme, and this adduct is subsequently converted into preQ(1) in two NADPH-dependent reduction steps. Here, we show that the Escherichia coli QueF binds preQ(0) in a strongly exothermic process (H = -80.3 kJ/mol; -TS = 37.9 kJ/mol, K-d = 39 nm) whereby the thioimide adduct is formed with half-of-the-sites reactivity in the homodimeric enzyme. Both steps of preQ(0) reduction involve transfer of the 4-pro-R-hydrogen from NADPH. They proceed about 4-7-fold more slowly than trapping of the enzyme-bound preQ(0) as covalent thioimide (1.63 s(-1)) and are thus mainly rate-limiting for the enzyme's k(cat) (=0.12 s(-1)). Kinetic studies combined with simulation reveal a large primary deuterium kinetic isotope effect of 3.3 on the covalent thioimide reduction and a smaller kinetic isotope effect of 1.8 on the imine reduction to preQ(1). 7-Formyl-7-deazaguanine, a carbonyl analogue of the imine intermediate, was synthesized chemically and is shown to be recognized by QueF as weak ligand for binding (H = -2.3 kJ/mol; -TS = -19.5 kJ/mol) but not as substrate for reduction or oxidation. A model of QueF substrate recognition and a catalytic pathway for the enzyme are proposed based on these data.	[Jung, Jihye; Wilding, Birgit; Nidetzky, Bernd] Austrian Ctr Ind Biotechnol, Petersgasse 14, A-8010 Graz, Austria; [Jung, Jihye; Czabany, Tibor; Nidetzky, Bernd] Graz Univ Technol, NAWIGraz, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria; [Wilding, Birgit; Klempier, Norbert] Graz Univ Technol, Inst Organ Chem, Stremayrgasse 9, A-8010 Graz, Austria	Austrian Centre of Industrial Biotechnology; Graz University of Technology; Graz University of Technology	Nidetzky, B (corresponding author), Austrian Ctr Ind Biotechnol, Petersgasse 14, A-8010 Graz, Austria.; Nidetzky, B (corresponding author), Graz Univ Technol, NAWIGraz, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at	Wilding, Birgit/D-3389-2017; Wilding, Birgit/AAL-8809-2020	Wilding, Birgit/0000-0002-1896-3708; Wilding, Birgit/0000-0002-1896-3708; Jung, Jihye/0000-0001-9186-7176; Czabany, Tibor/0000-0003-1754-6723	Federal Ministry of Economy, Family and Youth (BMWFW); Federal Ministry for Transport, Innovation and Technology (BMVIT); Styrian Business Promotion Agency (SFG); Vienna Business Agency; Standortagentur Tirol; Government of Lower Austria; Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program managed - Austrian Research Promotion Agency (FFG)	Federal Ministry of Economy, Family and Youth (BMWFW); Federal Ministry for Transport, Innovation and Technology (BMVIT); Styrian Business Promotion Agency (SFG); Vienna Business Agency; Standortagentur Tirol; Government of Lower Austria; Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program managed - Austrian Research Promotion Agency (FFG)	This work was supported by the Federal Ministry of Economy, Family and Youth (BMWFW), the Federal Ministry for Transport, Innovation and Technology (BMVIT), the Styrian Business Promotion Agency (SFG), the Vienna Business Agency, the Standortagentur Tirol, the Government of Lower Austria, and the Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program managed by the Austrian Research Promotion Agency (FFG). The authors declare that they have no conflicts of interest with the contents of this article.	ADKINS H, 1948, J AM CHEM SOC, V70, P695, DOI 10.1021/ja01182a080; Agrawal N, 2003, ANAL BIOCHEM, V322, P179, DOI 10.1016/j.ab.2003.08.012; AMUNDSEN LH, 1951, J AM CHEM SOC, V73, P242, DOI 10.1021/ja01145a082; Bagal DB, 2015, ADV SYNTH CATAL, V357, P883, DOI 10.1002/adsc.201400940; Brooks AF, 2010, TETRAHEDRON LETT, V51, P4163, DOI 10.1016/j.tetlet.2010.06.008; Caddick S, 2003, TETRAHEDRON, V59, P5417, DOI 10.1016/S0040-4020(03)00858-5; Chikwana VM, 2012, J BIOL CHEM, V287, P30560, DOI 10.1074/jbc.M112.388538; DURAND JM, 1994, J BACTERIOL, V176, P4627, DOI 10.1128/JB.176.15.4627-4634.1994; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Ge X, 1998, J AM CHEM SOC, V120, P6613, DOI 10.1021/ja9805977; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; HOOPS GC, 1995, BIOCHEMISTRY-US, V34, P15381, DOI 10.1021/bi00046a047; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411; Kim Y, 2010, J MOL BIOL, V404, P127, DOI 10.1016/j.jmb.2010.09.042; Klepper F, 2005, HELV CHIM ACTA, V88, P2610, DOI 10.1002/hlca.200590201; Kozlov AG, 1999, BIOCHEMISTRY-US, V38, P7388, DOI 10.1021/bi990309z; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Leroux AE, 2013, J BIOL CHEM, V288, P23751, DOI 10.1074/jbc.M113.483289; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; McCracken JA, 2004, ANAL BIOCHEM, V324, P131, DOI 10.1016/j.ab.2003.09.025; NAGAO T, 1992, J BACTERIOL, V174, P5013, DOI 10.1128/JB.174.15.5013-5020.1992; Olgen S, 2008, ARCH PHARM, V341, P113, DOI 10.1002/ardp.200700141; Olson LP, 1996, BIOCHEMISTRY-US, V35, P9782, DOI 10.1021/bi952020x; ORDMAN AB, 1977, BIOCHIM BIOPHYS ACTA, V481, P25, DOI 10.1016/0005-2744(77)90133-4; RAGG E, 1991, BIOCHIM BIOPHYS ACTA, V1076, P49, DOI 10.1016/0167-4838(91)90218-O; Ribeiro AJM, 2015, ACS CATAL, V5, P3740, DOI 10.1021/acscatal.5b00528; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Wilding B, 2013, CHEM-EUR J, V19, P7007, DOI 10.1002/chem.201300163; Wilding B, 2012, ADV SYNTH CATAL, V354, P2191, DOI 10.1002/adsc.201200109	35	5	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25411	25426		10.1074/jbc.M116.747014	http://dx.doi.org/10.1074/jbc.M116.747014			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27754868	hybrid, Green Published			2022-12-28	WOS:000390095300012
J	Yoshida, T; Delafontaine, P				Yoshida, Tadashi; Delafontaine, Patrice			An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; heart failure; muscle regeneration; skeletal muscle; stem cells; transcription enhancer	SKELETAL-MUSCLE REGENERATION; OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; DIABETIC-RATS; VASTUS LATERALIS; CANCER CACHEXIA; SOLEUS MUSCLE; MURINE MODEL; WEIGHT-LOSS; TRANSCRIPTION	Patients with advanced congestive heart failure (CHF) or chronic kidney disease often have increased angiotensin II (Ang II) levels and cachexia. We previously demonstrated that Ang II, via its type 1 receptor, causes muscle protein breakdown and apoptosis and inhibits satellite cell (SC) proliferation and muscle regeneration, likely contributing to cachexia in CHF and chronic kidney disease. In contrast, Ang II, via its type 2 receptor (AT2R) expression, is robustly induced during SC differentiation, and it potentiates muscle regeneration. To understand the mechanisms regulating AT2R expression and its potential role in muscle regeneration in chronic diseases, we used a mouse model of CHF and found that muscle regeneration was markedly reduced and that this was accompanied by blunted increase of AT2R expression. We performed AT2R promoter reporter analysis during satellite cell differentiation and found that the 70 bp upstream of the AT2R transcription start site contain a core promoter region, and regions upstream of 70 bp to 3 kbp are dispensable for AT2R induction. Instead, AT2R intron 2 acts as a transcriptional enhancer during SC differentiation. Further deletion/mutation analysis revealed that multiple transcription factor binding sites in the +286/+690 region within intron 2 coordinately regulate AT2R transcription. Importantly, +286/+690 enhancer activity was suppressed in CHF mouse skeletal muscle, suggesting that AT2R expression is suppressed in CHF via inhibition of AT2R intronic enhancer activity, leading to lowered muscle regeneration. Thus targeting intron 2 enhancer element could lead to the development of a novel intervention to increase AT2R expression in SCs and potentiate skeletal muscle regenerative capacity in chronic diseases.	[Yoshida, Tadashi; Delafontaine, Patrice] Univ Missouri, Sch Med, Dept Med & Med Pharmacol & Physiol, One Hosp Dr,M742, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Yoshida, T (corresponding author), Univ Missouri, Sch Med, Dept Med & Med Pharmacol & Physiol, One Hosp Dr,M742, Columbia, MO 65212 USA.	yoshidata@health.missouri.edu		Yoshida, Tadashi/0000-0002-4544-1497	National Institutes of Health from NHLBI [R01HL070241, R01-HL080682]; National Institutes of Health from NIGMS [P20-GM103629, P30-GM103337, U54-GM104940]; American Heart Association [15SDG25240022]; University of Missouri Department of Medicine Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070241, R01HL080682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337, P20GM103629, U54GM104940] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); University of Missouri Department of Medicine Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL070241 and R01-HL080682 from NHLBI and P20-GM103629, P30-GM103337, and U54-GM104940 from NIGMS, American Heart Association Grant 15SDG25240022, and University of Missouri Department of Medicine Research Council. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Aragno M, 2004, DIABETES, V53, P1082, DOI 10.2337/diabetes.53.4.1082; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; BRANNON MA, 1989, METABOLISM, V38, P348, DOI 10.1016/0026-0495(89)90123-6; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Cheung WW, 2012, AM J PHYSIOL-RENAL, V303, pF1315, DOI 10.1152/ajprenal.00341.2012; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Corrick KL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00184; Crul T, 2007, EUR J CLIN INVEST, V37, P897, DOI 10.1111/j.1365-2362.2007.01867.x; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Deplancke B, 2016, CELL, V166, P538, DOI 10.1016/j.cell.2016.07.012; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Grabe Niels, 2002, In Silico Biology, V2, pS1; GULATI AK, 1991, ANAT RECORD, V229, P298, DOI 10.1002/ar.1092290303; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; ICHIKI T, 1995, HYPERTENSION, V25, P720, DOI 10.1161/01.HYP.25.4.720; ICHIKI T, 1995, CIRC RES, V76, P693, DOI 10.1161/01.RES.76.5.693; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Krause MP, 2011, DIABETES, V60, P1964, DOI 10.2337/db11-0007; Langen RCJ, 2006, AM J RESP CELL MOL, V35, P689, DOI 10.1165/rcmb.2006-0103OC; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu W, 2001, INT J DEV BIOL, V45, P415; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mehl KA, 2005, J APPL PHYSIOL, V99, P2379, DOI 10.1152/japplphysiol.00778.2005; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Mozdziak PE, 2001, J APPL PHYSIOL, V91, P183, DOI 10.1152/jappl.2001.91.1.183; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nguyen T, 2000, J APPL PHYSIOL, V88, P1446, DOI 10.1152/jappl.2000.88.4.1446; Penafuerte CA, 2016, BRIT J CANCER, V114, P680, DOI 10.1038/bjc.2016.3; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Plank JL, 2014, STEM CELL RES, V12, P233, DOI 10.1016/j.scr.2013.10.008; Ramamoorthy S, 2009, AM J PHYSIOL-ENDOC M, V297, pE392, DOI 10.1152/ajpendo.90529.2008; Rezk BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030276; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Stadhouders R, 2012, TRANSCR-AUSTIN, V3, P181, DOI 10.4161/trns.20720; Su Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134511; Tabony AM, 2011, HYPERTENSION, V58, P643, DOI 10.1161/HYPERTENSIONAHA.111.174839; Tabony AM, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-20; Theriault ME, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-35; Vogiatzis I, 2010, EUR RESPIR J, V36, P301, DOI 10.1183/09031936.00112909; Wanek LJ, 2000, ANAT REC, V258, P176; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wieteska-Skrzeczynska W, 2009, J PHYSIOL PHARMACOL, V60, P29; Wu XW, 2013, BURNS, V39, P736, DOI 10.1016/j.burns.2012.10.016; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111; Yoshida T, 2015, AM J MED SCI, V350, P250, DOI 10.1097/MAJ.0000000000000511; Yoshida T, 2014, J BIOL CHEM, V289, P26239, DOI 10.1074/jbc.M114.585521; Yoshida T, 2013, INT J BIOCHEM CELL B, V45, P2322, DOI 10.1016/j.biocel.2013.05.035; Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074; Yoshida T, 2012, ENDOCRINOLOGY, V153, P1411, DOI 10.1210/en.2011-1764; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	62	3	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25578	25590		10.1074/jbc.M116.752501	http://dx.doi.org/10.1074/jbc.M116.752501			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756842	Green Published, hybrid			2022-12-28	WOS:000390095300025
J	Zheng, W; Yang, J; Beauchamp, E; Cai, RQ; Hussein, S; Hofmann, L; Li, Q; Flockerzi, V; Berthiaume, LG; Tang, JF; Chen, XZ				Zheng, Wang; Yang, JungWoo; Beauchamp, Erwan; Cai, Ruiqi; Hussein, Shaimaa; Hofmann, Laura; Li, Qiang; Flockerzi, Veit; Berthiaume, Luc G.; Tang, Jingfeng; Chen, Xing-Zhen			Regulation of TRPP3 Channel Function by N-terminal Domain Palmitoylation and Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; electrophysiology; phosphorylation; post-translational modification (PTM); Xenopus	POLYCYSTIC KIDNEY-DISEASE; POSTTRANSLATIONAL MODIFICATIONS; BETA(2)-ADRENERGIC RECEPTOR; TRANSIENT RECEPTOR; S-PALMITOYLATION; CALCIUM-CHANNEL; OFF-RESPONSE; PKD2L1; ACTIVATION; IDENTIFICATION	Transient receptor potential polycystin-3 (TRPP3) is a cation channel activated by calcium and proton and is involved in hedgehog signaling, intestinal development, and sour tasting. How TRPP3 channel function is regulated remains poorly understood. By N-terminal truncation mutations, electrophysiology, and Xenopus oocyte expression, we first identified fragment Asp-21-Ser-42 to be functionally important. We then found that deletion mutant 1-36 (TRPP3 missing fragment Met-1-Arg-36) has a similar function as wild-type TRPP3, whereas 1-38 is functionally dead, suggesting the importance of Val-37 or Cys-38. Further studies found that Cys-38, but not Val-37, is functionally critical. Cys-38 is a predicted site of palmitoylation, and indeed TRPP3 channel activity was inhibited by palmitoylation inhibitor 2-bromopalmitate and rescued by palmitoylation substrate palmitic acid. The TRPP3 N terminus (TRPP3NT, Met-1-Leu-95) localized along the plasma membrane of HEK293 cells but stayed in the cytoplasm with 2-bromopalmitate treatment or C38A mutation, indicating that TRPP3NT anchors to the surface membrane through palmitoylation at Cys-38. By acyl-biotin exchange assays, we showed that TRPP3, but not mutant C38A, is indeed palmitoylated. When putative phosphorylation sites near Cys-38 were mutated to Asp or Glu to mimic phosphorylation, only T39D and T39E reduced TRPP3 function. Furthermore, TRPP3NT displayed double bands in which the upper band was abolished by phosphatase treatment or T39A mutation. However, palmitoylation at Cys-38 and phosphorylation at Thr-39 independently regulated TRPP3 channel function, in contrast to previous reports about correlated palmitoylation with a proximate phosphorylation. Palmitoylation at Cys-38 represents a novel mechanism of functional regulation for TRPP3.	[Zheng, Wang; Yang, JungWoo; Cai, Ruiqi; Hussein, Shaimaa; Li, Qiang; Chen, Xing-Zhen] Univ Alberta, Membrane Prot Dis Res Grp, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Beauchamp, Erwan; Berthiaume, Luc G.] Univ Alberta, Dept Cell Biol, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada; [Hofmann, Laura; Flockerzi, Veit] Univ Saarland, Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Tang, Jingfeng; Chen, Xing-Zhen] Hubei Univ Technol, Inst Biomed & Pharmaceut Sci, Coll Bioengn, Wuhan 430068, Peoples R China; [Tang, Jingfeng; Chen, Xing-Zhen] Hubei Univ Technol, Prov Cooperat Innovat Ctr, Coll Bioengn, Wuhan 430068, Peoples R China	University of Alberta; University of Alberta; Saarland University; Hubei University of Technology; Hubei University of Technology	Chen, XZ (corresponding author), Univ Alberta, Membrane Prot Dis Res Grp, Dept Physiol, Edmonton, AB T6G 2H7, Canada.; Tang, JF; Chen, XZ (corresponding author), Hubei Univ Technol, Inst Biomed & Pharmaceut Sci, Coll Bioengn, Wuhan 430068, Peoples R China.; Tang, JF; Chen, XZ (corresponding author), Hubei Univ Technol, Prov Cooperat Innovat Ctr, Coll Bioengn, Wuhan 430068, Peoples R China.	jingfeng9930@163.com; xzchen@ualberta.ca	Hussein, Shaimaa/HHZ-5533-2022	Tang, jingfeng/0000-0002-5524-4518; Hussein, Shaimaa/0000-0003-0849-9670	Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China [8157041737, 81602448]; Alberta Innovates-Doctoral Graduate Student Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Alberta Innovates-Doctoral Graduate Student Scholarship	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada and National Natural Science Foundation of China Grants 8157041737 (to X.Z.C.) and 81602448 (to J.T.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the Alberta Innovates-Doctoral Graduate Student Scholarship.	Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Djenoune L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00026; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Feng S, 2011, J BIOL CHEM, V286, P18994, DOI 10.1074/jbc.M110.192286; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Gauthier-Kemper A, 2014, MOL BIOL CELL, V25, P3284, DOI 10.1091/mbc.E13-12-0737; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Hussein S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15752; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Li Q, 2002, FEBS LETT, V516, P270, DOI 10.1016/S0014-5793(02)02513-9; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Liu C, 2015, BIOCHEM BIOPH RES CO, V460, P22, DOI 10.1016/j.bbrc.2015.02.067; Loisel TP, 1999, J BIOL CHEM, V274, P31014, DOI 10.1074/jbc.274.43.31014; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moffett S, 1996, J BIOL CHEM, V271, P21490, DOI 10.1074/jbc.271.35.21490; Moffett S, 2001, J NEUROCHEM, V76, P269, DOI 10.1046/j.1471-4159.2001.00005.x; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Murakami M, 2005, J BIOL CHEM, V280, P5626, DOI 10.1074/jbc.M411496200; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Orts-Del'Immagine A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087748; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Voolstra O, 2014, CELLS-BASEL, V3, P258, DOI 10.3390/cells3020258; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Yao G, 2016, HUM MOL GENET, V25, P448, DOI 10.1093/hmg/ddv484; Yeste-Velasco M, 2015, BBA-REV CANCER, V1856, P107, DOI 10.1016/j.bbcan.2015.06.004; Zheng W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09460; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	53	11	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25678	25691		10.1074/jbc.M116.756544	http://dx.doi.org/10.1074/jbc.M116.756544			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27754867	Green Published, hybrid			2022-12-28	WOS:000390095300033
J	Dewar, S; Sienkiewicz, N; Ong, HB; Wall, RJ; Horn, D; Fairlamb, AH				Dewar, Simon; Sienkiewicz, Natasha; Ong, Han B.; Wall, Richard J.; Horn, David; Fairlamb, Alan H.			The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOZOAN PARASITE LEISHMANIA; HUMAN AFRICAN TRYPANOSOMIASIS; ANTIOPPORTUNISTIC INFECTION AGENTS; PTERIDINE REDUCTASE 1; BLOOD-STREAM FORMS; SLEEPING SICKNESS; DIHYDROFOLATE-REDUCTASE; THYMIDYLATE SYNTHASE; FOLIC-ACID; METHOTREXATE RESISTANCE	The aim of this study was to identify and characterize mechanisms of resistance to antifolate drugs in African trypanosomes. Genome-wide RNAi library screens were undertaken in bloodstream form Trypanosoma brucei exposed to the antifolates methotrexate and raltitrexed. In conjunction with drug susceptibility and folate transport studies, RNAi knockdown was used to validate the functions of the putative folate transporters. The transport kinetics of folate and methotrexate were further characterized in whole cells. RNA interference target sequencing experiments identified a tandem array of genes encoding a folate transporter family, TbFT1-3, as major contributors to antifolate drug uptake. RNAi knockdown of TbFT1-3 substantially reduced folate transport into trypanosomes and reduced the parasite's susceptibly to the classical antifolates methotrexate and raltitrexed. In contrast, knockdown of TKFT1-3 increased susceptibly to the non-classical antifolates pyrimethamine and nolatrexed. Both folate and methotrexate transport were inhibited by classical antifolates but not by non-classical antifolates or biopterin. Thus, TbFT1-3 mediates the uptake of folate and classical antifolates in trypanosomes, and TbFT1-3 loss-of-function is a mechanism of antifolate drug resistance.	[Dewar, Simon; Sienkiewicz, Natasha; Ong, Han B.; Wall, Richard J.; Horn, David; Fairlamb, Alan H.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Wellcome Trust Bldg, Dundee DD1 5EH, Scotland; [Ong, Han B.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Dundee; Wellcome Trust Sanger Institute	Fairlamb, AH (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Wellcome Trust Bldg, Dundee DD1 5EH, Scotland.	a.h.fairlamb@dundee.ac.uk	Fairlamb, Alan/A-5272-2009	Fairlamb, Alan/0000-0001-5134-0329; Horn, David/0000-0001-5173-9284; Ong, Han/0000-0003-3369-8196; Wall, Richard J./0000-0003-3487-3187	Wellcome Trust [104242, 100320, 105021, 079838]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants 104242 studentship (to S. D.), 100320 (to D. H.), and 105021 and 079838 (to A. H. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali JAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058034; Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chatelain E, 2011, DRUG DES DEV THER, V5, P175, DOI 10.2147/DDDT.S16381; Checchi F, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-16; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Dridi L, 2010, J BIOL CHEM, V285, P19767, DOI 10.1074/jbc.M110.114520; Dridi L, 2010, BIOCHEM PHARMACOL, V79, P30, DOI 10.1016/j.bcp.2009.07.019; Eadsforth TC, 2012, MOL BIOCHEM PARASIT, V181, P178, DOI 10.1016/j.molbiopara.2011.11.004; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Fairlamb AH, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.92, 10.1038/nmicrobiol.2016.92]; Fairlamb AH, 2012, NATURE, V482, P167, DOI 10.1038/482167a; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Gangjee A, 2007, ANTI-CANCER AGENT ME, V7, P524, DOI 10.2174/187152007781668724; Gazanion E, 2016, P NATL ACAD SCI USA, V113, pE3012, DOI 10.1073/pnas.1520693113; Gibson MW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004714; Glover L, 2015, NAT PROTOC, V10, P106, DOI 10.1038/nprot.2015.005; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; Graf FE, 2015, INT J PARASITOL-DRUG, V5, P65, DOI 10.1016/j.ijpddr.2015.04.002; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; JACKSON RC, 1984, ADV ENZYME REGUL, V22, P187, DOI 10.1016/0065-2571(84)90014-1; Jamonneau V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001691; Jansen G, 1999, MOL PHARMACOL, V55, P761; Jones DC, 2010, BIOCHEM PHARMACOL, V80, P1478, DOI 10.1016/j.bcp.2010.07.038; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Meiser J, 2016, FEBS J, V283, P3695, DOI 10.1111/febs.13731; Mpanya A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001467; Odiit M, 1997, E AFR MED J, V74, P792; Ong HB, 2013, MOL MICROBIOL, V90, P443, DOI 10.1111/mmi.12376; Ouameur AA, 2008, MOL BIOCHEM PARASIT, V162, P155, DOI 10.1016/j.molbiopara.2008.08.007; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Pelphrey PM, 2007, J MED CHEM, V50, P940, DOI 10.1021/jm061027h; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Richard D, 2002, J BIOL CHEM, V277, P29460, DOI 10.1074/jbc.M204796200; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Shanks EJ, 2010, ANAL BIOCHEM, V396, P194, DOI 10.1016/j.ab.2009.09.003; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; Sienkiewicz N, 2010, MOL MICROBIOL, V77, P658, DOI 10.1111/j.1365-2958.2010.07236.x; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; SIROTNAK FM, 1985, CANCER RES, V45, P3992; Sokolova AY, 2010, ANTIMICROB AGENTS CH, V54, P2893, DOI 10.1128/AAC.00332-10; Spinks D, 2011, CHEMMEDCHEM, V6, P302, DOI 10.1002/cmdc.201000450; Synold TW, 1996, LEUKEMIA LYMPHOMA, V21, P9, DOI 10.3109/10428199609067573; Tan THP, 2002, P NATL ACAD SCI USA, V99, P1152, DOI 10.1073/pnas.022522299; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vickers TJ, 2009, MOL BIOCHEM PARASIT, V166, P142, DOI 10.1016/j.molbiopara.2009.03.009; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; Wahlin A, 2002, PUBLIC HEALTH NUTR, V5, P505, DOI 10.1079/PHN200167; Wang P, 2007, MOL BIOCHEM PARASIT, V154, P40, DOI 10.1016/j.molbiopara.2007.04.002; WEBBER SE, 1993, J MED CHEM, V36, P733, DOI 10.1021/jm00058a010; WHO, 2012, ACC WORK OV GLOB IMP, P13; Widemann BC, 1999, CANCER CHEMOTH PHARM, V44, P439, DOI 10.1007/s002800051116	67	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24768	24778		10.1074/jbc.M116.750422	http://dx.doi.org/10.1074/jbc.M116.750422			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703008	hybrid, Green Published			2022-12-28	WOS:000388875500034
J	Park, M; Kaddai, V; Ching, JH; Fridianto, KT; Sieli, RJ; Sugii, S; Summers, SA				Park, Min; Kaddai, Vincent; Ching, Jianhong; Fridianto, Kevin T.; Sieli, Ryan J.; Sugii, Shigeki; Summers, Scott A.			A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; ceramide; insulin resistance; lipotoxicity; mitochondria; skeletal muscle; sphingolipid	PLECKSTRIN HOMOLOGY DOMAIN; SATURATED FATTY-ACIDS; ACCUMULATION; RESISTANCE; INHIBITION; OBESITY; DIACYLGLYCEROL; ACTIVATION; PREVENTS; SYNTHASE	The accumulation of sphingolipids in obesity leads to impairments in insulin sensitivity and mitochondrial metabolism, but the precise species driving these defects is unclear. We have modeled these obesity-induced effects in cultured C2C12 myotubes, using BSA-conjugated palmitate to increase synthesis of endogenous sphingolipids and to inhibit insulin signaling and oxidative phosphorylation. Palmitate (a) induced the accumulation of sphingomyelin (SM) precursors such as sphinganine, dihydroceramide, and ceramide; (b) inhibited insulin stimulation of a central modulator of anabolic metabolism, Akt/PKB; (c) inhibited insulin-stimulated glycogen synthesis; and (d) decreased oxygen consumption and ATP synthesis. Under these conditions, palmitate failed to alter levels of SMs, which are the most abundant sphingolipids, suggesting that they are not the primary intermediates accounting for the deleterious palmitate effects. Treating cells with a pharmacological inhibitor of SM synthase or using CRISPR to knock out the Sms2 gene recapitulated the palmitate effects by inducing the accumulation of SM precursors and impairing insulin signaling and mitochondrial metabolism. To profile the sphingolipids that accumulate in obesity, we performed lipidomics on quadriceps muscles from obese mice with impaired glucose tolerance. Like the cultured myotubes, these tissues accumulated ceramides but not SMs. Collectively, these data suggest that SM precursors such as ceramides, rather than SMs, are likely nutritional antagonists of metabolic function in skeletal muscle.	[Park, Min; Ching, Jianhong; Fridianto, Kevin T.; Sugii, Shigeki] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Disorders, Singapore 169857, Singapore; [Sugii, Shigeki] ASTAR, Singapore Bioimaging Consortium, Singapore 138667, Singapore; [Kaddai, Vincent; Summers, Scott A.] Baker IDI Heart & Diabet Inst, Translat & Metab Hlth Lab, Melbourne, Vic 3004, Australia; [Sieli, Ryan J.; Summers, Scott A.] Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT 84112 USA	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Baker Heart and Diabetes Institute; Utah System of Higher Education; University of Utah	Summers, SA (corresponding author), Baker IDI Heart & Diabet Inst, Translat & Metab Hlth Lab, Melbourne, Vic 3004, Australia.; Summers, SA (corresponding author), Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT 84112 USA.	scott.a.summers@health.utah.edu	/AAE-5384-2020; Fridianto, Kevin Timothy/AAW-8474-2020	Fridianto, Kevin Timothy/0000-0003-1842-7048; Sugii, Shigeki/0000-0002-2537-9534; Summers, Scott/0000-0002-4919-0592	National Health and Medical Research Council Senior Research Fellowship [APP1112502]; Victorian State Government OIS scheme; A*STAR Singapore-China Joint Research Grant [1412424003]	National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government OIS scheme; A*STAR Singapore-China Joint Research Grant(Agency for Science Technology & Research (A*STAR))	This work was supported by National Health and Medical Research Council Senior Research Fellowship APP1112502 (to S. A. S.), by the Victorian State Government OIS scheme, and by A*STAR Singapore-China Joint Research Grant 1412424003 (to S. S. and S. A. S.). S. A. S. is a cofounder and consultant of Centaurus Therapeutics, Inc.	Adibhatla RM, 2012, NEUROCHEM RES, V37, P671, DOI 10.1007/s11064-011-0659-z; Bikman BT, 2012, J BIOL CHEM, V287, P17426, DOI 10.1074/jbc.M112.359950; Chakraborty M, 2013, ADV EXP MED BIOL, V991, P1, DOI 10.1007/978-94-007-6331-9_1; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Holland WL, 2009, MOL PHARMACOL, V75, P740, DOI 10.1124/mol.109.054817; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Lipina C, 2015, FEBS LETT, V589, P3221, DOI 10.1016/j.febslet.2015.09.018; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; Petersen MC, 2016, J PHYSIOL-LONDON, V594, P3171, DOI 10.1113/JP271677; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Siddique MM, 2013, MOL CELL BIOL, V33, P2353, DOI 10.1128/MCB.00226-13; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Sugimoto M, 2016, BBA-MOL CELL BIOL L, V1861, P688, DOI 10.1016/j.bbalip.2016.04.019; Summers SA, 2016, J PHYSIOL-LONDON, V594, P3167, DOI 10.1113/JP271676; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Zama K, 2012, CHEM PHYS LIPIDS, V165, P760, DOI 10.1016/j.chemphyslip.2012.09.003	34	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23978	23988		10.1074/jbc.M116.737684	http://dx.doi.org/10.1074/jbc.M116.737684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703011	Green Published, hybrid			2022-12-28	WOS:000388498100014
J	Pinte, S; Caetano, B; Le Bras, A; Havet, C; Villain, G; Dernayka, R; Duez, C; Mattot, V; Soncin, F				Pinte, Sebastien; Caetano, Bertrand; Le Bras, Alexandra; Havet, Chantal; Villain, Gaelle; Dernayka, Racha; Duez, Catherine; Mattot, Virginie; Soncin, Fabrice			Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; endothelium; inflammation; leukocyte; NF-kappa B (NF-KB); vascular biology	NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; FACTOR ERG; TRANSENDOTHELIAL MIGRATION; LEUKOCYTE ADHESION; INHIBITOR; VCAM-1; ICAM-1; PHOSPHORYLATION	Activation of the blood vessel endothelium is a critical step during inflammation. Endothelial cells stimulated by pro-inflammatory cytokines play an essential part in the adhesion and extravasation of circulating leukocytes into inflamed tissues. The endothelial egfl7 gene (VE-statin) represses endothelial cell activation in tumors, and prior observations suggested that it could also participate in the regulation of endothelial cell activation during inflammation. We show here that Egfl7 expression is strongly repressed in mouse lung endothelial cells during LPS- and TNF-induced inflammation in vivo. LPS have a limited effect on Egfl7 expression by endothelial cells in vitro, whereas the pro-inflammatory cytokine TNF strongly represses Egfl7 expression in endothelial cells. TNF regulates the egfl7 gene promoter through regions located between -7585 and -5550 bp ahead of the main transcription start site and via an NF-B-dependent mechanism. Conversely, Egfl7 regulates the response of endothelial cells to TNF by restraining the induced expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin, resulting in a decreased adhesion of leukocytes onto endothelial cells stimulated by TNF. Egfl7 regulates the expression of these adhesion molecules through the NF-B and MEK/Erk pathways, in particular by preventing the proteasome-mediated degradation of IkB both in non-activated endothelial cells and during activation. Egfl7 is thus an endogenous and constitutive repressor of blood vessel endothelial cell activation in normal and inflammatory conditions and participates in a loop of regulation of activation of these cells by pro-inflammatory cytokines.	[Pinte, Sebastien; Caetano, Bertrand; Le Bras, Alexandra; Havet, Chantal; Villain, Gaelle; Dernayka, Racha; Mattot, Virginie; Soncin, Fabrice] Univ Lille, UMR 8161 M3T, Mech Tumorigenesis & Targeted Therapies, F-59000 Lille, France; [Duez, Catherine] Univ Lille, Ctr Infect & Immun Lille, U1019 UMR 8204, F-59000 Lille, France; [Pinte, Sebastien; Caetano, Bertrand; Le Bras, Alexandra; Havet, Chantal; Villain, Gaelle; Dernayka, Racha; Mattot, Virginie; Soncin, Fabrice] CNRS, UMR 8161, F-59000 Lille, France; [Duez, Catherine] CNRS, UMR 8204, F-59000 Lille, France; [Duez, Catherine] INSERM, U1019, F-59000 Lille, France; [Pinte, Sebastien; Caetano, Bertrand; Le Bras, Alexandra; Havet, Chantal; Villain, Gaelle; Dernayka, Racha; Duez, Catherine; Mattot, Virginie; Soncin, Fabrice] Inst Pasteur, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Soncin, F (corresponding author), Inst Biol Lille, 1 Rue Pr Calmette, F-59019 Lille, France.	fabrice.soncin@ibl.cnrs.fr	SONCIN, Fabrice/A-1475-2009; Duez, Catherine/B-8425-2018	SONCIN, Fabrice/0000-0001-6312-0673; Duez, Catherine/0000-0002-2327-1095; Le Bras, Alexandra/0000-0001-7898-4618	Fondation ARC pour la Recherche sur le Cancer; Ligue contre le Cancer; Institut National du Cancer	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from the Fondation ARC pour la Recherche sur le Cancer, Ligue contre le Cancer and the Institut National du Cancer. The authors declare that they have no conflicts of interest with the contents of this article.	Badiwala MV, 2011, CIRCULATION, V124, pS197, DOI 10.1161/CIRCULATIONAHA.110.011734; Badiwala MV, 2010, CIRCULATION, V122, pS156, DOI 10.1161/CIRCULATIONAHA.109.927715; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; BENEZRA D, 1990, ARCH OPHTHALMOL-CHIC, V108, P573, DOI 10.1001/archopht.1990.01070060121061; Campagnolo L, 2005, AM J PATHOL, V167, P275, DOI 10.1016/S0002-9440(10)62972-0; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; Charpentier MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116086; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Delfortrie S, 2011, CANCER RES, V71, P7176, DOI 10.1158/0008-5472.CAN-11-1301; DHORDAIN P, 1995, MECH DEVELOP, V50, P17, DOI 10.1016/0925-4773(94)00322-E; Dryden NH, 2012, J BIOL CHEM, V287, P12331, DOI 10.1074/jbc.M112.346791; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gustavsson M, 2007, J CEREBR BLOOD F MET, V27, P928, DOI 10.1038/sj.jcbfm.9600408; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Inoue K, 2006, ARTERIOSCL THROM VAS, V26, P2652, DOI 10.1161/01.ATV.0000247247.89787.e7; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Le Bras A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012156; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeng YS, 2006, CELL SIGNAL, V18, P994, DOI 10.1016/j.cellsig.2005.08.007; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Nichol D, 2012, BLOOD, V119, P1345, DOI 10.1182/blood-2011-10-322446; Nichol D, 2010, BLOOD, V116, P6133, DOI 10.1182/blood-2010-03-274860; Pannier D, 2016, ONCOL LETT, V12, P1422, DOI 10.3892/ol.2016.4791; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Patel CV, 1999, J BIOL CHEM, V274, P1415, DOI 10.1074/jbc.274.3.1415; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Poissonnier L, 2014, CARDIOVASC RES, V102, P436, DOI 10.1093/cvr/cvu040; Poissonnier L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090455; Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Sperone A, 2011, ARTERIOSCL THROM VAS, V31, P142, DOI 10.1161/ATVBAHA.110.216473; Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Verginelli F, 2015, ONCOTARGET, V6, P43216, DOI 10.18632/oncotarget.6456; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Winsauer G, 2007, THROMB HAEMOSTASIS, V97, P364, DOI 10.1160/TH06-08-0473; Xu D, 2008, AM J PHYSIOL-LUNG C, V294, pL17, DOI 10.1152/ajplung.00178.2007; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	55	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24017	24028		10.1074/jbc.M116.731331	http://dx.doi.org/10.1074/jbc.M116.731331			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27650497	Green Published, hybrid			2022-12-28	WOS:000388498100018
J	Haque, MM; Ray, SS; Stuehr, DJ				Haque, Mohammad Mahfuzul; Ray, Sougata Sinha; Stuehr, Dennis J.			Phosphorylation Controls Endothelial Nitric-oxide Synthase by Regulating Its Conformational Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFLAVIN ELECTRON-TRANSFER; HUMAN CYTOCHROME-P450 REDUCTASE; NO SYNTHASE; FMN DOMAIN; METHIONINE SYNTHASE; CALMODULIN-BINDING; DIFLAVIN REDUCTASE; 2-DOMAIN CONSTRUCT; ENZYME ACTIVATION; CATALYTIC CYCLE	The activity of endothelial NO synthase (eNOS) is triggered by calmodulin (CaM) binding and is often further regulated by phosphorylation at several positions in the enzyme. Phosphorylation at Ser(1179) occurs in response to diverse physiologic stimuli and increases the NO synthesis and cytochrome c reductase activities of eNOS, thereby enhancing its participation in biological signal cascades. Despite its importance, the mechanism by which Ser(1179) phosphorylation increases eNOS activity is not understood. To address this, we used stopped-flow spectroscopy and computer modeling approaches to determine how the phosphomimetic mutation (S1179D) may impact electron flux through eNOS and the conformational behaviors of its reductase domain, both in the absence and presence of bound CaM. We found that S1179D substitution in CaM-free eNOS had multiple effects; it increased the rate of flavin reduction, altered the conformational equilibrium of the reductase domain, and increased the rate of its conformational transitions. We found these changes were equivalent in degree to those caused by CaM binding to wild-type eNOS, and the S1179D substitution together with CaM binding caused even greater changes in these parameters. The modeling indicated that the changes caused by the S1179D substitution, despite being restricted to the reductase domain, are sufficient to explain the stimulation of both the cytochrome c reductase and NO synthase activities of eNOS. This helps clarify how Ser(1179) phosphorylation regulates eNOS and provides a foundation to compare its regulation by other phosphorylation events.	[Haque, Mohammad Mahfuzul; Ray, Sougata Sinha; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Haque, MM; Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	haquem@ccf.org; stuehrd@ccf.org		HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM051491, HL076491]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM051491 and HL076491 (to D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arnett DC, 2015, FEBS LETT, V589, P1173, DOI 10.1016/j.febslet.2015.03.035; Campbell MG, 2014, P NATL ACAD SCI USA, V111, pE3614, DOI 10.1073/pnas.1413763111; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; Feng CJ, 2006, J AM CHEM SOC, V128, P3808, DOI 10.1021/ja0578606; Finn RD, 2003, EUR J BIOCHEM, V270, P1164, DOI 10.1046/j.1432-1033.2003.03474.x; Frances O, 2015, BIOPHYS J, V108, P1527, DOI 10.1016/j.bpj.2015.01.032; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2012, FEBS J, V279, P1306, DOI 10.1111/j.1742-4658.2012.08525.x; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Gutierrez A, 2003, EUR J BIOCHEM, V270, P2612, DOI 10.1046/j.1432-1033.2003.03633.x; Hannibal L, 2015, BIOCHEM J, V467, P153, DOI 10.1042/BJ20141319; Haque MM, 2014, FEBS J, V281, P5325, DOI 10.1111/febs.13073; Haque MM, 2011, FEBS J, V278, P4055, DOI 10.1111/j.1742-4658.2011.08310.x; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2013, BIOCHEM J, V450, P607, DOI 10.1042/BJ20121488; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; He YF, 2015, P NATL ACAD SCI USA, V112, P11835, DOI 10.1073/pnas.1508829112; Hedison TM, 2015, FEBS J, V282, P4357, DOI 10.1111/febs.13501; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; KLATT P, 1992, J BIOL CHEM, V267, P11374; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Leferink NGH, 2015, FEBS J, V282, P3016, DOI 10.1111/febs.13171; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pudney CR, 2012, FEBS J, V279, P1534, DOI 10.1111/j.1742-4658.2011.08442.x; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Salerno JC, 2013, FEBS LETT, V587, P44, DOI 10.1016/j.febslet.2012.10.039; Sheng YH, 2015, J INORG BIOCHEM, V153, P186, DOI 10.1016/j.jinorgbio.2015.08.006; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tejero J, 2010, J BIOL CHEM, V285, P27232, DOI 10.1074/jbc.M110.138842; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Volkmann N, 2014, J STRUCT BIOL, V188, P46, DOI 10.1016/j.jsb.2014.08.006; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang ZQ, 2016, J INORG BIOCHEM, V158, P122, DOI 10.1016/j.jinorgbio.2016.03.002; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Yokom AL, 2014, J BIOL CHEM, V289, P16855, DOI 10.1074/jbc.M114.564005	57	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23047	23057		10.1074/jbc.M116.737361	http://dx.doi.org/10.1074/jbc.M116.737361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613870	Green Published, hybrid			2022-12-28	WOS:000387224800017
J	Izumikawa, T; Dejima, K; Watamoto, Y; Nomura, KH; Kanaki, N; Rikitake, M; Tou, M; Murata, D; Yanagita, E; Kano, A; Mitani, S; Nomura, K; Kitagawa, H				Izumikawa, Tomomi; Dejima, Katsufumi; Watamoto, Yukiko; Nomura, Kazuko H.; Kanaki, Nanako; Rikitake, Marika; Tou, Mai; Murata, Daisuke; Yanagita, Eri; Kano, Ai; Mitani, Shohei; Nomura, Kazuya; Kitagawa, Hiroshi			Chondroitin 4-O-Sulfotransferase Is Indispensable for Sulfation of Chondroitin and Plays an Important Role in Maintaining Normal Life Span and Oxidative Stress Responses in Nematodes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CAENORHABDITIS-ELEGANS; N-ACETYLGALACTOSAMINYLTRANSFERASE; POLYMERIZING FACTOR; LARVAL DEVELOPMENT; CELL-DIVISION; EXPRESSION; BIOSYNTHESIS; GLUCURONOSYLTRANSFERASE; SYNTHASE	Chondroitin sulfate (CS)/chondroitin (Chn) chains are indispensable for embryonic cell division and cytokinesis in the early developmental stages in Caenorhabditis elegans and mice, whereas heparan sulfate (HS) is essential for axon guidance during nervous system development. These data indicate that the fundamental functions of CS and HS are conserved from worms to mammals and that the function of CS/Chn differs from that of HS. Although previous studies have shown that C. elegans produces HS and non-sulfated Chn, whether the organism produces CS remains unclear. Here, we demonstrate that C. elegans produces a small amount of 4-O-sulfated Chn and report the identification of C41C4.1, an orthologue of the human chondroitin 4-O-sulfotransferase gene. Loss of C41C4.1 in C. elegans resulted in a decline in 4-O-sulfation of CS and an increase in the number of sulfated units in HS. C41C4.1 deletion mutants exhibited reduced survival rates after synchronization with sodium hypochlorite. Collectively, these results show for the first time that CS glycans are present in C. elegans and that the Chn 4-O-sulfotransferase responsible for the sulfation plays an important role in protecting nematodes from oxidative stress.	[Izumikawa, Tomomi; Watamoto, Yukiko; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan; [Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Dejima, Katsufumi; Nomura, Kazuko H.; Kanaki, Nanako; Rikitake, Marika; Tou, Mai; Murata, Daisuke; Yanagita, Eri; Kano, Ai; Nomura, Kazuya] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan	Kobe Pharmaceutical University; Tokyo Women's Medical University; Kyushu University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.; Nomura, K (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan.	knomuscb@kyushu-u.org; kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Corp.; Mizutani Foundation [120140];  [23110003];  [25293014];  [16H05088];  [16K07298]; Grants-in-Aid for Scientific Research [16K07298] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Corp.(Core Research for Evolutional Science and Technology (CREST)); Mizutani Foundation; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) and by Grants-in-aid for Scientific Research on Innovative Areas (23110003 to H. K.), Scientific Research B (25293014 and 16H05088 to H. K.), and Scientific Research C (16K07298 to K. N.). This work was also supported by grants from the Japan Society for the Promotion of Science (JSPS) and the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Corp. (to K. N.) and by Grant 120140 from the Mizutani Foundation (to K. N.). The authors declare that they have no conflicts of interest with respect to the contents of this article.	Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; Albertini R, 1997, FEBS LETT, V403, P154, DOI 10.1016/S0014-5793(97)00043-4; Albertini R, 1999, ARCH BIOCHEM BIOPHYS, V365, P143, DOI 10.1006/abbi.1999.1150; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Dejima K, 2010, J BIOL CHEM, V285, P24717, DOI 10.1074/jbc.M109.088229; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Fu XM, 2015, BIOCHEM BIOPH RES CO, V458, P896, DOI 10.1016/j.bbrc.2015.02.055; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; HABUCHI H, 1986, J BIOL CHEM, V261, P1031; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Izumikawa T, 2015, J BIOL CHEM, V290, P5438, DOI 10.1074/jbc.M114.603266; Izumikawa T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03701; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Johnston WL, 2012, GENESIS, V50, P333, DOI 10.1002/dvg.20823; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kiselova N, 2014, BIOCHEM BIOPH RES CO, V450, P598, DOI 10.1016/j.bbrc.2014.06.011; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Kitagawa H, 2014, BIOL PHARM BULL, V37, P1705, DOI 10.1248/bpb.b14-00613; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Koike T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08994; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; MATHEWS MB, 1966, J CLIN INVEST, V45, P1103, DOI 10.1172/JCI105416; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Miyata S, 2015, J BIOCHEM, V157, P13, DOI 10.1093/jb/mvu067; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizuguchi S, 2009, TRENDS GLYCOSCI GLYC, V21, P179, DOI 10.4052/tigg.21.179; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Ohkura K, 2011, BIOCHEM BIOPH RES CO, V406, P188, DOI 10.1016/j.bbrc.2011.02.003; Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008; Ortiz MA, 2014, G3-GENES GENOM GENET, V4, P1765, DOI 10.1534/g3.114.012351; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Shaham S., 2006, METHOD CELL BIOL, DOI [10.1895/wormbook.1.49.1, DOI 10.1895/WORMBOOK.1.49.1]; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Suttkus A, 2016, MOL NEUROBIOL, V53, P73, DOI 10.1007/s12035-014-8990-4; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsutsumi K, 1998, FEBS LETT, V441, P235, DOI 10.1016/S0014-5793(98)01532-4; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yutsudo N, 2015, EXP NEUROL, V274, P126, DOI 10.1016/j.expneurol.2015.07.009	65	15	16	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23294	23304		10.1074/jbc.M116.757328	http://dx.doi.org/10.1074/jbc.M116.757328			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27645998	hybrid, Green Published			2022-12-28	WOS:000387224800037
J	Piepenbrink, KH; Lillehoj, E; Harding, CM; Labonte, JW; Zuo, XT; Rapp, CA; Munson, RS; Goldblum, SE; Feldman, MF; Gray, JJ; Sundberg, EJ				Piepenbrink, Kurt H.; Lillehoj, Erik; Harding, Christian M.; Labonte, Jason W.; Zuo, Xiaotong; Rapp, Chelsea A.; Munson, Robert S., Jr.; Goldblum, Simeon E.; Feldman, Mario F.; Gray, Jeffrey J.; Sundberg, Eric J.			Structural Diversity in the Type IV Pili of Multidrug-resistant Acinetobacter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN-GLYCOSYLATION; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; BAUMANNII EVOLUTION; ANTIGENIC VARIATION; ESCHERICHIA-COLI; X-RAY; MOTILITY; IDENTIFICATION; PHENIX	Acinetobacter baumannii is a Gram-negative coccobacillus found primarily in hospital settings that has recently emerged as a source of hospital-acquired infections. A. baumannii expresses a variety of virulence factors, including type IV pili, bacterial extracellular appendages often essential for attachment to host cells. Here, we report the high resolution structures of the major pilin subunit, PilA, from three Acinetobacter strains, demonstrating that A. baumannii subsets produce morphologically distinct type IV pilin glycoproteins. We examine the consequences of this heterogeneity for protein folding and assembly as well as host-cell adhesion by Acinetobacter. Comparisons of genomic and structural data with pilin proteins from other species of soil gammaproteobacteria suggest that these structural differences stem from evolutionary pressure that has resulted in three distinct classes of type IVa pilins, each found in multiple species.	[Piepenbrink, Kurt H.; Rapp, Chelsea A.; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Goldblum, Simeon E.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Lillehoj, Erik] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Labonte, Jason W.; Zuo, Xiaotong; Gray, Jeffrey J.] Johns Hopkins Univ, Whiting Sch Engn, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Munson, Robert S., Jr.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Microbial Pathogenesis,Res Inst, Columbus, OH 43205 USA; [Munson, Robert S., Jr.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA; [Harding, Christian M.; Feldman, Mario F.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Johns Hopkins University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Washington University (WUSTL)	Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.; Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.; Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	esundberg@ihv.umaryland.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Piepenbrink, Kurt/0000-0002-2527-0301; Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074; Sundberg, Eric/0000-0003-0478-3033	National Institutes of Health [R01 AI114902]; National Institutes of Health Training Grant [T32 AI095190]; National Institutes of Health Fellowship [F32 AI110045, F32 CA189246]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114902, T32AI095190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R01 AI114902 (to E. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Training Grant T32 AI095190 and National Institutes of Health Fellowship F32 AI110045.r Supported by National Institutes of Health Fellowship F32 CA189246.	Aagesen AM, 2012, MICROB ECOL, V64, P509, DOI 10.1007/s00248-012-0021-2; Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allison TM, 2015, MICROBIOL-SGM, V161, P1780, DOI 10.1099/mic.0.000128; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Audette GF, 2004, BIOCHEMISTRY-US, V43, P11427, DOI 10.1021/bi048957s; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhardwaj V, 2014, VACCINE, V32, P6979, DOI 10.1016/j.vaccine.2014.10.031; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Blank TE, 2000, INFECT IMMUN, V68, P7028, DOI 10.1128/IAI.68.12.7028-7038.2000; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; Cagatay TI, 2008, VET MICROBIOL, V126, P160, DOI 10.1016/j.vetmic.2007.06.007; Carruthers Michael D, 2013, Genome Announc, V1, DOI 10.1128/genomeA.00906-13; Cehovin A, 2010, VACCINE, V28, P4817, DOI 10.1016/j.vaccine.2010.04.065; Chabane YN, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-62; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Doi Y, 2015, SEMIN RESP CRIT CARE, V36, P85, DOI 10.1055/s-0034-1398388; Drew K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067051; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Gault J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005162; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Harding CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005391; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Hu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070329; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jacobs AC, 2014, MBIO, V5, DOI 10.1128/mBio.01076-14; Jones A, 2006, LANCET INFECT DIS, V6, P317, DOI 10.1016/S1473-3099(06)70471-6; Jones CL, 2015, CLIN INFECT DIS, V61, P145, DOI 10.1093/cid/civ225; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Korpi Fatemeh, 2015, J Microbiol Biotechnol, DOI 10.4014/jmb.1507.07044; Lassak K, 2012, RES MICROBIOL, V163, P630, DOI 10.1016/j.resmic.2012.10.024; Lees-Miller RG, 2013, MOL MICROBIOL, V89, P816, DOI 10.1111/mmi.12300; Lillehoj EP, 2015, J BIOL CHEM, V290, P18316, DOI 10.1074/jbc.M115.657114; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Maldarelli GA, 2014, PATHOG DIS, V71, P302, DOI 10.1111/2049-632X.12137; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Oh MH, 2015, J MICROBIOL BIOTECHN, V25, P1390, DOI 10.4014/jmb.1504.04069; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piepenbrink KH, 2015, STRUCTURE, V23, P385, DOI 10.1016/j.str.2014.11.018; Piepenbrink KH, 2014, J BIOL CHEM, V289, P4334, DOI 10.1074/jbc.M113.534404; Scott NE, 2014, MOL CELL PROTEOMICS, V13, P2354, DOI 10.1074/mcp.M114.038315; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Smedley JG, 2005, INFECT IMMUN, V73, P7922, DOI 10.1128/IAI.73.12.7922-7931.2005; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Takahashi H, 2012, INFECT IMMUN, V80, P4154, DOI 10.1128/IAI.00423-12; Tan RM, 2015, INFECT IMMUN, V83, P1339, DOI 10.1128/IAI.02874-14; Tan RM, 2014, J INNATE IMMUN, V6, P227, DOI 10.1159/000354304; TANIGUCHI T, 1995, INFECT IMMUN, V63, P724, DOI 10.1128/IAI.63.2.724-728.1995; Toma C, 2002, FEMS IMMUNOL MED MIC, V33, P35, DOI 10.1111/j.1574-695X.2002.tb00569.x; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wilharm G, 2013, J BACTERIOL, V195, P4146, DOI 10.1128/JB.00754-13	75	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22924	22935		10.1074/jbc.M116.751099	http://dx.doi.org/10.1074/jbc.M116.751099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27634041	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000387224800006
J	Frey, AG; Palenchar, DJ; Wildemann, JD; Philpott, CC				Frey, Avery G.; Palenchar, Daniel J.; Wildemann, Justin D.; Philpott, Caroline C.			A Glutaredoxin center dot BolA Complex Serves as an Iron-Sulfur Cluster Chaperone for the Cytosolic Cluster Assembly Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotin; iron; iron-sulfur protein; metal homeostasis; metal ion-protein interaction; metalloprotein; BolA2; Ciapin1; Glrx3; Ndor1	SACCHAROMYCES-CEREVISIAE; MONOTHIOL GLUTAREDOXIN; PROTEIN BIOGENESIS; REGULATORY PROTEINS; PHP4 FUNCTION; 3 PICOT; ANAMORSIN; GRX4; HOMEOSTASIS; MATURATION	Cells contain hundreds of proteins that require iron cofactors for activity. Iron cofactors are synthesized in the cell, but the pathways involved in distributing heme, iron-sulfur clusters, and ferrous/ferric ions to apoproteins remain incompletely defined. In particular, cytosolic monothiol glutaredoxins and BolA-like proteins have been identified as [2Fe-2S]-coordinating complexes in vitro and iron-regulatory proteins in fungi, but it is not clear how these proteins function in mammalian systems or how this complex might affect Fe-S proteins or the cytosolic Fe-S assembly machinery. To explore these questions, we use quantitative immunoprecipitation and live cell proximity-dependent biotinylation to monitor interactions between Glrx3, BolA2, and components of the cytosolic iron-sulfur cluster assembly system. We characterize cytosolic Glrx3<bold>BolA</bold>2 as a [2Fe-2S] chaperone complex in human cells. Unlike complexes formed by fungal orthologs, human Glrx3-BolA2 interaction required the coordination of Fe-S clusters, whereas Glrx3 homodimer formation did not. Cellular Glrx3<bold>BolA</bold>2 complexes increased 6-8-fold in response to increasing iron, forming a rapidly expandable pool of Fe-S clusters. Fe-S coordination by Glrx3<bold>BolA</bold>2 did not depend on Ciapin1 or Ciao1, proteins that bind Glrx3 and are involved in cytosolic Fe-S cluster assembly and distribution. Instead, Glrx3 and BolA2 bound and facilitated Fe-S incorporation into Ciapin1, a [2Fe-2S] protein functioning early in the cytosolic Fe-S assembly pathway. Thus, Glrx3<bold>BolA is a </bold>[2Fe-2S] chaperone complex capable of transferring [2Fe-2S] clusters to apoproteins in human cells.	[Frey, Avery G.; Philpott, Caroline C.] NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bldg 10,Rm 9B-16,10 Ctr Dr,MSC 1800, Bethesda, MD 20892 USA; [Wildemann, Justin D.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; Ohio State University	Philpott, CC (corresponding author), NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bldg 10,Rm 9B-16,10 Ctr Dr,MSC 1800, Bethesda, MD 20892 USA.	Carolinep@mail.nih.gov			National Institutes of Health intramural research program of the NIDDK; Office of Dietary Supplements, Office of the Director, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054510] Funding Source: NIH RePORTER	National Institutes of Health intramural research program of the NIDDK; Office of Dietary Supplements, Office of the Director, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health intramural research program of the NIDDK and the Office of Dietary Supplements, Office of the Director, National Institutes of Health. This work was authored, in whole or in part, by National Institutes of Health staff. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Banci L, 2015, J AM CHEM SOC, V137, P16133, DOI 10.1021/jacs.5b10592; Banci L, 2015, NAT CHEM BIOL, V11, P772, DOI [10.1038/NCHEMBIO.1892, 10.1038/nchembio.1892]; Banci L, 2013, J BIOL INORG CHEM, V18, P883, DOI 10.1007/s00775-013-1033-1; Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; del Dedo JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005106; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jacques JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098959; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Jeong D, 2008, CIRC RES, V102, P711, DOI 10.1161/CIRCRESAHA.107.165985; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lipper CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139699; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Netz DJA, 2016, BIOCHEM J, V473, P2073, DOI 10.1042/BCJ20160416; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Oh JG, 2012, J MOL CELL CARDIOL, V53, P53, DOI 10.1016/j.yjmcc.2012.03.005; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Paul VD, 2015, ELIFE, V4, DOI 10.7554/eLife.08231; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; Stehling O., 2007, METHOD MOL BIOL, P325; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; Ueta R, 2012, MOL CELL BIOL, V32, P4998, DOI 10.1128/MCB.00726-12; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Zhang DL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00124; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang Y, 2014, P NATL ACAD SCI USA, V111, pE1695, DOI 10.1073/pnas.1405204111; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074	56	51	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22344	22356		10.1074/jbc.M116.744946	http://dx.doi.org/10.1074/jbc.M116.744946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27519415	Green Published, hybrid			2022-12-28	WOS:000386760600001
J	Xu, XH; Wang, JT; Li, M; Liu, YL				Xu, Xiaohua; Wang, Jiin-Tarng; Li, Min; Liu, Yilun			TIMELESS Suppresses the Accumulation of Aberrant CDC45 center dot MCM2-7 center dot GINS Replicative Helicase Complexes on Human Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cyclin-dependent kinase (CDK); DNA binding protein; DNA helicase; DNA replication; protein complex	CYCLIN-DEPENDENT KINASES; DNA-REPLICATION; CELL-CYCLE; S-PHASE; MCM2-7 HELICASE; SACCHAROMYCES-CEREVISIAE; RETINOBLASTOMA PROTEIN; INTERACTING PROTEIN; HUMAN FIBROBLASTS; UBIQUITIN LIGASE	The replication licensing factor CDC6 recruits the MCM2-7 replicative helicase to the replication origin, where MCM2-7 is activated to initiate DNA replication. MCM2-7 is activated by both the CDC7-Dbf4 kinase and cyclin-dependent kinase and via interactions with CDC45 and go-ichi-ni-san complex (GINS) to form the CDC45MCM2-7GINS (CMG) helicase complex. TIMELESS (TIM) is important for the subsequent coupling of CMG activity to DNA polymerases for efficient DNA synthesis. However, the mechanism by which TIM regulates CMG activity for proper replication fork progression remains unclear. Here we show that TIM interacts with MCM2-7 prior to the initiation of DNA replication. TIM depletion in various human cell lines results in the accumulation of aberrant CMG helicase complexes on chromatin. Importantly, the presence of these abnormal CMG helicase complexes is not restricted to cells undergoing DNA synthesis. Furthermore, even though these aberrant CMG complexes interact with the DNA polymerases on human chromatin, these complexes are not phosphorylated properly by cyclin-dependent kinase/CDC7-Dbf4 kinase and exhibit reduced DNA unwinding activity. This phenomenon coincides with a significant accumulation of the p27 and p21 replication inhibitors, reduced chromatin association of CDC6 and cyclin E, and a delay in S phase entry. Our results provide the first evidence that TIM is required for the correct chromatin association of the CMG complex to allow efficient DNA replication.	[Xu, Xiaohua; Wang, Jiin-Tarng; Li, Min; Liu, Yilun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, 1500 E Duarte Rd, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Liu, YL (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	yiliu@coh.org	Li, Min/J-9652-2017; liu, yi/GXE-9662-2022	Li, Min/0000-0002-7776-6536; xu, xioahua/0000-0003-3790-6386	NCI, National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA151245] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research reported in this publication included work performed in the Analytical Cytometry and Drug Discovery and Structural Biology Cores supported by the NCI, National Institutes of Health under Award P30CA33572. We thank Dr. Nancy Linford for comments and expert editing of the manuscript.	Aparicio T, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-18; Averbeck NB, 2014, CELL CYCLE, V13, P2509, DOI 10.4161/15384101.2015.941743; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Biggar KK, 2009, CURR GENOMICS, V10, P573, DOI 10.2174/138920209789503905; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Caracciolo V, 2006, ONCOGENE, V25, P5294, DOI 10.1038/sj.onc.1209681; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Foss EJ, 2001, GENETICS, V157, P567; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gamper AM, 2013, NUCLEIC ACIDS RES, V41, P10334, DOI 10.1093/nar/gkt833; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kim J, 2008, CELL CYCLE, V7, P146, DOI 10.4161/cc.7.2.5282; Komamura-Kohno Y, 2006, FEBS J, V273, P1224, DOI 10.1111/j.1742-4658.2006.05146.x; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Lunn CL, 2010, CELL CYCLE, V9, P4533, DOI 10.4161/cc.9.22.13789; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Masai H, 2005, IUBMB LIFE, V57, P323, DOI 10.1080/15216540500092419; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Moritani M, 2013, J BIOCHEM, V154, P363, DOI 10.1093/jb/mvt062; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Numata Y, 2010, J BIOCHEM, V147, P917, DOI 10.1093/jb/mvq028; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Park H, 1999, YEAST, V15, P35, DOI 10.1002/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.0.CO;2-R; Porras A, 1999, J VIROL, V73, P3102; Powell SK, 2015, EMBO J, V34, P531, DOI 10.15252/embj.201488307; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Smith-Roe SL, 2011, CELL CYCLE, V10, P1618, DOI 10.4161/cc.10.10.15613; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Wang JT, 2014, CELL REP, V7, P848, DOI 10.1016/j.celrep.2014.03.037; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034	79	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22544	22558		10.1074/jbc.M116.719963	http://dx.doi.org/10.1074/jbc.M116.719963			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587400	hybrid, Green Published			2022-12-28	WOS:000386760600016
J	Gong, JJ; Belinsky, G; Sagheer, U; Zhang, XC; Grippo, PJ; Chung, CH				Gong, Jingjing; Belinsky, Glenn; Sagheer, Usman; Zhang, Xuchen; Grippo, Paul J.; Chung, Chuhan			Pigment Epithelium-derived Factor (PEDF) Blocks Wnt3a Protein-induced Autophagy in Pancreatic Intraepithelial Neoplasms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; catalase; NFB (NFB); pancreas; superoxide dismutase (SOD); PEDF	NF-KAPPA-B; CANCER-CELLS; OXIDATIVE STRESS; TARGET GENES; EXPRESSION; MICE; ADENOCARCINOMA; DEATH; KRAS; CARCINOGENESIS	An increase in autophagy characterizes pancreatic carcinogenesis, but the signals that regulate this process are incompletely understood. Because canonical Wnt/-catenin signaling is necessary for the transition from early to advanced pancreatic intraepithelial neoplasia (PanIN) lesions, we assessed whether Wnt ligands and endogenous inhibitors of Wnt signaling modulate autophagy. In this study, canonical Wnt3a ligand induced autophagy markers and vacuoles in murine PanIN cells. Furthermore, pigment epithelium-derived factor (PEDF), a secreted glycoprotein known for its anti-tumor properties, blocked Wnt3a-directed induction of autophagy proteins. Autophagy inhibition was complemented by reciprocal regulation of the oxidative stress enzymes, superoxide dismutase 2 (SOD2) and catalase. Transcriptional control of Sod2 expression was mediated by PEDF-induced NFB nuclear translocation. PEDF-dependent SOD2 expression in PanIN lesions was recapitulated in a murine model of PanIN formation where PEDF was deleted. In human PanIN lesions, co-expression of PEDF and SOD2 was observed in the majority of early PanIN lesions (47/50, 94%), whereas PEDF and SOD2 immunolocalization in high-grade human PanIN-2/3 was uncommon (7/50, 14%). These results indicate that PEDF regulates autophagy through coordinate Wnt signaling blockade and NFB activation.	[Gong, Jingjing; Belinsky, Glenn; Chung, Chuhan] Yale Univ, Sch Med, Dept Med, 333 Cedar St, New Haven, CT 06520 USA; [Zhang, Xuchen] Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA; [Grippo, Paul J.] Univ Illinois, Dept Med, Sch Med, Chicago, IL 60612 USA; [Sagheer, Usman; Zhang, Xuchen; Chung, Chuhan] Vet Affairs Connecticut Healthcare Syst, West Haven, CT 06516 USA	Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Chung, CH (corresponding author), Yale Univ, Dept Med, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA.	chuhan.chung@yale.edu	zhang, xu/GYE-3558-2022	Zhang, Xuchen/0000-0002-1484-4672; Chung, Chuhan/0000-0003-2803-6745	National Institutes of Health [R21AA023607]; National Institutes of Health Liver Center Core Grant [DK34989]; Veterans Affairs Merit Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA023607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Liver Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant R21AA023607, National Institutes of Health Liver Center Core Grant DK34989, and a Veterans Affairs Merit Grant (to C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Saati T, 2013, AM J PATHOL, V182, P1996, DOI 10.1016/j.ajpath.2013.02.034; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Becerra SP, 2013, NAT REV CANCER, V13, P258, DOI 10.1038/nrc3484; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Chung CH, 2009, GASTROENTEROLOGY, V136, P331, DOI 10.1053/j.gastro.2008.09.065; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Du Q, 2009, CANCER RES, V69, P3764, DOI 10.1158/0008-5472.CAN-09-0014; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Garg AD, 2013, AUTOPHAGY, V9, P1292, DOI 10.4161/auto.25399; Gattu AK, 2013, FASEB J, V27, P4384, DOI 10.1096/fj.13-232900; Gibson SB, 2010, AUTOPHAGY, V6, P835, DOI 10.4161/auto.6.7.13335; Gong JJ, 2014, ONCOTARGET, V5, P2529, DOI 10.18632/oncotarget.1810; Grippo PJ, 2012, GUT, V61, P1454, DOI 10.1136/gutjnl-2011-300821; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P1199, DOI 10.1053/j.gastro.2013.02.007; Hase R, 2005, CLIN CANCER RES, V11, P8737, DOI 10.1158/1078-0432.CCR-05-1323; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2011, J BIOL CHEM, V286, P35943, DOI 10.1074/jbc.M111.266064; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Li F, 2015, J CELL PHYSIOL, V230, P1243, DOI 10.1002/jcp.24859; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Liou GY, 2016, CELL REP, V14, P2325, DOI 10.1016/j.celrep.2016.02.029; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Ma B, 2015, J CELL SCI, V128, P2430, DOI 10.1242/jcs.168542; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Philip B, 2013, GASTROENTEROLOGY, V145, P1449, DOI 10.1053/j.gastro.2013.08.018; Principe DR, 2016, ONCOTARGET, V7, P28218, DOI 10.18632/oncotarget.8587; Protiva P, 2015, CELL MOL GASTROENTER, V1, P535, DOI 10.1016/j.jcmgh.2015.06.006; Qi WW, 2015, DIABETES, V64, P1407, DOI 10.2337/db14-1111; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rao CV, 2012, NEOPLASIA, V14, P778, DOI 10.1593/neo.121026; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sreekumar BK, 2014, PANCREAS, V43, P1256, DOI 10.1097/MPA.0000000000000201; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Uehara H, 2004, CANCER RES, V64, P3533, DOI 10.1158/0008-5472.CAN-03-3725; WANG ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI [DOI 10.1038/nrgastro.2010.188, DOI 10.1038/NRGASTRO.2010.188]; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wheatley-Price P, 2008, CANCER-AM CANCER SOC, V112, P1037, DOI 10.1002/cncr.23267; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Williams JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043961; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yang SH, 2011, AUTOPHAGY, V7, P912, DOI 10.4161/auto.7.8.15762; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zhang YQ, 2013, CANCER RES, V73, P4909, DOI 10.1158/0008-5472.CAN-12-4384	47	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22074	22085		10.1074/jbc.M116.729962	http://dx.doi.org/10.1074/jbc.M116.729962			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27557659	Green Published, hybrid			2022-12-28	WOS:000386332600022
J	Pei, SS; Minhajuddin, M; D'Alessandro, A; Nemkov, T; Stevens, BM; Adane, B; Khan, N; Hagen, FK; Yadav, VK; De, S; Ashton, JM; Hansen, KC; Gutman, JA; Pollyea, DA; Crooks, PA; Smith, C; Jordan, CT				Pei, Shanshan; Minhajuddin, Mohammad; D'Alessandro, Angelo; Nemkov, Travis; Stevens, Brett M.; Adane, Biniam; Khan, Nabilah; Hagen, Fred K.; Yadav, Vinod K.; De, Subhajyoti; Ashton, John M.; Hansen, Kirk C.; Gutman, Jonathan A.; Pollyea, Daniel A.; Crooks, Peter A.; Smith, Clayton; Jordan, Craig T.			Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; drug development; drug resistance; endoplasmic reticulum stress (ER stress); leukemia; oxidative stress; 2-deoxyglucose; drug combination; parthenolide; temsirolimus	ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; SESQUITERPENE LACTONES; PROGENITOR CELLS; HUMAN CANCERS; EXPRESSION; INHIBITION; STRESS; HETEROGENEITY; PROTEOSTASIS	Although multidrug approaches to cancer therapy are common, few strategies are based on rigorous scientific principles. Rather, drug combinations are largely dictated by empirical or clinical parameters. In the present study we developed a strategy for rational design of a regimen that selectively targets human acute myelogenous leukemia (AML) stem cells. As a starting point, we used parthenolide, an agent shown to target critical mechanisms of redox balance in primary AML cells. Next, using proteomic, genomic, and metabolomic methods, we determined that treatment with parthenolide leads to induction of compensatory mechanisms that include up-regulated NADPH production via the pentose phosphate pathway as well as activation of the Nrf2-mediated oxidative stress response pathway. Using this knowledge we identified 2-deoxyglucose and temsirolimus as agents that can be added to a parthenolide regimen as a means to inhibit such compensatory events and thereby further enhance eradication of AML cells. We demonstrate that the parthenolide, 2-deoxyglucose, temsirolimus (termed PDT) regimen is a potent means of targeting AML stem cells but has little to no effect on normal stem cells. Taken together our findings illustrate a comprehensive approach to designing combination anticancer drug regimens.	[Pei, Shanshan; Minhajuddin, Mohammad; Stevens, Brett M.; Adane, Biniam; Khan, Nabilah; Gutman, Jonathan A.; Pollyea, Daniel A.; Smith, Clayton; Jordan, Craig T.] Univ Colorado Denver, Div Hematol, Aurora, CO 80045 USA; [D'Alessandro, Angelo; Nemkov, Travis; Hansen, Kirk C.] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Hagen, Fred K.] Univ Rochester, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA; [Ashton, John M.] Univ Rochester, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Yadav, Vinod K.; De, Subhajyoti] Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA; [Crooks, Peter A.] Univ Arkansas, Dept Pharmaceut Sci, Little Rock, AR 72205 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Rochester; University of Rochester; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Jordan, CT (corresponding author), Univ Colorado, Anschutz Med Campus,12700 E 19th Ave,Rm 10016, Aurora, CO 80045 USA.	craig.jordan@ucdenver.edu	PEI, SHANSHAN/D-8200-2016; Minhajuddin, Mohammad/AAC-9227-2022; D'Alessandro, Angelo/AAA-4695-2019; Stevens, Brett/AAL-1800-2021; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; D'Alessandro, Angelo/0000-0002-2258-6490; jordan, craig/0000-0003-0869-3465; Ashton, John/0000-0001-9875-5994	National Institutes of Health [R01 CA158275, R33 CA183685]; Leukemia and Lymphoma Society [TRP 6230-11, 6133-12]; NATIONAL CANCER INSTITUTE [R33CA183685, T32CA082086, R01CA158275] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA158275 (to P. A. C.) and R33 CA183685 (to K. C. H.). This work was also supported by Leukemia and Lymphoma Society Grants TRP 6230-11 and 6133-12 (to C. T. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003; Catenacci DVT, 2015, MOL ONCOL, V9, P967, DOI 10.1016/j.molonc.2014.09.011; D'Alessandro A, 2015, TRANSFUSION, V55, P1155, DOI 10.1111/trf.12975; D'Alessandro A, 2014, ONCOTARGET, V5, P7722, DOI 10.18632/oncotarget.2300; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Engreitz JM, 2010, J BIOMED INFORM, V43, P932, DOI 10.1016/j.jbi.2010.07.001; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Er TK, 2007, CLIN BIOCHEM, V40, P1015, DOI 10.1016/j.clinbiochem.2007.05.013; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Hassane DC, 2010, BLOOD, V116, P5983, DOI 10.1182/blood-2010-04-278044; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hoey T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001056; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000914; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Krause DS, 1996, BLOOD, V87, P1; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Mathema VB, 2012, INFLAMMATION, V35, P560, DOI 10.1007/s10753-011-9346-0; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nasim S, 2011, BIOORGAN MED CHEM, V19, P1515, DOI 10.1016/j.bmc.2010.12.045; Nemkov T, 2015, AMINO ACIDS, V47, P2345, DOI 10.1007/s00726-015-2019-9; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pei SS, 2013, J BIOL CHEM, V288, P33542, DOI 10.1074/jbc.M113.511170; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Sahasrabuddhe AA, 2015, IMMUNOL REV, V263, P224, DOI 10.1111/imr.12236; Salk JJ, 2010, ANNU REV PATHOL-MECH, V5, P51, DOI 10.1146/annurev-pathol-121808-102113; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Spaans SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00742; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhang Q, 2012, J MED CHEM, V55, P8757, DOI 10.1021/jm301064b; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	60	26	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21984	22000		10.1074/jbc.M116.750653	http://dx.doi.org/10.1074/jbc.M116.750653			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573247	Green Published, hybrid			2022-12-28	WOS:000386332600014
J	Qin, XK; Wang, YL; Paudel, HK				Qin, Xike; Wang, Yunling; Paudel, Hemant K.			Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of beta-Secretase 1 (BACE-1) in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (A); early growth response protein 1 (EGR1); gene regulation; neuroscience; promoter; transcription factor	ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; A-BETA; SYNAPTIC PLASTICITY; PRESENILIN-2 GENE; PROMOTER ACTIVITY; PEPTIDE LEVELS; EXPRESSION; PROTEIN; STRESS	Accumulation of amyloid- peptide (A) in the brain is regarded as central to Alzheimer's disease (AD) pathogenesis. A is generated by a sequential cleavage of amyloid precursor protein (APP) by -secretase 1 (BACE-1) followed by -secretase. BACE-1 cleavage of APP is the committed step in A synthesis. Understanding the mechanism by which BACE-1 is activated leading to A synthesis in the brain can provide better understanding of AD pathology and help to develop novel therapies. In this study, we found that the levels of A and BACE-1 are significantly reduced in the brains of mice lacking transcription factor early growth response 1 (Egr-1) when compared with the WT. We demonstrate that in COS-7 cells, Egr-1 binds to the BACE-1 promoter and activates BACE-1 transcription. In rat hippocampal primary neurons, overexpression of Egr-1 induces BACE-1 expression, activates BACE-1, promotes amyloidogenic APP processing, and enhances A synthesis. In mouse hippocampal primary neurons, knockdown of BACE-1 almost completely blocks Egr-1-induced amyloidogenic APP processing and A synthesis. Our data indicate that Egr-1 promotes A synthesis via transcriptional activation of BACE-1 and suggest that Egr-1 plays role in activation of BACE-1 and acceleration of A synthesis in AD brain. Egr-1 is a potential therapeutic target for AD.	[Qin, Xike; Wang, Yunling; Paudel, Hemant K.] Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada; [Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H4H 1R3, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer's Society of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada	This work was supported by grants from Canadian Institute for Health Research and Alzheimer's Society of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Bakalash S, 2011, INVEST OPHTH VIS SCI, V52, P9033, DOI 10.1167/iovs.11-7498; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Chu J, 2012, ANN NEUROL, V71, P57, DOI 10.1002/ana.22625; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cole SL, 2009, NEUROBIOL AGING, V30, P1535, DOI 10.1016/j.neurobiolaging.2007.12.012; Coma M, 2008, NEUROBIOL AGING, V29, P969, DOI 10.1016/j.neurobiolaging.2007.01.009; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Gatta V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.11; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Hendrickx A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074305; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; MacGibbon GA, 1997, EXP NEUROL, V147, P316, DOI 10.1006/exnr.1997.6600; Marwarha G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070773; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mokin M, 2006, J NEUROPHYSIOL, V95, P215, DOI 10.1152/jn.00737.2005; Mukherjee A, 2002, J ALZHEIMERS DIS, V4, P341, DOI 10.3233/JAD-2002-4501; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Ounallah-Saad H, 2009, GENE, V446, P81, DOI 10.1016/j.gene.2009.06.015; Piccini A, 2012, J NEUROCHEM, V122, P1023, DOI 10.1111/j.1471-4159.2012.07834.x; Qin XK, 2015, J BIOL CHEM, V290, P29603, DOI 10.1074/jbc.M115.668889; Renbaum P, 2003, GENE, V318, P113, DOI 10.1016/S0378-1119(03)00766-2; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stanzione R, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.370; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zimmerman SM, 2014, AGING CELL, V13, P329, DOI 10.1111/acel.12179	61	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22276	22287		10.1074/jbc.M116.738849	http://dx.doi.org/10.1074/jbc.M116.738849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27576688	hybrid, Green Published			2022-12-28	WOS:000386332600038
J	Kawashima, N; Nishimiya, Y; Takahata, S; Nakayama, K				Kawashima, Nagako; Nishimiya, Yoshiyuki; Takahata, Shouta; Nakayama, Ken-ichi			Induction of Glycosphingolipid GM3 Expression by Valproic Acid Suppresses Cancer Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; epidermal growth factor receptor (EGFR); ganglioside; glycolipid; histone deacetylase inhibitor (HDAC inhibitor) (HDI); GM3; glycosphingolipid; valproic acid	GANGLIOSIDE-MEDIATED MODULATION; TYROSINE KINASE-ACTIVITY; FACTOR RECEPTOR; HISTONE DEACETYLASE; INSULIN-RECEPTOR; PHOSPHORYLATION; SYNTHASE; GENE; DIFFERENTIATION; GLYCOLIPIDS	Glycosphingolipid GM3, a known suppressor of epidermal growth factor receptor (EGFR) phosphorylation, inhibits cell proliferation. Valproic acid, conversely, is known as an up-regulator of GM3 synthase gene (ST3GAL5). To test the possibility that valproic acid could inhibit EGFR phosphorylation by increasing the level of GM3 in cells, we treated A431 epidermoid carcinoma cells with valproic acid and found that valproic acid treatment caused an about 6-fold increase in the GM3 level but only a marginal increase in the GM2 level in these cells and that the observed increase in GM3 level was valproic acid dose-dependent. Consistent with this observation, valproic acid treatment induced GM3 synthase gene expression by about 8-fold. Furthermore, phosphorylation of EGFR was reduced, and cell proliferation was inhibited following valproic acid treatment. Consistent with these results, transient expression of GM3 synthase gene in A431 cells also increased cellular level of GM3, reduced phosphorylation of EGFR, and inhibited cell proliferation. Treatment with l-phenyl-2-decanoylamino-3-morpholino-l-propanol, an inhibitor of glucosylceramide synthesis, decreased the cellular level of GM3 and reduced the inhibitory effects of valproic acid on EGFR phosphorylation and cell proliferation. These results suggested that induction of GM3 synthesis was enough to inhibit proliferation of cancer cells by suppressing EGFR activity. Valproic acid treatment similarly increased the GM3 level and reduced phosphorylation of EGFR in U87MG glioma cells and inhibited their proliferation. These results suggested that up-regulators of GM3 synthase gene, such as valproic acid, are potential suppressors of cancer cell proliferation.	[Kawashima, Nagako; Nishimiya, Yoshiyuki; Takahata, Shouta; Nakayama, Ken-ichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido 0628517, Japan; [Kawashima, Nagako] Pacific Northwest Res Inst, Div Biomembrane Res Inst, Seattle, WA 98122 USA; [Nakayama, Ken-ichi] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Hiroshima 7390046, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Nakayama, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Hiroshima 7390046, Japan.	k-nakayama@aist.go.jp	Nishimiya, Yoshiyuki/M-4173-2018	Nishimiya, Yoshiyuki/0000-0002-0701-7775				Alvarez-Breckenridge CA, 2012, J VIROL, V86, P4566, DOI 10.1128/JVI.05545-11; BREMER EG, 1984, J BIOL CHEM, V259, P6818; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Fu J, 2010, NEURO-ONCOLOGY, V12, P328, DOI 10.1093/neuonc/nop005; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; HAKOMORI SI, 1977, VIROLOGY, V76, P485, DOI 10.1016/0042-6822(77)90231-8; HAKOMORI SI, 1971, VIROLOGY, V44, P609, DOI 10.1016/0042-6822(71)90375-8; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; INOKUCHI JI, 1987, J LIPID RES, V28, P565; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Makino A, 2006, BIOCHEMISTRY-US, V45, P4530, DOI 10.1021/bi052104y; Masoudi A, 2008, ANTICANCER RES, V28, P2437; Miura Y, 2004, P NATL ACAD SCI USA, V101, P16204, DOI 10.1073/pnas.0407297101; Noguchi M, 2007, CANCER SCI, V98, P1625, DOI 10.1111/j.1349-7006.2007.00578.x; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; Okuda T, 2010, GLYCOCONJUGATE J, V27, P287, DOI 10.1007/s10719-009-9277-2; Osuka S, 2012, NEUROL MED-CHIR, V52, P186, DOI 10.2176/nmc.52.186; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Song N, 2011, BMB REP, V44, P405, DOI 10.5483/BMBRep.2011.44.6.405; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; Tsai YT, 2014, J NEUROCHEM, V128, P101, DOI 10.1111/jnc.12456; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; ZHOU QG, 1994, J BIOL CHEM, V269, P1959	26	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21424	21433		10.1074/jbc.M116.751503	http://dx.doi.org/10.1074/jbc.M116.751503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539856	Green Published, hybrid			2022-12-28	WOS:000385999200011
J	Lu, H; Fagnant, PM; Krementsova, EB; Trybus, KM				Lu, Hailong; Fagnant, Patricia M.; Krementsova, Elena B.; Trybus, Kathleen M.			Severe Molecular Defects Exhibited by the R179H Mutation in Human Vascular Smooth Muscle -Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cofilin; contractile protein; formin; myosin; profilin; vascular smooth muscle cells	THORACIC AORTIC-ANEURYSMS; F-ACTIN; ACTA2 MUTATIONS; DYNAMICS; CELL; POLYMERIZATION; TROPOMYOSIN; DISEASE; DEPOLYMERIZATION; DISSECTIONS	Mutations in vascular smooth muscle -actin (SM -actin), encoded by ACTA2, are the most common cause of familial thoracic aortic aneurysms that lead to dissection (TAAD). The R179H mutation has a poor patient prognosis and is unique in causing multisystemic smooth muscle dysfunction (Milewicz, D. M., Ostergaard, J. R., Ala-Kokko, L. M., Khan, N., Grange, D. K., Mendoza-Londono, R., Bradley, T. J., Olney, A. H., Ades, L., Maher, J. F., Guo, D., Buja, L. M., Kim, D., Hyland, J. C., and Regalado, E. S. (2010) Am. J. Med. Genet. A 152A, 2437-2443). Here, we characterize this mutation in expressed human SM -actin. R179H actin shows severe polymerization defects, with a 40-fold higher critical concentration for assembly than WT SM -actin, driven by a high disassembly rate. The mutant filaments are more readily severed by cofilin. Both defects are attenuated by copolymerization with WT. The R179H monomer binds more tightly to profilin, and formin binding suppresses nucleation and slows polymerization rates. Linear filaments will thus not be readily formed, and cells expressing R179H actin will likely have increased levels of monomeric G-actin. The cotranscription factor myocardin-related transcription factor-A, which affects cellular phenotype, binds R179H actin with less cooperativity than WT actin. Smooth muscle myosin moves R179H filaments more slowly than WT, even when copolymerized with equimolar amounts of WT. The marked decrease in the ability to form filaments may contribute to the poor patient prognosis and explain why R179H disrupts even visceral smooth muscle cell function where the SM -actin isoform is present in low amounts. The R179H mutation has the potential to affect actin structure and function in both the contractile domain of the cell and the more dynamic cytoskeletal pool of actin, both of which are required for contraction.	[Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05446 USA; Univ Vermont, Burlington, VT 05446 USA	University of Vermont; University of Vermont	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05446 USA.	kathleen.trybus@uvm.edu	lu, hailong/C-7754-2009		National Institutes of Health [P01 HL110869]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant P01 HL110869. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aktories K, 2012, TOXICON, V60, P572, DOI 10.1016/j.toxicon.2012.04.338; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Barua B, 2013, J BIOL CHEM, V288, P9602, DOI 10.1074/jbc.M113.451161; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; De la Cruz EM, 2015, BIOPHYS J, V108, P2270, DOI 10.1016/j.bpj.2015.03.058; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Gallant C, 2011, AM J PHYSIOL-CELL PH, V300, pC1356, DOI 10.1152/ajpcell.00450.2010; Georgescu MM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0262-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Lu H, 2015, P NATL ACAD SCI USA, V112, pE4168, DOI 10.1073/pnas.1507587112; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 2010, AM J MED GENET A, V152A, P2437, DOI 10.1002/ajmg.a.33657; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Morisaki H, 2009, HUM MUTAT, V30, P1406, DOI 10.1002/humu.21081; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Mouilleron S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001750; Munot P, 2012, BRAIN, V135, P2506, DOI 10.1093/brain/aws172; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Regalado ES, 2015, CIRC-CARDIOVASC GENE, V8, P457, DOI 10.1161/CIRCGENETICS.114.000943; STRAUCH AR, 1984, J BIOL CHEM, V259, P7224; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Torres RA, 2011, ARTERIOSCL THROM VAS, V31, P2424, DOI 10.1161/ATVBAHA.111.232769; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Wangler MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004258; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yamin R, 2012, J PHYSIOL-LONDON, V590, P4145, DOI 10.1113/jphysiol.2012.232306; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zimmerman RA, 2004, J UROLOGY, V172, P1667, DOI 10.1097/01.ju.0000139874.48574.1b	36	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21729	21739		10.1074/jbc.M116.744011	http://dx.doi.org/10.1074/jbc.M116.744011			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551047	hybrid, Green Published			2022-12-28	WOS:000385999200037
J	Mezza, T; Shirakawa, J; Martinez, R; Hu, J; Giaccari, A; Kulkarni, RN				Mezza, Teresa; Shirakawa, Jun; Martinez, Rachael; Hu, Jiang; Giaccari, Andrea; Kulkarni, Rohit N.			Nuclear Export of FoxO1 Is Associated with ERK Signaling in -Cells Lacking Insulin Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (-cell); FOXO; insulin; insulin receptor; signal transduction	PANCREATIC BETA-CELLS; GENE-EXPRESSION; PROTEIN-KINASE; GLUCOSE-HOMEOSTASIS; ADIPOSE-TISSUE; IN-VIVO; SECRETION; MICE; ACTIVATION; GROWTH	The insulin/insulin-like growth factor (IGF) signaling pathway plays a critical role in the regulation of islet cell biology. However, the signaling pathway(s) utilized by insulin to directly modulate -cells is unclear. To interrogate whether insulin exerts endocrine effects in regulating proteins in the insulin/IGF-1 signaling cascade in vivo in physiological states via the insulin receptor, we designed two experimental approaches: 1) glucose gavage and 2) hyperinsulinemic intravenous infusion, for studies in either -cell specific insulin receptor knock-out (IRKO) or control mice. Immunostaining of sections of pancreas (collected immediately after glucose gavage or insulin infusion) from controls showed significant increases in pAKT+, p-p70S6K+, and pERK+ -cells and a significant decrease in % nuclear FoxO1+ -cells compared with corresponding vehicle-treated groups. In contrast, in IRKOs, we observed no significant changes in pAKT+ or p-p70S6K+ -cells in either experiment; however, pERK+ -cells were significantly increased, and an attenuated decrease in % nuclear FoxO1+ cells was evident in response to glucose gavage or insulin infusion. Treatment of control and IRKO -cell lines with glucose or insulin showed significantly decreased % nuclear FoxO1+ -cells suggesting direct effects. Furthermore, blocking MAPK signaling had virtually no effect on FoxO1 nuclear export in controls, in contrast to attenuated export in IRKO -cells. These data suggest insulin acts on -cells in an endocrine manner in the normal situation; and that in -cells lacking insulin receptors, insulin and glucose minimally activate the Akt pathway, while ERK phosphorylation and FoxO1 nuclear export occur independently of insulin signaling.	[Mezza, Teresa; Shirakawa, Jun; Martinez, Rachael; Hu, Jiang; Kulkarni, Rohit N.] Harvard Med Sch, Harvard Stem Cell Inst, Brigham & Womens Hosp, Islet Cell & Regenerat Biol,Joslin Diabet Ctr,Dep, Boston, MA 02215 USA; [Mezza, Teresa; Giaccari, Andrea] Univ Cattolica Sacro Cuore, Ctr Endocrine & Metab Dis, Policlin Gemelli, I-00168 Rome, Italy	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Kulkarni, RN (corresponding author), Joslin Diabet Ctr, Islet Cell & Regenerat Biol, 1 Joslin Pl, Boston, MA 02215 USA.	Rohit.Kulkarni@joslin.harvard.edu	Giaccari, Andrea/AAA-7824-2022	Giaccari, Andrea/0000-0002-7462-7792; Shirakawa, Jun/0000-0002-0822-8750	National Institutes of Health, Diabete Ricerca [R01 DK67536, R01 DK103215]; European Society for Clinical Nutrition and Metabolism; European Foundation for the study of Diabetes and Universita Cattolica del Sacro Cuore, Linea [D3.2 2015]; Japan Society for the Promotion of Science (JSPS); European Foundation for the Study of Diabetes [AZ CP 2014_2] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536, P30DK036836, R01DK103215] Funding Source: NIH RePORTER	National Institutes of Health, Diabete Ricerca(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Society for Clinical Nutrition and Metabolism; European Foundation for the study of Diabetes and Universita Cattolica del Sacro Cuore, Linea; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Foundation for the Study of Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grants R01 DK67536 (to R. N. K.) and R01 DK103215 (to R. N. K.) from the National Institutes of Health, Diabete Ricerca (to A. G. and T. M.), European Society for Clinical Nutrition and Metabolism (to T. M.), European Foundation for the study of Diabetes and Universita Cattolica del Sacro Cuore, Linea D3.2 2015 (to A. G.), and the Japan Society for the Promotion of Science (JSPS) (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Fabrizi M, 2014, DIABETES, V63, P2086, DOI 10.2337/db13-0939; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Halperin F, 2012, DIABETES, V61, P301, DOI 10.2337/db11-1067; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; LeRoith D, 2006, INT J BIOCHEM CELL B, V38, P904, DOI 10.1016/j.biocel.2005.01.019; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Lopez X, 2011, J CLIN ENDOCR METAB, V96, P3811, DOI 10.1210/jc.2011-0627; Mari A, 2011, DIABETES, V60, P3141, DOI 10.2337/db11-0827; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Mezza T, 2014, DIABETOLOGIA, V57, P1291, DOI 10.1007/s00125-014-3251-7; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Ohsugi M, 2005, J BIOL CHEM, V280, P4992, DOI 10.1074/jbc.M411727200; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Stamateris RE, 2016, DIABETES, V65, P981, DOI 10.2337/db15-0529; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Zhang C, 2016, AM J PHYSIOL-ENDOC M, V310, pE874, DOI 10.1152/ajpendo.00318.2015	30	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21485	21495		10.1074/jbc.M116.735738	http://dx.doi.org/10.1074/jbc.M116.735738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27535223	Green Published, hybrid			2022-12-28	WOS:000385999200016
J	Sun, M; Cai, JY; Anderson, RA; Sun, Y				Sun, Ming; Cai, Jinyang; Anderson, Richard A.; Sun, Yue			Type I Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; E3 ubiquitin ligase; epidermal growth factor receptor (EGFR); phosphatidylinositol phosphatase; ubiquitylation (ubiquitination); Mig6; NEDD4-1; PIPKIi5; tumor suppressor	GROWTH-FACTOR RECEPTOR; EGF RECEPTOR; LUNG-CANCER; CELL-MIGRATION; KINASE DOMAIN; ENDOGENOUS INHIBITOR; NEGATIVE REGULATOR; DOWN-REGULATION; C2 DOMAIN; GAMMA	Mitogen-inducible gene 6 (Mig6) is a tumor suppressor, and the disruption of Mig6 expression is associated with cancer development. Mig6 directly interacts with epidermal growth factor receptor (EGFR) to suppress the activation and downstream signaling of EGFR. Therefore, loss of Mig6 enhances EGFR-mediated signaling and promotes EGFR-dependent carcinogenesis. The molecular mechanism modulating Mig6 expression in cancer remains unclear. Here we demonstrate that type I phosphatidylinositol phosphate 5-kinase i5 (PIPKIi5), an enzyme producing phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2), stabilizes Mig6 expression. Knockdown of PIPKIi5 leads to the loss of Mig6 expression, which dramatically enhances and prolongs EGFR-mediated cell signaling. Loss of PIPKIi5 significantly promotes Mig6 protein degradation via proteasomes, but it does not affect the Mig6 mRNA level. PIPKIi5 directly interacts with the E3 ubiquitin ligase neuronal precursor cell-expressed developmentally down-regulated 4-1 (NEDD4-1). The C-terminal domain of PIPKIi5 and the WW1 and WW2 domains of NEDD4-1 are required for their interaction. The C2 domain of NEDD4-1 is required for its interaction with PtdIns(4,5)P-2. By binding with NEDD4-1 and producing PtdIns(4,5)P-2, PIPKIi5 perturbs NEDD4-1-mediated Mig6 ubiquitination and the subsequent proteasomal degradation. Thus, loss of NEDD4-1 can rescue Mig6 expression in PIPKIi5 knockdown cells. In this way, PIPKIi5, NEDD4-1, and Mig6 form a novel molecular nexus that controls EGFR activation and downstream signaling.	[Sun, Ming; Cai, Jinyang; Sun, Yue] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Sch Dent, 4154 Perkinson Bldg,1101 E Leigh St,POB 980566, Richmond, VA 23298 USA; [Sun, Ming; Cai, Jinyang; Sun, Yue] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Massey Canc Ctr, 4154 Perkinson Bldg,1101 E Leigh St,POB 980566, Richmond, VA 23298 USA; [Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Wisconsin System; University of Wisconsin Madison	Sun, Y (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Sch Dent, 4154 Perkinson Bldg,1101 E Leigh St,POB 980566, Richmond, VA 23298 USA.; Sun, Y (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Massey Canc Ctr, 4154 Perkinson Bldg,1101 E Leigh St,POB 980566, Richmond, VA 23298 USA.	ysun4@vcu.edu	Cai, Jinyang/HCH-0290-2022	Anderson, Richard/0000-0001-6265-8359; Cai, Jinyang/0000-0002-7385-8281	Scientist Development Grant from the American Heart Association [12SDG11950022]; Institutional Research Grant from the American Cancer Society [IRG-14-192-40]	Scientist Development Grant from the American Heart Association(American Heart Association); Institutional Research Grant from the American Cancer Society	This work was supported by Scientist Development Grant 12SDG11950022 from the American Heart Association and Institutional Research Grant IRG-14-192-40 from the American Cancer Society. The authors declare that they have no conflicts of interest with the contents of this article.	Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Casalini P, 2004, J CELL PHYSIOL, V200, P343, DOI 10.1002/jcp.20007; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Emerling BM, 2013, CELL, V155, P844, DOI 10.1016/j.cell.2013.09.057; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Grandal MV, 2007, CARCINOGENESIS, V28, P1408, DOI 10.1093/carcin/bgm058; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jung S, 2013, INT J ONCOL, V43, P1587, DOI 10.3892/ijo.2013.2064; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Maity TK, 2015, CANCER DISCOV, V5, P534, DOI 10.1158/2159-8290.CD-14-0750; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Nie J, 2010, FEBS LETT, V584, P3021, DOI 10.1016/j.febslet.2010.05.034; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakurada A, 2006, CLIN LUNG CANCER, V7, pS138, DOI 10.3816/CLC.2006.s.005; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sun AQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-248; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thapa N, 2015, J BIOL CHEM, V290, P18843, DOI 10.1074/jbc.M114.596742; Thapa N, 2013, J BIOL CHEM, V288, P34707, DOI 10.1074/jbc.M113.512848; Tsunoda T, 2002, CANCER RES, V62, P5668; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Xia Y, 2011, BIOCHEM BIOPH RES CO, V411, P416, DOI 10.1016/j.bbrc.2011.06.168; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yang YL, 2009, ENDOCRINOLOGY, V150, P727, DOI 10.1210/en.2008-0090; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	67	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21461	21473		10.1074/jbc.M116.736041	http://dx.doi.org/10.1074/jbc.M116.736041			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27557663	Green Published, hybrid			2022-12-28	WOS:000385999200014
J	Saadane, A; Mast, N; Dao, T; Ahmad, B; Pikuleva, IA				Saadane, Aicha; Mast, Natalia; Dao, Tung; Ahmad, Baseer; Pikuleva, Irina A.			Retinal Hypercholesterolemia Triggers Cholesterol Accumulation and Esterification in Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); cholesterol; cholesterol metabolism; cytochrome P450; eye; gas chromatography-mass spectrometry (GC-MS); pathogenesis; retina; retinal degeneration; retinal metabolism	SUBRETINAL DRUSENOID DEPOSITS; LIPOPROTEIN-LIKE PARTICLES; RETICULAR MACULAR DISEASE; AGE-RELATED MACULOPATHY; HUMAN BRUCHS MEMBRANE; ACYL-COENZYME; GEOGRAPHIC ATROPHY; MOUSE RETINA; LIPID HISTOCHEMISTRY; ACYLTRANSFERASE ACAT	The process of vision is impossible without the photoreceptor cells, which have a unique structure and specific maintenance of cholesterol. Herein we report on the previously unrecognized cholesterol-related pathway in the retina discovered during follow-up characterizations of Cyp27a1(-/-)Cyp46a1(-/-) mice. These animals have retinal hypercholesterolemia and convert excess retinal cholesterol into cholesterol esters, normally present in the retina in very small amounts. We established that in the Cyp27a1(-/-)Cyp46a1(-/-) retina, cholesterol esters are generated by and accumulate in the photoreceptor outer segments (OS), which is the retinal layer with the lowest cholesterol content. Mouse OS were also found to express the cholesterol-esterifying enzyme acyl-coenzyme A:cholesterol acyltransferase (ACAT1), but not lecithin-cholesterol acyltransferase (LCAT), and to differ from humans in retinal expression of ACAT1. Nevertheless, cholesterol esters were discovered to be abundant in human OS. We suggest a mechanism for cholesterol ester accumulation in the OS and that activity impairment of ACAT1 in humans may underlie the development of subretinal drusenoid deposits, a hallmark of age-related macular degeneration, which is a common blinding disease. We generated Cyp27a1(-/-)Cyp46a1(-/-)Acat1(-/-) mice, characterized their retina by different imaging modalities, and confirmed that unesterified cholesterol does accumulate in their OS and that there is photoreceptor apoptosis and OS degeneration in this line. Our results provide insights into the retinal response to local hypercholesterolemia and the retinal significance of cholesterol esterification, which could be cell-specific and both beneficial and detrimental for retinal structure and function.	[Saadane, Aicha; Mast, Natalia; Dao, Tung; Ahmad, Baseer; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd,Rm 303a, Cleveland, OH 44106 USA; [Ahmad, Baseer] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd,Rm 303a, Cleveland, OH 44106 USA.	iap8@case.edu		Saadane, Aicha/0000-0001-9985-2147; Pikuleva, Irina/0000-0001-9742-6232	National Institutes of Health [P30 EY11373]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY018383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the former members of the Pikuleva laboratory, Dr. Saida Omarova and Dr. Casey Charvet, for isolating the OS from donors 3-6; Dr. Cristine Curcio (University of Alabama at Birmingham) for providing retinal sections for these donors; Dr. Krzysztof Palczewski (Case Western Reserve University) for providing the anti-rhodopsin antibodies B6-30; and the Visual Sciences Research Center Core Facility (supported by National Institutes of Health Grant P30 EY11373) for assistance with mouse breeding (Heather Butler and Kathryn Franke), animal genotyping (John Denker), tissue sectioning (Cathy Doller), and microscopy (Dr. Scott Howell). We are also grateful to Dr. Hisashi Fujioka of the Case EM core facility and Dr. Patrick Leahy of the Case LCM core facility.	Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Amaratunga A, 1996, J BIOL CHEM, V271, P5628, DOI 10.1074/jbc.271.10.5628; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; BJORKHEM I, 1987, J LIPID RES, V28, P1137; Bjorkhem I, 2010, BIOCHEM BIOPH RES CO, V396, P46, DOI 10.1016/j.bbrc.2010.02.140; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; Bok D., 1979, PHAGOCYTIC PROPERTIE; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; CASTANHO MARB, 1992, J BIOL CHEM, V267, P204; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Charvet CD, 2013, J BIOL CHEM, V288, P29267, DOI 10.1074/jbc.M113.498832; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Curcio CA, 2005, EXP EYE RES, V81, P731, DOI 10.1016/j.exer.2005.04.012; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Elner Victor M, 2002, Trans Am Ophthalmol Soc, V100, P301; Farese RV, 2006, ARTERIOSCL THROM VAS, V26, P1684, DOI 10.1161/01.ATV.0000227511.35456.90; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Fliesler SJ, 2015, J LIPID RES, V56, P1, DOI 10.1194/jlr.C056358; GLOMSET JA, 1962, BIOCHIM BIOPHYS ACTA, V65, P128, DOI 10.1016/0006-3002(62)90156-7; GUYTON JR, 1988, J HISTOCHEM CYTOCHEM, V36, P1319, DOI 10.1177/36.10.2458408; Hirsch-Reinshagen V, 2009, J LIPID RES, V50, P885, DOI 10.1194/jlr.M800584-JLR200; Huisingh C, 2016, INVEST OPHTH VIS SCI, V57, P739, DOI 10.1167/iovs.15-18316; Jayakody SA, 2015, PROG RETIN EYE RES, V46, P31, DOI 10.1016/j.preteyeres.2015.01.003; Khelef N, 1998, J BIOL CHEM, V273, P11218, DOI 10.1074/jbc.273.18.11218; Klein R, 2008, AM J OPHTHALMOL, V145, P317, DOI 10.1016/j.ajo.2007.09.008; Kuhrt H, 1997, J BRAIN RES, V38, P223; Lee JW, 2006, EXP EYE RES, V83, P465, DOI 10.1016/j.exer.2005.11.018; Lei XF, 2010, J ATHEROSCLER THROMB, V17, P740, DOI 10.5551/jat.4416; Li CM, 2005, INVEST OPHTH VIS SCI, V46, P2576, DOI 10.1167/iovs.05-0034; Li CM, 2005, J LIPID RES, V46, P628, DOI 10.1194/jlr.M400428-JLR200; Li L, 2000, ARTERIOSCL THROM VAS, V20, P2636, DOI 10.1161/01.ATV.20.12.2636; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Liao WL, 2010, ANAL CHEM, V82, P5760, DOI 10.1021/ac100811x; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Marsiglia M, 2013, INVEST OPHTH VIS SCI, V54, P7362, DOI 10.1167/iovs.12-11073; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mrejen S, 2014, OPHTHALMOLOGY, V121, P545, DOI 10.1016/j.ophtha.2013.09.026; Oak ASW, 2014, RETINA-J RET VIT DIS, V34, P825, DOI 10.1097/IAE.0000000000000121; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002; Pumariega NM, 2011, OPHTHALMOLOGY, V118, P1619, DOI 10.1016/j.ophtha.2011.01.029; Querques G, 2014, RETINA-J RET VIT DIS, V34, P321, DOI 10.1097/IAE.0b013e3182993df1; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Saadane A, 2014, AM J PATHOL, V184, P2403, DOI 10.1016/j.ajpath.2014.05.024; Saade C, 2014, CLIN EXP OPHTHALMOL, V42, P865, DOI 10.1111/ceo.12353; Sakashita N, 2000, AM J PATHOL, V156, P227, DOI 10.1016/S0002-9440(10)64723-2; Sakashita N, 2010, J LIPID RES, V51, P1263, DOI [10.1194/jlr.M900288-JLR200, 10.1194/jlr.M900288]; Shanmugaratnam J, 1997, MOL BRAIN RES, V50, P113, DOI 10.1016/S0169-328X(97)00176-9; Steinberg JS, 2013, INVEST OPHTH VIS SCI, V54, P4054, DOI 10.1167/iovs.12-11538; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tserentsoodol N, 2006, MOL VIS, V12, P1319; UELMEN PJ, 1995, J BIOL CHEM, V270, P26192, DOI 10.1074/jbc.270.44.26192; Wang MY, 2012, ANAL CHEM, V84, P5186, DOI 10.1021/ac300587v; WOLTER JR, 1962, ARCH OPHTHALMOL-CHIC, V68, P219; Xu LN, 2013, RETINA-J RET VIT DIS, V33, P1850, DOI 10.1097/IAE.0b013e31828991b2; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Zarubina AV, 2016, OPHTHALMOLOGY, V123, P1090, DOI 10.1016/j.ophtha.2015.12.034; Zheng WC, 2015, J LIPID RES, V56, P81, DOI 10.1194/jlr.M053439; Zheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037926; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	75	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20427	20439		10.1074/jbc.M116.744656	http://dx.doi.org/10.1074/jbc.M116.744656			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514747	Green Published, hybrid			2022-12-28	WOS:000384574800012
J	Li, A; Gong, SZ; Johnson, KA				Li, An; Gong, Shanzhong; Johnson, Kenneth A.			Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MITOCHONDRIAL-DNA POLYMERASE; REAL-TIME MEASUREMENT; RNA-POLYMERASE; MUTATION-RATE; NUCLEOTIDE INCORPORATION; CONFORMATIONAL-CHANGE; TERNARY COMPLEXES; 3TC RESISTANCE; KINETIC-DATA	Previous measurements of the rates of polymerization and pyrophosphate release with DNA templates showed that pyrophosphate (PPi) dissociation was fast after nucleotide incorporation so that it did not contribute to enzyme specificity (k(cat)/K-m). Here, kinetic parameters governing nucleotide incorporation and PPi release were determined using an RNA template. Compared with a DNA template of the same sequence, the rate of chemistry increased by up to 10-fold (250 versus 24 s(-1)), whereas the rate of PPi release decreased to approximately 58 s(-1) so that PPi release became the rate-limiting step. During processive nucleotide incorporation, the first nucleotide (TTP) was incorporated at a fast rate (152 s(-1)), whereas the rates of incorporation of remaining nucleotides (CGTCG) were much slower with an average rate of 24 s(-1), suggesting that sequential incorporation events were limited by the relatively slow PPi release step. The accompanying paper shows that slow PPi release allows polymerization and RNase H to occur at comparable rates. Although PPi release is the rate-determining step, it is not the specificity-determining step for correct incorporation based on our current estimates of the rate of reversal of the chemistry step (3 s(-1)). In contrast, during misin-corporation, PPi release became extremely slow, which we estimated to be similar to 0.002 s(-1). These studies establish the mechanistic basis for DNA polymerase fidelity during reverse transcription and provide a free energy profile. We correct previous underestimates of discrimination by including the slow PPi release step. Our current estimate of 2.4 x 10(6) is >20-fold greater than estimated previously.	[Li, An; Gong, Shanzhong; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), 2500 Speedway MBB3-122, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [R01 GM084741]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084741. This work was also supported by a grant from the Welch Foundation (F-1604). K. A. J. is the president of KinTek Corp., which provided the AutoSF-200x stopped flow and RQF-3 quench-flow instruments and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Avidan O, 2002, EUR J BIOCHEM, V269, P859, DOI 10.1046/j.0014-2956.2001.02719.x; BAKHANASHVILI M, 1993, BIOCHEMISTRY-US, V32, P7559, DOI 10.1021/bi00080a030; Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182; Boutabout M, 2001, NUCLEIC ACIDS RES, V29, P2217, DOI 10.1093/nar/29.11.2217; BOYER JC, 1992, P NATL ACAD SCI USA, V89, P6919, DOI 10.1073/pnas.89.15.6919; Boyer PL, 2000, J VIROL, V74, P6494, DOI 10.1128/JVI.74.14.6494-6500.2000; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Da LT, 2012, J AM CHEM SOC, V134, P2399, DOI 10.1021/ja210656k; Das K, 2016, ACS CHEM BIOL, V11, P2158, DOI 10.1021/acschembio.6b00187; Das K, 2014, NUCLEIC ACIDS RES, V42, P8125, DOI 10.1093/nar/gku487; Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Genna V, 2016, NUCLEIC ACIDS RES, V44, P2827, DOI 10.1093/nar/gkw128; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Havlir DV, 1996, ANN INTERN MED, V124, P984, DOI 10.7326/0003-4819-124-11-199606010-00006; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; JI JP, 1992, BIOCHEMISTRY-US, V31, P954, DOI 10.1021/bi00119a002; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnson RS, 2011, J MOL BIOL, V412, P849, DOI 10.1016/j.jmb.2011.05.023; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kirmizialtin S, 2015, J PHYS CHEM B, V119, P11513, DOI 10.1021/acs.jpcb.5b05467; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; Li A, 2016, J BIOL CHEM, V291, P26566, DOI 10.1074/jbc.M116.753160; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Malinen AM, 2012, NUCLEIC ACIDS RES, V40, P7442, DOI 10.1093/nar/gks383; Mansky LM, 1996, AIDS RES HUM RETROV, V12, P307, DOI 10.1089/aid.1996.12.307; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; Morin JA, 2015, NUCLEIC ACIDS RES, V43, P3643, DOI 10.1093/nar/gkv204; NOWAK M, 1990, NATURE, V347, P522, DOI 10.1038/347522a0; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rezende LF, 1998, NUCLEIC ACIDS RES, V26, P3066, DOI 10.1093/nar/26.12.3066; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	59	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26554	26565		10.1074/jbc.M116.753152	http://dx.doi.org/10.1074/jbc.M116.753152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27777304	Green Published, hybrid			2022-12-28	WOS:000391568200027
J	Alekhina, O; Marchese, A				Alekhina, Olga; Marchese, Adriano			beta-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis via the Chemokine Receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; BREAST-CANCER; BETA-ARRESTIN; CXCR4-MEDIATED CHEMOTAXIS; LYSOSOMAL DEGRADATION; LIGASE AIP4; ACTIVATION; EXPRESSION; COMPLEX; PHOSPHORYLATION	The chemokine receptor CXCR4 and its chemokine ligand CXCL12 mediate directed cell migration during organogenesis, immune responses, and metastatic disease. However, the mechanisms governing CXCL12/CXCR4-dependent chemotaxis remain poorly understood. Here, we show that the beta-arrestin1.signal-transducing adaptor molecule 1 (STAM1) complex, initially identified to govern lysosomal trafficking of CXCR4, also mediates CXCR4-dependent chemotaxis. Expression of mini-gene fragments from beta-arrestin1 or STAM1, known to disrupt the beta-arrestin1.STAM1 complex, and RNAi against beta-arrestin1 or STAM1, attenuates CXCL12-induced chemotaxis. The beta-arrestin1.STAM1 complex is necessary for promoting autophosphorylation of focal adhesion kinase (FAK). FAK is necessary for CXCL12-induced chemotaxis and associates with and localizes with beta-arrestin1 and STAM1 in a CXCL12-dependent manner. Our data reveal previously unknown roles in CXCR4-dependent chemotaxis for beta-arrestin1 and STAM1, which we propose act in concert to regulate FAK signaling. The beta-arrestin1.STAM1 complex is a promising target for blocking CXCR4-promoted FAK autophosphorylation and chemotaxis.	[Alekhina, Olga; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd,BSB 355, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Marchese, A (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd,BSB 355, Milwaukee, WI 53226 USA.	amarchese@mcw.edu			National Institutes of Health [GM106727, GM106727-S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM106727 and GM106727-S1 (to A. M.). The authors declare the following patent (US8691188B2): Methods of Utilizing the Arrestin-2/STAM-1 Complex as a Therapeutic Target (to A. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2001, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb0901s00, DOI 10.1002/0471143030.CB0901S00]; Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cleghorn WM, 2015, MOL BIOL CELL, V26, P622, DOI 10.1091/mbc.E14-02-0740; DeFea KA, 2013, PROG MOL BIOL TRANSL, V118, P205, DOI 10.1016/B978-0-12-394440-5.00008-5; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Dillenburg-Pilla P, 2015, FASEB J, V29, P1056, DOI 10.1096/fj.14-260083; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Galet C, 2008, CELL SIGNAL, V20, P1822, DOI 10.1016/j.cellsig.2008.06.005; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Gurevich VV, 2015, CRIT REV BIOCHEM MOL, V50, P440, DOI 10.3109/10409238.2015.1067185; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Holleman J, 2014, MOL BIOL CELL, V25, P1892, DOI 10.1091/mbc.E13-10-0612; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jung O, 2012, J CELL SCI, V125, P5960, DOI 10.1242/jcs.100586; Kennedy JE, 2015, PROG MOL BIOL TRANSL, V132, P15, DOI 10.1016/bs.pmbts.2015.02.005; Le Y, 2005, J IMMUNOL, V174, P2582, DOI 10.4049/jimmunol.174.5.2582; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Lohi O, 1998, FEBS LETT, V436, P419, DOI 10.1016/S0014-5793(98)01171-5; Ma XJ, 2014, J BIOL CHEM, V289, P13638, DOI 10.1074/jbc.M113.511360; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2016, METHOD ENZYMOL, V570, P281, DOI 10.1016/bs.mie.2015.10.004; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Paradis JS, 2015, P NATL ACAD SCI USA, V112, pE5160, DOI 10.1073/pnas.1508836112; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peng SB, 2005, MOL CANCER RES, V3, P227; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Sengupta R, 2012, CANCER RES, V72, P122, DOI 10.1158/0008-5472.CAN-11-1701; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tavernier-Tardy E, 2009, LEUKEMIA RES, V33, P764, DOI 10.1016/j.leukres.2008.10.014; Verma R, 2015, J BIOL CHEM, V290, P6810, DOI 10.1074/jbc.M114.606699; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhang JP, 2007, INT J GYNECOL CANCER, V17, P478, DOI 10.1111/j.1525-1438.2007.00786.x; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	68	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26083	26097		10.1074/jbc.M116.757138	http://dx.doi.org/10.1074/jbc.M116.757138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27789711	Green Published, hybrid			2022-12-28	WOS:000390345200027
J	Burgess, JL; Burgess, RA; Morales, Y; Bouvang, JM; Johnson, SJ; Dickenson, NE				Burgess, Jamie L.; Burgess, R. Alan; Morales, Yalemi; Bouvang, Jenna M.; Johnson, Sean J.; Dickenson, Nicholas E.			Structural and Biochemical Characterization of Spa47 Provides Mechanistic Insight into Type III Secretion System ATPase Activation and Shigella Virulence Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC CHARACTERIZATION; APPARATUS NEEDLE; PROTEIN EXPORT; FLII ATPASE; FLEXNERI; SALMONELLA; OLIGOMERIZATION; INVASION; IPAD; TIP	Like many Gram-negative pathogens, Shigella rely on a complex type III secretion system (T3SS) to inject effector proteins into host cells, take over host functions, and ultimately establish infection. Despite these critical roles, the energetics and regulatory mechanisms controlling the T3SS and pathogen virulence remain largely unclear. In this study, we present a series of high resolution crystal structures of Spa47 and use the structures to model an activated Spa47 oligomer, finding that ATP hydrolysis may be supported by specific side chain contributions from adjacent protomers within the complex. Follow-up mutagenesis experiments targeting the predicted active site residues validate the oligomeric model and determined that each of the tested residues are essential for Spa47 ATPase activity, although they are not directly responsible for stable oligomer formation. Although N-terminal domain truncation was necessary for crystal formation, it resulted in strictly monomeric Spa47 that is unable to hydrolyze ATP, despite maintaining the canonical ATPase core structure and active site residues. Coupled with studies of ATPase inactive full-length Spa47 point mutants, we find that Spa47 oligomerization and ATP hydrolysis are needed for complete T3SS apparatus formation, a proper translocator secretion profile, and Shigella virulence. This work represents the first structure-function characterization of Spa47, uniquely complementing the multitude of included Shigella T3SS phenotype assays and providing a more complete understanding of T3SS ATPase-mediated pathogen virulence. Additionally, these findings provide a strong platform for follow-up studies evaluating regulation of Spa47 oligomerization in vivo as a much needed means of treating and perhaps preventing shigellosis.	[Burgess, Jamie L.; Burgess, R. Alan; Morales, Yalemi; Bouvang, Jenna M.; Johnson, Sean J.; Dickenson, Nicholas E.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Dickenson, NE (corresponding author), Utah State Univ, Dept Chem & Biochem, 0300 Old Main Hill, Logan, UT 84321 USA.	nick.dickenson@usu.edu	Johnson, Sean/G-8191-2012	Johnson, Sean/0000-0001-7992-2494; Morales, Yalemi/0000-0001-9697-099X; Dickenson, Nicholas/0000-0003-1572-6077; Burgess, Robert/0000-0003-4487-0959	National Institutes of Health [1K22AI099086-01A1]; National Science Foundation MRI [1530862]; R. Gaurth Hansen endowment funds; Utah State University; U.S. Dept. of Energy [DE-AC02-76SF00515]; National Institutes of Health NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI124108, K22AI099086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation MRI(National Science Foundation (NSF)); R. Gaurth Hansen endowment funds; Utah State University; U.S. Dept. of Energy(United States Department of Energy (DOE)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants 1K22AI099086-01A1, National Science Foundation MRI Grant 1530862, and R. Gaurth Hansen endowment funds (to N. E. D.) and by individual Utah State University Undergraduate Research and Creative Opportunity Grants (to J. L. B. and J. M. B.). The crystallographic data were collected at the Stanford Synchrotron Radiation Lightsource (Stanford University), which is supported by U.S. Dept. of Energy Contract DE-AC02-76SF00515 and National Institutes of Health NIGMS Grant P41GM103393. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Allison SE, 2014, J BIOL CHEM, V289, P23734, DOI 10.1074/jbc.M114.578476; Andrade A, 2007, ARCH BIOCHEM BIOPHYS, V468, P121, DOI 10.1016/j.abb.2007.09.020; Ashida H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00219; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Bozue J, 2012, FEMS MICROBIOL LETT, V332, P113, DOI 10.1111/j.1574-6968.2012.02583.x; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Burgess JL, 2016, PROTEIN SCI, V25, P1037, DOI 10.1002/pro.2917; Carayol N, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a016717; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung M, 2015, MOL MICROBIOL, V95, P31, DOI 10.1111/mmi.12843; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dickenson NE, 2012, INT J MOL SCI, V13, P15137, DOI 10.3390/ijms131115137; Dickenson NE, 2011, BIOCHEMISTRY-US, V50, P172, DOI 10.1021/bi101365f; Diepold A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0020; Dutta S, 2003, J CLIN MICROBIOL, V41, P5833, DOI 10.1128/JCM.41.12.5833-5834.2003; EICHELBERG K, 1994, J BACTERIOL, V176, P4501, DOI 10.1128/JB.176.15.4501-4510.1994; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Epler CR, 2012, J MOL BIOL, V420, P29, DOI 10.1016/j.jmb.2012.03.025; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Kato J, 2015, J BACTERIOL, V197, P3007, DOI 10.1128/JB.00434-15; Kazetani K, 2009, BIOCHEM BIOPH RES CO, V388, P323, DOI 10.1016/j.bbrc.2009.08.004; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Komoriya Y, 2012, J BIOL CHEM, V287, P15134, DOI 10.1074/jbc.M111.328153; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Makino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33341; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MENARD R, 1993, J BACTERIOL, V175, P5899; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2006, J MOL BIOL, V360, P510, DOI 10.1016/j.jmb.2006.05.010; Minamino T, 2016, MICROBIOLOGYOPEN, V5, P424, DOI 10.1002/mbo3.340; Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x; NIESEL DW, 1985, J CLIN MICROBIOL, V22, P897, DOI 10.1128/JCM.22.6.897-902.1985; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Portaliou AG, 2016, TRENDS BIOCHEM SCI, V41, P175, DOI 10.1016/j.tibs.2015.09.005; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Schroeder GN, 2007, MICROBIOL-SGM, V153, P2862, DOI 10.1099/mic.0.2007/007427-0; Senior AE, 2000, J BIOENERG BIOMEMBR, V32, P523, DOI 10.1023/A:1005625326721; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stensrud KF, 2008, J BIOL CHEM, V283, P18646, DOI 10.1074/jbc.M802799200; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Venkatesan MM, 2001, INFECT IMMUN, V69, P3271, DOI 10.1128/IAI.69.5.3271-3285.2001; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; WHO,, 2017, DIARRH DIS; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Yoshida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094347; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	75	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25837	25852		10.1074/jbc.M116.755256	http://dx.doi.org/10.1074/jbc.M116.755256			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27770024	Green Published, hybrid			2022-12-28	WOS:000390345200008
J	Dougherty, EJ; Elinoff, JM; Ferreyra, GA; Hou, A; Cai, RM; Sun, JF; Blaine, KP; Wang, SB; Danner, RL				Dougherty, Edward J.; Elinoff, Jason M.; Ferreyra, Gabriela A.; Hou, Angela; Cai, Rongman; Sun, Junfeng; Blaine, Kevin P.; Wang, Shuibang; Danner, Robert L.			Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling: DEPENDENCE ON DNA SEQUENCE, MR CONFORMATION, AND AP-1 FAMILY MEMBER EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); glucocorticoid receptor; inflammation; mineralocorticoid receptor; NF-B transcription factor; nuclear receptor; trans-repression	NF-KAPPA-B; GLUCOCORTICOID-RECEPTOR; RESPONSE ELEMENTS; TATA BOX; FOS-JUN; ALDOSTERONE; REPRESSION; TRANSCRIPTION; TRANSREPRESSION; ACTIVATION	Glucocorticoids are commonly used to treat inflammatory disorders. The glucocorticoid receptor (GR) can tether to inflammatory transcription factor complexes, such as NFB and AP-1, and trans-repress the transcription of cytokines, chemokines, and adhesion molecules. In contrast, aldosterone and the mineralocorticoid receptor (MR) primarily promote cardiovascular inflammation by incompletely understood mechanisms. Although MR has been shown to weakly repress NFB, its role in modulating AP-1 has not been established. Here, the effects of GR and MR on NFB and AP-1 signaling were directly compared using a variety of ligands, two different AP-1 consensus sequences, GR and MR DNA-binding domain mutants, and siRNA knockdown or overexpression of core AP-1 family members. Both GR and MR repressed an NFB reporter without influencing p65 or p50 binding to DNA. Likewise, neither GR nor MR affected AP-1 binding, but repression or activation of AP-1 reporters occurred in a ligand-, AP-1 consensus sequence-, and AP-1 family member-specific manner. Notably, aldosterone interactions with both GR and MR demonstrated a potential to activate AP-1. DNA-binding domain mutations that eliminated the ability of GR and MR to cis-activate a hormone response element-driven reporter variably affected the strength and polarity of these responses. Importantly, MR modulation of NFB and AP-1 signaling was consistent with a trans-mechanism, and AP-1 effects were confirmed for specific gene targets in primary human cells. Steroid nuclear receptor trans-effects on inflammatory signaling are context-dependent and influenced by nuclear receptor conformation, DNA sequence, and the expression of heterologous binding partners. Aldosterone activation of AP-1 may contribute to its proinflammatory effects in the vasculature.	[Dougherty, Edward J.; Elinoff, Jason M.; Ferreyra, Gabriela A.; Hou, Angela; Cai, Rongman; Sun, Junfeng; Blaine, Kevin P.; Wang, Shuibang; Danner, Robert L.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Hou, Angela] NYU, Langone Med Ctr, 550 1st Ave, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); New York University; NYU Langone Medical Center	Dougherty, EJ; Danner, RL (corresponding author), NIH, Dept Crit Care Med, 10 Ctr Dr,Rm 2C145, Bethesda, MD 20892 USA.	doughertye@cc.nih.gov; rdanner@nih.gov			National Institutes of Health intramural funds; CLINICAL CENTER [ZIACL000188] Funding Source: NIH RePORTER	National Institutes of Health intramural funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported by National Institutes of Health intramural funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bladh LG, 2005, MOL PHARMACOL, V67, P815, DOI 10.1124/mol.104.005801; Brown NJ, 2008, HYPERTENSION, V51, P161, DOI 10.1161/HYPERTENSIONAHA.107.095489; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Cerillo G, 1998, J STEROID BIOCHEM, V67, P79, DOI 10.1016/S0960-0760(98)00078-8; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Church DR, 2005, PROSTATE, V63, P155, DOI 10.1002/pros.20172; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; Fukuda S, 2011, CLIN EXP NEPHROL, V15, P41, DOI 10.1007/s10157-010-0373-1; Funder JW, 2004, MOL CELL ENDOCRINOL, V217, P263, DOI 10.1016/j.mce.2003.10.054; Gilbert KC, 2010, CURR OPIN ENDOCRINOL, V17, P199, DOI 10.1097/MED.0b013e3283391989; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; GuiochonMantel A, 1996, J STEROID BIOCHEM, V56, P3, DOI 10.1016/0960-0760(95)00268-5; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HENCH PS, 1949, ANN RHEUM DIS, V8, P97, DOI 10.1136/ard.8.2.97; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; KONIG H, 1992, EMBO J, V11, P2241, DOI 10.1002/j.1460-2075.1992.tb05283.x; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lemarie CA, 2009, CIRC RES, V105, P852, DOI 10.1161/CIRCRESAHA.109.196576; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Liden J, 1997, J BIOL CHEM, V272, P21467, DOI 10.1074/jbc.272.34.21467; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meijer OC, 2000, J NEUROENDOCRINOL, V12, P245; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Meyer T, 1997, J BIOL CHEM, V272, P21090, DOI 10.1074/jbc.272.34.21090; Miller DT, 2007, J AM COLL CARDIOL, V49, P1589, DOI 10.1016/j.jacc.2006.12.045; MINER JN, 1992, GENE DEV, V6, P2491, DOI 10.1101/gad.6.12b.2491; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Moss ME, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00153; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Nishikawa T, 2005, J STEROID BIOCHEM, V96, P309, DOI 10.1016/j.jsbmb.2005.03.005; Nishiyama A, 2005, HYPERTENSION, V45, P710, DOI 10.1161/01.HYP.0000154681.38944.9a; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Paakinaho V, 2014, NUCLEIC ACIDS RES, V42, P1575, DOI 10.1093/nar/gkt1033; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; Pierotti S, 2010, HORM MOL BIOL CLIN I, V4, P483, DOI 10.1515/HMBCI.2010.059; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rajaram N, 1997, EMBO J, V16, P2917, DOI 10.1093/emboj/16.10.2917; RAY A, 1990, MOL CELL BIOL, V10, P5736, DOI 10.1128/MCB.10.11.5736; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ripple MO, 1999, JNCI-J NATL CANCER I, V91, P1227, DOI 10.1093/jnci/91.14.1227; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Rollins DA, 2015, MOL ENDOCRINOL, V29, P502, DOI 10.1210/me.2015-1005; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Rossignol P, 2011, J AM COLL CARDIOL, V58, P1958, DOI 10.1016/j.jacc.2011.04.049; RUPPRECHT R, 1993, EUR J PHARM-MOLEC PH, V247, P145, DOI 10.1016/0922-4106(93)90072-H; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Sonder SUS, 2006, BRIT J PHARMACOL, V148, P46, DOI 10.1038/sj.bjp.0706700; Starr DB, 1996, GENE DEV, V10, P1271, DOI 10.1101/gad.10.10.1271; STROMSTEDT PE, 1991, MOL CELL BIOL, V11, P3379, DOI 10.1128/MCB.11.6.3379; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Suzukawa K, 2002, ONCOGENE, V21, P2181, DOI 10.1038/sj.onc.1205281; Terada Y, 2012, CLIN EXP NEPHROL, V16, P81, DOI 10.1007/s10157-011-0498-x; Teyssier C, 2003, MOL ENDOCRINOL, V17, P287, DOI 10.1210/me.2002-0324; Tostes RCA, 2002, CLIN SCI, V103, p25S, DOI 10.1042/CS103S025S; Vinson GP, 2011, J ENDOCRINOL, V211, P3, DOI 10.1530/JOE-11-0178; Zhou HM, 2005, DNA RES, V12, P139, DOI 10.1093/dnares/12.2.139; Zhu CJ, 2012, ACTA PHARMACOL SIN, V33, P873, DOI 10.1038/aps.2012.36; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	76	7	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23628	23644		10.1074/jbc.M116.732248	http://dx.doi.org/10.1074/jbc.M116.732248			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27650495	Green Published, hybrid			2022-12-28	WOS:000387884400023
J	Patel, D; Antwi, J; Koneru, PC; Serrao, E; Forli, S; Kessl, JJ; Feng, L; Deng, NJ; Levy, RM; Fuchs, JR; Olson, AJ; Engelman, AN; Bauman, JD; Kvaratskhelia, M; Arnold, E				Patel, Disha; Antwi, Janet; Koneru, Pratibha C.; Serrao, Erik; Forli, Stefano; Kessl, Jacques J.; Feng, Lei; Deng, Nanjie; Levy, Ronald M.; Fuchs, James R.; Olson, Arthur J.; Engelman, Alan N.; Bauman, Joseph D.; Kvaratskhelia, Mamuka; Arnold, Eddy			A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug discovery; drug screening; human immunodeficiency virus (HIV); integrase; medicinal chemistry; X-ray crystallography; HIV-1; HIV-1 integrase; allosteric inhibitor; fragment screening	SMALL-MOLECULE INHIBITORS; HIGH-THROUGHPUT; LEDGF/P75; PROTEIN; MULTIMERIZATION; REPLICATION; DISCOVERY; MECHANISM; EFFICIENCY; INFECTIVITY	HIV-1 integrase (IN) is essential for virus replication and represents an important multifunctional therapeutic target. Recently discovered quinoline-based allosteric IN inhibitors (ALLINIs) potently impair HIV-1 replication and are currently in clinical trials. ALLINIs exhibit a multimodal mechanism of action by inducing aberrant IN multimerization during virion morphogenesis and by competing with IN for binding to its cognate cellular cofactor LEDGF/p75 during early steps of HIV-1 infection. However, quinoline-based ALLINIs impose a low genetic barrier for the evolution of resistant phenotypes, which highlights a need for discovery of second-generation inhibitors. Using crystallographic screening of a library of 971 fragments against the HIV-1 IN catalytic core domain (CCD) followed by a fragment expansion approach, we have identified thiophenecarboxylic acid derivatives that bind at the CCD-CCD dimer interface at the principal lens epithelium-derived growth factor (LEDGF)/p75 binding pocket. The most active derivative (5) inhibited LEDGF/p75-dependent HIV-1 IN activity in vitro with an IC50 of 72 m and impaired HIV-1 infection of T cells at an EC50 of 36 m. The identified lead compound, with a relatively small molecular weight (221 Da), provides an optimal building block for developing a new class of inhibitors. Furthermore, although structurally distinct thiophenecarboxylic acid derivatives target a similar pocket at the IN dimer interface as the quinoline-based ALLINIs, the lead compound, 5, inhibited IN mutants that confer resistance to quinoline-based compounds. Collectively, our findings provide a plausible path for structure-based development of second-generation ALLINIs.	[Patel, Disha; Bauman, Joseph D.; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Antwi, Janet; Fuchs, James R.] Ohio State Univ, Div Med Chem & Pharmacognosy, Coll Pharm, Columbus, OH 43210 USA; [Koneru, Pratibha C.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Koneru, Pratibha C.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Serrao, Erik; Engelman, Alan N.] Harvard Med Sch, Dept Canc Immunol & Virol, Dana Farber Canc Inst, Boston, MA 02215 USA; [Serrao, Erik; Engelman, Alan N.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA; [Forli, Stefano; Olson, Arthur J.] Scripps Res Inst, Mol Graph Lab, Dept Integrat Struct & Computat Biol, MB 112, La Jolla, CA 92037 USA; [Kessl, Jacques J.] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Deng, Nanjie; Levy, Ronald M.] Temple Univ, Ctr Biophys & Computat Biol, Philadelphia, PA 19122 USA	Rutgers State University New Brunswick; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Scripps Research Institute; University of Southern Mississippi; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Arnold, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.; Kvaratskhelia, M (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.; Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu; arnold@cabm.rutgers.edu	Kessl, Jacques/AAV-2526-2021; Forli, Stefano/AFR-7638-2022	Forli, Stefano/0000-0002-5964-7111; Koneru, Pratibha Chowdary/0000-0003-3955-4548; ANTWI, JANET/0000-0002-8089-9540; Fuchs, James/0000-0002-8743-6389	National Institutes of Health [P50GM103368, R01AI110310, R21AI127282]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110270, R01AI110310, R21AI127282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030580, P50GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants P50GM103368 (to E. A., M. K., A. N. E., R. M. L., and A. J. O.), R01AI110310 (to M. K. and J. R. F.), and R21AI127282 (to J. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Bauman JD, 2013, J MED CHEM, V56, P2738, DOI 10.1021/jm301271j; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Cherepanov P, 2010, EMBO REP, V11, P328, DOI 10.1038/embor.2010.58; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; De Luca L, 2010, BIOORGAN MED CHEM, V18, P7515, DOI 10.1016/j.bmc.2010.08.051; De Luca L, 2009, CHEMMEDCHEM, V4, P1311, DOI 10.1002/cmdc.200900070; Deng NJ, 2011, J PHYS CHEM B, V115, P11902, DOI 10.1021/jp204047b; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0024-2014; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2016, ACS CHEM BIOL, V11, P1313, DOI 10.1021/acschembio.6b00167; Feng L, 2015, CURR TOP MICROBIOL, V389, P93, DOI 10.1007/82_2015_439; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fontana J, 2015, J VIROL, V89, P9765, DOI 10.1128/JVI.01522-15; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hayouka Z, 2010, BIOORGAN MED CHEM, V18, P8388, DOI 10.1016/j.bmc.2010.09.046; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Jurado KA, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.15; Kessl JJ, 2016, METHODS MOL BIOL, V1354, P149, DOI 10.1007/978-1-4939-3046-3_10; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Otwinowski Z, 2001, INT TABLES CRYSTAL F, VF, P226; Pandey KK, 2014, HIV AIDS-RES PALLIAT, V6, P81, DOI 10.2147/HIV.S39178; Patel D, 2014, PROG BIOPHYS MOL BIO, V116, P92, DOI 10.1016/j.pbiomolbio.2014.08.004; Peat TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040147; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rault S, 1996, J MED CHEM, V39, P2068, DOI 10.1021/jm950543x; Serrao E, 2013, J MED CHEM, V56, P2311, DOI 10.1021/jm301632e; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; van Bel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103552; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Y, 2005, J BIOMOL SCREEN, V10, P456, DOI 10.1177/1087057105275212	64	16	16	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23569	23577		10.1074/jbc.M116.753384	http://dx.doi.org/10.1074/jbc.M116.753384			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27645997	Green Published, hybrid			2022-12-28	WOS:000387884400018
J	Xiao, XJ; Jones, G; Sevilla, WA; Stolz, DB; Magee, KE; Haughney, M; Mukherjee, A; Wang, Y; Lowe, ME				Xiao, Xunjun; Jones, Gabrielle; Sevilla, Wednesday A.; Stolz, Donna B.; Magee, Kelsey E.; Haughney, Margaret; Mukherjee, Amitava; Wang, Yan; Lowe, Mark E.			A Carboxyl Ester Lipase (CEL) Mutant Causes Chronic Pancreatitis by Forming Intracellular Aggregates That Activate Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SALT-STIMULATED LIPASE; UNFOLDED PROTEIN RESPONSE; EXOCRINE DYSFUNCTION; HEREDITARY PANCREATITIS; DIGESTIVE ENZYMES; DEPENDENT LIPASE; ACINAR-CELLS; MUTATIONS; SECRETION	Patients with chronic pancreatitis (CP) frequently have genetic risk factors for disease. Many of the identified genes have been connected to trypsinogen activation or trypsin inactivation. The description of CP in patients with mutations in the variable number of tandem repeat (VNTR) domain of carboxyl ester lipase (CEL) presents an opportunity to study the pathogenesis of CP independently of trypsin pathways. We tested the hypothesis that a deletion and frameshift mutation (C563fsX673) in the CEL VNTR causes CP through proteotoxic gain-of-function activation of maladaptive cell signaling pathways including cell death pathways. HEK293 or AR42J cells were transfected with constructs expressing CEL with 14 repeats in the VNTR (CEL14R) or C563fsX673 CEL (CEL maturity onset diabetes of youth with a deletion mutation in the VNTR (MODY)). In both cell types, CEL MODY formed intracellular aggregates. Secretion of CEL MODY was decreased compared with that of CEL14R. Expression of CEL MODY increased endoplasmic reticulum stress, activated the unfolded protein response, and caused cell death by apoptosis. Our results demonstrate that disorders of protein homeostasis can lead to CP and suggest that novel therapies to decrease the intracellular accumulation of misfolded protein may be successful in some patients with CP.	[Xiao, Xunjun; Jones, Gabrielle; Sevilla, Wednesday A.; Magee, Kelsey E.; Haughney, Margaret; Mukherjee, Amitava; Wang, Yan; Lowe, Mark E.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lowe, ME (corresponding author), Childrens Hosp Pittsburgh, One Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	loweme2@upmc.edu		Magee, Kelsey/0000-0003-4220-3984; Xiao, Xunjun/0000-0001-5930-4664	National Institutes of Health [DK808820]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097241, R01DK080820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK808820. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Baek JH, 2016, NEUROPATH APPL NEURO, V42, P352, DOI 10.1111/nan.12260; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; Bruneau N, 2000, MICROSC RES TECHNIQ, V49, P329, DOI 10.1002/(SICI)1097-0029(20000515)49:4<329::AID-JEMT2>3.0.CO;2-H; Bruneau N, 1997, J BIOL CHEM, V272, P27353, DOI 10.1074/jbc.272.43.27353; Bruneau N, 1998, J CELL SCI, V111, P2665; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; Fagenholz PJ, 2007, PANCREAS, V35, P302, DOI 10.1097/MPA.0b013e3180cac24b; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Ji BA, 2011, GASTROENTEROLOGY, V141, P1972, DOI 10.1053/j.gastro.2011.10.021; Jin S., 2015, GASTROENTEROLOGY, V149; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; Kubisch Constanze H, 2008, Expert Rev Gastroenterol Hepatol, V2, P249, DOI 10.1586/17474124.2.2.249; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Logsdon CD, 2013, NAT REV GASTRO HEPAT, V10, P362, DOI 10.1038/nrgastro.2013.36; MacDonald RJ, 2010, PROG MOL BIOL TRANSL, V97, P1, DOI 10.1016/B978-0-12-385233-5.00001-5; Moore SA, 2001, J MOL BIOL, V312, P511, DOI 10.1006/jmbi.2001.4979; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pandol SJ, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00008; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; Raeder H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060229; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; Sah RP, 2014, J BIOL CHEM, V289, P27551, DOI 10.1074/jbc.M113.528174; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Seyhun E, 2011, AM J PHYSIOL-GASTR L, V301, pG773, DOI 10.1152/ajpgi.00483.2010; Stromqvist M, 1997, ARCH BIOCHEM BIOPHYS, V347, P30, DOI 10.1006/abbi.1997.0307; Szabo A, 2015, BBA-MOL BASIS DIS, V1852, P1372, DOI 10.1016/j.bbadis.2015.04.002; Szmola R, 2010, GUT, V59, P365, DOI 10.1136/gut.2009.198903; Tafaleng EN, 2015, HEPATOLOGY, V62, P147, DOI 10.1002/hep.27753; Torsvik J, 2014, J BIOL CHEM, V289, P29097, DOI 10.1074/jbc.M114.574244; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Vesterhus M, 2008, DIABETES CARE, V31, P1738, DOI 10.2337/dc07-2217; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; Xiao XJ, 2011, J BIOL CHEM, V286, P26353, DOI 10.1074/jbc.M111.249813; Zou WB, 2016, GASTROENTEROLOGY, V150, P1558, DOI 10.1053/j.gastro.2016.02.071	44	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23224	23236		10.1074/jbc.M116.734384	http://dx.doi.org/10.1074/jbc.M116.734384			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27650499	Green Published, hybrid			2022-12-28	WOS:000387224800031
J	Peng, ZM; Liao, ZP; Matsumoto, Y; Yang, A; Tomkinson, AE				Peng, Zhimin; Liao, Zhongping; Matsumoto, Yoshihiro; Yang, Austin; Tomkinson, Alan E.			Human DNA Ligase I Interacts with and Is Targeted for Degradation by the DCAF7 Specificity Factor of the Cul4-DDB1 Ubiquitin Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; DNA replication; proliferating cell nuclear antigen (PCNA); proteasome; protein turnover; proteolysis; ubiquitin; ubiquitin ligase; DNA ligase I; ubiquitylation	CELL NUCLEAR ANTIGEN; MOLECULAR-CLONING; REPLICATION FORK; GENE-EXPRESSION; AMINO-ACIDS; PHOSPHORYLATION; MUTATIONS; PROTEIN; INSTABILITY; CYCLE	The synthesis, processing, and joining of Okazaki fragments during DNA replication is complex, requiring the sequential action of a large number of proteins. Proliferating cell nuclear antigen, a DNA sliding clamp, interacts with and coordinates the activity of several DNA replication proteins, including the enzymes flap endonuclease 1 (FEN-1) and DNA ligase I that complete the processing and joining of Okazaki fragments, respectively. Although it is evident that maintaining the appropriate relative stoichiometry of FEN-1 and DNA ligase I, which compete for binding to proliferating cell nuclear antigen, is critical to prevent genomic instability, little is known about how the steady state levels of DNA replication proteins are regulated, in particular the proteolytic mechanisms involved in their turnover. Because DNA ligase I has been reported to be ubiquitylated, we used a proteomic approach to map ubiquitylation sites and screen for DNA ligase I-associated E3 ubiquitin ligases. We identified three ubiquitylated lysine residues and showed that DNA ligase I interacts with and is targeted for ubiquitylation by DCAF7, a specificity factor for the Cul4-DDB1 complex. Notably, knockdown of DCAF7 reduced the degradation of DNA ligase I in response to inhibition of proliferation and replacement of ubiquitylated lysine residues reduced the in vitro ubiquitylation of DNA ligase I by Cul4-DDB1 and DCAF7. In contrast, a different E3 ubiquitin ligase regulates FEN-1 turnover. Thus, although the expression of many of the genes encoding DNA replication proteins is coordinately regulated, our studies reveal that different mechanisms are involved in the turnover of these proteins.	[Peng, Zhimin; Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Peng, Zhimin; Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Peng, Zhimin; Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Liao, Zhongping; Yang, Austin] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Liao, Zhongping; Yang, Austin] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Liao, Zhongping] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Yang, Austin] NIA, NIH, Bethesda, MD 20892 USA	University of New Mexico; University of New Mexico; University of New Mexico; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tomkinson, AE (corresponding author), Canc Res Facil, 915 Camino Salud,1 Univ New Mexico, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu		Matsumoto, Yoshihiro/0000-0001-6580-7188	University of New Mexico Comprehensive Cancer Center [P30 CA118100]; National Institute of Health [R01 GM057479]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER	University of New Mexico Comprehensive Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of New Mexico Comprehensive Cancer Center (Grant P30 CA118100) and National Institute of Health Grant R01 GM057479 (to A. E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castel AL, 2009, J BIOL CHEM, V284, P26631, DOI 10.1074/jbc.M109.034405; CHEN JW, 1995, MOL CELL BIOL, V15, P5412; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Ferrari G, 2003, J BIOL CHEM, V278, P37761, DOI 10.1074/jbc.M304462200; Gajewski E, 2007, BIOCHEM PHARMACOL, V73, P1947, DOI 10.1016/j.bcp.2007.03.022; Goetz JDM, 2005, DNA REPAIR, V4, P649, DOI 10.1016/j.dnarep.2005.02.004; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Guo ZG, 2012, MOL CELL, V47, P444, DOI 10.1016/j.molcel.2012.05.042; Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014; Harrison C, 2002, CANCER RES, V62, P4065; Howes Timothy R L, 2012, Subcell Biochem, V62, P327, DOI 10.1007/978-94-007-4572-8_17; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kim IS, 2000, BBA-MOL CELL RES, V1496, P333, DOI 10.1016/S0167-4889(00)00029-X; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Levin DS, 2004, J BIOL CHEM, V279, P55196, DOI 10.1074/jbc.M409250200; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Liao Z, 2013, INT J PROTEOMICS, V2013, DOI DOI 10.1155/2013/291415; Liao ZP, 2012, ANAL CHEM, V84, P4535, DOI 10.1021/ac300510t; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PETRINI JHJ, 1991, P NATL ACAD SCI USA, V88, P7615, DOI 10.1073/pnas.88.17.7615; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pirzio LM, 2004, CYTOGENET GENOME RES, V104, P87, DOI 10.1159/000077470; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Ritterhoff S, 2010, EMBO J, V29, P3750, DOI 10.1038/emboj.2010.251; Rossi R, 1999, EMBO J, V18, P5745, DOI 10.1093/emboj/18.20.5745; Singh P, 2008, MOL CANCER RES, V6, P1710, DOI 10.1158/1541-7786.MCR-08-0269; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sun DY, 2001, CLIN CANCER RES, V7, P4143; Tan FW, 2008, PROTEOMICS, V8, P2885, DOI 10.1002/pmic.200700887; Terai K, 2013, J BIOL CHEM, V288, P30509, DOI 10.1074/jbc.C113.505586; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; WEI YF, 1995, MOL CELL BIOL, V15, P3206; WHITE JHM, 1986, EMBO J, V5, P1705, DOI 10.1002/j.1460-2075.1986.tb04414.x; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	58	12	12	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21893	21902		10.1074/jbc.M116.746198	http://dx.doi.org/10.1074/jbc.M116.746198			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573245	Green Published, hybrid			2022-12-28	WOS:000386332600006
J	Racca, JD; Chen, YS; Yang, YW; Phillips, NB; Weiss, MA				Racca, Joseph D.; Chen, Yen-Shan; Yang, Yanwu; Phillips, Nelson B.; Weiss, Michael A.			Human Sex Determination at the Edge of Ambiguity INHERITED XY SEX REVERSAL DUE TO ENHANCED UBIQUITINATION AND PROTEASOMAL DEGRADATION OF A MASTER TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						developmental factor; proteasome; protein degradation; reproduction; transcription; DNA-binding domain; Sywer syndrome; disorders of sexual development; intersex	TESTIS-DETERMINING GENE; DETERMINING FACTOR SRY; DNA-BINDING ACTIVITY; HMG BOX REGION; GONADAL-DYSGENESIS; CAMPOMELIC DYSPLASIA; NUCLEAR-LOCALIZATION; TRANSCRIPTIONAL ACTIVATOR; HISTONE MODIFICATIONS; REGULATORY NETWORKS	A general problem is posed by analysis of transcriptional thresholds governing cell fate decisions in metazoan development. A model is provided by testis determination in therian mammals. Its key step, Sertoli cell differentiation in the embryonic gonadal ridge, is initiated by SRY, a Y-encoded architectural transcription factor. Mutations in human SRY cause gonadal dysgenesis leading to XY female development (Swyer syndrome). Here, we have characterized an inherited mutation compatible with either male or female somatic phenotypes as observed in an XY father and XY daughter, respectively. The mutation (a crevice-forming substitution at a conserved back surface of the SRY high mobility group box) markedly destabilizes the domain but preserves specific DNA affinity and induced DNA bend angle. On transient transfection of diverse human and rodent cell lines, the variant SRY exhibited accelerated proteasomal degradation (relative to wild type) associated with increased ubiquitination; in vitro susceptibility to ubiquitin-independent (default) cleavage by the 20S core proteasome was unchanged. The variant's gene regulatory activity (as assessed in a cellular model of the rat embryonic XY gonadal ridge) was reduced by 2-fold relative to wild-type SRY at similar levels of mRNA expression. Chemical proteasome inhibition restored native-like SRY expression and transcriptional activity in association with restored occupancy of a sex-specific enhancer element in principal downstream gene Sox9, demonstrating that the variant SRY exhibits essentially native activity on a per molecule basis. Our findings define a novel mechanism of impaired organogenesis, accelerated ubiquitin-directed proteasomal degradation of a master transcription factor leading to a developmental decision poised at the edge of ambiguity.	[Racca, Joseph D.; Chen, Yen-Shan; Yang, Yanwu; Phillips, Nelson B.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA	Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	maw21@case.edu			National Institutes of Health [GM080505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work, a contribution from the Cleveland Center for Membrane and Structural Biology, was supported in part by National Institutes of Health Grant GM080505 (to M. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht KH, 2003, GENETICS, V164, P277; Arkin A, 1998, GENETICS, V149, P1633; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Assumpcao JG, 2002, J MOL MED, V80, P782, DOI 10.1007/s00109-002-0376-9; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Bowles J, 1999, NAT GENET, V22, P405, DOI 10.1038/11981; Chen Y., 2015, RARE DISORDERS DIAG, V1, P1; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3567, DOI 10.1073/pnas.1300828110; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3061, DOI 10.1073/pnas.1300860110; Correa SM, 2012, PLOS GENET, V8, P11, DOI 10.1371/journal.pgen.1002569; Czaja W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6434; Dahlmann B, 2016, ARCH BIOCHEM BIOPHYS, V591, P132, DOI 10.1016/j.abb.2015.12.012; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Desclozeaux M, 1998, J BIOL CHEM, V273, P7988, DOI 10.1074/jbc.273.14.7988; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; Domenice S, 1998, HUM GENET, V102, P213, DOI 10.1007/s004390050680; Dork T, 1998, HUM MUTAT, V11, P90; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; EICHER EM, 1983, J EXP ZOOL, V228, P297, DOI 10.1002/jez.1402280213; Eicher EM, 1996, NAT GENET, V14, P206, DOI 10.1038/ng1096-206; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Eicher EM, 2001, J EXP ZOOL, V290, P322, DOI 10.1002/jez.1072; ENNIS HL, 1964, SCIENCE, V146, P1474, DOI 10.1126/science.146.3650.1474; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Graves JAM, 2002, NOVART FDN SYMP, V244, P86; Graves JAM, 2015, NATURE, V528, P343, DOI 10.1038/528343a; Graves JAM, 2013, DEV DYNAM, V242, P354, DOI 10.1002/dvdy.23887; Haqq CM, 1998, PHYSIOL REV, V78, P1; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Hersmus R, 2009, EUR J HUM GENET, V17, P1642, DOI 10.1038/ejhg.2009.96; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; IKEGUCHI M, 1986, J BIOCHEM-TOKYO, V99, P1191, DOI 10.1093/oxfordjournals.jbchem.a135582; Imai A, 1999, ENDOCR J, V46, P735, DOI 10.1507/endocrj.46.735; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; JAGER RJ, 1992, HUM GENET, V90, P350; Jiang T., 2012, MOL BIOL REP, V316, P359; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jordan BK, 2002, J CLIN ENDOCR METAB, V87, P3428, DOI 10.1210/jc.87.7.3428; KAPP OH, 1995, PROTEIN SCI, V4, P2179, DOI 10.1002/pro.5560041024; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; KING CY, 1993, P NATL ACAD SCI USA, V90, P11990, DOI 10.1073/pnas.90.24.11990; Kirschner M, 1999, TRENDS CELL BIOL, V9, pM42, DOI 10.1016/S0962-8924(99)01666-9; Knower KC, 2003, CYTOGENET GENOME RES, V101, P185, DOI 10.1159/000074336; Knower KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017751; Kobayashi A, 2005, ANN NY ACAD SCI, V1061, P9, DOI 10.1196/annals.1336.003; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KURNIT DM, 1987, AM J HUM GENET, V41, P979; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; LEE CH, 1994, DEV BIOL, V165, P442, DOI 10.1006/dbio.1994.1266; Li B, 2006, J MOL BIOL, V360, P310, DOI 10.1016/j.jmb.2006.04.048; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Livneh I, 2016, CELL RES, V26, P869, DOI 10.1038/cr.2016.86; Lodish H., 2000, MOL CELL BIOL, P129; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Matthews BW, 1996, FASEB J, V10, P35, DOI 10.1096/fasebj.10.1.8566545; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Murphy FV, 1999, EMBO J, V18, P6610, DOI 10.1093/emboj/18.23.6610; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Park SY, 2005, ENDOCRINOLOGY, V146, P1035, DOI 10.1210/en.2004-1454; Payne JL, 2014, ARTIF LIFE, V20, P111, DOI 10.1162/ARTL_a_00099; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Phillips NB, 2006, J MOL BIOL, V358, P172, DOI 10.1016/j.jmb.2006.01.060; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; Phillips NB, 2011, J BIOL CHEM, V286, P36787, DOI 10.1074/jbc.M111.260091; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pingault V, 2013, AM J HUM GENET, V92, P707, DOI 10.1016/j.ajhg.2013.03.024; POULAT F, 1995, J CELL BIOL, V128, P737, DOI 10.1083/jcb.128.5.737; Privalov PL, 1999, J MOL BIOL, V294, P997, DOI 10.1006/jmbi.1999.3285; PTASHNE M, 1984, TRENDS BIOCHEM SCI, V9, P142, DOI 10.1016/0968-0004(84)90121-X; Ptashne M, 2004, GENETIC SWITCH PHAGE; Racca JD, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.597526; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; SAINI KS, 1990, MOL CELL BIOCHEM, V96, P15; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sekido R, 2010, INT J BIOCHEM CELL B, V42, P417, DOI 10.1016/j.biocel.2009.12.005; Sequeira P., 2015, EVOLUTIONARY BIOL BI, P141; Sim H, 2008, TRENDS ENDOCRIN MET, V19, P213, DOI 10.1016/j.tem.2008.04.002; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith JM, 2004, TRENDS GENET, V20, P4, DOI 10.1016/j.tig.2003.11.007; Stent G. S., 1978, MOL GENETICS INTRO N, P204; TAJIMA T, 1994, HUM MOL GENET, V3, P1187, DOI 10.1093/hmg/3.7.1187; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Volker C., 2012, PROTEASOME UBIQUITIN, P1; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Warr N, 2012, WIRES DEV BIOL, V1, P559, DOI 10.1002/wdev.42; Weiss MA, 1997, J BIOMOL STRUCT DYN, V15, P177, DOI 10.1080/07391102.1997.10508185; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WERNER MH, 1995, BIOCHEMISTRY-US, V34, P11998, DOI 10.1021/bi00037a042; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; Wuensche A., 2004, MODULARITY DEV EVOLU, P600; YAMADA S, 1995, J BIOCHEM, V117, P1162, DOI 10.1093/oxfordjournals.jbchem.a124839; Zhang LY, 2015, MOL MED REP, V11, P4365, DOI 10.3892/mmr.2015.3273; Zhao L, 2014, P NATL ACAD SCI USA, V111, P11768, DOI 10.1073/pnas.1400666111	111	6	7	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22173	22195		10.1074/jbc.M116.741959	http://dx.doi.org/10.1074/jbc.M116.741959			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27576690	Green Published, hybrid			2022-12-28	WOS:000386332600030
J	Siegmund, K; Klepsch, V; Hermann-Kleiter, N; Baier, G				Siegmund, Kerstin; Klepsch, Victoria; Hermann-Kleiter, Natascha; Baier, Gottfried			Proof of Principle for a T Lymphocyte Intrinsic Function of Coronin 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; autoimmunity; cell signaling; immunodeficiency; lymphocyte	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SEVERE COMBINED IMMUNODEFICIENCY; IMMUNE-RESPONSES; CELLS; SURVIVAL; DEFICIENCY; PROTEINS; MUTATION; CD4(+); MYCOBACTERIA	Coronins are evolutionarily conserved proteins that were originally identified as modulators of actin-dependent processes. Studies analyzing complete Coronin 1a knock-out mice have shown that this molecule is an important regulator of naive T cell homeostasis and it has been linked to immune deficiencies as well as autoimmune disorders. Nevertheless, because Coronin 1A is strongly expressed in all leukocyte subsets, it is not conclusive whether or not this phenotype is attributed to a T cell-intrinsic function of Coronin 1A. To address this research question, we have generated a T cell-specific Coronin 1a knock-out mouse (Coro1a(fl/fl) x Cd4[Cre]). Deletion of Coronin 1A specifically in T cells led to a strong reduction in T cell number and a shift toward the effector/memory phenotype in peripheral lymphoid organs when compared with Cd4[Cre] mice expressing wild-type Coronin 1A. In contrast to peripheral lymphoid tissue, thymocyte number and subsets were not affected by the deletion of Coronin 1a. Furthermore, T cell-specific Coronin 1a knock-out mice were largely resistant to the induction of autoimmunity when tested in the myelin oligoglycoprotein-induced EAE mouse model of multiple sclerosis. Thus, the phenotype of T cell-specific Coronin 1a deletion resembles the phenotype observed with conventional (whole body) Coronin 1a knock-out mice. In summary, our findings provide formal proof of the predominant T cell-intrinsic role of Coronin 1A.	[Siegmund, Kerstin; Klepsch, Victoria; Hermann-Kleiter, Natascha; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Peter Mayr Str 1a, AT-6020 Innsbruck, Austria		Siegmund, K; Baier, G (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, Peter Mayr Str 1a, AT-6020 Innsbruck, Austria.	kerstin.siegmund@i-med.ac.at; Gottfried.Baier@i-med.ac.at	Klepsch, Victoria/ABB-9476-2021; Bellaire-Siegmund, Kerstin/D-4774-2018; Kleiter, Natascha/I-5101-2018; Bellaire-Siegmund, Kerstin/AAA-9702-2021	Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Kleiter, Natascha/0000-0003-4389-9813; Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Baier, Gottfried/0000-0002-2085-8325; Klepsch, Victoria/0000-0003-4146-4664	FWF Austrian Science Fund "Lise-Meitner" [M1636-B23, 25044-B21]; Medical University Innsbruck for young scientists MUI-START project [2013042002]; Austrian Science Fund (FWF) [M 1636, P 25044] Funding Source: researchfish	FWF Austrian Science Fund "Lise-Meitner"; Medical University Innsbruck for young scientists MUI-START project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the FWF Austrian Science Fund "Lise-Meitner" M1636-B23 (to K. S.) and 25044-B21 (to G. B.) and intramural funding program of the Medical University Innsbruck for young scientists MUI-START project 2013042002 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arandjelovic S, 2010, J LEUKOCYTE BIOL, V88, P737, DOI 10.1189/jlb.0310131; Batoulis H, 2010, ANN ANAT, V192, P179, DOI 10.1016/j.aanat.2010.06.006; Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811; Combaluzier B, 2009, J IMMUNOL, V182, P2745, DOI 10.4049/jimmunol.0801812; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Foger N, 2011, J EXP MED, V208, P1777, DOI 10.1084/jem.20101757; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jayachandran R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001820; Kaminski S, 2011, J AUTOIMMUN, V37, P198, DOI 10.1016/j.jaut.2011.05.018; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Mace EM, 2014, P NATL ACAD SCI USA, V111, P6708, DOI 10.1073/pnas.1314975111; Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312; Moshous D, 2013, J ALLERGY CLIN IMMUN, V131, P1594, DOI 10.1016/j.jaci.2013.01.042; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Pieters J, 2013, NAT REV IMMUNOL, V13, P510, DOI 10.1038/nri3465; Punwani D, 2015, J CLIN IMMUNOL, V35, P100, DOI 10.1007/s10875-015-0130-z; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Seamons A, 2003, IMMUNOL RES, V28, P201, DOI 10.1385/IR:28:3:201; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002; Siegmund K, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0100-3; Siegmund K, 2013, IMMUNOL LETT, V153, P62, DOI 10.1016/j.imlet.2013.06.005; Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491; Stephens LA, 2009, EUR J IMMUNOL, V39, P1108, DOI 10.1002/eji.200839073; Stray-Pedersen A, 2014, J CLIN IMMUNOL, V34, P871, DOI 10.1007/s10875-014-0074-8; Suo D, 2014, NAT NEUROSCI, V17, P36, DOI 10.1038/nn.3593; Tchang VSY, 2013, MOL IMMUNOL, V56, P683, DOI 10.1016/j.molimm.2013.05.003; Wachowicz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096401; Westritschnig K, 2013, MOL IMMUNOL, V53, P379, DOI 10.1016/j.molimm.2012.09.002; Yee CS, 2016, J ALLERGY CLIN IMMUN, V137, P879, DOI 10.1016/j.jaci.2015.08.020	35	9	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22086	22092		10.1074/jbc.M116.748012	http://dx.doi.org/10.1074/jbc.M116.748012			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27566541	hybrid, Green Published			2022-12-28	WOS:000386332600023
J	Silverman, JM; Imperiali, B				Silverman, Julie Michelle; Imperiali, Barbara			Bacterial N-Glycosylation Efficiency Is Dependent on the Structural Context of Target Sequons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; oligosaccharyltransferase; protein folding; protein translocation; substrate specificity	LINKED PROTEIN GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; OLIGOSACCHARYL TRANSFERASE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; COMPLEX; STT3; IDENTIFICATION; CHAPERONES	Site selectivity of protein N-linked glycosylation is dependent on many factors, including accessibility of the modification site, amino acid composition of the glycosylation consensus sequence, and cellular localization of target proteins. Previous studies have shown that the bacterial oligosaccharyltransferase, PglB, of Campylobacter jejuni favors acceptor proteins with consensus sequences ((D/E)X1NX2(S/T), where X-1,X-2 proline) in flexible, solvent-exposed motifs; however, several native glycoproteins are known to harbor consensus sequences within structured regions of the acceptor protein, suggesting that unfolding or partial unfolding is required for efficient N-linked glycosylation in the native environment. To derive insight into these observations, we generated structural homology models of the N-linked glycoproteome of C. jejuni. This evaluation highlights the potential diversity of secondary structural conformations of previously identified N-linked glycosylation sequons. Detailed assessment of PglB activity with a structurally characterized acceptor protein, PEB3, demonstrated that this natively folded substrate protein is not efficiently glycosylated in vitro, whereas structural destabilization increases glycosylation efficiency. Furthermore, in vivo glycosylation studies in both glyco-competent Escherichia coli and the native system, C. jejuni, revealed that efficient glycosylation of glycoproteins, AcrA and PEB3, depends on translocation to the periplasmic space via the general secretory pathway. Our studies provide quantitative evidence that many acceptor proteins are likely to be N-linked-glycosylated before complete folding and suggest that PglB activity is coupled to general secretion-mediated translocation to the periplasm. This work extends our understanding of the molecular mechanisms underlying N-linked glycosylation in bacteria.	[Silverman, Julie Michelle; Imperiali, Barbara] MIT, Dept Biol, 77 Massachusetts Ave,68-380, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Imperiali, B (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,68-380, Cambridge, MA 02139 USA.	imper@mit.edu		Imperiali, Barbara/0000-0002-5749-7869	National Institutes of Health [GM-039334, AI109857]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI109857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM-039334 (to B. I.) and AI109857 (to J. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Chavan M, 2005, J BIOL CHEM, V280, P22917, DOI 10.1074/jbc.M502858200; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Chen W, 2000, MOL BIOL CELL, V11, P765, DOI 10.1091/mbc.11.2.765; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; Davis Lindsay, 2008, Curr Protoc Microbiol, VChapter 8, DOI [10.1002/9780471729259.mc08a01s10, 10.1002/9780471729259.mc08a02s10]; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Hitchcock A, 2010, MICROBIOL-SGM, V156, P2994, DOI 10.1099/mic.0.042788-0; Jaffe SRP, 2014, CURR OPIN BIOTECH, V30, P205, DOI 10.1016/j.copbio.2014.07.006; Jaffee MB, 2013, PROTEIN EXPRES PURIF, V89, P241, DOI 10.1016/j.pep.2013.04.001; Johnson DE, 2009, J BIOL CHEM, V284, P20499, DOI 10.1074/jbc.M109.019042; Kale A, 2011, J BIOL CHEM, V286, P21254, DOI 10.1074/jbc.M111.220442; Kawai F, 2012, J STRUCT BIOL, V177, P583, DOI 10.1016/j.jsb.2012.01.001; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; Min T, 2009, BIOCHEMISTRY-US, V48, P3057, DOI 10.1021/bi802195d; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Muller A, 2005, MOL MICROBIOL, V57, P143, DOI 10.1111/j.1365-2958.2005.04691.x; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nothaft H, 2012, MOL CELL PROTEOMICS, V11, P1203, DOI 10.1074/mcp.M112.021519; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Pandhal J, 2013, BIOTECHNOL BIOENG, V110, P2482, DOI 10.1002/bit.24920; Pandhal J, 2012, BIOCHEM BIOPH RES CO, V419, P472, DOI 10.1016/j.bbrc.2012.02.020; Pandhal J, 2010, BIOTECHNOL LETT, V32, P1189, DOI 10.1007/s10529-010-0289-6; PEI ZH, 1991, J BIOL CHEM, V266, P16363; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Rangarajan ES, 2007, PROTEIN SCI, V16, P990, DOI 10.1110/ps.062737507; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/NCHEMBIO.921, 10.1038/nchembio.921]; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Yusuf SNHM, 2013, BIOCHEM BIOPH RES CO, V432, P438, DOI 10.1016/j.bbrc.2013.01.128	72	25	27	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22001	22010		10.1074/jbc.M116.747121	http://dx.doi.org/10.1074/jbc.M116.747121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573243	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000386332600015
J	Hwang, EY; Jeong, MS; Park, SK; Ha, SC; Yu, HS; Jang, SB				Hwang, Eun Young; Jeong, Mi Suk; Park, Sang Kyun; Ha, Sung Chul; Yu, Hak Sun; Jang, Se Bok			Structural Basis for Carbohydrate Recognition and Anti-inflammatory Modulation by Gastrointestinal Nematode Parasite Toxascaris leonina Galectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; crystal structure; enzyme mutation; galectin; inflammation	T-CELL DEATH; MOLECULAR REPLACEMENT; PROTEIN AGGREGATION; DISEASE; DOMAINS; OLIGOSACCHARIDE; EXPRESSION; SEARCH; ACID	Toxascaris leonina galectin (Tl-gal) is a galectin-9 homologue protein isolated from an adult worm of the canine gastrointestinal nematode parasite, and Tl-gal-vaccinated challenge can inhibit inflammation in inflammatory bowel disease-induced mice. We determined the first X-ray structures of full-length Tl-gal complexes with carbohydrates (lactose, N-acetyllactosamine, lacto-N-tetraose, sialyllactose, and glucose). Bonds were formed on concave surfaces of both carbohydrate recognition domains (CRDs) in Tl-gal. All binding sites were found in the HXXXR and WGXEER motifs. Charged Arg(61)/Arg(196) and Glu(80)/Glu(215) on the conserved motif of Tl-gal N-terminal CRD and C-terminal CRD are critical amino acids for recognizing carbohydrate binding, and the residues can affect protein folding and structure. The polar amino acids His, Asn, and Trp are also important residues for the interaction with carbohydrates through hydrogen bonding. Hemagglutination activities of Tl-gal were inhibited by interactions with carbohydrates and mutations. We found that the mutation of Tl-gal (E80A/E215A) at the carbohydrate binding region induced protein aggregation and could be caused in many diseases. The short linker region between the N-terminal and C-terminal CRDs of Tl-gal was very stable against proteolysis and maintained its biological activity. This structural information is expected to elucidate the carbohydrate recognition mechanism of Tl-gal and improve our understanding of anti-inflammatory mediators and modulators of immune response.	[Hwang, Eun Young; Jeong, Mi Suk; Jang, Se Bok] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, 2,Busandaehak Ro 63beon Gil, Busan 46241, South Korea; [Ha, Sung Chul] Pohang Univ Sci & Technol, Pohang Accelerator Lab, 80,Jigok Ro 127 Beon Gil, Pohang Si 37673, Gyeongsangbuk D, South Korea; [Park, Sang Kyun; Yu, Hak Sun] Pusan Natl Univ, Sch Med, Dept Parasitol, 49 Busandaehak Ro, Yangsan Si 50612, Gyeongsangnam D, South Korea	Pusan National University; Pohang University of Science & Technology (POSTECH); Pusan National University	Jang, SB (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, 2,Busandaehak Ro 63beon Gil, Busan 46241, South Korea.	sbjang@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2015R1D1A1A01059594, 2016R1D1A1B02011142]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	We thank Dr. Sung Chul Ha at the Pohang Light Source (PLS-7A), Republic of Korea, for assistance with the X-ray diffraction experiments. This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, Grants 2015R1D1A1A01059594 (to S. B. J.) and 2016R1D1A1B02011142 (to J. M. S.).	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Collins PM, 2014, J MOL BIOL, V426, P1439, DOI 10.1016/j.jmb.2013.12.004; De Felice FG, 2004, FASEB J, V18, P1099, DOI 10.1096/fj.03-1072fje; Heusschen R, 2013, BBA-REV CANCER, V1836, P177, DOI 10.1016/j.bbcan.2013.04.006; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iglesias MM, 1998, EUR J BIOCHEM, V252, P400, DOI 10.1046/j.1432-1327.1998.2520400.x; Jeong MS, 2013, ACTA CRYSTALLOGR D, V69, P168, DOI 10.1107/S0907444912045106; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JY, 2010, MOL BIOCHEM PARASIT, V174, P53, DOI 10.1016/j.molbiopara.2010.06.014; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Lee KH, 2008, VET PARASITOL, V156, P216, DOI 10.1016/j.vetpar.2008.06.016; Li YR, 2011, MOL IMMUNOL, V48, P670, DOI 10.1016/j.molimm.2010.11.011; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reddy A, 2007, PARASITOL RES, V100, P921, DOI 10.1007/s00436-006-0416-4; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thijssen VL, 2014, GLYCOBIOLOGY, V24, P915, DOI 10.1093/glycob/cwu048; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wang J, 2007, VET PARASITOL, V148, P247, DOI 10.1016/j.vetpar.2007.06.024; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yoshida H, 2010, J BIOL CHEM, V285, P36969, DOI 10.1074/jbc.M110.163402	31	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25326	25338		10.1074/jbc.M116.743773	http://dx.doi.org/10.1074/jbc.M116.743773			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27742836	Green Published, hybrid			2022-12-28	WOS:000390095300005
J	Ramachandran, S; Osterhaus, SR; Parekh, KR; Jacobi, AM; Behlke, MA; McCray, PB				Ramachandran, Shyam; Osterhaus, Samantha R.; Parekh, Kalpaj R.; Jacobi, Ashley M.; Behlke, Mark A.; McCray, Paul B., Jr.			SYVN1, NEDD8, and FBXO2 Proteins Regulate F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; E3 ubiquitin ligase; endoplasmic-reticulum-associated protein degradation (ERAD); proteostasis; ubiquitylation (ubiquitination); airway epithelia; neddylation	SMALL-MOLECULE CORRECTORS; ENDOPLASMIC-RETICULUM; NEDD8-ACTIVATING ENZYME; CHLORIDE CHANNEL; QUALITY-CONTROL; PHARMACOLOGICAL CORRECTORS; CHEMICAL-MODIFICATION; AIRWAY EPITHELIA; GENETIC-ANALYSIS; CL-CONDUCTANCE	We previously reported that delivery of a microRNA-138 mimic or siRNA against SIN3A to cultured cystic fibrosis (F508/F508) airway epithelia partially restored F508-cystic fibrosis transmembrane conductance regulator (CFTR)-mediated cAMP-stimulated Cl- conductance. We hypothesized that dissecting this microRNA-138/SIN3A-regulated gene network would identify individual proteins contributing to the rescue of F508-CFTR function. Among the genes in the network, we rigorously validated candidates using functional CFTR maturation and electrolyte transport assays in polarized airway epithelia. We found that depletion of the ubiquitin ligase SYVN1, the ubiquitin/proteasome system regulator NEDD8, or the F-box protein FBXO2 partially restored F508-CFTR-mediated Cl- transport in primary cultures of human cystic fibrosis airway epithelia. Moreover, knockdown of SYVN1, NEDD8, or FBXO2 in combination with corrector compound 18 further potentiated rescue of F508-CFTR-mediated Cl- conductance. This study provides new knowledge of the CFTR biosynthetic pathway. It suggests that SYVN1 and FBXO2 represent two distinct multiprotein complexes that may degrade F508-CFTR in airway epithelia and identifies a new role for NEDD8 in regulating F508-CFTR ubiquitination.	[Ramachandran, Shyam; Osterhaus, Samantha R.; Parekh, Kalpaj R.; McCray, Paul B., Jr.] Univ Iowa, Pappajohn Biomed Inst, Dept Pediat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Jacobi, Ashley M.; Behlke, Mark A.] Integrated DNA Technol, Coralville, IA 52241 USA	University of Iowa	McCray, PB (corresponding author), Univ Iowa, Dept Pediat, Carver Coll Med, 169 Newton Rd,6320 PBDB, Iowa City, IA 52242 USA.	paul-mccray@uiowa.edu	Parekh, Kalpaj/E-4966-2012	Parekh, Kalpaj/0000-0001-6869-5441; McCray, Paul/0000-0002-4067-577X; Behlke, Mark/0000-0002-4218-857X	National Institutes of Health [P01 HL091842, P30 DK54759]; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, P01HL051670, R21HL104337, R01HL118000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Rob Piper, Chris Adams, Lynda Ostedgaard, Patrick Sinn, Colleen Stein, and Carolyn Yrigollen for critical comments on the manuscript. We also thank Philip Karp, Sarah Ernst, Lynda Ostedgaard, and Christine Wohlford-Lenane for technical assistance. We also acknowledge the support of the In Vitro Models and Cell Culture Core, which is partly supported by National Institutes of Health Grants P01 HL091842 and P30 DK54759 and the Cystic Fibrosis Foundation.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bulatov E, 2015, BIOCHEM J, V467, P365, DOI 10.1042/BJ20141450; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Collingwood MA, 2008, OLIGONUCLEOTIDES, V18, P187, DOI 10.1089/oli.2008.0123; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Esposito Speranza, 2016, Mol Cell Pediatr, V3, P13, DOI 10.1186/s40348-016-0040-z; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Godbersen JC, 2014, CLIN CANCER RES, V20, P1576, DOI 10.1158/1078-0432.CCR-13-0987; Gomes-Alves P, 2009, J PROTEOMICS, V73, P218, DOI 10.1016/j.jprot.2009.09.001; Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0; HAWS C, 1994, AM J PHYSIOL, V266, pL502, DOI 10.1152/ajplung.1994.266.5.L502; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Hussain M, 2016, PHARMACOL RES, V111, P34, DOI 10.1016/j.phrs.2016.05.027; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Itani OA, 2011, P NATL ACAD SCI USA, V108, P10260, DOI 10.1073/pnas.1106695108; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nawrocki ST, 2012, EXPERT OPIN INV DRUG, V21, P1563, DOI 10.1517/13543784.2012.707192; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pesce E, 2016, J CYST FIBROS, V15, P425, DOI 10.1016/j.jcf.2016.02.009; Ramachandran S, 2013, AM J PHYSIOL-LUNG C, V305, pL23, DOI 10.1152/ajplung.00426.2012; Ramachandran S, 2012, P NATL ACAD SCI USA, V109, P13362, DOI 10.1073/pnas.1210906109; Ramachandran S, 2011, METHODS MOL BIOL, V742, P193, DOI 10.1007/978-1-61779-120-8_12; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Sondo E, 2011, AM J PHYSIOL-CELL PH, V301, pC872, DOI 10.1152/ajpcell.00507.2010; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang DL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00176; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354	66	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25489	25504		10.1074/jbc.M116.754283	http://dx.doi.org/10.1074/jbc.M116.754283			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756846	hybrid, Green Published			2022-12-28	WOS:000390095300018
J	Xiao, ZC; Guo, WT; Sun, B; Hunt, DJ; Wei, JH; Liu, YJ; Wang, YD; Wang, RW; Jones, PP; Back, TG; Chen, SRW				Xiao, Zhichao; Guo, Wenting; Sun, Bo; Hunt, Donald J.; Wei, Jinhong; Liu, Yingjie; Wang, Yundi; Wang, Ruiwu; Jones, Peter P.; Back, Thomas G.; Chen, S. R. Wayne			Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; RYR2 MUTATIONS; SUDDEN-DEATH; MOLECULAR-IDENTIFICATION; ATRIAL-FIBRILLATION; RELEASE; CARVEDILOL; TERMINATION; THRESHOLD; PROTEINS	Recent three-dimensional structural studies reveal that the central domain of ryanodine receptor (RyR) serves as a transducer that converts long-range conformational changes into the gating of the channel pore. Interestingly, the central domain encompasses one of the mutation hotspots (corresponding to amino acid residues 3778 4201) that contains a number of cardiac RyR (RyR2) mutations associated with catecholaminergic polymorphic ventricular tachycardia (CPVT) and atrial fibrillation (AF). However, the functional consequences of these central domain RyR2 mutations are not well understood. To gain insights into the impact of the mutation and the role of the central domain in channel function, we generated and characterized eight disease-associated RyR2 mutations in the central domain. We found that all eight central domain RyR2 mutations enhanced the Ca2+-dependent activation of [H-3]ryanodine binding, increased cytosolic Ca2+-induced fractional Ca2+ release, and reduced the activation and termination thresholds for spontaneous Ca2+ release in HEK293 cells. We also showed that racemic carvedilol and the non-beta-blocking carvedilol enantiomer, (R)-carvedilol, suppressed spontaneous Ca2+ oscillations in HEK293 cells expressing the central domain RyR2 mutations associated with CPVT and AF. These data indicate that the central domain is an important determinant of cytosolic Ca2+ activation of RyR2. These results also suggest that altered cytosolic Ca2+ activation of RyR2 represents a common defect of RyR2 mutations associated with CPVT and AF, which could potentially be suppressed by carvedilol or (R)-carvedilol.	[Xiao, Zhichao; Guo, Wenting; Sun, Bo; Hunt, Donald J.; Wei, Jinhong; Liu, Yingjie; Wang, Yundi; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Jones, Peter P.] Univ Otago, Otago Sch Med Sci, Dept Physiol, Dunedin 9054, New Zealand; [Jones, Peter P.] Univ Otago, HeartOtago, Dunedin 9054, New Zealand; [Back, Thomas G.] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada; [Xiao, Zhichao] Huazhong Univ Sci & Technol, Dept Cardiol, Tongji Hosp, Tongji Med Sch, Wuhan 430030, Peoples R China	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Otago; University of Otago; University of Calgary; Huazhong University of Science & Technology	Chen, SRW (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Wei, Jinhong/GWV-0561-2022	Wei, Jinhong/0000-0002-5251-9192; Jones, Pete/0000-0001-7977-1737	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Graduate Studentship Award; Heart and Stroke Foundation of Canada Junior Fellowship Award; AIHS Fellowship Award; Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award; Alberta Innovates [201300501, 201500221, 201400104] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Graduate Studentship Award; Heart and Stroke Foundation of Canada Junior Fellowship Award; AIHS Fellowship Award; Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award; Alberta Innovates	This work was supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research (to S. R. W. C.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipients of the Alberta Innovates-Health Solutions (AIHS) Graduate Studentship Award.r Recipient of the Heart and Stroke Foundation of Canada Junior Fellowship Award and the AIHS Fellowship Award.r A recipient of the Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award.	Bai XC, 2016, CELL RES, V26, P995, DOI 10.1038/cr.2016.89; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Di Pino A, 2014, HEART RHYTHM, V11, P1480, DOI 10.1016/j.hrthm.2014.04.037; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Frishman WH, 1998, NEW ENGL J MED, V339, P1759, DOI 10.1056/NEJM199812103392407; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kazemian P, 2011, CAN J CARDIOL, V27, DOI 10.1016/j.cjca.2011.02.003; Krahn AD, 2009, CIRCULATION, V120, P278, DOI 10.1161/CIRCULATIONAHA.109.853143; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; O'Brien JJ, 2002, BIOPHYS J, V82, P2428, DOI 10.1016/S0006-3495(02)75586-0; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pizzale S, 2008, J CARDIOVASC ELECTR, V19, P1319, DOI 10.1111/j.1540-8167.2008.01211.x; Postma AV, 2005, J MED GENET, V42, P863, DOI 10.1136/jmg.2004.028993; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Stoschitzky K, 2001, CHIRALITY, V13, P342, DOI 10.1002/chir.1042; Sy RW, 2011, HEART RHYTHM, V8, P864, DOI 10.1016/j.hrthm.2011.01.048; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tester DJ, 2005, HEART RHYTHM, V2, P1099, DOI 10.1016/j.hrthm.2005.07.012; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Thul R, 2012, P NATL ACAD SCI USA, V109, P2150, DOI 10.1073/pnas.1115855109; Tian XX, 2013, J BIOL CHEM, V288, P4066, DOI 10.1074/jbc.M112.427864; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; VANZWIETEN PA, 1993, CARDIOLOGY, V82, P19, DOI 10.1159/000175939; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zhang JQ, 2015, BIOCHEM J, V470, P233, DOI 10.1042/BJ20150548; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	37	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24528	24537		10.1074/jbc.M116.756528	http://dx.doi.org/10.1074/jbc.M116.756528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27733687	Green Published, hybrid			2022-12-28	WOS:000388875500016
J	Haji-Ghassemi, O; Gilbert, M; Spence, J; Schur, MJ; Parker, MJ; Jenkins, ML; Burke, JE; van Faassen, H; Young, NM; Evans, SV				Haji-Ghassemi, Omid; Gilbert, Michel; Spence, Jenifer; Schur, Melissa J.; Parker, Matthew J.; Jenkins, Meredith L.; Burke, John E.; van Faassen, Henk; Young, N. Martin; Evans, Stephen V.			Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[14]GlcNAc), by Wisteria floribunda Agglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomarker; cancer; carbohydrate; carbohydrate-binding protein; lectin; structural biology; x-ray crystallography; agglutinin; glycobiomarker	HUMAN PERIPHERAL LYMPHOCYTES; WISTARIA-FLORIBUNDA; LEGUME LECTIN; HEPATOCELLULAR-CARCINOMA; LINKED OLIGOSACCHARIDES; N-ACETYLGALACTOSAMINE; ROBINIA-PSEUDOACACIA; SCHISTOSOMA-MANSONI; MASS-SPECTROMETRY; SOPHORA-JAPONICA	Aberrant glycosylation and the overexpression of specific carbohydrate epitopes is a hallmark of many cancers, and tumor-associated oligosaccharides are actively investigated as targets for immunotherapy and diagnostics. Wisteria floribunda agglutinin (WFA) is a legume lectin that recognizes terminal N-acetylgalactosaminides with high affinity. WFA preferentially binds the disaccharide LacdiNAc (-d-GalNAc-[14]-d-GlcNAc), which is associated with tumor malignancy in leukemia, prostate, pancreatic, ovarian, and liver cancers and has shown promise in cancer glycobiomarker detection. The mechanism of specificity for WFA recognition of LacdiNAc is not fully understood. To address this problem, we have determined affinities and structure of WFA in complex with GalNAc and LacdiNAc. Affinities toward Gal, GalNAc, and LacdiNAc were measured via surface plasmon resonance, yielding K-D values of 4.67 x 10(-4) m, 9.24 x 10(-5) m, and 5.45 x 10(-6) m, respectively. Structures of WFA in complex with LacdiNAc and GalNAc have been determined to 1.80-2.32 angstrom resolution. These high resolution structures revealed a hydrophobic groove complementary to the GalNAc and, to a minor extent, to the back-face of the GlcNAc sugar ring. Remarkably, the contribution of this small hydrophobic surface significantly increases the observed affinity for LacdiNAc over GalNAc. Tandem MS sequencing confirmed the presence of two isolectin forms in commercially available WFA differing only in the identities of two amino acids. Finally, the WFA carbohydrate binding site is similar to a homologous lectin isolated from Vatairea macrocarpa in complex with GalNAc, which, unlike WFA, binds not only GalNAc but also terminal Ser/Thr O-linked GalNAc (Tn antigen).	[Haji-Ghassemi, Omid; Spence, Jenifer; Parker, Matthew J.; Jenkins, Meredith L.; Burke, John E.; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8P 3P6, Canada; [Gilbert, Michel; Schur, Melissa J.; van Faassen, Henk; Young, N. Martin] Natl Res Council Canada, Human Hlth Therapeut, Ottawa, ON K1A 0R6, Canada	University of Victoria; National Research Council Canada	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8P 3P6, Canada.	svevans@uvic.ca	Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Jenkins, Meredith/0000-0002-0685-5048; Gilbert, Michel/0000-0002-0204-4408; Schur, Melissa/0000-0002-6047-1416; Haji-Ghassemi, Omid/0000-0003-0116-005X; Evans, Stephen/0000-0002-0366-4027	NIGMS, National Institutes of Health Grant [GM62116]; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health Grant; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the technical assistance of Nicholas I. Brodie and Evgeniy V. Petrotchenko at the Genome British Columbia Proteomics Centre, Vancouver Island Technology Park. We thank Dr. Greg Hussack for help with the SPR analysis, Dr. Evgeny Vinogradov for NMR analysis, and Jacek Stupak for mass spectrometry analysis of the LacdiNAc beta-pNP. The glycan array facility of the Center for Functional Glycomics was supported by NIGMS, National Institutes of Health Grant GM62116. Research described in this paper was performed at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	BAKER DA, 1983, BIOCHEMISTRY-US, V22, P2741, DOI 10.1021/bi00280a023; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bojarova P, 2009, GLYCOBIOLOGY, V19, P509, DOI 10.1093/glycob/cwp010; Chandra NR, 2001, PROTEIN ENG, V14, P857, DOI 10.1093/protein/14.11.857; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Drickamer K, 2002, GENOME BIOL, V3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frederiksen RF, 2015, J BIOL CHEM, V290, P5354, DOI 10.1074/jbc.M114.607291; Fujiyoshi M, 2015, J GASTROENTEROL, V50, P1134, DOI 10.1007/s00535-015-1063-2; Garcia-Pino A, 2006, J MOL BIOL, V361, P153, DOI 10.1016/j.jmb.2006.06.006; HANKINS CN, 1988, PLANT PHYSIOL, V86, P67, DOI 10.1104/pp.86.1.67; Hirano K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981627; Huang J, 2007, MOL CANCER RES, V5, P543, DOI 10.1158/1541-7786.MCR-06-0431; Iio E, 2016, INT J CANCER, V138, P1462, DOI 10.1002/ijc.29880; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kitamura N, 2003, INT J CANCER, V105, P533, DOI 10.1002/ijc.11115; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; KUROKAWA T, 1976, J BIOL CHEM, V251, P5686; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Matsuda A, 2015, ANAL CHEM, V87, P7274, DOI 10.1021/acs.analchem.5b01329; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MODY R, 1995, J PHARMACOL TOX MET, V33, P1, DOI 10.1016/1056-8719(94)00052-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Namdjou DJ, 2008, CHEMBIOCHEM, V9, P1632, DOI 10.1002/cbic.200700775; Narimatsu H, 2015, EXPERT REV PROTEOMIC, V12, P683, DOI 10.1586/14789450.2015.1084874; NYAME K, 1989, J BIOL CHEM, V264, P3235; PALCIC M M, 1991, Glycobiology, V1, P205, DOI 10.1093/glycob/1.2.205; Petrotchenko EV, 2014, METHODS MOL BIOL, V1156, P447, DOI 10.1007/978-1-4939-0685-7_30; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pohleven J, 2012, J BIOL CHEM, V287, P10602, DOI 10.1074/jbc.M111.317263; Rabijns A, 2001, PROTEINS, V44, P470, DOI 10.1002/prot.1112; Sasaki N, 2007, BIOCHEM BIOPH RES CO, V354, P522, DOI 10.1016/j.bbrc.2007.01.015; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Sato T., 2014, Google Patents, Patent No. [WO2014098112 A1, 2014098112]; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Soga K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083886; Sogabe M, 2014, J PROTEOME RES, V13, P1624, DOI 10.1021/pr401109n; Sousa BL, 2016, INT J BIOCHEM CELL B, V72, P27, DOI 10.1016/j.biocel.2015.12.016; SRIVATSAN J, 1994, J PARASITOL, V80, P884, DOI 10.2307/3283435; Sugahara D, 2015, PROTEOMICS, V15, P2921, DOI 10.1002/pmic.201400443; SUGII S, 1980, BIOCHEMISTRY-US, V19, P1192, DOI 10.1021/bi00547a024; Tamaki N, 2015, HEPATOL RES, V45, pE82, DOI 10.1111/hepr.12466; Toyoda H, 2016, LIVER INT, V36, P293, DOI 10.1111/liv.12907; TOYOSHIMA S, 1971, BIOCHEMISTRY-US, V10, P4457, DOI 10.1021/bi00800a016; TOYOSHIMA S, 1975, J BIOL CHEM, V250, P1655; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VanDamme EJM, 1995, PLANT MOL BIOL, V29, P579, DOI 10.1007/BF00020986; VanDamme EJM, 1997, PLANT MOL BIOL, V33, P523, DOI 10.1023/A:1005781103418; VANDENEIJNDEN DH, 1995, BIOCHEM SOC T, V23, P175, DOI 10.1042/bst0230175; Xu YF, 2005, IMMUNOL CELL BIOL, V83, P440, DOI 10.1111/j.1440-1711.2005.01347.x; Yamaguchi T, 2016, ANN SURG ONCOL, V23, P671, DOI 10.1245/s10434-015-4878-4; Yoshida K, 1999, AUST J PLANT PHYSIOL, V26, P495, DOI 10.1071/PP99048; Young NM, 1996, GLYCOCONJUGATE J, V13, P575, DOI 10.1007/BF00731445; YOUNG NM, 1995, J BIOL CHEM, V270, P2563, DOI 10.1074/jbc.270.6.2563; YUAN M, 1986, CANCER RES, V46, P4841	65	36	36	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24085	24095		10.1074/jbc.M116.750463	http://dx.doi.org/10.1074/jbc.M116.750463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27601469	Green Published, hybrid			2022-12-28	WOS:000388498100025
J	Ramirez-Escudero, M; del Pozo, MV; Marin-Navarro, J; Gonzalez, B; Golyshin, PN; Polaina, J; Ferrer, M; Sanz-Aparicio, J				Ramirez-Escudero, Mercedes; del Pozo, Mercedes V.; Marin-Navarro, Julia; Gonzalez, Beatriz; Golyshin, Peter N.; Polaina, Julio; Ferrer, Manuel; Sanz-Aparicio, Julia			Structural and Functional Characterization of a Ruminal -Glycosidase Defines a Novel Subfamily of Glycoside Hydrolase Family 3 with Permuted Domain Topology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme structure; glycoside hydrolase; metagenomics; protein structure; X-ray crystallography; GH3 family; -glycosidase; enzymology; permuted domains topology; phylogenetic analysis	BETA-GLUCOSIDASE; 3-DIMENSIONAL STRUCTURE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURES; BACTERIUM; GLUCOHYDROLASE; COMBINATION; SEQUENCE; CLONING; SOIL	Metagenomics has opened up a vast pool of genes for putative, yet uncharacterized, enzymes. It widens our knowledge on the enzyme diversity world and discloses new families for which a clear classification is still needed, as is exemplified by glycoside hydrolase family-3 (GH3) proteins. Herein, we describe a GH3 enzyme (GlyA(1)) from resident microbial communities in strained ruminal fluid. The enzyme is a -glucosidase/-xylosidase that also shows -galactosidase, -fucosidase, -arabinofuranosidase, and -arabinopyranosidase activities. Short cello- and xylo-oligosaccharides, sophorose and gentibiose, are among the preferred substrates, with the large polysaccharide lichenan also being hydrolyzed by GlyA(1). The determination of the crystal structure of the enzyme in combination with deletion and site-directed mutagenesis allowed identification of its unusual domain composition and the active site architecture. Complexes of GlyA(1) with glucose, galactose, and xylose allowed picturing the catalytic pocket and illustrated the molecular basis of the substrate specificity. A hydrophobic platform defined by residues Trp-711 and Trp-106, located in a highly mobile loop, appears able to allocate differently -linked bioses. GlyA(1) includes an additional C-terminal domain previously unobserved in GH3 members, but crystallization of the full-length enzyme was unsuccessful. Therefore, small angle x-ray experiments have been performed to investigate the molecular flexibility and overall putative shape. This study provided evidence that GlyA(1) defines a new subfamily of GH3 proteins with a novel permuted domain topology. Phylogenetic analysis indicates that this topology is associated with microbes inhabiting the digestive tracts of ruminants and other animals, feeding on chemically diverse plant polymeric materials.	[Ramirez-Escudero, Mercedes; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Phys Chem Rocasolano, Dept Crystallog & Struct Biol, Serrano 119, Madrid 28006, Spain; [del Pozo, Mercedes V.; Ferrer, Manuel] CSIC, Inst Catalysis & Petrochem, Marie Curie 2, Madrid 28049, Spain; [Marin-Navarro, Julia; Polaina, Julio] CSIC, Inst Agrochem & Food Technol, Carrer Catedrat Agustin Escardino Benlloch 7, Valencia 46980, Spain; [Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; [Golyshin, Peter N.] Immanuel Kant Balt Fed Univ, Kaliningrad 236040, Russia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Bangor University; Immanuel Kant Baltic Federal University	Sanz-Aparicio, J (corresponding author), CSIC, Inst Phys Chem Rocasolano, Dept Crystallog & Struct Biol, Serrano 119, Madrid 28006, Spain.; Ferrer, M (corresponding author), CSIC, Inst Catalysis & Petrochem, Marie Curie 2, Madrid 28049, Spain.	mferrer@icp.csic.es	Polaina, Julio/H-4498-2012; Gonzalez, Beatriz/M-1219-2014; ESCUDERO, MERCEDES RAMIREZ/Q-3965-2018; Sanz-Aparicio, Julia/F-6201-2013; Escudero, Mercedes Ramirez/O-1690-2019	Gonzalez, Beatriz/0000-0002-0710-0202; ESCUDERO, MERCEDES RAMIREZ/0000-0001-7253-9572; Sanz-Aparicio, Julia/0000-0002-6849-8621; Escudero, Mercedes Ramirez/0000-0001-7253-9572; Golyshin, Peter/0000-0002-5433-0350	European Community [283570]; BBSRC [BB/M029085/1] Funding Source: UKRI	European Community(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the German Electron Synchrotron (Hamburg, Germany) for assistance at Petra III P13 Beamline, the Diamond Synchrotron Radiation Source (Daresbury, UK) for assistance at I03 Beamline, and funding from the European Community's Seventh Framework Programme under BioStruct-X (Grant 283570). We also thank the staff of the European Synchrotron Radiation Facility at Grenoble (ESRF, France) for providing access and technical assistance at beamlines ID23-1 and BM29, and the Spanish Synchrotron at Barcelona (Alba, Spain) for assistance at XALOC beamline. We also acknowledge Rafael Bargiela for excellent support in the preparation of Figs. 1 and 5 and Oleg N. Reva for critical contribution to the compositional similarities analysis.	Agirre J, 2016, ACTA CRYSTALLOGR D, V72, P254, DOI 10.1107/S2059798315024237; Alcaide M, 2015, ENVIRON MICROBIOL, V17, P332, DOI 10.1111/1462-2920.12660; Alcaide M, 2013, BIOCHEM J, V454, P157, DOI 10.1042/BJ20130552; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Del Pozo MV, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-73; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer M, 2016, MICROB BIOTECHNOL, V9, P22, DOI 10.1111/1751-7915.12309; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hrmova M, 2005, BIOCHEMISTRY-US, V44, P16529, DOI 10.1021/bi0514818; Hrmova M, 2004, J BIOL CHEM, V279, P4970, DOI 10.1074/jbc.M307188200; Hrmova M, 2002, PLANT CELL, V14, P1033, DOI 10.1105/tpc.010442; Hrmova M, 2001, STRUCTURE, V9, P1005, DOI 10.1016/S0969-2126(01)00673-6; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lee JH, 2011, J APPL MICROBIOL, V111, P1097, DOI 10.1111/j.1365-2672.2011.05128.x; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Mai V, 2000, GENE, V247, P137, DOI 10.1016/S0378-1119(00)00106-2; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P121, DOI 10.1007/s00253-010-2845-3; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; McAndrew RP, 2013, J BIOL CHEM, V288, P14985, DOI 10.1074/jbc.M113.458356; Menigaud S, 2012, BIOINFORMATICS, V28, P1270, DOI 10.1093/bioinformatics/bts118; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller MEB, 2012, ENVIRON MICROBIOL, V14, P207, DOI 10.1111/j.1462-2920.2011.02593.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakatani Y, 2012, FEBS J, V279, P464, DOI 10.1111/j.1742-4658.2011.08439.x; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pitta DW, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00689; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Zhou J, 2012, LETT APPL MICROBIOL, V54, P79, DOI 10.1111/j.1472-765X.2011.03175.x; Zmudka MW, 2013, PROTEIN SCI, V22, P883, DOI 10.1002/pro.2204	50	13	14	2	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24200	24214		10.1074/jbc.M116.747527	http://dx.doi.org/10.1074/jbc.M116.747527			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679487	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000388498100034
J	Jain, A; Kuryatov, A; Wang, JY; Kamenecka, TM; Lindstrom, J				Jain, Akansha; Kuryatov, Alexander; Wang, Jingyi; Kamenecka, Theodore M.; Lindstrom, Jon			Unorthodox Acetylcholine Binding Sites Formed by alpha 5 and beta 3 Accessory Subunits in alpha 4 beta 2*Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						channel activation; electrophysiology; ion channel; nicotinic acetylcholine receptors (nAChR); site-directed mutagenesis; Xenopus	POSITIVE ALLOSTERIC MODULATOR; NEURONAL NICOTINIC RECEPTOR; AGONIST-BINDING; ALPHA-5 SUBUNIT; TOBACCO DEPENDENCE; CA2+ PERMEABILITY; BETA 2; STOICHIOMETRY; INTERFACE; ACTIVATION	All nicotinic acetylcholine receptors (nAChRs) evolved from homomeric nAChRs in which all five subunits are involved in forming acetylcholine (ACh) binding sites at their interfaces. Heteromeric 42* nAChRs typically have two ACh binding sites at 4/2 interfaces and a fifth accessory subunit surrounding the central cation channel. 2 accessory subunits do not form ACh binding sites, but 4 accessory subunits do at the 4/4 interface in (42)(2)4 nAChRs. 5 and 3 are closely related subunits that had been thought to act only as accessory subunits and not take part in forming ACh binding sites. The effect of agonists at various subunit interfaces was determined by blocking homologous sites at these interfaces using the thioreactive agent 2-((trimethylammonium)ethyl) methanethiosulfonate (MTSET). We found that 5/4 and 3/4 interfaces formed ACh binding sites in (42)(2)5 and (42)(2)3 nAChRs. The 4/5 interface in (24)(2)5 nAChRs also formed an ACh binding site. Blocking of these sites with MTSET reduced the maximal ACh evoked responses of these nAChRs by 30-50%. However, site-selective agonists NS9283 (for the 4/4 site) and sazetidine-A (for the 4/2 site) did not act on the ACh sites formed by the 5/4 or 3/4 interfaces. This suggests that unorthodox sites formed by 5 and 3 subunits have unique ligand selectivity. Agonists or antagonists for these unorthodox sites might be selective and effective drugs for modulating nAChR function to treat nicotine addiction and other disorders.	[Jain, Akansha; Kuryatov, Alexander; Lindstrom, Jon] Univ Penn, Dept Neurosci, Perelman Sch Med, 130A John Morgan Bldg, Philadelphia, PA 19104 USA; [Wang, Jingyi] Univ Texas Austin, Div Pharmacol & Toxicol, Coll Pharm, Austin, TX 78712 USA; [Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Austin; Scripps Research Institute	Lindstrom, J (corresponding author), Univ Penn, Dept Neurosci, Perelman Sch Med, 130A John Morgan Bldg, Philadelphia, PA 19104 USA.	JSLKK@mail.med.upenn.edu	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		National Institutes of Health National Institute on Drug Abuse [DA030929]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030929] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health National Institute on Drug Abuse Grant DA030929. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahring PK, 2015, NEUROPHARMACOLOGY, V92, P135, DOI 10.1016/j.neuropharm.2014.12.035; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Bailey CDC, 2010, J NEUROSCI, V30, P9241, DOI 10.1523/JNEUROSCI.2258-10.2010; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Brunzell Darlene H, 2015, Curr Addict Rep, V2, P33; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Crooks PA, 2014, ADV PHARMACOL, V69, P513, DOI 10.1016/B978-0-12-420118-7.00013-5; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Fowler CD, 2014, NEUROPHARMACOLOGY, V76, P533, DOI 10.1016/j.neuropharm.2013.09.008; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Gangitano D, 2009, GENES BRAIN BEHAV, V8, P398, DOI 10.1111/j.1601-183X.2009.00476.x; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hoft NR, 2009, NEUROPSYCHOPHARMACOL, V34, P698, DOI 10.1038/npp.2008.122; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Jin Z, 2014, BIOORG MED CHEM LETT, V24, P674, DOI 10.1016/j.bmcl.2013.11.049; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Lucero LM, 2016, J BIOL CHEM, V291, P2444, DOI 10.1074/jbc.M115.684373; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; Marotta CB, 2014, NEUROPHARMACOLOGY, V77, P342, DOI 10.1016/j.neuropharm.2013.09.028; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang JY, 2015, J BIOL CHEM, V290, P28834, DOI 10.1074/jbc.M115.676551; Wang J, 2015, NEUROPHARMACOLOGY, V96, P194, DOI 10.1016/j.neuropharm.2014.10.009; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	49	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23452	23463		10.1074/jbc.M116.749150	http://dx.doi.org/10.1074/jbc.M116.749150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27645992	Green Published, hybrid			2022-12-28	WOS:000387884400008
J	Medeiros, RCA; Girardi, KDD; Cardoso, FKL; Mietto, BD; Pinto, TGD; Gomez, LS; Rodrigues, LS; Gandini, M; Amaral, JJ; Antunes, SLG; Corte-Real, S; Rosa, PS; Pessolani, MCV; Nery, JAD; Sarno, EN; Batista-Silva, LR; Sola-Penna, M; Oliveira, MF; Moraes, MO; Lara, FA				Affonso Medeiros, Rychelle Clayde; de Vasconcelos Girardi, Karina do Carmo; Luz Cardoso, Fernanda Karlla; Mietto, Bruno de Siqueira; de Toledo Pinto, Thiago Gomes; Gomez, Lilian Sales; Rodrigues, Luciana Silva; Gandini, Mariana; Amaral, Julio Jablonski; Gomes Antunes, Sergio Luiz; Corte-Real, Suzana; Rosa, Patricia Sammarco; Vidal Pessolani, Maria Cristina; da Costa Nery, Jose Augusto; Sarno, Euzenir Nunes; Batista-Silva, Leonardo Ribeiro; Sola-Penna, Mauro; Oliveira, Marcus Fernandes; Moraes, Milton Ozorio; Lara, Flavio Alves			Subversion of Schwann Cell Glucose Metabolism by Mycobacterium leprae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell metabolism; glucose-6-phosphate dehydrogenase (G6PD or G6PDH); mitochondria; mycobacteria; neuron; oxidative stress; pentose phosphate pathway (PPP); Leprosy; glutathione; host-target therapy	LIPID DROPLETS; MONOCARBOXYLATE TRANSPORTERS; MITOCHONDRIAL METABOLISM; LEPROSY; LACTATE; INFECTION; MYELINATION; GLUTATHIONE; ACTIVATION; SURVIVAL	Mycobacterium leprae, the intracellular etiological agent of leprosy, infects Schwann promoting irreversible physical disabilities and deformities. These cells are responsible for myelination and maintenance of axonal energy metabolism through export of metabolites, such as lactate and pyruvate. In the present work, we observed that infected Schwann cells increase glucose uptake with a concomitant increase in glucose-6-phosphate dehydrogenase (G6PDH) activity, the key enzyme of the oxidative pentose pathway. We also observed a mitochondria shutdown in infected cells and mitochondrial swelling in pure neural leprosy nerves. The classic Warburg effect described in macrophages infected by Mycobacterium avium was not observed in our model, which presented a drastic reduction in lactate generation and release by infected Schwann cells. This effect was followed by a decrease in lactate dehydrogenase isoform M (LDH-M) activity and an increase in cellular protection against hydrogen peroxide insult in a pentose phosphate pathway and GSH-dependent manner. M. leprae infection success was also dependent of the glutathione antioxidant system and its main reducing power source, the pentose pathway, as demonstrated by a 50 and 70% drop in intracellular viability after treatment with the GSH synthesis inhibitor buthionine sulfoximine, and aminonicotinamide (6-ANAM), an inhibitor of G6PDH 6-ANAM, respectively. We concluded that M. leprae could modulate host cell glucose metabolism to increase the cellular reducing power generation, facilitating glutathione regeneration and consequently free-radical control. The impact of this regulation in leprosy neuropathy is discussed.	[Affonso Medeiros, Rychelle Clayde; de Vasconcelos Girardi, Karina do Carmo; Luz Cardoso, Fernanda Karlla; Gandini, Mariana; Vidal Pessolani, Maria Cristina; Lara, Flavio Alves] Fiocruz MS, Lab Microbiol Celular, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Corte-Real, Suzana] Fiocruz MS, Lab Biol Estrut, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Mietto, Bruno de Siqueira; de Toledo Pinto, Thiago Gomes; Gomes Antunes, Sergio Luiz; da Costa Nery, Jose Augusto; Sarno, Euzenir Nunes; Batista-Silva, Leonardo Ribeiro; Moraes, Milton Ozorio] Fiocruz MS, Lab Hanseniase, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Gomez, Lilian Sales; Sola-Penna, Mauro] Univ Estado Rio De Janeiro, Lab Enzimol & Controle Metabol, Rio De Janeiro, RJ, Brazil; [Rodrigues, Luciana Silva] Univ Estado Rio De Janeiro, Immunol Lab, Fac Med Sci, Rio De Janeiro, RJ, Brazil; [Amaral, Julio Jablonski] INMETRO, Natl Inst Metrol Qual & Technol, Rio De Janeiro, RJ, Brazil; [Rosa, Patricia Sammarco] Lauro de Souza Lima Inst, Dept Biol, Bauru, SP, Brazil; [Oliveira, Marcus Fernandes] Univ Fed Rio de Janeiro, Lab Bioquim Resposta Estresse, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Lara, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Ave Brasil,4365,Sala 27, BR-21040360 Rio De Janeiro, RJ, Brazil.	flavioalveslara2000@gmail.com	Moraes, Milton/AFF-1842-2022; Mietto, Bruno/J-1261-2016; Gandini, Mariana/AAZ-6964-2021; Oliveira, Marcus/G-3158-2011; Moraes, Milton Ozório/G-9753-2011; Sola-Penna, Mauro/E-8221-2011; Lara, Flavio Alves/L-1861-2013	Mietto, Bruno/0000-0002-4172-2670; Oliveira, Marcus/0000-0002-9890-8425; Moraes, Milton Ozório/0000-0003-2653-0037; Sola-Penna, Mauro/0000-0001-9796-6829; Nunes Sarno, Euzenir/0000-0003-0129-2159; Gandini, Mariana/0000-0003-3603-6921; Sales Gomez, Lilian/0000-0002-5309-7438				Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Guerreiro LTA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064748; Appelberg R, 2015, IMMUNOLOGY, V145, P498, DOI 10.1111/imm.12464; Beirowski B, 2014, NAT NEUROSCI, V17, P1351, DOI 10.1038/nn.3809; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; Bohl LP, 2012, CANCER INVEST, V30, P560, DOI 10.3109/07357907.2012.700985; Brown AM, 2012, ANN NEUROL, V72, P406, DOI 10.1002/ana.23607; Chiu SY, 2011, NEUROSCIENTIST, V17, P343, DOI 10.1177/1073858410393740; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; de Mattos KA, 2012, MEM I OSWALDO CRUZ, V107, P156, DOI 10.1590/S0074-02762012000900023; Diaz-Vivancos P, 2015, FREE RADICAL BIO MED, V89, P1154, DOI 10.1016/j.freeradbiomed.2015.09.023; Domenech-Estevez E, 2015, J NEUROSCI, V35, P4151, DOI 10.1523/JNEUROSCI.3534-14.2015; Douki T, 1996, FREE RADICAL RES, V24, P369, DOI 10.3109/10715769609088035; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Hsieh YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079566; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lobato LS, 2014, ANTIMICROB AGENTS CH, V58, P5766, DOI 10.1128/AAC.01826-13; Lockwood DNJ, 2005, B WORLD HEALTH ORGAN, V83, P230; LUZZATTO L, 1969, SCIENCE, V164, P839, DOI 10.1126/science.164.3881.839; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Matthews GM, 2005, HELICOBACTER, V10, P298, DOI 10.1111/j.1523-5378.2005.00327.x; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; Nagy C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00164; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pooya S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5993; Rodrigues LS, 2010, CELL MICROBIOL, V12, P42, DOI 10.1111/j.1462-5822.2009.01377.x; Save MP, 2009, LEPROSY REV, V80, P388; Scollard DM, 2015, CLIN DERMATOL, V33, P46, DOI 10.1016/j.clindermatol.2014.07.008; Siegl C, 2014, CELL REP, V9, P918, DOI 10.1016/j.celrep.2014.10.004; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; STOCKS J, 1971, BRIT J HAEMATOL, V20, P95, DOI 10.1111/j.1365-2141.1971.tb00790.x; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WISNIEWSKI HM, 1975, J EXP MED, V141, P346, DOI 10.1084/jem.141.2.346; World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P461; Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006	42	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21375	21387		10.1074/jbc.M116.725283	http://dx.doi.org/10.1074/jbc.M116.725283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27555322	hybrid, Green Published			2022-12-28	WOS:000385999200004
J	Wang, M; Liu, H; Zheng, J; Chen, BB; Zhou, M; Fan, WL; Wang, H; Liang, XY; Zhou, XL; Eriani, G; Jiang, PP; Guan, MX				Wang, Meng; Liu, Hao; Zheng, Jing; Chen, Bobei; Zhou, Mi; Fan, Wenlu; Wang, Hen; Liang, Xiaoyang; Zhou, Xiaolong; Eriani, Gilbert; Jiang, Pingping; Guan, Min-Xin			A Deafness- and Diabetes-associated tRNA Mutation Causes Deficient Pseudouridinylation at Position 55 in tRNA(Glu) and Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOBBLE MODIFICATION DEFICIENCY; PHENOTYPIC-EXPRESSION; NONSYNDROMIC DEAFNESS; CLINICAL-FEATURES; OXIDATIVE STRESS; LACTIC-ACIDOSIS; MESSENGER-RNA; DNA MUTATION; GENE; MTDNA	Several mitochondrial tRNA mutations have been associated with maternally inherited diabetes and deafness. However, the pathophysiology of these tRNA mutations remains poorly understood. In this report, we identified the novel homoplasmic 14692A -> G mutation in the mitochondrial tRNA(Glu) gene among three Han Chinese families with maternally inherited diabetes and deafness. The m.14692A -> G mutation affected a highly conserved uridine at position 55 of the T Psi C loop of tRNA(Glu). The uridine is modified to pseudouridine (Psi 55), which plays an important role in the structure and function of this tRNA. Using lymphoblastoid cell lines derived from a Chinese family, we demonstrated that the m.14692A -> G mutation caused loss of Psi 55 modification and increased angiogenin-mediated endonucleolytic cleavage in mutant tRNA(Glu). The destabilization of base-pairing (18A-Psi 55) caused by the m.14692A -> G mutation perturbed the conformation and stability of tRNA(Glu). An approximately 65% decrease in the steady-state level of tRNA(Glu) was observed in mutant cells compared with control cells. A failure in tRNA(Glu) metabolism impaired mitochondrial translation, especially for polypeptides with a high proportion of glutamic acid codons such as ND1, ND6, and CO2 in mutant cells. An impairment of mitochondrial translation caused defective respiratory capacity, especially reducing the activities of complexes I and IV. Furthermore, marked decreases in the levels of mitochondrial ATP and membrane potential were observed in mutant cells. These mitochondrial dysfunctions caused an increasing production of reactive oxygen species in the mutant cells. Our findings may provide new insights into the pathophysiology of maternally inherited diabetes and deafness, which is primarily manifested by the deficient nucleotide modification of mitochondrial tRNA(Glu).	[Wang, Meng; Zheng, Jing; Zhou, Mi; Liang, Xiaoyang; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Sch Med, Childrens Hosp, Div Clin Genet & Genom, Hangzhou 310001, Zhejiang, Peoples R China; [Wang, Meng; Liu, Hao; Zheng, Jing; Zhou, Mi; Liang, Xiaoyang; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Sch Med, Dept Genet, Hangzhou 310001, Zhejiang, Peoples R China; [Wang, Meng; Liu, Hao; Zheng, Jing; Zhou, Mi; Liang, Xiaoyang; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Joining Inst Genet & Genom Med Zhejiang Univ & Un, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Bobei] Wenzhou Med Univ, Affiliated Hosp 2, Dept Otolaryngol, Wenzhou 325035, Zhejiang, Peoples R China; [Chen, Bobei; Fan, Wenlu; Wang, Hen] Wenzhou Med Univ, Sch Life Sci, Attardi Inst Mitochondrial Biomed, Wenzhou 325035, Zhejiang, Peoples R China; [Zhou, Xiaolong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France	Zhejiang University; Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Div Clin Genet & Genom, Hangzhou 310001, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Dept Genet, Hangzhou 310001, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Joining Inst Genet & Genom Med Zhejiang Univ & Un, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn		Guan, Min-Xin/0000-0001-5067-6736; Eriani, Gilbert/0000-0002-8518-4675	National Basic Research Priorities Program of China [2014CB541700]; Chinese National Natural Science Foundation [81330024, 81500611]; Fundamental Research Funds for the Central Universities [2016QNA7022]	National Basic Research Priorities Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Priorities Program of China Grant 2014CB541700 and Chinese National Natural Science Foundation Grants 81330024 (to M. X. G.) and 81500611 (to M. W.), and Fundamental Research Funds for the Central Universities Grant 2016QNA7022 (to M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z; Chen DN, 2016, INT J BIOCHEM CELL B, V77, P1, DOI 10.1016/j.biocel.2016.05.012; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; Craven L, 2011, HUM MOL GENET, V20, pR168, DOI 10.1093/hmg/ddr373; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Ishida K, 2011, NUCLEIC ACIDS RES, V39, P2304, DOI 10.1093/nar/gkq1180; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; KING MP, 1993, J BIOL CHEM, V268, P10228; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Liu H, 2015, MITOCHONDRION, V21, P49, DOI 10.1016/j.mito.2015.01.004; Lu JX, 2006, BIOCHEM BIOPH RES CO, V348, P115, DOI 10.1016/j.bbrc.2006.07.010; Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007; Ma ZA, 2012, EXP DIABETES RES, DOI 10.1155/2012/703538; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Martinez-Zamora A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144273; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Morton CC, 2002, HUM MOL GENET, V11, P1229, DOI 10.1093/hmg/11.10.1229; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Negrier MLM, 1998, AM J HUM GENET, V63, P1227, DOI 10.1086/302045; ODAWARA M, 1995, J CLIN ENDOCR METAB, V80, P1290, DOI 10.1210/jc.80.4.1290; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Roovers M, 2006, NUCLEIC ACIDS RES, V34, P4293, DOI 10.1093/nar/gkl530; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138; Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028; Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001; THOMAS F, 1994, DIABETES, V43, P63, DOI 10.2337/diabetes.43.1.63; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2013, BIOCHEM J, V453, P455, DOI 10.1042/BJ20130294; Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811; Wang XP, 2008, IEEE/SOLI'2008: PROCEEDINGS OF 2008 IEEE INTERNATIONAL CONFERENCE ON SERVICE OPERATIONS AND LOGISTICS, AND INFORMATICS, VOLS 1 AND 2, P1059, DOI 10.1109/SOLI.2008.4686555; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001	80	46	47	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21029	+		10.1074/jbc.M116.739482	http://dx.doi.org/10.1074/jbc.M116.739482			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27519417	Green Published, hybrid			2022-12-28	WOS:000385406200019
J	Richards, J; Belasco, JG				Richards, Jamie; Belasco, Joel G.			Distinct requirements for 5 '-monophosphate-assisted RNA cleavage by Escherichia coli RNase E and RNase G (vol 291, pg 5038, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Richards J, 2016, J BIOL CHEM, V291, P5038, DOI 10.1074/jbc.M115.702555	1	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20825	20825		10.1074/jbc.A115.702555	http://dx.doi.org/10.1074/jbc.A115.702555			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27664066	Green Published, hybrid			2022-12-28	WOS:000384574800045
J	Lorenz, V; Ditamo, Y; Cejas, RB; Carrizo, ME; Bennett, EP; Clausen, H; Nores, GA; Irazoqui, FJ				Lorenz, Virginia; Ditamo, Yanina; Cejas, Romina B.; Carrizo, Maria E.; Bennett, Eric P.; Clausen, Henrik; Nores, Gustavo A.; Irazoqui, Fernando J.			Extrinsic Functions of Lectin Domains in O-N-Acetylgalactosamine Glycan Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycoprotein biosynthesis; glycosylation inhibitor; lectin; mucin	BETA-TREFOIL FOLD; POLYPEPTIDE GALNAC-TRANSFERASES; ACETYL-D-GALACTOSAMINE; CARBOHYDRATE-RECOGNITION; LINKED GLYCOSYLATION; UDP-GALNAC; BINDING; ORGANIZATION; SPECIFICITY; EXPRESSION	Glycan biosynthesis occurs mainly in Golgi. Molecular organization and functional regulation of this process are not well understood. We evaluated the extrinsic effect of lectin domains (-trefoil fold) of polypeptide GalNAc-transferases (ppGalNAc-Ts) on catalytic activity of glycosyltransferases during O-GalNAc glycan biosynthesis. The presence of lectin domain T3lec or T4lec during ppGalNAc-T2 and ppGalNAc-T3 catalytic reaction had a clear inhibitory effect on GalNAc-T activity. Interaction of T3lec or T4lec with ppGalNAc-T2 catalytic domain was not mediated by carbohydrate. T3lec, but not T2lec and T4lec, had a clear activating effect on Drosophila melanogaster core 1 galactosyltransferase enzyme activity and a predominant inhibitory effect on in vivo human core 1 glycan biosynthesis. The regulatory role of the -trefoil fold of ppGalNAc-Ts in enzymatic activity of glycosyltransferases involved in the O-glycan biosynthesis pathway, described here for the first time, helps clarify the mechanism of biosynthesis of complex biopolymers (such as glycans) that is not template-driven.	[Lorenz, Virginia; Ditamo, Yanina; Cejas, Romina B.; Carrizo, Maria E.; Nores, Gustavo A.; Irazoqui, Fernando J.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, Consejo Nacl Invest Cient & Tecn CONICET, Ciudad Univ,X5000HUA, Cordoba, Argentina; [Lorenz, Virginia; Ditamo, Yanina; Cejas, Romina B.; Carrizo, Maria E.; Nores, Gustavo A.; Irazoqui, Fernando J.] Univ Nacl Cordoba, Dept Quim Biol, Fac Ciencias Quim, Ciudad Univ,X5000HUA, Cordoba, Argentina; [Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Ctr Glyc, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; University of Copenhagen	Irazoqui, FJ (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, Consejo Nacl Invest Cient & Tecn CONICET, Ciudad Univ,X5000HUA, Cordoba, Argentina.; Irazoqui, FJ (corresponding author), Univ Nacl Cordoba, Dept Quim Biol, Fac Ciencias Quim, Ciudad Univ,X5000HUA, Cordoba, Argentina.	irazoqui@fcq.unc.edu.ar	clausen, henrik/AAD-8016-2021	Bennett, Eric Paul/0000-0002-4976-0647; Clausen, Henrik/0000-0002-0915-5055; Carrizo, Maria Elena/0000-0003-0501-8894; Cejas, Romina/0000-0002-5484-4722	Argentinean Institutions Consejo Nacional de Investigaciones Cientificas y Ticnicas; Argentinean Institutions Consejo Nacional de Investigaciones Cientificas y Tecnicas; Secretaria de Ciencia y Tecnologia (Universidad Nacional de Cordoba); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Cordoba); Agencia Nacional de Promocion Cientifica y Tecnologica PICT 967	Argentinean Institutions Consejo Nacional de Investigaciones Cientificas y Ticnicas; Argentinean Institutions Consejo Nacional de Investigaciones Cientificas y Tecnicas; Secretaria de Ciencia y Tecnologia (Universidad Nacional de Cordoba)(Secretaria de Ciencia y Tecnologia (SECYT)); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Cordoba); Agencia Nacional de Promocion Cientifica y Tecnologica PICT 967	This work was supported by funding from Argentinean Institutions Consejo Nacional de Investigaciones Cientificas y Tecnicas; Secretaria de Ciencia y Tecnologia (Universidad Nacional de Cordoba); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Cordoba); and Agencia Nacional de Promocion Cientifica y Tecnologica PICT 967 (to F. J. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; Azarkan M, 2011, J BIOL CHEM, V286, P43726, DOI 10.1074/jbc.M111.291310; BARONDES SH, 1988, TRENDS BIOCHEM SCI, V13, P480, DOI 10.1016/0968-0004(88)90235-6; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boraston AB, 2000, BIOCHEM J, V350, P933, DOI 10.1042/0264-6021:3500933; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fujimoto Z, 2013, BIOSCI BIOTECH BIOCH, V77, P1363, DOI 10.1271/bbb.130183; Hagen FK, 1999, J BIOL CHEM, V274, P6797, DOI 10.1074/jbc.274.10.6797; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Haudek KC, 2010, GLYCOBIOLOGY, V20, P1199, DOI 10.1093/glycob/cwq097; HAZES B, 1995, NAT STRUCT BIOL, V2, P358, DOI 10.1038/nsb0595-358; Imberty A, 1997, PROTEIN ENG, V10, P1353, DOI 10.1093/protein/10.12.1353; Irazoqui FJ, 2005, BIOCHEM BIOPH RES CO, V336, P14, DOI 10.1016/j.bbrc.2005.08.028; Jorgensen CS, 2000, EUR J BIOCHEM, V267, P2945, DOI 10.1046/j.1432-1033.2000.01309.x; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lira-Navarrete E, 2014, ANGEW CHEM INT EDIT, V53, P8206, DOI 10.1002/anie.201402781; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Rottger S, 1998, J CELL SCI, V111, P45; Sakono M, 2014, BBA-GEN SUBJECTS, V1840, P2904, DOI 10.1016/j.bbagen.2014.04.012; Satoh T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087963; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Varki A., 2009, ESSENTIALS GLYCOBIOL, P375; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Xu D, 2009, NAT CHEM BIOL, V5, P612, DOI 10.1038/nchembio0909-612; Yoshimura Y, 2012, GLYCOBIOLOGY, V22, P429, DOI 10.1093/glycob/cwr159; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5; Zlocowski N, 2013, BIOL CHEM, V394, P69, DOI 10.1515/hsz-2012-0191; Zurga S, 2015, J BIOCHEM, V158, P83, DOI 10.1093/jb/mvv025	36	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25339	25350		10.1074/jbc.M116.740795	http://dx.doi.org/10.1074/jbc.M116.740795			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27738109	hybrid, Green Published			2022-12-28	WOS:000390095300006
J	Wu, M; Ingram, L; Tolosa, EJ; Vera, RE; Li, QJ; Kim, S; Ma, YJ; Spyropoulos, DD; Beharry, Z; Huang, JT; Fernandez-Zapico, ME; Cai, HJ				Wu, Meng; Ingram, Lishann; Tolosa, Ezequiel J.; Vera, Renzo E.; Li, Qianjin; Kim, Sungjin; Ma, Yongjie; Spyropoulos, Demetri D.; Beharry, Zanna; Huang, Jiaoti; Fernandez-Zapico, Martin E.; Cai, Houjian			Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; GTPase Kras (KRAS); Hedgehog signaling pathway; p63; prostate cancer	HEDGEHOG SIGNALING PATHWAY; STEM-CELLS; MURINE PROSTATE; CANCER; P63; EXPRESSION; OVEREXPRESSION; REARRANGEMENTS; ACTIVATION; SUPPORTS	Although the differentiation of oncogenically transformed basal progenitor cells is one of the key steps in prostate tumorigenesis, the mechanisms mediating this cellular process are still largely unknown. Here we demonstrate that an expanded p63(+) and CK5(+) basal/progenitor cell population, induced by the concomitant activation of oncogenic Kras(G12D) and androgen receptor (AR) signaling, underwent cell differentiation in vivo. The differentiation process led to suppression of p63-expressing cells with a decreased number of CK5(+) basal cells but an increase of CK8(+) luminal tumorigenic cells and revealed a hierarchal lineage pattern consisting of p63(+)/CK5(+) progenitor, CK5(+)/CK8(+) transitional progenitor, and CK8(+) differentiated luminal cells. Further analysis of the phenotype showed that Kras-AR axis-induced tumorigenesis was mediated by Gli transcription factors. Combined blocking of the activators of this family of proteins (Gli1 and Gli2) inhibited the proliferation of p63(+) and CK5(+) basal/progenitor cells and development of tumors. Finally, we identified that Gli1 and Gli2 exhibited different functions in the regulation of p63 expression or proliferation of p63(+) cells in Kras-AR driven tumors. Gli2, but not Gli1, transcriptionally regulated the expression levels of p63 and prostate sphere formation. Our study provides evidence of a novel mechanism mediating pathological dysregulation of basal/progenitor cells through the differential activation of the Gli transcription factors. Also, these findings define Gli proteins as new downstream mediators of the Kras-AR axis in prostate carcinogenesis and open a potential therapeutic avenue of targeting prostate cancer progression by inhibiting Gli signaling.	[Wu, Meng; Ingram, Lishann; Li, Qianjin; Kim, Sungjin; Ma, Yongjie; Cai, Houjian] Univ Georgia, Dept Pharmaceut & Biomed Sci, Coll Pharm, Athens, GA 30602 USA; [Tolosa, Ezequiel J.; Vera, Renzo E.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Spyropoulos, Demetri D.] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Beharry, Zanna] Florida Gulf Coast Univ, Dept Chem & Phys, Ft Myers, FL 33965 USA; [Huang, Jiaoti] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA	University System of Georgia; University of Georgia; Mayo Clinic; Medical University of South Carolina; State University System of Florida; Florida Gulf Coast University; Duke University	Cai, HJ (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Coll Pharm, Athens, GA 30602 USA.	caihj@uga.edu	Tolosa, Ezequiel J/AAD-9799-2019; Cai, Houjian/AAJ-1290-2020; Wu, Meng/N-9345-2014	Tolosa, Ezequiel J/0000-0001-5167-0782; Huang, Jiaoti/0000-0003-1195-1998; Wu, Meng/0000-0001-8436-2209	National Institutes of Health [R01CA172495, CA136526]; DOD [W81XWH-15-1-0507]; NATIONAL CANCER INSTITUTE [R01CA172495, R01CA136526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01CA172495 (to H. C.) and CA136526 (to M. E. F. Z.) and DOD Grant W81XWH-15-1-0507 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Aberger F, 2012, VITAM HORM, V88, P25, DOI 10.1016/B978-0-12-394622-5.00002-X; Cai HJ, 2012, CANCER RES, V72, P4672, DOI 10.1158/0008-5472.CAN-12-0228; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Chari NS, 2013, CELL DEATH DIFFER, V20, P1080, DOI 10.1038/cdd.2013.41; Chen GC, 2011, BIOCHEM BIOPH RES CO, V404, P809, DOI 10.1016/j.bbrc.2010.12.065; Chen MQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-89; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Fernandez-Zapico ME, 2008, PANCREATOLOGY, V8, P227, DOI 10.1159/000134271; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Graham L, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0759-3; Huang YQ, 2015, J BIOL CHEM, V290, P17745, DOI 10.1074/jbc.M115.661033; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; KONISHI N, 1992, CANCER-AM CANCER SOC, V69, P2293, DOI 10.1002/1097-0142(19920501)69:9<2293::AID-CNCR2820690915>3.0.CO;2-O; Kumar RMR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-559; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Li N, 2014, PROSTATE, V74, P1400, DOI 10.1002/pros.22855; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Memmi EM, 2015, P NATL ACAD SCI USA, V112, P3499, DOI 10.1073/pnas.1500762112; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Ngalame NNO, 2016, CHEM RES TOXICOL, V29, P1458, DOI 10.1021/acs.chemrestox.6b00137; Ngalame NNO, 2014, TOXICOL SCI, V142, P489, DOI 10.1093/toxsci/kfu201; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Salm SN, 2002, PROSTATE, V51, P175, DOI 10.1002/pros.10075; Salmaninejad A, 2015, CLIN LAB, V61, P749, DOI 10.7754/Clin.Lab.2014.141210; Shigemura K, 2015, CURR DRUG TARGETS, V16, P258, DOI 10.2174/1389450115666141125122643; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang XS, 2011, CANCER DISCOV, V1, P35, DOI 10.1158/2159-8274.CD-10-0022; Wang XQ, 2001, J BIOL CHEM, V276, P1311, DOI 10.1074/jbc.M005191200; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Zheng DH, 2014, AM J RESP CELL MOL, V50, P595, DOI 10.1165/rcmb.2013-0327OC	49	14	14	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25749	25760		10.1074/jbc.M116.753129	http://dx.doi.org/10.1074/jbc.M116.753129			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27760825	Green Published, hybrid			2022-12-28	WOS:000390095300039
J	Andreu-Fernandez, V; Garcia-Murria, MJ; Bano-Polo, M; Martin, J; Monticelli, L; Orzaez, M; Mingarro, I				Andreu-Fernandez, Vicente; Garcia-Murria, Maria J.; Bano-Polo, Manuel; Martin, Juliette; Monticelli, Luca; Orzaez, Mar; Mingarro, Ismael			The C-terminal Domains of Apoptotic BH3-only Proteins Mediate Their Insertion into Distinct Biological Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE HELIX ASSOCIATION; OUTER MITOCHONDRIAL-MEMBRANE; PARTICLE MESH EWALD; ENDOPLASMIC-RETICULUM; BCL-2 FAMILY; CELL-DEATH; PAIR INTERACTIONS; SEC61 TRANSLOCON; PROLINE RESIDUES; FORCE-FIELD	Changes in the equilibrium of pro-and anti-apoptotic members of the B-cell lymphoma-2 (Bcl-2) protein family in the mitochondrial outer membrane (MOM) induce structural changes that commit cells to apoptosis. Bcl-2 homology-3 (BH3)-only proteins participate in this process by either activating pro-apoptotic effectors or inhibiting anti-apoptotic components and by promoting MOM permeabilization. The association of BH3-only proteins with MOMs is necessary for the activation and amplification of death signals; however, the nature of this association remains controversial, as these proteins lack a canonical transmembrane sequence. Here we used an in vitro expression system to study the insertion capacity of hydrophobic C-terminal regions of the BH3-only proteins Bik, Bim, Noxa, Bmf, and Puma into microsomal membranes. An Escherichia coli complementation assay was used to validate the results in a cellular context, and peptide insertions were modeled using molecular dynamics simulations. We also found that some of the C-terminal domains were sufficient to direct green fluorescent protein fusion proteins to specific membranes in human cells, but the domains did not activate apoptosis. Thus, the hydrophobic regions in the C termini of BH3-only members associated in distinct ways with various biological membranes, suggesting that a detailed investigation of the entire process of apoptosis should include studying the membranes as a setting for protein-protein and protein-membrane interactions.	[Andreu-Fernandez, Vicente; Garcia-Murria, Maria J.; Bano-Polo, Manuel; Mingarro, Ismael] Univ Valencia, Dept Bioquim & Biol Mol, ERI BioTecMed, E-46100 Burjassot, Spain; [Andreu-Fernandez, Vicente; Orzaez, Mar] Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, E-46012 Valencia, Spain; [Martin, Juliette; Monticelli, Luca] CNRS, UMR 5086, BMSSI, 7 Passage Vercors, F-69007 Lyon, France	University of Valencia; Prince Felipe Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mingarro, I (corresponding author), Univ Valencia, Dr Moliner 50, E-46100 Burjassot, Spain.	Ismael.Mingarro@uv.es	Garcia-Murria, Maria-Jesus/A-4855-2019; Polo, Manuel Bano/P-5346-2016; Mingarro, Ismael/B-4745-2014; Monticelli, Luca/C-4608-2008; Martin, Juliette/T-9457-2019; Martin, Juliette/N-5545-2016; Orzaez, Mar/B-4992-2014	Garcia-Murria, Maria-Jesus/0000-0002-8396-0335; Polo, Manuel Bano/0000-0002-4840-4480; Mingarro, Ismael/0000-0002-1910-1229; Monticelli, Luca/0000-0002-6352-4595; Martin, Juliette/0000-0002-4787-0885; Martin, Juliette/0000-0002-4787-0885; Orzaez, Mar/0000-0003-3231-5835; Andreu Fernandez, Vicente/0000-0001-7183-8706	Generalitat Valenciana [PROMETEOII/2014/061]; Spanish Ministry of Economy and Competitiveness [BFU2016-79487]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by Generalitat Valenciana Grant PROMETEOII/2014/061 and Spanish Ministry of Economy and Competitiveness Grant BFU2016-79487. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andreu-Fernandez V, 2014, ACS CHEM BIOL, V9, P1799, DOI 10.1021/cb5002679; Aranovich A, 2012, MOL CELL, V45, P754, DOI 10.1016/j.molcel.2012.01.030; Baeza-Delgado C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23397; Bano-Polo M, 2013, J MOL BIOL, V425, P830, DOI 10.1016/j.jmb.2012.12.001; Bano-Polo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044263; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen HC, 2015, NAT CELL BIOL, V17, P1270, DOI 10.1038/ncb3236; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doerflinger M, 2015, FEBS J, V282, P1006, DOI 10.1111/febs.13190; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gomez-Fernandez JC, 2014, CHEM PHYS LIPIDS, V183, P77, DOI 10.1016/j.chemphyslip.2014.05.003; Grespi F, 2010, CELL DEATH DIFFER, V17, P1672, DOI 10.1038/cdd.2010.97; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hill RB, 2015, J MOL BIOL, V427, P2257, DOI 10.1016/j.jmb.2015.04.005; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Jaud S, 2009, P NATL ACAD SCI USA, V106, P11588, DOI 10.1073/pnas.0900638106; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; LITHGOW T, 1994, CELL GROWTH DIFFER, V5, P411; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Martinez-Gil L, 2008, BIOPHYS J, V95, pL36, DOI 10.1529/biophysj.108.138602; Martinez-Gil L, 2007, VIROLOGY, V367, P348, DOI 10.1016/j.virol.2007.06.006; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Orzaez M, 2004, J MOL BIOL, V335, P631, DOI 10.1016/j.jmb.2003.10.062; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Pang XM, 2014, J BIOL CHEM, V289, P17802, DOI 10.1074/jbc.M114.548172; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Tamborero S, 2011, J MOL BIOL, V406, P571, DOI 10.1016/j.jmb.2011.01.009; Tatulian SA, 2012, BIOCHEMISTRY-US, V51, P9406, DOI 10.1021/bi301195f; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Wilfling F, 2012, CELL DEATH DIFFER, V19, P1328, DOI 10.1038/cdd.2012.9; WOOLFSON DN, 1990, FEBS LETT, V277, P185, DOI 10.1016/0014-5793(90)80839-B; Yao Y, 2015, J MOL BIOL, V427, P2262, DOI 10.1016/j.jmb.2015.02.019; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zheng JY, 2008, BIOPHYS J, V94, P286, DOI 10.1529/biophysj.107.104323; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	52	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25207	25216		10.1074/jbc.M116.733634	http://dx.doi.org/10.1074/jbc.M116.733634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758854	Green Published, hybrid			2022-12-28	WOS:000388880100034
J	Funakoshi, T; Aki, T; Tajiri, M; Unuma, K; Uemura, K				Funakoshi, Takeshi; Aki, Toshihiko; Tajiri, Masateru; Unuma, Kana; Uemura, Koichi			Necroptosis-like Neuronal Cell Death Caused by Cellular Cholesterol Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED NECROSIS; ANTIPSYCHOTIC-DRUGS; HOMEOSTASIS; DISEASE; PROTEIN; SREBP; EXPRESSION; BINDING; SCAP; C1	Aberrant cellular accumulation of cholesterol is associated with neuronal lysosomal storage disorders such as Niemann-Pick disease Type C (NPC). We have shown previously that L-norephedrine (L-Nor), a sympathomimetic amine, induces necrotic cell death associated with massive cytoplasmic vacuolation in SH-SY5Y human neuroblastoma cells. To reveal the molecular mechanism underling necrotic neuronal cell death caused by L-Nor, we examined alterations in the gene expression profile of cells during L-Nor exposure. DNA microarray analysis revealed that the gene levels for cholesterol transport (LDL receptor and NPC2) as well as cholesterol biosynthesis (mevalonate pathway enzymes) are increased after exposure to 3 mM L-Nor for similar to 6 h. Concomitant with this observation, the master transcriptional regulator of cholesterol homeostasis, SREBP-2, is activated by L-Nor. The increase in cholesterol uptake as well as biosynthesis is not accompanied by an increase in cholesterol in the plasma membrane, but rather by aberrant accumulation in cytoplasmic compartments. We also found that cell death by L-Nor can be suppressed by nec-1s, an inhibitor of a regulated form of necrosis, necroptosis. Abrogation of SREBP-2 activation by the small molecule inhibitor betulin or by overexpression of dominant-negative SREBP-2 efficiently reduces cell death by L-Nor. The mobilization of cellular cholesterol in the presence of cyclodextrin also suppresses cell death. These results were also observed in primary culture of striatum neurons. Taken together, our results indicate that the excessive uptake as well as synthesis of cholesterol should underlie neuronal cell death by L-Nor exposure, and suggest a possible link between lysosomal cholesterol storage disorders and the regulated form of necrosis in neuronal cells.	[Funakoshi, Takeshi; Aki, Toshihiko; Tajiri, Masateru; Unuma, Kana; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Aki, T (corresponding author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan.	aki.legm@tmd.ac.jp			Japan Society for the Promotion of Science [25860487]; MEXT [25460862]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 25860487 (to T. F.) and MEXT KAKENHI Grant 25460862 (to T. A.). The authors declare no conflicts of interest with the contents of this article.	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Appelqvist H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050262; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo E. L., 1988, HYPERTENSION, V11, pII7; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Canfran-Duque A, 2013, J LIPID RES, V54, P310, DOI 10.1194/jlr.M026948; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Dwane Susan, 2013, BMC Res Notes, V6, P366, DOI 10.1186/1756-0500-6-366; Ferno J, 2005, PHARMACOGENOMICS J, V5, P298, DOI 10.1038/sj.tpj.6500323; Ferno J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-69; Funakoshi T, 2013, BRAIN RES, V1490, P9, DOI 10.1016/j.brainres.2012.10.056; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; KRUTH HS, 1984, EXP MOL PATHOL, V40, P288, DOI 10.1016/0014-4800(84)90046-7; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Luu WN, 2016, ANNU REV PHARMACOL, V56, P447, DOI 10.1146/annurev-pharmtox-010715-103233; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Ordonez MP, 2012, HUM MOL GENET, V21, P2651, DOI 10.1093/hmg/dds090; Peake KB, 2012, J BIOL CHEM, V287, P9290, DOI 10.1074/jbc.M111.326405; PENTEL P, 1984, JAMA-J AM MED ASSOC, V252, P1898, DOI 10.1001/jama.252.14.1898; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rishi V, 2004, J BIOL CHEM, V279, P11863, DOI 10.1074/jbc.M308000200; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Saraiva D, 2011, J CHROMATOGR B, V879, P3806, DOI 10.1016/j.jchromb.2011.10.021; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tortelli B, 2014, HUM MOL GENET, V23, P6022, DOI 10.1093/hmg/ddu331; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vik-Mo Audun O., 2009, BMC Pharmacology, V9, P10, DOI 10.1186/1471-2210-9-10; Yamanaka K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.524; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yen M, 2012, J MED TOXICOL, V8, P145, DOI 10.1007/s13181-012-0213-7; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013	47	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25050	25065		10.1074/jbc.M116.727404	http://dx.doi.org/10.1074/jbc.M116.727404			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27756839	Green Published, hybrid			2022-12-28	WOS:000388880100021
J	Hinz, JM; Laughery, MF; Wyrick, JJ				Hinz, John M.; Laughery, Marian F.; Wyrick, John J.			Nucleosomes Selectively Inhibit Cas9 Off-target Activity at a Site Located at the Nucleosome Edge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA CLEAVAGE; RNA; CRISPR-CAS9; SPECIFICITY; NUCLEASES; ENDONUCLEASE; ENABLES	Nucleosomes affect Cas9 binding and activity at on-target sites, but their impact at off-target sites is unknown. To investigate how nucleosomes affect Cas9 cleavage at off-target sites in vitro, we used a single guide RNA (sgRNA) that has been previously shown to efficiently direct Cas9 cleavage at the edge of the strongly positioned 601 nucleosome. Our data indicate that single mismatches between the sgRNA and DNA target have relatively little effect on Cas9 cleavage of naked DNA substrates, but strongly inhibit cleavage of nucleosome substrates, particularly when the mismatch is in the sgRNA "seed" region. These findings indicate that nucleosomes may enhance Cas9 specificity by inhibiting cleavage of off-target sites at the nucleosome edge.	Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; Washington State University	Wyrick, JJ (corresponding author), Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci 241, Pullman, WA 99164 USA.	jwyrick@vetmed.wsu.edu		Wyrick, John/0000-0002-7911-3803	National Institutes of Health from the NIEHS [ES002614]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002614, R01ES002614] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant ES002614 (to J. J. W.) from the NIEHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; DUNN K, 1980, NUCLEIC ACIDS RES, V8, P555, DOI 10.1093/nar/8.3.555; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Hodges AJ, 2015, GENETICS, V200, P795, DOI 10.1534/genetics.115.175885; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; HOVATTER KR, 1987, P NATL ACAD SCI USA, V84, P1162, DOI 10.1073/pnas.84.5.1162; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004	25	13	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24851	24856		10.1074/jbc.C116.758706	http://dx.doi.org/10.1074/jbc.C116.758706			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27756838	hybrid, Green Published			2022-12-28	WOS:000388880100005
J	Gorelik, A; Heinz, LX; Illes, K; Superti-Furga, G; Nagar, B				Gorelik, Alexei; Heinz, Leonhard X.; Illes, Katalin; Superti-Furga, Giulio; Nagar, Bhushan			Crystal Structure of the Acid Sphingomyelinase-like Phosphodiesterase SMPDL3B Provides Insights into Determinants of Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface enzyme; crystal structure; lipid metabolism; sphingomyelinase; substrate specificity; SMPDL3B	PROTEOMIC ANALYSIS; IDENTIFICATION; PHOSPHATIDYLCHOLINE; PHENIX	The enzyme acid sphingomyelinase-like phosphodiesterase 3B (SMPDL3B) was shown to act as a negative regulator of innate immune signaling, affecting cellular lipid composition and membrane fluidity. Furthermore, several reports identified this enzyme as an off target of the therapeutic antibody rituximab, with implications in kidney disorders. However, structural information for this protein is lacking. Here we present the high resolution crystal structure of murine SMPDL3B, which reveals a substrate binding site strikingly different from its paralogs. The active site is located in a narrow boot-shaped cavity. We identify a unique loop near the active site that appears to impose size constraints on incoming substrates. A structure in complex with phosphocholine indicates that the protein recognizes this head group via an aromatic box, a typical choline-binding motif. Although a potential substrate for SMPDL3B is sphingomyelin, we identify other possible substrates such as CDP-choline, ATP, and ADP. Functional experiments employing structure-guided mutagenesis in macrophages highlight amino acid residues potentially involved in recognition of endogenous substrates. Our study is an important step toward elucidating the specific function of this poorly characterized enzyme.	[Gorelik, Alexei; Illes, Katalin; Nagar, Bhushan] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Gorelik, Alexei; Illes, Katalin; Nagar, Bhushan] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Heinz, Leonhard X.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	McGill University; McGill University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna	Nagar, B (corresponding author), Rm 464,3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	bhushan.nagar@mcgill.ca	Superti-Furga, Giulio/AAE-5681-2019	Gorelik, Alexei/0000-0001-6236-4633; Heinz, Leonhard/0000-0002-6921-1493	National Science Foundation; National Institutes of Health/National Institute of General Medical Sciences under National Science Foundation [DMR-1332208]; National Institute of General Medical Sciences of the National Institutes of Health [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences under National Science Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Guennadi Kozlov for crystallographic data collection. This work is based upon research conducted at the Cornell High Energy Synchrotron Source, which is supported by the National Science Foundation and the National Institutes of Health/National Institute of General Medical Sciences under National Science Foundation award DMR-1332208, using the Macromolecular Diffraction facility at the Cornell High Energy Synchrotron Source, which is supported by award GM-103485 from the National Institute of General Medical Sciences of the National Institutes of Health. We also thank Dr. Shaun Labiuk for crystallographic data collection performed at Beamline 08ID-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; Cortes LK, 2014, PROTEOMICS, V14, P2471, DOI 10.1002/pmic.201400148; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Gorelik A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12196; Gorelik A, 2016, J BIOL CHEM, V291, P6376, DOI 10.1074/jbc.M115.711085; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; Kornhuber J, 2015, BIOL CHEM, V396, P707, DOI 10.1515/hsz-2015-0109; Lim SM, 2016, FEBS J, V283, P1107, DOI 10.1111/febs.13655; Masuishi Y, 2013, J PROTEOME RES, V12, P4617, DOI 10.1021/pr4004807; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noto PB, 2012, MOL PHARMACOL, V82, P719, DOI 10.1124/mol.112.078865; Ogawa Y, 2011, BIOL PHARM BULL, V34, P13, DOI 10.1248/bpb.34.13; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picariello G, 2012, J CHROMATOGR A, V1227, P219, DOI 10.1016/j.chroma.2012.01.014; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Sleat DE, 2007, PROTEOM CLIN APPL, V1, P1134, DOI 10.1002/prca.200700250; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Takahashi Y, 2017, NEPHROLOGY, V22, P49, DOI 10.1111/nep.12737; Tasaki M, 2014, J AM SOC NEPHROL, V25, P737, DOI 10.1681/ASN.2013040363; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thouvenot E, 2008, J PROTEOME RES, V7, P4409, DOI 10.1021/pr8003858; Traini M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.612341; Wu J, 2005, BIOCHEM J, V386, P153, DOI 10.1042/BJ20041455; Xiong ZJ, 2016, J MOL BIOL, V428, P3026, DOI 10.1016/j.jmb.2016.06.012; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213	33	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24054	24064		10.1074/jbc.M116.755801	http://dx.doi.org/10.1074/jbc.M116.755801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27687724	hybrid, Green Published			2022-12-28	WOS:000388498100022
J	Sridharan, R; Connelly, SM; Naider, F; Dumont, ME				Sridharan, Rajashri; Connelly, Sara M.; Naider, Fred; Dumont, Mark E.			Variable Dependence of Signaling Output on Agonist Occupancy of Ste2p, a G Protein-coupled Receptor in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); pheromone; receptor; regulator of G protein signaling (RGS); signal transduction; signaling; yeast	ALPHA-FACTOR RECEPTOR; AFFECTING SEXUAL CONJUGATION; DOMINANT-NEGATIVE MUTATIONS; FACTOR PHEROMONE RECEPTOR; BETA-ADRENERGIC-RECEPTOR; SACCHAROMYCES-CEREVISIAE; ADENYLYL-CYCLASE; BETA-2-ADRENERGIC RECEPTOR; MUSCARINIC RECEPTOR; EXTRACELLULAR ENDS	We report here on the relationship between ligand binding and signaling responses in the yeast pheromone response pathway, a well characterized G protein-coupled receptor system. Responses to agonist (-factor) by cells expressing widely varying numbers of receptors depend primarily on fractional occupancy, not the absolute number of agonist-bound receptors. Furthermore, the concentration of competitive antagonist required to inhibit -factor-dependent signaling is more than 10-fold higher than predicted based on the known ligand affinities. Thus, responses to a particular number of agonist-bound receptors can vary greatly, depending on whether there are unoccupied or antagonist-bound receptors present on the same cell surface. This behavior does not appear to be due to pre-coupling of receptors to G protein or to the Sst2p regulator of G protein signaling. The results are consistent with a signaling response that is determined by the integration of positive signals from agonist-occupied receptors and inhibitory signals from unoccupied receptors, where the inhibitory signals can be diminished by antagonist binding.	[Sridharan, Rajashri; Connelly, Sara M.; Dumont, Mark E.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, POB 712, Rochester, NY 14642 USA; [Naider, Fred] CUNY Coll Staten Isl, Dept Chem, Staten Isl, NY 10314 USA; [Naider, Fred] CUNY Coll Staten Isl, Macromol Assembly Inst, Staten Isl, NY 10314 USA; [Naider, Fred] CUNY, Grad Ctr, PhD Programs Biochem & Chem, New York, NY 10016 USA; [Sridharan, Rajashri] Dept Microbiol & Immunol, 115 Biomed Res Bldg,3435 Main St, Buffalo, NY 14214 USA	University of Rochester; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System	Dumont, ME (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, POB 712, Rochester, NY 14642 USA.	mark_dumont@urmc.rochester.edu			National Institutes of Health [R01GM084083, RO1GM059357, R01GM114974, R01GM22087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022087, R01GM059357, R01GM084083, R01GM114974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM084083, RO1GM059357, and R01GM114974 (to M.E.D.) and Grant R01GM22087 (to F.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel MG, 1998, BBA-MOL CELL RES, V1448, P12, DOI 10.1016/S0167-4889(98)00109-8; Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; Bajaj A, 2004, BIOCHEMISTRY-US, V43, P13564, DOI 10.1021/bi0494018; Bajaj A, 2007, BBA-MOL CELL RES, V1773, P707, DOI 10.1016/j.bbamcr.2007.02.002; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4363, DOI 10.1073/pnas.87.11.4363; BOUVIER M, 1988, MOL PHARMACOL, V33, P133; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Bukusoglu G, 1996, MOL CELL BIOL, V16, P4818; Burchett SA, 2001, J BIOL CHEM, V276, P26472, DOI 10.1074/jbc.M103436200; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Celic Andjelka, 2004, Methods Mol Biol, V237, P105; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Chasse SA, 2006, EUKARYOT CELL, V5, P330, DOI 10.1128/EC.5.2.330-346.2006; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claeysen S, 2000, MOL PHARMACOL, V58, P136, DOI 10.1124/mol.58.1.136; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; Dixit G, 2014, MOL CELL, V55, P85, DOI 10.1016/j.molcel.2014.05.019; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Dosil M, 1998, MOL CELL BIOL, V18, P5981, DOI 10.1128/MCB.18.10.5981; ERIOTOUBARGIOTA E, 1992, BIOCHEMISTRY-US, V31, P551, DOI 10.1021/bi00117a036; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gehret AU, 2006, J BIOL CHEM, V281, P20698, DOI 10.1074/jbc.M513642200; Gehret AU, 2012, EUKARYOT CELL, V11, P1276, DOI 10.1128/EC.00172-12; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hao N, 2012, MOL BIOL CELL, V23, P3899, DOI 10.1091/mbc.E12-04-0333; HARTWELL LH, 1980, J CELL BIOL, V85, P811, DOI 10.1083/jcb.85.3.811; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Kim H, 2009, BIOCHEMISTRY-US, V48, P10976, DOI 10.1021/bi901291c; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; LAZARENO S, 1993, BRIT J PHARMACOL, V109, P1110, DOI 10.1111/j.1476-5381.1993.tb13737.x; Leavitt LM, 1999, MOL GEN GENET, V261, P917, DOI 10.1007/s004380051039; Limbird L. E., 2004, CELL SURFACE RECEPTO, P7; Lin JC, 2003, BIOCHEMISTRY-US, V42, P293, DOI 10.1021/bi026766o; MACKAY V, 1974, GENETICS, V76, P273; MACKAY V, 1974, GENETICS, V76, P255; MARSH L, 1992, MOL CELL BIOL, V12, P3959, DOI 10.1128/MCB.12.9.3959; Marunaka Y, 2005, J MEMBRANE BIOL, V203, P31, DOI 10.1007/s00232-004-0729-0; Mathew E, 2011, J MOL BIOL, V409, P513, DOI 10.1016/j.jmb.2011.03.059; Medici R, 1997, EMBO J, V16, P7241, DOI 10.1093/emboj/16.24.7241; MELLER E, 1990, MOL PHARMACOL, V37, P231; NEUBIG RR, 1988, BIOCHEMISTRY-US, V27, P2374, DOI 10.1021/bi00407a019; NICKERSON M, 1956, NATURE, V178, P697, DOI 10.1038/178697b0; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Pincus D, 2010, YEAST, V27, P423, DOI 10.1002/yea.1758; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; RATHS SK, 1988, J BIOL CHEM, V263, P17333; Redka DS, 2013, BIOCHEMISTRY-US, V52, P7405, DOI 10.1021/bi4003869; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; SCHILD HO, 1957, PHARMACOL REV, V9, P242; Shah A, 1996, BIOCHEM BIOPH RES CO, V226, P242, DOI 10.1006/bbrc.1996.1340; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; SIKORSKI RS, 1989, GENETICS, V122, P19; Sommers CM, 2000, BIOCHEMISTRY-US, V39, P6898, DOI 10.1021/bi992616a; SPRAGUE GF, 1981, NATURE, V289, P250, DOI 10.1038/289250a0; STEFAN CJ, 1994, MOL CELL BIOL, V14, P3339, DOI 10.1128/MCB.14.5.3339; Stefan CJ, 1998, MOL BIOL CELL, V9, P885, DOI 10.1091/mbc.9.4.885; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; TOLKOVSKY AM, 1981, J CYCLIC NUCL PROT, V7, P139; VARRAULT A, 1992, MOL PHARMACOL, V41, P999; VOGEL WK, 1995, J BIOL CHEM, V270, P15485, DOI 10.1074/jbc.270.26.15485; Whaley B. S., 1995, PHARM COMMUN, V6, P203; WHALEY BS, 1994, MOL PHARMACOL, V45, P481; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WREGGETT KA, 1984, MOL PHARMACOL, V26, P214; Yesilaltay A, 2000, MOL BIOL CELL, V11, P2873, DOI 10.1091/mbc.11.9.2873; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Yildirim N, 2004, METHOD ENZYMOL, V389, P383; Yin DZ, 2005, BIOCHEM BIOPH RES CO, V329, P281, DOI 10.1016/j.bbrc.2005.01.130; Yu RC, 2008, IET SYST BIOL, V2, P222, DOI 10.1049/iet-syb:20080127; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; ZHU BT, 1993, J PHARMACOL TOXICOL, V29, P85, DOI 10.1016/1056-8719(93)90055-J; Zolk O, 1998, BIOCHEM BIOPH RES CO, V248, P801, DOI 10.1006/bbrc.1998.9030	90	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24261	24279		10.1074/jbc.M116.733006	http://dx.doi.org/10.1074/jbc.M116.733006			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27646004	hybrid, Green Published			2022-12-28	WOS:000388498100038
J	Aicart-Ramos, C; He, SDQ; Land, M; Rubin, CS				Aicart-Ramos, Clara; He, Sophia Dan Qing; Land, Marianne; Rubin, Charles S.			A Novel Conserved Domain Mediates Dimerization of Protein Kinase D (PKD) Isoforms: DIMERIZATION IS ESSENTIAL FOR PKD-DEPENDENT REGULATION OF SECRETION AND INNATE IMMUNITY xref ref-type="fn" rid="FN1"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); innate immunity; protein kinase D (PKD); secretion; signal transduction; heterodimer; homodimer; native Mr; oligomerization domain	TRANS-GOLGI NETWORK; CAENORHABDITIS-ELEGANS; IN-VIVO; PANCREATIC ADENOCARCINOMA; MEMBRANE FISSION; GEL-FILTRATION; D ENZYMES; T-CELLS; EXPRESSION; ACTIVATION	Protein kinase D (PKD) isoforms are protein kinase C effectors in signaling pathways regulated by diacylglycerol. Important physiological processes (including secretion, immune responses, motility, and transcription) are placed under diacylglycerol control by the distinctive substrate specificity and subcellular distribution of PKDs. Potentially, broadly co-expressed PKD polypeptides may interact to generate homo- or heteromultimeric regulatory complexes. However, the frequency, molecular basis, regulatory significance, and physiological relevance of stable PKD-PKD interactions are largely unknown. Here, we demonstrate that mammalian PKDs 1-3 and the prototypical Caenorhabditis elegans PKD, DKF-2A, are exclusively (homo- or hetero-) dimers in cell extracts and intact cells. We discovered and characterized a novel, highly conserved N-terminal domain, comprising 92 amino acids, which mediates dimerization of PKD1, PKD2, and PKD3 monomers. A similar domain directs DKF-2A homodimerization. Dimerization occurred independently of properties of the regulatory and kinase domains of PKDs. Disruption of PKD dimerization abrogates secretion of PAUF, a protein carried in small trans-Golgi network-derived vesicles. In addition, disruption of DKF-2A homodimerization in C. elegans intestine impaired and degraded the immune defense of the intact animal against an ingested bacterial pathogen. Finally, dimerization was indispensable for the strong, dominant negative effect of catalytically inactive PKDs. Overall, the structural integrity and function of the novel dimerization domain are essential for PKD-mediated regulation of a key aspect of cell physiology, secretion, and innate immunity in vivo.	[Aicart-Ramos, Clara; He, Sophia Dan Qing; Land, Marianne; Rubin, Charles S.] Albert Einstein Coll Med, Dept Mol Pharmacol, Atran Labs, 1300 Morris Pk Ave, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Rubin, CS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Atran Labs, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	charles.rubin@einstein.yu.edu	Aicart-Ramos, Clara/C-7301-2016	Aicart-Ramos, Clara/0000-0002-1114-4259	NIGMS, National Institutes of Health [GM080615]; Alfonso Martin Escudero Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080615] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alfonso Martin Escudero Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS, National Institutes of Health Grant GM080615 (to C. S. R.) and a Fellowship from the Alfonso Martin Escudero Foundation (to C. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Borges S, 2015, MOL CANCER THER, V14, P1306, DOI 10.1158/1535-7163.MCT-14-0945; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Doppler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098090; Durand N, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020020; Durand N, 2015, CELL MOL LIFE SCI, V72, P4369, DOI 10.1007/s00018-015-2011-2; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ellwanger K, 2013, IUBMB LIFE, V65, P98, DOI 10.1002/iub.1116; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Feng H, 2007, J BIOL CHEM, V282, P31273, DOI 10.1074/jbc.M701532200; Feng H, 2006, J BIOL CHEM, V281, P17801, DOI 10.1074/jbc.M511899200; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000224; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; Kim SJ, 2013, ONCOGENE, V32, P3638, DOI 10.1038/onc.2012.366; Kim SA, 2009, CANCER SCI, V100, P828, DOI 10.1111/j.1349-7006.2009.01106.x; LAND M, 1994, J BIOL CHEM, V269, P9234; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liou GY, 2015, EXPERT REV GASTROENT, V9, P1143, DOI 10.1586/17474124.2015.1069706; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Navarro MN, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005477; Navarro MN, 2012, BIOCHEM J, V442, P649, DOI 10.1042/BJ20111700; NDUBUKA C, 1993, J BIOL CHEM, V268, P7621; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Park HD, 2011, ONCOGENE, V30, P201, DOI 10.1038/onc.2010.401; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Tandon M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075601, 10.1371/journal.pone.0081521]; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Wille Christoph, 2014, Bioarchitecture, V4, P111, DOI 10.4161/bioa.29273; Wu SL, 1998, J BIOL CHEM, V273, P1130, DOI 10.1074/jbc.273.2.1130; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zou ZP, 2012, J CELL SCI, V125, P4800, DOI 10.1242/jcs.106542	55	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23516	23531		10.1074/jbc.M116.735399	http://dx.doi.org/10.1074/jbc.M116.735399			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27662904	Green Published, hybrid			2022-12-28	WOS:000387884400014
J	Alicea-Velazquez, NL; Shinsky, SA; Loh, DM; Lee, JH; Skalnik, DG; Cosgrove, MS				Alicea-Velazquez, Nilda L.; Shinsky, Stephen A.; Loh, Daniel M.; Lee, Jeong-Heon; Skalnik, David G.; Cosgrove, Michael S.			Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; epigenetics; histone methylation; protein structure; protein-protein interaction; MLL1; SETd1A; WDR5; Win motif	HISTONE H3 LYSINE-4; STRUCTURAL BASIS; MOLECULAR REGULATION; SET1 FAMILY; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; FUSION PROTEIN; GENE; METHYLATION; RECOGNITION	MLL1 belongs to the SET1 family of histone H3 lysine 4 (H3K4) methyltransferases, composed of MLL1-4 and SETd1A/B. MLL1 translocations are present in acute leukemias, and mutations in several family members are associated with cancer and developmental disorders. MLL1 associates with a subcomplex containing WDR5, RbBP5, ASH2L, and DPY-30 (WRAD), forming the MLL1 core complex required for H3K4 mono- and dimethylation and transcriptional activation. Core complex assembly requires interaction of WDR5 with the MLL1 Win (WDR5 interaction) motif, which is conserved across the SET1 family. Agents that mimic the SET1 family Win motif inhibit the MLL1 core complex and have become an attractive approach for targeting MLL1 in cancers. Like MLL1, other SET1 family members interact with WRAD, but the roles of the Win motif in complex assembly and enzymatic activity remain unexplored. Here, we show that the Win motif is necessary for interaction of WDR5 with all members of the human SET1 family. Mutation of the Win motif-WDR5 interface severely disrupts assembly and activity of MLL1 and SETd1A complexes but only modestly disrupts MLL2/4 and SETd1B complexes without significantly altering enzymatic activity in vitro. Notably, in the absence of WDR5, MLL3 interacts with RAD and shows enhanced activity. To further probe the role of the Win motif-WDR5 interaction, we designed a peptidomimetic that binds WDR5 (K-d approximate to 3 nm) and selectively inhibits activity of MLL1 and SETd1A core complexes within the SET1 family. Our results reveal that SET1 family complexes with the weakest Win motif-WDR5 interaction are more susceptible to Win motif-based inhibitors.	[Alicea-Velazquez, Nilda L.; Shinsky, Stephen A.; Loh, Daniel M.; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA; [Lee, Jeong-Heon; Skalnik, David G.] Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu		Loh, Daniel/0000-0003-4706-3829; Shinsky, Stephen/0000-0001-5437-1729	National Institutes of Health [R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Grant R01CA140522 (to M. S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Artinger EL, 2013, P NATL ACAD SCI USA, V110, P12000, DOI 10.1073/pnas.1301278110; Benedikt A, 2011, LEUKEMIA, V25, P135, DOI 10.1038/leu.2010.249; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dobson CL, 1999, EMBO J, V18, P3564, DOI 10.1093/emboj/18.13.3564; Dorrance AM, 2008, BLOOD, V112, P2508, DOI 10.1182/blood-2008-01-134338; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emerenciano M, 2013, CANCER LETT, V332, P30, DOI 10.1016/j.canlet.2012.12.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Getlik M, 2016, J MED CHEM, V59, P2478, DOI 10.1021/acs.jmedchem.5b01630; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; He XX, 2015, NUCLEIC ACIDS RES, V43, P3712, DOI 10.1093/nar/gkv214; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Karatas H, 2010, J MED CHEM, V53, P5179, DOI 10.1021/jm100139b; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Li YJ, 2016, NATURE, V530, P447, DOI 10.1038/nature16952; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mersman DP, 2012, J BIOL CHEM, V287, P2652, DOI 10.1074/jbc.M111.280867; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pless B, 2011, LEUKEMIA, V25, P663, DOI 10.1038/leu.2010.308; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Senisterra G, 2013, BIOCHEM J, V449, P151, DOI 10.1042/BJ20121280; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shinsky SA, 2015, J BIOL CHEM, V290, P25819, DOI 10.1074/jbc.M115.684142; Shinsky SA, 2015, J BIOL CHEM, V290, P6361, DOI 10.1074/jbc.M114.627646; Shinsky SA, 2014, J MOL BIOL, V426, P2283, DOI 10.1016/j.jmb.2014.03.011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wilkinson AC, 2013, CELL REP, V3, P116, DOI 10.1016/j.celrep.2012.12.016; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	90	35	37	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22357	22372		10.1074/jbc.M116.752626	http://dx.doi.org/10.1074/jbc.M116.752626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27563068	Green Published, hybrid			2022-12-28	WOS:000386760600002
J	Fan, Y; He, JJ				Fan, Yan; He, Johnny J.			HIV-1 Tat Induces Unfolded Protein Response and Endoplasmic Reticulum Stress in Astrocytes and Causes Neurotoxicity through Glial Fibrillary Acidic Protein (GFAP) Activation and Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); glial cell; human immunodeficiency virus (HIV); neuron; unfolded protein response (UPR); Glial fibrillary acidic protein; HIV-1 Tat; astrocytes; endoplasmic reticulum stress; unfolded protein response	HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; MONOCYTE CHEMOATTRACTANT PROTEIN-1; POLYMERASE-CHAIN-REACTION; ALEXANDER-DISEASE; HIV-1-ASSOCIATED DEMENTIA; INTERMEDIATE-FILAMENTS; TRANSGENIC MICE; NEURONAL DAMAGE; CELLULAR RESERVOIRS	HIV-1 Tat is a major culprit for HIV/neuroAIDS. One of the consistent hallmarks of HIV/neuroAIDS is reactive astrocytes or astrocytosis, characterized by increased cytoplasmic accumulation of the intermediate filament glial fibrillary acidic protein (GFAP). We have shown that that Tat induces GFAP expression in astrocytes and that GFAP activation is indispensable for astrocyte-mediated Tat neurotoxicity. However, the underlying molecular mechanisms are not known. In this study, we showed that Tat expression or GFAP expression led to formation of GFAP aggregates and induction of unfolded protein response (UPR) and endoplasmic reticulum (ER) stress in astrocytes. In addition, we demonstrated that GFAP up-regulation and aggregation in astrocytes were necessary but also sufficient for UPR/ER stress induction in Tat-expressing astrocytes and for astrocyte-mediated Tat neurotoxicity. Importantly, we demonstrated that inhibition of Tat- or GFAP-induced UPR/ER stress by the chemical chaperone 4-phenylbutyrate significantly alleviated astrocyte-mediated Tat neurotoxicity in vitro and in the brain of Tat-expressing mice. Taken together, these results show that HIV-1 Tat expression leads to UPR/ER stress in astrocytes, which in turn contributes to astrocyte-mediated Tat neurotoxicity, and raise the possibility of developing HIV/neuroAIDS therapeutics targeted at UPR/ER stress.	[Fan, Yan; He, Johnny J.] Univ North Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center	He, JJ (corresponding author), Univ North Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu	Fan, Yan/F-5107-2018		NINDS, National Institutes of Health [R01NS065785, R01094108, R01MH092673]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094108, R01NS065785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043162] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NINDS, National Institutes of Health Grants R01NS065785, R01094108, and R01MH092673 (to J. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akay C, 2012, NEUROPATH APPL NEURO, V38, P175, DOI 10.1111/j.1365-2990.2011.01215.x; Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Benelli R, 2000, J INFECT DIS, V182, P1643, DOI 10.1086/317597; BLUM AL, 1979, INTERNIST, V20, P162; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; Caporello E, 2006, J NEUROCHEM, V98, P146, DOI 10.1111/j.1471-4159.2006.03863.x; Castilla J, 2004, CURR MOL MED, V4, P397, DOI 10.2174/1566524043360654; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; Chigurupati S, 2009, J BIOL CHEM, V284, P18323, DOI 10.1074/jbc.M109.020891; CHIU FC, 1985, J NEUROIMMUNOL, V8, P283, DOI 10.1016/S0165-5728(85)80067-9; Cho KJ, 2009, NEUROSCIENCE, V163, P1128, DOI 10.1016/j.neuroscience.2009.07.048; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Dash PK, 2011, J NEUROSCI, V31, P3148, DOI 10.1523/JNEUROSCI.5473-10.2011; de Paulis A, 2000, J IMMUNOL, V165, P7171, DOI 10.4049/jimmunol.165.12.7171; Deshpande M, 2005, NEUROTOX RES, V7, P183, DOI 10.1007/BF03036448; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Fan Y, 2015, CURR HIV RES, V13, P55, DOI 10.2174/1570162X13666150121115804; Fan Y, 2011, J NEUROIMMUNE PHARM, V6, P121, DOI 10.1007/s11481-010-9217-8; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gavriil ES, 2000, BIOCHEM BIOPH RES CO, V267, P252, DOI 10.1006/bbrc.1999.1894; Gorry PR, 2003, CURR HIV RES, V1, P463, DOI 10.2174/1570162033485122; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HELLAND DE, 1991, J VIROL, V65, P4547, DOI 10.1128/JVI.65.8.4547-4549.1991; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Irish BP, 2009, AM J INFECT DIS, V5, P231, DOI 10.3844/ajidsp.2009.231.258; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Lindl KA, 2007, NEUROPATH APPL NEURO, V33, P658, DOI 10.1111/j.1365-2990.2007.00866.x; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Liu ZQ, 2014, J NEUROVIROL, V20, P278, DOI 10.1007/s13365-014-0245-7; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Messam CA, 2000, J NEUROVIROL, V6, pS90; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 1998, INT J DEV BIOL, V42, P1019; Mignot C, 2004, CELL MOL LIFE SCI, V61, P369, DOI 10.1007/s00018-003-3143-3; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Norenburg M., 1997, ASTROCYTES BRAIN AGI; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2001, Prog Brain Res, V132, P23; Valero IP, 2014, J INT AIDS SOC, V17, P61, DOI 10.7448/IAS.17.4.19578; Peruzzi F, 2006, FRONT BIOSCI-LANDMRK, V11, P708, DOI 10.2741/1829; PRICE RW, 1988, J INFECT DIS, V158, P1079, DOI 10.1093/infdis/158.5.1079; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Rodriguez D, 2001, AM J HUM GENET, V69, P1134, DOI 10.1086/323799; Sabri F, 1999, VIROLOGY, V264, P370, DOI 10.1006/viro.1999.9998; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Sullivan SM, 2007, J BIOL CHEM, V282, P29414, DOI 10.1074/jbc.M704152200; Tanaka KF, 2007, GLIA, V55, P617, DOI 10.1002/glia.20486; Tewari M, 2015, J NEUROCHEM, V132, P464, DOI 10.1111/jnc.12953; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; TOMOKANE N, 1991, AM J PATHOL, V138, P875; Ton Hoai, 2013, J AIDS Clin Res, V4, P255; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; Vitkovic L, 1995, CURR TOP MICROBIOL, V202, P105; Vitkovic L, 1995, BRAIN BEHAV IMMUN, V9, P378, DOI 10.1006/brbi.1995.1035; Williams K C, 1996, J NeuroAIDS, V1, P31; Yuen KY, 1997, J INFECTION, V34, P29, DOI 10.1016/S0163-4453(97)80006-0; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zhou BY, 2004, NEUROSCI LETT, V359, P155, DOI 10.1016/j.neulet.2004.02.012; Zou W, 2007, AM J PATHOL, V171, P1923, DOI 10.2353/ajpath.2007.070333; Zou W, 2010, GLIA, V58, P1640, DOI 10.1002/glia.21038	90	49	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22819	22829		10.1074/jbc.M116.731828	http://dx.doi.org/10.1074/jbc.M116.731828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609520	Green Published, hybrid			2022-12-28	WOS:000386760600038
J	Resto, M; Kim, BH; Fernandez, AG; Abraham, BJ; Zhao, KJ; Lewis, BA				Resto, Melissa; Kim, Bong-Hyun; Fernandez, Alfonso G.; Abraham, Brian J.; Zhao, Keji; Lewis, Brian A.			O-GlcNAcase Is an RNA Polymerase II Elongation Factor Coupled to Pausing Factors SPT5 and TIF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; O-GlcNAcylation; RNA polymerase II; transcription; transcription elongation factor	TRANSCRIPTION IN-VITRO; 7SK SNRNP COMPLEX; P-TEFB; DROSOPHILA-MELANOGASTER; FUNCTIONAL-ANALYSIS; CHRONIC DISEASE; PROMOTER; GENES; RELEASE; PHOSPHORYLATION	We describe here the identification and functional characterization of the enzyme O-GlcNAcase (OGA) as an RNA polymerase II elongation factor. Using in vitro transcription elongation assays, we show that OGA activity is required for elongation in a crude nuclear extract system, whereas in a purified system devoid of OGA the addition of rOGA inhibited elongation. Furthermore, OGA is physically associated with the known RNA polymerase II (pol II) pausing/elongation factors SPT5 and TRIM28-KAP1-TIF1, and a purified OGA-SPT5-TIF1 complex has elongation properties. Lastly, ChIP-seq experiments show that OGA maps to the transcriptional start site/5 ends of genes, showing considerable overlap with RNA pol II, SPT5, TRIM28-KAP1-TIF1, and O-GlcNAc itself. These data all point to OGA as a component of the RNA pol II elongation machinery regulating elongation genome-wide. Our results add a novel and unexpected dimension to the regulation of elongation by the insertion of O-GlcNAc cycling into the pol II elongation regulatory dynamics.	[Resto, Melissa; Fernandez, Alfonso G.; Lewis, Brian A.] NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Kim, Bong-Hyun] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Abraham, Brian J.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Abraham, Brian J.; Zhao, Keji] NHLBI, Lab Epigenome Biol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Fernandez, Alfonso G.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Abraham, Brian J.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); St Jude Children's Research Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lewis, BA (corresponding author), NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	phdbiochemist@gmail.com	Abraham, Brian/C-2230-2019	Abraham, Brian/0000-0001-8085-3027; Lewis, Brian/0000-0002-8321-0665	NCI Intramural Program; NHLBI Intramural Program; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER	NCI Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI Intramural Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NCI Intramural Program (to B. A. L.) and the NHLBI Intramural Program (to K. Z.), National Institutes of Health. The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson TE, 2003, METHOD ENZYMOL, V371, P264; Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Bai X, 2013, DEV BIOL, V373, P422, DOI 10.1016/j.ydbio.2012.10.008; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Bunch H, 2014, NAT STRUCT MOL BIOL, V21, P876, DOI 10.1038/nsmb.2878; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Cheng B, 2009, METHODS, V48, P346, DOI 10.1016/j.ymeth.2009.02.026; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Das S, 2010, J PROTEOME RES, V9, P6696, DOI 10.1021/pr100843x; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Durning SP, 2016, J BIOL CHEM, V291, P2107, DOI 10.1074/jbc.M115.693580; FLORES O, 1989, J BIOL CHEM, V264, P8913; Gardini A, 2014, MOL CELL, V56, P128, DOI 10.1016/j.molcel.2014.08.004; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Hahne H, 2013, J PROTEOME RES, V12, P927, DOI 10.1021/pr300967y; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lewis BA, 2016, J BIOL CHEM, V291, P14056, DOI 10.1074/jbc.M115.684365; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; McNamara RP, 2016, GENOM DATA, V7, P250, DOI 10.1016/j.gdata.2016.01.019; McNamara RP, 2016, MOL CELL, V61, P39, DOI 10.1016/j.molcel.2015.11.004; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Okada T, 2009, GLYCOBIOLOGY, V19, P368, DOI 10.1093/glycob/cwn145; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Smith ER, 2008, P NATL ACAD SCI USA, V105, P8575, DOI 10.1073/pnas.0804379105; Stadelmayer B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6531; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Teo CF, 2016, GLYCOBIOLOGY, V26, P1198, DOI 10.1093/glycob/cww043; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Vaidyanathan K, 2014, J BIOL CHEM, V289, P34466, DOI 10.1074/jbc.R114.591560; Voet D., 2011, BIOCHEMISTRY-US, P566; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Weber A, 2005, MOL CELL BIOL, V25, P147, DOI 10.1128/mcb.25.1.147-161.2005; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	75	17	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22703	22713		10.1074/jbc.M116.751420	http://dx.doi.org/10.1074/jbc.M116.751420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601472	Green Published, hybrid			2022-12-28	WOS:000386760600029
J	Valabhoju, V; Agrawal, S; Sen, R				Valabhoju, Vishalini; Agrawal, Sonia; Sen, Ranjan			Molecular Basis of NusG-mediated Regulation of Rho-dependent Transcription Termination in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; bacteria; fluorescence; RNA polymerase; transcription termination; NusG; Rho	COLI RNA-POLYMERASE; ESCHERICHIA-COLI; ELONGATION COMPLEX; DEFECTIVE-MUTANTS; DNA; ACTIVATION; MECHANISM; LOCATION; RELEASE; PROTEIN	The bacterial transcription elongation factor NusG stimulates the Rho-dependent transcription termination through a direct interaction with Rho. The mechanistic basis of NusG dependence of the Rho function is not known. Here, we describe Rho* mutants I168V, R221C/A, and P235H that do not require NusG for their termination function. These Rho* mutants have acquired new properties, which otherwise would have been imparted by NusG. A detailed analyses revealed that they have more stable interactions at the secondary RNA binding sites of Rho, which reduced the lag in initiating its ATPase as well as the translocase activities. These more stable interactions arose from the significant spatial re-orientations of the P, Q, and R structural loops of the Rho central channel. We propose that NusG imparts similar conformational changes in the central channel of Rho, yielding faster isomerization of the open to the closed hexameric states of the latter during its RNA-loading step. This acceleration stabilizes the Rho-RNA interactions at many terminators having suboptimal rut sites, thus making Rho-NusG interactions so essential in vivo. Finally, identification of the NusG binding sites on the Rho hexamer led us to conclude that the former exerts its effect allosterically.	[Valabhoju, Vishalini; Agrawal, Sonia; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mouzamjahi Rd, Hyderabad 500001, Andhra Pradesh, India; [Valabhoju, Vishalini] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mouzamjahi Rd, Hyderabad 500001, Andhra Pradesh, India.	rsen@cdfd.org.in	Sen, Ranjan/AAP-7075-2021		DBT-Center of Excellence in Microbial Physiology; Center for DNA Fingerprinting and Diagnostics; University Grant Commission (UGC)	DBT-Center of Excellence in Microbial Physiology; Center for DNA Fingerprinting and Diagnostics; University Grant Commission (UGC)(University Grants Commission, India)	This work was supported in part by DBT-Center of Excellence in Microbial Physiology and Center for DNA Fingerprinting and Diagnostics intramural funding. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a University Grant Commission (UGC) Senior Research Fellow during the period of this study.	Banerjee S, 2006, J MICROBIOL, V44, P11; Burns CM, 1999, J BIOL CHEM, V274, P5245, DOI 10.1074/jbc.274.8.5245; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chalissery J, 2011, J MOL BIOL, V405, P49, DOI 10.1016/j.jmb.2010.10.044; Cheeran A, 2005, J MOL BIOL, V352, P28, DOI 10.1016/j.jmb.2005.06.052; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Dutta D, 2008, J BIOL CHEM, V283, P20243, DOI 10.1074/jbc.M801926200; Harinarayanan R, 2003, J MOL BIOL, V332, P31, DOI 10.1016/S0022-2836(03)00753-8; Kalarickal NC, 2010, J MOL BIOL, V395, P966, DOI 10.1016/j.jmb.2009.12.022; KUMAR KP, 1990, BIOCHEMISTRY-US, V29, P317, DOI 10.1021/bi00454a003; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; Pasman Z, 2000, BIOCHEMISTRY-US, V39, P5573, DOI 10.1021/bi992658z; PEREIRA S, 1995, J MOL BIOL, V251, P30, DOI 10.1006/jmbi.1995.0413; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Qayyum MZ, 2016, J BIOL CHEM, V291, P8090, DOI 10.1074/jbc.M115.701268; Ranjan A, 2013, NUCLEIC ACIDS RES, V41, P6839, DOI 10.1093/nar/gkt336; Sen R, 2003, METHOD ENZYMOL, V370, P598; Sen R., 2014, NUS FACTORS ESCHERIC; Shashni R, 2014, NUCLEIC ACIDS RES, V42, P9677, DOI 10.1093/nar/gku690; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Tomar SK, 2013, CHEM REV, V113, P8604, DOI 10.1021/cr400064k; Washburn RS, 1996, J MOL BIOL, V260, P332, DOI 10.1006/jmbi.1996.0404; Yakhnin AV, 2016, J BIOL CHEM, V291, P5299, DOI 10.1074/jbc.M115.704189	29	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22386	22403		10.1074/jbc.M116.745364	http://dx.doi.org/10.1074/jbc.M116.745364			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27605667	hybrid, Green Published			2022-12-28	WOS:000386760600004
J	Wadas, B; Piatkov, KI; Brower, CS; Varshavsky, A				Wadas, Brandon; Piatkov, Konstantin I.; Brower, Christopher S.; Varshavsky, Alexander			Analyzing N-terminal Arginylation through the Use of Peptide Arrays and Degradation Assays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-RULE PATHWAY; UBIQUITIN FUSION TECHNIQUE; RNA-PROTEIN TRANSFERASE; MODIFIED HISTONE TAILS; IN-VIVO; CARDIOVASCULAR DEVELOPMENT; TRANSCRIPTIONAL REPRESSOR; BINDING-SPECIFICITY; PROTEOMICS ANALYSIS; CELLULAR-PROTEINS	N-alpha-terminal arginylation (Nt-arginylation) of proteins is mediated by the Ate1 arginyltransferase (R-transferase), a component of the Arg/N-end rule pathway. This proteolytic system recognizes proteins containing N-terminal degradation signals called N-degrons, polyubiquitylates these proteins, and thereby causes their degradation by the proteasome. The definitively identified ("canonical") residues that are Nt-arginylated by R-transferase are N-terminal Asp, Glu, and (oxidized) Cys. Over the last decade, several publications have suggested (i) that Ate1 can also arginylate non-canonical N-terminal residues; (ii) that Ate1 is capable of arginylating not only alpha-amino groups of N-terminal residues but also gamma-carboxyl groups of internal (non-N-terminal) Asp and Glu; and (iii) that some isoforms of Ate1 are specific for substrates bearing N-terminal Cys residues. In the present study, we employed arrays of immobilized 11-residue peptides and pulse-chase assays to examine the substrate specificity of mouse R-transferase. We show that amino acid sequences immediately downstream of a substrate's canonical (Nt-arginylatable) N-terminal residue, particularly a residue at position 2, can affect the rate of Nt-arginylation by R-transferase and thereby the rate of degradation of a substrate protein. We also show that the four major isoforms of mouse R-transferase have similar Nt-arginylation specificities in vitro, contrary to the claim about the specificity of some Ate1 isoforms for N-terminal Cys. In addition, we found no evidence for a significant activity of the Ate1 R-transferase toward previously invoked non-canonical N-terminal or internal amino acid residues. Together, our results raise technical concerns about earlier studies that invoked non-canonical arginylation specificities of Ate1.	[Wadas, Brandon; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Piatkov, Konstantin I.] Skolkovo Inst Sci & Technol, Ctr Biotechnol & Biomed, Moscow 143026, Russia; [Brower, Christopher S.] Texas Womans Univ, Dept Biol, Denton, TX 76204 USA	California Institute of Technology; Skolkovo Institute of Science & Technology; Texas Womans University	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Wadas, Brandon/0000-0003-2796-2384	National Institutes of Health [R01-DK039520, R01-GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health Grants R01-DK039520 and R01-GM031530 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; An JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037414; An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bock I, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-48; Bock I, 2011, EPIGENETICS-US, V6, P256, DOI 10.4161/epi.6.2.13837; Brower CS, 2014, P NATL ACAD SCI USA, V111, pE4936, DOI 10.1073/pnas.1419587111; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Comachione AS, 2014, CELL REP, V8, P469, DOI 10.1016/j.celrep.2014.06.019; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Dorfel MJ, 2015, GENE, V567, P103, DOI 10.1016/j.gene.2015.04.085; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Ebhardt HA, 2014, RAPID COMMUN MASS SP, V28, P2735, DOI 10.1002/rcm.7069; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Eldeeb M, 2016, PROTEIN PEPTIDE LETT, V23, P343, DOI 10.2174/0929866523666160108115809; Eldeeb MA, 2014, ONCOTARGET, V5, P2714, DOI 10.18632/oncotarget.1931; Eriste E, 2005, J BIOL CHEM, V280, P35089, DOI 10.1074/jbc.M502567200; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Gibbs DJ, 2014, MOL CELL, V53, P369, DOI 10.1016/j.molcel.2013.12.020; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Hoernstein SNW, 2016, MOL CELL PROTEOMICS, V15, P1808, DOI 10.1074/mcp.M115.057190; Holman TJ, 2009, P NATL ACAD SCI USA, V106, P4549, DOI 10.1073/pnas.0810280106; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Hwang CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024925; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Khosrow-Khavar F, 2012, G3-GENES GENOM GENET, V2, P619, DOI 10.1534/g3.111.001933; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim ST, 2013, AUTOPHAGY, V9, P1100, DOI 10.4161/auto.24643; Kitamura K, 2013, FEBS LETT, V587, P214, DOI 10.1016/j.febslet.2012.11.028; Kurosaka S, 2012, J MOL CELL CARDIOL, V53, P333, DOI 10.1016/j.yjmcc.2012.05.007; Kurosaka S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000878; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Liu YJ, 2016, J BIOL CHEM, V291, P7426, DOI 10.1074/jbc.M116.714964; Majovsky P, 2014, J PROTEOME RES, V13, P4246, DOI 10.1021/pr500164j; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Piatkov KI, 2015, MICROB CELL, V2, P376, DOI 10.15698/mic2015.10.231; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, MOL CELL, V48, P926, DOI 10.1016/j.molcel.2012.10.012; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Prasad R, 2012, BIOCHEM BIOPH RES CO, V425, P689, DOI 10.1016/j.bbrc.2012.07.080; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; Rai R, 2008, DEVELOPMENT, V135, P3881, DOI 10.1242/dev.022723; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Saha S, 2011, CHEM BIOL, V18, P1369, DOI 10.1016/j.chembiol.2011.08.019; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Sultana R, 2012, EXP CELL RES, V318, P53, DOI 10.1016/j.yexcr.2011.09.010; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; van Dongen JT, 2015, ANNU REV PLANT BIOL, V66, P345, DOI 10.1146/annurev-arplant-043014-114813; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Varshavsky A, 2012, PROTEIN SCI, V21, P1634, DOI 10.1002/pro.2148; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wadas B, 2016, J BIOL CHEM, V291, P17178, DOI 10.1074/jbc.M116.734640; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wang JL, 2014, CHEM BIOL, V21, P331, DOI 10.1016/j.chembiol.2013.12.017; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Weits DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4425; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Wu CG, 2009, METHODS MOL BIOL, V570, P197, DOI 10.1007/978-1-60327-394-7_8; Xia ZX, 2008, J BIOL CHEM, V283, P28958, DOI 10.1074/jbc.M803980200; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xu T, 2009, NAT PROTOC, V4, P325, DOI 10.1038/nprot.2008.248; Xu ZZ, 2012, J BIOL CHEM, V287, P7495, DOI 10.1074/jbc.M111.301002; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yan OY, 2006, MUTAT RES-FUND MOL M, V596, P64, DOI 10.1016/j.mrfmmm.2005.12.016; Yang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014017; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681; Zhang FL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8517; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; Zhang GH, 2013, FASEB J, V27, P2893, DOI 10.1096/fj.12-222711; Zhang HT, 2015, PROTEOMICS, V15, P2447, DOI 10.1002/pmic.201400530; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	110	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20976	20992		10.1074/jbc.M116.747956	http://dx.doi.org/10.1074/jbc.M116.747956			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27510035	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000385406200015
J	Bendavit, G; Aboulkassim, T; Hilmi, K; Shah, S; Batist, G				Bendavit, Gabriel; Aboulkassim, Tahar; Hilmi, Khalid; Shah, Sujay; Batist, Gerald			Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; mammalian target of rapamycin (mTOR); NF-B (NF-KB); nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); phosphatidylinositol kinase (PI kinase)	NF-KAPPA-B; OXIDATIVE STRESS; BREAST-CANCER; MOLECULAR-MECHANISMS; INFLAMMATORY RESPONSE; SIGNALING PATHWAY; ACTIVATION; METHYLATION; APOPTOSIS; CELLS	Nrf2 is a master transcription factor that regulates a wide variety of cellular proteins by recognizing and binding to antioxidant response elements (AREs) in their gene promoter regions. In this study we show that increasing cellular Nrf2 results in transcriptional activation of the gene for mTOR, which is central to the PI3K signaling pathway. This is the case in cells with normal physiological PI3K. However, in cells with abnormally active PI3K increased cellular Nrf2 levels have no effect on mTOR. ChIP assays results show that increased Nrf2 binding is associated with decreased p65 binding and H3-K27me3 signal (marker of gene repression) as well as increased H3-K4me3 signal (marker of gene activation). However, in cells with PI3K activation, no effect of cellular Nrf2 increase on mTOR transcription was observed. In these cells, increasing Nrf2 levels increases Nrf2 promoter binding marginally, whereas p65 binding and H3-K27me3 mark were significantly increased, and H3-K4me3 signal is reduced. Together, these data show for the first time that Nrf2 directly regulates mTOR transcription when the PI3K pathway is intact, whereas this function is lost when PI3K is activated. We have identified a link between the Nrf2 system of sensing environmental stress and mTOR, which is a key cellular protein in metabolism. Studies in cells with activating mutations in the PI3K pathway suggest that Nrf2 transcriptional regulation of mTOR is related to promoter binding of p65 and of methylation of histone residues permissive of transcription.	[Bendavit, Gabriel; Aboulkassim, Tahar; Hilmi, Khalid; Shah, Sujay; Batist, Gerald] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University	Batist, G (corresponding author), McGill Univ, Segal Canc Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.; Batist, G (corresponding author), McGill Univ, Oncol, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	gerald.batist@mcgill.ca			Canadian Institutes for Health Research (CIHR) [MOP-126073]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research (CIHR) Grant MOP-126073. The authors declare that they have no conflicts of interest with the contents of this article.	Cescon DW, 2015, CLIN CANCER RES, V21, P2499, DOI 10.1158/1078-0432.CCR-14-2206; Chan J, 2014, CURR TREAT OPTION ON, V15, P365, DOI 10.1007/s11864-014-0294-4; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Chuang JI, 2015, FREE RADICAL BIO MED, V89, P274, DOI 10.1016/j.freeradbiomed.2015.08.011; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; George LE, 2012, AM J PHYSIOL-RENAL, V302, pF1440, DOI 10.1152/ajprenal.00006.2012; Guichard SM, 2015, MOL CANCER THER, V14, P2508, DOI 10.1158/1535-7163.MCT-15-0365; Ha KN, 2006, INVEST OPHTH VIS SCI, V47, P2709, DOI 10.1167/iovs.05-1322; Harada S, 2015, J PHARMACOL EXP THER, V355, P353, DOI 10.1124/jpet.115.226431; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Herndon TM, 2005, BIOCHEM BIOPH RES CO, V332, P1133, DOI 10.1016/j.bbrc.2005.05.064; Jin R, 2011, STROKE, V42, P2033, DOI 10.1161/STROKEAHA.110.601369; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Johnston SRD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv212; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Le Page C, 2005, PROSTATE, V65, P306, DOI 10.1002/pros.20291; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao CY, 2015, WORLD J GASTROENTERO, V21, P4555, DOI 10.3748/wjg.v21.i15.4555; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sasaki H, 2012, ONCOL LETT, V4, P1167, DOI 10.3892/ol.2012.938; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; Shibata T, 2010, CANCER RES, V70, P9095, DOI 10.1158/0008-5472.CAN-10-0384; Shin JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096035; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Verma AK, 2015, REDOX BIOL, V6, P80, DOI 10.1016/j.redox.2015.06.020; Vicier C, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3618; Watanabe R, 2011, J NUCL MED, V52, P497, DOI 10.2967/jnumed.111.089623; XIE T, 1995, J BIOL CHEM, V270, P6894, DOI 10.1074/jbc.270.12.6894; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Yoo KH, 2012, INT J BIOL SCI, V8, P59, DOI 10.7150/ijbs.8.59; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005	53	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25476	25488		10.1074/jbc.M116.760249	http://dx.doi.org/10.1074/jbc.M116.760249			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27784786	Green Published, hybrid			2022-12-28	WOS:000390095300017
J	Kwon, SH; Oh, S; Nacke, M; Mostov, KE; Lipschutz, JH				Kwon, Sang-Ho; Oh, Sekyung; Nacke, Marisa; Mostov, Keith E.; Lipschutz, Joshua H.			Adaptor Protein CD2AP and L-type Lectin LMAN2 Regulate Exosome Cargo Protein Trafficking through the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; extracellular vesicles; G protein-coupled receptor (GPCR); Golgi; membrane trafficking; CD2AP; exosomes; LMAN2; urinary proteins; multivesicular	CELL-SURFACE; RETROMER; SECRETION; BIOGENESIS; VESICLES; GPRC5B; VIP36; ACTIVATION; EXPRESSION; MATURATION	Exosomes, 40-150-nm extracellular vesicles, transport biological macromolecules that mediate intercellular communications. Although exosomes are known to originate from maturation of endosomes into multivesicular endosomes (also known as multivesicular bodies) with subsequent fusion of the multivesicular endosomes with the plasma membrane, it remains unclear how cargos are selected for exosomal release. Using an inducible expression system for the exosome cargo protein GPRC5B and following its trafficking trajectory, we show here that newly synthesized GPRC5B protein accumulates in the Golgi complex prior to its release into exosomes. The L-type lectin LMAN2 (also known as VIP36) appears to be specifically required for the accumulation of GPRC5B in the Golgi complex and restriction of GPRC5B transport along the exosomal pathway. This may occur due to interference with the adaptor protein GGA1-mediated trans Golgi network-to-endosome transport of GPRC5B. The adaptor protein CD2AP-mediated internalization following cell surface delivery appears to contribute to the Golgi accumulation of GPRC5B, possibly in parallel with biosynthetic/secretory trafficking from the endoplasmic reticulum. Our data thus reveal a Golgi-traversing pathway for exosomal release of the cargo protein GPRC5B in which CD2AP facilitates the entry and LMAN2 impedes the exit of the flux, respectively.	[Kwon, Sang-Ho; Lipschutz, Joshua H.] Med Univ South Carolina, Div Nephrol, Dept Med, Charleston, SC 29425 USA; [Oh, Sekyung] Stanford Univ, Sch Med, Dept Radiol, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Oh, Sekyung] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Nacke, Marisa; Mostov, Keith E.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Nacke, Marisa; Mostov, Keith E.] Univ Calif San Francisco, Dept Biochem Biophys, San Francisco, CA 94143 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA	Medical University of South Carolina; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kwon, SH (corresponding author), Med Univ South Carolina, Dept Med, 70 President St,Drug Discovery Bldg Rm 509, Charleston, SC 29425 USA.	kwonk@musc.edu	Oh, Sekyung/J-9331-2017	Oh, Sekyung/0000-0002-6880-5281; Kwon, Sang-Ho/0000-0001-9074-4641; mostov, keith/0000-0002-8123-6247	Medical University of South Carolina; American Society of Nephrology Gottschalk Research Scholar grant; National Institutes of Health [DK074398, DK091530, DK074038]; Veterans Affairs Merit Award [2I01BX000820]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398, P30DK026743, P30DK074038, R01DK091530] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	Medical University of South Carolina; American Society of Nephrology Gottschalk Research Scholar grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a start-up package from the Medical University of South Carolina and an American Society of Nephrology Gottschalk Research Scholar grant (to S.-H. K.), National Institutes of Health Grants DK074398 and DK091530 (to K. E. M.) and DK074038 (to J. H. L.), and Veterans Affairs Merit Award 2I01BX000820 (to J. H. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai HD, 2004, J BIOL CHEM, V279, P17411, DOI 10.1074/jbc.M401158200; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Engelsberg A, 2003, J BIOL CHEM, V278, P22998, DOI 10.1074/jbc.M301361200; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fullekrug J, 1999, J CELL SCI, V112, P2813; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gradilla AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6649; Gross JC, 2013, CURR OPIN GENET DEV, V23, P385, DOI 10.1016/j.gde.2013.02.017; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kurabayashi N, 2013, DEVELOPMENT, V140, P4335, DOI 10.1242/dev.099754; Kwon SH, 2014, CURR BIOL, V24, P199, DOI 10.1016/j.cub.2013.12.010; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matusek T, 2014, NATURE, V516, P99, DOI 10.1038/nature13847; Mukadam AS, 2015, FEBS LETT, V589, P2620, DOI 10.1016/j.febslet.2015.05.052; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Oh S, 2016, ONCOTARGET, V7, P28169, DOI 10.18632/oncotarget.8612; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reinhardt TA, 2013, J PROTEOMICS, V82, P141, DOI 10.1016/j.jprot.2013.02.013; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Seaman MNJ, 2013, TRENDS CELL BIOL, V23, P522, DOI 10.1016/j.tcb.2013.04.010; Shirakabe K, 2011, J BIOL CHEM, V286, P43154, DOI 10.1074/jbc.M111.275586; Silhankova M, 2010, EMBO J, V29, P4094, DOI 10.1038/emboj.2010.278; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zhang Jing, 2012, Cell Logist, V2, P161; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874	62	27	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25462	25475		10.1074/jbc.M116.729202	http://dx.doi.org/10.1074/jbc.M116.729202			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27765817	Green Published, hybrid			2022-12-28	WOS:000390095300016
J	Kumar, A; Sykorova, P; Demo, G; Dobes, P; Hyrsl, P; Wimmerova, M				Kumar, Atul; Sykorova, Petra; Demo, Gabriel; Dobes, Pavel; Hyrsl, Pavel; Wimmerova, Michaela			A Novel Fucose-binding Lectin from Photorhabdus luminescens (PLL) with an Unusual Heptabladed beta-Propeller Tetrameric Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERORHABDITIS-BACTERIOPHORA; CRYSTAL-STRUCTURE; PROTEIN; PATHOGENICITY; CRYSTALLOGRAPHY; XENORHABDUS; RESISTANCE; RECEPTORS; INFECTION; SEQUENCE	Photorhabdus luminescens is known for its symbiosis with the entomopathogenic nematode Heterorhabditis bacteriophora and its pathogenicity toward insect larvae. Ahypothetical protein from P. luminescens was identified, purified from the native source, and characterized as an L-fucose-binding lectin, named P. luminescens lectin (PLL). Glycan array and biochemical characterization data revealed PLL to be specific toward L-fucose and the disaccharide glycan 3,6-O-Me-2-Glc beta 1-4(2,3-O-Me-2)Rha alpha-O-(p-C6H4)-OCH2CH2NH2. PLL was discovered to be a homotetramer with an intersubunit disulfide bridge. The crystal structures of native and recombinant PLL revealed a seven-bladed beta-propeller fold creating seven putative fucose-binding sites per monomer. The crystal structure of the recombinant PLL.L-fucose complex confirmed that at least three sites were fucose-binding. Moreover, the crystal structures indicated that some of the other sites are masked either by the tetrameric nature of the lectin or by incorporation of the C terminus of the lectin into one of these sites. PLL exhibited an ability to bind to insect hemocytes and the cuticular surface of a nematode, H. bacteriophora.	[Kumar, Atul; Sykorova, Petra; Demo, Gabriel; Wimmerova, Michaela] Masaryk Univ, Cent European Inst Technol CEITEC, Brno 62500, Czech Republic; [Sykorova, Petra; Wimmerova, Michaela] Masaryk Univ, Fac Sci, Dept Biochem, Brno 62500, Czech Republic; [Demo, Gabriel; Wimmerova, Michaela] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Dobes, Pavel; Hyrsl, Pavel] Masaryk Univ, Inst Expt Biol, Dept Anim Physiol & Immunol, Brno 62500, Czech Republic; [Demo, Gabriel] Univ Massachusetts, Sch Med, RNA Therapeut Inst, 368 Plantat St, Worcester, MA 01605 USA	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; University of Massachusetts System; University of Massachusetts Worcester	Wimmerova, M (corresponding author), Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno 62500, Czech Republic.	michaw@chemi.muni.cz	Dobeš, Pavel/R-7150-2016; Wimmerova, Michaela/A-4114-2010; Hyrsl, Pavel/N-3371-2017; KUMAR, ATUL/W-1739-2018; Demo, Gabriel/D-7261-2012	Dobeš, Pavel/0000-0003-1699-0849; Wimmerova, Michaela/0000-0002-7108-4198; Hyrsl, Pavel/0000-0002-4266-5727; Demo, Gabriel/0000-0002-5472-9249	Czech Science Foundation [13-25401S]; Ministry of Education, Youth, and Sports of the Czech Republic [LQ1601]; project "Postdoc I" - European Social Fund [CZ.1.07/2.3.00/30.0009]; state budget of the Czech Republic	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); project "Postdoc I" - European Social Fund; state budget of the Czech Republic	This work was supported by Czech Science Foundation Project 13-25401S and by the Ministry of Education, Youth, and Sports of the Czech Republic under Project CEITEC 2020 (LQ1601). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the project "Postdoc I" (CZ.1.07/2.3.00/30.0009), co-financed by the European Social Fund and the state budget of the Czech Republic.	Amano K, 2012, BIOSCI BIOTECH BIOCH, V76, P967, DOI 10.1271/bbb.110982; Audfray A, 2012, J BIOL CHEM, V287, P4335, DOI 10.1074/jbc.M111.314831; Bandyopadhyay S, 2001, PLANT SCI, V161, P1025, DOI 10.1016/S0168-9452(01)00507-6; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BORREBAECK CAK, 1984, J BACTERIOL, V159, P53, DOI 10.1128/JB.159.1.53-56.1984; Browne N, 2013, VIRULENCE, V4, P597, DOI 10.4161/viru.25906; CAMPBELL LR, 1992, J NEMATOL, V24, P365; Cappello M, 2006, P NATL ACAD SCI USA, V103, P15154, DOI 10.1073/pnas.0607002103; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Cochran JR, 2001, TRENDS BIOCHEM SCI, V26, P304, DOI 10.1016/S0968-0004(01)01815-1; CONWAY EM, 1994, J CELL PHYSIOL, V158, P285, DOI 10.1002/jcp.1041580211; Dobes P, 2012, FLY, V6, P75, DOI 10.4161/fly.19553; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; EISEMANN CH, 1994, ENTOMOL EXP APPL, V72, P1, DOI 10.1007/BF02382409; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Frobius AC, 2000, EUR J BIOCHEM, V267, P2046, DOI 10.1046/j.1432-1327.2000.01207.x; Glatz R, 2004, J INSECT PHYSIOL, V50, P955, DOI 10.1016/j.jinsphys.2004.07.009; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Han RC, 2000, J INVERTEBR PATHOL, V75, P55, DOI 10.1006/jipa.1999.4900; Hao YJ, 2012, EXP PARASITOL, V130, P116, DOI 10.1016/j.exppara.2011.12.001; HAYDAK M. H., 1936, Journal of Economic Entomology, V29, pp, DOI 10.1093/jee/29.5.870; Heim C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1032-x; Houser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083077; Hu Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000614; Hui F, 2012, BIOCHEMISTRY-US, V51, P9911, DOI 10.1021/bi301386q; HUNTER SW, 1982, J BIOL CHEM, V257, P5072; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kondakov NN, 2015, RUSS CHEM B+, V64, P1142, DOI 10.1007/s11172-015-0991-6; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li YS, 2014, FEMS MICROBIOL LETT, V356, P23, DOI 10.1111/1574-6968.12474; Marchetti R, 2012, GLYCOBIOLOGY, V22, P1387, DOI 10.1093/glycob/cws105; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; NORDBRINGHERTZ B, 1979, NATURE, V281, P477, DOI 10.1038/281477a0; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peters A, 1997, J INVERTEBR PATHOL, V70, P161, DOI 10.1006/jipa.1997.4681; de Oliveira CFR, 2011, PROCESS BIOCHEM, V46, P498, DOI 10.1016/j.procbio.2010.09.025; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Staudacher E, 2012, BIOL CHEM, V393, P675, DOI 10.1515/hsz-2012-0132; Stefanovska T, 2008, Commun Agric Appl Biol Sci, V73, P693; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vojtek L, 2014, EUR J ENTOMOL, V111, P335, DOI 10.14411/eje.2014.045; WEBER K, 1969, J BIOL CHEM, V244, P4406; Williamson VM, 2003, NAT BIOTECHNOL, V21, P1294, DOI 10.1038/nbt1103-1294; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wohlschlager T, 2014, P NATL ACAD SCI USA, V111, pE2787, DOI 10.1073/pnas.1401176111	64	16	16	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25032	25049		10.1074/jbc.M115.693473	http://dx.doi.org/10.1074/jbc.M115.693473			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758853	hybrid, Green Published			2022-12-28	WOS:000388880100020
J	Grant, EJ; Josephs, TM; Valkenburg, SA; Wooldridge, L; Hellard, M; Rossjohn, J; Bharadwaj, M; Kedzierska, K; Gras, S				Grant, Emma J.; Josephs, Tracy M.; Valkenburg, Sophie A.; Wooldridge, Linda; Hellard, Margaret; Rossjohn, Jamie; Bharadwaj, Mandvi; Kedzierska, Katherine; Gras, Stephanie			Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct alpha beta T Cell Receptor Signatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; INFLUENZA-A; EPSTEIN-BARR; CLASS-I; STRUCTURAL FEATURES; ANTIVIRAL IMMUNITY; MOLECULAR-BASIS; TCR; MEMORY; RECOGNITION	alpha beta T cell receptor (TCR) genetic diversity is outnumbered by the quantity of pathogenic epitopes to be recognized. To provide efficient protective anti-viral immunity, a single TCR ideally needs to cross-react with a multitude of pathogenic epitopes. However, the frequency, extent, and mechanisms of TCR cross reactivity remain unclear, with conflicting results on anti-viral T cell cross-reactivity observed in humans. Namely, both the presence and lack of T cell cross-reactivity have been reported with HLA-A*02:01-restricted epitopes from the Epstein-Barr and influenza viruses (BMIT-1 and M1(58), respectively) or with the hepatitis C and influenza viruses (NS3(1073) and NA(231), respectively). Given the high sequence similarity of these paired viral epitopes (56 and 88%, respectively), the ubiquitous nature of the three viruses, and the high frequency of the HLA-A*02:01 allele, we selected these epitopes to establish the extent of T cell cross reactivity. We combined ex vivo and in vitro functional assays, single-cell alpha beta TCR repertoire sequencing, and structural analysis of these four epitopes in complex with HI,A-A*02:01 to determine whether they could lead to heterologous T cell cross-reactivity. Our data show that sequence similarity does not translate to structural mimicry of the paired epitopes in complexes with HLA-A*02:01, resulting in induction of distinct alpha beta TCR repertoires. The differences in epitope architecture might be an obstacle for TCR recognition, explaining the lack of T cell cross-reactivity observed. In conclusion, sequence similarity does not necessarily result in structural mimicry, and despite the need for cross-reactivity, antigen-specific TCR repertoires can remain highly specific.	[Grant, Emma J.; Valkenburg, Sophie A.; Bharadwaj, Mandvi; Kedzierska, Katherine] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia; [Josephs, Tracy M.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Josephs, Tracy M.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Josephs, Tracy M.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Wooldridge, Linda] Univ Bristol, Fac Hlth Sci, Bristol BS8 1TD, Avon, England; [Hellard, Margaret] Burnet Inst, Ctr Res Excellence Injecting Drug Use, Melbourne, Vic 3004, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; Monash University; Monash University; Monash University; University of Bristol; Burnet Institute; Cardiff University	Kedzierska, K (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia.; Gras, S (corresponding author), Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia.	kkedz@unimelb.edu.au; Stephanie.Gras@monash.edu	Grant, Emma/AAR-3766-2021; Bharadwaj, Mandvi/C-4446-2014; Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Wooldridge, Linda/0000-0002-6213-347X; gras, stephanie/0000-0001-7416-038X; Kedzierska, Katherine/0000-0001-6141-335X; Grant, Emma/0000-0001-7193-9427; Valkenburg, Sophie A/0000-0002-0768-9926	Australian NHMRC Project [AI1008854, AI1071916]; NHMRC Aboriginal and Torres Strait Islander Health Research Scholarship; Douglas and Lola Douglas Scholarship in Medical Science; NHMRC C. J. Martin Fellowship; NHMRC Australia Fellowship [AF50]; Australian Research Council (ARC) [FF120100416]; NHMRC Senior Research Fellow level B (SRFB) Fellowship	Australian NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Aboriginal and Torres Strait Islander Health Research Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Douglas and Lola Douglas Scholarship in Medical Science; NHMRC C. J. Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); NHMRC Senior Research Fellow level B (SRFB) Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian NHMRC Project Grant AI1008854 and Program Grant AI1071916 (to K. K.), an NHMRC Aboriginal and Torres Strait Islander Health Research Scholarship (to E. J. G.), a Douglas and Lola Douglas Scholarship in Medical Science (to E. J. G.), an NHMRC C. J. Martin Fellowship (to E. J. G.), NHMRC Australia Fellowship AF50 (to J. R.), Australian Research Council (ARC) Future Fellowship FF120100416 (to S. G.), and an NHMRC Senior Research Fellow level B (SRFB) Fellowship (to K. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chen AT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002633; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Clute SC, 2010, J IMMUNOL, V185, P6753, DOI 10.4049/jimmunol.1000812; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasprowicz V, 2008, J CLIN INVEST, V118, P1143, DOI 10.1172/JCI33082; Kedzierska K, 2008, P NATL ACAD SCI USA, V105, P19408, DOI 10.1073/pnas.0810274105; Kim SK, 2005, J EXP MED, V201, P523, DOI 10.1084/jem.20041337; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P595, DOI 10.1101/pdb.top115; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Liu YC, 2014, J BIOL CHEM, V289, P16688, DOI 10.1074/jbc.M114.563502; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Neveu B, 2008, HEPATOLOGY, V48, P713, DOI 10.1002/hep.22379; Nguyen THO, 2014, J IMMUNOL, V192, P5039, DOI 10.4049/jimmunol.1303147; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; Pasetto A, 2012, J GEN VIROL, V93, P247, DOI 10.1099/vir.0.037903-0; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reiser JB, 2014, J IMMUNOL, V193, P5816, DOI 10.4049/jimmunol.1303084; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Selin LK, 2011, AUTOIMMUNITY, V44, P328, DOI 10.3109/08916934.2011.523277; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; Shen ZT, 2013, J IMMUNOL, V191, P5139, DOI 10.4049/jimmunol.1300852; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Valkenburg SA, 2016, P NATL ACAD SCI USA, V113, P4440, DOI 10.1073/pnas.1603106113; Valkenburg SA, 2013, P NATL ACAD SCI USA, V110, P5570, DOI 10.1073/pnas.1302935110; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Wooldridge L, 2007, EUR J IMMUNOL, V37, P1323, DOI 10.1002/eji.200636765; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017	54	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24335	24351		10.1074/jbc.M116.753988	http://dx.doi.org/10.1074/jbc.M116.753988			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27645996	hybrid, Green Published			2022-12-28	WOS:000388875500002
J	Opelt, M; Eroglu, E; Waldeck-Weiermair, M; Russwurm, M; Koesling, D; Malli, R; Graier, WF; Fassett, JT; Schrammel, A; Mayer, B				Opelt, Marissa; Eroglu, Emrah; Waldeck-Weiermair, Markus; Russwurm, Michael; Koesling, Doris; Malli, Roland; Graier, Wolfgang F.; Fassett, John T.; Schrammel, Astrid; Mayer, Bernd			Formation of Nitric Oxide by Aldehyde Dehydrogenase-2 Is Necessary and Sufficient for Vascular Bioactivation of Nitroglycerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); metabolism; mutagenesis in vitro; nitric oxide; vascular smooth muscle cells; aldehyde dehydrogenase-2; nitroglycerin; site-directed mutagenesis	SOLUBLE GUANYLATE-CYCLASE; GLYCERYL TRINITRATE; NITRATE TOLERANCE; ORGANIC NITRATES; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; IN-VIVO; MITOCHONDRIAL; BIOTRANSFORMATION; ACTIVATION	Aldehyde dehydrogenase-2 (ALDH2) catalyzes vascular bioactivation of the antianginal drug nitroglycerin (GTN), resulting in activation of soluble guanylate cyclase (sGC) and cGMP-mediated vasodilation. We have previously shown that a minor reaction of ALDH2-catalyzed GTN bioconversion, accounting for about 5% of the main clearance-based turnover yielding inorganic nitrite, results in direct NO formation and concluded that this minor pathway could provide the link between vascular GTN metabolism and activation of sGC. However, lack of detectable NO at therapeutically relevant GTN concentrations (1 m) in vascular tissue called into question the biological significance of NO formation by purified ALDH2. We addressed this issue and used a novel, highly sensitive genetically encoded fluorescent NO probe (geNOp) to visualize intracellular NO formation at low GTN concentrations (1 m) in cultured vascular smooth muscle cells (VSMC) expressing an ALDH2 mutant that reduces GTN to NO but lacks clearance-based GTN denitration activity. NO formation was compared with GTN-induced activation of sGC. The addition of 1 m GTN to VSMC expressing either wild-type or C301S/C303S ALDH2 resulted in pronounced intracellular NO elevation, with maximal concentrations of 7 and 17 nm, respectively. Formation of GTN-derived NO correlated well with activation of purified sGC in VSMC lysates and cGMP accumulation in intact porcine aortic endothelial cells infected with wild-type or mutant ALDH2. Formation of NO and cGMP accumulation were inhibited by ALDH inhibitors chloral hydrate and daidzin. The present study demonstrates that ALDH2-catalyzed NO formation is necessary and sufficient for GTN bioactivation in VSMC.	[Opelt, Marissa; Fassett, John T.; Schrammel, Astrid; Mayer, Bernd] Graz Univ, Inst Pharmaceut Sci, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Eroglu, Emrah; Waldeck-Weiermair, Markus; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Russwurm, Michael; Koesling, Doris] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany	University of Graz; Medical University of Graz; Ruhr University Bochum	Mayer, B (corresponding author), Graz Univ, Dept Pharmacol & Toxicol, Humboldtstr 46-1, A-8010 Graz, Austria.	mayer@uni-graz.at	Waldeck-Weiermair, Markus/AAV-5193-2020; Eroglu, Emrah/X-3119-2019; Graier, Wolfgang F./B-7052-2008	Waldeck-Weiermair, Markus/0000-0002-5792-6766; Eroglu, Emrah/0000-0002-9373-0808; Graier, Wolfgang F./0000-0003-1871-3298; Mayer, Bernd/0000-0002-2921-3494; Malli, Roland/0000-0001-6327-8729	Austrian Science Fund (FWF) [P24946, W1226, P28529]; Nikon, Austria within the NIKON-Center of Excellence; Graz within the Doctoral School "MolMed" at the Medical University of Graz	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Nikon, Austria within the NIKON-Center of Excellence; Graz within the Doctoral School "MolMed" at the Medical University of Graz	This work was supported by Austrian Science Fund (FWF) Grants P24946, W1226, and P28529. This work was also supported by Nikon, Austria within the NIKON-Center of Excellence, Graz within the Doctoral School "MolMed" at the Medical University of Graz (to E.E.). The authors declare that they have no conflicts of interest with the contents of this article. We acknowledge the technical assistance of Dr. Rene Rost.	ALHEID U, 1987, BRIT J PHARMACOL, V92, P237, DOI 10.1111/j.1476-5381.1987.tb11317.x; Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; Beretta M, 2012, CIRC RES, V110, P385, DOI 10.1161/CIRCRESAHA.111.245837; Browner NC, 2004, J BIOL CHEM, V279, P46631, DOI 10.1074/jbc.M408518200; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; De la Lande IS, 1999, EUR J PHARMACOL, V374, P71, DOI 10.1016/S0014-2999(99)00319-2; de la Lande IS, 2004, EUR J PHARMACOL, V496, P141, DOI 10.1016/j.ejphar.2004.06.010; Eroglu E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10623; FEELISCH M, 1991, BIOCHEM BIOPH RES CO, V180, P286, DOI 10.1016/S0006-291X(05)81290-2; FUNG HL, 1984, J PHARMACOL EXP THER, V228, P334; IGNARRO LJ, 1980, BIOCHIM BIOPHYS ACTA, V631, P221, DOI 10.1016/0304-4165(80)90297-4; Janero DR, 2004, P NATL ACAD SCI USA, V101, P16958, DOI 10.1073/pnas.0406075101; Kleschyov AL, 2003, CIRC RES, V93, pE104, DOI 10.1161/01.RES.0000100067.62876.50; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Kollau A, 2009, NITRIC OXIDE-BIOL CH, V20, P53, DOI 10.1016/j.niox.2008.09.003; MALTA E, 1989, N-S ARCH PHARMACOL, V339, P236; MARKS GS, 1992, CAN J PHYSIOL PHARM, V70, P308, DOI 10.1139/y92-039; Martens D, 2001, BRIT J PHARMACOL, V132, P30, DOI 10.1038/sj.bjp.0703768; Mayer B, 2008, BRIT J PHARMACOL, V155, P170, DOI 10.1038/bjp.2008.263; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Miller MR, 2008, J VASC RES, V45, P375, DOI 10.1159/000121407; MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166; Munzel T, 2011, CIRCULATION, V123, P2132, DOI 10.1161/CIRCULATIONAHA.110.981407; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Russwurm M, 2005, METHOD ENZYMOL, V396, P492, DOI 10.1016/S0076-6879(05)96041-2; SCHMIDT K, 1989, EUR J PHARMACOL, V170, P157, DOI 10.1016/0014-2999(89)90536-0; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Wenzl MV, 2011, MOL PHARMACOL, V80, P258, DOI 10.1124/mol.111.071704; Wenzl MV, 2009, J BIOL CHEM, V284, P19878, DOI 10.1074/jbc.M109.005652; Wolkart G, 2013, BRIT J PHARMACOL, V168, P1868, DOI 10.1111/bph.12081; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	35	21	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24076	24084		10.1074/jbc.M116.752071	http://dx.doi.org/10.1074/jbc.M116.752071			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679490	hybrid, Green Published			2022-12-28	WOS:000388498100024
J	Sahni, JM; Gayle, SS; Bonk, KLW; Vite, LC; Yori, JL; Webb, B; Ramos, EK; Seachrist, DD; Landis, MD; Chang, JC; Bradner, JE; Keri, RA				Sahni, Jennifer M.; Gayle, Sylvia S.; Bonk, Kristen L. Weber; Vite, Leslie Cuellar; Yori, Jennifer L.; Webb, Bryan; Ramos, Erika K.; Seachrist, Darcie D.; Landis, Melissa D.; Chang, Jenny C.; Bradner, James E.; Keri, Ruth A.			Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; apoptosis; breast cancer; bromodomain-containing protein 4 (BRD4); cellular senescence; inhibition mechanism; Aurora kinase	SELECTIVE-INHIBITION; GENE-EXPRESSION; CELLS; SUBTYPES; PROGRESSION; RESISTANCE; TUMORS; MODELS; BRD4; OVEREXPRESSION	Bromodomain and extraterminal (BET) proteins are epigenetic readers that recognize acetylated histones and mark areas of the genome for transcription. BRD4, a BET family member protein, has been implicated in a number of types of cancer, and BET protein inhibitors (BETi) are efficacious in many preclinical cancer models. However, the drivers of response to BETi vary depending on tumor type, and little is known regarding the target genes conveying BETi activity in triple-negative breast cancer (TNBC). Here, we show that BETi repress growth of multiple in vitro and in vivo models of TNBC by inducing two terminal responses: apoptosis and senescence. Unlike in other cancers, response to BETi in TNBC is not dependent upon suppression of MYC. Instead, both end points are preceded by the appearance of polyploid cells caused by the suppression of Aurora kinases A and B (AURKA/B), which are critical mediators of mitosis. In addition, AURKA/B inhibitors phenocopy the effects of BETi. These results indicate that Aurora kinases play an important role in the growth suppressive activity of BETi in TNBC. Elucidating the mechanism of response to BETi in TNBC should 1) facilitate the prediction of how distinct TNBC tumors will respond to BETi and 2) inform the rational design of drug combination therapies.	[Sahni, Jennifer M.; Gayle, Sylvia S.; Bonk, Kristen L. Weber; Vite, Leslie Cuellar; Yori, Jennifer L.; Webb, Bryan; Ramos, Erika K.; Seachrist, Darcie D.; Keri, Ruth A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Dept Genet & Genome Sci & Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Landis, Melissa D.; Chang, Jenny C.] Houston Methodist Hosp, Methodist Canc Ctr, Houston, TX 77030 USA; [Bradner, James E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bradner, James E.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Case Western Reserve University; Case Western Reserve University; The Methodist Hospital System; The Methodist Hospital - Houston; Harvard University; Dana-Farber Cancer Institute; Novartis	Keri, RA (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.; Keri, RA (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci & Gen Med Sci Oncol, Cleveland, OH 44106 USA.	keri@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088; Sahni, Jennifer/0000-0002-2735-1789	National Institutes of Health [P30043703, T32CA059366, R25GM075207, T32GM008056, RO1CA154384, RO1CA206505]; NATIONAL CANCER INSTITUTE [T32CA059366, P30CA043703, R01CA206505, R01CA154384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803, R25GM075207, T32GM008056, T32GM007250] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants P30043703 (to the Core Facilities of the Case Comprehensive Cancer Center), T32CA059366 (to J.M.S. and S. S. G.), R25GM075207 (to L. C. V. and E. K. R.), T32GM008056 (to L. C. V.), RO1CA154384 (to R. A. K.), and RO1CA206505 (to R. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bolanos-Garcia VM, 2005, INT J BIOCHEM CELL B, V37, P1572, DOI 10.1016/j.biocel.2005.02.021; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dreier MR, 2009, EXP CELL RES, V315, P1085, DOI 10.1016/j.yexcr.2009.02.008; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kimura M, 2004, BIOCHEM BIOPH RES CO, V316, P930, DOI 10.1016/j.bbrc.2004.01.178; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Montanez-Wiscovich ME, 2009, ONCOGENE, V28, P3608, DOI 10.1038/onc.2009.221; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Sadaie M, 2015, MOL BIOL CELL, V26, P2971, DOI 10.1091/mbc.E15-01-0003; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Tatsuka M, 1998, CANCER RES, V58, P4811; Tolani B, 2014, ONCOGENE, V33, P2928, DOI 10.1038/onc.2013.242; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; You JX, 2009, MOL CELL BIOL, V29, P5094, DOI 10.1128/MCB.00299-09; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	44	37	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23756	23768		10.1074/jbc.M116.738666	http://dx.doi.org/10.1074/jbc.M116.738666			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27650498	hybrid, Green Published			2022-12-28	WOS:000387884400035
J	Heppner, DE; Hristova, M; Dustin, CM; Danyal, K; Habibovic, A; van der Vliet, A				Heppner, David E.; Hristova, Milena; Dustin, Christopher M.; Danyal, Karamatullah; Habibovic, Aida; van der Vliet, Albert			The NADPH Oxidases DUOX1 and NOX2 Play Distinct Roles in Redox Regulation of Epidermal Growth Factor Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; EPITHELIAL-CELL MIGRATION; ACTIVE-SITE CYSTEINE; KINASE INHIBITORS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; PROTEIN-KINASES; DUAL OXIDASE-1; LUNG-CANCER; SRC	The epidermal growth factor receptor (EGFR) plays a critical role in regulating airway epithelial homeostasis and responses to injury. Activation of EGFR is regulated by redox-dependent processes involving reversible cysteine oxidation by reactive oxygen species (ROS) and involves both ligand-dependent and -independent mechanisms, but the precise source(s) of ROS and the molecular mechanisms that control tyrosine kinase activity are incompletely understood. Here, we demonstrate that stimulation of EGFR activation by ATP in airway epithelial cells is closely associated with dynamic reversible oxidation of cysteine residues via sequential sulfenylation and S-glutathionylation within EGFR and the non-receptor-tyrosine kinase Src. Moreover, the intrinsic kinase activity of recombinant Src or EGFR was in both cases enhanced byH(2)O(2) but not by GSSG, indicating that the intermediate sulfenylation is the activating modification. H2O2-induced increase in EGFR tyrosine kinase activity was not observed with the C797S variant, confirming Cys-797 as the redox-sensitive cysteine residue that regulates kinase activity. Redox-dependent regulation of EGFR activation in airway epithelial cells was found to strongly depend on activation of either the NADPH oxidase DUOX1 or the homolog NOX2, depending on the activation mechanism. Whereas DUOX1 and Src play a primary role in EGFR transactivation by wound-derived signals such as ATP, direct ligand-dependent EGFR activation primarily involves NOX2 with a secondary role for DUOX1 and Src. Collectively, our findings establish that redox-dependent EGFR kinase activation involves a dynamic and reversible cysteine oxidation mechanism and that this activation mechanism variably involves DUOX1 and NOX2.	[Heppner, David E.; Hristova, Milena; Dustin, Christopher M.; Danyal, Karamatullah; Habibovic, Aida; van der Vliet, Albert] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT 05405 USA	University of Vermont	van der Vliet, A (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Coll Med, Hlth Sci Res Facil 216, 149 Beaumont Ave, Burlington, VT 05405 USA.	albert.van-der-vliet@med.uvm.edu	Heppner, David E./A-7029-2018	Heppner, David E./0000-0002-0722-5160	National Institutes of Health [R01 HL085646, R01 ES021476, T32 HL076122, F32 HL129706]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085646, F32HL129706, T32HL076122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL085646 and R01 ES021476 (to A. v. d. V.) and post-doctoral Fellowships T32 HL076122 and F32 HL129706 (to D. E. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Chiarugi P, 2008, MOL CELLS, V26, P329; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Defelipe LA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004051; Donko A, 2010, FREE RADICAL BIO MED, V49, P2040, DOI 10.1016/j.freeradbiomed.2010.09.027; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Gorissen SH, 2013, AM J RESP CELL MOL, V48, P337, DOI 10.1165/rcmb.2012-0393OC; Gupta V, 2016, CHEM SCI, V7, P400, DOI 10.1039/c5sc02569a; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Gupte SA, 2009, AM J PHYSIOL-HEART C, V296, pH1048, DOI 10.1152/ajpheart.00491.2008; Gushwa NN, 2012, J AM CHEM SOC, V134, P20214, DOI 10.1021/ja310659j; Heppner DE, 2016, REDOX BIOL, V8, P24, DOI 10.1016/j.redox.2015.12.002; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hristova M, 2016, J ALLERGY CLIN IMMUN, V137, P1545, DOI 10.1016/j.jaci.2015.10.003; Hristova M, 2014, REDOX BIOL, V2, P436, DOI 10.1016/j.redox.2013.12.030; Jagadeesha DK, 2012, CARDIOVASC RES, V93, P406, DOI 10.1093/cvr/cvr308; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kehasse A, 2013, AM J PATHOL, V183, P1841, DOI 10.1016/j.ajpath.2013.08.015; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Kwarcinski FE, 2012, ACS CHEM BIOL, V7, P1910, DOI 10.1021/cb300337u; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Liu GL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030335; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Perkins A, 2014, BIOCHEMISTRY-US, V53, P7693, DOI 10.1021/bi5013222; Poole TH, 2014, J AM CHEM SOC, V136, P6167, DOI 10.1021/ja500364r; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Rigutto S, 2009, J BIOL CHEM, V284, P6725, DOI 10.1074/jbc.M806893200; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Ruddraraju KV, 2015, J ORG CHEM, V80, P12015, DOI 10.1021/acs.joc.5b01949; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schwartz PA, 2014, P NATL ACAD SCI USA, V111, P173, DOI 10.1073/pnas.1313733111; Seiner DR, 2007, CHEM RES TOXICOL, V20, P1315, DOI 10.1021/tx700213s; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; Sham D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054391; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Sirokmany G, 2016, FREE RADICAL BIO MED, V97, P204, DOI 10.1016/j.freeradbiomed.2016.05.028; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Sun GQ, 2009, CELL CYCLE, V8, P2353, DOI 10.4161/cc.8.15.9225; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Truong TH, 2016, CELL CHEM BIOL, V23, P837, DOI 10.1016/j.chembiol.2016.05.017; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; van der Vliet A, 2011, BBA-GEN SUBJECTS, V1810, P1035, DOI 10.1016/j.bbagen.2011.03.004; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang HQ, 2015, ARCH BIOCHEM BIOPHYS, V568, P1, DOI 10.1016/j.abb.2015.01.001; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	73	41	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23282	23293		10.1074/jbc.M116.749028	http://dx.doi.org/10.1074/jbc.M116.749028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27650496	hybrid, Green Published			2022-12-28	WOS:000387224800036
J	Song, RS; Tolentino, R; Sobie, EA; Neves-Zaph, SR				Song, Roy S.; Tolentino, Rosa; Sobie, Eric A.; Neves-Zaph, Susana R.			Cross-regulation of Phosphodiesterase 1 and Phosphodiesterase 2 Activities Controls Dopamine-mediated Striatal alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; OXIDE SYNTHASE PHOSPHORYLATION; MEDIUM SPINY NEURONS; NITRIC-OXIDE; PROTEIN-KINASE; NMDA RECEPTOR; RAT-BRAIN; IN-VIVO; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS	Dopamine, a key striatal neuromodulator, increases synaptic strength by promoting surface insertion and/or retention of AMPA receptors (AMPARs). This process is mediated by the phosphorylation of the GluA1 subunit of AMPAR by cyclic nucleotide-dependent kinases, making cyclic nucleotide phosphodiesterases (PDEs) potential regulators of synaptic strength. In this study, we examined the role of phosphodiesterase 2 (PDE2), a medium spiny neuron-enriched and cGMP-activated PDE, in AMPAR trafficking. We found that inhibiting PDE2 resulted in enhancement of dopamine-induced surface GluA1 expression in dopamine receptor 1-expressing medium spiny neurons. Using pharmacological and genetic approaches, we found that inhibition of PDE1 resulted in a decrease in surface AMPAR levels because of the allosteric activation of PDE2. The cross-regulation of PDE1 and PDE2 activities results in counter-intuitive control of surface AMPAR expression, making it possible to regulate the directionality and magnitude of AMPAR trafficking.	[Song, Roy S.; Tolentino, Rosa; Sobie, Eric A.; Neves-Zaph, Susana R.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Neves-Zaph, SR (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA.	Susana.neves@mssm.edu		Neves-Zaph, Susana/0000-0002-3388-0054	NIGMS, National Institutes of Health [P41 GM103313]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103313, T32GM062754] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Masago Ishikawa and Dr. Eric Sweet for technical assistance and Dr. Manuela Zaccolo, Dr. Robbert Havekes, and Dr. Jin Zhang for reagents. We also thank Dr. Joe Beavo, Dr. Ravi Iyengar, Dr. Paul Kenny, and Dr. Robert Blitzer for helpful discussions. VCell is funded by NIGMS, National Institutes of Health Grant P41 GM103313.	Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; Calabresi P, 1999, J NEUROSCI, V19, P2489; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; CHARBONNEAU H, 1990, P NATL ACAD SCI USA, V87, P288, DOI 10.1073/pnas.87.1.288; Cherry JA, 1999, J COMP NEUROL, V407, P287; Conti M, 2014, J GEN PHYSIOL, V143, P29, DOI 10.1085/jgp.201311083; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; ERNEUX C, 1981, EUR J BIOCHEM, V115, P503; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Goraya TA, 2004, J BIOL CHEM, V279, P40494, DOI 10.1074/jbc.M313441200; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hwangpo TA, 2012, J BIOL CHEM, V287, P13674, DOI 10.1074/jbc.M111.320705; IWAMOTO T, 2003, THE JOURNAL OF BIOLO, V278, P16936, DOI DOI 10.1074/JBC.C300075200; Jager R, 2012, J BIOL CHEM, V287, P1210, DOI 10.1074/jbc.M111.263806; KAKIUCHI S, 1970, BIOCHEM BIOPH RES CO, V41, P1104, DOI 10.1016/0006-291X(70)90199-3; KAWABE J, 1994, J BIOL CHEM, V269, P16554; Kelly MP, 2014, CELL SIGNAL, V26, P383, DOI 10.1016/j.cellsig.2013.10.007; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KURODA S, 2001, THE JOURNAL OF NEURO, V21, P5693; Leroy MJ, 1996, BIOCHEMISTRY-US, V35, P10194, DOI 10.1021/bi952711t; Lin DTS, 2010, SYNAPSE, V64, P460, DOI 10.1002/syn.20750; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez SE., 2007, CYCLIC NUCLEOTIDE PH, P55; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; MARTINS TJ, 1982, THE JOURNAL OF BIOLO, V257, P1973; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; MERY PF, 1993, J BIOL CHEM, V268, P26286; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mika D, 2015, P NATL ACAD SCI USA, V112, P2023, DOI 10.1073/pnas.1419992112; Mironov SL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-29; MONS N, 1994, MOL BRAIN RES, V22, P236, DOI 10.1016/0169-328X(94)90052-3; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Neves-Zaph SR, 2015, METHODS MOL BIOL, V1294, P203, DOI 10.1007/978-1-4939-2537-7_16; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Noyama K, 2003, NEUROSCI RES, V45, P141, DOI 10.1016/S0168-0102(02)00208-0; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Perino A, 2012, CIRC RES, V111, P482, DOI 10.1161/CIRCRESAHA.111.262899; Plattner F, 2015, NAT NEUROSCI, V18, P1094, DOI 10.1038/nn.4066; Polito M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0060-15.2015; Polito M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00211; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rathje M, 2013, P NATL ACAD SCI USA, V110, P14426, DOI 10.1073/pnas.1312982110; REPASKE DR, 1993, NEUROSCIENCE, V56, P673, DOI 10.1016/0306-4522(93)90364-L; Rivero-Gutierrez B, 2014, ANAL BIOCHEM, V467, P1, DOI 10.1016/j.ab.2014.08.027; Rosman GJ, 1997, GENE, V191, P89, DOI 10.1016/S0378-1119(97)00046-2; Routh BN, 2009, J NEUROPHYSIOL, V102, P2288, DOI 10.1152/jn.00082.2009; Russwurm C, 2015, J BIOL CHEM, V290, P11936, DOI 10.1074/jbc.M114.595769; Sammut S, 2007, J NEUROCHEM, V103, P1145, DOI 10.1111/j.1471-4159.2007.04811.x; Sample V, 2012, NAT CHEM BIOL, V8, P375, DOI [10.1038/NCHEMBIO.799, 10.1038/nchembio.799]; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Sharma RK, 2006, INT J MOL MED, V18, P95; SHARMA RK, 1986, THE JOURNAL OF BIOLO, V261, P1322; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Song RS, 2013, P NATL ACAD SCI USA, V110, P15437, DOI 10.1073/pnas.1311783110; SONNENBURG WK, 1991, THE JOURNAL OF BIOLO, V266, P17655; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Stephenson DT, 2012, NEUROSCIENCE, V226, P145, DOI 10.1016/j.neuroscience.2012.09.011; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Tukey DS, 2013, J BIOL CHEM, V288, P35297, DOI 10.1074/jbc.M113.516690; van Staveren WCG, 2003, J COMP NEUROL, V467, P566, DOI 10.1002/cne.10955; WELLS JN, 1988, METHOD ENZYMOL, V159, P489; West AR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00055; West AR, 2004, J NEUROSCI, V24, P1924, DOI 10.1523/JNEUROSCI.4470-03.2004; WOLIN MS, 1982, THE JOURNAL OF BIOLO, V257, P13312; Wykes V, 2002, J NEUROCHEM, V83, P37, DOI 10.1046/j.1471-4159.2002.01106.x; Zhao CY, 2016, J MOL CELL CARDIOL, V91, P215, DOI 10.1016/j.yjmcc.2016.01.004; Zhao CY, 2015, J MOL CELL CARDIOL, V88, P29, DOI 10.1016/j.yjmcc.2015.09.011	91	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23257	23267		10.1074/jbc.M116.749747	http://dx.doi.org/10.1074/jbc.M116.749747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605670	Green Published, hybrid			2022-12-28	WOS:000387224800034
J	Feigerle, JT; Weil, PA				Feigerle, Jordan T.; Weil, P. Anthony			The C Terminus of the RNA Polymerase II Transcription Factor IID (TFIID) Subunit Taf2 Mediates Stable Association of Subunit Taf14 into the Yeast TFIID Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; RNA polymerase II; transcription coactivator; transcription regulation; yeast; ribosomes; TFIID; Taf14; Taf2; YEATS domain	TATA-BINDING PROTEIN; DEPENDENT INITIATOR FUNCTION; CORE PROMOTER ELEMENT; SACCHAROMYCES-CEREVISIAE; YEATS DOMAIN; ACTIVATED TRANSCRIPTION; HISTONE CROTONYLATION; MULTIPROTEIN COMPLEX; GENE-TRANSCRIPTION; CELL-GROWTH	The evolutionarily conserved RNA polymerase II transcription factor D (TFIID) complex is composed of TATA box-binding protein (TBP) and 13 TBP-associated factors (Tafs). The mechanisms by which many Taf subunits contribute to the essential function of TFIID are only poorly understood. To address this gap in knowledge, we present the results of a molecular genetic dissection of the TFIID subunit Taf2. Through systematic site-directed mutagenesis, we have discovered 12 taf2 temperature-sensitive (ts) alleles. Two of these alleles display growth defects that can be strongly suppressed by overexpression of the yeast-specific TFIID subunit TAF14 but not by overexpression of any other TFIID subunit. In Saccharomyces cerevisiae, Taf14 is also a constituent of six other transcription-related complexes, making interpretation of its role in each of these complexes difficult. Although Taf14 is not conserved as a TFIID subunit in metazoans, it is conserved through its chromatin-binding YEATS domain. Based on the Taf2-Taf14 genetic interaction, we demonstrate that Taf2 and Taf14 directly interact and mapped the Taf2-Taf14 interaction domains. We used this information to identify a Taf2 separation-of-function variant (Taf2-C). Although Taf2-C no longer interacts with Taf14 in vivo or in vitro, it stably incorporates into the TFIID complex. In addition, purified Taf2-C mutant TFIID is devoid of Taf14, making this variant a powerful reagent for determining the role of Taf14 in TFIID function. Furthermore, we characterized the mechanism through which Taf14 suppresses taf2(ts) alleles, shedding light on how Taf2-Taf14 interaction contributes to TFIID complex organization and identifying a potential role for Taf14 in mediating TFIID-chromatin interactions.	[Feigerle, Jordan T.; Weil, P. Anthony] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu			National Institutes of Health [R01 GM115892, T32 GM008554]; National Institutes of Health Center Core Grant [5P30CA068485-18]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115892, T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM115892 (to P. A. W.) and National Institutes of Health Center Core Grant 5P30CA068485-18. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant T32 GM008554.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Bai Y, 1997, MOL CELL BIOL, V17, P3081, DOI 10.1128/MCB.17.6.3081; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Brachmann CB, 1998, YEAST, V14, P115; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Dabrowski S, 1998, PROTEIN EXPRES PURIF, V14, P131, DOI 10.1006/prep.1998.0945; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Kaufmann J, 1996, GENE DEV, V10, P873, DOI 10.1101/gad.10.7.873; Kaufmann J, 1998, MOL CELL BIOL, V18, P233, DOI 10.1128/MCB.18.1.233; Klebanow ER, 1997, J BIOL CHEM, V272, P9436; Klebanow ER, 1996, J BIOL CHEM, V271, P13706, DOI 10.1074/jbc.271.23.13706; Knutson BA, 2011, MOL CELL BIOL, V31, P818, DOI 10.1128/MCB.00687-10; Kraemer SM, 2001, MOL CELL BIOL, V21, P1737, DOI 10.1128/MCB.21.5.1737-1746.2001; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Layer JH, 2013, J BIOL CHEM, V288, P23273, DOI 10.1074/jbc.M113.486829; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Matangkasombut O, 2000, GENE DEV, V14, P951; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Moqtaderi Z, 1996, P NATL ACAD SCI USA, V93, P14654, DOI 10.1073/pnas.93.25.14654; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; POON D, 1991, MOL CELL BIOL, V11, P4809, DOI 10.1128/MCB.11.10.4809; POON D, 1994, J BIOL CHEM, V269, P23135; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; RAY BL, 1991, CURR GENET, V20, P25, DOI 10.1007/BF00312761; REESE JC, 1994, NATURE, V371, P523, DOI 10.1038/371523a0; Reiss DJ, 2011, J BIOL CHEM, V286, P44726, DOI 10.1074/jbc.M111.290684; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Robinson MM, 2005, MOL CELL BIOL, V25, P945, DOI 10.1128/MCB.25.3.945-957.2005; Sanders SL, 2000, J BIOL CHEM, V275, P13895, DOI 10.1074/jbc.275.18.13895; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schulze JM, 2010, MOL GENET GENOMICS, V283, P365, DOI 10.1007/s00438-010-0523-x; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Shanle EK, 2015, GENE DEV, V29, P1795, DOI 10.1101/gad.269977.115; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Singh MV, 2004, MOL CELL BIOL, V24, P4929, DOI 10.1128/MCB.24.11.4929-4942.2004; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Trowitzsch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7011; van Nuland R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073495; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; WELCH MD, 1994, MOL BIOL CELL, V5, P617, DOI 10.1091/mbc.5.6.617; WOONTNER M, 1991, MOL CELL BIOL, V11, P4555, DOI 10.1128/MCB.11.9.4555; Yakovchuk P, 2010, J MOL BIOL, V397, P57, DOI 10.1016/j.jmb.2010.01.025; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yoshikawa K, 2011, YEAST, V28, P349, DOI 10.1002/yea.1843; Zhang ZJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07777	90	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22721	22740		10.1074/jbc.M116.751107	http://dx.doi.org/10.1074/jbc.M116.751107			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587401	hybrid, Green Published			2022-12-28	WOS:000386760600031
J	Addepalli, B; Limbach, PA				Addepalli, Balasubrahmanyam; Limbach, Patrick A.			Pseudouridine in the Anticodon of Escherichia coli tRNA(Tyr(Q Psi A)) Is Catalyzed by the Dual Specificity Enzyme RluF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical modification; mass spectrometry (MS); RNA modification; transfer RNA (tRNA); translation; CMCT; RluF; acrylonitrile; derivatization; pseudouridine	DESORPTION/IONIZATION MASS-SPECTROMETRY; TRANSFER-RNA; RIBOSOMAL-RNA; MODIFIED NUCLEOSIDES; DIGESTION PRODUCTS; RIBONUCLEIC-ACIDS; TRANSFER RNA(TYR); CRYSTAL-STRUCTURE; SYNTHASE; IDENTIFICATION	Pseudouridine is found in almost all cellular ribonucleic acids (RNAs). Of the multiple characteristics attributed to pseudouridine, making messenger RNAs (mRNAs) highly translatable and non-immunogenic is one such feature that directly implicates this modification in protein synthesis. We report the existence of pseudouridine in the anticodon of Escherichia coli tyrosine transfer RNAs (tRNAs) at position 35. Pseudouridine was verified by multiple detection methods, which include pseudouridine-specific chemical derivatization and gas phase dissociation of RNA during liquid chromatography tandem mass spectrometry (LC-MS/MS). Analysis of total tRNA isolated from E. coli pseudouridine synthase knock-out mutants identified RluF as the enzyme responsible for this modification. Furthermore, the absence of this modification compromises the translational ability of a luciferase reporter gene coding sequence when it is preceded by multiple tyrosine codons. This effect has implications for the translation of mRNAs that are rich in tyrosine codons in bacterial expression systems.	[Addepalli, Balasubrahmanyam; Limbach, Patrick A.] Univ Cincinnati, Dept Chem, Rieveschl Labs Mass Spectrometry, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Addepalli, B; Limbach, PA (corresponding author), Univ Cincinnati, Dept Chem, POB 210172, Cincinnati, OH 45221 USA.	balasual@ucmail.uc.edu; Pat.Limbach@uc.edu	Limbach, Patrick/A-9188-2009	Limbach, Patrick/0000-0003-1526-4546; Addepalli, Balasubrahmanyam/0000-0001-6257-7700	NIGMS, National Institutes of Health [R01 GM 058843]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058843] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM 058843 (to P. A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addepalli B, 2007, NUCLEIC ACIDS RES, V35, P4453, DOI 10.1093/nar/gkm457; Addepalli B, 2011, J AM SOC MASS SPECTR, V22, P1363, DOI 10.1007/s13361-011-0137-5; Addepalli B, 2015, RNA, V21, P1746, DOI 10.1261/rna.052472.115; Alian A, 2009, J MOL BIOL, V388, P785, DOI 10.1016/j.jmb.2009.03.029; BARE LA, 1986, BIOCHEMISTRY-US, V25, P5825, DOI 10.1021/bi00367a072; Boros G, 2013, J PHOTOCH PHOTOBIO B, V129, P93, DOI 10.1016/j.jphotobiol.2013.09.010; Carlile TM, 2015, METHOD ENZYMOL, V560, P219, DOI 10.1016/bs.mie.2015.03.011; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Charette M, 2000, IUBMB LIFE, V49, P341; COHN WE, 1951, NATURE, V167, P483, DOI 10.1038/167483a0; Conrad J, 1999, RNA, V5, P751, DOI 10.1017/S1355838299990167; CUNNINGHAM PR, 1991, BIOCHIMIE, V73, P789, DOI 10.1016/0300-9084(91)90058-9; Czudnochowski N, 2014, NUCLEIC ACIDS RES, V42, P2037, DOI 10.1093/nar/gkt1050; Dai Q, 2007, NUCLEIC ACIDS RES, V35, P6322, DOI 10.1093/nar/gkm657; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; Davis DR, 1998, J BIOMOL STRUCT DYN, V15, P1121, DOI 10.1080/07391102.1998.10509006; Del Campo M, 2001, RNA, V7, P1603; Durairaj A, 2008, ANAL CHIM ACTA, V623, P117, DOI 10.1016/j.aca.2008.06.027; Durairaj A, 2008, ANAL CHIM ACTA, V612, P173, DOI 10.1016/j.aca.2008.02.026; Durairaj A, 2008, RAPID COMMUN MASS SP, V22, P3727, DOI 10.1002/rcm.3789; Friedt J, 2014, NUCLEIC ACIDS RES, V42, P3857, DOI 10.1093/nar/gkt1331; GOODMAN HM, 1970, EUR J BIOCHEM, V13, P461, DOI 10.1111/j.1432-1033.1970.tb00950.x; Grosjean H, 1997, BIOCHIMIE, V79, P293, DOI 10.1016/S0300-9084(97)83517-1; Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588; Guymon R, 2007, RNA, V13, P396, DOI 10.1261/rna.361607; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Hossain M, 2007, RNA, V13, P295, DOI 10.1261/rna.272507; Houser WM, 2015, ANAL BIOCHEM, V478, P52, DOI 10.1016/j.ab.2015.03.016; Huang LX, 1998, BIOCHEMISTRY-US, V37, P344, DOI 10.1021/bi971874+; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; KAMMEN HO, 1988, J BIOL CHEM, V263, P2255; Kierzek E, 2014, NUCLEIC ACIDS RES, V42, P3492, DOI 10.1093/nar/gkt1330; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Krivos KL, 2011, RAPID COMMUN MASS SP, V25, P3609, DOI 10.1002/rcm.5266; Lee C, 2007, J BIOL CHEM, V282, P27744, DOI 10.1074/jbc.M704572200; Li MM, 2015, DRUG METAB DISPOS, V43, P1129, DOI 10.1124/dmd.115.064493; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; McCleverty CJ, 2007, J MOL BIOL, V373, P1243, DOI 10.1016/j.jmb.2007.08.053; McDonald MK, 2011, BIOCHEMISTRY-US, V50, P426, DOI 10.1021/bi101737z; Meeks LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008082; Meng ZJ, 2005, ANAL CHEM, V77, P1891, DOI 10.1021/ac048801y; Mengel-Jorgensen J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf135; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; Patteson KG, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e49; Pomerantz SC, 2005, ANAL CHEM, V77, P4687, DOI 10.1021/ac058023p; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Popova AM, 2014, J AM CHEM SOC, V136, P2058, DOI 10.1021/ja412084b; Ramamurthy V, 1999, J BIOL CHEM, V274, P22225, DOI 10.1074/jbc.274.32.22225; Raychaudhuri S, 1999, J BIOL CHEM, V274, P18880, DOI 10.1074/jbc.274.27.18880; Russell SP, 2013, J CHROMATOGR B, V923, P74, DOI 10.1016/j.jchromb.2013.02.010; Spedaliere CJ, 2004, J AM CHEM SOC, V126, P12758, DOI 10.1021/ja046375s; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; SZWEYKOWSKAKULINSKA Z, 1992, EMBO J, V11, P1907, DOI 10.1002/j.1460-2075.1992.tb05243.x; Taucher M, 2011, INT J MASS SPECTROM, V304, P91, DOI 10.1016/j.ijms.2010.05.024; Wang WP, 2015, J PHARMACOL EXP THER, V354, P131, DOI 10.1124/jpet.115.225631; WRZESINSKI J, 1995, RNA, V1, P437; Yang CX, 2005, J BIOL CHEM, V280, P6655, DOI 10.1074/jbc.M413288200; ZERFASS K, 1992, NUCLEIC ACIDS RES, V20, P5911, DOI 10.1093/nar/20.22.5911; Zhao XL, 2004, RNA, V10, P996, DOI 10.1261/rna.7110804	63	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22327	22337		10.1074/jbc.M116.747865	http://dx.doi.org/10.1074/jbc.M116.747865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27551044	Green Published, hybrid			2022-12-28	WOS:000386332600042
J	Feng, SM; Zhao, YC; Xu, YX; Ning, SK; Huo, W; Hou, M; Gao, G; Ji, JG; Guo, R; Xu, DY				Feng, Sumin; Zhao, Yichao; Xu, Yixi; Ning, Shaokai; Huo, Wei; Hou, Mei; Gao, Ge; Ji, Jianguo; Guo, Rong; Xu, Dongyi			Ewing Tumor-associated Antigen 1 Interacts with Replication Protein A to Promote Restart of Stalled Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; DNA recombination; DNA repair; DNA replication; ATR; ETAA1; Ewing tumor-associated antigen 1; RPA; stalled replication fork restart; ATR; replication stress	DNA-DAMAGE RESPONSE; SINGLE-STRANDED-DNA; RPA-SSDNA; CHECKPOINT; ACTIVATION; PATHWAYS; SMARCAL1; REPAIR; XRCC4	The replication protein A (RPA) complex binds single-stranded DNA generated at stalled replication forks and recruits other DNA repair proteins to promote recovery of these forks. Here, we identify Ewing tumor-associated antigen 1 (ETAA1), which has been linked to susceptibility to pancreatic cancer, as a new repair protein that is recruited to stalled forks by RPA. We demonstrate that ETAA1 interacts with RPA through two regions, each of which resembles two previously identified RPA-binding domains, RPA70N-binding motif and RPA32C-binding motif, respectively. In response to replication stress, ETAA1 is recruited to stalled forks where it colocalizes with RPA, and this recruitment is diminished when RPA is depleted. Notably, inactivation of the ETAA1 gene increases the collapse level of the stalled replication forks and decreases the recovery efficiency of these forks. Moreover, epistasis analysis shows that ETAA1 stabilizes stalled replication forks in an ataxia telangiectasia and Rad3-related protein (ATR)-independent manner. Thus, our results reveal that ETAA1 is a novel RPA-interacting protein that promotes restart of stalled replication forks.	[Feng, Sumin; Zhao, Yichao; Xu, Yixi; Ning, Shaokai; Huo, Wei; Hou, Mei; Gao, Ge; Ji, Jianguo; Guo, Rong; Xu, Dongyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Guo, R; Xu, DY (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	guorong@pku.edu.cn; xudongyi@pku.edu.cn		Xu, Dongyi/0000-0001-5711-2618	National Basic Research Program of China [2013CB911002]; National Natural Science Foundation of China [31271435, 31370836]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Basic Research Program of China Grant 2013CB911002 and the National Natural Science Foundation of China Grants 31271435 and 31370836. The authors declare that they have no conflicts of interest with the contents of this article.	Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Childs EJ, 2015, NAT GENET, V47, P911, DOI 10.1038/ng.3341; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Driscoll R, 2009, GENE DEV, V23, P2359, DOI 10.1101/gad.1860609; Elia AEH, 2015, MOL CELL, V60, P280, DOI 10.1016/j.molcel.2015.09.011; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Feldkamp MD, 2014, BIOCHEMISTRY-US, V53, P3052, DOI 10.1021/bi500252w; Gong ZH, 2011, J BIOL CHEM, V286, P22308, DOI 10.1074/jbc.M111.222869; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Katsube T, 2011, J RADIAT RES, V52, P415, DOI 10.1269/jrr.10168; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Liu SF, 2011, J BIOL CHEM, V286, P22314, DOI 10.1074/jbc.M111.222802; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xie S, 2014, FEBS J, V281, P3382, DOI 10.1111/febs.12867; Xing MT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7233; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	28	37	39	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21956	21962		10.1074/jbc.C116.747758	http://dx.doi.org/10.1074/jbc.C116.747758			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27601467	hybrid, Green Published			2022-12-28	WOS:000386332600011
J	Avila-Medina, J; Calderon-Sanchez, E; Gonzalez-Rodriguez, P; Monje-Quiroga, F; Rosado, JA; Castellano, A; Ordonez, A; Smani, T				Avila-Medina, Javier; Calderon-Sanchez, Eva; Gonzalez-Rodriguez, Patricia; Monje-Quiroga, Francisco; Antonio Rosado, Juan; Castellano, Antonio; Ordonez, Antonio; Smani, Tarik			Orai1 and TRPC1 Proteins Co-localize with Ca(V)1.2 Channels to Form a Signal Complex in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; RAT CORONARY-ARTERY; CA2+ ENTRY; STORE; STIM1; PATHWAY; INFLUX; VASOCONSTRICTION; INHIBITION; MECHANISMS	Voltage-dependent CaV1.2 L-type Ca2+ channels (LTCC) are the main route for calcium entry in vascular smooth muscle cells (VSMC). Several studies have also determined the relevant role of store-operated Ca2+ channels (SOCC) in vascular tone regulation. Nevertheless, the role of Orai1- and TRPC1-dependent SOCC in vascular tone regulation and their possible interaction with Ca(V)1.2 are still unknown. The current study sought to characterize the co-activation of SOCC and LTCC upon stimulation by agonists, and to determine the possible crosstalk between Orai1, TRPC1, and Ca(V)1.2. Aorta rings and isolated VSMCobtained from wild type or smooth muscle-selective conditional Ca(V)1.2 knock-out (Ca(V)1.2(KO)) mice were used to study vascular contractility, intracellular Ca2+ mobilization, and distribution of ion channels. We found that serotonin (5-HT) or store depletion with thapsigargin (TG) enhanced intracellular free Ca2+ concentration ([Ca2+](i)) and stimulated aorta contraction. These responses were sensitive to LTCC and SOCC inhibitors. Also, 5-HT-and TG-induced responses were significantly attenuated in Ca(V)1.2(KO) mice. Furthermore, hyperpolarization induced with cromakalim or valinomycin significantly reduced both 5-HT and TG responses, whereas these responses were enhanced with LTCC agonist Bay-K-8644. Interestingly, in situ proximity ligation assay revealed that Ca(V)1.2 interacts with Orai1 and TRPC1 in untreated VSMC. These interactions enhanced significantly after stimulation of cells with 5-HT and TG. Therefore, these data indicate for the first time a functional interaction between Orai1, TRPC1, and Ca(V)1.2 channels in VSMC, confirming that upon agonist stimulation, vessel contraction involves Ca2+ entry due to co-activation of Orai1- and TRPC1-dependent SOCC and LTCC.	[Avila-Medina, Javier; Gonzalez-Rodriguez, Patricia; Castellano, Antonio; Smani, Tarik] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Dept Fisiol Med & Biofis,Inst Biomed Sevilla IBiS, Seville 41013, Spain; [Avila-Medina, Javier; Calderon-Sanchez, Eva; Ordonez, Antonio; Smani, Tarik] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Grp Fisiopatol Cardiovasc,Inst Biomed Sevilla IBi, Seville 41013, Spain; [Monje-Quiroga, Francisco] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Neurophysiol & Neuropharmacol, A-1090 Vienna, Austria; [Antonio Rosado, Juan] Univ Extremadura, Dept Fisiol, Caceres 10071, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Medical University of Vienna; Universidad de Extremadura	Smani, T (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Grp Fisiopatol Cardiovasc, Lab 113, Ave Manuel Siurot S-N, Seville 41013, Spain.	tasmani@us.es	Rosado, Juan A/H-3488-2015; IBIS, NEUROBIOLOGIA/O-9922-2015; Castellano, Antonio/AAH-8829-2021; Calderón-Sánchez, Eva María/B-5906-2016; Castellano, Antonio/E-6285-2010; Rodriguez, Patricia Gonzalez/AAV-5006-2020; IBIS, CARDIOVASCULAR/P-3910-2015; IBIS, VASCULAR/P-3934-2015; Hajami, Tarik Smani/D-5372-2016	Rosado, Juan A/0000-0002-9749-2325; Castellano, Antonio/0000-0003-3955-5137; Calderón-Sánchez, Eva María/0000-0002-9599-3513; Castellano, Antonio/0000-0003-3955-5137; Rodriguez, Patricia Gonzalez/0000-0002-2561-3984; Hajami, Tarik Smani/0000-0002-1877-7438; Ordonez, Antonio/0000-0002-4344-8660; Avila-Medina, Javier/0000-0002-4044-4840	Spanish Ministry of Economy and Competitiveness [BFU2013-45564-C2-1-P, BFU2013-45564-C2-2-P]; Institute of Carlos III; Cardiovascular Network "RIC" [RD12/0042/0041, PI12/00941]; Andalusia Government [PI-0108-2012, P12-CTS-1965]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute of Carlos III; Cardiovascular Network "RIC"; Andalusia Government	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2013-45564-C2-1-P; BFU2013-45564-C2-2-P); the Institute of Carlos III and Cardiovascular Network "RIC" (RD12/0042/0041; PI12/00941); and the Andalusia Government (PI-0108-2012; P12-CTS-1965). The authors declare that they have no conflicts of interest with the contents of this article.	Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Beech DJ, 2012, PFLUG ARCH EUR J PHY, V463, P635, DOI 10.1007/s00424-012-1090-2; Berna-Erro A, 2012, ADV EXP MED BIOL, V740, P349, DOI 10.1007/978-94-007-2888-2_15; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bolotina VM, 2012, ARTERIOSCL THROM VAS, V32, P1066, DOI 10.1161/ATVBAHA.112.245449; BOLTON TB, 1979, PHYSIOL REV, V59, P606, DOI 10.1152/physrev.1979.59.3.606; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Derler I, 2013, CELL CALCIUM, V53, P139, DOI 10.1016/j.ceca.2012.11.005; Desai PN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8323; Dionisio N, 2015, BBA-MOL CELL RES, V1853, P1145, DOI 10.1016/j.bbamcr.2015.02.014; Dominguez-Rodriguez A, 2012, ARTERIOSCL THROM VAS, V32, P1325, DOI 10.1161/ATVBAHA.111.243014; Fernandez-Tenorio M, 2010, CIRC RES, V106, P1285, DOI 10.1161/CIRCRESAHA.109.213967; Funabashi K, 2010, AM J PHYSIOL-CELL PH, V298, pC786, DOI 10.1152/ajpcell.00469.2009; Hansen P.C., 2006, DEBLURRING IMAGES MA; He XD, 2012, AM J PHYSIOL-GASTR L, V303, pG240, DOI 10.1152/ajpgi.00102.2012; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hogan PG, 2015, BIOCHEM BIOPH RES CO, V460, P40, DOI 10.1016/j.bbrc.2015.02.110; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Noble D, 2014, CELL CALCIUM, V56, P188, DOI 10.1016/j.ceca.2014.07.003; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park KM, 2008, AM J PHYSIOL-HEART C, V294, pH1183, DOI 10.1152/ajpheart.01148.2007; RAMPE D, 1992, MOL PHARMACOL, V41, P599; Rodriguez-Moyano M, 2013, CARDIOVASC RES, V100, P297, DOI 10.1093/cvr/cvt196; Saponara S, 2008, EUR J PHARMACOL, V598, P75, DOI 10.1016/j.ejphar.2008.08.016; Smani T, 2002, CARDIOVASC RES, V53, P97, DOI 10.1016/S0008-6363(01)00422-9; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2008, AM J PHYSIOL-CELL PH, V294, pC1499, DOI 10.1152/ajpcell.00365.2007; Smani T, 2007, CIRC RES, V101, P1194, DOI 10.1161/CIRCRESAHA.107.159053; Smani T, 2011, CLIN EXP PHARMACOL P, V38, P71, DOI 10.1111/j.1440-1681.2010.05466.x; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Song K, 2015, BIOCHEM BIOPH RES CO, V466, P456, DOI 10.1016/j.bbrc.2015.09.049; Spinelli AM, 2016, AM J PHYSIOL-CELL PH, V310, pC402, DOI 10.1152/ajpcell.00355.2015; Tanner MK, 1998, METH MOL B, V91, P85; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086	39	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21148	21159		10.1074/jbc.M116.742171	http://dx.doi.org/10.1074/jbc.M116.742171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27535226	Green Published, hybrid			2022-12-28	WOS:000385406200029
J	Yamazaki, W; Amano, T; Bai, H; Takahashi, M; Kawahara, M				Yamazaki, Wataru; Amano, Tomoko; Bai, Hanako; Takahashi, Masashi; Kawahara, Manabu			The Influence of Polyploidy and Genome Composition on Genomic Imprinting in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRADER-WILLI-SYNDROME; DNA METHYLATION IMPRINTS; PREIMPLANTATION DEVELOPMENT; NUCLEAR TRANSPLANTATION; UNIPARENTAL FETUSES; MOUSE EMBRYOGENESIS; MAMMALIAN-CELLS; SYNDROME REGION; NERVOUS-SYSTEM; AXON GUIDANCE	Genomic imprinting is an epigenetic mechanism that switches the expression of imprinted genes involved in normal embryonic growth and development in a parent-of-origin-specific manner. Changes inDNAmethylation statuses from polyploidization are a well characterized epigenetic modification in plants. However, how changes in ploidy affect both imprinted gene expression and methylation status in mammals remains unclear. To address this, we used quantitative real time PCR to analyze expression levels of imprinted genes in mouse tetraploid fetuses. We used bisulfite sequencing to assess the methylation statuses of differentially methylated regions (DMRs) that regulate imprinted gene expression in triploid and tetraploid fetuses. The nine imprinted genes H19, Gtl2, Dlk1, Igf2r, Grb10, Zim1, Peg3, Ndn, and Ipw were all unregulated; in particular, the expression of Zim1 was more than 10-fold higher, and the expression of Ipw was repressed in tetraploid fetuses. The methylation statuses of four DMRs H19, intergenic (IG), Igf2r, and Snrpn in tetraploid and triploid fetuses were similar to those in diploid fetuses. We also performed allele-specific RT-PCR sequencing to determine the alleles expressing the three imprinted genes Igf2, Gtl2, and Dlk1 in tetraploid fetuses. These three imprinted genes showed monoallelic expression in a parent-of-origin-specific manner. Expression of non-imprinted genes regulating neural cell development significantly decreased in tetraploid fetuses, which might have been associated with unregulated imprinted gene expression. This study provides the first detailed analysis of genomic imprinting in tetraploid fetuses, suggesting that imprinted gene expression is disrupted, but DNA methylation statuses of DMRs are stable following changes in ploidy in mammals.	[Yamazaki, Wataru; Bai, Hanako; Takahashi, Masashi; Kawahara, Manabu] Hokkaido Univ, Res Fac Agr, Lab Anim Genet & Reprod, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan; [Amano, Tomoko] Rakuno Gakuen Univ, Coll Agr Food & Environm Sci, Dept Sustainable Agr, Lab Anim Genet, Bunkyodai Midorimachi, Ebetsu, Hokkaido 0698501, Japan	Hokkaido University; Rakuno Gakuen University	Kawahara, M (corresponding author), Hokkaido Univ, Res Fac Agr, Lab Anim Genet & Reprod, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	k-hara@anim.agr.hokudai.ac.jp	Bai, Hanako/K-4769-2019	Bai, Hanako/0000-0001-9940-1880	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K14587, 15H04579]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-aid for Research on Priority Area to Challenging Exploratory Research 16K14587 (to M. K.) and a Grant-in-aid for Scientific Research (B) 15H04579 (to M. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Al Adhami H, 2015, GENOME RES, V25, P353, DOI 10.1101/gr.175919.114; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Andrieu D, 2003, GENE EXPR PATTERNS, V3, P761, DOI 10.1016/S1567-133X(03)00138-8; Arnaud P, 2006, HUM MOL GENET, V15, P589, DOI 10.1093/hmg/ddi475; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CUELLAR O, 1972, CYTOGENETICS, V11, P508, DOI 10.1159/000130217; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gallardo MH, 1999, NATURE, V401, P341, DOI 10.1038/43815; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Hiura H, 2007, FEBS LETT, V581, P1255, DOI 10.1016/j.febslet.2007.02.034; Horii T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08907; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; KAUFMAN MH, 1989, DEVELOPMENT, V105, P137; KAUFMAN MH, 1990, DEVELOPMENT, V110, P1121; KAUFMAN MH, 1991, HUM REPROD, V6, P8, DOI 10.1093/oxfordjournals.humrep.a137263; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Loebel DAF, 2004, NATURE, V428, P809, DOI 10.1038/428809a; Lutz A M, 1907, Science, V26, P151, DOI 10.1126/science.26.657.151; Mastick GS, 1997, DEVELOPMENT, V124, P1985; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MCKINNELL RG, 1964, GENETICS, V49, P895; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Obata Y, 2014, REPRODUCTION, V147, pH1, DOI 10.1530/REP-13-0359; Obata Y, 2011, J REPROD DEVELOP, V57, P327, DOI 10.1262/jrd.10-145A; Ogawa H, 2006, FEBS LETT, V580, P5377, DOI 10.1016/j.febslet.2006.08.087; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Peters Jo, 2004, Briefings in Functional Genomics & Proteomics, V2, P320, DOI 10.1093/bfgp/2.4.320; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; QUINN P, 1985, FERTIL STERIL, V44, P493; QUINN P, 1982, J REPROD FERTIL, V66, P161; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song QX, 2015, CURR OPIN PLANT BIOL, V24, P101, DOI 10.1016/j.pbi.2015.02.007; Sotomaru Y, 2002, J BIOL CHEM, V277, P12474, DOI 10.1074/jbc.M109212200; Sotomaru Y, 2001, J BIOL CHEM, V276, P26694, DOI 10.1074/jbc.M101367200; Stelzer Y, 2014, NAT GENET, V46, P551, DOI 10.1038/ng.2968; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Watrin F, 1997, EUR J HUM GENET, V5, P324, DOI 10.1159/000484784; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7; Yamazaki W, 2015, ZYGOTE, V23, P874, DOI 10.1017/S0967199414000550; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596	58	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20924	20931		10.1074/jbc.M116.744144	http://dx.doi.org/10.1074/jbc.M116.744144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27531747	Green Published, hybrid			2022-12-28	WOS:000385406200011
J	Li, H; Sineshchekov, OA; Wu, G; Spudich, JL				Li, Hai; Sineshchekov, Oleg A.; Wu, Gang; Spudich, John L.			In Vitro Activity of a Purified Natural Anion Channelrhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; electron paramagnetic resonance (EPR); lipid vesicle; membrane reconstitution; photoreceptor; LUV; flash photolysis; retinal protein; chloride channel	GATED CATION CHANNEL; CHLORIDE CHANNEL; PROTON PUMP; LIGHT; BACTERIORHODOPSIN; RECONSTITUTION; LIPOSOMES; PROTEORHODOPSIN; PROTEOLIPOSOMES; HALORHODOPSIN	Natural anion channelrhodopsins (ACRs) recently discovered in cryptophyte algae are the most active rhodopsin channels known. They are of interest both because of their unique natural function of light-gated chloride conductance and because of their unprecedented efficiency of membrane hyperpolarization for optogenetic neuron silencing. Light-induced currents of ACRs have been studied in HEK cells and neurons, but light-gated channel conductance of ACRs in vitro has not been demonstrated. Here we report light-induced chloride channel activity of a purified ACR protein reconstituted in large unilamellar vesicles (LUVs). EPR measurements establish that the channels are inserted uniformly inside-out with their cytoplasmic surface facing the medium of the LUV suspension. We show by time-resolved flash spectroscopy that the photochemical reaction cycle of a functional purified ACR from Guillardia theta (GtACR1) in LUVs exhibits similar spectral shifts, indicating similar photocycle intermediates as GtACR1 in detergent micelles. Furthermore, the photocycle rate is dependent on electric potential generated by chloride gradients in the LUVs in the same manner as in voltage-clamped animal cells. We confirm with this system that, in contrast to cation-conducting channelrhodopsins, opening of the channel occurs prior to deprotonation of the Schiff base. However, the photointermediate transitions in the LUVs exhibit faster kinetics. The ACR-incorporated LUVs provide a purified defined system amenable to EPR, optical and vibrational spectroscopy, and fluorescence resonance energy transfer measurements of structural changes of ACRs with the molecules in a demonstrably functional state.	[Li, Hai; Sineshchekov, Oleg A.; Wu, Gang; Spudich, John L.] Univ Texas Hlth Sci Ctr, McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Wu, Gang] Univ Texas Hlth Sci Ctr, McGovern Med Sch, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Spudich, JL (corresponding author), Univ Texas, Dept Biochem & Mol Biol, McGovern Med Sch, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu			National Institutes of Health [R01GM027750]; Robert A. Welch Foundation [AU-0009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM027750 (to J. L. S.) and Endowed Chair Number AU-0009 from the Robert A. Welch Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; BOGOMOLNI RA, 1984, P NATL ACAD SCI-BIOL, V81, P5408, DOI 10.1073/pnas.81.17.5408; Bruun S, 2011, FEBS LETT, V585, P3998, DOI 10.1016/j.febslet.2011.11.007; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Dioumaev AK, 2003, BIOCHEMISTRY-US, V42, P6582, DOI 10.1021/bi034253r; DUSCHL A, 1988, J BIOL CHEM, V263, P17016; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Gan BS, 1998, AM J PHYSIOL-CELL PH, V275, pC1158, DOI 10.1152/ajpcell.1998.275.4.C1158; Govorunova E. G., 2017, ANN REV BIO IN PRESS, V86; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; GULIKKRZYWICKI T, 1987, J BIOL CHEM, V262, P15580; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; LEACH SJ, 1960, J AM CHEM SOC, V82, P4790, DOI 10.1021/ja01503a008; Li H, 2015, BIOPHYS J, V109, P1446, DOI 10.1016/j.bpj.2015.08.018; Lindholm L, 2015, BBA-BIOENERGETICS, V1847, P698, DOI 10.1016/j.bbabio.2015.04.011; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; RIGAUD JL, 1988, BIOCHEMISTRY-US, V27, P2677, DOI 10.1021/bi00408a007; RIGAUD JL, 1983, BIOCHEM BIOPH RES CO, V111, P373, DOI 10.1016/0006-291X(83)90316-9; Rink T, 1997, BIOPHYS J, V73, P983, DOI 10.1016/S0006-3495(97)78131-1; Sineshchekov OA, 2016, P NATL ACAD SCI USA, V113, pE1993, DOI 10.1073/pnas.1525269113; Sineshchekov OA, 2015, P NATL ACAD SCI USA, V112, P14236, DOI 10.1073/pnas.1513602112; Sineshchekov OA, 2013, BIOPHYS J, V104, P807, DOI 10.1016/j.bpj.2013.01.002; Volz P, 2016, J BIOL CHEM, V291, P17382, DOI 10.1074/jbc.M115.711200; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Wu G, 2007, BIOCHEMISTRY-US, V46, P534, DOI 10.1021/bi061859h	29	7	8	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25319	25325		10.1074/jbc.C116.760041	http://dx.doi.org/10.1074/jbc.C116.760041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27789708	hybrid, Green Published			2022-12-28	WOS:000390095300004
J	Manya, H; Yamaguchi, Y; Kanagawa, M; Kobayashi, K; Tajiri, M; Akasaka-Manya, K; Kawakami, H; Mizuno, M; Wada, Y; Toda, T; Endo, T				Manya, Hiroshi; Yamaguchi, Yoshiki; Kanagawa, Motoi; Kobayashi, Kazuhiro; Tajiri, Michiko; Akasaka-Manya, Keiko; Kawakami, Hiroko; Mizuno, Mamoru; Wada, Yoshinao; Toda, Tatsushi; Endo, Tamao			The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol beta 1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DYSTROGLYCAN; IDENTIFICATION; PHOSPHATE; LAMININ; BINDING; BRAIN; ISPD; IX	A defect in O-mannosyl glycan is the cause of alpha-dystroglycanopathy, a group of congenital muscular dystrophies caused by aberrant a-dystroglycan (alpha-DG) glycosylation. Recently, the entire structure of O-mannosyl glycan, [3GlcA beta 1-3Xyl alpha 1](n)-3GlcA beta 1-4Xyl-Rbo5P-1Rbo5P-3GalNAc beta 1-3GlcNAc beta 1-4 (phospho-6)Man alpha 1-, which is required for the binding of alpha-DG to extracellular matrix ligands, has been proposed. However, the linkage of the first Xyl residue to ribitol 5-phosphate (Rbo5P) is not clear. TMEM5 is a gene product responsible for alpha-dystroglycanopathy and was reported as a potential enzyme involved in this linkage formation, although the experimental evidence is still incomplete. Here, we report that TMEM5 is a xylosyltransferase that forms the Xyl beta 1-4Rbo5P linkage on O-mannosyl glycan. The anomeric configuration and linkage position of the product (beta 1,4 linkage) was determined by NMR analysis. The introduction of two missense mutations in TMEM5 found in alpha-dystroglycanopathy patients impaired xylosyltransferase activity. Furthermore, the disruption of the TMEM5 gene by CRISPR/Cas9 abrogated the elongation of the (-3GlcA beta 1-3Xyl alpha 1-) unit on O-mannosyl glycan. Based on these results, we concluded that TMEM5 acts as a UDP-e-xylose:ribitol-5-phosphate beta 1,4-xylosyltransferase in the biosynthetic pathway of O-mannosyl glycan.	[Manya, Hiroshi; Akasaka-Manya, Keiko; Endo, Tamao] Tokyo Metropolitan Geriatr Hosp, Res Team Mech Aging, Mol Glycobiol, Tokyo 1730015, Japan; [Manya, Hiroshi; Akasaka-Manya, Keiko; Endo, Tamao] Inst Gerontol, Tokyo 1730015, Japan; [Yamaguchi, Yoshiki] R1KEN Global Res Cluster, Struct Glycobiol Team, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Wako, Saitama 3510198, Japan; [Kanagawa, Motoi; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Tajiri, Michiko; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Izumi Ku, Osaka 5941101, Japan; [Tajiri, Michiko; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Kawakami, Hiroko; Mizuno, Mamoru] Noguchi Inst, Lab Glycoorgan Chem, Itabashi Ku, Tokyo 1730003, Japan	Tokyo Metropolitan Institute of Gerontology; RIKEN; Kobe University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Endo, T (corresponding author), 35-2 Sakaecho,Itabashi Ku, Tokyo 1730015, Japan.	endo@tmig.or.jp	Kobayashi, Kazuhiro/AAH-8638-2021; Yamaguchi, Yoshiki/N-5246-2015	Kobayashi, Kazuhiro/0000-0001-7801-147X; Yamaguchi, Yoshiki/0000-0003-0100-5439; Manya, Hiroshi/0000-0003-1573-9177; Kanagawa, Motoi/0000-0003-0984-6398	National Center of Neurology and Psychiatry (NCNP) Intramural Research Grant [26-8]; Japan Agency for Medical Research and Development (AMED) [16gm0810010h0201, 16gm0810010h0001, 15dk0310041h0002]; Japan Society for the Promotion of Science [26253057, 16K08262, 23390081, 15H04352, 24687017, 26670499, 16H05353, 24619014]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [26110712, 26110727]; Mizutani Foundation for Glycoscience [150171]; Grants-in-Aid for Scientific Research [16H04758, 25460054] Funding Source: KAKEN	National Center of Neurology and Psychiatry (NCNP) Intramural Research Grant; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Center of Neurology and Psychiatry (NCNP) Intramural Research Grant 26-8 (to T. T. and T. E.), the Japan Agency for Medical Research and Development (AMED) Grants 16gm0810010h0201 (to H. M.), 16gm0810010h0001 (to M. K.), and 15dk0310041h0002 (to T. T.), the Japan Society for the Promotion of Science Grants 26253057 (to T. T.), 16K08262 (to T. E), 23390081 (to Y. W.), 15H04352 and 24687017 (to M. K.), 26670499 and 16H05353 (to K. K.), and 24619014 (to M. T.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) Grants 26110712 (to M. K.) and 26110727 (to H. M.), and the Mizutani Foundation for Glycoscience Grant 150171 (to H. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Astrea G, 2016, NEUROMUSCULAR DISORD, V26, P459, DOI 10.1016/j.nmd.2016.05.003; Chiba A, 1997, J BIOL CHEM, V272, P2156; Endo T, 2015, J BIOCHEM, V157, P1, DOI 10.1093/jb/mvu066; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H., 2015, SUGAR CHAINS DECODIN, P235; Ohtsuka Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08316; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	19	48	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24618	24627		10.1074/jbc.M116.751917	http://dx.doi.org/10.1074/jbc.M116.751917			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27733679	Green Published, hybrid			2022-12-28	WOS:000388875500023
J	Qian, YW; Li, C; Jiang, AP; Ge, SF; Gu, P; Fan, XQ; Li, TS; Jin, X; Wang, JH; Wang, ZL				Qian, Yi-Wen; Li, Chuan; Jiang, Ai-Ping; Ge, Shengfang; Gu, Ping; Fan, Xianqun; Li, Tai-Sheng; Jin, Xia; Wang, Jian-Hua; Wang, Zhi-Liang			HIV-1 gp120 Glycoprotein Interacting with Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Down-Regulates Tight Junction Proteins to Disrupt the Blood Retinal Barrier and Increase Its Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL TRANS-INFECTION; MATRIX METALLOPROTEINASES; CEREBROSPINAL-FLUID; CAPTURE HIV-1; EBOLA-VIRUS; INHIBITORS; COMPARTMENTS; ASSOCIATION; ASTROCYTES	Approximately 70% of HIV-1 infected patients acquire ocular opportunistic infections and manifest eye disorders during the course of their illness. The mechanisms by which pathogens invade the ocular site, however, are unclear. Under normal circumstances, vascular endothelium and retinal pigment epithelium(RPE), which possess a well developed tight junction complex, form the blood-retinal barrier (BRB) to prevent pathogen invasion. We hypothesize that disruption of the BRB allows pathogen entry into ocular sites. The hypothesis was tested using in vitro models. We discovered that human RPE cells could bind to either HIV-1 gp120 glycoproteins or HIV-1 viral particles. Furthermore, the binding was mediated by dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) expressed on RPE cells. Upon gp120 binding to DC-SIGN, cellular NF-kappa B signaling was triggered, leading to the induction of matrix metalloproteinases, which subsequently degraded tight junction proteins and disrupted the BRB integrity. DC-SIGN knockdown or prior blocking with a specific antibody abolished gp120-induced matrix metalloproteinase expression and reduced the degradation of tight junction proteins. This study elucidates a novel mechanism by which HIV, type 1 invades ocular tissues and provides additional insights into the translocation or invasion process of ocular complication-associated pathogens.	[Qian, Yi-Wen; Li, Chuan; Ge, Shengfang; Gu, Ping; Fan, Xianqun; Wang, Zhi-Liang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Ophthalmol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China; [Jiang, Ai-Ping; Jin, Xia; Wang, Jian-Hua] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Shanghai 200031, Peoples R China; [Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Vaccine Ctr, Shanghai 200031, Peoples R China; [Li, Tai-Sheng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, ZL (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Ophthalmol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Wang, JH (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jh_wang@sibs.ac.cn; ophwzl@163.com			National Grant Program on Key Infectious Disease Grant [2014ZX10001003]; Natural Science Foundation of China [81572001]; Natural Science Foundation of China-National Institutes of Health Joint Grant [81561128009]; Science and Technology Commission of Shanghai [15ZR1425400]; National High Technology Research and Development Program (863 Program) [2015AA020311]	National Grant Program on Key Infectious Disease Grant; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China-National Institutes of Health Joint Grant; Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China)	This work was supported by National Grant Program on Key Infectious Disease Grant 2014ZX10001003, Natural Science Foundation of China Grant 81572001, and the Natural Science Foundation of China-National Institutes of Health Joint Grant 81561128009 (to J. H. W.). This work was also supported by Science and Technology Commission of Shanghai Grant 15ZR1425400 and National High Technology Research and Development Program (863 Program) Grant 2015AA020311 (to Z. L. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABLASHI D V, 1987, Journal of Experimental Pathology (New York), V3, P693; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Ambiya Vikas, 2012, Med J Armed Forces India, V68, P214, DOI 10.1016/j.mjafi.2012.01.006; Baribaud Frederic, 2002, Expert Opin Ther Targets, V6, P423, DOI 10.1517/14728222.6.4.423; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Chen Y, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI 10.1155/2013/245958; Cioni C, 2002, NEUROSCI LETT, V330, P299, DOI 10.1016/S0304-3940(02)00814-5; Craigo JK, 2006, CURR OPIN HIV AIDS, V1, P97, DOI 10.1097/01.COH.0000200507.27578.26; Cunningham ET, 1998, NEW ENGL J MED, V339, P236, DOI 10.1056/NEJM199807233390406; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Han Y, 2011, AIDS, V25, P1925, DOI 10.1097/QAD.0b013e32834b3578; Harrington PR, 2009, AIDS, V23, P907, DOI 10.1097/QAD.0b013e3283299129; Hu N, 2014, BRAIN RES, V1551, P13, DOI 10.1016/j.brainres.2014.01.015; Jang JW, 2014, J NEUROL SCI, V339, P75, DOI 10.1016/j.jns.2014.01.024; Jiang AP, 2016, J VIROL, V90, P2928, DOI 10.1128/JVI.03008-15; Jiang AP, 2015, J VIROL, V89, P8050, DOI 10.1128/JVI.01021-15; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lambert V, 2002, AM J PATHOL, V161, P1247, DOI 10.1016/S0002-9440(10)64401-X; Louboutin JP, 2011, EUR J NEUROSCI, V34, P2015, DOI 10.1111/j.1460-9568.2011.07908.x; Louboutin JP, 2010, J NEUROPATH EXP NEUR, V69, P801, DOI 10.1097/NEN.0b013e3181e8c96f; LOUBOUTIN JP, 2012, SCI WORLD J, V2012, DOI DOI 10.1100/2012/482575; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Nakamuta S, 2008, J NEUROVIROL, V14, P186, DOI 10.1080/13550280801993630; Ng WT, 2005, CLIN EXP OPHTHALMOL, V33, P317, DOI 10.1111/j.1442-9071.2005.01001.x; Peng CH, 2005, OPHTHALMOLOGICA, V219, P101, DOI 10.1159/000083269; Rahner C, 2004, J CELL SCI, V117, P3307, DOI 10.1242/jcs.01181; Ricardo-Dukelow M, 2007, J NEUROIMMUNOL, V185, P37, DOI 10.1016/j.jneuroim.2007.01.004; Rizzolo LJ, 2011, PROG RETIN EYE RES, V30, P296, DOI 10.1016/j.preteyeres.2011.06.002; Sarkar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059073; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Shah A, 2011, BIOCHEM BIOPH RES CO, V414, P112, DOI 10.1016/j.bbrc.2011.09.033; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Sharew G, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/965627; Silverstein PS, 2012, CURR HIV RES, V10, P369, DOI 10.2174/157016212802138724; Singh D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00019; SKOLNIK PR, 1989, AM J OPHTHALMOL, V107, P361, DOI 10.1016/0002-9394(89)90659-4; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Strain MC, 2005, J VIROL, V79, P1772, DOI 10.1128/JVI.79.3.1772-1788.2005; Svicher V, 2014, CURR HIV-AIDS REP, V11, P186, DOI 10.1007/s11904-014-0207-y; Tan SY, 2014, LAB INVEST, V94, P777, DOI 10.1038/labinvest.2014.72; TERVO T, 1986, LANCET, V1, P379; Thorne JE, 2006, OPHTHALMOLOGY, V113, P1432, DOI 10.1016/j.ophtha.2006.03.021; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; Wang S, 2015, INVEST OPHTH VIS SCI, V56, P2971, DOI 10.1167/iovs.14-15874; Wang ZL, 2012, AM J OPHTHALMOL, V153, P363, DOI 10.1016/j.ajo.2011.07.018; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308	55	3	4	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22977	22987		10.1074/jbc.M116.744615	http://dx.doi.org/10.1074/jbc.M116.744615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605665	hybrid, Green Published			2022-12-28	WOS:000387224800011
J	Cox, D; Selig, E; Griffin, MDW; Carver, JA; Ecroyd, H				Cox, Dezerae; Selig, Emily; Griffin, Michael D. W.; Carver, John A.; Ecroyd, Heath			Small Heat-shock Proteins Prevent -Synuclein Aggregation via Transient Interactions and Their Efficacy Is Affected by the Rate of Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein (a-synuclein); amyloid; analytical ultracentrifugation; fibril; molecular chaperone; Parkinson disease; protein aggregation; small heat shock protein (sHsp); synuclein	ALPHA-B-CRYSTALLIN; AMYLOID FIBRIL FORMATION; NATIVELY UNFOLDED PROTEINS; APOLIPOPROTEIN C-II; MOLECULAR CHAPERONE; PARKINSONS-DISEASE; SUBUNIT EXCHANGE; LEWY BODIES; ANALYTICAL ULTRACENTRIFUGATION; POLYGLUTAMINE AGGREGATION	The aggregation of -synuclein (-syn) into amyloid fibrils is associated with neurodegenerative diseases, collectively referred to as the -synucleinopathies. In vivo, molecular chaperones, such as the small heat-shock proteins (sHsps), normally act to prevent protein aggregation; however, it remains to be determined how aggregation-prone -syn evades sHsp chaperone action leading to its disease-associated deposition. This work examines the molecular mechanism by which two canonical sHsps, B-crystallin (B-c) and Hsp27, interact with aggregation-prone -syn to prevent its aggregation in vitro. Both sHsps are very effective inhibitors of -syn aggregation, but no stable complex between the sHsps and -syn was detected, indicating that the sHsps inhibit -syn aggregation via transient interactions. Moreover, the ability of these sHsps to prevent -syn aggregation was dependent on the kinetics of aggregation; the faster the rate of aggregation (shorter the lag phase), the less effective the sHsps were at inhibiting fibril formation of -syn. Thus, these findings indicate that the rate at which -syn aggregates in cells may be a significant factor in how it evades sHsp chaperone action in the -synucleinopathies.	[Cox, Dezerae; Ecroyd, Heath] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Cox, Dezerae; Ecroyd, Heath] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Selig, Emily; Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Carver, John A.] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia	University of Wollongong; University of Wollongong; University of Melbourne; Australian National University	Ecroyd, H (corresponding author), Northfields Ave, Wollongong, NSW 2522, Australia.	heathe@uow.edu.au	Cox, Dezerae/I-7265-2019; Carver, John Adrian/J-3825-2014	Cox, Dezerae/0000-0002-5345-8360; Carver, John Adrian/0000-0002-2441-8108; Ecroyd, Heath/0000-0001-7574-0044; Selig, Emily/0000-0002-3012-6814	Australian Department of Health and Aging; University of Wollongong; Australian Postgraduate Award; Australian Research Council [FT110100586, FT140100544]; Australian National Health and Medical Research Council [1068087]	Australian Department of Health and Aging(Australian Government); University of Wollongong; Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the Australian Department of Health and Aging and the University of Wollongong. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by an Australian Postgraduate Award.r Supported by Australian Research Council Future Fellowships FT110100586 and FT140100544.r Supported by an Australian National Health and Medical Research Council project Grant 1068087.	Ahmad MF, 2008, J MOL BIOL, V375, P1040, DOI 10.1016/j.jmb.2007.11.019; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Baba M, 1998, AM J PATHOL, V152, P879; Bakthisaran R, 2016, BBA-GEN SUBJECTS, V1860, P167, DOI 10.1016/j.bbagen.2015.09.017; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Balbo A., 2005, PROTEIN PROTEIN INTE; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartelt-Kirbach B, 2014, CELL STRESS CHAPERON, V19, P145, DOI [10.1007/s12192-013-0452-9, 10.1007/s12192-013-0465-4]; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Binger KJ, 2013, FASEB J, V27, P1214, DOI 10.1096/fj.12-220657; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bruinsma IB, 2011, PROTEINS, V79, P2956, DOI 10.1002/prot.23152; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Devlin GL, 2003, J BIOL CHEM, V278, P48644, DOI 10.1074/jbc.M308376200; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Esposito G, 2013, J BIOL CHEM, V288, P17844, DOI 10.1074/jbc.M112.448639; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fu XM, 2004, BIOCHEM BIOPH RES CO, V316, P291, DOI 10.1016/j.bbrc.2004.02.053; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; Ghahghaei A, 2007, BBA-PROTEINS PROTEOM, V1774, P102, DOI 10.1016/j.bbapap.2006.10.002; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Healy EF, 2014, CELL BIOCHEM BIOPHYS, V69, P275, DOI 10.1007/s12013-013-9795-1; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; HORWITZ J, 2005, PROTEIN FOLDING HD 2, P858; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; KATO K, 1994, J BIOL CHEM, V269, P11274; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kulig M, 2012, BIOCHEM J, V448, P343, DOI 10.1042/BJ20121187; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; LANDRY J, 1992, J BIOL CHEM, V267, P794; Leak RK, 2014, J CELL COMMUN SIGNAL, V8, P293, DOI 10.1007/s12079-014-0243-9; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Rekas A, 2007, FEBS J, V274, P6290, DOI 10.1111/j.1742-4658.2007.06144.x; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Wang J, 2008, NEUROBIOL AGING, V29, P586, DOI 10.1016/j.neurobiolaging.2006.11.009; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	92	74	77	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22618	22629		10.1074/jbc.M116.739250	http://dx.doi.org/10.1074/jbc.M116.739250			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587396	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000386760600022
J	Dyachok, J; Earnest, S; Iturraran, EN; Cobb, MH; Ross, EM				Dyachok, Julia; Earnest, Svetlana; Iturraran, Erica N.; Cobb, Melanie H.; Ross, Elliott M.			Amino Acids Regulate mTORC1 by an Obligate Two-step Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; cell signaling; lysosome; mammalian target of rapamycin (mTOR); mTOR complex (mTORC); protein kinase; S6 kinase	P70 S6 KINASE; RAG GTPASES; LEUCINE SENSOR; GAP ACTIVITY; SUFFICIENCY; ACTIVATION; ARGININE; COMPLEX; TARGET; GROWTH	The mechanistic target of rapamycin complex 1 (mTORC1) coordinates cell growth with its nutritional, hormonal, energy, and stress status. Amino acids are critical regulators of mTORC1 that permit other inputs to mTORC1 activity. However, the roles of individual amino acids and their interactions in mTORC1 activation are not well understood. Here we demonstrate that activation of mTORC1 by amino acids includes two discrete and separable steps: priming and activation. Sensitizing mTORC1 activation by priming amino acids is a prerequisite for subsequent stimulation of mTORC1 by activating amino acids. Priming is achieved by a group of amino acids that includes l-asparagine, l-glutamine, l-threonine, l-arginine, l-glycine, l-proline, l-serine, l-alanine, and l-glutamic acid. The group of activating amino acids is dominated by l-leucine but also includes l-methionine, l-isoleucine, and l-valine. l-Cysteine predominantly inhibits priming but not the activating step. Priming and activating steps differ in their requirements for amino acid concentration and duration of treatment. Priming and activating amino acids use mechanisms that are distinct both from each other and from growth factor signaling. Neither step requires intact tuberous sclerosis complex of proteins to activate mTORC1. Concerted action of priming and activating amino acids is required to localize mTORC1 to lysosomes and achieve its activation.	[Dyachok, Julia; Earnest, Svetlana; Iturraran, Erica N.; Cobb, Melanie H.; Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Dyachok, Julia; Iturraran, Erica N.; Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Dyachok, Julia] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Growth & Dev, Dallas, TX 75390 USA; [Iturraran, Erica N.] St Georges Univ, Sch Vet Med, True Blue, Grenada	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ross, EM (corresponding author), UT Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Elliott.Ross@UTSouthwestern.edu		Ross, Elliott M./0000-0002-0252-8197; Cobb, Melanie/0000-0003-0833-5473	Cancer Prevention and Research Institute of Texas [RP120695]; National Institutes of Health [R01GM30355, R01DK34128]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034128, R37DK034128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030355] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Cancer Prevention and Research Institute of Texas Grant RP120695 and National Institutes of Health Grants R01GM30355 and R01DK34128. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Awadi F, 2008, ANTICANCER RES, V28, P2541; Ban H, 2004, INT J MOL MED, V13, P537; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carroll B, 2016, ELIFE, V5, DOI 10.7554/eLife.11058; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2012, CURR OPIN NEPHROL HY, V21, P251, DOI 10.1097/MNH.0b013e3283520f38; ISHII T, 1981, J BIOL CHEM, V256, P2387; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kim JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09502; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin J, 2010, CANCER RES, V70, P2397, DOI 10.1158/0008-5472.CAN-09-3648; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Milkereit R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8250; Murphy G, 2011, GUT, V60, P618, DOI 10.1136/gut.2010.225854; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Perl A, 2015, ANN NY ACAD SCI, V1346, P33, DOI 10.1111/nyas.12756; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Thomas JD, 2014, CANCER CELL, V26, P754, DOI 10.1016/j.ccell.2014.09.008; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	49	45	46	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22414	22426		10.1074/jbc.M116.732511	http://dx.doi.org/10.1074/jbc.M116.732511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587390	Green Published, hybrid			2022-12-28	WOS:000386760600006
J	Maganti, AV; Tersey, SA; Syed, F; Nelson, JB; Colvin, SC; Maier, B; Mirmira, RG				Maganti, Aarthi V.; Tersey, Sarah A.; Syed, Farooq; Nelson, Jennifer B.; Colvin, Stephanie C.; Maier, Bernhard; Mirmira, Raghavendra G.			Peroxisome Proliferator-activated Receptor- Activation Augments the -Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and Cell Death in Non-obese Diabetic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; beta cell (B-cell); diabetes; endoplasmic reticulum stress (ER stress); insulin; peroxisome proliferator-activated receptor (PPAR); unfolded protein response (UPR)	ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELL; PPAR-GAMMA; NOD MOUSE; INSULIN-SECRETION; OXIDATIVE STRESS; ER-STRESS; T-CELLS; IN-VIVO; PIOGLITAZONE	Type 1 diabetes is an autoimmune disorder that is characterized by a failure of the unfolded protein response in islet cells with subsequent endoplasmic reticulum stress and cellular death. Thiazolidinediones are insulin sensitizers that activate the nuclear receptor PPAR- and have been shown to partially ameliorate autoimmune type 1 diabetes in humans and non-obese diabetic (NOD) mice. We hypothesized that thiazolidinediones reduce cell stress and death independently of insulin sensitivity. To test this hypothesis, female NOD mice were administered pioglitazone during the pre-diabetic phase and assessed for insulin sensitivity and cell function relative to controls. Pioglitazone-treated mice showed identical weight gain, body fat distribution, and insulin sensitivity compared with controls. However, treated mice showed significantly improved glucose tolerance with enhanced serum insulin levels, reduced cell death, and increased cell mass. The effect of pioglitazone was independent of actions on T cells, as pancreatic lymph node T cell populations were unaltered and T cell proliferation was unaffected by pioglitazone. Isolated islets of treated mice showed a more robust unfolded protein response, with increases in Bip and ATF4 and reductions in spliced Xbp1 mRNA. The effect of pioglitazone appears to be a direct action on cells, as islets from mice treated with pioglitazone showed reductions in PPAR- (Ser-273) phosphorylation. Our results demonstrate that PPAR- activation directly improves cell function and survival in NOD mice by enhancing the unfolded protein response and suggest that blockade of PPAR- (Ser-273) phosphorylation may prevent type 1 diabetes.	[Maganti, Aarthi V.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Maganti, Aarthi V.; Tersey, Sarah A.; Colvin, Stephanie C.; Maier, Bernhard; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Tersey, Sarah A.; Syed, Farooq; Nelson, Jennifer B.; Colvin, Stephanie C.; Maier, Bernhard; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Biosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Mirmira, RG (corresponding author), 635 Barnhill Dr,MS2031B, Indianapolis, IN 46202 USA.	rmirmira@iu.edu	Vijaykumar, Aarthi Maganti/AAC-6844-2019; Mirmira, Raghavendra G/AAD-7592-2020; Syed, Farooq/AAK-6781-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Syed, Farooq/0000-0002-0284-0631; Tersey, Sarah/0000-0003-0667-2361	National Institutes of Health [P30 DK097512]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104166, R01DK105588, F32DK094489, R01DK060581, P30DK097512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Stull and K. Benninger of the Center for Diabetes and Metabolic Diseases Islet and Physiology Core laboratory for expert assistance in the isolation of islets and in the metabolic characterization of mice. This work utilized core services supported by National Institutes of Health Grant P30 DK097512 to the Indiana University School of Medicine.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Beales PE, 1998, EUR J PHARMACOL, V357, P221, DOI 10.1016/S0014-2999(98)00574-3; Beales PE, 2002, DIABETES-METAB RES, V18, P114, DOI 10.1002/dmrr.262; Bhat R, 2007, DIABETES RES CLIN PR, V78, P349, DOI 10.1016/j.diabres.2007.04.012; Cabrera SM, 2013, CLIN EXP IMMUNOL, V172, P375, DOI 10.1111/cei.12068; Carrington EM, 2011, EUR J IMMUNOL, V41, P2238, DOI 10.1002/eji.201141476; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi SS, 2016, DIABETES, V65, P829, DOI 10.2337/db15-1382; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Colvin SC, 2013, J BIOL CHEM, V288, P36226, DOI 10.1074/jbc.M113.473942; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Ferrannini E, 2010, DIABETES, V59, P679, DOI 10.2337/db09-1378; Fisher MM, 2013, ENDOCRINOLOGY, V154, P3476, DOI 10.1210/en.2013-1223; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Gastaldelli A, 2007, AM J PHYSIOL-ENDOC M, V292, pE871, DOI 10.1152/ajpendo.00551.2006; Gupta D, 2010, DIABETES OBES METAB, V12, P1036, DOI 10.1111/j.1463-1326.2010.01299.x; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Ishida H, 2004, METABOLISM, V53, P488, DOI 10.1016/j.metabol.2003.11.021; Iwasaki N, 2015, J CELL BIOCHEM, V116, P1300, DOI 10.1002/jcb.25085; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Jorns A, 2014, DIABETOLOGIA, V57, P512, DOI 10.1007/s00125-013-3125-4; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kawano Y, 2009, INTERNAL MED, V48, P1037, DOI 10.2169/internalmedicine.48.1990; Klotz L, 2009, J IMMUNOL, V183, P129, DOI 10.4049/jimmunol.0804260; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Lamontagne J, 2013, DIABETES, V62, P2122, DOI 10.2337/db12-0428; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; LEITER EH, 1987, AM J PATHOL, V128, P380; Lipson KL, 2006, CURR MOL MED, V6, P71, DOI 10.2174/156652406775574613; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Maganti A, 2014, ISLETS, V6, DOI 10.4161/isl.28778; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marre ML, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00067; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; McGinty JW, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0657-7; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Nishio N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13519; O'Sullivan-Murphy B, 2012, DIABETES, V61, P780, DOI 10.2337/db12-0091; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tersey SA, 2014, MOL CELL BIOL, V34, P3735, DOI 10.1128/MCB.00157-14; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Watkins RA, 2016, TRANSL RES, V168, P96, DOI 10.1016/j.trsl.2015.08.010; Watkins RA, 2014, TRANSL RES, V164, P110, DOI 10.1016/j.trsl.2014.02.004; Zdravkovic V, 2006, J PEDIATR-US, V149, P845, DOI 10.1016/j.jpeds.2006.08.049	63	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22524	22533		10.1074/jbc.M116.741694	http://dx.doi.org/10.1074/jbc.M116.741694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27613867	Green Published, hybrid			2022-12-28	WOS:000386760600014
J	Nakamura, A; Tasaki, T; Ishiwata, D; Yamamoto, M; Okuni, Y; Visootsat, A; Maximilien, M; Noji, H; Uchiyama, T; Samejima, M; Igarashi, K; Iino, R				Nakamura, Akihiko; Tasaki, Tomoyuki; Ishiwata, Daiki; Yamamoto, Mayuko; Okuni, Yasuko; Visootsat, Akasit; Maximilien, Morice; Noji, Hiroyuki; Uchiyama, Taku; Samejima, Masahiro; Igarashi, Kiyohiko; Iino, Ryota			Single-molecule Imaging Analysis of Binding, Processive Movement, and Dissociation of Cellobiohydrolase Trichoderma reesei Cel6A and Its Domains on Crystalline Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulase; cellulose; enzyme kinetics; enzyme mechanism; microscopic imaging; molecular motor; processivity; protein domain; single-molecule biophysics	BIOMASS RECALCITRANCE; CEL7A; SURFACE; HYDROLYSIS; MICROCRYSTALS; ADSORPTION; ENZYMES; SYSTEM; MODULE; MOTION	Trichoderma reesei Cel6A (TrCel6A) is a cellobiohydrolase that hydrolyzes crystalline cellulose into cellobiose. Here we directly observed the reaction cycle (binding, surface movement, and dissociation) of single-molecule intact TrCel6A, isolated catalytic domain (CD), cellulose-binding module (CBM), and CBM and linker (CBM-linker) on crystalline cellulose I. The CBM-linker showed a binding rate constant almost half that of intact TrCel6A, whereas those of the CD and CBM were only one-tenth of intact TrCel6A. These results indicate that the glycosylated linker region largely contributes to initial binding on crystalline cellulose. After binding, all samples showed slow and fast dissociations, likely caused by the two different bound states due to the heterogeneity of cellulose surface. The CBM showed much higher specificity to the high affinity site than to the low affinity site, whereas the CD did not, suggesting that the CBM leads the CD to the hydrophobic surface of crystalline cellulose. On the cellulose surface, intact molecules showed slow processive movements (8.8 +/- 5.5 nm/s) and fast diffusional movements (30-40 nm/s), whereas the CBM-Linker, CD, and a catalytically inactive full-length mutant showed only fast diffusional movements. These results suggest that both direct binding and surface diffusion contribute to searching of the hydrolysable point of cellulose chains. The duration time constant for the processive movement was 7.7 s, and processivity was estimated as 68 +/- 42. Our results reveal the role of each domain in the elementary steps of the reaction cycle and provide the first direct evidence of the processive movement of TrCel6A on crystalline cellulose.	[Nakamura, Akihiko; Ishiwata, Daiki; Yamamoto, Mayuko; Okuni, Yasuko; Iino, Ryota] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Iino, Ryota] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Nakamura, Akihiko; Iino, Ryota] Grad Univ Adv Studies SOKENDAI, Dept Funct Mol Sci, Sch Phys Sci, Hayama, Kanagawa 2400193, Japan; [Tasaki, Tomoyuki; Noji, Hiroyuki] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Visootsat, Akasit] Kasetsart Univ, Dept Biochem, Fac Sci, Bangkok 10900, Thailand; [Maximilien, Morice] Natl Chem Engn Inst Paris, F-75005 Paris, France; [Uchiyama, Taku; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Igarashi, Kiyohiko] VTT Tech Res Ctr Finland, FI-02044 Espoo, Vtt, Finland	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; University of Tokyo; Kasetsart University; University of Tokyo; VTT Technical Research Center Finland	Iino, R (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan.	iino@ims.ac.jp	Nakamura, Akihiko/U-1988-2019; Igarashi, Kiyohiko/E-6799-2016; Iino, Ryota/B-7746-2011	Nakamura, Akihiko/0000-0003-0409-5759; Igarashi, Kiyohiko/0000-0001-5152-7177; Iino, Ryota/0000-0003-0110-5704; VISOOTSAT, AKASIT/0000-0002-1258-6745	Ministry of Education, Culture, Sports, Science, and Technology [16H00789, 16H00858, 15H04366, 15H06898]; Imaging Science Project of the Center for Novel Science Initiatives, National Institutes of Natural Sciences Grants [IS271006, IS281005]; ORION project of Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences; Grants-in-Aid for Scientific Research [24114008, 16H00789, 26000011, 15K07383] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Imaging Science Project of the Center for Novel Science Initiatives, National Institutes of Natural Sciences Grants; ORION project of Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology 16H00789, 16H00858, and 15H04366 (to R. I.) and 15H06898 (to A. N.); Imaging Science Project of the Center for Novel Science Initiatives, National Institutes of Natural Sciences Grants IS271006 and IS281005 (to R. I.), and ORION project of Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences (to R. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brady SK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10149; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Carrard G, 1999, EUR J BIOCHEM, V262, P637, DOI 10.1046/j.1432-1327.1999.00455.x; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Igarashi K., 2012, Journal of Applied Glycoscience, V59, P105, DOI 10.5458/jag.jag.JAG-2011_029; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; Isojima H, 2016, NAT CHEM BIOL, V12, P290, DOI [10.1038/NCHEMBIO.2028, 10.1038/nchembio.2028]; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kairdolf BA, 2013, ANNU REV ANAL CHEM, V6, P143, DOI 10.1146/annurev-anchem-060908-155136; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; REINIKAINEN T, 1995, PROTEINS, V22, P392, DOI 10.1002/prot.340220409; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Sugimoto N, 2012, LANGMUIR, V28, P14323, DOI 10.1021/la302352k; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Ueno Hiroshi, 2014, J Biol Chem, V289, P31212, DOI 10.1074/jbc.M114.598177; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wu M, 2013, J BIOL CHEM, V288, P33107, DOI 10.1074/jbc.M113.502765; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	43	32	32	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22404	22413		10.1074/jbc.M116.752048	http://dx.doi.org/10.1074/jbc.M116.752048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609516	Green Published, hybrid			2022-12-28	WOS:000386760600005
J	Lee, JY; Qi, Z; Greene, EC				Lee, Ja Yil; Qi, Zhi; Greene, Eric C.			ATP hydrolysis Promotes Duplex DNA Release by the RecA Presynaptic Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; DNA recombination; DNA repair; homologous recombination; single-molecule biophysics	SINGLE-STRANDED-DNA; HOMOLOGY SEARCH; SACCHAROMYCES-CEREVISIAE; PROTEIN; RECOMBINATION; EXCHANGE; FILAMENTS; RAD51; MECHANISMS; MOLECULES	Homologous recombination is an important DNA repair pathway that plays key roles in maintaining genome stability. Escherichia coli RecA is an ATP-dependent DNA-binding protein that catalyzes the DNA strand exchange reactions in homologous recombination. RecA assembles into long helical filaments on single-stranded DNA, and these presynaptic complexes are responsible for locating and pairing with a homologous duplex DNA. Recent single molecule studies have provided new insights into RecA behavior, but the potential influence of ATP in the reactions remains poorly understood. Here we examine how ATP influences the ability of the RecA presynaptic complex to interact with homologous dsDNA. We demonstrate that over short time regimes, RecA presynaptic complexes sample heterologous dsDNA similarly in the presence of either ATP or ATPS, suggesting that initial interactions do not depend on ATP hydrolysis. In addition, RecA stabilizes pairing intermediates in three-base steps, and stepping energetics is seemingly unaltered in the presence of ATP. However, the overall dissociation rate of these paired intermediates with ATP is approximate to 4-fold higher than with ATPS. These experiments suggest that ATP plays an unanticipated role in promoting the turnover of captured duplex DNA intermediates as RecA attempts to align homologous sequences during the early stages of recombination.	[Lee, Ja Yil; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, Black Bldg Rm 536,650 West 168th St, New York, NY 10032 USA; [Qi, Zhi] Peking Univ, Ctr Quantitat Biol, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Qi, Zhi] Peking Univ, Ctr Life Sci, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China	Columbia University; Peking University; Peking University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Black Bldg Rm 536,650 West 168th St, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu	LEE, JA YIL/S-2207-2016	LEE, JA YIL/0000-0002-5726-9022	National Institutes of Health [R356M118026]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R356M118026 (to E. C. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Bianco P R, 1998, Front Biosci, V3, pD570; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; COX MM, 1994, TRENDS BIOCHEM SCI, V19, P217, DOI 10.1016/0968-0004(94)90025-6; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Danilowicz C, 2014, NUCLEIC ACIDS RES, V42, P526, DOI 10.1093/nar/gkt867; Danilowicz C, 2012, NUCLEIC ACIDS RES, V40, P1717, DOI 10.1093/nar/gkr855; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Gibb B, 2012, ANAL CHEM, V84, P7607, DOI 10.1021/ac302117z; GONDA DK, 1986, J BIOL CHEM, V261, P3087; GONDA DK, 1983, CELL, V34, P647, DOI 10.1016/0092-8674(83)90397-5; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jiang LL, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022704; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kates-Harbeck J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012702; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Prentiss M, 2015, CRIT REV BIOCHEM MOL, V50, P453, DOI 10.3109/10409238.2015.1092943; Qi Z, 2016, METHODS, V105, P62, DOI 10.1016/j.ymeth.2016.03.027; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Renkawitz J, 2013, MOL CELL, V50, P261, DOI 10.1016/j.molcel.2013.02.020; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Weiner A, 2009, NAT REV MICROBIOL, V7, P748, DOI 10.1038/nrmicro2206; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	49	21	22	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22218	22230		10.1074/jbc.M116.740563	http://dx.doi.org/10.1074/jbc.M116.740563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27587394	Green Published, hybrid			2022-12-28	WOS:000386332600033
J	Lee, J; Moraes-Vieira, PM; Castoldi, A; Aryal, P; Yee, EU; Vickers, C; Parnas, O; Donaldson, CJ; Saghatelian, A; Kahn, BB				Lee, Jennifer; Moraes-Vieira, Pedro M.; Castoldi, Angela; Aryal, Pratik; Yee, Eric U.; Vickers, Christopher; Parnas, Oren; Donaldson, Cynthia J.; Saghatelian, Alan; Kahn, Barbara B.			Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Protect against Colitis by Regulating Gut Innate and Adaptive Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						colitis; defensin; innate immunity; lipid; T helper cells; anti-inflammatory lipids; branched fatty acid esters of hydroxy fatty acids; immune regulation; Paneth cell; ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; MOUSE MODEL; EPITHELIAL BARRIER; TH17 CELLS; PROSTAGLANDINS; PREVALENCE; INDUCTION; REMISSION	We recently discovered a structurally novel class of endogenous lipids, branched palmitic acid esters of hydroxy stearic acids (PAHSAs), with beneficial metabolic and anti-inflammatory effects. We tested whether PAHSAs protect against colitis, which is a chronic inflammatory disease driven predominantly by defects in the innate mucosal barrier and adaptive immune system. There is an unmet clinical need for safe and well tolerated oral therapeutics with direct anti-inflammatory effects. Wild-type mice were pretreated orally with vehicle or 5-PAHSA (10 mg/kg) and 9-PAHSA (5 mg/kg) once daily for 3 days, followed by 10 days of either 0% or 2% dextran sulfate sodium water with continued vehicle or PAHSA treatment. The colon was collected for histopathology, gene expression, and flow cytometry. Intestinal crypt fractions were prepared for ex vivo bactericidal assays. Bone marrow-derived dendritic cells pretreated with vehicle or PAHSA and splenic CD4(+) T cells from syngeneic mice were co-cultured to assess antigen presentation and T cell activation in response to LPS. PAHSA treatment prevented weight loss, improved colitis scores (stool consistency, hematochezia, and mouse appearance), and augmented intestinal crypt Paneth cell bactericidal potency via a mechanism that may involve GPR120. In vitro, PAHSAs attenuated dendritic cell activation and subsequent T cell proliferation and Th1 polarization. The anti-inflammatory effects of PAHSAs in vivo resulted in reduced colonic T cell activation and pro-inflammatory cytokine and chemokine expression. These anti-inflammatory effects appear to be partially GPR120-dependent. We conclude that PAHSA treatment regulates innate and adaptive immune responses to prevent mucosal damage and protect against colitis. Thus, PAHSAs may be a novel treatment for colitis and related inflammation-driven diseases.	[Lee, Jennifer; Moraes-Vieira, Pedro M.; Castoldi, Angela; Aryal, Pratik; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Yee, Eric U.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA 02215 USA; [Vickers, Christopher; Donaldson, Cynthia J.; Saghatelian, Alan] Salk Inst Biol Studies, Helmsley Ctr Genom Med, Clayton Fdn, Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Parnas, Oren] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Moraes-Vieira, Pedro M.] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Inst Biol, BR-13083970 Sao Paulo, SP, Brazil; [Castoldi, Angela] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Ave Prof Lineu Prestes 1730 Cidade Univ, BR-05508900 Sao Paulo, SP, Brazil; [Parnas, Oren] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Med, Lautenberg Ctr Immunol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Salk Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidade Estadual de Campinas; Universidade de Sao Paulo; Hebrew University of Jerusalem; Hadassah University Medical Center	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.; Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Moraes-Vieira, Pedro/C-8701-2014; Castoldi, Angela/K-1889-2015	Moraes-Vieira, Pedro/0000-0002-8263-786X; Castoldi, Angela/0000-0002-8434-7989; Aryal, Pratik/0000-0001-6443-8974	NIDDK, National Institutes of Health [RO1 DK043051, P30DK57521, RO1 DK106210]; JPB Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/02218-6, 2011/15682-4, 5T32DK007516-31]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R01DK098002, T32DK007516, R01DK043051, R01DK106210] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JPB Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants RO1 DK043051 and P30DK57521 (to B. B. K.) and RO1 DK106210 (to B. B. K. and A. S.), a grant from the JPB Foundation (to B. B. K.), Leona M. and Harry B. Helmsley Charitable Trust Grant 2012-PG-MED002 (to A. S.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2014/02218-6 and 2011/15682-4 (to A. C.), and 5T32DK007516-31 (to B. B. K. and J. L.). B. B. K., A. S., and P. V. are inventors on a patent and patent applications related to the fatty acid hydroxy fatty acids. J. L. is an inventor on a patent application related to the lipids. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almallah YZ, 1998, AM J GASTROENTEROL, V93, P804, DOI 10.1111/j.1572-0241.1998.229_a.x; Bewtra M, 2014, INFLAMM BOWEL DIS, V20, P103, DOI 10.1097/01.MIB.0000437498.14804.50; Bosco N, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-81; Bressenot A, 2015, GUT, V64, P1412, DOI 10.1136/gutjnl-2014-307477; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Castoldi A, 2015, CURR PROTEIN PEPT SC, V16, P655, DOI 10.2174/1389203716666150630133141; Chen C, 2008, CELL METAB, V7, P135, DOI 10.1016/j.cmet.2007.12.003; Cho JY, 2011, MOL NUTR FOOD RES, V55, P239, DOI 10.1002/mnfr.201000070; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; COREY EJ, 1970, J AM CHEM SOC, V92, P397, DOI 10.1021/ja00705a609; Curdia, 2015, REV ESP ENFERM DIG, V107, P614; Damas OM, 2015, J CROHNS COLITIS, V9, P928, DOI 10.1093/ecco-jcc/jjv118; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Feuerstein JD, 2014, MAYO CLIN PROC, V89, P1553, DOI 10.1016/j.mayocp.2014.07.002; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Geremia A, 2012, EXPERT REV GASTROENT, V6, P223, DOI [10.1586/EGH.11.107, 10.1586/egh.11.107]; Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x; Gonzalez-Cabrera PJ, 2012, MOL PHARMACOL, V81, P166, DOI 10.1124/mol.111.076109; Higenbottam T, 1998, HEART, V80, P151, DOI 10.1136/hrt.80.2.151; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Horst S, 2014, GASTROENTEROL CLIN N, V43, P495, DOI 10.1016/j.gtc.2014.05.005; Ishida T, 2010, INFLAMM BOWEL DIS, V16, P87, DOI 10.1002/ibd.21029; Julia A, 2014, HUM MOL GENET, V23, P6927, DOI 10.1093/hmg/ddu398; KITAHORA T, 1995, J GASTROENTEROL, V30, P5; Lakatos L, 2004, WORLD J GASTROENTERO, V10, P404; Linden C, 1999, DRUG AGING, V14, P387, DOI 10.2165/00002512-199914050-00006; Loeschke K, 1996, DIGEST DIS SCI, V41, P2087, DOI 10.1007/BF02093614; Maxwell Joseph R, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0558s47; Middleton SJ, 2002, ALIMENT PHARM THER, V16, P1131, DOI 10.1046/j.1365-2036.2002.01286.x; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; MONCADA S, 1978, PHARMACOL REV, V30, P293; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Moraes-Vieira PMM, 2014, EUR J IMMUNOL, V44, P794, DOI 10.1002/eji.201343592; Muller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; PATERSON JC, 1961, AM J PATHOL, V38, P243; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sikiric P, 2014, CURR PHARM DESIGN, V20, P1039, DOI 10.2174/138161282007140221100428; Simpson SJ, 1997, EUR J IMMUNOL, V27, P17, DOI 10.1002/eji.1830270104; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; Turner D, 2007, CLIN GASTROENTEROL H, V5, P103, DOI 10.1016/j.cgh.2006.09.033; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Woodworth HL, 2010, CANCER RES, V70, P7960, DOI 10.1158/0008-5472.CAN-10-1396; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	50	81	81	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22207	22217		10.1074/jbc.M115.703835	http://dx.doi.org/10.1074/jbc.M115.703835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573241	hybrid, Green Published			2022-12-28	WOS:000386332600032
J	Li, YP; Dillon, TJ; Takahashi, M; Earley, KT; Stork, PJS				Li, Yanping; Dillon, Tara J.; Takahashi, Maho; Earley, Keith T.; Stork, Philip J. S.			Protein Kinase A-independent Ras Protein Activation Cooperates with Rap1 Protein to Mediate Activation of the Extracellular Signal-regulated Kinases (ERK) by cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); extracellular-signal-regulated kinase (ERK); guanine nucleotide exchange factor (GEF); Ras protein; Ras-related protein 1 (Rap1)	NUCLEOTIDE-EXCHANGE FACTOR; EARLY GENE-PRODUCTS; NERVE GROWTH-FACTOR; B-RAF; CYCLIC-AMP; DEPENDENT ACTIVATION; CELL-PROLIFERATION; MELANOMA-CELLS; MAP KINASE; PC12 CELLS	Cyclic adenosine monophosphate (cAMP) is an important mediator of hormonal stimulation of cell growth and differentiation through its activation of the extracellular signal-regulated kinase (ERK) cascade. Two small G proteins, Ras and Rap1, have been proposed to mediate this activation, with either Ras or Rap1 acting in distinct cell types. Using Hek293 cells, we show that both Ras and Rap1 are required for cAMP signaling to ERKs. The roles of Ras and Rap1 were distinguished by their mechanism of activation, dependence on the cAMP-dependent protein kinase (PKA), and the magnitude and kinetics of their effects on ERKs. Ras was required for the early portion of ERK activation by cAMP and was activated independently of PKA. Ras activation required the Ras/Rap guanine nucleotide exchange factor (GEF) PDZ-GEF1. Importantly, this action of PDZ-GEF1 was disrupted by mutation within its putative cyclic nucleotide-binding domain within PDZ-GEF1. Compared with Ras, Rap1 activation of ERKs was of longer duration. Rap1 activation was dependent on PKA and required Src family kinases and the Rap1 exchanger C3G. This is the first report of a mechanism for the cooperative actions of Ras and Rap1 in cAMP activation of ERKs. One physiological role for the sustained activation of ERKs is the transcription and stabilization of a range of transcription factors, including c-FOS. We show that the induction of c-FOS by cAMP required both the early and sustained phases of ERK activation, requiring Ras and Rap1, as well as for each of the Raf isoforms, B-Raf and C-Raf.	[Li, Yanping; Dillon, Tara J.; Takahashi, Maho; Earley, Keith T.; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Oregon Health & Science University	Stork, PJS (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	stork@ohsu.edu	li, yan/GTI-4638-2022		National Institutes of Health [R01 DK090309, R21 CA191392-01]; NATIONAL CANCER INSTITUTE [R21CA191392, T32CA106195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01 DK090309 and R21 CA191392-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alleaume C, 2003, NEUROPEPTIDES, V37, P98, DOI 10.1016/S0143-4179(03)00020-9; Amsen EM, 2006, J BIOL CHEM, V281, P121, DOI 10.1074/jbc.M507595200; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bouschet T, 2003, J BIOL CHEM, V278, P4778, DOI 10.1074/jbc.M204652200; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Largaespada DA, 2003, CANCER CELL, V4, P3, DOI 10.1016/S1535-6108(03)00171-5; Le Pechon-Vallee C, 2000, NEUROENDOCRINOLOGY, V72, P46, DOI 10.1159/000054570; Li YP, 2013, J BIOL CHEM, V288, P27646, DOI 10.1074/jbc.M113.463067; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lorenz K, 2009, INT J BIOCHEM CELL B, V41, P2351, DOI 10.1016/j.biocel.2009.08.002; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Merkel MJ, 2010, AM J PHYSIOL-HEART C, V298, pH679, DOI 10.1152/ajpheart.00533.2009; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Pak Y, 2002, MOL CELL BIOL, V22, P7942, DOI 10.1128/MCB.22.22.7942-7952.2002; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Romano D, 2003, J BIOL CHEM, V278, P51386, DOI 10.1074/jbc.M308372200; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Schmitt JM, 2002, J BIOL CHEM, V277, P43024, DOI 10.1074/jbc.M204006200; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Van Kolen K, 2010, NEUROPHARMACOLOGY, V58, P135, DOI 10.1016/j.neuropharm.2009.06.022; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Wittchen Erika S, 2011, Small GTPases, V2, P65; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zeiller C, 2012, CELL SIGNAL, V24, P2237, DOI 10.1016/j.cellsig.2012.08.006	69	25	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21584	21595		10.1074/jbc.M116.730978	http://dx.doi.org/10.1074/jbc.M116.730978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531745	hybrid, Green Published			2022-12-28	WOS:000385999200025
J	Liu, L; Phua, YW; Lee, RS; Ma, XQ; Jenkins, Y; Novy, K; Humphrey, ES; Chan, H; Shearer, R; Ong, PC; Dai, WW; Saunders, DN; Lucet, IS; Daly, RJ				Liu, Ling; Phua, Yu Wei; Lee, Rachel S.; Ma, Xiuquan; Jenkins, Yiping; Novy, Karel; Humphrey, Emily S.; Chan, Howard; Shearer, Robert; Ong, Poh Chee; Dai, Weiwen; Saunders, Darren N.; Lucet, Isabelle S.; Daly, Roger J.			Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; oncogene; protein kinase; scaffold protein; signal transduction	EPITHELIAL-CELLS; CARCINOMA-CELLS; PROTEIN; GROWTH; CANCER; QUANTIFICATION; REVEALS; KINASES; PRAGMIN; GENOME	SgK269/PEAK1 is a pseudokinase and scaffolding protein that plays a critical role in regulating growth factor receptor signal output and is implicated in the progression of several cancers, including those of the breast, colon, and pancreas. SgK269 is structurally related to SgK223, a human pseudokinase that also functions as a scaffold but recruits a distinct repertoire of signaling proteins compared with SgK269. Structural similarities between SgK269 and SgK223 include a predicted -helical region (designated CH) immediately preceding the conserved C-terminal pseudokinase (PK) domain. Structure-function analyses of SgK269 in MCF-10A mammary epithelial cells demonstrated a critical role for the CH and PK regions in promoting cell migration and Stat3 activation. Characterization of the SgK269 interactome by mass spectrometry-based proteomics identified SgK223 as a novel binding partner, and association of SgK269 with SgK223 in cells was dependent on the presence of the CH and PK domains of both pseudokinases. Homotypic association of SgK269 and SgK223 was also demonstrated and exhibited the same structural requirements. Further analysis using pulldowns and size-exclusion chromatography underscored the critical role of the CH region in SgK269/SgK223 association. Importantly, although SgK269 bridged SgK223 to Grb2, it was unable to activate Stat3 or efficiently enhance migration in SgK223 knock-out cells generated by CRISPR/Cas9. These results reveal previously unrecognized interplay between two oncogenic scaffolds and demonstrate a novel signaling mechanism for pseudokinases whereby homotypic and heterotypic association is used to assemble scaffolding complexes with distinct binding properties and hence qualitatively regulate signal output.	[Liu, Ling; Phua, Yu Wei; Lee, Rachel S.; Ma, Xiuquan; Jenkins, Yiping; Novy, Karel; Chan, Howard; Ong, Poh Chee; Daly, Roger J.] Monash Univ, Biomed Discovery Inst, Canc Program, Level 1,Bldg 77, Clayton, Vic 3800, Australia; [Liu, Ling; Phua, Yu Wei; Lee, Rachel S.; Ma, Xiuquan; Jenkins, Yiping; Novy, Karel; Chan, Howard; Ong, Poh Chee; Daly, Roger J.] Monash Univ, Dept Biochem & Mol Biol, Level 1,Bldg 77, Clayton, Vic 3800, Australia; [Humphrey, Emily S.; Shearer, Robert; Saunders, Darren N.] Kinghorn Canc Ctr, Garvan Inst Med Res, Canc Res Program, 384 Victoria St, Sydney, NSW 2010, Australia; [Dai, Weiwen; Lucet, Isabelle S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Dai, Weiwen; Lucet, Isabelle S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Saunders, Darren N.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia	Monash University; Monash University; Garvan Institute of Medical Research; Walter & Eliza Hall Institute; University of Melbourne; University of New South Wales Sydney	Daly, RJ (corresponding author), Monash Univ, Biomed Discovery Inst, Canc Program, Level 1,Bldg 77, Clayton, Vic 3800, Australia.	roger.daly@monash.edu	Ma, Hugh/S-4266-2019	Ma, Hugh/0000-0001-7227-1289; Daly, Roger/0000-0002-5739-8027; Saunders, Darren/0000-0003-0924-0513	National Health and Medical Research Council of Australia [1084621]; National Health and Medical Research Council ECR Fellowship [1054497]; Research Scholar Award from the Cancer Institute of New South Wales [10/RSA/1-28]; Australian Postgraduate Award from the University of New South Wales; Baxter Family Scholarship; Australian Cancer Research Foundation; National Health and Medical Research Council [1052963]; Walter and Eliza Hall Institute; National Health and Medical Research Council Fellowship [1058540]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council ECR Fellowship; Research Scholar Award from the Cancer Institute of New South Wales; Australian Postgraduate Award from the University of New South Wales; Baxter Family Scholarship; Australian Cancer Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Walter and Eliza Hall Institute; National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Project Grant 1084621 from the National Health and Medical Research Council of Australia. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council ECR Fellowship 1054497.; Recipient of Research Scholar Award 10/RSA/1-28 from the Cancer Institute of New South Wales and an Australian Postgraduate Award from the University of New South Wales.; Supported by a Baxter Family Scholarship.; Supported by the Australian Cancer Research Foundation.; Supported by National Health and Medical Research Council Grant 1052963.; Supported by Australian Cancer Research Foundation and by the Walter and Eliza Hall Institute.; Supported by National Health and Medical Research Council Fellowship 1058540. To whom correspondence should be addressed. Tel.: 61-3-990-29301; Fax: 61-3-990-29500; E-mail: roger.daly@monash.edu.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croucher DR, 2013, CANCER RES, V73, P1969, DOI 10.1158/0008-5472.CAN-12-1472; Croucher DR, 2010, MOL CELL BIOL, V30, P5057, DOI 10.1128/MCB.00249-10; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Lavoie H, 2014, TRENDS BIOCHEM SCI, V39, P475, DOI 10.1016/j.tibs.2014.08.004; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiterer V, 2014, TRENDS CELL BIOL, V24, P489, DOI 10.1016/j.tcb.2014.03.008; Safari F, 2011, P NATL ACAD SCI USA, V108, P14938, DOI 10.1073/pnas.1107740108; Tactacan CM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0412-3; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	24	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21571	21583		10.1074/jbc.M116.748897	http://dx.doi.org/10.1074/jbc.M116.748897			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531744	hybrid, Green Published			2022-12-28	WOS:000385999200024
J	Smith, J; Yang, YW; Levy, S; Adelusi, OO; Hahn, MG; O'Neill, MA; Bar-Peled, M				Smith, James; Yang, Yiwen; Levy, Shahar; Adelusi, Oluwatoyin Oluwayemi; Hahn, Michael G.; O'Neill, Malcolm A.; Bar-Peled, Maor			Functional Characterization of UDP-apiose Synthases from Bryophytes and Green Algae Provides Insight into the Appearance of Apiose-containing Glycans during Plant Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; decarboxylase; glycosyltransferase; plant cell wall; vascular	D-XYLOSE SYNTHASE; POLYSACCHARIDE RHAMNOGALACTURONAN II; BETA-D-XYLOSYLTRANSFERASE; CELL-WALL; PECTIC POLYSACCHARIDE; PHYSCOMITRELLA-PATENS; ESCHERICHIA-COLI; GLUCURONIC ACID; CROSS-LINKING; BORATE ESTER	Apiose is a branched monosaccharide that is present in the cell wall pectic polysaccharides rhamnogalacturonan II and apiogalacturonan and in numerous plant secondary metabolites. These apiose-containing glycans are synthesized using UDP-apiose as the donor. UDP-apiose (UDP-Api) together with UDP-xylose is formed from UDP-glucuronic acid (UDP-GlcA) by UDP-Api synthase (UAS). It was hypothesized that the ability to form Api distinguishes vascular plants from the avascular plants and green algae. UAS from several dicotyledonous plants has been characterized; however, it is not known if avascular plants or green algae produce this enzyme. Here we report the identification and functional characterization of UAS homologs from avascular plants (mosses, liverwort, and hornwort), from streptophyte green algae, and from a monocot (duckweed). The recombinant UAS homologs all form UDP-Api from UDP-glucuronic acid albeit in different amounts. Apiose was detected in aqueous methanolic extracts of these plants. Apiose was detected in duckweed cell walls but not in the walls of the avascular plants and algae. Overexpressing duckweed UAS in the moss Physcomitrella patens led to an increase in the amounts of aqueous methanol-acetonitrile-soluble apiose but did not result in discernible amounts of cell wall-associated apiose. Thus, bryophytes and algae likely lack the glycosyltransferase machinery required to synthesize apiose-containing cell wall glycans. Nevertheless, these plants may have the ability to form apiosylated secondary metabolites. Our data are the first to provide evidence that the ability to form apiose existed prior to the appearance of rhamnogalacturonan II and apiogalacturonan and provide new insights into the evolution of apiose-containing glycans.	[Smith, James; Hahn, Michael G.; O'Neill, Malcolm A.; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Smith, James; Levy, Shahar; Adelusi, Oluwatoyin Oluwayemi] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Yang, Yiwen; Hahn, Michael G.; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, CCRC 315 Riverbend Rd, Athens, GA 30602 USA; [Yang, Yiwen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Bar-Peled, M (corresponding author), Univ Georgia, Dept Plant Biol, CCRC 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu	Hahn, Michael/AHC-5847-2022		Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-12ER16324, DE-FG02-12ER16326]; United States Department of Energy [DE-FG02-93ER20097]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-12ER16324 and Grant DE-FG02-12ER16326 (to M. A. O and M. B.-P.) for funding studies of apiose synthesis and United States Department of Energy-funded Center for Plant and Microbial Complex Carbohydrates Grant DE-FG02-93ER20097 for funding analytical equipment support. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Bar-Peled M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00092; Baylson FA, 2001, J PHYCOL, V37, P796, DOI 10.1046/j.1529-8817.2001.00179.x; Beck E., 1990, Methods in Plant Biochemistry, Vol. 2: Carbohydrates., P235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Broach B, 2012, FEBS J, V279, P100, DOI 10.1111/j.1742-4658.2011.08402.x; Camacho-Cristobal JJ, 2008, J INTEGR PLANT BIOL, V50, P1247, DOI 10.1111/j.1744-7909.2008.00742.x; Choi SH, 2012, J AM CHEM SOC, V134, P13946, DOI 10.1021/ja305322x; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; Dumont M, 2014, ANN BOT-LONDON, V114, P1177, DOI 10.1093/aob/mcu093; ECKEYKALTENBACH H, 1993, PHYTOCHEMISTRY, V34, P687, DOI 10.1016/0031-9422(93)85340-W; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; Gloaguen V, 2010, J NAT PROD, V73, P1087, DOI 10.1021/np100092c; Golovchenko VV, 2002, PHYTOCHEMISTRY, V60, P89, DOI 10.1016/S0031-9422(02)00040-7; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Grisebach H., 1980, The biochemistry of plants. A comprehensive treatise. Volume 3. Carbohydrates: structure and function., P171; GRISEBACH H, 1964, BIOCHEM BIOPH RES CO, V17, P737, DOI 10.1016/0006-291X(64)90423-1; Gu XG, 2011, MICROBIOL-SGM, V157, P260, DOI 10.1099/mic.0.040758-0; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; HART DA, 1970, BIOCHEM J, V116, P569, DOI 10.1042/bj1160569; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Hwang S, 2014, J BIOL CHEM, V289, P35620, DOI 10.1074/jbc.M114.614917; Ishii T, 1996, CARBOHYD RES, V284, P1, DOI 10.1016/0008-6215(96)00010-9; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Kobayashi M, 2002, PLANT CELL PHYSIOL, V43, P1259, DOI 10.1093/pcp/pcf157; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; LONGLAND JM, 1989, PLANT PHYSIOL, V90, P972, DOI 10.1104/pp.90.3.972; Matasci N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-17; MATOH T, 1993, PLANT CELL PHYSIOL, V34, P639; Matoh T, 1996, PLANT CELL PHYSIOL, V37, P636, DOI 10.1093/oxfordjournals.pcp.a028992; McCarthy TW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-79; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; Neilson EH, 2013, TRENDS PLANT SCI, V18, P250, DOI 10.1016/j.tplants.2013.01.001; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Ortiz-Ramirez C, 2016, MOL PLANT, V9, P205, DOI 10.1016/j.molp.2015.12.002; ORTMANN R, 1972, BIOCHIM BIOPHYS ACTA, V289, P293, DOI 10.1016/0005-2744(72)90080-0; Pabst M, 2013, PLANT J, V76, P61, DOI 10.1111/tpj.12271; Picmanova M, 2016, GLYCOBIOLOGY, V26, P430, DOI 10.1093/glycob/cww012; Polizzi SJ, 2012, BIOCHEMISTRY-US, V51, P8844, DOI 10.1021/bi301135b; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Roberts AW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00166; SANDERMA.H, 1968, BIOCHIM BIOPHYS ACTA, V165, P552, DOI 10.1016/0304-4165(68)90239-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Vidali L, 2007, PLANT CELL, V19, P3705, DOI 10.1105/tpc.107.053413; Wakuta S, 2015, PLANT CELL PHYSIOL, V56, P852, DOI 10.1093/pcp/pcv011; Walsh RM, 2015, BIOCHEMISTRY-US, V54, P807, DOI 10.1021/bi501357c; Watson R R, 1975, Adv Carbohydr Chem Biochem, V31, P135; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang T, 2012, ANAL BIOCHEM, V421, P691, DOI 10.1016/j.ab.2011.12.028; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; Yin YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027995; YORK WS, 1986, METHOD ENZYMOL, V118, P3	64	10	10	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21434	21447		10.1074/jbc.M116.749069	http://dx.doi.org/10.1074/jbc.M116.749069			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551039	Green Published, hybrid			2022-12-28	WOS:000385999200012
J	Wang, ZH; Bhattacharya, A; Villacorta, J; Diaz-Griffero, F; Ivanov, DN				Wang, Zhonghua; Bhattacharya, Akash; Villacorta, Jessica; Diaz-Griffero, Felipe; Ivanov, Dmitri N.			Allosteric Activation of SAMHD1 Protein by Deoxynucleotide Triphosphate (dNTP)-dependent Tetramerization Requires dNTP Concentrations That Are Similar to dNTP Concentrations Observed in Cycling T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; human immunodeficiency virus (HIV); innate immunity; nucleoside; nucleotide metabolism; retrovirus	IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCYTE-DERIVED MACROPHAGES; RESTRICTION FACTOR SAMHD1; DEOXYGUANOSINE TRIPHOSPHATE; ESCHERICHIA-COLI; STRUCTURAL BASIS; HIV-1 INFECTION; TRIPHOSPHOHYDROLASE; PHOSPHORYLATION; INHIBITION	SAMHD1 is a dNTP hydrolase, whose activity is required for maintaining low dNTP concentrations in non-cycling T cells, dendritic cells, and macrophages. SAMHD1-dependent dNTP depletion is thought to impair retroviral replication in these cells, but the relationship between the dNTPase activity and retroviral restriction is not fully understood. In this study, we investigate allosteric activation of SAMHD1 by deoxynucleotide-dependent tetramerization and measure how the lifetime of the enzymatically active tetramer is affected by different dNTP ligands bound in the allosteric site. The EC50dNTP values for SAMHD1 activation by dNTPs are in the 2-20 m range, and the half-life of the assembled tetramer after deoxynucleotide depletion varies from minutes to hours depending on what dNTP is bound in the A2 allosteric site. Comparison of the wild-type SAMHD1 and the T592D mutant reveals that the phosphomimetic mutation affects the rates of tetramer dissociation, but has no effect on the equilibrium of allosteric activation by deoxynucleotides. Collectively, our data suggest that deoxynucleotide-dependent tetramerization contributes to regulation of deoxynucleotide levels in cycling cells, whereas in non-cycling cells restrictive to retroviral replication, SAMHD1 activation is likely to be achieved through a distinct mechanism.	[Wang, Zhonghua; Bhattacharya, Akash; Villacorta, Jessica; Ivanov, Dmitri N.] Univ Texas San Antonio, Dept Biochem, Hlth Sci Ctr, San Antonio, TX 78229 USA; [Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; Yeshiva University; Albert Einstein College of Medicine	Ivanov, DN (corresponding author), Univ Texas San Antonio, Dept Biochem, Hlth Sci Ctr, San Antonio, TX 78229 USA.	ivanov@uthscsa.edu	Bhattacharya, Akash/G-9154-2016; Ivanov, Dmitri/B-4600-2011	Bhattacharya, Akash/0000-0001-8748-9969; 	National Institutes of Health [R01 AI104476, R01 AI087390]; Voelcker Fund Young Investigator Award; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087390, R01AI104476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R01 AI104476 (to D. N. I.) and R01 AI087390 to (F. D.-G.) and a Voelcker Fund Young Investigator Award (to D. N. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold LH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005194; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BEAUCHAMP BB, 1988, P NATL ACAD SCI USA, V85, P2563, DOI 10.1073/pnas.85.8.2563; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Bhattacharya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31353; Brandariz-Nunez A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-131; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hollenbaugh JA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0063-2; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; SETO D, 1988, J BIOL CHEM, V263, P1494; Welbourn S, 2016, VIROLOGY, V488, P271, DOI 10.1016/j.virol.2015.11.022; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2015, ACTA CRYSTALLOGR D, V71, P516, DOI 10.1107/S1399004714027527; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	28	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21407	21413		10.1074/jbc.C116.751446	http://dx.doi.org/10.1074/jbc.C116.751446			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27566548	Green Published, hybrid			2022-12-28	WOS:000385999200006
J	Richard, J; Kim, ED; Nguyen, H; Kim, CD; Kim, S				Richard, Jessica; Kim, Elizabeth D.; Hoang Nguyen; Kim, Catherine D.; Kim, Sunyoung			Allostery Wiring Map for Kinesin Energy Transduction and Its Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DOUBLE-MUTANT CYCLES; PHYLOGENETIC TREES; NECK-LINKER; LONG-RANGE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; MOLECULAR MOTORS; ACTIVE-SITE; PROTEINS	How signals between the kinesin active and cytoskeletal binding sites are transmitted is an open question and an allosteric question. By extracting correlated evolutionary changes within 700+ sequences, we built a model of residues that are energetically coupled and that define molecular routes for signal transmission. Typically, these coupled residues are located at multiple distal sites and thus are predicted to form a complex, non-linear network that wires together different functional sites in the protein. Of note, our model connected the site for ATP hydrolysis with sites that ultimately utilize its free energy, such as the microtubule-binding site, drug-binding loop 5, and necklinker. To confirm the calculated energetic connectivity between non-adjacent residues, double-mutant cycle analysis was conducted with 22 kinesin mutants. There was a direct correlation between thermodynamic coupling in experiment and evolutionarily derived energetic coupling. We conclude that energy transduction is coordinated by multiple distal sites in the protein rather than only being relayed through adjacent residues. Moreover, this allosteric map forecasts how energetic orchestration gives rise to different nanomotor behaviors within the superfamily.	Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Kim, Sunyoung] Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA	Louisiana State University System	Kim, S (corresponding author), Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.; Kim, S (corresponding author), LSU Sch Med, 1901 Perdido St, New Orleans, LA 70112 USA.	skim3@lsuhsc.edu			National Institutes of Health [R01GM097350]; Louisiana Board of Regents; School of Graduate Studies at Louisiana State University Health Sciences Center in New Orleans; Louisiana State University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; School of Graduate Studies at Louisiana State University Health Sciences Center in New Orleans; Louisiana State University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM097350 (to S. K.) and by funds from the Louisiana Board of Regents (to S. K.), the School of Graduate Studies at Louisiana State University Health Sciences Center in New Orleans (to J. R.), and Louisiana State University School of Medicine (to H. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2010, PROTEIN ENG DES SEL, V23, P321, DOI 10.1093/protein/gzp078; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Caraglio M, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062712; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Friel CT, 2012, J MUSCLE RES CELL M, V33, P377, DOI 10.1007/s10974-012-9289-6; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; HOROVITZ A, 1994, J MOL BIOL, V238, P133, DOI 10.1006/jmbi.1994.1275; Howard J., 2011, POINC SEM 2009; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Istomin AY, 2008, PROTEINS, V70, P915, DOI 10.1002/prot.21620; Juanico B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.238104; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Lawrence CJ, 2002, J MOL EVOL, V54, P42, DOI 10.1007/s00239-001-0016-y; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; LEVY RM, 1982, P NATL ACAD SCI USA, V79, P1346, DOI 10.1073/pnas.79.4.1346; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu LQ, 2014, J BIOL CHEM, V289, P16601, DOI 10.1074/jbc.M114.551408; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luccioli S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046008; Ma CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026453; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; MILDVAN AS, 1992, ARCH BIOCHEM BIOPHYS, V294, P327, DOI 10.1016/0003-9861(92)90692-P; Miller M. A., 2010, P GAT COMP ENV WORKS, ps1; Nicolai A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18128; Oster G., 2002, MOL MOTORS; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Pervez MT, 2014, EVOL BIOINFORM, V10, DOI 10.4137/EBO.S19199; Piazza F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046014; Prosdocimi F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-5; Reynolds KA, 2013, METHOD ENZYMOL, V523, P213, DOI 10.1016/B978-0-12-394292-0.00010-2; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Scarabelli G, 2014, BIOPHYS J, V107, P2204, DOI 10.1016/j.bpj.2014.09.019; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; van den Berg BHJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010642; Vologodskii A, 2006, PHYS LIFE REV, V3, P119, DOI 10.1016/j.plrev.2006.02.002; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wickstead B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-110; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023; Yu J., 2012, SATE	71	8	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20932	20945		10.1074/jbc.M116.733675	http://dx.doi.org/10.1074/jbc.M116.733675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27507814	hybrid, Green Published			2022-12-28	WOS:000385406200012
J	Suess, PM; Gomer, RH				Suess, Patrick M.; Gomer, Richard H.			Extracellular Polyphosphate Inhibits Proliferation in an Autocrine Negative Feedback Loop in Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell growth; cell proliferation; Dictyostelium; stress; inositol hexakisphosphate kinase; polyphosphate; polyphosphate kinase	REPRESSES CELL-PROLIFERATION; INORGANIC POLYPHOSPHATE; STATIONARY-PHASE; SACCHAROMYCES-CEREVISIAE; EPIDERMAL CHALONE; ESCHERICHIA-COLI; RECEPTOR-BINDING; GROWTH; MOLECULE; KINASE	Polyphosphate is a polymer of phosphate residues linked by high energy phosphoanhydride bonds. Despite being highly conserved throughout nature, its function is poorly understood. Here we show that Dictyostelium cells accumulate extracellular polyphosphate, and this acts to inhibit proliferation at high cell densities. In shaking culture, extracellular polyphosphate concentrations increase as cell density increases, and if the concentration of polyphosphate observed at the stationary phase is added to cells at mid-log, proliferation is halted. Adding an exopolyphosphatase to cell cultures or stationary phase conditioned medium decreases polyphosphate levels and abrogates the anti-proliferative effect. The cells show saturable binding of polyphosphate, suggesting the presence of a cell surface polyphosphate receptor. Extracellular polyphosphate accumulation is potentiated by decreased nutrient levels, potentially as a means to anticipate starvation. Loss of the Dictyostelium polyphosphate kinase DdPpk1 causes intracellular polyphosphate levels to become undetectable and negatively affects fitness, cytokinesis, and germination. However, cells lacking DdPpk1 accumulate approximate to 50% normal levels of extracellular polyphosphate, suggesting an additional means of synthesis. We found that cells lacking inositol hexakisphosphate kinase, which is responsible for the synthesis of the inositol pyrophosphates IP7 and IP8, reach abnormally high cell densities and show decreased extracellular polyphosphate levels. Two different enzymes thus appear to mediate the synthesis of Dictyostelium extracellular polyphosphate, which is used as a signal in an autocrine negative feedback loop to regulate cell proliferation.	[Suess, Patrick M.; Gomer, Richard H.] Texas A&M Univ, Dept Biol, ILSB 301 Old Main Dr, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, ILSB 301 Old Main Dr, College Stn, TX 77843 USA.	rgomer@tamu.edu		Suess, Patrick/0000-0002-9805-9005; Gomer, Richard/0000-0003-2361-4307	National Institutes of Health [R01 GM102280]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 GM102280. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achbergerova L, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-63; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-44; BOLDINGH WH, 1968, EUR J BIOCHEM, V5, P191; BRITIGAN BE, 1994, ADV EXP MED BIOL, V357, P143; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; BULLOUGH WS, 1965, CANCER RES, V25, P1683; BULLOUGH WS, 1964, EXP CELL RES, V36, P192, DOI 10.1016/0014-4827(64)90172-7; CATERINA MJ, 1995, J BIOL CHEM, V270, P4418, DOI 10.1074/jbc.270.9.4418; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choe JM, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-4; Choi SH, 2010, BIOCHEMISTRY-US, V49, P9935, DOI 10.1021/bi1014437; Ghosh S, 2013, BLOOD, V122, P1478, DOI 10.1182/blood-2013-01-481549; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Kolozsvari B, 2014, BIOCHEM J, V460, P377, DOI 10.1042/BJ20140237; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Livermore TM, 2016, P NATL ACAD SCI USA, V113, P996, DOI 10.1073/pnas.1519440113; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; LOW JE, 1986, J PHARMACOL EXP THER, V238, P39; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; METCALF D, 1964, TRANSPLANTATION, V2, P387, DOI 10.1097/00007890-196405000-00008; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Morrissey JH, 2013, BLOOD, V122, P1331, DOI 10.1182/blood-2013-07-511006; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Muller A, 1996, J IMMUNOL, V156, P3418; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Nikel PI, 2013, MICROB CELL FACT, V12, DOI [10.1186/s12934-014-0159-3, 10.1186/1475-2859-12-50]; PEERS FG, 1953, BIOCHEM J, V53, P102, DOI 10.1042/bj0530102; Phillips JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096633; Pisani F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085533; Rao N N, 1999, Prog Mol Subcell Biol, V23, P183; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; SAETREN H, 1956, EXP CELL RES, V11, P229, DOI 10.1016/0014-4827(56)90212-9; Saiardi Adolfo, 2012, Advances in Biological Regulation, V52, P351, DOI 10.1016/j.jbior.2012.03.002; SASSIER P, 1977, CELL TISSUE KINET, V10, P223, DOI 10.1111/j.1365-2184.1977.tb00290.x; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; SODA R, 1984, BLOOD, V63, P270; SOLL DR, 1976, J CELL SCI, V20, P513; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; WURST H, 1994, J BIOL CHEM, V269, P10996; WURSTER B, 1980, EUR J BIOCHEM, V109, P613, DOI 10.1111/j.1432-1033.1980.tb04834.x; Yamanaka Y, 1999, ENDOCRINOLOGY, V140, P1319, DOI 10.1210/en.140.3.1319; YARGER J, 1974, J CELL SCI, V14, P681; Zhang HY, 2007, P NATL ACAD SCI USA, V104, P16486, DOI 10.1073/pnas.0706847104; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P2731, DOI 10.1073/pnas.0500023102	52	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20260	20269		10.1074/jbc.M116.737825	http://dx.doi.org/10.1074/jbc.M116.737825			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27519410	hybrid, Green Published			2022-12-28	WOS:000383243100044
J	Colombo, SF; Cardani, S; Maroli, A; Vitiello, A; Soffientini, P; Crespi, A; Bram, RJ; Benfante, R; Borgese, N				Colombo, Sara Francesca; Cardani, Silvia; Maroli, Annalisa; Vitiello, Adriana; Soffientini, Paolo; Crespi, Arianna; Bram, Richard J.; Benfante, Roberta; Borgese, Nica			Tail-anchored protein insertion in mammals. FUNCTION AND RECIPROCAL INTERACTIONS OF THE TWO SUBUNITS OF THE TRC4O RECEPTOR (vol 291, pg 15292, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Benfante, Roberta/C-1513-2015; Borgese, Nica/GWZ-8895-2022	Benfante, Roberta/0000-0001-5396-5429; Borgese, Nica/0000-0002-7537-3974; Soffientini, Paolo/0000-0002-1730-5615				Colombo SF, 2016, J BIOL CHEM, V291, P15292, DOI 10.1074/jbc.M115.707752	1	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18855	18855		10.1074/jbc.A115.707752	http://dx.doi.org/10.1074/jbc.A115.707752			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27591255	Green Published, hybrid			2022-12-28	WOS:000383242300023
J	Wang, ZQ; Liu, Q; Lu, JH; Fan, P; Xie, WD; Qiu, W; Wang, F; Hu, GN; Zhang, Y				Wang, Ziqiang; Liu, Qing; Lu, Jinhua; Fan, Ping; Xie, Weidong; Qiu, Wei; Wang, Fan; Hu, Guangnan; Zhang, Yaou			Serine/Arginine-rich Splicing Factor 2 Modulates Herpes Simplex Virus Type 1 Replication via Regulating Viral Gene Transcriptional Activity and Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; SR PROTEINS; POLYMERASE-II; HIV-1 RNA; SC35; INFECTION; ICP0; DEGRADATION; IMMUNOPRECIPITATION; COMPLEX	Once it enters the host cell, herpes simplex virus type 1 (HSV-1) recruits a series of host cell factors to facilitate its life cycle. Here, we demonstrate that serine/arginine-rich splicing factor 2 (SRSF2), which is an important component of the splicing speckle, mediates HSV-1 replication by regulating viral gene expression at the transcriptional and posttranscriptional levels. Our results indicate that SRSF2 functions as a transcriptional activator by directly binding to infected cell polypeptide 0 (ICP0), infected cell polypeptide 27 (ICP27), and thymidine kinase promoters. Moreover, SRSF2 participates in ICP0 pre-mRNA splicing by recognizing binding sites in ICP0 exon 3. These findings provide insight into the functions of SRSF2 in HSV-1 replication and gene expression.	[Wang, Ziqiang; Liu, Qing; Fan, Ping; Qiu, Wei; Wang, Fan] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Ziqiang; Liu, Qing; Fan, Ping; Xie, Weidong; Qiu, Wei; Wang, Fan; Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Hlth Sci & Technol, Div Life Sci, Shenzhen 518055, Peoples R China; [Lu, Jinhua] Shenzhen South China Pharmaceut Co Ltd, Shenzhen 518055, Peoples R China; [Hu, Guangnan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of Massachusetts System; University of Massachusetts Worcester	Zhang, Y (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Hlth Sci & Technol, Div Life Sci, Shenzhen 518055, Peoples R China.	zhangyo@sz.tsinghua.edu.cn	liu, qingqing/HHD-0360-2022; Wang, Ziqiang/AAW-5525-2020; Liu, Qing/GWC-9222-2022	wang, ziqiang/0000-0002-4676-3447; Zhang, Yaou/0000-0002-2501-8093	National Natural Science Foundation of China [31371315]; Ministry of Health, China [2012ZX09102301-019]; Basic Research Fund of Shenzhen [JCYJ20150724173156330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health, China; Basic Research Fund of Shenzhen	This work was supported by the National Natural Science Foundation of China (31371315), the Ministry of Health, China (2012ZX09102301-019), and Basic Research Fund of Shenzhen (JCYJ20150724173156330). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Dujaili LJ, 2011, FUTURE MICROBIOL, V6, P877, DOI 10.2217/FMB.11.73; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Boe SO, 1998, VIROLOGY, V244, P473, DOI 10.1006/viro.1998.9110; Burge CB, 1999, RNA WORLD, P525; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; Erkelenz S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0154-8; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Gu HD, 2007, P NATL ACAD SCI USA, V104, P17134, DOI 10.1073/pnas.0707266104; Gu HD, 2003, P NATL ACAD SCI USA, V100, P8963, DOI 10.1073/pnas.1533420100; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Hsia S C, 2013, Br Microbiol Res J, V3, P706; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kalamvoki M, 2009, P NATL ACAD SCI USA, V106, P14576, DOI 10.1073/pnas.0906905106; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; McFarlane M, 2015, J VIROL, V89, P5276, DOI 10.1128/JVI.03434-14; OReilly D, 1997, EMBO J, V16, P2420, DOI 10.1093/emboj/16.9.2420; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Pinnoji RC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-56; QUINLAN MP, 1984, CELL, V36, P857, DOI 10.1016/0092-8674(84)90035-7; RICE SA, 1995, J VIROL, V69, P5550, DOI 10.1128/JVI.69.9.5550-5559.1995; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Rowles DL, 2015, PROTEOMICS, V15, P1968, DOI 10.1002/pmic.201500035; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; Sedlackova L, 2008, J VIROL, V82, P268, DOI 10.1128/JVI.01588-07; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Workenhe ST, 2016, ONCOGENE, V35, P2465, DOI 10.1038/onc.2015.303; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	37	11	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26377	26387		10.1074/jbc.M116.753046	http://dx.doi.org/10.1074/jbc.M116.753046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27784784	Green Published, hybrid			2022-12-28	WOS:000391568200012
J	Minard, AY; Wong, MKL; Chaudhuri, R; Tan, SX; Humphrey, SJ; Parker, BL; Yang, JY; Laybutt, DR; Cooney, GJ; Coster, ACF; Stockli, J; James, DE				Minard, Annabel Y.; Wong, Martin K. L.; Chaudhuri, Rima; Tan, Shi-Xiong; Humphrey, Sean J.; Parker, Benjamin L.; Yang, Jean Y.; Laybutt, D. Ross; Cooney, Gregory J.; Coster, Adelle C. F.; Stockli, Jacqueline; James, David E.			Hyperactivation of the Insulin Signaling Pathway Improves Intracellular Proteostasis by Coordinately Up-regulating the Proteostatic Machinery in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; insulin; insulin resistance; proteomics; proteostasis; pulse-chase SILAC	ENDOPLASMIC-RETICULUM STRESS; LIFE-SPAN EXTENSION; PROTEIN-SYNTHESIS; ADIPOSE-TISSUE; ER STRESS; RESISTANCE; AGGREGATION; EXPRESSION; AUTOPHAGY; OBESITY	Hyperinsulinemia, which is associated with aging and metabolic disease, may lead to defective protein homeostasis (proteostasis) due to hyperactivation of insulin-sensitive pathways such as protein synthesis. We investigated the effect of chronic hyperinsulinemia on proteostasis by generating a time-resolved map of insulin-regulated protein turnover in adipocytes using metabolic pulse-chase labeling and high resolution mass spectrometry. Hyperinsulinemia increased the synthesis of nearly half of all detected proteins and did not affect protein degradation despite suppressing autophagy. Unexpectedly, this marked elevation in protein synthesis was accompanied by enhanced protein stability and folding and not by markers of proteostasis stress such as protein carbonylation and aggregation. The improvement in proteostasis was attributed to a coordinate up-regulation of proteins in the global proteostasis network, including ribosomal, proteasomal, chaperone, and endoplasmic reticulum/mitochondrial unfolded protein response proteins. We conclude that defects associated with hyperactivation of the insulin signaling pathway are unlikely attributed to defective proteostasis because up-regulation of protein synthesis by insulin is accompanied by up-regulation of proteostatic machinery.	[Minard, Annabel Y.; Wong, Martin K. L.; Tan, Shi-Xiong; Laybutt, D. Ross] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Minard, Annabel Y.; Wong, Martin K. L.; Chaudhuri, Rima; Humphrey, Sean J.; Parker, Benjamin L.; Cooney, Gregory J.; Stockli, Jacqueline; James, David E.] Univ Sydney, Sch Life Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Wong, Martin K. L.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Yang, Jean Y.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Coster, Adelle C. F.] Univ New South Wales, Sch Math & Stat, Dept Appl Math, Sydney, NSW 2052, Australia; [Tan, Shi-Xiong] Republ Polytech, Sch Appl Sci, Singapore 738964, Singapore	Garvan Institute of Medical Research; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney	James, DE (corresponding author), Univ Sydney, Sch Life Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au	Yang, Jean YH/D-2920-2015; Coster, Adelle/AAX-4829-2020; Humphrey, Sean/AAC-1425-2019; Coster, Adelle CF/A-7234-2013; Stoeckli, Jacqueline/D-7053-2016; Stoeckli, Jacqueline/Z-4443-2019; Tan, Shi-Xiong/Y-3728-2019	Yang, Jean YH/0000-0002-5271-2603; Coster, Adelle/0000-0002-5572-6832; Coster, Adelle CF/0000-0002-5572-6832; Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; James, David/0000-0001-5946-5257; Tan, Shi-Xiong/0000-0002-0020-2572; Humphrey, Sean/0000-0002-2666-9744; Minard, Annabel Yurie/0000-0003-0715-622X	National Health and Medical Research Council (NHMRC) [GNT1061122, GNT1086850]; Australian postgraduate award scholarship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award scholarship	This work was supported in part by National Health and Medical Research Council (NHMRC) Project Grants GNT1061122 and GNT1086850 (to D.E.J.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Australian postgraduate award scholarship.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; ALEXANDER M, 1985, J BIOL CHEM, V260, P1978; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Boden G, 2014, DIABETES, V63, P912, DOI 10.2337/db13-0906; Boden G, 2011, METHOD ENZYMOL, V489, P67, DOI 10.1016/B978-0-12-385116-1.00004-2; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Di Carlo M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/147835; Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Gawron D, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156662; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hands SL, 2009, AGING-US, V1, P586, DOI 10.18632/aging.100070; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Iadevaia V, 2012, BIOCHEM SOC T, V40, P168, DOI 10.1042/BST20110682; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Laybutt DR, 1997, AM J PHYSIOL-ENDOC M, V273, pE1, DOI 10.1152/ajpendo.1997.273.1.E1; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Novosyadlyy R, 2008, CELL DEATH DIFFER, V15, P1304, DOI 10.1038/cdd.2008.52; OKABAYASHI Y, 1989, DIABETES, V38, P182, DOI 10.2337/diabetes.38.2.182; ONG JM, 1988, J BIOL CHEM, V263, P12933; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ortega-Molina A, 2015, CELL METAB, V21, P558, DOI 10.1016/j.cmet.2015.02.017; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; R Development Core Team, 2008, LANG ENV STAT COMP; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Robles MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004047; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Tyagi R, 2015, CELL REP, V10, P684, DOI 10.1016/j.celrep.2015.01.014; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang XF, 2014, J ENDOCRINOL, V221, P469, DOI 10.1530/JOE-14-0117; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	78	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25629	25640		10.1074/jbc.M116.741140	http://dx.doi.org/10.1074/jbc.M116.741140			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27738101	Green Published, hybrid			2022-12-28	WOS:000390095300029
J	Valiente, E; Bouche, L; Hitchen, P; Faulds-Pain, A; Songane, M; Dawson, LF; Donahue, E; Stabler, RA; Panico, M; Morris, HR; Bajaj-Elliott, M; Logan, SM; Dell, A; Wren, BW				Valiente, Esmeralda; Bouche, Laura; Hitchen, Paul; Faulds-Pain, Alexandra; Songane, Mario; Dawson, Lisa F.; Donahue, Elizabeth; Stabler, Richard A.; Panico, Maria; Morris, Howard R.; Bajaj-Elliott, Mona; Logan, Susan M.; Dell, Anne; Wren, Brendan W.			Role of Glycosyltransferases Modifying Type B Flagellin of Emerging Hypervirulent Clostridium difficile Lineages and Their Impact on Motility and Biofilm Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; biofilm; glycosylation; glycosyltransferase; mutant; Clostridium difficile; flagella; gram positive bacteria	CAMPYLOBACTER-JEJUNI; GLYCOSYLATION ISLAND; ESCHERICHIA-COLI; TOXIN-B; PROTEIN; COLONIZATION; INFECTION; BIOSYNTHESIS; EPIDEMIOLOGY; VIRULENCE	Clostridium difficile is the principal cause of nosocomial infectious diarrhea worldwide. The pathogen modifies its flagellin with either a type A or type B O-linked glycosylation system, which has a contributory role in pathogenesis. We study the functional role of glycosyltransferases modifying type B flagellin in the 023 and 027 hypervirulent C. difficile lineages by mutagenesis of five putative glycosyltransferases and biosynthetic genes. We reveal their roles in the biosynthesis of the flagellin glycan chain and demonstrate that flagellar post-translational modification affects motility and adhesion-related bacterial properties of these strains. We show that the glycosyltransferases 1 and 2 (GT1 and GT2) are responsible for the sequential addition of a GlcNAc and two rhamnoses, respectively, and that GT3 is associated with the incorporation of a novel sulfonated peptidyl-amido sugar moiety whose structure is reported in our accompanying paper (Bouche, L., Panico, M., Hitchen, P., Binet, D., Sastre, F., Faulds-Pain, A., Valiente, E., Vinogradov, E., Aubry, A., Fulton, K., Twine, S., Logan, S. M., Wren, B. W., Dell, A., and Morris, H. R. (2016) J. Biol. Chem. 291, 25439-25449). GT2 is also responsible for methylation of the rhamnoses. Whereas type B modification is not required for flagellar assembly, some mutations that result in truncation or abolition of the glycan reduce bacterial motility and promote autoaggregation and biofilm formation. The complete lack of flagellin modification also significantly reduces adhesion of C. difficile to Caco-2 intestinal epithelial cells but does not affect activation of human TLR5. Our study advances our understanding of the genes involved in flagellar glycosylation and their biological roles in emerging hypervirulent C. difficile strains.	[Valiente, Esmeralda; Faulds-Pain, Alexandra; Dawson, Lisa F.; Donahue, Elizabeth; Stabler, Richard A.; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England; [Bouche, Laura; Hitchen, Paul; Panico, Maria; Morris, Howard R.; Dell, Anne] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Songane, Mario; Bajaj-Elliott, Mona] UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [Logan, Susan M.] CNR, Vaccine Program, Human Hlth Therapeut Portfolio, Ottawa, ON K1A 0R6, Canada; [Morris, Howard R.] BioPharmaSpec Ltd, Lido Med Ctr, Suite 3-1,St Saviours Rd, Jersey JE2 7LA, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London; National Research Council Canada	Wren, BW (corresponding author), London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	Brendan.wren@lshtm.ac.uk		Stabler, Richard/0000-0002-2402-6630; Bajaj-Elliott, Mona/0000-0002-5234-576X; Dell, Anne/0000-0003-1380-2347	Wellcome Trust [102979/Z/13/Z, 105609/Z/14/Z]; Medical Research Council [MR/K000551/1]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-252207-CDI]; Commonwealth Scholarship [MZCS-2011-280]; BBSRC [BB/D521849/1, BB/F008309/1, BB/K016164/1] Funding Source: UKRI; MRC [MR/K000551/1, G1000214] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D521849/1] Funding Source: researchfish; Medical Research Council [G1000214] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Intra-European Fellowship(European Commission); Commonwealth Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Grants 102979/Z/13/Z and 105609/Z/14/Z, Medical Research Council Grant MR/K000551/1, and Biotechnology and Biological Sciences Research Council Grants BB/K016164/1 and BB/F008309/1. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Marie Curie Intra-European Fellowship for Career Development PIEF-GA-2009-252207-CDI.; Recipient of Commonwealth Scholarship MZCS-2011-280.	Arora SK, 2004, J BACTERIOL, V186, P2115, DOI 10.1128/JB.186.7.2115-2122.2004; Baban ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073026; Barketi-Klai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096876; Batah J, 2016, ANAEROBE, V38, P116, DOI 10.1016/j.anaerobe.2016.01.002; Bouche L, 2016, J BIOL CHEM, V291, P25439, DOI 10.1074/jbc.M116.749481; Cairns MD, 2012, FUTURE MICROBIOL, V7, P945, DOI [10.2217/FMB.12.73, 10.2217/fmb.12.73]; Calabi E, 2002, J BACTERIOL, V184, P3886, DOI 10.1128/JB.184.14.3886-3897.2002; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Faulds-Pain A, 2014, MOL MICROBIOL, V94, P272, DOI 10.1111/mmi.12755; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Ghose C, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.8; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hanuszkiewicz A, 2014, J BIOL CHEM, V289, P19231, DOI 10.1074/jbc.M114.562603; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; Hitchen PG, 2010, BIOCHEM SOC T, V38, P1307, DOI 10.1042/BST0381307; Howard SL, 2009, INFECT IMMUN, V77, P2544, DOI 10.1128/IAI.01425-08; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; McFarland LV, 2008, NAT CLIN PRACT GASTR, V5, P40, DOI 10.1038/ncpgasthep1029; Misawa N, 2000, INFECT IMMUN, V68, P6168, DOI 10.1128/IAI.68.11.6168-6175.2000; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; ROGGENKAMP A, 1995, MOL MICROBIOL, V16, P1207, DOI 10.1111/j.1365-2958.1995.tb02343.x; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schutze GE, 2013, PEDIATRICS, V131, P196, DOI 10.1542/peds.2012-2992; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stephenson HN, 2014, J INFECT DIS, V210, P1487, DOI 10.1093/infdis/jiu287; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Valiente E, 2014, CLIN MICROBIOL INFEC, V20, P396, DOI 10.1111/1469-0691.12619; Vijay-Kumar M, 2008, SEMIN IMMUNOPATHOL, V30, P11, DOI 10.1007/s00281-007-0100-5; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; WILLIAMS DR, 1990, J GEN MICROBIOL, V136, P819, DOI 10.1099/00221287-136-5-819; WILSON KH, 1988, INFECT IMMUN, V56, P2610, DOI 10.1128/IAI.56.10.2610-2614.1988; Wren MWD, 2009, BRIT J BIOMED SCI, V66, P175, DOI 10.1080/09674845.2009.11730269; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173; Zawadzka-Skomial J, 2006, J BACTERIOL, V188, P1875, DOI 10.1128/JB.188.5.1875-1881.2006	54	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25450	25461		10.1074/jbc.M116.749523	http://dx.doi.org/10.1074/jbc.M116.749523			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27703012	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000390095300015
J	Galdieri, L; Gatla, H; Vancurova, I; Vancura, A				Galdieri, Luciano; Gatla, Himavanth; Vancurova, Ivana; Vancura, Ales			Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HISTONE DEACETYLASE INHIBITORS; ALPHA-TUBULIN ACETYLATION; COA CARBOXYLASE ACTIVITY; FATTY-ACID SYNTHASE; PROTEASOME INHIBITION; RESPIRATORY-CHAIN; DIABETIC-PATIENTS; IMMUNE-RESPONSES; CELLULAR-ENERGY	AMP-activated protein kinase (AMPK) is an energy sensor and master regulator of metabolism. AMPK functions as a fuel gauge monitoring systemic and cellular energy status. Activation of AMPK occurs when the intracellular AMP/ATP ratio increases and leads to a metabolic switch from anabolism to catabolism. AMPK phosphorylates and inhibits acetyl-CoA carboxylase (ACC), which catalyzes carboxylation of acetyl-CoA to malonyl-CoA, the first and rate-limiting reaction in de novo synthesis of fatty acids. AMPK thus regulates homeostasis of acetylCoA, a key metabolite at the crossroads of metabolism, signaling, chromatin structure, and transcription. Nucleocytosolic concentration of acetyl-CoA affects histone acetylation and links metabolism and chromatin structure. Here we show that activation of AMPK with the widely used antidiabetic drug metformin or with the AMP mimetic 5-aminoimidazole-4-carboxamide ribonucleotide increases the inhibitory phosphorylation of ACC and decreases the conversion of acetyl-CoA to malonyl-CoA, leading to increased protein acetylation and altered gene expression in prostate and ovarian cancer cells. Direct inhibition of ACC with allosteric inhibitor 5-(tetradecyloxy)-2-furoic acid also increases acetylation of histones and non-histone proteins. Because AMPK activation requires liver kinase B1, metformin does not induce protein acetylation in liver kinase B1-deficient cells. Together, our data indicate that AMPK regulates the availability of nucleocytosolic acetyl-CoA for protein acetylation and that AMPK activators, such as metformin, have the capacity to increase protein acetylation and alter patterns of gene expression, further expanding the plethora of metformin's physiological effects.	[Galdieri, Luciano; Gatla, Himavanth; Vancurova, Ivana; Vancura, Ales] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA; [Galdieri, Luciano] Washington Univ, Sch Med, ICCE Inst, St Louis, MO 63110 USA	Saint John's University; Washington University (WUSTL)	Vancura, A (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA.	vancuraa@stjohns.edu	Gatla, Himavanth/AAP-7955-2021; Galdieri, Luciano/GYD-4538-2022	Vancura, Ales/0000-0002-5895-1218	National Institutes of Health [GM106324, GM120710]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106324, R15GM120710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM106324 and GM120710 (to A. V). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Bassam J, 2012, P NATL ACAD SCI USA, V109, P19515, DOI 10.1073/pnas.1217594109; Beld J, 2015, MOL BIOSYST, V11, P38, DOI 10.1039/c4mb00443d; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chow JDY, 2014, MOL METAB, V3, P419, DOI 10.1016/j.molmet.2014.02.004; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DAVIES SP, 1992, EUR J BIOCHEM, V203, P615, DOI 10.1111/j.1432-1033.1992.tb16591.x; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Farria A, 2015, ONCOGENE, V34, P4901, DOI 10.1038/onc.2014.453; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Flavin R, 2011, J PATHOL, V223, P283, DOI 10.1002/path.2809; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Galdieri L, 2016, MOL CELL BIOL, V36, P1064, DOI 10.1128/MCB.00770-15; Galdieri L, 2014, EUKARYOT CELL, V13, P1472, DOI 10.1128/EC.00189-14; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gu SC, 2016, J BIOL CHEM, V291, P5396, DOI 10.1074/jbc.M115.713123; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Hsu YC, 2015, CELL MOL BIOL, V61, P69; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Janke R, 2015, ANNU REV CELL DEV BI, V31, P473, DOI 10.1146/annurev-cellbio-100814-125544; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Laurenzana A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058267; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Manna S, 2013, J IMMUNOL, V191, P2837, DOI 10.4049/jimmunol.1300895; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Piekarz RL, 2004, BLOOD, V103, P4636, DOI 10.1182/blood-2003-09-3068; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Ramaswami S, 2012, METHODS MOL BIOL, V809, P121, DOI 10.1007/978-1-61779-376-9_8; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Salminen A, 2016, CELL SIGNAL, V28, P887, DOI 10.1016/j.cellsig.2016.03.009; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Singha B, 2014, J BIOL CHEM, V289, P2687, DOI 10.1074/jbc.M113.502641; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Travers MT, 1997, BIOCHEM SOC T, V25, P1215, DOI 10.1042/bst0251215; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang C, 2009, BIOCHEM BIOPH RES CO, V385, P302, DOI 10.1016/j.bbrc.2009.05.045; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WOODS A, 1994, J BIOL CHEM, V269, P19509; Zadra G, 2010, CLIN CANCER RES, V16, P3322, DOI 10.1158/1078-0432.CCR-09-1955; Zhang M, 2013, MOL CELL BIOL, V33, P4701, DOI 10.1128/MCB.00198-13	83	58	60	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25154	25166		10.1074/jbc.M116.742247	http://dx.doi.org/10.1074/jbc.M116.742247			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27733682	Green Published, hybrid			2022-12-28	WOS:000388880100030
J	Wittenborn, EC; Jost, M; Wei, YF; Stubbe, J; Drennan, CL				Wittenborn, Elizabeth C.; Jost, Marco; Wei, Yifeng; Stubbe, JoAnne; Drennan, Catherine L.			Structure of the Catalytic Domain of the Class I Polyhydroxybutyrate Synthase from Cupriavidus necator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARRIER HYDROGEN-BOND; CHROMATIUM-VINOSUM; CRYSTAL-STRUCTURE; RALSTONIA-EUTROPHA; CHAIN TERMINATION; PHB SYNTHASE; PROTEIN-STRUCTURE; GASTRIC LIPASE; MECHANISM; BIOSYNTHESIS	Polyhydroxybutyrate synthase (PhaC) catalyzes the polymerization of 3-(R)-hydroxybutyryl-coenzyme A as a means of carbon storage in many bacteria. The resulting polymers can be used to make biodegradable materials with properties similar to those of thermoplastics and are an environmentally friendly alternative to traditional petroleum-based plastics. A full biochemical and mechanistic understanding of this process has been hindered in part by a lack of structural information on PhaC. Here we present the first structure of the catalytic domain (residues 201-589) of the class I PhaC from Cupriavidus necator (formerly Ralstonia eutropha) to 1.80 angstrom resolution. We observe a symmetrical dimeric architecture in which the active site of each monomer is separated from the other by similar to 33 angstrom across an extensive dimer interface, suggesting a mechanism in which polyhydroxybutyrate biosynthesis occurs at a single active site. The structure additionally highlights key side chain interactions within the active site that play likely roles in facilitating catalysis, leading to the proposal of a modified mechanistic scheme involving two distinct roles for the active site histidine. We also identify putative substrate entrance and product egress routes within the enzyme, which are discussed in the context of previously reported biochemical observations. Our structure lays a foundation for further biochemical and structural characterization of PhaC, which could assist in engineering efforts for the production of eco-friendly materials.	[Wittenborn, Elizabeth C.; Jost, Marco; Wei, Yifeng; Stubbe, JoAnne; Drennan, Catherine L.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Stubbe, JoAnne; Drennan, Catherine L.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Jost, Marco] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Wei, Yifeng] Agcy Sci Technol & Res, Metab Engn Res Lab, Inst Sci, Singapore 138669, Singapore; [Wei, Yifeng] Agcy Sci Technol & Res, Metab Engn Res Lab, Engn Inst, Singapore 138669, Singapore	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR)	Stubbe, J (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Stubbe, J (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	stubbe@mit.edu; cdrennan@mit.edu			National Institute of General Medical Sciences through National Institutes of Health [P41 GM103403]; National Institutes of Health-Office of Research Infrastructure Programs High End Instrumentation [S10RR029205]; Office of Science [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049171, P41GM103403, T32GM008334, R01GM069857] Funding Source: NIH RePORTER	National Institute of General Medical Sciences through National Institutes of Health; National Institutes of Health-Office of Research Infrastructure Programs High End Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to Prof. Ping Li for providing an alignment of class I PhaC sequences. We additionally thank Tsehai Grell and David Born for helpful conversations. This work is based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences through National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on Beamline 24-ID-C is funded by National Institutes of Health-Office of Research Infrastructure Programs High End Instrumentation Grant S10RR029205. This research used resources of the Advanced Photon Source, a Department of Energy Office of Science User Facility operated for the Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2015, PYMOL MOL GRAPHICS S; Aschauer P, 2016, BBA-MOL CELL BIOL L, V1861, P462, DOI 10.1016/j.bbalip.2016.02.005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buckley R. M., 2013, THESIS; Buckley RM, 2015, BIOCHEMISTRY-US, V54, P2117, DOI 10.1021/bi501405b; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Cassidy CS, 1997, BIOCHEMISTRY-US, V36, P4576, DOI 10.1021/bi962013o; Chen C, 2015, ACS CHEM BIOL, V10, P1330, DOI 10.1021/cb5009958; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YJ, 2014, ENZYME MICROB TECH, V56, P60, DOI 10.1016/j.enzmictec.2014.01.005; Cho M., 2012, THESIS; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; GERNGROSS TU, 1994, BIOCHEMISTRY-US, V33, P9311, DOI 10.1021/bi00197a035; GERNGROSS TU, 1995, P NATL ACAD SCI USA, V92, P6279, DOI 10.1073/pnas.92.14.6279; Goettig P, 2005, J BIOL CHEM, V280, P33387, DOI 10.1074/jbc.M505030200; Gog A, 2012, RENEW ENERG, V39, P10, DOI 10.1016/j.renene.2011.08.007; GRIEBEL R, 1968, BIOCHEMISTRY-US, V7, P3676, DOI 10.1021/bi00850a047; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Ishida T, 2006, BIOCHEMISTRY-US, V45, P5413, DOI 10.1021/bi051515b; Jia Y, 2000, BIOCHEMISTRY-US, V39, P3927, DOI 10.1021/bi9928086; Jia Y, 2001, BIOCHEMISTRY-US, V40, P1011, DOI 10.1021/bi002219w; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keshavarz T, 2010, CURR OPIN MICROBIOL, V13, P321, DOI 10.1016/j.mib.2010.02.006; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Lawrence AG, 2005, BIOMACROMOLECULES, V6, P2113, DOI 10.1021/bm0501048; Li P, 2009, BIOCHEMISTRY-US, V48, P9202, DOI 10.1021/bi901329b; LIEBERGESELL M, 1994, EUR J BIOCHEM, V226, P71, DOI 10.1111/j.1432-1033.1994.tb20027.x; LIEBERGESELL M, 1992, EUR J BIOCHEM, V209, P135, DOI 10.1111/j.1432-1033.1992.tb17270.x; Lin J, 1998, BIOCHEMISTRY-US, V37, P11940, DOI 10.1021/bi980278s; Madden LA, 1999, INT J BIOL MACROMOL, V25, P43, DOI 10.1016/S0141-8130(99)00014-8; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Moynihan PJ, 2014, BIOCHEMISTRY-US, V53, P6243, DOI 10.1021/bi501002d; Muh U, 1999, BIOCHEMISTRY-US, V38, P826, DOI 10.1021/bi9818319; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Rehm BHA, 2002, BBA-PROTEIN STRUCT M, V1594, P178, DOI 10.1016/S0167-4838(01)00299-0; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Sayer C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25542; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Stubbe J, 2005, ANNU REV BIOCHEM, V74, P433, DOI 10.1146/annurev.biochem.74.082803.133013; Stubbe J, 2003, NAT PROD REP, V20, P445, DOI 10.1039/b209687k; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Tian J, 2005, BIOCHEMISTRY-US, V44, P1495, DOI 10.1021/bi047734z; Tian JM, 2005, BIOCHEMISTRY-US, V44, P8369, DOI 10.1021/bi050331u; Tian JM, 2005, J BACTERIOL, V187, P3825, DOI 10.1128/JB.187.11.3825-3832.2005; Ushimaru K, 2013, APPL MICROBIOL BIOT, V97, P1175, DOI 10.1007/s00253-012-4089-x; Wodzinska J, 1996, J AM CHEM SOC, V118, P6319, DOI 10.1021/ja961108a; Yahya ARM, 1998, ENZYME MICROB TECH, V23, P438, DOI 10.1016/S0141-0229(98)00065-9; Yuan W, 2001, ARCH BIOCHEM BIOPHYS, V394, P87, DOI 10.1006/abbi.2001.2522; Zhang SM, 2000, BIOMACROMOLECULES, V1, P244, DOI 10.1021/bm005513c; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	65	53	55	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25264	25277		10.1074/jbc.M116.756833	http://dx.doi.org/10.1074/jbc.M116.756833			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27742839	Green Published, hybrid			2022-12-28	WOS:000388880100040
J	Petrey, AC; de la Motte, CA				Petrey, Aaron C.; de la Motte, Carol A.			Thrombin Cleavage of Inter-alpha-inhibitor Heavy Chain 1 Regulates Leukocyte Binding to an Inflammatory Hyaluronan Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN AMNIOTIC MEMBRANE; EXTRACELLULAR-MATRIX; TRYPSIN INHIBITOR; RHEUMATOID-ARTHRITIS; ACTIVATED RECEPTORS; BLOOD-COAGULATION; ENDOTHELIAL-CELLS; SYNOVIAL-FLUID; CD44	Dynamic alterations of the extracellular matrix in response to injury directly modulate inflammation and consequently the promotion and resolution of disease. During inflammation, hyaluronan (HA) is increased at sites of inflammation where it may be covalently modified with the heavy chains (HC) of inter-alpha-trypsin inhibitor. Deposition of this unique, pathological form of HA (HC-HA) leads to the formation of cable-like structures that promote adhesion of leukocytes. Naive mononuclear leukocytes bind specifically to inflammation-associated HA matrices but do not adhere to HA constitutively expressed under homeostatic conditions. In this study, we have directly investigated a role for the blood-coagulation protease thrombin in regulating the adhesion of monocytic cells to smooth muscle cells producing an inflammatory matrix. Our data demonstrate that the proteolytic activity of thrombin negatively regulates the adhesion of monocytes to an inflammatory HG-HA complex. This effect is independent of protease-activated receptor activation but requires proteolytic activity toward a novel substrate. Components of HC-HA complexes were predicted to contain conserved thrombin-susceptible cleavage sites based on sequence analysis, and heavy chain 1 (HC1) was confirmed to be a substrate of thrombin. Thrombin treatment is sufficient to cleave HC1 associated with either cell-surface HA or serum inter-alpha-trypsin inhibitor. Furthermore, thrombin treatment of the inflammatory matrix leads to dissolution of HC-HA cable structures and abolishes leukocyte adhesion. These data establish a novel mechanism whereby thrombin cleavage of HC1 regulates the adhesive properties of an inflammatory HA matrix.	[Petrey, Aaron C.; de la Motte, Carol A.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	de la Motte, CA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	delamoc@ccf.org	Petrey, Aaron C./AAD-8623-2020	Petrey, Aaron C./0000-0002-2696-599X	National Institutes of Health Programs of Excellence in Glycosciences Grant from the NHLBI [HL107147]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097948] Funding Source: NIH RePORTER	National Institutes of Health Programs of Excellence in Glycosciences Grant from the NHLBI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Programs of Excellence in Glycosciences Grant HL107147 from the NHLBI (to C. A. d. I. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albeiroti S, 2015, BLOOD, V125, P1460, DOI 10.1182/blood-2014-07-590513; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Black KE, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-23; Blom AM, 1997, BIOCHEM J, V328, P185; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRATT T, 1993, BIOCHIM BIOPHYS ACTA, V1157, P147, DOI 10.1016/0304-4165(93)90058-G; Chamouard P, 1995, EUR J GASTROEN HEPAT, V7, P1183; CHAN P, 1995, BIOCHEM J, V306, P505, DOI 10.1042/bj3060505; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Daveau M, 1998, ARCH BIOCHEM BIOPHYS, V350, P315, DOI 10.1006/abbi.1997.0515; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; DICORLETO PE, 1989, BIOCHEM J, V264, P71, DOI 10.1042/bj2640071; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Evanko SP, 1998, AM J PATHOL, V152, P533; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; FOGELMAN AM, 1988, J LIPID RES, V29, P1243; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P682; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Kaplan ZS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8835; Kaplanski G, 1998, BLOOD, V92, P1259, DOI 10.1182/blood.V92.4.1259.416k11_1259_1267; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kessler S. P., 2015, INT J CELL BIOL, V2015; Kessler S, 2008, CTS-CLIN TRANSL SCI, V1, P57, DOI 10.1111/j.1752-8062.2008.00025.x; KOIZUMI M, 1992, GASTROENTEROLOGY, V103, P840, DOI 10.1016/0016-5085(92)90015-Q; Lauer ME, 2015, J BIOL CHEM, V290, P23124, DOI 10.1074/jbc.M115.663823; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; LINDQVIST A, 1992, BIOCHIM BIOPHYS ACTA, V1130, P63, DOI 10.1016/0167-4781(92)90462-9; LIOTTA LA, 1981, CANCER RES, V41, P4629; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; MAHADEVAN P, 1995, DIABETOLOGIA, V38, P298, DOI 10.1007/s001250050285; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Mizon C, 1996, J IMMUNOL METHODS, V190, P61, DOI 10.1016/0022-1759(95)00257-X; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; NISHIMURA H, 1995, FEBS LETT, V357, P207; Olszewska-Pazdrak Barbara, 2009, P115, DOI 10.1007/978-0-387-09637-7_7; PAKIANATHAN DR, 1995, J LEUKOCYTE BIOL, V57, P699, DOI 10.1002/jlb.57.5.699a; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Popovic M, 2012, MOL CELL BIOCHEM, V359, P301, DOI 10.1007/s11010-011-1024-x; POZSGAY M, 1981, EUR J BIOCHEM, V115, P491; Rohatgi T, 2004, NEUROSCIENTIST, V10, P501, DOI 10.1177/1073858404269955; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SAGE H, 1981, BIOCHEMISTRY-US, V20, P3778, DOI 10.1021/bi00516a017; SALIER JP, 1993, BIOCHEM J, V296, P85, DOI 10.1042/bj2960085; Sanggaard KW, 2010, BBA-PROTEINS PROTEOM, V1804, P1011, DOI 10.1016/j.bbapap.2010.01.013; Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wilkins MR, 1999, METH MOL B, V112, P531; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873	77	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24324	24334		10.1074/jbc.M116.755660	http://dx.doi.org/10.1074/jbc.M116.755660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27679489	Green Published, hybrid			2022-12-28	WOS:000388875500001
J	Pozner, A; Terooatea, TW; Buck-Koehntop, BA				Pozner, Amir; Terooatea, Tommy W.; Buck-Koehntop, Bethany A.			Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL REPRESSOR; NUCLEAR-LOCALIZATION; PARTNER KAISO; BINDING; CANCER; EXPRESSION; PROMOTES	The correlation between aberrant DNA methylation with cancer promotion and progression has prompted an interest in discerning the associated regulatory mechanisms. Kaiso (ZBTB33) is a specialized transcription factor that selectively recognizes methylated CpG-containing sites as well as a sequence-specific DNA target. Increasing reports link ZBTB33 overexpression and transcriptional activities with metastatic potential and poor prognosis in cancer, although there is little mechanistic insight into how cells harness ZBTB33 transcriptional capabilities to promote and progress disease. Here we report mechanistic details for how ZBTB33 mediates cell-specific cell cycle regulation. By utilizing ZBTB33 depletion and overexpression studies, it was determined that in HeLa cells ZBTB33 directly occupies the promoters of cyclin D1 and cyclin El, inducing proliferation by promoting retinoblastoma phosphorylation and allowing for E2F transcriptional activity that accelerates G(1)- to S-phase transition. Conversely, in HEK293 cells ZBTB33 indirectly regulates cyclin E abundance resulting in reduced retinoblastoma phosphorylation, decreased E2F activity, and decelerated G(1) transition. Thus, we identified a novel mechanism by which ZBTB33 mediates the cyclin D-1/cyclin El/RB1/E2E pathway, controlling passage through the G(1) restriction point and accelerating cancer cell proliferation.	[Pozner, Amir; Terooatea, Tommy W.; Buck-Koehntop, Bethany A.] Univ Utah, Dept Chem, 315 South 1400 East,Rm 2020, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Buck-Koehntop, BA (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East,Rm 2020, Salt Lake City, UT 84112 USA.	koehntop@chern.utah.edu	Buck-Koehntop, Bethany A./ABI-2583-2020		Department of Chemistry, University of Utah; American Cancer Society [RSG-14-185-01-DMC]; National Institutes of Health from the NCI [P30CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	Department of Chemistry, University of Utah; American Cancer Society(American Cancer Society); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Chemistry, University of Utah, Grant RSG-14-185-01-DMC from the American Cancer Society, and National Institutes of Health Award P30CA042014 from the NCI for Huntsman Cancer Institute core facilities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Bassey-Archibong BI, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.17; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; Buck-Koehntop BA, 2012, FEBS LETT, V586, P734, DOI 10.1016/j.febslet.2012.01.045; Capecchi MR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9763; Chano T, 2006, INT J MOL MED, V18, P425; Chaudhary R., 2013, PLOS ONE, V8; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cofre J, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-28; Comstock CES, 2007, BRIT J CANCER, V96, P970, DOI 10.1038/sj.bjc.6603615; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dai SD, 2010, LUNG CANCER, V67, P205, DOI 10.1016/j.lungcan.2009.06.013; Dai SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-178; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Donaldson NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050398; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Jiang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030303; Jones J, 2016, CANCER LETT, V380, P513, DOI 10.1016/j.canlet.2016.06.025; Jones J, 2014, CLIN EXP METASTAS, V31, P497, DOI 10.1007/s10585-014-9644-7; Jones J, 2012, AM J PATHOL, V181, P1836, DOI 10.1016/j.ajpath.2012.08.008; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koh DI, 2014, P NATL ACAD SCI USA, V111, P15078, DOI 10.1073/pnas.1318780111; Koh DI, 2013, BIOCHEM BIOPH RES CO, V442, P177, DOI 10.1016/j.bbrc.2013.11.046; Kulikov AV, 2016, BEHAV BRAIN RES, V297, P76, DOI 10.1016/j.bbr.2015.10.003; Lents NH, 2004, TRENDS ENDOCRIN MET, V15, P1, DOI 10.1016/j.tem.2003.10.011; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ozbek E., 2000, TURKISH J CANC, V30, P15; Pierre CC, 2015, BBA-GENE REGUL MECH, V1849, P1432, DOI 10.1016/j.bbagrm.2015.10.018; Pierre CC, 2015, BBA-MOL BASIS DIS, V1852, P1846, DOI 10.1016/j.bbadis.2015.06.011; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Soubry A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009203; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Spruijt CG, 2014, NAT STRUCT MOL BIOL, V21, P949, DOI 10.1038/nsmb.2910; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vance KW, 2010, MOL BIOL CELL, V21, P2770, DOI 10.1091/mbc.E09-12-1029; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Wang HH, 2016, ONCOTARGET, V7, P5677, DOI 10.18632/oncotarget.6801; Wang XD, 2003, ONCOGENE, V22, P769, DOI 10.1038/sj.onc.1206166; Yamamoto A, 2000, J CELL BIOL, V150, P873, DOI 10.1083/jcb.150.4.873; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	62	27	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24538	24550		10.1074/jbc.M116.746370	http://dx.doi.org/10.1074/jbc.M116.746370			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27694442	hybrid, Green Published			2022-12-28	WOS:000388875500017
J	Ricq, EL; Hooker, JM; Haggarty, SJ				Ricq, Emily L.; Hooker, Jacob M.; Haggarty, Stephen J.			Activity-dependent Regulation of Histone Lysine Demethylase KDM1 A by a Putative Thiol/Disulfide Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE-OXIDASE-A; STRUCTURAL BASIS; MOLECULAR-MECHANISMS; DNA OXIDATION; LSD1; INACTIVATION; INHIBITION; ASSAY; TRANSCRIPTION; METHYLATION	Lysine demethylation of proteins such as histones is catalyzed by several classes of enzymes, including the FAD-dependent amine oxidases KDM1A/B. The KDM1 family is homologous to the mitochondrial monoamine oxidases MAO-A/B and produces hydrogen peroxide in the nucleus as a byproduct of demethylation. Here, we show KDM1A is highly thiol-reactive in vitro and in cellular models. Enzyme activity is potently and reversibly inhibited by the drug disulfiram and by hydrogen peroxide. Hydrogen peroxide produced by KDM1A catalysis reduces thiol labeling and inactivates demethylase activity over time. MALDI-TOF mass spectrometry indicates that hydrogen peroxide blocks labeling of cysteine 600, which we propose forms an intramolecular disulfide with cysteine 618 to negatively regulate the catalytic activity of KDM1A. This activity dependent regulation is unique among histone-modifying enzymes but consistent with redox sensitivity of epigenetic regulators.	[Ricq, Emily L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Ricq, Emily L.; Hooker, Jacob M.] Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Ricq, Emily L.; Haggarty, Stephen J.] Harvard Med Sch, Massachusetts Gen Hosp, Chem Neurobiol Lab, Ctr Human Genet Res,Dept Neurol, Boston, MA 02114 USA; [Ricq, Emily L.; Haggarty, Stephen J.] Harvard Med Sch, Massachusetts Gen Hosp, Chem Neurobiol Lab, Ctr Human Genet Res,Dept Psychiat, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Haggarty, SJ (corresponding author), Massachusetts Gen Hosp, Chem Neurobiol Lab, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	shaggarty@mgh.harvard.edu	Haggarty, Stephen J/M-9495-2016; Hooker, Jacob M/P-5716-2018	Haggarty, Stephen J/0000-0002-7872-168X; Hooker, Jacob M/0000-0002-9394-7708	National Institute of Mental Health [R01MH095088]; National Institutes of Health [2T90DA022759-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095088] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by National Institute of Mental Health Grant R01MH095088. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Training Grant 2T90DA022759-06.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Baldwin AD, 2011, BIOCONJUGATE CHEM, V22, P1946, DOI 10.1021/bc200148v; Burg JM, 2015, BIOPOLYMERS, V104, P213, DOI 10.1002/bip.22643; Chuang JY, 2011, FREE RADICAL BIO MED, V51, P2309, DOI 10.1016/j.freeradbiomed.2011.10.001; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; De Colibus L, 2005, P NATL ACAD SCI USA, V102, P12684, DOI 10.1073/pnas.0505975102; Doyle K, 2010, J BIOL CHEM, V285, P17417, DOI 10.1074/jbc.M109.089250; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Gaweska H, 2009, BIOCHEMISTRY-US, V48, P5440, DOI 10.1021/bi900499w; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Hayward D, 2016, METHOD ENZYMOL, V573, P261, DOI 10.1016/bs.mie.2016.01.020; Hubalek F, 2003, J BIOL CHEM, V278, P28612, DOI 10.1074/jbc.M303712200; Kakizawa T, 2016, BIOORG MED CHEM LETT, V26, P1193, DOI 10.1016/j.bmcl.2016.01.036; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Laitaoja M, 2016, PROTEIN SCI, V25, P572, DOI 10.1002/pro.2849; Li JF, 2013, ANTIOXID REDOX SIGN, V18, P2429, DOI 10.1089/ars.2012.5107; Lu YH, 2014, CELL REP, V8, P500, DOI 10.1016/j.celrep.2014.06.035; Lu YH, 2011, MOL CELL BIOL, V31, P3339, DOI 10.1128/MCB.01121-10; Luka Z, 2011, BIOCHEMISTRY-US, V50, P4750, DOI 10.1021/bi200247b; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Neelamegam R, 2012, ACS CHEM NEUROSCI, V3, P120, DOI 10.1021/cn200104y; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Sablin SO, 1998, J BIOL CHEM, V273, P14074, DOI 10.1074/jbc.273.23.14074; Sekirnik R, 2009, CHEM COMMUN, P6376, DOI 10.1039/b916357c; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SILVERMAN RB, 1986, BIOCHEM BIOPH RES CO, V135, P154, DOI 10.1016/0006-291X(86)90955-1; TAMAI K, 1990, BIOCHEM BIOPH RES CO, V167, P331, DOI 10.1016/0006-291X(90)91769-O; Vintem APB, 2005, BIOORGAN MED CHEM, V13, P3487, DOI 10.1016/j.bmc.2005.02.061; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Wigle TJ, 2015, J BIOMOL SCREEN, V20, P810, DOI 10.1177/1087057115575689; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yang MJ, 2007, BIOCHEMISTRY-US, V46, P8058, DOI 10.1021/bi700664y; Yang S, 2015, PROSTATE, V75, P936, DOI 10.1002/pros.22977; Zhang Q, 2013, CELL RES, V23, P225, DOI 10.1038/cr.2012.177	42	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24756	24767		10.1074/jbc.M116.734426	http://dx.doi.org/10.1074/jbc.M116.734426			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27634040	Green Published, hybrid			2022-12-28	WOS:000388875500033
J	Colon, S; Bhave, G				Colon, Selene; Bhave, Gautam			Proprotein Convertase Processing Enhances Peroxidasin Activity to Reinforce Collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basement membrane; collagen; extracellular matrix; furin; peroxidase; collagen IV; proprotein convertase; sulfilimine bond; peroxidasin	EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; PROTEIN; ARCHITECTURE; EVOLUTION; CLEAVAGE; FURIN; BOND	The basement membrane (BM) is a form of extracellular matrix that underlies cell layers in nearly all animal tissues. Type IV collagen, a major constituent of BMs, is critical for tissue development and architecture. The enzyme peroxidasin (Pxdn), an extracellular matrix-associated protein, catalyzes the formation of structurally reinforcing sulfilimine cross-links within the collagen IV network, an event essential to basement membrane integrity. Although the catalytic function of Pxdn is known, the regulation of its activity remains unclear. In this work we show through N-terminal sequencing, pharmacologic studies, and mutational analysis that proprotein convertases (PCs) proteolytically process human Pxdn at Arg-1336, a location relatively close to its C terminus. PC processing enhances the enzymatic activity of Pxdn and facilitates the formation of sulfilimine cross-links in collagen IV. Thus, PC processing of Pxdn is a key regulatory step that contributes to its function and, therefore, supports BM integrity and homeostasis.	[Colon, Selene; Bhave, Gautam] Vanderbilt Univ, Div Nephrol & Hypertens, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Colon, Selene] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37209 USA; [Colon, Selene; Bhave, Gautam] Vanderbilt Univ, Vanderbilt Ctr Kidney Dis, Med Ctr, Nashville, TN 37232 USA; [Bhave, Gautam] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University; Tennessee State University; Vanderbilt University; Vanderbilt University	Bhave, G (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, S-3223 Med Ctr North, Nashville, TN 37232 USA.	gautam.bhave@vanderbilt.edu			National Institutes of Health [K08 DK 097306]; Burroughs-Wellcome Fund Career Award for Medical Scientists [13030995]; Vanderbilt University Division of Nephrology and Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Vanderbilt University Division of Nephrology and Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K08 DK 097306 (to G.B.). This work was also supported by a Burroughs-Wellcome Fund Career Award for Medical Scientists (13030995) and developmental funds from the Vanderbilt University Division of Nephrology and Hypertension (to G.B.). S.C. presented this work in partial fulfillment of her doctoral dissertation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Brandes RP, 2011, CARDIOVASC RES, V91, P1, DOI 10.1093/cvr/cvr120; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Ero-Tolliver IA, 2015, J BIOL CHEM, V290, P21741, DOI 10.1074/jbc.M115.673996; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Lazar E, 2015, FREE RADICAL BIO MED, V83, P273, DOI 10.1016/j.freeradbiomed.2015.02.015; Le Fourn V, 2005, J BIOL CHEM, V280, P4568, DOI 10.1074/jbc.M408042200; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; McCormick S, 2012, ARCH BIOCHEM BIOPHYS, V527, P31, DOI 10.1016/j.abb.2012.07.013; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Raghunath M, 1999, J CELL SCI, V112, P1093; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Soudi M, 2015, J BIOL CHEM, V290, P10876, DOI 10.1074/jbc.M114.632273; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950	24	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24009	24016		10.1074/jbc.M116.745935	http://dx.doi.org/10.1074/jbc.M116.745935			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27697841	Green Published, hybrid			2022-12-28	WOS:000388498100017
J	Patra, A; Zhang, QQ; Guengerich, FP; Egli, M				Patra, Amitraj; Zhang, Qianqian; Guengerich, F. Peter; Egli, Martin			Mechanisms of Insertion of dCTP and dTTP Opposite the DNA Lesion O-6-Methyl-2 '-deoxyguanosine by Human DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; enzyme kinetics; mass spectrometry (MS); X-ray crystallography	TRIPHOSPHATE INCORPORATION OPPOSITE; STRUCTURAL BASIS; MOLECULAR-STRUCTURE; KINETIC-ANALYSIS; O-6-METHYLGUANINE; BYPASS; SITE; DPO4; KAPPA; O-6-ALKYLGUANINE	O-6-Methyl-2-deoxyguanosine (O-6-MeG) is a ubiquitous DNA lesion, formed not only by xenobiotic carcinogens but also by the endogenous methylating agent S-adenosylmethionine. It can introduce mutations during DNA replication, with different DNA polymerases displaying different ratios of correct or incorrect incorporation opposite this nucleoside. Of the translesion Y-family human DNA polymerases (hpols), hpol is most efficient in incorporating equal numbers of correct and incorrect C and T bases. However, the mechanistic basis for this specific yet indiscriminate activity is not known. To explore this question, we report biochemical and structural analysis of the catalytic core of hpol . Activity assays showed the truncated form displayed similar misincorporation properties as the full-length enzyme, incorporating C and T equally and extending from both. X-ray crystal structures of both dC and dT paired with O-6-MeG were solved in both insertion and extension modes. The structures revealed a Watson-Crick-like pairing between O-6-MeG and 2"-deoxythymidine-5"-[(, )-imido]triphosphate (approximating dT) at both the insertion and extension stages with formation of two H-bonds. Conversely, both the structures with O-6- MeG opposite dCTP and dC display sheared configuration of base pairs but to different degrees, with formation of two bifurcated H-bonds and two single H-bonds in the structures trapped in the insertion and extension states, respectively. The structural data are consistent with the observed tendency of hpol to insert both dC and dT opposite the O-6-MeG lesion with similar efficiencies. Comparison of the hpol active site configurations with either O-6-MeG:dC or O-6-MeG:dT bound compared with the corresponding situations in structures of complexes of Sulfolobus solfataricus Dpo4, a bypass pol that favors C relative to T by a factor of approximate to 4, helps rationalize the more error-prone synthesis opposite the lesion by hpol eta.	[Patra, Amitraj; Zhang, Qianqian; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Zhang, Qianqian] Waters Corp, Bldg 13,1000 Jinhai Rd, Shanghai 201206, Peoples R China	Vanderbilt University	Guengerich, FP (corresponding author), Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.; Egli, M (corresponding author), Dept Biochem, 868A Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu; egli@vanderbilt.edu			National Institutes of Health [R01 ES010375, R01 ES010546, P01 CA160032]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010546, R01ES010375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 and R01 ES010546 (to F. G.) and P01 CA160032 (to M. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARROWS LR, 1981, TOXICOL APPL PHARM, V60, P334, DOI 10.1016/0041-008X(91)90236-8; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BROOKES P, 1961, J CHEM SOC, P3923, DOI 10.1039/jr9610003923; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Chowdhury G, 2011, CURR PROT NUCL ACID, DOI [10.1002/0471142700.nc0716s47, DOI 10.1002/0471142700.NC0716S47]; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; GAFFNEY BL, 1984, BIOCHEMISTRY-US, V23, P5686, DOI 10.1021/bi00319a004; GAFFNEY BL, 1989, BIOCHEMISTRY-US, V28, P5881, DOI 10.1021/bi00440a026; GINELL SL, 1990, BIOCHEMISTRY-US, V29, P10461, DOI 10.1021/bi00498a005; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Irimia A, 2010, ACTA CRYSTALLOGR F, V66, P1013, DOI 10.1107/S1744309110029374; LAWLEY PD, 1995, BIOESSAYS, V17, P561, DOI 10.1002/bies.950170615; LEONARD GA, 1990, P NATL ACAD SCI USA, V87, P9573, DOI 10.1073/pnas.87.24.9573; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; Lupari E, 2012, DNA REPAIR, V11, P579, DOI 10.1016/j.dnarep.2012.03.004; O'Flaherty DK, 2016, CHEM SCI, V7, P4896, DOI 10.1039/c6sc00666c; O'Flaherty D. K., 2014, CURR PROTOC NUCL ACI, V59, DOI [10.1002/0471142700.nc0721s5, DOI 10.1002/0471142700.NC0721S5]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL DJ, 1986, BIOCHEMISTRY-US, V25, P1036, DOI 10.1021/bi00353a013; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Patra A, 2015, J AM CHEM SOC, V137, P7011, DOI 10.1021/jacs.5b02701; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Pence MG, 2010, J BIOL CHEM, V285, P40666, DOI 10.1074/jbc.M110.183665; Peng CH, 2016, CANCER RES, V76, P2340, DOI 10.1158/0008-5472.CAN-15-1884; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SRIRAM M, 1992, EMBO J, V11, P225, DOI 10.1002/j.1460-2075.1992.tb05045.x; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	42	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24304	24313		10.1074/jbc.M116.755462	http://dx.doi.org/10.1074/jbc.M116.755462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27694439	hybrid, Green Published			2022-12-28	WOS:000388498100041
J	Sassa, A; Caglayan, M; Rodriguez, Y; Beard, WA; Wilson, SH; Nohmi, T; Honma, M; Yasui, M				Sassa, Akira; Caglayan, Melike; Rodriguez, Yesenia; Beard, William A.; Wilson, Samuel H.; Nohmi, Takehiko; Honma, Masamitsu; Yasui, Manabu			Impact of Ribonucleotide Backbone on Translesion Synthesis and Repair of 7,8-Dihydro-8-oxoguanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-oxoguanine (8-oxoG); base excision repair (BER); DNA damage; DNA polymerase; oxidative stress; ribonucleotide; translesion DNA synthesis	DNA-POLYMERASE-KAPPA; ERROR-FREE; EXCISION-REPAIR; BYPASS; LESION; EXTENSION; 8-OXOGUANINE; SUBSTRATE; EFFICIENT; MECHANISM	Numerous ribonucleotides are incorporated into the genome during DNA replication. Oxidized ribonucleotides can also be erroneously incorporated into DNA. Embedded ribonucleotides destabilize the structure of DNA and retard DNA synthesis by DNA polymerases (pols), leading to genomic instability. Mammalian cells possess translesion DNA synthesis (TLS) pols that bypass DNA damage. The mechanism of TLS and repair of oxidized ribonucleotides remains to be elucidated. To address this, we analyzed the miscoding properties of the ribonucleotides riboguanosine (rG) and 7,8-dihydro-8-oxo-riboguanosine (8-oxo-rG) during TLS catalyzed by the human TLS pols and in vitro. The primer extension reaction catalyzed by human replicative pol was strongly blocked by 8-oxo-rG. pol inefficiently bypassed rG and 8-oxo-rG compared with dG and 7,8-dihydro-8-oxo-2-deoxyguanosine (8-oxo-dG), whereas pol easily bypassed the ribonucleotides. pol exclusively inserted dAMP opposite 8-oxo-rG. Interestingly, pol preferentially inserted dCMP opposite 8-oxo-rG, whereas the insertion of dAMP was favored opposite 8-oxo-dG. In addition, pol accurately bypassed 8-oxo-rG. Furthermore, we examined the activity of the base excision repair (BER) enzymes 8-oxoguanine DNA glycosylase (OGG1) and apurinic/apyrimidinic endonuclease 1 on the substrates, including rG and 8-oxo-rG. Both BER enzymes were completely inactive against 8-oxo-rG in DNA. However, OGG1 suppressed 8-oxo-rG excision by RNase H2, which is involved in the removal of ribonucleotides from DNA. These results suggest that the different sugar backbones between 8-oxo-rG and 8-oxo-dG alter the capacity of TLS and repair of 8-oxoguanine.	[Sassa, Akira; Nohmi, Takehiko; Honma, Masamitsu; Yasui, Manabu] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan; [Caglayan, Melike; Rodriguez, Yesenia; Beard, William A.; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institute of Health Sciences - Japan; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Sassa, A; Yasui, M (corresponding author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	a-sassa@nihs.go.jp; m-yasui@nihs.go.jp	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Sassa, Akira/0000-0003-2454-0223; CAGLAYAN, MELIKE/0000-0003-1107-1042	Ministry of Education, Culture, Sports, Science and Technology in Japan [16K16195, 25281022]; Intramural Research Program of the National Institutes of Health, NIEHS [Z01 ES050158, Z01 ES050159]; Grants-in-Aid for Scientific Research [16K16195] Funding Source: KAKEN; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050159] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intramural Research Program of the National Institutes of Health, NIEHS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant-in-Aid for Young Scientists B (16K16195) and for Scientific Research B (25281022) from the Ministry of Education, Culture, Sports, Science and Technology in Japan and the Intramural Research Program of the National Institutes of Health, NIEHS Grants Z01 ES050158 and Z01 ES050159. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Calabretta A, 2015, NUCLEIC ACIDS RES, V43, P4713, DOI 10.1093/nar/gkv377; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Cilli P, 2015, J BIOL CHEM, V290, P26259, DOI 10.1074/jbc.M115.679209; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; DeRose EF, 2012, BIOCHEMISTRY-US, V51, P2407, DOI 10.1021/bi201710q; Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kamiya H, 2007, FREE RADICAL BIO MED, V43, P837, DOI 10.1016/j.freeradbiomed.2007.05.034; Kamiya H, 2012, CHEM RES TOXICOL, V25, P1771, DOI 10.1021/tx300259x; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Kupfer PA, 2007, NUCLEIC ACIDS RES, V35, P58, DOI 10.1093/nar/gkl948; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Lim YW, 2015, ELIFE, V4, DOI 10.7554/eLife.08007; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Niimi N, 2009, BIOCHEMISTRY-US, V48, P4239, DOI 10.1021/bi900153t; Ordonez H, 2014, NUCLEIC ACIDS RES, V42, P12722, DOI 10.1093/nar/gku1027; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rodriguez GP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003682; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sassa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142218; Sassa A, 2014, J BIOL CHEM, V289, P13996, DOI 10.1074/jbc.M114.557769; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Sassa A, 2011, J MOL BIOL, V406, P679, DOI 10.1016/j.jmb.2011.01.005; Sassa A, 2011, MUTAT RES-GEN TOX EN, V718, P10, DOI 10.1016/j.mrgentox.2010.11.002; Sastre-Moreno G, 2014, NUCLEIC ACIDS RES, V42, P9821, DOI 10.1093/nar/gku711; SHIBUTANI S, 1993, CHEM RES TOXICOL, V6, P625, DOI 10.1021/tx00035a006; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Tominaga Y, 2004, NUCLEIC ACIDS RES, V32, P3198, DOI 10.1093/nar/gkh642; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; UESUGI S, 1977, J AM CHEM SOC, V99, P3250, DOI 10.1021/ja00452a008; Vaisman A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003878; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yasui M, 2008, J MOL BIOL, V377, P1015, DOI 10.1016/j.jmb.2008.01.033; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1	54	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24314	24323		10.1074/jbc.M116.738732	http://dx.doi.org/10.1074/jbc.M116.738732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27660390	Green Published, hybrid			2022-12-28	WOS:000388498100042
J	Tian, YF; Gawlak, G; Tian, XY; Shah, AS; Sarich, N; Citi, S; Birukova, AA				Tian, Yufeng; Gawlak, Grzegorz; Tian, Xinyong; Shah, Alok S.; Sarich, Nicolene; Citi, Sandra; Birukova, Anna A.			Role of Cingulin in Agonist-induced Vascular Endothelial Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelium; lung injury; permeability; Rho (Rho GTPase); signal transduction; vascular biology	NUCLEOTIDE EXCHANGE FACTOR; TIGHT JUNCTIONS; BARRIER DYSFUNCTION; GENE-EXPRESSION; CLAUDIN-2 EXPRESSION; PULMONARY-EDEMA; CELL-ADHESION; IN-VIVO; RHO; GEF-H1	Agonist-induced activation of Rho GTPase signaling leads to endothelial cell (EC) permeability and may culminate in pulmonary edema, a devastating complication of acute lung injury. Cingulin is an adaptor protein first discovered in epithelium and is involved in the organization of the tight junctions. This study investigated the role of cingulin in control of agonist-induced lung EC permeability via interaction with RhoA-specific activator GEF-H1. The siRNA-induced cingulin knockdown augmented thrombin-induced EC permeability monitored by measurements of transendothelial electrical resistance and endothelial cell permeability for macromolecules. Increased thrombin-induced permeability in ECs with depleted cingulin was associated with increased activation of GEF-H1 and RhoA detected in pulldown activation assays. Increased GEF-H1 association with cingulin was essential for down-regulation of thrombin-induced RhoA barrier disruptive signaling. Using cingulin-truncated mutants, we determined that GEF-H1 interaction with the rod + tail domain of cingulin was required for inactivation of GEF-H1 and endothelial cell barrier preservation. The results demonstrate the role for association of GEF-H1 with cingulin as the mechanism of RhoA pathway inactivation and rescue of EC barrier after agonist challenge.	[Tian, Yufeng; Gawlak, Grzegorz; Tian, Xinyong; Shah, Alok S.; Sarich, Nicolene; Birukova, Anna A.] Univ Chicago, Sect Pulm & Crit Care Med, Dept Med, 5841 S Maryland Ave,MC 6026, Chicago, IL 60637 USA; [Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1205 Geneva, Switzerland	University of Chicago; University of Geneva	Birukova, AA (corresponding author), Univ Chicago, Sect Pulm & Crit Care Med, Dept Med, 5841 S Maryland Ave,MC 6026, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu			National Institutes of Health Grants from NHLBI [HL107920, HL130431]; National Institutes of Health Grant from NIGMS [GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130431, R01HL107920, R56HL107920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171] Funding Source: NIH RePORTER	National Institutes of Health Grants from NHLBI; National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL107920 and HL130431 from NHLBI and National Institutes of Health Grant GM114171 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2016, CELL SIGNAL, V28, P541, DOI 10.1016/j.cellsig.2016.02.015; Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098; Birukova AA, 2013, MICROVASC RES, V87, P50, DOI 10.1016/j.mvr.2012.12.006; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Citi S, 2000, J STRUCT BIOL, V131, P135, DOI 10.1006/jsbi.2000.4284; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Citi S, 2009, ANN NY ACAD SCI, V1165, P88, DOI 10.1111/j.1749-6632.2009.04053.x; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Garcia Joe G. N., 1996, Seminars in Thrombosis and Hemostasis, V22, P309, DOI 10.1055/s-2007-999025; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Guillemot L, 2012, J CELL SCI, V125, P5005, DOI 10.1242/jcs.101261; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; LO SK, 1985, J APPL PHYSIOL, V58, P1421, DOI 10.1152/jappl.1985.58.5.1421; Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Ogita H, 2010, P JPN ACAD B-PHYS, V86, P621, DOI 10.2183/pjab.86.621; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schossleitner K, 2016, ARTERIOSCL THROM VAS, V36, P647, DOI 10.1161/ATVBAHA.115.307032; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Zebda N, 2013, J BIOL CHEM, V288, P18290, DOI 10.1074/jbc.M112.432757	54	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23681	23692		10.1074/jbc.M116.720763	http://dx.doi.org/10.1074/jbc.M116.720763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27590342	hybrid, Green Published			2022-12-28	WOS:000387884400028
J	Huang, HC; Svoboda, RA; Lazenby, AJ; Saowapa, J; Chaika, N; Ding, K; Wheelock, MJ; Johnson, KR				Huang, Huocong; Svoboda, Robert A.; Lazenby, Audrey J.; Saowapa, Jintana; Chaika, Nina; Ding, Ke; Wheelock, Margaret J.; Johnson, Keith R.			Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; MESENCHYMAL TRANSITION; CELL-ADHESION; PYK2; EXPRESSION; INHIBITION; PROMOTES; BINDING; SRC; IDENTIFICATION	Pancreatic ductal adenocarcinomas are highly malignant cancers characterized by extensive invasion into surrounding tissues, metastasis to distant organs, and a limited response to therapy. A main feature of pancreatic ductal adenocarcinomas is desmoplasia, which leads to extensive deposition of collagen I. We have demonstrated that collagen I can induce epithelialmesenchymal transition (EMT) in pancreatic cancer cells. A hallmark of EMT is an increase in the expression of the mesenchymal cadherin N-cadherin. Previously we showed up-regulation of N-cadherin promotes tumor cell invasion and that collagen I-induced EMT is mediated by two collagen receptors, alpha 2 beta 1-integrin and discoidin domain receptor 1 (DDR1). DDR1 is a receptor-tyrosine kinase widely expressed during embryonic development and in many adult tissues and is also highly expressed in many different cancers. In the signaling pathway initiated by collagen, we have shown proline-rich tyrosine kinase 2 (Pyk2) is downstream of DDR1. In this study we found isoform b of DDR1 is responsible for collagen I-induced up-regulation of N-cadherin and tyrosine 513 of DDR1b is necessary. Knocking down Shc1, which binds to tyrosine 513 of DDR1b via its PTB (phosphotyrosine binding) domain, eliminates the upregulation of N-cadherin. The signaling does not require a functional SH2 domain or the tyrosine residues commonly phosphorylated in Shc1 but is mediated by the interaction between a short segment of the central domain of Shc1 and the proline-rich region of Pyk2. Taken together, these data illustrate DDR1b, but not DDR1a, mediates collagen I-induced N-cadherin up-regulation, and Shc1 is involved in this process by coupling to both DDR1 and Pyk2.	[Huang, Huocong; Wheelock, Margaret J.; Johnson, Keith R.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Svoboda, Robert A.; Saowapa, Jintana; Wheelock, Margaret J.; Johnson, Keith R.] Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA; [Lazenby, Audrey J.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE 68198 USA; [Chaika, Nina; Wheelock, Margaret J.; Johnson, Keith R.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Ding, Ke] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China; [Johnson, Keith R.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; University of Nebraska System; University of Nebraska Medical Center	Johnson, KR (corresponding author), Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	kjohnsonr@unmc.edu		Huang, Huocong/0000-0002-6345-4566; Ding, Ke/0000-0001-9016-812X	National Institutes of Health [U54CA163120, P50CA127297, U01CA111294, P30CA036727, R01GM051188, R21CA137401]; NIGMS, National Institutes of Health [P30GM106397]; Nebraska Department of Health and Human Services; NATIONAL CANCER INSTITUTE [P50CA127297, U54CA163120, P30CA036727, U01CA111294, R21CA137401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397, R01GM051188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nebraska Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants U54CA163120 (to S. Batra), P50CA127297 and U01CA111294 (to M. A. Hollingsworth), P30CA036727 (to K. H. Cowan), R01GM051188 (to M. J. W. and K. R. J.), and R21CA137401 (K. R. J.) and an Institutional Development Award (IDeA) from the NIGMS, National Institutes of Health Grant P30GM106397 (to K. R. J.) and a grant from the Nebraska Department of Health and Human Services (to K. R. J.). K. R. J. receives royalties from the sale of one of the antibodies used in these studies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Health and Human Services of the State of Nebraska.	Aguilera K. Y., 2014, CANC RES S19, V74, p182a; Aguilera KY, 2014, CANCER RES, V74, P1032, DOI 10.1158/0008-5472.CAN-13-2800; ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Ali-Rahmani F, 2016, CANCER RES, V76, P1560, DOI 10.1158/0008-5472.CAN-15-2401; Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Bhattacharya SK, 2012, BIOORG MED CHEM LETT, V22, P7523, DOI 10.1016/j.bmcl.2012.10.039; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Faure C, 2013, CELL MOL LIFE SCI, V70, P137, DOI 10.1007/s00018-012-1075-5; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Grignani F, 1998, CANCER RES, V58, P14; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Iansante V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8882; ILLC D, 1995, NATURE, V377, P539; JOHNSON KR, 1993, EXP CELL RES, V207, P252, DOI 10.1006/excr.1993.1191; Kamohara H, 2001, FASEB J, V15, P2724, DOI 10.1096/fj.01-0359fje; Kim H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1111/CHS0.12019; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Lemeer S, 2012, J PROTEOMICS, V75, P3465, DOI 10.1016/j.jprot.2011.10.007; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1999, J BIOL CHEM, V274, P8917, DOI 10.1074/jbc.274.13.8917; Li YP, 2015, J MED CHEM, V58, P3287, DOI 10.1021/jm5012319; Lind J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096488; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Northey JJ, 2013, J BIOL CHEM, V288, P5210, DOI 10.1074/jbc.M112.424804; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Rui YN, 2015, AUTOPHAGY, V11, P812, DOI 10.1080/15548627.2015.1034402; Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shintani Y, 2008, INT J CANCER, V122, P71, DOI 10.1002/ijc.23027; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Shokat K, 2002, DRUG DISCOV TODAY, V7, P872, DOI 10.1016/S1359-6446(02)02391-7; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Sorokin A, 2001, J BIOL CHEM, V276, P21521, DOI 10.1074/jbc.M008869200; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; vanderGeer P, 1996, P NATL ACAD SCI USA, V93, P963, DOI 10.1073/pnas.93.3.963; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Whatcott CJ., 2012, DESMOPLASIA CHEMORES; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769; Xiong WC, 1998, J CELL SCI, V111, P1981; Yang G, 2009, PROTEOMICS, V9, P4944, DOI 10.1002/pmic.200800762; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhao M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149231; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	69	37	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23208	23223		10.1074/jbc.M116.740605	http://dx.doi.org/10.1074/jbc.M116.740605			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605668	Green Published, hybrid			2022-12-28	WOS:000387224800030
J	Nair, B; Wong-Riley, MTT				Nair, Bindu; Wong-Riley, Margaret T. T.			Transcriptional Regulation of Brain-derived Neurotrophic Factor Coding Exon IX: ROLE OF NUCLEAR RESPIRATORY FACTOR 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain-derived neurotrophic factor (BDNF); chromatin immunoprecipitation (ChiP); short hairpin RNA (shRNA); transcription factor; transcription regulation	NUCLEAR RESPIRATORY FACTOR-2; CYTOCHROME-C-OXIDASE; CONTROLLING MITOCHONDRIAL BIOGENESIS; RECEPTOR SUBUNIT GENES; RAT BDNF-GENE; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; ENERGY-METABOLISM; CORTICAL-NEURONS; BIPOLAR DISORDER	Brain-derived neurotrophic factor (BDNF) is an active neurotrophin abundantly expressed throughout the nervous system. It plays an important role in synaptic transmission, plasticity, neuronal proliferation, differentiation, survival, and death. The Bdnf gene in rodents has eight non-coding exons and only a single coding exon (IX). Despite its recognized regulation by neuronal activity, relatively little is known about its transcriptional regulation, and even less about the transcription factor candidates that may play such a role. The goal of the present study was to probe for such a candidate that may regulate exon IX in the rat Bdnf gene. Our in silico analysis revealed tandem binding sites for nuclear respiratory factor 2 (NRF-2) on the promoter of exon IX. NRF-2 is of special significance because it co-regulates the expressions of mediators of energy metabolism (cytochrome c oxidase) and mediators of neuronal activity (glutamatergic receptors). To test our hypothesis that NRF-2 also regulates the Bdnf gene, we performed electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (ChIP), promoter cloning, and site-directed mutagenesis, real-time quantitative PCR (RT-qPCR), and Western blotting analysis. Results indicate that NRF-2 functionally regulates exon IX of the rat Bdnf gene. The binding sites of NRF-2 are conserved between rats and mice. Overexpressing NRF-2 up-regulated the expression of Bdnf exon IX, whereas knocking down NRF-2 down-regulated such expression. These findings are consistent with our hypothesis that NRF-2, in addition to regulating the coupling between neuronal activity and energy metabolism, also regulates the expression of BDNF, which is intimately associated with energy-demanding neuronal activity.	[Nair, Bindu; Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Wong-Riley, MTT (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mwr@mcw.edu	Wong-Riley, Margaret/AGM-6202-2022		National Institutes of Health [R01 EY018441]; NATIONAL EYE INSTITUTE [R01EY018441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY018441. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi Naoki, 2014, World J Biol Chem, V5, P409, DOI 10.4331/wjbc.v5.i4.409; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BISHOP JF, 1994, MOL BRAIN RES, V26, P225, DOI 10.1016/0169-328X(94)90094-9; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Castren E, 2004, MOL NEUROBIOL, V29, P289, DOI 10.1385/MN:29:3:289; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; Conner JM, 1997, J NEUROSCI, V17, P2295; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; Dhar SS, 2009, J NEUROSCI, V29, P483, DOI 10.1523/JNEUROSCI.3704-08.2009; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Jiang XY, 2008, J NEUROSCI, V28, P1118, DOI 10.1523/JNEUROSCI.2262-07.2008; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Lahiri DK, 2000, BRAIN RES PROTOC, V5, P257, DOI 10.1016/S1385-299X(00)00021-0; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; Liang HL, 2010, J NEUROSCI RES, V88, P640, DOI 10.1002/jnr.22222; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Markham A, 2014, BRIT J PHARMACOL, V171, P2206, DOI 10.1111/bph.12531; Martin Jean-Luc, 2011, Commun Integr Biol, V4, P14, DOI 10.4161/cib.4.1.13761; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McCarthy Deirdre M., 2012, Yale Journal of Biology and Medicine, V85, P437; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nair B, 2016, BBA-MOL CELL RES, V1863, P1, DOI 10.1016/j.bbamcr.2015.10.005; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Ongwijitwat S, 2005, GENE, V360, P65, DOI 10.1016/j.gene.2005.06.015; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Palomino A, 2006, SCHIZOPHR RES, V86, P321, DOI 10.1016/j.schres.2006.05.028; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Priya A, 2014, BBA-MOL CELL RES, V1843, P3018, DOI 10.1016/j.bbamcr.2014.09.006; Priya A, 2013, BBA-MOL CELL RES, V1833, P48, DOI 10.1016/j.bbamcr.2012.10.014; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Takei N, 1997, J NEUROCHEM, V68, P370; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhang CY, 1999, J NEUROCYTOL, V28, P525, DOI 10.1023/A:1007053204929; Zheng Fei, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P188; Zheng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028441	68	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22583	22593		10.1074/jbc.M116.742304	http://dx.doi.org/10.1074/jbc.M116.742304			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27624937	hybrid, Green Published			2022-12-28	WOS:000386760600019
J	Shah, S; King, EM; Mostafa, MM; Altonsy, MO; Newton, R				Shah, Suharsh; King, Elizabeth M.; Mostafa, Mahmoud M.; Altonsy, Mohammed O.; Newton, Robert			DUSP1 Maintains IRF1 and Leads to Increased Expression of IRF1-dependent Genes A MECHANISM PROMOTING GLUCOCORTICOID INSENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucocorticoid; inflammation; innate immunity; interferon regulatory factor (IRF); mitogen-activated protein kinase (MAPK); CXCL10; DUSP1; glucocorticoid resistance; IRF1; MKP-1	ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; AIRWAY EPITHELIAL-CELLS; UBIQUITIN-PROTEASOME PATHWAY; SPECIFICITY PHOSPHATASE 1; INNATE IMMUNE-RESPONSES; SMOOTH-MUSCLE-CELLS; REGULATORY FACTOR-I; IFN-GAMMA; TRANSCRIPTION FACTORS	Although the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, mediates dexamethasone-induced repression of MAPKs, 14 of 46 interleukin-1 (IL1B)-induced mRNAs were significantly enhanced by DUSP1 overexpression in pulmonary A549 cells. These include the interferon regulatory factor, IRF1, and the chemokine, CXCL10. Of these, DUSP1-enhanced mRNAs, 10 including CXCL10, were IRF1-dependent. MAPK inhibitors and DUSP1 overexpression prolonged IRF1 expression by elevating transcription and increasing IRF1 mRNA and protein stability. Conversely, DUSP1 silencing increased IL1B-induced MAPK phosphorylation while significantly reducing IRF1 protein expression at 4 h. This confirms a regulatory network whereby DUSP1 switches off MAPKs to maintain IRF1 expression. There was no repression of IRF1 expression by dexamethasone in primary human bronchial epithelial cells, and in A549 cells IL1B-induced IRF1 protein was only modestly and transiently repressed. Although dexamethasone did not repress IL1B-induced IRF1 protein expression at 4-6 h, silencing of IL1B plus dexamethasone-induced DUSP1 significantly reduced IRF1 expression. IL1B-induced expression of CXCL10 was largely insensitive to dexamethasone, whereas other DUSP1-enhanced, IRF1-dependent mRNAs showed various degrees of repression. With IL1B plus dexamethasone, CXCL10 expression was also IRF1-dependent, and expression was reduced by DUSP1 silencing. Thus, IL1B plus dexamethasone-induced DUSP1 maintains expression of IRF1 and the IRF1-dependent gene, CXCL10. This is supported by chromatin immunoprecipitation showing IRF1 recruitment to be essentially unaffected by dexamethasone at the CXCL10 promoter or at the promoters of more highly repressed IRF1-dependent genes. Since IRF1-dependent genes, such as CXCL10, are central to host defense, these data may help explain the reduced effectiveness of glucocorticoids during asthma exacerbations.	[Shah, Suharsh; King, Elizabeth M.; Mostafa, Mahmoud M.; Altonsy, Mohammed O.; Newton, Robert] Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB T2N 4Z6, Canada; [Altonsy, Mohammed O.] Sohag Univ, Dept Zool, Sohag 825224, Egypt	University of Calgary; Egyptian Knowledge Bank (EKB); Sohag University	Newton, R (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	rnewton@ucalgary.ca	; Newton, Robert/C-6814-2012	Mostafa, Mahmoud/0000-0001-6377-911X; Newton, Robert/0000-0002-4919-8498; Altonsy, Mohammed Omar/0000-0002-9086-5934	Canadian Fund of Innovation (CFI); Alberta Science and Research Authority	Canadian Fund of Innovation (CFI); Alberta Science and Research Authority	Real-time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund of Innovation (CFI) and the Alberta Science and Research Authority.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chapin WJ, 2015, PHARMACOGENET GENOM, V25, P126, DOI 10.1097/FPC.0000000000000116; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Gavrila A, 2015, AM J RESP CELL MOL, V53, P728, DOI 10.1165/rcmb.2014-0477OC; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Holden NS, 2004, EUR J BIOCHEM, V271, P785, DOI 10.1111/j.1432-1033.2004.03982.x; Huang GH, 2011, IMMUNITY, V35, P45, DOI 10.1016/j.immuni.2011.05.014; Huang Y, 2002, J IMMUNOL, V169, P2627, DOI 10.4049/jimmunol.169.5.2627; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kadiyala V, 2016, J BIOL CHEM, V291, P12673, DOI 10.1074/jbc.M116.721217; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Korhonen R, 2012, MOL IMMUNOL, V51, P219, DOI 10.1016/j.molimm.2012.03.019; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; LEIGH R, 2016, PHARMACOL RES PERSPE, V4, P1; Maki CG, 1996, CANCER RES, V56, P2649; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Miyamoto NG, 2000, J NEUROIMMUNOL, V105, P78, DOI 10.1016/S0165-5728(00)00195-8; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Newton R, 2000, BRIT J PHARMACOL, V130, P1353, DOI 10.1038/sj.bjp.0703431; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; O'Connell D, 2015, AM J PHYSIOL-LUNG C, V309, pL348, DOI 10.1152/ajplung.00099.2015; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pawliczak R, 2005, PHYSIOL GENOMICS, V23, P28, DOI 10.1152/physiolgenomics.00011.2005; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Sasse SK, 2016, AM J PHYSIOL-LUNG C, V311, pL421, DOI 10.1152/ajplung.00179.2016; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Shah S, 2016, J BIOL CHEM, V291, P110, DOI 10.1074/jbc.M115.697599; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shi LH, 2011, GENE, V487, P21, DOI 10.1016/j.gene.2011.07.004; Smallie T, 2015, J IMMUNOL, V195, P277, DOI 10.4049/jimmunol.1402830; Stellato C, 2007, J ALLERGY CLIN IMMUN, V120, P1247, DOI 10.1016/j.jaci.2007.10.041; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; Wang YL, 2008, RESP MED, V102, P949, DOI 10.1016/j.rmed.2008.01.017; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Zaheer RS, 2010, AM J RESP CELL MOL, V43, P413, DOI 10.1165/rcmb.2009-0203OC; Zaheer RS, 2009, J IMMUNOL, V182, P4854, DOI 10.4049/jimmunol.0802401; Zhang N, 2007, J IMMUNOL, V179, P578, DOI 10.4049/jimmunol.179.1.578; Zhao BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134984; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P14329, DOI 10.1073/pnas.250494697	69	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21802	21816		10.1074/jbc.M116.728964	http://dx.doi.org/10.1074/jbc.M116.728964			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551049	Green Published, hybrid			2022-12-28	WOS:000385999200043
J	Smith, SS; Dole, NS; Franceschetti, T; Hrdlicka, HC; Delany, AM				Smith, Spenser S.; Dole, Neha S.; Franceschetti, Tiziana; Hrdlicka, Henry C.; Delany, Anne M.			MicroRNA-433 Dampens Glucocorticoid Receptor Signaling, Impacting Circadian Rhythm and Osteoblastic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; circadian; circadian rhythm; glucocorticoid receptor; microRNA (miRNA); microRNA mechanism; osteoblast; post-transcriptional regulation	MESSENGER-RNA; I COLLAGEN; TISSUE SENSITIVITY; BONE-FORMATION; STEM-CELLS; ERR-GAMMA; METABOLISM; MECHANISMS; TRANSCRIPTOME; OSTEOPOROSIS	Serum glucocorticoids play a critical role in synchronizing circadian rhythm in peripheral tissues, and multiple mechanisms regulate tissue sensitivity to glucocorticoids. In the skeleton, circadian rhythm helps coordinate bone formation and resorption. Circadian rhythm is regulated through transcriptional and post-transcriptional feedback loops that include microRNAs. How microRNAs regulate circadian rhythm in bone is unexplored. We show that in mouse calvaria, miR-433 displays robust circadian rhythm, peaking just after dark. In C3H/10T1/2 cells synchronized with a pulse of dexamethasone, inhibition of miR-433 using a tough decoy altered the period and amplitude of Per2 gene expression, suggesting that miR-433 regulates rhythm. Although miR-433 does not directly target the Per2 3-UTR, it does target two rhythmically expressed genes in calvaria, Igf1 and Hif1. miR-433 can target the glucocorticoid receptor; however, glucocorticoid receptor protein abundance was unaffected in miR-433 decoy cells. Rather, miR-433 inhibition dramatically enhanced glucocorticoid signaling due to increased nuclear receptor translocation, activating glucocorticoid receptor transcriptional targets. Last, in calvaria of transgenic mice expressing a miR-433 decoy in osteoblastic cells (Col3.6 promoter), the amplitude of Per2 and Bmal1 mRNA rhythm was increased, confirming that miR-433 regulates circadian rhythm. miR-433 was previously shown to target Runx2, and mRNA for Runx2 and its downstream target, osteocalcin, were also increased in miR-433 decoy mouse calvaria. We hypothesize that miR-433 helps maintain circadian rhythm in osteoblasts by regulating sensitivity to glucocorticoid receptor signaling.	[Smith, Spenser S.; Dole, Neha S.; Franceschetti, Tiziana; Hrdlicka, Henry C.; Delany, Anne M.] UConn Hlth, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA; [Dole, Neha S.] Univ Calif San Francisco, Sch Med, Dept Orthoped Surg, San Francisco, CA 94143 USA; [Franceschetti, Tiziana] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of California System; University of California San Francisco; University of Aberdeen	Delany, AM (corresponding author), UConn Hlth, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	adelany@uchc.edu		Franceschetti, Tiziana/0000-0002-8839-0247; Dole, Neha/0000-0003-4675-2649; Smith, Spenser/0000-0002-3984-3174; Hrdlicka, Henry/0000-0002-7014-7919	NIAMS, National Institutes of Health [AR044877]; NIDCR, National Institutes of Health [5T90DE21989]; American Society for Bone and Mineral Research; UConn Health Center Research Advisory Council; Center for Molecular Medicine at UConn Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR044877, R29AR044877, R01AR044877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021989] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Society for Bone and Mineral Research; UConn Health Center Research Advisory Council; Center for Molecular Medicine at UConn Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIAMS, National Institutes of Health, Grant AR044877; NIDCR, National Institutes of Health, Grant 5T90DE21989; a Grant-in-Aid award from the American Society for Bone and Mineral Research; the UConn Health Center Research Advisory Council; and the Center for Molecular Medicine at UConn Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; BAMBERGER CM, 1995, J CLIN INVEST, V95, P2435, DOI 10.1172/JCI117943; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Cain DW, 2015, BEST PRACT RES CL EN, V29, P545, DOI 10.1016/j.beem.2015.04.007; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; DELANY AM, 1994, J CELL BIOCHEM, V56, P295, DOI 10.1002/jcb.240560304; Dufour CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002143; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gimble JM, 2009, J CELL BIOCHEM, V107, P569, DOI 10.1002/jcb.22153; Golombek DA, 2013, J PHYSIOL-PARIS, V107, P310, DOI 10.1016/j.jphysparis.2013.03.007; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; HASSAGER C, 1992, J BONE MINER RES, V7, P1307; Heshmati HM, 1998, J CLIN ENDOCR METAB, V83, P751, DOI 10.1210/jc.83.3.751; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Jeong BC, 2010, J BONE MINER RES, V25, P262, DOI 10.1359/jbmr.090718; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kawai M, 2010, ENDOCRINOLOGY, V151, P4861, DOI 10.1210/en.2010-0407; Kim EJ, 2013, LIFE SCI, V92, P562, DOI 10.1016/j.lfs.2013.01.015; Kojima S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011264; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Merrill GF, 1998, METHOD CELL BIOL, V57, P229; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Moutsatsou P, 2012, TRENDS MOL MED, V18, P348, DOI 10.1016/j.molmed.2012.04.005; Na YJ, 2009, EXP MOL MED, V41, P638, DOI 10.3858/emm.2009.41.9.070; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nandi A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-45; Nicolaides NC, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-71; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Oishi Katsutaka, 2006, J Circadian Rhythms, V4, P13, DOI 10.1186/1740-3391-4-13; PIETSCHMANN P, 1990, EUR J CLIN INVEST, V20, P310, DOI 10.1111/j.1365-2362.1990.tb01861.x; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Regan JN, 2014, P NATL ACAD SCI USA, V111, P8673, DOI 10.1073/pnas.1324290111; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Riester A, 2012, ENDOCRINOLOGY, V153, P212, DOI 10.1210/en.2011-1285; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Witt-Enderby PA, 2012, J PINEAL RES, V53, P374, DOI 10.1111/j.1600-079X.2012.01007.x; Wu XY, 2008, BONE, V42, P861, DOI 10.1016/j.bone.2007.12.226; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1359/jbmr.061114	58	32	33	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21717	21728		10.1074/jbc.M116.737890	http://dx.doi.org/10.1074/jbc.M116.737890			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551048	hybrid, Green Published			2022-12-28	WOS:000385999200036
J	Peterson, RL; Galaleldeen, A; Villarreal, J; Taylor, AB; Cabelli, DE; Hart, PJ; Culotta, VC				Peterson, Ryan L.; Galaleldeen, Ahmad; Villarreal, Johanna; Taylor, Alexander B.; Cabelli, Diane E.; Hart, P. John; Culotta, Valeria C.			The Phylogeny and Active Site Design of Eukaryotic Copper-only Superoxide Dismutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; ZINC; BINDING; SOD1; PH; GENE; ERYTHROCUPREIN; MECHANISM; EVOLUTION; INSIGHTS	In eukaryotes the bimetallic Cu/Zn superoxide dismutase (SOD) enzymes play important roles in the biology of reactive oxygen species by disproportionating superoxide anion. Recently, we reported that the fungal pathogen Candida albicans expresses a novel copper-only SOD, known as SOD5, that lacks the zinc cofactor and electrostatic loop (ESL) domain of Cu/Zn-SODs for substrate guidance. Despite these abnormalities, C. albicans SOD5 can disproportionate superoxide at rates limited only by diffusion. Here we demonstrate that this curious copper-only SOD occurs throughout the fungal kingdom as well as in phylogenetically distant oomycetes or "pseudofungi" species. It is the only form of extracellular SOD in fungi and oomycetes, in stark contrast to the extracellular Cu/Zn-SODs of plants and animals. Through structural biology and biochemical approaches we demonstrate that these copper-only SODs have evolved with a specialized active site consisting of two highly conserved residues equivalent to SOD5 Glu-110 and Asp-113. The equivalent positions are zinc binding ligands in Cu/ZnSODs and have evolved in copper-only SODs to control catalysis and copper binding in lieu of zinc and the ESL. Similar to the zinc ion in Cu/Zn-SODs, SOD5 Glu-110 helps orient a key copper-coordinating histidine and extends the pH range of enzyme catalysis. SOD5 Asp-113 connects to the active site in a manner similar to that of the ESL in Cu/Zn-SODs and assists in copper cofactor binding. Copper-only SODs are virulence factors for certain fungal pathogens; thus this unique active site may be a target for future anti-fungal strategies.	[Peterson, Ryan L.; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Galaleldeen, Ahmad; Villarreal, Johanna] St Marys Univ, Dept Biol Sci, San Antonio, TX 78228 USA; [Galaleldeen, Ahmad; Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Cabelli, Diane E.] Brookhaven Natl Labs, Dept Chem, Upton, NY 11973 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Health San Antonio; United States Department of Energy (DOE); Brookhaven National Laboratory; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	vculott1@jhu.edu		Taylor, Alexander/0000-0003-3517-6033; Galaleldeen, Ahmad/0000-0003-1160-6908	National Institutes of Health [P41 GM103403, P30 CA054174]; United States Department of Energy [DE-AC02-06CH11357]; Office of the Vice President for Research; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98-CH10886]; NATIONAL CANCER INSTITUTE [T32CA009110, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM112320, R01GM050016, P41GM103403] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Office of the Vice President for Research; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Drs. Julie Gleason and Brian Learn for helpful discussions and Professor Jiou Wang for assistance with protein purification. Support for Northeastern Collaborative Access Team beamline 24-ID-E was provided by National Institutes of Health Grant P41 GM103403 and United States Department of Energy Grant DE-AC02-06CH11357. The X-Ray Crystallography Core Laboratory at the University of Texas Health Science Center at San Antonio is supported in part by the Office of the Vice President for Research and by National Institutes of Health Grant P30 CA054174 (Cancer Therapy and Research Center). Pulse radiolysis studies were carried out using the Van de Graaff facilities of the BNL Accelerator Center for Energy Research, which is supported by United States Department of Energy, Office of Science, Office of Basic Energy Sciences through Grant DE-AC02-98-CH10886.	Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Achkar JM, 2010, CLIN MICROBIOL REV, V23, P253, DOI 10.1128/CMR.00076-09; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Antonyuk SV, 2009, J MOL BIOL, V388, P310, DOI 10.1016/j.jmb.2009.03.026; BANCI L, 1991, EUR J BIOCHEM, V196, P123, DOI 10.1111/j.1432-1033.1991.tb15794.x; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; BENOV L, 1995, ARCH BIOCHEM BIOPHYS, V319, P508, DOI 10.1006/abbi.1995.1324; Broxton CN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005295; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Davis D, 2003, CURR GENET, V44, P58, DOI [10.1007/s00294-003-0415-2, 10.1007/s00294-003-0431-2]; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHER CL, 1994, PROTEINS, V19, P24, DOI 10.1002/prot.340190105; Fisher CL, 1997, PROTEINS, V29, P103, DOI 10.1002/(SICI)1097-0134(199709)29:1<103::AID-PROT8>3.0.CO;2-G; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Judelson HS, 2012, EUKARYOT CELL, V11, P1304, DOI 10.1128/EC.00155-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Latijnhouwers M, 2003, TRENDS MICROBIOL, V11, P462, DOI 10.1016/j.tim.2003.08.002; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1982, CLIN CHIM ACTA, V126, P41, DOI 10.1016/0009-8981(82)90360-6; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Mason KL, 2012, INFECT IMMUN, V80, P150, DOI 10.1128/IAI.05162-11; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miramon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052850; Ogihara NL, 1996, BIOCHEMISTRY-US, V35, P2316, DOI 10.1021/bi951930b; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2011, P NATL ACAD SCI USA, V108, P15258, DOI 10.1073/pnas.1105100108; Richards TA, 2007, PLANT SIGNAL BEHAV, V2, P112, DOI 10.4161/psb.2.2.3640; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenbach A, 2010, EUKARYOT CELL, V9, P1075, DOI 10.1128/EC.00034-10; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; STROMQVIST M, 1991, J CHROMATOGR, V548, P293, DOI 10.1016/S0021-9673(01)88611-8; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; VALENTINE JS, 1979, P NATL ACAD SCI USA, V76, P4245, DOI 10.1073/pnas.76.9.4245; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713	58	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20911	20923		10.1074/jbc.M116.748251	http://dx.doi.org/10.1074/jbc.M116.748251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27535222	hybrid, Green Published			2022-12-28	WOS:000385406200010
J	Soniat, M; Cagatay, T; Chook, YM				Soniat, Michael; Cagatay, Tolga; Chook, Yuh Min			Recognition Elements in the Histone H3 and H4 Tails for Seven Different Importins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; NUCLEOSOME CORE PARTICLE; STRUCTURAL BASIS; CELL-CYCLE; IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; LINKER HISTONES; T-ANTIGEN; PROTEIN; CHROMATIN	N-terminal tails of histones H3 and H4 are known to bind several different Importins to import the histones into the cell nucleus. However, it is not known what binding elements in the histone tails are recognized by the individual Importins. Biochemical studies of H3 and H4 tails binding to seven Importins, Imp beta, Kap beta 2, Imp4, Imp5, Imp7, Imp9, and Imp beta, show the H3 tail binding more tightly than the H4 tail. The H3 tail binds Kap beta 2 and Imp5 with K-D values of 77 and 57 nM, respectively, and binds the other five Importins more weakly. Mutagenic analysis shows H3 tail residues 11-27 to be the sole binding segment for Imp beta, Kap beta 2, and Imp4. However, Imp5, Imp7, Imp9, and Imp beta bind two separate elements in the H3 tail: the segment at residues 11-27 and an isoleucine-lysine nuclear localization signal (IK-NLS) motif at residues 35-40. The H4 tail also uses either one or two basic segments to bind the same set of Importins with a similar trend of relative affinities as the H3 tail, albeit at least 10-fold weaker. Of the many lysine residues in the H3 and H4 tails, only acetylation of the H3 Lys14 substantially decreased binding to several Importins. Lastly, we show that, in addition to the N-terminal tails, the histone fold domains of H3 and H4 and/or the histone chaperone Asf1b are important for Importin-histone recognition.	[Soniat, Michael; Cagatay, Tolga; Chook, Yuh Min] Univ Texas Southwestern, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chook, YM (corresponding author), Univ Texas Southwestern, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	yuhmin.chook@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019	Soniat, Michael/0000-0003-3670-4344	United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098256, R01GM069909] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bing Li for histone constructs, Chad Brautigam and Thomas Scheuermann from the Macromolecular Biophysics Resource at University of Texas Southwestern for assistance in ITC experiments, Diana Tomchick and James Chen from Structural Biology Laboratory at University of Texas Southwestern for assistance in crystallographic data collection, Ho Yee Joyce Fung and Szu-Chin Fu for comments, and Xian-Jin Xie for help with statistical analysis. The use of SBC 19ID beamline at Advanced Photon Source is supported by United States Department of Energy Contract DE-AC02-06CH11357.	Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Alvarez F, 2011, J BIOL CHEM, V286, P17714, DOI 10.1074/jbc.M111.223453; Annunziato AT, 2012, BBA-GENE REGUL MECH, V1819, P196, DOI 10.1016/j.bbagrm.2011.07.005; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; Baake M, 2001, J CELL BIOCHEM, V81, P333, DOI 10.1002/1097-4644(20010501)81:2<333::AID-JCB1048>3.3.CO;2-4; Bevington PR., 2002, DATA REDUCTION ERROR; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2002, BIOCHEMISTRY-US, V41, P6955, DOI 10.1021/bi012122p; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Ejlassi-Lassallette A, 2011, MOL BIOL CELL, V22, P245, DOI 10.1091/mbc.E10-07-0633; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Greiner M, 2004, EUR J CELL BIOL, V83, P511, DOI 10.1078/0171-9335-00418; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Johnson-Saliba M, 2000, FEBS LETT, V467, P169, DOI 10.1016/S0014-5793(00)01142-X; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Keck KM, 2012, BBA-GENE REGUL MECH, V1819, P277, DOI 10.1016/j.bbagrm.2011.09.007; Kobayashi J, 2013, J MOL BIOL, V425, P1852, DOI 10.1016/j.jmb.2013.02.035; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li Y, 2014, GENE DEV, V28, P1217, DOI 10.1101/gad.240531.114; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; McLane LM, 2008, NUCLEIC ACIDS RES, V36, P4317, DOI 10.1093/nar/gkn383; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Soniat M., 2016, STRUCTURE IN PRESS; Soniat M, 2015, BIOCHEM J, V468, P353, DOI 10.1042/BJ20150368; Suel KE, 2009, J BIOL CHEM, V284, P15416, DOI 10.1074/jbc.M809384200; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Xu DR, 2015, BIOINFORMATICS, V31, P1357, DOI 10.1093/bioinformatics/btu826; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109; Zhang ZC, 2011, MOL BIOL CELL, V22, P4657, DOI 10.1091/mbc.E11-03-0222	62	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21171	+		10.1074/jbc.M116.730218	http://dx.doi.org/10.1074/jbc.M116.730218			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27528606	Green Published, hybrid			2022-12-28	WOS:000385406200031
J	Reid, HM; Kinsella, BT				Reid, Helen M.; Kinsella, B. Therese			The alpha, but not the beta, isoform of the human thromboxane A(2) receptor is a target for nitric oxide-mediated desensitization. INDEPENDENT MODULATION OF TP SIGNALING BY NITRIC OXIDE AND PROSTACYCLIN (Retracted vol 278, pg 51190, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200	1	0	0	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19260	19260		10.1074/jbc.A116.309314	http://dx.doi.org/10.1074/jbc.A116.309314			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27613956	Green Published, hybrid			2022-12-28	WOS:000383242800007
J	Sun, SH; Zhang, XT; Lyu, L; Li, XX; Yao, SL; Zhang, JJ				Sun, Shuhong; Zhang, Xiaotian; Lyu, Lin; Li, Xixi; Yao, Siliang; Zhang, Junjie			Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOGENIC FACTOR; MESSENGER-RNAS; THP-1 CELLS; ACID; IDENTIFICATION; MOTILITY; TARGET; CARCINOMA; PATHWAYS; SEQUENCE	Autotaxin (ATX) is a key enzyme that converts lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA), a lysophospholipid mediator that regulates cellular activities through its specific G protein-coupled receptors. The ATX-LPA axis plays an important role in various physiological and pathological processes, especially in inflammation and cancer development. Although the transcriptional regulation of ATX has been widely studied, the post-transcriptional regulation of ATX is largely unknown. In this study, we identified conserved adenylate-uridylate (AU)-rich elements in the ATX mRNA 3'-untranslated region (3'UTR). The RNA-binding proteins HuR and AUF1 directly bound to the ATX mRNA 3'UTR and had antagonistic functions in ATX expression. HuR enhanced ATX expression by increasing ATX mRNA stability, whereas AUF1 suppressed ATX expression by promoting ATX mRNA decay. HuR and AUF1 were involved in ATX regulation in Colo320 human colon cancer cells and the LPS-stimulated human monocytic THP-1 cells. HuR knockdown suppressed ATX expression in B16 mouse melanoma cells, leading to inhibition of cell migration. This effect was reversed by AUF1 knockdown to recover ATX expression or by the addition of LPA. These results suggest that the post-transcriptional regulation of ATX expression by HuR and AUF1 modulates cancer cell migration. In summary, we identified HuR and AUF1 as novel post-transcriptional regulators of ATX expression, thereby elucidating a novel mechanism regulating the ATX-LPA axis.	[Sun, Shuhong; Zhang, Xiaotian; Lyu, Lin; Yao, Siliang; Zhang, Junjie] Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing 100875, Peoples R China; [Li, Xixi] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Zhang, XT; Zhang, JJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing 100875, Peoples R China.	xiaotianzhang@bnu.edu.cn; jjzhang@bnu.edu.cn		Zhang, Junjie/0000-0001-8809-1485	National Natural Science Foundation of China [31500619, 31470765]; Beijing Normal University [2014NT24]; Key Laboratory of Cell Proliferation and Regulation Biology (Beijing Normal University), Ministry of Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Normal University; Key Laboratory of Cell Proliferation and Regulation Biology (Beijing Normal University), Ministry of Education	This work was supported by Grants 31500619 and 31470765 from the National Natural Science Foundation of China, Grant 2014NT24 from the Young Teacher Fund of Beijing Normal University, and the Open Fund of the Key Laboratory of Cell Proliferation and Regulation Biology (Beijing Normal University), Ministry of Education. The authors declare that they have no conflicts of interest with the contents of this article.	Black EJ, 2004, ONCOGENE, V23, P2357, DOI 10.1038/sj.onc.1207377; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Chang CL, 2008, J BIOMED SCI, V15, P357, DOI 10.1007/s11373-007-9223-x; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Euer N, 2002, ANTICANCER RES, V22, P733; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Farina AR, 2012, FEBS LETT, V586, P3681, DOI 10.1016/j.febslet.2012.08.026; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Grammatikakis I., 2016, WILEY INTERDISCIP RE, DOI [10.1002/wrna.1372, DOI 10.1002/WRNA.1372]; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Li S, 2012, FEBS LETT, V586, P792, DOI 10.1016/j.febslet.2012.01.044; Li S, 2009, BIOCHEM BIOPH RES CO, V378, P264, DOI 10.1016/j.bbrc.2008.11.047; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Nabors LB, 2001, CANCER RES, V61, P2154; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Rubenfeld J, 2006, AM J PHYSIOL-LUNG C, V290, pL66, DOI 10.1152/ajplung.00473.2004; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Song JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136629; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Wang L, 2004, CELL SIGNAL, V16, P991, DOI 10.1016/j.cellsig.2004.02.001; Yi XF, 2009, AUST NZ J OBSTET GYN, V49, P93, DOI 10.1111/j.1479-828X.2008.00937.x; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhu ZP, 2013, TUMOR BIOL, V34, P2299, DOI 10.1007/s13277-013-0774-3; Zucconi B.E., 2013, FRONT BIOSCI, V16, P2307	34	23	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25823	25836		10.1074/jbc.M116.756908	http://dx.doi.org/10.1074/jbc.M116.756908			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27784781	Green Published, hybrid			2022-12-28	WOS:000390345200007
J	Brunetti, J; Roscia, G; Lampronti, I; Gambari, R; Quercini, L; Falciani, C; Bracci, L; Pini, A				Brunetti, Jlenia; Roscia, Giulia; Lampronti, Ilaria; Gambari, Roberto; Quercini, Leila; Falciani, Chiara; Bracci, Luisa; Pini, Alessandro			Immunomodulatory and Anti-inflammatory Activity in Vitro and in Vivo of a Novel Antimicrobial Candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); drug discovery; infectious disease; inflammation; LPS; anti-inflammatory agents	HOST-DEFENSE PEPTIDES; CYSTIC-FIBROSIS; BRANCHED PEPTIDES; RESISTANCE; MECHANISM; SELECTION; TOXICITY; LUNGS; DRUG	The synthetic antimicrobial peptide SET-M33 has strong activity against bacterial infections caused by Gram-negative bacteria. It is currently in preclinical development as a new drug to treat lung infections caused by Gram-negative bacteria. Here we report its strong anti-inflammatory activity in terms of reduced expression of a number of cytokines, enzymes, and signal transduction factors involved in inflammation triggered by LPS from Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. Sixteen cytokines and other major agents involved in inflammation were analyzed in macrophages and bronchial cells after stimulation with LPS and incubation with SET-M33. The bronchial cells were obtained from a cystic fibrosis patient. A number of these proteins showed up to 100% reduction in expression as measured by RT-PCR, Western blotting, or Luminex technology. LPS neutralization was also demonstrated in vivo by challenging bronchoalveolar lavage of SET-M33-treated mice with LPS, which led to a sharp reduction in TNF- with respect to non-SET-M33-treated animals. We also describe a strong activity of SET-M33 in stimulating cell migration of keratinocytes in wound healing experiments in vitro, demonstrating a powerful immunomodulatory action generally characteristic of molecules taking part in innate immunity.	[Brunetti, Jlenia; Roscia, Giulia; Quercini, Leila; Bracci, Luisa; Pini, Alessandro] Univ Siena, Dept Med Biotechnol, Via Aldo Moro 2, I-53100 Siena, Italy; [Lampronti, Ilaria; Gambari, Roberto] Univ Ferrara, Dept Life Sci & Biotechnol, Via Fossato Mortara 74, I-44121 Ferrara, Italy; [Falciani, Chiara] SetLance Srl, Via Fiorentina 1, I-53100 Siena, Italy	University of Siena; University of Ferrara	Pini, A (corresponding author), Univ Siena, Dept Med Biotechnol, Via Aldo Moro 2, I-53100 Siena, Italy.	pinia@unisi.it	Bracci, Luisa/V-9913-2018; Pini, Alessandro/R-1359-2018; Falciani, Chiara/R-1330-2018; Brunetti, Luisa/E-6464-2019	Bracci, Luisa/0000-0002-0738-5746; Pini, Alessandro/0000-0002-3832-8349; Falciani, Chiara/0000-0002-1027-8482; Brunetti, Luisa/0000-0001-8144-7186	European Community [604434]; Italian Foundation for Cystic Fibrosis [12/2013, 17/2016]	European Community(European Commission); Italian Foundation for Cystic Fibrosis(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This work was supported by the European Community Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 604434 (PNEUMO-NP) and by the Italian Foundation for Cystic Fibrosis (Projects FFC# 12/2013 and FFC# 17/2016 to A. P.). The peptide SET-M33 is covered by three patents owned by or licensed to SetLance. C. F., A, P., and L. B. are partners of SetLance.	BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Brunetti J., 2016, CURR TOP MED CHEM; Brunetti J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26077; Brunetti J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17736; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Falciani C, 2007, MOL CANCER THER, V6, P2441, DOI 10.1158/1535-7163.MCT-07-0164; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Falciani C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046259; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Lam SJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.162, 10.1038/nmicrobiol.2016.162]; Lampronti I, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/960603; Lee TH, 2016, CURR TOP MED CHEM, V16, P25, DOI 10.2174/1568026615666150703121700; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Pini A, 2008, CURR PROTEIN PEPT SC, V9, P468, DOI 10.2174/138920308785915227; Pini A, 2007, J PEPT SCI, V13, P393, DOI 10.1002/psc.858; Pini A, 2012, AMINO ACIDS, V43, P467, DOI 10.1007/s00726-011-1103-z; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Roscia G, 2013, CURR PROTEIN PEPT SC, V14, P641, DOI 10.2174/138920371408131227155308; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tamanini A, 2011, AM J PHYSIOL-LUNG C, V300, pL380, DOI 10.1152/ajplung.00129.2010; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Zhang PX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7221	27	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25742	25748		10.1074/jbc.M116.750257	http://dx.doi.org/10.1074/jbc.M116.750257			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27758868	Green Published, hybrid			2022-12-28	WOS:000390095300038
J	Zhuang, J; Kamp, WM; Li, J; Liu, CY; Kang, JG; Wang, PY; Hwang, PM				Zhuang, Jie; Kamp, William M.; Li, Jie; Liu, Chengyu; Kang, Ju-Gyeong; Wang, Ping-Yuan; Hwang, Paul M.			Forkhead Box O3A (FOXO3) and the Mitochondrial Disulfide Relay Carrier (CHCHD4) Regulate p53 Protein Nuclear Activity in Response to Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; ENDURANCE EXERCISE; PATHWAY; SIRT1; PHOSPHORYLATION; TRANSLOCATION; HOMEOSTASIS; BIOGENESIS; METABOLISM; TURNOVER	Although exercise is linked with improved health, the specific molecular mechanisms underlying its various benefits require further clarification. Here we report that exercise increases the nuclear localization and activity of p53 by acutely down-regulating coiled-coil-helix-coiled-coil-helix domain 4 (CHCHD4), a carrier protein that mediates p53 import into the mitochondria. This response to exercise is lost in transgenic mice with constitutive expression of CHCHD4. Mechanistically, exercise-induced nuclear transcription factor FOXO3 binds to the CHCHD4 promoter and represses its expression, preventing the translocation of p53 to the mitochondria and thereby increasing p53 nuclear localization. The synergistic increase in nuclear p53 and FOXO3 by exercise can facilitate their known interaction in transactivating Sirtuin 1 (SIRT1), a NAD(+)-dependent histone deacetylase that mediates adaptation to various stresses. Thus, our results reveal one mechanism by which exercise could be involved in preventing cancer and potentially other diseases associated with aging.	[Zhuang, Jie; Kamp, William M.; Li, Jie; Kang, Ju-Gyeong; Wang, Ping-Yuan; Hwang, Paul M.] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hwang, PM (corresponding author), 10CRC 5-5330,10 Ctr Dr, Bethesda, MD 20892 USA.	hwangp@mail.nih.gov			Division of Intramural Research of the NHLBI, National Institutes of Health [HL005101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006051, ZICHL005907, ZIGHL006020, Z01HL005101] Funding Source: NIH RePORTER	Division of Intramural Research of the NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research of the NHLBI, National Institutes of Health Grant HL005101 (to P. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bartlett JD, 2014, SPORTS MED, V44, P303, DOI 10.1007/s40279-013-0127-9; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hagenbuchner J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00147; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hood DA, 2015, PROG MOL BIOL TRANSL, V135, P99, DOI 10.1016/bs.pmbts.2015.07.007; Kamp WM, 2016, CURR OPIN GENET DEV, V38, P16, DOI 10.1016/j.gde.2016.02.007; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Liu J, 2016, MOL PHARMACEUT, V13, P73, DOI 10.1021/acs.molpharmaceut.5b00516; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Park JH, 2016, FEBS LETT; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Patino WD, 2006, CIRC RES, V98, P1282, DOI 10.1161/01.RES.0000222284.48288.28; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Rogers CJ, 2008, SPORTS MED, V38, P271, DOI 10.2165/00007256-200838040-00002; Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; Slopack D, 2014, J PHYSIOL-LONDON, V592, P4069, DOI 10.1113/jphysiol.2014.275867; Stefanetti RJ, 2015, PFLUG ARCH EUR J PHY, V467, P1523, DOI 10.1007/s00424-014-1587-y; Tachtsis B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00144; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wang PY, 2013, NEW ENGL J MED, V368, P1027, DOI 10.1056/NEJMoa1214091; Zhuang J, 2013, P NATL ACAD SCI USA, V110, P17356, DOI 10.1073/pnas.1310908110; Zhuang J, 2012, FREE RADICAL BIO MED, V53, P1279, DOI 10.1016/j.freeradbiomed.2012.07.026	37	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24819	24827		10.1074/jbc.M116.745737	http://dx.doi.org/10.1074/jbc.M116.745737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27687729	Green Published, hybrid			2022-12-28	WOS:000388880100002
J	Saederup, KL; Stodkilde, K; Graversen, JH; Dickson, CF; Etzerodt, A; Hansen, SWK; Fago, A; Gell, D; Andersen, CBF; Moestrup, SK				Saederup, Kirstine Lindhardt; Stodkilde, Kristian; Graversen, Jonas Heilskov; Dickson, Claire F.; Etzerodt, Anders; Hansen, Soren Werner Karlskov; Fago, Angela; Gell, David; Andersen, Christian Brix Folsted; Moestrup, Soren Kragh			The Staphylococcus aureus Protein IsdH Inhibits Host Hemoglobin Scavenging to Promote Heme Acquisition by the Pathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; hemoglobin; iron; macrophage; Staphylococcus aureus (S; aureus); CD163; Iron-regulated Surface Determinant; IsdH; haptoglobin; heme acquisition	CYSTEINE-RICH DOMAIN; SURFACE PROTEIN; MOLECULAR-BASIS; RECEPTOR CD163; HAPTOGLOBIN; IRON; BINDING; SUSCEPTIBILITY; IDENTIFICATION; DETERMINANTS	Hemolysis is a complication in septic infections with Staphylococcus aureus, which utilizes the released Hb as an iron source. S. aureus can acquire heme in vitro from hemoglobin (Hb) by a heme-sequestering mechanism that involves proteins from the S. aureus iron-regulated surface determinant (Isd) system. However, the host has its own mechanism to recapture the free Hb via haptoglobin (Hp) binding and uptake of Hb-Hp by the CD163 receptor in macrophages. It has so far remained unclear how the Isd system competes with this host iron recycling system in situ to obtain the important nutrient. By binding and uptake studies, we now show that the IsdH protein, which serves as an Hb receptor in the Isd system, directly interferes with the CD163-mediated clearance by binding the Hb-Hp complex and inhibiting CD163 recognition. Analysis of truncated IsdH variants including one or more of three near iron transporter domains, IsdH(N1), IsdH(N2), and IsdH(N3), revealed that Hb binding of IsdH(N1) and IsdH(N2) accounted for the high affinity for Hb-Hp complexes. The third near iron transporter domain, IsdH(N3), exhibited redox-dependent heme extraction, when Hb in the Hb-Hp complex was in the oxidized met form but not in the reduced oxy form. IsdB, the other S. aureus Hb receptor, failed to extract heme from Hb-Hp, and it was a poor competitor for Hb-Hp binding to CD163. This indicates that Hb recognition by IsdH, but not by IsdB, sterically inhibits the receptor recognition of Hb-Hp. This function of IsdH may have an overall stimulatory effect on S. aureus heme acquisition and growth.	[Saederup, Kirstine Lindhardt; Graversen, Jonas Heilskov; Hansen, Soren Werner Karlskov; Moestrup, Soren Kragh] Univ Southern Denmark, Dept Mol Med, DK-5000 Odense, Denmark; [Stodkilde, Kristian; Etzerodt, Anders; Andersen, Christian Brix Folsted; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Fago, Angela] Aarhus Univ, Zoophysiol Sect, Dept Biosci, DK-8000 Aarhus, Denmark; [Dickson, Claire F.; Gell, David] Univ Tasmania, Sch Med, Hobart, Tas 7005, Australia; [Moestrup, Soren Kragh] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark	University of Southern Denmark; Aarhus University; Aarhus University; University of Tasmania; University of Southern Denmark; Odense University Hospital	Moestrup, SK (corresponding author), Univ Southern Denmark, Inst Mol Med, JB Winslows Vej 25, DK-5000 Odense C, Denmark.	smoestrup@health.sdu.dk	Moestrup, Søren Kragh/AAD-1735-2019; Etzerodt, Anders/O-9860-2019; Fago, Angela/J-5946-2013; Moestrup, Soren Kragh/A-1403-2014	Etzerodt, Anders/0000-0002-6757-2068; Hansen, Soren/0000-0002-8186-4630; Graversen, Jonas Heilskov/0000-0001-7119-2108; Stodkilde-Jorgensen, Kristian/0000-0002-7324-305X; Saederup, Kirstine Lindhardt/0000-0001-5724-491X; Fago, Angela/0000-0001-7315-2628; Moestrup, Soren Kragh/0000-0003-3862-2107; Gell, David/0000-0003-0382-1181	Novo Nordisk Foundation; Lundbeck Foundation; Danish Medical Research Council; European Research Council TROJA Grant [233312]; Lundbeck Foundation [R54-2010-5637, R180-2014-3649] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0008781, NNF14OC0011537] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council TROJA Grant; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Novo Nordisk Foundation, the Lundbeck Foundation, and Danish Medical Research Council and European Research Council TROJA Grant 233312). The authors declare that they have no conflicts of interest with the contents of this article.	Alayash AI, 2013, TRENDS BIOTECHNOL, V31, P2, DOI 10.1016/j.tibtech.2012.10.003; Andersen C. B., 2016, ANTIOXIDANT IN PRESS; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, V1; Boretti FS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00385; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Etzerodt A, 2012, J CONTROL RELEASE, V160, P72, DOI 10.1016/j.jconrel.2012.01.034; Fonner BA, 2014, BIOCHEMISTRY-US, V53, P3922, DOI 10.1021/bi5005188; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; HWANG PK, 1980, J BIOL CHEM, V255, P3038; JOHNSON MK, 1980, INFECT IMMUN, V29, P1028; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nielsen MJ, 2013, J BIOL CHEM, V288, P18834, DOI 10.1074/jbc.M113.471060; Nielsen MJ, 2006, J LEUKOCYTE BIOL, V79, P837, DOI 10.1189/jlb.1005602; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Schaer DJ, 2002, BRIT J HAEMATOL, V119, P239, DOI 10.1046/j.1365-2141.2002.03790.x; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sjodt M, 2016, J MOL BIOL, V428, P1107, DOI 10.1016/j.jmb.2015.02.008; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; SMITH HW, 1963, J PATHOL BACTERIOL, V85, P197, DOI 10.1002/path.1700850119; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Stodkilde K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6487; VALDES R, 1978, P NATL ACAD SCI USA, V75, P5493, DOI 10.1073/pnas.75.11.5493; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0	41	18	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23989	23998		10.1074/jbc.M116.755934	http://dx.doi.org/10.1074/jbc.M116.755934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27681593	Green Published, hybrid			2022-12-28	WOS:000388498100015
J	Dandekar, A; Qiu, YN; Kim, H; Wang, JM; Hou, X; Zhang, XB; Zheng, Z; Mendez, R; Yu, FS; Kumar, A; Fang, DY; Sun, F; Zhang, KZ				Dandekar, Aditya; Qiu, Yining; Kim, Hyunbae; Wang, Jiemei; Hou, Xia; Zhang, Xuebao; Zheng, Ze; Mendez, Roberto; Yu, Fu-Shin; Kumar, Ashok; Fang, Deyu; Sun, Fei; Zhang, Kezhong			Toll-like Receptor (TLR) Signaling Interacts with CREBH to Modulate High-density Lipoprotein (HDL) in Response to Bacterial Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; FATTY-ACID OXIDATION; TRANSCRIPTION FACTOR; SEVERE SEPSIS; A-IV; TRAF6; ACTIVATION; STRESS; ACETYLATION; METABOLISM	Bacterial endotoxin can induce inflammatory and metabolic changes in the host. In this study, we revealed a molecular mechanism by which a stress-inducible, liver-enriched transcription factor, cAMP-responsive element-binding protein hepatic-specific (CREBH), modulates lipid profiles to protect the liver from injuries upon the bacterial endotoxin lipopolysaccharide (LPS). LPS challenge can activate CREBH in mouse liver tissues in a toll-like receptor (TLR)/MyD88-dependent manner. Upon LPS challenge, CREBH interacts with TNF receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase that functions as a key mediator of TLR signaling, and this interaction relies on MyD88. Further analysis demonstrated that TRAF6 mediates K63-linked ubiquitination of CREBH to facilitate CREBH cleavage and activation. CREBH directly activates expression of the gene encoding Apolipoprotein A4 (ApoA4) under LPS challenge, leading to modulation of high-density lipoprotein (HDL) in animals. CREBH deficiency led to reduced production of circulating HDL and increased liver damage upon high-dose LPS challenge. Therefore, TLR/MyD88-dependent, TRAF6-facilitated CREBH activation represents a mammalian hepatic defense response to bacterial endotoxin by modulating HDL.	[Qiu, Yining; Kim, Hyunbae; Wang, Jiemei; Zhang, Xuebao; Zheng, Ze; Mendez, Roberto; Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Dandekar, Aditya; Zhang, Kezhong] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA; [Hou, Xia; Sun, Fei] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Yu, Fu-Shin; Kumar, Ashok] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Northwestern University; Feinberg School of Medicine	Zhang, KZ (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, 3202 Scott Hall,540 East Canfield, Detroit, MI 48201 USA.	kzhang@med.wayne.edu	Dandekar, Aditya/L-9510-2019; Hou, Xia/AAD-2235-2020; Wang, Jie-Mei/N-9528-2019	Dandekar, Aditya/0000-0002-3803-4930; Wang, Jie-Mei/0000-0002-8723-4410; Hou, Xia/0000-0002-6733-086X; Zhang, Kezhong/0000-0002-6062-235X; Zheng, Ze/0000-0002-4453-224X	National Institutes of Health (NIH) [DK090313, ES017829, AR066634]; American Heart Association [09GRNT2280479]; NATIONAL EYE INSTITUTE [R01EY017960, R01EY010869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK090313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017829] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) Grants DK090313 and ES017829 (to K. Z.), AR066634 (to K. Z. and D. F.), and American Heart Association Grant 09GRNT2280479 (to K. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; GHISELLI G, 1989, BIOCHIM BIOPHYS ACTA, V1006, P26, DOI 10.1016/0005-2760(89)90319-6; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kapatos G, 2007, J NEUROCHEM, V101, P1119, DOI 10.1111/j.1471-4159.2007.04486.x; Khovidhunkit W, 2004, ATHEROSCLEROSIS, V176, P37, DOI 10.1016/j.atherosclerosis.2004.04.018; Kim H, 2015, MOL CELL BIOL, V35, P4121, DOI 10.1128/MCB.00665-15; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Saemann MD, 2010, EUR J CLIN INVEST, V40, P1131, DOI 10.1111/j.1365-2362.2010.02361.x; Tsai MH, 2009, J HEPATOL, V50, P906, DOI 10.1016/j.jhep.2008.12.024; van Leeuwen HJ, 2001, NETH J MED, V59, P102, DOI 10.1016/S0300-2977(01)00144-9; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zheng Z, 2016, DIABETES, V65, P3369, DOI 10.2337/db16-0298	31	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23149	23158		10.1074/jbc.M116.755728	http://dx.doi.org/10.1074/jbc.M116.755728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27637329	hybrid, Green Published			2022-12-28	WOS:000387224800025
J	Susanti, D; Loganathan, U; Mukhopadhyay, B				Susanti, Dwi; Loganathan, Usha; Mukhopadhyay, Biswarup			A Novel F-420-dependent Thioredoxin Reductase Gated by Low Potential FAD A TOOL FOR REDOX REGULATION IN AN ANAEROBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP-NOV REPRESENTS; ESCHERICHIA-COLI; 8-HYDROXY-5-DEAZAFLAVIN-REDUCING HYDROGENASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; BIOCHEMICAL-CHARACTERIZATION; THERMOPLASMA-ACIDOPHILUM; METHANOCOCCUS-JANNASCHII; METHANOPYRUS-KANDLERI; REDUCED THIOREDOXIN; CRYSTAL-STRUCTURE	A recent report suggested that the thioredoxin-dependent metabolic regulation, which is widespread in all domains of life, existed in methanogenic archaea about 3.5 billion years ago. We now show that the respective electron delivery enzyme (thioredoxin reductase, TrxR), although structurally similar to flavin-containing NADPH-dependent TrxRs (NTR), lacked an NADPH-binding site and was dependent on reduced coenzyme F-420 (F420H2), a stronger reductant with a mid-point redox potential (E'(0)) of -360 mV; E'(0) of NAD(P)H is -320 mV. Because F-420 is a deazaflavin, this enzyme was named deazaflavin-dependent flavin-containing thioredoxin reductase (DFTR). It transferred electrons from F420H2 to thioredoxin via protein-bound flavin; K-m values for thioredoxin and F420H2 were 6.3 and 28.6 mu M, respectively. The E'(0) of DFTR-bound flavin was approximately -389 mV, making electron transfer from NAD(P) H or F420H2 to flavin endergonic. However, under high partial pressures of hydrogen prevailing on early Earth and present day deep-sea volcanoes, the potential for the F-420/F420H2 pair could be as low as -425 mV, making DFTR efficient. The presence of DFTR exclusively in ancient methanogens and mostly in the early Earth environment of deep-sea volcanoes and DFTR's characteristics suggest that the enzyme developed on early Earth and gave rise to NTR. A phylogenetic analysis revealed six more novel-type TrxR groups and suggested that the broader flavin-containing disulfide oxidoreductase family is more diverse than previously considered. The unprecedented structural similarities between an F-420-dependent enzyme (DFTR) and an NADPH-dependent enzyme (NTR) brought new thoughts to investigations on F-420 systems involved in microbial pathogenesis and antibiotic production.	[Susanti, Dwi; Loganathan, Usha; Mukhopadhyay, Biswarup] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Mukhopadhyay, Biswarup] Virginia Tech, Biocomplex Inst, Blacksburg, VA 24061 USA; [Mukhopadhyay, Biswarup] Virginia Tech, Virginia Tech Caril Sch Med, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Mukhopadhyay, B (corresponding author), Dept Biochem, Engel Hall,340 West Campus Dr, Blacksburg, VA 24061 USA.	biswarup@vt.edu		Mukhopadhyay, Biswarup/0000-0003-0736-0298	National Aeronautics and Space Administration Astrobiology: Exobiology and Evolutionary Biology Grant [NNX13AI05G]; Virginia Tech Agricultural Experiment Station Hatch Program, CRIS Project [VA-160021]	National Aeronautics and Space Administration Astrobiology: Exobiology and Evolutionary Biology Grant; Virginia Tech Agricultural Experiment Station Hatch Program, CRIS Project	This work was supported by National Aeronautics and Space Administration Astrobiology: Exobiology and Evolutionary Biology Grant NNX13AI05G (to B. M.) and Virginia Tech Agricultural Experiment Station Hatch Program, CRIS Project VA-160021. The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amegbey GY, 2003, BIOCHEMISTRY-US, V42, P8001, DOI 10.1021/bi030021g; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Aufhammer SW, 2005, PROTEIN SCI, V14, P1840, DOI 10.1110/ps.041289805; Balsera M, 2013, PLANTA, V237, P619, DOI 10.1007/s00425-012-1803-y; Berk H, 1998, FEBS LETT, V438, P124, DOI 10.1016/S0014-5793(98)01288-5; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Boone David R., 1993, P35; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brochier C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r17; Buchanan BB, 2002, PHOTOSYNTH RES, V73, P215, DOI 10.1023/A:1020407432008; Buey RM, 2017, MOL PLANT, V10, P212, DOI 10.1016/j.molp.2016.06.019; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ceh K, 2009, BIOCHEMISTRY-US, V48, P10098, DOI 10.1021/bi901104d; CHEN JS, 1974, BIOCHIM BIOPHYS ACTA, V371, P283, DOI 10.1016/0005-2795(74)90025-7; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; de Poorter LMI, 2005, MICROBIOL-SGM, V151, P1697, DOI 10.1099/mic.0.27679-0; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EIRICH LD, 1979, J BACTERIOL, V140, P20, DOI 10.1128/JB.140.1.20-27.1979; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Graham DE, 2002, NAT PROD REP, V19, P133, DOI 10.1039/b103714p; Grimaldi P, 2008, EXTREMOPHILES, V12, P553, DOI 10.1007/s00792-008-0161-y; HAASE P, 1992, EUR J BIOCHEM, V203, P527, DOI 10.1111/j.1432-1033.1992.tb16579.x; Hamill MJ, 2008, BIOCHEMISTRY-US, V47, P9738, DOI 10.1021/bi800676g; HAMMEL KE, 1983, P NATL ACAD SCI-BIOL, V80, P3681, DOI 10.1073/pnas.80.12.3681; Harms C, 1998, MICROBIOL-UK, V144, P793, DOI 10.1099/00221287-144-3-793; Hendrickson EL, 2008, J BACTERIOL, V190, P4818, DOI 10.1128/JB.00255-08; Hendrickson EL, 2007, P NATL ACAD SCI USA, V104, P8930, DOI 10.1073/pnas.0701157104; Hernandez HH, 2008, BIOCHEMISTRY-US, V47, P9728, DOI 10.1021/bi8006753; Hicks M. A., 2014, PROTEIN FAMILIES REL, P127; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; Hocking WP, 2015, ARCHAEA, V2015, DOI 10.1155/2015/235384; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hosoya-Matsuda N, 2009, MOL PLANT, V2, P336, DOI 10.1093/mp/ssn077; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Jeon SJ, 2002, EUR J BIOCHEM, V269, P5423, DOI 10.1046/j.1432-1033.2002.03231.x; Johnson EF, 2005, J BIOL CHEM, V280, P38776, DOI 10.1074/jbc.M503492200; Johnson EF., 2007, P INT S MICR SULF ME, P202; JOHNSON TC, 1984, J BACTERIOL, V158, P1061, DOI 10.1128/JB.158.3.1061-1069.1984; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Kanzok SM, 2002, METHOD ENZYMOL, V347, P370; Kashima Y, 2003, ARCH BIOCHEM BIOPHYS, V418, P179, DOI 10.1016/j.abb.2003.08.002; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; KIENER A, 1983, SYST APPL MICROBIOL, V4, P305, DOI 10.1016/S0723-2020(83)80017-4; Kumar AK, 2015, BIOCHEMISTRY-US, V54, P3122, DOI 10.1021/acs.biochem.5b00137; Kumar AK, 2011, ACTA CRYSTALLOGR F, V67, P775, DOI 10.1107/S1744309111017234; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; KURR M, 1991, ARCH MICROBIOL, V156, P239, DOI 10.1007/BF00262992; Lee DY, 2000, BIOCHEMISTRY-US, V39, P6652, DOI 10.1021/bi000035b; Lennon BW, 1999, PROTEIN SCI, V8, P2366; LIN XL, 1986, J BACTERIOL, V168, P444, DOI 10.1128/jb.168.1.444-448.1986; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; McCarver AC, 2014, FEBS J, V281, P4598, DOI 10.1111/febs.12964; MCFARLAN SC, 1992, J BIOL CHEM, V267, P10561; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Mukhopadhyay B, 2000, BBA-GEN SUBJECTS, V1475, P191, DOI 10.1016/S0304-4165(00)00064-7; MUTH E, 1987, EUR J BIOCHEM, V169, P571, DOI 10.1111/j.1432-1033.1987.tb13647.x; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Palfey B. A., 1998, COMPREHENSIVE BIOL C, P88; Patel MP, 1998, FEMS MICROBIOL LETT, V166, P155, DOI 10.1111/j.1574-6968.1998.tb13197.x; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pieulle L, 2011, J BIOL CHEM, V286, P7812, DOI 10.1074/jbc.M110.197988; PRONGAY AJ, 1992, J BIOL CHEM, V267, P25181; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; PURWANTINI E, 1992, ANAL BIOCHEM, V205, P342, DOI 10.1016/0003-2697(92)90446-E; Purwantini E, 1997, FEMS MICROBIOL LETT, V146, P129, DOI 10.1016/S0378-1097(96)00465-X; Purwantini E, 2016, J BACTERIOL, V198, P2020, DOI 10.1128/JB.01035-15; Purwantini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081985; Reott MA, 2009, J BACTERIOL, V191, P3384, DOI 10.1128/JB.01665-08; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Ruggiero A, 2009, BBA-PROTEINS PROTEOM, V1794, P554, DOI 10.1016/j.bbapap.2008.11.011; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; SEGERER A, 1988, SYST APPL MICROBIOL, V10, P161, DOI 10.1016/S0723-2020(88)80031-6; Sheehan R, 2015, J IND MICROBIOL BIOT, V42, P965, DOI 10.1007/s10295-015-1592-y; Susanti D, 2014, P NATL ACAD SCI USA, V111, P2608, DOI 10.1073/pnas.1324240111; Susanti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045313; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; THELANDER L, 1967, J BIOL CHEM, V242, P852; THELANDER L, 1968, EUR J BIOCHEM, V4, P407, DOI 10.1111/j.1432-1033.1968.tb00227.x; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004; Yang XQ, 2010, J BACTERIOL, V192, P1370, DOI 10.1128/JB.01035-09	96	19	20	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23084	23100		10.1074/jbc.M116.750208	http://dx.doi.org/10.1074/jbc.M116.750208			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27590343	Green Published, hybrid			2022-12-28	WOS:000387224800020
J	Hu, XD; Jogasuria, A; Wang, JY; Kim, C; Han, Y; Shen, H; Wu, JS; You, M				Hu, Xudong; Jogasuria, Alvin; Wang, Jiayou; Kim, Chunki; Han, Yoonhee; Shen, Hong; Wu, Jiashin; You, Min			MitoNEET Deficiency Alleviates Experimental Alcoholic Steatohepatitis in Mice by Stimulating Endocrine Adiponectin-Fgf15 Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adiponectin; alcohol; intestine; iron; liver injury	DRUG TARGET MITONEET; FATTY LIVER; PROTECTIVE ACTION; BETA-KLOTHO; GROWTH; PROTEIN; ETHANOL; INJURY; INFLAMMATION; METABOLISM	MitoNEET (mNT) (CDGSH iron-sulfur domain-containing protein 1 or CISD1) is an outer mitochondrial membrane protein that donates 2Fe-2S clusters to apo-acceptor proteins. In the present study, using a global mNT knock-out (mNTKO) mouse model, we investigated the in vivo functional role of mNT in the development of alcoholic steatohepatitis. Experimental alcoholic steatohepatitis was achieved by pair feeding wild-type (WT) and mNTKO mice with Lieber-DeCarli ethanol-containing diets for 4 weeks. Strikingly, chronically ethanol-fed mNTKO mice were completely resistant to ethanol-induced steatohepatitis as revealed by dramatically reduced hepatic triglycerides, decreased hepatic cholesterol level, diminished liver inflammatory response, and normalized serum ALT levels. Mechanistic studies demonstrated that ethanol administration to mNTKO mice induced two pivotal endocrine hormones, namely, adipose-derived adiponectin and gut-derived fibroblast growth factor 15 (Fgf15). The elevation in circulating levels of adiponectin and Fgf15 led to normalized hepatic and serum levels of bile acids, limited hepatic accumulation of toxic bile, attenuated inflammation, and amelioration of liver injury in the ethanol-fed mNTKO mice. Other potential mechanisms such as reduced oxidative stress, activated Sirt1 signaling, and diminished NF-B activity also contribute to hepatic improvement in the ethanol-fed mNTKO mice. In conclusion, the present study identified adiponectin and Fgf15 as pivotal adipose-gut-liver metabolic coordinators in mediating the protective action of mNT deficiency against development of alcoholic steatohepatitis in mice. Our findings may help to establish mNT as a novel therapeutic target and pharmacological inhibition of mNT may be beneficial for the prevention and treatment of human alcoholic steatohepatitis.	[Hu, Xudong; Jogasuria, Alvin; Wang, Jiayou; Kim, Chunki; Han, Yoonhee; Shen, Hong; Wu, Jiashin; You, Min] Northeast Ohio Med Univ, Coll Pharm, Rootstown, OH 44272 USA; [Hu, Xudong] Shanghai Univ Tradit Chinese Med, Dept Biol, Sch Basic Med Sci, Shanghai 201203, Peoples R China; [Shen, Hong] Guangdong Hosp Tradit Chinese Med Zhuhai, Dept Liver Dis, Zhuhai 519015, Peoples R China	Northeast Ohio Medical University (NEOMED); Shanghai University of Traditional Chinese Medicine; Guangxi University of Chinese Medicine; Guangzhou University of Chinese Medicine	You, M (corresponding author), 4209 State Route 44, Rootstown, OH 44272 USA.	myou@neomed.edu	Wang, Jiayou/AAN-4760-2021; hu, xudong/GNM-7161-2022	Wang, Jiayou/0000-0001-9697-2004; Kim, Chunki/0000-0003-2410-9118; JOGASURIA, ALVIN/0000-0002-8569-339X	National Institute on Alcoholism and Alcohol Abuse [AA013623, AA015951]; Natural Science Foundation of China [81273967]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013623, R01AA015951] Funding Source: NIH RePORTER	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institute on Alcoholism and Alcohol Abuse Grants AA013623 and AA015951 (to M. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Natural Science Foundation of China Grant 81273967.	Asimakopoulou A, 2016, HEPATOLOGY, V63, P669, DOI 10.1002/hep.27930; Bechmann LP, 2013, HEPATOLOGY, V57, P1394, DOI 10.1002/hep.26225; Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Cai Y, 2016, AM J PATHOL, V186, P2417, DOI 10.1016/j.ajpath.2016.05.006; Chanda D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068845; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003; Drafahl KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014412; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Ge HF, 2014, J BIOL CHEM, V289, P30470, DOI 10.1074/jbc.M114.592022; Geldenhuys WJ, 2014, DRUG DISCOV TODAY, V19, P1601, DOI 10.1016/j.drudis.2014.05.001; Hao YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072345; Hu M, 2013, HEPATOLOGY, V58, P1953, DOI 10.1002/hep.26589; Hunter RL, 2008, NEUROSCI LETT, V432, P198, DOI 10.1016/j.neulet.2007.12.019; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jahn D, 2015, CYTOKINE GROWTH F R, V26, P625, DOI 10.1016/j.cytogfr.2015.07.016; Kohgo Y, 2008, J GASTROEN HEPATOL, V23, pS78, DOI 10.1111/j.1440-1746.2007.05290.x; Kolumam G, 2015, EBIOMEDICINE, V2, P730, DOI 10.1016/j.ebiom.2015.05.028; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kusminski CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4962; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Landry AP, 2014, J BIOL CHEM, V289, P4307, DOI 10.1074/jbc.M113.542050; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Logan SJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0471-z; Luo YD, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-21; Moreno-Navarrete JM, 2016, OBESITY, V24, P139, DOI 10.1002/oby.21334; Mutanen A, 2015, J HEPATOL, V62, P1391, DOI [10.1016/j.jhep.2015.03.012, 10.1016/j.jhep.2015.01.004]; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Park Pil-Hoon, 2015, Curr Pathobiol Rep, V3, P243; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Salem AF, 2012, CELL CYCLE, V11, P4174, DOI 10.4161/cc.22376; Sanchez-Infantes D, 2015, INT J OBESITY, V39, P742, DOI 10.1038/ijo.2015.2; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Song BJ, 2014, REDOX BIOL, V3, P109, DOI 10.1016/j.redox.2014.10.004; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Tan GQ, 2012, BIOMETALS, V25, P1177, DOI 10.1007/s10534-012-9580-4; Tsai PH, 2015, STEM CELLS DEV, V24, P2561, DOI 10.1089/scd.2015.0066; Wang CH, 2014, HUM MOL GENET, V23, P4770, DOI 10.1093/hmg/ddu193; Wang DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081190; Wieser V, 2016, J HEPATOL, V64, P872, DOI 10.1016/j.jhep.2015.11.037; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Wu WB, 2014, BIOCHEM BIOPH RES CO, V443, P68, DOI 10.1016/j.bbrc.2013.11.057; Xie GX, 2013, FASEB J, V27, P3583, DOI 10.1096/fj.13-231860; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61; Zhang R, 2014, DIGEST DIS SCI, V59, P89, DOI 10.1007/s10620-013-2877-5; Zhao YS, 2016, AM J PHYSIOL-ENDOC M, V310, pE289, DOI 10.1152/ajpendo.00356.2015; Zhong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091308; Zhou M, 2016, HEPATOLOGY, V63, P914, DOI 10.1002/hep.28257; Zuris JA, 2012, J BIOL CHEM, V287, P11649, DOI 10.1074/jbc.M111.319731	58	22	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22482	22495		10.1074/jbc.M116.737015	http://dx.doi.org/10.1074/jbc.M116.737015			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27573244	Green Published, hybrid			2022-12-28	WOS:000386760600011
J	Walker, EC; Johnson, RW; Hu, YF; Brennan, HJ; Poulton, IJ; Zhang, JG; Jenkins, BJ; Smyth, GK; Nicola, NA; Sims, NA				Walker, Emma C.; Johnson, Rachelle W.; Hu, Yifang; Brennan, Holly J.; Poulton, Ingrid J.; Zhang, Jian-Guo; Jenkins, Brendan J.; Smyth, Gordon K.; Nicola, Nicos A.; Sims, Natalie A.			Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; osteoblast; osteocyte; signal transducers and activators of transcription 1 (STAT1); STAT3; glycoprotein 130; leukemia inhibitory factor; oncostatin M	NF-KAPPA-B; SOLUBLE INTERLEUKIN-6; M OSM; TARGETED DISRUPTION; NEGATIVE REGULATION; GENE-EXPRESSION; STEM-CELLS; CYTOKINE; INFLAMMATION; ROLES	Oncostatin M (OSM) and leukemia inhibitory factor (LIF) are IL-6 family members with a wide range of biological functions. Human OSM (hOSM) and murine LIF (mLIF) act in mouse cells via a LIF receptor (LIFR)-glycoprotein 130 (gp130) heterodimer. In contrast, murine OSM (mOSM) signals mainly via an OSM receptor (OSMR)-gp130 heterodimer and binds with only very low affinity to mLIFR. hOSM and mLIF stimulate bone remodeling by both reducing osteocytic sclerostin and up-regulating the pro-osteoclastic factor receptor activator of NF-B ligand (RANKL) in osteoblasts. In the absence of OSMR, mOSM still strongly suppressed sclerostin and stimulated bone formation but did not induce RANKL, suggesting that intracellular signaling activated by the low affinity interaction of mOSM with mLIFR is different from the downstream effects when mLIF or hOSM interacts with the same receptor. Both STAT1 and STAT3 were activated by mOSM in wild type cells or by mLIF/hOSM in wild type and Osmr(-/-) cells. In contrast, in Osmr(-/-) primary osteocyte-like cells stimulated with mOSM (therefore acting through mLIFR), microarray expression profiling and Western blotting analysis identified preferential phosphorylation of STAT3 and induction of its target genes but not of STAT1 and its target genes; this correlated with reduced phosphorylation of both gp130 and LIFR. In a mouse model of spontaneous osteopenia caused by hyperactivation of STAT1/3 signaling downstream of gp130 (gp130(Y757F/Y757F)), STAT1 deletion rescued the osteopenic phenotype, indicating a beneficial effect of promoting STAT3 signaling over STAT1 downstream of gp130 in this low bone mass condition, and this may have therapeutic value.	[Walker, Emma C.; Johnson, Rachelle W.; Brennan, Holly J.; Poulton, Ingrid J.; Sims, Natalie A.] St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia; [Hu, Yifang; Zhang, Jian-Guo; Smyth, Gordon K.; Nicola, Nicos A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Jenkins, Brendan J.] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Jenkins, Brendan J.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Mol Translat Sci, Clayton, Vic 3168, Australia; [Smyth, Gordon K.] Univ Melbourne, St Vincents Hosp, Dept Math & Stat, Melbourne, Vic 3010, Australia; [Zhang, Jian-Guo; Nicola, Nicos A.] Univ Melbourne, St Vincents Hosp, Dept Med Biol, Melbourne, Vic 3010, Australia; [Sims, Natalie A.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic 3010, Australia	St. Vincent's Institute of Medical Research; Walter & Eliza Hall Institute; Hudson Institute of Medical Research; Monash University; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Sims, NA (corresponding author), St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia.	nsims@svi.edu.au	Sims, Natalie Ann/A-7192-2012	Sims, Natalie Ann/0000-0003-1421-8468; Jenkins, Brendan/0000-0002-7552-4656	National Health and Medical Research Council (NHMRC) (Australia) [1004945, 1058625, 1054618]; NHMRC	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council (NHMRC) (Australia) Project Grants 1004945 (to N. A. S. and J.-G. Z.) and 1058625 (to N. A. S.) and Program Grant 1054618 (to G. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an NHMRC senior research fellowship.	Achtman AH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003515; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolin Celeste, 2012, Genes Cancer, V3, P117, DOI 10.1177/1947601912458284; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Buttmann M, 2007, J VASC RES, V44, P51, DOI 10.1159/000097977; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Devlin RD, 1996, J CLIN ENDOCR METAB, V81, P1893, DOI 10.1210/jc.81.5.1893; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fairlie WD, 2004, J BIOL CHEM, V279, P2125, DOI 10.1074/jbc.M310103200; Fernandes TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073266; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Haan S, 1999, J BIOL CHEM, V274, P1342, DOI 10.1074/jbc.274.3.1342; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Ichihara M, 1997, BLOOD, V90, P165; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Johnson RW, 2015, BONE, V81, P343, DOI 10.1016/j.bone.2015.08.005; Johnson RW, 2014, J BONE MINER RES, V29, P1492, DOI 10.1002/jbmr.2159; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kartsogiannis V, 2008, J BIOL CHEM, V283, P30850, DOI 10.1074/jbc.M801761200; King KY, 2011, BLOOD, V118, P1525, DOI 10.1182/blood-2011-01-328682; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Kotake S, 1996, J BONE MINER RES, V11, P88; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Kyrtsonis MC, 1996, BRIT J HAEMATOL, V93, P398, DOI 10.1046/j.1365-2141.1996.4721018.x; Larsen JV, 2010, MOL CELL BIOL, V30, P4175, DOI 10.1128/MCB.00274-10; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357, DOI 10.1128/MCB.18.6.3357; Louro R, 2004, BIOCHEM BIOPH RES CO, V316, P618, DOI 10.1016/j.bbrc.2004.02.091; Madoux F., 2010, PROBE REPORTS NIH MO; Malilas W, 2013, CANCER GENE THER, V20, P125, DOI 10.1038/cgt.2012.96; Marques L, 2004, J IMMUNOL, V173, P1103, DOI 10.4049/jimmunol.173.2.1103; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mitchell TJ, 2003, CANCER RES, V63, P9048; MITSUYAMA K, 1995, GUT, V36, P45, DOI 10.1136/gut.36.1.45; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; NAIR BC, 1992, SCIENCE, V255, P1430, DOI 10.1126/science.1542792; Nguyen TT, 2002, J INTERF CYTOK RES, V22, P899, DOI 10.1089/107999002760274926; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; Obana M, 2012, AM J PHYSIOL-HEART C, V303, pH569, DOI 10.1152/ajpheart.00060.2012; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Poling J, 2012, CELL CYCLE, V11, P439, DOI 10.4161/cc.11.3.19024; Pradeep AR, 2010, BIOMARKERS, V15, P277, DOI 10.3109/13547500903573209; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Quach JM, 2011, J BIOL CHEM, V286, P4186, DOI 10.1074/jbc.M110.178251; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rogerson FM, 2010, ARTHRITIS RHEUM-US, V62, P3365, DOI 10.1002/art.27661; ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584; Saleh H, 2011, ENDOCRINOLOGY, V152, P1911, DOI 10.1210/en.2010-1268; Schmitz J, 2000, J IMMUNOL, V164, P848, DOI 10.4049/jimmunol.164.2.848; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Simpson JL, 2009, EXP LUNG RES, V35, P781, DOI 10.3109/01902140902906412; Sims NA, 1996, CALCIFIED TISSUE INT, V59, P121, DOI 10.1007/s002239900098; Sims NA, 2004, J CLIN INVEST, V113, P379, DOI 10.1172/JCI200419872; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sims NA, 2015, CYTOKINE GROWTH F R, V26, P517, DOI 10.1016/j.cytogfr.2015.07.014; Sims Natalie A, 2014, Bonekey Rep, V3, P527, DOI 10.1038/bonekey.2014.22; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajima K, 2010, J ORTHOP RES, V28, P937, DOI 10.1002/jor.21086; Takyar FM, 2013, J BONE MINER RES, V28, P912, DOI 10.1002/jbmr.1820; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Taniya T, 2012, GENOMICS, V99, P1, DOI 10.1016/j.ygeno.2011.10.002; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Walker EC, 2012, J BONE MINER RES, V27, P902, DOI 10.1002/jbmr.1506; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Wong PKK, 2006, ARTHRITIS RHEUM-US, V54, P158, DOI 10.1002/art.21537; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	90	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21703	21716		10.1074/jbc.M116.748483	http://dx.doi.org/10.1074/jbc.M116.748483			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539849	Green Published, hybrid			2022-12-28	WOS:000385999200035
J	Duan, HQ; Wang, CL; Wang, M; Gao, XJ; Yan, MM; Akram, S; Peng, W; Zou, HF; Wang, D; Zhou, JJ; Chu, YJ; Dou, Z; Barrett, G; Green, HN; Wang, FJ; Tian, RJ; He, P; Wang, WW; Liu, X; Yao, XB				Duan, Hequan; Wang, Chunli; Wang, Ming; Gao, Xinjiao; Yan, Maomao; Akram, Saima; Peng, Wei; Zou, Hanfa; Wang, Dong; Zhou, Jiajia; Chu, Youjun; Dou, Zhen; Barrett, Gregory; Green, Hadiyah-Nichole; Wang, Fangjun; Tian, Ruijun; He, Ping; Wang, Wenwen; Liu, Xing; Yao, Xuebiao			Phosphorylation of PP1 Regulator Sds22 by PLK1 Ensures Accurate Chromosome Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 1; POLO-LIKE KINASE-1; AURORA B KINASE; SPINDLE-ASSEMBLY CHECKPOINT; THR-3 PHOSPHORYLATION; CELL-DIVISION; KINETOCHORE; MITOSIS; BINDING; HASPIN	During cell division, accurate chromosome segregation is tightly regulated by Polo-like kinase 1 (PLK1) and opposing activities of Aurora B kinase and protein phosphatase 1 (PP1). However, the regulatory mechanisms underlying the aforementioned hierarchical signaling cascade during mitotic chromosome segregation have remained elusive. Sds22 is a conserved regulator of PP1 activity, but how it regulates PP1 activity in space and time during mitosis remains elusive. Here we show that Sds22 is a novel and cognate substrate of PLK1 in mitosis, and the phosphorylation of Sds22 by PLK1 elicited an inhibition of PP1-mediated dephosphorylation of Aurora B at threonine 232 (Thr(232)) in a dose-dependent manner. Overexpression of a phosphomimetic mutant of Sds22 causes a dramatic increase in mitotic delay, whereas overexpression of a non-phosphorylatable mutant of Sds22 results in mitotic arrest. Mechanistically, the phosphorylation of Sds22 by PLK1 strengthens the binding of Sds22 to PP1 and inhibits the dephosphorylation of Thr(232) of Aurora B to ensure arobust, error-freemetaphase-anaphasetransition. Thesefindings delineate a conserved signaling hierarchy that orchestrates dynamic protein phosphorylation and dephosphorylation of critical mitotic regulators during chromosome segregation to guard chromosome stability.	[Duan, Hequan; Wang, Ming; Gao, Xinjiao; Yan, Maomao; Akram, Saima; Peng, Wei; Wang, Dong; Zhou, Jiajia; Chu, Youjun; Dou, Zhen; Wang, Wenwen; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, MOE Collaborat Innovat Ctr Chem Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Duan, Hequan; Chu, Youjun; Barrett, Gregory; Green, Hadiyah-Nichole; Wang, Wenwen; Liu, Xing] Morehouse Sch Med, Atlanta, GA 30310 USA; [Duan, Hequan; Chu, Youjun; Barrett, Gregory; Green, Hadiyah-Nichole; Wang, Wenwen; Liu, Xing] Atlanta Clin & Translat Sci Inst, Atlanta, GA 30310 USA; [Wang, Chunli; Zou, Hanfa; Wang, Fangjun] Chinesse Acad Sci, Natl Chromatog Res & Anal Ctr, Dalian 116023, Peoples R China; [Tian, Ruijun; He, Ping] Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China; [Tian, Ruijun; He, Ping] South Univ Sci & Technol China, Ctr Mol Prote, Shenzhen 518055, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Southern University of Science & Technology	Wang, WW; Liu, X; Yao, XB (corresponding author), Univ Sci & Technol China, MOE Collaborat Innovat Ctr Chem Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.; Wang, WW; Liu, X (corresponding author), Morehouse Sch Med, Atlanta, GA 30310 USA.; Wang, WW; Liu, X (corresponding author), Atlanta Clin & Translat Sci Inst, Atlanta, GA 30310 USA.	wwwang@mail.ustc.edu.cn; xing1017@ustc.edu.cn; yaoxb@ustc.edu.cn	Liu, Xing/H-2989-2018; WANG, WENWEN/AAF-1080-2020; DOU, ZHEN/N-2022-2013; Tian, Ruijun/J-3019-2014; Yao, Xuebiao/P-5771-2014	Liu, Xing/0000-0002-7480-5085; WANG, WENWEN/0000-0002-1545-4369; Wang, Ming/0000-0002-7000-1063; Peng, Wei/0000-0001-7541-1494; Tian, Ruijun/0000-0001-9521-5124; DOU, ZHEN/0000-0003-3303-9393; Fangjun, Wang/0000-0002-8118-7019	Chinese Natural Science Foundation [31430054, 31320103904, 91313303, 31621002, 31501095, 31671405, 31371363, 31601097]; Chinese 973 Project [2012CB917204, 2012CB945002, 2002CB713700]; Anhui Province Key Project Grant [08040102005]; Chinese Academy of Sciences Center of Excellence Grant [2015HSC-UE010]; Anhui Provincial Natural Science Foundation [1508085SMC213]; National Institutes of Health [DK056292, CA164133]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project Grant; Chinese Academy of Sciences Center of Excellence Grant; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Chinese Natural Science Foundation Grants 31430054, 31320103904, 91313303, 31621002, 31501095, 31671405, 31371363, and 31601097; Chinese 973 Project Grants 2012CB917204, 2012CB945002, and 2002CB713700; Anhui Province Key Project Grant 08040102005; Chinese Academy of Sciences Center of Excellence Grant 2015HSC-UE010; and Anhui Provincial Natural Science Foundation Grant 1508085SMC213. This work was also supported in part by National Institutes of Health Grants DK056292 and CA164133. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Dinischiotu A, 1997, FEBS LETT, V402, P141, DOI 10.1016/S0014-5793(96)01514-1; Dou Z, 2015, P NATL ACAD SCI USA, V112, pE4546, DOI 10.1073/pnas.1508791112; Eiteneuer A, 2014, EMBO J, V33, P2704, DOI 10.15252/embj.201489054; Ghenoiu C, 2013, MOL CELL, V52, P734, DOI 10.1016/j.molcel.2013.10.002; Han GH, 2008, PROTEOMICS, V8, P1346, DOI 10.1002/pmic.200700884; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jiang H, 2015, J BIOL CHEM, V290, P28272, DOI 10.1074/jbc.M115.668855; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Li HC, 2010, EMBO J, V29, P2953, DOI 10.1038/emboj.2010.174; Liu D, 2012, J CELL BIOL, V198, P491, DOI 10.1083/jcb.201205090; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Mo F, 2016, NAT CHEM BIOL, V12, P226, DOI [10.1038/NCHEMBIO.2017, 10.1038/nchembio.2017]; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; RENOUF S, 1995, FEBS LETT, V375, P75, DOI 10.1016/0014-5793(95)01180-M; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rodrigues NTL, 2015, NATURE, V524, P489, DOI 10.1038/nature14496; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shao HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12204; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zannini L, 2014, J MOL CELL BIOL, V6, P442, DOI 10.1093/jmcb/mju045; Zhou LL, 2014, EMBO REP, V15, P273, DOI 10.1002/embr.201338080; Zhu LJ, 2015, J BIOL CHEM, V290, P27053, DOI 10.1074/jbc.M115.658534; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	50	12	12	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21123	+		10.1074/jbc.M116.745372	http://dx.doi.org/10.1074/jbc.M116.745372			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27557660	Green Published, hybrid			2022-12-28	WOS:000385406200027
J	Konishi, A; Izumi, T; Shimizu, S				Konishi, Akimitsu; Izumi, Takashi; Shimizu, Shigeomi			TRF2 Protein Interacts with Core Histones to Stabilize Chromosome Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromosomes; DNA damage response; histone; telomere; GAR domain; core histone	HUMAN TELOMERES; MAMMALIAN TELOMERES; EPIGENETIC REGULATION; CHROMATIN; COMPLEX; BINDING; LOOP; NUCLEOSOMES; RECRUITMENT; METHYLATION	Mammalian chromosome ends are protected by a specialized nucleoprotein complex called telomeres. Both shelterin, a telomere-specific multi-protein complex, and higher order telomeric chromatin structures combine to stabilize the chromosome ends. Here, we showed that TRF2, a component of shelterin, binds to core histones to protect chromosome ends from inappropriate DNA damage response and loss of telomeric DNA. The N-terminal Gly/Arg-rich domain (GAR domain) of TRF2 directly binds to the globular domain of core histones. The conserved arginine residues in the GAR domain of TRF2 are required for this interaction. A TRF2 mutant with these arginine residues substituted by alanine lost the ability to protect telomeres and induced rapid telomere shortening caused by the cleavage of a loop structure of the telomeric chromatin. These findings showed a previously unnoticed interaction between the shelterin complex and nucleosomal histones to stabilize the chromosome ends.	[Konishi, Akimitsu; Shimizu, Shigeomi] Tokyo Med & Dent Univ, Dept Pathol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Konishi, Akimitsu] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Bunkyo Ku, Tokyo 1138510, Japan; [Konishi, Akimitsu; Izumi, Takashi] Gunma Univ, Dept Biochem, Grad Sch Med, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan; [Konishi, Akimitsu] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Gunma University; Rockefeller University	Konishi, A (corresponding author), Gunma Univ, Dept Biochem, Grad Sch Med, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	akimitsukonishi@gunma-u.ac.jp	Konishi, Akimitsu/J-4024-2019	Konishi, Akimitsu/0000-0002-3291-0821	Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF)	Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Benetti R, 2008, CELL CYCLE, V7, P3461, DOI 10.4161/cc.7.21.7013; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2010, COLD SH Q B, V75, P167, DOI 10.1101/sqb.2010.75.017; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Galati A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034386; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grigoriev M, 1998, MOL CELL, V2, P373, DOI 10.1016/S1097-2765(00)80281-6; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim KY, 2013, J VIROL, V87, P6782, DOI 10.1128/JVI.00011-13; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Konishi A, 2012, J BIOL CHEM, V287, P13919, DOI 10.1074/jbc.M112.348375; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mitchell TRH, 2009, MOL CELL BIOL, V29, P4918, DOI 10.1128/MCB.00009-09; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; Utley RT, 1996, METHOD ENZYMOL, V274, P276; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025	40	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20798	20810		10.1074/jbc.M116.719021	http://dx.doi.org/10.1074/jbc.M116.719021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514743	Green Published, hybrid			2022-12-28	WOS:000384574800040
J	Pan, JY; Yuan, SJ; Yu, T; Su, CL; Liu, XL; He, J; Li, H				Pan, Jing-Ying; Yuan, Shijin; Yu, Tao; Su, Cong-Lin; Liu, Xiao-Long; He, Jun; Li, He			Regulation of L-type Ca2+ Channel Activity and Insulin Secretion by Huntingtin-associated Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; GATED CALCIUM-CHANNELS; INTRACELLULAR TRAFFICKING; MUTANT HUNTINGTIN; MOLECULAR-MECHANISMS; VESICULAR TRANSPORT; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; EXOCYTOSIS; DISEASE	Huntingtin-associated protein 1 (Hap1) was originally identified as a protein that binds to the Huntington disease protein, huntingtin. Growing evidence has shown that Hap1 participates in intracellular trafficking via its association with various microtubule-dependent transporters and organelles. Recent studies also revealed that Hap1 is involved in exocytosis such as insulin release from pancreatic beta-cells. However, the mechanism underlying the action of Hap1 on insulin release remains to be investigated. We found that Hap1 knock-out mice had a lower plasma basal insulin level than control mice. Using cultured pancreatic beta-cell lines, INS-1 cells, we confirmed that decreasing Hap1 reduces the number of secreted vesicles and inhibits vesicle exocytosis. Electrophysiology and imaging of intracellular Ca2+ measurements demonstrated that Hap1 depletion significantly reduces the influx of Ca2+ mediated by L-type Ca2+ channels (Cav). This decrease is not due to reduced expression of Cav1.2 channel mRNA but results from the decreased distribution of Cav1.2 on the plasma membrane of INS-1 cells. Fluorescence recovery after photobleaching showed a defective movement of Cav1.2 in Hap1 silencing INS-1 cells. Our findings suggest that Hap1 is important for insulin secretion of pancreatic beta-cells via regulating the intracellular trafficking and plasma membrane localization of Cav1.2, providing new insight into the mechanisms that regulate insulin release from pancreatic beta-cells.	[Pan, Jing-Ying; Yuan, Shijin; Su, Cong-Lin; Liu, Xiao-Long; He, Jun; Li, He] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Histol & Embryol, Wuhan 430030, Peoples R China; [Pan, Jing-Ying; Yuan, Shijin; Su, Cong-Lin; Liu, Xiao-Long; He, Jun; Li, He] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Yu, Tao] Wuhan Childrens Hosp, Clin Lab, Wuhan 430016, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	He, J; Li, H (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Histol & Embryol, Wuhan 430030, Peoples R China.; He, J; Li, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430030, Peoples R China.	junhe@mails.tjmu.edu.cn; heli@mails.tjmu.edu.cn			National Natural Science Foundation of China [30871311, 31171155, 31371217]; Research Fund for the Doctoral Program of Higher Education of China [20070487184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China Grants 30871311, 31171155, and 31371217 and Research Fund for the Doctoral Program of Higher Education of China Grant 20070487184. The authors declare that they have no conflicts of interest with the contents of this article.	AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Bito M, 2013, BIOL PHARM BULL, V36, P31, DOI 10.1248/bpb.b12-00425; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Burcelin R, 2008, DIABETES METAB, V34, pS49, DOI 10.1016/S1262-3636(08)73395-0; Cape A, 2012, CELL MOL LIFE SCI, V69, P1305, DOI 10.1007/s00018-011-0692-8; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Dragatsis I, 2000, NEUROSCI LETT, V282, P37, DOI 10.1016/S0304-3940(00)00872-7; FARRER LA, 1985, CLIN GENET, V27, P62; Gandini MA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187757; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; IWASHIMA Y, 1993, DIABETES, V42, P948, DOI 10.2337/diabetes.42.7.948; KEOGH HJ, 1976, J NEUROL NEUROSUR PS, V39, P244, DOI 10.1136/jnnp.39.3.244; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; LAVIN PJM, 1981, J NEUROL NEUROSUR PS, V44, P414, DOI 10.1136/jnnp.44.5.414; Li SH, 2003, J NEUROSCI, V23, P6956; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Liao M, 2005, J HISTOCHEM CYTOCHEM, V53, P1517, DOI 10.1369/jhc.5A6662.2005; Liao M, 2010, J HISTOCHEM CYTOCHEM, V58, P255, DOI 10.1369/jhc.2009.954479; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; Martin EJ, 1999, J COMP NEUROL, V403, P421; Mayer BJ, 2001, J CELL SCI, V114, P1253; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI13310; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; PODOLSKY S, 1977, GERONTOLOGY, V23, P55, DOI 10.1159/000212174; PODOLSKY S, 1972, LANCET, V1, P1356; Roe MW, 1996, AM J PHYSIOL-ENDOC M, V270, pE133, DOI 10.1152/ajpendo.1996.270.1.E133; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; Rong JA, 2007, J BIOL CHEM, V282, P4748, DOI 10.1074/jbc.M609057200; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; Saleh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004962; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Sher E, 2003, J BIOENERG BIOMEMBR, V35, P687, DOI 10.1023/B:JOBB.0000008032.49504.48; Smith R, 2009, HUM MOL GENET, V18, P3942, DOI 10.1093/hmg/ddp336; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Tang TS, 2004, EUR J NEUROSCI, V20, P1779, DOI 10.1111/j.1460-9568.2004.03633.x; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tian G, 2012, J BIOL CHEM, V287, P9862, DOI 10.1074/jbc.M111.292854; Wang S, 2006, BIOCHEM SOC T, V34, P687, DOI 10.1042/BST0340687; Wang Z, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/165631; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Yamada Y, 2001, DIABETES-METAB RES, V17, P213, DOI 10.1002/dmrr.193; YAMADA Y, 1995, GENOMICS, V27, P312, DOI 10.1006/geno.1995.1048; Yang G, 2015, CELL MOL LIFE SCI, V72, P1197, DOI 10.1007/s00018-014-1737-6; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yang SN, 2005, AM J PHYSIOL-ENDOC M, V288, pE16, DOI 10.1152/ajpendo.00042.2004; Ye CF, 2009, BIOSCI BIOTECH BIOCH, V73, P1787, DOI 10.1271/bbb.90147; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2	64	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26352	26363		10.1074/jbc.M116.727990	http://dx.doi.org/10.1074/jbc.M116.727990			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27624941	Green Published, hybrid			2022-12-28	WOS:000391568200010
J	Lisanti, S; Garlick, DS; Bryant, KG; Tavecchio, M; Mills, GB; Lu, YL; Kossenkov, AV; Showe, LC; Languino, LR; Altieri, DC				Lisanti, Sofia; Garlick, David S.; Bryant, Kelly G.; Tavecchio, Michele; Mills, Gordon B.; Lu, Yiling; Kossenkov, Andrew V.; Showe, Louise C.; Languino, Lucia R.; Altieri, Dario C.			Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90; INHIBITOR; HOMEOSTASIS; NEOPLASIA; DYNAMICS; MUTATION; TARGETS; INDUCE; CELLS	Protein homeostasis, or proteostasis, is required for mitochondrial function, but its role in cancer is controversial. Here we show that transgenic mice expressing the mitochondrial chaperone TNFR-associated protein 1 (TRAP1) in the prostate develop epithelial hyperplasia and cellular atypia. When examined on a Pten(+/-) background, a common alteration in human prostate cancer, TRAP1 transgenic mice showed accelerated incidence of invasive prostatic adenocarcinoma, characterized by increased cell proliferation and reduced apoptosis, in situ. Conversely, homozygous deletion of TRAP1 delays prostatic tumorigenesis in Pten(+/-) mice without affecting hyperplasia or prostatic intraepithelial neoplasia. Global profiling of Pten(+/-) TRAP1 transgenic mice by RNA sequencing and reverse phase protein array reveals modulation of oncogenic networks of cell proliferation, apoptosis, cell motility, and DNA damage. Mechanistically, reconstitution of Pten(+/-) prostatic epithelial cells with TRAP1 increases cell proliferation, reduces apoptosis, and promotes cell invasion without changes in mitochondrial bioenergetics. Therefore, TRAP1 is a driver of prostate cancer in vivo and an "actionable" therapeutic target.	[Lisanti, Sofia; Garlick, David S.; Bryant, Kelly G.; Tavecchio, Michele; Languino, Lucia R.; Altieri, Dario C.] Wistar Inst Anat & Biol, Prostate Canc Discovery & Dev Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Lisanti, Sofia; Bryant, Kelly G.; Tavecchio, Michele; Altieri, Dario C.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Kossenkov, Andrew V.; Showe, Louise C.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Showe, Louise C.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Mills, Gordon B.; Lu, Yiling] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Languino, Lucia R.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	The Wistar Institute; The Wistar Institute; The Wistar Institute; The Wistar Institute; University of Texas System; UTMD Anderson Cancer Center; Jefferson University	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org			Cancer Center Support Grants [CA010815, CA016672]; NATIONAL CANCER INSTITUTE [R01CA190027, P30CA016672, R01CA078810, R01CA089720, P30CA010815, P01CA140043, R50CA211199, T32CA009171] Funding Source: NIH RePORTER	Cancer Center Support Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for the core facilities utilized in this study was provided by Cancer Center Support Grants CA010815 to The Wistar Institute and CA016672 to The University of Texas MD Anderson Cancer Center.	Agliarulo I, 2015, BBA-MOL CELL RES, V1853, P2570, DOI 10.1016/j.bbamcr.2015.05.034; Agorreta J, 2014, MOL CANCER RES, V12, P660, DOI 10.1158/1541-7786.MCR-13-0481; Altieri DC, 2012, BBA-MOL CELL RES, V1823, P767, DOI 10.1016/j.bbamcr.2011.08.007; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Cagin U, 2015, P NATL ACAD SCI USA, V112, pE6000, DOI 10.1073/pnas.1505036112; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Chae YC, 2012, CANCER CELL, V22, P331, DOI 10.1016/j.ccr.2012.07.015; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Goard CA, 2014, ONCOGENE, V33, P2690, DOI 10.1038/onc.2013.228; Hubner A, 2012, P NATL ACAD SCI USA, V109, P12046, DOI 10.1073/pnas.1209660109; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang BH, 2010, CLIN CANCER RES, V16, P4779, DOI 10.1158/1078-0432.CCR-10-1818; Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015; Kim H, 2016, J BIOL CHEM, V291, P1841, DOI 10.1074/jbc.M115.656934; Kleine T, 2016, BBA-BIOENERGETICS, V1857, P1313, DOI 10.1016/j.bbabio.2016.03.017; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Leav I, 2010, AM J PATHOL, V176, P393, DOI 10.2353/ajpath.2010.090521; Lebedev I, 2016, J MOL BIOL, V428, P4154, DOI 10.1016/j.jmb.2016.08.001; Lee CW, 2015, J AM CHEM SOC, V137, P4358, DOI 10.1021/ja511893n; Lisanti S, 2014, CELL REP, V8, P671, DOI 10.1016/j.celrep.2014.06.061; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Sciacovelli M, 2013, CELL METAB, V17, P988, DOI 10.1016/j.cmet.2013.04.019; Sung N, 2016, P NATL ACAD SCI USA, V113, P2952, DOI 10.1073/pnas.1516167113; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Yan Y, 1997, PROSTATE, V32, P129; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Zhang B, 2015, ONCOTARGET, V6, P44495, DOI 10.18632/oncotarget.6252; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661	36	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25247	25254		10.1074/jbc.M116.745950	http://dx.doi.org/10.1074/jbc.M116.745950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27754870	Green Published, hybrid			2022-12-28	WOS:000388880100038
J	Wen, X; Li, XG; Tang, YB; Tang, JZ; Zhou, S; Xie, YL; Guo, JY; Yang, J; Du, XL; Su, N; Chen, L				Wen, Xuan; Li, Xiaogang; Tang, Yubin; Tang, Junzhou; Zhou, Siru; Xie, Yangli; Guo, Jingyuan; Yang, Jing; Du, Xiaolan; Su, Nan; Chen, Lin			Chondrocyte FGFR3 Regulates Bone Mass by Inhibiting Osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR-3; MESENCHYMAL STEM-CELLS; SKELETAL DEVELOPMENT; HYPERTROPHIC CHONDROCYTES; ENDOCHONDRAL OSSIFICATION; OSTEOCLAST FORMATION; PLATE DEVELOPMENT; BETA-CATENIN; TGF-BETA; MUTATION	Chondrogenesis can regulate bone formation. Fibroblast growth factor receptor 3, highly expressed in chondrocytes, is a negative regulator of bone growth. To investigate whether chondrocyte FGFR3 regulates osteogenesis, thereby contributing to postnatal bone formation and bone remodeling, mice with conditional knock-out of Fgfr3 in chondrocytes (mutant (MUT)) were generated. MUT mice displayed overgrowth of bone with lengthened growth plates. Bone mass of MUT mice was significantly increased at both 1 month and 4 months of age. Histological analysis showed that osteoblast number and bone formation were remarkably enhanced after deletion of Fgfr3 in chondrocytes. Chondrocyte-osteoblast co-culture assay further revealed that Fgfr3 deficiency in chondrocytes promoted differentiation and mineralization of osteoblasts by up-regulating the expressions of Ihh, Bmp2, Bmp4, Bmp7, Wnt4, and Tgf-beta 1, as well as down-regulating Nog expression. In addition, osteoclastogenesis was also impaired in MUT mice with decreased number of osteoclasts lining trabecular bone, which may be related to the reduced ratio of Rankl to Opg in Fgfr3-deficient chondrocytes. This study reveals that chondrocyte FGFR3 is involved in the regulation of bone formation and bone remodeling by a paracrine mechanism.	[Wen, Xuan; Li, Xiaogang; Tang, Yubin; Tang, Junzhou; Zhou, Siru; Xie, Yangli; Guo, Jingyuan; Yang, Jing; Du, Xiaolan; Su, Nan; Chen, Lin] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Ctr Bone Metab & Repair,Trauma Ctr, Dept Rehabil Med,Res Inst Surg,Daping Hosp, Chongqing 400042, Peoples R China; [Li, Xiaogang] Chinese Peoples Liberat Army, Hosp 305, Beijing 100017, Peoples R China; [Tang, Yubin] Chinese Peoples Liberat Army, Lanzhou Command, Lanzhou Gen Hosp, Dept Emergency Treatment, Lanzhou 730050, Peoples R China	Army Medical University	Su, N; Chen, L (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Ctr Bone Metab & Repair,Trauma Ctr, Dept Rehabil Med,Res Inst Surg,Daping Hosp, Chongqing 400042, Peoples R China.	sunansyd@163.com; linchen70@163.com	su, nan/GRS-5213-2022	Wen, Xuan/0000-0003-2074-3701; Su, Nan/0000-0002-0653-923X	Special Funds for the Major State Basic Research Program of China (973 Program) [2014CB942904]; National Natural Science Foundation of China [81530071, 81270012]; Basic and Advanced Research Project in Chongqing [CSTC2013jcyjC0009]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1216]	Special Funds for the Major State Basic Research Program of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic and Advanced Research Project in Chongqing; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The work was supported by Special Funds for the Major State Basic Research Program of China (973 Program) (Grants 2014CB942904), the National Natural Science Foundation of China (Grants 81530071 and 81270012), and the Basic and Advanced Research Project in Chongqing (Grant CSTC2013jcyjC0009), and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (IRT1216). The authors declare that they have no conflicts of interest with the contents of this article.	Andrade AC, 2007, BONE, V40, P1361, DOI 10.1016/j.bone.2007.01.005; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chen HY, 2014, J BONE MINER RES, V29, P2653, DOI 10.1002/jbmr.2287; Chen L, 1999, J CLIN INVEST, V104, P1517, DOI 10.1172/JCI6690; Chung UI, 2004, ENDOCR J, V51, P19, DOI 10.1507/endocrj.51.19; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Dao DY, 2012, J BONE MINER RES, V27, P1680, DOI 10.1002/jbmr.1639; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; Datta NS, 2005, J BONE MINER RES, V20, P1051, DOI 10.1359/JBMR.050106; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Du XL, 2012, J CELL PHYSIOL, V227, P3731, DOI 10.1002/jcp.24083; Eswarakumar VP, 2007, P NATL ACAD SCI USA, V104, P3937, DOI 10.1073/pnas.0700012104; Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636; Gerstenfeld LC, 2002, J BONE MINER RES, V17, P221, DOI 10.1359/jbmr.2002.17.2.221; Golovchenko S, 2013, BONE, V55, P102, DOI 10.1016/j.bone.2013.03.019; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Horton WA, 2009, TRENDS ENDOCRIN MET, V20, P341, DOI 10.1016/j.tem.2009.04.003; Kanaan RA, 2006, MED SCI MONITOR, V12, pRA164; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Krejci P, 2014, MUTAT RES-REV MUTAT, V759, P40, DOI 10.1016/j.mrrev.2013.11.001; Krejci P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003961; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Li TF, 2005, FRONT BIOSCI-LANDMRK, V10, P681, DOI 10.2741/1563; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Lui JLC, 2012, HUM MOL GENET, V21, P5193, DOI 10.1093/hmg/dds347; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Muenke M, 1997, AM J HUM GENET, V60, P555; Mugniery E, 2012, HUM MOL GENET, V21, P2503, DOI 10.1093/hmg/dds065; Nakaoka R, 2006, TISSUE ENG, V12, P2425, DOI 10.1089/ten.2006.12.2425; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Parafioriti A, 2009, J ORTHOP SCI, V14, P623, DOI 10.1007/s00776-009-1355-6; So N, 2008, BIOCHEM BIOPH RES CO, V376, P454, DOI 10.1016/j.bbrc.2008.08.165; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Su N, 2013, J BONE MINER RES, V28, P660, DOI 10.1002/jbmr.1778; Su N, 2010, INT J BIOL SCI, V6, P327; Su N, 2010, HUM MOL GENET, V19, P1199, DOI 10.1093/hmg/ddp590; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Toydemir RM, 2006, AM J HUM GENET, V79, P935, DOI 10.1086/508433; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Valverde-Franco G, 2004, HUM MOL GENET, V13, P271, DOI 10.1093/hmg/ddh034; Wang BL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13667; Weng TJ, 2014, J BONE MINER RES, V29, P820, DOI 10.1002/jbmr.2087; Wongdee K, 2012, J PHYSIOL SCI, V62, P299, DOI 10.1007/s12576-012-0212-0; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Wu MR, 2014, INT J BIOL SCI, V10, P861, DOI 10.7150/ijbs.8521; Xie YL, 2014, J MOL ENDOCRINOL, V53, pT11, DOI 10.1530/JME-14-0012; Yang G, 2014, CELL RES, V24, P1266, DOI 10.1038/cr.2014.111; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhang JH, 2005, DEV BIOL, V284, P311, DOI 10.1016/j.ydbio.2005.05.036; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820; Zhou ZQ, 2015, HUM MOL GENET, V24, P1764, DOI 10.1093/hmg/ddu594	64	33	35	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24912	24921		10.1074/jbc.M116.730093	http://dx.doi.org/10.1074/jbc.M116.730093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27729453	Green Published, hybrid			2022-12-28	WOS:000388880100011
J	Bussche, L; Rauner, G; Antonyak, M; Syracuse, B; McDowell, M; Brown, AMC; Cerione, RA; Van de Walle, GR				Bussche, Leen; Rauner, Gat; Antonyak, Marc; Syracuse, Bethany; McDowell, Melissa; Brown, Anthony M. C.; Cerione, Richard A.; Van de Walle, Gerlinde R.			Microvesicle-mediated Wnt/beta-Catenin Signaling Promotes Interspecies Mammary Stem/Progenitor Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; STEM-CELLS; SELF-RENEWAL; WNT PROTEINS; BREAST-CANCER; GLAND DEVELOPMENT; EPITHELIAL-CELLS; STROMAL CELLS; EXOSOMES; TRANSFORMATION	Signaling mechanisms that regulate mammary stem/progenitor cell (MaSC) self-renewal are essential for developmental changes that occur in the mammary gland during pregnancy, lactation, and involution. We observed that equine MaSCs (eMaSCs) maintain their growth potential in culture for an indefinite period, whereas canine MaSCs (cMaSCs) lose their growth potential in long term cultures. We then used this system to investigate the role of microvesicles (MVs) in promoting self-renewal properties. We found that Wnt3a and Wnt1 were expressed at higher levels in MVs isolated from eMaSCs coin pared with those from cMaSCs. Furthermore, eMaSC-MVs were able to induce Wnt/beta-catenin signaling in different target cells, including cMaSCs. Interestingly, the induction of Wnt/beta-catenin signaling in cMaSCs was prolonged when using eMaSC-MVs compared with recombinant Wnt proteins, indicating that MVs are not only important for transport of Wnt proteins, but they also enhance their signaling activity. Finally, we demonstrate that the eMaSC-MVs-mediated activation of the Wnt/beta-catenin signaling pathway in cMaSCs significantly improves the ability of cMaSCs to grow as mammospheres and, importantly, that this effect is abolished when eMaSC-MVs are treated with Wnt ligand inhibitors. This suggests that this novel form of intercellular communication plays an important role in self-renewal.	[Bussche, Leen; Rauner, Gat; Syracuse, Bethany; McDowell, Melissa; Van de Walle, Gerlinde R.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Antonyak, Marc; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Brown, Anthony M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Bussche, Leen] Belgian Amer Educ Fdn, Brussels, Belgium	Cornell University; Cornell University; Cornell University	Van de Walle, GR (corresponding author), Hungerford Hill Rd, Ithaca, NY 14853 USA.	grv23@cornell.edu		Van de Walle, Gerlinde/0000-0002-2064-8029	National Institutes of Health [R21 CA186981]; NATIONAL CANCER INSTITUTE [R21CA186981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R21 CA186981 (to A. M. C. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Barker Nick, 2008, V468, P91, DOI 10.1007/978-1-59745-249-6_7; Borena BM, 2013, STEM CELLS DEV, V22, P1743, DOI 10.1089/scd.2012.0677; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Bussche L, 2014, STEM CELL TRANSL MED, V3, P1514, DOI 10.5966/sctm.2014-0138; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096161; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P153, DOI 10.4161/oxim.3.2.11758; Crampton SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007841; Demeule B, 2007, INT J PHARMACEUT, V329, P37, DOI 10.1016/j.ijpharm.2006.08.024; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Ercan C, 2011, CURR MOL MED, V11, P270, DOI 10.2174/156652411795678007; Gangoda L, 2015, PROTEOMICS, V15, P260, DOI 10.1002/pmic.201400234; Giarre M, 1998, ANN NY ACAD SCI, V857, P43, DOI 10.1111/j.1749-6632.1998.tb10106.x; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Gonzalez E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083955; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia D, 2015, CELL DEATH DIFFER, V22, P298, DOI 10.1038/cdd.2014.145; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; Koch R, 2014, BLOOD, V123, P2189, DOI 10.1182/blood-2013-08-523886; Koles Kate, 2012, Cell Logist, V2, P169; Komiya Yuko, 2008, Organogenesis, V4, P68; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lang M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-41; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lewis MT, 2001, DEV BIOL, V238, P133, DOI 10.1006/dbio.2001.0410; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lohr C, 2009, METHOD ENZYMOL, V465, P143, DOI 10.1016/S0076-6879(09)65008-4; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Many AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101800; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rotherham M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121761; Spaas JH, 2012, STEM CELLS DEV, V21, P3055, DOI 10.1089/scd.2012.0042; Spike BT, 2014, STEM CELL REP, V2, P427, DOI 10.1016/j.stemcr.2014.02.010; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang L, 2014, CURR OPIN GENET DEV, V27, P14, DOI 10.1016/j.gde.2014.03.006; Zhu GY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05390	57	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24390	24405		10.1074/jbc.M116.726117	http://dx.doi.org/10.1074/jbc.M116.726117			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27733685	Green Published, hybrid			2022-12-28	WOS:000388875500006
J	Fujii, N; Matsuo, Y; Matsunaga, T; Endo, S; Sakai, H; Yamaguchi, M; Yamazaki, Y; Sugatani, J; Ikari, A				Fujii, Naoko; Matsuo, Yukinobu; Matsunaga, Toshiyuki; Endo, Satoshi; Sakai, Hideki; Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Sugatani, Junko; Ikari, Akira			Hypotonic Stress-induced Down-regulation of Claudin-1 and-2 Mediated by Dephosphorylation and Clathrin-dependent Endocytosis in Renal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; MDCK II CELLS; TIGHT JUNCTIONS; PROXIMAL TUBULES; PARACELLULAR PERMEABILITY; BARRIER FUNCTION; VOLUME DECREASE; PROTEIN; EXPRESSION; PHOSPHORYLATION	Hypotonic stress decreased claudin-1 and-2 expression levels in renal tubular epithelial HK-2 and Madin-Darby canine kidney cells. Here, we examined the regulatory mechanism involved in this decrease. The hypotonicity-induced decrease in claudin expression was inhibited by the following: SB202190, a p38 MAPK inhibitor, but not by U0126, a MEK inhibitor; Go6983, a protein kinase C inhibitor; or SP600125, a Jun N-terminal protein kinase inhibitor. Hypotonic stress increased transepithelial electrical resistance, which was inhibited by SB202190. The mRNA expression level of claudin-1 was decreased by hypotonic stress but that of claudin-2 was not. Hypotonic stress decreased the protein stability of claudin-1 and-2. The hypotonicity-induced decrease in claudin expression was inhibited by the following: chloroquine, a lysosome inhibitor; dynasore and monodansylcadaverine, clathrin-dependent endocytosis inhibitors; and siRNA against clathrin heavy chain. Claudin-1 and-2 were mainly distributed in the cytosol and tight junctions (TJs) in the chloroquine- and monodansylcadaverine-treated cells, respectively. Hypotonic stress decreased the phosphorylation levels of claudin-1 and-2, which were inhibited by the protein phosphatase inhibitors okadaic acid and cantharidin. Dephosphorylated mutants of claudin-1 and-2 were mainly distributed in the cytosol, which disappeared in response to hypotonic stress. In contrast, mimicking phosphorylatkin mutants were distributed in the TJs, which were not decreased by hypotonic stress. We suggest that hypotonic stress induces dephosphorylation, clathrin-dependent endocytosis, and degradation of claudin-1 and-2 in lysosomes, resulting in disruption of the TJ barrier in renal tubular epithelial cells.	[Fujii, Naoko; Matsuo, Yukinobu; Matsunaga, Toshiyuki; Endo, Satoshi; Ikari, Akira] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan; [Sakai, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Sugatani, Junko] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Gifu Pharmaceutical University; University of Toyama; University of Shizuoka	Ikari, A (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ikari@gifu-pu.ac.jp	Endo, Satoshi/F-8059-2011	Endo, Satoshi/0000-0003-0578-9672	Japan Society for the Promotion of Science KAKENHI [15H04657]; Mishimakaiun Memorial Foundation; Grants-in-Aid for Scientific Research [15K15029] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mishimakaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) from the Japan Society for the Promotion of Science KAKENHI 15H04657 and by grants from Mishimakaiun Memorial Foundation (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-229; Akimova OA, 2008, PURINERG SIGNAL, V4, P183, DOI 10.1007/s11302-007-9057-z; Akimova OA, 2008, CELL PHYSIOL BIOCHEM, V21, P315, DOI 10.1159/000129390; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; BANK N, 1990, J CLIN INVEST, V86, P309, DOI 10.1172/JCI114700; Barriere H, 2003, J GEN PHYSIOL, V122, P177, DOI 10.1085/jgp.200308820; D'Souza SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006010; D'Souza T, 2005, J BIOL CHEM, V280, P26233, DOI 10.1074/jbc.M502003200; Fazlollahi F, 2011, NANOMED-NANOTECHNOL, V7, P588, DOI 10.1016/j.nano.2011.01.008; Fujibe M, 2004, EXP CELL RES, V295, P36, DOI 10.1016/j.yexcr.2003.12.014; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Galizia L, 2012, J CELL BIOCHEM, V113, P580, DOI 10.1002/jcb.23382; Garcia-Hernandez V, 2015, J CELL PHYSIOL, V230, P105, DOI 10.1002/jcp.24687; Gonzalez JE, 2009, FREE RADICAL BIO MED, V47, P1561, DOI 10.1016/j.freeradbiomed.2009.08.024; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Ikari A, 2006, J CELL SCI, V119, P1781, DOI 10.1242/jcs.02901; Ikari A, 2015, J CELL PHYSIOL, V230, P2776, DOI 10.1002/jcp.25004; Ikari A, 2013, BBA-MOL CELL RES, V1833, P2617, DOI 10.1016/j.bbamcr.2013.06.016; Ikari A, 2012, BBA-MOL CELL RES, V1823, P1110, DOI 10.1016/j.bbamcr.2012.04.005; Ikari A, 2012, J CELL BIOCHEM, V113, P499, DOI 10.1002/jcb.23373; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Ikari A, 2011, J CELL PHYSIOL, V226, P1471, DOI 10.1002/jcp.22386; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; KNOBLAUCH C, 1989, AM J PHYSIOL, V256, pC252, DOI 10.1152/ajpcell.1989.256.2.C252; l'Hoste S, 2010, AM J PHYSIOL-RENAL, V298, pF435, DOI 10.1152/ajprenal.00286.2009; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Lipschutz JH, 2005, J BIOL CHEM, V280, P3780, DOI 10.1074/jbc.M408122200; Marschitz I, 2000, AM J PHYSIOL-CELL PH, V279, pC1472, DOI 10.1152/ajpcell.2000.279.5.C1472; Miaczynska M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009035; Molina-Jijon E, 2015, J NUTR BIOCHEM, V26, P441, DOI 10.1016/j.jnutbio.2014.11.018; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Niisato N, 2012, AM J PHYSIOL-RENAL, V303, pF240, DOI 10.1152/ajprenal.00198.2011; Nofziger C, 2008, CELL PHYSIOL BIOCHEM, V22, P487, DOI 10.1159/000185505; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Peerapen P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01041; Pessoa TD, 2014, J AM SOC NEPHROL, V25, P2028, DOI 10.1681/ASN.2013060588; Reyes JL, 2002, KIDNEY INT, V62, P476, DOI 10.1046/j.1523-1755.2002.00479.x; Shiomi R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13262; Soma T, 2004, EXP CELL RES, V300, P202, DOI 10.1016/j.yexcr.2004.07.012; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Van Itallie CM, 2012, J CELL SCI, V125, P4902, DOI 10.1242/jcs.111237; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947	51	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24787	24799		10.1074/jbc.M116.728196	http://dx.doi.org/10.1074/jbc.M116.728196			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27733684	hybrid, Green Published			2022-12-28	WOS:000388875500036
J	Liu, C; Ma, YM; Yang, Y; Zheng, Y; Shang, J; Zhou, YS; Jiang, SB; Du, LY; Li, JR; Li, F				Liu, Chang; Ma, Yuanmei; Yang, Yang; Zheng, Yuan; Shang, Jian; Zhou, Yusen; Jiang, Shibo; Du, Lanying; Li, Jianrong; Li, Fang			Cell Entry of Porcine Epidemic Diarrhea Coronavirus Is Activated by Lysosomal Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; TO-HUMAN TRANSMISSION; SPIKE PROTEIN; CATHEPSIN-L; NEUTRALIZING ANTIBODIES; PROTEOLYTIC ACTIVATION; SARS-CORONAVIRUS; RECEPTOR USAGE; UNITED-STATES; VIRUS	Porcine epidemic diarrhea coronavirus (PEDV) is currently devastating the United States pork industry by causing an 80-100% fatality rate in infected piglets. Coronavirus spike proteins mediate virus entry into cells, a process that requires the spike proteins to be proteolytically activated. It has been a conundrum which proteases activate PEDV entry. Here we systematically investigated the roles of different proteases in PEDV entry using pseudovirus entry, biochemical, and live virus infection assays. We found that the PEDV spike is activated by lysosomal cysteine proteases but not proprotein convertases or cell surface serine proteases. Extracellular trypsin activates PEDV entry when lysosomal cysteine proteases are inhibited. We further pinpointed cathepsin L and cathepsin B as the lysosomal cysteine proteases that activate the PEDV spike. These results advance our understanding of the molecular mechanism for PEDV entry and identify potential antiviral targets for curbing the spread of PEDV.	[Liu, Chang; Yang, Yang; Zheng, Yuan; Shang, Jian; Li, Fang] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Ma, Yuanmei; Li, Jianrong] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Jiang, Shibo; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Sch Basic Med, Minist Educ, Shanghai 200032, Peoples R China; [Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Sch Basic Med, Minist Hlth, Shanghai 200032, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University; Beijing Institute of Microbiology & Epidemiology; New York Blood Center; Fudan University; Fudan University	Li, F (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.; Li, JR (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA.	li.926@osu.edu; lifang@umn.edu	LI, JIAN/GRY-2197-2022; Jiang, Shibo/L-4500-2014; Yang, Yang/R-7215-2016; Shang, Jian/T-3587-2019; li, jian/GSE-0245-2022	Jiang, Shibo/0000-0001-8283-7135; Yang, Yang/0000-0001-9061-3828; Shang, Jian/0000-0003-2600-6059; 	NIAID, National Institutes of Health [R01AI089728]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089728] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grants R01AI089728 (to F. L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BANDO Y, 1986, J BIOCHEM-TOKYO, V100, P35, DOI 10.1093/oxfordjournals.jbchem.a121703; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; DUCATELLE R, 1981, ARCH VIROL, V68, P35, DOI 10.1007/BF01315165; DUCATELLE R, 1982, VET PATHOL, V19, P57, DOI 10.1177/030098588201900109; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Hofmann H, 2004, J VIROL, V78, P6134, DOI 10.1128/JVI.78.12.6134-6142.2004; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li WT, 2016, VIRUS RES, V226, P117, DOI 10.1016/j.virusres.2016.05.031; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Mole B, 2013, NATURE, V499, P388, DOI 10.1038/499388a; Nomura T, 1996, BIOCHEM BIOPH RES CO, V228, P792, DOI 10.1006/bbrc.1996.1733; Oka T, 2014, VET MICROBIOL, V173, P258, DOI 10.1016/j.vetmic.2014.08.012; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shirato K, 2011, J VIROL, V85, P7872, DOI 10.1128/JVI.00464-11; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; Wicht O, 2014, J VIROL, V88, P7952, DOI 10.1128/JVI.00297-14; Yang Y, 2015, J VIROL, V89, P9119, DOI 10.1128/JVI.01279-15; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111	35	29	29	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24779	24786		10.1074/jbc.M116.740746	http://dx.doi.org/10.1074/jbc.M116.740746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27729455	Green Published, hybrid			2022-12-28	WOS:000388875500035
J	Ni, J; Bao, SJ; Johnson, RI; Zhu, BB; Li, JH; Vadaparampil, J; Smith, CM; Campbell, KN; Grahammer, F; Huber, TB; He, JC; D'Agati, VD; Chan, A; Kaufman, L				Ni, Jie; Bao, Sujin; Johnson, Ruth I.; Zhu, Bingbing; Li, Jianhua; Vadaparampil, Justin; Smith, Christopher M.; Campbell, Kirk N.; Grahammer, Florian; Huber, Tobias B.; He, John C.; D'Agati, Vivette D.; Chan, Andrew; Kaufman, Lewis			MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; RESISTANT NEPHROTIC SYNDROME; DROSOPHILA EYE; PROTEIN MAGI-1; CELL-DEATH; ADHESION; KIDNEY; GENE; EXPRESSION; JUNCTION	MAGI-1 is a multidomain cytosolic scaffolding protein that in the kidney is specifically located at the podocyte slit diaphragm, a specialized junction that is universally injured in proteinuric diseases. There it interacts with several essential molecules, including nephrin and nephl, which are required for slit diaphragm formation and as an intracellular signaling hub. Here, we show that diminished MAGI-1 expression in cultured podocytes reduced nephrin and nephl membrane localization and weakened tight junction integrity. Global magil knock-out mice, however, demonstrated normal glomerular histology and function into adulthood. We hypothesized that a second mild but complementary genetic insult might induce glomerular disease susceptibility in these mice. To identify such a gene, we utilized the developing fly eye to test for functional complementation between MAGI and its binding partners. In this way, we identified diminished expression of fly Hibris (nephrin) or Roughest (nephl) as dramatically exacerbating the effects of MAGI depletion. Indeed, when these combinations were studied in mice, the addition of nephrin, but not nephl, heterozygosity to homozygous deletion of MAGI-1 resulted in spontaneous glomerulosclerosis. In cultured podocytes, MAGI-1 depletion reduced intercellular contact-induced Rapl activation, a pathway critical for proper podocyte function. Similarly, magi1 knock-out mice showed diminished glomerular Rap1 activation, an effect dramatically enhanced by concomitant nephrin haploinsufficiency. Finally, combined overexpression of MAGI-1 and nephrin increased Rap 1 activation, but not when substituting a mutant MAGI-1 that cannot bind nephrin. We conclude that the interaction between nephrin and MAGI-1 regulates Rap1 activation in podocytes to maintain long term slit diaphragm structure.	[Ni, Jie; Zhu, Bingbing; Li, Jianhua; Vadaparampil, Justin; Smith, Christopher M.; Campbell, Kirk N.; He, John C.; Kaufman, Lewis] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY 10029 USA; [Ni, Jie] Harbin Med Univ, Affiliated Hosp 1, Div Nephrol, Harbin 150001, Peoples R China; [Bao, Sujin] Wesleyan Univ, St James Sch Med, St Vincent & Grenadines, Middletown, CT 06459 USA; [Johnson, Ruth I.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Zhu, Bingbing] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Lab Renal Dis, Dept Nephrol, Shanghai 200062, Peoples R China; [Grahammer, Florian; Huber, Tobias B.] Univ Freiburg, Dept Med 4, Med Ctr, Fac Med, D-79106 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, FRIAS, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, Ctr Syst Biol ZBSA, D-79104 Freiburg, Germany; [D'Agati, Vivette D.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10032 USA; [Chan, Andrew] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Icahn School of Medicine at Mount Sinai; Harbin Medical University; Wesleyan University; Wesleyan University; Shanghai University of Traditional Chinese Medicine; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Columbia University; Chinese University of Hong Kong	Kaufman, L (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Renal, One Gustave L Levy Pl,Box 1243, New York, NY 10029 USA.	lewis.kaufman@mssm.edu	Chan, Andrew Man-Lok/J-9497-2013; Chan, Andrew/AAC-1145-2020; Grahammer, Florian/ABB-7775-2021	Chan, Andrew Man-Lok/0000-0001-9923-5464; Chan, Andrew/0000-0001-9923-5464; Huber, Tobias B./0000-0001-7175-5062	NIDDK, National Institutes of Health [1R01DK104712-01A1]; German Research Foundation (DFG) [CRC 1140]; Heisenberg program; European Research Council (ERC) [616891]; BMBF-Joint Transnational Grant [STOP-FSGS 01GM1518C]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103022, R01DK104712] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); German Research Foundation (DFG)(German Research Foundation (DFG)); Heisenberg program(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)); BMBF-Joint Transnational Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIDDK, National Institutes of Health, Grant 1R01DK104712-01A1 (to L. K.); by German Research Foundation (DFG) Grant CRC 1140 (to F. G. and T. B. H.) and the Heisenberg program (to T. B. H.); by European Research Council (ERC) Grant 616891 (to T. B. H.); and by the BMBF-Joint Transnational Grant STOP-FSGS 01GM1518C (to T. B. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balbas MD, 2014, P NATL ACAD SCI USA, V111, P14876, DOI 10.1073/pnas.1417297111; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; BOSCHERT U, 1990, J NEUROGENET, V6, P153, DOI 10.3109/01677069009107107; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dworak HA, 2001, DEVELOPMENT, V128, P4265; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Ihara KI, 2014, AM J PATHOL, V184, P2699, DOI 10.1016/j.ajpath.2014.06.019; Johnson RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007008; Kanwar YS, 2015, AM J PHYSIOL-RENAL, V308, pF420, DOI 10.1152/ajprenal.00640.2014; Kaufman L, 2010, J BIOL CHEM, V285, P25677, DOI 10.1074/jbc.M110.133959; Kawata A, 2006, J BIOCHEM, V139, P931, DOI 10.1093/jb/mvj105; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Lahdenkari AT, 2004, KIDNEY INT, V65, P1856, DOI 10.1111/j.1523-1755.2004.00583.x; Lefebvre J, 2015, KIDNEY INT, V88, P321, DOI 10.1038/ki.2015.140; Lowik M, 2008, NEPHROL DIAL TRANSPL, V23, P3146, DOI 10.1093/ndt/gfn208; McCarthy HJ, 2013, CLIN J AM SOC NEPHRO, V8, P637, DOI 10.2215/CJN.07200712; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Philippe A, 2008, J AM SOC NEPHROL, V19, P1871, DOI 10.1681/ASN.2008010059; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; Potla U, 2014, J CLIN INVEST, V124, P1757, DOI 10.1172/JCI67846; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Santin S, 2009, KIDNEY INT, V76, P1268, DOI 10.1038/ki.2009.381; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; WOLFF T, 1991, DEVELOPMENT, V113, P825; Zaessinger S, 2015, DEVELOPMENT, V142, P1102, DOI 10.1242/dev.116277	36	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24406	24417		10.1074/jbc.M116.745026	http://dx.doi.org/10.1074/jbc.M116.745026			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27707879	hybrid, Green Published			2022-12-28	WOS:000388875500007
J	Chanmee, T; Ontong, P; Izumikawa, T; Higashide, M; Mochizuki, N; Chokchaitaweesuk, C; Khansai, M; Nakajima, K; Kakizaki, I; Kongtawelert, P; Taniguchi, N; Itano, N				Chanmee, Theerawut; Ontong, Pawared; Izumikawa, Tomomi; Higashide, Miho; Mochizuki, Nobutoshi; Chokchaitaweesuk, Chatchadawalai; Khansai, Manatsanan; Nakajima, Kazuki; Kakizaki, Ikuko; Kongtawelert, Prachya; Taniguchi, Naoyuki; Itano, Naoki			Hyaluronan Production Regulates Metabolic and Cancer Stem-like Properties of Breast Cancer Cells via Hexosamine Biosynthetic Pathway-coupled HIF-1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer stem cells; cell metabolism; glycolysis; hyaluronan; hypoxia-inducible factor (HIF); hexosamine biosynthetic pathway	C-MYC; GLUCOSE-METABOLISM; NUCLEOTIDE SUGARS; O-GLCNACYLATION; HYPOXIA; EXPRESSION; INVOLVEMENT; HIF-1-ALPHA; ACTIVATION; RESISTANCE	Cancer stem cells (CSCs) represent a small subpopulation of self-renewing oncogenic cells. As in many other stem cells, metabolic reprogramming has been implicated to be a key characteristic of CSCs. However, little is known about how the metabolic features of cancer cells are controlled to orchestrate their CSC-like properties. We recently demonstrated that hyaluronan (HA) overproduction allowed plastic cancer cells to revert to stem cell states. Here, we adopted stable isotope-assisted tracing and mass spectrometry profiling to elucidate the metabolic features of HA-overproducing breast cancer cells. These integrated approaches disclosed an acceleration of metabolic flux in the hexosamine biosynthetic pathway (HBP). A metabolic shift toward glycolysis was also evident by quantitative targeted metabolomics, which was validated by the expression profiles of key glycolytic enzymes. Forced expression of glutamine:fructose-6-phosphate amidotransferase 1 (GFAT1), an HBP rate-limiting enzyme, resembled the results of HA overproduction with regard to HIF-1 accumulation and glycolytic program, whereas GFAT1 inhibition significantly decreased HIF-1 protein level in HA-overproducing cancer cells. Moreover, inhibition of the HBP-HIF-1 axis abrogated HA-driven glycolytic enhancement and reduced the CSC-like subpopulation. Taken together, our results provide compelling evidence that HA production regulates the metabolic and CSC-like properties of breast cancer cells via HBP-coupled HIF-1 signaling.	[Chanmee, Theerawut; Izumikawa, Tomomi; Higashide, Miho; Mochizuki, Nobutoshi; Chokchaitaweesuk, Chatchadawalai; Khansai, Manatsanan; Itano, Naoki] Kyoto Sangyo Univ, Grad Sch Engn, Dept Mol Biosci, Fac Life Sci,Kita Ku, Kyoto 6038555, Japan; [Ontong, Pawared; Itano, Naoki] Kyoto Sangyo Univ, Grad Sch Engn, Div Engn Biotechnol, Kita Ku, Kyoto 6038555, Japan; [Khansai, Manatsanan; Kongtawelert, Prachya] Chiang Mai Univ, Dept Biochem, Thailand Excellence Ctr Tissue Engn & Stem Cells, Fac Med, Chiang Mai 50200, Thailand; [Nakajima, Kazuki] Fujita Hlth Univ Sch, Div Clin Res Promot, Toyoake, Aichi 4701192, Japan; [Nakajima, Kazuki] Fujita Hlth Univ Sch, Support Ctr Res Promot, Toyoake, Aichi 4701192, Japan; [Kakizaki, Ikuko] Hirosaki Univ, Dept Glycotechnol, Ctr Adv Med Res, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan; [Taniguchi, Naoyuki] RIKEN, Max Planck Joint Res Ctr, Global Res Cluster, Dis Glyc Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Chiang Mai University; Hirosaki University; RIKEN	Itano, N (corresponding author), Kyoto Sangyo Univ, Grad Sch Engn, Dept Mol Biosci, Fac Life Sci,Kita Ku, Kyoto 6038555, Japan.	itanon@cc.kyoto-su.ac.jp	Kakizaki, Ikuko/AAO-5489-2020; Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016	Kakizaki, Ikuko/0000-0002-6702-5830; Taniguchi, Naoyuki/0000-0001-5889-5968; Chanmee, Theerawut/0000-0001-6577-4216; kongtawelert, prachya/0000-0002-5963-2796	JSPS KAKENHI [26430125]; Tokyo Biochemical Research Foundation postdoctoral fellowships for Asian researchers in Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Biochemical Research Foundation postdoctoral fellowships for Asian researchers in Japan	This work was supported by JSPS KAKENHI Grant 26430125 (to N.I.) and Tokyo Biochemical Research Foundation postdoctoral fellowships for Asian researchers in Japan (to T.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Alt J, 2015, ANAL BIOCHEM, V474, P28, DOI 10.1016/j.ab.2015.01.001; Bourguignon LYW, 2012, J BIOL CHEM, V287, P32800, DOI 10.1074/jbc.M111.308528; Calvani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038388; Chanmee T, 2014, J BIOL CHEM, V289, P26038, DOI 10.1074/jbc.M114.564120; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; HARTMAN SC, 1973, J BIOL CHEM, V248, P8506; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Menendez JA, 2013, CELL CYCLE, V12, P1166, DOI 10.4161/cc.24479; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Moon SO, 1998, EXP MOL MED, V30, P29, DOI 10.1038/emm.1998.4; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Nakajima K, 2013, MOL CELL PROTEOMICS, V12, P2468, DOI 10.1074/mcp.M112.027151; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhou J, 2003, MOL BIOL CELL, V14, P2216, DOI 10.1091/mbc.E02-09-0598; Zundel W, 2000, GENE DEV, V14, P391	45	48	50	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24105	24120		10.1074/jbc.M116.751263	http://dx.doi.org/10.1074/jbc.M116.751263			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27758869	hybrid, Green Published			2022-12-28	WOS:000388498100027
J	Luo, M; Gamage, TT; Arentson, BW; Schlasner, KN; Becker, DF; Tanner, JJ				Luo, Min; Gamage, Thameesha T.; Arentson, Benjamin W.; Schlasner, Katherine N.; Becker, Donald F.; Tanner, John J.			Structures of Proline Utilization A (PutA) Reveal the Fold and Functions of the Aldehyde Dehydrogenase Superfamily Domain of Unknown Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; flavoprotein; nicotinamide adenine dinucleotide (NAD); oligomerization; protein domain; small-angle X-ray scattering (SAXS); X-ray crystallography; aldehyde dehydrogenase superfamily; proline catabolism; proline utilization A	X-RAY-SCATTERING; ESCHERICHIA-COLI; PYRROLINE-5-CARBOXYLIC ACID; SUBSTRATE RECOGNITION; PROTEIN; STATE; SAXS; SEMIALDEHYDE; FLAVOENZYME; COMPUTATION	Aldehyde dehydrogenases (ALDHs) catalyze the NAD(P)(+)-dependent oxidation of aldehydes to carboxylic acids and are important for metabolism and detoxification. Although the ALDH superfamily fold is well established, some ALDHs contain an uncharacterized domain of unknown function (DUF) near the C terminus of the polypeptide chain. Herein, we report the first structure of a protein containing the ALDH superfamily DUF. Proline utilization A from Sinorhizobium meliloti (SmPutA) is a 1233-residue bifunctional enzyme that contains the DUF in addition to proline dehydrogenase and l-glutamate--semialdehyde dehydrogenase catalytic modules. Structures of SmPutA with a proline analog bound to the proline dehydrogenase site and NAD(+) bound to the ALDH site were determined in two space groups at 1.7-1.9 angstrom resolution. The DUF consists of a Rossmann dinucleotide-binding fold fused to a three-stranded -flap. The Rossmann domain resembles the classic ALDH superfamily NAD(+)-binding domain, whereas the flap is strikingly similar to the ALDH superfamily dimerization domain. Paradoxically, neither structural element performs its implied function. Electron density maps show that NAD(+) does not bind to the DUF Rossmann fold, and small-angle X-ray scattering reveals a novel dimer that has never been seen in the ALDH superfamily. The structure suggests that the DUF is an adapter domain that stabilizes the aldehyde substrate binding loop and seals the substrate-channeling tunnel via tertiary structural interactions that mimic the quaternary structural interactions found in non-DUF PutAs. Kinetic data for SmPutA indicate a substrate-channeling mechanism, in agreement with previous studies of other PutAs.	[Luo, Min; Gamage, Thameesha T.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Arentson, Benjamin W.; Schlasner, Katherine N.; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Arentson, Benjamin W.; Schlasner, Katherine N.; Becker, Donald F.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	tannerjj@missouri.edu		Tanner, John/0000-0001-8314-113X	NIGMS [U54GM094662]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Institute of Health project MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065546, R01GM061068, U54GM094662, R01GM105404, P30GM103335] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1461240] Funding Source: National Science Foundation	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of Health project MINOS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Prof. Steve Almo and the NYSGRC for the SmPutA clone. The NYSGRC is supported by NIGMS Grant U54GM094662. We thank Dr. Jay Nix for help with X-ray diffraction data collection and Kevin Dyer for collecting the SAXS data through the SIBYLS mail-in program at the Advanced Light Source. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231. Additional support for the SYBILS beamline comes from the National Institute of Health project MINOS (R01GM105404).	ADAMS MJ, 1970, NATURE, V227, P1098, DOI 10.1038/2271098a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson KS, 1999, METHOD ENZYMOL, V308, P111; Arentson BW, 2014, BIOCHEMISTRY-US, V53, P5150, DOI 10.1021/bi5007404; Arentson BW, 2012, FRONT BIOSCI-LANDMRK, V17, P375, DOI 10.2741/3932; BEARNE SL, 1995, BIOCHEMISTRY-US, V34, P11515, DOI 10.1021/bi00036a026; Becker DF, 2001, BIOCHEMISTRY-US, V40, P4714, DOI 10.1021/bi0019491; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; de Jong RM, 2003, EMBO J, V22, P4933, DOI 10.1093/emboj/cdg479; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Farrant RD, 2001, J BIOL CHEM, V276, P15107, DOI 10.1074/jbc.M010860200; Hanna MC, 2009, NEUROGENETICS, V10, P217, DOI 10.1007/s10048-009-0172-6; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Koppaka V, 2012, PHARMACOL REV, V64, P520, DOI 10.1124/pr.111.005538; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lagautriere T, 2014, ACTA CRYSTALLOGR D, V70, P968, DOI 10.1107/S1399004713034391; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Luo M, 2015, BIOCHEMISTRY-US, V54, P5513, DOI 10.1021/acs.biochem.5b00754; Luo M, 2014, BIOCHEMISTRY-US, V53, P5661, DOI 10.1021/bi500693a; Luo M, 2012, BIOCHEMISTRY-US, V51, P10099, DOI 10.1021/bi301312f; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; Pemberton TA, 2013, ARCH BIOCHEM BIOPHYS, V538, P34, DOI 10.1016/j.abb.2013.07.024; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; Singh RK, 2011, J BIOL CHEM, V286, P43144, DOI 10.1074/jbc.M111.292474; Srivastava D, 2012, J MOL BIOL, V420, P176, DOI 10.1016/j.jmb.2012.04.010; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Tanner JJ, 2013, HANDBOOK OF FLAVOPROTEINS, VOL 1: OXIDASES, DEHYDROGENASES AND RELATED SYSTEMS, P31; Vasiliou V, 2013, CHEM-BIOL INTERACT, V202, P22, DOI 10.1016/j.cbi.2012.12.018; Vlieg JETV, 2001, J BACTERIOL, V183, P5058, DOI 10.1128/JB.183.17.5058-5066.2001; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084	47	26	26	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24065	24075		10.1074/jbc.M116.756965	http://dx.doi.org/10.1074/jbc.M116.756965			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679491	hybrid, Green Published			2022-12-28	WOS:000388498100023
J	Ringel, MT; Drager, G; Bruser, T				Ringel, Michael T.; Draeger, Gerald; Brueser, Thomas			PvdN Enzyme Catalyzes a Periplasmic Pyoverdine Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						decarboxylase; enzyme; iron; pyridoxal phosphate; siderophore; periplasmic tailoring; pyoverdines; siderophore maturation; periplasmic tailoring; Pseudomonas fluorescens	PYOCYANEUS-FLUORESCENS GROUP; PSEUDOMONAS-AERUGINOSA; POLYACRYLAMIDE GELS; BIOCHEMICAL RELATIONSHIPS; ELECTROPHORETIC TRANSFER; ESCHERICHIA-COLI; PROTEINS; SIDEROPHORES; BIOSYNTHESIS; NITROCELLULOSE	Pyoverdines are high affinity siderophores produced by a broad range of pseudomonads to enhance growth under iron deficiency. They are especially relevant for pathogenic and mutualistic strains that inhabit iron-limited environments. Pyoverdines are generated from non-ribosomally synthesized highly modified peptides. They all contain an aromatic chromophore that is formed in the periplasm by intramolecular cyclization steps. Although the cytoplasmic peptide synthesis and side-chain modifications are well characterized, the periplasmic maturation steps are far from understood. Out of five periplasmic enzymes, PvdM, PvdN, PvdO, PvdP, and PvdQ, functions have been attributed only to PvdP and PvdQ. The other three enzymes are also regarded as essential for siderophore biosynthesis. The structure of PvdN has been solved recently, but no function could be assigned. Here we present the first in-frame deletion of the PvdN-encoding gene. Unexpectedly, PvdN turned out to be required for a specific modification of pyoverdine, whereas the overall amount of fluorescent pyoverdines was not altered by the mutation. The mutant strain grew normally under iron-limiting conditions. Mass spectrometry identified the PvdN-dependent modification as a transformation of the N-terminal glutamic acid to a succinamide. We postulate a pathway for this transformation catalyzed by the enzyme PvdN, which is most likely functional in the case of all pyoverdines.	[Ringel, Michael T.; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany; [Draeger, Gerald] Leibniz Univ Hannover, Inst Organ Chem, Schneiderberg 1 B, D-30167 Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306	German Research Foundation (DFG) [GRK1798]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) as a project of the GRK1798 "Signaling at the Plant-Soil Interface." The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnow LE, 1937, J BIOL CHEM, V118, P531; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cezard C, 2015, CURR MED CHEM, V22, P165, DOI 10.2174/0929867321666141011194624; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; Drake EJ, 2016, ACTA CRYSTALLOGR F, V72, P403, DOI 10.1107/S2053230X16006257; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Gessard M. C., 1892, ANN I PASTEUR, V4, P88; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; Hartney SL, 2013, J BACTERIOL, V195, P765, DOI 10.1128/JB.01639-12; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ize B, 2014, METHODS MOL BIOL, V1149, P185, DOI 10.1007/978-1-4939-0473-0_15; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jimenez PN, 2010, MICROBIOL-SGM, V156, P49, DOI 10.1099/mic.0.030973-0; KOEDAM N, 1994, BIOMETALS, V7, P287; Kvitko BH, 2011, METHODS MOL BIOL, V712, P109, DOI 10.1007/978-1-61737-998-7_10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Matsui D, 2009, APPL MICROBIOL BIOT, V83, P1045, DOI 10.1007/s00253-009-1942-7; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; MEYER JM, 1978, J GEN MICROBIOL, V107, P319, DOI 10.1099/00221287-107-2-319; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nurizzo D, 2001, BIOCHEMISTRY-US, V40, P13857, DOI 10.1021/bi011355d; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHAFER H, 1991, Z NATURFORSCH C, V46, P398; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turfitt GE, 1936, BIOCHEM J, V30, P1323, DOI 10.1042/bj0301323; Turfitt GE, 1937, BIOCHEM J, V31, P212, DOI 10.1042/bj0310212; Voulhoux R, 2006, J BACTERIOL, V188, P3317, DOI 10.1128/JB.188.9.3317-3323.2006; Wang M, 2016, J AM CHEM SOC, V138, P6348, DOI 10.1021/jacs.6b01751; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0	47	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23929	23938		10.1074/jbc.M116.755611	http://dx.doi.org/10.1074/jbc.M116.755611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703013	hybrid, Green Published			2022-12-28	WOS:000388498100010
J	Lucas, R; Yue, Q; Alli, A; Duke, BJ; Al-Khalili, O; Thai, TL; Hamacher, J; Sridhar, S; Lebedyeva, I; Su, HB; Tzotzos, S; Fischer, B; Gameiro, AF; Loose, M; Chakraborty, T; Shabbir, W; Aufy, M; Lemmens-Gruber, R; Eaton, DC; Czikora, I				Lucas, Rudolf; Yue, Qiang; Alli, Abdel; Duke, Billie Jeanne; Al-Khalili, Otor; Thai, Tiffany L.; Hamacher, Juerg; Sridhar, Supriya; Lebedyeva, Iryna; Su, Huabo; Tzotzos, Susan; Fischer, Bernhard; Gameiro, Armanda Formigao; Loose, Maria; Chakraborty, Trinad; Shabbir, Waheed; Aufy, Mohammed; Lemmens-Gruber, Rosa; Eaton, Douglas C.; Czikora, Istvan			The Lectin-like Domain of TNF Increases ENaC Open Probability through a Novel Site at the Interface between the Second Transmembrane and C-terminal Domains of the -Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); peptides; Streptococcus; tumor necrosis factor (TNF); ubiquitylation (ubiquitination)	EPITHELIAL SODIUM-CHANNEL; TUMOR-NECROSIS-FACTOR; XENOPUS 2F3 CELLS; ACUTE LUNG INJURY; FACTOR-ALPHA; NA+ CHANNEL; EDEMA REABSORPTION; FLUID TRANSPORT; PULMONARY-EDEMA; TRAFFICKING	Regulation of the epithelial sodium channel (ENaC), which regulates fluid homeostasis and blood pressure, is complex and remains incompletely understood. The TIP peptide, a mimic of the lectin-like domain of TNF, activates ENaC by binding to glycosylated residues in the extracellular loop of ENaC-, as well as to a hitherto uncharacterized internal site. Molecular docking studies suggested three residues, Val(567), Glu(568), and Glu(571), located at the interface between the second transmembrane and C-terminal domains of ENaC-, as a critical site for binding of the TIP peptide. We generated Ala replacement mutants in this region of ENaC- and examined its interaction with TIP peptide (3M, V567A/E568A/E571A; 2M, V567A/E568A; and 1M, E571A). 3M and 2M ENaC-, but not 1M ENaC-, displayed significantly reduced binding capacity to TIP peptide and to TNF. When overexpressed in H441 cells, 3M mutant ENaC- formed functional channels with similar gating and density characteristics as the WT subunit and efficiently associated with the and subunits in the plasma membrane. We subsequently assayed for increased open probability time and membrane expression, both of which define ENaC activity, following addition of TIP peptide. TIP peptide increased open probability time in H441 cells overexpressing wild type and 1M ENaC- channels, but not 3M or 2M ENaC- channels. On the other hand, TIP peptide-mediated reduction in ENaC ubiquitination was similar in cells overexpressing either WT or 3M ENaC- subunits. In summary, this study has identified a novel site in ENaC- that is crucial for activation of the open probability of the channel, but not membrane expression, by the lectin-like domain of TNF.	[Lucas, Rudolf; Sridhar, Supriya; Su, Huabo; Czikora, Istvan] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Lucas, Rudolf] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Lucas, Rudolf] Med Coll Georgia, Div Pulm & Crit Care Med, Augusta, GA 30912 USA; [Lebedyeva, Iryna; Gameiro, Armanda Formigao] Augusta Univ, Dept Chem, Augusta, GA 30912 USA; [Yue, Qiang; Alli, Abdel; Duke, Billie Jeanne; Al-Khalili, Otor; Thai, Tiffany L.; Eaton, Douglas C.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Alli, Abdel] Univ Florida, Coll Med, Dept Physiol & Funct Gen, Gainesville, FL 32610 USA; [Hamacher, Juerg] Univ Saarland, Dept Pulmonol, D-66421 Homburg, Germany; [Tzotzos, Susan; Fischer, Bernhard] Apeptico Res & Dev, A-1150 Vienna, Austria; [Loose, Maria; Chakraborty, Trinad] Justus Liebig Univ, Inst Med Microbiol, D-35390 Giessen, Germany; [Shabbir, Waheed; Aufy, Mohammed; Lemmens-Gruber, Rosa] Univ Vienna, Dept Pharmacol & Toxicol, A-1010 Vienna, Austria	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Emory University; State University System of Florida; University of Florida; Saarland University; Justus Liebig University Giessen; University of Vienna	Lucas, R; Czikora, I (corresponding author), Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA.; Lucas, R (corresponding author), Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.; Lucas, R (corresponding author), Med Coll Georgia, Div Pulm & Crit Care Med, Augusta, GA 30912 USA.; Eaton, DC (corresponding author), Emory Univ, Dept Physiol, Atlanta, GA 30322 USA.; Lucas, R; Czikora, I (corresponding author), Augusta Univ, Vasc Biol Ctr, Med Coll Georgia, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	rlucas@augusta.edu; deaton@emory.edu; iczikora@augusta.edu	Lucas, Rudolf/ABA-3011-2020	Czikora, Istvan/0000-0002-8247-9494; Lucas, Rudolf/0000-0003-3805-8868; Aufy, Mohammed/0000-0002-6693-4530; Loose, Maria/0000-0003-2319-7734; Su, Huabo/0000-0002-8475-2685	American Heart Association Postdoctoral Award [15POST22820021]; Bridge Funding Award from the vice-president for research at Augusta University; Deutsche Forschungsgemeinschaft [Transregio 84/2 SFB]; NIDDK, National Institutes of Health [R37 DK037963, R01 DK100564, K01 DK099617]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100564, K01DK099617, R37DK037963] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Award(American Heart Association); Bridge Funding Award from the vice-president for research at Augusta University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by American Heart Association Postdoctoral Award 15POST22820021, by a Bridge Funding Award from the vice-president for research at Augusta University, by a Transregio 84/2 SFB Grant from the Deutsche Forschungsgemeinschaft "Innate Immunity of the Lung," and by NIDDK, National Institutes of Health Grants R37 DK037963, R01 DK100564, and K01 DK099617. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Alli AA, 2012, AM J PHYSIOL-RENAL, V303, pF800, DOI 10.1152/ajprenal.00703.2011; Alli AA, 2012, J BIOL CHEM, V287, P30073, DOI 10.1074/jbc.M111.338574; Alli AA, 2010, J CELL BIOCHEM, V110, P985, DOI 10.1002/jcb.22612; Baldwin RL, 1996, P NATL ACAD SCI USA, V93, P1021, DOI 10.1073/pnas.93.3.1021; Bao HF, 2007, AM J PHYSIOL-RENAL, V293, pF1178, DOI 10.1152/ajprenal.00153.2007; Bertok S, 2012, THORAX, V67, P244, DOI 10.1136/thoraxjnl-2011-200590; Boncoeur E, 2010, AM J PHYSIOL-LUNG C, V298, pL417, DOI 10.1152/ajplung.00170.2009; Braun C, 2005, J IMMUNOL, V175, P3402, DOI 10.4049/jimmunol.175.5.3402; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Copeland SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC231, DOI 10.1152/ajpcell.2001.281.1.C231; Czikora I, 2014, AM J RESP CRIT CARE, V190, P522, DOI 10.1164/rccm.201405-0833OC; Dagenais A, 2004, AM J PHYSIOL-LUNG C, V286, pL301, DOI 10.1152/ajplung.00326.2002; Eaton Douglas C, 2010, Proc Am Thorac Soc, V7, P54, DOI 10.1513/pats.200909-096JS; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Elia N, 2003, AM J RESP CRIT CARE, V168, P1043, DOI 10.1164/rccm.200206-618OC; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; Lopitz-Otsoa F, 2012, J PROTEOMICS, V75, P2998, DOI 10.1016/j.jprot.2011.12.001; Lucas R, 2012, P NATL ACAD SCI USA, V109, P2084, DOI 10.1073/pnas.1121075109; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Mall MA, 2015, J CYST FIBROS, V14, P561, DOI 10.1016/j.jcf.2015.06.002; Marquardt A, 2007, J PEPT SCI, V13, P803, DOI 10.1002/psc.902; Matalon S, 2015, AM J PHYSIOL-LUNG C, V309, pL1229, DOI 10.1152/ajplung.00319.2015; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Migneault F, 2013, AM J PHYSIOL-LUNG C, V305, pL747, DOI 10.1152/ajplung.00023.2013; Mukherjee A, 2014, J BIOL CHEM, V289, P14351, DOI 10.1074/jbc.M113.526020; Ostrand A. B., 2015, AM J PHYSIOL-LUNG C, V308, pL22; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Reifenberger MS, 2014, AM J PHYSIOL-RENAL, V307, pF86, DOI 10.1152/ajprenal.00251.2013; Roux J, 2013, FASEB J, V27, P1095, DOI 10.1096/fj.12-219295; Shabbir W, 2015, BIOCHEM PHARMACOL, V98, P740, DOI 10.1016/j.bcp.2015.08.003; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Sieck GC, 2014, AM J RESP CRIT CARE, V190, P595, DOI 10.1164/rccm.201407-1364ED; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Wagener BM, 2015, ANESTHESIOLOGY, V122, P1084, DOI 10.1097/ALN.0000000000000595; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Yamagata T, 2009, RESP PHYSIOL NEUROBI, V166, P16, DOI 10.1016/j.resp.2008.12.008; Zhu J, 2012, FEBS J, V279, P2632, DOI 10.1111/j.1742-4658.2012.08642.x	54	15	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23440	23451		10.1074/jbc.M116.718163	http://dx.doi.org/10.1074/jbc.M116.718163			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27645999	Green Published, hybrid			2022-12-28	WOS:000387884400007
J	Zhang, ZZZ; Lee, EE; Sudderth, J; Yue, YB; Zia, A; Glass, D; Deberardinis, RJ; Wang, RC				Zhang, Zhuzhen Z.; Lee, Eunice E.; Sudderth, Jessica; Yue, Yangbo; Zia, Ayesha; Glass, Donald; Deberardinis, Ralph J.; Wang, Richard C.			Glutathione Depletion, Pentose Phosphate Pathway Activation, and Hemolysis in Erythrocytes Protecting Cancer Cells from Vitamin C-induced Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT DEHYDROASCORBIC ACID; ASCORBIC-ACID; G-6-PD DEFICIENCY; HOMEOSTASIS; BLOOD; GLUT1	The discovery that oxidized vitamin C, dehydroascorbate (DHA), can induce oxidative stress and cell death in cancer cells has rekindled interest in the use of high dose vitamin C (VC) as a cancer therapy. However, high dose VC has shown limited efficacy in clinical trials, possibly due to the decreased bioavailability of oral VC. Because human erythrocytes express high levels of Glut1, take up DHA, and reduce it to VC, we tested how erythrocytes might impact high dose VC therapies. Cancer cells are protected from VC-mediated cell death when co-cultured with physiologically relevant numbers of erythrocytes. Pharmacological doses of VC induce oxidative stress, GSH depletion, and increased glucose flux through the oxidative pentose phosphate pathway (PPP) in erythrocytes. Incubation of erythrocytes with VC induced hemolysis, which was exacerbated in erythrocytes from glucose-6-phosphate dehydrogenase (G6PD) patients and rescued by antioxidants. Thus, erythrocytes protect cancer cells from VC-induced oxidative stress and undergo hemolysis in vitro, despite activation of the PPP. These results have implications on the use of high dose VC in ongoing clinical trials and highlight the importance of the PPP in the response to oxidative stress.	[Zhang, Zhuzhen Z.; Lee, Eunice E.; Yue, Yangbo; Glass, Donald; Wang, Richard C.] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, NL08-110FB,5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Zia, Ayesha; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Sudderth, Jessica; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Glass, Donald; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, RC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, NL08-110FB,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	richard.wang@utsouthwestern.edu	Glass, Donald A/A-1908-2013; Glass, Donald/AGI-6735-2022; Wang, Richard/AAW-3066-2021; Zia, Ayesha/K-8063-2019	Glass, Donald/0000-0003-0866-770X; Wang, Richard/0000-0003-4543-8295; Zia, Ayesha/0000-0003-3283-0415; Zhang, Zhuzhen/0000-0001-6787-3920	National Institutes of Health [R01 CA157996, K23 AR069728, K23 HL132054, K08 CA164047]; Burroughs Wellcome Fund Career Award for Medical Scientists (CAMS) [1010978]; Disease Oriented Clinical Scholar Awards; NATIONAL CANCER INSTITUTE [K08CA164047, R01CA157996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL132054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR069728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists (CAMS); Disease Oriented Clinical Scholar Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R01 CA157996 (to R. J. D.), K23 AR069728 (to D. G.), K23 HL132054 (to A. Z.), and K08 CA164047 (to R. C. W.). This work was also supported by Burroughs Wellcome Fund Career Award for Medical Scientists (CAMS) (Grant 1010978) and Disease Oriented Clinical Scholar Awards (to R. C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Arruda MM, 2013, BRIT J HAEMATOL, V160, P688, DOI 10.1111/bjh.12185; BRAM S, 1980, NATURE, V284, P629, DOI 10.1038/284629a0; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; DHARIWAL KR, 1991, AM J CLIN NUTR, V54, P712, DOI 10.1093/ajcn/54.4.712; Duconge J, 2008, P R HEALTH SCI J, V27, P7; Jacobs C, 2015, ONCOLOGIST, V20, P210, DOI 10.1634/theoncologist.2014-0381; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Lang F, 2014, ANTIOXID REDOX SIGN, V21, P138, DOI 10.1089/ars.2013.5747; Lee EE, 2015, MOL CELL, V58, P845, DOI 10.1016/j.molcel.2015.04.015; May JM, 2001, BBA-GEN SUBJECTS, V1528, P159, DOI 10.1016/S0304-4165(01)00188-X; MAY JM, 1995, BIOCHEMISTRY-US, V34, P12721, DOI 10.1021/bi00039a031; MEHTA JB, 1990, LANCET, V336, P944, DOI 10.1016/0140-6736(90)92317-B; Mendiratta S, 1998, FREE RADICAL BIO MED, V24, P789, DOI 10.1016/S0891-5849(97)00351-1; Pallotta V, 2014, BLOOD TRANSFUS-ITALY, V12, P376, DOI 10.2450/2014.0266-13; REES DC, 1993, BRIT MED J, V306, P841, DOI 10.1136/bmj.306.6881.841; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Sage JM, 2014, AM J PHYSIOL-CELL PH, V306, pC910, DOI 10.1152/ajpcell.00044.2014; TOTH KM, 1984, J CLIN INVEST, V74, P292, DOI 10.1172/JCI111414; Vani R., 2015, ADV HEMATOL, V2015; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004	23	32	35	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22861	22867		10.1074/jbc.C116.748848	http://dx.doi.org/10.1074/jbc.C116.748848			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27660392	Green Published, hybrid			2022-12-28	WOS:000387224800001
J	Huynh, VTT; Lim, YS; Tran, SC; Pham, TM; Nguyen, LN; Hwang, SB				Huynh, Van T. T.; Lim, Yun-Sook; Tran, Si C.; Pham, Tu M.; Nguyen, Lam N.; Hwang, Soon B.			Hepatitis C Virus Nonstructural 5A Protein Interacts with Abelson Interactor 1 and Modulates Epidermal Growth Factor-mediated MEK/ERK Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						early growth response protein 1 (EGR1); epidermal growth factor (EGF); extracellular-signal-regulated kinase (ERK); growth factor receptor-bound protein 2 (GRB2); hepatitis C virus (HCV); signal transduction	FACTOR RECEPTOR; RAS; ACTIVATION; COMPLEX; KINASE; EPS8; REPLICATION; NS5A; E3B1; ABI1	The propagation of hepatitis C virus (HCV) is highly dependent on host cellular factors. To identify the cellular factors involved in HCV propagation, we have previously performed protein microarray assays using the HCV nonstructural 5A (NS5A) protein as a probe. Of approximate to 9,000 host proteins immobilized in a microarray, approximate to 90 cellular proteins were identified as HCV NS5A interacting partners. Of these candidates, we selected Abelson interactor 1 (Abi1) for further characterization. Binding of HCV NS5A to Abi1 was verified by both in vitro pulldown and coimmunoprecipitation assays. HCV NS5A interacted with Abi1 through regions I + II of Abi1 and domain I of NS5A. We further demonstrated that Abi1 colocalized with the HCV NS5A protein in the cytoplasm. We showed that NS5A inhibited epidermal growth factor-mediated ERK and Egr1 activations and this inhibitory activity of NS5A was nullified in Abi1-knockdown cells. Moreover, silencing of Abi1 expression impaired HCV replication, whereas overexpression of Abi1 promoted HCV propagation. Collectively, these data indicate that HCV exploits host Abi1 protein via NS5A to modulate MEK/ERK signaling pathway for its own propagation.	Hallym Univ, Natl Res Lab Hepatitis Virus C, Anyang 14066, South Korea; Hallym Univ, Ilsong Inst Life Sci, Anyang 14066, South Korea	Hallym University; Hallym University	Hwang, SB (corresponding author), 1605-4 Gwanyang Dong, Anyang 431060, South Korea.	sbhwang@hallym.ac.kr	Huynh, Van/GSM-7997-2022; Nguyen, Nhat Lam/ABD-9095-2020	Nguyen, Nhat Lam/0000-0002-3461-8103	Basic Science Research Program Grant from the Ministry of Science, ICT and Future Planning, Korea [2016R010886]; Korean Health Technology RAMP;D Project Grant from the Ministry of Health and Welfare, Korea [HI13C1746]	Basic Science Research Program Grant from the Ministry of Science, ICT and Future Planning, Korea; Korean Health Technology RAMP;D Project Grant from the Ministry of Health and Welfare, Korea	This work was supported by Basic Science Research Program Grant 2016R010886 from the Ministry of Science, ICT and Future Planning, Korea and Korean Health Technology R&D Project Grant HI13C1746 from the Ministry of Health and Welfare, Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; Cui MH, 2010, MED ONCOL, V27, P632, DOI 10.1007/s12032-009-9260-6; Fan PD, 2000, MOL CELL BIOL, V20, P7591, DOI 10.1128/MCB.20.20.7591-7601.2000; Georgopoulou U, 2003, ARCH VIROL, V148, P237, DOI 10.1007/s00705-002-0925-0; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Jenei V, 2005, EXP CELL RES, V310, P463, DOI 10.1016/j.yexcr.2005.08.010; Kotula L, 2012, FEBS LETT, V586, P2790, DOI 10.1016/j.febslet.2012.05.015; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lim YS, 2011, J VIROL, V85, P8777, DOI 10.1128/JVI.02533-10; Macdonald A, 2005, J GEN VIROL, V86, P1027, DOI 10.1099/vir.0.80724-0; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mankouri J, 2008, TRAFFIC, V9, P1497, DOI 10.1111/j.1600-0854.2008.00779.x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Ndjomou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007498; Ngo HTT, 2013, J VIROL, V87, P5718, DOI 10.1128/JVI.03353-12; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Park C, 2015, J VIROL, V89, P10073, DOI 10.1128/JVI.01707-15; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533	29	8	9	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22607	22617		10.1074/jbc.M116.727081	http://dx.doi.org/10.1074/jbc.M116.727081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27551040	hybrid, Green Published			2022-12-28	WOS:000386760600021
J	Reppschlager, K; Gosselin, J; Dangelmaier, CA; Thomas, DH; Carpino, N; McKenzie, SE; Kunapuli, SP; Tsygankov, AY				Reppschlaeger, Kevin; Gosselin, Jeanne; Dangelmaier, Carol A.; Thomas, Dafydd H.; Carpino, Nick; McKenzie, Steven E.; Kunapuli, Satya P.; Tsygankov, Alexander Y.			TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)(346), a Regulatory Site of Syk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						platelet; protein phosphorylation; signaling; spleen tyrosine kinase (Syk); tyrosine-protein kinase (tyrosine kinase); tyrosine-protein phosphatase (tyrosine phosphatase); GPVI receptor; ITAM; TULA-2	TYROSINE KINASE SYK; LINKER REGION TYROSINES; CELL ANTIGEN RECEPTOR; IN-VIVO; INTEGRIN ALPHA(IIB)BETA(3); PHARMACOLOGICAL ANALYSES; PHOSPHOLIPASE C-GAMMA-2; CARBOXYL-TERMINUS; STRUCTURAL BASIS; GLYCOPROTEIN-VI	Protein-tyrosine phosphatase TULA-2 has been shown to regulate receptor signaling in several cell types, including platelets. Platelets are critical for maintaining vascular integrity; this function is mediated by platelet aggregation in response to recognition of the exposed basement membrane collagen by the GPVI receptor, which is non-covalently associated with the signal-transducing FcR polypeptide chain. Our previous studies suggested that TULA-2 plays an important role in negatively regulating signaling through GPVI-FcR and indicated that the tyrosine-protein kinase Syk is a key target of the regulatory action of TULA-2 in platelets. However, the molecular basis of the down-regulatory effect of TULA-2 on Syk activation via FcR remained unclear. In this study, we demonstrate that suppression of Syk activation by TULA-2 is mediated, to a substantial degree, by dephosphorylation of Tyr(P)(346), a regulatory site of Syk, which becomes phosphorylated soon after receptor ligation and plays a critical role in initiating the process that yields fully activated Syk. TULA-2 is capable of dephosphorylating Tyr(P)(346) with high efficiency, thus controlling the overall activation of Syk, but is less efficient in dephosphorylating other regulatory sites of this kinase. Therefore, dephosphorylation of Tyr(P)(346) may be considered an important checkpoint in the regulation of Syk activation process. Putative biological functions of TULA-2-mediated dephosphorylation of Tyr(P)(346) may include deactivation of receptor-activated Syk or suppression of Syk activation by suboptimal stimulation.	[Reppschlaeger, Kevin; Gosselin, Jeanne; Tsygankov, Alexander Y.] Temple Univ, Dept Microbiol & Immunol, Lewis Katz Sch Med, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Dangelmaier, Carol A.; Thomas, Dafydd H.; Kunapuli, Satya P.; Tsygankov, Alexander Y.] Temple Univ, Lewis Katz Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Carpino, Nick] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [McKenzie, Steven E.] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; [Reppschlaeger, Kevin] Ernst Moritz Arndt Univ Greifswald, D-17489 Greifswald, Germany; [Gosselin, Jeanne] Polytech Clermont Ferrand, Ingenieur Genie Biol, F-63178 Clermont Ferrand, Auvergne, France; [Thomas, Dafydd H.] PMV Pharmaceut, Cranbury Township, NJ 08512 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Jefferson University; Ernst Moritz Arndt Universitat Greifswald; Universite Clermont Auvergne (UCA)	Tsygankov, AY (corresponding author), Temple Univ, Lewis Katz Sch Med, Kresge Bldg,Rm 506,3440 N Broad St, Philadelphia, PA 19140 USA.	tsygan@temple.edu	Tsygankov, Alexander Y/K-6205-2017	Fechtner, Kevin/0000-0003-3841-0331; McKenzie, Steven/0000-0003-2654-8560	American Heart Association [13IRG14230008]; National Institutes of Health [HL93231, HL118593, HL110860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110860, R01HL118593, R01HL093231] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or part by American Heart Association Grant 13IRG14230008 (to A. Y. T.) and National Institutes of Health Grants HL93231 and HL118593 (to S. P. K.) and HL110860 (to S. E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Asazuma N, 2000, J BIOL CHEM, V275, P33427, DOI 10.1074/jbc.M001439200; Back SH, 2013, CELL MOL LIFE SCI, V70, P1269, DOI 10.1007/s00018-012-1203-2; Bauer M, 2001, THROMB HAEMOSTASIS, V85, P331, DOI 10.1055/s-0037-1615689; BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; Briddon SJ, 1999, BIOCHEM J, V338, P203, DOI 10.1042/0264-6021:3380203; Bye AP, 2016, J THROMB HAEMOST, V14, P918, DOI 10.1111/jth.13302; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Chen XW, 2010, J BIOL CHEM, V285, P31268, DOI 10.1074/jbc.M110.114181; Cieniewicz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090196; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617; de Castro RO, 2010, J BIOL CHEM, V285, P26674, DOI 10.1074/jbc.M110.134262; de Castro RO, 2012, J BIOL CHEM, V287, P8194, DOI 10.1074/jbc.M111.326850; Dunster JL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004589; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Keshvara LM, 1997, J BIOL CHEM, V272, P10377; Kleinman H, 2006, ACTA CRYSTALLOGR F, V62, P218, DOI 10.1107/S1744309106003320; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Law CL, 1996, MOL CELL BIOL, V16, P1305; Law DA, 1999, BLOOD, V93, P2645, DOI 10.1182/blood.V93.8.2645.408k13_2645_2652; Luis BS, 2014, FEBS J, V281, P696, DOI 10.1111/febs.12615; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Newman TN, 2014, IMMUNOL CELL BIOL, V92, P837, DOI 10.1038/icb.2014.60; Quek LS, 2000, BLOOD, V96, P4246; Raguz J, 2007, FEBS LETT, V581, P4767, DOI 10.1016/j.febslet.2007.08.077; San Luis B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177634; Simon M, 2005, J BIOL CHEM, V280, P4510, DOI 10.1074/jbc.M410326200; Smirnova EV, 2008, VIROLOGY, V372, P10, DOI 10.1016/j.virol.2007.10.012; Thien CBF, 1999, J IMMUNOL, V162, P7133; Thomas DH, 2010, BLOOD, V116, P2570, DOI 10.1182/blood-2010-02-268136; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Tsygankov AY, 2008, IUBMB LIFE, V60, P224, DOI 10.1002/iub.36; Tsygankov AY, 2013, J CELL PHYSIOL, V228, P43, DOI 10.1002/jcp.24128; Tsygankov AY, 2009, CELL MOL LIFE SCI, V66, P2949, DOI 10.1007/s00018-009-0071-x; TSYGANKOV AY, 1994, J LEUKOCYTE BIOL, V55, P289, DOI 10.1002/jlb.55.3.289; Tsygankov AY, 2003, FRONT BIOSCI-LANDMRK, V8, pS595, DOI 10.2741/1106; TSYGANKOV AY, 1994, J BIOL CHEM, V269, P7792; Watson SP, 1999, THROMB HAEMOSTASIS, V82, P365; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang J, 2015, STEM CELL REP, V5, P633, DOI 10.1016/j.stemcr.2015.08.006; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhou YH, 2015, BLOOD, V126, P2871, DOI 10.1182/blood-2015-02-631135	60	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22427	22441		10.1074/jbc.M116.743732	http://dx.doi.org/10.1074/jbc.M116.743732			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609517	Green Published, hybrid			2022-12-28	WOS:000386760600007
J	Yoshitake, J; Soeda, Y; Ida, T; Sumioka, A; Yoshikawa, M; Matsushita, K; Akaike, T; Takashima, A				Yoshitake, Jun; Soeda, Yoshiyuki; Ida, Tomoaki; Sumioka, Akio; Yoshikawa, Misato; Matsushita, Kenji; Akaike, Takaaki; Takashima, Akihiko			Modification of Tau by 8-Nitroguanosine 3,5-Cyclic Monophosphate (8-Nitro-cGMP): EFFECTS OF NITRIC OXIDE-LINKED CHEMICAL MODIFICATION ON TAU AGGREGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; chemical modification; oxidative stress; protein aggregation; Tau protein (Tau); tauopathy; 8-nitro-cGMP; S-guanylation; cysteine modification	PAIRED HELICAL FILAMENTS; PROTEIN S-GUANYLATION; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; BETA-STRUCTURE; OLIGOMERS; MODEL; NEURODEGENERATION; TAUOPATHIES; DEFENSE	Neurofibrillar tangles caused by intracellular hyperphosphorylated tau inclusion and extracellular amyloid peptide deposition are hallmarks of Alzheimer's disease. Tau contains one or two cysteine residues in three or four repeats of the microtubule binding region following alternative splicing of exon 10, and formation of intermolecular cysteine disulfide bonds accelerates tau aggregation. 8-Nitroguanosine 3,5-cyclic monophosphate (8-nitro-cGMP) acts as a novel second messenger of nitric oxide (NO) by covalently binding cGMP to cysteine residues by electrophilic properties, a process termed protein S-guanylation. Here we studied S-guanylation of tau and its effects on tau aggregation. 8-Nitro-cGMP exposure induced S-guanylation of tau both in vitro and in tau-overexpressed HEK293T cells. S-guanylated tau inhibited heparin-induced tau aggregation in a thioflavin T assay. Atomic force microscopy observations indicated that S-guanylated tau could not form tau granules and fibrils. Further biochemical analyses showed that S-guanylated tau was inhibited at the step of tau oligomer formation. In P301L tau-expressing Neuro2A cells, 8-nitro-cGMP treatment significantly reduced the amount of sarcosyl-insoluble tau. NO-linked chemical modification on cysteine residues of tau could block tau aggregation, and therefore, increasing 8-nitro-cGMP levels in the brain could become a potential therapeutic strategy for Alzheimer's disease.	[Yoshitake, Jun; Soeda, Yoshiyuki; Yoshikawa, Misato] Natl Ctr Geriatr & Gerontol, Dept Aging Neurobiol, 7-430 Morioka Cho, Obu, Aichi 4748511, Japan; [Yoshitake, Jun; Matsushita, Kenji] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, 7-430 Morioka Cho, Obu, Aichi 4748511, Japan; [Ida, Tomoaki; Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Sumioka, Akio; Takashima, Akihiko] Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology; Tohoku University; Gakushuin University	Takashima, A (corresponding author), Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	20160021@gakushuin.ac.jp			Mext; National Center for Geriatrics and Gerontology	Mext(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Geriatrics and Gerontology	This work was supported by Mext grant-in-aid projects Scientific Research on Innovation Area (Brain Protein Aging and Dementia Control (to A. T.) and Brain Environment (to A. T.)), Mext Strategic Research Program for Brain Science (Integrated Research on Neuropsychiatric Disorders) (to A. T.), and an intramural grant of the National Center for Geriatrics and Gerontology (to A. T.).	Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Balez R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3806157; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Colton CA, 2006, P NATL ACAD SCI USA, V103, P12867, DOI 10.1073/pnas.0601075103; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Hardingham N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00190; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ito C, 2013, MOL CELL, V52, P794, DOI 10.1016/j.molcel.2013.10.024; Kimura T, 2010, J BIOL CHEM, V285, P38692, DOI 10.1074/jbc.M110.136630; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Nakashima H, 2004, FREE RADICAL BIO MED, V37, P176, DOI 10.1016/j.freeradbiomed.2004.04.037; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Siuda J, 2014, PARKINSONISM RELAT D, V20, P957, DOI 10.1016/j.parkreldis.2014.06.004; Soeda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10216; Takashima A, 2013, J ALZHEIMERS DIS, V37, P565, DOI 10.3233/JAD-130653; Ueno H, 2007, BIOCHEM BIOPH RES CO, V358, P602, DOI 10.1016/j.bbrc.2007.04.176; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523	31	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22714	22720		10.1074/jbc.M116.734350	http://dx.doi.org/10.1074/jbc.M116.734350			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601475	Green Published, hybrid			2022-12-28	WOS:000386760600030
J	Slapsak, U; Salzano, G; Amin, L; Abskharon, RNN; Ilc, G; Zupancic, B; Biljan, I; Plavec, J; Giachin, G; Legname, G				Slapsak, Urska; Salzano, Giulia; Amin, Ladan; Abskharon, Romany N. N.; Ilc, Gregor; Zupancic, Blaz; Biljan, Ivana; Plavec, Janez; Giachin, Gabriele; Legname, Giuseppe			The N Terminus of the Prion Protein Mediates Functional Interactions with the Neuronal Cell Adhesion Molecule (NCAM) Fibronectin Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; fibronectin; nuclear magnetic resonance (NMR); prion; protein-protein interaction; NCAM; NMR spectroscopy; prion protein; fibronectin type-3 domain; stimulated emission depletion microscopy; STED	COPPER-BINDING SITE; SYNAPTIC PLASTICITY; ALTERED FLEXIBILITY; STRUCTURAL BIOLOGY; NEURITE OUTGROWTH; SELF-RENEWAL; RECEPTOR; DIFFERENTIATION; PROLIFERATION; NEUROGENESIS	The cellular form of the prion protein (PrPC) is a highly conserved glycoprotein mostly expressed in the central and peripheral nervous systems by different cell types in mammals. A misfolded, pathogenic isoform, denoted as prion, is related to a class of neurodegenerative diseases known as transmissible spongiform encephalopathy. PrPC function has not been unequivocally clarified, and it is rather defined as a pleiotropic protein likely acting as a dynamic cell surface scaffolding protein for the assembly of different signaling modules. Among the variety of PrPC protein interactors, the neuronal cell adhesion molecule (NCAM) has been studied in vivo, but the structural basis of this functional interaction is still a matter of debate. Here we focused on the structural determinants responsible for human PrPC (HuPrP) and NCAM interaction using stimulated emission depletion (STED) nanoscopy, SPR, and NMR spectroscopy approaches. PrPC co-localizes with NCAM in mouse hippocampal neurons, and this interaction is mainly mediated by the intrinsically disordered PrPC N-terminal tail, which binds with high affinity to the NCAM fibronectin type-3 domain. NMR structural investigations revealed surface-interacting epitopes governing the interaction between HuPrP N terminus and the second module of the NCAM fibronectin type-3 domain. Our data provided molecular details about the interaction between HuPrP and the NCAM fibronectin domain, and revealed a new role of PrPC N terminus as a dynamic and functional element responsible for protein-protein interaction.	[Slapsak, Urska; Ilc, Gregor; Zupancic, Blaz; Plavec, Janez] Natl Inst Chem, Slovenian NMR Ctr, Hajdrihova 19, SI-1000 Ljubljana, Slovenia; [Salzano, Giulia; Amin, Ladan; Giachin, Gabriele; Legname, Giuseppe] SISSA, Dept Neurosci, Lab Prion Biol, Via Bonomea 265, I-34136 Trieste, Italy; [Abskharon, Romany N. N.] Vrije Univ Brussel VIB, Struct Biol Res Ctr, Pleinlaan 2, B-1050 Brussels, Belgium; [Ilc, Gregor; Plavec, Janez] EN FIST Ctr Excellence, Dunajska 156, SI-1000 Ljubljana, Slovenia; [Biljan, Ivana] Univ Zagreb, Fac Sci, Dept Chem, Horvatovac 102A, HR-10000 Zagreb, Croatia; [Plavec, Janez] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, Vecna Pot 113, SI-1000 Ljubljana, Slovenia; [Giachin, Gabriele] ESRF, Struct Biol Grp, 71 Ave Martyrs, F-38000 Grenoble, France; [Abskharon, Romany N. N.] NIOF, Cairo 11516, Egypt; [Abskharon, Romany N. N.] Van Andel Res Inst, Grand Rapids, MI 49503 USA	National Institute of Chemistry - Slovenia; International School for Advanced Studies (SISSA); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Zagreb; University of Ljubljana; European Synchrotron Radiation Facility (ESRF); Egyptian Knowledge Bank (EKB); National Institute of Oceanography & Fisheries (NIOF); Van Andel Institute	Plavec, J (corresponding author), Natl Inst Chem, Slovenian NMR Ctr, Hajdrihova 19, SI-1000 Ljubljana, Slovenia.; Legname, G (corresponding author), SISSA, Dept Neurosci, Lab Prion Biol, Via Bonomea 265, I-34136 Trieste, Italy.	janez.plavec@ki.si; legname@sissa.it	Salzano, Giulia/AAA-2705-2019; Giachin, Gabriele/AAE-2348-2020; Legname, Giuseppe/C-1723-2012	Giachin, Gabriele/0000-0001-7550-0307; Legname, Giuseppe/0000-0003-0716-4393; Biljan, Ivana/0000-0002-0650-1063; Salzano, Giulia/0000-0001-9770-794X	CERIC-ERIC	CERIC-ERIC	Access to NMR spectrometers was funded partially through CERIC-ERIC. We acknowledge Dr. Federico Carafoli (Imperial College London, London, UK) for providing the plasmid encoding for FNIII1,2 and Dr. Dan Cojoc (IOM-CNR, Trieste, Italy) for technical support. We are grateful to Jan Steyaert (VUB, Brussels, Belgium) for providing valuable information and suggestions.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Boutin C, 2009, EUR J NEUROSCI, V30, P1209, DOI 10.1111/j.1460-9568.2009.06928.x; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Caiati MD, 2013, J NEUROSCI, V33, P2973, DOI 10.1523/JNEUROSCI.4149-12.2013; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Cavanagh J., 1995, PROTEIN NMR SPECTROS; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; D'Angelo P, 2012, BIOCHEMISTRY-US, V51, P6068, DOI 10.1021/bi300233n; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devanathan V, 2010, J NEUROSCI, V30, P9292, DOI 10.1523/JNEUROSCI.5657-09.2010; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; FREI T, 1992, J CELL BIOL, V118, P177, DOI 10.1083/jcb.118.1.177; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Giachin G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15253; Goddard D., 2008, SPARKY 3; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Jacobsen J, 2008, NEUROCHEM RES, V33, P2532, DOI 10.1007/s11064-008-9680-2; Keller R., 2004, COMPUTER AIDED RESON, V1; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kulahin N, 2011, FEBS LETT, V585, P58, DOI 10.1016/j.febslet.2010.11.043; Lee YJ, 2013, J NEUROCHEM, V124, P310, DOI 10.1111/j.1471-4159.2012.07913.x; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McElroy C, 2002, J MOL BIOL, V323, P463, DOI 10.1016/S0022-2836(02)00940-3; Mehrabian M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133741; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; Prodromidou K, 2014, STEM CELLS, V32, P1674, DOI 10.1002/stem.1663; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Requena JR, 2014, PRION, V8, P60, DOI 10.4161/pri.28368; Santos TG, 2011, STEM CELLS, V29, P1126, DOI 10.1002/stem.664; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Silva JL, 2011, METHODS, V53, P306, DOI 10.1016/j.ymeth.2010.12.002; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Soroka V, 2010, ADV EXP MED BIOL, V663, P3, DOI 10.1007/978-1-4419-1170-4_1; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Taubner LM, 2010, J MOL BIOL, V395, P475, DOI 10.1016/j.jmb.2009.10.075; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Wassenaar TA, 2012, J GRID COMPUT, V10, P743, DOI 10.1007/s10723-012-9246-z; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	59	22	23	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21857	21868		10.1074/jbc.M116.743435	http://dx.doi.org/10.1074/jbc.M116.743435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27535221	Green Published, hybrid			2022-12-28	WOS:000386332600003
J	Subramanian, C; Yun, MK; Yao, JW; Sharma, LK; Lee, RE; White, SW; Jackowski, S; Rock, CO				Subramanian, Chitra; Yun, Mi-Kyung; Yao, Jiangwei; Sharma, Lalit Kumar; Lee, Richard E.; White, Stephen W.; Jackowski, Suzanne; Rock, Charles O.			Allosteric Regulation of Mammalian Pantothenate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); allosteric regulation; coenzyme A (CoA); cooperativity; enzyme kinetics; vitamin; X-ray crystallography	COENZYME-A; CONFORMATIONAL DYNAMICS; FEEDBACK-REGULATION; PROTEIN; MODEL; INHIBITION; DEFICIENCY; SOFTWARE; REVEALS; DOMAIN	Pantothenate kinase is the master regulator of CoA biosynthesis and is feedback-inhibited by acetyl-CoA. Comparison of the human PANK3acetyl-CoA complex to the structures of PANK3 in four catalytically relevant complexes, 5'-adenylyl-beta,gamma-imidodiphosphate (AMPPNP)center dot Mg2+, AMPPNP center dot Mg(2+)pantothenate, ADP center dot Mg(2+)phosphopantothenate, and AMP phosphoramidate (AMPPN)center dot Mg2+, revealed a large conformational change in the dimeric enzyme. The amino-terminal nucleotide binding domain rotates to close the active site, and this allows the P-loop to engage ATP and facilitates required substrate/product interactions at the active site. Biochemical analyses showed that the transition between the inactive and active conformations, as assessed by the binding of either ATP center dot Mg2+ or acyl-CoA to PANK3, is highly cooperative indicating that both protomers move in concert. PANK3(G19V) cannot bind ATP, and biochemical analyses of an engineered PANK3/PANK3(G19V) heterodimer confirmed that the two active sites are functionally coupled. The communication between the two protomers is mediated by an -helix that interacts with the ATP-binding site at its amino terminus and with the substrate/inhibitor-binding site of the opposite protomer at its carboxyl terminus. The two alpha-helices within the dimer together with the bound ligands create a ring that stabilizes the assembly in either the active closed conformation or the inactive open conformation. Thus, both active sites of the dimeric mammalian pantothenate kinases coordinately switch between the on and off states in response to intracellular concentrations of ATP and its key negative regulators, acetyl(acyl)-CoA.	[Subramanian, Chitra; Yao, Jiangwei; Jackowski, Suzanne; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Yun, Mi-Kyung; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Sharma, Lalit Kumar; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Jackowski, Suzanne/N-8168-2018; Lee, Richard/J-4997-2013; Lee, Richard/AAX-3996-2021; Subramanian, Chitra/N-9210-2018; Chitra, S/GPX-8113-2022; White, Stephen W/N-8164-2018	Jackowski, Suzanne/0000-0002-6855-1429; Lee, Richard/0000-0002-2397-0443; Lee, Richard/0000-0002-2397-0443; Subramanian, Chitra/0000-0003-1101-5307; 	National Institutes of Health [GM034496, GM062896]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496, R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants GM034496 (to C. O. R.), GM062896 (to S. J.), and Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; BARRIO JR, 1972, P NATL ACAD SCI USA, V69, P2039, DOI 10.1073/pnas.69.8.2039; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Dansie LE, 2014, BIOCHEM SOC T, V42, P1033, DOI 10.1042/BST20140096; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040871; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; Hong BS, 2006, STRUCTURE, V14, P1251, DOI 10.1016/j.str.2006.06.008; HSU KHL, 1975, P NATL ACAD SCI USA, V72, P4729, DOI 10.1073/pnas.72.12.4729; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Leonardi R, 2014, DIABETOLOGIA, V57, P1466, DOI 10.1007/s00125-014-3245-5; Leonardi R, 2010, CHEM BIOL, V17, P892, DOI 10.1016/j.chembiol.2010.06.006; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Liu J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004966; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mottaghi K., 2013, THESIS; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; SECRIST JA, 1972, SCIENCE, V177, P279, DOI 10.1126/science.177.4045.279; Sharma LK, 2015, J MED CHEM, V58, P1563, DOI 10.1021/jm501585q; Virga KG, 2006, BIOORGAN MED CHEM, V14, P1007, DOI 10.1016/j.bmc.2005.09.021; Zano SP, 2015, MOL GENET METAB, V116, P281, DOI 10.1016/j.ymgme.2015.10.011; Zhang YM, 2005, J BIOL CHEM, V280, P32594, DOI 10.1074/jbc.M506275200; Zhang YM, 2004, J BIOL CHEM, V279, P50969, DOI 10.1074/jbc.M409607200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	40	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22302	22314		10.1074/jbc.M116.748061	http://dx.doi.org/10.1074/jbc.M116.748061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27555321	Green Published, hybrid			2022-12-28	WOS:000386332600040
J	Suzuki, H; Matsuoka, M				Suzuki, Hiroaki; Matsuoka, Masaaki			The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig's disease); cell death; lysosome; neurodegenerative disease; TAR DNA-binding protein 43 (TDP-43) (TARDBP); Frontotemporal lobar degeneration; Transmembrane protein 106B	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; RISK-FACTOR; TMEM106B; DEMENTIA; PROGRANULIN; TDP-43; STRESS; ALS; NEUROPATHOLOGY	A common genetic variation in the transmembrane protein 106B (TMEM106B) gene has been suggested to be a risk factor for frontotemporal lobar degeneration (FTLD) with inclusions of transactive response DNA-binding protein-43 (TDP-43) (FTLD-TDP), the most common pathological subtype in FTLD. Furthermore, previous studies have shown that TMEM106B levels are up-regulated in the brains of FTLD-TDP patients, although the significance of this finding remains unknown. In this study, we show that the overexpression of TMEM106B and its N-terminal fragments induces cell death, enhances oxidative stress-induced cytotoxicity, and causes the cleavage of TDP-43, which represents TDP-43 pathology, using cell-based models. TMEM106B-induced death is mediated by the caspase-dependent mitochondrial cell death pathways and possibly by the lysosomal cell death pathway. These findings suggest that the up-regulation of TMEM106B may increase the risk of FTLD by directly causing neurotoxicity and a pathological phenotype linked to FTLD-TDP.	[Suzuki, Hiroaki; Matsuoka, Masaaki] Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan; [Matsuoka, Masaaki] Tokyo Med Univ, Dept Dermatol Neurosci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan	Tokyo Medical University; Tokyo Medical University	Matsuoka, M (corresponding author), Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp			Japan Society for the Promotion of Science [15H04689, 25460342]; Japan ALS association (JALSA); Naito Foundation Natural Science Scholarship; Akaeda Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan ALS association (JALSA); Naito Foundation Natural Science Scholarship; Akaeda Medical Research Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (B) 15H04689 (to M. M.) and Grant-in-Aid for Scientific Research (C) 25460342 (to H. S.) from the Japan Society for the Promotion of Science, by a grant from the Japan ALS association (JALSA) (to H. S.), by a Naito Foundation Natural Science Scholarship (to M. M.), and by a research grant from the Akaeda Medical Research Foundation (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brady OA, 2014, J BIOL CHEM, V289, P19670, DOI 10.1074/jbc.M113.515700; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Busch J. I., 2016, HUM MOL GENET, DOI [10.1093/hmg/ddw127, DOI 10.1093/HMG/DDW127]; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cruts M, 2013, TRENDS NEUROSCI, V36, P450, DOI 10.1016/j.tins.2013.04.010; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Gallagher MD, 2014, ACTA NEUROPATHOL, V127, P407, DOI 10.1007/s00401-013-1239-x; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Lattante S, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.06.023; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Peters OM, 2015, J CLIN INVEST, V125, P1767, DOI 10.1172/JCI71601; Pottier C, 2016, J NEUROCHEM, V138, P32, DOI 10.1111/jnc.13622; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Schwenk BM, 2014, EMBO J, V33, P450, DOI 10.1002/embj.201385857; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Stagi M, 2014, MOL CELL NEUROSCI, V61, P226, DOI 10.1016/j.mcn.2014.07.006; Suzuki H, 2015, HUM MOL GENET, V24, P1513, DOI 10.1093/hmg/ddu563; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tanaka Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0078-x; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van Blitterswijk M, 2014, ACTA NEUROPATHOL, V127, P397, DOI 10.1007/s00401-013-1240-4; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043	40	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21448	21460		10.1074/jbc.M116.737171	http://dx.doi.org/10.1074/jbc.M116.737171			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27563066	hybrid, Green Published			2022-12-28	WOS:000385999200013
J	Gakh, O; Ranatunga, W; Smith, DY; Ahlgren, EC; Al-Karadaghi, S; Thompson, JR; Isaya, G				Gakh, Oleksandr; Ranatunga, Wasantha; Smith, Douglas Y.; Ahlgren, Eva-Christina; Al-Karadaghi, Salam; Thompson, James R.; Isaya, Grazia			Architecture of the Human Mitochondrial Iron-Sulfur Cluster Assembly Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; N-HYDROXYSUCCINIMIDE ESTERS; X-RAY CRYSTALLOGRAPHY; YEAST FRATAXIN; FRIEDREICH ATAXIA; ESCHERICHIA-COLI; SCAFFOLD PROTEIN; BINDING-SITES; CYSTEINE DESULFURASE; ELECTRON-MICROSCOPY	Fe-S clusters, essential cofactors needed for the activity of many different enzymes, are assembled by conserved protein machineries inside bacteria and mitochondria. As the architecture of the human machinery remains undefined, we co-expressed in Escherichia coli the following four proteins involved in the initial step of Fe-S cluster synthesis: FXN42-210 (iron donor); [NFS1]center dot[ISD11] (sulfur donor); and ISCU (scaffold upon which new clusters are assembled). We purified a stable, active complex consisting of all four proteins with 1:1:1:1 stoichiometry. Using negative staining transmission EM and single particle analysis, we obtained a three-dimensional model of the complex with similar to 14 angstrom resolution. Molecular dynamics flexible fitting of protein structures docked into the EM map of the model revealed a [FXN42-210](24)center dot[NFS1](24)center dot[ISD11](24)center dot[ISCU](24) complex, consistent with the measured 1:1:1:1 stoichiometry of its four components. The complex structure fulfills distance constraints obtained from chemical cross-linking of the complex at multiple recurring interfaces, involving hydrogen bonds, salt bridges, or hydrophobic interactions between conserved residues. The complex consists of a central roughly cubic [FXN42-210](24)center dot[ISCU](24) sub-complex with one symmetric ISCU trimer bound on top of one symmetric FXN42-210 trimer at each of its eight vertices. Binding of 12 [NFS1](2)center dot[ISD11](2) sub-complexes to the surface results in a globular macromolecule with a diameter of similar to 15 nm and creates 24 Fe-S cluster assembly centers. The organization of each center recapitulates a previously proposed conserved mechanism for sulfur donation from NFS1 to ISCU and reveals, for the first time, a path for iron donation from FXN42-210 to ISCU.	[Gakh, Oleksandr; Ranatunga, Wasantha; Smith, Douglas Y.; Isaya, Grazia] Mayo Clin, Childrens Res Ctr, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Gakh, Oleksandr; Ranatunga, Wasantha; Smith, Douglas Y.; Isaya, Grazia] Mayo Clin, Childrens Res Ctr, Dept Biochem Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Ahlgren, Eva-Christina; Al-Karadaghi, Salam] Lund Univ, Inst Chem & Chem Engn, Ctr Mol Prot Sci, POB 124, SE-22100 Lund, Sweden	Mayo Clinic; Mayo Clinic; Mayo Clinic; Lund University	Isaya, G (corresponding author), Mayo Clin, 200 First St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health from NIA [AG15709-19]; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health from NIA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant AG15709-19 from NIA (to G.I. and J.T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Amela I, 2013, PROTEIN J, V32, P183, DOI 10.1007/s10930-013-9475-4; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Blanc B, 2015, BBA-MOL CELL RES, V1853, P1436, DOI 10.1016/j.bbamcr.2014.12.009; Blow DM, 2002, ACTA CRYSTALLOGR D, V58, P792, DOI 10.1107/S0907444902003931; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Chan KY, 2011, STRUCTURE, V19, P1211, DOI 10.1016/j.str.2011.07.017; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3880, DOI 10.1021/bi5014497; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Hagel L, 1996, J CHROMATOGR A, V743, P33, DOI 10.1016/0021-9673(96)00130-6; HEMPSTEAD PD, 1994, FEBS LETT, V350, P258, DOI 10.1016/0014-5793(94)00781-0; Jobling RK, 2015, BRAIN, V138, P1505, DOI 10.1093/brain/awv057; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kim JH, 2015, BBA-MOL CELL RES, V1853, P1416, DOI 10.1016/j.bbamcr.2014.11.020; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Li HQ, 2013, J BIOL CHEM, V288, P4116, DOI 10.1074/jbc.M112.435263; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Madler S, 2010, ANAL BIOCHEM, V398, P123, DOI 10.1016/j.ab.2009.11.020; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Manicki M, 2014, J BIOL CHEM, V289, P30268, DOI 10.1074/jbc.M114.596726; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; MOORE S, 1963, J BIOL CHEM, V238, P235; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Neupane GP, 2009, TRANSFUSION, V49, P1762, DOI 10.1111/j.1537-2995.2009.02186.x; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Saha PP, 2015, J BIOL CHEM, V290, P25876, DOI 10.1074/jbc.M115.678508; Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Seguin A, 2010, BBA-MOL BASIS DIS, V1802, P531, DOI 10.1016/j.bbadis.2010.03.008; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Tsai CL, 2011, BIOCHEMISTRY-US, V50, P6478, DOI 10.1021/bi200666h; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	75	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21296	+		10.1074/jbc.M116.738542	http://dx.doi.org/10.1074/jbc.M116.738542			69	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27519411	Green Published, hybrid			2022-12-28	WOS:000385406200041
J	Nadtochiy, SM; Schafer, X; Fu, D; Nehrke, K; Munger, J; Brookes, PS				Nadtochiy, Sergiy M.; Schafer, Xenia; Fu, Dragony; Nehrke, Keith; Munger, Joshua; Brookes, Paul S.			Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acidosis; cancer; epigenetics; hypoxia; metabolism; 2-hydroxyglutarate	L-2-HYDROXYGLUTARIC ACIDURIA; ALPHA-KETOGLUTARATE; CANCER; DEHYDROGENASE; CELLS; ACIDIFICATION; ACTIVATION; SIGNATURE; ACIDOSIS; ANOXIA	2-Hydroxyglutarate (2-HG) is an important epigenetic regulator, with potential roles in cancer and stem cell biology. The d-(R)-enantiomer (d-2-HG) is an oncometabolite generated from -ketoglutarate (-KG) by mutant isocitrate dehydrogenase, whereas l-(S)-2-HG is generated by lactate dehydrogenase and malate dehydrogenase in response to hypoxia. Because acidic pH is a common feature of hypoxia, as well as tumor and stem cell microenvironments, we hypothesized that pH may regulate cellular 2-HG levels. Herein we report that cytosolic acidification under normoxia moderately elevated 2-HG in cells, and boosting endogenous substrate -KG levels further stimulated this elevation. Studies with isolated lactate dehydrogenase-1 and malate dehydrogenase-2 revealed that generation of 2-HG by both enzymes was stimulated severalfold at acidic pH, relative to normal physiologic pH. In addition, acidic pH was found to inhibit the activity of the mitochondrial l-2-HG removal enzyme l-2-HG dehydrogenase and to stimulate the reverse reaction of isocitrate dehydrogenase (carboxylation of -KG to isocitrate). Furthermore, because acidic pH is known to stabilize hypoxia-inducible factor (HIF) and 2-HG is a known inhibitor of HIF prolyl hydroxylases, we hypothesized that 2-HG may be required for acid-induced HIF stabilization. Accordingly, cells stably overexpressing l-2-HG dehydrogenase exhibited a blunted HIF response to acid. Together, these results suggest that acidosis is an important and previously overlooked regulator of 2-HG accumulation and other oncometabolic events, with implications for HIF signaling.	[Nadtochiy, Sergiy M.; Brookes, Paul S.] Univ Rochester, Dept Anesthesiol, Rochester, NY 14642 USA; [Schafer, Xenia; Munger, Joshua] Univ Rochester, Dept Biochem, Rochester, NY 14642 USA; [Fu, Dragony] Univ Rochester, Dept Biol, Rochester, NY 14642 USA; [Nehrke, Keith] Univ Rochester, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Brookes, PS (corresponding author), Univ Rochester, Dept Anesthesiol, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.	paul_brookes@urmc.rochester.edu	Munger, Joshua/ABA-6395-2020	Munger, Joshua/0000-0001-5379-9440; Brookes, Paul/0000-0002-8639-8413; Fu, Dragony/0000-0002-8725-8658; Nehrke, Keith/0000-0001-9697-726X	National Institutes of Health [RO1 HL-071158, R01 AI-081773, R01-HL127891]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127891, R01HL071158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127370, R01AI081773, R56AI081773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants RO1 HL-071158 (to P. S. B.), R01 AI-081773 (to J. M.), and R01-HL127891 (to P. S. B. and K. W. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barth PG, 1998, J INHERIT METAB DIS, V21, P251, DOI 10.1023/A:1005316121584; Butler JA, 2013, AGING CELL, V12, P130, DOI 10.1111/acel.12029; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; De Los Angeles A, 2015, NATURE, V525, pE6, DOI 10.1038/nature15513; GASBARRINI A, 1992, J BIOL CHEM, V267, P6654; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Jin YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131998; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Ladilov YV, 1998, CIRC RES, V82, P451, DOI 10.1161/01.RES.82.4.451; Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Nadtochiy SM, 2015, J MOL CELL CARDIOL, V88, P64, DOI 10.1016/j.yjmcc.2015.09.008; Nadtochiy SM, 2014, BRIT J PHARMACOL, V171, P2091, DOI 10.1111/bph.12405; Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; ROSE UM, 1995, PFLUG ARCH EUR J PHY, V429, P722, DOI 10.1007/BF00373995; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Rzem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119540; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; Struys EA, 2006, J INHERIT METAB DIS, V29, P21, DOI 10.1007/s10545-006-0317-9; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Teng X, 2016, ACS CHEM BIOL, V11, P2420, DOI 10.1021/acschembio.6b00290; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Venneti S, 2013, BRAIN PATHOL, V23, P217, DOI 10.1111/bpa.12022; Wang P, 2015, CELL REP, V13, P2353, DOI 10.1016/j.celrep.2015.11.029; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	37	93	93	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20188	20197		10.1074/jbc.M116.738799	http://dx.doi.org/10.1074/jbc.M116.738799			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27510037	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000383243100038
J	Jenkins, LM; Singh, P; Varadaraj, A; Lee, NY; Shah, S; Flores, HV; O'Connell, K; Mythreye, K				Jenkins, Laura M.; Singh, Priyanka; Varadaraj, Archana; Lee, Nam Y.; Shah, Shreya; Flores, Haley V.; O'Connell, Kathleen; Mythreye, Karthikeyan			Altering the Proteoglycan State of Transforming Growth Factor Type III Receptor (TRIII)/Betaglycan Modulates Canonical Wnt/-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell signaling; glycosaminoglycan; transforming growth factor (TGF-); Wnt signaling; TBRIII; betaglycan	TGF-BETA RECEPTOR; HEPARAN-SULFATE; OVARIAN-CANCER; MESENCHYMAL TRANSITION; MAMMARY TUMORIGENESIS; CHONDROITIN SULFATE; LIGAND-BINDING; CELL-SURVIVAL; EXPRESSION; PROMOTES	Hyperactive Wnt/-catenin signaling is linked to cancer progression and developmental abnormalities, making identification of mechanisms controlling Wnt/-catenin signaling vital. Transforming growth factor type III receptor (TRIII/betaglycan) is a transmembrane proteoglycan co-receptor that exists with or without heparan and/or chondroitin sulfate glycosaminoglycan (GAG) modifications in cells and has established roles in development and cancer. Our studies here demonstrate that TRIII, independent of its TGF co-receptor function, regulates canonical Wnt3a signaling by controlling Wnt3a availability through its sulfated GAG chains. Our findings revealed, for the first time, opposing functions for the different GAG modifications on TRIII suggesting that Wnt interactions with the TRIII heparan sulfate chains result in inhibition of Wnt signaling, likely via Wnt sequestration, whereas the chondroitin sulfate GAG chains on TRIII promote Wnt3a signaling. These studies identify a novel, dual role for TRIII/betaglycan and define a key requirement for the balance between chondroitin sulfate and heparan sulfate chains in dictating ligand responses with implications for both development and cancer.	[Jenkins, Laura M.; Singh, Priyanka; Varadaraj, Archana; Shah, Shreya; Flores, Haley V.; O'Connell, Kathleen; Mythreye, Karthikeyan] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Mythreye, Karthikeyan] Univ South Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA; [Lee, Nam Y.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA	University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University System of Ohio; Ohio State University	Mythreye, K (corresponding author), Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.	mythreye@sc.edu	Karthikeyan, Mythreye/ABC-7345-2020	Karthikeyan, Mythreye/0000-0001-5478-0098; Varadaraj, Archana/0000-0002-1868-1268; JENKINS, LAURA/0000-0003-0563-9519	Ovarian Cancer Research Fund [258785]; National Institutes of Health [P20 GM109091]; Minority Graduate Research Fellowship from the University of South Carolina; NATIONAL CANCER INSTITUTE [R01CA178443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109091] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minority Graduate Research Fellowship from the University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant 258785 from the Ovarian Cancer Research Fund (to K. M.), National Institutes of Health Grant P20 GM109091 (to K. M.), and a Minority Graduate Research Fellowship from the University of South Carolina (to L. M. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; ANDRES JL, 1992, J BIOL CHEM, V267, P5927; Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI 10.1016/j.ygyno.2013.09.034; Asad M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.302; Badiglian L, 2009, ONCOL REP, V21, P313, DOI 10.3892/or_00000223; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Capurro M, 2014, J CELL SCI, V127, P1565, DOI 10.1242/jcs.140871; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1989, J BIOL CHEM, V264, P12025; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COHEN IR, 1994, CANCER RES, V54, P5771; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; Dhodapkar MV, 1998, BLOOD, V91, P2679, DOI 10.1182/blood.V91.8.2679.2679_2679_2688; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Eickelberg O, 2002, J BIOL CHEM, V277, P823, DOI 10.1074/jbc.M105110200; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Jovanovic B, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3684; King ML, 2015, ONCOGENE, V34, P3452, DOI 10.1038/onc.2014.277; Knelson EH, 2013, J CLIN INVEST, V123, P4786, DOI 10.1172/JCI69657; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lambert KE, 2011, MOL BIOL CELL, V22, P1463, DOI 10.1091/mbc.E10-11-0877; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Mendoza V, 2009, BIOCHEMISTRY-US, V48, P11755, DOI 10.1021/bi901528w; Meyer AE, 2014, MOL BIOL CELL, V25, P2291, DOI 10.1091/mbc.E14-03-0825; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mythreye K, 2013, ONCOGENE, V32, P1416, DOI 10.1038/onc.2012.157; Mythreye K, 2009, CELL CYCLE, V8, P3069, DOI 10.4161/cc.8.19.9419; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; Oh SY, 2013, BIOCHEM J, V454, P79, DOI 10.1042/BJ20121701; Peters MG, 2003, BREAST CANCER RES TR, V80, P221, DOI 10.1023/A:1024549729256; Prinz RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092381; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Qi LS, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0107-4; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SEGARINI PR, 1988, J BIOL CHEM, V263, P8366; Shiau CE, 2010, DEV BIOL, V348, P107, DOI 10.1016/j.ydbio.2010.09.017; Shortkroff S, 2007, OSTEOARTHR CARTILAGE, V15, P147, DOI 10.1016/j.joca.2006.07.004; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Steller MD, 2005, MOL CANCER RES, V3, P50; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Tung EKK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036565; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Usongo M, 2013, DEV DYNAM, V242, P291, DOI 10.1002/dvdy.23919; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Vinyoles M, 2014, MOL CELL, V53, P444, DOI 10.1016/j.molcel.2013.12.010; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Willis CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103966	77	14	14	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25716	25728		10.1074/jbc.M116.748624	http://dx.doi.org/10.1074/jbc.M116.748624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27784788	hybrid, Green Published			2022-12-28	WOS:000390095300036
J	Liang, XJ; Liu, L; Fu, TT; Zhou, Q; Zhou, DX; Xiao, LW; Liu, J; Kong, Y; Xie, H; Yi, FC; Lai, L; Vega, RB; Kelly, DP; Smith, SR; Gan, ZJ				Liang, Xijun; Liu, Lin; Fu, Tingting; Zhou, Qian; Zhou, Danxia; Xiao, Liwei; Liu, Jing; Kong, Yan; Xie, Hui; Yi, Fanchao; Lai, Ling; Vega, Rick B.; Kelly, Daniel P.; Smith, Steven R.; Gan, Zhenji			Exercise Inducible Lactate Dehydrogenase B Regulates Mitochondrial Function in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; exercise; gene regulation; mitochondria; skeletal muscle	FIBER-TYPE; LACTIC DEHYDROGENASES; PGC-1-ALPHA CONTROLS; ENDURANCE EXERCISE; METABOLISM; HUMANS; MEN; ADAPTATIONS; BIOGENESIS; ACTIVATION	Lactate dehydrogenase (LDH) catalyzes the interconversion of pyruvate and lactate, which are critical fuel metabolites of skeletal muscle particularly during exercise. However, the physiological relevance of LDH remains poorly understood. Here we show that Ldhb expression is induced by exercise in human muscle and negatively correlated with changes in intramuscular pH levels, a marker of lactate production, during isometric exercise. We found that the expression of Ldhb is regulated by exercise-induced peroxisome proliferator-activated receptor coactivator 1 (PGC-1). Ldhb gene promoter reporter studies demonstrated that PGC-1 activates Ldhb gene expression through multiple conserved estrogen-related receptor (ERR) and myocyte enhancer factor 2 (MEF2) binding sites. Transgenic mice overexpressing Ldhb in muscle (muscle creatine kinase (MCK)-Ldhb) exhibited increased exercise performance and enhanced oxygen consumption during exercise. MCK-Ldhb muscle was shown to have enhanced mitochondrial enzyme activity and increased mitochondrial gene expression, suggesting an adaptive oxidative muscle transformation. In addition, mitochondrial respiration capacity was increased and lactate production decreased in MCK-Ldhb skeletal myotubes in culture. Together, these results identified a previously unrecognized Ldhb-driven alteration in muscle mitochondrial function and suggested a mechanism for the adaptive metabolic response induced by exercise training.	[Liang, Xijun; Liu, Lin; Fu, Tingting; Zhou, Qian; Zhou, Danxia; Xiao, Liwei; Liu, Jing; Gan, Zhenji] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China; [Liang, Xijun; Liu, Lin; Fu, Tingting; Zhou, Qian; Zhou, Danxia; Xiao, Liwei; Liu, Jing; Gan, Zhenji] Nanjing Univ, Minist Educ, Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Kong, Yan] Southeast Univ, Sch Med, Dept Biochem & Mol Biol, Nanjing 210009, Jiangsu, Peoples R China; [Xie, Hui; Yi, Fanchao; Smith, Steven R.] Florida Hosp, Translat Res Inst Metab & Diabet, Orlando, FL 32804 USA; [Lai, Ling; Vega, Rick B.; Kelly, Daniel P.] Sanford Burnham Prebys Med Discovery Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA; [Gan, Zhenji] Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China	Nanjing University; Nanjing University; Southeast University - China; Adventist Health Services; AdventHealth; Sanford Burnham Prebys Medical Discovery Institute	Gan, ZJ (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	ganzj@nju.edu.cn	KONG, YAN/AGT-7798-2022; Smith, Steven/HDM-9496-2022; Kelly, Daniel/ABG-2056-2021	Gan, Zhenji/0000-0001-5940-207X; Smith, Steven/0000-0002-5098-8147	Ministry of Science and Technology of China 973 Program [2015CB856300]; National Natural Science Foundation of China [31471110, 81400821]; Natural Science Foundation of Jiangsu Province [BK20140600]; National Institutes of Health [RO1DK045416]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416] Funding Source: NIH RePORTER	Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Ministry of Science and Technology of China 973 Program Grant 2015CB856300, National Natural Science Foundation of China Grants 31471110 and 81400821, Natural Science Foundation of Jiangsu Province Grant BK20140600 (to Z. G.), and National Institutes of Health Grant RO1DK045416 (to D. P. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	APPLE FS, 1986, J APPL PHYSIOL, V61, P477, DOI 10.1152/jappl.1986.61.2.477; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bajpeyi S, 2011, J CLIN ENDOCR METAB, V96, P1160, DOI 10.1210/jc.2010-1621; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Burke L M, 1999, Curr Opin Clin Nutr Metab Care, V2, P515, DOI 10.1097/00075197-199911000-00015; CAHN RD, 1962, SCIENCE, V136, P962, DOI 10.1126/science.136.3520.962; Cairns SP, 2006, SPORTS MED, V36, P279, DOI 10.2165/00007256-200636040-00001; COGGAN AR, 1991, SPORTS MED, V11, P102, DOI 10.2165/00007256-199111020-00003; Costford SR, 2010, AM J PHYSIOL-ENDOC M, V298, pE117, DOI 10.1152/ajpendo.00318.2009; DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929; Draoui N, 2011, DIS MODEL MECH, V4, P727, DOI 10.1242/dmm.007724; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Elustondo PA, 2013, J BIOL CHEM, V288, P25309, DOI 10.1074/jbc.M113.476648; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; HAGBERG JM, 1988, J APPL PHYSIOL, V65, P900, DOI 10.1152/jappl.1988.65.2.900; Hargreaves M, 2004, P NUTR SOC, V63, P217, DOI 10.1079/PNS2004344; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Hawley JA, 2002, CLIN EXP PHARMACOL P, V29, P218, DOI 10.1046/j.1440-1681.2002.03623.x; Hittel DS, 2005, J APPL PHYSIOL, V98, P168, DOI 10.1152/japplphysiol.00331.2004; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Holloszy John O., 1998, Frontiers in Bioscience, V3, pD1011; JORFELDT L, 1970, SCAND J CLIN LAB INV, V26, P73, DOI 10.3109/00365517009049217; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; KNIGHT DR, 1992, J APPL PHYSIOL, V73, P1114, DOI 10.1152/jappl.1992.73.3.1114; Li SS, 2015, MOL CELL, V60, P408, DOI 10.1016/j.molcel.2015.09.024; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu J, 2016, EMBO MOL MED, V8, P1212, DOI 10.15252/emmm.201606372; Liu J, 2015, SCI CHINA LIFE SCI, V58, P321, DOI 10.1007/s11427-015-4833-4; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; Martin OJ, 2014, CIRC RES, V114, P626, DOI 10.1161/CIRCRESAHA.114.302562; Mujika I, 2001, MED SCI SPORT EXER, V33, P1297, DOI 10.1097/00005768-200108000-00009; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; OMACHI A, 1956, AM J PHYSIOL, V185, P35, DOI 10.1152/ajplegacy.1956.185.1.35; PESCE A, 1964, J BIOL CHEM, V239, P1753; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Rowe GC, 2014, CIRCULATION, V129, P798, DOI 10.1161/CIRCULATIONAHA.113.001590; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Seiler SE, 2015, CELL METAB, V22, P65, DOI 10.1016/j.cmet.2015.06.003; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Van Hall G, 2000, ACTA PHYSIOL SCAND, V168, P643, DOI 10.1046/j.1365-201x.2000.00716.x; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	48	31	31	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25306	25318		10.1074/jbc.M116.749424	http://dx.doi.org/10.1074/jbc.M116.749424			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27738103	Green Published, hybrid			2022-12-28	WOS:000390095300003
J	Roberts, BJ; Svoboda, RA; Overmiller, AM; Lewis, JD; Kowalczyk, AP; Mahoney, MG; Johnson, KR; Wahl, JK				Roberts, Brett J.; Svoboda, Robert A.; Overmiller, Andrew M.; Lewis, Joshua D.; Kowalczyk, Andrew P.; Mahoney, My G.; Johnson, Keith R.; Wahl, James K., III			Palmitoylation of Desmoglein 2 Is a Regulator of Assembly Dynamics and Protein Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESMOSOME DYNAMICS; PLASMA-MEMBRANE; P120 CATENIN; CELLS; IDENTIFICATION; ACYLATION; DISEASE; DIFFERENTIATION; DESMOPLAKIN; JUNCTIONS	Desmosomes are prominent adhesive junctions present between many epithelial cells as well as cardiomyocytes. The mechanisms controlling desmosome assembly and remodeling in epithelial and cardiac tissue are poorly understood. We recently identified protein palmitoylation as a mechanism regulating desmosome dynamics. In this study, we have focused on the palmitoylation of the desmosomal cadherin desmoglein-2 (Dsg2) and characterized the role that palmitoylation of Dsg2 plays in its localization and stability in cultured cells. We identified two cysteine residues in the juxtamembrane (intracellular anchor) domain of Dsg2 that, when mutated, eliminate its palmitoylation. These cysteine residues are conserved in all four desmoglein family members. Although mutant Dsg2 localizes to endogenous desmosomes, there is a significant delay in its incorporation into junctions, and the mutant is also present in a cytoplasmic pool. Triton X-100 solubility assays demonstrate that mutant Dsg2 is more soluble than wild-type protein. Interestingly, trafficking of the mutant Dsg2 to the cell surface was delayed, and a pool of the non-palmitoylated Dsg2 co-localized with lysosomal markers. Taken together, these data suggest that palmitoylation of Dsg2 regulates protein transport to the plasma membrane. Modulation of the palmitoylation status of desmosomal cadherins can affect desmosome dynamics.	[Roberts, Brett J.; Svoboda, Robert A.; Johnson, Keith R.; Wahl, James K., III] Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA; [Johnson, Keith R.] Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Overmiller, Andrew M.; Mahoney, My G.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Lewis, Joshua D.; Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Lewis, Joshua D.; Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; Jefferson University; Emory University; Emory University	Wahl, JK (corresponding author), Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA.	jwahl@unmc.edu			Nebraska Research Initiative and the Eppley Cancer Center [P30CA036727]; Nebraska Center for Cellular Signaling CoBRE (National Institutes of Health) [P30GM106397]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR065074, R01AR048266, F31AR066476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	Nebraska Research Initiative and the Eppley Cancer Center; Nebraska Center for Cellular Signaling CoBRE (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Microscopy images were acquired and processed at the University of Nebraska Medical Center Advanced Microscopy Core Facility supported by the Nebraska Research Initiative and the Eppley Cancer Center (P30CA036727) and Nebraska Center for Cellular Signaling CoBRE (National Institutes of Health P30GM106397). The anti-Lamp-1 hybridoma supernatant developed by J. T. August and J. E. K. Hildreth was obtained from the Developmental Studies Hybridoma Bank, created by NICHD, National Institutes of Health and maintained at the Department of Biology, University of Iowa, Iowa City, IA 52242.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Allen E, 1996, J CELL BIOL, V133, P1367, DOI 10.1083/jcb.133.6.1367; Bezzina CR, 2015, CIRC RES, V116, P1919, DOI 10.1161/CIRCRESAHA.116.304030; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Broussard JA, 2015, CELL TISSUE RES, V360, P501, DOI 10.1007/s00441-015-2136-5; Chalker JM, 2009, CHEM-ASIAN J, V4, P630, DOI 10.1002/asia.200800427; Chen J, 2012, J CELL BIOL, V199, P699, DOI 10.1083/jcb.201202105; Chum T, 2016, J CELL SCI, V129, P95, DOI 10.1242/jcs.175190; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; FALCONE D, 1991, MOL CELL BIOL, V11, P2656, DOI 10.1128/MCB.11.5.2656; Franke WW, 2007, EUR J CELL BIOL, V86, P127, DOI 10.1016/j.ejcb.2006.11.003; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Gehmlich K, 2010, HEART RHYTHM, V7, P1446, DOI 10.1016/j.hrthm.2010.08.007; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2014, J PATHOL, V233, P4, DOI 10.1002/path.4339; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Harmon RM, 2013, CELL COMMUN ADHES, V20, P171, DOI 10.3109/15419061.2013.855204; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu KM, 2015, J INVEST DERMATOL, V135, P2603, DOI 10.1038/jid.2015.240; McGuinn KP, 2014, METHODS MOL BIOL, V1195, P133, DOI 10.1007/7651_2014_71; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; Nitoiu D, 2014, CELL COMMUN ADHES, V21, P129, DOI 10.3109/15419061.2014.908854; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Roberts BJ, 2014, J CELL SCI, V127, P3782, DOI 10.1242/jcs.149849; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; SCHMELZ M, 1986, EUR J CELL BIOL, V42, P177; Setzer SV, 2004, J INVEST DERMATOL, V123, P426, DOI 10.1111/j.0022-202X.2004.23319.x; Sobolik-Delmaire T, 2007, CELL COMMUN ADHES, V14, P99, DOI 10.1080/15419060701463082; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Stahley SN, 2015, CELL TISSUE RES, V360, P439, DOI 10.1007/s00441-015-2155-2; Stahley SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087809; Wahl JK, 2000, J CELL SCI, V113, P1737; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	48	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24857	24865		10.1074/jbc.M116.739458	http://dx.doi.org/10.1074/jbc.M116.739458			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27703000	Green Published, hybrid			2022-12-28	WOS:000388880100006
J	Park, SH; Kim, J; Yu, M; Park, JH; Kim, YS; Moon, Y				Park, Seong-Hwan; Kim, Juil; Yu, Mira; Park, Jae-Hong; Kim, Yong Sik; Moon, Yuseok			Epithelial Cholesterol Deficiency Attenuates Human Antigen R-linked Pro-inflammatory Stimulation via an SREBP2-linked Circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; ELEMENT-BINDING PROTEIN-2; PPAR-GAMMA; LIPID RAFTS; CELLS; ALPHA; TRANSCRIPTION; EXPRESSION; GENE; PHOSPHORYLATION	Patients with chronic intestinal ulcerative diseases, such as inflammatory bowel disease, tend to exhibit abnormal lipid profiles, which may affect the gut epithelial integrity. We hypothesized that epithelial cholesterol depletion may trigger inflammation-checking machinery via cholesterol sentinel signaling molecules whose disruption in patients may aggravate inflammation and disease progression. In the present study, sterol regulatory element-binding protein 2 (SREBP2) as the cholesterol sentinel was assessed for its involvement in the epithelial inflammatory responses in cholesterol-depleted enterocytes. Patients and experimental animals with intestinal ulcerative injuries showed suppression in epithelial SREBP2. Moreover, SREBP2-deficient enterocytes showed enhanced pro-inflammatory signals in response to inflammatory insults, indicating regulatory roles of SREBP2 in gut epithelial inflammation. However, epithelial cholesterol depletion transiently induced pro inflammatory chemokine expression regardless of the well known pro-inflammatory nuclear factor-kappa B signals. In contrast, cholesterol depletion also exerts regulatory actions to maintain epithelial homeostasis against excessive inflammation via SREBP2-associated signals in a negative feedback loop. Mechanistically, SREBP2 and its induced target EGR-1 were positively involved in induction of peroxisome proliferator-activated receptor gamma (PPAR gamma), a representative anti-inflammatory transcription factor. As a crucial target of the SREBP2-EGR-1-PPAR gamma-associated signaling pathways, the mRNA stabilizer, human antigen R (HuR) was retained in nuclei, leading to reduced stability of pro-inflammatory chemokine transcripts. This mechanistic investigation provides clinical insights into protective roles of the epithelial cholesterol deficiency against excessive inflammatory responses via the SREBP2-HuR circuit, although the deficiency triggers transient pro-inflammatory signals.	[Park, Seong-Hwan; Kim, Juil; Yu, Mira; Moon, Yuseok] Pusan Natl Univ, Sch Med, Lab Mucosal Exposome & Biomodulat, Dept Biomed Sci, Yangsan 50612, South Korea; [Park, Seong-Hwan; Kim, Juil; Yu, Mira; Moon, Yuseok] Pusan Natl Univ, Sch Med, Med Res Inst, Yangsan 50612, South Korea; [Park, Jae-Hong] Pusan Natl Univ, Dept Pediat, Yangsan 50612, South Korea; [Kim, Yong Sik] Seoul Natl Univ, Dept Pharmacol, Coll Med, Seoul 03080, South Korea; [Moon, Yuseok] Brain Busan 21 Project, Immunoregulatory Therapeut Grp, Busan 46241, South Korea	Pusan National University; Pusan National University; Pusan National University; Seoul National University (SNU)	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Biomed Sci, Yangsan 50612, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020; Yu, Mi Ra/AAF-2735-2020	Yu, Mi Ra/0000-0002-2141-0012; MOON, YUSEOK/0000-0001-8686-8166	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2015R1A2A1A15056056]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2015R1A2A1A15056056). The authors declare that they have no conflicts of interest with the contents of this article.	Abe J, 2013, CIRCULATION, V128, P579, DOI 10.1161/CIRCULATIONAHA.113.004390; Agouridis AP, 2011, ANN GASTROENTEROL, V24, P181; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Aoyagi Y, 2010, PEDIATR INT, V52, P729, DOI 10.1111/j.1442-200X.2010.03195.x; Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200; Biyyani RSRS, 2010, J CLIN LIPIDOL, V4, P478, DOI 10.1016/j.jacl.2010.08.021; Bowie RV, 2012, AM J PHYSIOL-GASTR L, V302, pG781, DOI 10.1152/ajpgi.00002.2011; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Calleros L, 2006, CELL SIGNAL, V18, P2292, DOI 10.1016/j.cellsig.2006.05.012; Chang TH, 2012, VIROLOGY, V422, P205, DOI 10.1016/j.virol.2011.10.029; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Choi HJ, 2013, INFECT IMMUN, V81, P1860, DOI 10.1128/IAI.00162-13; Choi HJ, 2009, TOXICOL APPL PHARM, V240, P46, DOI 10.1016/j.taap.2009.06.023; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; FEINGOLD KR, 1989, DIABETES, V38, P141, DOI 10.2337/diabetes.38.2.141; Field FJ, 2001, J LIPID RES, V42, P1687; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fu MG, 2002, J BIOL CHEM, V277, P26808, DOI 10.1074/jbc.M203748200; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Klopotek A, 2006, EXP BIOL MED, V231, P1365, DOI 10.1177/153537020623100810; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; KWONG LK, 1991, DIABETES, V40, P1630, DOI 10.2337/diabetes.40.12.1630; LIU JW, 1993, CELL GROWTH DIFFER, V4, P611; Lyles BE, 2009, CELL CYCLE, V8, P268, DOI 10.4161/cc.8.2.7584; Lynch RD, 2007, EXP CELL RES, V313, P2597, DOI 10.1016/j.yexcr.2007.05.009; Miyata M, 2014, BIOCHEM BIOPH RES CO, V443, P477, DOI 10.1016/j.bbrc.2013.11.126; Moon Y, 2008, TOXICOL APPL PHARM, V231, P94, DOI 10.1016/j.taap.2008.03.016; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Park SH, 2010, J IMMUNOL, V185, P5522, DOI 10.4049/jimmunol.1001315; Park SH, 2013, J IMMUNOL, V191, P5170, DOI 10.4049/jimmunol.1301145; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Pramfalk C, 2010, J LIPID RES, V51, P1354, DOI [10.1194/jlr.M900274-JLR200, 10.1194/jlr.M900274]; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Roth A, 2008, PHARMACOGENET GENOM, V18, P325, DOI 10.1097/FPC.0b013e3282f706e0; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Taylor HE, 2011, J VIROL, V85, P7699, DOI 10.1128/JVI.00337-11; Thebault S, 2006, PROTEOMICS, V6, P3926, DOI 10.1002/pmic.200500714; Triantafilou M, 2002, J CELL SCI, V115, P2603; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Warren CA, 2008, J INFECT DIS, V198, P143, DOI 10.1086/588819; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yamamoto-Furusho JK, 2011, INFLAMM BOWEL DIS, V17, P680, DOI 10.1002/ibd.21322; Yeh M, 2004, CIRC RES, V95, P780, DOI 10.1161/01.RES.0000146030.53089.18; Zhao RZ, 2014, BIOCHEM BIOPH RES CO, V448, P329, DOI 10.1016/j.bbrc.2014.04.052	52	9	9	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24641	24656		10.1074/jbc.M116.723973	http://dx.doi.org/10.1074/jbc.M116.723973			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703009	hybrid, Green Published			2022-12-28	WOS:000388875500025
J	Salim, NN; Ganaie, SS; Roy, A; Jeeva, S; Mir, MA				Salim, Nilshad N.; Ganaie, Safder S.; Roy, Anuradha; Jeeva, Subbiah; Mir, Mohammad A.			Targeting a Novel RNA-Protein Interaction for Therapeutic Intervention of Hantavirus Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANSLATION INITIATION; VIRUS NUCLEOCAPSID PROTEIN; MESSENGER-RNA; 5' TERMINUS; S-SEGMENT; INHIBITORS; IDENTIFICATION; REPLICATION; BINDING; CAP	An evolutionarily conserved sequence at the 5' terminus of hantaviral genomic RNA plays an important role in viral transcription initiation and packaging of the viral genome into viral nucleocapsids. Interaction of viral nucleocapsid protein (N) with this conserved sequence facilitates mRNA translation by a unique N-mediated translation strategy. Whereas this evolutionarily conserved sequence facilitates virus replication with the assistance of N in eukaryotic hosts having multifaceted antiviral defense, we demonstrate its interaction with N presents a novel target for therapeutic intervention of hantavirus disease. Using a high throughput screening approach, we identified three lead inhibitors that bind and induce structural perturbations in N. The inhibitors interrupt N-RNA interaction and abrogate both viral genomic RNA synthesis and N-mediated translation strategy without affecting the canonical translation machinery of the host cell. The inhibitors are well tolerated by cells and inhibit hantavirus replication with the same potency as ribavarin, a commercially available antiviral. We report the identification of a unique chemical scaffold that disrupts a critical RNA-protein interaction in hantaviruses and holds promise for the development of the first anti-hantaviral therapeutic with broad spectrum antiviral activity.	[Salim, Nilshad N.; Ganaie, Safder S.] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA; [Roy, Anuradha] Univ Kansas, Lawrence, KS 66045 USA; [Jeeva, Subbiah; Mir, Mohammad A.] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; Western University of Health Sciences	Mir, MA (corresponding author), Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA.	mmir@westernu.edu	Ganaie, Safder/AAH-5010-2020; Ganaie, Safder/AAB-8857-2022		National Institutes of Health [RO1 AI095236-01, 1R21 AI097355-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095236, R21AI097355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 AI095236-01 and 1R21 AI097355-01.The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Battisti AJ, 2011, J VIROL, V85, P835, DOI 10.1128/JVI.01847-10; Breuer S, 2012, J MED CHEM, V55, P4968, DOI 10.1021/jm201442t; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Cheng ED, 2014, J VIROL, V88, P8706, DOI 10.1128/JVI.00405-14; Cheng E, 2012, J VIROL, V86, P10173, DOI 10.1128/JVI.05560-11; Cheng E, 2011, J BIOL CHEM, V286, P11814, DOI 10.1074/jbc.M110.210179; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Ellenbecker M, 2012, J BIOMOL SCREEN, V17, P1062, DOI 10.1177/1087057112448100; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Ganaie SS, 2014, BIOCHEM J, V464, P109, DOI 10.1042/BJ20140449; Haque A, 2010, J VIROL, V84, P12450, DOI 10.1128/JVI.01388-10; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Hussein ITM, 2012, J VIROL, V86, P7520, DOI 10.1128/JVI.07204-11; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Mir MA, 2006, J VIROL, V80, P6276, DOI 10.1128/JVI.00147-06; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2010, J VIROL, V84, P8937, DOI 10.1128/JVI.02720-09; Mir MA, 2010, J BIOL CHEM, V285, P11357, DOI 10.1074/jbc.M110.102459; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; RAJU R, 1987, J VIROL, V61, P667, DOI 10.1128/JVI.61.3.667-672.1987; RAJU R, 1986, VIRUS RES, V5, P1, DOI 10.1016/0168-1702(86)90061-4; Rice WG, 1997, NAT MED, V3, P341, DOI 10.1038/nm0397-341; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; SCHMALJOHN CS, 1996, MOL BIOL HANTAVIRUSE, P63; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; Stellbrink Hans-Juergen, 2009, Antiviral Chemistry & Chemotherapy, V19, P189; Warui DM, 2012, J MED CHEM, V55, P4132, DOI 10.1021/jm2007694	33	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24702	24714		10.1074/jbc.M116.750729	http://dx.doi.org/10.1074/jbc.M116.750729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27733686	hybrid, Green Published			2022-12-28	WOS:000388875500029
J	Hill, RJ; Ringel, A; Knuepfer, E; Moon, RW; Blackman, MJ; van Ooij, C				Hill, Ross J.; Ringel, Alessa; Knuepfer, Ellen; Moon, Robert W.; Blackman, Michael J.; van Ooij, Christiaan			Regulation and Essentiality of the StAR-related Lipid Transfer (START) Domain-containing Phospholipid Transfer Protein PFA0210c in Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid transport; malaria; parasitology; phospholipid; plasmodium	PLASMODIUM-FALCIPARUM; PHOSPHATIDYLCHOLINE; ERYTHROCYTES; METABOLISM; TRANSPORT; VIRULENCE; INVASION; SEQUENCE; SYSTEM	StAR-related lipid transfer (START) domains are phospholipid- or sterol-binding modules that are present in many proteins. START domain-containing proteins (START proteins) play important functions in eukaryotic cells, including the redistribution of phospholipids to subcellular compartments and delivering sterols to the mitochondrion for steroid synthesis. How the activity of the START domain is regulated remains unknown for most of these proteins. The Plasmodium falciparum START protein PFA0210c (PF3D7_0104200) is a broad-spectrum phospholipid transfer protein that is conserved in all sequenced Plasmodium species and is most closely related to the mammalian START proteins STARD2 and STARD7. PFA0210c is unusual in that it contains a signal sequence and a PEXEL export motif that together mediate transfer of the protein from the parasite to the host erythrocyte. The protein also contains a C-terminal extension, which is very uncommon among mammalian START proteins. Whereas the biochemical properties of PFA0210c have been characterized, the function of the protein remains unknown. Here, we provide evidence that the unusual C-terminal extension negatively regulates phospholipid transfer activity. Furthermore, we use the genetically tractable Plasmodium knowlesi model and recently developed genetic technology in P. falciparum to show that the protein is essential for growth of the parasite during the clinically relevant asexual blood stage life cycle. Finally, we show that the regulation of phospholipid transfer by PFA0210c is required in vivo, and we identify a potential second regulatory domain. These findings provide insight into a novel mechanism of regulation of phospholipid transfer in vivo and may have important implications for the interaction of the malaria parasite with its host cell.	[Hill, Ross J.; Ringel, Alessa; Knuepfer, Ellen; Blackman, Michael J.; van Ooij, Christiaan] Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England; [Moon, Robert W.] London Sch Hyg & Trop Med, Dept Infect & Immun, London WC1E 7HT, England; [Blackman, Michael J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England; [Ringel, Alessa] Westfal Wilhelms Univ Munster, D-48149 Munster, Germany	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Munster	van Ooij, C (corresponding author), Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England.	christiaan.vanOoij@crick.ac.uk	Singh, Balbir/A-3610-2009; Moon, Robert/AAF-9808-2019	Moon, Robert/0000-0002-9070-4292; Hill, Ross/0000-0003-2847-6855; Knuepfer, Ellen/0000-0002-6090-1877; Ringel, Alessa/0000-0002-6392-6076	Cancer Research UK [FC001043]; MRC [MR/M021157/1] Funding Source: UKRI; Medical Research Council [MR/M021157/1] Funding Source: researchfish; The Francis Crick Institute [10044, 10043, 10320] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We are indebted to Prof. Shamshad Cockcroft and Nick Blunsom (University College London) for assistance with scintillation counting, Prof. Angelika Grundling (Imperial College London) for assistance with protein purification, and Dr. Marcus Lee (The Wellcome Trust Sanger Institute) for sharing the pDC2-cam-Cas9-U6-hDHFR plasmid. The Francis Crick Institute received its core funding from Cancer Research UK Grant FC001043.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; de Koning-Ward TF, 2015, NAT REV MICROBIOL, V13, P373, DOI 10.1038/nrmicro3450; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170; Fougere A., 2016, PLOS PATHOG IN PRESS; Frech C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-427; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jones ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep21800; Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; KASPER AM, 1981, BIOCHEMISTRY-US, V20, P146, DOI 10.1021/bi00504a024; Lee MCS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0063-9; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Lim MYX, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.166, 10.1038/nmicrobiol.2016.166]; MARKS PA, 1960, J BIOL CHEM, V235, P2579; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Mundwiler-Pachlatko E, 2013, P NATL ACAD SCI USA, V110, P19987, DOI 10.1073/pnas.1309247110; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Olayioye MA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M701990200; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Sam-Yellowe TY, 2009, TRENDS PARASITOL, V25, P277, DOI 10.1016/j.pt.2009.03.009; Sherling ES, 2016, FEMS MICROBIOL REV, V40, P701, DOI 10.1093/femsre/fuw016; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; van Ooij C, 2013, J BIOL CHEM, V288, P31971, DOI 10.1074/jbc.M113.474189; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; Zhong D, 2009, J CELL SCI, V122, P414, DOI 10.1242/jcs.027482	45	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24280	24292		10.1074/jbc.M116.740506	http://dx.doi.org/10.1074/jbc.M116.740506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27694132	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000388498100039
J	Klein, G; Stupak, A; Biernacka, D; Wojtkiewicz, P; Lindner, B; Raina, S				Klein, Gracjana; Stupak, Anna; Biernacka, Daria; Wojtkiewicz, Pawel; Lindner, Buko; Raina, Satish			Multiple Transcriptional Factors Regulate Transcription of the rpoE Gene in Escherichia coli under Different Growth Conditions and When the Lipopolysaccharide Biosynthesis Is Defective	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK SIGMA-FACTOR; ENVELOPE-STRESS; OUTER-MEMBRANE; RESPONSE REGULATOR; RNA-POLYMERASE; FUNCTIONAL-CHARACTERIZATION; 2-COMPONENT SYSTEM; STRUCTURAL BASIS; SOLUBLE-RNA; PROTEIN	The RpoE sigma factor is essential for the viability of Escherichia coli. RpoE regulates extracytoplasmic functions including lipopolysaccharide (LPS) translocation and some of its non-stoichiometric modifications. Transcription of the rpoE gene is positively autoregulated by E sigma(E) and by unknown mechanisms that control the expression of its distally located promoter(s). Mapping of 5' ends of rpoE mRNA identified five new transcriptional initiation sites (P1 to P5) located distal to E sigma(E)-regulated promoter. These promoters are activated in response to unique signals. Of these P2, P3, and P4 defined major promoters, recognized by RpoN, RpoD, and RpoS sigma factors, respectively. Isolation of trans-acting factors, in vitro transcriptional and gel retardation assays revealed that the RpoN-recognized P2 promoter is positively regulated by a QseE/F two-component system and NtrC activator, whereas the RpoD-regulated P3 promoter is positively regulated by a Rcs system in response to defects in LPS core biosynthesis, overproduction of certain lipoproteins, and the global regulator CRP. Strains synthesizing Kdo2-LA LPS caused up to 7-fold increase in the rpoEP3 activity, which was abrogated in Delta (waaC rcsB). Overexpression of a novel 73-nucleotide sRNA rirA (RfaH interacting RNA) generated by the processing of 5'UTR of the waaQ mRNA induces the rpoEP3 promoter activity concomitant with a decrease in LPS content and defects in the O-antigen incorporation. In the presence of RNA polymerase, RirA binds LPS regulator RfaH known to prevent premature transcriptional termination of waaQ and rfb operons. RirA in excess could titrate out RfaH causing LPS defects and the activation of rpoE transcription.	[Klein, Gracjana; Stupak, Anna; Biernacka, Daria; Wojtkiewicz, Pawel; Raina, Satish] Gdansk Univ Technol, Unit Bacterial Genet, Narutowicza 11-12, PL-80233 Gdansk, Poland; [Lindner, Buko] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Pk Allee 22, D-23845 Borstel, Germany	Fahrenheit Universities; Gdansk University of Technology; Forschungszentrum Borstel	Raina, S (corresponding author), Gdansk Univ Technol, Unit Bacterial Genet, Narutowicza 11-12, PL-80233 Gdansk, Poland.	satish.raina@pg.gda.pl	Raina, Satish/AAU-9550-2021; Biernacka, Daria/X-2755-2019	Raina, Satish/0000-0003-3175-4932; Klein, Gracjana/0000-0001-8695-8065; Stupak, Anna/0000-0003-4731-8879	National Science Grants [2011/03/B/NZ1/02825, 2013/11/B/NZ2/02641]	National Science Grants	This work was supported by National Science Grants 2011/03/B/NZ1/02825 and 2013/11/B/NZ2/02641 (to S. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Bianchi AA, 1999, MOL MICROBIOL, V34, P1029, DOI 10.1046/j.1365-2958.1999.01664.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Burmann BM, 2012, CELL, V150, P291, DOI 10.1016/j.cell.2012.05.042; Coornaert A, 2010, MOL MICROBIOL, V76, P467, DOI 10.1111/j.1365-2958.2010.07115.x; CREEGER ES, 1984, J BIOL CHEM, V259, P3064; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gerken H, 2009, MOL MICROBIOL, V72, P1408, DOI 10.1111/j.1365-2958.2009.06728.x; Gronow S, 2010, EUR J CELL BIOL, V89, P3, DOI 10.1016/j.ejcb.2009.10.002; Guckes KR, 2013, P NATL ACAD SCI USA, V110, P16592, DOI 10.1073/pnas.1315320110; Guo MS, 2014, GENE DEV, V28, P1620, DOI 10.1101/gad.243485.114; Janaszak A, 2009, FEMS MICROBIOL LETT, V291, P65, DOI 10.1111/j.1574-6968.2008.01436.x; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2003, MOL MICROBIOL, V48, P269, DOI 10.1046/j.1365-2958.2003.03449.x; Klein G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/153561; Klein G, 2013, J BIOL CHEM, V288, P8111, DOI 10.1074/jbc.M112.445981; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Madhugiri R, 2010, MOL GENET GENOMICS, V284, P307, DOI 10.1007/s00438-010-0568-x; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Marolda CL, 1998, J BACTERIOL, V180, P3070, DOI 10.1128/JB.180.12.3070-3079.1998; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; Miyadai H, 2004, J BIOL CHEM, V279, P39807, DOI 10.1074/jbc.M406390200; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Noor R, 2009, GENES CELLS, V14, P885, DOI 10.1111/j.1365-2443.2009.01318.x; PARKER CT, 1992, J BACTERIOL, V174, P2525, DOI 10.1128/jb.174.8.2525-2538.1992; Pesavento C, 2012, NUCLEIC ACIDS RES, V40, P4783, DOI 10.1093/nar/gks055; Pratt LA, 1996, P NATL ACAD SCI USA, V93, P2488, DOI 10.1073/pnas.93.6.2488; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; RAINA S, 1991, NUCLEIC ACIDS RES, V19, P3811, DOI 10.1093/nar/19.14.3811; Reading NC, 2010, MICROBIOL-SGM, V156, P1167, DOI 10.1099/mic.0.033027-0; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Reichenbach B, 2009, MOL MICROBIOL, V74, P1054, DOI 10.1111/j.1365-2958.2009.06918.x; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Santos JM, 2006, MOL MICROBIOL, V60, P177, DOI 10.1111/j.1365-2958.2006.05078.x; Sikdar R, 2013, J BACTERIOL, V195, P12, DOI 10.1128/JB.00762-12; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Syed A, 1997, MOL MICROBIOL, V23, P987, DOI 10.1046/j.1365-2958.1997.2851651.x; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tao K, 2012, J BACTERIOL, V194, P3643, DOI 10.1128/JB.00553-12; TAYLOR WE, 1984, CELL, V38, P371, DOI 10.1016/0092-8674(84)90492-6; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Xiao JF, 2012, LETT APPL MICROBIOL, V55, P91, DOI 10.1111/j.1472-765X.2012.03260.x; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yethon JA, 2000, J BACTERIOL, V182, P5620, DOI 10.1128/JB.182.19.5620-5623.2000; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	63	31	33	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22999	23019		10.1074/jbc.M116.748954	http://dx.doi.org/10.1074/jbc.M116.748954			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27629414	Green Published, hybrid			2022-12-28	WOS:000387224800013
J	Bolduc, F; Garant, JM; Allard, F; Perreault, JP				Bolduc, Francois; Garant, Jean-Michel; Allard, Felix; Perreault, Jean-Pierre			Irregular G-quadruplexes Found in the Untranslated Regions of Human mRNAs Influence Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-quadruplex; gene expression; RNA; RNA structure; translation; in-line probing	TELOMERIC DNA; STABILITY; LOOP; OLIGONUCLEOTIDES; POLYADENYLATION; SUPPRESSION; EXPRESSION; CANCER; LENGTH; CELLS	G-quadruplex structures are composed of coplanar guanines and are found in both DNA and RNA. They are formed by the stacking of two or more G-quartets that are linked together by three loops. The current belief is that RNA G-quadruplexes include loops of l to 7 nucleotides in length, although recent evidence indicates that the central loop (loop 2) can be longer if loops 1 and 3 are limited to a single nucleotide each. With the objective of broadening the definition of irregular RNA G-quadruplexes, a bioinformatic search was performed to find potential G-quadruplexes located in the untranslated regions of human mRNAs (i.e. in the 5 and 3-UTRs) that contain either a long loop 1 or 3 of up to 40 nucleotides in length. RNA molecules including the potential sequences were then synthesized and examined in vitro by in-line probing for the formation of G-quadruplex structures. The sequences that adopted a G-quadruplex structure were cloned into a luciferase dual vector and examined for their ability to modulate translation in cellulo. Some irregular G-quadruplexes were observed to either promote or repress translation regardless of the position or the size of the long loop they possessed. Even if the composition of a RNA G-quadruplex is not quite completely understood, the results presented in this report clearly demonstrate that what defines a RNA G-quadruplex is much broader than what we previously believed.	[Bolduc, Francois; Garant, Jean-Michel; Allard, Felix; Perreault, Jean-Pierre] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, RNA Grp,Grp ARN, Pavillon Rech Appl Canc, Sherbrooke, PQ J1E 4K8, Canada; [Perreault, Jean-Pierre] CHUS, Ctr Rech, Paris, France	University of Sherbrooke	Perreault, JP (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Pavillon Rech Appl Canc,3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	jean-pierre.perreault@usherbrooke.ca	Garant, Jean-Michel/AAA-1692-2019	Garant, Jean-Michel/0000-0002-0559-5598	Universite de Sherbrooke	Universite de Sherbrooke	We thank Andrea Brumwell for technical assistance. The RNA group is supported by a grant from the Universite de Sherbrooke.	Agarwala P, 2015, ORG BIOMOL CHEM, V13, P5570, DOI 10.1039/c4ob02681k; Agarwala P, 2014, BBA-GEN SUBJECTS, V1840, P3503, DOI 10.1016/j.bbagen.2014.08.017; Agarwala P, 2013, BIOCHEMISTRY-US, V52, P1528, DOI 10.1021/bi301365g; Arora A, 2011, RNA BIOL, V8, P802, DOI 10.4161/rna.8.5.16038; Beaudoin JD, 2014, NUCLEIC ACIDS RES, V42, P1209, DOI 10.1093/nar/gkt904; Beaudoin JD, 2013, METHODS, V64, P79, DOI 10.1016/j.ymeth.2013.02.017; Beaudoin JD, 2013, NUCLEIC ACIDS RES, V41, P5898, DOI 10.1093/nar/gkt265; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Crenshaw E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143160; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Dhayan H, 2014, ARCH BIOCHEM BIOPHYS, V560, P52, DOI 10.1016/j.abb.2014.07.016; Endoh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22719; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Halder K, 2011, METAL IONS LIFE SCI, V9, P125, DOI 10.1039/978184973251200125; Halder K, 2009, NUCLEIC ACIDS RES, V37, P6811, DOI 10.1093/nar/gkp696; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Joachimi A, 2009, BIOORGAN MED CHEM, V17, P6811, DOI 10.1016/j.bmc.2009.08.043; Jodoin R, 2014, RNA, V20, P1129, DOI 10.1261/rna.044578.114; Johnson JE, 2008, BIOCHIMIE, V90, P1250, DOI 10.1016/j.biochi.2008.02.013; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Morris MJ, 2010, J AM CHEM SOC, V132, P17831, DOI 10.1021/ja106287x; Pandey S, 2013, J PHYS CHEM B, V117, P6896, DOI 10.1021/jp401739m; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Ribeiro MM, 2015, HUM GENET, V134, P37, DOI 10.1007/s00439-014-1485-6; Rouleau SG, 2015, NUCLEIC ACIDS RES, V43, P595, DOI 10.1093/nar/gku1311; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Thandapani P, 2015, ELIFE, V4, DOI 10.7554/eLife.06234; Wang CQ, 2015, INT J BIOL SCI, V11, P316, DOI 10.7150/ijbs.10528; Wang SK, 2015, CURR TOP MED CHEM, V15, P1947, DOI 10.2174/1568026615666150515145733; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Zhang AYQ, 2011, BIOCHEMISTRY-US, V50, P7251, DOI 10.1021/bi200805j	41	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21751	21760		10.1074/jbc.M116.744839	http://dx.doi.org/10.1074/jbc.M116.744839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27557661	Green Published, hybrid			2022-12-28	WOS:000385999200039
J	ElRamlawy, KG; Fujimura, T; Baba, K; Kim, JW; Kawamoto, C; Isobe, T; Abe, T; Hodge-Hanson, K; Downs, DM; Refaat, IH; Al-Azhary, DB; Aki, T; Asaoku, Y; Hayashi, T; Katsutani, T; Tsuboi, S; Ono, K; Kawamoto, S				ElRamlawy, Kareem Gamal; Fujimura, Takashi; Baba, Koji; Kim, Ji Won; Kawamoto, Chika; Isobe, Toshihide; Abe, Takuya; Hodge-Hanson, Kelsey; Downs, Diana M.; Refaat, Inas Hussein; Al-Azhary, Diaa Beshr; Aki, Tsunehiro; Asaoku, Yoshiko; Hayashi, Takaharu; Katsutani, Takashi; Tsuboi, Shinji; Ono, Kazuhisa; Kawamoto, Seiji			Der f 34, a Novel Major House Dust Mite Allergen Belonging to a Highly Conserved Rid/YjgF/YER057c/UK114 Family of Imine Deaminases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergen; allergy; Aspergillus; asthma; fungi; immunoglobulin E (IgE); Rid; YjgF; YER057c; UK114 family; house dust mite; imine deaminase	CRYPTOMERIA-JAPONICA POLLEN; SERINE-PROTEASE ALLERGEN; OF-THE-ART; DERMATOPHAGOIDES-FARINAE; INTERNATIONAL CONSENSUS; GENOME SEQUENCE; CLONING; IMMUNOTHERAPY; PTERONYSSINUS; BINDING	The high prevalence of house dust mite (HDM) allergy is a growing health problem worldwide, and the characterization of clinically important HDM allergens is a prerequisite for the development of diagnostic and therapeutic strategies. Here, we report a novel HDM allergen that belongs structurally to the highly conserved Rid/YjgF/YER057c/UK114 family (Rid family) with imine deaminase activity. Isolated HDM cDNA, named der f 34, encodes 128 amino acids homologous to Rid-like proteins. This new protein belongs to the Rid family and has seven conserved residues involved in enamine/imine deaminase activity. Indeed, we demonstrated that purified Der f 34 had imine deaminase activity that preferentially acted on leucine and methionine. Native Der f 34 showed a high IgE binding frequency as revealed by two-dimensional immunoblotting (62.5%) or ELISA (68%), which was comparable with those of a major HDM allergen Der f 2 (77.5 and 79%, respectively). We also found that Der f 34 showed cross-reactivity with another prominent indoor allergen source, Aspergillus fumigatus. This is the first report showing that the Rid family imine deaminase represents an additional important pan-allergen that is conserved across organisms.	[ElRamlawy, Kareem Gamal; Fujimura, Takashi; Baba, Koji; Kim, Ji Won; Kawamoto, Chika; Isobe, Toshihide; Abe, Takuya; Aki, Tsunehiro; Ono, Kazuhisa; Kawamoto, Seiji] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima Res Ctr Healthy Aging HiHA, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan; [ElRamlawy, Kareem Gamal; Refaat, Inas Hussein; Al-Azhary, Diaa Beshr] Menia Univ, Fac Sci, Dept Zool, Al Minya 61519, Egypt; [Hodge-Hanson, Kelsey; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Asaoku, Yoshiko; Hayashi, Takaharu] Takanobashi Cent Hosp, Hiroshima, Hiroshima 7300042, Japan; [Katsutani, Takashi] Katsutani Ogasawara Clin, Hiroshima 7380042, Japan; [Tsuboi, Shinji] Tsuboi Clin, Hiroshima 7390613, Japan; [Ono, Kazuhisa] Hiroshima Inst Technol, Fac Life Sci, Dept Food Sci & Biotechnol, Hiroshima, Hiroshima 7315193, Japan	Hiroshima University; Egyptian Knowledge Bank (EKB); Minia University; University System of Georgia; University of Georgia; Hiroshima Institute of Technology	Fujimura, T; Kawamoto, S (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan.	fmuratks@hiroshima-u.ac.jp; skawa@hiroshima-u.ac.jp	Aki, Tsunehiro/B-6719-2012; Kawamoto, Seiji/F-3423-2015; Fujimura, Takashi/V-5310-2017	Aki, Tsunehiro/0000-0001-9753-2043; Kawamoto, Seiji/0000-0002-2056-4802; Fujimura, Takashi/0000-0001-7442-5974; refaat, inas/0000-0002-5432-062X	JSPS KAKENHI [14360209]; National Institutes of Health [GMO95837]; Ministry of higher education (MoHE), Egypt; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of higher education (MoHE), Egypt(Ministry of Higher Education & Scientific Research (MHESR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Grant-in-Aid for Scientific Research (B), JSPS KAKENHI Grant 14360209 (to K. O. and S. K.), and National Institutes of Health Grant GMO95837 (to D. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Ministry of higher education (MoHE), Egypt.	AKI T, 1995, J ALLERGY CLIN IMMUN, V96, P74, DOI 10.1016/S0091-6749(95)70035-8; AKI T, 1994, INT ARCH ALLERGY IMM, V103, P349, DOI 10.1159/000236653; AKI T, 1994, J BIOCHEM, V115, P435, DOI 10.1093/oxfordjournals.jbchem.a124356; ARRUDA LK, 1990, J EXP MED, V172, P1529, DOI 10.1084/jem.172.5.1529; Asaoku Y, 1995, Arerugi, V44, P692; Baldacci S, 2015, RESP MED, V109, P1089, DOI 10.1016/j.rmed.2015.05.017; Bennett BJ, 1996, CLIN EXP ALLERGY, V26, P1150, DOI 10.1111/j.1365-2222.1996.tb00501.x; Boden R, 2011, J BACTERIOL, V193, P7001, DOI 10.1128/JB.06267-11; Ceciliani F, 1996, FEBS LETT, V393, P147, DOI 10.1016/0014-5793(96)00850-2; Chruszcz M, 2009, J MOL BIOL, V386, P520, DOI 10.1016/j.jmb.2008.12.049; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; DAVIS L, 1965, ANAL BIOCHEM, V12, P36, DOI 10.1016/0003-2697(65)90139-9; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; Fujii S, 1996, IMMUNOL LETT, V49, P37, DOI 10.1016/0165-2478(95)02475-1; Fujikawa A, 1998, CLIN EXP ALLERGY, V28, P1549, DOI 10.1046/j.1365-2222.1998.00433.x; Fujikawa A, 1996, MOL IMMUNOL, V33, P311, DOI 10.1016/0161-5890(95)00127-1; Fujimura T, 2005, CLIN EXP ALLERGY, V35, P234, DOI 10.1111/j.1365-2222.2005.02167.x; Fujimura T, 2004, INT ARCH ALLERGY IMM, V133, P125, DOI 10.1159/000076438; Fujimura T, 2015, ALLERGOL INT, V64, P312, DOI 10.1016/j.alit.2015.05.008; Fujimura Takashi, 2010, Allergology International, V59, P21, DOI 10.2332/allergolint.09-RAI-0151; Funaro A, 1999, EXP CELL RES, V247, P441, DOI 10.1006/excr.1998.4384; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Ichikawa S, 2009, GENES CELLS, V14, P1055, DOI 10.1111/j.1365-2443.2009.01334.x; Jutel M, 2016, J ALLERGY CLIN IMMUN, V137, P358, DOI 10.1016/j.jaci.2015.12.1300; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kawamoto S, 2002, J BIOSCI BIOENG, V94, P285, DOI 10.1016/S1389-1723(02)80166-9; Kawamoto S, 2002, FEBS LETT, V516, P234, DOI 10.1016/S0014-5793(02)02540-1; Kawamoto S, 1999, BBA-MOL BASIS DIS, V1454, P201, DOI 10.1016/S0925-4439(99)00041-1; King C, 1996, J ALLERGY CLIN IMMUN, V98, P739, DOI 10.1016/S0091-6749(96)70121-5; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Niehaus TD, 2014, PLANT CELL, V26, P3010, DOI 10.1105/tpc.114.126854; Nishiyama C, 1995, FEBS LETT, V377, P62, DOI 10.1016/0014-5793(95)01291-5; Oh HM, 2010, J BACTERIOL, V192, P4530, DOI 10.1128/JB.00683-10; Panerai AE, 1999, ANN NY ACAD SCI, V876, P229, DOI 10.1111/j.1749-6632.1999.tb07643.x; Racca S, 1997, VIRCHOWS ARCH, V431, P323, DOI 10.1007/s004280050106; Rittmeyer D, 2012, INT ARCH ALLERGY IMM, V159, P216, DOI 10.1159/000338994; Shigeta S, 1995, Arerugi, V44, P170; Singh Kumar Saurabh, 2014, J Genomics, V2, P118, DOI 10.7150/jgen.9123; SMITH WA, 1994, CLIN EXP ALLERGY, V24, P220, DOI 10.1111/j.1365-2222.1994.tb00223.x; Takenaka S, 2000, ARCH MICROBIOL, V174, P265, DOI 10.1007/s002030000203; Thomas WR, 2015, ALLERGOL INT, V64, P304, DOI 10.1016/j.alit.2015.05.004; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288; YASUEDA H, 1993, CLIN EXP ALLERGY, V23, P384, DOI 10.1111/j.1365-2222.1993.tb00343.x; Zhou L, 2013, MOL MICROBIOL, V87, P80, DOI 10.1111/mmi.12084	49	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21607	21615		10.1074/jbc.M116.728006	http://dx.doi.org/10.1074/jbc.M116.728006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539850	Green Published, hybrid			2022-12-28	WOS:000385999200027
J	Sahu, U; Rangarajan, PN				Sahu, Umakant; Rangarajan, Pundi N.			Methanol Expression Regulator 1 (Mxr1p) Is Essential for the Utilization of Amino Acids as the Sole Source of Carbon by the Methylotrophic Yeast, Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; glutamate dehydrogenase; transcription factor; transcription regulation; yeast; methanol expression regulator 1; Pichia pastoris; amino acids; aspartate aminotransferase; malate dehydrogenase	SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE; UTILIZATION PATHWAY; AOX1 PROMOTER; METABOLISM; PROTEIN; IDENTIFICATION; BINDING; SUPPLEMENTATION	Unlike Saccharomyces cerevisiae, the methylotrophic yeast Pichia pastoris can assimilate amino acids as the sole source of carbon and nitrogen. It can grow in media containing yeast extract and peptone (YP), yeast nitrogen base (YNB) + glutamate (YNB + Glu), or YNB + aspartate (YNB + Asp). Methanol expression regulator 1 (Mxr1p), a zinc finger transcription factor, is essential for growth in these media. Mxr1p regulates the expression of several genes involved in the utilization of amino acids as the sole source of carbon and nitrogen. These include the following: (i) GDH2 encoding NAD-dependent glutamate dehydrogenase; (ii) AAT1 and AAT2 encoding mitochondrial and cytosolic aspartate aminotransferases, respectively; (iii) MDH1 and MDH2 encoding mitochondrial and cytosolic malate dehydrogenases, respectively; and (iv) GLN1 encoding glutamine synthetase. Synthesis of all these enzymes is regulated by Mxr1p at the level of transcription except GDH2, whose synthesis is regulated at the level of translation. Mxr1p activates the transcription of AAT1, AAT2, and GLN1 in cells cultured in YP as well as in YNB + Glu media, whereas transcription of MDH1 and MDH2 is activated in cells cultured in YNB + Glu but not in YP. A truncated Mxr1p composed of 400 N-terminal amino acids activates transcription of target genes in cells cultured in YP but not in YNB + Glu. Mxr1p binds to Mxr1p response elements present in the promoters of AAT2, MDH2, and GLN1. We conclude that Mxr1p is essential for utilization of amino acids as the sole source of carbon and nitrogen, and it is a global regulator of multiple metabolic pathways in P. pastoris.	[Sahu, Umakant; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India.	pnr@biochem.iisc.ernet.in	Rangarajan, Pundi/A-7365-2009	Rangarajan, Pundi/0000-0002-6536-9891	Department of Biotechnology, New Delhi [BT/PR3889/BRB/10/996/2011]; J. C. Bose Fellowship by Science and Engineering Research Board, New Delhi, India [SB/S2/JCB-02/2015]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); J. C. Bose Fellowship by Science and Engineering Research Board, New Delhi, India	This work was supported by Research Grant BT/PR3889/BRB/10/996/2011 from the Department of Biotechnology, New Delhi, and J. C. Bose Fellowship Grant SB/S2/JCB-02/2015 by the Science and Engineering Research Board, New Delhi, India (to P. N. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Freese S, 2011, YEAST, V28, P375, DOI 10.1002/yea.1845; Gorgens JF, 2005, APPL MICROBIOL BIOT, V67, P684, DOI 10.1007/s00253-004-1803-3; Gorgens JF, 2005, FEMS YEAST RES, V5, P677, DOI 10.1016/j.femsyr.2004.12.003; Heyland J, 2011, BIOTECHNOL BIOENG, V108, P1942, DOI 10.1002/bit.23114; Jorda J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-57; Kranthi BV, 2006, NUCLEIC ACIDS RES, V34, P4060, DOI 10.1093/nar/gkl577; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Kumar NV, 2012, J BIOL CHEM, V287, P34465, DOI 10.1074/jbc.M112.365304; Kumar NV, 2011, MICROBIOL-SGM, V157, P3361, DOI 10.1099/mic.0.053488-0; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Magasanik B, 2003, EUKARYOT CELL, V2, P827, DOI 10.1128/EC.2.5.827-829.2003; MascorroGallardo JO, 1996, GENE, V172, P169, DOI 10.1016/0378-1119(96)00059-5; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; Sahu U, 2016, J BIOL CHEM, V291, P3648, DOI 10.1074/jbc.M115.673640; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094; Wang XL, 2016, J BIOL CHEM, V291, P6245, DOI 10.1074/jbc.M115.692053; Wang XL, 2016, BIOTECHNOL LETT, V38, P291, DOI 10.1007/s10529-015-1972-4	23	10	10	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20588	20601		10.1074/jbc.M116.740191	http://dx.doi.org/10.1074/jbc.M116.740191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27519409	hybrid, Green Published			2022-12-28	WOS:000384574800024
J	Boehm, E; Zornoza, M; Jourdain, AA; Magdalena, AD; Garcia-Consuegra, I; Merino, RT; Orduna, A; Martin, MA; Martinou, JC; De la Fuente, MA; Simarro, M				Boehm, Erik; Zornoza, Maria; Jourdain, Alexis A.; Delmiro Magdalena, Aitor; Garcia-Consuegra, Ines; Torres Merino, Rebeca; Orduna, Antonio; Martin, Miguel A.; Martinou, Jean-Claude; De la Fuente, Miguel A.; Simarro, Maria			Role of FAST Kinase Domains 3 (FASTKD3) in Post-transcriptional Regulation of Mitochondrial Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; RNA GRANULES; SUPERCOMPLEX; ORGANIZATION; MUTATION; TRANSLATION; COX7A2L; RAP	The Fas-activated serine/threonine kinase (FASTK) family of proteins has recently emerged as a central regulator of mitochondrial gene expression through the function of an unusual RNA-binding domain named RAP (for RNA-binding domain abundant in Apicomplexans), shared by all six members of the family. Here we describe the role of one of the less characterized members, FASTKD3, in mitochondrial RNA metabolism. First, we show that, in contrast to FASTK, FASTKD2, and FASTKD5, FASTKD3 does not localize in mitochondrial RNA granules, which are sites of processing and maturation of mtRNAs and ribosome biogenesis. Second, we generated FASTKD3 homozygous knockout cell lines by homologous recombination and observed that the absence of FASTKD3 resulted in increased steady-state levels and half-lives of a subset of mature mitochondrial mRNAs: ND2, ND3, CYTB, COX2, and ATP8/6. No aberrant processing of RNA precursors was observed. Rescue experiments demonstrated that RAP domain is required for FASTKD3 function in mRNA stability. Besides, we describe that FASTKD3 is required for efficient COX1 mRNA translation without altering mRNA levels, which results in a decrease in the steady-state levels of COX1 protein. This finding is associated with reduced mitochondrial complex IV assembly and activity. Our observations suggest that the function of this family of proteins goes beyond RNA processing and ribosome assembly and includes RNA stability and translation regulation within mitochondria.	[Boehm, Erik; Jourdain, Alexis A.; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Zornoza, Maria; Torres Merino, Rebeca; De la Fuente, Miguel A.] Univ Valladolid, Inst Biol & Genet Mol, Dept Biol Histol & Farmacol, Valladolid 47003, Spain; [Delmiro Magdalena, Aitor; Garcia-Consuegra, Ines; Martin, Miguel A.] Hosp Univ 12 Octubre i 12, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Inst Invest, U723, Madrid 28041, Spain; [Orduna, Antonio; Simarro, Maria] Fac Med, Dept Microbiol, Edificio Ciencias Salud, Valladolid 47005, Spain; [Simarro, Maria] Fac Enfermeria, Dept Enfermeria, Edificio Ciencias Salud,Avda Ramon & Cajal 7, Valladolid 47005, Spain; [Jourdain, Alexis A.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA	University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Simarro, M (corresponding author), Fac Enfermeria, Dept Enfermeria, Edificio Ciencias Salud,Avda Ramon & Cajal 7, Valladolid 47005, Spain.	maria.simarro.grande@uva.es	de la Fuente, Miguel A/C-7478-2013; Delmiro Magdalena, Aitor/H-4769-2017; Orduna, Antonio/I-3498-2019; Martin, Miguel A/S-2758-2018; Jourdain, Alexis A./ABF-4838-2020; Orduna, Antonio/K-7325-2019; Simarro, Maria/M-3947-2015	de la Fuente, Miguel A/0000-0003-4619-8756; Martin, Miguel A/0000-0003-4741-772X; martinou, Jean-claude/0000-0002-9847-2051; Simarro, Maria/0000-0001-8917-7328; Jourdain, Alexis A./0000-0001-5321-6938	Consejeria de Sanidad JCyL [BIO/VA20/15, BIO/VA21/15]; Roche Diagnostics S.L.; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [310030B_160257/1]; iGE3; State of Geneva	Consejeria de Sanidad JCyL; Roche Diagnostics S.L.; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); iGE3; State of Geneva	This work was supported by Consejeria de Sanidad JCyL Grants BIO/VA20/15 (to M. S.) and BIO/VA21/15 (to M. A. D. l. F.), Roche Diagnostics S.L. (to M. S.), the Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant 310030B_160257/1 (to J. C. M.), iGE3, and the State of Geneva. The authors declare that they have no conflicts of interest with the contents of this article.	Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Boulouis A, 2015, PLANT CELL, V27, P984, DOI 10.1105/tpc.15.00010; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Eberhard S, 2011, PLANT J, V67, P1055, DOI 10.1111/j.1365-313X.2011.04657.x; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jourdain AA, 2016, J CELL BIOL, V212, P611, DOI 10.1083/jcb.201507125; Jourdain AA, 2015, CELL REP, V10, P1110, DOI 10.1016/j.celrep.2015.01.063; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kleinknecht L, 2014, PLANT CELL, V26, P777, DOI 10.1105/tpc.114.122853; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; Lefebvre-Legendre L, 2015, PLANT PHYSIOL, V167, P1527, DOI 10.1104/pp.114.253906; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005; Nagao A, 2008, METHOD ENZYMOL, V447, P489, DOI 10.1016/S0076-6879(08)02223-4; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Perez-Perez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081; Popow J, 2015, RNA, V21, P1873, DOI 10.1261/rna.052365.115; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; Simarro M, 2007, P NATL ACAD SCI USA, V104, P11370, DOI 10.1073/pnas.0704964104; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25877	25887		10.1074/jbc.M116.730291	http://dx.doi.org/10.1074/jbc.M116.730291			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27789713	hybrid, Green Published			2022-12-28	WOS:000390345200011
J	Johnson, JL; Ramadass, M; He, J; Brown, SJ; Zhang, JZ; Abgaryan, L; Biris, N; Gavathiotis, E; Rosen, H; Catz, SD				Johnson, Jennifer L.; Ramadass, Mahalakshmi; He, Jing; Brown, Steven J.; Zhang, Jinzhong; Abgaryan, Lusine; Biris, Nikolaos; Gavathiotis, Evripidis; Rosen, Hugh; Catz, Sergio D.			Identification of Neutrophil Exocytosis Inhibitors (Nexinhibs), Small Molecule Inhibitors of Neutrophil Exocytosis and Inflammation DRUGGABILITY OF THE SMALL GTPase Rab27a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; NADPH OXIDASE; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; RAB27A; MYELOPEROXIDASE; PROTEIN; TRAFFICKING; MECHANISMS; ELASTASE	Neutrophils constitute the first line of cellular defense in response to bacterial and fungal infections and rely on granular proteins to kill microorganisms, but uncontrolled secretion of neutrophil cargos is injurious to the host and should be closely regulated. Thus, increased plasma levels of neutrophil secretory proteins, including myeloperoxidase and elastase, are associated with tissue damage and are hallmarks of systemic inflammation. Here, we describe a novel high-throughput screening approach to identify small molecule inhibitors of the interaction between the small GTPase Rab27a and its effector JFC1, two central regulators of neutrophil exocytosis. Using this assay, we have identified small molecule inhibitors of Rab27a-JFC1 binding that were also active in cell-based neutrophil-specific exocytosis assays, demonstrating the druggability of Rab GTPases and their effectors. These compounds, named Nexinhibs (neutrophil exocytosis inhibitors), inhibit exocytosis of azurophilic granules in human neutrophils without affecting other important innate immune responses, including phagocytosis and neutrophil extracellular trap production. Furthermore, the compounds are reversible and potent inhibitors of the extracellular production of superoxide anion by preventing the up-regulation of the granule membrane-associated subunit of the NADPH oxidase at the plasma membrane. Nexinhibs also inhibit the upregulation of activation signature molecules, including the adhesion molecules CD11b and CD66b. Importantly, by using a mouse model of endotoxin-induced systemic inflammation, we show that these inhibitors have significant activity in vivo manifested by decreased plasma levels of neutrophil secretory proteins and significantly decreased tissue infiltration by inflammatory neutrophils. Altogether, our data present the first neutrophil exocytosis-specific inhibitor with in vivo anti-inflammatory activity, supporting its potential use as an inhibitor of systemic inflammation.	[Johnson, Jennifer L.; Ramadass, Mahalakshmi; He, Jing; Zhang, Jinzhong; Catz, Sergio D.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Brown, Steven J.; Abgaryan, Lusine; Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Biris, Nikolaos; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Biris, Nikolaos; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [He, Jing; Zhang, Jinzhong] Cystinosis Res Fdn, Irvine, CA USA	Scripps Research Institute; Scripps Research Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	scatz@scripps.edu	Zhang, Jinzhong/E-5670-2012	Zhang, Jinzhong/0000-0002-2540-2749; Catz, Sergio/0000-0002-1873-0277; Biris, Nikolaos/0000-0003-4055-5521; Gavathiotis, Evripidis/0000-0001-6319-8331	National Institutes of Health from USPHS [HL088256, GM105894]; American Heart Association	National Institutes of Health from USPHS; American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants HL088256 and GM105894 from USPHS (to S. D. C.) and by American Heart Association fellowships (to M. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BABIOR BM, 1990, SEMIN HEMATOL, V27, P247; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; BORREGAARD N, 1988, J BIOENERG BIOMEMBR, V20, P637, DOI 10.1007/BF00762546; Borregaard Niels, 1997, Blood, V89, P3503; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brovkovych V, 2008, AM J PHYSIOL-LUNG C, V295, pL96, DOI 10.1152/ajplung.00450.2007; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Catz SD, 2002, P NATL ACAD SCI USA, V99, P11652, DOI 10.1073/pnas.172382799; Catz SD, 2014, CELL MICROBIOL, V16, P1301, DOI 10.1111/cmi.12328; Chavas LMG, 2008, STRUCTURE, V16, P1468, DOI 10.1016/j.str.2008.07.015; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Croker BA, 2011, P NATL ACAD SCI USA, V108, P13135, DOI 10.1073/pnas.1110358108; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; Holt O, 2008, TRAFFIC, V9, P446, DOI 10.1111/j.1600-0854.2008.00714.x; Iwata K, 2010, INTERNAL MED, V49, P2423, DOI 10.2169/internalmedicine.49.4010; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Johnson JL, 2016, J BIOL CHEM, V291, P3423, DOI 10.1074/jbc.M115.705871; Johnson JL, 2013, MOL CELL BIOL, V33, P2950, DOI 10.1128/MCB.00417-13; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Johnson JL, 2011, INFECT IMMUN, V79, P3607, DOI 10.1128/IAI.05043-11; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Johnson JL, 2005, TRAFFIC, V6, P667, DOI 10.1111/j.1600-0854.2005.00308.x; Kimura T, 2008, J CELL SCI, V121, P3092, DOI 10.1242/jcs.030544; KLEMPNER MS, 1980, J CELL BIOL, V86, P21, DOI 10.1083/jcb.86.1.21; Kothari N, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.001; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Madoux F, 2008, MOL PHARMACOL, V73, P1776, DOI 10.1124/mol.108.045963; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; Monfregola J, 2012, J BIOL CHEM, V287, P44603, DOI 10.1074/jbc.M112.414029; Moraes TJ, 2003, CRIT CARE MED, V31, pS189, DOI 10.1097/01.CCM.0000057842.90746.1E; Munafo DB, 2007, BIOCHEM J, V402, P229, DOI 10.1042/BJ20060950; Munafo DB, 2009, J INNATE IMMUN, V1, P527, DOI 10.1159/000235860; NUIJENS JH, 1992, J LAB CLIN MED, V119, P159; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Riddle SM, 2006, ANAL BIOCHEM, V356, P108, DOI 10.1016/j.ab.2006.05.017; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sergienko E, 2009, J BIOMOL SCREEN, V14, P824, DOI 10.1177/1087057109338517; Shimoda N, 2007, AM J PATHOL, V170, P930, DOI 10.2353/ajpath.2007.060486; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Uriarte SM, 2013, SHOCK, V39, P286, DOI 10.1097/SHK.0b013e318282c9a1; Uriarte Silvia M, 2011, J Immunol, V187, P391, DOI 10.4049/jimmunol.1003112; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Walsh JS, 2011, ANNU REV PHARMACOL, V51, P145, DOI 10.1146/annurev-pharmtox-010510-100514; Watson RWG, 1999, FEBS LETT, V453, P67, DOI 10.1016/S0014-5793(99)00688-2; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Yamauchi A, 2001, MICROBIOL IMMUNOL, V45, P249, DOI 10.1111/j.1348-0421.2001.tb02614.x; Yoon J, 2007, J IMMUNOL, V179, P8454, DOI 10.4049/jimmunol.179.12.8454; Zhang CX, 2003, AM J PHYSIOL-HEART C, V285, pH2563, DOI 10.1152/ajpheart.00435.2003; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	62	50	50	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25965	25982		10.1074/jbc.M116.741884	http://dx.doi.org/10.1074/jbc.M116.741884			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27702998	Green Published, hybrid			2022-12-28	WOS:000390345200018
J	Mays, SG; Okafor, CD; Whitby, RJ; Goswami, D; Stec, J; Flynn, AR; Dugan, MC; Jui, NT; Griffin, PR; Ortlund, EA				Mays, Suzanne G.; Okafor, C. Denise; Whitby, Richard J.; Goswami, Devrishi; Stec, Jozef; Flynn, Autumn R.; Dugan, Michael C.; Jui, Nathan T.; Griffin, Patrick R.; Ortlund, Eric A.			Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; diabetes; molecular dynamics; nuclear receptor; phosphatidylcholine; lipids	MOLECULAR-DYNAMICS; GENE-EXPRESSION; WATER-MOLECULES; LRH-1; METABOLISM; ACTIVATION; SOFTWARE; SYSTEM; NR5A2	Liver receptor homolog 1 (NR5A2, LRH-1) is an orphan nuclear hormone receptor that regulates diverse biological processes, including metabolism, proliferation, and the resolution of endoplasmic reticulum stress. Although preclinical and cellular studies demonstrate that LRH-1 has great potential as a therapeutic target for metabolic diseases and cancer, development of LRH-1 modulators has been difficult. Recently, systematic modifications to one of the few known chemical scaffolds capable of activating LRH-1 failed to improve efficacy substantially. Moreover, mechanisms through which LRH-1 is activated by synthetic ligands are entirely unknown. Here, we use x-ray crystallography and other structural methods to explore conformational changes and receptor-ligand interactions associated with LRH-1 activation by a set of related agonists. Unlike phospholipid LRH-1 ligands, these agonists bind deep in the pocket and do not interact with residues near the mouth nor do they expand the pocket like phospholipids. Unexpectedly, two closely related agonists with similar efficacies (GSK8470 and RJW100) exhibit completely different binding modes. The dramatic repositioning is influenced by a differential ability to establish stable face-to-face --stacking with the LRH-1 residue His-390, as well as by a novel polar interaction mediated by the RJW100 hydroxyl group. The differing binding modes result in distinct mechanisms of action for the two agonists. Finally, we identify a network of conserved water molecules near the ligand-binding site that are important for activation by both agonists. This work reveals a previously unappreciated complexity associated with LRH-1 agonist development and offers insights into rational design strategies.	[Mays, Suzanne G.; Okafor, C. Denise; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Flynn, Autumn R.; Dugan, Michael C.; Jui, Nathan T.] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA; [Whitby, Richard J.; Stec, Jozef] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Jupiter, FL 33458 USA	Emory University; Emory University; University of Southampton; Scripps Research Institute	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Flynn, Autumn/0000-0003-2504-2365	National Institutes of Health [T32-GM008602, F31DK111171, R01DK095750]; Emory Catalyst Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095750, F31DK111171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680, T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Catalyst Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants T32-GM008602 (to S. G. M.), F31DK111171 (to S. G. M.), and R01DK095750 (to E. A. O.) and an Emory Catalyst Grant (to E. A. O. and N. T. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barillari C, 2007, J AM CHEM SOC, V129, P2577, DOI 10.1021/ja066980q; Bayrer JR, 2015, P NATL ACAD SCI USA, V112, P2467, DOI 10.1073/pnas.1500978112; Benod C, 2013, J BIOL CHEM, V288, P19830, DOI 10.1074/jbc.M112.411686; Bianco S, 2014, CANCER RES, V74, P2015, DOI 10.1158/0008-5472.CAN-13-2351; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bolado-Carrancio A, 2014, BIOCHEM BIOPH RES CO, V446, P614, DOI 10.1016/j.bbrc.2014.03.010; Case D., 2014, AMBER TOOLS VERSION; Case D., 2012, AMBERTOOLS VERSION 1; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Clyne CD, 2004, MOL CELL ENDOCRINOL, V215, P39, DOI 10.1016/j.mce.2003.11.001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Klebe G, 2015, NAT REV DRUG DISCOV, V14, P95, DOI 10.1038/nrd4486; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lai CF, 2013, NUCLEIC ACIDS RES, V41, P10228, DOI 10.1093/nar/gkt827; Lalit M, 2013, J MOL STRUCT, V1049, P315, DOI 10.1016/j.molstruc.2013.06.035; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Lin QS, 2014, CANCER LETT, V345, P85, DOI 10.1016/j.canlet.2013.11.014; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mamrosh JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01694; Musille PM, 2016, J BIOL CHEM, V291, P1411, DOI 10.1074/jbc.M115.662874; Musille PM, 2012, NAT STRUCT MOL BIOL, V19, P532, DOI 10.1038/nsmb.2279; Ogata K, 2002, PROTEIN ENG, V15, P697, DOI 10.1093/protein/15.8.697; Oosterveer MH, 2012, J CLIN INVEST, V122, P2817, DOI 10.1172/JCI62368; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sablin EP, 2015, J STRUCT BIOL, V192, P342, DOI 10.1016/j.jsb.2015.09.012; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Stec J, 2010, THESIS; Stein S, 2014, CELL METAB, V20, P603, DOI 10.1016/j.cmet.2014.07.023; Thiruchelvam PTR, 2011, BREAST CANCER RES TR, V127, P385, DOI 10.1007/s10549-010-0994-9; Venteclef N, 2006, MOL CELL BIOL, V26, P6799, DOI 10.1128/MCB.00579-06; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Whitby RJ, 2006, J MED CHEM, V49, P6652, DOI 10.1021/jm060990k; Whitby RJ, 2011, J MED CHEM, V54, P2266, DOI 10.1021/jm1014296; Zhang ZQ, 2007, BIOPHYS J, V93, P1484, DOI 10.1529/biophysj.106.100537	46	16	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25281	25291		10.1074/jbc.M116.753541	http://dx.doi.org/10.1074/jbc.M116.753541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27694446	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000390095300001
J	Xiong, XP; Li, X; Wen, YA; Gao, TY				Xiong, Xiaopeng; Li, Xin; Wen, Yang-An; Gao, Tianyan			Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; SIGNALING PATHWAYS; TUMOR PROGRESSION; CANCER; PHLPP; AKT; PKC; MORPHOGENESIS; PROLIFERATION; APOPTOSIS	The proper establishment of epithelial polarity allows cells to sense and respond to signals that arise from the microenvironment in a spatiotemporally controlled manner. Atypical PKCs (aPKCs) are implicated as key regulators of epithelial polarity. However, the molecular mechanism underlying the negative regulation of aPKCs remains largely unknown. In this study, we demonstrated that PH domain leucine-rich repeat protein phosphatase (PHLPP), a novel family of Ser/Thr protein phosphatases, plays an important role in regulating epithelial polarity by controlling the phosphorylation of both aPKC isoforms. Altered expression of PHLPP1 or PHLPP2 disrupted polarization of Caco2 cells grown in 3D cell cultures as indicated by the formation of aberrant multi-lumen structures. Overexpression of PHLPP resulted in a decrease in aPKC phosphorylation at both the activation loop and the turn motif sites; conversely, knockdown of PHLPP increased aPKC phosphorylation. Moreover, in vitro dephosphorylation experiments revealed that both aPKC isoforms were substrates of PHLPP. Interestingly, knockdown of PKC zeta, but not PKC iota, led to similar disruption of the polarized lumen structure, suggesting that PKC zeta likely controls the polarization process of Caco2 cells. Furthermore, knockdown of PHLPP altered the apical membrane localization of aPKCs and reduced the formation of aPKC-Par3 complex. Taken together, our results identify a novel role of PHLPP in regulating aPKC and cell polarity.	[Xiong, Xiaopeng; Li, Xin; Wen, Yang-An; Gao, Tianyan] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Gao, TY (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu	xiong, xiaopeng/M-2120-2017	Gao, Tianyan/0000-0003-1159-3625	Biostatistics Shared Resources of the University of Kentucky Markey Cancer Center [P30CA177558]; NATIONAL CANCER INSTITUTE [R01CA133429, P30CA177558] Funding Source: NIH RePORTER	Biostatistics Shared Resources of the University of Kentucky Markey Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by the Biostatistics Shared Resources of the University of Kentucky Markey Cancer Center (Grant P30CA177558).	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Chang RM, 2014, HEPATOLOGY, V60, P1251, DOI 10.1002/hep.27221; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Fleming TP, 2000, SEMIN CELL DEV BIOL, V11, P291, DOI 10.1006/scdb.2000.0179; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ivey RA, 2014, J BIOL CHEM, V289, P25021, DOI 10.1074/jbc.M114.565671; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kemler R, 1992, Semin Cell Biol, V3, P149; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Li X, 2014, GASTROENTEROLOGY, V146, P1301, DOI 10.1053/j.gastro.2014.02.003; Li X, 2014, EMBO REP, V15, P191, DOI 10.1002/embr.201338119; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Linch M, 2014, CARCINOGENESIS, V35, P396, DOI 10.1093/carcin/bgt313; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Magudia K, 2012, J CELL BIOL, V198, P185, DOI 10.1083/jcb.201202108; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; McCaffrey LM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009654; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nitsche C, 2012, GASTROENTEROLOGY, V142, P377, DOI 10.1053/j.gastro.2011.10.026; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Wen YA, 2015, BBA-MOL BASIS DIS, V1852, P2013, DOI 10.1016/j.bbadis.2015.07.012; Wen YA, 2013, MOL CELL BIOL, V33, P4594, DOI 10.1128/MCB.00695-13; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433	49	7	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25167	25178		10.1074/jbc.M116.740639	http://dx.doi.org/10.1074/jbc.M116.740639			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27760826	Green Published, hybrid			2022-12-28	WOS:000388880100031
J	Chang, HHY; Watanabe, G; Gerodinnos, CA; Ochi, T; Blundell, TL; Jackson, SP; Lieber, MR				Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Ochi, Takashi; Blundell, Tom L.; Jackson, Stephen P.; Lieber, Michael R.			Different DNA End Configurations Dictate Which NHEJ Components Are Most Important for Joining Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XRCC4-DNA LIGASE-IV; STRAND BREAK REPAIR; V(D)J RECOMBINATION; ARTEMIS; COMPLEX; PROTEIN; KU; XLF; PATHWAY; KINASE	The nonhomologous DNA end-joining (NHEJ) pathway is a key mechanism for repairing dsDNA breaks that occur often in eukaryotic cells. In the simplest model, these breaks are first recognized by Ku, which then interacts with other NHEJ proteins to improve their affinity at DNA ends. These include DNA-PKcs and Artemis for trimming the DNA ends; DNA polymerase mu and lambda to add nucleotides; and the DNA ligase IV complex to ligate the ends with the additional factors, XRCC4 (X-ray repair cross-complementing protein 4), XLF (XRCC4-like factor/Cernunos), and PAXX (paralog of XRCC4 and XLF). In vivo studies have demonstrated the degrees of importance of these NHEJ proteins in the mechanism of repair of dsDNA breaks, but interpretations can be confounded by other cellular processes. In vitro studies with NHEJ proteins have been performed to evaluate the nucleolytic resection, polymerization, and ligation steps, but a complete system has been elusive. Here we have developed a NHEJ reconstitution system that includes the nuclease, polymerase, and ligase components to evaluate relative NHEJ efficiency and analyze ligated junctional sequences for various types of DNA ends, including blunt, 5' overhangs, and 3' overhangs. We find that different dsDNA end structures have differential dependence on these enzymatic components. The dependence of some end joining on only Ku and XRCCLE DNA ligase IV allows us to formulate a physical model that incorporates nuclease and polymerase components as needed.	[Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; [Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Sect Mol & Computat Biol, Los Angeles, CA 90033 USA; [Ochi, Takashi; Blundell, Tom L.; Jackson, Stephen P.] Univ Cambridge, Gordon Inst, Cambridge CB2 1QN, England; [Ochi, Takashi; Blundell, Tom L.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Ochi, Takashi] MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0OH, England	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Cambridge; University of Cambridge	Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA.; Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.; Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.; Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Sect Mol & Computat Biol, Los Angeles, CA 90033 USA.	lieber@usc.edu	Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Ochi, Takashi/0000-0001-8546-6341; Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health; Cancer Research UK Program [C6/A11224, C6946/A14492]; Wellcome Trust [WT092096, WT 093167]; NATIONAL CANCER INSTITUTE [R01CA196671, R01CA100504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118009] Funding Source: NIH RePORTER; Cancer Research UK [18796] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK Program(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK)	This work was supported by a National Institutes of Health grant (to M. R. L.), Cancer Research UK Program Grants C6/A11224 and C6946/A14492 (to S. P. J.), and Wellcome Trust Grant WT092096. This work was also supported by Wellcome Trust Grant WT 093167 (to T.O. and T. L. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Chang HHY, 2015, J BIOL CHEM, V290, P24036, DOI 10.1074/jbc.M115.680900; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; De Ioannes P, 2012, CELL REP, V2, P1505, DOI 10.1016/j.celrep.2012.11.004; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Franco S, 2008, J EXP MED, V205, P557, DOI 10.1084/jem.20080044; Grawunder U, 1998, J BIOL CHEM, V273, P24708, DOI 10.1074/jbc.273.38.24708; Grawunder U, 1998, CURR BIOL, V8, P873, DOI 10.1016/S0960-9822(07)00349-1; Gu JF, 2007, NUCLEIC ACIDS RES, V35, P5755, DOI 10.1093/nar/gkm579; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Li SC, 2011, J BIOL CHEM, V286, P36368, DOI 10.1074/jbc.M111.287797; Liang ZB, 2016, NUCLEIC ACIDS RES, V44, P2769, DOI 10.1093/nar/gkw013; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; MARTIN GM, 1985, ISRAEL J MED SCI, V21, P296; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; MIMORI T, 1986, J BIOL CHEM, V261, P375; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; Ochi T, 2015, SCIENCE, V347, P185, DOI 10.1126/science.1261971; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Pannunzio NR, 2014, DNA REPAIR, V17, P74, DOI 10.1016/j.dnarep.2014.02.006; Pryor JM, 2015, P NATL ACAD SCI USA, V112, pE4537, DOI 10.1073/pnas.1505805112; Reid DA, 2015, P NATL ACAD SCI USA, V112, pE2575, DOI 10.1073/pnas.1420115112; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Roy S, 2015, MOL CELL BIOL, V35, P3017, DOI 10.1128/MCB.01503-14; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Xing MT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7233	42	58	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24377	24389		10.1074/jbc.M116.752329	http://dx.doi.org/10.1074/jbc.M116.752329			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703001	hybrid, Green Published			2022-12-28	WOS:000388875500005
J	Baas, R; Sijm, A; van Teeffelen, HAAM; van Es, R; Vos, HR; Marc Timmers, HT				Baas, Roy; Sijm, Ayestha; van Teeffelen, Hetty A. A. M.; van Es, Robert; Vos, Harmjan R.; Marc Timmers, H. Th.			Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); nuclear translocation; proteomics; SMAD transcription factor; transcription regulation	GROWTH-FACTOR-BETA; NUCLEAR-LOCALIZATION SIGNAL; UBIQUITIN LIGASE; BINDING PROTEIN; BMP; INTERACTS; MEMBRANE; TARGETS; CLONING; MAN1	Gene-specific transcription factors (GSTFs) control gene transcription by DNA binding and specific protein complex recruitment, which regulates promoter accessibility for transcription initiation by RNA polymerase II. Mutations in the GSTFs Suppressor of Mothers Against Decapentaplegic 2 (SMAD2) and SMAD4 are frequently associated with colon and rectal carcinomas. These proteins play an important role in bone morphogenic protein (BMP) and transforming growth factor (TGF-) signaling pathways controlling cell fate and proliferation. To study the protein interactome of the SMAD protein family we generated a quantitative proteomics pipeline that allows for inducible expression of GFP-tagged SMAD proteins followed by affinity purification and quantitative mass spectrometry analysis. Data are available via ProteomeXchange with identifier PXD004529. The nuclear importin IPO5 was identified as a novel interacting protein of SMAD1. Overexpression of IPO5 in various cell lines specifically increases nuclear localization of BMP receptor-activated SMADs (R-SMADs) confirming a functional relationship between IPO5 and BMP but not TGF- R-SMADs. Finally, we provide evidence that variation in length of the lysine stretch of the nuclear localization sequence is a determinant for importin specificity.	[Marc Timmers, H. Th.] Univ Med Ctr Utrecht, Dept Mol Canc Res, Regenerat Med Ctr, Ctr Mol Med, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Stem Cells, Regenerat Med Ctr, Ctr Mol Med, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Marc Timmers, HT (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Regenerat Med Ctr, Ctr Mol Med, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	H.T.M.Timmers@umcutrecht.nl		Vos, Harmjan/0000-0002-4696-6068; Baas, Roy/0000-0002-3535-3565	NWO-Life Sciences Grant [821.02.012]	NWO-Life Sciences Grant	This work was supported by NWO-Life Sciences Grant 821.02.012 (to H. Th. M. T.). The authors declare that they have no conflict of interest with the contents of this article.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Baymaz HI, 2014, METHODS MOL BIOL, V1188, P207, DOI 10.1007/978-1-4939-1142-4_15; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Chen XC, 2010, MOL CELL BIOL, V30, P4022, DOI 10.1128/MCB.00124-10; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Guo X, 2013, MOL CELL, V51, P1, DOI 10.1016/j.molcel.2013.06.016; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Koster MJE, 2015, CELL, V161, P724, DOI 10.1016/j.cell.2015.04.033; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lebrun JJ, 1999, MOL ENDOCRINOL, V13, P15, DOI 10.1210/me.13.1.15; Lechleider RJ, 1996, J BIOL CHEM, V271, P17617, DOI 10.1074/jbc.271.30.17617; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Team RC., 2013, R LANG ENV STAT COMP; Tsubakihara Y, 2015, J BIOCHEM, V158, P61, DOI 10.1093/jb/mvv024; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Xiao Z, 2003, ONCOGENE, V22, P1057, DOI 10.1038/sj.onc.1206212; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451; Yingling JM, 1996, P NATL ACAD SCI USA, V93, P8940, DOI 10.1073/pnas.93.17.8940; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	42	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24121	24132		10.1074/jbc.M116.748582	http://dx.doi.org/10.1074/jbc.M116.748582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703004	Green Published, hybrid			2022-12-28	WOS:000388498100028
J	Gabriel, CH; Gross, F; Karl, M; Stephanowitz, H; Hennig, AF; Weber, M; Gryzik, S; Bachmann, I; Hecklau, K; Wienands, J; Schuchhardt, J; Herzel, H; Radbruch, A; Krause, E; Baumgrass, R				Gabriel, Christian H.; Gross, Fridolin; Karl, Martin; Stephanowitz, Heike; Hennig, Anna Floriane; Weber, Melanie; Gryzik, Stefanie; Bachmann, Ivo; Hecklau, Katharina; Wienands, Juergen; Schuchhardt, Johannes; Herzel, Hanspeter; Radbruch, Andreas; Krause, Eberhard; Baumgrass, Ria			Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP1); bioinformatics; cAMP-response element-binding protein (CREB); lymphocyte; mass spectrometry (MS); NFAT transcription factor; protein-protein interaction; RUNX transcription factor; SILAC	NF-KAPPA-B; TRANSCRIPTION FACTOR NFAT1; GENE-EXPRESSION; BINDING-PROTEIN; CALCINEURIN INHIBITORS; EFFECTOR FUNCTIONS; FOXP3; KINASE; FOS; JUN	Transcription factors of the nuclear factor of activated T cell (NFAT) family are essential for antigen-specific T cell activation and differentiation. Their cooperative DNA binding with other transcription factors, such as AP1 proteins (FOS, JUN, and JUNB), FOXP3, IRFs, and EGR1, dictates the gene regulatory action of NFATs. To identify as yet unknown interaction partners of NFAT, we purified biotin-tagged NFATc1/A, NFATc1/C, and NFATc2/C protein complexes and analyzed their components by stable isotope labeling by amino acids in cell culture-based mass spectrometry. We revealed more than 170 NFAT-associated proteins, half of which are involved in transcriptional regulation. Among them are many hitherto unknown interaction partners of NFATc1 and NFATc2 in T cells, such as Raptor, CHEK1, CREB1, RUNX1, SATB1, Ikaros, and Helios. The association of NFATc2 with several other transcription factors is DNA-dependent, indicating cooperative DNA binding. Moreover, our computational analysis discovered that binding motifs for RUNX and CREB1 are found preferentially in the direct vicinity of NFAT-binding motifs and in a distinct orientation to them. Furthermore, we provide evidence that mTOR and CHEK1 kinase activity influence NFAT's transcriptional potency. Finally, our dataset of NFAT-associated proteins provides a good basis to further study NFAT's diverse functions and how these are modulated due to the interplay of multiple interaction partners.	[Gabriel, Christian H.; Karl, Martin; Hennig, Anna Floriane; Weber, Melanie; Gryzik, Stefanie; Hecklau, Katharina; Radbruch, Andreas; Baumgrass, Ria] German Rheumatism Res Ctr DRFZ, Leibniz Inst, D-10117 Berlin, Germany; [Gross, Fridolin; Herzel, Hanspeter] Charite, Inst Theoret Biol, D-10015 Berlin, Germany; [Gross, Fridolin; Herzel, Hanspeter] Humboldt Univ, D-10015 Berlin, Germany; [Stephanowitz, Heike; Krause, Eberhard] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Bachmann, Ivo; Schuchhardt, Johannes] MicroDiscovery GmbH, D-10405 Berlin, Germany; [Wienands, Juergen] Georg August Univ Gottingen, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Gottingen	Baumgrass, R (corresponding author), DRFZ Berlin, Charitepl 1, D-10117 Berlin, Germany.	baumgrass@drfz.de		Hennig, Anna Floriane/0000-0002-3942-3209; Gabriel, Christian/0000-0003-2081-1743; Hecklau, Katharina/0000-0002-7743-5366; Baumgrass, Ria/0000-0002-3289-1608; Gryzik, Stefanie/0000-0001-5871-539X; Radbruch, Andreas/0000-0001-5753-0000	"e:Bio-Innovationswettbewerb Systembiologie" Program from the German Federal Ministry of Education and Research Grant T-Sys; Deutsche Forschungsgemeinschaft [TR52, SFB650]	"e:Bio-Innovationswettbewerb Systembiologie" Program from the German Federal Ministry of Education and Research Grant T-Sys; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the "e:Bio-Innovationswettbewerb Systembiologie" Program from the German Federal Ministry of Education and Research Grant T-Sys (to R. B., H. H., J. S., and A. R.) and by Deutsche Forschungsgemeinschaft Grants TR52 and SFB650 (to R. B. and A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banks CAS, 2014, MOL CELL PROTEOMICS, V13, P1510, DOI 10.1074/mcp.M113.033902; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benary M., 2013, COBINDR FINDING COOC; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carneiro FRG, 2011, MOL CELL BIOL, V31, P2889, DOI 10.1128/MCB.00974-10; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Chuvpilo S, 1999, J IMMUNOL, V162, P7294; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Cobbold SP, 2013, IMMUNOLOGY, V140, P391, DOI 10.1111/imm.12162; Crisafuli FAP, 2015, EUR BIOPHYS J BIOPHY, V44, P1, DOI 10.1007/s00249-014-0995-4; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gomez-Casero E, 2007, CELL SIGNAL, V19, P1652, DOI 10.1016/j.cellsig.2007.02.010; Guzi TJ, 2011, MOL CANCER THER, V10, P591, DOI 10.1158/1535-7163.MCT-10-0928; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; Hwang JS, 2015, J IMMUNOL, V194, P1963, DOI 10.4049/jimmunol.1401862; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Klein-Hessling S, 2008, J BIOL CHEM, V283, P31030, DOI 10.1074/jbc.M805929200; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Lee SH, 2009, BIOCHEM BIOPH RES CO, V381, P214, DOI 10.1016/j.bbrc.2009.02.026; Lee Yue-Hien, 2010, V22, P84; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Marcilla M, 2011, TALANTA, V84, P430, DOI 10.1016/j.talanta.2011.01.050; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nayak A, 2009, J BIOL CHEM, V284, P10935, DOI 10.1074/jbc.M900465200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pages H., 2016, BIOSTRINGS STRING OB; Park HJ, 2015, J CELL PHYSIOL, V230, P667, DOI 10.1002/jcp.24790; Pasquinelli V, 2009, J INFECT DIS, V199, P661, DOI 10.1086/596742; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Rush D, 2013, TRANSPLANT REV-ORLAN, V27, P93, DOI 10.1016/j.trre.2013.04.003; RYSECK RP, 1991, ONCOGENE, V6, P533; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schaffer U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1178; Serfling E, 2006, EUR J IMMUNOL, V36, P2837, DOI 10.1002/eji.200536618; Serfling E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-16; Shin DS, 2014, EMBO REP, V15, P991, DOI 10.15252/embr.201338233; Shou JW, 2015, CANCER LETT, V361, P174, DOI 10.1016/j.canlet.2015.03.005; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; Srikanth S, 2013, MOL CELLS, V35, P182, DOI 10.1007/s10059-013-0073-2; Stroud JC, 2003, J MOL BIOL, V334, P1009, DOI 10.1016/j.jmb.2003.09.065; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tse AN, 2007, CLIN CANCER RES, V13, P591, DOI 10.1158/1078-0432.CCR-06-1424; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; Vazquez-Cedeira M, 2012, J BIOL CHEM, V287, P42739, DOI 10.1074/jbc.M112.404285; Vihma H, 2008, GENOMICS, V92, P279, DOI 10.1016/j.ygeno.2008.06.011; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang F, 2000, J IMMUNOL, V165, P1762, DOI 10.4049/jimmunol.165.4.1762; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	99	22	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24172	24187		10.1074/jbc.M116.739326	http://dx.doi.org/10.1074/jbc.M116.739326			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27637333	Green Published, hybrid			2022-12-28	WOS:000388498100032
J	Gladyshev, VN; Arner, ES; Berry, MJ; Brigelius-Flohe, R; Bruford, EA; Burk, RF; Carlson, BA; Castellano, S; Chavatte, L; Conrad, M; Copeland, PR; Diamond, AM; Driscoll, DM; Ferreiro, A; Flohe, L; Green, FR; Guigo, R; Handy, DE; Hatfield, DL; Hesketh, J; Hoffmann, PR; Holmgren, A; Hondal, RJ; Howard, MT; Huang, K; Kim, HY; Kim, IY; Kohrle, J; Krol, A; Kryukov, GV; Lee, BJ; Lee, BC; Lei, XG; Liu, Q; Lescure, A; Lobanov, AV; Loscalzo, J; Maiorino, M; Mariotti, M; Prabhu, KS; Rayman, MP; Rozovsky, S; Salinas, G; Schmidt, EE; Schomburg, L; Schweizer, U; Simonovic, M; Sunde, RA; Tsuji, PA; Tweedie, S; Ursini, F; Whanger, PD; Zhang, Y				Gladyshev, Vadim N.; Arner, Elias S.; Berry, Marla J.; Brigelius-Flohe, Regina; Bruford, Elspeth A.; Burk, Raymond F.; Carlson, Bradley A.; Castellano, Sergi; Chavatte, Laurent; Conrad, Marcus; Copeland, Paul R.; Diamond, Alan M.; Driscoll, Donna M.; Ferreiro, Ana; Flohe, Leopold; Green, Fiona R.; Guigo, Roderic; Handy, Diane E.; Hatfield, Dolph L.; Hesketh, John; Hoffmann, Peter R.; Holmgren, Arne; Hondal, Robert J.; Howard, Michael T.; Huang, Kaixun; Kim, Hwa-Young; Kim, Ick Young; Koehrle, Josef; Krol, Alain; Kryukov, Gregory V.; Lee, Byeong Jae; Lee, Byung Cheon; Lei, Xin Gen; Liu, Qiong; Lescure, Alain; Lobanov, Alexei V.; Loscalzo, Joseph; Maiorino, Matilde; Mariotti, Marco; Sandeep Prabhu, K.; Rayman, Margaret P.; Rozovsky, Sharon; Salinas, Gustavo; Schmidt, Edward E.; Schomburg, Lutz; Schweizer, Ulrich; Simonovic, Miljan; Sunde, Roger A.; Tsuji, Petra A.; Tweedie, Susan; Ursini, Fulvio; Whanger, Philip D.; Zhang, Yan			Selenoprotein Gene Nomenclature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genomics; selenium; selenocysteine; selenoprotein; structure-function; function; gene name; nomenclature	HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; AMINO-ACID-SEQUENCE; THIOREDOXIN REDUCTASE; RAT-LIVER; IODOTHYRONINE 5-DEIODINASE; EUKARYOTIC SELENOPROTEINS; SELENIUM METABOLISM; CONTAINING PROTEINS; MESSENGER-RNA; SELENOCYSTEINE	The human genome contains 25 genes coding for selenocysteine-containing proteins (selenoproteins). These proteins are involved in a variety of functions, most notably redox homeostasis. Selenoprotein enzymes with known functions are designated according to these functions: TXNRD1, TXNRD2, and TXNRD3 (thioredoxin reductases), GPX1, GPX2, GPX3, GPX4, and GPX6 (glutathione peroxidases), DIO1, DIO2, and DIO3 (iodothyronine deiodinases), MSRB1 (methionine sulfoxide reductase B1), and SEPHS2 (selenophosphate synthetase 2). Selenoproteins without known functions have traditionally been denoted by SEL or SEP symbols. However, these symbols are sometimes ambiguous and conflict with the approved nomenclature for several other genes. Therefore, there is a need to implement a rational and coherent nomenclature system for selenoprotein-encoding genes. Our solution is to use the root symbol SELENO followed by a letter. This nomenclature applies to SELENOF (selenoprotein F, the 15-kDa selenoprotein, SEP15), SELENOH (selenoprotein H, SELH, C11orf31), SELENOI (selenoprotein I, SELI, EPT1), SELENOK (selenoprotein K, SELK), SELENOM (selenoprotein M, SELM), SELENON (selenoprotein N, SEPN1, SELN), SELENOO (selenoprotein O, SELO), SELENOP (selenoprotein P, SeP, SEPP1, SELP), SELENOS (selenoprotein S, SELS, SEPS1, VIMP), SELENOT (selenoprotein T, SELT), SELENOV (selenoprotein V, SELV), and SELENOW (selenoprotein W, SELW, SEPW1). This system, approved by the HUGO Gene Nomenclature Committee, also resolves conflicting, missing, and ambiguous designations for selenoprotein genes and is applicable to selenoproteins across vertebrates.	[Gladyshev, Vadim N.; Lobanov, Alexei V.; Mariotti, Marco] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Arner, Elias S.; Holmgren, Arne] Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys MBB, SE-17177 Stockholm, Sweden; [Berry, Marla J.; Hoffmann, Peter R.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Brigelius-Flohe, Regina] German Inst Human Nutr Potsdam Rehbrucke, D-14558 Nuthetal, Germany; [Bruford, Elspeth A.; Tweedie, Susan] HUGOGene Nomenclature Comm HGNC, European Bioinformat Inst European Mol Biol Lab E, Hinxton CB10 1SD, England; [Burk, Raymond F.] Vanderbilt Univ, Div Gastroenterol Hepatol & Nutr, Dept Med, Sch Med, Nashville, TN 37232 USA; [Carlson, Bradley A.; Hatfield, Dolph L.] Ctr Canc Res, NIH, Mouse Canc Genet Program, Mol Biol Selenium Sect, Bethesda, MD 20892 USA; [Castellano, Sergi] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Chavatte, Laurent] INSERM, CIRI, U1111, F-69007 Lyon, France; [Chavatte, Laurent] CNRS, ENS UMR5308, F-69007 Lyon, France; [Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Copeland, Paul R.] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Diamond, Alan M.] Univ Illinois, Dept Pathol, Chicago, IL 60607 USA; [Driscoll, Donna M.] Cleveland Clin Fdn, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Ferreiro, Ana] Univ Paris Diderot, Sorbonne Paris Cite, Pathophysiol Striated Muscles Lab, Unit Funct & Adapt Biol BFA,UMR CNRS 8251 BFA, F-75250 Paris, France; [Ferreiro, Ana] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Malad Neuromusculaires Paris Est, F-75013 Paris, France; [Flohe, Leopold] Univ Republica, Facultad Med, Dept Bioquim, Montevideo 11800, Uruguay; [Flohe, Leopold] Univ Padua, Dept Mol Med, I-35121 Padua, Italy; [Green, Fiona R.] Univ Manchester, Div Cardiovasc Sci, Sch Med Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Guigo, Roderic] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Guigo, Roderic] UPF, Barcelona 08002, Spain; [Handy, Diane E.] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Handy, Diane E.] Harvard Med Sch, Boston, MA 02115 USA; [Hesketh, John] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hesketh, John] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hesketh, John] Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hondal, Robert J.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Howard, Michael T.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Huang, Kaixun] Huazhong Univ Sci & Technol, Hubei Key Lab Bioinorgan Chem & Mat Med, Sch Chem & Chem Engn, Wuhan 430074, Peoples R China; [Kim, Hwa-Young] Yeungnam Univ, Dept Biochem & Mol Biol, Coll Med, Daegu 42415, South Korea; [Kim, Ick Young; Lee, Byung Cheon] Korea Univ, Coll Life Sci & Biotechnol, Seoul 02841, South Korea; [Koehrle, Josef; Schomburg, Lutz] Charite, Inst Expt Endocrinol, D-13353 Berlin, Germany; [Krol, Alain; Lescure, Alain] Univ Strasbourg, Architecture & Reactivite ARN, Ctr Natl Rech Sci, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Kryukov, Gregory V.] KSQ Therapeut, Cambridge, MA 02139 USA; [Lee, Byeong Jae] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Lei, Xin Gen] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Liu, Qiong; Zhang, Yan] Shenzhen Univ, Shenzhen Key Lab Marine Biotechnol & Ecol, Coll Life Sci, Shenzhen 518060, Guangdong Provi, Peoples R China; [Lescure, Alain] Ctr Natl Rech Sci, F-75794 Paris, France; [Loscalzo, Joseph] Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Sandeep Prabhu, K.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Rayman, Margaret P.] Univ Surrey, Dept Nut Sci, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Rozovsky, Sharon] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Salinas, Gustavo] Inst Higiene, Catedra Inmunol, Fac Quim, Montevideo 11600, Uruguay; [Schmidt, Edward E.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Schweizer, Ulrich] Rhein Friedrich Wilhelms Univ Bonn, Inst Biochem & Molekularbiol, D-53115 Bonn, Germany; [Simonovic, Miljan] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Tsuji, Petra A.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA; [Whanger, Philip D.] Oregon State Univ, Dept Environm & Mol Toxicol, Coll Agr Sci, Corvallis, OR 97331 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Karolinska Institutet; University of Hawaii System; University of Hawaii Manoa; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Max Planck Society; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cleveland Clinic Foundation; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidad de la Republica, Uruguay; University of Padua; University of Manchester; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Vermont; Utah System of Higher Education; University of Utah; Huazhong University of Science & Technology; Yeungnam University; Korea University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Seoul National University (SNU); Cornell University; Shenzhen University; Centre National de la Recherche Scientifique (CNRS); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Surrey; University of Delaware; Universidad de la Republica, Uruguay; Montana State University System; Montana State University Bozeman; University of Bonn; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; Towson University; Oregon State University	Gladyshev, VN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA.; Gladyshev, VN (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	vgladyshev@rics.bwh.harvard.edu	Arnér, Elias/K-6737-2019; Tweedie, Susan/B-3695-2019; Köhrle, Josef/AAH-6438-2020; Ferreiro, Ana/F-5371-2011; Arnér, Elias S.J./J-5832-2012; Bruford, Elspeth/AAU-4961-2020; Loscalzo, Joseph/ABD-8980-2021; rozovsky, sharon/S-4534-2016; Liu, Qiong/AAK-1556-2021; Guigo, Roderic/D-1303-2010; Schomburg, Lutz/D-8096-2013; Conrad, Marcus/E-8792-2015; Mariotti, Marco/AAB-7136-2019; Castellano, Sergi/A-7437-2016	Arnér, Elias/0000-0002-4807-6114; Tweedie, Susan/0000-0003-1818-8243; Köhrle, Josef/0000-0002-9187-9078; Ferreiro, Ana/0000-0003-2806-5386; Arnér, Elias S.J./0000-0002-4807-6114; Bruford, Elspeth/0000-0002-8380-5247; rozovsky, sharon/0000-0003-4902-0777; Guigo, Roderic/0000-0002-5738-4477; Schomburg, Lutz/0000-0001-9445-1555; Conrad, Marcus/0000-0003-1140-5612; Mariotti, Marco/0000-0002-7411-4161; Simonovic, Miljan/0000-0002-1576-2222; Salinas, Gustavo/0000-0003-3350-3002; Handy, Diane/0000-0002-4310-8527; Kryukov, Gregory/0000-0002-6131-9483; Copeland, Paul/0000-0003-3343-0587; Gladyshev, Vadim/0000-0002-0372-7016; Castellano, Sergi/0000-0002-5819-4210; Chavatte, Laurent/0000-0001-7696-2431; Schweizer, Ulrich/0000-0003-1380-4780; Lee, Byung Cheon/0000-0003-1467-1940	National Institutes of Health [GM061603]; NATIONAL CANCER INSTITUTE [R01CA193497, R01CA080946, R01CA162665, R21CA182103] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG003345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114291, R01GM061603, R01GM097042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG055022, R01AG040020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061603. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansong E, 2014, MOL NUTR FOOD RES, V58, P117, DOI 10.1002/mnfr.201300543; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BEHNE D, 1990, BIOCHEM BIOPH RES CO, V173, P1143, DOI 10.1016/S0006-291X(05)80905-2; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; BRIGELIUS-FLOHE R, 1994, J BIOL CHEM, V269, P7342; Burk RF, 2015, ANNU REV NUTR, V35, P109, DOI 10.1146/annurev-nutr-071714-034250; BURK RF, 1982, ARCH BIOCHEM BIOPHYS, V213, P73, DOI 10.1016/0003-9861(82)90441-6; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Castellano S, 2005, P NATL ACAD SCI USA, V102, P16188, DOI 10.1073/pnas.0505146102; Castellano S, 2004, EMBO REP, V5, P71, DOI 10.1038/sj.embor.7400036; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHU FF, 1993, J BIOL CHEM, V268, P2571; DAVEY JC, 1995, J BIOL CHEM, V270, P26786, DOI 10.1074/jbc.270.45.26786; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; Fradejas-Villar N., 2016, FASEB J; GASDASKA PY, 1995, FEBS LETT, V373, P5, DOI 10.1016/0014-5793(95)01003-W; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gladyshev VN, 1998, J BIOL CHEM, V273, P8910, DOI 10.1074/jbc.273.15.8910; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; GUNZLER WA, 1984, H-S Z PHYSIOL CHEM, V365, P195, DOI 10.1515/bchm2.1984.365.1.195; HILL KE, 1993, P NATL ACAD SCI USA, V90, P537, DOI 10.1073/pnas.90.2.537; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2000, GENES CELLS, V5, P1049, DOI 10.1046/j.1365-2443.2000.00392.x; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; MILLS GC, 1957, J BIOL CHEM, V229, P189; MOTSENBOCKER MA, 1982, BIOCHIM BIOPHYS ACTA, V719, P147, DOI 10.1016/0304-4165(82)90318-X; Novoselov SV, 2006, BIOCHEM J, V394, P575, DOI 10.1042/BJ20051569; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Shchedrina VA, 2007, P NATL ACAD SCI USA, V104, P13919, DOI 10.1073/pnas.0703448104; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sunde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129801; TAKAHASHI K, 1990, J BIOCHEM-TOKYO, V108, P145, DOI 10.1093/oxfordjournals.jbchem.a123172; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; VENDELAND SC, 1995, P NATL ACAD SCI USA, V92, P8749, DOI 10.1073/pnas.92.19.8749; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	49	157	167	5	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24036	24040		10.1074/jbc.M116.756155	http://dx.doi.org/10.1074/jbc.M116.756155			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27645994	Green Published, hybrid			2022-12-28	WOS:000388498100020
J	McMillan, DGG; Watanabe, R; Ueno, H; Cook, GM; Noji, H				McMillan, Duncan G. G.; Watanabe, Rikiya; Ueno, Hiroshi; Cook, Gregory M.; Noji, Hiroyuki			Biophysical Characterization of a Thermoalkaliphilic Molecular Motor with a High Stepping Torque Gives Insight into Evolutionary ATP Synthase Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; enzyme kinetics; enzyme mechanism; F1F0-ATPase; respiratory chain; single molecule biophysics; adaptation; rotation; thermoalkaliphile; torque	ESCHERICHIA-COLI F-1-ATPASE; BACILLUS-FIRMUS OF4; SP STRAIN TA2.A1; ENTEROCOCCUS-HIRAE; EPSILON-SUBUNIT; V-ATPASE; RING STOICHIOMETRY; F1FO-ATP SYNTHASE; F1F0-ATP SYNTHASE; ROTARY MECHANISM	F1F0 ATP synthases are bidirectional molecular motors that translocate protons across the cell membrane by either synthesizing or hydrolyzing ATP. Alkaliphile ATP synthases are highly adapted, performing oxidative phosphorylation at high pH against an inverted pH gradient (acid(in)/alkaline(out)). Unlike mesophilic ATP synthases, alkaliphilic enzymes have tightly regulated ATP hydrolysis activity, which can be relieved in the presence of lauryldimethylamine oxide. Here, we characterized the rotary dynamics of the Caldalkalibacillus thermarum TA2.A1 F-1 ATPase (TA2F(1)) with two forms of single molecule analysis, a magnetic bead duplex and a gold nanoparticle. TA2F(1) rotated in a counterclockwise direction in both systems, adhering to Michaelis-Menten kinetics with a maximum rotation rate (V-max) of 112.4 revolutions/s. TA2F(1) displayed 120 degrees unitary steps coupled with ATP hydrolysis. Torque measurements revealed the highest torque (52.4 piconewtons) derived from an F-1 molecule using fluctuation theorem. The implications of high torque in terms of extreme environment adaptation are discussed.	[McMillan, Duncan G. G.; Watanabe, Rikiya; Ueno, Hiroshi; Noji, Hiroyuki] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, POB 56, Dunedin 9054, New Zealand	University of Tokyo; University of Otago	McMillan, DGG; Noji, H (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	duncan.mcmillan@nojilab.t.u-tokyo.ac.jp; hnoji@appchem.t.u-tokyo.ac.jp	McMillan, Duncan/AAT-7415-2021; Watanabe, Rikiya/AAO-1390-2021; Cook, Gregory/ABF-4208-2020	McMillan, Duncan/0000-0001-6614-4494; Watanabe, Rikiya/0000-0001-7146-2745; 	long term Japan Society for the Promotion of Sciences International Fellowship [P14383]; Grants-in-Aid for Scientific Research [26000011, 16K14706] Funding Source: KAKEN	long term Japan Society for the Promotion of Sciences International Fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by long term Japan Society for the Promotion of Sciences International Fellowship P14383 (to D. G. G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Albers SV, 2001, EXTREMOPHILES, V5, P285, DOI 10.1007/s007920100214; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Borsch M, 2011, CHEMPHYSCHEM, V12, P542, DOI 10.1002/cphc.201000702; Borsch M, 1998, FEBS LETT, V437, P251, DOI 10.1016/S0014-5793(98)01247-2; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cook GM, 2003, J BACTERIOL, V185, P4442, DOI 10.1128/JB.185.15.4442-4449.2003; Deckers-Hebestreit G, 2000, BBA-BIOENERGETICS, V1458, P364, DOI 10.1016/S0005-2728(00)00087-6; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dimroth P, 2004, ADV MICROB PHYSIOL, V49, P175, DOI 10.1016/S0065-2911(04)49004-3; GUFFANTI AA, 1994, J BIOL CHEM, V269, P21576; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; HICKS DB, 1990, J BIOL CHEM, V265, P20547; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMANN A, 1990, EUR J BIOCHEM, V194, P423, DOI 10.1111/j.1432-1033.1990.tb15635.x; Hornung T, 2008, BBA-BIOENERGETICS, V1777, P579, DOI 10.1016/j.bbabio.2008.04.016; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kalamorz F, 2011, J BACTERIOL, V193, P4290, DOI 10.1128/JB.05035-11; KASHO VN, 1989, P NATL ACAD SCI USA, V86, P8708, DOI 10.1073/pnas.86.22.8708; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; Kishikawa J, 2014, EUR BIOPHYS J BIOPHY, V43, P415, DOI 10.1007/s00249-014-0973-x; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Kohori A, 2011, BIOPHYS J, V101, P188, DOI 10.1016/j.bpj.2011.05.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matthies D, 2009, J MOL BIOL, V388, P611, DOI 10.1016/j.jmb.2009.03.052; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; McMillan DGG, 2009, APPL ENVIRON MICROB, V75, P7649, DOI 10.1128/AEM.01639-09; Meier T, 2005, FEBS J, V272, P5474, DOI [10.1111/j.1742-4658.2005.04940.x, 10.1111/j.1742-4685.2005.04940.x]; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112; Muller DJ, 2001, FEBS LETT, V504, P219, DOI 10.1016/S0014-5793(01)02708-9; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2003, J BIOL CHEM, V278, P21162, DOI 10.1074/jbc.M301620200; Murata T, 2008, P NATL ACAD SCI USA, V105, P8607, DOI 10.1073/pnas.0800992105; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Noji H, 1998, SCIENCE, V282, P1844, DOI 10.1126/science.282.5395.1844; PAIK SR, 1994, BIOCHEMISTRY-US, V33, P126, DOI 10.1021/bi00167a016; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Peddie CJ, 1999, J BACTERIOL, V181, P3172, DOI 10.1128/JB.181.10.3172-3177.1999; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stocker A, 2005, J STRUCT BIOL, V152, P140, DOI 10.1016/j.jsb.2005.08.005; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Svergun DI, 1998, BIOCHEMISTRY-US, V37, P17659, DOI 10.1021/bi982367a; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Ueno Hiroshi, 2014, J Biol Chem, V289, P31212, DOI 10.1074/jbc.M114.598177; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	78	16	16	5	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23965	23977		10.1074/jbc.M116.743633	http://dx.doi.org/10.1074/jbc.M116.743633			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27624936	Green Published, hybrid			2022-12-28	WOS:000388498100013
J	Yang, XD; Mudgett, J; Bou-About, G; Champy, MF; Jacobs, H; Monassier, L; Pavlovic, G; Sorg, T; Herault, Y; Petit-Demouliere, B; Lu, K; Feng, W; Wang, HW; Ma, LJ; Askew, R; Erion, MD; Kelley, DE; Myers, RW; Li, C; Guan, HP				Yang, Xiaodong; Mudgett, John; Bou-About, Ghina; Champy, Marie-France; Jacobs, Hugues; Monassier, Laurent; Pavlovic, Guillaume; Sorg, Tania; Herault, Yann; Petit-Demouliere, Benoit; Lu, Ku; Feng, Wen; Wang, Hongwu; Ma, Li-Jun; Askew, Roger; Erion, Mark D.; Kelley, David E.; Myers, Robert W.; Li, Cai; Guan, Hong-Ping			Physiological Expression of AMPK2(RG) Mutation Causes Wolff-Parkinson-White Syndrome and Induces Kidney Injury in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetes; glycogen storage disease; insulin resistance; kidney metabolism; liver metabolism	ACTIVATED PROTEIN-KINASE; GLYCOGEN-STORAGE; ENERGY SENSOR; CARDIAC-HYPERTROPHY; SKELETAL-MUSCLE; FATTY-ACID; AMPK ACTIVATION; DISEASE; SURVIVAL; GLUCOSE	Mutations of the AMP-activated kinase gamma 2 subunit (AMPK2), N488I (AMPK2(NI)) and R531G (AMPK2(RG)), are associated with Wolff-Parkinson-White (WPW) syndrome, a cardiac disorder characterized by ventricular pre-excitation in humans. Cardiac-specific transgenic overexpression of human AMPK2(NI) or AMPK2(RG) leads to constitutive AMPK activation and the WPW phenotype in mice. However, overexpression of these mutant proteins also caused profound, non-physiological increase in cardiac glycogen, which might abnormally alter the true phenotype. To investigate whether physiological levels of AMPK2(NI) or AMPK2(RG) mutation cause WPW syndrome and metabolic changes in other organs, we generated two knock-in mouse lines on the C57BL/6N background harboring mutations of human AMPK2(NI) and AMPK2(RG), respectively. Similar to the reported phenotypes of mice overexpressing AMPK2(NI) or AMPK2(RG) in the heart, both lines developed WPW syndrome and cardiac hypertrophy; however, these effects were independent of cardiac glycogen accumulation. Compared with AMPK2(WT) mice, AMPK2(NI) and AMPK2(RG) mice exhibited reduced body weight, fat mass, and liver steatosis when fed with a high fat diet (HFD). Surprisingly, AMPK2(RG) but not AMPK2(NI) mice fed with an HFD exhibited severe kidney injury characterized by glycogen accumulation, inflammation, apoptosis, cyst formation, and impaired renal function. These results demonstrate that expression of AMPK2(NI) and AMPK2(RG) mutations at physiological levels can induce beneficial metabolic effects but that this is accompanied by WPW syndrome. Our data also reveal an unexpected effect of AMPK2(RG) in the kidney, linking lifelong constitutive activation of AMPK to a potential risk for kidney dysfunction in the context of an HFD.	[Yang, Xiaodong; Lu, Ku; Feng, Wen; Ma, Li-Jun; Erion, Mark D.; Kelley, David E.; Myers, Robert W.; Li, Cai; Guan, Hong-Ping] Merck Res Labs, Dept Cardiometabol Dis, Kenilworth, NJ 07033 USA; [Mudgett, John; Askew, Roger] Merck Res Labs, Dept Genet Engn Models, Kenilworth, NJ 07033 USA; [Wang, Hongwu] Merck Res Labs, Dept Kenilworth Chem & Modeling Informat, Kenilworth, NJ 07033 USA; [Bou-About, Ghina; Champy, Marie-France; Jacobs, Hugues; Pavlovic, Guillaume; Sorg, Tania; Herault, Yann; Petit-Demouliere, Benoit] Univ Strasbourg, Inst Clin Souris, Ctr Europeen Rech Biol & Med GIE Groupement Inter, PHENOMIN,CNRS UMR 7104,INSERM U964, F-67404 Illkirch Graffenstaden, France; [Monassier, Laurent] Univ Strasbourg, Lab Neurobiol & Cardiovasc Pharmacol Dept, Federat Med Translationnelle, EA 7296, F-67000 Strasbourg, France	Merck & Company; Merck & Company; Merck & Company; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guan, HP (corresponding author), Merck Res Labs, Dept Cardiometabol Dis, Kenilworth, NJ 07033 USA.; Guan, HP (corresponding author), MRL, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	Hong-Ping_Guan@merck.com	Pavlovic, Guillaume/C-9907-2013; Monassier, Laurent/AAE-4446-2022; Herault, Yann/B-5500-2012	Pavlovic, Guillaume/0000-0001-9122-4592; Herault, Yann/0000-0001-7049-6900	Merck Research Laboratories	Merck Research Laboratories(Merck & Company)	This work was supported by the Merck Research Laboratories. The authors declare that they have no conflicts of interest with the contents of this article.	Accornero F, 2011, CIRC RES, V109, P272, DOI 10.1161/CIRCRESAHA.111.240820; Arad M, 2003, CIRCULATION, V107, P2850, DOI 10.1161/01.CIR.0000075270.13497.2B; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; BENDITT DG, 1978, CIRCULATION, V57, P454, DOI 10.1161/01.CIR.57.3.454; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; Cammisotto PG, 2008, AM J PHYSIOL-RENAL, V294, pF881, DOI 10.1152/ajprenal.00373.2007; Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Chopra I, 2008, CIRCULATION, V118, pS486; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Costford SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000903; Davies JK, 2006, AM J PHYSIOL-HEART C, V290, pH1942, DOI 10.1152/ajpheart.01020.2005; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Decleves AE, 2014, NEPHRON EXP NEPHROL, V128, P98, DOI 10.1159/000368932; Fraser S, 2005, AM J PHYSIOL-RENAL, V288, pF578, DOI 10.1152/ajprenal.00190.2004; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hallows KR, 2010, AM J PHYSIOL-RENAL, V298, pF1067, DOI 10.1152/ajprenal.00005.2010; Halse R, 2003, DIABETES, V52, P9, DOI 10.2337/diabetes.52.1.9; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jensen KK, 2012, AM J PHYSIOL-ENDOC M, V302, pE209, DOI 10.1152/ajpendo.00436.2011; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim M, 2014, CIRC RES, V114, P966, DOI 10.1161/CIRCRESAHA.114.302364; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kume S, 2012, DIABETES, V61, P23, DOI 10.2337/db11-0555; Light PE, 2003, CIRCULATION, V107, P1962, DOI 10.1161/01.CIR.0000069269.60167.02; Light Peter E, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS158, DOI 10.1111/j.1540-8167.2006.00399.x; Luptak I, 2007, J CLIN INVEST, V117, P1432, DOI 10.1172/JCI30658; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Yung MMH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-327; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505	47	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23428	23439		10.1074/jbc.M116.738591	http://dx.doi.org/10.1074/jbc.M116.738591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621313	Green Published, hybrid			2022-12-28	WOS:000387884400006
J	Port, SA; Mendes, A; Valkova, C; Spillner, C; Fahrenkrog, B; Kaether, C; Kehlenbach, RH				Port, Sarah A.; Mendes, Adelia; Valkova, Christina; Spillner, Christiane; Fahrenkrog, Birthe; Kaether, Christoph; Kehlenbach, Ralph H.			The Oncogenic Fusion Proteins SET-Nup214 and Sequestosome-1 (SQSTM1)-Nup214 Form Dynamic Nuclear Bodies and Differentially Affect Nuclear Protein and Poly(A)(+) RNA Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; LEPTOMYCIN B; STRUCTURAL BASIS; BINDING-PROTEIN; SET-CAN; NUCLEOPORIN; LEUKEMIA; CRM1; TRANSCRIPTION	Genetic rearrangements are a hallmark of several forms of leukemia and can lead to oncogenic fusion proteins. One example of an affected chromosomal region is the gene coding for Nup214, a nucleoporin that localizes to the cytoplasmic side of the nuclear pore complex (NPC). We investigated two such fusion proteins, SET-Nup214 and SQSTM1 (sequestosome)Nup214, both containing C-terminal portions of Nup214. SETNup214 nuclear bodies containing the nuclear export receptor CRM1 were observed in the leukemia cell lines LOUCY and MEGAL. Overexpression of SET-Nup214 in HeLa cells leads to the formation of similar nuclear bodies that recruit CRM1, export cargo proteins, and certain nucleoporins and concomitantly affect nuclear protein and poly(A)(+) RNA export. SQSTM1-Nup214, although mostly cytoplasmic, also forms nuclear bodies and inhibits nuclear protein but not poly(A)(+) RNA export. The interaction of the fusion proteins with CRM1 is RanGTP-dependent, as shown in co-immunoprecipitation experiments and binding assays. Further analysis revealed that the Nup214 parts mediate the inhibition of nuclear export, whereas the SET or SQSTM1 part determines the localization of the fusion protein and therefore the extent of the effect. SETNup214 nuclear bodies are highly mobile structures, which are in equilibrium with the nucleoplasm in interphase and disassemble during mitosis or upon treatment of cells with the CRM1-inhibitor leptomycin B. Strikingly, we found that nucleoporins can be released from nuclear bodies and reintegrated into existing NPC. Our results point to nuclear bodies as a means of preventing the formation of potentially insoluble and harmful protein aggregates that also may serve as storage compartments for nuclear transport factors.	[Port, Sarah A.; Spillner, Christiane; Kehlenbach, Ralph H.] Georg August Univ, Fac Med, Dept Mol Biol, Humboldtallee 23, D-37073 Gottingen, Germany; [Port, Sarah A.; Spillner, Christiane; Kehlenbach, Ralph H.] Georg August Univ, Gottingen Ctr Mol Biosci GZMB, Humboldtallee 23, D-37073 Gottingen, Germany; [Mendes, Adelia; Fahrenkrog, Birthe] Univ Libre Bruxelles, Inst Mol Biol & Med, B-6041 Charleroi, Belgium; [Valkova, Christina; Kaether, Christoph] Fritz Lipmann Inst, Leibniz Inst Aging, Beutenbergstr 11, D-07745 Jena, Germany	University of Gottingen; University of Gottingen; Universite Libre de Bruxelles; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Kehlenbach, RH (corresponding author), Georg August Univ, Fac Med, Dept Mol Biol, Humboldtallee 23, D-37073 Gottingen, Germany.; Kehlenbach, RH (corresponding author), Georg August Univ, Gottingen Ctr Mol Biosci GZMB, Humboldtallee 23, D-37073 Gottingen, Germany.	rkehlen@gwdg.de	Port, Sarah A./J-7188-2019	Port, Sarah A./0000-0002-1897-0510; Kehlenbach, Ralph/0000-0003-4920-9916	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 860]; Sachbeihilfe [KA1751/4-2]; Fonds de la Recherche Scientifique (FNRS) Belgium [T.0082.14, J.0136, F3/5/5-MCF/XH/FC-18103]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sachbeihilfe; Fonds de la Recherche Scientifique (FNRS) Belgium(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 860 (to R. H. K.), Sachbeihilfe KA1751/4-2 (to C. K.), and Grants T.0082.14 and J.0136 (to B. F.) and F3/5/5-MCF/XH/FC-18103 (to A. M.) from Fonds de la Recherche Scientifique (FNRS) Belgium. The authors declare that they have no conflicts of interest with the contents of this article.	Ausubel F. M., 2003, CALCIUM PHOSPHATE TR; Bastos R, 1997, J CELL BIOL, V137, P989, DOI 10.1083/jcb.137.5.989; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Conway AE, 2015, LEUKEMIA, V29, P423, DOI 10.1038/leu.2014.221; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dickmanns A, 2015, INT REV CEL MOL BIO, V320, P171, DOI 10.1016/bs.ircmb.2015.07.010; Dickmanns A, 2015, CELLS-BASEL, V4, P538, DOI 10.3390/cells4030538; Dolker N, 2013, STRUCTURE, V21, P1350, DOI 10.1016/j.str.2013.05.015; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Ernoult-Lange M, 2009, MOL BIOL CELL, V20, P176, DOI 10.1091/mbc.E08-09-0904; Fong KW, 2013, J CELL BIOL, V203, P149, DOI 10.1083/jcb.201303145; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FORNEROD M, 1995, ONCOGENE, V10, P1739; Fornerod M, 1996, ONCOGENE, V13, P1801; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Fu GK, 1997, P NATL ACAD SCI USA, V94, P1811, DOI 10.1073/pnas.94.5.1811; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Gorello P, 2010, HAEMATOL-HEMATOL J, V95, P2161, DOI 10.3324/haematol.2010.029769; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kirli K, 2015, ELIFE, V4, DOI 10.7554/eLife.11466; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Knockenhauer KE, 2016, CELL, V164, P1162, DOI 10.1016/j.cell.2016.01.034; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Milles S, 2013, EMBO REP, V14, P178, DOI 10.1038/embor.2012.204; Oka M, 2016, ELIFE, V5, DOI 10.7554/eLife.09540; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Port SA, 2015, CELL REP, V13, P690, DOI 10.1016/j.celrep.2015.09.042; Quentmeier H, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-3; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; Roloff S, 2013, J BIOL CHEM, V288, P3952, DOI 10.1074/jbc.M112.433243; Romana S, 2016, CHROMOSOMA, V125, P789, DOI 10.1007/s00412-015-0567-0; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Saito S, 2016, MOL CELL BIOL, V36, P1820, DOI 10.1128/MCB.00158-16; Thakar K, 2013, MOL CELL PROTEOMICS, V12, P664, DOI 10.1074/mcp.M112.024877; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1990, MOL CELL BIOL, V10, P4016, DOI 10.1128/MCB.10.8.4016; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Waldmann I, 2012, J CELL SCI, V125, P144, DOI 10.1242/jcs.090316; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhou MH, 2014, ONCOL LETT, V8, P959, DOI 10.3892/ol.2014.2263; Zwerger M, 2016, NUCLEUS-PHILA, V7, P1, DOI 10.1080/19491034.2015.1130197	66	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23068	23083		10.1074/jbc.M116.735340	http://dx.doi.org/10.1074/jbc.M116.735340			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613868	Green Published, hybrid			2022-12-28	WOS:000387224800019
J	Baboolal, TG; Mashanov, GI; Nenasheva, TA; Peckham, M; Molloy, JE				Baboolal, Thomas G.; Mashanov, Gregory I.; Nenasheva, Tatiana A.; Peckham, Michelle; Molloy, Justin E.			A Combination of Diffusion and Active Translocation Localizes Myosin 10 to the Filopodial Tip	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; molecular imaging; myosin; single particle analysis; single-molecule biophysics; TIRF	SINGLE MOLECULES; MOTOR-ACTIVITY; UNCONVENTIONAL MYOSIN; CARGO RECOGNITION; STRUCTURAL BASIS; BUNDLED ACTIN; DOMAIN; FILAMENTS; CELLS; MOTILITY	Myosin 10 is an actin-based molecular motor that localizes to the tips of filopodia in mammalian cells. To understand how it is targeted to this distinct region of the cell, we have used total internal reflection fluorescence microscopy to study the movement of individual full-length and truncated GFP-tagged molecules. Truncation mutants lacking the motor region failed to localize to filopodial tips but still bound transiently at the plasma membrane. Deletion of the single -helical and anti-parallel coiled-coil forming regions, which lie between the motor and pleckstrin homology domains, reduced the instantaneous velocity of intrafilopodial movement but did not affect the number of substrate adherent filopodia. Deletion of the anti-parallel coiled-coil forming region, but not the EKR-rich region of the single -helical domain, restored intrafilopodial trafficking, suggesting this region is important in determining myosin 10 motility. We propose a model by which myosin 10 rapidly targets to the filopodial tip via a sequential reduction in dimensionality. Molecules first undergo rapid diffusion within the three-dimensional volume of the cell body. They then exhibit periods of slower two-dimensional diffusion in the plane of the plasma membrane. Finally, they move in a unidimensional, highly directed manner along the polarized actin filament bundle within the filopodium becoming confined to a single point at the tip. Here we have observed directly each phase of the trafficking process using single molecule fluorescence imaging of live cells and have quantified our observations using single particle tracking, autocorrelation analysis, and kymographs.	[Baboolal, Thomas G.; Peckham, Michelle] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Baboolal, Thomas G.; Peckham, Michelle] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Mashanov, Gregory I.; Nenasheva, Tatiana A.; Molloy, Justin E.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	University of Leeds; University of Leeds; Francis Crick Institute	Peckham, M (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.; Peckham, M (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Molloy, JE (corresponding author), Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England.	m.peckham@leeds.ac.uk; justin.molloy@crick.ac.uk	Peckham, Michelle/J-4991-2015; Baboolal, Thomas/AAA-5491-2019; Nenasheva, Tatiana/AAM-8556-2020	Peckham, Michelle/0000-0002-3754-2028; Baboolal, Thomas/0000-0003-4444-0318; Nenasheva, Tatiana/0000-0002-1669-5244; Molloy, Justin/0000-0002-8307-2450	Francis Crick Institute [FC001119]; UK Medical Research Council [FC001119]; Wellcome Trust [FC001119]; Biotechnology and Biological Sciences Research Council, UK [BB/C004906/1, BB/M009114/1]; European Molecular Biology Organization Fellowship; Cancer Research UK; BBSRC [BB/M009114/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M009114/1, BB/C004906/1] Funding Source: researchfish; Medical Research Council [1106254] Funding Source: researchfish; The Francis Crick Institute [10119] Funding Source: researchfish	Francis Crick Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization Fellowship(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK Grant FC001119, UK Medical Research Council Grant FC001119, Wellcome Trust Grant FC001119, Biotechnology and Biological Sciences Research Council, UK, Grants BB/C004906/1 and BB/M009114/1, and a short term European Molecular Biology Organization Fellowship (to T. A. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Billington N, 2015, CURR BIOL, V25, P942, DOI 10.1016/j.cub.2015.02.012; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; Creed SJ, 2011, EXP CELL RES, V317, P249, DOI 10.1016/j.yexcr.2010.10.019; Gunning PW, 2015, J CELL SCI, V128, P2009, DOI 10.1242/jcs.165563; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Lu Q, 2011, MOL BIOL CELL, V22, P4268, DOI 10.1091/mbc.E11-04-0354; Makowska KA, 2015, CELL REP, V13, P2118, DOI 10.1016/j.celrep.2015.11.012; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Mashanov GI, 2010, J BIOL CHEM, V285, P3664, DOI 10.1074/jbc.M109.039974; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Peckham M, 2011, BIOCHEM SOC T, V39, P1142, DOI 10.1042/BST0391142; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Ricca BL, 2010, BIOPHYS J, V99, P1818, DOI 10.1016/j.bpj.2010.06.066; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Svitkina TM, 2013, CURR OPIN CELL BIOL, V25, P574, DOI 10.1016/j.ceb.2013.04.003; Tacon D, 2004, BIOCHEM SOC T, V32, P689, DOI 10.1042/BST0320689; Takagi Y, 2014, P NATL ACAD SCI USA, V111, pE1833, DOI 10.1073/pnas.1320122111; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Vavra KC, 2016, BIOPHYS J, V110, P2517, DOI 10.1016/j.bpj.2016.04.048; Watanabe TM, 2010, J BIOL CHEM, V285, P19605, DOI 10.1074/jbc.M109.093864; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	49	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22373	22385		10.1074/jbc.M116.730689	http://dx.doi.org/10.1074/jbc.M116.730689			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27566544	Green Published, hybrid			2022-12-28	WOS:000386760600003
J	Moreno, E; Plata, C; Rodriguez-Gama, A; Argaiz, ER; Vazquez, N; Leyva-Rios, K; Islas, L; Cutler, C; Pacheco-Alvarez, D; Mercado, A; Carino-Cortes, R; Castaneda-Bueno, M; Gamba, G				Moreno, Erika; Plata, Consuelo; Rodriguez-Gama, Alejandro; Argaiz, Eduardo R.; Vazquez, Norma; Leyva-Rios, Karla; Islas, Leon; Cutler, Christopher; Pacheco-Alvarez, Diana; Mercado, Adriana; Carino-Cortes, Raquel; Castaneda-Bueno, Maria; Gamba, Gerardo			The European Eel NCC Gene Encodes a Thiazide-resistant Na-Cl Cotransporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; renal physiology; sodium transport; structure-function; transporter	CATION-CHLORIDE-COTRANSPORTERS; SENSITIVE NA+; INTRACELLULAR CHLORIDE; MUTATIONS; HYPERTENSION; KINASES; FAMILY; SPAK; PATHOPHYSIOLOGY; TRANSPORTERS	The thiazide-sensitive Na-Cl cotransporter (NCC) is the major pathway for salt reabsorption in the mammalian distal convoluted tubule. NCC plays a key role in the regulation of blood pressure. Its inhibition with thiazides constitutes the primary baseline therapy for arterial hypertension. However, the thiazide-binding site in NCC is unknown. Mammals have only one gene encoding for NCC. The eel, however, contains a duplicate gene. NCC is an ortholog of mammalian NCC and is expressed in the kidney. NCC is present in the apical membrane of the rectum. Here we cloned and functionally characterized NCC from the European eel. The cRNA encodes a 1043-amino acid membrane protein that, when expressed in Xenopus oocytes, functions as an Na-Cl cotransporter with two major characteristics, making it different from other known NCCs. First, eel NCC is resistant to thiazides. Single-point mutagenesis supports that the absence of thiazide inhibition is, at least in part, due to the substitution of a conserved serine for a cysteine at position 379. Second, NCC is not activated by low-chloride hypotonic stress, although the unique Ste20-related proline alanine-rich kinase (SPAK) binding site in the amino-terminal domain is conserved. Thus, NCC exhibits significant functional differences from NCCs that could be helpful in defining several aspects of the structure-function relationship of this important cotransporter.	[Moreno, Erika; Plata, Consuelo; Argaiz, Eduardo R.; Vazquez, Norma; Castaneda-Bueno, Maria; Gamba, Gerardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14080, DF, Mexico; [Rodriguez-Gama, Alejandro; Argaiz, Eduardo R.; Vazquez, Norma; Leyva-Rios, Karla; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Mol Physiol Unit, Inst Invest Biomed, Mexico City 14080, DF, Mexico; [Islas, Leon] Univ Nacl Autonoma Mexico, Fac Med, Dept Physiol, Mexico City 04510, DF, Mexico; [Cutler, Christopher] Georgia Southern Univ, Dept Biol, Statesboro, GA 30460 USA; [Pacheco-Alvarez, Diana] Univ Panamer, Escuela Med, Mexico City 03920, DF, Mexico; [Mercado, Adriana] Inst Nacl Cardiol Ignacio Chavez, Dept Nephrol, Mexico City 14080, DF, Mexico; [Carino-Cortes, Raquel] Univ Autonoma Estado Hidalgo, Sch Med, Pachuca 42034, Hidalgo, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University System of Georgia; Georgia Southern University; Universidad Panamericana - Ciudad de Mexico; National Institute of Cardiology - Mexico; Universidad Autonoma del Estado de Hidalgo	Gamba, G (corresponding author), Vasco de Quiroga 15, Mexico City 14080, DF, Mexico.	gamba@biomedicas.unam.mx	Plata, Consuelo/M-6461-2019; Mercado, Adriana/AAR-6143-2021; CASTANEDA-BUENO, MARIA/GYR-1202-2022; Cariño-Cortes, Raquel/E-5302-2018; Gamba, Gerardo/P-4873-2016; Plata, Consuelo/M-4482-2015	Mercado, Adriana/0000-0002-6881-0160; Argaiz, Eduardo/0000-0002-5542-6098; Carino, Raquel/0000-0003-4776-3534; Pacheco-Alvarez, Diana/0000-0001-5454-9267; Rodriguez Gama, Alejandro/0000-0003-3257-5549; Gamba, Gerardo/0000-0002-4378-9043; Plata, Consuelo/0000-0001-9340-8950; Castaneda-Bueno, Maria/0000-0002-5801-3504; Moreno Martinez, Reyna Erika/0000-0002-7563-0379	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [222918, 165815, 188712]; National Science Foundation [NSF-IOS 0844818]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT) Grants 222918 (to E. M.) and 165815 and 188712 (to G. G.) and National Science Foundation Grant NSF-IOS 0844818 (to C. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Appel LJ, 2002, JAMA-J AM MED ASSOC, V288, P3039, DOI 10.1001/jama.288.23.3039; Bazua-Valenti S, 2015, J AM SOC NEPHROL, V26, P1781, DOI 10.1681/ASN.2014050470; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Castaneda-Bueno M, 2010, AM J PHYSIOL-RENAL, V299, pF1111, DOI 10.1152/ajprenal.00412.2010; Chavez-Canales M, 2014, HYPERTENSION, V64, P1047, DOI 10.1161/HYPERTENSIONAHA.114.04036; Coady MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC124, DOI 10.1152/ajpcell.00220.2009; Cutler CP, 2008, COMP BIOCHEM PHYS B, V149, P63, DOI 10.1016/j.cbpb.2007.08.007; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gamba G, 2009, AM J PHYSIOL-RENAL, V297, pF838, DOI 10.1152/ajprenal.00159.2009; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lagnaz D, 2014, AM J PHYSIOL-RENAL, V307, pF275, DOI 10.1152/ajprenal.00574.2013; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Moes AD, 2014, PFLUG ARCH EUR J PHY, V466, P107, DOI 10.1007/s00424-013-1407-9; Monroy A, 2000, AM J PHYSIOL-RENAL, V279, pF161, DOI 10.1152/ajprenal.2000.279.1.F161; Moreno E, 2006, J BIOL CHEM, V281, P17266, DOI 10.1074/jbc.M602614200; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; Arroyo JP, 2013, MOL ASPECTS MED, V34, P288, DOI 10.1016/j.mam.2012.05.002; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Plata C, 2001, AM J PHYSIOL-RENAL, V280, pF574, DOI 10.1152/ajprenal.2001.280.4.F574; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Tovar-Palacio C, 2004, AM J PHYSIOL-RENAL, V287, pF570, DOI 10.1152/ajprenal.00124.2004; Vazquez N, 2002, AM J PHYSIOL-RENAL, V282, pF599, DOI 10.1152/ajprenal.00284.2001; Wang YF, 2009, AM J PHYSIOL-REG I, V296, pR1650, DOI 10.1152/ajpregu.00119.2009; Watanabe S, 2011, COMP BIOCHEM PHYS A, V159, P427, DOI 10.1016/j.cbpa.2011.04.009; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005	39	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22472	22481		10.1074/jbc.M116.742783	http://dx.doi.org/10.1074/jbc.M116.742783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587391	Green Published, hybrid			2022-12-28	WOS:000386760600010
J	Entingh-Pearsall, A; Kahn, CR				Entingh-Pearsall, Amelia; Kahn, C. Ronald			Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I (vol 279, pg 38016, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228				Entingh-Pearsall A, 2004, J BIOL CHEM, V279, P38016, DOI 10.1074/jbc.M313201200	1	4	4	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22339	22340		10.1074/jbc.A116.313201	http://dx.doi.org/10.1074/jbc.A116.313201			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27742877	Green Published, hybrid			2022-12-28	WOS:000386332600044
J	Bezawork-Geleta, A; Dong, LF; Rohlena, J; Neuzil, J				Bezawork-Geleta, Ayenachew; Dong, Lanfeng; Rohlena, Jakub; Neuzil, Jiri			The Assembly Factor SDHAF2 Is Dispensable for Flavination of the Catalytic Subunit of Mitochondrial Complex II in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell biology; mammal; mitochondria; mitochondrial respiratory chain complex; SDH assembly factor; SDHA; complex II assembly; flavinylation; mitochondrial complex II; succinate dehydrogenase; flavin adenine dinucleotide; flavination; assembly factor; SDHAF2; cancer cells	SUCCINATE-UBIQUINONE OXIDOREDUCTASE; GASTROINTESTINAL STROMAL TUMORS; FLAVINYLATION FACTOR SDH5; RESPIRATORY-CHAIN; PYRUVATE CARBOXYLATION; BINDING-SITE; DEHYDROGENASE; MUTATIONS; GENE; FLAVOPROTEIN	Mitochondrial complex II or succinate dehydrogenase (SDH) is at the crossroads of oxidative phosphorylation and the tricarboxylic acid cycle. It has been shown that Sdh5 (SDHAF2/SDH5 in mammals) is required for flavination of the subunit Sdh1 (SDHA in human cells) in yeast. Here we demonstrate that in human breast cancer cells, SDHAF2/SDH5 is dispensable for SDHA flavination. In contrast to yeast, CRISPR-Cas9 nickase-mediated SDHAF2 KO breast cancer cells feature flavinated SDHA and retain fully assembled and functional complex II, as well as normal mitochondrial respiration. Our data show that SDHA flavination is independent of SDHAF2 in breast cancer cells, employing an alternative mechanism.	[Bezawork-Geleta, Ayenachew; Dong, Lanfeng; Neuzil, Jiri] Griffith Univ, Sch Med Sci, Southport, Qld 4222, Australia; [Rohlena, Jakub; Neuzil, Jiri] Acad Sci Czech Republic, Inst Biotechnol, Prague 25250, Czech Republic	Griffith University; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences	Bezawork-Geleta, A; Neuzil, J (corresponding author), Griffith Univ, Mitochondria Apoptosis & Canc Res Grp, Sch Med Sci, Menzies Hlth Inst Queensland, Southport, Qld 4222, Australia.	a.bezawork-geleta@griffith.edu.au; j.neuzil@griffith.edu.au	DONG, LANFENG/S-8805-2019; Neuzil, Jiri/H-7204-2014; Rohlena, Jakub/H-6699-2014	Neuzil, Jiri/0000-0002-2478-2460; Rohlena, Jakub/0000-0001-5427-6502; Dong, Lanfeng/0000-0002-9857-6352; Bezawork-Geleta, Ayenachew/0000-0001-5404-5093	Australian Research Council; Griffith University New Researcher grant; Czech Research Foundation [15-02203S, 16-22823S]; BIOCEV [CZ.1.05/1.1.00/02.0109]	Australian Research Council(Australian Research Council); Griffith University New Researcher grant; Czech Research Foundation; BIOCEV	This work was supported by a grant from the Australian Research Council, a Griffith University New Researcher grant, Czech Research Foundation Grants 15-02203S and 16-22823S, and funding from BIOCEV (Grant CZ.1.05/1.1.00/02.0109). The authors declare that they have no conflicts of interest with the contents of this article.	Acin-Perez R, 2014, CELL METAB, V19, P1020, DOI 10.1016/j.cmet.2014.04.015; Ackrell BAC, 2000, FEBS LETT, V466, P1, DOI 10.1016/S0014-5793(99)01749-4; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Bezawork-Geleta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17397; Bezawork-Geleta A, 2014, FASEB J, V28, P1794, DOI 10.1096/fj.13-242420; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Eletsky A, 2012, BIOCHEMISTRY-US, V51, P8475, DOI 10.1021/bi301171u; Favier J, 2015, NAT REV ENDOCRINOL, V11, P101, DOI 10.1038/nrendo.2014.188; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; Grimm S, 2013, BBA-BIOENERGETICS, V1827, P565, DOI 10.1016/j.bbabio.2012.09.009; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hechtman JF, 2015, GENE CHROMOSOME CANC, V54, P177, DOI 10.1002/gcc.22230; Huang SB, 2013, PLANT J, V73, P429, DOI 10.1111/tpj.12041; Italiano A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-408; Kluckova K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.110; Kluckova Katarina, 2015, Methods Mol Biol, V1265, P181, DOI 10.1007/978-1-4939-2288-8_14; Kluckova K, 2013, BBA-BIOENERGETICS, V1827, P552, DOI 10.1016/j.bbabio.2012.10.015; Kounosu A, 2014, FEBS LETT, V588, P1058, DOI 10.1016/j.febslet.2014.02.022; Lemarie A, 2011, CELL DEATH DIFFER, V18, P338, DOI 10.1038/cdd.2010.93; Liu J, 2013, J BIOL CHEM, V288, P29965, DOI 10.1074/jbc.M113.450106; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005; Maklashina E, 2016, J BIOL CHEM, V291, P2904, DOI 10.1074/jbc.M115.690396; McNeil MB, 2013, BIOCHEMISTRY-US, V52, P7628, DOI 10.1021/bi401006a; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Nath AK, 2015, CELL REP, V10, P694, DOI 10.1016/j.celrep.2015.01.010; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Siebels I, 2013, BBA-BIOENERGETICS, V1827, P1156, DOI 10.1016/j.bbabio.2013.06.005; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Van Vranken JG, 2015, CRIT REV BIOCHEM MOL, V50, P168, DOI 10.3109/10409238.2014.990556; Vondrusova Magdalena, 2015, Methods Mol Biol, V1265, P195, DOI 10.1007/978-1-4939-2288-8_15; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yan B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1394-7; Zafreen L, 2016, ARCH BIOCHEM BIOPHYS, V604, P47, DOI 10.1016/j.abb.2016.06.006	47	10	11	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21414	21420		10.1074/jbc.C116.755017	http://dx.doi.org/10.1074/jbc.C116.755017			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27587393	hybrid, Green Published			2022-12-28	WOS:000385999200007
J	Mosca, B; Eckhardt, J; Bergamelli, L; Treves, S; Bongianino, R; De Negri, M; Priori, SG; Protasi, F; Zorzato, F				Mosca, Barbara; Eckhardt, Jan; Bergamelli, Leda; Treves, Susan; Bongianino, Rossana; De Negri, Marco; Priori, Silvia G.; Protasi, Feliciano; Zorzato, Francesco			Role of the JP45-calsequestrin complex on calcium entry in slow twitch skeletal muscles (vol 291, pg 14555, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Priori, Silvia G G/A-6116-2014; Priori, Silvia G/ABH-6894-2020; /AAD-2015-2020; denegri, marco/D-9307-2019	Priori, Silvia G G/0000-0001-6877-0288; Priori, Silvia G/0000-0001-6877-0288; denegri, marco/0000-0003-1665-0625; Treves, Susan/0000-0002-0007-9631; Bongianino, Rossana/0000-0002-7880-1065				Mosca B, 2016, J BIOL CHEM, V291, P14555, DOI 10.1074/jbc.M115.709071	1	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20824	20824		10.1074/jbc.A115.709071	http://dx.doi.org/10.1074/jbc.A115.709071			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27664065	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000384574800044
J	Baker-Nigh, AT; Mawuenyega, KG; Bollinger, JG; Ovod, V; Kasten, T; Franklin, EE; Liao, F; Jiang, H; Holtzman, D; Cairns, NJ; Morris, JC; Bateman, RJ				Baker-Nigh, Alaina T.; Mawuenyega, Kwasi G.; Bollinger, James G.; Ovod, Vitaliy; Kasten, Tom; Franklin, Erin E.; Liao, Fan; Jiang, Hong; Holtzman, David; Cairns, Nigel J.; Morris, John C.; Bateman, Randall J.			Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E ISOFORMS; ONSET ALZHEIMER-DISEASE; TANDEM MASS-SPECTROMETRY; A-BETA CLEARANCE; CEREBROSPINAL-FLUID; NEUROPATHOLOGIC ASSESSMENT; E GENOTYPE; PEPTIDE; LIPOPROTEINS; PROTEIN	The risk of Alzheimer's disease (AD) is highly dependent on apolipoprotein-E (apoE) genotype. The reasons for apoE isoform-selective risk are uncertain; however, both the amounts and structure of human apoE isoforms have been hypothesized to lead to amyloidosis increasing the risk for AD. To address the hypothesis that amounts of apoE isoforms are different in the human CNS, we developed a novel isoform-specific method to accurately quantify apoE isoforms in clinically relevant samples. The method utilizes an antibody-free enrichment step and isotope-labeled physiologically relevant lipoprotein particle standards produced by immortalized astrocytes. We applied this method to a cohort of well characterized clinical samples and observed the following findings. The apoE isoform amounts are not different in cerebrospinal fluid (CSF) from young normal controls, suggesting that the amount of apoE isoforms is not the reason for risk of amyloidosis prior to the onset of advanced age. We did, however, observe an age-related increase in both apoE isoforms. In contrast to normal aging, the presence of amyloid increased apoE3, whereas apoE4 was unchanged or decreased. Importantly, for heterozygotes, the apoE4/apoE3 isoform ratio was increased in the CNS, although the reverse was true in the periphery. Finally, CSF apoE levels, but not plasma apoE levels, correlated with CSF beta-amyloid levels. Collectively, these findings support the hypothesis that CNS and peripheral apoE are separate pools and differentially regulated. Furthermore, these results suggest that apoE mechanisms for the risk of amyloidosis and AD are related to an interaction between apoE, aging, and the amount of amyloid burden.	[Baker-Nigh, Alaina T.; Mawuenyega, Kwasi G.; Bollinger, James G.; Ovod, Vitaliy; Kasten, Tom; Liao, Fan; Jiang, Hong; Holtzman, David; Cairns, Nigel J.; Morris, John C.; Bateman, Randall J.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Franklin, Erin E.; Cairns, Nigel J.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Franklin, Erin E.; Holtzman, David; Cairns, Nigel J.; Morris, John C.; Bateman, Randall J.] Washington Univ, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Holtzman, David; Cairns, Nigel J.; Morris, John C.; Bateman, Randall J.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bateman, RJ (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,Box 8111, St Louis, MO 63110 USA.	batemanr@wustl.edu	Cairns, Nigel/AAB-9713-2020; Baker-Nigh, Alaina/AAM-9568-2020	Cairns, Nigel/0000-0001-9858-3344; Baker-Nigh, Alaina/0000-0002-4627-6024; Holtzman, David/0000-0002-3400-0856; Liao, Fan/0000-0003-4874-460X; Bateman, Randall/0000-0002-7729-1702; Ovod, Vitaliy/0000-0001-6722-4883	National Institutes of Health [5P50AG005681-31, R01NS065667, P01AG003991, P01AG026276]; Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026276, P50AG005681, P01AG003991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants 5P50AG005681-31, R01NS065667, P01AG003991, and P01AG026276 and the Alzheimer's Drug Discovery Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Belinson H, 2010, J ALZHEIMERS DIS, V22, P959, DOI 10.3233/JAD-2010-101008; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Blalock EM, 2003, J NEUROSCI, V23, P3807; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Cairns NJ, 2010, ALZHEIMERS DEMENT, V6, P274, DOI 10.1016/j.jalz.2010.03.012; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Christensen DZ, 2010, ACTA NEUROPATHOL, V119, P555, DOI 10.1007/s00401-010-0666-1; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dorey E, 2014, NEUROSCI BULL, V30, P317, DOI 10.1007/s12264-013-1422-z; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Fukumoto H, 2003, EXP NEUROL, V183, P249, DOI 10.1016/S0014-4886(03)00088-8; Fukuyama R, 2000, EUR NEUROL, V43, P161, DOI 10.1159/000008157; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; Hoofnagle AN, 2009, J IMMUNOL METHODS, V347, P3, DOI 10.1016/j.jim.2009.06.003; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P51, DOI 10.1001/archneurol.2011.235; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; KRUL ES, 1988, J LIPID RES, V29, P1309; Liao F, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0250-y; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Martinez-Morillo E, 2014, ACTA NEUROPATHOL, V127, P633, DOI 10.1007/s00401-014-1266-2; Martinez-Morillo E, 2014, J PROTEOME RES, V13, P1077, DOI 10.1021/pr401060x; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Oikawa N, 2014, J NEUROSCI RES, V92, P641, DOI 10.1002/jnr.23341; Panza F, 2003, NEUROREPORT, V14, P605, DOI 10.1097/00001756-200303240-00016; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Potter R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005615; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Simon R, 2012, MOL CELL PROTEOMICS, V11, P1389, DOI 10.1074/mcp.M112.018861; STEINMETZ A, 1989, ARTERIOSCLEROSIS, V9, P405, DOI 10.1161/01.ATV.9.3.405; Stratman NC, 2005, CHEM PHYS LIPIDS, V137, P52, DOI 10.1016/j.chemphyslip.2005.06.005; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Toledo JB, 2014, ACTA NEUROPATHOL, V127, P621, DOI 10.1007/s00401-013-1236-0; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wahrle SE, 2003, EXP NEUROL, V183, P4, DOI 10.1016/S0014-4886(03)00185-7; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Wildsmith KR, 2009, ANAL BIOCHEM, V395, P116, DOI 10.1016/j.ab.2009.07.049; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zhao WJ, 2014, HUM MOL GENET, V23, P1365, DOI 10.1093/hmg/ddt525	62	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27204	27218		10.1074/jbc.M116.721779	http://dx.doi.org/10.1074/jbc.M116.721779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27793990	Green Published, hybrid			2022-12-28	WOS:000391576300019
J	Chandramouli, B; Bernacchioni, C; Di Maio, D; Turano, P; Brancato, G				Chandramouli, Balasubramanian; Bernacchioni, Caterina; Di Maio, Danilo; Turano, Paola; Brancato, Giuseppe			Electrostatic and Structural Bases of Fe2+ Translocation through Ferritin Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ferritin; ion channel; iron; molecular dynamics; translocation; ferritin channels; iron uptake; multi-ion mechanism; structure	PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; PROTEIN NANOCAGES; BINDING SITES; IRON-BINDING; ION CHANNELS; SUBSTRATE; RESIDUES; STORAGE; MECHANISM	Ferritin molecular cages are marvelous 24-mer supramolecular architectures that enable massive iron storage (>2000 iron atoms) within their inner cavity. This cavity is connected to the outer environment by two channels at C3 and C4 symmetry axes of the assembly. Ferritins can also be exploited as carriers for in vivo imaging and therapeutic applications, owing to their capability to effectively protect synthetic non-endogenous agents within the cage cavity and deliver them to targeted tissue cells without stimulating adverse immune responses. Recently, X-ray crystal structures of Fe2+-loaded ferritins provided important information on the pathways followed by iron ions toward the ferritin cavity and the catalytic centers within the protein. However, the specific mechanisms enabling Fe2+ uptake through wild-type and mutant ferritin channels is largely unknown. To shed light on this question, we report extensive molecular dynamics simulations, site-directed mutagenesis, and kinetic measurements that characterize the transport properties and translocation mechanism of Fe2+ through the two ferritin channels, using the wild-type bullfrog Rana catesbeiana H protein and some of its variants as case studies. We describe the structural features that determine Fe2+ translocation with atomistic detail, and we propose a putative mechanism for Fe2+ transport through the channel at the C3 symmetry axis, which is the only iron-permeable channel in vertebrate ferritins. Our findings have important implications for understanding how ion permeation occurs, and further how it may be controlled via purposely engineered channels for novel biomedical applications based on ferritin.	[Chandramouli, Balasubramanian; Di Maio, Danilo; Brancato, Giuseppe] Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy; [Chandramouli, Balasubramanian; Di Maio, Danilo; Brancato, Giuseppe] INFN, Sez Pisa, Largo Bruno Pontecorvo 3, I-56127 Pisa, Italy; [Bernacchioni, Caterina; Turano, Paola] Univ Florence, Magnet Resonance Ctr CERM, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy; [Chandramouli, Balasubramanian; Turano, Paola] Univ Florence, Dept Chem, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy	Scuola Normale Superiore di Pisa; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; University of Florence	Chandramouli, B; Brancato, G (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy.	bala.chandramouli@sns.it; giuseppe.brancato@sns.it	Brancato, Giuseppe/A-4346-2010; CHANDRAMOULI, BALASUBRAMANIAN/L-9556-2018; Brancato, Giuseppe/U-7083-2019; Turano, Paola/F-9089-2011	CHANDRAMOULI, BALASUBRAMANIAN/0000-0002-6837-4709; Brancato, Giuseppe/0000-0001-8059-2517; Turano, Paola/0000-0002-7683-8614; Bernacchioni, Caterina/0000-0002-1023-0067	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) through the PRIN program [2012SK7ASN]; Scuola Normale Superiore Young Researchers Grant [2015/58]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) through the PRIN program; Scuola Normale Superiore Young Researchers Grant	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) through the PRIN program (Contract 2012SK7ASN). This work was also supported by a Scuola Normale Superiore Young Researchers Grant (2015/58) (to B.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Arosio P, 2015, BIOCHEM J, V472, P1, DOI 10.1042/BJ20150787; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Banghart MR, 2006, BIOCHEMISTRY-US, V45, P15129, DOI 10.1021/bi0618058; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Behera RK, 2015, J BIOL INORG CHEM, V20, P957, DOI 10.1007/s00775-015-1279-x; Behera RK, 2014, P NATL ACAD SCI USA, V111, P7925, DOI 10.1073/pnas.1318417111; Bernacchioni C, 2016, RSC ADV, V6, P21219, DOI 10.1039/c5ra25056k; Bernacchioni C, 2016, CHEM-EUR J, V22, P16213, DOI 10.1002/chem.201602842; Bernacchioni C, 2015, BBA-PROTEINS PROTEOM, V1854, P1118, DOI 10.1016/j.bbapap.2015.02.011; Bernacchioni C, 2014, ACS CHEM BIOL, V9, P2517, DOI 10.1021/cb500431r; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; Bou-Abdallah F, 2010, BBA-GEN SUBJECTS, V1800, P719, DOI 10.1016/j.bbagen.2010.03.021; Chandramouli B, 2016, BBA-BIOMEMBRANES, V1858, P689, DOI 10.1016/j.bbamem.2015.12.030; Chandramouli B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120196; Chasteen ND, 1998, MET IONS BIOL SYST, V35, P479; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Di Maio D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140258; Ebrahimi KH, 2015, CHEM REV, V115, P295, DOI 10.1021/cr5004908; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Heger Z, 2014, NANOMEDICINE-UK, V9, P2233, DOI [10.2217/NNM.14.119, 10.2217/nnm.14.119]; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jutz G, 2015, CHEM REV, V115, P1653, DOI 10.1021/cr400011b; Laghaei R, 2013, PROTEINS, V81, P1042, DOI 10.1002/prot.24251; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pozzi C, 2015, ACTA CRYSTALLOGR D, V71, P1909, DOI 10.1107/S1399004715013073; Pozzi C, 2015, ACTA CRYSTALLOGR D, V71, P941, DOI 10.1107/S1399004715002333; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Theil EC, 2000, INORG CHIM ACTA, V297, P242, DOI 10.1016/S0020-1693(99)00375-8; Theil EC, 2016, ACCOUNTS CHEM RES, V49, P784, DOI 10.1021/ar500469e; Theil EC, 2014, J BIOL INORG CHEM, V19, P615, DOI 10.1007/s00775-014-1103-z; Vasalatiy O, 2006, CONTRAST MEDIA MOL I, V1, P10, DOI 10.1002/cmmi.93	45	29	30	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25617	25628		10.1074/jbc.M116.748046	http://dx.doi.org/10.1074/jbc.M116.748046			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756844	hybrid, Green Published			2022-12-28	WOS:000390095300028
J	Mita, P; Savas, JN; Briggs, EM; Ha, S; Gnanakkan, V; Yates, JR; Robins, DM; David, G; Boeke, JD; Garabedian, MJ; Logan, SK				Mita, Paolo; Savas, Jeffrey N.; Briggs, Erica M.; Ha, Susan; Gnanakkan, Veena; Yates, John R.; Robins, Diane M.; David, Gregory; Boeke, Jef D.; Garabedian, Michael J.; Logan, Susan K.			URI Regulates KAP1 Phosphorylation and Transcriptional Repression via PP2A Phosphatase in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; prostate cancer; protein phosphatase 2 (PP2A); transcription regulation; transcription repressor; unconventional prefoldin RPB5 interactor (URI)	ANTISENSE PROMOTER; BINDING-PROTEIN; GENES; EXPRESSION; RETROTRANSPOSITION; METHYLTRANSFERASE; RETROELEMENTS; COMPLEXES; ELEMENTS; SUBUNIT	URI (unconventional prefoldin RPB5 interactor protein) is an unconventional prefoldin, RNA polymerase II interactor that functions as a transcriptional repressor and is part of a larger nuclear protein complex. The components of this complex and the mechanism of transcriptional repression have not been characterized. Here we show that KAP1 (KRAB-associated protein 1) and the protein phosphatase PP2A interact with URI. Mechanistically, we show that KAP1 phosphorylation is decreased following recruitment of PP2A by URI. We functionally characterize the novel URI-KAP1-PP2A complex, demonstrating a role of URI in retrotransposon repression, a key function previously demonstrated for the KAP1-SETDB1 complex. Microarray analysis of annotated transposons revealed a selective increase in the transcription of LINE-1 and L1PA2 retroelements upon knockdown of URI. These data unveil a new nuclear function of URI and identify a novel post-transcriptional regulation of KAP1 protein that may have important implications in reactivation of transposable elements in prostate cancer cells.	[Mita, Paolo; Boeke, Jef D.] NYU, Sch Med, Inst Syst Genet, New York, NY 10016 USA; [Mita, Paolo; Briggs, Erica M.; Ha, Susan; David, Gregory; Boeke, Jef D.; Logan, Susan K.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave,MSB424, New York, NY 10016 USA; [Ha, Susan; Garabedian, Michael J.; Logan, Susan K.] NYU, Sch Med, Dept Urol, 550 First Ave,MSB424, New York, NY 10016 USA; [Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Savas, Jeffrey N.; Yates, John R.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Gnanakkan, Veena; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Robins, Diane M.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	New York University; New York University; New York University; New York University; Scripps Research Institute; Johns Hopkins University; University of Michigan System; University of Michigan	Logan, SK (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave,MSB424, New York, NY 10016 USA.; Logan, SK (corresponding author), NYU, Sch Med, Dept Urol, 550 First Ave,MSB424, New York, NY 10016 USA.	susan.logan@nyumc.org		Robins, Diane M./0000-0001-6727-6309; Logan, Susan/0000-0002-7904-5927; , gregory/0000-0002-3371-4558	National Institutes of Health [R01 CA112226, P41 GM103533, R01 MH067880]; National Institute on Aging [F32 AG039127]; Department of Defense [W81XWH-10-1-0431]; urology department at New York University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA112226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107632, T32GM066704, P41GM103533, T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Defense(United States Department of Defense); urology department at New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 CA112226 (to S. K. L.) and P41 GM103533 and R01 MH067880 (to J. R. Y.), National Institute on Aging Fellowship F32 AG039127 (to J. N. S.), Department of Defense Fellowship W81XWH-10-1-0431 (to P. M.), and funds from the urology department at New York University School of Medicine (to S. K. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrova EA, 2012, GENE, V511, P46, DOI 10.1016/j.gene.2012.09.026; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Blasche S, 2013, METHODS MOL BIOL, V1064, P17, DOI 10.1007/978-1-62703-601-6_2; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Miron-Garcia MC, 2014, NUCLEIC ACIDS RES, V42, P9666, DOI 10.1093/nar/gku685; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Doucet-O'Hare TT, 2015, P NATL ACAD SCI USA, V112, pE4894, DOI 10.1073/pnas.1502474112; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Ewing AD, 2015, GENOME RES, V25, P1536, DOI 10.1101/gr.196238.115; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gnanakkan VP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-869; Goering W, 2011, CARCINOGENESIS, V32, P1484, DOI 10.1093/carcin/bgr181; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Guicciardi ME, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.17pe9; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kazazian HH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-62; Kirchner J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-36; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; LI XX, 2010, 2010 C MOD HYDR ENG, P1; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu JP, 2012, CELL CYCLE, V11, P2643, DOI 10.4161/cc.20957; Lu YY, 2013, CELL SIGNAL, V25, P479, DOI [10.1016/j.cellsig.2012.11.004, 10.3760/cma.j.issn.2095-4352.2013.08.008]; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Mita P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063879; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Nyswaner KM, 2008, GENETICS, V178, P197, DOI 10.1534/genetics.107.082602; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rangwala SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r100; Rodic N, 2015, NAT MED, V21, P1060, DOI 10.1038/nm.3919; Rodic N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003402; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wei WX, 2003, CELL RES, V13, P111, DOI 10.1038/sj.cr.7290155; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005	57	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25516	25528		10.1074/jbc.M116.741660	http://dx.doi.org/10.1074/jbc.M116.741660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27780869	hybrid, Green Published			2022-12-28	WOS:000390095300020
J	Hosoi, A; Su, Y; Torikai, M; Jono, H; Ishikawa, D; Soejima, K; Higuchi, H; Guo, J; Ueda, M; Suenaga, G; Motokawa, H; Ikeda, T; Senju, S; Nakashima, T; Ando, Y				Hosoi, Akihiko; Su, Yu; Torikai, Masaharu; Jono, Hirofumi; Ishikawa, Daisuke; Soejima, Kenji; Higuchi, Hirofumi; Guo, Jianying; Ueda, Mitsuharu; Suenaga, Genki; Motokawa, Hiroaki; Ikeda, Tokunori; Senju, Satoru; Nakashima, Toshihiro; Ando, Yukio			Novel Antibody for the Treatment of Transthyretin Amyloidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTIC EPITOPES; IN-VIVO; POLYNEUROPATHY; INHIBITION; EXPRESSION; DEPOSITION; MECHANISM; PROGRESS; PLASMA; TISSUE	Familial amyloidotic polyneuropathy (FAP) is a systemic amyloidosis mainly caused by amyloidogenic transthyretin (ATTR). This incurable disease causes death similar to 10 years after onset. Although it has been widely accepted that conformational change of the monomeric form of transthyretin (TTR) is very important for amyloid formation and deposition in the organs, no effective therapy targeting this step is available. In this study, we generated a mouse monoclonal antibody, T24, that recognized the cryptic epitope of conformationally changed TTR. T24 inhibited TTR accumulation in FAP model rats, which expressed human ATTR V30M in various tissues and exhibited non-fibrillar deposits of ATTR in the gastrointestinal tracts. Additionally, humanized T24 (RT24) inhibited TTR fibrillation and promoted macrophage phagocytosis of aggregated TTR. This antibody did not recognize normal serum TTR functioning properly in the blood. These results demonstrate that RT24 would be an effective novel therapeutic antibody for FAP.	[Hosoi, Akihiko; Torikai, Masaharu; Ishikawa, Daisuke; Soejima, Kenji; Higuchi, Hirofumi; Nakashima, Toshihiro] Chemoserotherapeut Res Inst KAKETSUKEN, 1314-1 Kyokushi Kawabe Kikuchi, Kumamoto 8691298, Japan; [Su, Yu; Guo, Jianying; Ueda, Mitsuharu; Suenaga, Genki; Motokawa, Hiroaki; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Ikeda, Tokunori; Senju, Satoru] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Jono, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Jono, Hirofumi] Kumamoto Univ Hosp, Dept Pharm, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto University	Nakashima, T (corresponding author), Chemoserotherapeut Res Inst KAKETSUKEN, 1314-1 Kyokushi Kawabe Kikuchi, Kumamoto 8691298, Japan.; Ando, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	nakashima-to@kaketsuken.or.jp; andoy709@kumamoto-u.ac.jp	Ikeda, Tokunori/S-6043-2019; Ueda, Mitsuharu/Q-8595-2019	Ando, Yukio/0000-0001-7115-9105	Adaptable and Seamless Technology Transfer Program through Target-driven RAMP;D, Japan Science and Technology Agency [AS2311336G]; Surveys and Research on Specific Disease, the Ministry of Health and Welfare of Japan; Ministry of Education, Sports, Science and Technology of Japan [24249036, 15H04841, 15K15195, 15K15006]	Adaptable and Seamless Technology Transfer Program through Target-driven RAMP;D, Japan Science and Technology Agency; Surveys and Research on Specific Disease, the Ministry of Health and Welfare of Japan; Ministry of Education, Sports, Science and Technology of Japan(Core Research for Evolutional Science and Technology (CREST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency, (AS2311336G), grants from the Surveys and Research on Specific Disease, the Ministry of Health and Welfare of Japan, Grants-in-Aid for Scientific Research from the Ministry of Education, Sports, Science and Technology of Japan: (A) 24249036 and (B) 15H04841, and Challenging Exploratory Research 15K15195 (to Y. A.) and 15K15006 (to H. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; Ando Y, 1996, TRANSPLANTATION, V62, P1037, DOI 10.1097/00007890-199610150-00028; Araki S, 2010, P JPN ACAD B-PHYS, V86, P694, DOI 10.2183/pjab.86.694; Arsequell G, 2012, CURR MED CHEM, V19, P2343, DOI 10.2174/092986712800269281; Bergstrom J, 2006, BIOCHEM BIOPH RES CO, V348, P532, DOI 10.1016/j.bbrc.2006.07.140; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Eneqvist T, 2002, BIOCHEMISTRY-US, V41, P13143, DOI 10.1021/bi025800w; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Falk RH, 2010, PROG CARDIOVASC DIS, V52, P347, DOI 10.1016/j.pcad.2009.11.007; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; GLENNER GG, 1980, NEW ENGL J MED, V302, P1333, DOI 10.1056/NEJM198006123022403; Goldsteins G, 1999, P NATL ACAD SCI USA, V96, P3108, DOI 10.1073/pnas.96.6.3108; GUSTAVSSON A, 1994, AM J PATHOL, V144, P1301; Haruta M, 2013, GENE THER, V20, P504, DOI 10.1038/gt.2012.59; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kohno K, 1997, AM J PATHOL, V150, P1497; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Matsubara K, 2003, PROTEIN EXPRES PURIF, V30, P55, DOI 10.1016/S1046-5928(03)00069-X; Phay M, 2014, REJUV RES, V17, P97, DOI 10.1089/rej.2013.1524; Said G, 2012, NAT REV DRUG DISCOV, V11, P185, DOI 10.1038/nrd3675; Su Y, 2012, AMYLOID, V19, P45, DOI 10.3109/13506129.2012.674075; Terazaki H, 2006, LAB INVEST, V86, P23, DOI 10.1038/labinvest.3700365; Ueda M, 2007, BIOCHEM BIOPH RES CO, V352, P299, DOI 10.1016/j.bbrc.2006.11.045; Ueda M, 2006, J RHEUMATOL, V33, P2260; Ueda M, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-19; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Wisniewski T, 2015, NEURON, V85, P1162, DOI 10.1016/j.neuron.2014.12.064; Yonemura H, 2004, J BIOCHEM, V135, P577, DOI 10.1093/jb/mvh070	33	29	38	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25096	25105		10.1074/jbc.M116.738138	http://dx.doi.org/10.1074/jbc.M116.738138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758856	Green Published, hybrid			2022-12-28	WOS:000388880100025
J	Dizhoor, AM; Olshevskaya, EV; Peshenko, IV				Dizhoor, Alexander M.; Olshevskaya, Elena V.; Peshenko, Igor V.			The R838S Mutation in Retinal Guanylyl Cyclase 1 (RetGC1) Alters Calcium Sensitivity of cGMP Synthesis in the Retina and Causes Blindness in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; ACTIVATING PROTEINS GCAPS; AUTOSOMAL-DOMINANT CONE; CAUSES PHOTORECEPTOR DEGENERATION; KNOCK-OUT MICE; 3 RD3 PROTEIN; ROD DYSTROPHY; MOUSE MODEL; DIMERIZATION DOMAIN; GENE-THERAPY	Substitutions of Arg(838) in the dimerization domain of a human retinal membrane guanylyl cyclase 1 (RetGC1) linked to autosomal dominant cone-rod degeneration type 6 (CORD6) change RetGC1 regulation in vitro by Ca2+. In addition, we find that R838S substitution makes RetGC1 less sensitive to inhibition by retinal degeneration-3 protein (RD3). We selectively expressed human R838S RetGC1 in mouse rods and documented the decline in rod vision and rod survival. To verify that changes in rods were specifically caused by the CORD6 mutation, we used for comparison cones, which in the same mice did not express R838S RetGC1 from the transgenic construct. The R838S RetGC1 expression in rod outer segments reduced inhibition of cGMP production in the transgenic mouse retinas at the free calcium concentrations typical for dark-adapted rods. The transgenic mice demonstrated early-onset and rapidly progressed with age decline in visual responses from the targeted rods, in contrast to the longer lasting preservation of function in the non-targeted cones. The decline in rod function in the retina resulted from a progressive degeneration of rods between 1 and 6 months of age, with the severity and pace of the degeneration consistent with the extent to which the Ca2+ sensitivity of the retinal cGMP production was affected. Our study presents a new experimental model for exploring cellular mechanisms of the CORD6-related photoreceptor death. This mouse model provides the first direct biochemical and physiological in vivo evidence for the Ares substitutions in RetGC1 being the culprit behind the pathogenesis of the CORD6 congenital blindness.	[Dizhoor, Alexander M.; Olshevskaya, Elena V.; Peshenko, Igor V.] Salus Univ, Dept Res, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522]; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY11522 from the NEI and a CURE grant from Pennsylvania Department of Health. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Boye SL, 2015, HUM GENE THER, V26, P575, DOI 10.1089/hum.2015.053; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Collery RF, 2013, EXP EYE RES, V108, P120, DOI 10.1016/j.exer.2013.01.003; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1667; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; Garcia-Hoyos M, 2011, MOL VIS, V17, P1103; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Gregory-Evans K, 2000, OPHTHALMOLOGY, V107, P55, DOI 10.1016/S0161-6420(99)00038-X; Helten A, 2007, J NEUROCHEM, V103, P1439, DOI 10.1111/j.1471-4159.2007.04923.x; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Ito S, 2004, JPN J OPHTHALMOL, V48, P228, DOI 10.1007/s10384-003-0050-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2008, INVEST OPHTH VIS SCI, V49, P5015, DOI 10.1167/iovs.08-1901; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Lazar CH, 2015, INVEST OPHTH VIS SCI, V56, P420, DOI 10.1167/iovs.14-15647; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Mihelec M, 2011, HUM GENE THER, V22, P1179, DOI 10.1089/hum.2011.069; Milam AH, 2003, OPHTHALMOLOGY, V110, P549, DOI 10.1016/S0161-6420(02)01757-8; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 2001, J MED GENET, V38, P611, DOI 10.1136/jmg.38.9.611; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Udar N, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9109; Weigell-Weber M, 2000, ARCH OPHTHALMOL-CHIC, V118, P300; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zagel P, 2013, BIOCHEMISTRY-US, V52, P5065, DOI 10.1021/bi400288p; Zhao X, 2013, MOL VIS, V19, P1039; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	76	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24504	24516		10.1074/jbc.M116.755553	http://dx.doi.org/10.1074/jbc.M116.755553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703005	Green Published, hybrid			2022-12-28	WOS:000388875500014
J	Suzuki, Y; Ohya, S; Yamamura, H; Giles, WR; Imaizumi, Y				Suzuki, Yoshiaki; Ohya, Susumu; Yamamura, Hisao; Giles, Wayne R.; Imaizumi, Yuji			A New Splice Variant of Large Conductance Ca2+-activated K+ (BK) Channel Subunit Alters Human Chondrocyte Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; chondrocyte; fluorescence resonance energy transfer (FRET); molecular imaging; patch clamp; potassium channel; single molecule biophysics	POTASSIUM CHANNELS; CA2+ CHANNELS; EXPRESSION; TRAFFICKING; ACTIVATION; HISTAMINE; COMPLEX; STOICHIOMETRY; SURFACE; STRESS	Large conductance Ca2+-activated K+ (BK) channels play essential roles in both excitable and non-excitable cells. For example, in chondrocytes, agonist-induced Ca2+ release from intracellular store activates BK channels, and this hyperpolarizes these cells, augments Ca2+ entry, and forms a positive feed-back mechanism for Ca2+ signaling and stimulation-secretion coupling. In the present study, functional roles of a newly identified splice variant in the BK channel subunit (BKe2) were examined in a human chondrocyte cell line, OUMS-27, and in a HEK293 expression system. Although BKe2 lacks exon2, which codes the intracellular S0-S1 linker (Glu-127-Leu-180), significant expression was detected in several tissues from humans and mice. Molecular image analyses revealed that BKe2 channels are not expressed on plasma membrane but can traffic to the plasma membrane after forming hetero-tetramer units with wild-type BK (BKWT). Single-channel current analyses demonstrated that BK hetero-tetramers containing one, two, or three BKe2 subunits are functional. These hetero-tetramers have a smaller single channel conductance and exhibit lower trafficking efficiency than BKWT homo-tetramers in a stoichiometry-dependent manner. Site-directed mutagenesis of residues in exon2 identified Helix2 and the linker to S1 (Trp-158-Leu-180, particularly Arg-178) as an essential segment for channel function including voltage dependence and trafficking. BKe2 knockdown in OUMS-27 chondrocytes increased BK current density and augmented the responsiveness to histamine assayed as cyclooxygenase-2 gene expression. These findings provide significant new evidence that BKe2 can modulate cellular responses to physiological stimuli in human chondrocyte and contribute under pathophysiological conditions, such as osteoarthritis.	[Suzuki, Yoshiaki; Ohya, Susumu; Yamamura, Hisao; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan; [Ohya, Susumu] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol, Kyoto 6078414, Japan; [Giles, Wayne R.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Giles, Wayne R.] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada	Nagoya City University; Kyoto Pharmaceutical University; University of Calgary; University of Calgary	Imaizumi, Y (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Ohya, Susumu/AAB-3618-2020; Suzuki, Yoshiaki/ABH-5320-2020; Imaizumi, Yuji/AAF-6585-2020	Ohya, Susumu/0000-0002-5765-0667; Suzuki, Yoshiaki/0000-0002-7879-6059; 	Japan Society for the Promotion of Science [26293021, 15H01408, 26860059, 16H06215, 16K15127, 16K08278]; Takeda Science Foundation; Salt Science Research Foundation [1637]; Grants-in-Aid for Scientific Research [16K15127, 16K08278, 15H01408, 26293021] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 26293021 and 15H01408 (to Y.I.), 26860059, 16H06215, and 16K15127 (to Y.S.), and 16K08278 (to H.Y.). This work was also supported by a grant-in-aid from Takeda Science Foundation (to Y.S.) and Salt Science Research Foundation Grant 1637 (to Y.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Barrett-Jolley R, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00135; Bharill S, 2014, P NATL ACAD SCI USA, V111, P6491, DOI 10.1073/pnas.1400248111; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; Dabertrand F, 2006, CELL CALCIUM, V40, P11, DOI 10.1016/j.ceca.2006.03.008; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Funabashi K, 2010, AM J PHYSIOL-CELL PH, V298, pC786, DOI 10.1152/ajpcell.00469.2009; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Gueguinou M, 2014, BBA-MOL CELL RES, V1843, P2322, DOI 10.1016/j.bbamcr.2014.02.019; Inayama M, 2015, CELL CALCIUM, V57, P337, DOI 10.1016/j.ceca.2015.02.005; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kitazawa M, 2014, J BIOL CHEM, V289, P17597, DOI 10.1074/jbc.M114.563452; Kurita T, 2015, MOL PHARMACOL, V88, P113, DOI 10.1124/mol.115.098160; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Lewis R, 2013, CHANNELS, V7, P459, DOI 10.4161/chan.26071; Lewis R, 2011, CELL PHYSIOL BIOCHEM, V28, P1111, DOI 10.1159/000335847; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Mobasheri A, 2010, J CELL PHYSIOL, V223, P511, DOI 10.1002/jcp.22075; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; Shi P, 2013, BIOCHEM BIOPH RES CO, V437, P408, DOI 10.1016/j.bbrc.2013.06.091; Sugita S, 2015, P NATL ACAD SCI USA, V112, P3080, DOI 10.1073/pnas.1419699112; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Suzuki Y, 2013, BIOCHEM BIOPH RES CO, V430, P1169, DOI 10.1016/j.bbrc.2012.12.015; Tetlow LC, 2005, RHEUMATOL INT, V26, P173, DOI 10.1007/s00296-005-0622-x; Tetlow LC, 2002, ANN RHEUM DIS, V61, P737, DOI 10.1136/ard.61.8.737; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101	30	18	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24247	24260		10.1074/jbc.M116.743302	http://dx.doi.org/10.1074/jbc.M116.743302			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27758860	hybrid, Green Published			2022-12-28	WOS:000388498100037
J	Zhang, CM; Zhao, NH; Chen, Y; Zhang, DH; Yan, JY; Zou, W; Zhang, KQ; Huang, XW				Zhang, Chunmei; Zhao, Ninghui; Chen, Yao; Zhang, Donghua; Yan, Jinyuan; Zou, Wei; Zhang, Keqin; Huang, Xiaowei			The Signaling Pathway of Caenorhabditis elegans Mediates Chemotaxis Response to the Attractant 2-Heptanone in a Trojan Horse-like Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; Caenorhabditis elegans (C; elegans); chemotaxis; G protein-coupled receptor (GPCR); signal transduction; 2-heptanone; chemotaxis response; co-evolution; microbial pathogens; olfactory pathway	NUCLEOTIDE-GATED CHANNEL; CHEMOSENSORY NEURONS; ODORANT RECEPTOR; G-PROTEINS; EXPRESSION; MUTATIONS; OLFACTION; FAMILY; GENES	The nematode Caenorhabditis elegans exhibits behavioral responses to a wide range of odorants associated with food and pathogens. A previous study described a Trojan Horse-like strategy of pathogenesis whereby the bacterium Bacillus nematocida B16 emits the volatile organic compound 2-heptanone to trap C. elegans for successful infection. Here, we further explored the receptor for 2-heptanone as well as the pathway involved in signal transduction in C. elegans. Our experiments showed that 2-heptanone sensing depended on the function of AWC neurons and a GPCR encoded by str-2. Consistent with the above observation, the HEK293 cells expressing STR-2 on their surfaces showed a transient elevation in intracellular Ca2+ levels after 2-heptanone applications. After combining the assays of RNA interference and gene mutants, we also identified the G subunits and their downstream components in the olfactory signal cascade that are necessary for responding to 2-heptanone, including G subunits of egl-30 and gpa-3, phospholipase C of plc-1and egl-8, and the calcium channel of cmk-1 and cal-1. Our work demonstrates for the first time that an integrated signaling pathway for 2-heptanone response in C. elegans involves recognition by GPCR STR-2, activation by G subunits of egl-30/gpa-3 and transfer to the PLC pathway, indicating that a potentially novel olfactory pathway exists in AWC neurons. Meanwhile, since 2-heptanone, a metabolite from the pathogenic bacterium B. nematocida B16, can be sensed by C. elegans and thus strongly attract its host, our current work also suggested coevolution between the pathogenic microorganism and the chemosensory system in C. elegans.	[Zhang, Chunmei; Chen, Yao; Zhang, Donghua; Zou, Wei; Zhang, Keqin; Huang, Xiaowei] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China; [Zhang, Chunmei; Chen, Yao; Zhang, Donghua; Zou, Wei; Zhang, Keqin; Huang, Xiaowei] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Yunnan, Peoples R China; [Zhao, Ninghui] Kunming Med Univ, Hosp 2, Neurosurg, Kunming 650101, Peoples R China; [Yan, Jinyuan] Kunming Med Univ, Hosp 2, Ctr Lab, Kunming 650101, Peoples R China	Yunnan University; Yunnan University; Kunming Medical University; Kunming Medical University	Huang, XW (corresponding author), Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China.; Huang, XW (corresponding author), Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	zhang, ke/AAH-8217-2019	Yan, Jinyuan/0000-0002-3398-3459	National Basic Research Program of China [2013CB127500]; National Natural Science Foundation Program of China [31370162, 31460024]; Department of Science and Technology of Yunnan Province, China [2014FA019]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation Program of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Grant no. 2013CB127500), the National Natural Science Foundation Program of China (Grants no. 31370162 and no. 31460024), and the Department of Science and Technology of Yunnan Province, China (Grant no. 2014FA019). The authors declare that they have no conflicts of interest with the contents of this article.	BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Birnby DA, 2000, GENETICS, V155, P85; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Deng Xinyang, 2013, ScientificWorldJournal, V2013, P123731, DOI 10.1155/2013/123731; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; GREWAL P S, 1992, Fundamental and Applied Nematology, V15, P159; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Mori I, 1997, BIOESSAYS, V19, P1055, DOI 10.1002/bies.950191204; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; STARICH TA, 1995, GENETICS, V139, P171; Torto B, 2007, P NATL ACAD SCI USA, V104, P8374, DOI 10.1073/pnas.0702813104; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wood W. B., 1988, COMMUNITY C ELEGANS; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhang CM, 2014, BIOTECHNOL ADV, V32, P290, DOI 10.1016/j.biotechadv.2013.10.010; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zwaal RR, 1997, GENETICS, V145, P715	34	28	33	3	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23618	23627		10.1074/jbc.M116.741132	http://dx.doi.org/10.1074/jbc.M116.741132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27660389	hybrid, Green Published			2022-12-28	WOS:000387884400022
J	Ashley, JW; Hancock, WD; Nelson, AJ; Bone, RN; Tse, HM; Wohltmann, M; Turk, J; Ramanadham, S				Ashley, Jason W.; Hancock, William D.; Nelson, Alexander J.; Bone, Robert N.; Tse, Hubert M.; Wohltmann, Mary; Turk, John; Ramanadham, Sasanka			Polarization of Macrophages toward M2 Phenotype Is Favored by Reduction in iPLA(2)beta (Group VIA Phospholipase A(2))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; ENDOPLASMIC-RETICULUM STRESS; HUMAN MONOCYTE CHEMOTAXIS; LYSOPHOSPHATIDIC ACID; CELL APOPTOSIS; PROINFLAMMATORY CYTOKINES; DIABETES-MELLITUS; OXIDATIVE STRESS; EXPRESS GROUP; T-CELLS	Macrophages are important in innate and adaptive immunity. Macrophage participation in inflammation or tissue repair is directed by various extracellular signals and mediated by multiple intracellular pathways. Activation of group VIA phospholipase A(2) (iPLA(2)beta) causes accumulation of arachidonic acid, lysophospholipids, and eicosanoids that can promote inflammation and pathologic states. We examined the role of iPLA(2)beta in peritoneal macrophage immune function by comparing wild type (WT) and iPLA(2)beta(-/-) mouse macrophages. Compared with WT, iPLA(2)beta(-/-) macrophages exhibited reduced proinflammatory M1 markers when classically activated. In contrast, antiinflammatory M2 markers were elevated under naive conditions and induced to higher levels by alternative activation in iPLA(2)beta(-/-) macrophages compared with WT. Induction of eicosanoid (12-lipoxygenase (12-LO) and cyclooxygenase 2 (COX2))-and reactive oxygen species (NADPH oxidase 4 (NOX4))-generating enzymes by classical activation pathways was also blunted in iPLA(2)beta(-/-) macrophages compared with WT. The effects of inhibitors of iPLA(2)beta, COX2, or 12-LO to reduce M1 polarization were greater than those to enhance M2 polarization. Certain lipids (lysophosphatidylcholine, lysophosphatidic acid, and prostaglandin E-2) recapitulated M1 phenotype in iPLA(2)beta(-/-) macrophages, but none tested promoted M2 phenotype. These findings suggest that (a) lipids generated by iPLA(2)beta and subsequently oxidized by cyclooxygenase and 12-LO favor macrophage inflammatory M1 polarization, and (b) the absence of iPLA(2)beta promotes macrophage M2 polarization. Reducing macrophage iPLA(2)beta activity and thereby attenuating macrophage M1 polarization might cause a shift from an inflammatory to a recovery/repair milieu.	[Ashley, Jason W.] Eastern Washington Univ, Dept Biol, Cheney, WA 99004 USA; [Hancock, William D.; Nelson, Alexander J.; Ramanadham, Sasanka] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, SHEL 1205,1720 2nd Ave S, Birmingham, AL 35294 USA; [Hancock, William D.; Nelson, Alexander J.; Tse, Hubert M.; Ramanadham, Sasanka] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Tse, Hubert M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Bone, Robert N.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Wohltmann, Mary; Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Eastern Washington University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University Bloomington; Washington University (WUSTL)	Ramanadham, S (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, SHEL 1205,1720 2nd Ave S, Birmingham, AL 35294 USA.	sramvem@uab.edu	Ashley, Jason Waid/S-9142-2019	Ashley, Jason/0000-0003-1064-542X; Tse, Hubert/0000-0001-5861-7597; Bone, Robert/0000-0003-3222-8918	NIDDK, National Institutes of Health [DK-69455, DK-110292, DK-099550]; University of Alabama at Birmingham Department of Cell, Developmental, and Integrative Biology; American Diabetes Association; United States Public Health Service by WUSM Dean's Bridge Funds [P41 GM103422, P30 DK056341, P30 DK020579]; WUSM Department Medicine Bridge Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099550, R01DK110292, P30DK056341, P30DK020579, R01DK069455, P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422, K12GM081259] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Alabama at Birmingham Department of Cell, Developmental, and Integrative Biology; American Diabetes Association(American Diabetes Association); United States Public Health Service by WUSM Dean's Bridge Funds; WUSM Department Medicine Bridge Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grants DK-69455 and DK-110292 (to S. R.) and DK-099550 (to H. M. T). This work was also supported by the University of Alabama at Birmingham Department of Cell, Developmental, and Integrative Biology and the American Diabetes Association (to S. R. and H. M. T.). Work at the Washington University School of Medicine (WUSM) (to J. T.) was supported by United States Public Health Service Grants P41 GM103422, P30 DK056341, and P30 DK020579 by WUSM Dean's Bridge Funds and WUSM Department Medicine Bridge Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Ayilavarapu S, 2010, J IMMUNOL, V184, P1507, DOI 10.4049/jimmunol.0901219; Balboa MA, 2002, J BIOL CHEM, V277, P40384, DOI 10.1074/jbc.M206155200; Balboa MA, 2008, FEBS J, V275, P1915, DOI 10.1111/j.1742-4658.2008.06350.x; Balsinde J, 2000, J BIOL CHEM, V275, P22544, DOI 10.1074/jbc.M910163199; Balsinde J, 2002, BIOCHEM J, V364, P695, DOI 10.1042/BJ20020142; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/989372; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bone RN, 2015, DIABETES, V64, P541, DOI 10.2337/db14-0097; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Ganapathy V, 2000, INT IMMUNOL, V12, P851, DOI 10.1093/intimm/12.6.851; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gilroy DW, 2004, FASEB J, V18, P489, DOI 10.1096/fj.03-0837com; Topal JLG, 2006, J PHARMACOL EXP THER, V318, P1368, DOI 10.1124/jpet.106.103747; Green-Mitchell SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056763; Grewal S, 2003, J CELL SCI, V116, P2303, DOI 10.1242/jcs.00446; Grzesik WJ, 2015, J CLIN ENDOCR METAB, V100, pE387, DOI 10.1210/jc.2014-3630; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Ho Victor W. H., 2009, V531, P173, DOI 10.1007/978-1-59745-396-7_12; Hsu FF, 2000, J BIOL CHEM, V275, P16579, DOI 10.1074/jbc.M908342199; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2014, ENDOCRINOLOGY, V155, P3352, DOI 10.1210/en.2013-2134; Lei XY, 2013, ISLETS, V5, P29, DOI 10.4161/isl.23758; Lei XY, 2012, AM J PHYSIOL-ENDOC M, V303, pE1386, DOI 10.1152/ajpendo.00234.2012; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Magrioti V, 2010, EXPERT OPIN THER PAT, V20, P1, DOI 10.1517/13543770903463905; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marathe C, 2006, J BIOL CHEM, V281, P32197, DOI 10.1074/jbc.M605237200; Marshall J, 2000, J IMMUNOL, V164, P2084, DOI 10.4049/jimmunol.164.4.2084; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez J, 2001, ARCH BIOCHEM BIOPHYS, V392, P257, DOI 10.1006/abbi.2001.2439; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Ming XF, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000992; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Nikolic DM, 2007, J BIOL CHEM, V282, P33405, DOI 10.1074/jbc.M704133200; Norris Paul C., 2014, Advances in Biological Regulation, V54, P99, DOI 10.1016/j.jbior.2013.09.009; Padgett LE, 2015, DIABETES, V64, P937, DOI 10.2337/db14-0929; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Panni RZ, 2013, IMMUNOTHERAPY-UK, V5, P1075, DOI 10.2217/imt.13.102; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Perez-Chacon G, 2010, J IMMUNOL, V184, P1071, DOI 10.4049/jimmunol.0902257; Pindado J, 2007, J IMMUNOL, V179, P4821, DOI 10.4049/jimmunol.179.7.4821; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Song HW, 2014, J BIOL CHEM, V289, P14194, DOI 10.1074/jbc.M114.561910; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Tan CY, 2014, ARTERIOSCL THROM VAS, V34, P768, DOI 10.1161/ATVBAHA.113.302847; Teslenko V, 1997, BBA-LIPID LIPID MET, V1344, P189, DOI 10.1016/S0005-2760(96)00137-3; Ueno N, 2011, J BIOL CHEM, V286, P37249, DOI 10.1074/jbc.M111.290312; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; Vazquez-Medina JP, 2016, FASEB J, V30, P2885, DOI 10.1096/fj.201500146R; Vujanovic NL, 2011, IMMUNOL RES, V50, P159, DOI 10.1007/s12026-011-8228-8; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Zaitseva LG, 2000, B EXP BIOL MED+, V130, P879	80	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23268	23281		10.1074/jbc.M116.754945	http://dx.doi.org/10.1074/jbc.M116.754945			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27650501	hybrid, Green Published			2022-12-28	WOS:000387224800035
J	Kosic, M; Arsikin-Csordas, K; Paunovic, V; Firestone, RA; Ristic, B; Mircic, A; Petricevic, S; Bosnjak, M; Zogovic, N; Mandic, M; Bumbasirevic, V; Trajkovic, V; Harhaji-Trajkovic, L				Kosic, Milica; Arsikin-Csordas, Katarina; Paunovic, Verica; Firestone, Raymond A.; Ristic, Biljana; Mircic, Aleksandar; Petricevic, Sasa; Bosnjak, Mihajlo; Zogovic, Nevena; Mandic, Milos; Bumbasirevic, Vladimir; Trajkovic, Vladimir; Harhaji-Trajkovic, Ljubica			Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT N-DODECYLIMIDAZOLE; CYTOCHROME-C RELEASE; CELL-DEATH; OXIDATIVE STRESS; CANCER-CELLS; PROSTATE-CANCER; LYSOSOMOTROPIC DETERGENTS; GLUCOSE-METABOLISM; CROSS-TALK; IN-VITRO	We investigated the in vitro and in vivo anticancer effect of combining lysosomal membrane permeabilization (LMP)-inducing agent N-dodecylimidazole (NDI) with glycolytic inhibitor 2-deoxy-D-glucose (2DG). NDI-triggered LMP and 2DG-mediated glycolysis block synergized in inducing rapid ATP depletion, mitochondrial damage, and reactive oxygen species production, eventually leading to necrotic death of U251 glioma cells but not primary astrocytes. NDI/2DG-induced death of glioma cells was partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant alpha-tocopherol, suggesting the involvement of LMP and oxidative stress in the observed cytotoxicity. LMP-inducing agent chloroquine also displayed a synergistic anticancer effect with 2DG, whereas glucose deprivation or glycolytic inhibitors iodoacetate and sodium fluoride synergistically cooperated with NDI, thus further indicating that the anticancer effect of NDI/2DG combination was indeed due to LMP and glycolysis block. The two agents synergistically induced ATP depletion, mitochondrial depolarization, oxidative stress, and necrotic death also in B16 mouse melanoma cells. Moreover, the combined oral administration of NDI and 2DG reduced in vivo melanoma growth in C57BL/6 mice by inducing necrotic death of tumor cells, without causing liver, spleen, or kidney toxicity. Based on these results, we propose that NDI-triggered LMP causes initial mitochondrial damage that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial health. This leads to a positive feedback cycle of mitochondrial dysfunction, ATP loss, and reactive oxygen species production, culminating in necrotic cell death. Therefore, the combination of LMP-inducing agents and glycolysis inhibitors seems worthy of further exploration as an anticancer strategy.	[Kosic, Milica; Arsikin-Csordas, Katarina; Paunovic, Verica; Ristic, Biljana; Mandic, Milos; Trajkovic, Vladimir] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Dr Subotica 1, Belgrade 11000, Serbia; [Mircic, Aleksandar; Bosnjak, Mihajlo; Bumbasirevic, Vladimir] Univ Belgrade, Sch Med, Inst Histol & Embryol, Visegradska 26, Belgrade 11000, Serbia; [Petricevic, Sasa] Inst Biomed Res, Pasterova 2, Belgrade 11000, Serbia; [Zogovic, Nevena; Harhaji-Trajkovic, Ljubica] Univ Belgrade, Inst Biol Res, Despot Stefan Blvd 142, Belgrade 11000, Serbia; [Firestone, Raymond A.] 30 West 72 St,Apartment 10A, New York, NY 10023 USA	University of Belgrade; University of Belgrade; University of Belgrade	Trajkovic, V (corresponding author), Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Dr Subotica 1, Belgrade 11000, Serbia.; Harhaji-Trajkovic, L (corresponding author), Univ Belgrade, Inst Biol Res, Despot Stefan Blvd 142, Belgrade 11000, Serbia.	vtrajkovic@med.bg.ac.rs; buajk@yahoo.com	Kosic, Milica/E-6689-2016	Kosic, Milica/0000-0003-2925-8470; Zogovic, Nevena/0000-0003-4240-3193; Harhaji-Trajkovic, Ljubica/0000-0001-8757-555X; Mandic, Milos/0000-0001-9280-1021; Ristic, Biljana/0000-0002-7255-6556; Paunovic, Verica/0000-0002-4912-7761; bosnjak, mihajlo/0000-0002-5973-8275; Trajkovic, Vladimir/0000-0002-8061-2968	Ministry of Education, Science, and Technological Development of the Republic of Serbia [41025, 173053]	Ministry of Education, Science, and Technological Development of the Republic of Serbia	This work was supported by Ministry of Education, Science, and Technological Development of the Republic of Serbia Grants 41025 (to V. T.) and 173053 (to L. H.-T.). The authors declare that they have no conflicts of interest with the contents of this article.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Bell SE, 1998, BRIT J CANCER, V78, P1464, DOI 10.1038/bjc.1998.708; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; BOYER MJ, 1993, BRIT J CANCER, V67, P81, DOI 10.1038/bjc.1993.13; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dehay B, 2012, P NATL ACAD SCI USA, V109, P9611, DOI 10.1073/pnas.1112368109; Denamur S, 2011, FREE RADICAL BIO MED, V51, P1656, DOI 10.1016/j.freeradbiomed.2011.07.015; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; DREWINKO B, 1976, CANCER BIOCHEM BIOPH, V1, P187; Dwarakanath BS, 2009, J CANCER RES THER, V5, P27, DOI 10.4103/0973-1482.55137; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; FIRESTONE RA, 1979, J MED CHEM, V22, P1130, DOI 10.1021/jm00195a026; FIRESTONE RA, 1982, J MED CHEM, V25, P539, DOI 10.1021/jm00347a012; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Ghosh M, 2011, FEBS LETT, V585, P623, DOI 10.1016/j.febslet.2010.12.043; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Kaludjerovic GN, 2005, INT J CANCER, V116, P479, DOI 10.1002/ijc.21080; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kim S, 2013, SCI WORLD J, DOI 10.1155/2013/175702; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; MACK P, 1988, EUR J CANCER CLIN ON, V24, P1433, DOI 10.1016/0277-5379(88)90333-1; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MILLER DK, 1983, J CELL BIOL, V97, P1841, DOI 10.1083/jcb.97.6.1841; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Ramirez-Peinado S, 2013, J BIOL CHEM, V288, P30387, DOI 10.1074/jbc.M113.490581; Repnik U, 2010, MITOCHONDRION, V10, P662, DOI 10.1016/j.mito.2010.07.008; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sato T, 2008, J IMMUNOL, V181, P197, DOI 10.4049/jimmunol.181.1.197; Seitz C, 2013, INT J CANCER, V132, P2682, DOI 10.1002/ijc.27935; Simons AL, 2007, INT J RADIAT ONCOL, V69, P1222, DOI 10.1016/j.ijrobp.2007.07.2343; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Sottnik JL, 2011, CLIN EXP METASTAS, V28, P865, DOI 10.1007/s10585-011-9417-5; Tagg SLC, 2008, BRIT J CANCER, V99, P1842, DOI 10.1038/sj.bjc.6604752; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Terman A, 2006, IUBMB LIFE, V58, P531, DOI 10.1080/15216540600904885; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Vucicevic L, 2014, AUTOPHAGY, V10, P2362, DOI 10.4161/15548627.2014.984270; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang L, 2016, ONCOTARGET, V7, P7, DOI DOI 10.3389/FMICB.2016.00593; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEBSTER HDF, 1965, J CELL BIOL, V26, P885; WILSON PD, 1987, J CELL BIOL, V104, P1223, DOI 10.1083/jcb.104.5.1223; WILSON PD, 1989, CANCER RES, V49, P507; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zagorodna O, 2012, ONCOGENE, V31, P2738, DOI 10.1038/onc.2011.454; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	76	9	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22936	22948		10.1074/jbc.M116.752113	http://dx.doi.org/10.1074/jbc.M116.752113			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27587392	Green Published, hybrid			2022-12-28	WOS:000387224800007
J	Lalic, J; Marjanovic, MP; Palazzo, L; Perina, D; Sabljic, I; Zaja, R; Colby, T; Plese, B; Halasz, M; Jankevicius, G; Bucca, G; Ahel, M; Matic, I; Cetkovic, H; Luic, M; Mikoc, A; Ahel, I				Lalic, Jasna; Marjanovic, Melanija Posavec; Palazzo, Luca; Perina, Dragutin; Sabljic, Igor; Zaja, Rokoz; Colby, Thomas; Plese, Bruna; Halasz, Mirna; Jankevicius, Gytis; Bucca, Giselda; Ahel, Marijan; Matic, Ivan; Cetkovic, Helena; Luic, Marija; Mikoc, Andreja; Ahel, Ivan			Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATED PROTEINS; DNA-REPAIR; POLY(ADP-RIBOSE); IDENTIFICATION; FAMILY; GENE; DIFFERENTIATION; MECHANISM; RIBOSE; SITE	ADP-ribosylation is a post-translational modification that can alter the physical and chemical properties of target proteins and that controls many important cellular processes. Macrodomains are evolutionarily conserved structural domains that bind ADP-ribose derivatives and are found in proteins with diverse cellular functions. Some proteins from the macrodomain family can hydrolyze ADP-ribosylated substrates and therefore reverse this post-translational modification. Bacteria and Streptomyces, in particular, are known to utilize protein ADP-ribosylation, yet very little is known about their enzymes that synthesize and remove this modification. We have determined the crystal structure and characterized, both biochemically and functionally, the macrodomain protein SCO6735 from Streptomyces coelicolor. This protein is a member of an uncharacterized subfamily of macrodomain proteins. Its crystal structure revealed a highly conserved macrodomain fold. We showed that SCO6735 possesses the ability to hydrolyze PARP-dependent protein ADP-ribosylation. Furthermore, we showed that expression of this protein is induced upon DNA damage and that deletion of this protein in S. coelicolor increases antibiotic production. Our results provide the first insights into the molecular basis of its action and impact on Streptomyces metabolism.	[Lalic, Jasna; Marjanovic, Melanija Posavec; Perina, Dragutin; Plese, Bruna; Halasz, Mirna; Cetkovic, Helena; Mikoc, Andreja] Rudjer Boskovic Inst, Div Mol Biol, Zagreb 10002, Croatia; [Sabljic, Igor] Rudjer Boskovic Inst, Div Phys Chem, Zagreb 10002, Croatia; [Zaja, Rokoz; Ahel, Marijan] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb 10002, Croatia; [Palazzo, Luca; Jankevicius, Gytis; Ahel, Ivan] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Colby, Thomas; Matic, Ivan] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Bucca, Giselda] Univ Brighton, Sch Pharm & Biomol Sci, Huxley Bldg, Brighton BN2 4GJ, E Sussex, England	Rudjer Boskovic Institute; Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of Oxford; Max Planck Society; University of Brighton	Mikoc, A (corresponding author), Rudjer Boskovic Inst, Div Mol Biol, Zagreb 10002, Croatia.; Ahel, I (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England.	mikoc@irb.hr; ivan.ahel@path.ox.ac.uk	Matic, Ivan/F-7284-2010; Palazzo, Luca/Q-1084-2017; Plese, Bruna/L-8289-2016	Matic, Ivan/0000-0003-0170-7991; Palazzo, Luca/0000-0002-5556-5549; Halasz, Mirna/0000-0003-1715-1625; Zaja, Roko/0000-0003-3944-0153; Bucca, Giselda/0000-0001-5286-7771; Sabljic, Igor/0000-0001-9044-2678; Ahel, Ivan/0000-0002-9446-3756; Plese, Bruna/0000-0001-6690-3876; Ahel, Marijan/0000-0001-6923-8461	Unity through Knowledge Fund Grant UKF [1B 2/13]; European Research Council [281739]; Wellcome Trust [101794]; Cancer Research UK [C35050/A22284]; European Community [283570]; Cancer Research UK [22284] Funding Source: researchfish	Unity through Knowledge Fund Grant UKF; European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); European Community(European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by Unity through Knowledge Fund Grant UKF 1B 2/13, European Research Council Grant 281739, Wellcome Trust Grant 101794, Cancer Research UK Grant C35050/A22284, and European Community's Seventh Framework Programme FP7/2007-2013 under BioStruct-X Grant 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2002, FEMS MICROBIOL LETT, V209, P133, DOI 10.1111/j.1574-6968.2002.tb11121.x; BALTZ RH, 1985, MOL GEN GENET, V200, P351, DOI 10.1007/BF00425716; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; Barkauskaite E, 2013, FEBS J, V280, P3491, DOI 10.1111/febs.12358; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Coze F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084151; EASTMAN D, 1994, MICROBIOL-UK, V140, P3167, DOI 10.1099/13500872-140-11-3167; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P542, DOI 10.1038/nrm3623; Gamulin V, 2004, FEMS MICROBIOL LETT, V238, P57, DOI 10.1016/j.femsle.2004.07.017; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Golia B, 2015, FRONT BIOSCI-LANDMRK, V20, P440, DOI 10.2741/4318; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hawse WF, 2009, J BIOL CHEM, V284, P33654, DOI 10.1074/jbc.M109.024521; Hildebrandt K, 1997, MOL MICROBIOL, V23, P231, DOI 10.1046/j.1365-2958.1997.2111575.x; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Huh JW, 1996, J BACTERIOL, V178, P4935, DOI 10.1128/jb.178.16.4935-4941.1996; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Kim T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-266; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Lambrecht MJ, 2015, J AM CHEM SOC, V137, P3558, DOI 10.1021/ja512528p; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; MALPARTIDA F, 1986, MOL GEN GENET, V205, P66, DOI 10.1007/BF02428033; Moure VR, 2015, CURR TOP MICROBIOL, V384, P89, DOI 10.1007/82_2014_380; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano T, 2013, TOXICON, V63, P55, DOI 10.1016/j.toxicon.2012.11.019; OCHI K, 1992, J GEN MICROBIOL, V138, P1745, DOI 10.1099/00221287-138-8-1745; Palazzo L, 2016, FEBS J, V283, P3371, DOI 10.1111/febs.13811; Palazzo L, 2015, BIOCHEM J, V468, P293, DOI 10.1042/BJ20141554; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P302, DOI 10.1016/S0966-842X(01)02074-1; PENYIGE A, 1992, GENE, V115, P181, DOI 10.1016/0378-1119(92)90557-6; Penyige A, 1996, MICROBIOL-UK, V142, P1937, DOI 10.1099/13500872-142-8-1937; Penyige A, 2009, J MICROBIOL, V47, P549, DOI 10.1007/s12275-009-0032-y; Perina D, 2014, DNA REPAIR, V23, P4, DOI 10.1016/j.dnarep.2014.05.003; Peterson FC, 2011, J BIOL CHEM, V286, P35955, DOI 10.1074/jbc.M111.276238; Pfaffl MW, 2004, A Z QUANTITATIVE PCR, P87; PIGAC J, 1995, APPL ENVIRON MICROB, V61, P352, DOI 10.1128/AEM.61.1.352-356.1995; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rack JGM, 2016, ANNU REV BIOCHEM, V85, P431, DOI 10.1146/annurev-biochem-060815-014935; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Serres MH, 1996, J BACTERIOL, V178, P6074, DOI 10.1128/jb.178.20.6074-6077.1996; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Shima J, 1996, J BACTERIOL, V178, P3785, DOI 10.1128/jb.178.13.3785-3790.1996; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Stallings CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021807; STONESIFER J, 1985, P NATL ACAD SCI USA, V82, P1180, DOI 10.1073/pnas.82.4.1180; Sugawara K, 2002, BIOSCI BIOTECH BIOCH, V66, P2292, DOI 10.1271/bbb.66.2292; Szirak K, 2012, J MICROBIOL, V50, P409, DOI 10.1007/s12275-012-1440-y; TAKADA T, 1993, J BIOL CHEM, V268, P17837; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xiao YH, 2011, METHODS MOL BIOL, V687, P277, DOI 10.1007/978-1-60761-944-4_20	75	13	13	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23175	23187		10.1074/jbc.M116.721894	http://dx.doi.org/10.1074/jbc.M116.721894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27634042	hybrid, Green Published			2022-12-28	WOS:000387224800027
J	Le, NH; Molle, V; Eynard, N; Miras, M; Stella, A; Bardou, F; Galandrin, S; Guillet, V; Andre-Leroux, G; Bellinzoni, M; Alzari, P; Mourey, L; Burlet-Schiltz, O; Daffe, M; Marrakchi, H				Nguyen-Hung Le; Molle, Virginie; Eynard, Nathalie; Miras, Mathieu; Stella, Alexandre; Bardou, Fabienne; Galandrin, Segolene; Guillet, Valerie; Andre-Leroux, Gwenaelle; Bellinzoni, Marco; Alzari, Pedro; Mourey, Lionel; Burlet-Schiltz, Odile; Daffe, Mamadou; Marrakchi, Hedia			Ser/Thr Phosphorylation Regulates the Fatty Acyl-AMP Ligase Activity of FadD32, an Essential Enzyme in Mycolic Acid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; lipid metabolism; mycobacteria; post-translational modification (PTM); protein phosphorylation	MYCOBACTERIUM-TUBERCULOSIS; PROTEIN-KINASES; SYNTHASE; MECHANISM; SYSTEM; PHOSPHATASES; EXPRESSION; INHIBITORS; CATALYZES; TARGETS	Mycolic acids are essential components of the mycobacterial cell envelope, and their biosynthetic pathway is a well known source of antituberculous drug targets. Among the promising new targets in the pathway, FadD32 is an essential enzyme required for the activation of the long meromycolic chain of mycolic acids and is essential for mycobacterial growth. Following the in-depth biochemical, biophysical, and structural characterization of FadD32, we investigated its putative regulation via post-translational modifications. Comparison of the fatty acyl-AMP ligase activity between phosphorylated and dephosphorylated FadD32 isoforms showed that the native protein is phosphorylated by serine/threonine protein kinases and that this phosphorylation induced a significant loss of activity. Mass spectrometry analysis of the native protein confirmed the post-translational modifications and identified Thr-552 as the phosphosite. Phosphoablative and phosphomimetic FadD32 mutant proteins confirmed both the position and the importance of the modification and its correlation with the negative regulation of FadD32 activity. Investigation of the mycolic acid condensation reaction catalyzed by Pks13, involving FadD32 as a partner, showed that FadD32 phosphorylation also impacts the condensation activity. Altogether, our results bring to light FadD32 phosphorylation by serine/threonine protein kinases and its correlation with the enzyme-negative regulation, thus shedding a new horizon on the mycolic acid biosynthesis modulation and possible inhibition strategies for this promising drug target.	[Nguyen-Hung Le; Eynard, Nathalie; Miras, Mathieu; Stella, Alexandre; Bardou, Fabienne; Galandrin, Segolene; Guillet, Valerie; Mourey, Lionel; Burlet-Schiltz, Odile; Daffe, Mamadou; Marrakchi, Hedia] Univ Toulouse, Inst Pharmacol & Biol Struct, CNRS, UPS, Toulouse, France; [Molle, Virginie] Univ Montpellier, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Pl Eugene Bataillon, F-34095 Montpellier 05, France; [Andre-Leroux, Gwenaelle; Bellinzoni, Marco; Alzari, Pedro] Inst Pasteur, Unite Microbiol Struct, 25 Rue Docteur Roux, F-75724 Paris 15, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Daffe, M; Marrakchi, H (corresponding author), Inst Pharmacol & Biol Struct, 205 Route Narbonne,BP 64182, F-31077 Toulouse 4, France.	mamadou.daffe@ipbs.fr; hedia.marrakchi@ipbs.fr	Marrakchi, Hedia/AAF-2657-2020; MOLLE, Virginie/D-4050-2019; Mourey, Lionel/B-5662-2009	MOLLE, Virginie/0000-0002-6573-3411; Mourey, Lionel/0000-0002-8259-1259; Schiltz, Odile/0000-0002-3606-2356; Alzari, Pedro/0000-0002-4233-1903; Marrakchi, Hedia/0000-0003-2749-5966; Bellinzoni, Marco/0000-0002-8887-6917; Le, Nguyen-Hung/0000-0001-8659-6949	European Union NM4TB [LSHP-CT-2005-018923]; Agence Nationale de la Recherche, FASMY [ANR-14-CE16-0012]; French Foreign Office (Ministere des Affaires Etrangeres); Region Midi-Pyrenees; European funds (Fonds Europeens de Developpement Regional, FEDER); Toulouse Metropole; French Ministry of Research; Investissement d'Avenir Infrastructures Nationales en Biologie et SanteProgram (ProFI, Proteomics French Infrastructure Project) [ANR-10-INBS-08]	European Union NM4TB; Agence Nationale de la Recherche, FASMY(French National Research Agency (ANR)); French Foreign Office (Ministere des Affaires Etrangeres); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European funds (Fonds Europeens de Developpement Regional, FEDER); Toulouse Metropole; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Investissement d'Avenir Infrastructures Nationales en Biologie et SanteProgram (ProFI, Proteomics French Infrastructure Project)(French National Research Agency (ANR))	This work was supported in part by European Union NM4TB, Grant LSHP-CT-2005-018923, and the Agence Nationale de la Recherche, FASMY, Grant ANR-14-CE16-0012. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a fellowship from the French Foreign Office (Ministere des Affaires Etrangeres).r Supported in part by the Region Midi-Pyrenees, European funds (Fonds Europeens de Developpement Regional, FEDER), Toulouse Metropole, and the French Ministry of Research with the Investissement d'Avenir Infrastructures Nationales en Biologie et SanteProgram (ProFI, Proteomics French Infrastructure Project, ANR-10-INBS-08).	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Baronian G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119907; Bekesova S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00336; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Cortes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029306; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Fortuin S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00006; Galandrin S, 2013, J BIOMOL SCREEN, V18, P576, DOI 10.1177/1087057112474691; Gavalda S, 2014, CHEM BIOL, V21, P1660, DOI 10.1016/j.chembiol.2014.10.011; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Guillet V, 2016, J BIOL CHEM, V291, P7973, DOI 10.1074/jbc.M115.712612; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kinoshita-Kikuta E, 2015, METHODS MOL BIOL, V1295, P323, DOI 10.1007/978-1-4939-2550-6_24; Kuhn ML, 2016, ACS INFECT DIS, V2, P579, DOI 10.1021/acsinfecdis.6b00082; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Sajid A, 2015, ANNU REV MICROBIOL, V69, P527, DOI 10.1146/annurev-micro-020415-111342; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Shirude PS, 2012, ACS MED CHEM LETT, V3, P736, DOI 10.1021/ml300134b; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Stanley SA, 2013, P NATL ACAD SCI USA, V110, P11565, DOI 10.1073/pnas.1302114110; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Vergnolle O, 2013, J BIOL CHEM, V288, P28116, DOI 10.1074/jbc.M113.495549; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004115; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Xie LX, 2015, INT J BIOCHEM CELL B, V59, P193, DOI 10.1016/j.biocel.2014.11.010; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	45	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22793	22805		10.1074/jbc.M116.748053	http://dx.doi.org/10.1074/jbc.M116.748053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27590338	Green Published, hybrid			2022-12-28	WOS:000386760600036
J	Chen, KH; Liu, SH; Leysath, CE; Miller-Randolph, S; Zhang, Y; Fattah, R; Bugge, TH; Leppla, SH				Chen, Kuang-Hua; Liu, Shihui; Leysath, Clinton E.; Miller-Randolph, Sharmina; Zhang, Yi; Fattah, Rasem; Bugge, Thomas H.; Leppla, Stephen H.			Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anthrax toxin; mutagenesis in vitro; phage display; receptor; tumor therapy; CMG2; TEM8; protective antigen	CAPILLARY MORPHOGENESIS PROTEIN-2; CRYSTAL-STRUCTURE; LETHAL FACTOR; CELLS; INTERNALIZATION; PATHOGENESIS; PROTEASE; BINDING; FURIN; HOST	The protective antigen (PA) moiety of anthrax toxin binds to cellular receptors and mediates the translocation of the two enzymatic moieties of the toxin to the cytosol. Two PA receptors are known, with capillary morphogenesis protein 2 (CMG2) being the more important for pathogenesis and tumor endothelial marker 8 (TEM8) playing a minor role. The C-terminal PA domain 4 (PAD4) has extensive interactions with the receptors and is required for binding. Our previous study identified PAD4 variants having enhanced TEM8 binding specificity. To obtain PA variants that selectively bind to CMG2, here we performed phage display selections using magnetic beads having bound CMG2. We found that PA residue isoleucine 656 plays a critical role in PA binding to TEM8 but has a much lesser effect on PA binding to CMG2. We further characterized the role of residue 656 in distinguishing PA binding to CMG2 versus TEM8 by substituting it with the other 19 amino acids. Of the resulting variants, PA I656Q and PA I656V had significantly reduced activity on TEM8-expressing CHO cells but maintained their activity on CMG2-expressing CHO cells. The preference of these PA mutants for CMG2 over TEM8 was further demonstrated using mouse embryonic fibroblast cells and mice deficient in the CMG2 and/or the TEM8 receptors. The structural basis of the alterations in the receptor binding activities of these mutants is also discussed.	[Chen, Kuang-Hua; Liu, Shihui; Leysath, Clinton E.; Miller-Randolph, Sharmina; Zhang, Yi; Fattah, Rasem; Leppla, Stephen H.] NIAID, Parasit Dis Lab, NIH, Bldg 33,Rm 1W20B, Bethesda, MD 20892 USA; [Liu, Shihui; Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Leysath, Clinton E.] Texas A&M Hlth Sci Ctr, Ctr Innovat Adv Dev & Mfg, Off Publ Hlth Preparedness & Response, 8441 State Hwy 47,Suite 3200, Bryan, TX 77807 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Leppla, SH (corresponding author), NIAID, Parasit Dis Lab, NIH, Bldg 33,Rm 1W20B, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov		Liu, Shihui/0000-0003-3444-1069	NIAID, National Institutes of Health; NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the intramural research programs of the NIAID and the NIDCR, National Institutes of Health. K. H. C., S. L., C. E. L., T. H. B., and S. H. L. are inventors on patents of targeted toxins that have all been assigned to the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachran C, 2016, TOXINS, V8, DOI 10.3390/toxins8070197; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chen KH, 2007, J BIOL CHEM, V282, P9834, DOI 10.1074/jbc.M611142200; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; ITTELSON TR, 1973, NATURE, V242, P330, DOI 10.1038/242330b0; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Liu SH, 2016, P NATL ACAD SCI USA, V113, pE4079, DOI 10.1073/pnas.1600982113; Liu SH, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P361, DOI 10.1016/B978-0-12-800188-2.00013-6; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Liu SH, 2013, TOXINS, V5, P1, DOI 10.3390/toxins5010001; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Martin EW, 2015, ONCOTARGET, V6, P33534, DOI 10.18632/oncotarget.5214; Mechaly A, 2012, MBIO, V3, DOI 10.1128/mBio.00088-12; Moayeri M, 2015, ANNU REV MICROBIOL, V69, P185, DOI 10.1146/annurev-micro-091014-104523; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Phillips DD, 2013, J BIOL CHEM, V288, P9058, DOI 10.1074/jbc.M113.452110; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Wein AN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16267; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	30	13	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22021	22029		10.1074/jbc.M116.753301	http://dx.doi.org/10.1074/jbc.M116.753301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27555325	Green Published, hybrid			2022-12-28	WOS:000386332600017
J	Singh, SK; Hasan, SS; Zakharov, SD; Naurin, S; Cohn, W; Ma, J; Whitelegge, JP; Cramer, WA				Singh, Sandeep K.; Hasan, S. Saif; Zakharov, Stanislav D.; Naurin, Sejuti; Cohn, Whitaker; Ma, Jia; Whitelegge, Julian P.; Cramer, William A.			Trans-membrane Signaling in Photosynthetic State Transitions: REDOX- AND STRUCTURE-DEPENDENT INTERACTION IN VITRO BETWEEN STT7 KINASE AND THE CYTOCHROME b(6)f COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome; light-harvesting complex (antenna complex); redox signaling; serine; threonine protein kinase; signal transduction; state transitions; Stt7; cytochrome b6f	THYLAKOID PROTEIN-KINASE; CIRCULAR-DICHROISM SPECTRA; CHLAMYDOMONAS-REINHARDTII; TRANSMEMBRANE HELICES; PROLYL ISOMERIZATION; DISULFIDE-ISOMERASE; SECONDARY STRUCTURE; LIPID FUNCTIONS; PHOSPHORYLATION; DYNAMICS	Trans-membrane signaling involving a serine/threonine kinase (Stt7 in Chlamydomonas reinhardtii) directs light energy distribution between the two photosystems of oxygenic photosynthesis. Oxidation of plastoquinol mediated by the cytochrome b(6)f complex on the electrochemically positive side of the thylakoid membrane activates the kinase domain of Stt7 on the trans (negative) side, leading to phosphorylation and redistribution (state transition) of the light-harvesting chlorophyll proteins between the two photosystems. The molecular description of the Stt7 kinase and its interaction with the cytochrome b(6)f complex are unknown or unclear. In this study, Stt7 kinase has been cloned, expressed, and purified in a heterologous host. Stt7 kinase is shown to be active in vitro in the presence of reductant and purified as a tetramer, as determined by analytical ultracentrifugation, electron microscopy, and electrospray ionization mass spectrometry, with a molecular weight of 332 kDa, consisting of an 83.41-kDa monomer. Far-UV circular dichroism spectra show Stt7 to be mostly -helical and document a physical interaction with the b(6)f complex through increased thermal stability of Stt7 secondary structure. The activity of wild-type Stt7 and its Cys-Ser mutant at positions 68 and 73 in the presence of a reductant suggest that the enzyme does not require a disulfide bridge for its activity as suggested elsewhere. Kinase activation in vivo could result from direct interaction between Stt7 and the b(6)f complex or long-range reduction of Stt7 by superoxide, known to be generated in the b(6)f complex by quinol oxidation.	[Singh, Sandeep K.; Hasan, S. Saif; Zakharov, Stanislav D.; Naurin, Sejuti; Cramer, William A.] Purdue Univ, Bindley Biosci Ctr, Dept Biol Sci, W Lafayette, IN 47907 USA; [Ma, Jia] Purdue Univ, Bindley Biosci Ctr, Biophys Anal Lab, W Lafayette, IN 47907 USA; [Whitelegge, Julian P.; Cramer, William A.] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cramer, WA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA.; Cramer, WA (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	waclab@purdue.edu		Cohn, Whitaker/0000-0001-9198-8904; Singh, Sandeep/0000-0001-9322-2929	National Institutes of Health [GMS-038323]; Purdue University Center for Cancer Research [P30 CA23168]; University of California, San Diego/Los Angeles NIDDK, National Institutes of Health Diabetes Research Center [P30 DK063491]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Center for Cancer Research; University of California, San Diego/Los Angeles NIDDK, National Institutes of Health Diabetes Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GMS-038323 (to W. A. C.), Purdue University Center for Cancer Research Grant P30 CA23168 (to W. A. C.), and University of California, San Diego/Los Angeles NIDDK, National Institutes of Health Diabetes Research Center Grant P30 DK063491 (to J. P. W.). A preliminary account was presented at the meeting of the Biophysical Society, February 27-March 2, 2016, Los Angeles, CA ((2016) Biophys. J. 110, 91a). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Baniulis D, 2013, BIOCHEMISTRY-US, V52, P8975, DOI 10.1021/bi4013534; Baniulis D, 2009, J BIOL CHEM, V284, P9861, DOI 10.1074/jbc.M809196200; BARBER J, 1982, BIOSCIENCE REP, V2, P1, DOI 10.1007/BF01142194; BARBER J, 1982, ANNU REV PLANT PHYS, V33, P261, DOI 10.1146/annurev.pp.33.060182.001401; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Guo JT, 2013, PROTEIN CELL, V4, P607, DOI 10.1007/s13238-013-3034-9; Hari SB, 2013, CHEM BIOL, V20, P806, DOI 10.1016/j.chembiol.2013.05.005; Hasan SS, 2014, BIOPHYS J, V107, P1620, DOI 10.1016/j.bpj.2014.08.003; Hasan SS, 2014, STRUCTURE, V22, P1008, DOI 10.1016/j.str.2014.05.004; Hasan SS, 2013, BBA-BIOENERGETICS, V1827, P1295, DOI 10.1016/j.bbabio.2013.03.002; Hasan SS, 2013, P NATL ACAD SCI USA, V110, P4297, DOI 10.1073/pnas.1222248110; Hasan SS, 2012, PHILOS T R SOC B, V367, P3406, DOI 10.1098/rstb.2012.0058; Hasan SS, 2011, J MOL BIOL, V414, P145, DOI 10.1016/j.jmb.2011.09.023; HORTON P, 1981, FEBS LETT, V125, P193, DOI 10.1016/0014-5793(81)80716-8; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kruse O, 1999, PHOTOSYNTH RES, V61, P43, DOI 10.1023/A:1006229308606; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; MILLNER PA, 1982, J BIOL CHEM, V257, P1736; Minagawa J, 2015, PLANT J, V82, P413, DOI 10.1111/tpj.12805; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; PETERSON DA, 1994, BIOCHEM BIOPH RES CO, V200, P1586, DOI 10.1006/bbrc.1994.1632; Petlicki J, 1998, J CHEM SOC FARADAY T, V94, P2763, DOI 10.1039/a804551h; Puthiyaveetil S, 2011, FEBS LETT, V585, P1717, DOI 10.1016/j.febslet.2011.04.076; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shapiguzov A, 2016, PLANT PHYSIOL, V171, P82, DOI 10.1104/pp.15.01893; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10115; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961; Zito F, 2002, J BIOL CHEM, V277, P12446, DOI 10.1074/jbc.M110914200	65	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21740	21750		10.1074/jbc.M116.732545	http://dx.doi.org/10.1074/jbc.M116.732545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539852	Green Published, hybrid			2022-12-28	WOS:000385999200038
J	Miggin, SM; Lawler, OA; Kinsella, BT				Miggin, Sinead M.; Lawler, Orlaith A.; Kinsella, B. Therese			RETRACTION: Palmitoylation of the human prostacyclin receptor. FUNCTIONAL IMPLICATIONS OF PALMITOYLATION AND ISOPRENYLATION. (Retraction of vol 278, pg 6947, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Miggin SM, 2003, J BIOL CHEM, V278, P6947, DOI 10.1074/jbc.M210637200	1	0	0	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19259	19259		10.1074/jbc.A116.210637	http://dx.doi.org/10.1074/jbc.A116.210637			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27613955	Green Published, hybrid			2022-12-28	WOS:000383242800006
J	Kont, R; Kari, J; Borch, K; Westh, P; Valjamae, P				Kont, Riin; Kari, Jeppe; Borch, Kim; Westh, Peter; Valjamae, Priit			Inter-domain Synergism Is Required for Efficient Feeding of Cellulose Chain into Active Site of Cellobiohydrolase Cel7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; CARBOHYDRATE-BINDING MODULES; CRYSTALLINE CELLULOSE; RECALCITRANT POLYSACCHARIDES; PROCESSIVE CELLULASES; GLYCOSIDE HYDROLASES; SUBSTRATE AFFINITY; KINETIC-MODEL; HYDROLYSIS; DEGRADATION	Structural polysaccharides like cellulose and chitin are abundant and their enzymatic degradation to soluble sugars is an important route in green chemistry. Processive glycoside hydrolases (GHs), like cellobiohydrolase Cel7A of Trichoderma reesei (TrCel7A) are key components of efficient enzyme systems. TrCel7A consists of a catalytic domain (CD) and a smaller carbohydrate-binding module (CBM) connected through the glycosylated linker peptide. A tunnel-shaped active site rests in the CD and contains 10 glucose unit binding sites. The active site of TrCel7A is lined with four Trp residues with two of them, Trp-40 and Trp-38, in the substrate binding sites near the tunnel entrance. Although addressed in numerous studies the elucidation of the role of CBM and active site aromatics has been obscured by a complex multistep mechanism of processive GHs. Here we studied the role of the CBM-linker and Trp-38 of TrCel7A with respect to binding affinity, on-and off-rates, processivity, and synergism with endoglucanase. The CBM-linker increased the on-rate and substrate affinity of the enzyme. The Trp-38 to Ala substitution resulted in increased off-rates and decreased processivity. The effect of the Trp-38 to Ala substitution on on-rates was strongly dependent on the presence of the CBM-linker. This compensation between CBM-linker and Trp-38 indicates synergism between CBM-linker and CD in feeding the cellulose chain into the active site. The inter-domain synergism was pre-requisite for the efficient degradation of cellulose in the presence of endoglucanase.	[Kont, Riin; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Kari, Jeppe; Westh, Peter] Roskilde Univ, Dept Sci & Environm, DK-4000 Roskilde, Denmark; [Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	University of Tartu; Roskilde University; Novozymes	Valjamae, P (corresponding author), Riia 23B-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018; Kari, Jeppe/AAP-6649-2021; Westh, Peter/AAR-9731-2021	Väljamäe, Priit/0000-0002-1035-9493; Kari, Jeppe/0000-0003-3792-3856; Westh, Peter/0000-0002-6185-0637	Danish Agency for Science, Technology, and Innovation; Programme Commission on Sustainable Energy and Environment [2104-07-0028]; Carlsberg Foundation [2013-01-0208]; Estonian Science Agency [PUT1024]; Novo Nordisk Fonden [NNF15OC0016606] Funding Source: researchfish	Danish Agency for Science, Technology, and Innovation; Programme Commission on Sustainable Energy and Environment; Carlsberg Foundation(Carlsberg Foundation); Estonian Science Agency; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Agency for Science, Technology, and Innovation, Programme Commission on Sustainable Energy and Environment Grant 2104-07-0028, Carlsberg Foundation Grant 2013-01-0208, and Estonian Science Agency Grant PUT1024. K. B. works at Novozymes, which is a major enzyme producing company.	Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2016, J PHYS CHEM B, V120, P5591, DOI 10.1021/acs.jpcb.6b01877; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; GhattyVenkataKrishna PK, 2013, BIOPHYS J, V104, P904, DOI 10.1016/j.bpj.2012.12.052; Guo J, 2013, BIOMACROMOLECULES, V14, P1268, DOI 10.1021/bm300810t; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Hilden L, 2005, J BIOTECHNOL, V118, P386, DOI 10.1016/j.jbiotec.2005.05.001; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jana S, 2016, J PHYS CHEM B, V120, P1236, DOI 10.1021/acs.jpcb.5b12610; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Kostylev M, 2014, BIOTECHNOL BIOENG, V111, P664, DOI 10.1002/bit.25139; Kostylev M, 2013, BIOCHEMISTRY-US, V52, P5656, DOI 10.1021/bi400358v; Kurasin M, 2015, J BIOL CHEM, V290, P29074, DOI 10.1074/jbc.M115.684977; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; Luterbacher JS, 2013, BIOTECHNOL BIOENG, V110, P108, DOI 10.1002/bit.24597; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nakamura A, 2013, J BIOL CHEM, V288, P13503, DOI 10.1074/jbc.M113.452623; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Sipos B, 2010, APPL BIOCHEM BIOTECH, V161, P347, DOI 10.1007/s12010-009-8824-4; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Sugimoto N, 2012, LANGMUIR, V28, P14323, DOI 10.1021/la302352k; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Valjamae P, 2001, EUR J BIOCHEM, V268, P4520, DOI 10.1046/j.1432-1327.2001.02377.x; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7625; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x	71	24	25	4	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26013	26023		10.1074/jbc.M116.756007	http://dx.doi.org/10.1074/jbc.M116.756007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780868	Green Published, hybrid			2022-12-28	WOS:000390345200021
J	Bleymuller, WM; Lammermann, N; Ebbes, M; Maynard, D; Geerds, C; Niemann, HH				Bleymueller, Willem M.; Laemmermann, Nina; Ebbes, Maria; Maynard, Daniel; Geerds, Christina; Niemann, Hartmut H.			MET-activating Residues in the B-repeat of the Listeria monocytogenes Invasion Protein InlB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cell surface receptor; dimerization; growth factor; protein domain; protein structure; protein-protein interaction; receptor tyrosine kinase; signal transduction; structure-function	RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; LEUCINE-RICH REPEAT; STEM-CELL FACTOR; TUMOR PROGRESSION; STRUCTURAL BASIS; MAMMALIAN-CELLS; SCATTER FACTOR; INIB PROTEIN; GW DOMAINS	The facultative intracellular pathogen Listeria monocytogenes causes listeriosis, a rare but life-threatening disease. Host cell entry begins with activation of the human receptor tyrosine kinase MET through the bacterial invasion protein InlB, which contains an internalin domain, a B-repeat, and three GW domains. The internalin domain is known to bind MET, but no interaction partner is known for the B-repeat. Adding the B-repeat to the internalin domain potentiates MET activation and is required to stimulate Madin-Darby canine kidney (MDCK) cell scatter. Therefore, it has been hypothesized that the B-repeat may bind a co-receptor on host cells. To test this hypothesis, we mutated residues that might be important for binding an interaction partner. We identified two adjacent residues in strand 2 of the -grasp fold whose mutation abrogated induction of MDCK cell scatter. Biophysical analysis indicated that these mutations do not alter protein structure. We then tested these mutants in human HT-29 cells that, in contrast to the MDCK cells, were responsive to the internalin domain alone. These assays revealed a dominant negative effect, reducing the activity of a construct of the internalin domain and mutated B-repeat below that of the individual internalin domain. Phosphorylation assays of MET and its downstream targets AKT and ERK confirmed the dominant negative effect. Attempts to identify a host cell receptor for the B-repeat were not successful. We conclude that there is limited support for a co-receptor hypothesis and instead suggest that the B-repeat contributes to MET activation through low affinity homodimerization.	[Bleymueller, Willem M.; Laemmermann, Nina; Ebbes, Maria; Maynard, Daniel; Geerds, Christina; Niemann, Hartmut H.] Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany	University of Bielefeld	Niemann, HH (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	Hartmut.Niemann@uni-bielefeld.de	Niemann, Hartmut/F-7947-2011	Niemann, Hartmut/0000-0002-8582-0360	Deutsche Forschungsgemeinschaft [NI694/1-3, NI694/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants NI694/1-3 and NI694/3-1 from the Deutsche Forschungsgemeinschaft (to H. H. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Basilico C, 2014, J CLIN INVEST, V124, P3172, DOI 10.1172/JCI72316; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Carpenter BL, 2015, J BIOL CHEM, V290, P27228, DOI 10.1074/jbc.M115.686873; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen PH, 2015, J MOL BIOL, V427, P3921, DOI 10.1016/j.jmb.2015.10.003; Copp J, 2003, J BIOL CHEM, V278, P7783, DOI 10.1074/jbc.M211666200; Dietz MS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-6; Ebbes M, 2011, J BIOL CHEM, V286, P15496, DOI 10.1074/jbc.M110.189951; Ferraris DM, 2010, J MOL BIOL, V395, P522, DOI 10.1016/j.jmb.2009.10.074; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Graille M, 2001, STRUCTURE, V9, P679, DOI 10.1016/S0969-2126(01)00630-X; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7373; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Koschut D, 2016, BBA-MOL CELL RES, V1863, P1552, DOI 10.1016/j.bbamcr.2016.04.015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Machner MP, 2003, MOL MICROBIOL, V48, P1525, DOI 10.1046/j.1365-2958.2003.03532.x; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Niemann HH, 2013, BBA-PROTEINS PROTEOM, V1834, P2195, DOI 10.1016/j.bbapap.2012.10.012; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olaku V, 2011, MOL BIOL CELL, V22, P2777, DOI 10.1091/mbc.E11-02-0134; Opatowsky Y, 2014, P NATL ACAD SCI USA, V111, P1772, DOI 10.1073/pnas.1323254111; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Overington J.P., 1992, CURR OPIN STRUC BIOL, V2, P394, DOI 10.1016/0959-440X(92)90231-U; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Perica T, 2010, CURR OPIN STRUC BIOL, V20, P367, DOI 10.1016/j.sbi.2010.03.007; Reshetnyak AV, 2015, MOL CELL, V57, P191, DOI 10.1016/j.molcel.2014.11.021; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz GE, 2010, J MOL BIOL, V395, P834, DOI 10.1016/j.jmb.2009.10.044; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; STERNBERG MJE, 1990, PROTEIN ENG, V3, P245, DOI 10.1093/protein/3.4.245; STOKER M, 1985, J CELL SCI, V77, P209; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Ueki R, 2016, ANGEW CHEM INT EDIT, V55, P579, DOI 10.1002/anie.201508572; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	61	6	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25567	25577		10.1074/jbc.M116.746685	http://dx.doi.org/10.1074/jbc.M116.746685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27789707	Green Published, hybrid			2022-12-28	WOS:000390095300024
J	Jafari, N; Zheng, QD; Li, LQ; Li, W; Qi, L; Xiao, JY; Gao, TY; Huang, C				Jafari, Naser; Zheng, Qiaodan; Li, Liqing; Li, Wei; Qi, Lei; Xiao, Jianyong; Gao, Tianyan; Huang, Cai			p70S6K1 (S6K1)-mediated Phosphorylation Regulates Phosphatidylinositol 4-Phosphate 5-Kinase Type I Degradation and Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; cell migration; phosphatidylinositol kinase; protein degradation; S6 kinase; PIP5K1C	FOCAL ADHESION DYNAMICS; E3 UBIQUITIN LIGASES; PHOSPHATE KINASE; BREAST-CANCER; MATRIX METALLOPROTEINASES; N-WASP; MIGRATION; GAMMA; PROTEIN; TALIN	Phosphatidylinositol 4-phosphate 5-kinase type I (PIPKI90) ubiquitination and subsequent degradation regulate focal adhesion assembly, cell migration, and invasion. However, it is unknown how upstream signals control PIPKI90 ubiquitination or degradation. Here we show that p70S6K1 (S6K1), a downstream target of mechanistic target of rapamycin (mTOR), phosphorylates PIPKI90 at Thr-553 and Ser-555 and that S6K1-mediated PIPKI90 phosphorylation is essential for cell migration and invasion. Moreover, PIPKI90 phosphorylation is required for the development of focal adhesions and invadopodia, key machineries for cell migration and invasion. Surprisingly, substitution of Thr-553 and Ser-555 with Ala promoted PIPKI90 ubiquitination but enhanced the stability of PIPKI90, and depletion of S6K1 also enhanced the stability of PIPKI90, indicating that PIPKI90 ubiquitination alone is insufficient for its degradation. These data suggest that S6K1-mediated PIPKI90 phosphorylation regulates cell migration and invasion by controlling PIPKI90 degradation.	[Jafari, Naser; Zheng, Qiaodan; Li, Liqing; Li, Wei; Qi, Lei; Xiao, Jianyong; Gao, Tianyan; Huang, Cai] Univ Kentucky, Markey Canc Ctr, BBSRB Rm B359,741 S Limestone, Lexington, KY 40506 USA; [Huang, Cai] Univ Kentucky, Dept Pharmacol & Nutr Sci, BBSRB Rm B359,741 S Limestone, Lexington, KY 40506 USA; [Jafari, Naser; Huang, Cai] Vet Affairs Med Ctr, Lexington, KY 40502 USA	University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Huang, C (corresponding author), Univ Kentucky, Markey Canc Ctr, BBSRB Rm B359,741 S Limestone, Lexington, KY 40506 USA.; Huang, C (corresponding author), Univ Kentucky, Dept Pharmacol & Nutr Sci, BBSRB Rm B359,741 S Limestone, Lexington, KY 40506 USA.	cai-huang@uky.edu	li, li/GPX-3938-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022; LI, LI/GVS-5344-2022; li, li/AAT-2097-2020		American Cancer Society Research Scholar [RSG-13-184-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA133429, P30CA177558] Funding Source: NIH RePORTER	American Cancer Society Research Scholar(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Cancer Society Research Scholar Grant RSG-13-184-01-CSM (to C. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brown GT, 2015, J PATHOL, V237, P273, DOI 10.1002/path.4586; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Dar A, 2014, MOL CELL BIOL, V34, P4049, DOI 10.1128/MCB.00838-14; Deng SS, 2014, CELL ADHES MIGR, V8, P49, DOI 10.4161/cam.27480; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; HONEYMAN TW, 1983, BIOCHEM J, V212, P489, DOI 10.1042/bj2120489; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang C, 2010, BIOTECHNIQUES, V49, P881, DOI 10.2144/000113550; Huang C, 2010, CELL ADHES MIGR, V4, P10, DOI 10.4161/cam.4.1.9834; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Khotskaya YB, 2014, AM J TRANSL RES, V6, P361; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Le OTT, 2015, BBA-MOL CELL RES, V1853, P2432, DOI 10.1016/j.bbamcr.2015.07.001; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Qi L, 2016, J CELL SCI, V129, P3661, DOI 10.1242/jcs.185959; Rafiq K, 2012, J BIOL CHEM, V287, P5327, DOI 10.1074/jbc.M111.307009; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Shi Z, 2012, REPROD SYS SEX DISOR, V1, P102, DOI [10.4172/2161-038X.1000102, DOI 10.4172/2161-038X.1]; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Weiner H, 1999, FEBS LETT, V455, P75, DOI 10.1016/S0014-5793(99)00868-6; Wu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024775; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	52	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25729	25741		10.1074/jbc.M116.742742	http://dx.doi.org/10.1074/jbc.M116.742742			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27780861	Green Published, hybrid			2022-12-28	WOS:000390095300037
J	Deering-Rice, CE; Stockmann, C; Romero, EG; Lu, ZY; Shapiro, D; Stone, BL; Fassl, B; Nkoy, F; Uchida, DA; Ward, RM; Veranth, JM; Reilly, CA				Deering-Rice, Cassandra E.; Stockmann, Chris; Romero, Erin G.; Lu, Zhenyu; Shapiro, Darien; Stone, Bryan L.; Fassl, Bernhard; Nkoy, Flory; Uchida, Derek A.; Ward, Robert M.; Veranth, John M.; Reilly, Christopher A.			Characterization of Transient Receptor Potential Vanilloid-1 (TRPV1) Variant Activation by Coal Fly Ash Particles and Associations with Altered Transient Receptor Potential Ankyrin-1 (TRPA1) Expression and Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ENDOPLASMIC-RETICULUM STRESS; AIR-POLLUTION; CELL-DEATH; SENSORY NEURONS; PARTICULATE MATERIAL; EPITHELIAL-CELLS; LUNG-CELLS; CAPSAICIN RESPONSIVENESS; ENVIRONMENTAL PARTICLES	Transient receptor potential (TRP) channels are activated by environmental particulate materials. We hypothesized that polymorphic variants of transient receptor potential vanilloid-1 (TRPV1) would be uniquely responsive to insoluble coal fly ash compared with the prototypical soluble agonist capsaicin. Furthermore, these changes would manifest as differences in lung cell responses to these agonists and perhaps correlate with changes in asthma symptom control. The TRPV1-I315M and -T469I variants were more responsive to capsaicin and coal fly ash. The I585V variant was less responsive to coal fly ash particles due to reduced translation of protein and an apparent role for Ile-585 in activation by particles. In HEK-293 cells, I585V had an inhibitory effect on wild-type TRPV1 expression, activation, and internalization/agonist-induced desensitization. In normal human bronchial epithelial cells, IL-8 secretion in response to coal fly ash treatment was reduced for cells heterozygous for TRPV1-I585V. Finally, both the I315M and I585V variants were associated with worse asthma symptom control with the effects of I315M manifesting in mild asthma and those of the I585V variant manifesting in severe, steroid-insensitive individuals. This effect may be due in part to increased transient receptor potential ankyrin-1 (TRPA1) expression by lung epithelial cells expressing the TRPV1-I585V variant. These findings suggest that specific molecular interactions control TRPV1 activation by particles, differential activation, and desensitization of TRPV1 by particles and/or other agonists, and cellular changes in the expression of TRPA1 as a result of I585V expression could contribute to variations in asthma symptom control.	[Deering-Rice, Cassandra E.; Stockmann, Chris; Romero, Erin G.; Lu, Zhenyu; Shapiro, Darien; Veranth, John M.; Reilly, Christopher A.] Univ Utah, Dept Pharmacol & Toxicol, 30 South 2000 East,201 Skaggs Hall, Salt Lake City, UT 84112 USA; [Stone, Bryan L.; Fassl, Bernhard; Nkoy, Flory; Uchida, Derek A.; Ward, Robert M.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Reilly, CA (corresponding author), Univ Utah, Dept Pharmacol & Toxicol, 30 South 2000 East,201 Skaggs Hall, Salt Lake City, UT 84112 USA.	Chris.Reilly@pharm.utah.edu	Sherwin, Catherine Mary Turner/B-2888-2012	Sherwin, Catherine Mary Turner/0000-0002-0844-3207	National Center for Research Resources NCRR Shared Equipment Grant [1S10RR024761-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060559] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017431] Funding Source: NIH RePORTER	National Center for Research Resources NCRR Shared Equipment Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Imaging was performed at the Fluorescence Microscopy Core Facility, a part of the Health Sciences Cores at the University of Utah. Microscopy equipment was purchased using National Center for Research Resources NCRR Shared Equipment Grant 1S10RR024761-01.	Agopyan N, 2003, TOXICOL APPL PHARM, V186, P63, DOI 10.1016/S0041-008X(02)00013-3; Aguilera I, 2009, ENVIRON HEALTH PERSP, V117, P1322, DOI 10.1289/ehp.0800256; Akopian AN, 2008, J NEUROSCI, V28, P1064, DOI 10.1523/JNEUROSCI.1565-06.2008; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Allen RW, 2008, INHAL TOXICOL, V20, P423, DOI 10.1080/08958370801903826 ; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Cantero-Recasens G, 2010, J BIOL CHEM, V285, P27532, DOI 10.1074/jbc.C110.159491; Chen CL, 2015, ALLERGY ASTHMA PROC, V36, pE29, DOI 10.2500/aap.2015.36.3828; Deering-Rice CE, 2015, AM J RESP CELL MOL, V53, P893, DOI 10.1165/rcmb.2015-0086OC; Deering-Rice CE, 2012, MOL PHARMACOL, V81, P411, DOI 10.1124/mol.111.076067; Deering-Rice CE, 2011, CHEM RES TOXICOL, V24, P950, DOI 10.1021/tx200123z; Dicpinigaitis PV, 2001, THORAX, V56, P162; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Epton MJ, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-16; Fujimura M, 1998, Respirology, V3, P267, DOI 10.1111/j.1440-1843.1998.tb00133.x; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Iskandar A, 2012, THORAX, V67, P252, DOI 10.1136/thoraxjnl-2011-200324; Jacquemin B, 2009, EUR RESPIR J, V34, P834, DOI 10.1183/09031936.00138208; Johansen ME, 2006, TOXICOL SCI, V89, P278, DOI 10.1093/toxsci/kfi292; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McConnell R, 2010, ENVIRON HEALTH PERSP, V118, P1021, DOI 10.1289/ehp.0901232; McGarvey LP, 2014, J ALLERGY CLIN IMMUN, V133, P704, DOI 10.1016/j.jaci.2013.09.016; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nieto L, 2003, RESP MED, V97, P393, DOI 10.1053/rmed.2002.1460; Nkoy FL, 2013, PEDIATRICS, V132, pE1554, DOI 10.1542/peds.2013-1389; Nkoy Flory L, 2012, AMIA Annu Symp Proc, V2012, P663; Oortgiesen M, 2000, AM J PHYSIOL-LUNG C, V278, pL683, DOI 10.1152/ajplung.2000.278.4.L683; Portnov BA, 2012, INT J ENVIRON HEAL R, V22, P249, DOI 10.1080/09603123.2011.634387; Rehman R, 2013, INT IMMUNOPHARMACOL, V15, P597, DOI 10.1016/j.intimp.2013.02.010; Reilly CA, 2005, J BIOCHEM MOL TOXIC, V19, P266, DOI 10.1002/jbt.20084; Reilly CA, 2003, TOXICOL SCI, V73, P170, DOI 10.1093/toxsci/kfg044; Ren YF, 2015, PEDIATR RES, V77, P506, DOI 10.1038/pr.2015.11; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schembari A, 2014, ENVIRON HEALTH PERSP, V122, P317, DOI 10.1289/ehp.1306802; Shapiro D, 2013, CHEM RES TOXICOL, V26, P750, DOI 10.1021/tx400024h; Smit LAM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-26; Smith KR, 2006, TOXICOL SCI, V93, P390, DOI 10.1093/toxsci/kfl062; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Stockmann C, 2015, J ALLERGY CLIN IMMUN, V136, P505, DOI 10.1016/j.jaci.2015.02.009; Stockmann C, 2013, J PEDIATR-US, V162, P1222, DOI 10.1016/j.jpeds.2012.11.031; Thomas KC, 2007, J PHARMACOL EXP THER, V321, P830, DOI 10.1124/jpet.107.119412; Thomas KC, 2012, AM J PHYSIOL-LUNG C, V302, pL111, DOI 10.1152/ajplung.00231.2011; Veranth JM, 2004, TOXICOL SCI, V82, P88, DOI 10.1093/toxsci/kfh248; Veranth JM, 2008, TOXICOL IN VITRO, V22, P498, DOI 10.1016/j.tiv.2007.10.011; Veronesi B, 2003, NEUROTOXICOLOGY, V24, P463, DOI 10.1016/S0161-813X(03)00022-6; Veronesi B, 1999, NEUROPEPTIDES, V33, P447, DOI 10.1054/npep.1999.0761; Xu H, 2007, AM J PHYSIOL-RENAL, V293, pF1865, DOI 10.1152/ajprenal.00347.2007	56	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24866	24879		10.1074/jbc.M116.746156	http://dx.doi.org/10.1074/jbc.M116.746156			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758864	Green Published, hybrid			2022-12-28	WOS:000388880100007
J	Fukui, N; Araki, K; Hongo, K; Mizobata, T; Kawata, Y				Fukui, Naoya; Araki, Kiho; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi			Modulating the Effects of the Bacterial Chaperonin GroEL on Fibrillogenic Polypeptides through Modification of Domain Hinge Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; BETA-AMYLOID FIBRILS; ALZHEIMERS-DISEASE; APICAL DOMAIN; PROTEINS; AGGREGATION; SYNUCLEIN; TOXICITY; HSP70; BINDING	The isolated apical domain of the Escherichia coli GroEL subunit displays the ability to suppress the irreversible fibrillation of numerous amyloid-forming polypeptides. In previous experiments, we have shown that mutating Gly-192 (located at hinge II that connects the apical domain and the intermediate domain) to a tryptophan results in an inactive chaperonin whose apical domain is disoriented. In this study, we have utilized this disruptive effect of Gly-192 mutation to our advantage, by substituting this residue with amino acid residues of varying van der Waals volumes with the intent to modulate the affinity of GroEL toward fibrillogenic peptides. The affinities of GroEL toward fibrillogenic polypeptides such as A beta(1-40) (amyloid-beta(1-40)) peptide and alpha-synuclein increased in accordance to the larger van der Waals volume of the substituent amino acid side chain in the G192X mutants. When we compared the effects of wildtype GroEL and selected GroEL G192X mutants on alpha-synuclein fibril formation, we found that the effects of the chaperonin on alpha-synuclein fibrillation were different; the wild-type chaperonin caused changes in both the initial lag phase and the rate of fibril extension, whereas the effects of the G192X mutants were more specific toward the nucleus-forming lag phase. The chaperonins also displayed differential effects on alpha-synuclein fibril morphology, suggesting that through mutation of Gly-192, we may induce changes to the intermolecular affinities between GroEL and alpha-synuclein, leading to more efficient fibril suppression, and in specific cases, modulation of fibril morphology.	[Fukui, Naoya; Araki, Kiho; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Tottori 6808552, Japan	Tottori University; Tottori University	Kawata, Y (corresponding author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan.	kawata@bio.tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Mizobata, Tomohiro/V-6672-2019	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Japan Society for the Promotion of Science (JSPS) [25440027]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2411376]; Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development (AMED)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by Grant-in-Aid for Scientific Research (C) 25440027 from the Japan Society for the Promotion of Science (JSPS) and Grant-in-Aid for Scientific Research on Innovative Areas 2411376 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This research was also partially supported by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Chaudhuri TK, 2009, PROG BIOPHYS MOL BIO, V99, P42, DOI 10.1016/j.pbiomolbio.2008.10.007; Darby N. J., 1993, PROTEIN STRUCTURE FO; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Jacobson D R, 1991, Adv Hum Genet, V20, P69; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Knight SD, 2013, BIOCHEMISTRY-US, V52, P7523, DOI 10.1021/bi400908x; KUBO T, 1993, J BIOL CHEM, V268, P19346; Kulig M, 2012, BIOCHEM J, V448, P343, DOI 10.1042/BJ20121187; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Machida K, 2009, BBA-PROTEINS PROTEOM, V1794, P1344, DOI 10.1016/j.bbapap.2008.12.003; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Nishida N, 2013, J BIOSCI BIOENG, V116, P160, DOI 10.1016/j.jbiosc.2013.02.012; Noi K., 2012, AM J MOL BIOL, V2, P265, DOI [10.4236/ajmb.2012.23028, DOI 10.4236/AJMB.2012.23028]; Ohi T, 2004, J NEUROL SCI, V225, P19, DOI 10.1016/j.jns.2004.06.008; Ojha B, 2016, SCI REP-UK, V6, DOI 10.1038/srep31041; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Sakane I, 2007, J MOL BIOL, V367, P1171, DOI 10.1016/j.jmb.2007.01.037; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yagi-Utsumi M, 2013, FEBS LETT, V587, P1605, DOI 10.1016/j.febslet.2013.04.007	36	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25217	25226		10.1074/jbc.M116.751925	http://dx.doi.org/10.1074/jbc.M116.751925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27742838	hybrid, Green Published			2022-12-28	WOS:000388880100035
J	Horibata, Y; Ando, H; Zhang, PX; Vergnes, L; Aoyama, C; Itoh, M; Reue, K; Sugimoto, H				Horibata, Yasuhiro; Ando, Hiromi; Zhang, Peixiang; Vergnes, Laurent; Aoyama, Chieko; Itoh, Masahiko; Reue, Karen; Sugimoto, Hiroyuki			StarD7 Protein Deficiency Adversely Affects the Phosphatidylcholine Composition, Respiratory Activity, and Cristae Structure of Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; LIPID TRANSPORT; MEMBRANE-FUSION; PHOSPHOLIPIDS; DOMAIN; OPA1	Phosphatidylcholine (PC) is a major phospholipid of mitochondria, comprising 40-50% of both the outer and the inner membranes. However, PC must be imported from its production organelles because mitochondria lack the enzymes essential for PC biosynthesis. In a previous study, we found that StarD7 mediates the intracellular transfer of PC to mitochondria. Therefore, in this study, we analyzed the contribution of StarD7 to the maintenance of mitochondrial phospholipid content and function using siRNA-mediated knockdown and knock-out (KO) of the StarD7 gene in HEPA-1 cells. Real time analysis of respiratory activity demonstrated that the oxygen consumption rate and activity of mitochondrial complexes were impaired in StarD7-KD cells. To confirm these results, we established StarD7-KO HEPA-1 cells by double nicking using CRISPR/Cas9n. As expected, StarD7-KD and - KO cells showed a significant reduction in mitochondrial PC content. The ATP level and growth rate of KO cells were notably lower compared with wild-type cells when cultured in glucose-free galactose-containing medium to force cells to rely on mitochondrial ATP production. In KO cells, the level of the MTCO1 protein, a primary subunit of complex IV, was reduced without a concomitant decrease in its mRNA, but the level was restored when StarD7-I was overexpressed. StarD7-KO cells showed impaired formation of the mitochondrial supercomplexes and exhibited a disorganized cristae structure, with no changes in optic atrophy 1 protein. These findings indicate that StarD7 plays important roles in maintaining the proper composition of mitochondrial phospholipids as well as mitochondrial function and morphogenesis.	[Horibata, Yasuhiro; Ando, Hiromi; Aoyama, Chieko; Itoh, Masahiko; Sugimoto, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Biochem, 880 Kitakobayashi, Mibu, Tochigi, Japan; [Zhang, Peixiang; Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Dokkyo Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Sugimoto, H (corresponding author), Dokkyo Med Univ, Sch Med, Dept Biochem, 880 Kitakobayashi, Mibu, Tochigi, Japan.	h-sugi@dokkyomed.ac.jp		vergnes, laurent/0000-0002-8804-589X	Ministry of Education, Culture, Sports, Science and Technology, Japanese Government [25870668]; U. S. Public Health Services [P01 HL028481]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL028481] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U. S. Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Grant-in-aid for Young Scientists (B) 25870668 from the Ministry of Education, Culture, Sports, Science and Technology, Japanese Government and U. S. Public Health Services Grant P01 HL028481. The authors declare that they have no conflicts of interest with the contents of this article.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Belenguer P, 2013, BBA-MOL CELL RES, V1833, P176, DOI 10.1016/j.bbamcr.2012.08.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fritz JM, 2015, ONCOTARGET, V6, P20744, DOI 10.18632/oncotarget.5233; GIRDLESTONE J, 1981, BIOCHEMISTRY-US, V20, P152, DOI 10.1021/bi00504a025; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jousse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104896; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schenkel L.C., 2014, INT J CELL BIOL, V2014, P709828; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; VALPUESTA JM, 1988, BIOCHIM BIOPHYS ACTA, V942, P341, DOI 10.1016/0005-2736(88)90036-3; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang L, 2015, J IMMUNOL, V194, P5635, DOI 10.4049/jimmunol.1500231	33	18	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24880	24891		10.1074/jbc.M116.736793	http://dx.doi.org/10.1074/jbc.M116.736793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27694445	hybrid, Green Published			2022-12-28	WOS:000388880100008
J	Wei, H; Cai, HY; Wu, JW; Wei, ZQ; Zhang, F; Huang, X; Ma, L; Feng, LL; Zhang, RX; Wang, YJ; Ragg, H; Zheng, Y; Zhou, AW				Wei, Hudie; Cai, Haiyan; Wu, Jiawei; Wei, Zhenquan; Zhang, Fei; Huang, Xin; Ma, Lina; Feng, Lingling; Zhang, Ruoxi; Wang, Yunjie; Ragg, Hermann; Zheng, Ying; Zhou, Aiwu			Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C INHIBITOR; COFACTOR-II; ALPHA-1-ANTITRYPSIN PITTSBURGH; CRYSTAL-STRUCTURES; SERPIN STRUCTURE; TERNARY COMPLEX; ANTI-THROMBIN; HELIX-D; ANTITHROMBIN; ACTIVATION	Lamprey angiotensinogen (l-ANT) is a hormone carrier in the regulation of blood pressure, but it is also a heparin-dependent thrombin inhibitor in lamprey blood coagulation system. The detailed mechanisms on how angiotensin is carried by l-ANT and how heparin binds l-ANT and mediates thrombin inhibition are unclear. Here we have solved the crystal structure of cleaved l-ANT at 2.7 angstrom resolution and characterized its properties in heparin binding and protease inhibition. The structure reveals that l-ANT has a conserved serpin fold with a labile N-terminal angiotensin peptide and undergoes a typical stressed-to-relaxed conformational change when the reactive center loop is cleaved. Heparin binds l-ANT tightly with a dissociation constant of similar to 10 nM involving similar to 8 monosaccharides and similar to 6 ionic interactions. The heparin binding site is located in an extensive positively charged surface area around helix D involving residues Lys-148, Lys-151, Arg-155, and Arg-380. Although l-ANT by itself is a poor thrombin inhibitor with a second order rate constant of 500 M-1 s(-1), its interaction with thrombin is accelerated 90-fold by high molecular weight heparin following a bell-shaped dose-dependent curve. Short heparin chains of 6-20 monosaccharide units are insufficient to promote thrombin inhibition. Furthermore, an l-ANT mutant with the P1 Ile mutated to Arg inhibits thrombin nearly 1500-fold faster than the wild type, which is further accelerated by high molecular weight heparin. Taken together, these results suggest that heparin binds l-ANT at a conserved heparin binding site around helix D and promotes the interaction between l-ANT and thrombin through a template mechanism conserved in vertebrates.	[Wei, Hudie; Cai, Haiyan; Wu, Jiawei; Wei, Zhenquan; Zhang, Fei; Huang, Xin; Ma, Lina; Feng, Lingling; Zhang, Ruoxi; Zheng, Ying; Zhou, Aiwu] Shanghai Jiao Tong Univ, Hongqiao Int Inst Med,Sch Med,Chinese Minist Educ, Shanghai Tongren Hosp,Fac Basic Med,Chem Biol Div, Key Lab Cell Differentiat & Apoptosis,Shanghai Un, Shanghai 200025, Peoples R China; [Wang, Yunjie; Ragg, Hermann] Univ Bielefeld, Fac Technol, D-33613 Bielefeld, Germany	Shanghai Jiao Tong University; University of Bielefeld	Zheng, Y; Zhou, AW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Hongqiao Int Inst Med, 280 Chongqing Rd, Shanghai 200025, Peoples R China.	aiwuzhou@gmail.com	Wang, Yunjie/AGT-2005-2022	ZHOU, Aiwu/0000-0002-2555-5091	National Basic Research Program of China (973 Program) [2014CB910304]; National Natural Science Foundation of China [31370727, 31170724, 81572090]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program; Innovation Program of Shanghai Municipal Education Commission Grant [12ZZ113]; British Heart Foundation	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program(Shanghai Pujiang Program); Innovation Program of Shanghai Municipal Education Commission Grant; British Heart Foundation(British Heart Foundation)	This work was supported in part by National Basic Research Program of China (973 Program) Grant 2014CB910304; National Natural Science Foundation of China Grants 31370727, 31170724, and 81572090; the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; the Shanghai PuJiang Program; Innovation Program of Shanghai Municipal Education Commission Grant 12ZZ113. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a British Heart Foundation Senior Research Fellowship. To whom correspondence may be addressed: Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, 280 Chongqing Rd., Shanghai 200025, China. Tel.: 86-13916791990; E-mail: aiwuzhou@gmail.com.	Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beauchamp NJ, 1998, BLOOD, V92, P2696, DOI 10.1182/blood.V92.8.2696.420a43_2696_2706; Belzar KJ, 2002, J BIOL CHEM, V277, P8551, DOI 10.1074/jbc.M110807200; BRAY B, 1989, BIOCHEM J, V262, P225, DOI 10.1042/bj2620225; Carrell R, 2011, METHOD ENZYMOL, V501, P89, DOI 10.1016/B978-0-12-385950-1.00006-7; Ciaccia AV, 1997, J BIOL CHEM, V272, P888, DOI 10.1074/jbc.272.2.888; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Di Cera E, 2007, J THROMB HAEMOST, V5, P196; Doolittle RF, 2009, COLD SH Q B, V74, P35, DOI 10.1101/sqb.2009.74.001; DOOLITTLE RF, 1983, SCIENCE, V222, P417, DOI 10.1126/science.6604942; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Fournier D, 2012, J MOL MED, V90, P495, DOI 10.1007/s00109-012-0894-z; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Hua BL, 2009, HAEMATOL-HEMATOL J, V94, P881, DOI 10.3324/haematol.2008.004739; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huntington JA, 2013, J THROMB HAEMOST, V11, P254, DOI 10.1111/jth.12252; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KEIJER J, 1991, BLOOD, V78, P1254; Khakoo AY, 2008, CANCER RES, V68, P9112, DOI 10.1158/0008-5472.CAN-08-0851; Kumar A, 2015, PEERJ, V3, DOI 10.7717/peerj.1026; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Li W, 2007, J BIOL CHEM, V282, P13759, DOI 10.1074/jbc.M701074200; Li W, 2012, BLOOD, V120, P459, DOI 10.1182/blood-2012-03-415869; Li W, 2008, J BIOL CHEM, V283, P36039, DOI 10.1074/jbc.M805974200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; O'Keeffe D, 2004, J BIOL CHEM, V279, P50267, DOI 10.1074/jbc.M408774200; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; RAGG H, 1990, J BIOL CHEM, V265, P22386; Ragg H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-208; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Rau JC, 2011, SEMIN THROMB HEMOST, V37, P339, DOI 10.1055/s-0031-1276582; Rein CM, 2011, METHOD ENZYMOL, V501, P105, DOI 10.1016/B978-0-12-385950-1.00007-9; Ritchie AW, 2013, J PHYS CHEM B, V117, P11473, DOI 10.1021/jp404582w; Schedin-Weiss S, 2008, BIOCHEMISTRY-US, V47, P13610, DOI 10.1021/bi801656u; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; STONE SR, 1994, BIOCHEMISTRY-US, V33, P7731, DOI 10.1021/bi00190a028; Tollefsen DM, 1997, ADV EXP MED BIOL, V425, P35; VIDAUD D, 1992, J CLIN INVEST, V89, P1537, DOI 10.1172/JCI115746; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang YJ, 2011, FEBS LETT, V585, P2395, DOI 10.1016/j.febslet.2011.06.021; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wong MKS, 2011, J ENDOCRINOL, V209, P127, DOI 10.1530/JOE-10-0422; Yang LK, 2012, BIOCHEMISTRY-US, V51, P4078, DOI 10.1021/bi300353c; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	63	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24900	24911		10.1074/jbc.M116.725895	http://dx.doi.org/10.1074/jbc.M116.725895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27681598	hybrid, Green Published			2022-12-28	WOS:000388880100010
J	Daiho, T; Yamasaki, K; Danko, S; Suzuki, H				Daiho, Takashi; Yamasaki, Kazuo; Danko, Stefania; Suzuki, Hiroshi			Glycine 105 as Pivot for a Critical Knee-like Joint between Cytoplasmic and Transmembrane Segments of the Second Transmembrane Helix in Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; ADP-INSENSITIVE PHOSPHOENZYME; STABLE STRUCTURAL ANALOG; CA2+ TRANSPORT ACTIVITY; CALCIUM-PUMP; CRYSTAL-STRUCTURE; ADENOSINE-TRIPHOSPHATASE; PHOSPHORYLATED INTERMEDIATE; ANGSTROM RESOLUTION; KINETIC-PROPERTIES	The cytoplasmic actuator domain of the sarco(endo)plasmic reticulum Ca2+-ATPase undergoes large rotational movements that influence the distant transmembrane transport sites, and a long second transmembrane helix (M2) connected with this domain plays critical roles in transmitting motions between the cytoplasmic catalytic domains and transport sites. Here we explore possible structural roles of Gly(105) between the cytoplasmic (M2c) and transmembrane (M2m) segments of M2 by introducing mutations that limit/increase conformational freedom. Alanine substitution G105A markedly retards isomerization of the phosphoenzyme intermediate (E1PCa(2) -> E2PCa(2) -> E2P + 2Ca(2+)), and disrupts Ca2+ occlusion in E1PCa(2) and E2PCa(2) at the transport sites uncoupling ATP hydrolysis and Ca2+ transport. In contrast, this substitution accelerates the ATPase activation (E2 -> E1Ca(2)). Introducing a glycine by substituting another residue on M2 in the G105A mutant (i.e. "G-shift substitution") identifies the glycine positions required for proper Ca2+ handling and kinetics in each step. All wild-type kinetic properties, including coupled transport, are fully restored in the (4-shift substitution at position 112 (G105A/A112(4) located on the same side of the M2c helix as Gly(105) facing M4/phosphorylation domain. Results demonstrate that Gly(105) functions as a flexible knee-like joint during the Ca2+ transport cycle, so that cytoplasmic domain motions can bend and strain M2 in the correct direction or straighten the helix for proper gating and coupling of Ca2+ transport and ATP hydrolysis.	[Daiho, Takashi; Yamasaki, Kazuo; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Daiho, T (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	daiho@asahikawa-med.ac.jp			JSPS [JP15H04346, JP26440017]; Grants-in-Aid for Scientific Research [15H04346] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants JP15H04346 and JP26440017. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1154; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2001, J BIOL CHEM, V276, P32771, DOI 10.1074/jbc.M101229200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2014, J BIOL CHEM, V289, P31241, DOI 10.1074/jbc.M114.584086; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; Fersht A. R., 1999, STRUCTURE MECH PROTE, P14; HANEL AM, 1991, BIOCHEMISTRY-US, V30, P11320, DOI 10.1021/bi00111a019; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; NAKAMURA Y, 1984, J BIOL CHEM, V259, P8183; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200; Yamasaki K, 2015, J BIOL CHEM, V290, P27868, DOI 10.1074/jbc.M115.693770	48	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24688	24701		10.1074/jbc.M116.759704	http://dx.doi.org/10.1074/jbc.M116.759704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27733680	Green Published, hybrid			2022-12-28	WOS:000388875500028
J	Ly, K; Essalmani, R; Desjardins, R; Seidah, NG; Day, R				Ly, Kevin; Essalmani, Rachid; Desjardins, Roxane; Seidah, Nabil G.; Day, Robert			An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; FAMILIAL HYPERCHOLESTEROLEMIA; INTRACELLULAR DEGRADATION; LIVER-REGENERATION; ANNEXIN A2; PROTEIN; PATHWAY; BINDING; CHOLESTEROL; ENDOCYTOSIS	The mechanism of LDL receptor (LDLR) degradation mediated by the proprotein convertase subtilisin/kexin type 9 (PCSK9) has been extensively studied; however, many steps within this process remain unclear and still require characterization. Recent studies have shown that PCSK9 lacking its Cys/His-rich domain can still promote LDLR internalization, but the complex does not reach the lysosome suggesting the presence of an additional interaction partner(s). In this study we carried out an unbiased screening approach to identify PCSK9-interacting proteins in the HepG2 cells' secretome using co-immunoprecipitation combined with mass spectrometry analyses. Several interacting proteins were identified, including glypican-3 (GPC3), phospholipid transfer protein, matrilin-3, tissue factor pathway inhibitor, fibrinogen-like 1, and plasminogen activator inhibitor-1. We then validated these interactions by co-immunoprecipitation and Western blotting. Furthermore, functional validation was examined by silencing each candidate protein in HepG2 cells using short hairpin RNAs to determine their effect on LDL, uptake and LDLR levels. Only GPC3 and phospholipid transfer protein silencing in HepG2 cells significantly increased LDI, uptake in these cells and displayed higher total LDLR protein levels compared with control cells. Moreover, our study provides the first evidence that GPC3 can modulate the PCSK9 extracellular activity as a competitive binding partner to the LDLR in HepG2 cells.	[Ly, Kevin; Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, Dept Surg,Urol Div, Sherbrooke, PQ J1H 5N4, Canada; [Essalmani, Rachid; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	University of Sherbrooke; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Day, R (corresponding author), Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, 3001 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	robert.day@usherbrooke.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Fondation Leducq [13 CVD 03]; Canada Research Chair [126684]; Pfizer ASPIRE CV IIR Grant; Fonds de Recherche du Quebec-Sante (FRQS)	Fondation Leducq(Leducq Foundation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Pfizer ASPIRE CV IIR Grant; Fonds de Recherche du Quebec-Sante (FRQS)	This work was supported in part by Fondation Leducq Grant 13 CVD 03 (to R. D. and N.G. S.), by Canada Research Chair 126684 (to N.G. S.), and in part by a Pfizer ASPIRE CV IIR Grant (to N.G. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of studentship support from the Fonds de Recherche du Quebec-Sante (FRQS).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Capurro M, 2014, J CELL SCI, V127, P1565, DOI 10.1242/jcs.140871; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2012, J CELL SCI, V125, P3380, DOI 10.1242/jcs.098889; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dashty M, 2014, THROMB HAEMOSTASIS, V111, P518, DOI 10.1160/TH13-02-0178; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; Demchev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058084; Denis N, 2011, J PROTEOME RES, V10, P2011, DOI 10.1021/pr2000072; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; Filmus J, 2013, FEBS J, V280, P2471, DOI 10.1111/febs.12126; Fu SJ, 2013, SURGERY, V154, P536, DOI 10.1016/j.surg.2013.02.014; Gao Wei, 2011, Cancer Rep, V1, P14; Hamik A, 1999, J BIOL CHEM, V274, P4962, DOI 10.1074/jbc.274.8.4962; Haruyama Y, 2016, WORLD J GASTROENTERO, V22, P275, DOI 10.3748/wjg.v22.i1.275; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Holla OL, 2010, MOL GENET METAB, V99, P149, DOI 10.1016/j.ymgme.2009.09.012; Hsu HC, 1997, CANCER RES, V57, P5179; Iglesias BV, 2008, HISTOL HISTOPATHOL, V23, P1333, DOI 10.14670/HH-23.1333; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Leren TP, 2014, ATHEROSCLEROSIS, V237, P76, DOI 10.1016/j.atherosclerosis.2014.08.038; Llorente-Cortes V, 2004, CIRCULATION, V110, P452, DOI 10.1161/01.CIR.0000136032.40666.3D; Ly K, 2014, J BIOL CHEM, V289, P17732, DOI 10.1074/jbc.M113.541094; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Murdoch SJ, 2002, J LIPID RES, V43, P1256, DOI 10.1194/jlr.M100373-JLR200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Norman D, 1999, J CLIN INVEST, V104, P619, DOI 10.1172/JCI6677; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Strickland DK, 2014, ARTERIOSCL THROM VAS, V34, P487, DOI 10.1161/ATVBAHA.113.301924; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Tveten K, 2012, HUM MOL GENET, V21, P1402, DOI 10.1093/hmg/ddr578; Weider E, 2016, J BIOL CHEM, V291, P16659, DOI 10.1074/jbc.M116.717736; Xu WM, 2012, MOLECULES, V17, P12086, DOI 10.3390/molecules171012086; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	52	7	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24676	24687		10.1074/jbc.M116.746883	http://dx.doi.org/10.1074/jbc.M116.746883			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27758865	hybrid, Green Published			2022-12-28	WOS:000388875500027
J	Sharma, AK; Arora, D; Singh, LK; Gangwal, A; Sajid, A; Molle, V; Singh, Y; Nandicoori, VK				Sharma, Aditya K.; Arora, Divya; Singh, Lalit K.; Gangwal, Aakriti; Sajid, Andaleeb; Molle, Virginie; Singh, Yogendra; Nandicoori, Vinay Kumar			Serine/Threonine Protein Phosphatase PstP of Mycobacterium tuberculosis Is Necessary for Accurate Cell Division and Survival of Pathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; cell signaling; mycobacteria; Mycobacterium tuberculosis; phosphatase; phosphorylation; protein serine; threonine phosphatase (PSP); PstP; cell division	VACUOLAR-H+-ATPASE; TYROSINE PHOSPHATASES; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; KINASES PKNA; IN-VITRO; PHOSPHORYLATION; THREONINE; SERINE; GROWTH	Protein phosphatases play vital roles in phosphorylation-mediated cellular signaling. Although there are 11 serine/threonine protein kinases in Mycobacterium tuberculosis, only one serine/threonine phosphatase, PstP, has been identified. Although PstP has been biochemically characterized and multiple in vitro substrates have been identified, its physiological role has not yet been elucidated. In this study, we have investigated the impact of PstP on cell growth and survival of the pathogen in the host. Overexpression of PstP led to elongated cells and partially compromised survival. We find that depletion of PstP is detrimental to cell survival, eventually leading to cell death. PstP depletion results in elongated multiseptate cells, suggesting a role for PstP in regulating cell division events. Complementation experiments performed with PstP deletion mutants revealed marginally compromised survival, suggesting that all of the domains, including the extracellular domain, are necessary for complete rescue. On the other hand, the catalytic activity of PstP is absolutely essential for the in vitro growth. Mice infection experiments establish a definitive role for PstP in pathogen survival within the host. Depletion of PstP from established infections causes pathogen clearance, indicating that the continued presence of PstP is necessary for pathogen survival. Taken together, our data suggest an important role for PstP in establishing and maintaining infection, possibly via the modulation of cell division events.	[Arora, Divya; Nandicoori, Vinay Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Sharma, Aditya K.; Singh, Lalit K.; Sajid, Andaleeb; Singh, Yogendra] CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India; [Gangwal, Aakriti; Singh, Yogendra] Univ Delhi, Dept Zool, Delhi 110007, India; [Molle, Virginie] Univ Montpellier 2, CNRS, Lab Dynam Interact Membranaires Normales & Pathol, UMR 5235, Montpellier, France; [Sharma, Aditya K.] CSIR IGIB, Acad Sci & Innovat Res AcSIR, Delhi 110025, India; [Sajid, Andaleeb] NIAID, NIH, Bethesda, MD 20814 USA	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.; Singh, Y (corresponding author), CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.; Singh, Y (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	ysingh@igib.res.in; vinaykn@nii.ac.in	Sajid, Andaleeb/AAI-2960-2020; MOLLE, Virginie/D-4050-2019	Sajid, Andaleeb/0000-0001-6248-4985; MOLLE, Virginie/0000-0002-6573-3411; Nandicoori, Vinay/0000-0002-5682-4178; Sharma, Aditya Kumar/0000-0002-1085-5665	Indo French Centre for the Promotion of Advanced Research Grant [5303-1, BSC0104]	Indo French Centre for the Promotion of Advanced Research Grant	This work was supported by Indo French Centre for the Promotion of Advanced Research Grant 5303-1 (to V.K.N., Y.S., and V.M.) and BSC0104 (CSIR) (to Y.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bohmer F, 2013, FEBS J, V280, P413, DOI 10.1111/j.1742-4658.2012.08655.x; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; BOTTA GA, 1981, ANTIMICROB AGENTS CH, V19, P891, DOI 10.1128/AAC.19.5.891; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P113, DOI 10.1016/j.mib.2010.02.003; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Chiaradia LD, 2012, J MED CHEM, V55, P390, DOI 10.1021/jm2012062; Chopra P, 2003, BIOCHEM BIOPH RES CO, V311, P112, DOI 10.1016/j.bbrc.2003.09.173; Clarke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008585; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Dhiman A, 2014, FEBS OPEN BIO, V4, P65, DOI 10.1016/j.fob.2013.12.005; Fay A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004516; Fortuin S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00006; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; Gopalaswamy R, 2004, PROTEIN EXPRES PURIF, V36, P82, DOI 10.1016/j.pep.2004.03.011; Grundner C, 2008, FEMS MICROBIOL LETT, V287, P181, DOI 10.1111/j.1574-6968.2008.01309.x; Hatzios SK, 2013, P NATL ACAD SCI USA, V110, pE5069, DOI 10.1073/pnas.1321205110; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kaur K, 2016, FEBS J, V283, P2949, DOI 10.1111/febs.13787; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Lakshminarayan H, 2008, PROTEIN EXPRES PURIF, V58, P309, DOI 10.1016/j.pep.2007.12.012; LAPORTE DC, 1985, J BIOL CHEM, V260, P5291; Mascarello A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077081; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2003, BIOCHEM BIOPH RES CO, V308, P820, DOI 10.1016/S0006-291X(03)01476-1; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Nagarajan SN, 2015, J BIOL CHEM, V290, P9626, DOI 10.1074/jbc.M114.611822; Nakedi KC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00237; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Osaki M, 2009, J BACTERIOL, V191, P4943, DOI 10.1128/JB.00196-09; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Prisic S, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0006-2013; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Sajid A, 2015, ANNU REV MICROBIOL, V69, P527, DOI 10.1146/annurev-micro-020415-111342; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Shi L, 2004, FRONT BIOSCI-LANDMRK, V9, P1382, DOI 10.2741/1318; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sieger B, 2013, MOL MICROBIOL, V90, P966, DOI 10.1111/mmi.12411; Singh LK, 2015, ENVIRON MICROBIOL, V17, P855, DOI 10.1111/1462-2920.12548; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Soni V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005235; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; WEIDEL W, 1964, ADV ENZYMOL REL S BI, V26, P193; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Zheng JH, 2015, J PROTEOMICS, V126, P189, DOI 10.1016/j.jprot.2015.06.003; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107	68	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24215	24230		10.1074/jbc.M116.754531	http://dx.doi.org/10.1074/jbc.M116.754531			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27758870	Green Published, hybrid			2022-12-28	WOS:000388498100035
J	Cuny, H; Kompella, SN; Tae, HS; Yu, RL; Adams, DJ				Cuny, Hartmut; Kompella, Shiva N.; Tae, Han-Shen; Yu, Rilei; Adams, David J.			Key Structural Determinants in the Agonist Binding Loops of Human beta 2 and beta 4 Nicotinic Acetylcholine Receptor Subunits Contribute to alpha 3 beta 4 Subtype Selectivity of alpha-Conotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; homology modeling; molecular dynamics; nicotinic acetylcholine receptors (nAChR); oocyte; site-directed mutagenesis; toxin; Xenopus	REGIIA; ALPHA-4/7-CONOTOXIN; SENSITIVITY; RESIDUES; STATES; BUIA; LVIA; RAT	alpha-Conotoxins represent a large group of pharmacologically active peptides that antagonize nicotinic acetylcholine receptors (nAChRs). The 34 nAChR, a predominant subtype in the peripheral nervous system, has been implicated in various pathophysiological conditions. As many -conotoxins have multiple pharmacological targets, compounds specifically targeting individual nAChR subtypes are needed. In this study, we performed mutational analyses to evaluate the key structural components of human 2 aR. -Conotoxin RegIIA was used to evaluate the impact of non-conserved hund 4 nAChR subunits that determine -conotoxin selectivity for 34 nAChman 2 and 4 residues on peptide affinity. Two mutations, 32[T59K] and 32[S113R], strongly enhanced RegIIA affinity compared with wild-type 32, as seen by substantially increased inhibitory potency and slower off-rate kinetics. Opposite point mutations in 34 had the contrary effect, emphasizing the importance of loop D residue 59 and loop E residue 113 as determinants for RegIIA affinity. Molecular dynamics simulation revealed the side chains of 4 Lys(59) and 4 Arg(113) formed hydrogen bonds with RegIIA loop 2 atoms, whereas the 2 Thr(59) and 2 Ser(113) side chains were not long enough to form such interactions. Residue 4 Arg(113) has been identified for the first time as a crucial component facilitating antagonist binding. Another -conotoxin, AuIB, exhibited low activity at human 32 and 34 nAChRs. Molecular dynamics simulation indicated the key interactions with the subunit are different to RegIIA. Taken together, these data elucidate the interactions with specific individual subunit residues that critically determine affinity and pharmacological activity of -conotoxins RegIIA and AuIB at human nAChRs.	[Cuny, Hartmut; Tae, Han-Shen; Adams, David J.] Univ Wollongong, Illawarra Hlth & Med Res Inst IHMRI, Wollongong, NSW 2522, Australia; [Cuny, Hartmut; Kompella, Shiva N.; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Yu, Rilei] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Chinese Minist Educ, Qingdao 266003, Peoples R China; [Kompella, Shiva N.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Wollongong; Royal Melbourne Institute of Technology (RMIT); Ocean University of China; University of Sydney	Adams, DJ (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst IHMRI, Wollongong, NSW 2522, Australia.	djadams@uow.edu.au	Tae, Han-Shen/AAA-1904-2020; Adams, David John/K-3578-2019; Yu, Rilei/G-2353-2014	Tae, Han-Shen/0000-0001-8961-7194; Adams, David John/0000-0002-7030-2288; Cuny, Hartmut/0000-0002-1551-2354; Kompella, Shiva/0000-0001-5625-2491; Yu, Rilei/0000-0001-6625-2014	Australian Research Council [DP150103990]; Natural Science Foundation of China [81502977]; Fundamental Research Funds for the Central Universities	Australian Research Council(Australian Research Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Australian Research Council Discovery Project Grant DP150103990 (to D. J. A.), Natural Science Foundation of China Grant 81502977 (to R. Y.), and Fundamental Research Funds for the Central Universities (to R. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; [Anonymous], 2008, AMBER 10; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grishin AA, 2013, J BIOL CHEM, V288, P34428, DOI 10.1074/jbc.M113.512582; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Kompella SN, 2015, MOL PHARMACOL, V88, P993, DOI 10.1124/mol.115.100503; Kompella SN, 2015, J BIOL CHEM, V290, P1039, DOI 10.1074/jbc.M114.605592; Lebbe EKM, 2014, MAR DRUGS, V12, P2970, DOI 10.3390/md12052970; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2014, FASEB J, V28, P1842, DOI 10.1096/fj.13-244103; Luo SL, 2013, J MED CHEM, V56, P9655, DOI 10.1021/jm401254c; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muttenthaler M, 2011, CURR PHARM DESIGN, V17, P4226, DOI 10.2174/138161211798999384; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Yu RL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002011; Zhangsun DT, 2015, J BIOL CHEM, V290, P9855, DOI 10.1074/jbc.M114.632646; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	38	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23779	23792		10.1074/jbc.M116.730804	http://dx.doi.org/10.1074/jbc.M116.730804			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27646000	Green Published, hybrid			2022-12-28	WOS:000387884400037
J	Hoppstadter, J; Hachenthal, N; Valbuena-Perez, JV; Lampe, S; Astanina, K; Kunze, MM; Bruscoli, S; Riccardi, C; Schmid, T; Diesel, B; Kiemer, AK				Hoppstaedter, Jessica; Hachenthal, Nina; Valbuena-Perez, Jenny Vanessa; Lampe, Sebastian; Astanina, Ksenia; Kunze, Michael M.; Bruscoli, Stefano; Riccardi, Carlo; Schmid, Tobias; Diesel, Britta; Kiemer, Alexandra K.			Induction of Glucocorticoid-induced Leucine Zipper (GILZ) Contributes to Anti-inflammatory Effects of the Natural Product Curcumin in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN HUR; INFLAMMATORY-BOWEL-DISEASE; FACTOR-KAPPA-B; MESSENGER-RNA; NITRIC-OXIDE; TRANSLATIONAL CONTROL; TRANSGENIC MICE; HUMAN ALVEOLAR; CELL-DEATH; RECEPTOR 4	GILZ (glucocorticoid-induced leucine zipper) is inducible by glucocorticoids and plays a key role in their mode of action. GILZ attenuates inflammation mainly by inhibition of NF-kappa B and mitogen-activated protein kinase activation but does not seem to be involved in the severe side effects observed after glucocorticoid treatment. Therefore, GILZ might be a promising target for new therapeutic approaches. The present work focuses on the natural product curcumin, which has previously been reported to inhibit NF-kappa B. GILZ was inducible by curcumin in macrophage cell lines, primary human monocyte-derived macrophages, and murine bone marrow-derived macrophages. The up-regulation of GILZ was neither associated with glucocorticoid receptor activation nor with transcriptional induction or mRNA or protein stabilization but was a result of enhanced translation. Because the GILZ 3'-UTR contains AU-rich elements (AREs), we analyzed the role of the mRNA-binding protein HuR, which has been shown to promote the translation of ARE-containing mRNAs. Our results suggest that curcumin treatment induces HuR expression. An RNA immunoprecipitation assay confirmed that HuR can bind GILZ mRNA. In accordance, HuR overexpression led to increased GILZ protein levels but had no effect on GILZ mRNA expression. Our data employing siRNA in LPS-activated RAW264.7 macrophages show that curcumin facilitates its anti-inflammatory action by induction of GILZ in macrophages. Experiments with LPS-activated bone marrow-derived macrophages from wild-type and GILZ knock-out mice demonstrated that curcumin inhibits the activity of inflammatory regulators, such as NF-kappa B or ERK, and subsequent TNF-kappa production via GILZ. In summary, our data indicate that HuR-dependent GILZ induction contributes to the anti-inflammatory properties of curcumin.	[Hoppstaedter, Jessica; Hachenthal, Nina; Valbuena-Perez, Jenny Vanessa; Astanina, Ksenia; Diesel, Britta; Kiemer, Alexandra K.] Univ Saarland, Dept Pharm, Pharmaceut Biol, D-66041 Saarbrucken, Germany; [Lampe, Sebastian; Kunze, Michael M.; Schmid, Tobias] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60590 Frankfurt, Germany; [Bruscoli, Stefano; Riccardi, Carlo] Univ Perugia, Pharmacol Sect, Dept Med, I-06132 Perugia, Italy	Saarland University; Goethe University Frankfurt; University of Perugia	Kiemer, AK (corresponding author), Univ Saarland, Pharmaceut Biol, POB 15 11 50, D-66041 Saarbrucken, Germany.	pharm.bio.kiemer@mx.uni-saarland.de	Hoppstädter, Jessica/AAM-2548-2020; Kiemer, Alexandra K./I-9300-2012; Riccardi, Carlo/N-4610-2014	Kiemer, Alexandra K./0000-0002-7224-9900; Riccardi, Carlo/0000-0001-9257-3997; Hoppstadter, Jessica/0000-0001-8758-1554; Valbuena Perez, J. Vanessa/0000-0001-7734-6251; Schmid, Tobias/0000-0002-1952-5259	Deutsche Forschungsgemeinschaft, Bonn, Germany [KI702]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This work was supported, in part, by Deutsche Forschungsgemeinschaft, Bonn, Germany (Grant KI702). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Aggarwal B. B., 2013, British Journal of Pharmacology, V169, P1672, DOI 10.1111/bph.12131; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Astanina K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11453; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Brumatti LV, 2014, MOLECULES, V19, P21127, DOI 10.3390/molecules191221127; Bruscoli S, 2015, BLOOD, V126, P1790, DOI 10.1182/blood-2015-03-631580; Carroll R. E., 2011, CANCER PREV RES, DOI [10.1158/1940-6207, DOI 10.1158/1940-6207]; Chakravarti N., 2010, CANCER PREV RES, DOI [10.1158/1940-6207, DOI 10.1158/1940-6207]; Chen FY, 2014, J CARDIOVASC PHARM, V63, P544, DOI 10.1097/FJC.0000000000000079; Cheng AL, 2001, ANTICANCER RES, V21, P2895; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; de Oliveira LF, 2016, LANGMUIR, V32, P3217, DOI 10.1021/acs.langmuir.6b00214; Delfino DV, 2006, INT IMMUNOPHARMACOL, V6, P1126, DOI 10.1016/j.intimp.2006.02.001; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fejer G, 2015, IMMUNOBIOLOGY, V220, P169, DOI 10.1016/j.imbio.2014.11.005; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gao SS, 2015, J MOL CELL CARDIOL, V85, P131, DOI 10.1016/j.yjmcc.2015.04.025; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hahn RT, 2014, ATHEROSCLEROSIS, V234, P391, DOI 10.1016/j.atherosclerosis.2014.03.028; Hamdi H, 2007, HEPATOLOGY, V46, P1986, DOI 10.1002/hep.21880; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Hoppstadter J, 2015, ONCOTARGET, V6, P38446, DOI 10.18632/oncotarget.6197; Hoppstadter J, 2015, J IMMUNOL, V194, P6057, DOI 10.4049/jimmunol.1403207; Hoppstadter J, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00055; Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081; Hoppstadter J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-124; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kiemer AK, 2002, IMMUNOL CELL BIOL, V80, P550, DOI 10.1046/j.1440-1711.2002.01124.x; Kiemer AK, 2001, IMMUNOL CELL BIOL, V79, P11, DOI 10.1046/j.1440-1711.2001.00969.x; Kiemer AK, 2009, J INNATE IMMUN, V1, P29, DOI 10.1159/000142731; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Kunze MM, 2016, BBA-GENE REGUL MECH, V1859, P848, DOI 10.1016/j.bbagrm.2016.05.005; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2009, MOL CELL BIOL, V29, P2622, DOI 10.1128/MCB.01495-08; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Parodi FE, 2006, ANN VASC SURG, V20, P360, DOI 10.1007/s10016-006-9054-7; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Soetikno V., 2011, NUTR METAB LOND; Vago JP, 2015, J IMMUNOL, V194, P4940, DOI 10.4049/jimmunol.1401722; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Yoon JH, 2014, NUCLEIC ACIDS RES, V42, P1196, DOI 10.1093/nar/gkt903; Young NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111559; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou YY, 2015, CELL PHYSIOL BIOCHEM, V36, P631, DOI 10.1159/000430126; Zhou Y, 2016, J BIOL CHEM, V291, P291, DOI 10.1074/jbc.M115.693853; Ziaei A, 2015, J ETHNOPHARMACOL, V160, P94, DOI 10.1016/j.jep.2014.10.041	61	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22949	22960		10.1074/jbc.M116.733253	http://dx.doi.org/10.1074/jbc.M116.733253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27629417	Green Published, hybrid			2022-12-28	WOS:000387224800008
J	Prigozhin, DM; Papavinasasundaram, KG; Baer, CE; Murphy, KC; Moskaleva, A; Chen, TY; Alber, T; Sassetti, CM				Prigozhin, Daniil M.; Papavinasasundaram, Kadamba G.; Baer, Christina E.; Murphy, Kenan C.; Moskaleva, Alisa; Chen, Tony Y.; Alber, Tom; Sassetti, Christopher M.			Structural and Genetic Analyses of the Mycobacterium tuberculosis Protein Kinase B Sensor Domain Identify a Potential Ligand-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SER/THR KINASE; PKNB; VIRULENCE; SYSTEM; TOOL	Monitoring the environment with serine/threonine protein kinases is critical for growth and survival of Mycobacterium tuberculosis, a devastating human pathogen. Protein kinase B (PknB) is a transmembrane serine/threonine protein kinase that acts as an essential regulator of mycobacterial growth and division. The PknB extracellular domain (ECD) consists of four repeats homologous to penicillin-binding protein and serine/threonine kinase associated (PASTA) domains, and binds fragments of peptidoglycan. These properties suggest that PknB activity is modulated by ECD binding to peptidoglycan substructures, however, the molecular mechanisms underpinning PknB regulation remain unclear. In this study, we report structural and genetic characterization of the PknB ECD. We determined the crystal structures of overlapping ECD fragments at near atomic resolution, built a model of the full ECD, and discovered a region on the C-terminal PASTA domain that has the properties of a ligand-binding site. Hydrophobic interaction between this surface and a bound molecule of citrate was observed in a crystal structure. Our genetic analyses in M. tuberculosis showed that nonfunctional alleles were produced either by deletion of any of single PASTA domain or by mutation of individual conserved residues lining the putative ligand-binding surface of the C-terminal PASTA repeat. These results define two distinct structural features necessary for PknB signal transduction, a fully extended ECD and a conserved, membrane-distal putative ligand-binding site.	[Prigozhin, Daniil M.; Moskaleva, Alisa; Chen, Tony Y.; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, 229 Stanley Hall, Berkeley, CA 94720 USA; [Papavinasasundaram, Kadamba G.; Baer, Christina E.; Murphy, Kenan C.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Prigozhin, Daniil M.] Univ Cambridge, MRC Lab Mol Biol, Dept Med, Mol Immun Unit, Cambridge CB2 0QH, England	University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester; MRC Laboratory Molecular Biology; University of Cambridge	Sassetti, CM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA.	sassetti@umassmed.edu	Chen, Tony/AAU-1761-2020; Murphy, Kenan/AHB-4771-2022	Murphy, Kenan/0000-0002-3677-2876; Prigozhin, Daniil M/0000-0003-2075-0231; Baer, Christina/0000-0002-8909-2583	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135, R01AI064282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070962] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to James Holton, George Meigs, and Jane Tanamachi for assistance with Beamline 8.3.1 at the Lawrence Berkeley National Laboratory Advanced Light Source. We thank Dirk Schnappinger for sharing the various mycobacterial promoter and expression plasmids used in this study. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Brown Amanda Claire, 2008, V465, P337, DOI 10.1007/978-1-59745-207-6_23; Cavazos A, 2012, J MOL BIOL, V422, P488, DOI 10.1016/j.jmb.2012.06.011; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Murphy Kenan C, 2015, Methods Mol Biol, V1285, P177, DOI 10.1007/978-1-4939-2450-9_10; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paracuellos P, 2010, J MOL BIOL, V404, P847, DOI 10.1016/j.jmb.2010.10.012; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruggiero A, 2011, BIOCHEM J, V435, P33, DOI 10.1042/BJ20101643; Schnappinger Dirk, 2015, Methods Mol Biol, V1285, P151, DOI 10.1007/978-1-4939-2450-9_9; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Turapov O, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150025; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7	34	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22961	22969		10.1074/jbc.M116.731760	http://dx.doi.org/10.1074/jbc.M116.731760			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27601474	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000387224800009
J	Quevedo, MF; Lucchesi, O; Bustos, MA; Pocognoni, CA; De la Iglesia, PX; Tomes, CN				Quevedo, Maria F.; Lucchesi, Ornella; Bustos, Matias A.; Pocognoni, Cristian A.; De la Iglesia, Paola X.; Tomes, Claudia N.			The Rab3A-22A Chimera Prevents Sperm Exocytosis by Stabilizing Open Fusion Pores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE GRANULE EXOCYTOSIS; ACROSOMAL EXOCYTOSIS; CA2+-TRIGGERED EXOCYTOSIS; SYNAPTIC VESICLE; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; HUMAN SPERMATOZOA; SNARE COMPLEX; RAB GTPASES; MECHANISM	At the final stage of exocytotis, a fusion pore opens between the plasma and a secretory vesicle membranes; typically, when the pore dilates the vesicle releases its cargo. Sperm contain a large dense-core secretory granule (the acrosome) whose contents are secreted by regulated exocytosis at fertilization. Minutes after the arrival of the triggering signal, the acrosomal and plasma membranes dock at multiple sites and fusion pores open at the contact points. It is believed that immediately afterward, fusion pores dilate spontaneously. Rab3A is an essential component of human sperm exocytotic machinery. Yet, recombinant, persistently active Rab3A halts calcium-triggered secretion when introduced after docking into streptolysin O-permeabilized cells; so does a Rab3A-22A chimera. Here, we applied functional assays, electron and confocal microscopy to show that the secretion blockage is due to the stabilization of open fusion pores. Other novel findings are that sperm SNAREs engage in alpha-SNAP/NSF-sensitive complexes at a post-fusion stage. Complexes are disentangled by these chaperons to achieve vesiculation and acrosomal contents release. Thus, post-fusion regulation of the pores determines their expansion and the success of the acrosome reaction.	[Quevedo, Maria F.; Lucchesi, Ornella; Bustos, Matias A.; Pocognoni, Cristian A.; De la Iglesia, Paola X.; Tomes, Claudia N.] Univ Nacl Cuyo, IHEM, CONICET, Fac Ciencias Med, CC56, RA-5500 Mendoza, Argentina; [Bustos, Matias A.] John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA; [De la Iglesia, Paola X.] Hosp Italiano Buenos Aires, Serv Patol, C1199ABD, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; John Wayne Cancer Institute; Hospital Italiano de Buenos Aires; University of Buenos Aires	Tomes, CN (corresponding author), Univ Nacl Cuyo, IHEM, CONICET, Fac Ciencias Med, CC56, RA-5500 Mendoza, Argentina.	ctomes@fcm.uncu.edu.ar		Bustos, Matias A./0000-0001-9625-1127	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT2010-0342, PICT2013-1216]; Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo (Argentina) [06/J416]	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo (Argentina)	This study was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (Grant numbers PICT2010-0342 and PICT2013-1216, Argentina) and Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo (Grant number 06/J416, Argentina) (to C. N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Belmonte SA, 2016, ADV ANAT EMBRYOL CEL, V220, P71, DOI 10.1007/978-3-319-30567-7_4; Binotti B, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010007; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Buffone MG, 2012, MOL REPROD DEV, V79, P4, DOI 10.1002/mrd.21393; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Bustos MA, 2014, J MOL CELL BIOL, V6, P286, DOI 10.1093/jmcb/mju021; Bustos MA, 2012, P NATL ACAD SCI USA, V109, pE2057, DOI 10.1073/pnas.1121173109; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chiang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4356; CROSS NL, 1986, GAMETE RES, V15, P213, DOI 10.1002/mrd.1120150303; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Dhara M, 2014, J CELL BIOL, V204, P1123, DOI 10.1083/jcb.201311085; Fang QH, 2014, PHYSIOLOGY, V29, P278, DOI 10.1152/physiol.00026.2013; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Han X, 2006, J CELL BIOL, V172, P281, DOI 10.1083/jcb.200510012; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; Lai Y, 2013, P NATL ACAD SCI USA, V110, P1333, DOI 10.1073/pnas.1218818110; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Lucchesi O, 2016, BBA-MOL CELL RES, V1863, P544, DOI 10.1016/j.bbamcr.2015.12.007; Lui PPY, 1997, BIOL SIGNAL, V6, P45; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Zoppino FCM, 2012, FERTIL STERIL, V97, P1309, DOI 10.1016/j.fertnstert.2012.03.002; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Neuland K, 2014, J CELL SCI, V127, P5218, DOI 10.1242/jcs.153742; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Pelletan LE, 2015, J BIOL CHEM, V290, P9823, DOI 10.1074/jbc.M114.629006; Pellizzari R, 1999, PHILOS T R SOC B, V354, P259, DOI 10.1098/rstb.1999.0377; Pocognoni CA, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132001; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rodriguez F, 2012, J BIOL CHEM, V287, P43825, DOI 10.1074/jbc.M112.409649; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Ruete MC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0043-0; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Sosa CM, 2015, MOL HUM REPROD, V21, P244, DOI 10.1093/molehr/gau110; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Tomes CN, 2015, BIOCHEM J, V465, P359, DOI 10.1042/BJ20141169; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Vardjan N, 2013, NEUROSCIENTIST, V19, P160, DOI 10.1177/1073858412461691; Wang XY, 2008, J PHYSIOL-LONDON, V586, P3949, DOI 10.1113/jphysiol.2008.151191; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; Zhao WD, 2016, NATURE, V534, P548, DOI 10.1038/nature18598	57	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23101	23111		10.1074/jbc.M116.729954	http://dx.doi.org/10.1074/jbc.M116.729954			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613869	Green Published, hybrid			2022-12-28	WOS:000387224800021
J	Chan, H; Pearson, CS; Green, CM; Li, Z; Zhang, J; Belfort, G; Shekhtman, A; Li, HM; Belfort, M				Chan, Hon; Pearson, C. Seth; Green, Cathleen M.; Li, Zhong; Zhang, Jing; Belfort, Georges; Shekhtman, Alex; Li, Hongmin; Belfort, Marlene			Exploring Intein Inhibition by Platinum Compounds as an Antimicrobial Strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inhibition mechanism; intein; metal ion-protein interaction; Mycobacterium tuberculosis; protein drug interaction; protein splicing	PROTEIN; CISPLATIN; COMPLEXES; BINDING; SYSTEM; FEATURES	Inteins, self-splicing protein elements, interrupt genes and proteins in many microbes, including the human pathogen Mycobacterium tuberculosis. Using conserved catalytic nucleophiles at their N- and C-terminal splice junctions, inteins are able to excise out of precursor polypeptides. The splicing of the intein in the mycobacterial recombinase RecA is specifically inhibited by the widely used cancer therapeutic cisplatin, cis-[Pt(NH3)(2)Cl-2], and this compound inhibits mycobacterial growth. Mass spectrometric and crystallographic studies of Pt(II) binding to the RecA intein revealed a complex in which two platinum atoms bind at N- and C-terminal catalytic cysteine residues. Kinetic analyses of NMR spectroscopic data support a two-step binding mechanism in which a Pt(II) first rapidly interacts reversibly at the N terminus followed by a slower, first order irreversible binding event involving both the N and C termini. Notably, the ligands of Pt(II) compounds that are required for chemotherapeutic efficacy and toxicity are no longer bound to the metal atom in the intein adduct. The lack of ammine ligands and need for phosphine represent a springboard for future design of platinum-based compounds targeting inteins. Because the intein splicing mechanism is conserved across a range of pathogenic microbes, developing these drugs could lead to novel, broad range antimicrobial agents.	[Chan, Hon; Pearson, C. Seth; Green, Cathleen M.; Belfort, Marlene] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Chan, Hon; Pearson, C. Seth; Green, Cathleen M.; Belfort, Marlene] SUNY Albany, RNA Inst, Albany, NY 12222 USA; [Shekhtman, Alex] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Chan, Hon; Pearson, C. Seth; Belfort, Georges] Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; [Chan, Hon; Pearson, C. Seth; Belfort, Georges] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Li, Zhong; Zhang, Jing; Li, Hongmin] New York State Dept Hlth, Lab Computat & Struct Biol, Wadsworth Ctr, Albany, NY 12208 USA; [Li, Hongmin] SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Belfort, M (corresponding author), SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA.; Belfort, M (corresponding author), SUNY Albany, RNA Inst, Albany, NY 12222 USA.	mbelfort@albany.edu	Li, Hongmin/ABI-2439-2020	Li, Hongmin/0000-0002-8684-5308; Li, Zhong/0000-0002-1039-7000; Shekhtman, Alexander/0000-0003-2649-2675	LSBR; NSLSII; SMB; SSRL under NIH-NIGMS [P41GM111244, P41GM103393]; DOE BER [DE-SC0012704]; DOE BES contract [DE-AC02-76SF00515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039422, P41GM103393, R01GM044844, R01GM085006, T32GM067545, P41GM111244, R01GM039422] Funding Source: NIH RePORTER	LSBR; NSLSII; SMB; SSRL under NIH-NIGMS; DOE BER(United States Department of Energy (DOE)); DOE BES contract(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Matthew Stanger for help in purifying protein and rendering figures for this manuscript; Dr. Danielle Fabris and Michael Miller for help with the mass spectrometry experiments; Dr. Stephen Lippard for providing platinum compounds Pttfbz and phenanthriplatin, comments on the manuscript, and insight into platinum chemistry; Dr. Brian Murray for help with modeling kinetics; Dr. Subhabrata Majumder for help in NMR analysis; and Dr. Vivian Stojanoff at the Brookhaven National Laboratory for help in x-ray diffraction data collection. We also thank the NSLS-SSRL user transition program supported jointly by the LSBR, NSLSII and SMB, SSRL under NIH-NIGMS Grants P41GM111244 and P41GM103393, and DOE BER contracts DE-SC0012704. SSRL is operated under DOE BES contract DE-AC02-76SF00515.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Callahan BP, 2013, BIOTECHNOL BIOENG, V110, P1565, DOI 10.1002/bit.24821; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen Helen H. W., 2010, Metal-Based Drugs, P430939, DOI 10.1155/2010/430939; Chen SM, 2013, CHEM COMMUN, V49, P1226, DOI 10.1039/c2cc38517a; Chen W, 2012, J AM CHEM SOC, V134, P2500, DOI 10.1021/ja211010g; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Cohen SM, 2001, PROG NUCLEIC ACID RE, V67, P93, DOI 10.1016/S0079-6603(01)67026-0; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Du ZM, 2010, J MOL BIOL, V400, P755, DOI 10.1016/j.jmb.2010.05.044; Eryilmaz E, 2014, J BIOL CHEM, V289, P14506, DOI 10.1074/jbc.R113.540302; Ferraro G, 2015, CHEM COMMUN, V51, P9436, DOI 10.1039/c5cc01751c; Gangopadhyay JP, 2003, ANAL CHEM, V75, P2456, DOI 10.1021/ac020756b; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; Hunt L. B., 1984, PLATIN MET REV, V28, P76; Johnstone TC, 2014, ANTICANCER RES, V34, P471; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Keller R., 2004, COMPUTER AIDED RESON, V1; LOKKEN SJ, 1963, INORG CHEM, V2, P562, DOI 10.1021/ic50007a034; Marasco D, 2015, DALTON T, V44, P10392, DOI 10.1039/c5dt01279a; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Matteelli A, 2014, CLIN EPIDEMIOL, V6, P111, DOI 10.2147/CLEP.S35839; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park GY, 2012, P NATL ACAD SCI USA, V109, P11987, DOI 10.1073/pnas.1207670109; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Paulus H, 2003, FRONT BIOSCI, V8, pS1157, DOI 10.2741/1195; Pearson CS, 2015, BIOMOL NMR ASSIGN, V9, P235, DOI 10.1007/s12104-014-9581-z; Peck SH, 2011, CHEM BIOL, V18, P619, DOI 10.1016/j.chembiol.2011.02.014; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Pruchnik H, 2015, J ORGANOMET CHEM, V791, P124, DOI 10.1016/j.jorganchem.2015.05.050; Skretas G, 2005, J MOL BIOL, V349, P464, DOI 10.1016/j.jmb.2005.04.009; Topilina NI, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-5; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031; Wilson JJ, 2012, J MED CHEM, V55, P5326, DOI 10.1021/jm3002857; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; World Health Organization, 2015, GLOB TUB REP 2015; Zhang LY, 2011, J BIOL CHEM, V286, P1277, DOI 10.1074/jbc.M110.171124	44	21	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22661	22670		10.1074/jbc.M116.747824	http://dx.doi.org/10.1074/jbc.M116.747824			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609519	hybrid, Green Published			2022-12-28	WOS:000386760600026
J	Tsai, WC; Gayatri, S; Reineke, LC; Sbardella, G; Bedford, MT; Lloyd, RE				Tsai, Wei-Chih; Gayatri, Sitaram; Reineke, Lucas C.; Sbardella, Gianluca; Bedford, Mark T.; Lloyd, Richard E.			Arginine Demethylation of G3BP1 Promotes Stress Granule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; post-translational modification (PTM); protein arginine N-methyltransferase 5 (PRMT5); RNA binding protein; stress granule; G3BP1; protein arginine N-methyltransferase (PRMT)	DOMAIN-CONTAINING PROTEIN; RNA-BINDING PROTEINS; CELL-FREE FORMATION; MESSENGER-RNA; HISTONE DEMETHYLATION; DEPENDENT MECHANISM; PROCESSING BODIES; PHASE-SEPARATION; CANCER-CELLS; P-BODIES	Stress granules (SGs) are cytoplasmic condensates of stalled messenger ribonucleoprotein complexes (mRNPs) that form when eukaryotic cells encounter environmental stress. RNA-binding proteins are enriched for arginine methylation and facilitate SG assembly through interactions involving regions of low amino acid complexity. How methylation of specific RNA-binding proteins regulates RNA granule assembly has not been characterized. Here, we examined the potent SG-nucleating protein Ras-GAP SH3-binding protein 1 (G3BP1), and found that G3BP1 is differentially methylated on specific arginine residues by protein arginine methyltransferase (PRMT) 1 and PRMT5 in its RGG domain. Several genetic and biochemical interventions that increased methylation repressed SG assembly, whereas interventions that decreased methylation promoted SG assembly. Arsenite stress quickly and reversibly decreased asymmetric arginine methylation on G3BP1. These data indicate that arginine methylation in the RGG domain prevents large SG assembly and rapid demethylation is a novel signal that regulates SG formation.	[Tsai, Wei-Chih; Reineke, Lucas C.; Lloyd, Richard E.] Baylor Coll Med, Dept Mol Virol & Microbiol, One Baylor Plaza, Houston, TX 77030 USA; [Gayatri, Sitaram; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Sbardella, Gianluca] Univ Salerno, Epigenet Med Chem Lab, Dipartimento Farm, Via Giovanni Paolo 2 132, I-84084 Salerno, Italy	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Salerno	Lloyd, RE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, One Baylor Plaza, Houston, TX 77030 USA.	rlloyd@bcm.edu	Gayatri, Sitaram/GLT-7340-2022; Sbardella, Gianluca/E-2823-2010	Sbardella, Gianluca/0000-0003-0748-1145	National Institutes of Health Public Health Service Grant [AI50237]; NCI Cancer Center Support Grant [P30CA125123]; Integrated Microscopy Core at Baylor College of Medicine; National Institutes of Health [HD007495, DK56338, CA125123]; Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; National Institutes of Health funding [DK062248]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, T32HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050237, R01AI050237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, P30DK056338, R01DK062248] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Grant; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Integrated Microscopy Core at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; National Institutes of Health funding(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health Public Health Service Grant AI50237 and NCI Cancer Center Support Grant (P30CA125123). Additional support was provided by the Integrated Microscopy Core at Baylor College of Medicine with funding from the National Institutes of Health (HD007495, DK56338, and CA125123), the Dan L. Duncan Cancer Center, and the John S. Dunn Gulf Coast Consortium for Chemical Genomics. Work in the laboratory of Mark T. Bedford is supported by National Institutes of Health funding (DK062248). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alahari S, 2015, ENDOCRINOLOGY, V156, P3012, DOI 10.1210/en.2015-1262; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; Aulas A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-54; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; Bottger A, 2015, BIOCHEM J, V468, P191, DOI 10.1042/BJ20150278; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brown JAL, 2011, MOL CELL BIOL, V31, P4417, DOI 10.1128/MCB.05987-11; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Cheng DH, 2012, METHOD ENZYMOL, V512, P71, DOI 10.1016/B978-0-12-391940-3.00004-4; Courchet J, 2008, J BIOL CHEM, V283, P32131, DOI 10.1074/jbc.M802927200; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Eram MS, 2016, ACS CHEM BIOL, V11, P772, DOI 10.1021/acschembio.5b00839; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Gal J., 2010, NEUROBIOL AGING, V32, pe27; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Johnson ME, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0914-4; Kaehler C, 2015, EXP CELL RES, V334, P114, DOI 10.1016/j.yexcr.2015.02.022; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kobayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035820; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee YH, 2011, CELL CYCLE, V10, P1343, DOI 10.4161/cc.10.9.15379; Lee YJ, 2014, FEBS J, V281, P352, DOI 10.1111/febs.12606; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Sahoo PK, 2012, BIOL OPEN, V1, P109, DOI 10.1242/bio.2011023; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tradewell ML, 2012, HUM MOL GENET, V21, P136, DOI 10.1093/hmg/ddr448; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049267; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409	75	100	103	12	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22671	22685		10.1074/jbc.M116.739573	http://dx.doi.org/10.1074/jbc.M116.739573			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601476	Green Published, hybrid			2022-12-28	WOS:000386760600027
J	Zhang, H; Zhou, MX; Yang, TD; Haslam, SM; Dell, A; Wu, H				Zhang, Hua; Zhou, Meixian; Yang, Tiandi; Haslam, Stuart M.; Dell, Anne; Wu, Hui			New Helical Binding Domain Mediates a Glycosyltransferase Activity of a Bifunctional Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; crystal structure; glycoprotein biosynthesis; glycosylation; glycosyltransferase; Streptococcus	FIMBRIAE-ASSOCIATED ADHESIN; STREPTOCOCCUS-PARASANGUIS; MOLECULAR CHAPERONE; FUNCTIONAL-ANALYSIS; BIOFILM FORMATION; UNKNOWN FUNCTION; SURFACE PROTEIN; FAP1; GLYCOSYLATION; GLYCOPROTEIN	Serine-rich repeat glycoproteins (SRRPs) conserved in streptococci and staphylococci are important for bacterial colonization and pathogenesis. Fap1, a well studied SRRP is a major surface constituent of Streptococcus parasanguinis and is required for bacterial adhesion and biofilm formation. Biogenesis of Fap1 is a multistep process that involves both glycosylation and secretion. A series of glycosyltransferases catalyze sequential glycosylation of Fap1. We have identified a unique hybrid protein dGT1 (dual glycosyltransferase 1) that contains two distinct domains. N-terminal DUF1792 is a novel GT-D-type glycosyltransferase, transferring Glc residues to Glc-GlcNAc-modified Fap1. C-terminal dGT1 (CgT) is predicted to possess a typical GT-A-type glycosyltransferase, however, the activity remains unknown. In this study, we determine that CgT is a distinct glycosyltransferase, transferring GlcNAc residues to Glc-Glc-GlcNAc-modified Fap1. A 2.4- x-ray crystal structure reveals that CgT has a unique binding domain consisting of three helices in addition to a typical GT-A-type glycosyltransferase domain. The helical domain is crucial for the oligomerization of CgT. Structural and biochemical studies revealed that the helix domain is required for the protein-protein interaction and crucial for the glycosyltransferase activity of CgT in vitro and in vivo. As the helix domain presents a novel structural fold, we conclude that CgT represents a new member of GT-A-type glycosyltransferases.	[Zhang, Hua; Zhou, Meixian; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, Birmingham, AL 35294 USA; [Zhang, Hua; Zhou, Meixian; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Microbiol, Birmingham, AL 35294 USA; [Zhang, Hua; Zhou, Meixian; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Pediat Dent, Birmingham, AL 35294 USA; [Zhang, Hua; Zhou, Meixian; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Yang, Tiandi; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Imperial College London	Wu, H (corresponding author), 1919 7th Ave South, Birmingham, AL 35294 USA.	hwu@uab.edu		Dell, Anne/0000-0003-1380-2347	National Institutes of Health Shared Instrumentation Grant [1S10RR026478]; Shared Facility Program of the UAB Comprehensive Cancer Center Grant [316851]; BBSRC [BB/K016164/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F33DE022215, R01DE017954] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K016164/1] Funding Source: researchfish	National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Facility Program of the UAB Comprehensive Cancer Center Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Zhengrong Yang for helping to access the Auto-iTC200 in the Biocalorimetry Laboratory supported by National Institutes of Health Shared Instrumentation Grant 1S10RR026478 and Shared Facility Program of the UAB Comprehensive Cancer Center Grant 316851. X-ray data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Echlin H, 2013, J BACTERIOL, V195, P2166, DOI 10.1128/JB.02255-12; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; Izquierdo L, 2015, GLYCOBIOLOGY, V25, P438, DOI 10.1093/glycob/cwu131; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Nakanishi M, 2014, PARASITOL INT, V63, P513, DOI 10.1016/j.parint.2014.01.007; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Otwinowski Z., 2001, INT TABLES CRYSTALLO, V276, P226; Peng Z, 2008, ORAL MICROBIOL IMMUN, V23, P70, DOI 10.1111/j.1399-302X.2007.00401.x; Peng Z., 2008, BMC MICROBIOL, V8, P52; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Sobhany M, 2005, J BIOL CHEM, V280, P23441, DOI 10.1074/jbc.M413379200; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Takahashi Y, 2006, INFECT IMMUN, V74, P740, DOI 10.1128/IAI.74.1.740-743.2006; Takahashi Y, 2004, INFECT IMMUN, V72, P3876, DOI 10.1128/IAI.72.7.3876-3882.2004; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Wu R, 2011, J BIOL CHEM, V286, P34923, DOI 10.1074/jbc.M111.239350; Yang Yong Ryoul, 2014, Advances in Biological Regulation, V54, P68, DOI 10.1016/j.jbior.2013.09.007; Zegzouti H., 2013, GLYCOBIOLOGY, P2001; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhang H, 2013, ACTA CRYSTALLOGR F, V69, P520, DOI 10.1107/S1744309113007161; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x; Zhou M, 2008, J MICROBIOL METH, V72, P249, DOI 10.1016/j.mimet.2007.12.002; Zhou MX, 2012, MOL MICROBIOL, V83, P866, DOI 10.1111/j.1365-2958.2012.07970.x; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhu F, 2015, J DENT RES, V94, P659, DOI 10.1177/0022034515574865; Zhu Fan, 2013, Methods Mol Biol, V1022, P29, DOI 10.1007/978-1-62703-465-4_3; Zhu F, 2011, J BIOL CHEM, V286, P27048, DOI 10.1074/jbc.M110.208629	51	13	13	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22106	22117		10.1074/jbc.M116.731695	http://dx.doi.org/10.1074/jbc.M116.731695			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27539847	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000386332600025
J	Bandara, M; Corey, RA; Martin, R; Skehel, JM; Blocker, AJ; Jenkinson, HF; Collinson, I				Bandara, Mikaila; Corey, Robin A.; Martin, Remy; Skehel, J. Mark; Blocker, Ariel J.; Jenkinson, Howard F.; Collinson, Ian			Composition and Activity of the Non-canonical Gram-positive SecY2 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; complex; membrane; secretion; transport; SecY2; Streptococcus gordonii; accessory Sec system; translocon	BINDING-PROTEIN-GSPB; MOLECULAR-DYNAMICS SIMULATIONS; GROUP-A STREPTOCOCCI; ANTIGEN-I/II FAMILY; ESCHERICHIA-COLI; CELL-SURFACE; PREPROTEIN TRANSLOCASE; BIOFILM FORMATION; GORDONII; EXPORT	The accessory Sec system in Streptococcus gordonii DL1 is a specialized export system that transports a large serine-rich repeat protein, Hsa, to the bacterial surface. The system is composed of core proteins SecA2 and SecY2 and accessory Sec proteins Asp1-Asp5. Similar to canonical SecYEG, SecY2 forms a channel for translocation of the Hsa adhesin across the cytoplasmic membrane. Accessory Sec proteins Asp4 and Asp5 have been suggested to work alongside SecY2 to form the translocon, similar to the associated SecY, SecE, and SecG of the canonical system (SecYEG). To test this theory, S. gordonii secY2, asp4, and asp5 were co-expressed in Escherichia coli. The resultant complex was subsequently purified, and its composition was confirmed by mass spectrometry to be SecY2-Asp4-Asp5. Like SecYEG, the non-canonical complex activates the ATPase activity of the SecA motor (SecA2). This study also shows that Asp4 and Asp5 are necessary for optimal adhesion of S. gordonii to glycoproteins gp340 and fibronectin, known Hsa binding partners, as well as for early stage biofilm formation. This work opens new avenues for understanding the structure and function of the accessory Sec system.	[Bandara, Mikaila; Jenkinson, Howard F.] Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England; [Bandara, Mikaila; Corey, Robin A.; Martin, Remy; Blocker, Ariel J.; Collinson, Ian] Univ Bristol, Sch Biochem, Univ Walk, Bristol BS8 1TD, Avon, England; [Bandara, Mikaila; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Univ Walk, Bristol BS8 1TD, Avon, England; [Skehel, J. Mark] MRC, Mol Biol Lab, Biol Mass Spectrometry & Prote, Francis Crick Ave, Cambridge CB2 0QH, England	University of Bristol; University of Bristol; University of Bristol; MRC Laboratory Molecular Biology	Collinson, I (corresponding author), Univ Bristol, Sch Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	ian.collinson@bristol.ac.uk	Jenkinson, Howard/ABI-1842-2020; Jenkinson, Howard/AAD-9282-2022; Corey, Robin A/AAI-7251-2020	Corey, Robin A/0000-0003-1820-7993; Jayaweera Bandara, Mikaila/0000-0002-6195-6116; Collinson, Ian/0000-0002-3931-0503; Jenkinson, Howard/0000-0002-9195-7945; Martin, Remy/0000-0001-7924-6254	Biotechnology and Biological Sciences Research Council [BB/I008675/1]; Medical Research Council Doctoral Training Grant [2011-G1001606]; Biotechnology and Biological Sciences Research Council South West Bioscience Doctoral Training Partnership; University of Bristol postgraduate scholarship; BBSRC [BB/I008675/1] Funding Source: UKRI; MRC [MC_U105178788] Funding Source: UKRI; Medical Research Council [1168597, MC_U105178788] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council South West Bioscience Doctoral Training Partnership(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Bristol postgraduate scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work supported by Biotechnology and Biological Sciences Research Council Project Grant BB/I008675/1 (to I. C.), Medical Research Council Doctoral Training Grant 2011-G1001606 (to M. B.), Biotechnology and Biological Sciences Research Council South West Bioscience Doctoral Training Partnership (to R. A. C.), and University of Bristol postgraduate scholarship (to R. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15598; Bensing B. A., 2013, BIOCHIM BIOPHYS ACTA, V1843, P1674; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Collinson I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0025; Corey RA, 2016, STRUCTURE, V24, P518, DOI 10.1016/j.str.2016.02.001; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Garnier F, 1997, J CLIN MICROBIOL, V35, P2337, DOI 10.1128/JCM.35.9.2337-2341.1997; Gold VAM, 2007, J BIOL CHEM, V282, P17424, DOI 10.1074/jbc.M702066200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; ITO K, 1984, MOL GEN GENET, V197, P204, DOI 10.1007/BF00330964; Jack AA, 2015, MICROBIOL-SGM, V161, P411, DOI 10.1099/mic.0.000010; Jakubovics NS, 2009, MICROBIOL-SGM, V155, P3572, DOI 10.1099/mic.0.032078-0; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jang A., 2014, J BACTERIOL VIROL, V44, P317; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; MCNAB R, 1994, MOL MICROBIOL, V14, P743, DOI 10.1111/j.1365-2958.1994.tb01311.x; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Nijeholt JALA, 2013, FEBS LETT, V587, P3083, DOI 10.1016/j.febslet.2013.07.046; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Nobbs AH, 2007, J BACTERIOL, V189, P3106, DOI 10.1128/JB.01535-06; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; Tanaka Y, 2015, CELL REP, V13, P1561, DOI 10.1016/j.celrep.2015.10.025; Tieleman DP, 1999, BIOPHYS J, V76, P40, DOI 10.1016/S0006-3495(99)77176-6; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yen YT, 2013, J BACTERIOL, V195, P682, DOI 10.1128/JB.01742-12; Yen YT, 2011, J BACTERIOL, V193, P3165, DOI 10.1128/JB.00057-11; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	58	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21474	21484		10.1074/jbc.M116.729806	http://dx.doi.org/10.1074/jbc.M116.729806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551046	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000385999200015
J	Dvornikov, AV; Smolin, N; Zhang, MJ; Martin, JL; Robia, SL; de Tombe, PP				Dvornikov, Alexey V.; Smolin, Nikolai; Zhang, Mengjie; Martin, Jody L.; Robia, Seth L.; de Tombe, Pieter P.			Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						contractile protein; heart; molecular dynamics; phosphorylation; troponin; contractility; length-dependent activation; myocardium; myofilament	PROTEIN-KINASE-A; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR-DYNAMICS SIMULATIONS; CALCIUM SENSITIVITY; HUMAN CARDIOMYOCYTES; FORCE GENERATION; THIN-FILAMENTS; GENE-MUTATIONS; PHOSPHORYLATION; MUSCLE	The cardiac troponin I (cTnI) R145W mutation is associated with restrictive cardiomyopathy (RCM). Recent evidence suggests that this mutation induces perturbed myofilament length-dependent activation (LDA) under conditions of maximal protein kinase A (PKA) stimulation. Some cardiac disease-causing mutations, however, have been associated with a blunted response to PKA-mediated phosphorylation; whether this includes LDA is unknown. Endogenous troponin was exchanged in isolated skinned human myocardium for recombinant troponin containing either cTnI R145W, PKA/PKC phosphomimetic charge mutations (S23D/S24D and T143E), or various combinations thereof. Myofilament Ca2+ sensitivity of force, tension cost, LDA, and single myofibril activation/relaxation parameters were measured. Our results show that both R145W and T143E uncouple the impact of S23D/S24D phosphomimetic on myofilament function, including LDA. Molecular dynamics simulations revealed a marked reduction in interactions between helix C of cTnC (residues 56, 59, and 63), and cTnI (residue 145) in the presence of either cTnI RCM mutation or cTnI PKC phosphomimetic. These results suggest that the RCM-associated cTnI R145W mutation induces a permanent structural state that is similar to, but more extensive than, that induced by PKC-mediated phosphorylation of cTnI Thr-143. We suggest that this structural conformational change induces an increase in myofilament Ca2+ sensitivity and, moreover, uncoupling from the impact of phosphorylation of cTnI mediated by PKA at the Ser-23/Ser-24 target sites. The R145W RCM mutation by itself, however, does not impact LDA. These perturbed biophysical and biochemical myofilament properties are likely to significantly contribute to the diastolic cardiac pump dysfunction that is seen in patients suffering from a restrictive cardiomyopathy that is associated with the cTnI R145W mutation.	[Dvornikov, Alexey V.; Smolin, Nikolai; Zhang, Mengjie; Martin, Jody L.; Robia, Seth L.; de Tombe, Pieter P.] Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, 2160 S First Ave, Maywood, IL 60153 USA	Loyola University Chicago	de Tombe, PP (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, 2160 S First Ave, Maywood, IL 60153 USA.	pdetombe@luc.edu	Smolin, Nikolai/C-6606-2008		National Science Foundation [ACI-1053575]; National Institute of Health [1G20RR030939]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR030939] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321, R01HL075494, P01HL062426] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are indebted to Drs. Yuanhua Cheng and Stefan Lindert for sharing the troponin Protein Data Bank structure (40) used in the MD simulations. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant ACI-1053575. This research was supported by equipment and facilities provided by National Institute of Health Grant "Loyola Research Computing Core" 1G20RR030939.	Ait-Mou Y, 2016, P NATL ACAD SCI USA, V113, P2306, DOI 10.1073/pnas.1516732113; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Cheng YH, 2015, J BIOL CHEM, V290, P27749, DOI 10.1074/jbc.M115.683045; Cheng YH, 2014, BIOPHYS J, V107, P1675, DOI 10.1016/j.bpj.2014.08.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; de Tombe PP, 2007, J PHYSIOL-LONDON, V584, P591, DOI 10.1113/jphysiol.2007.138693; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Dvornikov AV, 2014, J PHYSIOL-LONDON, V592, P1949, DOI 10.1113/jphysiol.2014.270678; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Hanft LM, 2013, J PHYSIOL-LONDON, V591, P4535, DOI 10.1113/jphysiol.2013.258400; Hanft LM, 2009, AM J PHYSIOL-HEART C, V296, pH1524, DOI 10.1152/ajpheart.00864.2008; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; Kumar M, 2015, J BIOL CHEM, V290, P29241, DOI 10.1074/jbc.M115.686790; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Lindert S, 2015, BIOPHYS J, V108, P395, DOI 10.1016/j.bpj.2014.11.3461; Lindhout DA, 2002, BIOCHEMISTRY-US, V41, P7267, DOI 10.1021/bi020100c; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086279; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336; Nixon BR, 2012, J BIOL CHEM, V287, P19136, DOI 10.1074/jbc.M111.323048; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1986, PHYS REV B, V33, P339, DOI 10.1103/PhysRevB.33.339; Papadaki M, 2015, CARDIOVASC RES, V108, P99, DOI 10.1093/cvr/cvv181; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Poggesi C, 2005, PFLUG ARCH EUR J PHY, V449, P505, DOI 10.1007/s00424-004-1363-5; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rao VS, 2013, J PHYSIOL-LONDON, V591, P475, DOI 10.1113/jphysiol.2012.241604; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Sen-Chowdhry Srijita, 2010, Heart Fail Clin, V6, P179, DOI 10.1016/j.hfc.2009.11.005; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Stehle R, 2009, PFLUG ARCH EUR J PHY, V458, P337, DOI 10.1007/s00424-008-0630-2; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Towbin JA, 2014, CIRC J, V78, P2347, DOI 10.1253/circj.CJ-14-0893; Ulrich E, 1995, J CHEM PHYS, V103, P8577; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; van der Velden J, 2014, PFLUG ARCH EUR J PHY, V466, P1023, DOI 10.1007/s00424-014-1531-1; Walker JS, 2011, AM J PHYSIOL-HEART C, V301, pH138, DOI 10.1152/ajpheart.00838.2010; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Wijnker PJM, 2014, AM J PHYSIOL-HEART C, V306, pH1171, DOI 10.1152/ajpheart.00580.2013; Wijnker PJM, 2013, AM J PHYSIOL-HEART C, V304, pH260, DOI 10.1152/ajpheart.00498.2012; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zamora JE, 2016, PHYS CHEM CHEM PHYS, V18, P20691, DOI 10.1039/c6cp02610a; Zhang MJ, 2015, AM J PHYSIOL-HEART C, V309, pH1509, DOI 10.1152/ajpheart.00598.2015; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388	58	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21817	21828		10.1074/jbc.M116.746172	http://dx.doi.org/10.1074/jbc.M116.746172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27557662	Green Published, hybrid			2022-12-28	WOS:000385999200044
J	Franco, ML; Melero, C; Sarasola, E; Acebo, P; Luque, A; Calatayud-Baselga, I; Garcia-Barcina, M; Vilar, M				Luisa Franco, Maria; Melero, Cristina; Sarasola, Esther; Acebo, Paloma; Luque, Alfonso; Calatayud-Baselga, Isabel; Garcia-Barcina, Maria; Vilar, Marcal			Mutations in TrkA Causing Congenital Insensitivity to Pain with Anhidrosis (CIPA) Induce Misfolding, Aggregation, and Mutation-dependent Neurodegeneration by Dysfunction of the Autophagic Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; ER quality control; neurodegeneration; protein aggregation; TRK1-transforming tyrosine kinase protein (Trk-A); autophagic flux; congenital insensitivity to pain with anhidrosis	NERVE GROWTH-FACTOR; PROTEIN-QUALITY CONTROL; RECEPTOR TYROSINE KINASE; CELL-DEATH; NTRK1 GENE; ACTIVATION; SURVIVAL; STRESS; ROLES; ER	Congenital insensitivity to pain with anhidrosis (CIPA) is a rare autosomal recessive disorder characterized by insensitivity to noxious stimuli and variable intellectual disability (ID) due to mutations in the NTRK1 gene encoding the NGF receptor TrkA. To get an insight in the effect of NTRK1 mutations in the cognitive phenotype we biochemically characterized three TrkA mutations identified in children diagnosed of CIPA with variable ID. These mutations are located in different domains of the protein; L213P in the extracellular domain, 736 in the kinase domain, and C300stop in the extracellular domain, a new mutation causing CIPA diagnosed in a Spanish teenager. We found that TrkA mutations induce misfolding, retention in the endoplasmic reticulum (ER), and aggregation in a mutation-dependent manner. The distinct mutations are degraded with a different kinetics by different ER quality control mechanisms; although C300stop is rapidly disposed by autophagy, 736 degradation is sensitive to the proteasome and to autophagy inhibitors, and L213P is a long-lived protein refractory to degradation. In addition L213P enhances the formation of autophagic vesicles triggering an increase in the autophagic flux with deleterious consequences. Mouse cortical neurons expressing L213P showed the accumulation of LC3-GFP positive puncta and dystrophic neurites. Our data suggest that TrkA misfolding and aggregation induced by some CIPA mutations disrupt the autophagy homeostasis causing neurodegeneration. We propose that distinct disease-causing mutations of TrkA generate different levels of cell toxicity, which may provide an explanation of the variable intellectual disability observed in CIPA patients.	[Luisa Franco, Maria; Melero, Cristina; Calatayud-Baselga, Isabel; Vilar, Marcal] IBV CSIC, Inst Biomed Valencia, Mol Basis Neurodegenerat Unit, C-O Jaume Roig 11, Valencia 46010, Spain; [Sarasola, Esther; Garcia-Barcina, Maria] Basurto Univ Hosp, Dept Genet, Serv Vasco Salud, Bilbao, Spain; [Acebo, Paloma] ISCIII, Chron, Madrid 28220, Spain; [Luque, Alfonso] ISCIII, Rare Dis Ctr, Crta Majadahonda Pozuelo Km 2 Majadahonda, Madrid 28220, Spain; [Melero, Cristina] Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Basurto Hospital; Instituto de Salud Carlos III; Instituto de Salud Carlos III; University of Manchester	Vilar, M (corresponding author), IBV CSIC, Inst Biomed Valencia, Mol Basis Neurodegenerat Unit, C-O Jaume Roig 11, Valencia 46010, Spain.	mvilar@ibv.csic.es	Vilar, Marçal/B-4581-2016; Luque, Alfonso/C-5846-2018	Vilar, Marçal/0000-0002-9376-6544; Calatayud-Baselga, Isabel/0000-0001-8653-2662	Spanish Minister of Economy and Competitiveness [BFU2013/42746-P, TPY-M-1068/13]	Spanish Minister of Economy and Competitiveness(Spanish Government)	This work was supported in part by the Spanish Minister of Economy and Competitiveness Grants BFU2013/42746-P (to M. V.) and TPY-M-1068/13 (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bodnarchuk TW, 2012, J NEURO-ONCOL, V109, P485, DOI 10.1007/s11060-012-0927-z; Bonkowsky JL, 2003, PEDIATRICS, V112, pE237, DOI 10.1542/peds.112.3.e237; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Erez DL, 2010, DEV MED CHILD NEUROL, V52, P559, DOI 10.1111/j.1469-8749.2009.03567.x; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geetha T, 2008, BIOCHEM BIOPH RES CO, V374, P33, DOI 10.1016/j.bbrc.2008.06.082; Gestwicki JE, 2012, PROG MOL BIOL TRANSL, V107, P327, DOI 10.1016/B978-0-12-385883-2.00003-5; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hansen K, 2007, J NEUROCHEM, V103, P259, DOI 10.1111/j.1471-4159.2007.04753.x; Houck SA, 2014, MOL CELL, V54, P166, DOI 10.1016/j.molcel.2014.02.025; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Indo Y, 2001, HUM MUTAT, V18, P462, DOI 10.1002/humu.1224; Indo Y, 2001, HUM MUTAT, V18, P308, DOI 10.1002/humu.1192; Indo Y, 2010, EXPERT REV NEUROTHER, V10, P1707, DOI [10.1586/ern.10.154, 10.1586/ERN.10.154]; Indo Yasuhiro, 2002, Clin Auton Res, V12 Suppl 1, pI20, DOI 10.1007/s102860200016; Jung EJ, 2008, MOL CELLS, V26, P12; Jung EJ, 2011, BIOCHEM BIOPH RES CO, V404, P841, DOI 10.1016/j.bbrc.2010.12.072; Jung EJ, 2010, MOL CELLS, V30, P121, DOI 10.1007/s10059-010-0096-x; Kaasinen SK, 2008, INT J DEV NEUROSCI, V26, P625, DOI 10.1016/j.ijdevneu.2008.03.011; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Li CH, 2010, J NEUROCHEM, V112, P882, DOI 10.1111/j.1471-4159.2009.06507.x; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Mardy S, 1999, AM J HUM GENET, V64, P1570, DOI 10.1086/302422; Mardy S, 2001, HUM MOL GENET, V10, P179, DOI 10.1093/hmg/10.3.179; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Matus S, 2008, CURR MOL MED, V8, P157, DOI 10.2174/156652408784221324; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Miranda C, 2002, J BIOL CHEM, V277, P6455, DOI 10.1074/jbc.M110016200; Mnich K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.173; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Nixon RA, 2014, BIOESSAYS, V36, P547, DOI 10.1002/bies.201400064; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Sarasola E, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-86; Schecterson LC, 2010, MOL CELL NEUROSCI, V43, P403, DOI 10.1016/j.mcn.2010.01.007; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Sztriha L, 2001, PEDIATR NEUROL, V25, P63, DOI 10.1016/S0887-8994(01)00278-8; Tanaka K, 2014, BBA-MOL CELL RES, V1843, P197, DOI 10.1016/j.bbamcr.2013.03.012; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Yan CH, 2002, CANCER RES, V62, P4867	57	21	22	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21363	21374		10.1074/jbc.M116.722587	http://dx.doi.org/10.1074/jbc.M116.722587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551041	Green Published, hybrid			2022-12-28	WOS:000385999200003
J	Kim, GD; Das, R; Goduni, L; McClellan, S; Hazlett, LD; Mahabeleshwar, GH				Kim, Gun-Dong; Das, Riku; Goduni, Lediana; McClellan, Sharon; Hazlett, Linda D.; Mahabeleshwar, Ganapati H.			Kruppel-like Factor 6 Promotes Macrophage-mediated Inflammation by Suppressing B Cell Leukemia/Lymphoma 6 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IN-VIVO; POLARIZATION; PLASTICITY; GENE; DIFFERENTIATION; DYNAMICS; BCL-6; TRANSCRIPTION; HOMEOSTASIS	Macrophages are the predominant innate immune cells recruited to tissues following injury or infection. These early-responding, pro-inflammatory macrophages play an essential role in the amplification of inflammation. However, macrophage pro-inflammatory gene expression should be tightly regulated to avert host tissue damage. In this study, we identify the Kruppel-like transcription factor 6 (KLF6)-B cell leukemia/lymphoma 6 (BCL6) signaling axis as a novel regulator of macrophage inflammatory gene expression and function. Utilizing complementary gain-and loss-of-function studies, we observed that KLF6 is essential for macrophage motility under ex vivo and in vivo conditions. Concordant with these observations, myeloid-specific deficiency of KLF6 significantly attenuates macrophage pro-inflammatory gene expression, recruitment, and progression of inflammation. At the molecular level, KLF6 suppresses BCL6 mRNA and protein expression by elevating PR domain-containing 1 with ZNF domain (PRDM1) levels in macrophages. Interestingly, pharmacological or genetic inhibition of BCL6 in KLF6-deficient macrophages completely abrogated the attenuation of pro-inflammatory cytokine/chemokine expression and cellular motility. Collectively, our observations reveal that KLF6 repress BCL6 to enhance macrophage inflammatory gene expression and function.	[Kim, Gun-Dong; Goduni, Lediana; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Das, Riku] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [McClellan, Sharon; Hazlett, Linda D.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Wayne State University	Mahabeleshwar, GH (corresponding author), Case Cardiovasc Res Inst, Harrington Heart & Vasc Inst, Dept Med, Wolstein Res Bldg,Rm 4524,2103 Cornell Rd, Cleveland, OH 44106 USA.	ghm4@case.edu			National Institutes of Health [HL126626]; Cleveland Digestive Diseases Research Core Center Pilot/Feasibility Award [P30DK097948]; Crohn's and Colitis Foundation of America Senior Research Award [421904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Digestive Diseases Research Core Center Pilot/Feasibility Award; Crohn's and Colitis Foundation of America Senior Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant HL126626, Cleveland Digestive Diseases Research Core Center Pilot/Feasibility Award P30DK097948, and Crohn's and Colitis Foundation of America Senior Research Award 421904 (to G. H. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Goodman WA, 2016, MUCOSAL IMMUNOL, V9, P1250, DOI 10.1038/mi.2016.1; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nayak L, 2013, AM J PATHOL, V182, P1696, DOI 10.1016/j.ajpath.2013.01.029; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Palau N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-825; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smale ST, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016261; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; YE BHH, 1993, CANCER RES, V53, P2732; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang Y, 2014, J BIOL CHEM, V289, P12876, DOI 10.1074/jbc.M113.535831	35	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21271	21282		10.1074/jbc.M116.738617	http://dx.doi.org/10.1074/jbc.M116.738617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27539853	Green Published, hybrid			2022-12-28	WOS:000385406200039
J	Wu, SY; Zou, P; Fuller, AW; Mishra, S; Wang, Z; Schey, KL; Mchaourab, HS				Wu, Shu-Yu; Zou, Ping; Fuller, Alexandra W.; Mishra, Sanjay; Wang, Zhen; Schey, Kevin L.; Mchaourab, Hassane S.			Expression of Cataract-linked -Crystallin Variants in Zebrafish Reveals a Proteostasis Network That Senses Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; cataract; chaperone; crystallin; lens; proteostasis; small heat shock protein (sHsp); zebrafish	HEAT-SHOCK PROTEINS; ALPHA-A-CRYSTALLIN; GAMMA-D-CRYSTALLIN; FIBER CELL DENUCLEATION; MOUSE EYE LENS; CHAPERONE FUNCTION; NUCLEAR CATARACT; GENE-EXPRESSION; 2-DIMENSIONAL ELECTROPHORESIS; MOLECULAR CHAPERONE	The refractivity and transparency of the ocular lens is dependent on the stability and solubility of the crystallins in the fiber cells. A number of mutations of lens crystallins have been associated with dominant cataracts in humans and mice. Of particular interest were B- and D-crystallin mutants linked to dominant cataracts in mouse models. Although thermodynamically destabilized and aggregation-prone, these mutants were found to have weak affinity to the resident chaperone -crystallin in vitro. To better understand the mechanism of the cataract phenotype, we transgenically expressed different D-crystallin mutants in the zebrafish lens and observed a range of lens defects that arise primarily from the aggregation of the mutant proteins. Unlike mouse models, a strong correlation was observed between the severity and penetrance of the phenotype and the level of destabilization of the mutant. We interpret this result to reflect the presence of a proteostasis network that can sense protein stability. In the more destabilized mutants, the capacity of this network is overwhelmed, leading to the observed increase in phenotypic penetrance. Overexpression of A-crystallin had no significant effects on the penetrance of lens defects, suggesting that its chaperone capacity is not limiting. Although consistent with the prevailing hypothesis that a chaperone network is required for lens transparency, our results suggest that A-crystallin may not be efficient to inhibit aggregation of lens -crystallin. Furthermore, our work implicates additional inputs/factors in this underlying proteostasis network and demonstrates the utility of zebrafish as a platform to delineate mechanisms of cataract.	[Wu, Shu-Yu; Zou, Ping; Fuller, Alexandra W.; Mishra, Sanjay; Mchaourab, Hassane S.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Wang, Zhen; Schey, Kevin L.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Wang, Zhen; Schey, Kevin L.] Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu	Mishra, Sanjay/ABF-9252-2021	Mishra, Sanjay/0000-0002-7775-9600	National Institutes of Health [R01 EY12018, R01 EY13462, P30 EY008126]; Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center; Vanderbilt University Medical Center Cell Imaging Shared Resource; NATIONAL EYE INSTITUTE [R01EY013462, R01EY012018, P30EY008126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center; Vanderbilt University Medical Center Cell Imaging Shared Resource; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01 EY12018 (to H. S. M.), R01 EY13462 (to K. L. S.), and P30 EY008126 (to H. S. M. and K. L. S.) and by the Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center and Vanderbilt University Medical Center Cell Imaging Shared Resource. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee PR, 2011, P NATL ACAD SCI USA, V108, P574, DOI 10.1073/pnas.1014653107; Bassnett S, 1997, INVEST OPHTH VIS SCI, V38, P1678; Beebe DC, 2001, INVEST OPHTH VIS SCI, V42, P727; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384; Goishi K, 2006, DEVELOPMENT, V133, P2585, DOI 10.1242/dev.02424; Hanson SRA, 1998, EXP EYE RES, V67, P301, DOI 10.1006/exer.1998.0530; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harocopos GJ, 1998, INVEST OPHTH VIS SCI, V39, P2696; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hayes JM, 2012, MOL BIOL CELL, V23, P4725, DOI 10.1091/mbc.E12-09-0672; Hill EG, 2008, J PROTEOME RES, V7, P3091, DOI 10.1021/pr070520u; Hinaux H, 2015, DEV NEUROBIOL, V75, P505, DOI 10.1002/dneu.22239; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JAENISCH R, 1981, CELL, V24, P519, DOI 10.1016/0092-8674(81)90343-3; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Koteiche HA, 2015, BIOCHEMISTRY-US, V54, P5949, DOI 10.1021/acs.biochem.5b00678; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k; Lampi KJ, 2002, MOL VIS, V8, P359; Lampi KJ, 2002, INVEST OPHTH VIS SCI, V43, P216; LI WC, 1995, J CELL BIOL, V130, P169, DOI 10.1083/jcb.130.1.169; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Michiel M, 2010, EXP EYE RES, V90, P688, DOI 10.1016/j.exer.2010.02.007; Mishra S, 2012, FEBS LETT, V586, P330, DOI 10.1016/j.febslet.2012.01.019; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Nuckels R. J., 2007, CSH PROTOC; Okamura Nobuaki, 2002, Medical Electron Microscopy, V35, P234, DOI 10.1007/s007950200027; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rossant J, 2011, P NATL ACAD SCI USA, V108, P7659, DOI 10.1073/pnas.1104844108; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sharma KK, 1997, BIOCHEM BIOPH RES CO, V239, P217, DOI 10.1006/bbrc.1997.7460; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; TARDIEU A, 1988, ANNU REV BIOPHYS BIO, V17, P47; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Uribe R. A, 2007, CSH PROTOC; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wang Z, 2015, INVEST OPHTH VIS SCI, V56, P8349, DOI 10.1167/iovs.15-18273; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x; Zhang L, 2010, CURR MOL MED, V10, P864, DOI 10.2174/156652410793937741; Zhang LY, 2007, MOL VIS, V13, P2096; Zou P, 2015, EXP EYE RES, V138, P104, DOI 10.1016/j.exer.2015.07.001	65	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25387	25397		10.1074/jbc.M116.749606	http://dx.doi.org/10.1074/jbc.M116.749606			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27770023	Green Published, hybrid			2022-12-28	WOS:000390095300010
J	Sellmann, C; Doerner, A; Knuehl, C; Rasche, N; Sood, V; Krah, S; Rhiel, L; Messemer, A; Wesolowski, J; Schuette, M; Becker, S; Toleikis, L; Kolmar, H; Hock, B				Sellmann, Carolin; Doerner, Achim; Knuehl, Christine; Rasche, Nicolas; Sood, Vanita; Krah, Simon; Rhiel, Laura; Messemer, Annika; Wesolowski, John; Schuette, Mark; Becker, Stefan; Toleikis, Lars; Kolmar, Harald; Hock, Bjoern			Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) X c-MET Antibodies and Antibody-Drug Conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; ACQUIRED-RESISTANCE; ANTITUMOR-ACTIVITY; ANTIGEN-EXPRESSION; LUNG-CANCER; INHIBITION; CETUXIMAB; DESIGN; TARGET; PROTEINS	Bispecific antibodies (bsAbs) and antibody-drug conjugates (ADCs) have already demonstrated benefits for the treatment of cancer in several clinical studies, showing improved drug selectivity and efficacy. In particular, simultaneous targeting of prominent cancer antigens, such as EGF receptor (EGFR) and c-MET, by bsAbs has raised increasing interest for potentially circumventing receptor cross-talk and c-MET-mediated acquired resistance during anti-EGFR monotherapy. In this study, we combined the selectivity of EGFR x c-MET bsAbs with the potency of cytotoxic agents via bispecific antibody-toxin conjugation. Affinity-attenuated bispecific EGFR x c-MET antibody-drug conjugates demonstrated high in vitro selectivity toward tumor cells overexpressing both antigens and potent anti-tumor efficacy. Due to basal EGFR expression in the skin, ADCs targeting EGFR in general warrant early safety assessments. Reduction in EGFR affinity led to decreased toxicity in keratinocytes. Thus, the combination of bsAb affinity engineering with the concept of toxin conjugation may be a viable route to improve the safety profile of ADCs targeting ubiquitously expressed antigens.	[Sellmann, Carolin; Krah, Simon; Messemer, Annika; Kolmar, Harald] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Alarich Weiss Str 4, D-64287 Darmstadt, Germany; [Sellmann, Carolin; Doerner, Achim; Rasche, Nicolas; Krah, Simon; Rhiel, Laura; Schuette, Mark; Becker, Stefan; Toleikis, Lars; Hock, Bjoern] Merck KGaA, Prot Engn & Antibody Technol, Frankfurter Str 250, D-64293 Darmstadt, Germany; [Knuehl, Christine] Merck KGaA, Merck Res & Dev, Frankfurter Str 250, D-64293 Darmstadt, Germany; [Sood, Vanita; Wesolowski, John] EMD Serono Res & Dev Inst, Billerica, MA 01821 USA	Technical University of Darmstadt; Merck KGaA; Merck KGaA	Kolmar, H (corresponding author), Tech Univ Darmstadt, Inst Organ Chem & Biochem, Alarich Weiss Str 4, D-64287 Darmstadt, Germany.; Hock, B (corresponding author), Merck KGaA, Prot Engn & Antibody Technol, Frankfurter Str 250, D-64293 Darmstadt, Germany.	Kolmar@Biochemie-TUD.de; Bjoern.Hock@merckgroup.com	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993; Sood, Vanita/0000-0001-6714-3725; Doerner, Achim/0000-0002-4741-8039				BALINT RF, 1993, GENE, V137, P109, DOI 10.1016/0378-1119(93)90258-5; Basilico C, 2014, J CLIN INVEST, V124, P3172, DOI 10.1172/JCI72316; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; BIRD RE, 1991, TRENDS BIOTECHNOL, V9, P132, DOI 10.1016/0167-7799(91)90044-I; Castoldi R, 2013, ONCOGENE, V32, P5593, DOI 10.1038/onc.2013.245; Castoldi R, 2012, PROTEIN ENG DES SEL, V25, P551, DOI 10.1093/protein/gzs048; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dantas G, 2007, J MOL BIOL, V366, P1209, DOI 10.1016/j.jmb.2006.11.080; Davies J., 2013, U.S. Patent, Patent No. [8,398,974B2, 8398974]; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Diamantis N, 2016, BRIT J CANCER, V114, P362, DOI 10.1038/bjc.2015.435; Dickgiesser S, 2015, ACS CHEM BIOL, V10, P2158, DOI 10.1021/acschembio.5b00315; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garber K, 2014, NAT REV DRUG DISCOV, V13, P799, DOI 10.1038/nrd4478; Goetsch L., 2012, U.S. Patent, Patent No. [8,329,173B2, 8329173]; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Holmes D, 2011, NAT REV DRUG DISCOV, V10, P798, DOI 10.1038/nrd3581; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Hyatt DC, 2008, EXP CELL RES, V314, P3415, DOI 10.1016/j.yexcr.2008.08.020; Jarantow SW, 2015, J BIOL CHEM, V290, P24689, DOI 10.1074/jbc.M115.651653; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kim YJ, 2014, INT J CANCER, V134, P2424, DOI 10.1002/ijc.28566; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Kontermann RE, 2015, DRUG DISCOV TODAY, V20, P838, DOI 10.1016/j.drudis.2015.02.008; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leal M, 2014, ANN NY ACAD SCI, V1321, P41, DOI 10.1111/nyas.12499; Lee BS, 2016, ANN SURG ONCOL, V23, P2046, DOI 10.1245/s10434-015-5084-0; Lee JM, 2016, ONCOGENE, V35, P4437, DOI 10.1038/onc.2015.514; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Li Ning, 2008, V457, P305, DOI 10.1007/978-1-59745-261-8_23; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-0568; Liu L, 2014, CLIN CANCER RES, V20, P6059, DOI 10.1158/1078-0432.CCR-14-0543; Martin P, 2016, CLIN LUNG CANCER, V17, P375, DOI 10.1016/j.cllc.2016.01.002; Mazor Y, 2015, MABS-AUSTIN, V7, P461, DOI 10.1080/19420862.2015.1022695; Mazor Y, 2015, MABS-AUSTIN, V7, P377, DOI 10.1080/19420862.2015.1007816; Melosky B, 2009, CURR ONCOL, V16, P16; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Muda M, 2011, PROTEIN ENG DES SEL, V24, P447, DOI 10.1093/protein/gzq123; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P329, DOI 10.1038/nrd4009; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oh YM, 2012, MOL CELLS, V34, P523, DOI 10.1007/s10059-012-0194-z; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Peng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092924, 10.1371/journal.pone.0084502, 10.1371/journal.pone.0085663]; Perez HL, 2014, DRUG DISCOV TODAY, V19, P869, DOI 10.1016/j.drudis.2013.11.004; Phillips AC, 2016, MOL CANCER THER, V15, P661, DOI 10.1158/1535-7163.MCT-15-0901; Prat M, 2014, BIOMEDICINES, V2, P359, DOI 10.3390/biomedicines2040359; Rakestraw JA, 2009, BIOTECHNOL BIOENG, V103, P1192, DOI 10.1002/bit.22338; Reilly EB, 2015, MOL CANCER THER, V14, P1141, DOI 10.1158/1535-7163.MCT-14-0820; Rhoden JJ, 2016, J BIOL CHEM, V291, P11337, DOI 10.1074/jbc.M116.714287; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Ritchie M, 2013, MABS-AUSTIN, V5, P13, DOI 10.4161/mabs.22854; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Schwall R. H., 2001, U.S. Patent, Patent No. [6,214,344B1, 6214344]; Sengers BG, 2016, MABS-AUSTIN, V8, P905, DOI 10.1080/19420862.2016.1178437; Sharma Neelesh, 2011, Ther Adv Med Oncol, V3, pS37, DOI 10.1177/1758834011423403; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Troiani T, 2013, CLIN CANCER RES, V19, P6751, DOI 10.1158/1078-0432.CCR-13-0423; Wang JY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2138-z; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3; Yewale C, 2013, BIOMATERIALS, V34, P8690, DOI 10.1016/j.biomaterials.2013.07.100; Zheng SM, 2016, MABS-AUSTIN, V8, P551, DOI 10.1080/19420862.2015.1136762	74	37	39	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25106	25119		10.1074/jbc.M116.753491	http://dx.doi.org/10.1074/jbc.M116.753491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27694443	Green Published, hybrid			2022-12-28	WOS:000388880100026
J	Davis, MI; Pragani, R; Fox, JT; Shen, M; Parmar, K; Gaudiano, EF; Liu, L; Tanega, C; Mcgee, L; Hall, MD; McKnight, C; Shinn, P; Nelson, H; Chattopadhyay, D; D'Andrea, AD; Auld, DS; DeLucas, LJ; Li, ZY; Boxer, MB; Sinneonov, A				Davis, Mindy I.; Pragani, Rajan; Fox, Jennifer T.; Shen, Min; Parmar, Kalindi; Gaudiano, Emily F.; Liu, Li; Tanega, Cordelle; McGee, Lauren; Hall, Matthew D.; McKnight, Crystal; Shinn, Paul; Nelson, Henrike; Chattopadhyay, Debasish; D'Andrea, Alan D.; Auld, Douglas S.; DeLucas, Larry J.; Li, Zhuyin; Boxer, Matthew B.; Sinneonov, Anton			Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; PROSTATE-CANCER; DNA-DAMAGE; STABILITY; REPAIR; TARGET	Deubiquitinases are important components of the protein degradation regulatory network. We report the discovery of ML364, a small molecule inhibitor of the deubiquitinase USP2 and its use to interrogate the biology of USP2 and its putative substrate cyclin DL ML364 has an IC50 of 1.1 mu M in a biochemical assay using an internally quenched fluorescent di-ubiquitin substrate. Direct binding of ML364 to USP2 was demonstrated using microscale thermophoresis. ML364 induced an increase in cellular cyclin D1 degradation and caused cell cycle arrest as shown in Western blottings and flow cytometry assays utilizing both Mino and HCT116 cancer cell lines. ML364, and not the inactive analog 2, was antiproliferative in cancer cell lines. Consistent with the role of cyclin D1 in DNA damage response, ML364 also caused a decrease in homologous recombination mediated DNA repair. These effects by a small molecule inhibitor support a key role for USP2 as a regulator of cell cycle, DNA repair, and tumor cell growth.	[Davis, Mindy I.; Pragani, Rajan; Fox, Jennifer T.; Shen, Min; Liu, Li; Tanega, Cordelle; McGee, Lauren; Hall, Matthew D.; McKnight, Crystal; Shinn, Paul; Nelson, Henrike; Auld, Douglas S.; Li, Zhuyin; Boxer, Matthew B.; Sinneonov, Anton] NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Parmar, Kalindi; Gaudiano, Emily F.; D'Andrea, Alan D.] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Chattopadhyay, Debasish; DeLucas, Larry J.] Univ Alabama Birmingham, Struct Biol Ctr, Birmingham, AL 35294 USA; [Auld, Douglas S.] Novartis Inst Biomed Res, Ctr Proteorn Chem, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Novartis	Boxer, MB; Sinneonov, A (corresponding author), NIH, NCATS, 9800 Med Ctr Dr, Rockville, MD 20850 USA.	boxerrn@mail.nih.gov; asimeono@mail.nih.gov		McGee, Lauren/0000-0003-0166-7256	NCATS Intramural Research Program; Molecular Libraries Initiative of the National Institutes of Health Common Fund; National Institutes of Health [U54 MH 084681]; Alabama Drug Discovery Alliance; National Institutes of Health/NCI Grant [5P30CA13148-37]; Translational Research Grant from the Leukemia & Lymphoma Society [6237-13]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER	NCATS Intramural Research Program; Molecular Libraries Initiative of the National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alabama Drug Discovery Alliance; National Institutes of Health/NCI Grant; Translational Research Grant from the Leukemia & Lymphoma Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCATS Intramural Research Program, Molecular Libraries Initiative of the National Institutes of Health Common Fund, National Institutes of Health Grant U54 MH 084681, Alabama Drug Discovery Alliance, National Institutes of Health/NCI Grant 5P30CA13148-37, and Translational Research Grant from the Leukemia & Lymphoma Society Grant 6237-13. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Avdeef A, 2001, PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH, P305, DOI 10.1002/9783906390437.ch18; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Bozza WP, 2012, BIOCHEMISTRY-US, V51, P10075, DOI 10.1021/bi3009104; Byun S, 2013, CLIN CANCER RES, V19, P3894, DOI 10.1158/1078-0432.CCR-12-3696; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Copeland R.A, 2005, EVALUATION ENZYME IN, P48; Di L, 2006, INT J PHARMACEUT, V317, P54, DOI 10.1016/j.ijpharm.2006.03.007; Fernadez V, 2005, J CLIN ONCOL, V23, P6364, DOI 10.1200/JCO.2005.05.019; Flohr S., 2007, U. S. Patent, Patent No. [WO2007009715, 2007009715]; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Halford B, 2012, CHEM ENG NEWS, V90, P34; Hunt DA, 2007, ANTICANCER RES, V27, P27; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Issaenko OA, 2012, CELL CYCLE, V11, P1804, DOI 10.4161/cc.20174; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lai R, 2002, LEUKEMIA RES, V26, P849, DOI 10.1016/S0145-2126(02)00013-9; Li JY, 1999, AM J PATHOL, V154, P1449, DOI 10.1016/S0002-9440(10)65399-0; Marampon F, 2016, ONCOTARGET, V7, P5383, DOI 10.18632/oncotarget.6579; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Nicholson B, 2008, PROTEIN SCI, V17, P1035, DOI 10.1110/ps.083450408; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Seidel SAI, 2012, ANGEW CHEM INT EDIT, V51, P10656, DOI 10.1002/anie.201204268; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhou RF, 2013, J BIOL CHEM, V288, P5389, DOI 10.1074/jbc.M112.425272	36	81	83	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24628	24640		10.1074/jbc.M116.738567	http://dx.doi.org/10.1074/jbc.M116.738567			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27681596	Green Published, hybrid			2022-12-28	WOS:000388875500024
J	Sharma, V; Purushotham, R; Kaur, R				Sharma, Vandana; Purushotham, Rajaram; Kaur, Rupinder			The Phosphoinositide 3-Kinase Regulates Retrograde Trafficking of the Iron Permease CgFtr1 and Iron Homeostasis in Candida glabrata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FET3 GENE; YEAST; TRANSPORT; VIRULENCE; PROTEIN; EPIDEMIOLOGY; VACUOLE; COMPLEX; COPPER	The phosphoinositide 3-kinase (PI3K), which phosphorylates phosphatidylinositol and produces PI3P, has been implicated in protein trafficking, intracellular survival, and virulence in the pathogenic yeast Candida glabrata. Here, we demonstrate PI3-kinase (CgVps34) to be essential for maintenance of cellular iron homeostasis. We examine how CgVps34 regulates the fundamental process of iron acquisition, and underscore its function in vesicular trafficking as a central determinant. RNA sequencing analysis revealed iron homeostasis genes to be differentially expressed upon CgVps34 disruption. Consistently, the Cgvps34 Delta mutant displayed growth attenuation in low- and high-iron media, increased intracellular iron content, elevated mitochondrial aconitase activity, impaired biofilm formation, and extenuated mouse organ colonization potential. Furthermore, we demonstrate for the first time that C. glabrata cells respond to iron limitation by expressing the iron permease CgFtr1 primarily on the cell membrane, and to iron excess via internalization of the plasma membrane-localized CgFtr1 to the vacuole. Our data show that CgVps34 is essential for the latter process. We also report that macrophage-internalized C glabrata cells express CgFtr1 on the cell membrane indicative of an iron-restricted macrophage internal milieu, and Cgrps34 Delta cells display better survival in iron-enriched medium-cultured macrophages. Overall, our data reveal the centrality of PI3K signaling in iron metabolism and host colonization.	[Sharma, Vandana; Purushotham, Rajaram; Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Survey 728,729,730 & 734, Hyderabad 500039, Ranga Reddy Dis, India; [Sharma, Vandana] Manipal Univ, Grad Studies, Manipal, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Kaur, R (corresponding author), Wellcome Trust DBT India Alliance, Hyderabad, Telangana, India.	rkaur@cdfd.org.in		sharma, vandana/0000-0002-2676-3239	Department of Biotechnology, Government of India [BT/PR5145/MED/29/470/2012, BT/PR7388/MED/29/650/2012, BT/PR7123/BRB/10/1149/2012]; University Grants Commission, New Delhi, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported in part by Department of Biotechnology, Government of India Grants BT/PR5145/MED/29/470/2012, BT/PR7388/MED/29/650/2012, and BT/PR7123/BRB/10/1149/2012 (to R. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Junior and Senior Fellowship sponsored by the University Grants Commission, New Delhi, India.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Bairwa G, 2014, BIOCHEM J, V458, P323, DOI 10.1042/BJ20130757; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; De Freitas J, 2003, BIOMETALS, V16, P185, DOI 10.1023/A:1020771000746; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; DIX DR, 1994, J BIOL CHEM, V269, P26092; Fanning S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002585; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Gabaldon T, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fov110; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Jean S, 2014, J CELL SCI, V127, P923, DOI 10.1242/jcs.093773; Johnson M, 2005, J BACTERIOL, V187, P8211, DOI 10.1128/JB.187.23.8211-8215.2005; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Linder MC, 2013, NUTRIENTS, V5, P4022, DOI 10.3390/nu5104022; Lortholary O, 2014, INTENS CARE MED, V40, P1303, DOI 10.1007/s00134-014-3408-3; Martinez CE, 2000, ENVIRON POLLUT, V107, P153, DOI 10.1016/S0269-7491(99)00111-6; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Nevitt T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001322; Noble SM, 2013, CURR OPIN MICROBIOL, V16, P708, DOI 10.1016/j.mib.2013.09.006; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Pfaller MA, 2006, CLIN INFECT DIS, V43, pS3, DOI 10.1086/504490; Rai MN, 2015, CELL MICROBIOL, V17, P269, DOI 10.1111/cmi.12364; Rai MN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002863; Ramirez MA, 2007, EUKARYOT CELL, V6, P280, DOI 10.1128/EC.00372-06; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; Schwarzmuller T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004211; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Singh A, 2006, J BIOL CHEM, V281, P13355, DOI 10.1074/jbc.M512042200; Srivastava VK, 2015, FEBS J, V282, P2142, DOI 10.1111/febs.13264; Srivastava VK, 2014, BIOCHEM J, V463, P103, DOI 10.1042/BJ20140598; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Strochlic TI, 2008, MOL BIOL CELL, V19, P4694, DOI 10.1091/mbc.E08-03-0296; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; Tortorano AM, 2012, MYCOSES, V55, P73, DOI 10.1111/j.1439-0507.2011.02044.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Ho A, 2002, ANNU REV MICROBIOL, V56, P237, DOI 10.1146/annurev.micro.56.012302.160847; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; Zordan RE, 2013, G3-GENES GENOM GENET, V3, P1675, DOI 10.1534/g3.113.006908	61	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24715	24734		10.1074/jbc.M116.751529	http://dx.doi.org/10.1074/jbc.M116.751529			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27729452	hybrid, Green Published			2022-12-28	WOS:000388875500030
J	Kimura, A; Hata, S; Suzuki, T				Kimura, Ayano; Hata, Saori; Suzuki, Toshiharu			Alternative Selection of beta-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid beta-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the A beta Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid- (A); -secretase 1 (BACE1); secretase	ALPHA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; CYTOPLASMIC DOMAIN; CULTURED-CELLS; FAMILY-MEMBERS; PEPTIDE; BRAIN; NEURONS; IDENTIFICATION	beta-Site APP-cleaving enzyme 1 (BACE1) cleaves amyloid -protein precursor (APP) at the bond between Met(671) and Asp(672) (-site) to generate the carboxyl-terminal fragment (CTF/C99). BACE1 also cleaves APP at another bond between Thr(681) and Gln(682) (-site), yielding CTF/C89. Cleavage of CTF/C99 by -secretase generates A(1-XX), whereas cleavage of CTF/C89 generates A(11-XX). Thus, -site cleavage by BACE1 is amyloidolytic rather than amyloidogenic. cleavage of mouse APP is more common than the corresponding cleavage of human APP. We found that the H684R substitution within human A, which replaces the histidine in the human protein with the arginine found at the corresponding position in mouse, facilitated cleavage irrespective of the species origin of BACE1, thereby significantly increasing the level of A(11-XX) and decreasing the level of A(1-XX). Thus, amino acid substitutions within the A sequence influenced the selectivity of alternative - or -site cleavage of APP by BACE1. In familial Alzheimer's disease (FAD), the APP gene harbors pathogenic variations such as the Swedish (K670N/M671L), Leuven (E682K), and A673V mutations, all of which decrease A(11-40) generation, whereas the protective Icelandic mutation (A673T) increases generation of A(11-40). Thus, A673T promotes cleavage of APP and protects subjects against AD. In addition, CTF/C99 was cleaved by excess BACE1 activity to generate CTF/C89, followed by A(11-40), even if APP harbored pathogenic mutations. The resultant A(11-40) was more metabolically labile in vivo than A(1-40). Our analysis suggests that some FAD mutations in APP are amyloidogenic and/or amyloidolytic via selection of alternative BACE1 cleavage sites.	[Kimura, Ayano; Hata, Saori; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Suzuki, Toshiharu/B-5342-2013; Hata, Saori/AAP-9634-2020	Hata, Saori/0000-0003-4723-5993	Ministry of Education, Culture, Sports, Science, and Technology of Japan [262930110, 16K14690, 15K18854]; Bilateral Joint Research Project of the Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bilateral Joint Research Project of the Japan Society for the Promotion of Science	This work was supported in part by Grants-in-aid for Scientific Research 262930110 and 16K14690 (to T. S.) and 15K18854 (to S. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Bilateral Joint Research Project of the Japan Society for the Promotion of Science (to S. H.). The authors declare that they have no conflict of interest with the contents of this article.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Caillava C, 2014, NEUROBIOL AGING, V35, P1570, DOI 10.1016/j.neurobiolaging.2014.01.011; Chiba K, 2014, MOL BIOL CELL, V25, P3569, DOI 10.1091/mbc.E14-06-1111; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gouras GK, 1998, J NEUROCHEM, V71, P1920; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Iijima K, 1998, BIOCHEM J, V330, P29, DOI 10.1042/bj3300029; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JOHNSTON JA, 1994, FEBS LETT, V354, P274, DOI 10.1016/0014-5793(94)01137-0; Jonson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133272; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Meral D, 2013, J MOL BIOL, V425, P2260, DOI 10.1016/j.jmb.2013.03.010; Messa M, 2014, J BIOL CHEM, V289, P24143, DOI 10.1074/jbc.M114.576256; Moore BD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt121; Motodate R, 2016, BRAIN RES, V1646, P227, DOI 10.1016/j.brainres.2016.05.054; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; PEACOCK ML, 1993, NEUROLOGY, V43, P1254, DOI 10.1212/WNL.43.6.1254; Piao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062431; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Takami M., 2012, INT J ALZHEIMERS DIS, DOI [10.1055/2012/591392, DOI 10.1055/2012/591392]; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Vanderstichele H, 2005, CLIN CHEM, V51, P1650, DOI 10.1373/clinchem.2005.051201; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yan RQ, 2016, NEUROSCI BIOBEHAV R, V65, P326, DOI 10.1016/j.neubiorev.2016.03.025; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	55	53	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24041	24053		10.1074/jbc.M116.744722	http://dx.doi.org/10.1074/jbc.M116.744722			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27687728	hybrid, Green Published			2022-12-28	WOS:000388498100021
J	Ramakrishnan, SK; Russo, L; Ghanem, SS; Patel, PR; Oyarce, AM; Heinrich, G; Najjar, SM				Ramakrishnan, Sadeesh K.; Russo, Lucia; Ghanem, Simona S.; Patel, Payal R.; Oyarce, Ana Maria; Heinrich, Garrett; Najjar, Sonia M.			Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid oxidation; fatty acid synthase (FAS); insulin resistance; insulin secretion; peroxisome proliferator-activated receptor (PPAR); fenofibrate; insulin clearance; insulin metabolism	ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID OXIDATION; PPAR-ALPHA; PROTEIN EXPRESSION; LIPID-METABOLISM; GENE-EXPRESSION; LONG-CHAIN; NULL MICE; BETA-CELL; IN-VIVO	High fat diet reduces the expression of CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1), a transmembrane glycoprotein that promotes insulin clearance and down-regulates fatty acid synthase activity in the liver upon its phosphorylation by the insulin receptor. Because peroxisome proliferator-activated receptor (PPAR) transcriptionally suppresses CEACAM1 expression, we herein examined whether high fat down-regulates CEACAM1 expression in a PPAR-dependent mechanism. By activating PPAR, the lipid-lowering drug fenofibrate reverses dyslipidemia and improves insulin sensitivity in type 2 diabetes in part by promoting fatty acid oxidation. Despite reducing glucose-stimulated insulin secretion, fenofibrate treatment does not result in insulin insufficiency. To examine whether this is mediated by a parallel decrease in CEACAM1-dependent hepatic insulin clearance pathways, we fed wild-type and Ppar(-/-) null mice a high fat diet supplemented with either fenofibrate or Wy14643, a selective PPAR agonist, and examined their effect on insulin metabolism and action. We demonstrated that the decrease in insulin secretion by fenofibrate and Wy14643 is accompanied by reduction in insulin clearance in wild-type but not Ppar(-/-) mice, thereby maintaining normoinsulinemia and insulin sensitivity despite continuous high fat intake. Intact insulin secretion in L-CC1 mice with protected hepatic insulin clearance and CEACAM1 levels provides in vivo evidence that insulin secretion responds to changes in insulin clearance to maintain physiologic insulin and glucose homeostasis. These results also emphasize the relevant role of hepatic insulin extraction in regulating insulin sensitivity.	[Ramakrishnan, Sadeesh K.; Russo, Lucia; Ghanem, Simona S.; Patel, Payal R.; Oyarce, Ana Maria; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Oyarce, Ana Maria; Heinrich, Garrett] Univ Toledo, Dept Pharmacol & Expt Therapeut, Coll Pharm & Pharmaceut Sci, Toledo, OH 43614 USA; [Najjar, Sonia M.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; Ohio University	Najjar, SM (corresponding author), 1 Ohio Univ, Heritage Coll Osteopath Med, Off Grants & Res, Irvine Hall,Rm 220B, Athens, OH 45701 USA.	najjar@ohio.edu	Najjar, Sonia M/GXW-2217-2022		National Institutes of Health [R01 DK054254, R01 DK083850, R01 HL112248]; American Heart Association; Middle-East Diabetes Research Center; Heritage College of Osteopathic Medicine at Ohio University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054254, R01DK083850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Middle-East Diabetes Research Center; Heritage College of Osteopathic Medicine at Ohio University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK054254, R01 DK083850, and R01 HL112248 (to S. M. N.), a postdoctoral fellowship from the American Heart Association (to L. R.), the Middle-East Diabetes Research Center (to S. S. G.), and an intramural start-up fund from the Heritage College of Osteopathic Medicine at Ohio University (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ader M, 2014, OBESITY, V22, P1238, DOI 10.1002/oby.20625; Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; FERRARI C, 1977, METABOLISM, V26, P129, DOI 10.1016/0026-0495(77)90048-8; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Gremlich S, 2005, ENDOCRINOLOGY, V146, P375, DOI 10.1210/en.2004-0667; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim SH, 2016, J INVEST MED, V64, P1162, DOI 10.1136/jim-2016-000149; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kulkarni RN, 2004, INT J BIOCHEM CELL B, V36, P365, DOI 10.1016/j.biocel.2003.08.010; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu SN, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-176; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pereira S, 2014, AM J PHYSIOL-ENDOC M, V307, pE34, DOI 10.1152/ajpendo.00436.2013; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Ramakrishnan SK, 2016, J BIOL CHEM, V291, P8121, DOI 10.1074/jbc.M116.714014; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; Rudovich NN, 2004, DIABETES, V53, P2359, DOI 10.2337/diabetes.53.9.2359; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Shipman KE, 2016, WORLD J DIABETES, V7, P74, DOI 10.4239/wjd.v7.i5.74; Sozio MS, 2010, SEMIN LIVER DIS, V30, P378, DOI 10.1055/s-0030-1267538; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; Vu-Dac N, 1998, J BIOL CHEM, V273, P25713, DOI 10.1074/jbc.273.40.25713; Wiesenthal SR, 1999, DIABETES, V48, P766, DOI 10.2337/diabetes.48.4.766; Xiao C, 2006, DIABETOLOGIA, V49, P1371, DOI 10.1007/s00125-006-0211-x; Yoshii H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1089, DOI 10.1152/ajpendo.00306.2005; Zhou YT, 1998, P NATL ACAD SCI USA, V95, P8898, DOI 10.1073/pnas.95.15.8898	40	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23915	23924		10.1074/jbc.M116.745778	http://dx.doi.org/10.1074/jbc.M116.745778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27662905	Green Published, hybrid			2022-12-28	WOS:000388498100007
J	Ramani, K; Mavila, N; Ko, KS; Mato, JM; Lu, SC				Ramani, Komal; Mavila, Nirmala; Ko, Kwang Suk; Mato, Jose M.; Lu, Shelly C.			Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell growth; cell proliferation; hepatocellular carcinoma; hepatocyte; RNA; CCCTC-binding transcription factor; H19; Prohibitin 1; imprinting control region; insulin-like growth factor 2	HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; LIVER-INJURY; H19; ENHANCER; IGF2; STABILIZATION; METHYLATION; ACTIVATION; EXPRESSION	Prohibitin 1 (PHB1) is a mitochondrial chaperone that regulates cell growth. Phb1 knock-out mice exhibit liver injury and hepatocellular carcinoma (HCC). Phb1 knock-out livers show induction of tumor growth-associated genes, H19 and insulin-like growth factor 2 (Igf2). These genes are controlled by the imprinting control region (ICR) containing CCCTC-binding transcription factor (CTCF)-binding sites. Because Phb1 knock-out mice exhibited induction of H19 and Igf2, we hypothesized that PHB1-mediated regulation of the H19-Igf2 axis might control cell proliferation in normal hepatocytes. H19 and Igf2 were induced (8-20-fold) in 3-week-old Phb1 knock-out livers, in Phb1 siRNA-treated AML12 hepatocytes (2-fold), and HCC cell lines when compared with control. Phb1 knockdown lowered CTCF protein in AML12 by approximate to 30% when compared with control. CTCF overexpression lowered basal H19 and Igf2 expression by 30% and suppressed Phb1 knockdown-mediated induction of these genes. CTCF and PHB1 co-immunoprecipitated and co-localized on the ICR element, and Phb1 knockdown lowered CTCF ICR binding activity. The results suggest that PHB1 and CTCF cooperation may control the H19-Igf2 axis. Human HCC tissues with high levels of H19 and IGF2 exhibited a 40-50% reduction in PHB1 and CTCF expression and their ICR binding activity. Silencing Phb1 or overexpressing H19 in the mouse HCC cell line, SAMe-D, induced cell growth. Blocking H19 induction prevented Phb1 knockdown-mediated growth, whereas H19 overexpression had the reverse effect. Interestingly H19 silencing induced PHB1 expression. Taken together, our results demonstrate that the H19-Igf2 axis is negatively regulated by CTCF-PHB1 cooperation and that H19 is involved in modulating the growth-suppressive effect of PHB1 in the liver.	[Ramani, Komal; Mavila, Nirmala; Lu, Shelly C.] Cedars Sinai Med Ctr, Div Gastroenterol & Hepatol, Los Angeles, CA 90048 USA; [Ko, Kwang Suk] Ewha Womans Univ, Coll Hlth Sci, Dept Nutr Sci & Food Management, Seoul 03760, South Korea; [Mato, Jose M.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC bioGUNE, Technol Pk Bizkaia, Derio 48160, Bizkaia, Spain	Cedars Sinai Medical Center; Ewha Womans University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Lu, SC (corresponding author), Cedars Sinai Med Ctr, Div Gastroenterol & Hepatol, Los Angeles, CA 90048 USA.	shelly.lu@cshs.org	Lu, Shelly/AAH-5937-2021; Mavila, Nirmala/AAH-6140-2021; Ramani, Komal/AAH-5913-2021; MATO, JOSE/A-5187-2011	Lu, Shelly/0000-0003-2128-5407; MATO, JOSE/0000-0003-1264-3153	National Institutes of Health [R01CA172086]; Plan Nacional of I+D SAF [2014-52097R]; Departamento de Educacion del Gobierno Vasco; National Research Foundation of Korea [NRF-2012R1A1A1012261]; NATIONAL CANCER INSTITUTE [R01CA172086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional of I+D SAF; Departamento de Educacion del Gobierno Vasco; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01CA172086 (to S. C. L., H. P. Yang, and J. M. M.), Plan Nacional of I+D SAF 2014-52097R, and Departamento de Educacion del Gobierno Vasco (to J. M. M.), and National Research Foundation of Korea NRF-2012R1A1A1012261 (to K. S. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bayoumi AS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030356; Chowdhury I, 2014, J CELL PHYSIOL, V229, P998, DOI 10.1002/jcp.24531; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kim KS, 1997, CANCER LETT, V119, P143, DOI 10.1016/S0304-3835(97)00264-4; Ko KS, 2010, HEPATOLOGY, V52, P2096, DOI 10.1002/hep.23919; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Martinez-Lopez N, 2010, HEPATOLOGY, V52, P1621, DOI 10.1002/hep.23860; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Ramani K, 2015, J CELL PHYSIOL, V230, P1075, DOI 10.1002/jcp.24839; Sanchez-Quiles V, 2012, J PROTEOMICS, V75, P5783, DOI 10.1016/j.jprot.2012.08.009; Sasaki H, 2000, J BIOCHEM, V127, P711, DOI 10.1093/oxfordjournals.jbchem.a022661; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Thorvaldsen JL, 2002, MOL CELL BIOL, V22, P2450, DOI 10.1128/MCB.22.8.2450-2462.2002; Toretsky JA, 1996, J ENDOCRINOL, V149, P367, DOI 10.1677/joe.0.1490367; Vernucci M, 2000, ONCOGENE, V19, P6376, DOI 10.1038/sj.onc.1204024; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Yamamoto Y, 2004, J HEPATOL, V40, P808, DOI 10.1016/j.jhep.2004.01.022; Zhou TB, 2013, SCI REP-UK, V3, DOI 10.1038/srep03123	26	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24148	24159		10.1074/jbc.M116.744045	http://dx.doi.org/10.1074/jbc.M116.744045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27687727	Green Published, hybrid			2022-12-28	WOS:000388498100030
J	Haller, M; Khalid, S; Kremser, L; Fresser, F; Furlan, T; Hermann, M; Guenther, J; Drasche, A; Leitges, M; Giorgio, M; Baier, G; Lindner, H; Troppmair, J				Haller, Martina; Khalid, Sana; Kremser, Leopold; Fresser, Friedrich; Furlan, Tobias; Hermann, Martin; Guenther, Julia; Drasche, Astrid; Leitges, Michael; Giorgio, Marco; Baier, Gottfried; Lindner, Herbert; Troppmair, Jakob			Novel Insights into the PKC-dependent Regulation of the Oxidoreductase p66Shc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; phosphotyrosine binding (PTB) domain; PKC; reactive oxygen species (ROS); redox signaling; p66shc; phosphorylation	ISCHEMIA-REPERFUSION INJURY; KINASE-C-BETA; INDUCED OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; N-ACETYLCYSTEINE; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; PROTEIN-PHOSPHORYLATION; SIGNALING PATHWAY; P66(SHC) ABLATION	Dysfunctional mitochondria contribute to the development of many diseases and pathological conditions through the excessive production of reactive oxygen species (ROS), and, where studied, ablation of p66Shc (p66) was beneficial. p66 translocates to the mitochondria and oxidizes cytochrome c to yield H2O2, which in turn initiates cell death. PKC-mediated phosphorylation of serine 36 in p66 has been implicated as a key regulatory step preceding mitochondrial translocation, ROS production, and cell death, and PKC thus may provide a target for therapeutic intervention. We performed a reassessment of PKC regulation of the oxidoreductase activity of p66. Although our experiments did not substantiate Ser(36) phosphorylation by PKC, they instead provided evidence for Ser(139) and Ser(213) as PKC phosphorylation sites regulating the pro-oxidant and pro-apoptotic function of p66. Mutation of another predicted PKC phosphorylation site also located in the phosphotyrosine binding domain, threonine 206, had no phenotype. Intriguingly, p66 with Thr(206) and Ser(213) mutated to glutamic acid showed a gain-of-function phenotype with significantly increased ROS production and cell death induction. Taken together, these data argue for a complex mechanism of PKC-dependent regulation of p66 activation involving Ser(139) and a motif surrounding Ser(213).	[Haller, Martina; Khalid, Sana; Furlan, Tobias; Guenther, Julia; Drasche, Astrid; Troppmair, Jakob] Med Univ Innsbruck, Daniel Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, Innrain 66, A-6020 Innsbruck, Austria; [Kremser, Leopold; Lindner, Herbert] Med Univ Innsbruck, Div Clin Biochem, Prot Microanal Facil, Innrain 66, A-6020 Innsbruck, Austria; [Fresser, Friedrich; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Div Translat Cell Genet, Innrain 66, A-6020 Innsbruck, Austria; [Hermann, Martin] Med Univ Innsbruck, Dept Anesthesiol & Intens Care, Innrain 66, A-6020 Innsbruck, Austria; [Leitges, Michael] Biotechnol Ctr Oslo, N-0349 Oslo, Norway; [Giorgio, Marco] European Inst Oncol, I-20139 Milan, Italy	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; IRCCS European Institute of Oncology (IEO)	Troppmair, J (corresponding author), Med Univ Innsbruck, Daniel Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, Innrain 66, A-6020 Innsbruck, Austria.	jakob.troppmair@i-med.ac.at	Leitges, Michael/AAN-1953-2021; Giorgio, Marco/I-9425-2012; Guenther, Julia/T-9990-2017	Giorgio, Marco/0000-0002-5842-6042; Baier, Gottfried/0000-0002-2085-8325; Hermann, Martin/0000-0003-2213-3448; Guenther, Julia/0000-0002-2726-7982; Leitges, Michael/0000-0003-4203-6995	Jubilaumsfond der Oesterreichischen Nationalbank (OeNB) [13273]; Austrian Science Fund (FWF) [W1101]; Austrian Federal Ministries BMVIT/BMWFJ (via FFG); Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT); Osterreichische Krebshilfe Tirol	Jubilaumsfond der Oesterreichischen Nationalbank (OeNB); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Ministries BMVIT/BMWFJ (via FFG); Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT); Osterreichische Krebshilfe Tirol	This work has been supported by grants from the Jubilaumsfond der Oesterreichischen Nationalbank (OeNB) Project 13273, Austrian Science Fund (FWF) W1101, Austrian Federal Ministries BMVIT/BMWFJ (via FFG), the Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT), and the Osterreichische Krebshilfe Tirol. The authors declare that they have no conflicts of interest with the contents of this article.	Abe M, 2008, J PHARMACOL SCI, V106, P571, DOI 10.1254/jphs.FP0071664; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Arany I, 2010, AM J PHYSIOL-RENAL, V298, pF1214, DOI 10.1152/ajprenal.00639.2009; Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Borkowska A, 2012, EUR J NUTR, V51, P817, DOI 10.1007/s00394-011-0260-x; Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chambers JW, 2013, J BIOL CHEM, V288, P4000, DOI 10.1074/jbc.M112.406777; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Churchill EN, 2007, BIOCHEM SOC T, V35, P1040, DOI 10.1042/BST0351040; Di Stefano V, 2009, CARDIOVASC RES, V82, P421, DOI 10.1093/cvr/cvp082; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Farooq A, 2003, STRUCTURE, V11, P905, DOI 10.1016/S0969-2126(03)00134-5; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Fuller TF, 2004, J UROLOGY, V171, P1296, DOI 10.1097/01.ju.0000103928.64939.6a; Galimov ER, 2010, ACTA NATURAE, V2, P44, DOI 10.32607/20758251-2010-2-4-44-51; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gruber T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000046; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Hermann Martin, 2008, Cell Commun Signal, V6, P4, DOI 10.1186/1478-811X-6-4; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Jegatheeswaran S, 2011, HPB, V13, P71, DOI 10.1111/j.1477-2574.2010.00263.x; Khalid S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20930; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Koziel K, 2013, EXP CELL RES, V319, P2728, DOI 10.1016/j.yexcr.2013.07.029; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; Kulkarni AC, 2007, ANTIOXID REDOX SIGN, V9, P1717, DOI 10.1089/ars.2007.1724; Kumetsov AV, 2004, FEBS LETT, V577, P1, DOI 10.1016/j.febslet.2004.10.021; Kuznetsov AV, 2008, MOL CELL BIOL, V28, P2304, DOI 10.1128/MCB.00683-07; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; Lebiedzinska M, 2009, ARCH BIOCHEM BIOPHYS, V486, P73, DOI 10.1016/j.abb.2009.03.007; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Z, 2007, J CELL BIOL, V179, P23, DOI 10.1083/jcb.200706097; Malhotra A, 2009, AM J PHYSIOL-HEART C, V296, pH380, DOI 10.1152/ajpheart.00225.2008; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mckay A, 2008, J HEPATO-BILIARY-PAN, V15, P473, DOI 10.1007/s00534-007-1306-6; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; Park JE, 2012, CELL DEATH DIFFER, V19, P153, DOI 10.1038/cdd.2011.82; Pellegrini M, 2007, CELL DEATH DIFFER, V14, P338, DOI 10.1038/sj.cdd.4401997; Piccoli C, 2006, FEBS LETT, V580, P4539, DOI 10.1016/j.febslet.2006.06.085; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rapino C, 2005, AGING CELL, V4, P177, DOI 10.1111/j.1474-9726.2005.00161.x; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; Sobieszek A, 2006, ARCH BIOCHEM BIOPHYS, V454, P197, DOI 10.1016/j.abb.2006.08.004; Sucher R, 2009, TRANSPL INT, V22, P922, DOI 10.1111/j.1432-2277.2009.00883.x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vagnozzi RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006479; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Yonekawa H, 2008, FEBS J, V275, P4005, DOI 10.1111/j.1742-4658.2008.06558.x; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	68	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23557	23568		10.1074/jbc.M116.752766	http://dx.doi.org/10.1074/jbc.M116.752766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27624939	Green Published, hybrid			2022-12-28	WOS:000387884400017
J	De Laurentiis, EI; Mercier, E; Wieden, HJ				De Laurentiis, Evelina Ines; Mercier, Evan; Wieden, Hans-Joachim			The C-terminal Helix of Pseudomonas aeruginosa Elongation Factor Ts Tunes EF-Tu Dynamics to Modulate Nucleotide Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; ANGSTROM RESOLUTION; KINETIC MECHANISM; GTP HYDROLYSIS; P-LOOP; RIBOSOME; COMPLEX; CONFORMATION	Little is known about the conservation of critical kinetic parameters and the mechanistic strategies of elongation factor (EF) Ts-catalyzed nucleotide exchange in EF-Tu in bacteria and particularly in clinically relevant pathogens. EF-Tu from the clinically relevant pathogen Pseudomonas aeruginosa shares over 84% sequence identity with the corresponding elongation factor from Escherichia coli. Interestingly, the functionally closely linked EF-Ts only shares 55% sequence identity. To identify any differences in the nucleotide binding properties, as well as in the EF-Ts-mediated nucleotide exchange reaction, we performed a comparative rapid kinetics and mutagenesis analysis of the nucleotide exchange mechanism for both the E. coli and P. aeruginosa systems, identifying helix 13 of EF-Ts as a previously unnoticed regulatory element in the nucleotide exchange mechanism with species-specific elements. Our findings support the base side-first entry of the nucleotide into the binding pocket of the EF-Tu.EF-Ts binary complex, followed by displacement of helix 13 and rapid binding of the phosphate side of the nucleotide, ultimately leading to the release of EF-Ts.	[De Laurentiis, Evelina Ines; Mercier, Evan; Wieden, Hans-Joachim] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Wieden, HJ (corresponding author), Univ Lethbridge, Dept Chem & Biochem, 4401 Univ Dr, Lethbridge, AB T1K 3M4, Canada.	hj.wieden@uleth.ca		Wieden, Hans-Joachim/0000-0001-5181-6059	National Science and Engineering Research Council [326979-2011]; Canada Foundation for Innovation [202588]; Alberta Innovates Technology Futures New Investigator Award; Alberta Innovates Technology Futures postgraduate scholarships	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Innovates Technology Futures New Investigator Award; Alberta Innovates Technology Futures postgraduate scholarships	This work was supported by National Science and Engineering Research Council Operating Grant 326979-2011 (to H.-J. W.), Canada Foundation for Innovation Grant 202588 (to H.-J. W.), an Alberta Innovates Technology Futures New Investigator Award (to H.-J. W.), and Alberta Innovates Technology Futures postgraduate scholarships (to E. M.), as well as resource allocations by Compute Canada and Westgrid. The authors declare that they have no conflicts of interest with the contents of this article.	Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Arike L, 2012, J PROTEOMICS, V75, P5437, DOI 10.1016/j.jprot.2012.06.020; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; CHAU V, 1981, J BIOL CHEM, V256, P5591; Dahl LD, 2006, J BIOL CHEM, V281, P21139, DOI 10.1074/jbc.M602068200; De Laurentiis EI, 2011, BBA-PROTEINS PROTEOM, V1814, P684, DOI 10.1016/j.bbapap.2011.02.007; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mercier E, 2015, SCI REP-UK, V5, DOI 10.1038/srep07677; Miller DL, 1977, MOL MECH PROTEIN BIO, P323; Nicholas K.B., 1997, EMBNET NEWS, V4, P4; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PINGOUD A, 1983, J BIOL CHEM, V258, P4200; RCoreTeam, 2013, R LANG ENV STAT COMP; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Rosler KS, 2015, J BIOL CHEM, V290, P18650, DOI 10.1074/jbc.M114.598227; Schummer T, 2007, BIOCHEMISTRY-US, V46, P4977, DOI 10.1021/bi602486c; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shields MJ, 2009, BIOCHEMISTRY-US, V48, P10793, DOI 10.1021/bi901074h; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Wieden HJ, 2010, BIOPHYS J, V99, P3735, DOI 10.1016/j.bpj.2010.10.013; Wieden HJ, 2002, J BIOL CHEM, V277, P6032, DOI 10.1074/jbc.M110888200; Wilkins MR, 1999, METH MOL B, V112, P531; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; Zhang YL, 1998, J BIOL CHEM, V273, P4556, DOI 10.1074/jbc.273.8.4556	38	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23136	23148		10.1074/jbc.M116.740381	http://dx.doi.org/10.1074/jbc.M116.740381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27624934	hybrid, Green Published			2022-12-28	WOS:000387224800024
J	McGettigan, BM; McMahan, RH; Luo, YH; Wang, XXX; Orlicky, DJ; Porsche, C; Levi, M; Rosen, HR				McGettigan, Brett M.; McMahan, Rachel H.; Luo, Yuhuan; Wang, Xiaoxin X.; Orlicky, David J.; Porsche, Cara; Levi, Moshe; Rosen, Hugo R.			Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID-BINDING; INSULIN-RESISTANCE; FIBROSIS; MICE; ACTIVATION; CELLS; EPIDEMIOLOGY; INFLAMMATION; CHOLESTEROL; CONTRIBUTES	Bile acid sequestrants are synthetic polymers that bind bile acids in the gut and are used to treat dyslipidemia and hyperphosphatemia. Recently, these agents have been reported to lower blood glucose and increase insulin sensitivity by altering bile acid signaling pathways. In this study, we assessed the efficacy of sevelamer in treating mice with non-alcoholic fatty liver disease (NAFLD). We also analyzed how sevelamer alters inflammation and bile acid signaling in NAFLD livers. Mice were fed a low-fat or Western diet for 12 weeks followed by a diet-plus-sevelamer regimen for 2 or 12 weeks. At the end of treatment, disease severity was assessed, hepatic leukocyte populations were examined, and expression of genes involved in farnesoid X receptor (FXR) signaling in the liver and intestine was analyzed. Sevelamer treatment significantly reduced liver steatosis and lobular inflammation. Sevelamer-treated NAFLD livers had notably fewer pro-inflammatory infiltrating macrophages and a significantly greater fraction of alternatively activated Kupffer cells compared with controls. Expression of genes involved in FXR signaling in the liver and intestine was significantly altered in mice with NAFLD as well as in those treated with sevelamer. In a mouse model of NAFLD, sevelamer improved disease and counteracted innate immune cell dysregulation in the liver. This study also revealed a dysregulation of FXR signaling in the liver and intestine of NAFLD mice that was counteracted by sevelamer treatment.	[McGettigan, Brett M.; McMahan, Rachel H.; Porsche, Cara; Rosen, Hugo R.] Univ Colorado, Dept Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Luo, Yuhuan; Wang, Xiaoxin X.; Levi, Moshe] Univ Colorado, Dept Renal Dis & Hypertens, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [McGettigan, Brett M.; Rosen, Hugo R.] Univ Colorado, Dept Immunol & Microbiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rosen, HR (corresponding author), Div GI Hepatol, B-158,Acad Off Bldg 1,12631 E 17th Ave,Rm 7614, Aurora, CO 80045 USA.	hugo.rosen@ucdenver.edu	McGettigan, Brett/AAT-2828-2021	McGettigan, Brett/0000-0002-3120-0123	Veterans Affairs Merit Review grant; National Institute of Health [5K01DK096025]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096025, P30DK048520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	Veterans Affairs Merit Review grant(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a Veterans Affairs Merit Review grant (to H. R. R.) and National Institute of Health Grant 5K01DK096025 (to R. H. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Braunlin W, 2002, KIDNEY INT, V62, P611, DOI 10.1046/j.1523-1755.2002.00459.x; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Cheng QQ, 2015, MOL ENDOCRINOL, V29, P571, DOI 10.1210/me.2014-1337; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Claria J, 2012, GUT, V61, P792, DOI 10.1136/gutjnl-2011-301968; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Lesmana CRA, 2009, J DIGEST DIS, V10, P201, DOI 10.1111/j.1751-2980.2009.00386.x; Levene AP, 2012, HISTOPATHOLOGY, V61, P141, DOI 10.1111/j.1365-2559.2011.04145.x; Longato L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-14; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Potthoff MJ, 2013, AM J PHYSIOL-GASTR L, V304, pG371, DOI 10.1152/ajpgi.00400.2012; Rastogi Anjay, 2013, Ther Adv Cardiovasc Dis, V7, P322, DOI 10.1177/1753944713513061; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Staels B, 2010, CURR DIABETES REP, V10, P70, DOI 10.1007/s11892-009-0087-5; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Taniai M, 2009, HEPATOL RES, V39, P685, DOI 10.1111/j.1872-034X.2009.00507.x; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tuominen Iina, 2015, Hepatology, V62, P646, DOI 10.1002/hep.27910; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Watanabe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038286; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Yao J, 2014, WORLD J GASTROENTERO, V20, P14430, DOI 10.3748/wjg.v20.i39.14430	45	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23058	23067		10.1074/jbc.M116.731042	http://dx.doi.org/10.1074/jbc.M116.731042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605663	hybrid, Green Published			2022-12-28	WOS:000387224800018
J	Gade, P; Kimball, AS; DiNardo, AC; Gangwal, P; Ross, DD; Boswell, HS; Keay, SK; Kalvakolanu, DV				Gade, Padmaja; Kimball, Amy S.; DiNardo, Angela C.; Gangwal, Priyamvada; Ross, Douglas D.; Boswell, H. Scott; Keay, Susan K.; Kalvakolanu, Dhananjaya V.			Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cytokine action; endoplasmic reticulum stress (ER stress); transcription factor; tumor suppressor gene	ENDOPLASMIC-RETICULUM STRESS; BCL-X-L; DAP-KINASE; CELL-DEATH; IFN-GAMMA; B-CELLS; MEDIATED PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; DRUG-RESISTANCE	Expression of DAPK1, a critical regulator of autophagy and apoptosis, is lost in a wide variety of tumors, although the mechanisms are unclear. A transcription factor complex consisting of ATF6 (an endoplasmic reticulum-resident factor) and C/EBP- is required for the IFN--induced expression of DAPK1. IFN--induced proteolytic processing of ATF6 and phosphorylation of C/EBP- are obligatory for the formation of this transcriptional complex. We report that defects in this pathway fail to control growth of chronic lymphocytic leukemia (CLL). Consistent with these observations, IFN- and chemotherapeutics failed to activate autophagy in CLL patient samples lacking ATF6 and/or C/EBP-. Together, these results identify a molecular basis for the loss of DAPK1 expression in CLL.	[Gade, Padmaja; DiNardo, Angela C.; Gangwal, Priyamvada; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Kimball, Amy S.; Ross, Douglas D.; Keay, Susan K.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Ross, Douglas D.] Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Ross, Douglas D.; Keay, Susan K.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Boswell, H. Scott] Indianapolis Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu			National Institutes of Health [CA78282]; University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE [R01CA078282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA78282 (to D. V. K.), and Cigarette Restitution funds from the University of Maryland Greenebaum Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Begleiter A, 1996, LEUKEMIA LYMPHOMA, V23, P187, DOI 10.3109/10428199609054821; Bialik S, 2014, APOPTOSIS, V19, P316, DOI 10.1007/s10495-013-0926-3; Burgler S, 2015, CRIT REV IMMUNOL, V35, P417, DOI 10.1615/CritRevImmunol.v35.i5.50; Buggins AGS, 2010, CANCER RES, V70, P7523, DOI 10.1158/0008-5472.CAN-10-1634; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Burgler S, 2015, J IMMUNOL, V194, P827, DOI 10.4049/jimmunol.1401350; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Eisenberg-Lerner A, 2012, CELL DEATH DIFFER, V19, P788, DOI 10.1038/cdd.2011.149; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Gade P, 2014, MOL CELL BIOL, V34, P4033, DOI 10.1128/MCB.00397-14; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gade P, 2009, INT J CANCER, V125, P1566, DOI 10.1002/ijc.24493; Galluzzi L, 2016, TRENDS CELL BIOL, V26, P1, DOI 10.1016/j.tcb.2015.11.001; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; GALTON DAG, 1966, CAN MED ASSOC J, V94, P1005; Gao YX, 2004, CLIN CHIM ACTA, V349, P173, DOI 10.1016/j.cccn.2004.07.006; Gonzalez-Gomez P, 2003, ONCOL REP, V10, P1031; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Harrison B, 2008, J BIOL CHEM, V283, P9999, DOI 10.1074/jbc.M706040200; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hoare M, 2011, SEMIN CANCER BIOL, V21, P397, DOI 10.1016/j.semcancer.2011.09.004; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kissil JL, 1997, ONCOGENE, V15, P403, DOI 10.1038/sj.onc.1201172; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kubisch J, 2013, SEMIN CANCER BIOL, V23, P252, DOI 10.1016/j.semcancer.2013.06.009; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Mahoney E, 2012, BLOOD, V120, P1262, DOI 10.1182/blood-2011-12-400184; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Os A, 2013, CELL REP, V4, P566, DOI 10.1016/j.celrep.2013.07.011; Panasci L, 2001, CLIN CANCER RES, V7, P454; PERILLO NL, 1993, MECH AGEING DEV, V67, P173, DOI 10.1016/0047-6374(93)90121-7; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Reyes E, 1998, AM J HEMATOL, V57, P93, DOI 10.1002/(SICI)1096-8652(199802)57:2<93::AID-AJH1>3.0.CO;2-W; Roy SK, 2000, J BIOL CHEM, V275, P12626, DOI 10.1074/jbc.275.17.12626; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schmeisser H, 2013, AUTOPHAGY, V9, P683, DOI 10.4161/auto.23921; Sedlacek HH, 1996, INT J ONCOL, V9, P1143, DOI 10.3892/ijo.9.6.1143; Shanmugam R, 2012, CLIN CANCER RES, V18, P360, DOI 10.1158/1078-0432.CCR-10-3022; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Simpson DJ, 2002, ONCOGENE, V21, P1217, DOI 10.1038/sj.onc.1205195; So A, 2009, CANCER METAST REV, V28, P219, DOI 10.1007/s10555-008-9180-5; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Tomizawa M, 2003, ANTICANCER RES, V23, P351; Wu XP, 2014, INT J CANCER, V135, P61, DOI 10.1002/ijc.28649; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zaki M, 2000, LEUKEMIA RES, V24, P611, DOI 10.1016/S0145-2126(00)00022-9; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhao J, 2015, J CLIN INVEST, V125, P2707, DOI 10.1172/JCI70805	62	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22030	22042		10.1074/jbc.M116.725796	http://dx.doi.org/10.1074/jbc.M116.725796			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27590344	hybrid, Green Published			2022-12-28	WOS:000386332600018
J	Zheng, HD; Zhang, X; Castillo, EF; Luo, Y; Liu, ML; Yang, XXO				Zheng, Handong; Zhang, Xing; Castillo, Eliseo F.; Luo, Yan; Liu, Meilian; Yang, Xuexian O.			Leptin Enhances TH2 and ILC2 Responses in Allergic Airway Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; inflammation; innate immunity; leptin; T helper cells	INNATE LYMPHOID-CELLS; T-CELLS; TGF-BETA; PROMOTES; ASTHMA; SURVIVAL; IMMUNITY; IL-9; PROLIFERATION; INITIATION	Allergic asthma and obesity are the leading health problems in the world. Many studies have shown that obesity is a risk factor of development of asthma. However, the underlying mechanism has not been well established. In this study, we demonstrate that leptin, an adipokine elevated in obese individuals, promoted proliferation and survival of pro-allergic type 2 helper T cells and group 2 innate lymphoid cells and production of type 2 cytokines, which together contribute to allergic responses. Leptin activates mTORC1, MAPK, and STAT3 pathways in TH2 cells. The effects of leptin on TH2 cell proliferation, survival, and cytokine production are dependent on the mTORC1 and MAPK pathways as revealed by specific inhibitors. In vivo, leptin-deficiency led to attenuated experimental allergic airway inflammation. Our results thus support that obesity-associated elevation of leptin contributes to the increased susceptibility of asthma via modulation of pro-allergic lymphocyte responses.	[Zheng, Handong; Zhang, Xing; Castillo, Eliseo F.; Yang, Xuexian O.] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Pathol, Albuquerque, NM 87131 USA; [Zhang, Xing; Luo, Yan; Liu, Meilian] Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Luo, Yan] Cent S Univ, Xiangya Hosp 2, Dept Endocrinol & Metab,Natl Clin Res Ctr Metab D, Metab Syndrome Res Ctr,Key Lab Diabet Immunol,Min, Changsha 410011, Hunan, Peoples R China	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Central South University	Yang, XXO (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Pathol, Albuquerque, NM 87131 USA.; Liu, ML (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	meilianliu@salud.unm.edu; xyang@salud.unm.edu	Yang, Xuexian/Y-2472-2019	Yang, Xuexian/0000-0001-6816-7024; Castillo, Eliseo/0000-0002-5083-560X; Zhang, Xing/0000-0002-5877-627X	National Institutes of Health [R56AI110442, R56AI116772]; American Lung Association [RG-268131]; UNM Cancer Center Pilot Award through contract National Institutes of Health Grant [P30CA118100]; American Diabetes Association [1-13-JF-37]; American Heart Association [15GRNT24940018]; CoBRE Pilot Award through National Institutes of Health [P30GM103400]; UNM RAC Pilot Awards; American Association of Immunologists; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI116772, R56AI110442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; UNM Cancer Center Pilot Award through contract National Institutes of Health Grant; American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); CoBRE Pilot Award through National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNM RAC Pilot Awards; American Association of Immunologists; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R56AI110442 and R56AI116772, American Lung Association Grant RG-268131, and UNM Cancer Center Pilot Award through contract National Institutes of Health Grant P30CA118100 (to X. O. Y.), and American Diabetes Association Junior Faculty Research Award 1-13-JF-37, American Heart Association Grant-in-Aid Award 15GRNT24940018, and CoBRE Pilot Award through National Institutes of Health Grant P30GM103400 and UNM RAC Pilot Awards (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a Careers in Immunology Fellowship from the American Association of Immunologists.	Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fernandez-Riejos P, 2008, CLIN EXP IMMUNOL, V151, P505, DOI 10.1111/j.1365-2249.2007.03563.x; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Mattioli B, 2009, FEBS LETT, V583, P1102, DOI 10.1016/j.febslet.2009.02.029; MILNE J, 1975, BRIT J IND MED, V32, P302; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Oriss TB, 1997, J IMMUNOL, V158, P3666; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanos SL, 2013, IMMUNOL CELL BIOL, V91, P215, DOI 10.1038/icb.2013.3; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Soto-Mera MT, 2000, ALLERGY, V55, P983, DOI 10.1034/j.1398-9995.2000.00780.x; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takeda K, 1998, J IMMUNOL, V161, P4652; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Walker JA, 2013, CURR OPIN IMMUNOL, V25, P148, DOI 10.1016/j.coi.2013.02.010; Wilhelm C, 2012, NAT IMMUNOL, V13, P637, DOI 10.1038/ni.2303; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Youssef DM, 2013, J BRAS PNEUMOL, V39, P562, DOI 10.1590/S1806-37132013000500006; Yu HS, 2010, J KOREAN MED SCI, V25, P829, DOI 10.3346/jkms.2010.25.6.829	45	50	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22043	22052		10.1074/jbc.M116.743187	http://dx.doi.org/10.1074/jbc.M116.743187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27566543	hybrid, Green Published			2022-12-28	WOS:000386332600019
J	Soller, KJ; Yang, J; Veglia, G; Bowser, MT				Soller, Kailey J.; Yang, Jing; Veglia, Gianluigi; Bowser, Michael T.			Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyopathy; fluorescence anisotropy; microRNA (miRNA); protein complex; RNA-protein interaction; Phospholamban (PLN); calcium ATPase (SERCA); oligonucleotide analogs; structure-function; protein-nucleic acid interaction	SARCOPLASMIC-RETICULUM; THERAPEUTIC TARGET; THERMUS-AQUATICUS; GENE-THERAPY; MICRORNAS; HEART; DNA; PHOSPHORYLATION; MUTATION; ATPASE	The sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) and phospholamban (PLN) complex regulates heart relaxation through its removal of cytosolic Ca2+ during diastole. Dysfunction of this complex has been related to many heart disorders and is therefore a key pharmacological target. There are currently no therapeutics that directly target either SERCA or PLN. It has been previously reported that single-stranded DNA binds PLN with strong affinity and relieves inhibition of SERCA in a length-dependent manner. In the current article, we demonstrate that RNAs and single-stranded oligonucleotide analogs, or xeno nucleic acids (XNAs), also bind PLN strongly (K-d <10 nm) and relieve inhibition of SERCA. Affinity for PLN is sequence-independent. Relief of PLN inhibition is length-dependent, allowing SERCA activity to be restored incrementally. The improved in vivo stability of XNAs offers more realistic pharmacological potential than DNA or RNA. We also found that microRNAs (miRNAs) 1 and 21 bind PLN strongly and relieve PLN inhibition of SERCA to a greater extent than a similar length random sequence RNA mixture. This may suggest that miR-1 and miR-21 have evolved to contain distinct sequence elements that are more effective at relieving PLN inhibition than random sequences.	[Soller, Kailey J.; Yang, Jing; Veglia, Gianluigi; Bowser, Michael T.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Veglia, Gianluigi] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Veglia, Gianluigi] Univ Minnesota, Dept Mol Biol, Minneapolis, MN 55455 USA; [Veglia, Gianluigi] Univ Minnesota, Dept Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Veglia, G (corresponding author), Dept Chem & Biochem, 321 Church St SE, Minneapolis, MN 55455 USA.; Veglia, G (corresponding author), Depts Mol Biol & Biophys, 321 Church St SE, Minneapolis, MN 55455 USA.; Bowser, MT (corresponding author), Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	vegli001@umn.edu; bowser@umn.edu	Yang, Jing/B-8964-2017; Bowser, Michael/HCI-4724-2022	Yang, Jing/0000-0003-3363-5515; 	National Institutes of Health [GM063533, GM072701]; AHA [13PRE16950023]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072701, R01GM063533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM063533 (to M. B.) and GM072701 (to G. V.) and the AHA (13PRE16950023 to K. S). G. V. and M. B. have filed a U. S. Patent (application no. 15, 056, 761, February 29, 2016) for the use of XNAs as therapeutics for heart failure. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai YL, 2013, CIRC RES, V113, P517, DOI 10.1161/CIRCRESAHA.113.301678; Bao MH, 2013, INT J MOL SCI, V14, P23086, DOI 10.3390/ijms141123086; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Buck B, 2003, PROTEIN EXPRES PURIF, V30, P253, DOI 10.1016/S1046-5928(03)00127-X; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Datta K, 2003, NUCLEIC ACIDS RES, V31, P5590, DOI 10.1093/nar/gkg774; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Gottesfeld JM, 2001, BIOCHEMISTRY-US, V40, P10927, DOI 10.1021/bi0109966; Grol T., 2014, PLOS ONE, V9; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Gwathmey JK, 2013, HUM GENE THER, V24, P937, DOI 10.1089/hum.2013.2512; Ha KN, 2007, J BIOL CHEM, V282, P37205, DOI 10.1074/jbc.M704056200; Ha KN, 2012, J MUSCLE RES CELL M, V33, P485, DOI 10.1007/s10974-012-9319-4; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Jing M, 2011, ANAL CHIM ACTA, V686, P9, DOI 10.1016/j.aca.2010.10.032; Kairouz V, 2012, ANN NY ACAD SCI, V1254, P42, DOI 10.1111/j.1749-6632.2012.06520.x; Keklikoglou I, 2015, ONCOGENE, V34, P4867, DOI 10.1038/onc.2014.408; Kranias E. G., 2007, V45, P523; Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MADDEN TD, 1979, NATURE, V279, P538, DOI 10.1038/279538a0; Mishra PK, 2013, BBA-MOL BASIS DIS, V1832, P2271, DOI 10.1016/j.bbadis.2013.09.004; Mishra PK, 2009, J CELL MOL MED, V13, P778, DOI 10.1111/j.1582-4934.2009.00744.x; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shackman JG, 2004, J CHROMATOGR A, V1040, P273, DOI 10.1016/j.chroma.2004.04.004; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Soller KJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13000; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; TADA M, 1975, J BIOL CHEM, V250, P2640; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tijsen AJ, 2012, CARDIOVASC RES, V93, P573, DOI 10.1093/cvr/cvr344; van der Zwaag PA, 2012, EUR J HEART FAIL, V14, P1199, DOI 10.1093/eurjhf/hfs119; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Vostrikov VV, 2015, BBA-BIOMEMBRANES, V1848, P315, DOI 10.1016/j.bbamem.2014.09.007; Wijnen WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096290; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhou Qiulian, 2014, Front Genet, V5, P185, DOI 10.3389/fgene.2014.00185	53	13	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21510	21518		10.1074/jbc.M116.738807	http://dx.doi.org/10.1074/jbc.M116.738807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531746	Green Published, hybrid			2022-12-28	WOS:000385999200018
J	Vrentas, CE; Moayeri, M; Keefer, AB; Greaney, AJ; Tremblay, J; O'Mard, D; Leppla, SH; Shoemaker, CB				Vrentas, Catherine E.; Moayeri, Mahtab; Keefer, Andrea B.; Greaney, Allison J.; Tremblay, Jacqueline; O'Mard, Danielle; Leppla, Stephen H.; Shoemaker, Charles B.			A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anthrax toxin; antibody; epitope mapping; microbial pathogenesis; phage display; toxin; EF; LF; VHH; VNA	MONOCLONAL-ANTIBODIES; NEUTRALIZING AGENT; VARIABLE DOMAINS; RICIN TOXIN; CHALLENGE; MICE; INHIBITORS; NANOBODIES	Infection with Bacillus anthracis, the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic treatment. VHH single-domain antibodies have been demonstrated to neutralize diverse bacterial toxins both in vitro and in vivo, with protein properties such as small size and high stability that make them attractive therapeutic candidates. Recently, we reported on VHHs with in vivo activity against the protective antigen component of the anthrax toxins. Here, we characterized a new set of 15 VHHs against the anthrax toxins that act by binding to the edema factor (EF) and/or lethal factor (LF) components. Six of these VHHs are cross-reactive against both EF and LF and recognize the N-terminal domain (LFN, EFN) of their target(s) with subnanomolar affinity. The cross-reactive VHHs block binding of EF/LF to the protective antigen C-terminal binding interface, preventing toxin entry into the cell. Another VHH appears to recognize the LF C-terminal domain and exhibits a kinetic effect on substrate cleavage by LF. A subset of the VHHs neutralized against EF and/or LF in murine macrophage assays, and the neutralizing VHHs that were tested improved survival of mice in a spore model of anthrax infection. Finally, a bispecific VNA (VHH-based neutralizing agent) consisting of two linked toxin-neutralizing VHHs, JMN-D10 and JMO-G1, was fully protective against lethal anthrax spore infection in mice as a single dose. This set of VHHs should facilitate development of new therapeutic VNAs and/or diagnostic agents for anthrax.	[Vrentas, Catherine E.] Frostburg State Univ, Dept Biol, Frostburg, MD 21532 USA; [Vrentas, Catherine E.; Moayeri, Mahtab; Keefer, Andrea B.; Greaney, Allison J.; O'Mard, Danielle; Leppla, Stephen H.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Tremblay, Jacqueline; Shoemaker, Charles B.] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA	University System of Maryland; Frostburg State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tufts University	Shoemaker, CB (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, 200 Westboro Rd, North Grafton, MA 01536 USA.	charles.shoemaker@tufts.edu	Greaney, Allison/HDM-8896-2022	Greaney, Allison/0000-0001-7202-3349; Moayeri, Mahtab/0000-0002-4448-8883	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000929, U54AI057159] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID) and by National Institutes of Health Grant U54 AI057159 (to C.B.S). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams R, 2016, MABS-AUSTIN, V8, P1336, DOI 10.1080/19420862.2016.1185581; Chen ZC, 2011, TOXINS, V3, P1004, DOI 10.3390/toxins3081004; Chen ZC, 2009, INFECT IMMUN, V77, P3902, DOI 10.1128/IAI.00200-09; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Herrera C, 2015, J BIOL CHEM, V290, P27880, DOI 10.1074/jbc.M115.658070; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Kaliberov SA, 2014, LAB INVEST, V94, P893, DOI 10.1038/labinvest.2014.82; Leysath CE, 2011, INFECT IMMUN, V79, P4609, DOI 10.1128/IAI.05314-11; Lim NK, 2005, INFECT IMMUN, V73, P6547, DOI 10.1128/IAI.73.10.6547-6551.2005; LITTLE SF, 1988, INFECT IMMUN, V56, P1807, DOI 10.1128/IAI.56.7.1807-1813.1988; Lopez-Requena A, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00159; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; Moayeri M, 2016, CLIN VACCINE IMMUNOL, V23, P213, DOI 10.1128/CVI.00611-15; Moayeri M, 2015, ANNU REV MICROBIOL, V69, P185, DOI 10.1146/annurev-micro-091014-104523; Moayeri M, 2015, J BIOL CHEM, V290, P6584, DOI 10.1074/jbc.M114.627943; Moayeri M, 2013, ANTIMICROB AGENTS CH, V57, P4139, DOI 10.1128/AAC.00941-13; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Pant N, 2011, FUTURE MICROBIOL, V6, P583, DOI [10.2217/fmb.11.32, 10.2217/FMB.11.32]; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Thullier P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065855; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207	29	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21596	21606		10.1074/jbc.M116.749184	http://dx.doi.org/10.1074/jbc.M116.749184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539858	Green Published, hybrid			2022-12-28	WOS:000385999200026
J	Choi, JY; Patra, A; Yeom, M; Lee, YS; Zhang, QQ; Egli, M; Guengerich, FP				Choi, Jeong-Yun; Patra, Amritaj; Yeom, Mina; Lee, Young-Sam; Zhang, Qianqian; Egli, Martin; Guengerich, F. Peter			Kinetic and Structural Impact of Metal Ions and Genetic Variations on Human DNA Polymerase iota	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERROR-PRONE BYPASS; TRANSLESION SYNTHESIS; LESION-BYPASS; B-FAMILY; REPLICATION; ADDUCTS; OPPOSITE; ETA; BASE; FIDELITY	DNA polymerase (pol) iota is a Y-family polymerase involved in translesion synthesis, exhibiting higher catalytic activity with Mn2+ than Mg2+. The human germline R96G variant impairs both Mn2+-dependent and Mg2+-dependent activities of pol iota, whereasthe Delta 1-25 variant selectively enhances its Mg2+-dependent activity. We analyzed pre-steady-state kinetic and structural effects of these two metal ions and genetic variations on pol iota using pol iota core (residues 1-445) proteins. The presence of Mn2+ (0.15 mM) instead of Mg2+ (2 mM) caused a 770-fold increase in efficiency (k(pol)/K-d,K-dCTP) of pol iota for dCTP insertion opposite G, mainly due to a 450-fold decrease in K-d,K-dCTP. The R96G and Delta 1-25 variants displayed a 53-fold decrease and a 3-fold increase, respectively, in k(pol)/K-d,K-dCTP for dCTP insertion opposite G with Mg2+ when compared with wild type, substantially attenuated by substitution with Mn2+. Crystal structures of pol (iota) ternary complexes, including the primer terminus 3'-OH and a non-hydrolyzable dCTP analogue opposite G with the active-site Mg2+ or Mn2+, revealed that Mn2+ achieves more optimal octahedral coordination geometry than Mg2+, with lower values in average coordination distance geometry in the catalytic metal A-site. Crystal structures of R96G revealed the loss of three H-bonds of residues Gly-96 and Tyr-93 with an incoming dNTP, due to the lack of an arginine, as well as a destabilized Tyr-93 side chain secondary to the loss of a cation-pi interaction between both side chains. These results provide a mechanistic basis for alteration in pol iota catalytic function with coordinating metals and genetic variation.	[Choi, Jeong-Yun; Yeom, Mina] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Pharmacol,Dept Mol Cell Biol, Gyeonggi Do 16419, South Korea; [Patra, Amritaj; Zhang, Qianqian; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Lee, Young-Sam] Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Daegu 42988, South Korea	Sungkyunkwan University (SKKU); Vanderbilt University; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 ES010375, R01 ES010546, P01 CA160032]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A01057577]; DGIST R&D Program of the Ministry of Science, ICT and Technology of Korea [20160165]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, R01ES010546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; DGIST R&D Program of the Ministry of Science, ICT and Technology of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 and R01 ES010546 (to F. P. G.) and P01 CA160032 (to M. E.). This work was also supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (Grant NRF-2015R1D1A1A01057577) (to J.-Y. C.) and the DGIST R&D Program of the Ministry of Science, ICT and Technology of Korea (20160165) (to Y.-S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Blanca G, 2003, BIOCHEMISTRY-US, V42, P7467, DOI 10.1021/bi034198m; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2011, CURR CANCER RES, P345, DOI 10.1007/978-1-61737-995-6_16; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Choi JY, 2009, J MOL BIOL, V389, P264, DOI 10.1016/j.jmb.2009.04.023; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Dumstorf CA, 2006, P NATL ACAD SCI USA, V103, P18083, DOI 10.1073/pnas.0605247103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank EG, 2002, NUCLEIC ACIDS RES, V30, P5284, DOI 10.1093/nar/gkf643; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Iguchi M, 2014, ONCOGENE, V33, P3612, DOI 10.1038/onc.2013.331; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Joyce CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1032, DOI 10.1016/j.bbapap.2009.07.021; Kim J, 2014, CHEM RES TOXICOL, V27, P1837, DOI 10.1021/tx5002755; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P11233, DOI 10.1093/nar/gku789; Koag MC, 2014, J BIOL CHEM, V289, P31341, DOI 10.1074/jbc.M114.605451; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Song I, 2014, CHEM RES TOXICOL, V27, P919, DOI 10.1021/tx500072m; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vaisman A, 2003, DNA REPAIR, V2, P991, DOI 10.1016/S1568-7864(03)00094-6; Vashishtha AK, 2016, BIOCHEMISTRY-US, V55, P2661, DOI 10.1021/acs.biochem.5b01350; Xia SL, 2011, BIOCHEMISTRY-US, V50, P9114, DOI 10.1021/bi201260h; Yang J, 2004, CANCER RES, V64, P5597, DOI 10.1158/0008-5472.CAN-04-0603; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yeom M, 2016, CHEM RES TOXICOL, V29, P367, DOI 10.1021/acs.chemrestox.5b00513; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Yuan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069317; Zhang YB, 2002, MUTAT RES-FUND MOL M, V510, P23, DOI 10.1016/S0027-5107(02)00249-X; Zhang YB, 2002, NUCLEIC ACIDS RES, V30, P1630, DOI 10.1093/nar/30.7.1630; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109; Zhou JD, 2012, CANCER SCI, V103, P1574, DOI 10.1111/j.1349-7006.2012.02309.x	54	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21063	+		10.1074/jbc.M116.748285	http://dx.doi.org/10.1074/jbc.M116.748285			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27555320	hybrid, Green Published			2022-12-28	WOS:000385406200022
J	Feinberg, H; Rambaruth, NDS; Jegouzo, SAF; Jacobsen, KM; Djurhuus, R; Poulsen, TB; Weis, WI; Taylor, ME; Drickamer, K				Feinberg, Hadar; Rambaruth, Neela D. S.; Jegouzo, Sabine A. F.; Jacobsen, Kristian M.; Djurhuus, Rasmus; Poulsen, Thomas B.; Weis, William I.; Taylor, Maureen E.; Drickamer, Kurt			Binding Sites for Acylated Trehalose Analogs of Glycolipid Ligands on an Extended Carbohydrate Recognition Domain of the Macrophage Receptor Mincle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTINS; ASIALOGLYCOPROTEIN RECEPTOR; TRIMERIC STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL-BASIS; DENDRITIC-CELL; MECHANISM; PROTEIN; MODEL	The macrophage receptor mincle binds to trehalose dimycolate on the surface of Mycobacterium tuberculosis. Signaling initiated by this interaction leads to cytokine production, which underlies the ability of mycobacteria to evade the immune system and also to function as adjuvants. In previous work the mechanism for binding of the sugar headgroup of trehalose dimycolate to mincle has been elucidated, but the basis for enhanced binding to glycolipid ligands, in which hydrophobic substituents are attached to the 6-hydroxyl groups, has been the subject of speculation. In the work reported here, the interaction of trehalose derivatives with bovine mincle has been probed with a series of synthetic mimics of trehalose dimycolate in binding assays, in structural studies by x-ray crystallography, and by site-directed mutagenesis. Binding studies reveal that, rather than reflecting specific structural preference, the apparent affinity of mincle for ligands with hydrophobic substituents correlates with their overall size. Structural and mutagenesis analysis provides evidence for interaction of the hydrophobic substituents with multiple different portions of the surface of mincle and confirms the presence of three Ca2+-binding sites. The structure of an extended portion of the extracellular domain of mincle, beyond the minimal C-type carbohydrate recognition domain, also constrains the way the binding domains may interact on the surface of macrophages.	[Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Rambaruth, Neela D. S.; Jegouzo, Sabine A. F.; Taylor, Maureen E.; Drickamer, Kurt] Imperial Coll, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England; [Jacobsen, Kristian M.; Djurhuus, Rasmus; Poulsen, Thomas B.] Aarhus Univ, Dept Chem, Biol Chem Lab, DK-8000 Aarhus, Denmark	Stanford University; Imperial College London; Aarhus University	Drickamer, K (corresponding author), Imperial Coll, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Weis, William I/G-1437-2011; Jacobsen, Kristian Mark/AAQ-4526-2020; Poulsen, Thomas/C-5953-2017	Weis, William I/0000-0002-5583-6150; Poulsen, Thomas/0000-0002-0763-9996; Taylor, Maureen/0000-0001-8300-4987; Jegouzo, Sabine/0000-0001-7768-0102; Jacobsen, Kristian Mark/0000-0002-3450-0850	United States DOE [DE-AC02-06CH11357]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; BBSRC [BB/K007718/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K007718/1] Funding Source: researchfish; Lundbeck Foundation [R105-2011-9308] Funding Source: researchfish	United States DOE(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden)	We thank Paul Hitchen for obtaining mass spectrometry data, the NMR facility of the Department of Chemistry, Imperial College London, for access to the NMR instruments, and Thomas Rowntree and David Staunton in the Department of Biochemistry, University of Oxford, for providing assistance with the dynamic light scattering measurements. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by DOE Office of Biological and Environmental Research and by the NIGMS, National Institutes of Health (including P41GM103393).	Cormack B, 2001, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0411s03; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jacobsen KM, 2015, MEDCHEMCOMM, V6, P647, DOI 10.1039/c4md00512k; Jegouzo SAF, 2015, J BIOL CHEM, V290, P16759, DOI 10.1074/jbc.M115.660613; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lang R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00005; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levitzki A., 1997, PROTEIN FUNCTION PRA, P101; Masumoto M, 1999, J IMMUNOL, V163, P5039; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Nagae M, 2013, J BIOL CHEM, V288, P33598, DOI 10.1074/jbc.M113.513572; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; Rambaruth NDS, 2015, MOLECULES, V20, P6670, DOI 10.3390/molecules20046670; Shang FF, 2011, J BIOL CHEM, V286, P757, DOI 10.1074/jbc.M110.175265; Stocker BL, 2014, CHEMBIOCHEM, V15, P382, DOI 10.1002/cbic.201300674; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	35	47	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21222	+		10.1074/jbc.M116.749515	http://dx.doi.org/10.1074/jbc.M116.749515			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542410	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000385406200035
J	Li, L; Li, D; Tian, F; Cen, J; Chen, XT; Ji, Y; Hui, LJ				Li, Lu; Li, Dan; Tian, Feng; Cen, Jin; Chen, Xiaotao; Ji, Yuan; Hui, Lijian			Hepatic Loss of Borealin Impairs Postnatal Liver Development, Regeneration, and Hepatocarcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR CELLS; MATURE HEPATOCYTES; PROMOTES EXPANSION; CANCER-CELLS; STEM-CELLS; SURVIVIN; PROTEIN; AURORA; PROLIFERATION; TUMORIGENESIS	Borealin, a member of the chromosomal passenger complex, plays a key regulatory role at centromeres and the central spindle during mitosis. Loss of Borealin leads to defective cell proliferation and early embryonic lethality. The in vivo functions of Borealin in mammalian postnatal development, tissue homeostasis, and tumorigenesis remain elusive. We specifically analyzed the role of Borealin in regulating postnatal liver development, damage-induced liver regeneration, and liver carcinogenesis using mice carrying conditional Borealin alleles. Perinatal loss of Borealin caused increased genome ploidy and enlarged cell size in hepatocytes, likely due to the impaired function of the chromosomal passenger complex in mitosis. Borealin deletion also showed attenuated expansion of Sox9(+)HNF4 alpha(+) progenitor-like cells in liver regeneration during 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-inducedliverinjury. Moreover, Delta N90-beta-Catenin and c-Met-induced hepatocarcinogenesis development was largely impeded by Borealin deletion. These findings indicate that Borealin plays a key role in liver development, regeneration, and tumorigenesis and suggests that Borealin could be a potential target for related liver diseases.	[Li, Lu; Li, Dan; Cen, Jin; Chen, Xiaotao; Hui, Lijian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Li, Lu] Univ Chinese Acad Sci, Shanghai, Peoples R China; [Tian, Feng; Ji, Yuan] Fudan Univ, Zhongshan Hosp, Dept Pathol, Fenglin Rd 180, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University	Li, D; Hui, LJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.	lidan@sibcb.ac.cn; ljhui@sibcb.ac.cn		Li, Dan/0000-0002-8777-4580	Ministry of Science and Technology (MOST) of China [2014CB910601, 2012CB945001]; National Science Foundation of China (NSFC) [31225016, 81471948, 31501111]; Shanghai Science and Technology Committee [12JC1409500, 14XD1404200]; Postdoctor Research Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2014KIP302]; China Postdoctoral Science Foundation [2015M580361]	Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Postdoctor Research Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by Ministry of Science and Technology (MOST) of China Grants 2014CB910601 and 2012CB945001, National Science Foundation of China (NSFC) Grants 31225016, 81471948, and 31501111, and Shanghai Science and Technology Committee Grants 12JC1409500 and 14XD1404200. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant 2014KIP302, and China Postdoctoral Science Foundation Grant 2015M580361. To whom correspondence may be addressed. E-mail: lidan@sibcb.ac.cn.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Chang JL, 2006, EXP CELL RES, V312, P962, DOI 10.1016/j.yexcr.2005.12.015; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hagemann S, 2013, CELL DEATH DIFFER, V20, P834, DOI 10.1038/cdd.2013.20; Hanson KK, 2005, DEVELOPMENT, V132, P4777, DOI 10.1242/dev.02057; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Li D, 2016, HEPATOLOGY, V64, P1105, DOI [10.1002/hep.28637, 10.1002/hep.28837]; Li D, 2013, HEPATOLOGY, V58, P2109, DOI 10.1002/hep.26601; Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203; Michalopoulos GK, 2015, GASTROENTEROLOGY, V149, P876, DOI 10.1053/j.gastro.2015.08.004; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tatsuka M, 1998, CANCER RES, V58, P4811; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wang EY, 2011, P NATL ACAD SCI USA, V108, P18384, DOI 10.1073/pnas.1116386108; Wang Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0248-5; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011	26	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21137	+		10.1074/jbc.M116.736173	http://dx.doi.org/10.1074/jbc.M116.736173			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542413	Green Published, hybrid			2022-12-28	WOS:000385406200028
J	Petrie, M; Esquibel, J; Kabachinski, G; Maciuba, S; Takahashi, H; Edwardson, JM; Martin, TFJ				Petrie, Matt; Esquibel, Joseph; Kabachinski, Greg; Maciuba, Stephanie; Takahashi, Hirohide; Edwardson, J. Michael; Martin, Thomas F. J.			The Vesicle Priming Factor CAPS Functions as a Homodimer via C2 Domain Interactions to Promote Regulated Vesicle Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE-CORE VESICLES; CA2+-DEPENDENT ACTIVATOR PROTEIN; C. ELEGANS NEURONS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TETHERING FACTORS; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; SINGLE-MOLECULE; MUN DOMAIN; FUSION	Neurotransmitters and peptide hormones are secreted by regulated vesicle exocytosis. CAPS (also known as CADPS) is a 145-kDa cytosolic and peripheral membrane protein required for vesicle docking and priming steps that precede Ca2+-triggered vesicle exocytosis. CAPS binds phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) and SNARE proteins and is proposed to promote SNARE protein complex assembly for vesicle docking and priming. We characterized purified soluble CAPS as mainly monomer in equilibrium with small amounts of dimer. However, the active form of CAPS bound to PC12 cell membranes or to liposomes containing PI(4,5)P-2 and Q-SNARE proteins was mainly dimer. CAPS dimer formation required its C2 domain based on mutation or deletion studies. Moreover, C2 domain mutations or deletions resulted in a loss of CAPS function in regulated vesicle exocytosis, indicating that dimerization is essential for CAPS function. Comparison of the CAPS C2 domain to a structurally defined Munc13-1 C2A domain dimer revealed conserved residues involved in CAPS dimerization. We conclude that CAPS functions as a C2 domain-mediated dimer in regulated vesicle exocytosis. The unique tandem C2-PH domain of CAPS may serve as a PI(4,5)P-2-triggered switch for dimerization. CAPS dimerization may be coupled to oligomeric SNARE complex assembly for vesicle docking and priming.	[Petrie, Matt; Esquibel, Joseph; Kabachinski, Greg; Maciuba, Stephanie; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Esquibel, Joseph; Martin, Thomas F. J.] Univ Wisconsin, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA; [Petrie, Matt; Kabachinski, Greg; Maciuba, Stephanie; Martin, Thomas F. J.] Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA; [Takahashi, Hirohide; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	tfmartin@wisc.edu	Martin, Thomas F/A-6962-2009	Martin, Thomas F/0000-0002-5204-0202; Takahashi, Hirohide/0000-0002-2553-8806	University of Wisconsin-Madison; National Science Foundation (NSF) [BIR-95212577]; National Institutes of Health [S10RR13790]; University of Wisconsin Carbone Center Support Grant [P30 CA014520]; NSF summer research program [DBI-1063085]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040428, R01DK025861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119158, T32GM008688] Funding Source: NIH RePORTER	University of Wisconsin-Madison; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Carbone Center Support Grant; NSF summer research program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the help provided by D. McCaslin with the analytic ultracentrifugation conducted at the University of Wisconsin-Madison Biophysics Instrumentation Facility established with support from the University of Wisconsin-Madison, National Science Foundation (NSF) Grant BIR-95212577, and National Institutes of Health Grant S10RR13790. FACS sorting was assisted by the University of Wisconsin Carbone Center Support Grant P30 CA014520. We acknowledge the help of M. Reddick in single molecule studies in an NSF summer research program (Grant DBI-1063085).	Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Chia Pei Zhi Cheryl, 2014, F1000Prime Rep, V6, P74, DOI 10.12703/P6-74; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Farina M, 2015, ELIFE, V4, DOI [10.7554/eLife.05438, 10.7554/eLife.12968]; Fong JH, 2009, BIOINFORMATICS, V25, P1862, DOI 10.1093/bioinformatics/btp334; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Guan R, 2007, BIOCHEMISTRY-US, V46, P8988, DOI 10.1021/bi700698a; Hammarlund M, 2008, J CELL BIOL, V180, P483, DOI 10.1083/jcb.200708018; Imig C, 2014, NEURON, V84, P416, DOI 10.1016/j.neuron.2014.10.009; Jain A, 2012, NAT PROTOC, V7, P445, DOI 10.1038/nprot.2011.452; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kabachinski G, 2016, MOL BIOL CELL, V27, P654, DOI 10.1091/mbc.E15-07-0509; Kabachinski G, 2014, MOL BIOL CELL, V25, P508, DOI 10.1091/mbc.E12-11-0829; Khodthong C, 2011, CELL METAB, V14, P254, DOI 10.1016/j.cmet.2011.07.002; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Kulkarni Aditya, 2012, Bioarchitecture, V2, P59; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Lin XG, 2010, BIOCHEM BIOPH RES CO, V397, P526, DOI 10.1016/j.bbrc.2010.05.148; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Liu YY, 2010, J CELL BIOL, V190, P1067, DOI 10.1083/jcb.201001164; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Lu J, 2006, PLOS BIOL, V4, P1159, DOI 10.1371/journal.pbio.0040192; MARTIN TFJ, 1989, J BIOL CHEM, V264, P10299; Martin TFJ, 2015, BBA-MOL CELL BIOL L, V1851, P785, DOI 10.1016/j.bbalip.2014.09.017; Masumoto T, 2012, MOL CELL NEUROSCI, V49, P1, DOI 10.1016/j.mcn.2011.09.007; Nojiri M, 2009, J BIOL CHEM, V284, P18707, DOI 10.1074/jbc.M109.017483; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parsaud L, 2013, J BIOL CHEM, V288, P23050, DOI 10.1074/jbc.M113.494088; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Sadakata T, 2013, J NEUROSCI, V33, P17326, DOI 10.1523/JNEUROSCI.2777-13.2013; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Stieglitz B, 2012, J BIOL CHEM, V287, P20823, DOI 10.1074/jbc.M112.359547; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; Yang XY, 2015, NAT STRUCT MOL BIOL, V22, P547, DOI 10.1038/nsmb.3038; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317; Zhou KM, 2007, NEURON, V56, P657, DOI 10.1016/j.neuron.2007.09.015; Ziemba BP, 2013, BIOCHEMISTRY-US, V52, P4820, DOI 10.1021/bi400488f	58	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21257	21270		10.1074/jbc.M116.728097	http://dx.doi.org/10.1074/jbc.M116.728097			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27528604	Green Published, hybrid			2022-12-28	WOS:000385406200038
J	Fields, JB; Nemeth-Cahalan, KL; Freites, JA; Vorontsova, I; Hall, JE; Tobias, DJ				Fields, James B.; Nemeth-Cahalan, Karin L.; Freites, J. Alfredo; Vorontsova, Irene; Hall, James E.; Tobias, Douglas J.			Calmodulin Gates Aquaporin 0 Permeability through a Positively Charged Cytoplasmic Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWNIAN DYNAMICS SIMULATIONS; PROTEIN-PROTEIN ASSOCIATION; MOLECULAR-DYNAMICS; WATER-CHANNEL; HYDRODYNAMIC INTERACTIONS; ELECTRON-TRANSFER; STRUCTURAL BASIS; HUMAN LENS; MEMBRANE; PHOSPHORYLATION	Aquaporin 0 (AQP0), the major intrinsic protein of the eye lens, plays a vital role in maintaining lens clarity by facilitating the transport of water across lens fiber cell membranes. AQP0 reduces its osmotic water permeability constant (P-f) in response to increases in the external calcium concentration, an effect that is mediated by an interaction with the calcium-binding messenger protein, calmodulin (CaM), and phosphorylation of the CaM-binding site abolishes calcium sensitivity. Despite recent structural characterization of the AQP0-CaM complex, the mechanism by which CaM modulates AQP0 remains poorly understood. By combining atomistic molecular dynamics simulations and oocyte permeability assays, we conclude that serine phosphorylation of AQP0 does not inhibit CaM binding to the whole AQP0 protein. Instead, AQP0 phosphorylation alters calcium sensitivity by modifying the AQP0-CaM interaction interface, particularly at an arginine-rich loop that connects the fourth and fifth transmembrane helices. This previously unexplored loop, which sits outside of the canonical CaM-binding site on the AQP0 cytosolic face, mechanically couples CaM to the pore-gating residues of the second constriction site. We show that this allosteric loop is vital for CaM regulation of the channels, facilitating cooperativity between adjacent subunits and regulating factors such as serine phosphorylation. Similar allosteric interactions may also mediate CaM modulation of the properties of other CaM-regulated proteins.	[Fields, James B.; Freites, J. Alfredo; Tobias, Douglas J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Nemeth-Cahalan, Karin L.; Vorontsova, Irene; Hall, James E.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Tobias, DJ (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.; Hall, JE (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	jhall@uci.edu; dtobias@uci.edu	Freites, J. Alfredo/S-8027-2017; Tobias, Douglas J/B-6799-2015	Freites, J. Alfredo/0000-0001-5842-7443; Vorontsova, Irene/0000-0002-3793-9201; Tobias, Douglas/0000-0002-6971-9828	National Science Foundation [ACI-1053575]; NATIONAL EYE INSTITUTE [R01EY005661] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We acknowledge all of the members of the Hall and Tobias laboratories that participated in many thoughtful discussions throughout this collaboration, in particular Matthias Heyden and Eric K. Wong, who helped to facilitate the computational portion of this research. We also thank Nathan Crawford and Joseph Farran for outstanding computational support. This work used computing resources through the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant ACI-1053575.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; Benson NC, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012500084; Best RB, 2012, BIOPHYS J, V103, P1045, DOI 10.1016/j.bpj.2012.07.042; BLOEMENDAL H, 1972, Cell Differentiation, V1, P91, DOI 10.1016/0045-6039(72)90032-2; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chepelinsky AB, 2003, J EXP ZOOL PART A, V300A, P41, DOI 10.1002/jez.a.10307; Cormen T. H., 2009, INTRO ALGORITHMS, P693; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fields JB, 2015, BIOCHEMISTRY-US, V54, P7272, DOI 10.1021/acs.biochem.5b00569; Flock D, 2004, BIOPHYS J, V87, P65, DOI 10.1529/biophysj.103.035261; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Frembgen-Kesner T, 2010, BIOPHYS J, V99, pL75, DOI 10.1016/j.bpj.2010.09.006; Frick A, 2014, P NATL ACAD SCI USA, V111, P6305, DOI 10.1073/pnas.1321406111; Gabdoulline RR, 2009, J AM CHEM SOC, V131, P9230, DOI 10.1021/ja809567k; Gabdoulline RR, 2001, J MOL BIOL, V306, P1139, DOI 10.1006/jmbi.2000.4404; Gabdoulline RR, 1996, J PHYS CHEM-US, V100, P3868, DOI 10.1021/jp953109f; Gabdoulline RR, 1998, METHODS, V14, P329, DOI 10.1006/meth.1998.0588; Garland DL, 1996, EXP EYE RES, V62, P285, DOI 10.1006/exer.1996.0034; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; GIRSCH SJ, 1991, CURR EYE RES, V10, P839, DOI 10.3109/02713689109013880; Gold MG, 2012, EMBO MOL MED, V4, P15, DOI 10.1002/emmm.201100184; Golestaneh N, 2008, MOL VIS, V14, P1006; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gorba C, 2004, J CHEM PHYS, V121, P457, DOI 10.1063/1.1755668; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MO, 2008, P NATL ACAD SCI USA, V105, P14430, DOI 10.1073/pnas.0802401105; Kalman K, 2008, J BIOL CHEM, V283, P21278, DOI 10.1074/jbc.M801740200; Kitchen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143027; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lin H, 2007, MOL VIS, V13, P1822; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez M, 2015, J COMPUT CHEM, V36, P1631, DOI 10.1002/jcc.23971; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Novotny J, 1997, J MOL BIOL, V268, P401, DOI 10.1006/jmbi.1997.0961; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rabaud NE, 2009, BIOCHEM BIOPH RES CO, V383, P54, DOI 10.1016/j.bbrc.2009.03.128; Rankin W. T., 1995, Proceedings of the Fourth IEEE International Symposium on High Performance Distributed Computing (Cat. No.95TB8075), P17, DOI 10.1109/HPDC.1995.518690; Reichow SL, 2008, STRUCTURE, V16, P1389, DOI 10.1016/j.str.2008.06.011; Reichow SL, 2013, NAT STRUCT MOL BIOL, V20, P1085, DOI 10.1038/nsmb.2630; Rose KML, 2008, BIOCHEMISTRY-US, V47, P339, DOI 10.1021/bi701980t; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schilder J, 2013, CURR OPIN STRUC BIOL, V23, P911, DOI 10.1016/j.sbi.2013.07.009; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Team R. D. C., 2008, R LANG ENV STAT COMP; Wolfram Research, 2015, MATHEMATICA; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yu YB, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-6; ZHOU HX, 1993, BIOPHYS J, V64, P1711, DOI 10.1016/S0006-3495(93)81543-1	59	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					185	195		10.1074/jbc.M116.743724	http://dx.doi.org/10.1074/jbc.M116.743724			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27660387	Green Published, hybrid			2022-12-28	WOS:000391578000016
J	Houwman, JA; Andre, E; Westphal, AH; van Berkel, WJH; van Mierlo, CPM				Houwman, Joseline A.; Andre, Estelle; Westphal, Adrie H.; van Berkel, Willem J. H.; van Mierlo, Carlo P. M.			The Ribosome Restrains Molten Globule Formation in Stalled Nascent Flavodoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA PARALLEL PROTEIN; AZOTOBACTER-VINELANDII APOFLAVODOXIN; IN-VIVO; FOLDING INTERMEDIATE; NMR-SPECTROSCOPY; ENERGY LANDSCAPE; EXCHANGE REVEALS; REDOX PROPERTIES; CHAIN COMPLEXES; PATHWAY	Folding of proteins usually involves intermediates, of which an important type is the molten globule (MG). MGs are ensembles of interconverting conformers that contain (non-) native secondary structure and lack the tightly packed tertiary structure of natively folded globular proteins. Whereas MGs of various purified proteins have been probed to date, no data are available on their presence and/or effect during protein synthesis. To study whether MGs arise during translation, we use ribosomenascent chain (RNC) complexes of the electron transfer protein flavodoxin. Full-length isolated flavodoxin, which contains a non-covalently bound flavin mononucleotide (FMN) as cofactor, acquires its native alpha/beta parallel topology via a folding mechanism that contains an off-pathway intermediate with molten globular characteristics. Extensive population of this MG state occurs at physiological ionic strength for apoflavodoxin variant F44Y, in which a phenylalanine at position 44 is changed to a tyrosine. Here, we show for the first time that ascertaining the binding rate of FMN as a function of ionic strength can be used as a tool to determine the presence of the off-pathway MG on the ribosome. Application of this methodology to F44Y apoflavodoxin RNCs shows that at physiological ionic strength the ribosome influences formation of the off-pathway MG and forces the nascent chain toward the native state.	[Houwman, Joseline A.; Andre, Estelle; Westphal, Adrie H.; van Berkel, Willem J. H.; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, Stippeneng 4, NL-6708 WE Wageningen, Netherlands	Wageningen University & Research	van Mierlo, CPM (corresponding author), Wageningen Univ, Biochem Lab, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	vanMierlo, Carlo p/B-4491-2016; van Berkel, Willem J.H./O-2431-2014; Westphal, Adrie Herman/L-3517-2019	vanMierlo, Carlo p/0000-0002-5358-8392; van Berkel, Willem J.H./0000-0002-6551-2782; Westphal, Adrie Herman/0000-0003-4264-6267; Houwman, Joseline/0000-0003-1221-990X	ECHO from Netherlands Organisation for Scientific Research (NWO) [711.011.007]	ECHO from Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by ECHO Grant 711.011.007 from Netherlands Organisation for Scientific Research (NWO) (to C. P. M. v. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bhattacharyya S, 2013, CURR OPIN STRUC BIOL, V23, P11, DOI 10.1016/j.sbi.2012.10.010; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Bollen YJM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2010; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Chakraborty S, 2001, BIOCHEMISTRY-US, V40, P7228, DOI 10.1021/bi010004w; Cymer F, 2015, J BIOL CHEM, V290, P10208, DOI 10.1074/jbc.M115.641555; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P133; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Ellis JP, 2008, ACS CHEM BIOL, V3, P555, DOI 10.1021/cb800059u; Ellis JP, 2009, PROTEIN SCI, V18, P2003, DOI 10.1002/pro.196; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; Engelhard M, 1996, FOLD DES, V1, pR31, DOI 10.1016/S1359-0278(96)00016-8; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; Houwman JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1317, DOI 10.1016/j.bbapap.2015.06.004; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kelkar DA, 2012, J BIOL CHEM, V287, P2568, DOI 10.1074/jbc.M111.318766; KLUGKIST J, 1986, EUR J BIOCHEM, V155, P33, DOI 10.1111/j.1432-1033.1986.tb09455.x; KURODA Y, 1992, J MOL BIOL, V223, P1139, DOI 10.1016/0022-2836(92)90265-L; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Lamprou P, 2014, CHEMBIOCHEM, V15, P977, DOI 10.1002/cbic.201400014; Lindhoud S, 2015, J MOL BIOL, V427, P3148, DOI 10.1016/j.jmb.2015.07.002; Lindhoud S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046838; Lindhoud S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041363; LOH SN, 1995, P NATL ACAD SCI USA, V92, P5446, DOI 10.1073/pnas.92.12.5446; Nabuurs SM, 2010, J BIOL CHEM, V285, P4165, DOI 10.1074/jbc.M109.087932; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nabuurs SM, 2009, J AM CHEM SOC, V131, P2739, DOI 10.1021/ja8089476; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Plaxco KW, 1996, CURR OPIN STRUC BIOL, V6, P630, DOI 10.1016/S0959-440X(96)80029-7; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; SHASTRY MCR, 1995, J MOL BIOL, V247, P1013, DOI 10.1006/jmbi.1994.0196; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; TAYLOR MF, 1990, BIOCHEMISTRY-US, V29, P6911, DOI 10.1021/bi00481a022; Timasheff S. N., 1989, STABILIZATION PROTEI, P331; Van Der Goot Francoise G., 1992, Trends in Cell Biology, V2, P343; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Visser NV, 2008, BIOPHYS J, V95, P2462, DOI 10.1529/biophysj.108.132001; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411	61	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25911	25920		10.1074/jbc.M116.756205	http://dx.doi.org/10.1074/jbc.M116.756205			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27784783	hybrid, Green Published			2022-12-28	WOS:000390345200014
J	Larson, ME; Falconer, DJ; Myers, AM; Barb, AW				Larson, Mark E.; Falconer, Daniel J.; Myers, Alan M.; Barb, Adam W.			Direct Characterization of the Maize Starch Synthase IIa Product Shows Maltodextrin Elongation Occurs at the Non-reducing End	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-SITE INSERTION MECHANISM; GLYCOGEN-SYNTHASE; ARABIDOPSIS-THALIANA; DIPHOSPHATE GLUCOSE; GRANULE INITIATION; CATALYTIC DOMAIN; POTATO-TUBERS; BIOSYNTHESIS; PRIMER; PURIFICATION	A comprehensive description of starch biosynthesis and granule assembly remains undefined despite the central nature of starch as an energy storage molecule in plants and as a fundamental calorie source for many animals. Multiple theories regarding the starch synthase (SS)-catalyzed assembly of (alpha 1-4)-linked D-glucose molecules into maltodextrins generally agree that elongation occurs at the non-reducing terminus based on the degradation of radiolabeled maltodextrins, although recent reports challenge this hypothesis. Surprisingly, a direct analysis of the SS catalytic product has not been reported, to our knowledge. We expressed and characterized recombinant Zea mays SSIIa and prepared pure ADP-[C-13(U)] glucose in a one-pot enzymatic synthesis to address the polarity of maltodextrin chain elongation. We synthesized maltoheptaose (degree of polymerization 7) using ADP-[C-13(U)] glucose, maltohexaose (degree of polymerization 6), and SSIIa. Product analysis by ESI-MS revealed that the [C-13(U)] glucose unit was added to the non-reducing end of the growing chain, and SSIIa demonstrated a > 7,850-fold preference for addition to the non-reducing end versus the reducing end. Independent analysis of [C-13(U)] glucose added to maltohexaose by SSIIa using solution NMR spectroscopy confirmed the polarity of maltodextrin chain elongation.	[Larson, Mark E.; Falconer, Daniel J.; Myers, Alan M.; Barb, Adam W.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 2437 Pammel Dr,Mol Biol Bldg,Rm 4210, Ames, IA 50011 USA	Iowa State University	Barb, AW (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 2437 Pammel Dr,Mol Biol Bldg,Rm 4210, Ames, IA 50011 USA.	abarb@iastate.edu		Myers, Alan/0000-0002-9619-4692; Barb, Adam/0000-0003-3290-8649	NIGMS, National Institutes of Health [R01-GM115489]; Roy J. Carver Department of Biochemistry, Biophysics AMP; Molecular Biology at Iowa State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115489] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1517256] Funding Source: National Science Foundation	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Roy J. Carver Department of Biochemistry, Biophysics AMP; Molecular Biology at Iowa State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Grant R01-GM115489 from the NIGMS, National Institutes of Health and by funds from the Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Busi MV, 2008, PROTEINS, V70, P31, DOI 10.1002/prot.21469; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Cuesta-Seijo JA, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01265; Cuesta-Seijo JA, 2013, ACTA CRYSTALLOGR D, V69, P1013, DOI 10.1107/S090744491300440X; DEFEKETE MAR, 1960, NATURE, V187, P918, DOI 10.1038/187918a0; Denyer K, 1999, BIOCHEM J, V340, P183, DOI 10.1042/0264-6021:3400183; Edwards A, 1999, EUR J BIOCHEM, V266, P724, DOI 10.1046/j.1432-1327.1999.00861.x; Huang BQ, 2016, ARCH BIOCHEM BIOPHYS, V596, P63, DOI 10.1016/j.abb.2016.02.032; Imparl-Radosevich JM, 1998, ARCH BIOCHEM BIOPHYS, V353, P64, DOI 10.1006/abbi.1998.0613; Jane JL, 2009, FOOD SCI TECHNOL-INT, P193, DOI 10.1016/B978-0-12-746275-2.00006-9; Keeling PL, 2010, ANNU REV FOOD SCI T, V1, P271, DOI 10.1146/annurev.food.102308.124214; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; LELOIR LF, 1961, J BIOL CHEM, V236, P636; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Matsui M., 2010, FASEB J, V24, P835; Momma M, 2012, BIOSCI BIOTECH BIOCH, V76, P1591, DOI 10.1271/bbb.120305; Mukerjea R, 2005, CARBOHYD RES, V340, P2206, DOI 10.1016/j.carres.2005.06.021; Mukerjea R, 2005, CARBOHYD RES, V340, P245, DOI 10.1016/j.carres.2004.11.010; Mukerjea R, 2002, CARBOHYD RES, V337, P1015, DOI 10.1016/S0008-6215(02)00067-8; Mukerjea R, 2012, CARBOHYD RES, V352, P137, DOI 10.1016/j.carres.2011.11.024; Mukerjea R, 2010, CARBOHYD RES, V345, P1555, DOI 10.1016/j.carres.2010.04.022; OShea MG, 1996, ELECTROPHORESIS, V17, P681, DOI 10.1002/elps.1150170410; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; RECONDO E, 1961, BIOCHEM BIOPH RES CO, V6, P85, DOI 10.1016/0006-291X(61)90389-8; Senoura T, 2004, BIOSCI BIOTECH BIOCH, V68, P1949, DOI 10.1271/bbb.68.1949; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; Soya N, 2011, GLYCOBIOLOGY, V21, P547, DOI 10.1093/glycob/cwq190; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; Valdez HA, 2008, BIOCHEMISTRY-US, V47, P3026, DOI 10.1021/bi702418h; Yep A, 2004, ANAL BIOCHEM, V324, P52, DOI 10.1016/j.ab.2003.09.024; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	35	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24951	24960		10.1074/jbc.M116.754705	http://dx.doi.org/10.1074/jbc.M116.754705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27733678	Green Published, hybrid			2022-12-28	WOS:000388880100014
J	Li, CJ; Tan, BK; Zhao, JS; Guan, ZQ				Li, Chijun; Tan, Brandon K.; Zhao, Jinshi; Guan, Ziqiang			In Vivo and in Vitro Synthesis of Phosphatidylglycerol by an Escherichia coli Cardiolipin Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGSA NULL MUTANT; MASS-SPECTROMETRY; LACKING PHOSPHATIDYLGLYCEROL; ANIONIC PHOSPHOLIPIDS; BACILLUS-MEGATERIUM; PHOSPHATIDYLETHANOLAMINE; IDENTIFICATION; BIOSYNTHESIS; LIPIDS; IONIZATION	Phosphatidylglycerol (PG) makes up 5-20% of the phospholipids of Escherichia coli and is essential for growth in wild-type cells. PG is synthesized from the dephosphorylation of its immediate precursor, phosphatidylglycerol phosphate (PGP) whose synthase in E. coli is PgsA. Using genetic, biochemical, and highly sensitive mass spectrometric approaches, we identified an alternative mechanism for PG synthesis in E. coli that is PgsA independent. The reaction of synthesis involves the conversion of phosphatidylethanolamine and glycerol into PG and is catalyzed by ClsB, a phospholipase D-type cardiolipin synthase. This enzymatic reaction is demonstrated herein both in vivo and in vitro as well as by using the purified ClsB protein. When the growth medium was supplemented with glycerol, the expression of E. coli ClsB significantly increased PG and cardiolipin levels, with the growth deficiency of pgsA null strain also being complemented under such conditions. Identification of this alternative mechanism for PG synthesis not only expands our knowledge of bacterial anionic phospholipid biosynthesis, but also sheds light on the biochemical functions of the cls gene redundancy in E. coli and other bacteria. Finally, the PGP-independent PG synthesis in E. coli may also have important implications for the understanding of PG biosynthesis in eukaryotes that remains incomplete.	[Li, Chijun; Tan, Brandon K.; Zhao, Jinshi; Guan, Ziqiang] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Guan, ZQ (corresponding author), POB 3711, Durham, NC 27710 USA.	ziqiang.guan@duke.edu	Guan, Ziqiang/AAE-5110-2019		National Institutes of Health [GM069338, EY023666]; NATIONAL EYE INSTITUTE [R01EY023666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Lipid Maps Collaborative Grant GM069338 and EY023666 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Dowhan W, 2013, BBA-MOL CELL BIOL L, V1831, P471, DOI 10.1016/j.bbalip.2012.08.007; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Guan ZQ, 2007, BIOCHEMISTRY-US, V46, P14500, DOI 10.1021/bi701907g; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P800, DOI 10.1016/j.bbalip.2011.04.009; Guan ZQ, 2005, ANAL BIOCHEM, V345, P336, DOI 10.1016/j.ab.2005.07.002; Guo DG, 2000, BBA-MOL CELL BIOL L, V1483, P263, DOI 10.1016/S1388-1981(99)00193-6; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; Kanipes MI, 2001, J BIOL CHEM, V276, P1156, DOI 10.1074/jbc.M009019200; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; LOMBARDI FJ, 1980, J BACTERIOL, V141, P618, DOI 10.1128/JB.141.2.618-625.1980; LOMBARDI FJ, 1980, J BACTERIOL, V141, P626, DOI 10.1128/JB.141.2.626-634.1980; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Nagahama H, 2006, J GEN APPL MICROBIOL, V52, P91, DOI 10.2323/jgam.52.91; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Suzuki M, 2002, J BACTERIOL, V184, P5418, DOI 10.1128/JB.184.19.5418-5425.2002; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; WALTON PA, 1987, J BIOL CHEM, V262, P10355; Ward WC, 2007, J LIPID RES, V48, P1457, DOI 10.1194/jlr.C700008-JLR200; XIA WM, 1995, P NATL ACAD SCI USA, V92, P783, DOI 10.1073/pnas.92.3.783; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	40	26	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25144	25153		10.1074/jbc.M116.762070	http://dx.doi.org/10.1074/jbc.M116.762070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27760827	Green Published, hybrid			2022-12-28	WOS:000388880100029
J	Zhang, PP; Tsuchiya, K; Kinoshita, T; Kushiyama, H; Suidasari, S; Hatakeyama, M; Imura, H; Kato, N; Suda, T				Zhang, Peipei; Tsuchiya, Kohsuke; Kinoshita, Takeshi; Kushiyama, Hiroko; Suidasari, Sofya; Hatakeyama, Mizuki; Imura, Hisanori; Kato, Norihisa; Suda, Takashi			Vitamin B6 Prevents IL-1 beta Protein Production by Inhibiting NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NALP3 INFLAMMASOME; LISTERIA-MONOCYTOGENES; ALZHEIMERS-DISEASE; ENDOTOXIC-SHOCK; CROHNS-DISEASE; MICE DEFICIENT; CASPASE-1; INNATE; MACROPHAGES	Vitamin B6 includes six water-soluble vitamers: pyridoxal (PL), pyridoxamine (PM), pyridoxine (PN), and their phosphorylated forms. Pyridoxal 5'-phosphate (PLP) is an important cofactor for many metabolic enzymes. Several lines of evidence demonstrate that blood levels of PLP are significantly lower in patients with inflammation than in control subjects and that vitamin B6 has anti-inflammatory effects, with therapeutic potential for a variety of inflammatory diseases. Although one of our group previously demonstrated that PL inhibits the NF-kappa B pathway, the molecular mechanism by which vitamin B6 suppresses inflammation is not well understood, Here, we showed that both PL and PLP suppressed the expression of cytokine genes in macrophages by inhibiting Toll-like receptor (TLR)-mediated TAK1 phosphorylation and the subsequent NE-kappa B and JNK activation. Furthermore, PL and PEP abolished NLRP3-dependent caspase-1 processing and the subsequent secretion of mature IL-1 beta and IL-18 in LPS-primed macrophages. In contrast, PM and PN had little effect on IL-1 beta production. PLP, but not PL, markedly reduced the production of mitochondrial reactive oxygen species (ROS) in peritoneal macrophages. Importantly, PL and PLP reduced IL-1 beta production induced by LPS and ATP, or by LPS alone, in mice. Moreover, PL and PLP protected mice from lethal endotoxic shock. Collectively, these findings reveal novel anti-inflammatory activities for vitamin B6 and suggest its potential for preventing inflammatory diseases driven by the NLRP3 inflammasome.	[Zhang, Peipei; Tsuchiya, Kohsuke; Kinoshita, Takeshi; Kushiyama, Hiroko; Suda, Takashi] Kanazawa Univ, Canc Res Inst, Dept Immunol & Mol Biol, Kakumamachi, Kanazawa, Ishikawa 9201192, Japan; [Suidasari, Sofya; Kato, Norihisa] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Hatakeyama, Mizuki; Imura, Hisanori] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Hiroshima University; Kanazawa University	Suda, T (corresponding author), Kanazawa Univ, Canc Res Inst, Dept Immunol & Mol Biol, Kakumamachi, Kanazawa, Ishikawa 9201192, Japan.	sudat@staff.kanazawa-u.ac.jp	Tsuchiya, Kohsuke/D-8463-2015; Tsuchiya, Kohsuke/P-6959-2019	Tsuchiya, Kohsuke/0000-0001-8540-6920; Tsuchiya, Kohsuke/0000-0001-8540-6920	Japan Society for the Promotion of Science [15K15078, 26110002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Challenging Exploratory Research 15K15078 and by Grant-in-Aid for Scientific Research on Innovative Areas 26110002 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Alves JN, 2013, ARCH BIOCHEM BIOPHYS, V537, P72, DOI 10.1016/j.abb.2013.06.019; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Galluzzi L, 2013, ONCOGENE, V32, P4995, DOI 10.1038/onc.2012.623; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Huang SC, 2010, EUR J CLIN NUTR, V64, P1007, DOI 10.1038/ejcn.2010.107; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Institute of and Medicine U. S., 1998, DIET REF INT THIAM R, P150; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Komatsu S, 2001, J NUTR, V131, P2204, DOI 10.1093/jn/131.8.2204; Kuemmerle-Deschner JB, 2015, SEMIN IMMUNOPATHOL, V37, P377, DOI 10.1007/s00281-015-0491-7; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mooney S, 2009, MOLECULES, V14, P329, DOI 10.3390/molecules14010329; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Murakami K, 2010, BRIT J NUTR, V104, P757, DOI 10.1017/S0007114510001005; Saibeni S, 2003, AM J GASTROENTEROL, V98, P112, DOI 10.1111/j.1572-0241.2003.07160.x; Sakakeeny L, 2012, J NUTR, V142, P1280, DOI 10.3945/jn.111.153056; Sakao Y, 1999, INT IMMUNOL, V11, P471, DOI 10.1093/intimm/11.3.471; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sun SY, 2012, DIABETES, V61, P1471, DOI 10.2337/db11-1389; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; U.S. Department of Health and Human Services; Food and Drug Administration (FDA); Center for Drug Evaluation and Research (CDER), 2005, GUID IND EST MAX SAF, P6; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yanaka N, 2005, INT J MOL MED, V16, P1071; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	54	50	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24517	24527		10.1074/jbc.M116.743815	http://dx.doi.org/10.1074/jbc.M116.743815			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27733681	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000388875500015
J	Bahng, S; Hayama, R; Marians, KJ				Bahng, Soon; Hayama, Ryo; Marians, Kenneth J.			MukB-mediated Catenation of DNA Is ATP and MukEF Independent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA binding protein; DNA structure; DNA topology; nucleic acid enzymology; DNA enzymes	BACTERIAL CONDENSIN MUKB; ESCHERICHIA-COLI; TOPOISOMERASE-IV; IN-VITRO; MAGNESIUM CONTENT; CHROMOSOME; COMPLEX; PROTEINS; IDENTIFICATION; LOCALIZATION	Properly condensed chromosomes are necessary for accurate segregation of the sisters after DNA replication. The Escherichia coli condesin is MukB, a structural maintenance of chromosomes (SMC)-like protein, which forms a complex with MukE and the kleisin MukF. MukB is known to be able to mediate knotting of a DNA ring, an intramolecular reaction. In our investigations of how MukB condenses DNA we discovered that it can also mediate catenation of two DNA rings, an intermolecular reaction. This activity of MukB requires DNA binding by the head domains of the protein but does not require either ATP or its partner proteins MukE or MukF. The ability of MukB to mediate DNA catenation underscores its potential for bringing distal regions of a chromosome together.	[Bahng, Soon; Hayama, Ryo; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Hayama, Ryo] Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Marians, KJ (corresponding author), 1275 York Ave, New York, NY 10065 USA.	mariansk@mskcc.org		Hayama, Ryo/0000-0001-8706-213X	National Institutes of Health [GM34558]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34558 (to K.J.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; DIGATE RJ, 1988, J BIOL CHEM, V263, P13366; Elbatsh AMO, 2016, MOL CELL, V61, P575, DOI 10.1016/j.molcel.2016.01.025; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hayama R, 2013, J BIOL CHEM, V288, P7653, DOI 10.1074/jbc.M112.418087; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; HIASA H, 1994, J BIOL CHEM, V269, P2093; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; HIRAGA S, 1991, RES MICROBIOL, V142, P189, DOI 10.1016/0923-2508(91)90029-A; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KRASNOW MA, 1982, J BIOL CHEM, V257, P2687; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Mascarenhas J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-28; MONCANY MLJ, 1981, EXPERIENTIA, V37, P846, DOI 10.1007/BF01985672; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Niki H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29469; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Petrushenko ZM, 2010, EMBO J, V29, P1126, DOI 10.1038/emboj.2009.414; Pong H, 1999, METH MOL B, V94, P163; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Shin HC, 2009, FEBS J, V276, P5101, DOI 10.1111/j.1742-4658.2009.07206.x; Sun MX, 2013, NUCLEIC ACIDS RES, V41, P6149, DOI 10.1093/nar/gkt303; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Ullsperger C, 1996, J BIOL CHEM, V271, P31549, DOI 10.1074/jbc.271.49.31549; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873	36	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23999	24008		10.1074/jbc.M116.749994	http://dx.doi.org/10.1074/jbc.M116.749994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27697840	hybrid, Green Published			2022-12-28	WOS:000388498100016
J	Xu, H; Chakrabarty, Y; Philmus, B; Mehta, AP; Bhandari, D; Hohmann, HP; Begley, TP				Xu, Hui; Chakrabarty, Yindrila; Philmus, Benjamin; Mehta, Angad P.; Bhandari, Dhananjay; Hohmann, Hans-Peter; Begley, Tadhg P.			Identification of the First Riboflavin Catabolic Gene Cluster Isolated from Microbacterium maritypicum G10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cloning; enzyme mechanism; flavoprotein; quorum sensing; riboflavin; Vitamin B2; catabolism; lyase; reconstitution	BACTERIAL-DEGRADATION; MICROBIOLOGICAL ASPECTS; CATALYTIC MECHANISM; ACID THIAMINE; ACETIC-ACID; LUMICHROME; METABOLISM; OXIDATION	Riboflavin is a common cofactor, and its biosynthetic pathway is well characterized. However, its catabolic pathway, despite intriguing hints in a few distinct organisms, has never been established. This article describes the isolation of a Microbacterium maritypicum riboflavin catabolic strain, and the cloning of the riboflavin catabolic genes. RcaA, RcaB, RcaD, and RcaE were overexpressed and biochemically characterized as riboflavin kinase, riboflavin reductase, ribokinase, and riboflavin hydrolase, respectively. Based on these activities, a pathway for riboflavin catabolism is proposed.	[Xu, Hui; Chakrabarty, Yindrila; Philmus, Benjamin; Mehta, Angad P.; Bhandari, Dhananjay; Hohmann, Hans-Peter; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Begley, TP (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.; Begley, TP (corresponding author), 3474 TAMU,ILSB Rm 2107, College Stn, TX 77843 USA.	begley@tamu.edu		Philmus, Benjamin/0000-0003-2085-0873	National Institutes of Health [DK44083]; Robert A. Welch Foundation [A-0034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044083, R37DK044083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grant DK44083 and Robert A. Welch Foundation Grant A-0034. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bacher A, 1980, Methods Enzymol, V66, P652; Cheng L, 2011, MOL BIOSYST, V7, P920, DOI 10.1039/c0mb00237b; da Cruz MDF, 2015, FASEB J, V29; Foster JW, 1944, J BACTERIOL, V47, P27, DOI 10.1128/JB.47.1.27-41.1944; Foster JW, 1944, J BACTERIOL, V48, P97, DOI 10.1128/JB.48.1.97-111.1944; HARKNESS DR, 1965, J BIOL CHEM, V240, P4089; IM WB, 1970, J BIOL CHEM, V245, P6269; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kincaid VA, 2012, BIOCHEMISTRY-US, V51, P545, DOI 10.1021/bi201347n; Luzhetskii A. N., 2001, Genetika, V37, P1340; Marchena M, 2011, J PHYS CHEM B, V115, P2424, DOI 10.1021/jp110134f; MAZODIER P, 1989, J BACTERIOL, V171, P3583, DOI 10.1128/jb.171.6.3583-3585.1989; Mukherjee T, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P649; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; NEAL RA, 1969, J BIOL CHEM, V244, P5201; NEAL RA, 1968, J BIOL CHEM, V243, P4634; NEAL RA, 1970, J BIOL CHEM, V245, P2599; Phillips DA, 1999, P NATL ACAD SCI USA, V96, P12275, DOI 10.1073/pnas.96.22.12275; Rajamani S, 2008, MOL PLANT MICROBE IN, V21, P1184, DOI 10.1094/MPMI-21-9-1184; SMYRNIOTIS PZ, 1958, J AM CHEM SOC, V80, P2541, DOI 10.1021/ja01543a047; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yamamoto K, 2015, APPL ENVIRON MICROB, V81, P7360, DOI 10.1128/AEM.02166-15; YANAGITA T, 1956, J BIOL CHEM, V221, P593; Yang C. S., 1971, METHOD ENZYMOL, V18, P571	25	8	9	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23506	23515		10.1074/jbc.M116.729871	http://dx.doi.org/10.1074/jbc.M116.729871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27590337	hybrid, Green Published			2022-12-28	WOS:000387884400013
J	Xu, YJ; Pang, WJ; Lu, JS; Shan, AD; Zhang, Y				Xu, Yingjiao; Pang, Wenjie; Lu, Jishun; Shan, Aidong; Zhang, Yan			Polypeptide N-Acetylgalactosaminyltransferase 13 Contributes to Neurogenesis via Stabilizing the Mucin-type O-Glycoprotein Podoplanin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; glycosylation; glycosyltransferase; neurodifferentiation; protein stability; Galnt13; mucin-type O-glycoprotein; neuronal differentiation; podoplanin; ppGalNAc-T13	EMBRYONAL CARCINOMA-CELLS; AGGREGATION-INDUCING FACTOR; TRANSFERASE GENE FAMILY; TRIMERIC TN ANTIGEN; GALNAC-TRANSFERASE; LINKED GLYCOSYLATION; NEURONAL DIFFERENTIATION; NEURAL DEVELOPMENT; DEVELOPMENTAL-CHANGES; RECEPTOR EXPRESSION	Mucin-type O-glycosylation is initiated by an evolutionarily conserved family of polypeptide N-acetylgalactosaminyltransferases (ppGalNAc-Ts). Previously, it was reported that ppGalNAc-T13 is restrictively expressed at a high level in the brain. Here we provide evidence for the critical role of ppGalNAc-T13 in neural differentiation. In detail, we show that the expression of ppGalNAc-T13 was dramatically up-regulated during early neurogenesis in mouse embryonic brains. Similar changes were also observed in cell models of neuronal differentiation by using either primary mouse cortical neural precursor cells or murine embryonal carcinoma P19 cells. Knockout of ppGalNAc-T13 in P19 cells suppressed not only neural induction but also neuronal differentiation. These effects are at least partly mediated by the mucin-type O-glycoprotein podoplanin (PDPN), as knockdown of PDPN led to a similar inhibition of neuronal differentiation and PDPN was significantly reduced at the posttranscriptional level after ppGalNAc-T13 knockout. Further data demonstrate that PDPN acts as a substrate of ppGalNAc-T13 and that the ppGalNAc-T13-mediated O-glycosylation on PDPN is important for its stability. Taken together, this study suggests that ppGalNAc-T13 contributes to neuronal differentiation through glycosylating and stabilizing PDPN, which provides insights into the regulatory roles of O-glycosylation in mammalian neural development.	[Xu, Yingjiao; Pang, Wenjie; Lu, Jishun; Shan, Aidong; Zhang, Yan] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, 800 Dong Chuan Rd, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University	Zhang, Y (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, 800 Dong Chuan Rd, Shanghai 200240, Peoples R China.; Zhang, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yanzhang2006@sjtu.edu.cn	Yang, Fang/AAF-3024-2019		National Basic Research Program of China [2012CB822103]; National High Technology Research and Development Program of China [2012AA020203]; National Natural Science Foundation [30970642, 31170771, 31370806, 31570796]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20130073110088]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020203] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Basic Research Program of China Grant 2012CB822103, National High Technology Research and Development Program of China Grant 2012AA020203, National Natural Science Foundation Grants 30970642, 31170771, 31370806, and 31570796, and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20130073110088. The authors declare that they have no conflicts of interest with the contents of this article.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berois N, 2006, CLIN CHEM, V52, P1701, DOI 10.1373/clinchem.2006.067975; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Breen KC, 1998, MOL NEUROBIOL, V16, P163, DOI 10.1007/BF02740643; Dani N, 2014, J NEUROSCI, V34, P13047, DOI 10.1523/JNEUROSCI.1484-14.2014; Delgado-Esteban M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3879; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Grau SJ, 2015, INT J CLIN EXP PATHO, V8, P8663; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kaneko MK, 2007, FEBS LETT, V581, P331, DOI 10.1016/j.febslet.2006.12.044; Kaneko MK, 2006, GENE, V378, P52, DOI 10.1016/j.gene.2006.04.023; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kotani M, 2003, J NEUROSCI RES, V73, P603, DOI 10.1002/jnr.10696; Kotani M, 2002, J NEUROSCI RES, V67, P595, DOI 10.1002/jnr.10150; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Li X, 2012, GLYCOBIOLOGY, V22, P602, DOI 10.1093/glycob/cwr179; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; MacPherson Paul A., 1995, Methods (Orlando), V7, P238, DOI 10.1006/meth.1995.1029; Matsumoto Y, 2013, J BIOL CHEM, V288, P24264, DOI 10.1074/jbc.M113.455006; Matsumoto Y, 2012, BIOCHEM BIOPH RES CO, V419, P7, DOI 10.1016/j.bbrc.2012.01.086; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Monlauzeur L, 1998, J BIOL CHEM, V273, P30263, DOI 10.1074/jbc.273.46.30263; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Pan YF, 2014, BLOOD, V124, P3656, DOI 10.1182/blood-2014-04-572107; Park M, 2003, J CELL PHYSIOL, V196, P512, DOI 10.1002/jcp.10332; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; REDDY P, 1989, J BIOL CHEM, V264, P17329; Resende RR, 2007, NEUROSCIENCE, V146, P1169, DOI 10.1016/j.neuroscience.2007.02.041; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Scott Hilary, 2014, Adv Neurobiol, V9, P367, DOI 10.1007/978-1-4939-1154-7_17; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Suzuki M, 2003, J BIOL CHEM, V278, P49459, DOI 10.1074/jbc.M308316200; Suzuki-Inoue Katsue, 2009, Rinsho Ketsueki, V50, P389; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Takasaki N, 2014, P NATL ACAD SCI USA, V111, P1120, DOI 10.1073/pnas.1310777111; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Thompson JA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-62; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Voglmeir J, 2015, COMP BIOCHEM PHYS B, V180, P40, DOI 10.1016/j.cbpb.2014.10.003; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; White RB, 2008, PHYSIOL GENOMICS, V33, P41, DOI 10.1152/physiolgenomics.00256.2007; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zamze S, 1999, GLYCOBIOLOGY, V9, P823, DOI 10.1093/glycob/9.8.823; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200; Ziman MR, 2001, EXP CELL RES, V268, P220, DOI 10.1006/excr.2001.5282	69	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23477	23488		10.1074/jbc.M116.743955	http://dx.doi.org/10.1074/jbc.M116.743955			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27629416	Green Published, hybrid			2022-12-28	WOS:000387884400010
J	Traxlmayr, MW; Kiefer, JD; Srinivas, RR; Lobner, E; Tisdale, AW; Mehta, NK; Yang, NJ; Tidor, B; Wittrup, KD				Traxlmayr, Michael W.; Kiefer, Jonathan D.; Srinivas, Raja R.; Lobner, Elisabeth; Tisdale, Alison W.; Mehta, Naveen K.; Yang, Nicole J.; Tidor, Bruce; Wittrup, K. Dane			Strong Enrichment of Aromatic Residues in Binding Sites from a Charge-neutralized Hyperthermostable Sso7d Scaffold Library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; epidermal growth factor receptor (EGFR); molecular evolution; protein stability; scaffold protein; aromatic amino acids; protein charge; yeast display	YEAST SURFACE DISPLAY; IN-VIVO; SULFOLOBUS-SOLFATARICUS; DIRECTED EVOLUTION; PROTEIN INTERFACES; HUMAN-ANTIBODIES; STABILITY; AFFINITY; RECEPTOR; SPECIFICITY	The Sso7d protein from the hyperthermophilic archaeon Sulfolobus solfataricus is an attractive binding scaffold because of its small size (7 kDa), high thermal stability (T-m of 98 degrees C), and absence of cysteines and glycosylation sites. However, as a DNA-binding protein, Sso7d is highly positively charged, introducing a strong specificity constraint for binding epitopes and leading to nonspecific interaction with mammalian cell membranes. In the present study, we report charge-neutralized variants of Sso7d that maintain high thermal stability. Yeast-displayed libraries that were based on this reduced charge Sso7d (rcSso7d) scaffold yielded binders with low nanomolar affinities against mouse serum albumin and several epitopes on human epidermal growth factor receptor. Importantly, starting from a charge-neutralized scaffold facilitated evolutionary adaptation of binders to differentially charged epitopes on mouse serum albumin and human epidermal growth factor receptor, respectively. Interestingly, the distribution of amino acids in the small and rigid binding surface of enriched rcSso7d-based binders is very different from that generally found in more flexible antibody complementarity-determining region loops but resembles the composition of antibody-binding energetic hot spots. Particularly striking was a strong enrichment of the aromatic residues Trp, Tyr, and Phe in rcSso7d-based binders. This suggests that the rigidity and small size of this scaffold determines the unusual amino acid composition of its binding sites, mimicking the energetic core of antibody paratopes. Despite the high frequency of aromatic residues, these rcSso7d-based binders are highly expressed, thermostable, and monomeric, suggesting that the hyperstability of the starting scaffold and the rigidness of the binding surface confer a high tolerance to mutation.	[Traxlmayr, Michael W.; Kiefer, Jonathan D.; Tisdale, Alison W.; Mehta, Naveen K.; Yang, Nicole J.; Wittrup, K. Dane] MIT, Koch Inst Integrat Canc Res, 500 Main St, Cambridge, MA 02139 USA; [Srinivas, Raja R.; Tisdale, Alison W.; Mehta, Naveen K.; Tidor, Bruce; Wittrup, K. Dane] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Traxlmayr, Michael W.; Yang, Nicole J.; Wittrup, K. Dane] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Lobner, Elisabeth] BOKU Univ Nat Resources & Life Sci, Div Biochem, Dept Chem, A-1190 Vienna, Austria	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Natural Resources & Life Sciences, Vienna	Wittrup, KD (corresponding author), MIT, Koch Inst Integrat Canc Res, 500 Main St, Cambridge, MA 02139 USA.; Traxlmayr, MW (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.	michael.traxlmayr@boku.ac.at; wittrup@mit.edu		Traxlmayr, Michael/0000-0002-2108-582X; Laurent, Elisabeth/0000-0002-5234-5524; /0000-0002-3320-3969	Koch Institute Genomics Core; Koch Institute Flow Cytometry Core; Koch Institute Support (core) Grant from the National Cancer Institute [P30CA14051]; National Science Foundation [0070319]; National Institutes of Health [S10 OD016326]; Austrian Science Fund (FWF) [J 3496] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA096504, P30CA014051, R01CA174795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082209] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016326] Funding Source: NIH RePORTER	Koch Institute Genomics Core; Koch Institute Flow Cytometry Core; Koch Institute Support (core) Grant from the National Cancer Institute; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge support by the Koch Institute Genomics Core and the Koch Institute Flow Cytometry Core, which is supported in part by Koch Institute Support (core) Grant P30CA14051 from the National Cancer Institute. The Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (National Science Foundation Grant 0070319) is gratefully acknowledged for enabling use of the Octet biolayer interferometry system (National Institutes of Health Grant S10 OD016326).	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; BAUMANN H, 1994, NAT STRUCT BIOL, V1, P808, DOI 10.1038/nsb1194-808; Beehar G, 2013, PROTEIN ENG DES SEL, V26, P267, DOI 10.1093/protein/gzs106; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen TF, 2013, METHOD ENZYMOL, V523, P303, DOI 10.1016/B978-0-12-394292-0.00014-X; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; de Picciotto S, 2016, J MOL BIOL, V428, P4228, DOI 10.1016/j.jmb.2016.07.004; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048928; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Gilbreth RN, 2008, J MOL BIOL, V381, P407, DOI 10.1016/j.jmb.2008.06.014; Hackel BJ, 2010, J MOL BIOL, V401, P84, DOI 10.1016/j.jmb.2010.06.004; Kangas E, 1999, PHYS REV E, V59, P5958, DOI 10.1103/PhysRevE.59.5958; Knapp S, 1996, J MOL BIOL, V264, P1132, DOI 10.1006/jmbi.1996.0701; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Lahti JL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000499; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; McCrary BS, 1996, J MOL BIOL, V264, P784, DOI 10.1006/jmbi.1996.0677; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Miller EA, 2016, MOL SYST DES ENG, V1, P377, DOI [10.1039/c6me00032k, 10.1039/C6ME00032K]; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654; Robin G, 2014, J MOL BIOL, V426, P3729, DOI 10.1016/j.jmb.2014.08.013; Schlehuber S, 2002, BIOPHYS CHEM, V96, P213, DOI 10.1016/S0301-4622(02)00026-1; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Silverman AP, 2011, J MOL RECOGNIT, V24, P127, DOI 10.1002/jmr.1036; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Steemson JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086050; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Traxlmayr MW, 2012, ARCH BIOCHEM BIOPHYS, V526, P174, DOI 10.1016/j.abb.2012.04.022; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	46	29	33	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22496	22508		10.1074/jbc.M116.741314	http://dx.doi.org/10.1074/jbc.M116.741314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27582495	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000386760600012
J	Wang, ZN; DiDonato, JA; Buffa, J; Comhair, SA; Aronica, MA; Dweik, RA; Lee, NA; Lee, JJ; Thomassen, MJ; Kavuru, M; Erzurum, SC; Hazen, SL				Wang, Zeneng; DiDonato, Joseph A.; Buffa, Jennifer; Comhair, Suzy A.; Aronica, Mark A.; Dweik, Raed A.; Lee, Nancy A.; Lee, James J.; Thomassen, Mary Jane; Kavuru, Mani; Erzurum, Serpil C.; Hazen, Stanley L.			Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; eosinophil; inflammation; peroxidase; post-translational modification (PTM)	ENVIRONMENTAL TOBACCO-SMOKE; LOW-DENSITY-LIPOPROTEIN; HYDROGEN-PEROXIDE; NITRIC-OXIDE; ALLERGIC-ASTHMA; MOUSE MODEL; IN-VIVO; SINONASAL POLYPOSIS; LIPID-PEROXIDATION; THIOCYANATE LEVELS	The biochemical mechanisms through which eosinophils contribute to asthma pathogenesis are unclear. Here we show eosinophil peroxidase (EPO), an abundant granule protein released by activated eosinophils, contributes to characteristic asthma-related phenotypes through oxidative posttranslational modification (PTM) of proteins in asthmatic airways through a process called carbamylation. Using a combination of studies we now show EPO uses plasma levels of the pseudohalide thiocyanate (SCN-) as substrate to catalyze protein carbamylation, as monitored by PTM of protein lysine residues into N-E-carbamyllysine (homocitrulline), and contributes to the pathophysiological sequelae of eosinophil activation. Studies using EPO-deficient mice confirm EPO serves as a major enzymatic source for protein carbamylation during eosinophilic inflammatory models, including aeroallergen challenge. Clinical studies similarly revealed significant enrichment in carbamylation of airway proteins recovered from atopic asthmatics versus healthy controls in response to segmental allergen challenge. Protein-bound homocitrulline is shown to be co-localized with EPO within human asthmatic airways. Moreover, pathophysiologically relevant levels of carbamylated protein either incubated with cultured human airway epithelial cells in vitro, or provided as an aerosolized exposure in non-sensitized mice, induced multiple asthma-associated phenotypes including induction of mucin, Th2 cytokines, IFN, TGF, and epithelial cell apoptosis. Studies with scavenger receptor-A1 null mice reveal reduced IL-13 generation following exposure to aerosolized carbamylated protein, but no changes in other asthma-related phenotypes. In summary, EPO-mediated protein carbamylation is promoted during allergen-induced asthma exacerbation, and can both modulate immune responses and trigger a cascade of many of the inflammatory signals present in asthma.	[Wang, Zeneng; DiDonato, Joseph A.; Buffa, Jennifer; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Comhair, Suzy A.; Aronica, Mark A.; Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Dept Pulm Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Lee, Nancy A.; Lee, James J.] Mayo Clin, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Thomassen, Mary Jane] East Carolina Univ, Div Pulm Crit Care & Sleep Med, Greenville, NC 27834 USA; [Kavuru, Mani] Thomas Jefferson Univ & Hosp, Div Pulm & Crit Care Med, Philadelphia, PA 19107 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Mayo Clinic; Mayo Clinic Phoenix; University of North Carolina; East Carolina University; Jefferson University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Wang, Zeneng/AAK-6119-2021		AB SCIEX Center of Innovation award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, R01HL124165, R56HL058723, U10HL109250, R01HL058723, R01HL130819, P01HL076491, P01HL103453] Funding Source: NIH RePORTER	AB SCIEX Center of Innovation award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Horkko, University of Oulu, Finland, for the generous gift of the carbamylation-specific single chain antibody. We thank G. Chang and L. Ruple for assistance in measuring pulmonary function and also E. R. Rodriguez for immunohistochemical staining. Mass spectrometry studies were performed on instruments housed in a facility in part supported through an AB SCIEX Center of Innovation award.	Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Apostolov EO, 2009, ARTERIOSCL THROM VAS, V29, P1622, DOI 10.1161/ATVBAHA.109.189795; Arlandson M, 2001, J BIOL CHEM, V276, P215, DOI 10.1074/jbc.M004881200; BABIOR BM, 1976, J CLIN INVEST, V58, P989, DOI 10.1172/JCI108553; Bae CJ, 2011, TOXICOL SCI, V120, P349, DOI 10.1093/toxsci/kfr004; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; BOBB D, 1971, ANAL BIOCHEM, V40, P209, DOI 10.1016/0003-2697(71)90094-7; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Boyce JA, 2012, J ALLERGY CLIN IMMUN, V129, P335, DOI 10.1016/j.jaci.2011.12.968; Brennan ML, 2003, AMINO ACIDS, V25, P365, DOI 10.1007/s00726-003-0023-y; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Cannady SB, 2007, J ALLERGY CLIN IMMUN, V120, P1346, DOI 10.1016/j.jaci.2007.07.067; Carr AC, 1998, BBA-LIPID LIPID MET, V1392, P254, DOI 10.1016/S0005-2760(98)00038-1; Chandler JD, 2013, BRIT J PHARMACOL, V169, P1166, DOI 10.1111/bph.12206; Chandler JD, 2015, AM J RESP CELL MOL, V53, P193, DOI 10.1165/rcmb.2014-0208OC; CHEN Y, 1990, ARCH ENVIRON HEALTH, V45, P163, DOI 10.1080/00039896.1990.9936710; CHILMONCZYK BA, 1993, NEW ENGL J MED, V328, P1665, DOI 10.1056/NEJM199306103282303; Citardi MJ, 2006, AM J RHINOL, V20, P353, DOI 10.2500/ajr.2006.20.2858; Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]; Corren J, 2011, CURR OPIN PULM MED, V17, P29, DOI 10.1097/MCP.0b013e3283413105; CURNUTTE JT, 1974, NEW ENGL J MED, V290, P593, DOI 10.1056/NEJM197403142901104; Demkowska I, 2011, J EXPO SCI ENV EPID, V21, P656, DOI 10.1038/jes.2011.19; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; El-Gamal D, 2014, KIDNEY INT, V86, P923, DOI 10.1038/ki.2014.218; Fahy JV, 2002, CHEST, V122, p320S, DOI 10.1378/chest.122.6_suppl.320S; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Galijasevic S, 2006, BIOCHEMISTRY-US, V45, P1255, DOI 10.1021/bi051438k; Gould NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-119; Guilloteau LA, 2003, INFECT IMMUN, V71, P621, DOI 10.1128/IAI.71.2.621-628.2003; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hazen SL, 1996, J BIOL CHEM, V271, P23080, DOI 10.1074/jbc.271.38.23080; Holzer M, 2011, ANTIOXID REDOX SIGN, V14, P2337, DOI 10.1089/ars.2010.3640; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; HUSGAFVELPURSIAINEN K, 1987, INT ARCH OCC ENV HEA, V59, P337, DOI 10.1007/BF00405277; Jacobsen EA, 2014, CLIN EXP ALLERGY, V44, P1119, DOI 10.1111/cea.12358; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Jiang L, 2014, ANN ALLERG ASTHMA IM, V113, P137, DOI 10.1016/j.anai.2014.05.030; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kim DY, 2011, BRIT J PHARMACOL, V162, P210, DOI 10.1111/j.1476-5381.2010.01033.x; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; KRAUS LM, 1991, J LAB CLIN MED, V118, P555; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Lacy F, 1998, J HYPERTENS, V16, P291, DOI 10.1097/00004872-199816030-00006; Lankford SM, 2005, IN VITRO CELL DEV-AN, V41, P217; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Lee KS, 2005, FASEB J, V19, P1033, DOI 10.1096/fj.04-3309fje; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacPherson JC, 2001, J IMMUNOL, V166, P5763, DOI 10.4049/jimmunol.166.9.5763; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Mitra SN, 2000, REDOX REP, V5, P215, DOI 10.1179/135100000101535771; Morgan PE, 2011, FREE RADICAL BIO MED, V51, P1815, DOI 10.1016/j.freeradbiomed.2011.08.008; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; OLEA F, 1992, J ANAL TOXICOL, V16, P258, DOI 10.1093/jat/16.4.258; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Poliakov E, 2003, FASEB J, V17, P2209, DOI 10.1096/fj.03-0086com; Sanders PN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006135; Scanlon CEO, 1996, ATHEROSCLEROSIS, V121, P23, DOI 10.1016/0021-9150(95)05672-6; Shiue I, 2015, ENVIRON SCI POLLUT R, V22, P5952, DOI 10.1007/s11356-014-3777-8; SLUNGAARD A, 1991, J BIOL CHEM, V266, P4903; Son JN, 2011, INT J CARDIOL, V146, P428, DOI 10.1016/j.ijcard.2010.10.098; Speer T, 2014, EUR HEART J, V35, P3021, DOI 10.1093/eurheartj/ehu111; Stark G R, 1977, Methods Enzymol, V47, P129; STARK GR, 1965, BIOCHEMISTRY-US, V4, P588, DOI 10.1021/bi00879a032; STARK GR, 1960, J BIOL CHEM, V235, P3177; STARK RG, 1964, J BIOL CHEM, V239, P1411; Sullivan PW, 2014, J ASTHMA, V51, P769, DOI 10.3109/02770903.2014.906607; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Talib J, 2014, BIOCHEM J, V457, P89, DOI 10.1042/BJ20131135; THOMAS EL, 1994, INFECT IMMUN, V62, P529, DOI 10.1128/IAI.62.2.529-535.1994; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wedes SH, 2011, J PEDIATR-US, V159, P248, DOI 10.1016/j.jpeds.2011.01.029; Wedes SH, 2009, CTS-CLIN TRANSL SCI, V2, P112, DOI 10.1111/j.1752-8062.2009.00095.x; WEVER R, 1982, BIOCHIM BIOPHYS ACTA, V709, P212, DOI 10.1016/0167-4838(82)90463-0; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Wu WJ, 1999, J BIOL CHEM, V274, P25933, DOI 10.1074/jbc.274.36.25933; Wu WJ, 1999, BIOCHEMISTRY-US, V38, P3538, DOI 10.1021/bi982401l; Xu WL, 2014, REDOX BIOL, V2, P513, DOI 10.1016/j.redox.2014.01.004; Xu X, 2009, SURGERY, V146, P506, DOI 10.1016/j.surg.2009.03.022; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810; Zheng S, 2003, IMMUNITY, V18, P619, DOI 10.1016/S1074-7613(03)00114-6	95	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22118	22135		10.1074/jbc.M116.750034	http://dx.doi.org/10.1074/jbc.M116.750034			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27587397	Green Published, hybrid			2022-12-28	WOS:000386332600026
J	Zemoura, K; Trumpler, C; Benke, D				Zemoura, Khaled; Truempler, Claudia; Benke, Dietmar			Lys-63-linked Ubiquitination of -Aminobutyric Acid (GABA), Type B1, at Multiple Sites by the E3 Ligase Mind Bomb-2 Targets GABA(B) Receptors to Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; GABA receptor; lysosome; protein degradation; ubiquitylation (ubiquitination)	DIFFERENTIAL REGULATION; PROXIMITY LIGATION; IN-SITU; TRAFFICKING; PROTEIN; INTERNALIZATION; ACTIVATION; COMPLEXES; GLUTAMATE; NETWORK	GABA(B) receptors are heterodimeric G protein-coupled receptors, which control neuronal excitability by mediating prolonged inhibition. The magnitude of GABA(B) receptor-mediated inhibition essentially depends on the amount of receptors in the plasma membrane. However, the factors regulating cell surface expression of GABA(B) receptors are poorly characterized. Cell surface GABA(B) receptors are constitutively internalized and either recycled to the plasma membrane or degraded in lysosomes. The signal that sorts GABA(B) receptors to lysosomes is currently unknown. Here we show that Mind bomb-2 (MIB2)-mediated Lys-63-linked ubiquitination of the GABA(B1) subunit at multiple sites is the lysosomal sorting signal for GABA(B) receptors. We found that inhibition of lysosomal activity in cultured rat cortical neurons increased the fraction of Lys-63-linked ubiquitinated GABA(B) receptors and enhanced the expression of total as well as cell surface GABA(B) receptors. Mutational inactivation of four putative ubiquitination sites in the GABA(B1) subunit significantly diminished Lys-63-linked ubiquitination of GABA(B) receptors and prevented their lysosomal degradation. We identified MIB2 as the E3 ligase triggering Lys-63-linked ubiquitination and lysosomal degradation of GABA(B) receptors. Finally, we show that sustained activation of glutamate receptors, a condition occurring in brain ischemia that down-regulates GABA(B) receptors, considerably increased the expression of MIB2 and Lys-63-linked ubiquitination of GABA(B) receptors. Interfering with Lys-63-linked ubiquitination by overexpressing ubiquitin mutants or GABA(B1) mutants deficient in Lys-63-linked ubiquitination prevented glutamate-induced down-regulation of the receptors. These findings indicate that Lys-63-linked ubiquitination of GABA(B1) at multiple sites by MIB2 controls sorting of GABA(B) receptors to lysosomes for degradation under physiological and pathological conditions.	[Zemoura, Khaled; Truempler, Claudia; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Benke, Dietmar] Univ Zurich, Neuroscience Ctr Zurich, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Benke, Dietmar] Swiss Fed Inst Technol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Benke, Dietmar] Drug Discovery Network Zurich, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch			Swiss National Science Foundation [31003A_138382]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 31003A_138382 (to D. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Benke D, 2002, J RECEPT SIGNAL TR R, V22, P253, DOI 10.1081/RRS-120014600; Benke Dietmar, 2012, World J Biol Chem, V3, P61, DOI 10.4331/wjbc.v3.i4.61; Benke D, 2010, ADV PHARMACOL, V58, P93, DOI 10.1016/S1054-3589(10)58004-9; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Craig MT, 2014, CURR OPIN NEUROBIOL, V26, P15, DOI 10.1016/j.conb.2013.10.002; Dores MR, 2014, CURR OPIN CELL BIOL, V27, P44, DOI 10.1016/j.ceb.2013.11.004; Gaiarsa JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00206; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Guo BQ, 2016, CURR OPIN STRUC BIOL, V41, P38, DOI 10.1016/j.sbi.2016.05.012; Hannan S, 2011, J BIOL CHEM, V286, P24324, DOI 10.1074/jbc.M110.220814; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kantamneni S, 2008, J NEUROCHEM, V107, P86, DOI 10.1111/j.1471-4159.2008.05580.x; Kantamneni S, 2014, J BIOL CHEM, V289, P6681, DOI 10.1074/jbc.M113.487348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kim S, 2015, KOREAN J PHYSIOL PHA, V19, P515, DOI 10.4196/kjpp.2015.19.6.515; Kohl MM, 2010, ADV PHARMACOL, V58, P205, DOI 10.1016/S1054-3589(10)58009-8; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Lahaie N, 2016, J BIOL CHEM, V291, P7156, DOI 10.1074/jbc.M115.686907; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Maier PJ, 2014, J BIOL CHEM, V289, P12896, DOI 10.1074/jbc.M114.550517; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Ng EL, 2012, CELL BIOCHEM FUNCT, V30, P515, DOI 10.1002/cbf.2827; Pagano A, 2001, J NEUROSCI, V21, P1189; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Schwenk J, 2016, NAT NEUROSCI, V19, P233, DOI 10.1038/nn.4198; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stempin CC, 2011, J BIOL CHEM, V286, P37147, DOI 10.1074/jbc.M111.263384; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Tseng LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093394; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Ye JS, 2014, J VIROL, V88, P12765, DOI 10.1128/JVI.02037-14; Zemoura K, 2014, J BIOL CHEM, V289, P7738, DOI 10.1074/jbc.M113.541987; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745	46	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21682	21693		10.1074/jbc.M116.750968	http://dx.doi.org/10.1074/jbc.M116.750968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27573246	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000385999200033
J	Zhang, TM; Xue, L; Li, L; Tang, CY; Wan, ZQ; Wang, RX; Tan, JQ; Tan, Y; Han, HL; Tian, RY; Billiar, TR; Tao, WA; Zhang, ZH				Zhang, Tongmei; Xue, Liang; Li, Li; Tang, Chengyuan; Wan, Zhengqing; Wang, Ruoxi; Tan, Jieqiong; Tan, Ya; Han, Hailong; Tian, Runyi; Billiar, Timothy R.; Tao, W. Andy; Zhang, Zhuohua			BNIP3 Protein Suppresses PINK1 Kinase Proteolytic Cleavage to Promote Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; mitochondria; parkin; Parkinson's disease; ubiquitin	CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; PARKINSON-DISEASE; OXIDATIVE STRESS; AUTOPHAGY; MUTATIONS; INDUCTION; LIGASE; DROSOPHILA-PINK1; DESTABILIZATION	Mutations in PINK1 (PTEN-induced putative kinase 1) cause early onset familial Parkinson's disease (PD). PINK1 accumulates on the outer membrane of damaged mitochondria followed by recruiting parkin to promote mitophagy. Here, we demonstrate that BCL2/adenovirus E1B 19-kDa interacting protein 3 (BNIP3), a mitochondrial BH3-only protein, interacts with PINK1 to promote the accumulation of full-length PINK1 on the outer membrane of mitochondria, which facilitates parkin recruitment and PINK1/parkin-mediated mitophagy. Inactivation of BNIP3 in mammalian cells promotes PINK1 proteolytic processing and suppresses PINK1/parkin-mediated mitophagy. Hypoxia-induced BNIP3 expression results in increased expression of full-length PINK1 and mitophagy. Consistently, expression of BNIP3 in Drosophila suppresses muscle degeneration and the mitochondrial abnormality caused by PINK1 inactivation. Together, the results suggest that BNIP3 plays a vital role in regulating PINK1 mitochondrial outer membrane localization, the proteolytic process of PINK1 and PINK1/parkin-mediated mitophagy under physiological conditions. Functional up-regulation of BNIP3 may represent a novel therapeutic strategy to suppress the progression of PD.	[Zhang, Tongmei; Li, Li; Tang, Chengyuan; Wan, Zhengqing; Wang, Ruoxi; Tan, Jieqiong; Tan, Ya; Han, Hailong; Tian, Runyi; Billiar, Timothy R.; Zhang, Zhuohua] Cent South Univ, Xiangya Hosp, Inst Precis Med, Changsha 410078, Hunan, Peoples R China; [Zhang, Tongmei; Li, Li; Tang, Chengyuan; Wan, Zhengqing; Wang, Ruoxi; Tan, Jieqiong; Tan, Ya; Han, Hailong; Tian, Runyi; Billiar, Timothy R.; Zhang, Zhuohua] Cent South Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Xue, Liang; Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15213 USA; [Zhang, Zhuohua] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200032, Peoples R China	Central South University; Central South University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University	Zhang, ZH (corresponding author), Cent South Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn	Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020	Tao, Weiguo/0000-0002-5535-5517	Chinese National 973 Projects [2011CB510000]; Natural Science Foundation of China [313300257, 81429002, 81161120498]; Discipline Innovative Engineering Plan (111 Program) of China	Chinese National 973 Projects(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Discipline Innovative Engineering Plan (111 Program) of China	This work was supported by Chinese National 973 Projects 2011CB510000 (to Z. Z.), Natural Science Foundation of China Grants 313300257, 81429002, and 81161120498 (to Z. Z.), and the Discipline Innovative Engineering Plan (111 Program) of China (to Z. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Awan MUF, 2014, MOL BIOL REP, V41, P5729, DOI 10.1007/s11033-014-3444-7; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Choo YS, 2012, HUM MOL GENET, V21, P2514, DOI 10.1093/hmg/dds070; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sulistijo ES, 2006, J MOL BIOL, V364, P974, DOI 10.1016/j.jmb.2006.09.065; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vasagiri N, 2014, MOL BIOL REP, V41, P7705, DOI 10.1007/s11033-014-3664-x; Venegas V., 2011, CURR PROTOC HUM GENE, V68, DOI [DOI 10.1002/0471142905.HG1907S68, 10.1002/0471142905.hg1907s68]; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	55	145	150	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21616	21629		10.1074/jbc.M116.733410	http://dx.doi.org/10.1074/jbc.M116.733410			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27528605	Green Published, hybrid			2022-12-28	WOS:000385999200028
J	Jiang, Y; Sverdlov, MS; Toth, PT; Huang, LS; Du, GW; Liu, YY; Natarajan, V; Minshall, RD				Jiang, Ying; Sverdlov, Maria S.; Toth, Peter T.; Huang, Long Shuang; Du, Guangwei; Liu, Yiyao; Natarajan, Viswanathan; Minshall, Richard D.			Phosphatidic Acid Produced by RalA-activated PLD2 Stimulates Caveolae-mediated Endocytosis and Trafficking in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolin; endocytosis; filamin; Ras protein; trafficking	PHOSPHOLIPASE-D; PLASMA-MEMBRANE; TYROSINE PHOSPHORYLATION; LIPID RAFTS; LYSOPHOSPHATIDIC ACID; ACTIN CYTOSKELETON; EXOCYST COMPLEX; PROTEIN; INSULIN; RECEPTOR	Caveolae are the primary route for internalization and transendothelial transport of macromolecules, such as insulin and albumin. Caveolae-mediated endocytosis is activated by Src-dependent caveolin-1 (Cav-1) phosphorylation and subsequent recruitment of dynamin-2 and filamin A (FilA), which facilitate vesicle fission and trafficking, respectively. Here, we tested the role of RalA and phospholipase D (PLD) signaling in the regulation of caveolae-mediated endocytosis and trafficking. The addition of albumin to human lung microvascular endothelial cells induced the activation of RalA within minutes, and siRNA-mediated down-regulation of RalA abolished fluorescent BSA uptake. Co-immunoprecipitation studies revealed that albumin induced the association between RalA, Cav-1, and FilA; however, RalA knockdown with siRNA did not affect FilA recruitment to Cav-1, suggesting that RalA was not required for FilA and Cav-1 complex formation. Rather, RalA probably facilitates caveolae-mediated endocytosis by activating downstream effectors. PLD2 was shown to be activated by RalA, and inhibition of PLD2 abolished Alexa-488-BSA uptake, indicating that phosphatidic acid (PA) generated by PLD2 may facilitate caveolae-mediated endocytosis. Furthermore, using a PA biosensor, GFP-PASS, we observed that BSA induced an increase in PA co-localization with Cav-1-RFP, which could be blocked by a dominant negative PLD2 mutant. Total internal reflection fluorescence microscopy studies of Cav-1-RFP also showed that fusion of caveolae with the basal plasma membrane was dependent on PLD2 activity. Thus, our results suggest that the small GTPase RalA plays an important role in promoting invagination and trafficking of caveolae, not by potentiating the association between Cav-1 and FilA but by stimulating PLD2-mediated generation of phosphatidic acid.	[Jiang, Ying; Liu, Yiyao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Sichuan, Peoples R China; [Jiang, Ying; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Coll Med, Chicago, IL 60612 USA; [Sverdlov, Maria S.; Toth, Peter T.; Huang, Long Shuang; Natarajan, Viswanathan; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Huang, Long Shuang; Natarajan, Viswanathan] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA; [Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol, Houston, TX 77030 USA; [Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Pharmacol, Houston, TX 77030 USA	University of Electronic Science & Technology of China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Minshall, RD (corresponding author), Univ Illinois, Dept Anesthesiol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.; Minshall, RD (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.	rminsh@uic.edu	Huang, Longshuang/H-9553-2016	Toth, Peter/0000-0003-2168-0124; Liu, Yiyao/0000-0002-7222-739X; Du, Guangwei/0000-0003-4193-6975	National Institutes of Health [R01 HL071626, HL125356, P01 HL060678, P01HL98050, R01HL119478, T32 HL007692]; National Natural Science Foundation of China [11272083, 31470906]; China Scholarship Council (CSC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071626, T32HL007692, R01HL119478, P01HL098050, P01HL060678, R01HL125356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL071626 and HL125356 (to R. D. M.), P01 HL060678 Project 4 and Core D (to R. D. M.), P01HL98050 (to V. N.), R01HL119478 (to G. D.), and T32 HL007692 (to M. S. S.); National Natural Science Foundation of China Grants 11272083 and 31470906; and the China Scholarship Council (CSC). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Cullis DN, 2002, J BIOL CHEM, V277, P49158, DOI 10.1074/jbc.M206316200; Dobrinskikh E, 2014, AM J PHYSIOL-RENAL, V306, pF941, DOI 10.1152/ajprenal.00532.2013; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Hazelett CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039602; Hiroyama M, 2005, J CELL BIOCHEM, V95, P149, DOI 10.1002/jcb.20351; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Itach SBS, 2012, DEV BIOL, V362, P154, DOI 10.1016/j.ydbio.2011.12.002; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Lopez JA, 2008, J BIOL CHEM, V283, P17939, DOI 10.1074/jbc.M800321200; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430; Miliaras NB, 2004, CELL BIOCHEM BIOPHYS, V41, P295, DOI 10.1385/CBB:41:2:295; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Natarajan V, 1997, CHEM PHYS LIPIDS, V86, P65, DOI 10.1016/S0009-3084(97)02660-1; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Parinandi NL, 1999, ANTIOXID REDOX SIGN, V1, P193, DOI 10.1089/ars.1999.1.2-193; Parinandi NL, 2001, ARCH BIOCHEM BIOPHYS, V396, P231, DOI 10.1006/abbi.2001.2609; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Pleskot R, 2010, PLANT J, V62, P494, DOI 10.1111/j.1365-313X.2010.04168.x; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Schafer DA, 2000, TRAFFIC, V1, P892; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zimnicka AM, 2016, MOL BIOL CELL, V27, P2090, DOI 10.1091/mbc.E15-11-0756	52	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20729	20738		10.1074/jbc.M116.752485	http://dx.doi.org/10.1074/jbc.M116.752485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27510034	Green Published, hybrid			2022-12-28	WOS:000384574800034
J	Tutunea-Fatan, E; Caetano, FA; Gros, R; Ferguson, SSG				Tutunea-Fatan, Elena; Caetano, Fabiana A.; Gros, Robert; Ferguson, Stephen S. G.			GRK2 targeted knock-down results in spontaneous hypertension, and altered vascular GPCR signaling (vol 290, pg 5141, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Gros, Robert/A-3010-2009	Gros, Robert/0000-0002-3667-8011				Tutunea-Fatan E, 2015, J BIOL CHEM, V290, P5141, DOI 10.1074/jbc.M114.615658	1	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20822	20822		10.1074/jbc.A114.615658	http://dx.doi.org/10.1074/jbc.A114.615658			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27664063	Green Published, hybrid			2022-12-28	WOS:000384574800042
J	Kalous, KS; Wynia-Smith, SL; Olp, MD; Smith, BC				Kalous, Kelsey S.; Wynia-Smith, Sarah L.; Olp, Michael D.; Smith, Brian C.			Mechanism of Sirt1 NAD(+)-dependent Protein Deacetylase Inhibition by Cysteine S-Nitrosation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; allosteric regulation; enzyme inactivation; inhibition mechanism; nicotinamide adenine dinucleotide (NAD); nitric oxide; nitrosylation; sirtuin 1 (SIRT1); zinc; nitrosation	NITRIC-OXIDE SYNTHASE; SECONDARY STRUCTURE ANALYSES; DRUG-LIKE MOLECULES; REDOX REGULATION; ACETYL-LYSINE; RAT-LIVER; NITROSYLATION; GLUTATHIONE; STRESS; GAPDH	The sirtuin family of proteins catalyze the NAD(+)-dependent deacylation of acyl-lysine residues. Humans encode seven sirtuins (Sirt1-7), and recent studies have suggested that post-translational modification of Sirt1 by cysteine S-nitrosation correlates with increased acetylation of Sirt1 deacetylase substrates. However, the mechanism of Sirt1 inhibition by S-nitrosation was unknown. Here, we show that Sirt1 is transnitrosated and inhibited by the physiologically relevant nitrosothiol S-nitrosoglutathione. Steady-state kinetic analyses and binding assays were consistent with Sirt1 S-nitrosation inhibiting binding of both the NAD(+) and acetyl-lysine substrates. Sirt1 S-nitrosation correlated with Zn2+ release from the conserved sirtuin Zn2+-tetrathiolate and a loss of -helical structure without overall thermal destabilization of the enzyme. Molecular dynamics simulations suggested that Zn2+ loss due to Sirt1 S-nitrosation results in repositioning of the tetrathiolate subdomain away from the rest of the catalytic domain, thereby disrupting the NAD(+) and acetyl-lysine-binding sites. Sirt1 S-nitrosation was reversed upon exposure to the thiol-based reducing agents, including physiologically relevant concentrations of the cellular reducing agent glutathione. Reversal of S-nitrosation resulted in full restoration of Sirt1 activity only in the presence of Zn2+, consistent with S-nitrosation of the Zn2+-tetrathiolate as the primary source of Sirt1 inhibition upon S-nitrosoglutathione treatment.	[Kalous, Kelsey S.; Wynia-Smith, Sarah L.; Olp, Michael D.; Smith, Brian C.] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Smith, BC (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	brismith@mcw.edu	Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768; Wynia-Smith, Sarah/0000-0003-0985-2843; Olp, Michael/0000-0002-3821-435X	American Heart Association Scientist Development [15SDG25830057]; Medical College of Wisconsin Research Affairs Committee; American Cancer Society [14-247-29-IRG, 86-004-26-IRG]; Advancing a Healthier Wisconsin Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080202] Funding Source: NIH RePORTER	American Heart Association Scientist Development(American Heart Association); Medical College of Wisconsin Research Affairs Committee; American Cancer Society(American Cancer Society); Advancing a Healthier Wisconsin Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Heart Association Scientist Development Grant 15SDG25830057 (to B. C. S.), the Medical College of Wisconsin Research Affairs Committee (to B. C. S.), Institutional Research Grants 14-247-29-IRG and 86-004-26-IRG from the American Cancer Society (to B. C. S.), and the Advancing a Healthier Wisconsin Endowment (to B. C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand P, 2014, P NATL ACAD SCI USA, V111, P18572, DOI 10.1073/pnas.1417816112; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Broniowska KA, 2006, J BIOL CHEM, V281, P33835, DOI 10.1074/jbc.M603248200; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Chen W. C., 2000, FMOC SOLID PHASE PEP, P9; Dai H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8645; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Ghisays F, 2015, CELL REP, V10, P1665, DOI 10.1016/j.celrep.2015.02.036; Ginnan R, 2008, FREE RADICAL BIO MED, V44, P1232, DOI 10.1016/j.freeradbiomed.2007.12.025; Giustarini D, 2008, NITRIC OXIDE-BIOL CH, V19, P252, DOI 10.1016/j.niox.2008.07.003; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Hothersall JS, 1997, BIOCHEM J, V322, P477, DOI 10.1042/bj3220477; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Jung SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065415; KELLER GA, 1985, ARCH SURG-CHICAGO, V120, P941; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; MCKELVEY TG, 1988, AM J PHYSIOL, V254, pG753, DOI 10.1152/ajpgi.1988.254.5.G753; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; OKABE H, 1994, J SURG RES, V57, P416, DOI 10.1006/jsre.1994.1163; Pan M, 2012, J BIOL CHEM, V287, P2468, DOI 10.1074/jbc.M111.285031; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peralta D, 2015, NAT CHEM BIOL, V11, P156, DOI [10.1038/NCHEMBIO.1720, 10.1038/nchembio.1720]; Rodriguez-Ortigosa CM, 2014, GASTROENTEROLOGY, V147, P1084, DOI 10.1053/j.gastro.2014.07.030; Santos L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9831825; Schultheisz HL, 2009, J AM CHEM SOC, V131, P14571, DOI 10.1021/ja903155s; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Seneviratne U, 2013, J AM CHEM SOC, V135, P7693, DOI 10.1021/ja401565w; Shao D, 2014, J BIOL CHEM, V289, P7293, DOI 10.1074/jbc.M113.520403; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shinozaki S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005375; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Smith BC, 2007, J AM CHEM SOC, V129, P5802, DOI 10.1021/ja070162w; Smith BC, 2012, CURR OPIN CHEM BIOL, V16, P498, DOI 10.1016/j.cbpa.2012.10.016; Smith BC, 2012, BIOCHEMISTRY-US, V51, P1028, DOI 10.1021/bi201818c; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Truong T. H., 2012, CURR PROTOC CHEM BIO, DOI [10.1002/9780470559277.ch110219, DOI 10.1002/9780470559277]; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251	52	31	31	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25398	25410		10.1074/jbc.M116.754655	http://dx.doi.org/10.1074/jbc.M116.754655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756843	hybrid, Green Published			2022-12-28	WOS:000390095300011
J	Bellet, MM; Masri, S; Astarita, G; Sassone-Corsi, P; Della Fazia, MA; Servillo, G				Bellet, Marina Maria; Masri, Selma; Astarita, Giuseppe; Sassone-Corsi, Paolo; Della Fazia, Maria Agnese; Servillo, Giuseppe			Histone Deacetylase SIRT1 Controls Proliferation, Circadian Rhythm, and Lipid Metabolism during Liver Regeneration in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-METABOLISM; IN-VIVO; CLOCK; TRANSCRIPTION; EXPRESSION; PROGRESSION; MECHANISM; SIRTUINS; RECEPTOR; CANCER	Liver regeneration offers a distinctive opportunity to study cell proliferation in vivo. Mammalian silent information regulator 1 (SIRT1), a NAD(+)-dependent histone deacetylase, is an important regulator of various cellular processes, including proliferation, metabolism, and circadian rhythms. In the liver, SIRT1 coordinates the circadian oscillation of clock-controlled genes, including genes that encode enzymes involved in metabolic pathways. We performed partial hepatectomy in WT and liver-specific Sirt1-deficient mice and analyzed the expression of cell cycle regulators in liver samples taken at different times during the regenerative process, by real time PCR, Western blotting analysis, and immunohistochemistry. Lipidomic analysis was performed in the same samples by MS/HPLC. We showed that G(1)/S progression was significantly affected by absence of SIRT1 in the liver, as well as circadian gene expression. This was associated to lipid accumulation due to defective fatty acid beta-oxidation. Our study revealed for the first time the importance of SIRT1 in the regulation of hepatocellular proliferation, circadian rhythms, and lipid metabolism during liver regeneration in mice. These results represent an additional step toward the characterization of SIRT1 function in the liver.	[Bellet, Marina Maria; Della Fazia, Maria Agnese; Servillo, Giuseppe] Univ Perugia, Dept Expt Med, Piazza Severi 1, I-06132 Perugia, Italy; [Masri, Selma; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Astarita, Giuseppe] Waters Corp, Hlth Sci, Milford, MA 01757 USA; [Astarita, Giuseppe] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA	University of Perugia; University of California System; University of California Irvine; Waters Corporation; Georgetown University	Bellet, MM; Servillo, G (corresponding author), Univ Perugia, Dept Expt Med, Piazza Severi 1, I-06132 Perugia, Italy.	marina_bellet@yahoo.com; giuseppe.servillo@unipg.it	Astarita, Giuseppe/AAD-1239-2019; Bellet, Marina Maria/K-7794-2016; Astarita, Giuseppe/N-7346-2014	Bellet, Marina Maria/0000-0001-7604-0189; Servillo, Giuseppe/0000-0001-7960-7689; Masri, Selma/0000-0002-8619-8331; Astarita, Giuseppe/0000-0001-6700-301X; Della Fazia, Maria Agnese/0000-0002-5373-8477	AUCC (Associazione Umbra per la lotta Contro il Cancro); AIRC (Associazione Italiana per la Ricerca sul Cancro); Fondazione Umberto Veronesi; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	AUCC (Associazione Umbra per la lotta Contro il Cancro); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by AUCC (Associazione Umbra per la lotta Contro il Cancro). The authors declare that they have no conflict of interest with the contents of this article.r Supported by a fellowship from AIRC (Associazione Italiana per la Ricerca sul Cancro) and Fondazione Umberto Veronesi. To whom correspondence may be addressed: Dept. of Experimental Medicine, University of Perugia, piazza Severi 1, 06132 Perugia, Italy. Tel.: 075 585 8109-12; E-mail: marina_bellet@yahoo.com.	Abel S, 2001, CARCINOGENESIS, V22, P795, DOI 10.1093/carcin/22.5.795; Aguilar-Arnal L, 2015, NAT STRUCT MOL BIOL, V22, P312, DOI 10.1038/nsmb.2990; Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bartoli D, 2016, CELL CYCLE, P1; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; Bellet MM, 2014, CELL CYCLE, V13, P1902, DOI 10.4161/cc.28760; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Della Fazia MA, 2005, J CELL SCI, V118, P3185, DOI 10.1242/jcs.02452; Della Fazia MA, 2001, J HEPATOL, V34, P555, DOI 10.1016/S0168-8278(00)00065-9; Farrell GC, 2004, HEPATOLOGY, V40, P1252, DOI 10.1002/hep.20522; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Garcia-Rodriguez JL, 2014, HEPATOLOGY, V59, P1972, DOI 10.1002/hep.26971; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Higgins GM, 1931, ARCH PATHOL, V12, P186; Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rudnick DA, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/549241; Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Servillo G, 1998, GENE DEV, V12, P3639, DOI 10.1101/gad.12.23.3639; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462	39	52	53	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23318	23329		10.1074/jbc.M116.737114	http://dx.doi.org/10.1074/jbc.M116.737114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27634039	Green Published, hybrid			2022-12-28	WOS:000387224800039
J	Liu, ZL; Huang, X; Hu, LN; Pham, L; Poole, KM; Tang, Y; Mahon, BP; Tang, WX; Li, KH; Goldfarb, NE; Dunn, BM; McKenna, R; Fanucci, GE				Liu, Zhanglong; Huang, Xi; Hu, Lingna; Linh Pham; Poole, Katye M.; Tang, Yan; Mahon, Brian P.; Tang, Wenxing; Li, Kunhua; Goldfarb, Nathan E.; Dunn, Ben M.; McKenna, Robert; Fanucci, Gail E.			Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; drug resistance; enzyme inhibitor; enzyme kinetics; HIV-1 protease; nuclear magnetic resonance (NMR); PELDOR; site-directed spin-labeling; backbone dynamics; double electron-electron resonance (DEER)	RESISTANT HIV-1 PROTEASE; ACTIVE-SITE; INHIBITOR RESISTANCE; PULSED EPR; SUBTYPE-B; ANTIRETROVIRAL THERAPY; GENETIC DIVERSITY; 20 MUTATIONS; BINDING; STABILITY	Multidrug resistance to current Food and Drug Administration-approved HIV-1 protease (PR) inhibitors drives the need to understand the fundamental mechanisms of how drug pressure-selected mutations, which are oftentimes natural polymorphisms, elicit their effect on enzyme function and resistance. Here, the impacts of the hinge-region natural polymorphism at residue 35, glutamate to aspartate (E35D), alone and in conjunction with residue 57, arginine to lysine (R57K), are characterized with the goal of understanding how altered salt bridge interactions between the hinge and flap regions are associated with changes in structure, motional dynamics, conformational sampling, kinetic parameters, and inhibitor affinity. The combined results reveal that the single E35D substitution leads to diminished salt bridge interactions between residues 35 and 57 and gives rise to the stabilization of open-like conformational states with overall increased backbone dynamics. In HIV-1 PR constructs where sites 35 and 57 are both mutated (e.g. E35D and R57K), x-ray structures reveal an altered network of interactions that replace the salt bridge thus stabilizing the structural integrity between the flap and hinge regions. Despite the altered conformational sampling and dynamics when the salt bridge is disrupted, enzyme kinetic parameters and inhibition constants are similar to those obtained for subtype B PR. Results demonstrate that these hinge-region natural polymorphisms, which may arise as drug pressure secondary mutations, alter protein dynamics and the conformational landscape, which are important thermodynamic parameters to consider for development of inhibitors that target for non-subtype B PR.	[Liu, Zhanglong; Huang, Xi; Hu, Lingna; Linh Pham; Li, Kunhua; Fanucci, Gail E.] Univ Florida, Dept Chem, POB 117200, Gainesville, FL 32611 USA; [Poole, Katye M.; Tang, Yan; Mahon, Brian P.; Tang, Wenxing; Goldfarb, Nathan E.; Dunn, Ben M.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Huang, Xi] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Hu, Lingna] Baxter Int Inc, SIP, B3 1 Pk, Suzhou 215021, Peoples R China; [Linh Pham] Texas A&M Univ Cent Texas, Dept Sci & Math, Killeen, TX 76549 USA; [Goldfarb, Nathan E.] Calif Hlth Sci Univ, 120 North Clovis Ave, Clovis, CA 93612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Gilead Sciences; Texas A&M University System; California Health Sciences University (CHSU)	Fanucci, GE (corresponding author), Univ Florida, Dept Chem, POB 117200, Gainesville, FL 32611 USA.	fanucci@chem.ufl.edu	hu, ling/GWC-1104-2022	Li, Kunhua/0000-0002-9139-4257; Mahon, Brian/0000-0002-5571-8058	National Institutes of Health [GM105409, S10RR031603, R37 A128571]; National Science Foundation [DMR-1157490]; State of Florida; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); State of Florida; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM105409 (to G. E. F.), S10RR031603 (to G. E. F.), and R37 A128571 (to B. M. D.). A portion of this work was performed at the McKnight Brain Institute at the National High Magnetic Field Laboratory AMRIS Facility, which is supported by National Science Foundation Cooperative Agreement No. DMR-1157490 and the State of Florida. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agniswamy J, 2013, J MED CHEM, V56, P4017, DOI 10.1021/jm400231v; Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P2819, DOI 10.1021/bi2018317; Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P1041, DOI 10.1021/bi201809s; Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007; Bandaranayake RM, 2008, J VIROL, V82, P6762, DOI 10.1128/JVI.00018-08; Bandaranayake RM, 2010, J VIROL, V84, P9995, DOI 10.1128/JVI.00505-10; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Batista PR, 2006, CELL BIOCHEM BIOPHYS, V44, P395, DOI 10.1385/CBB:44:3:395; Bieri M, 2011, J BIOMOL NMR, V50, P147, DOI 10.1007/s10858-011-9509-1; Blackburn ME, 2009, BIOCHEMISTRY-US, V48, P8765, DOI 10.1021/bi901201q; Cai YF, 2014, J CHEM THEORY COMPUT, V10, P3438, DOI 10.1021/ct4010454; Carter JD, 2014, FEBS LETT, V588, P3123, DOI 10.1016/j.febslet.2014.06.051; Casey TM, 2015, METHOD ENZYMOL, V564, P153, DOI 10.1016/bs.mie.2015.07.019; Chang MW, 2011, J MOL BIOL, V410, P756, DOI 10.1016/j.jmb.2011.03.038; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clemente JC, 2006, BIOCHEMISTRY-US, V45, P5468, DOI 10.1021/bi051886s; Clemente JC, 2003, BIOCHEMISTRY-US, V42, P15029, DOI 10.1021/bi035701y; Coman RM, 2008, BIOCHEMISTRY-US, V47, P731, DOI 10.1021/bi7018332; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; de Vera IMS, 2013, BIOCHEMISTRY-US, V52, P3278, DOI 10.1021/bi400109d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Ding F, 2008, J AM CHEM SOC, V130, P7184, DOI 10.1021/ja800893d; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foulkes-Murzycki JE, 2007, STRUCTURE, V15, P225, DOI 10.1016/j.str.2007.01.006; Galiano L, 2007, J AM CHEM SOC, V129, P11004, DOI 10.1021/ja073684k; Galiano L, 2009, J AM CHEM SOC, V131, P430, DOI 10.1021/ja807531v; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Ghosh AK, 2016, J MED CHEM, V59, P5172, DOI 10.1021/acs.jmedchem.5b01697; Ghosh AK, 2012, ANGEW CHEM INT EDIT, V51, P1778, DOI 10.1002/anie.201102762; Goldfarb NE, 2015, BIOCHEMISTRY-US, V54, P422, DOI 10.1021/bi501088e; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Huang X, 2014, J BIOL CHEM, V289, P17203, DOI 10.1074/jbc.M114.571836; Huang X, 2012, J PHYS CHEM B, V116, P14235, DOI 10.1021/jp308207h; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G, 2006, PHYS CHEM CHEM PHYS, V8, P4095, DOI 10.1039/b607826e; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kantor R, 2002, ANTIMICROB AGENTS CH, V46, P1086, DOI 10.1128/AAC.46.4.1086-1092.2002; Kear J. L., 2010, THESIS; Kear JL, 2009, J AM CHEM SOC, V131, P14650, DOI 10.1021/ja907088a; King NM, 2012, ACS CHEM BIOL, V7, P1536, DOI 10.1021/cb300191k; King NM, 2004, J VIROL, V78, P12012, DOI 10.1128/JVI.78.21.12012-12021.2004; Kozisek M, 2014, FEBS J, V281, P1834, DOI 10.1111/febs.12743; Laco GS, 2015, BIOCHIMIE, V118, P90, DOI 10.1016/j.biochi.2015.08.009; Lafont V, 2007, CHEM BIOL DRUG DES, V69, P413, DOI 10.1111/j.1747-0285.2007.00519.x; Langs-Barlow A, 2014, VIRUSES-BASEL, V6, P3855, DOI 10.3390/v6103855; Lazaro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026244; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Liu ZL, 2016, PHYS CHEM CHEM PHYS, V18, P5819, DOI 10.1039/c5cp04556h; Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108; Martinez-Cajas JL, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-11; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; Muzammil S, 2003, BIOCHEMISTRY-US, V42, P631, DOI 10.1021/bi027019u; Naicker P, 2014, FEBS J, V281, P5395, DOI 10.1111/febs.13084; Naicker P, 2014, BIOL CHEM, V395, P1151, DOI 10.1515/hsz-2014-0162; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; Olajuyigbe FM, 2010, ACS MED CHEM LETT, V1, P254, DOI 10.1021/ml100046d; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; Piana S, 2002, PROTEIN SCI, V11, P2393, DOI 10.1110/ps.0206702; Ragland DA, 2014, J AM CHEM SOC, V136, P11956, DOI 10.1021/ja504096m; Robbins AH, 2010, ACTA CRYSTALLOGR D, V66, P233, DOI 10.1107/S0907444909054298; Santoro MM, 2013, ISRN MICROBIOL, V2013, DOI DOI 10.1155/2013/481314; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Saskova KG, 2009, J VIROL, V83, P8810, DOI 10.1128/JVI.00451-09; Sayer JM, 2008, J BIOL CHEM, V283, P13459, DOI 10.1074/jbc.M708506200; Shafer RW, 2008, AIDS REV, V10, P67; Shen CH, 2015, J MOL GRAPH MODEL, V62, P87, DOI 10.1016/j.jmgm.2015.09.006; Silver NW, 2013, J CHEM THEORY COMPUT, V9, P5098, DOI 10.1021/ct400383v; Soares EAJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000730; SPINELLI S, 1991, BIOCHIMIE, V73, P1391, DOI 10.1016/0300-9084(91)90169-2; Tsvetkov YD, 2009, INSTRUM EXP TECH+, V52, P615, DOI 10.1134/S0020441209050017; UNAIDS, 2016, UNAIDS REP GLOB AIDS; Venkatakrishnan B, 2012, VIRUSES-BASEL, V4, P348, DOI 10.3390/v4030348; Weber IT, 2015, FUTURE MED CHEM, V7, P1023, DOI [10.4155/FMC.15.44, 10.4155/fmc.15.44]; Wilson SI, 1997, BBA-PROTEIN STRUCT M, V1339, P113, DOI 10.1016/S0167-4838(96)00224-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; Yedidi RS, 2014, ANTIMICROB AGENTS CH, V58, P3679, DOI 10.1128/AAC.00107-14; Yilmaz NK, 2016, TRENDS MICROBIOL, V24, P547, DOI 10.1016/j.tim.2016.03.010; Zhang Y, 2014, ACS CHEM BIOL, V9, P1351, DOI 10.1021/cb4008875; Zhou QB, 2014, MOL THER, V22, P378, DOI 10.1038/mt.2013.243	87	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22741	22756		10.1074/jbc.M116.747568	http://dx.doi.org/10.1074/jbc.M116.747568			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27576689	Green Published, hybrid			2022-12-28	WOS:000386760600032
J	Riggs, JW; Rockwell, NC; Cavales, PC; Callis, J				Riggs, John W.; Rockwell, Nathan C.; Cavales, Philip C.; Callis, Judy			Identification of the Plant Ribokinase and Discovery of a Role for Arabidopsis Ribokinase in Nucleoside Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; carbohydrate processing; enzyme; nucleoside; nucleotide metabolism; phosphorylation; plant biochemistry; carbohydrate kinase	ESCHERICHIA-COLI RIBOKINASE; ADENOSINE KINASE; DEGRADATION; FAMILY; PURIFICATION; MONOVALENT; SEQUENCE; PROTEIN; RIBOSE; ACTIVATION	Ribose can be used for energy or as a component of several important biomolecules, but for it to be used in either capacity it must first be phosphorylated by ribokinase (RBSK). RBSK proteins are part of the phosphofructokinase-B (pfkB) family of carbohydrate kinases. Sequence comparisons of pfkB proteins from the model plant Arabidopsis thaliana with the human and Escherichia coli RBSK identified a single candidate RBSK, At1g17160 (AtRBSK). AtRBSK is more similar to predicted RBSKs from other plant species and known mammalian and prokaryotic RBSK than to all other PfkB proteins in Arabidopsis. AtRBSK contains a predicted chloroplast transit peptide, and we confirmed plastid localization using AtRBSK fused to YFP. Structure prediction software verified that the AtRBSK sequence mapped onto a known RBSK structure. Kinetic parameters of purified recombinant AtRBSK were determined to be K-mribose = 150 m +/- 17 m, K-mATP = 45 m +/- 5.6 m, and k(cat) = 2.0 s(-1). Substrate inhibition was observed for AtRBSK (K-iATP = 2.44 mm +/- 0.36 mm), as has been demonstrated for other RBSK proteins. Ribose accumulated in Arabidopsis plants lacking AtRBSK. Such plants grew normally unless media was supplemented with ribose, which led to chlorosis and growth inhibition. Both chlorosis and ribose accumulation were abolished upon the introduction of a transgene expressing AtRBSK-MYC, demonstrating that the loss of protein is responsible for ribose hypersensitivity. Ribose accumulation in plants lacking AtRBSK was reduced in plants also deficient in the nucleoside ribohydrolase NSH1, linking AtRBSK activity to nucleoside metabolism.	[Riggs, John W.; Rockwell, Nathan C.; Cavales, Philip C.; Callis, Judy] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Callis, J (corresponding author), Univ Calif Davis, 1 Shields Ave, Davis, CA 95616 USA.	jcallis@ucdavis.edu		Callis, Judy/0000-0002-0622-078X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-09ER16077, DE-SC0002175]; Eric and Louise Conn Graduate Student Fellowship in Plant Biochemistry	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Eric and Louise Conn Graduate Student Fellowship in Plant Biochemistry	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grants DE-FG02-09ER16077 and DE-SC0002175 and a Eric and Louise Conn Graduate Student Fellowship in Plant Biochemistry (to J. R.). The authors declare they have no conflict of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersson CE, 2002, J MOL BIOL, V315, P409, DOI 10.1006/jmbi.2001.5248; BABUL J, 1978, J BIOL CHEM, V253, P4350; Cabrera R, 2010, ARCH BIOCHEM BIOPHYS, V502, P23, DOI 10.1016/j.abb.2010.06.024; Chuvikovsky DV, 2006, BIOORGAN MED CHEM, V14, P6327, DOI 10.1016/j.bmc.2006.05.057; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fiehn Oliver, 2006, V323, P439; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; HOPE JN, 1986, J BIOL CHEM, V261, P7663; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IIDA A, 1984, J BACTERIOL, V158, P674, DOI 10.1128/JB.158.2.674-682.1984; Jung B, 2011, PLANT J, V65, P703, DOI 10.1111/j.1365-313X.2010.04455.x; Jung B, 2009, PLANT CELL, V21, P876, DOI 10.1105/tpc.108.062612; Kraft E., 2007, THESIS; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Maj MC, 2002, BIOCHEMISTRY-US, V41, P4059, DOI 10.1021/bi0119161; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Parducci RE, 2006, BIOCHEMISTRY-US, V45, P9291, DOI 10.1021/bi060026o; Park J, 2008, CELL MOL LIFE SCI, V65, P2875, DOI 10.1007/s00018-008-8123-1; Park J, 2007, FEBS LETT, V581, P3211, DOI 10.1016/j.febslet.2007.06.009; Paul R, 2015, ADV EXP MED BIOL, V842, P293, DOI 10.1007/978-3-319-11280-0_19; PERIGNON JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P130, DOI 10.1016/0167-4889(87)90113-3; Quiroga-Roger D, 2015, BIOMETALS, V28, P401, DOI 10.1007/s10534-015-9844-x; Riegler H, 2011, NEW PHYTOL, V191, P349, DOI 10.1111/j.1469-8137.2011.03711.x; Rockwell NC, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-123; Rogers JS, 1999, MOL BIOL EVOL, V16, P1079, DOI 10.1093/oxfordjournals.molbev.a026197; SCHAFER G, 1977, PLANT PHYSIOL, V60, P286, DOI 10.1104/pp.60.2.286; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Stone J., 1998, EFFICIENT LIB PARALL; Terasawa K, 2005, PLANT CELL PHYSIOL, V46, P649, DOI 10.1093/pcp/pci070; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	36	16	17	6	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22572	22582		10.1074/jbc.M116.754689	http://dx.doi.org/10.1074/jbc.M116.754689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601466	Green Published, hybrid			2022-12-28	WOS:000386760600018
J	Luo, MC; Zhou, SY; Feng, DY; Xiao, J; Li, WY; Xu, CD; Wang, HY; Zhou, T				Luo, Mao-Cai; Zhou, Si-Yuan; Feng, Dan-Ying; Xiao, Jun; Li, Wei-Yun; Xu, Chun-Di; Wang, Hong-Yan; Zhou, Tong			Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggered Inflammation and Septic Shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; lipopolysaccharide (LPS); NF-B (NF-KB); sepsis; Toll-like receptor 4 (TLR4); RUNX1; p50	NF-KAPPA-B; ACUTE KIDNEY INJURY; REGULATORY T-CELLS; GENE-EXPRESSION; TLR4 ACTIVATION; DNA-BINDING; LEUKEMIA; SEPSIS; PHOSPHORYLATION; HEMATOPOIESIS	An appropriate inflammatory response plays critical roles in eliminating pathogens, whereas an excessive inflammatory response can cause tissue damage. Runt-related transcription factor 1 (RUNX1), a master regulator of hematopoiesis, plays critical roles in T cells; however, its roles in Toll-like receptor 4 (TLR4)-mediated inflammation in macrophages are unclear. Here, we demonstrated that upon TLR4 ligand stimulation by lipopolysaccharide (LPS), macrophages reduced the expression levels of RUNX1. Silencing of Runx1 attenuated the LPS-induced IL-1 and IL-6 production levels, but the TNF- levels were not affected. Overexpression of RUNX1 promoted IL-1 and IL-6 production in response to LPS stimulation. Moreover, RUNX1 interacted with the NF-B subunit p50, and coexpression of RUNX1 with p50 further enhanced the NF-B luciferase activity. Importantly, treatment with the RUNX1 inhibitor, Ro 5-3335, protected mice from LPS-induced endotoxic shock and substantially reduced the IL-6 levels. These findings suggest that RUNX1 may be a new potential target for resolving TLR4-associated uncontrolled inflammation and preventing sepsis.	[Luo, Mao-Cai; Zhou, Si-Yuan; Feng, Dan-Ying; Xu, Chun-Di; Zhou, Tong] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pediat, Sch Med, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China; [Xiao, Jun; Li, Wei-Yun; Wang, Hong-Yan] Chinese Acad Sci, Key Lab Syst Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biol Sc, Innovat Ctr Cell Signaling Network,Inst Biochem &, 320 Yue Yang Rd, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	Zhou, T (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pediat, Sch Med, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China.; Wang, HY (corresponding author), Chinese Acad Sci, Key Lab Syst Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biol Sc, Innovat Ctr Cell Signaling Network,Inst Biochem &, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	hongyanwang@sibcb.ac.cn; zhoutong_cn@hotmail.com	, 肖俊/AAO-9118-2020		Ministry of Science and Technology of China [2016YFD05002007, 2016YFC0902200, 2012CB910800]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; National Natural Science Foundation of China [81270801, 81470941, 31422018, 81571617, 81570508]; Instrument Developing Project of the Chinese Academy of Sciences [YZ201339]; Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Instrument Developing Project of the Chinese Academy of Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by Ministry of Science and Technology of China Grants 2016YFD05002007, 2016YFC0902200, and 2012CB910800, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000, National Natural Science Foundation of China Grants 81270801, 81470941, 31422018, 81571617, and 81570508, and Instrument Developing Project of the Chinese Academy of Sciences Grant YZ201339. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Hundred Talents Program of the Chinese Academy of Sciences. To whom correspondence may be addressed. Tel.: 86-21-54921086; E-mail: hongyanwang@sibcb.ac.cn.	Aderem A, 2001, CRIT CARE MED, V29, pS16, DOI 10.1097/00003246-200107001-00008; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cai XS, 2015, POWDER TECHNOL, V282, P1, DOI 10.1016/j.powtec.2015.06.012; Collins PE, 2015, J BIOL CHEM, V290, P15687, DOI 10.1074/jbc.M115.643700; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Elliott J, 2004, TRENDS IMMUNOL, V25, P434, DOI 10.1016/j.it.2004.05.012; Frank R, 1995, ONCOGENE, V11, P2667; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Komeno Y, 2014, BLOOD, V123, P3760, DOI 10.1182/blood-2013-08-521252; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee K, 2012, J NEUROCHEM, V122, P272, DOI 10.1111/j.1471-4159.2012.07786.x; Li WY, 2015, J CLIN INVEST, V125, P4239, DOI 10.1172/JCI81203; Liu X, 2009, LEUKEMIA, V23, P739, DOI 10.1038/leu.2008.350; Nakagawa M, 2011, BLOOD, V118, P6626, DOI 10.1182/blood-2010-12-326710; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Ran D, 2013, BLOOD, V121, P2882, DOI 10.1182/blood-2012-08-451641; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Scheitz CJF, 2012, EMBO J, V31, P4124, DOI 10.1038/emboj.2012.270; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Uchida H, 1997, J IMMUNOL, V158, P2251; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Wong WF, 2012, J IMMUNOL, V188, P5408, DOI 10.4049/jimmunol.1102991; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; Zhang YB, 2014, IMMUNITY, V40, P501, DOI 10.1016/j.immuni.2014.01.013; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	56	37	40	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22011	22020		10.1074/jbc.M116.715953	http://dx.doi.org/10.1074/jbc.M116.715953			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573239	Green Published, hybrid			2022-12-28	WOS:000386332600016
J	Walliser, C; Hermkes, E; Schade, A; Wiese, S; Deinzer, J; Zapatka, M; Desire, L; Mertens, D; Stilgenbauer, S; Gierschik, P				Walliser, Claudia; Hermkes, Elisabeth; Schade, Anja; Wiese, Sebastian; Deinzer, Julia; Zapatka, Marc; Desire, Laurent; Mertens, Daniel; Stilgenbauer, Stephan; Gierschik, Peter			The Phospholipase C gamma(2) Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						leukemia; lymphoma; phosphatidylinositol signaling; phospholipase C; Rac (Rac GTPase); chronic lymphocytic leukemia; ibrutinib resistance; leukemia	BRUTONS TYROSINE KINASE; SMALL-MOLECULE INHIBITOR; FAMILY SMALL GTPASES; B-CELL ACTIVATION; ANTIGEN RECEPTOR; IN-VITRO; VAV; STIMULATION; DISEASE; BTK	Mutations in the gene encoding phospholipase C-(2) (PLC2) have been shown to be associated with resistance to targeted therapy of chronic lymphocytic leukemia (CLL) with the Bruton's tyrosine kinase inhibitor ibrutinib. The fact that two of these mutations, R665W and L845F, imparted upon PLC2 an approximate to 2-3-fold ibrutinib-insensitive increase in the concentration of cytosolic Ca2+ following ligation of the B cell antigen receptor (BCR) led to the assumption that the two mutants exhibit constitutively enhanced intrinsic activity. Here, we show that the two PLC2 mutants are strikingly hypersensitive to activation by Rac2 such that even wild-type Rac2 suffices to activate the mutant enzymes upon its introduction into intact cells. Enhanced basal activity of PLC2 in intact cells is shown using the pharmacologic Rac inhibitor EHT 1864 and the PLC2F897Q mutation mediating Rac resistance to be caused by Rac-stimulated rather than by constitutively enhanced PLC2 activity. We suggest that R665W and L845F be referred to as allomorphic rather than hypermorphic mutations of PLCG2. Rerouting of the transmembrane signals emanating from BCR and converging on PLC2 through Rac in ibrutinib-resistant CLL cells may provide novel drug treatment strategies to overcome ibrutinib resistance mediated by PLCG2 mutations or to prevent its development in ibrutinib-treated CLL patients.	[Walliser, Claudia; Hermkes, Elisabeth; Schade, Anja; Deinzer, Julia; Gierschik, Peter] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89070 Ulm, Germany; [Mertens, Daniel; Stilgenbauer, Stephan] Univ Ulm, Med Ctr, Dept Internal Med 3, D-89070 Ulm, Germany; [Wiese, Sebastian] Univ Ulm, Fac Med, Core Unit Mass Spectrometry & Prote, D-89081 Ulm, Germany; [Zapatka, Marc] German Canc Res Ctr, Div Mol Genet, D-69121 Heidelberg, Germany; [Desire, Laurent] Diaxonhit, 63-65 Blvd Massena, F-75013 Paris, France	Ulm University; Ulm University; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ)	Gierschik, P (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	peter.gierschik@uni-ulm.de	Mertens, Daniel/F-4681-2011; Zapatka, Marc/G-9896-2013; Stilgenbauer, Stephan/ABE-6609-2020	Mertens, Daniel/0000-0003-0227-7188; Zapatka, Marc/0000-0001-8287-5967; 	Deutsche Forschungsgemeinschaft [SFB 1074]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant SFB 1074, TP A8 from the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Bertrand L., 2004, Patent No. [WO2004076445A2, 2004076445]; Bunney TD, 2012, STRUCTURE, V20, P2062, DOI 10.1016/j.str.2012.09.005; Burger JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11589; CAMPS M, 1990, BIOCHEM J, V271, P743, DOI 10.1042/bj2710743; Chakraborty R, 2015, EXPERT REV HEMATOL, V8, P569, DOI 10.1586/17474086.2015.1061427; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cramer P, 2016, EUR J HAEMATOL, V96, P9, DOI 10.1111/ejh.12678; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; de Claro RA, 2015, CLIN CANCER RES, V21, P3586, DOI 10.1158/1078-0432.CCR-14-2225; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Everett KL, 2011, MOL CELL BIOL, V31, P1240, DOI 10.1128/MCB.01408-10; Everett KL, 2009, J BIOL CHEM, V284, P23083, DOI 10.1074/jbc.M109.019265; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hendriks RW, 2006, SEMIN IMMUNOL, V18, P67, DOI 10.1016/j.smim.2005.10.002; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hikida M, 2005, ADV IMMUNOL, V88, P73, DOI 10.1016/S0065-2776(05)88003-4; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Illenberger D, 2000, METHOD ENZYMOL, V325, P167; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kokhaei P, 2016, J DRUG TARGET, V24, P373, DOI 10.3109/1061186X.2015.1086357; Komarova NL, 2014, P NATL ACAD SCI USA, V111, P13906, DOI 10.1073/pnas.1409362111; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Liu TM, 2015, BLOOD, V126, P61, DOI 10.1182/blood-2015-02-626846; Maddocks KJ, 2015, JAMA ONCOL, V1, P80, DOI 10.1001/jamaoncol.2014.218; Mancini M, 2016, SEMIN CELL DEV BIOL, V50, P164, DOI 10.1016/j.semcdb.2015.09.018; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; Meyer S. L., 1975, DATA ANAL SCI ENG, P39; Montresor A, 2015, ONCOTARGET, V6, P34245, DOI 10.18632/oncotarget.5196; Muzio M, 2008, BLOOD, V112, P188, DOI 10.1182/blood-2007-09-111344; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; Packard Thomas A, 2013, F1000Prime Rep, V5, P40, DOI 10.12703/P5-40; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Shinohara M, 2014, BONE, V60, P8, DOI 10.1016/j.bone.2013.11.025; Shirakawa AK, 2010, CELL MOL IMMUNOL, V7, P428, DOI 10.1038/cmi.2010.46; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Stamatopoulos B, 2012, HAEMATOL-HEMATOL J, V97, P608, DOI 10.3324/haematol.2011.052779; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tedder TF, 2010, J IMMUNOL, V184, P2231, DOI 10.4049/jimmunol.1090001; ten Hacken E, 2016, BBA-MOL CELL RES, V1863, P401, DOI 10.1016/j.bbamcr.2015.07.009; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Walliser C, 2015, J BIOL CHEM, V290, P17056, DOI 10.1074/jbc.M115.645739; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Zheng H, 2009, AM J PHYSIOL-CELL PH, V297, pC188, DOI 10.1152/ajpcell.00052.2009; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	68	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22136	22148		10.1074/jbc.M116.746842	http://dx.doi.org/10.1074/jbc.M116.746842			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27542411	Green Published, hybrid			2022-12-28	WOS:000386332600027
J	Luo, RB; Chen, PW; Wagenbach, M; Jian, XY; Jenkins, L; Wordeman, L; Randazzo, PA				Luo, Ruibai; Chen, Pei-Wen; Wagenbach, Michael; Jian, Xiaoying; Jenkins, Lisa; Wordeman, Linda; Randazzo, Paul A.			Direct Functional Interaction of the Kinesin-13 Family Membrane Kinesin-like Protein 2A (Kif2A) and Arf GAP with GTP-binding Protein-like, Ankyrin Repeats and PH Domains1 (AGAP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP ribosylation factor (ARF); cell biology; enzyme; GTPase activating protein (GAP); kinesin; protein complex; small GTPase; AGAP1; Kif2A; kinesin-13; Arf GTPase-activating protein; PH domain	ADP-RIBOSYLATION FACTOR; FOCAL ADHESION KINASE; ACTIVATING PROTEIN; ACTIN CYTOSKELETON; MCAK; NOMENCLATURE; HYDROLYSIS; REGULATORS; TRANSPORT; DYNAMICS	The molecular basis for control of the cytoskeleton by the Arf GTPase-activating protein AGAP1 has not been characterized. AGAP1 is composed of G-protein-like (GLD), pleckstrin homology (PH), Arf GAP, and ankyrin repeat domains. Kif2A was identified in screens for proteins that bind to AGAP1. The GLD and PH domains of AGAP1 bound the motor domain of Kif2A. Kif2A increased GAP activity of AGAP1, and a protein composed of the GLD and PH domains of AGAP1 increased ATPase activity of Kif2A. Knockdown (KD) of Kif2A or AGAP1 slowed cell migration and accelerated cell spreading. The effect of Kif2A KD on spreading could be rescued by expression of Kif2A-GFP or FLAG-AGAP1, but not by Kif2C-GFP. The effect of AGAP1 KD could be rescued by FLAG-AGAP1, but not by an AGAP1 mutant that did not bind Kif2A efficiently, ArfGAP1-HA or Kif2A-GFP. Taken together, the results support the hypothesis that the Kif2AAGAP1 complex contributes to control of cytoskeleton remodeling involved in cell movement.	[Luo, Ruibai; Chen, Pei-Wen; Jian, Xiaoying; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA; [Jenkins, Lisa] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Chen, Pei-Wen] Grinnell Coll, Dept Biol, Grinnell, IA 50112 USA; [Wagenbach, Michael; Wordeman, Linda] Univ Washington, Dept Physiol & Biophys, Sch Med, Seattle, WA 98195 USA; [Chen, Pei-Wen] Williams Coll, Williamstown, MA 01267 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; Williams College	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Jenkins, Lisa/AAI-2490-2021	Wordeman, Linda/0000-0002-9444-0650	intramural program of the National Cancer Institute [BC007365]; National Institute of General Medical Sciences [GM069429]; NATIONAL CANCER INSTITUTE [Z01BC007365, ZICBC011430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069429] Funding Source: NIH RePORTER	intramural program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the intramural program of the National Cancer Institute (Project BC007365) and by the National Institute of General Medical Sciences (Grant GM069429) (to L. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bendor J, 2010, EMBO J, V29, P2813, DOI 10.1038/emboj.2010.154; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Drum BML, 2016, J MOL CELL CARDIOL, V93, P32, DOI 10.1016/j.yjmcc.2016.02.012; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ginkel LM, 2000, MOL BIOL CELL, V11, P4143, DOI 10.1091/mbc.11.12.4143; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hood EA, 2012, MOL BIOL CELL, V23, P2264, DOI 10.1091/mbc.E11-12-1013; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; James P, 1996, GENETICS, V144, P1425; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Knowlton AL, 2009, CURR BIOL, V19, P758, DOI 10.1016/j.cub.2009.03.018; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Luo RB, 2012, J BIOL CHEM, V287, P17176, DOI 10.1074/jbc.M111.334458; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2003, DEV CELL, V5, P513, DOI 10.1016/S1534-5807(03)00234-X; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Santama N, 1998, EMBO J, V17, P5855, DOI 10.1093/emboj/17.20.5855; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Walczak CE, 2013, ANNU REV CELL DEV BI, V29, P417, DOI 10.1146/annurev-cellbio-101512-122345; Wang CQ, 2010, ORAL ONCOL, V46, P65, DOI 10.1016/j.oraloncology.2009.11.003; Wang JL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-461; Wu YJ, 2013, BIOCHEM J, V452, P411, DOI 10.1042/BJ20121004; Zaganjor E, 2014, ONCOGENE, V33, P5457, DOI 10.1038/onc.2013.486; Zhu YJ, 2009, J BIOL CHEM, V284, P13489, DOI 10.1074/jbc.M900469200	43	4	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21350	21362		10.1074/jbc.M116.732479	http://dx.doi.org/10.1074/jbc.M116.732479			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531749	Green Published, hybrid			2022-12-28	WOS:000385999200002
J	Ovchinnikova, OG; Doyle, L; Huang, BS; Kimber, MS; Lowary, TL; Whitfield, C				Ovchinnikova, Olga G.; Doyle, Liam; Huang, Bo-Shun; Kimber, Matthew S.; Lowary, Todd L.; Whitfield, Chris			Biochemical Characterization of Bifunctional 3-Deoxy--d-manno-oct-2-ulosonic Acid (-Kdo) Transferase KpsC from Escherichia coli Involved in Capsule Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface; Escherichia coli (E; coli); glycoconjugate; glycolipid structure; glycosyltransferase; gram-negative bacteria; oligosaccharide; Kdo; capsular polysaccharide	TRANSPORTER-DEPENDENT PATHWAYS; POLYSACCHARIDES; GLYCOSYLTRANSFERASES; LIPOPOLYSACCHARIDE	3-Deoxy-d-manno-oct-2-ulosonic acid (Kdo) is an essential component of bacterial lipopolysaccharides, where it provides the linkage between lipid and carbohydrate moieties. In all known LPS structures, Kdo residues possess -anomeric configurations, and the corresponding inverting -Kdo transferases are well characterized. Recently, it has been shown that a large group of capsular polysaccharides from Gram-negative bacteria, produced by ATP-binding cassette transporter-dependent pathways, are also attached to a lipid anchor through a conserved Kdo oligosaccharide. In the study reported here, the structure of this Kdo linker was determined by NMR spectroscopy, revealing alternating -(24)- and -(27)-linked Kdo residues. KpsC contains two retaining -Kdo glycosyltransferase domains belonging to family GT99 that are responsible for polymerizing the -Kdo linker on its glycolipid acceptor. Full-length Escherichia coli KpsC was expressed and purified, together with the isolated N-terminal domain and a mutant protein (KpsC D160A) containing a catalytically inactivated N-terminal domain. The Kdo transferase activities of these proteins were determined in vitro using synthetic acceptors, and the reaction products were characterized using TLC, mass spectrometry, and NMR spectroscopy. The N- and C-terminal domains were found to catalyze formation of -(24) and -(27) linkages, respectively. Based on phylogenetic analyses, we propose the linkage specificities of the glycosyltransferase domains are conserved in KpsC homologs from other bacterial species.	[Ovchinnikova, Olga G.; Doyle, Liam; Kimber, Matthew S.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Huang, Bo-Shun; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Huang, Bo-Shun; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Lowary, Todd L/F-9608-2019; Kimber, Matthew/Q-8144-2019	Lowary, Todd L/0000-0002-8331-8211; Whitfield, Chris/0000-0002-5267-7027	Canadian Institutes of Health Research; Discovery Grants from the National Science and Engineering Research Council of Canada; Canadian Glycomics Network (GlycoNEt, National Centres of Excellence Program)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Discovery Grants from the National Science and Engineering Research Council of Canada; Canadian Glycomics Network (GlycoNEt, National Centres of Excellence Program)	This work was supported by operating funding from the Canadian Institutes of Health Research (to C. W.), Discovery Grants from the National Science and Engineering Research Council of Canada (to M. S. K., T. L. L., and C. W.), and the Canadian Glycomics Network (GlycoNEt, National Centres of Excellence Program) (to M. S. K, T. L. L., and C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alqasim A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-830; Frirdich E, 2004, J BIOL CHEM, V279, P27928, DOI 10.1074/jbc.M402549200; Gronow S, 2000, EUR J BIOCHEM, V267, P6602, DOI 10.1046/j.1432-1327.2000.01754.x; Klonis N, 1996, J Fluoresc, V6, P147, DOI 10.1007/BF00732054; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LENTER M, 1990, CARBOHYD RES, V197, P197, DOI 10.1016/0008-6215(90)84142-H; Lin CH, 1997, BIOCHEMISTRY-US, V36, P780, DOI 10.1021/bi962055c; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mannerstedt K, 2007, CARBOHYD RES, V342, P631, DOI 10.1016/j.carres.2006.08.021; Ovchinnikova OG, 2016, P NATL ACAD SCI USA, V113, pE3120, DOI 10.1073/pnas.1603146113; Schmidt H, 2012, P NATL ACAD SCI USA, V109, P6253, DOI 10.1073/pnas.1119894109; Starr KF, 2016, INFECT IMMUN, V84, P1775, DOI 10.1128/IAI.00128-16; UNGER FM, 1980, CARBOHYD RES, V80, P191, DOI 10.1016/S0008-6215(00)85325-2; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110	18	16	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21519	21530		10.1074/jbc.M116.751115	http://dx.doi.org/10.1074/jbc.M116.751115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27535220	Green Published, hybrid			2022-12-28	WOS:000385999200019
J	Chen, SH; Byrne-Nash, RT; Cox, MM				Chen, Stefanie H.; Byrne-Nash, Rose T.; Cox, Michael M.			Escherichia coli RadD Protein Functionally Interacts with the Single-stranded DNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; DNA repair; protein-DNA interaction; protein-protein interaction; radiation biology; SSB; helicase	COMPLEX-FORMATION; SSB; REPLICATION; HELICASE; PURIFICATION; MECHANISM; RADIATION; RESIDUES; SUBUNITS; REPAIR	The bacterial single-stranded DNA binding protein (SSB) acts as an organizer of DNA repair complexes. The radD gene was recently identified as having an unspecified role in repair of radiation damage and, more specifically, DNA double-strand breaks. Purified RadD protein displays a DNA-independent ATPase activity. However, ATP hydrolytic rates are stimulated by SSB through its C terminus. The RadD and SSB proteins also directly interact in vivo in a yeast two-hybrid assay and in vitro through ammonium sulfate co-precipitation. Therefore, it is likely that the repair function of RadD is mediated through interaction with SSB at the site of damage.	[Chen, Stefanie H.; Byrne-Nash, Rose T.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, 433 Babcock Dr,Rm 337, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Chen, SH (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr,Rm 337, Madison, WI 53706 USA.	slchen3@wisc.edu		Nash, Rose/0000-0002-9706-5585; Chen, Stefanie/0000-0002-9550-971X	National Institutes of Health [GM032335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM032335, R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by the National Institutes of Health Grant GM032335 (to M. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antony E, 2013, J MOL BIOL, V425, P4802, DOI 10.1016/j.jmb.2013.08.021; Aramaki T, 2015, J BIOCHEM, V157, P529, DOI 10.1093/jb/mvv014; Baharoglu Z, 2014, NUCLEIC ACIDS RES, V42, P2366, DOI 10.1093/nar/gkt1259; Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Chen SH, 2015, MOL MICROBIOL, V95, P754, DOI 10.1111/mmi.12885; Cooper DL, 2016, ELIFE, V5, DOI 10.7554/eLife.10807; Furukohri A, 2012, NUCLEIC ACIDS RES, V40, P6039, DOI 10.1093/nar/gks264; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; James P, 1996, GENETICS, V144, P1425; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; Lu D, 2011, NUCLEIC ACIDS RES, V39, P6536, DOI 10.1093/nar/gkr315; Lu D, 2009, BIOCHEMISTRY-US, V48, P6764, DOI 10.1021/bi900361r; Marceau Aimee H, 2012, Methods Mol Biol, V922, P151, DOI 10.1007/978-1-62703-032-8_9; Mawer JSP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004485; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Page AN, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.210187; Petzold C, 2015, J BIOL CHEM, V290, P14626, DOI 10.1074/jbc.M115.655134; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rudolph CJ, 2013, NATURE, V500, P608, DOI 10.1038/nature12312; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wessel SR, 2013, J BIOL CHEM, V288, P17569, DOI 10.1074/jbc.M113.478156	28	16	16	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20779	20786		10.1074/jbc.M116.736223	http://dx.doi.org/10.1074/jbc.M116.736223			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27519413	Green Published, hybrid			2022-12-28	WOS:000384574800038
J	Yin, QH; Zhang, R; Li, L; Wang, YT; Liu, JP; Zhang, J; Bai, L; Cheng, JQ; Fu, P; Liu, F				Yin, Qing-hua; Zhang, Rui; Li, Li; Wang, Yi-ting; Liu, Jing-ping; Zhang, Jie; Bai, Lin; Cheng, Jing-qiu; Fu, Ping; Liu, Fang			Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; RENAL LIPID-METABOLISM; APOLIPOPROTEIN-A-I; PROTEIN-KINASE; ACCELERATES ATHEROSCLEROSIS; GENE-EXPRESSION; EXPORTER ABCA1; INFLAMMATION; ACTIVATION; ACCUMULATION	ATP-binding cassette transporter A1 (ABCA1), which promotes cholesterol efflux from cells and inhibits inflammatory responses, is highly expressed in the kidney. Research has shown that exendin-4, a glucagon-like peptide-1 receptor (GLP-1R) agonist, promotes ABCA1 expression in multiple tissues and organs; however, the mechanisms underlying exendin-4 induction of ABCA1 expression in glomerular endothelial cells are not fully understood. In this study we investigated the effect of exendin-4 on ABCA1 in glomerular endothelial cells of diabetic kidney disease (DKD) and the possible mechanism. We observed a marked increase in glomerular lipid deposits in tissues of patients with DKD and diabetic apolipoprotein E knock-out (apoE(-/-)) mice by Oil Red O staining and biochemical analysis of cholesterol. We found significantly decreased ABCA1 expression in glomerular endothelial cells of diabetic apoE(-/-) mice and increased renal lipid, cholesterol, and inflammatory cytokine levels. Exendin-4 decreased renal cholesterol accumulation and inflammation and increased cholesterol efflux by up-regulating ABCA1. In human glomerular endothelial cells, GLP-1R-mediated signaling pathways (e.g. Ca2+/calmodulin-dependent protein kinase, cAMP/PKA, PI3K/AKT, and ERK1/2) were involved in cholesterol efflux and inflammatory responses by regulating ABCA1 expression. We propose that exendin-4 increases ABCA1 expression in glomerular endothelial cells, which plays an important role in alleviating renal lipid accumulation, inflammation, and proteinuria in mice with type 2 diabetes.	[Yin, Qing-hua; Zhang, Rui; Li, Li; Wang, Yi-ting; Fu, Ping; Liu, Fang] Sichuan Univ, Div Nephrol, West China Hosp, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China; [Liu, Jing-ping; Zhang, Jie; Bai, Lin; Cheng, Jing-qiu] Sichuan Univ, Regenerat Med Res Ctr, Key Lab Transplant Engn & Immunol, Minist Hlth,West China Hosp, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University	Liu, F (corresponding author), Sichuan Univ, Div Nephrol, West China Hosp, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China.	liufangfh@163.com	Liu, Jingping/P-8908-2019; wang, yiting/GYU-5306-2022		National Natural Science Foundation of China [81370823, 81670662]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Grants 81370823 and 81670662 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Aryal B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12313; Attie AD, 2007, TRENDS BIOCHEM SCI, V32, P172, DOI 10.1016/j.tibs.2007.02.001; Birjmohun RS, 2007, ARTERIOSCL THROM VAS, V27, P1153, DOI 10.1161/ATVBAHA.106.136325; Bochem AE, 2015, ARTERIOSCL THROM VAS, V35, P1663, DOI 10.1161/ATVBAHA.114.304959; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Byron A, 2014, J AM SOC NEPHROL, V25, P953, DOI 10.1681/ASN.2013070795; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chehade JM, 2013, METABOLISM, V62, P265, DOI 10.1016/j.metabol.2012.07.005; Cooper Mark E, 2005, Curr Diab Rep, V5, P445, DOI 10.1007/s11892-005-0053-9; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Gupta A, 2011, NEW ENGL J MED, V364, P1472, DOI 10.1056/NEJMc1101853; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Hong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082311; Hu YW, 2014, J LIPID RES, V55, P681, DOI 10.1194/jlr.M044669; Hu Yan-Wei, 2009, Atherosclerosis, V204, pe35, DOI 10.1016/j.atherosclerosis.2008.11.003; Huang CX, 2013, J LIPID RES, V54, P1231, DOI 10.1194/jlr.M032482; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Izquierdo-Lahuerta A, 2016, J NEPHROL, V29, P603, DOI 10.1007/s40620-016-0278-5; Jandeleit-Dahm K, 1999, KIDNEY INT, V56, pS31, DOI 10.1046/j.1523-1755.1999.07109.x; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Kiss E, 2013, AM J PATHOL, V182, P727, DOI 10.1016/j.ajpath.2012.11.033; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Li JH, 2010, J CELL MOL MED, V14, P1083, DOI 10.1111/j.1582-4934.2009.00955.x; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113639; Lindahl M, 2015, J LIPID RES, V56, P2248, DOI 10.1194/jlr.M054767; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Liu DM, 2005, ENDOCRINOLOGY, V146, P1312, DOI 10.1210/en.2004-1221; Matsumoto K, 2008, EXP HEMATOL, V36, P390, DOI 10.1016/j.exphem.2007.11.013; Merscher-Gomez S, 2013, DIABETES, V62, P3817, DOI 10.2337/db13-0399; Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824; Miyai Y, 2011, J ENDOCRINOL INVEST, V34, pE268, DOI 10.3275/7683; MOORHEAD JF, 1982, LANCET, V2, P1309; Mostafa AM, 2015, BIOCHEM BIOPH RES CO, V468, P900, DOI 10.1016/j.bbrc.2015.11.054; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Natarajan R, 1999, HYPERTENSION, V33, P378, DOI 10.1161/01.HYP.33.1.378; Ou HC, 2010, TOXICOL APPL PHARM, V248, P134, DOI 10.1016/j.taap.2010.07.025; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Soro-Paavonen A, 2006, ANN MED, V38, P229, DOI 10.1080/07853890500526352; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tang CR, 2010, J LIPID RES, V51, P1719, DOI 10.1194/jlr.M003525; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Tashiro Y, 2014, PEPTIDES, V54, P19, DOI 10.1016/j.peptides.2013.12.015; Tremblay F, 2003, DIABETES, V52, P29, DOI 10.2337/diabetes.52.1.29; Tsun JGS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105787; Vaisman BL, 2012, J LIPID RES, V53, P158, DOI 10.1194/jlr.M018713; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Westerterp M, 2016, ARTERIOSCL THROM VAS, V36, P1328, DOI 10.1161/ATVBAHA.115.306670; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xing SS, 2015, VASC PHARMACOL, V72, P141, DOI 10.1016/j.vph.2015.07.004; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082275; Zhang Y, 2016, FREE RADICAL BIO MED, V95, P278, DOI 10.1016/j.freeradbiomed.2016.03.035; Zhao HJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE1431, DOI 10.1152/ajpendo.00017.2014; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	67	35	39	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26487	26501		10.1074/jbc.M116.730564	http://dx.doi.org/10.1074/jbc.M116.730564			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27784780	Green Published, hybrid			2022-12-28	WOS:000391568200022
J	Fatehchand, K; McMichael, EL; Reader, BF; Fang, H; Santhanam, R; Gautam, S; Elavazhagan, S; Mehta, P; Buteyn, NJ; Merchand-Reyes, G; Vasu, S; Mo, XK; Benson, DM; Blachly, JS; Carson, WE; Byrd, JC; Butchar, JP; Tridandapani, S				Fatehchand, Kavin; McMichael, Elizabeth L.; Reader, Brenda F.; Fang, Huiqing; Santhanam, Ramasamy; Gautam, Shalini; Elavazhagan, Saranya; Mehta, Payal; Buteyn, Nathaniel J.; Merchand-Reyes, Giovanna; Vasu, Sumithira; Mo, Xiaokui; Benson, Don M.; Blachly, James S.; Carson, William E., III; Byrd, John C.; Butchar, Jonathan P.; Tridandapani, Susheela			Interferon- Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; Fc receptor; interferon; signal transduction; tumor immunology	FC-GAMMA-RI; CHRONIC GRANULOMATOUS-DISEASE; TUMOR-ASSOCIATED MACROPHAGES; AFFINITY IGG RECEPTOR; GEMTUZUMAB OZOGAMICIN; MULTIPLE-MYELOMA; CD38 EXPRESSION; TARGETING CD38; RETINOIC ACID; SCID MICE	Acute myeloid leukemia (AML) is characterized by the proliferation of immature myeloid lineage blasts. Due to its heterogeneity and to the high rate of acquired drug resistance and relapse, new treatment strategies are needed. Here, we demonstrate that IFN promotes AML blasts to act as effector cells within the context of antibody therapy. Treatment with IFN drove AML blasts toward a more differentiated state, wherein they showed increased expression of the M1-related markers HLA-DR and CD86, as well as of FcRI, which mediates effector responses to therapeutic antibodies. Importantly, IFN was able to up-regulate CD38, the target of the therapeutic antibody daratumumab. Because the antigen (CD38) and effector receptor (FcRI) were both simultaneously up-regulated on the AML blasts, we tested whether IFN treatment of the AML cell lines THP-1 and MV4-11 could stimulate them to target one another after the addition of daratumumab. Results showed that IFN significantly increased daratumumab-mediated cytotoxicity, as measured both by Cr-51 release and lactate dehydrogenase release assays. We also found that the combination of IFN and activation of FcR led to the release of granzyme B by AML cells. Finally, using a murine NSG model of subcutaneous AML, we found that treatment with IFN plus daratumumab significantly attenuated tumor growth. Taken together, these studies show a novel mechanism of daratumumab-mediated killing and a possible new therapeutic strategy for AML.	[Fatehchand, Kavin; Carson, William E., III; Byrd, John C.; Tridandapani, Susheela] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Fatehchand, Kavin; McMichael, Elizabeth L.; Carson, William E., III; Byrd, John C.; Tridandapani, Susheela] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Fatehchand, Kavin; McMichael, Elizabeth L.; Reader, Brenda F.; Fang, Huiqing; Santhanam, Ramasamy; Gautam, Shalini; Elavazhagan, Saranya; Mehta, Payal; Vasu, Sumithira; Benson, Don M.; Blachly, James S.; Carson, William E., III; Byrd, John C.; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Buteyn, Nathaniel J.; Merchand-Reyes, Giovanna; Tridandapani, Susheela] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Tridandapani, S (corresponding author), Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA.; Tridandapani, S (corresponding author), Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA.; Butchar, JP; Tridandapani, S (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.; Tridandapani, S (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA.	butchar.2@osu.edu; tridandapani.2@osu.edu			National Institutes of Health [P01-CA095426, R01 CA162411, T32 HL007946, P30 CA016058]; NATIONAL CANCER INSTITUTE [R01CA203584, P01CA095426, R35CA197734, P30CA016058, R01CA162411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01-CA095426 (to S. T. and J. C. B.); R01 CA162411 (to S. T. and J. C. B.), T32 HL007946 (to B. F. R.), and P30 CA016058 (to the Ohio State University Comprehensive Cancer Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adib-Conquy M, 2014, IMMUNOL CELL BIOL, V92, P256, DOI 10.1038/icb.2013.99; Bevaart L, 2006, CANCER RES, V66, P1261, DOI 10.1158/0008-5472.CAN-05-2856; Bong AB, 2002, DERMATOLOGY, V205, P135, DOI 10.1159/000063904; BREITMAN TR, 1981, BLOOD, V57, P1000; Busfield SJ, 2014, LEUKEMIA, V28, P2213, DOI 10.1038/leu.2014.128; Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Cohen AD, 2002, BONE MARROW TRANSPL, V30, P23, DOI 10.1038/sj.bmt.1703602; Costello RT, 1998, EUR J IMMUNOL, V28, P90, DOI 10.1002/(SICI)1521-4141(199801)28:01<90::AID-IMMU90>3.0.CO;2-5; Curran E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00083; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dombret H, 2016, BLOOD, V127, P53, DOI 10.1182/blood-2015-08-604520; Elavazhagan S, 2015, J IMMUNOL, V194, P2786, DOI 10.4049/jimmunol.1402316; Errante Paolo R, 2008, Recent Pat Antiinfect Drug Discov, V3, P225, DOI 10.2174/157489108786242378; Estey E, 2015, BLOOD, V125, P2461, DOI 10.1182/blood-2015-01-561373; Funaro A, 1997, TISSUE ANTIGENS, V49, P7, DOI 10.1111/j.1399-0039.1997.tb02703.x; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; GRIMALDI JC, 1995, J IMMUNOL, V155, P811; Gupta V, 2011, BLOOD, V117, P2307, DOI 10.1182/blood-2010-10-265603; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Joshi T, 2006, MOL IMMUNOL, V43, P839, DOI 10.1016/j.molimm.2005.06.037; Kell J, 2016, EXPERT REV ANTICANC, V16, P377, DOI 10.1586/14737140.2016.1162099; Keyhani A, 2000, LEUKEMIA RES, V24, P153, DOI 10.1016/S0145-2126(99)00147-2; Lowenberg B, 2016, BLOOD, V127, P1, DOI 10.1182/blood-2015-10-662684; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Masoumi-Dehshiri R, 2014, IRAN J PEDIATR HEMAT, V4, P188; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Moreno-Garcia ME, 2005, J IMMUNOL, V174, P2687, DOI 10.4049/jimmunol.174.5.2687; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nakamura K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26529; Nijhof IS, 2015, LEUKEMIA, V29, P2039, DOI 10.1038/leu.2015.123; Nunoi H, 2004, JPN J INFECT DIS, V57, pS25; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; SHULTZ LD, 1995, J IMMUNOL, V154, P180; So EY, 2010, INT J BIOL SCI, V6, P675; Stein EM, 2016, BLOOD, V127, P71, DOI 10.1182/blood-2015-07-604538; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; THOMAS ED, 1979, NEW ENGL J MED, V301, P597, DOI 10.1056/NEJM197909133011109; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; van de Donk NWCJ, 2016, IMMUNOL REV, V270, P95, DOI 10.1111/imr.12389; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Vasu S, 2016, BLOOD, V127, P2879, DOI 10.1182/blood-2015-11-680546; Wang Z Y, 2000, Lancet Oncol, V1, P101, DOI 10.1016/S1470-2045(00)00017-6; Wilson CJ, 2000, ARCH DIS CHILD, V83, P449, DOI 10.1136/adc.83.5.449; Yea K, 2015, P NATL ACAD SCI USA, V112, pE6158, DOI 10.1073/pnas.1519079112; Zhong RK, 2001, J HEMATOTH STEM CELL, V10, P95, DOI 10.1089/152581601750098318	55	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25656	25666		10.1074/jbc.M116.753145	http://dx.doi.org/10.1074/jbc.M116.753145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27780867	Green Published, hybrid			2022-12-28	WOS:000390095300031
J	Hnida, K; Stamnaes, J; du Pre, MF; Mysling, S; Jorgensen, TJD; Sollid, LM; Iversen, R				Hnida, Kathrin; Stamnaes, Jorunn; du Pre, M. Fleur; Mysling, Simon; Jorgensen, Thomas J. D.; Sollid, Ludvig M.; Iversen, Rasmus			Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; antibody; autoimmunity; enzyme catalysis; mass spectrometry (MS); transglutaminase; capillary electrophoresis; celiac disease; hydrogen; deuterium exchange	PIG LIVER TRANSGLUTAMINASE; TISSUE TRANSGLUTAMINASE; POSTTRANSLATIONAL MODIFICATION; 2-SPECIFIC AUTOANTIBODIES; STRUCTURAL BASIS; PLASMA-CELLS; MECHANISM; IDENTIFICATION; INACTIVATION; BINDING	Transglutaminase 2 (TG2) is a Ca2+-dependent cross-linking enzyme involved in the pathogenesis of CD. We have previously characterized a panel of anti-TG2 mAbs generated from gut plasma cells of celiac patients and identified four epitopes (epitopes 1-4) located in the N-terminal part of TG2. Binding of the mAbs induced allosteric changes in TG2. Thus, we aimed to determine whether these mAbs could influence enzymatic activity through modulation of TG2 susceptibility to oxidative inactivation and Ca2+ affinity. All tested epitope 1 mAbs, as well as 679-14-D04, which recognizes a previously uncharacterized epitope, prevented oxidative inactivation and increased Ca2+ sensitivity of TG2. We have identified crucial residues for binding of 679-14-D04 located within a Ca2+ binding site. Epitope 1 mAbs and 679-14-D04, although recognizing separate epitopes, behaved similarly when assessing their effect on TG2 conformation, suggesting that the shared effects on TG2 function can be explained by induction of the same conformational changes. None of the mAbs targeting other epitopes showed these effects, but epitope 2 mAbs reduced the rate of TG2-catalyzed reactions. Collectively, these effects could be relevant to the pathogenesis of CD. In A20 B cells transduced with TG2-specific B-cell receptor, epitope 2-expressing cells had poorer uptake of TG2-gluten complexes and were less efficient in gluten epitope presentation to T cells than cells expressing an epitope 1 receptor. Thus, the ability of epitope 1-targeting B cells to keep TG2 active and protected from oxidation might explain why generation of epitope 1-targeting plasma cells seems to be favored in celiac patients.	[Hnida, Kathrin; Stamnaes, Jorunn; du Pre, M. Fleur; Sollid, Ludvig M.; Iversen, Rasmus] Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway; [Hnida, Kathrin; Stamnaes, Jorunn; du Pre, M. Fleur; Sollid, Ludvig M.; Iversen, Rasmus] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Hnida, Kathrin; Stamnaes, Jorunn; du Pre, M. Fleur; Sollid, Ludvig M.; Iversen, Rasmus] Oslo Univ Hosp, N-0372 Oslo, Norway; [Mysling, Simon; Jorgensen, Thomas J. D.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Oslo; University of Oslo; University of Oslo; University of Southern Denmark	Hnida, K (corresponding author), Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway.; Hnida, K (corresponding author), Univ Oslo, Dept Immunol, N-0372 Oslo, Norway.	kathrin.hnida@medisin.uio.no		Stamnaes, Jorunn/0000-0002-0257-2112; du Pre, M. Fleur/0000-0001-9231-643X; Jorgensen, Thomas J.D./0000-0002-7149-316X; Mysling, Simon/0000-0003-4221-6320; Iversen, Rasmus/0000-0002-3292-1766	European Community [MRTN-CT-2011-289964, ERC-2010-Ad-268541]; Research Council of Norway through Centres of Excellence [179573/V40]; South-Eastern Norway Regional Health Authority	European Community(European Commission); Research Council of Norway through Centres of Excellence; South-Eastern Norway Regional Health Authority	This work was supported by the European Community's Seventh Framework Programme through Grants MRTN-CT-2011-289964 and ERC-2010-Ad-268541, by the Research Council of Norway through Centres of Excellence Funding Scheme Project 179573/V40, and by the South-Eastern Norway Regional Health Authority. The authors declare that they have no conflicts of interest with the contents of this article.	Adamczyk M, 2015, J CELL SCI, V128, P4615, DOI 10.1242/jcs.175968; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; BOOTHE RL, 1969, J BIOL CHEM, V244, P399; Caputo I, 2009, AMINO ACIDS, V36, P693, DOI 10.1007/s00726-008-0120-z; Cardoso I, 2017, AMINO ACIDS, V49, P489, DOI 10.1007/s00726-016-2296-y; Cardoso I, 2015, FEBS J, V282, P2063, DOI 10.1111/febs.13276; Cervio E, 2007, GASTROENTEROLOGY, V133, P195, DOI 10.1053/j.gastro.2007.04.070; Chen X, 2015, J BIOL CHEM, V290, P21365, DOI 10.1074/jbc.M115.669895; CHUNG SI, 1970, J BIOL CHEM, V245, P6424; CONNELLAN JM, 1969, J BIOL CHEM, V244, P3173; Darrah E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005370; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Di Simone N, 2010, AM J GASTROENTEROL, V105, P2254, DOI 10.1038/ajg.2010.233; Dieterich W, 2003, GUT, V52, P1562, DOI 10.1136/gut.52.11.1562; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; FOLK JE, 1967, J BIOL CHEM, V242, P1838; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Iversen R, 2015, J IMMUNOL, V195, P5159, DOI 10.4049/jimmunol.1501363; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; Jang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107005; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Kalliokoski S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065887; Kanchan K, 2013, BIOCHEM J, V455, P261, DOI 10.1042/BJ20130696; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kiraly R, 2006, J AUTOIMMUN, V26, P278, DOI 10.1016/j.jaut.2006.03.002; Kiraly R, 2009, FEBS J, V276, P7083, DOI 10.1111/j.1742-4658.2009.07420.x; Lai TS, 2007, FASEB J, V21, P4131, DOI 10.1096/fj.06-7598com; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Myrsky E, 2009, CELL MOL LIFE SCI, V66, P3375, DOI 10.1007/s00018-009-0116-1; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Roth EB, 2003, AUTOIMMUNITY, V36, P221, DOI 10.1080/0891693031000118974; ROTH WJ, 1986, J LEUKOCYTE BIOL, V39, P629, DOI 10.1002/jlb.39.6.629; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Snir O, 2015, J IMMUNOL, V194, P5703, DOI 10.4049/jimmunol.1402611; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; Sollid LM, 2015, DIGEST DIS, V33, P115, DOI 10.1159/000369512; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; UPCHURCH HF, 1987, IN VITRO CELL DEV B, V23, P795; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	53	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25542	25552		10.1074/jbc.M116.738161	http://dx.doi.org/10.1074/jbc.M116.738161			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27784785	Green Published, hybrid			2022-12-28	WOS:000390095300022
J	Liu, X; Shu, S; Billington, N; Williamson, CD; Yu, S; Brzeska, H; Donaldson, JG; Sellers, JR; Korn, ED				Liu, Xiong; Shu, Shi; Billington, Neil; Williamson, Chad D.; Yu, Shuhua; Brzeska, Hanna; Donaldson, Julie G.; Sellers, James R.; Korn, Edward D.			Mammalian Nonmuscle Myosin II Binds to Anionic Phospholipids with Concomitant Dissociation of the Regulatory Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE MYOSIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TRANSPORT VESICLES; PLASMA-MEMBRANE; GOLGI MEMBRANES; ATPASE ACTIVITY; IN-VITRO; PHOSPHORYLATION; ACTIN	Mammalian cells express three Class II nonmuscle myosins (NM): NM2A, NM2B, and NM2C. The three NM2s have well established essential roles in cell motility, adhesion, and cytokinesis and less well defined roles in vesicle transport and other processes that would require association of NM2s with cell membranes. Previous evidence for the mechanism of NM2-membrane association includes direct interaction of NM2s with membrane lipids and indirect interaction by association of NM2s with membrane-bound F-actin or peripheral membrane proteins. Direct binding of NM2s to phosphatidylserine-liposomes, but not to phosphatidylcholine-liposomes, has been reported, but the molecular basis of the interaction between NM2s and acidic phospholipids has not been previously investigated. We now show that filamentous, full-length NM2A, NM2B, and NM2C and monomeric, non-filamentous heavy meromyosin bind to liposomes containing one or more acidic phospholipids (phosphatidylserine, phosphatidylinositol 4,5-diphosphate, and phosphatidylinositol 3,4,5-triphosphate) but do not bind to 100% phosphatidylcholine-liposomes. Binding of NM2s to acidic liposomes occurs predominantly through interaction of the liposomes with the regulatory light chain (RLC) binding site in the myosin heavy chain with concomitant dissociation of the RLC. Phosphorylation of myosin-bound RLC by myosin light chain kinase substantially inhibits binding to liposomes of both filamentous NM2 and non-filamentous heavy meromyosin; the addition of excess unbound RLC, but not excess unbound essential light chain, competes with liposome binding. Consistent with the in vitro data, we show that endogenous and expressed NM2A associates with the plasma membrane of HeLa cells and fibrosarcoma cells independently of F-actin.	[Liu, Xiong; Shu, Shi; Williamson, Chad D.; Yu, Shuhua; Brzeska, Hanna; Donaldson, Julie G.; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bldg 50,Rm 2517,9000 Rockville Pike, Bethesda, MD 20892 USA; [Billington, Neil; Sellers, James R.] NHLBI, Labs Mol Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Korn, ED (corresponding author), NHLBI, Cell Biol Lab, NIH, Bldg 50,Rm 2517,9000 Rockville Pike, Bethesda, MD 20892 USA.	edk@nih.gov		Korn, Edward/0000-0003-3867-6295; Billington, Neil/0000-0003-2306-0228	Electron and Light Microscopy Cores of the NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001786, ZIAHL006130] Funding Source: NIH RePORTER	Electron and Light Microscopy Cores of the NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the support of the Electron and Light Microscopy Cores of the NHLBI, National Institutes of Health. We thank Dr. John Hammer 3rd (NHLBI) for NM2A-mTomato and Dr. Fang Zhang (NHLBI) for purified myosin light chain kinase.	ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Barylko B, 2005, ACTA BIOCHIM POL, V52, P373; Billington N, 2013, J BIOL CHEM, V288, P33398, DOI 10.1074/jbc.M113.499848; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2012, J BIOL CHEM, V287, P14923, DOI 10.1074/jbc.M111.318667; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; DeGiorgis JA, 2002, MOL BIOL CELL, V13, P1046, DOI 10.1091/mbc.01-06-0315; DePina AS, 2007, CELL MOTIL CYTOSKEL, V64, P739, DOI 10.1002/cm.20219; Dulyaninova Natalya G, 2013, Bioarchitecture, V3, P77; Duran JM, 2003, MOL BIOL CELL, V14, P445, DOI 10.1091/mbc.E02-04-0214; Ecay TW, 1997, BIOCHEM BIOPH RES CO, V231, P369, DOI 10.1006/bbrc.1997.6093; Fath KR, 2005, CELL MOTIL CYTOSKEL, V60, P222, DOI 10.1002/cm.20060; FECHHEIMER M, 1982, J CELL BIOL, V93, P261, DOI 10.1083/jcb.93.2.261; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Ikonen E, 1997, J CELL SCI, V110, P2155; Ishmael JE, 2007, BRAIN RES, V1143, P46, DOI 10.1016/j.brainres.2007.01.061; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; LEBOWITZ EA, 1978, J BIOL CHEM, V253, P5443; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Linz-McGillem LA, 2003, EXP EYE RES, V76, P543, DOI 10.1016/S0014-4835(03)00031-9; Liu X, 2013, P NATL ACAD SCI USA, V110, pE33, DOI 10.1073/pnas.1219727110; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Morimura S, 2011, BIOCHEM BIOPH RES CO, V404, P834, DOI 10.1016/j.bbrc.2010.12.069; Murakami N, 1995, BIOCHEMISTRY-US, V34, P16046, DOI 10.1021/bi00049a019; MURAKAMI N, 1994, J BIOL CHEM, V269, P16082; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Sanborn KB, 2011, BLOOD, V118, P5862, DOI 10.1182/blood-2011-03-344846; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stow JL, 1998, BBA-MOL CELL RES, V1404, P161, DOI 10.1016/S0167-4889(98)00055-X; SUZUKI H, 1982, J BIOCHEM-TOKYO, V91, P1699, DOI 10.1093/oxfordjournals.jbchem.a133861; SWANLJUNGCOLLINS H, 1992, J BIOL CHEM, V267, P3445; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; TROTTER JA, 1979, J BIOL CHEM, V254, P8781; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786	44	18	19	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24828	24837		10.1074/jbc.M116.739185	http://dx.doi.org/10.1074/jbc.M116.739185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27697842	hybrid, Green Published			2022-12-28	WOS:000388880100003
J	Li, MM; Yang, SY; Xu, D				Li, Miaomiao; Yang, Shuying; Xu, Ding			Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; dimerization; heparan sulfate; osteoblast; small-angle X-ray scattering (SAXS); RANKL; osteoclastogenesis; osteoprotegerin; ternary complex	KAPPA-B LIGAND; RECEPTOR ACTIVATOR; INHIBITORY FACTOR; DECOY RECEPTOR; BONE-DENSITY; PROTEIN; RANKL; GLYCOSAMINOGLYCANS; DIFFERENTIATION; CYTOKINE	Osteoprotegerin (OPG), a decoy receptor secreted by osteoblasts, is a major negative regulator of bone resorption. It functions by neutralizing the receptor activator of nuclear factor B ligand (RANKL), which plays a central role in promoting osteoclastogenesis. OPG is known to be a high-affinity heparan sulfate (HS)-binding protein. Presumably, HS could regulate the function of OPG and affect how it inhibits RANKL. However, the molecular detail of HS-OPG interaction remains poorly understood, which hinders our understanding of how HS functions in osteoclastogenesis. Here we report mapping of the HS-binding site of OPG. The HS-binding site, identified by mutagenesis study, consists of eight basic residues that are located mostly at the junction of the second death domain and the C-terminal domain. We further show that heparin-derived dodecasaccharide is able to induce dimerization of OPG monomers with a stoichiometry of 1:1. Small-angle X-ray scattering analysis revealed that upon binding of HS, OPG undergoes a dramatic conformational change, resulting in a more compact and less flexible structure. Importantly, we present here three lines of evidence that HS, OPG, and RANKL form a stable ternary complex. Using a HS binding-deficient OPG mutant, we further show that in an osteoblast/bone marrow macrophage co-culture system, immobilization of OPG by HS at the osteoblast cell surface substantially lowers the inhibitory threshold of OPG toward RANKL. These discoveries strongly suggest that HS plays an active role in regulating OPG-RANKL interaction and osteoclastogenesis.	[Li, Miaomiao; Yang, Shuying; Xu, Ding] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Xu, D (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA.	dingxu@buffalo.edu	Xu, ding/B-2493-2009	Xu, ding/0000-0001-9380-2712; Li, Miaomiao/0000-0003-4508-196X	DOE Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048388] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Xue Yuan for help with osteoblasts isolation and setting up co-culture osteoclastogenesis assay. We also thank Dr. Lars Pedersen for reviewing the manuscript. SAXS data collection was conducted at the Advanced Light Source (ALS), a national user facility operated by the Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research.	Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Ganesh VK, 2004, P NATL ACAD SCI USA, V101, P8924, DOI 10.1073/pnas.0400744101; Irie A, 2007, BONE, V41, P165, DOI 10.1016/j.bone.2007.04.190; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamoureux F, 2009, CANCER RES, V69, P526, DOI 10.1158/0008-5472.CAN-08-2648; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Standal T, 2002, BLOOD, V100, P3002, DOI 10.1182/blood-2002-04-1190; Theoleyre S, 2006, BIOCHEM BIOPH RES CO, V347, P460, DOI 10.1016/j.bbrc.2006.06.120; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Yamaguchi K, 1998, J BIOL CHEM, V273, P5117, DOI 10.1074/jbc.273.9.5117; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yuan X, 2015, CELL DEATH DIFFER, V22, P2046, DOI 10.1038/cdd.2015.45; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	26	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24160	24171		10.1074/jbc.M116.751974	http://dx.doi.org/10.1074/jbc.M116.751974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27697839	Green Published, hybrid			2022-12-28	WOS:000388498100031
J	Lu, ZY; Reddy, MVVVS; Liu, JF; Kalichava, A; Liu, JK; Zhang, L; Chen, F; Wang, Y; Holthauzen, LMF; White, MA; Seshadrinathan, S; Zhong, XY; Ren, G; Rudenko, G				Lu, Zhuoyang; Reddy, M. V. V. V. Sekhar; Liu, Jianfang; Kalichava, Ana; Liu, Jiankang; Zhang, Lei; Chen, Fang; Wang, Yun; Holthauzen, Luis Marcelo F.; White, Mark A.; Seshadrinathan, Suchithra; Zhong, Xiaoying; Ren, Gang; Rudenko, Gabby			Molecular Architecture of Contactin-associated Protein-like 2 (CNTNAP2) and Its Interaction with Contactin 2 (CNTN2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell surface receptor; protein-protein interaction; structural biology; synapse; contactin; contactin-associated protein like; neuropsychiatric disorders; single particle analysis; synaptic organizer	NEGATIVE-STAINING PROTOCOL; MYELINATED AXONS; EXTRACELLULAR DOMAIN; ELECTRON-MICROSCOPY; SYNAPTIC CLEFT; CASPR2; SPECTRUM; REVEALS; VISUALIZATION; ABNORMALITIES	Contactin-associated protein-like 2 (CNTNAP2) is a large multidomain neuronal adhesion molecule implicated in a number of neurological disorders, including epilepsy, schizophrenia, autism spectrum disorder, intellectual disability, and language delay. We reveal here by electron microscopy that the architecture of CNTNAP2 is composed of a large, medium, and small lobe that flex with respect to each other. Using epitope labeling and fragments, we assign the F58C, L1, and L2 domains to the large lobe, the FBG and L3 domains to the middle lobe, and the L4 domain to the small lobe of the CNTNAP2 molecular envelope. Our data reveal that CNTNAP2 has a very different architecture compared with neurexin 1, a fellow member of the neurexin superfamily and a prototype, suggesting that CNTNAP2 uses a different strategy to integrate into the synaptic protein network. We show that the ectodomains of CNTNAP2 and contactin 2 (CNTN2) bind directly and specifically, with low nanomolar affinity. We show further that mutations in CNTNAP2 implicated in autism spectrum disorder are not segregated but are distributed over the whole ectodomain. The molecular shape and dimensions of CNTNAP2 place constraints on how CNTNAP2 integrates in the cleft of axo-glial and neuronal contact sites and how it functions as an organizing and adhesive molecule.	[Lu, Zhuoyang; Liu, Jianfang; Zhang, Lei; Ren, Gang] Lawrence Berkeley Natl Lab, Mol Foundry, Rm 2220,1 Cyclotron Rd,MS 67R2206, Berkeley, CA 94720 USA; [Lu, Zhuoyang; Liu, Jiankang] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Lu, Zhuoyang; Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Reddy, M. V. V. V. Sekhar; Kalichava, Ana; Seshadrinathan, Suchithra; Zhong, Xiaoying; Rudenko, Gabby] Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA; [Reddy, M. V. V. V. Sekhar; Kalichava, Ana; Holthauzen, Luis Marcelo F.; White, Mark A.; Seshadrinathan, Suchithra; Zhong, Xiaoying; Rudenko, Gabby] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA; [White, Mark A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Chen, Fang; Wang, Yun] Univ Michigan, Ann Arbor, MI 48109 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Xi'an Jiaotong University; Xi'an Jiaotong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Michigan System; University of Michigan	Ren, G (corresponding author), Lawrence Berkeley Natl Lab, Mol Foundry, Rm 2220,1 Cyclotron Rd,MS 67R2206, Berkeley, CA 94720 USA.; Rudenko, G (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.; Rudenko, G (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA.	gren@lbl.gov; garudenk@utmb.edu	Rudenko, Gabrielle (Gabby)/O-7938-2018; Reddy, M. V. V. V. Sekhar/I-1093-2019; Liu, Jiankang/A-1610-2011; Ren, Gang/B-1567-2012; M, Sekharreddy/C-9428-2014; White, Mark Andrew/B-1723-2012; Zhang, Lei/G-6427-2012	Rudenko, Gabrielle (Gabby)/0000-0002-7372-0530; Ren, Gang/0000-0002-8036-2321; White, Mark Andrew/0000-0003-1057-4203; Zhang, Lei/0000-0002-4880-824X; manukonda, veera/0000-0002-9917-8778; Liu, Jianfang/0000-0001-6786-8873	NIMH, National Institutes of Health [R01MH077303]; Sealy Center for Structural Biology and Molecular Biophysics (University of Texas Medical Branch); Brain and Behavior Research Foundation; United States Department of Energy [DE-AC02-05CH11231]; National Basic Research Program of the Ministry of Science and Technology, China [2015CB553602]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077303] Funding Source: NIH RePORTER	NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sealy Center for Structural Biology and Molecular Biophysics (University of Texas Medical Branch); Brain and Behavior Research Foundation; United States Department of Energy(United States Department of Energy (DOE)); National Basic Research Program of the Ministry of Science and Technology, China; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH, National Institutes of Health, Grant R01MH077303 with additional support provided by the Sealy Center for Structural Biology and Molecular Biophysics (University of Texas Medical Branch) and the Brain and Behavior Research Foundation (to G. Rudenko). Work at the Molecular Foundry (G. Ren) was supported by the United States Department of Energy under Contract DE-AC02-05CH11231. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the National Basic Research Program of the Ministry of Science and Technology, China (Grant 2015CB553602).	Al-Murrani A, 2012, CASE REP GENET, V2012, DOI DOI 10.1155/2012/172408; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Anderson GR, 2012, P NATL ACAD SCI USA, V109, P18120, DOI 10.1073/pnas.1216398109; Arroyo EJ, 2001, CELL TISSUE RES, V305, P53, DOI 10.1007/s004410100403; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Banerjee S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025926; Becker EBE, 2012, J NEUROL NEUROSUR PS, V83, P437, DOI 10.1136/jnnp-2011-301506; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Buchner DA, 2012, MAMM GENOME, V23, P431, DOI 10.1007/s00335-012-9400-8; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Chen N, 2015, BBA-PROTEINS PROTEOM, V1854, P827, DOI 10.1016/j.bbapap.2015.02.008; Comoletti D, 2010, STRUCTURE, V18, P1044, DOI 10.1016/j.str.2010.06.005; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; de Arce KP, 2015, NEURON, V88, P1165, DOI 10.1016/j.neuron.2015.11.011; Faivre-Sarrailh C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00196; Falivelli G, 2012, HUM MOL GENET, V21, P4761, DOI 10.1093/hmg/dds320; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gdalyahu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125633; Gregor A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-106; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; High Brigit, 2015, Front Synaptic Neurosci, V7, P9, DOI 10.3389/fnsyn.2015.00009; Irani SR, 2012, ANN NEUROL, V72, P241, DOI 10.1002/ana.23577; Irani SR, 2012, ARQ NEURO-PSIQUIAT, V70, P300, DOI 10.1590/S0004-282X2012000400015; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Lancaster E, 2011, ANN NEUROL, V69, P303, DOI 10.1002/ana.22297; Linsalata AE, 2014, J COMP NEUROL, V522, P921, DOI 10.1002/cne.23453; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Melzer N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-160; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Murdoch JD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004852; Nans A, 2011, J NEUROSCI RES, V89, P310, DOI 10.1002/jnr.22561; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Olsen AL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000127; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinatel D, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00265, 10.3389/fncel.2015.00265]; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rodenas-Cuadrado P, 2014, EUR J HUM GENET, V22, P171, DOI 10.1038/ejhg.2013.100; Rubio-Marrero EN, 2016, J BIOL CHEM, V291, P5788, DOI 10.1074/jbc.M115.705681; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Sampath S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077906; Savvaki M, 2010, J NEUROSCI, V30, P13943, DOI 10.1523/JNEUROSCI.2574-10.2010; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Varea O, 2015, P NATL ACAD SCI USA, V112, P6176, DOI 10.1073/pnas.1423205112; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030249, 10.1371/journal.pone.0030592]; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102; Zweier C, 2011, MOL SYNDROMOL, V2, P181, DOI 10.1159/000331270; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	64	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24133	24147		10.1074/jbc.M116.748236	http://dx.doi.org/10.1074/jbc.M116.748236			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27621318	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000388498100029
J	Mathieu, C; Duval, R; Cocaign, A; Petit, E; Bui, LC; Haddad, I; Vinh, J; Etchebest, C; Dupret, JM; Rodrigues-Lima, F				Mathieu, Cecile; Duval, Romain; Cocaign, Angelique; Petit, Emile; Bui, Linh-Chi; Haddad, Iman; Vinh, Joelle; Etchebest, Catherine; Dupret, Jean-Marie; Rodrigues-Lima, Fernando			An Isozyme-specific Redox Switch in Human Brain Glycogen Phosphorylase Modulates Its Allosteric Activation by AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; brain metabolism; carbohydrate metabolism; disulfide; glycogen; glycogen storage disease; redox regulation	HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; OXIDATIVE STRESS; DISULFIDE BOND; METABOLISM; THIOREDOXIN; CHEMISTRY; DISEASE; SITE; NEURODEGENERATION	Brain glycogen and its metabolism are increasingly recognized as major players in brain functions. Moreover, alteration of glycogen metabolism in the brain contributes to neurodegenerative processes. In the brain, both muscle and brain glycogen phosphorylase isozymes regulate glycogen mobilization. However, given their distinct regulatory features, these two isozymes could confer distinct metabolic functions of glycogen in brain. Interestingly, recent proteomics studies have identified isozyme-specific reactive cysteine residues in brain glycogen phosphorylase (bGP). In this study, we show that the activity of human bGP is redox-regulated through the formation of a disulfide bond involving a highly reactive cysteine unique to the bGP isozyme. We found that this disulfide bond acts as a redox switch that precludes the allosteric activation of the enzyme by AMP without affecting its activation by phosphorylation. This unique regulatory feature of bGP sheds new light on the isoform-specific regulation of glycogen phosphorylase and glycogen metabolism.	[Mathieu, Cecile; Duval, Romain; Cocaign, Angelique; Petit, Emile; Bui, Linh-Chi; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, CNRS UMR 8251, Sorbonne Paris Cite, Unite BFA, F-75013 Paris, France; [Haddad, Iman; Vinh, Joelle] PSL Res Univ, ESPCI Paris, CNRS USR 3149, Spectromet Masse Biol & Proteom SMPB, 10 Rue Vauquelin, F-75231 Paris 05, France; [Etchebest, Catherine] Univ Paris Diderot, INSERM, UMR S1134, F-75015 Paris, France; [Etchebest, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, F-75013 Paris, France; [Etchebest, Catherine] INTS, F-75015 Paris, France; [Etchebest, Catherine] GR Ex, Lab Dexcellence, F-75015 Paris, France; [Etchebest, Catherine; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, CNRS UMR 8251, Sorbonne Paris Cite, Unite BFA, F-75013 Paris, France.; Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France.	fernando.rodrigues-lima@univ-paris-diderot.fr	etchebest, catherine/O-2485-2019; Duval, Romain/D-7764-2015; Vinh, Joelle/K-1347-2015	etchebest, catherine/0000-0002-5871-2372; Vinh, Joelle/0000-0001-7184-2668; Duval, Romain/0000-0002-5785-0685	University Paris Diderot; CNRS; University Paris Diderot (Ecole Doctorale BioSPC); Region Ile de France	University Paris Diderot; CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot (Ecole Doctorale BioSPC); Region Ile de France(Region Ile-de-France)	This work was supported by the University Paris Diderot and CNRS. This work was also supported by Ph.D. fellowships from the University Paris Diderot (Ecole Doctorale BioSPC) (to C. M.), Region Ile de France (to R. D.), and University Paris Diderot (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Atmane N, 2003, J BIOL CHEM, V278, P35086, DOI 10.1074/jbc.M303813200; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bhattacharya S, 2008, BIOORG MED CHEM LETT, V18, P5856, DOI 10.1016/j.bmcl.2008.06.029; Bogumil R, 2000, EUR J BIOCHEM, V267, P1407, DOI 10.1046/j.1432-1327.2000.01133.x; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Cook KM, 2013, J BIOL CHEM, V288, P34920, DOI 10.1074/jbc.M113.523506; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dairou J, 2007, J MOL BIOL, V372, P1009, DOI 10.1016/j.jmb.2007.07.011; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; GERTZ HJ, 1985, MECH AGEING DEV, V31, P25, DOI 10.1016/0047-6374(85)90024-7; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gibbs ME, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00070; Giulivi C, 2001, J BIOL CHEM, V276, P24129, DOI 10.1074/jbc.M010697200; Go YM, 2015, FREE RADICAL BIO MED, V84, P227, DOI 10.1016/j.freeradbiomed.2015.03.022; Gould NS, 2015, CHEM BIOL, V22, P965, DOI 10.1016/j.chembiol.2015.06.010; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Hampton MB, 2002, FEBS LETT, V517, P229, DOI 10.1016/S0014-5793(02)02629-7; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Hossain MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097570; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jamsen J, 2010, BIOCHEMISTRY-US, V49, P1005, DOI 10.1021/bi9019737; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lindahl E, 2015, METHODS MOL BIOL, V1215, P3, DOI 10.1007/978-1-4939-1465-4_1; Lo Conte M, 2015, ACS CHEM BIOL, V10, P1825, DOI 10.1021/acschembio.5b00124; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; MADDAIAH VT, 1966, J BIOL CHEM, V241, P3873; MARTIN JL, 1990, BIOCHEMISTRY-US, V29, P10745, DOI 10.1021/bi00500a005; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Mathieu C, 2016, J BIOL CHEM, V291, P18072, DOI 10.1074/jbc.M116.738898; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; Nishii W, 2015, NAT CHEM BIOL, V11, P46, DOI 10.1038/nchembio.1688; PARK EM, 1989, ARCH BIOCHEM BIOPHYS, V272, P25, DOI 10.1016/0003-9861(89)90190-2; de la Cruz VP, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/494316; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato N, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3339/fnagi.2015,00199, 10.3389/fnagi.2015.00199]; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Seiwert B, 2008, J AM SOC MASS SPECTR, V19, P1, DOI 10.1016/j.jasms.2007.10.001; SPRANG SR, 1991, SCIENCE, V254, P1367, DOI 10.1126/science.1962195; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Swanson R A, 1989, Neurol Res, V11, P24; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Yang J, 2015, NAT PROTOC, V10, P1022, DOI 10.1038/nprot.2015.062; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005	64	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23842	23853		10.1074/jbc.M116.757062	http://dx.doi.org/10.1074/jbc.M116.757062			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27660393	Green Published, hybrid			2022-12-28	WOS:000388498100001
J	Subramani, J; Kundumani-Sridharan, V; Hilgers, RHP; Owens, C; Das, KC				Subramani, Jaganathan; Kundumani-Sridharan, Venkatesh; Hilgers, Rob H. P.; Owens, Cade; Das, Kumuda C.			Thioredoxin Uses a GSH-independent Route to Deglutathionylate Endothelial Nitric-oxide Synthase and Protect against Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial dysfunction; glutathionylation; heart failure; ischemia; myocardial infarction; nitric-oxide synthase; thioredoxin; thioredoxin reductase; reperfusion	OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; S-GLUTATHIONYLATION; VASCULAR-DISEASE; CARDIOVASCULAR-DISEASES; ENDOGENOUS THIOREDOXIN; SUPEROXIDE-DISMUTASE; REPERFUSION INJURY; GENE-EXPRESSION; NO SYNTHASE	Reversible glutathionylation plays a critical role in protecting protein function under conditions of oxidative stress generally and for endothelial nitric-oxide synthase (eNOS) specifically. Glutathione-dependent glutaredoxin-mediated deglutathionylation of eNOS has been shown to confer protection in a model of heart damage termed ischemia-reperfusion injury, motivating further study of eNOS deglutathionylation in general. In this report, we present evidence for an alternative mechanism of deglutathionylation. In this pathway thioredoxin (Trx), a small cellular redox protein, is shown to rescue eNOS from glutathionylation during ischemia-reperfusion in a GSH-independent manner. By comparing mice with global overexpression of Trx and mice with cardiomyocyte-specific overexpression of Trx, we demonstrate that vascular Trx-mediated deglutathionylation of eNOS protects against ischemia-reperfusion-mediated myocardial infarction. Trx deficiency in endothelial cells promoted eNOS glutathionylation and reduced its enzymatic activity, whereas increased levels of Trx led to deglutathionylated eNOS. Thioredoxin-mediated deglutathionylation of eNOS in the coronary artery in vivo protected against reperfusion injury, even in the presence of normal levels of GSH. We further show that Trx directly interacts with eNOS, and we confirmed that Cys-691 and Cys-910 are the glutathionylated sites, as mutation of these cysteines partially rescued the decrease in eNOS activity, whereas mutation of a distal site, Cys-384, did not. Collectively, this study shows for the first time that Trx is a potent deglutathionylating protein in vivo and in vitro that can deglutathionylate proteins in the presence of high levels of GSSG in conditions of oxidative stress.	[Subramani, Jaganathan; Kundumani-Sridharan, Venkatesh; Hilgers, Rob H. P.; Owens, Cade; Das, Kumuda C.] Texas Tech Univ, Dept Anesthesiol, Hlth Sci Ctr, 3601 4th St,STOP 6598, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Das, KC (corresponding author), Texas Tech Univ, Dept Anesthesiol, Hlth Sci Ctr, 3601 4th St,STOP 6598, Lubbock, TX 79430 USA.	kumuda.das@ttuhsc.edu	Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Subramani, Jaganathan/0000-0002-5707-8621	National Institutes of Health [HL 1R01HL107885, 1R01HL109397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107885, R01HL109397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL 1R01HL107885 and 1R01HL109397 (to K. C. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bohl S, 2009, AM J PHYSIOL-HEART C, V297, pH2054, DOI 10.1152/ajpheart.00836.2009; Brunner F, 2001, CIRCULATION, V104, P3097, DOI 10.1161/hc5001.101966; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen CA, 2013, BIOCHEMISTRY-US, V52, P6712, DOI 10.1021/bi400404s; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Das KC, 2000, BIOCHEM BIOPH RES CO, V277, P443, DOI 10.1006/bbrc.2000.3689; Das KC, 1999, AM J PHYSIOL-LUNG C, V276, pL530, DOI 10.1152/ajplung.1999.276.3.L530; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; De Pascali F, 2014, BIOCHEMISTRY-US, V53, P3679, DOI 10.1021/bi500076r; Duncan MC, 2001, NAT CELL BIOL, V3, P687, DOI 10.1038/35083087; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Godecke A, 2001, J PHYSIOL-LONDON, V532, P195, DOI 10.1111/j.1469-7793.2001.0195g.x; Hilgers RHP, 2015, HYPERTENSION, V65, P130, DOI 10.1161/HYPERTENSIONAHA.114.04473; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Holmgren Arne, 2000, Biofactors, V11, P63; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Jin YX, 2012, METHODS MOL BIOL, V843, P147, DOI 10.1007/978-1-61779-523-7_14; Kanno S, 2000, CIRCULATION, V101, P2742, DOI 10.1161/01.CIR.101.23.2742; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579, DOI 10.2174/13816128113196660748; Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Kundumani-Sridharan V, 2015, J BIOL CHEM, V290, P17505, DOI 10.1074/jbc.M115.660365; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lee MCI, 2014, BIOCHEMISTRY-US, V53, P6615, DOI 10.1021/bi500582r; LEFER AM, 1991, FASEB J, V5, P2029, DOI 10.1096/fasebj.5.7.2010056; Li HG, 2013, CURR OPIN PHARMACOL, V13, P161, DOI 10.1016/j.coph.2013.01.006; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Muniyappa H, 2009, J BIOL CHEM, V284, P17069, DOI 10.1074/jbc.M109.008557; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Qian J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00347; Ravi D, 2005, J BIOL CHEM, V280, P40084, DOI 10.1074/jbc.M507192200; Sadek HA, 2003, ARCH BIOCHEM BIOPHYS, V420, P201, DOI 10.1016/j.abb.2003.09.029; Schiffrin EL, 2008, HYPERTENSION, V51, P31, DOI 10.1161/HYPERTENSIONAHA.107.103226; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261; Zweier JL, 2011, ANTIOXID REDOX SIGN, V14, P1769, DOI 10.1089/ars.2011.3904	50	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23374	23389		10.1074/jbc.M116.745034	http://dx.doi.org/10.1074/jbc.M116.745034			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27587398	Green Published, hybrid			2022-12-28	WOS:000387884400002
J	Habeck, M; Tokhtaeva, E; Nadav, Y; Ben Zeev, E; Ferris, SP; Kaufman, RJ; Bab-Dinitz, E; Kaplan, JH; Dada, LA; Farfel, Z; Tal, DM; Katz, A; Sachs, G; Vagin, O; Karlish, SJD				Habeck, Michael; Tokhtaeva, Elmira; Nadav, Yotam; Ben Zeev, Efrat; Ferris, Sean P.; Kaufman, Randal J.; Bab-Dinitz, Elizabeta; Kaplan, Jack H.; Dada, Laura A.; Farfel, Zvi; Tal, Daniel M.; Katz, Adriana; Sachs, George; Vagin, Olga; Karlish, Steven J. D.			Selective Assembly of Na,K-ATPase alpha(2)beta(2) Heterodimers in the Heart DISTINCT FUNCTIONAL PROPERTIES AND ISOFORM-SELECTIVE INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; CARDIAC NA/K ATPASE; NA+/K+-ATPASE; PICHIA-PASTORIS; K-ATPASE; ADHESION MOLECULE; CRYSTAL-STRUCTURE; ALPHA-2 ISOFORM; BETA-SUBUNIT; INTRAOCULAR-PRESSURE	The Na, K-ATPase alpha(2) subunit plays a key role in cardiac muscle contraction by regulating intracellular Ca2+, whereas alpha(1) has a more conventional role of maintaining ion homeostasis. The beta subunit differentially regulates maturation, trafficking, and activity of alpha-beta heterodimers. It is not known whether the distinct role of alpha(2) in the heart is related to selective assembly with a particular one of the three beta isoforms. We show here by immunofluorescence and co-immunoprecipitation that alpha(2) is preferentially expressed with beta(2) in T-tubules of cardiac myocytes, forming alpha(2)beta(2) heterodimers. We have expressed human alpha(1)beta(1), alpha(2)beta(1), alpha(2)beta(2), and alpha(2)beta(3) in Pichia pastoris, purified the complexes, and compared their functional properties. alpha(2)beta(2) and alpha(2)beta(3) differ significantly from both alpha(2)beta(1) and alpha(1)beta(1) in having a higher K0.5K+ and lower K0.5Na+ for activating Na, K-ATPase. These features are the result of a large reduction in binding affinity for extracellular K+ and shift of the E1P-E2P conformational equilibrium toward E1P. A screen of perhydro-1,4-oxazepine derivatives of digoxin identified several derivatives (e.g. cyclobutyl) with strongly increased selectivity for inhibition of alpha(2)beta(2) and alpha(2)beta(3) over alpha(1)beta(1) (range 22-33-fold). Molecular modeling suggests a possible basis for isoform selectivity. The preferential assembly, specific T-tubular localization, and low K+ affinity of alpha(2)beta(2) could allow an acute response to raised ambient K+ concentrations in physiological conditions and explain the importance of alpha(2)beta(2) for cardiac muscle contractility. The high sensitivity of alpha(2)beta(2) to digoxin derivatives explains beneficial effects of cardiac glycosides for treatment of heart failure and potential of alpha(2)beta(2)-selective digoxin derivatives for reducing cardiotoxicity.	[Bab-Dinitz, Elizabeta; Farfel, Zvi; Tal, Daniel M.; Katz, Adriana; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biomol Sci, IL-7610001 Rehovot, Israel; [Ben Zeev, Efrat] Weizmann Inst Sci, Israel Natl Ctr Personalized Med, IL-7610001 Rehovot, Israel; [Farfel, Zvi] Tel Aviv Univ, Sch Med, IL-6997801 Tel Aviv, Israel; [Tokhtaeva, Elmira; Sachs, George; Vagin, Olga] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; [Tokhtaeva, Elmira; Sachs, George; Vagin, Olga] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Ferris, Sean P.; Kaufman, Randal J.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Dada, Laura A.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Ferris, Sean P.] Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,Hlth Sci West 451,Box 0102, San Francisco, CA 94143 USA; [Kaufman, Randal J.] Sanford Burnham Prebys Med Discovery Inst, Rm 7103,10901 N Torrey Pines Rd, La Jolla, CA 92037 USA	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; Sanford Burnham Prebys Medical Discovery Institute	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-7610001 Rehovot, Israel.; Vagin, O (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA.; Vagin, O (corresponding author), Vet Adm Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA.	olgav@ucla.edu; Steven.Karlish@weizmann.ac.il		Habeck, Michael/0000-0002-4586-0499	Israel Science Foundation [789/12]; US-Israel Binational Science Foundation [711993]; National Institutes of Health [R37-HL48129, RO1HL113350]; USVA [2I01BX001006, 1RO1DK105156-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113350, R37HL048129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001006] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USVA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Israel Science Foundation (789/12) and US-Israel Binational Science Foundation (711993, to S. J. D. K.) and, in part, by National Institutes of Health Grants R37-HL48129 (to L. A. D.), RO1HL113350 (to L. A. D. and O. V.), USVA 2I01BX001006 (to G. S.), and 1RO1DK105156-01 (to G. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BLANCO G, 1995, BIOCHEMISTRY-US, V34, P319, DOI 10.1021/bi00001a039; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Chan KE, 2010, J AM SOC NEPHROL, V21, P1550, DOI 10.1681/ASN.2009101047; Cirri E, 2011, BIOCHEMISTRY-US, V50, P3736, DOI 10.1021/bi2001714; Clausen T, 2008, AM J PHYSIOL-ENDOC M, V295, pE727, DOI 10.1152/ajpendo.90494.2008; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Correll RN, 2014, CIRC RES, V114, P249, DOI 10.1161/CIRCRESAHA.114.302293; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Despa S, 2012, CARDIOVASC RES, V95, P480, DOI 10.1093/cvr/cvs213; DiFranco M, 2015, J GEN PHYSIOL, V146, P281, DOI 10.1085/jgp.201511407; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; EAKLE KA, 1994, J BIOL CHEM, V269, P6550; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; FORBUSH B, 1983, CURR TOP MEMBR TRANS, V19, P167; Gatto C, 1998, J BIOL CHEM, V273, P10578, DOI 10.1074/jbc.273.17.10578; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; Harada K, 2006, J PHYSIOL SCI, V56, P113, DOI 10.2170/physiolsci.RP001905; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Haviv H, 2013, J BIOL CHEM, V288, P10073, DOI 10.1074/jbc.M112.446997; Hoffman B. K., 1985, PHARMACOL BASIS THER, P716; Howie J, 2013, BIOCHEM SOC T, V41, P95, DOI 10.1042/BST20120269; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Juhaszova M, 1997, ANN NY ACAD SCI, V834, P524, DOI 10.1111/j.1749-6632.1997.tb52310.x; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Katz A, 2015, P NATL ACAD SCI USA, V112, P13723, DOI 10.1073/pnas.1514569112; Katz A, 2014, J BIOL CHEM, V289, P21153, DOI 10.1074/jbc.M114.557629; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Larsen BR, 2014, GLIA, V62, P608, DOI 10.1002/glia.22629; Laursen M, 2015, P NATL ACAD SCI USA, V112, P1755, DOI 10.1073/pnas.1422997112; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Loreaux EL, 2008, J AM SOC NEPHROL, V19, P1947, DOI 10.1681/ASN.2008020174; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; McDonough AA, 1996, AM J PHYSIOL-CELL PH, V270, pC1221, DOI 10.1152/ajpcell.1996.270.4.C1221; Mishra NK, 2015, J BIOL CHEM, V290, P28746, DOI 10.1074/jbc.M115.687913; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Pavlovic D, 2013, J MOL CELL CARDIOL, V61, P83, DOI 10.1016/j.yjmcc.2013.05.002; Rindler TN, 2011, AM J PHYSIOL-HEART C, V301, pH1396, DOI 10.1152/ajpheart.00121.2011; SCHMALZING G, 1992, J BIOL CHEM, V267, P20212; Schwinger RHG, 2003, CARDIOVASC RES, V57, P913, DOI 10.1016/S0008-6363(02)00767-8; Shattock MJ, 2015, J PHYSIOL-LONDON, V593, P1361, DOI 10.1113/jphysiol.2014.282319; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Stanley CM, 2015, BIOPHYS J, V109, P1852, DOI 10.1016/j.bpj.2015.09.015; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Tal DM, 2016, MAGN RESON CHEM, V54, P260, DOI 10.1002/mrc.4380; Tokhtaeva E, 2012, J BIOL CHEM, V287, P26115, DOI 10.1074/jbc.M112.370734; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2007, J BIOENERG BIOMEMBR, V39, P367, DOI 10.1007/s10863-007-9103-0; Vagin O, 2007, CELL BIOCHEM BIOPHYS, V47, P376, DOI 10.1007/s12013-007-0033-6; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yang EH, 2012, AM J MED, V125, P337, DOI 10.1016/j.amjmed.2011.09.019	76	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23159	23174		10.1074/jbc.M116.751735	http://dx.doi.org/10.1074/jbc.M116.751735			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27624940	hybrid, Green Published			2022-12-28	WOS:000387224800026
J	Wylezinski, LS; Hawiger, J				Wylezinski, Lukasz S.; Hawiger, Jacek			Interleukin 2 Activates Brain Microvascular Endothelial Cells Resulting in Destabilization of Adherens Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; VE-CADHERIN; TYROSINE PHOSPHORYLATION; VASCULAR-PERMEABILITY; RECEPTOR COMPLEX; BARRIER FUNCTION; UP-REGULATION; BETA-CATENIN; IN-VIVO; P120-CATENIN	The pleiotropic cytokine interleukin 2 (IL2) disrupts the blood-brain barrier and alters brain microcirculation, underlying vascular leak syndrome that complicates cancer immunotherapy with IL2. The microvascular effects of IL2 also play a role in the development of multiple sclerosis and other chronic neurological disorders. The mechanism of IL2-induced disruption of brain microcirculation has not been determined previously. We found that both human and murine brain microvascular endothelial cells express constituents of the IL2 receptor complex. Then we established that signaling through this receptor complex leads to activation of the transcription factor, nuclear factor kappa B, resulting in expression of proinflammatory interleukin 6 and monocyte chemoattractant protein 1. We also discovered that IL2 induces disruption of adherens junctions, concomitant with cytoskeletal reorganization, ultimately leading to increased endothelial cell permeability. IL2-induced phosphorylation of vascular endothelial cadherin (VE-cadherin), a constituent of adherens junctions, leads to dissociation of its stabilizing adaptor partners, p120-catenin and beta-catenin. Increased phosphorylation of VE-cadherin was also accompanied by a reduction of Src homology 2 domain-containing protein-tyrosine phosphatase 2, known to maintain vascular barrier function. These results unravel the mechanism of deleterious effects induced by IL2 on brain microvascular endothelial cells and may inform the development of new measures to improve IL2 cancer immunotherapy, as well as treatments for autoimmune diseases affecting the central nervous system.	[Wylezinski, Lukasz S.; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Div Allergy Pulm & Crit Care Med,Sch Med, Nashville, TN 37232 USA; [Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med,Sch Med, 1161 21st Ave South,T1218 MCN, Nashville, TN 37232 USA; [Hawiger, Jacek] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Hawiger, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med,Sch Med, 1161 21st Ave South,T1218 MCN, Nashville, TN 37232 USA.	jacek.hawiger@vanderbilt.edu		Wylezinski, Lukasz/0000-0001-6481-8379	National Institutes of Health [CA68485, DK20593, DK58404, DK59637, EY08126]; Vanderbilt Ingram Cancer Center (National Institutes of Health) [P30 CA68485]; Vanderbilt Digestive Disease Research Center (National Institutes of Health) [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765, R01HL069452, R01HL085833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593, P30DK058404, U24DK059637] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Professor Babette Weksler (Weil-Cornell Medical College, New York, NY) and Professor Pierre-Olivier Couraud and Dr. Nacho Romero (Institute Cochin, INSERM, Paris, France) for generously providing human BMEC line hCMEC/D3 and for helpful comments concerning the manuscript. We also thank Alyssa Hasty, Roger Colbran, David G. Harrison, Luc Van Kaer, and Ruth Ann Veach for valuable and constructive comments during the course of this study. Additionally, we thank Jozef Zienkiewicz for insightful discussions and suggestions throughout the course of experimentation and preparation of this manuscript. Fluorescence microscopy and analysis were performed in part through the use of the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by National Institutes of Health Grants CA68485, DK20593, DK58404, DK59637, and EY08126). Flow cytometry experiments were performed in the Vanderbilt Medical Center (VMC) Flow Cytometry Shared Resource. The VMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (National Institutes of Health Grant P30 CA68485) and the Vanderbilt Digestive Disease Research Center (National Institutes of Health Grant DK058404).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abu Taha A, 2014, CELL ADHES MIGR, V8, P125, DOI 10.4161/cam.28243; Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; ARIMA N, 1992, J IMMUNOL, V149, P83; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Chang SF, 2014, P NATL ACAD SCI USA, V111, P1855, DOI 10.1073/pnas.1323761111; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; DENICOFF KD, 1987, ANN INTERN MED, V107, P293, DOI 10.7326/0003-4819-107-2-293; Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415; Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x; DONALD R, 1995, J BIOL CHEM, V270, P9, DOI 10.1074/jbc.270.1.9; Gallo P, 1992, Ital J Neurol Sci, V13, P65; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Hatanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037600; Hawiger J, 2015, J THROMB HAEMOST, V13, P1743, DOI 10.1111/jth.13061; Ichinose K, 2015, CLIN IMMUNOL, V157, P114, DOI 10.1016/j.clim.2015.01.010; Jee Y, 2002, J NEUROIMMUNOL, V128, P49, DOI 10.1016/S0165-5728(02)00147-9; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Kim DW, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-113; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Lampugnani MG, 2007, THROMB RES, V120, pS1, DOI 10.1016/S0049-3848(07)70124-X; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Middleton J, 2005, J PATHOL, V206, P260, DOI 10.1002/path.1788; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Qiao H, 2014, J BIOL CHEM, V289, P21973, DOI 10.1074/jbc.M114.588723; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Ruiz-Medina BE, 2015, J BIOL CHEM, V290, P20972, DOI 10.1074/jbc.M115.660654; SARIS SC, 1989, J NEUROSURG, V71, P169, DOI 10.3171/jns.1989.71.2.0169; Sheibani N, 1998, MOL BIOL CELL, V9, P701, DOI 10.1091/mbc.9.4.701; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stone KP, 2011, CELL PHYSIOL BIOCHEM, V28, P115, DOI 10.1159/000331720; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; WESTLIN WF, 1993, AM J PATHOL, V142, P117; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	49	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22913	22923		10.1074/jbc.M116.729038	http://dx.doi.org/10.1074/jbc.M116.729038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27601468	Green Published, hybrid			2022-12-28	WOS:000387224800005
J	Miller, BR; Drake, EJ; Shi, C; Aldrich, CC; Gulick, AM				Miller, Bradley R.; Drake, Eric J.; Shi, Ce; Aldrich, Courtney C.; Gulick, Andrew M.			Structures of a Nonribosomal Peptide Synthetase Module Bound to MbtH-like Proteins Support a Highly Dynamic Domain Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyl carrier protein (ACP); bacterial metabolism; enzyme mechanism; enzyme mutation; multifunctional protein; natural product biosynthesis; siderophore; structural biology	CONDENSATION DOMAIN; ADENYLATION DOMAIN; CRYSTAL-STRUCTURE; BIOSYNTHESIS; ENZYMES; ENTB; CRYSTALLIZATION; IDENTIFICATION; ACTIVATION; BIOLOGY	Nonribosomal peptide synthetases (NRPSs) produce a wide variety of peptide natural products. During synthesis, the multidomain NRPSs act as an assembly line, passing the growing product from one module to the next. Each module generally consists of an integrated peptidyl carrier protein, an amino acid-loading adenylation domain, and a condensation domain that catalyzes peptide bond formation. Some adenylation domains interact with small partner proteins called MbtH-like proteins (MLPs) that enhance solubility or activity. A structure of an MLP bound to an adenylation domain has been previously reported using a truncated adenylation domain, precluding any insight that might be derived from understanding the influence of the MLP on the intact adenylation domain or on the dynamics of the entire NRPS module. Here, we present the structures of the full-length NRPS EntF bound to the MLPs from Escherichia coli and Pseudomonas aeruginosa. These new structures, along with biochemical and bioinformatics support, further elaborate the residues that define the MLP-adenylation domain interface. Additionally, the structures highlight the dynamic behavior of NRPS modules, including the module core formed by the adenylation and condensation domains as well as the orientation of the mobile thioesterase domain.	[Miller, Bradley R.; Drake, Eric J.; Gulick, Andrew M.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Miller, Bradley R.; Drake, Eric J.; Gulick, Andrew M.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Shi, Ce; Aldrich, Courtney C.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA; [Shi, Ce; Aldrich, Courtney C.; Gulick, Andrew M.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gulick, AM (corresponding author), Hauptman Woodward Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	gulick@hwi.buffalo.edu		Gulick, Andrew/0000-0003-4238-7453	National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences, [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM116957] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alyssa Aldridge for technical assistance with the NikP1 rnutagenesis experiments. We also thank Professors Christopher Walsh and Michael Thomas for generously providing bacterial strains. The General Medical Sciences and Cancer Institutes Structural Biology Facility at the Advanced Photon Source (GM/CA@APS) has been funded in whole or in part with federal funds from the National Cancer Institute (Grant ACB-12002) and the National Institute of General Medical Sciences (Grant AGM-12006). This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the Stanford Synchrotron Radiation Light source (SSRL) is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences, including Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Mestarihi AH, 2015, CHEMBIOCHEM, V16, P1307, DOI 10.1002/cbic.201402711; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bloudoff K, 2013, J MOL BIOL, V425, P3137, DOI 10.1016/j.jmb.2013.06.003; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Buchko GW, 2010, TUBERCULOSIS, V90, P245, DOI 10.1016/j.tube.2010.04.002; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen WH, 2016, ACS CHEM BIOL, V11, P2293, DOI 10.1021/acschembio.6b00332; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Heemstra JR, 2009, J AM CHEM SOC, V131, P15317, DOI 10.1021/ja9056008; Herbst DA, 2013, J BIOL CHEM, V288, P1991, DOI 10.1074/jbc.M112.420182; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labby KJ, 2015, NAT PROD REP, V32, P641, DOI 10.1039/c4np00120f; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Luft JR, 1999, ACTA CRYSTALLOGR D, V55, P988, DOI 10.1107/S0907444999002085; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Miller BR, 2016, METHODS MOL BIOL, V1401, P3, DOI 10.1007/978-1-4939-3375-4_1; Miller BR, 2014, PROTEINS, V82, P2691, DOI 10.1002/prot.24635; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Mossialos D, 2002, MOL MICROBIOL, V45, P1673, DOI 10.1046/j.1365-2958.2002.03120.x; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Reimer JM, 2016, NATURE, V529, P239, DOI 10.1038/nature16503; Roche ED, 2003, BIOCHEMISTRY-US, V42, P1334, DOI 10.1021/BI026867m; RUSNAK F, 1989, BIOCHEMISTRY-US, V28, P6827, DOI 10.1021/bi00443a008; Samel SA, 2008, MOL BIOSYST, V4, P387, DOI 10.1039/b717538h; Sundlov JA, 2013, ACTA CRYSTALLOGR D, V69, P1482, DOI 10.1107/S0907444913009372; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Walsh CT, 2016, NAT PROD REP, V33, P127, DOI 10.1039/c5np00035a; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Weissman KJ, 2015, NAT CHEM BIOL, V11, P660, DOI [10.1038/NCHEMBIO.1883, 10.1038/nchembio.1883]; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b; Zolova OE, 2012, MEDCHEMCOMM, V3, P950, DOI 10.1039/c2md20131c	45	65	66	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22559	22571		10.1074/jbc.M116.746297	http://dx.doi.org/10.1074/jbc.M116.746297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27597544	hybrid, Green Published			2022-12-28	WOS:000386760600017
J	Sano, R; Nakajima, T; Takahashi, Y; Kubo, R; Kobayashi, M; Takahashi, K; Takeshita, H; Ogasawara, K; Kominato, Y				Sano, Rie; Nakajima, Tamiko; Takahashi, Yoichiro; Kubo, Rieko; Kobayashi, Momoko; Takahashi, Keiko; Takeshita, Haruo; Ogasawara, Kenichi; Kominato, Yoshihiko			Epithelial Expression of Human ABO Blood Group Genes Is Dependent upon a Downstream Regulatory Element Functioning through an Epithelial Cell-specific Transcription Factor, Elf5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; epithelial cell; ETS transcription factor family; gene regulation; tissue-specific transcription factor; transcription enhancer; ABO; Elf5	MAMMARY-GLAND DEVELOPMENT; DNA METHYLATION; GATA SITE; CBF/NF-Y; B GENE; PROMOTER; GENOME; REGION; SUBFAMILY; MUTATION	The human ABO blood group system is of great importance in blood transfusion and organ transplantation. The ABO system is composed of complex carbohydrate structures that are biosynthesized by A- and B-transferases encoded by the ABO gene. However, the mechanisms regulating ABO gene expression in epithelial cells remain obscure. On the basis of DNase I-hypersensitive sites in and around ABO in epithelial cells, we prepared reporter plasmid constructs including these sites. Subsequent luciferase assays and histone modifications indicated a novel positive regulatory element, designated the +22.6-kb site, downstream from ABO, and this was shown to enhance ABO promoter activity in an epithelial cell-specific manner. Expression of ABO and B-antigen was reduced in gastric cancer KATOIII cells by biallelic deletion of the +22.6-kb site using the CRISPR/Cas9 system. Electrophoretic mobility shift assay and chromatin immunoprecipitation assay demonstrated that the site bound to an epithelial cell-specific transcription factor, Elf5. Mutation of the Ets binding motifs to abrogate binding of this factor reduced the regulatory activity of the +22.6-kb site. Furthermore, ELF5 knockdown with shRNA reduced both endogenous transcription from ABO and B-antigen expression in KATOIII cells. Thus, Elf5 appeared to be involved in the enhancer potential of the +22.6-kb site. These results support the contention that ABO expression is dependent upon a downstream positive regulatory element functioning through a tissue-restricted transcription factor, Elf5, in epithelial cells.	[Sano, Rie; Nakajima, Tamiko; Takahashi, Yoichiro; Kubo, Rieko; Kobayashi, Momoko; Takahashi, Keiko; Kominato, Yoshihiko] Gunma Univ, Dept Legal Med, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan; [Takeshita, Haruo] Shimane Univ, Sch Med, Dept Legal Med, Izumo, Shimane, Japan; [Ogasawara, Kenichi] Japanese Red Cross Cent Blood Inst, Tokyo, Japan	Gunma University; Shimane University	Sano, R (corresponding author), Gunma Univ, Dept Legal Med, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	takagirie@gunma-u.ac.jp			Japan Society for the Promotion of Science [25460861, 25860486, 26293161]; Grants-in-Aid for Scientific Research [16K19293, 26293161] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grants-in-Aid 25460861 (to T. N.), 25860486 (to Y. T.), and 26293161 (to Y. K.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; Bochert MA, 1998, BIOCHEM BIOPH RES CO, V246, P176, DOI 10.1006/bbrc.1998.8560; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Daniels G., 2013, HUMAN BLOOD GROUPS, V3; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Escamilla-Hernandez R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-68; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Hata Y, 2002, VOX SANG, V82, P39, DOI 10.1046/j.0042-9007.2001.00134.x; Hay ED, 1995, ACTA ANAT, V154, P8; Ichikawa D, 1997, CANCER RES, V57, P3092; Iwamoto S, 1999, GLYCOCONJUGATE J, V16, P659, DOI 10.1023/A:1007085202379; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; Kominato Y, 1999, J BIOL CHEM, V274, P37240, DOI 10.1074/jbc.274.52.37240; Kominato Y, 2002, J BIOL CHEM, V277, P37936, DOI 10.1074/jbc.M204238200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lapinskas EJ, 2004, HISTOCHEM CELL BIOL, V122, P521, DOI 10.1007/s00418-004-0713-x; LEE JS, 1991, NEW ENGL J MED, V324, P1084, DOI 10.1056/NEJM199104183241603; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; Nakajima T, 2013, TRANSFUSION, V53, P2917, DOI 10.1111/trf.12181; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Oda A, 2015, VOX SANG, V108, P425, DOI 10.1111/vox.12229; Orlow I, 1998, INT J CANCER, V75, P819, DOI 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sano R, 2015, VOX SANG, V108, P310, DOI 10.1111/vox.12216; Sano R, 2015, VOX SANG, V108, P302, DOI 10.1111/vox.12220; Sano R, 2012, BLOOD, V119, P5301, DOI 10.1182/blood-2011-10-387167; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Takahashi Y, 2014, VOX SANG, V106, P167, DOI 10.1111/vox.12077; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thuresson B, 2013, VOX SANG, V105, P44; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Vernimmen D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004668; Yamamoto F, 2000, VOX SANG, V78, P91; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198; Zhou S, 2014, WORLD J CARDIOL, V6, P985, DOI 10.4330/wjc.v6.i9.985; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	48	10	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22594	22606		10.1074/jbc.M116.730655	http://dx.doi.org/10.1074/jbc.M116.730655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587399	Green Published, hybrid			2022-12-28	WOS:000386760600020
J	Song, ZW; Fusco, J; Zimmerman, R; Fischbach, S; Chen, CD; Ricks, DM; Prasadan, K; Shiota, C; Xiao, XW; Gittes, GK				Song, Zewen; Fusco, Joseph; Zimmerman, Ray; Fischbach, Shane; Chen, Congde; Ricks, David Matthew; Prasadan, Krishna; Shiota, Chiyo; Xiao, Xiangwei; Gittes, George K.			Epidermal Growth Factor Receptor Signaling Regulates Cell Proliferation in Adult Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell ( cell); cell proliferation; cyclin D1; diabetes; epidermal growth factor receptor (EGFR)	PANCREATIC BETA-CELL; PRIMARY MECHANISM; ISLET CELLS; MASS; REPLICATION; ACTIVATION; DIFFERENTIATION; REGENERATION; MACROPHAGES; PROGENITORS	A thorough understanding of the signaling pathways involved in the regulation of cell proliferation is an important initial step in restoring cell mass in the diabetic patient. Here, we show that epidermal growth factor receptor 1 (EGFR) was significantly up-regulated in the islets of C57BL/6 mice after 50% partial pancreatectomy (PPx), a model for workload-induced cell proliferation. Specific deletion of EGFR in the cells of adult mice impaired cell proliferation at baseline and after 50% PPx, suggesting that the EGFR signaling pathway plays an essential role in adult cell proliferation. Further analyses showed that cell-specific depletion of EGFR resulted in impaired expression of cyclin D1 and impaired suppression of p27 after PPx, both of which enhance cell proliferation. These data highlight the importance of EGFR signaling and its downstream signaling cascade in postnatal cell growth.	[Song, Zewen; Fusco, Joseph; Zimmerman, Ray; Fischbach, Shane; Chen, Congde; Ricks, David Matthew; Prasadan, Krishna; Shiota, Chiyo; Xiao, Xiangwei; Gittes, George K.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Pediat Surg, Dept Surg,Sch Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Song, Zewen] Cent S Univ, Xiangya Hosp 3, Dept Oncol, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China; [Chen, Congde] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pediat Surg, Wenzhou 325000, Peoples R China; [Chen, Congde] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Wenzhou Medical University; Wenzhou Medical University	Xiao, XW; Gittes, GK (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Pediat Surg, Dept Surg,Sch Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	Xiangwei.xiao@chp.edu; gittesgk@upmc.edu	Song, Zewen/ABA-2788-2020	Xiao, Xiangwei/0000-0003-0890-9203; song, zewen/0000-0002-9685-0725	National Institutes of Health [R01 DK098196]; Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (to G. K. G, Grant R01 DK098196) and the Children's Hospital of Pittsburgh. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Brown ML, 2010, TRENDS ENDOCRIN MET, V21, P441, DOI 10.1016/j.tem.2010.02.008; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Gohary Y, 2014, DIABETES, V63, P224, DOI 10.2337/db13-0432; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gunasekaran U, 2012, CELL CYCLE, V11, P2431, DOI 10.4161/cc.20545; Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350; Hakonen E, 2011, DIABETOLOGIA, V54, P1735, DOI 10.1007/s00125-011-2153-1; Hakonen E, 2014, DIABETOLOGIA, V57, P970, DOI 10.1007/s00125-014-3175-2; He LM, 2009, MOL ENDOCRINOL, V23, P1865, DOI 10.1210/me.2009-0057; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miettinen PJ, 2000, DEVELOPMENT, V127, P2617; Narita Y, 2002, CANCER RES, V62, P6764; Oh YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023894; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Saunders D, 2016, J AUTOIMMUN, V71, P59, DOI 10.1016/j.jaut.2016.03.014; Stewart AF, 2015, DIABETES, V64, P1872, DOI 10.2337/db14-1843; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; Tao YG, 2005, EXP CELL RES, V303, P240, DOI 10.1016/j.yexcr.2004.09.030; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Xiao XW, 2016, ENDOCRINOLOGY, V157, P1348, DOI 10.1210/en.2015-1986; Xiao XW, 2015, STEM CELL TRANSL MED, V4, P655, DOI 10.5966/sctm.2014-0248; Xiao XW, 2014, DIABETOLOGIA, V57, P991, DOI 10.1007/s00125-014-3179-y; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xiao XW, 2013, J BIOL CHEM, V288, P25297, DOI 10.1074/jbc.M113.484022; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xiao XW, 2013, J BIOL CHEM, V288, P8636, DOI 10.1074/jbc.M112.422949; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zarrouki B, 2014, DIABETES, V63, P982, DOI 10.2337/db13-0425	42	20	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22630	22637		10.1074/jbc.M116.747840	http://dx.doi.org/10.1074/jbc.M116.747840			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587395	Green Published, hybrid			2022-12-28	WOS:000386760600023
J	Takeuchi, H; Kobayashi, Y; Ishigaki, S; Doyu, M; Sobue, G				Takeuchi, Hideyuki; Kobayashi, Yasushi; Ishigaki, Shinsuke; Doyu, Manabu; Sobue, Gen			Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis (vol 277, pg 50966, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													ISHIGAKI, Shinsuke/I-7305-2014	Ishigaki, Shinsuke/0000-0002-9555-0659				Takeuchi H, 2002, J BIOL CHEM, V277, P50966, DOI 10.1074/jbc.M209356200	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22341	22343		10.1074/jbc.A116.209356	http://dx.doi.org/10.1074/jbc.A116.209356			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27742878	Green Published, hybrid			2022-12-28	WOS:000386332600045
J	Wang, YM; Shao, Q; Hall, CK				Wang, Yiming; Shao, Qing; Hall, Carol K.			N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register beta-Sheets via Multiple Nucleation-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibril; kinetics; prion disease; protein aggregation; thermodynamics; amino acid substitution; amyloid core; discontinuous molecular dynamics	MOLECULAR-DYNAMICS SIMULATIONS; AMYLOID CORE STRUCTURE; FIBRIL FORMATION; NEURODEGENERATIVE DISEASES; AGGREGATION KINETICS; MAMMALIAN PRIONS; Y145STOP VARIANT; STOP MUTANTS; RESIDUE 129; TEMPERATURE	The prion diseases are a family of fatal neurodegenerative diseases associated with the misfolding and accumulation of normal prion protein (PrPC) into its pathogenic scrapie form (PrPSc). Understanding the fundamentals of prion protein aggregation and the molecular architecture of PrPSc is key to unraveling the pathology of prion diseases. Our work investigates the early-stage aggregation of three prion protein peptides, corresponding to residues 120-144 of human (Hu), bank vole (BV), and Syrian hamster (SHa) prion protein, from disordered monomers to -sheet-rich fibrillar structures. Using 12 s discontinuous molecular dynamics simulations combined with the PRIME20 force field, we find that the Hu-, BV-, and SHaPrP(120-144) aggregate via multiple nucleation-dependent pathways to form U-shaped, S-shaped, and -shaped protofilaments. The S-shaped HuPrP(120-144) protofilament is similar to the amyloid core structure of HuPrP(112-141) predicted by Zweckstetter. HuPrP(120-144) has a shorter aggregation lag phase than BVPrP(120-144) followed by SHaPrP(120-144), consistent with experimental findings. Two amino acid substitutions I138M and I139M retard the formation of parallel in-register -sheet dimers during the nucleation stage by increasing side chain-side chain association and reducing side chain interaction specificity. On average, HuPrP(120-144) aggregates contain more parallel -sheet content than those formed by BV- and SHaPrP(120-144). Deletion of the C-terminal residues 138-144 prevents formation of fibrillar structures in agreement with the experiment. This work sheds light on the amyloid core structures underlying prion strains and how I138M, I139M, and S143N affect prion protein aggregation kinetics.	[Wang, Yiming; Shao, Qing; Hall, Carol K.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Hall, CK (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	hall@ncsu.edu	Wang, Yiming/T-4946-2017; Wang, Yiming/K-9382-2019	Wang, Yiming/0000-0003-3657-6100; Wang, Yiming/0000-0003-3657-6100; Hall, Carol/0000-0002-7425-587X	National Institutes of Health [GM056766, EB006006]; National Science Foundation Research Triangle Materials Research Science and Engineering Centers (MRSEC) [DMR-1121107]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Research Triangle Materials Research Science and Engineering Centers (MRSEC); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM056766 and EB006006 and in part by National Science Foundation Research Triangle Materials Research Science and Engineering Centers (MRSEC) Grant DMR-1121107. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Andrews JM, 2007, J PHYS CHEM B, V111, P7897, DOI 10.1021/jp070212j; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Apostol MI, 2010, J BIOL CHEM, V285, P29671, DOI 10.1074/jbc.C110.158303; Baftizadeh F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168103; Berka K, 2010, J CHEM THEORY COMPUT, V6, P2191, DOI 10.1021/ct100007y; Biswal HS., 2015, NONCOVALENT FORCES, V9(2), P15; Chatterjee B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067967; Cheon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004258; Cheon M, 2012, PROTEIN SCI, V21, P1514, DOI 10.1002/pro.2141; Cheon M, 2011, BIOPHYS J, V101, P2493, DOI 10.1016/j.bpj.2011.08.042; Cheon M, 2010, PROTEINS, V78, P2950, DOI 10.1002/prot.22817; Cho KR, 2011, J AM CHEM SOC, V133, P8586, DOI 10.1021/ja1117446; Chuang CC, 2013, AMINO ACIDS, V45, P785, DOI 10.1007/s00726-013-1522-0; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Dougherty RC, 1998, J CHEM PHYS, V109, P7372, DOI 10.1063/1.477343; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Latshaw DC, 2014, J PHYS CHEM B, V118, P13513, DOI 10.1021/jp508970q; Latshaw DC, 2015, BIOPHYS J, V109, P124, DOI 10.1016/j.bpj.2015.05.032; Li HC, 2012, LANGMUIR, V28, P16979, DOI 10.1021/la302655p; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Lin NS, 2010, CHEM-EUR J, V16, P5492, DOI 10.1002/chem.200903290; Marchut AJ, 2006, COMPUT BIOL CHEM, V30, P215, DOI 10.1016/j.compbiolchem.2006.01.003; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Ricchiuto P, 2012, J PHYS CHEM B, V116, P5384, DOI 10.1021/jp302797c; Skora L, 2013, J BIOL CHEM, V288, P2994, DOI 10.1074/jbc.M112.423715; Skora L, 2012, PROTEIN SCI, V21, P1948, DOI 10.1002/pro.2170; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smith AV, 2001, PROTEINS, V44, P344, DOI 10.1002/prot.1100; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Wagoner VA, 2012, J MOL BIOL, V416, P598, DOI 10.1016/j.jmb.2011.12.038; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Zweckstetter M, 2013, PRION, V7, P193, DOI 10.4161/pri.23956	62	23	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22093	22105		10.1074/jbc.M116.744573	http://dx.doi.org/10.1074/jbc.M116.744573			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27576687	Green Published, hybrid			2022-12-28	WOS:000386332600024
J	Martin, BR; Lambert, NA				Martin, Brent R.; Lambert, Nevin A.			Activated G Protein G alpha(s) Samples Multiple Endomembrane Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; G protein-coupled receptor (GPCR); heterotrimeric G protein; intracellular trafficking; lipase; protein acylation; protein palmitoylation; endosomes	HETEROTRIMERIC G-PROTEINS; INDUCED SUBCELLULAR REDISTRIBUTION; BETA-ADRENERGIC-RECEPTOR; PLASMA-MEMBRANE; ALPHA-SUBUNITS; CHOLERA-TOXIN; PALMITOYLATION; RAS; TRANSLOCATION; LOCALIZATION	Heterotrimeric G proteins are localized to the plasma membrane where they transduce extracellular signals to intracellular effectors. G proteins also act at intracellular locations, and can translocate between cellular compartments. For example, G(s) can leave the plasma membrane and move to the cell interior after activation. However, the mechanism of G(s) translocation and its intracellular destination are not known. Here we use bioluminescence resonance energy transfer (BRET) to show that after activation, G(s) rapidly associates with the endoplasmic reticulum, mitochondria, and endosomes, consistent with indiscriminate sampling of intracellular membranes from the cytosol rather than transport via a specific vesicular pathway. The primary source of G(s) for endosomal compartments is constitutive endocytosis rather than activity-dependent internalization. Recycling of G(s) to the plasma membrane is complete 25 min after stimulation is discontinued. We also show that an acylation-deacylation cycle is important for the steady-state localization of G(s) at the plasma membrane, but our results do not support a role for deacylation in activity-dependent G(s) internalization.	[Martin, Brent R.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lambert, Nevin A.] Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, CB3522,1120 15th St, Augusta, GA 30912 USA	University of Michigan System; University of Michigan; University System of Georgia; Augusta University	Lambert, NA (corresponding author), Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, CB3522,1120 15th St, Augusta, GA 30912 USA.	nelambert@augusta.edu	Martin, Brent/B-4370-2012	Martin, Brent/0000-0002-7136-2397	National Institutes of Health [GM078319, GM109879, GM114848]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM114848, R01GM078319, R01GM109879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM078319 and GM109879 (to N. A. L.) and GM114848 (to B. R. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Balla A, 2012, J BIOL CHEM, V287, P9090, DOI 10.1074/jbc.M111.293944; DEGTYAREV MY, 1993, J BIOL CHEM, V268, P23769; DEGTYAREV MY, 1993, BIOCHEMISTRY-US, V32, P8057, DOI 10.1021/bi00083a001; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Jones TLZ, 1997, BIOCHEMISTRY-US, V36, P7185, DOI 10.1021/bi9628376; KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LYNCH CJ, 1986, FEBS LETT, V200, P333, DOI 10.1016/0014-5793(86)81163-2; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; O'Neill PR, 2012, P NATL ACAD SCI USA, V109, pE3568, DOI 10.1073/pnas.1205345109; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; Takida S, 2004, FEBS LETT, V567, P209, DOI 10.1016/j.febslet.2004.04.062; Thiyagarajan MM, 2002, BIOCHEMISTRY-US, V41, P9470, DOI 10.1021/bi025533u; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/NCHEMBIO.1611, 10.1038/nchembio.1611]; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wedegaertner Philip B, 2012, Subcell Biochem, V63, P193, DOI 10.1007/978-94-007-4765-4_11; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zheng H, 2007, J BIOL CHEM, V282, P25760, DOI 10.1074/jbc.M700437200	38	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20295	20302		10.1074/jbc.M116.729731	http://dx.doi.org/10.1074/jbc.M116.729731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27528603	hybrid, Green Published			2022-12-28	WOS:000384574800002
J	Rosato, RR; Kolla, SS; Hock, SK; Almenara, JA; Patel, A; Amin, S; Atadja, P; Fisher, PB; Dent, P; Grant, S				Rosato, Roberto R.; Kolla, Sarah S.; Hock, Stefanie K.; Almenara, Jorge A.; Patel, Ankita; Amin, Sanjay; Atadja, Peter; Fisher, Paul B.; Dent, Paul; Grant, Steven			RETRACTION: Histone deacetylase inhibitors activate NF-kappa B in human leukemia cells through an ATM/NEMO-related pathway (Retraction of vol 285, pg 10064, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Rosato RR, 2010, J BIOL CHEM, V285, P10064, DOI 10.1074/jbc.M109.095208	1	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17535	17535		10.1074/jbc.A109.095208	http://dx.doi.org/10.1074/jbc.A109.095208			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27543593	hybrid, Green Published			2022-12-28	WOS:000383241300005
J	Bloom, J; Metz, C; Nalawade, S; Casabar, J; Cheng, KF; He, MZ; Sherry, B; Coleman, T; Forsthuber, T; Al-Abed, Y				Bloom, Joshua; Metz, Christine; Nalawade, Saisha; Casabar, Julian; Cheng, Kai Fan; He, Mingzhu; Sherry, Barbara; Coleman, Thomas; Forsthuber, Thomas; Al-Abed, Yousef			Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE RHEUMATOID-ARTHRITIS; ANTIINFLAMMATORY AGENT 3-FORMYLAMINO-7-METHYLSULFONYLAMINO-6-PHENOXY-4H-1-BENZOPYRAN-4-ONE; KAPPA-B ACTIVATION; ANTIRHEUMATIC DRUG; IN-VITRO; OSTEOCLAST DIFFERENTIATION; SYNOVIAL FIBROBLASTS; CYTOKINE PRODUCTION; REGULATORY ROLE; ADVERSE EVENTS	Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has been implicated in a broad range of inflammatory and oncologic diseases. MIF is unique among cytokines in terms of its release profile and inflammatory role, notably as an endogenous counter-regulator of the anti-inflammatory effects of glucocorticoids. In addition, it exhibits a catalytic tautomerase activity amenable to the design of high affinity small molecule inhibitors. Although several classes of these compounds have been identified, biologic characterization of these molecules remains a topic of active investigation. In this study, we used in vitro LPS-driven assays to characterize representative molecules from several classes of MIF inhibitors. We determined that MIF inhibitors exhibit distinct profiles of anti-inflammatory activity, especially with regard to TNF alpha. We further investigated a molecule with relatively low anti-inflammatory activity, compound T-614 (also known as the anti-rheumatic drug iguratimod), and found that, in addition to exhibiting selective MIF inhibition in vitro and in vivo, iguratimod also has additive effects with glucocorticoids. Furthermore, we found that iguratimod synergizes with glucocorticoids in attenuating experimental autoimmune encephalitis, a model of multiple sclerosis. Our work identifies iguratimod as a valuable new candidate for drug repurposing to MIF-relevant diseases, including multiple sclerosis.	[Bloom, Joshua; Metz, Christine; Sherry, Barbara; Al-Abed, Yousef] Hofstra Northwell Sch Med, Hempstead, NY 11549 USA; [Bloom, Joshua; Cheng, Kai Fan; He, Mingzhu; Al-Abed, Yousef] Feinstein Inst Med Res, Ctr Mol Innovat, 350 Community Dr, Manhasset, NY 11030 USA; [Metz, Christine] Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY 11030 USA; [Sherry, Barbara] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA; [Coleman, Thomas] Feinstein Inst Med Res, Off Technol Transfer, Manhasset, NY 11030 USA; [Nalawade, Saisha; Casabar, Julian; Forsthuber, Thomas] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	Northwell Health; Northwell Health; Northwell Health; Northwell Health; Northwell Health; University of Texas System; University of Texas at San Antonio (UTSA)	Al-Abed, Y (corresponding author), Feinstein Inst Med Res, Ctr Mol Innovat, 350 Community Dr, Manhasset, NY 11030 USA.; Bloom, J (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	jbloom2@northwell.edu; yalabed@northwell.edu	Sherry, Barbara/GSD-7179-2022; Nalawade, Saisha/AAU-7060-2021; Forsthuber, Thomas/AID-8080-2022	Sherry, Barbara/0000-0003-3119-1463; Christine, Metz/0000-0002-1013-1691; /0000-0003-0692-7125	National Institutes of Health from NIAID [R21AI110771]; Small Business Innovation Research Grant [1R43AR062401]; Hofstra-Northwell School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR062401] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Small Business Innovation Research Grant; Hofstra-Northwell School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R21AI110771 from NIAID (to T. F.) and Small Business Innovation Research Grant 1R43AR062401 (to T. C.). Yousef Al-Abed is the inventor or co-inventor of several small molecule inhibitors of MIF.r Recipient of M.D./Ph.D. candidate stipend from the Hofstra-Northwell School of Medicine. To whom correspondence may be addressed: Feinstein Institute for Medical Research, 350 Community Dr., Manhasset, NY 11030. Tel.: 516-562-2690; E-mail: jbloom2@northwell.edu.	Aikawa Y, 2002, INFLAMM RES, V51, P188, DOI 10.1007/PL00000291; Aikawa Y, 1998, J NEUROIMMUNOL, V89, P35, DOI 10.1016/S0165-5728(98)00056-3; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Al-Abed Y, 2011, P NATL ACAD SCI USA, V108, P8224, DOI 10.1073/pnas.1017624108; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Ayroldi E, 2014, FASEB J, V28, P5055, DOI 10.1096/fj.14-254755; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bacher M, 1997, AM J PATHOL, V150, P235; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bloom J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-11; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cheng KF, 2006, BIOORG MED CHEM LETT, V16, P3376, DOI 10.1016/j.bmcl.2006.04.038; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Chesney JA, 2015, MOL MED, V21, pS19, DOI 10.2119/molmed.2015.00055; Ciccone A., 2008, COCHRANE DB SYST REV, V2008; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Crichlow GV, 2007, J BIOL CHEM, V282, P23089, DOI 10.1074/jbc.M701825200; Curtis JR, 2006, ARTHRIT RHEUM-ARTHR, V55, P420, DOI 10.1002/art.21984; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Dickerhof N, 2015, FREE RADICAL BIO MED, V89, P498, DOI 10.1016/j.freeradbiomed.2015.09.009; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Dooley D, 2014, PHARMACOL THERAPEUT, V141, P21, DOI 10.1016/j.pharmthera.2013.08.001; Duan XW, 2015, CLIN RHEUMATOL, V34, P1513, DOI 10.1007/s10067-015-2999-6; Eisai Co. Ltd, 2016, CAR TABL PACK INS; Fan HP, 2014, ARTHRITIS RHEUMATOL, V66, P2059, DOI 10.1002/art.38689; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Gan K, 2016, INT IMMUNOPHARMACOL, V35, P294, DOI 10.1016/j.intimp.2016.03.038; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Griga T, 2007, HEPATO-GASTROENTEROL, V54, P784; Gu R, 2015, CYTOKINE, V72, P135, DOI 10.1016/j.cyto.2014.11.015; Harper JM, 2010, FASEB J, V24, P2436, DOI 10.1096/fj.09-152223; He XX, 2009, MOL MED, V15, P1, DOI 10.2119/molmed.2008.00107; Healy ZR, 2011, CANCER EPIDEM BIOMAR, V20, P1516, DOI 10.1158/1055-9965.EPI-11-0279; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Huscher D, 2009, ANN RHEUM DIS, V68, P1119, DOI 10.1136/ard.2008.092163; Ioannou K, 2014, INT J ONCOL, V45, P1457, DOI 10.3892/ijo.2014.2551; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Ji NN, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000139; Jiang CL, 2015, STEROIDS, V102, P27, DOI 10.1016/j.steroids.2015.06.015; Johnston L, 2015, IMMUNOBIOLOGY, V220, P1305, DOI 10.1016/j.imbio.2015.07.014; Kaltsonoudis E, 2014, AUTOIMMUN REV, V13, P54, DOI 10.1016/j.autrev.2013.09.002; Kawakami A, 1999, J LAB CLIN MED, V133, P566, DOI 10.1016/S0022-2143(99)90186-5; Kerschbaumer RJ, 2012, J BIOL CHEM, V287, P7446, DOI 10.1074/jbc.M111.329664; Kohno M, 2001, J RHEUMATOL, V28, P2591; Kudrin A, 2006, J BIOL CHEM, V281, P29641, DOI 10.1074/jbc.M601103200; Kuriyama K, 2002, BIOCHEM BIOPH RES CO, V299, P903, DOI 10.1016/S0006-291X(02)02754-7; Lang TL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00577; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lu LJ, 2008, CHINESE MED J-PEKING, V121, P615, DOI 10.1097/00029330-200804010-00008; Lu LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P979, DOI 10.1002/art.24643; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Luo Q, 2013, J IMMUNOL, V191, P4969, DOI 10.4049/jimmunol.1300832; Matsumoto T, 2013, CLIN RHEUMATOL, V32, P271, DOI 10.1007/s10067-012-2113-2; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Madeira MFM, 2012, MICROBES INFECT, V14, P198, DOI 10.1016/j.micinf.2011.09.005; Morrison MC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00308; Mucke HAM, 2012, DRUG TODAY, V48, P577, DOI 10.1358/dot.2012.48.9.1855758; Okamura K, 2015, MOD RHEUMATOL, V25, P534, DOI 10.3109/14397595.2014.998361; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190; Orita M, 2002, CURR PHARM DESIGN, V8, P1297, DOI 10.2174/1381612023394674; Orita M, 2001, J MED CHEM, V44, P540, DOI 10.1021/jm000386o; Ouertatani-Sakouhi H, 2010, J BIOMOL SCREEN, V15, P347, DOI 10.1177/1087057110363825; Ouertatani-Sakouhi H, 2009, BIOCHEMISTRY-US, V48, P9858, DOI 10.1021/bi900957e; Pantouris G, 2015, CHEM BIOL, V22, P1197, DOI 10.1016/j.chembiol.2015.08.006; Petrovsky N, 2003, IMMUNOL CELL BIOL, V81, P137, DOI 10.1046/j.0818-9641.2002.01148.x; Powell ND, 2005, J IMMUNOL, V175, P5611, DOI 10.4049/jimmunol.175.9.5611; Ratzer R, 2016, MULT SCLER J, V22, P926, DOI 10.1177/1352458515605908; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Santos L, 2001, CLIN EXP IMMUNOL, V123, P309, DOI 10.1046/j.1365-2249.2001.01423.x; Savaskan Nic E, 2012, Int J Cell Biol, V2012, P139573, DOI 10.1155/2012/139573; Sawada T, 2000, IMMUNOPHARMACOLOGY, V49, P285, DOI 10.1016/S0162-3109(00)00242-3; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Stathas T, 2013, EUR REV MED PHARMACO, V17, P1455; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Tanaka K, 2007, INFLAMM RES, V56, P17, DOI 10.1007/s00011-007-6022-9; Tanaka K, 2003, RHEUMATOLOGY, V42, P1365, DOI 10.1093/rheumatology/keg381; TANAKA K, 1992, ARZNEIMITTEL-FORSCH, V42-2, P935; TANAKA K, 1992, J PHARMACOBIO-DYNAM, V15, P649, DOI 10.1248/bpb1978.15.649; TANAKA K, 1995, JPN J PHARMACOL, V67, P305, DOI 10.1254/jjp.67.305; TANAKA K, 1992, ARZNEIMITTEL-FORSCH, V42-2, P945; Tanaka K, 2009, RHEUMATOL REP, V1, P11, DOI 10.4081/rr.2009.e4; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Vivarelli M, 2007, CLIN EXP RHEUMATOL, V25, P775; Vujicic M, 2014, EUR J PHARMACOL, V740, P683, DOI 10.1016/j.ejphar.2014.06.009; Wei Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/214683; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Wu JP, 2000, NEUROSCI LETT, V292, P203, DOI 10.1016/S0304-3940(00)01472-5; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Xu L, 2014, J MED CHEM, V57, P3737, DOI 10.1021/jm401908w; Yamamoto T., 2007, JPN PHARMACOL THER, V35, P561; Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11	107	30	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26502	26514		10.1074/jbc.M116.743328	http://dx.doi.org/10.1074/jbc.M116.743328			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27793992	Green Published, hybrid			2022-12-28	WOS:000391568200023
J	Stenvang, M; Dueholm, MS; Vad, BS; Seviour, T; Zeng, GH; Geifman-Shochat, S; Sondergaard, MT; Christiansen, G; Meyer, RL; Kjelleberg, S; Nielsen, PH; Otzen, DE				Stenvang, Marcel; Dueholm, Morten S.; Vad, Brian S.; Seviour, Thomas; Zeng, Guanghong; Geifman-Shochat, Susana; Sondergaard, Mads T.; Christiansen, Gunna; Meyer, Rikke Louise; Kjelleberg, Staffan; Nielsen, Per Halkjaer; Otzen, Daniel E.			Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; CYSTIC-FIBROSIS; ALPHA-SYNUCLEIN; BACTERIAL BIOFILMS; CELL-SURFACE; EGCG; BETA; FIBRILS; INHIBITORS; INFECTION	Epigallocatechin-3-gallate (EGCG) is the major polyphenol in green tea. It has antimicrobial properties and disrupts the ordered structure of amyloid fibrils involved in human disease. The antimicrobial effect of EGCG against the opportunistic pathogen Pseudomonas aeruginosa has been shown to involve disruption of quorum sensing (QS). Functional amyloid fibrils in P. aeruginosa (Fap) are able to bind and retain quorum-sensing molecules, suggesting that EGCG interferes with QS through structural remodeling of amyloid fibrils. Here we show that EGCG inhibits the ability of Fap to form fibrils; instead, EGCG stabilizes protein oligomers. Existing fibrils are remodeled by EGCG into non-amyloid aggregates. This fibril remodeling increases the binding of pyocyanin, demonstrating a mechanism by which EGCG can affect the QS function of functional amyloid. EGCG reduced the amyloid-specific fluorescent thioflavin T signal in P. aeruginosa biofilms at concentrations known to exert an antimicrobial effect. Nanoindentation studies showed that EGCG reduced the stiffness of biofilm containing Fap fibrils but not in biofilm with little Fap. In a combination treatment with EGCG and tobramycin, EGCG had a moderate effect on the minimum bactericidal eradication concentration against wild-type P. aeruginosa biofilms, whereas EGCG had a more pronounced effect when Fap was overexpressed. Our results provide a direct molecular explanation for the ability of EGCG to disrupt P. aeruginosa QS and modify its biofilm and strengthens the case for EGCG as a candidate in multidrug treatment of persistent biofilm infections.	[Stenvang, Marcel; Vad, Brian S.; Zeng, Guanghong; Meyer, Rikke Louise; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Stenvang, Marcel; Vad, Brian S.; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Meyer, Rikke Louise] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Stenvang, Marcel] Sinodanish Ctr Educ & Res SDC, DK-8000 Aarhus C, Denmark; [Dueholm, Morten S.; Sondergaard, Mads T.; Nielsen, Per Halkjaer] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Commun, DK-9000 Aalborg, Denmark; [Seviour, Thomas; Kjelleberg, Staffan; Nielsen, Per Halkjaer] Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Geifman-Shochat, Susana] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Kjelleberg, Staffan] Univ New South Wales, Ctr Marine Bioinnovat, Mosman, NSW 2088, Australia; [Kjelleberg, Staffan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Mosman, NSW 2088, Australia	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aalborg University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of New South Wales Sydney; University of New South Wales Sydney	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.; Otzen, DE (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark.	dao@inano.au.dk	Nielsen, Per Halkjær/T-6796-2018; Dueholm, Morten Simonsen/T-6718-2018; Kjelleberg, Staffan/AAB-4641-2020; Meyer, Rikke Louise/AAB-5377-2021; Kjelleberg, Staffan/C-9229-2015	Nielsen, Per Halkjær/0000-0002-6402-1877; Dueholm, Morten Simonsen/0000-0003-4135-2670; Kjelleberg, Staffan/0000-0003-4271-6413; Meyer, Rikke Louise/0000-0002-6485-5134; Kjelleberg, Staffan/0000-0003-4271-6413; Christiansen, Gunna/0000-0003-0540-1367; Sondergaard, Mads Toft/0000-0001-6779-5109	Singapore's National Research Foundation; Ministry of Education; Nanyang Technological University (NTU); National University of Singapore (NUS)	Singapore's National Research Foundation(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University (NTU)(Nanyang Technological University); National University of Singapore (NUS)(National University of Singapore)	We are grateful to Jorgen Kjems (iNANO, Aarhus University) for the use of the Gel Doc EZ system, Brian S. Vad (iNANO, Aarhus University) for discussion of results and experimental setup, and Chuah York Wieo for assistance with surface plasmon resonance assays. We also appreciate constructive suggestions by Per Hammarstrom and Niels Heegaard. The Singapore Centre on Environmental Life Sciences Engineering is supported by Singapore's National Research Foundation, the Ministry of Education, Nanyang Technological University (NTU), and National University of Singapore (NUS) and hosted by NTU in partnership with NUS.	Andreasen M, 2012, J BIOL CHEM, V287, P34730, DOI 10.1074/jbc.M112.379552; Banerjee D, 2000, DRUGS, V60, P1053, DOI 10.2165/00003495-200060050-00006; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bikels-Goshen T, 2010, INT J FOOD MICROBIOL, V138, P26, DOI 10.1016/j.ijfoodmicro.2010.01.011; Bjarnsholt T, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001420; Cao P, 2012, BIOCHEMISTRY-US, V51, P2670, DOI 10.1021/bi2015162; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiang WC, 2013, ANTIMICROB AGENTS CH, V57, P2352, DOI 10.1128/AAC.00001-13; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cui Y, 2012, FOOD MICROBIOL, V29, P80, DOI 10.1016/j.fm.2011.08.019; DePas WH, 2012, RES MICROBIOL, V163, P592, DOI 10.1016/j.resmic.2012.10.009; Dueholm M. S., 2013, FUNCTIONAL AMYLOIDS, P411; Dueholm MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076630; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Dueholm MS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00898-14; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Ferreira N, 2009, FEBS LETT, V583, P3569, DOI 10.1016/j.febslet.2009.10.062; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Grelle G, 2011, BIOCHEMISTRY-US, V50, P10624, DOI 10.1021/bi2012383; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; He J, 2009, J AGR FOOD CHEM, V57, P11391, DOI 10.1021/jf902664f; Herbst FA, 2015, J PROTEOME RES, V14, P72, DOI 10.1021/pr500938x; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; Huber B, 2003, Z NATURFORSCH C, V58, P879; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Ishii T, 2011, BIOSCI BIOTECH BIOCH, V75, P100, DOI 10.1271/bbb.100600; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381; Jordal PB, 2009, APPL ENVIRON MICROB, V75, P4101, DOI 10.1128/AEM.02107-08; Kim JY, 2016, J AM CHEM SOC, V138, P402, DOI 10.1021/jacs.5b11357; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kronvall G, 2010, J CLIN MICROBIOL, V48, P4445, DOI 10.1128/JCM.01101-10; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Miyata M, 2010, BIOCHEMISTRY-US, V49, P6104, DOI 10.1021/bi1004409; Nakayama M, 2013, FOOD CONTROL, V33, P433, DOI [10.1016/j.foodcont.2013.03.016, 10.1016/j.f]; Nakayama M, 2011, J MICROBIOL METH, V86, P97, DOI 10.1016/j.mimet.2011.04.010; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; O'May C, 2012, BIOFOULING, V28, P1063, DOI 10.1080/08927014.2012.725130; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; PAZ MA, 1991, J BIOL CHEM, V266, P689; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Ruddy J, 2013, J AEROSOL MED PULM D, V26, P69, DOI 10.1089/jamp.2011.0942; Serra DO, 2016, MOL MICROBIOL, V101, P136, DOI 10.1111/mmi.13379; Seviour T, 2015, J BIOL CHEM, V290, P6457, DOI 10.1074/jbc.M114.613810; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Sun Y, 2009, BIOPHYS J, V96, P1026, DOI 10.1016/j.bpj.2008.11.007; Suzuki Y, 2012, BIOCHEMISTRY-US, V51, P8154, DOI 10.1021/bi3012548; Turner KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004518; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Vert M, 2012, PURE APPL CHEM, V84, P377, DOI 10.1351/PAC-REC-10-12-04; Wiehlmann L, 2007, INT J MED MICROBIOL, V297, P615, DOI 10.1016/j.ijmm.2007.03.014; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Yamada H, 2006, J ALTERN COMPLEM MED, V12, P669, DOI 10.1089/acm.2006.12.669; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang L, 2010, MOLECULES, V15, P780, DOI 10.3390/molecules15020780; Yi SM, 2010, INT J FOOD MICROBIOL, V144, P111, DOI 10.1016/j.ijfoodmicro.2010.09.005; Young LM, 2014, J AM CHEM SOC, V136, P660, DOI 10.1021/ja406831n; Zeng GH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01099; Zeng GH, 2014, LANGMUIR, V30, P4019, DOI 10.1021/la404673q; Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200	81	43	49	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26540	26553		10.1074/jbc.M116.739953	http://dx.doi.org/10.1074/jbc.M116.739953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27784787	Green Published, hybrid			2022-12-28	WOS:000391568200026
J	Davies, HM; Thalassinos, K; Osborne, AR				Davies, Heledd M.; Thalassinos, Konstantinos; Osborne, Andrew R.			Expansion of Lysine-rich Repeats in Plasmodium Proteins Generates Novel Localization Sequences That Target the Periphery of the Host Erythrocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; AMINO-ACID-COMPOSITION; TANDEM REPEATS; MALARIA PARASITES; MEMBRANE PROTEIN-1; SURFACE-ANTIGEN; TRANSCRIPTOME ANALYSIS; MECHANICAL-PROPERTIES; KNOB PROTEIN; FALCIPARUM	Repetitive low complexity sequences, mostly assumed to have no function, are common in proteins that are exported by the malaria parasite into its host erythrocyte. We identify a group of exported proteins containing short lysine-rich tandemly repeated sequences that are sufficient to localize to the erythrocyte periphery, where key virulence-related modifications to the plasma membrane and the underlying cytoskeleton are known to occur. Efficiency of targeting is dependent on repeat number, indicating that novel targeting modules could evolve by expansion of short lysine-rich sequences. Indeed, analysis of fragments of GARP from different species shows that two novel targeting sequences have arisen via the process of repeat expansion in this protein. In the protein Hyp12, the targeting function of a lysine-rich sequence is masked by a neighboring repetitive acidic sequence, further highlighting the importance of repetitive low complexity sequences. We show that sequences capable of targeting the erythrocyte periphery are present in at least nine proteins from Plasmodium falciparum and one from Plasmodium knowlesi. We find these sequences in proteins known to be involved in erythrocyte rigidification and cytoadhesion as well as in previously uncharacterized exported proteins. Together, these data suggest that expansion and contraction of lysine-rich repeats could generate targeting sequences de novo as well as modulate protein targeting efficiency and function in response to selective pressure.	[Davies, Heledd M.; Thalassinos, Konstantinos; Osborne, Andrew R.] Birkbeck & Univ Coll London, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 6BT, England	University of London; Birkbeck University London	Osborne, AR (corresponding author), Birkbeck & Univ Coll London, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 6BT, England.	a.osborne@ucl.ac.uk		Davies, Heledd/0000-0003-3475-0080	Wellcome Trust [091095/Z/10/Z, 099764 Z/12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants 091095/Z/10/Z and 099764 Z/12/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Bennett BJ, 1997, J BIOL CHEM, V272, P15299, DOI 10.1074/jbc.272.24.15299; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Brandt GS, 2013, MOL BIOCHEM PARASIT, V191, P20, DOI 10.1016/j.molbiopara.2013.08.003; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Craig AG, 2012, MALAYS J MED SCI, V19, P5; CULVENOR JG, 1987, EXP PARASITOL, V63, P58, DOI 10.1016/0014-4894(87)90078-6; Dalby AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006231; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Diez-Silva M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00614; DNASTAR, 2014, SEQMAN NGEN VERS 12; Doerig C, 2015, NAT REV MICROBIOL, V13, P160, DOI 10.1038/nrmicro3402; Fankhauser N, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-20; Fatih FA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-33; Ferguson DJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113923; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FOLEY M, 1991, MOL BIOCHEM PARASIT, V46, P137, DOI 10.1016/0166-6851(91)90207-M; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Frech C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-427; FUJIOKA H, 1994, EXP PARASITOL, V78, P371, DOI 10.1006/expr.1994.1040; Ganguly AK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08617; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gemayel R, 2015, MOL CELL, V59, P615, DOI 10.1016/j.molcel.2015.07.003; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; Glenister FK, 2009, BLOOD, V113, P919, DOI 10.1182/blood-2008-05-157735; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Goel S, 2014, J BIOL CHEM, V289, P34408, DOI 10.1074/jbc.M114.615393; Guy AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141729; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hirawake H, 1997, BBA-MOL BASIS DIS, V1360, P105, DOI 10.1016/S0925-4439(97)00007-0; Hodder AN, 2009, MOL MICROBIOL, V71, P48, DOI 10.1111/j.1365-2958.2008.06508.x; HOWARD RJ, 1987, J CELL BIOL, V104, P1269, DOI 10.1083/jcb.104.5.1269; Hughes AL, 2004, J MOL EVOL, V59, P528, DOI 10.1007/s00239-004-2645-4; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; KAUR P, 1990, INT J PEPT PROT RES, V36, P515; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; KILEJIAN A, 1991, MOL BIOCHEM PARASIT, V44, P175, DOI 10.1016/0166-6851(91)90003-O; Kishore SP, 2009, J MOL EVOL, V68, P706, DOI 10.1007/s00239-009-9245-2; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Lin WH, 2012, NUCLEIC ACIDS RES, V40, P2399, DOI 10.1093/nar/gkr1078; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lopes SCP, 2014, J INFECT DIS, V209, P1403, DOI 10.1093/infdis/jiu018; Luo H, 2014, BRIEF BIOINFORM, V15, P582, DOI 10.1093/bib/bbt003; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Mankelow TJ, 2012, BLOOD CELL MOL DIS, V49, P1, DOI 10.1016/j.bcmd.2012.03.001; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Marti M, 2013, CURR OPIN MICROBIOL, V16, P445, DOI 10.1016/j.mib.2013.04.010; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; McHugh E, 2015, MOL MICROBIOL, V98, P1101, DOI 10.1111/mmi.13201; Mendes TAO, 2013, MOL BIOL EVOL, V30, P951, DOI 10.1093/molbev/mst001; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Mills JP, 2007, P NATL ACAD SCI USA, V104, P9213, DOI 10.1073/pnas.0703433104; Muralidharan V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003488; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Nunes MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011747; Oakley MSM, 2006, AM J TROP MED HYG, V75, P279; Oberli A, 2016, CELL MICROBIOL, V18, P1415, DOI 10.1111/cmi.12583; Oberli A, 2014, FASEB J, V28, P4420, DOI 10.1096/fj.14-256057; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Paila U, 2008, NUCLEIC ACIDS RES, V36, P6664, DOI 10.1093/nar/gkn635; Parish LA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-160; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; Pei XH, 2007, J BIOL CHEM, V282, P26754, DOI 10.1074/jbc.M701612200; Pei XH, 2007, BLOOD, V110, P1036, DOI 10.1182/blood-2007-02-076919; Pelle KG, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0133-7; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petersen W, 2015, MOL BIOCHEM PARASIT, V200, P25, DOI 10.1016/j.molbiopara.2015.04.005; Philipps D, 2003, NUCLEIC ACIDS RES, V31, P6502, DOI 10.1093/nar/gkg845; Proellocks NI, 2014, FASEB J, V28, P3103, DOI 10.1096/fj.14-250399; Radfar A, 2009, NAT PROTOC, V4, P1899, DOI 10.1038/nprot.2009.198; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Rambaut A., 2014, FIGTREE VERSION 1 4; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; SCHERF A, 1992, EMBO J, V11, P2293, DOI 10.1002/j.1460-2075.1992.tb05288.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sundararaman SA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11078; Tan JC, 2010, J MOL EVOL, V71, P268, DOI 10.1007/s00239-010-9381-8; Tanaka TQ, 2013, MOL BIOCHEM PARASIT, V188, P20, DOI 10.1016/j.molbiopara.2013.02.005; Tarr SJ, 2014, MOL BIOCHEM PARASIT, V196, P29, DOI 10.1016/j.molbiopara.2014.07.011; Tiburcio M, 2012, BLOOD, V119, pE172, DOI 10.1182/blood-2012-03-414557; Toll-Riera M, 2012, MOL BIOL EVOL, V29, P883, DOI 10.1093/molbev/msr263; TRIGLIA T, 1987, EMBO J, V6, P1413, DOI 10.1002/j.1460-2075.1987.tb02382.x; TRIGLIA T, 1988, MOL BIOCHEM PARASIT, V31, P199, DOI 10.1016/0166-6851(88)90170-3; van Ooij C, 2013, J BIOL CHEM, V288, P31971, DOI 10.1074/jbc.M113.474189; Verra F, 1999, MOL BIOL EVOL, V16, P627, DOI 10.1093/oxfordjournals.molbev.a026145; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Waller KL, 2007, BBA-BIOMEMBRANES, V1768, P2145, DOI 10.1016/j.bbamem.2007.04.027; Waller KL, 2010, BBA-BIOMEMBRANES, V1798, P861, DOI 10.1016/j.bbamem.2010.01.018; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; Watermeyer JM, 2016, BLOOD, V127, P343, DOI 10.1182/blood-2015-10-674002; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	119	18	18	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26188	26207		10.1074/jbc.M116.761213	http://dx.doi.org/10.1074/jbc.M116.761213			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777305	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000390345200035
J	Shields-Cutler, RR; Crowley, JR; Miller, CD; Stapleton, AE; Cui, WD; Henderson, JP				Shields-Cutler, Robin R.; Crowley, Jan R.; Miller, Connelly D.; Stapleton, Ann E.; Cui, Weidong; Henderson, Jeffrey P.			Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDEROPHORE-BINDING-PROTEINS; TRACT-INFECTION; IRON ACQUISITION; STRUCTURAL-CHARACTERIZATION; BACTERIAL-INFECTION; MASS-SPECTROMETRY; IMMUNE-SYSTEM; LIPOCALIN 2; PATHOGEN; ENTEROBACTIN	In human urinary tract infections, host cells release the antimicrobial protein siderocalin (SCN; also known as lipocalin-2, neutrophil gelatinase-associated lipocalin, or 24p3) into the urinary tract. By binding to ferric catechol complexes, SCN can sequester iron, a growth-limiting nutrient for most bacterial pathogens. Recent evidence links the antibacterial activity of SCN in human urine to iron sequestration and metabolomic variation between individuals. To determine whether these metabolomic associations correspond to functional Fe(III)binding SCN ligands, we devised a biophysical protein binding screen to identify SCN ligands through direct analysis of human urine. This screen revealed a series of physiologic unconjugated urinary catechols that were able to function as SCN ligands of which pyrogallol in particular was positively associated with high urinary SCN activity. In a purified, defined culture system, these physiologic SCN ligands were sufficient to activate SCN antibacterial activity against Escherichia coli. In the presence of multiple SCN ligands, native mass spectrometry demonstrated that SCN may preferentially combine different ligands to coordinate iron, suggesting that availability of specific ligand combinations affects in vivo SCN antibacterial activity. These results support a mechanistic link between the human urinary metabolome and innate immune function.	[Shields-Cutler, Robin R.; Miller, Connelly D.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Div Infect Dis, Dept Med, St Louis, MO 63110 USA; [Shields-Cutler, Robin R.; Miller, Connelly D.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Crowley, Jan R.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Stapleton, Ann E.] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Cui, Weidong] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; Washington University (WUSTL)	Henderson, JP (corresponding author), Washington Univ, Sch Med, Div Infect Dis, 660 S Euclid, St Louis, MO 63110 USA.	jhenderson@DOM.wustl.edu	Stapleton, Ann E/N-2428-2015; Henderson, Jeffrey P/D-3337-2015	Stapleton, Ann E/0000-0003-0130-8659; 	NIDDK, National Institutes of Health [R01DK099534, P50DK064540, R56DK111930]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000448]; Longer Life Foundation; United States Public Health Service [P41-RR00954, P30-DK20579, P30-DK56341, 8P41GM103422]; National Institutes of Health [T32GM007067-37]; Monsanto Excellence Fund graduate fellowship; Burroughs Wellcome Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540, R01DK099534, R56DK111930, P30DK056341, P30DK020579, R01DK088830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Longer Life Foundation; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Monsanto Excellence Fund graduate fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIDDK, National Institutes of Health Grants R01DK099534, P50DK064540, and R56DK111930; National Center for Advancing Translational Sciences, National Institutes of Health Grant UL1TR000448; and the Longer Life Foundation (to J. P. H.). Mass spectrometry was supported by United States Public Health Service Grants P41-RR00954, P30-DK20579, P30-DK56341, and 8P41GM103422. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant T32GM007067-37 and a Monsanto Excellence Fund graduate fellowship.r Recipient of a Career Award for Medical Scientists from the Burroughs Wellcome Fund.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Bao GH, 2015, RSC ADV, V5, P28527, DOI 10.1039/c5ra02509e; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; BOOTH AN, 1959, J BIOL CHEM, V234, P3014; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Cherayil BJ, 2011, IMMUNOL RES, V50, P1, DOI 10.1007/s12026-010-8199-1; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Correnti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043696; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Cui WD, 2011, ANALYST, V136, P3854, DOI 10.1039/c1an15286f; Doneanu Catalin E, 2004, J Biomol Tech, V15, P208; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Foxman B, 2013, CURR INFECT DIS REP, V15, P124, DOI 10.1007/s11908-013-0317-5; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gomez-Casado C, 2013, J MOL GRAPH MODEL, V45, P111, DOI 10.1016/j.jmgm.2013.08.013; Gonthier MP, 2003, J NUTR, V133, P461, DOI 10.1093/jn/133.2.461; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hoette TM, 2011, ACS CHEM BIOL, V6, P1327, DOI 10.1021/cb200331g; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Paragas N, 2014, J CLIN INVEST, V124, P2963, DOI 10.1172/JCI71630; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Ruotolo BT, 2006, CURR OPIN CHEM BIOL, V10, P402, DOI 10.1016/j.cbpa.2006.08.020; Shields-Cutler RR, 2015, J BIOL CHEM, V290, P15949, DOI 10.1074/jbc.M115.645812; Sia AK, 2013, CURR OPIN CHEM BIOL, V17, P150, DOI 10.1016/j.cbpa.2012.11.014; Sorrell FJ, 2010, J PHARMACEUT BIOMED, V52, P802, DOI 10.1016/j.jpba.2010.02.024; Steigedal M, 2014, J IMMUNOL, V193, P6081, DOI 10.4049/jimmunol.1401528; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106	38	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25901	25910		10.1074/jbc.M116.759183	http://dx.doi.org/10.1074/jbc.M116.759183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780864	Green Published, hybrid			2022-12-28	WOS:000390345200013
J	Yang, YK; Yang, C; Chan, WP; Wang, ZQ; Deibel, KE; Pomerantz, JL				Yang, Yong-Kang; Yang, Chao; Chan, Waipan; Wang, Zhaoquan; Deibel, Katelynn E.; Pomerantz, Joel L.			Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMMUNE-RESPONSES; MALT1 CLEAVES; MICE LACKING; ACTIVATION; CARMA1; LUBAC; UBIQUITINATION; MUTATIONS; COMPLEX	The activation of NF-kappa B downstream of T cell receptor (TCR) engagement is a key signaling step required for normal lymphocyte function during the adaptive immune response. During TCR signaling, the adaptor protein Bcl10 is inducibly recruited to the CARD11 scaffold protein as part of a multicomponent complex that induces I kappa B kinase (IKK) activity and NF-kappa B activation. Here, we show that a consequence of this recruitment is the TCR-induced conjugation of Bcl10 with linear-linked polyubiquitin chains to generate the signaling intermediate Lin(Ub)(n)-Bcl10, which is required for the association of Bcl10 with the NEMO subunit of the IKK complex. The TCR-induced generation of Lin(Ub)(n)-Bcl10 requires Bcl10 lysines 17, 31, and 63, CARD11, MALT1, and the HOIP subunit of the linear ubiquitin chain assembly complex (LUBAC) but not the HOIP accessory protein SHARPIN. CARD11 promotes signal-induced Lin(Ub)(n)-Bcl10 generation by co-recruiting Bcl10 with HOIP, thereby bringing substrate to enzyme. The CARD11-HOIP interaction is rendered TCR-inducible by the four autoinhibitory repressive elements in the CARD11 inhibitory domain and involves the CARD11 coiled-coil domain and two independent regions of HOIP. Interestingly, oncogenic CARD11 variants associated with diffuse large B cell lymphoma spontaneously induce Lin(Ub)(n)-Bcl10 production to extents that correlate with their abilities to activate NF-kappa B and with their enhanced abilities to bind HOIP and Bcl10. Our results define molecular determinants that control the production of Lin(Ub)(n)-Bcl10, an important signaling intermediate in TCR and oncogenic CARD11 signaling.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Chan, Waipan] NIAID, NIH, Lab Syst Biol, Lymphocyte Biol Sect, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pomerantz, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Inst Cell Engn, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA.	joel.pomerantz@jhmi.edu	YANG, YONGKANG/AEP-2772-2022	YANG, YONGKANG/0000-0002-0333-7712	Quest for Cures Grant from the Leukemia and Lymphoma Society [0793-14]; National Institutes of Health [RO1CA177600]; Johns Hopkins University Institute for Cell Engineering; Leukemia and Lymphoma Society	Quest for Cures Grant from the Leukemia and Lymphoma Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Institute for Cell Engineering; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	This work was supported in part by Quest for Cures Grant 0793-14 from the Leukemia and Lymphoma Society, Grant RO1CA177600 from the National Institutes of Health, and funds from The Johns Hopkins University Institute for Cell Engineering. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of a Leukemia and Lymphoma Society Fellow Award.	Alexia C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004496; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Bu R, 2012, LEUKEMIA LYMPHOMA, V53, P1971, DOI 10.3109/10428194.2012.668286; Chan WP, 2013, MOL CELL BIOL, V33, P429, DOI 10.1128/MCB.00850-12; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Dubois SM, 2014, BLOOD, V123, P2199, DOI 10.1182/blood-2013-05-504019; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Elton L, 2016, FEBS J, V283, P403, DOI 10.1111/febs.13597; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Jattani RP, 2016, J BIOL CHEM, V291, P8338, DOI 10.1074/jbc.M116.717322; Jattani RP, 2016, J BIOL CHEM, V291, P8324, DOI 10.1074/jbc.M115.683714; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Montesinos-Rongen M, 2010, ACTA NEUROPATHOL, V120, P529, DOI 10.1007/s00401-010-0709-7; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Pedersen SM, 2016, MOL CELL BIOL, V36, P794, DOI 10.1128/MCB.00876-15; de Diego RP, 2015, J ALLERGY CLIN IMMUN, V136, P1139, DOI 10.1016/j.jaci.2015.06.031; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Satpathy S., 2015, MOL SYST BIOL, V11, P810, DOI [10.15252/msb.20145880, DOI 10.15252/MSB.20145880]; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yagi H, 2012, EMBO REP, V13, P462, DOI 10.1038/embor.2012.24; Yang YB, 2016, CANCER CELL, V29, P494, DOI 10.1016/j.ccell.2016.03.006; Yang YB, 2014, CANCER DISCOV, V4, P480, DOI 10.1158/2159-8290.CD-13-0915	58	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25921	25936		10.1074/jbc.M116.754028	http://dx.doi.org/10.1074/jbc.M116.754028			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777308	hybrid, Green Published			2022-12-28	WOS:000390345200015
J	Matsui, Y; Shindo, K; Nagata, K; Yoshinaga, N; Shirakawa, K; Kobayashi, M; Takaori-Kondo, A				Matsui, Yusuke; Shindo, Keisuke; Nagata, Kayoko; Yoshinaga, Noriyoshi; Shirakawa, Kotaro; Kobayashi, Masayuki; Takaori-Kondo, Akifumi			Core Binding Factor beta Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIF-INDUCED DEGRADATION; CBF-BETA; UBIQUITIN LIGASE; T-LYMPHOCYTES; E3 LIGASE; APOBEC3G; MDM2; P53; RESTRICTION	HIV, type 1 overcomes host restriction factor apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APO-BEC3) proteins by organizing an E3 ubiquitin ligase complex together with viral infectivity factor (Vif) and a host transcription cofactor core binding factor beta (CBF beta). CBF beta is essential for Vif to counteract APOBEC3 by enabling the recruitment of cullin 5 to the complex and increasing the steady-state level of Vif protein; however, the mechanisms by which CBF beta up-regulates Vif protein remains unclear. Because we have reported previously that mouse double minute 2 homolog (MDM2) is an E3 ligase for Vif, we hypothesized that CBF beta might protect Vif from MDM2-mediated degradation. Co-immunoprecipitation analyses showed that Vif mutants that do not bind to CBF beta preferentially interact with MDM2 and that overexpression of CBF beta disrupts the interaction between MDM2 and Vif. Knockdown of CBF beta reduced the steady-state level of Vif in MDM2-proficient cells but not in MDM2-null cells. Cycloheximide chase analyses revealed that Vif E88A/W89A, which does not interact with CBF beta, degraded faster than wild-type Vif in MDM2-proficient cells but not in MDM2-null cells, suggesting that Vif stabilization by CBF beta is mainly caused by impairing MDM2-mediated degradation. We identified Vif R93E as a Vif variant that does not bind to MDM2, and the virus with this substitution mutation was more resistant to APOBEC3G than the parental virus. Combinatory substitution of Vif residues required for CBF beta binding and MDM2 binding showed full recovery of Vif steady-state levels, supporting our hypothesis. Our data provide new insights into the mechanism of Vif augmentation by CBF beta	[Matsui, Yusuke; Shindo, Keisuke; Nagata, Kayoko; Yoshinaga, Noriyoshi; Shirakawa, Kotaro; Kobayashi, Masayuki; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan	Kyoto University	Shindo, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, 54 Shogoin Kawaracho, Kyoto 6068507, Japan.	shind009@kuhp.kyoto-u.ac.jp		Shindo, Keisuke/0000-0001-8793-8189	Ministry of Education, Culture, Sports, Science, and Technology [JP24115004]; Japan Society for the Promotion of Science [JP16K08807]; Ministry of Health, Labor, and Welfare in Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	Twhis study was partly supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI #JP24115004), Japan Society for the Promotion of Science (KAKENHI #JP16K08807), and the Ministry of Health, Labor, and Welfare in Japan. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Dussart S, 2004, BIOCHEM BIOPH RES CO, V315, P66, DOI 10.1016/j.bbrc.2004.01.023; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fribourgh JL, 2014, J VIROL, V88, P3309, DOI 10.1128/JVI.03824-13; Fujita M, 2004, MICROBES INFECT, V6, P791, DOI 10.1016/j.micinf.2004.04.011; Fujita M, 2003, J VIROL, V77, P1626, DOI 10.1128/JVI.77.2.1626-1632.2003; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; GABUZDA DH, 1994, J ACQ IMMUN DEF SYND, V7, P908; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; Hache G, 2008, CURR BIOL, V18, P819, DOI 10.1016/j.cub.2008.04.073; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Izumi T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-1; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; LUNA RMD, 1995, NATURE, V378, P203; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Malbec M, 2010, VIROLOGY, V405, P414, DOI 10.1016/j.virol.2010.06.021; Matsui M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-122; Matsui Y, 2014, VIROLOGY, V449, P82, DOI 10.1016/j.virol.2013.11.004; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Miyagi E, 2014, J VIROL, V88, P4839, DOI 10.1128/JVI.03359-13; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Salter JD, 2014, TRENDS BIOCHEM SCI, V39, P373, DOI 10.1016/j.tibs.2014.07.001; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718	39	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24892	24899		10.1074/jbc.M116.734673	http://dx.doi.org/10.1074/jbc.M116.734673			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758855	Green Published, hybrid			2022-12-28	WOS:000388880100009
J	Sato, K; Kimura, M; Sugiyama, K; Nishikawa, M; Okano, Y; Nagaoka, H; Nagase, T; Kitade, Y; Ueda, H				Sato, Katsuya; Kimura, Masashi; Sugiyama, Kazue; Nishikawa, Masashi; Okano, Yukio; Nagaoka, Hitoshi; Nagase, Takahiro; Kitade, Yukio; Ueda, Hiroshi			Four-and-a-half LIM Domains 1 (FHL1) Protein Interacts with the Rho Guanine Nucleotide Exchange Factor PLEKHG2/FLJ00018 and Regulates Cell Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; ONLY PROTEIN; NEURO-2A CELLS; FAMILY; CYTOSKELETON; ACTIVATION; NUCLEUS; GTPASES; IDENTIFICATION; LOCALIZATION	PLEKHG2/FLJ00018 is a G beta gamma-dependent guanine nucleotide exchange factor for the small GTPases Rac and Cdc42 and has been shown to mediate the signaling pathways leading to actin cytoskeleton reorganization. Here we showed that the zinc finger domain-containing protein four-and-a-half LIM domains 1 (FHL1) acts as a novel interaction partner of PLEKHG2 by the yeast two-hybrid system. Among the isoforms of FHL1 (i.e. FHL1A, FHL1B, and FHL1C), FHL1A and FHL1B interacted with PLEKHG2. We found that there was an FHL1-binding region at amino acids 58-150 of PLEKHG2. The overexpression of FHL1A but not FHL1B enhanced the PLEKHG2-induced serum response element-dependent gene transcription. The co-expression of FHL1A and G beta gamma synergistically enhanced the PLEKHG2-induced serum response element-dependent gene transcription. Increased transcription activity was decreased by FHL1A knock-out with the CRISPR/Cas9 system. Compared with PLEKHG2-expressing cells, the number and length of finger-like protrusions were increased in PLEKHG2-, G beta gamma-, and FHL1A-expressing cells. Our results provide evidence that FHL1A interacts with PLEKHG2 and regulates cell morphological change through the activity of PLEKHG2.	[Sato, Katsuya; Sugiyama, Kazue; Nishikawa, Masashi; Kitade, Yukio; Ueda, Hiroshi] Gifu Univ, Grad Sch Med, United Grad Sch Drug Discovery & Med Informat Sci, Yanagido 1-1, Gifu 5011193, Japan; [Sato, Katsuya; Kimura, Masashi; Okano, Yukio; Nagaoka, Hitoshi] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Yanagido 1-1, Gifu 5011193, Japan; [Nagase, Takahiro] Kazusa DNA Res Inst, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan; [Kitade, Yukio; Ueda, Hiroshi] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Yanagido 1-1, Gifu 5011193, Japan; [Kimura, Masashi] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Yanagido 1-1, Gifu 5011193, Japan	Gifu University; Gifu University; Kazusa DNA Research Institute; Gifu University; Gifu University	Ueda, H (corresponding author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Yanagido 1-1, Gifu 5011193, Japan.	hueda@gifu-u.ac.jp		Nishikawa, Masashi/0000-0003-2542-8057; Sato, Katsuya/0000-0002-5573-746X	JSPS [23590073, 15K07927]; Division of Genomic Research at the Life Science Research Center at Gifu University	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Division of Genomic Research at the Life Science Research Center at Gifu University	This study was supported by JSPS KAKENHI Grants 23590073 and 15K07927. The DNA sequence analysis was supported by the Division of Genomic Research at the Life Science Research Center at Gifu University. The authors declare that they have no conflicts of interest with the contents of this article.	Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Lee SMY, 1999, GENE, V237, P253, DOI 10.1016/S0378-1119(99)00251-6; Li HY, 2001, CELL MOTIL CYTOSKEL, V48, P11, DOI 10.1002/1097-0169(200101)48:1<11::AID-CM2>3.0.CO;2-I; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nagae R, 2011, BIOCHEM BIOPH RES CO, V415, P168, DOI 10.1016/j.bbrc.2011.10.047; Pen AE, 2015, EUR J MED GENET, V58, P222, DOI 10.1016/j.ejmg.2015.02.003; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Runne C, 2013, MOL CELL BIOL, V33, P4294, DOI 10.1128/MCB.00879-13; Sato K, 2014, J BIOL CHEM, V289, P10045, DOI 10.1074/jbc.M113.521880; Sato K, 2014, CELL SIGNAL, V26, P691, DOI 10.1016/j.cellsig.2013.12.006; Sato K, 2013, CELL SIGNAL, V25, P41, DOI 10.1016/j.cellsig.2012.09.015; Schessl J, 2009, BRAIN, V132, P452, DOI 10.1093/brain/awn325; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wong CH, 2010, FEBS LETT, V584, P4511, DOI 10.1016/j.febslet.2010.10.022; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	27	7	8	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25227	25238		10.1074/jbc.M116.759571	http://dx.doi.org/10.1074/jbc.M116.759571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27765816	Green Published, hybrid			2022-12-28	WOS:000388880100036
J	Letts, JA; Degliesposti, G; Fiedorczuk, K; Skehel, M; Sazanov, LA				Letts, James A.; Degliesposti, Gianluca; Fiedorczuk, Karol; Skehel, Mark; Sazanov, Leonid A.			Purification of Ovine Respiratory Complex I Results in a Highly Active and Stable Preparation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; CYTOCHROME-C-OXIDASE; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; INACTIVE TRANSITION; ACCESSORY SUBUNITS; DOMESTIC SHEEP; ATP SYNTHASE; DNA SEQUENCE	NADH-ubiquinone oxidoreductase (complex I) is the largest (similar to 1 MDa) and the least characterized complex of the mitochondrial electron transport chain, Because of the ease of sample availability, previous work has focused almost exclusively on bovine complex I. However, only medium resolution structural analyses of this complex have been reported. Working with other mammalian complex I homologues is a potential approach for overcoming these limitations. Due to the inherent difficulty of expressing large membrane protein complexes, screening of complex I homologues is limited to large mammals reared for human consumption. The high sequence identity among these available sources may preclude the benefits of screening. Here, we report the characterization of complex I purified from Ovis aries (ovine) heart mitochondria. All 44 unique subunits of the intact complex were identified by mass spectrometry. We identified differences in the subunit composition of subcomplexes of ovine complex I as compared with bovine, suggesting differential stability of inter-subunit interactions within the complex. Furthermore, the 42-kDa subunit, which is easily lost from the bovine enzyme, remains tightly bound to ovine complex I. Additionally, we developed a novel purification protocol for highly active and stable mitochondrial complex I using the branched-chain detergent lauryl maltose neopentyl glycol. Our data demonstrate that, although closely related, significant differences exist between the biochemical properties of complex I prepared from ovine and bovine mitochondria and that ovine complex I represents a suitable alternative target for further structural studies.	[Letts, James A.; Fiedorczuk, Karol; Sazanov, Leonid A.] IST Austria, A-3400 Klosterneuburg, Austria; [Degliesposti, Gianluca; Skehel, Mark] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Institute of Science & Technology - Austria; MRC Laboratory Molecular Biology	Sazanov, LA (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	sazanov@ist.ac.at	Fiedorczuk, Karol/ABC-1161-2021; Sazanov, Leonid A/ABF-2125-2021; Letts, James Anthony/AAN-6632-2020; Degliesposti, Gianluca/AAR-3501-2020	Sazanov, Leonid A/0000-0002-0977-7989; Letts, James Anthony/0000-0002-9864-3586; Degliesposti, Gianluca/0000-0001-6387-2533	European Union [701309]; FEBS long-term fellowship; Medical Research Council UK; MRC [MC_U105178788, MC_U105674180] Funding Source: UKRI; Medical Research Council [1373852, 1601061, MC_U105178788, MC_U105674180] Funding Source: researchfish	European Union(European Commission); FEBS long-term fellowship; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by European Union's 2020 Research and Innovation Program under Grant 701309. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a FEBS long-term fellowship.; Supported in part by a Medical Research Council UK Ph.D. fellowship.	Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; ANDERSON RL, 1982, CLIN CHIM ACTA, V121, P111, DOI 10.1016/0009-8981(82)90216-9; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Birrell JA, 2011, FEBS LETT, V585, P2318, DOI 10.1016/j.febslet.2011.05.065; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Chae PS, 2012, CHEM-EUR J, V18, P9485, DOI 10.1002/chem.201200069; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; deCoo RFM, 1997, GENOMICS, V45, P434, DOI 10.1006/geno.1997.4930; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; ESPOSTI MD, 1994, BIOCHEM J, V301, P161, DOI 10.1042/bj3010161; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Hatefi Y, 1978, Methods Enzymol, V53, P5; Hatefi Y., 1978, BIOMEMBRANE, V53, P11; Hauer F, 2015, STRUCTURE, V23, P1769, DOI 10.1016/j.str.2015.06.029; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hiendleder S, 1998, J HERED, V89, P113, DOI 10.1093/jhered/89.2.113; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 1998, ANIM GENET, V29, P116, DOI 10.1046/j.1365-2052.1998.00295.x; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kmita K, 2013, BIOCHEM SOC T, V41, P1272, DOI 10.1042/BST20130091; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KOTLYAR AB, 1992, BIOCHIM BIOPHYS ACTA, V1098, P144, DOI 10.1016/S0005-2728(05)80329-9; Letts JA, 2015, CURR OPIN STRUC BIOL, V33, P135, DOI 10.1016/j.sbi.2015.08.008; Lewinson O, 2008, J MOL BIOL, V377, P62, DOI 10.1016/j.jmb.2007.12.059; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Mariotti M, 2013, MITOCHONDR DNA, V24, P577, DOI 10.3109/19401736.2013.770493; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112; Murai M, 2016, BBA-BIOENERGETICS, V1857, P884, DOI 10.1016/j.bbabio.2015.11.009; Okun JG, 2000, BBA-BIOENERGETICS, V1459, P77, DOI 10.1016/S0005-2728(00)00115-8; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/BSE0470001, 10.1042/bse0470001]; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2000, J MOL BIOL, V302, P455, DOI 10.1006/jmbi.2000.4079; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Shinkarev VP, 1997, BIOPHYS J, V72, P2304, DOI 10.1016/S0006-3495(97)78875-1; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; SKEHEL JM, 1991, FEBS LETT, V282, P135, DOI 10.1016/0014-5793(91)80462-C; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Stevens TJ, 2001, PROTEIN SCI, V10, P2507, DOI 10.1110/ps.ps.10501; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Uenishi H, 2004, NUCLEIC ACIDS RES, V32, pD484, DOI 10.1093/nar/gkh037; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Vinogradov AD, 2016, BBA-BIOENERGETICS, V1857, P863, DOI 10.1016/j.bbabio.2015.11.004; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Yamaguchi M, 1998, J BIOL CHEM, V273, P8094, DOI 10.1074/jbc.273.14.8094; Yang CT, 2017, MITOCHONDRIAL DNA A, V28, P315, DOI 10.3109/19401736.2015.1122761; Ye RS, 2012, MOL BIOL REP, V39, P5767, DOI 10.1007/s11033-011-1387-9; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zhu JP, 2015, P NATL ACAD SCI USA, V112, P12087, DOI 10.1073/pnas.1510577112; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	79	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24657	24675		10.1074/jbc.M116.735142	http://dx.doi.org/10.1074/jbc.M116.735142			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27672209	Green Published, hybrid			2022-12-28	WOS:000388875500026
J	Schmidt, A; Lohrer, D; Alsop, RJ; Lenzig, P; Oslender-Bujotzek, A; Wirtz, M; Rheinstadter, MC; Grunder, S; Wiemuth, D				Schmidt, Axel; Lohrer, Daniel; Alsop, Richard J.; Lenzig, Pia; Oslender-Bujotzek, Adrienne; Wirtz, Monika; Rheinstadter, Maikel C.; Grunder, Stefan; Wiemuth, Dominik			A Cytosolic Amphiphilic alpha-Helix Controls the Activity of the Bile Acid-sensitive Ion Channel (BASIC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; ANIONIC LIPID-MEMBRANES; NA+ CHANNEL; LIDDLES SYNDROME; ACTIVATION; ASIC3; PAIN; ENAC; MECHANOTRANSDUCTION; CHOLESTEROL	The bile acid-sensitive ion channel (BASIC) is a member of the degenerin/epithelial Na+ channel (Deg/ENaC) family of ion channels. It is mainly found in bile duct epithelial cells, the intestinal tract, and the cerebellum and is activated by alterations of its membrane environment. Bile acids, one class of putative physiological activators, exert their effect by changing membrane properties, leading to an opening of the channel. The physiological function of BASIC, however, is unknown. Deg/ENaC channels are characterized by a trimeric subunit composition. Each subunit is composed of two transmembrane segments, which are linked by a large extracellular domain. The termini of the channels protrude into the cytosol. Many Deg/ENaC channels contain regulatory domains and sequence motifs within their cytosolic domains. In this study, we show that BASIC contains an amphiphilic alpha-helical structure within its N-terminal domain. This alpha-helix binds to the cytosolic face of the plasma membrane and stabilizes a closed state. Truncation of this domain renders the channel hyperactive. Collectively, we identify a cytoplasmic domain, unique to BASIC, that controls channel activity via membrane interaction.	[Schmidt, Axel; Lohrer, Daniel; Lenzig, Pia; Oslender-Bujotzek, Adrienne; Wirtz, Monika; Grunder, Stefan; Wiemuth, Dominik] Rhein Westfal TH Aachen, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Alsop, Richard J.; Rheinstadter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	RWTH Aachen University; McMaster University	Wiemuth, D (corresponding author), Rhein Westfal TH Aachen, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	dwiernuth@ukaachen.de	Rheinstadter, Maikel C/D-5322-2009; Schmidt, Axel/GLR-2893-2022; Gründer, Stefan/I-2495-2019	Rheinstadter, Maikel C/0000-0002-0558-7475; Schmidt, Axel/0000-0002-9780-7243; Gründer, Stefan/0000-0002-7635-9883	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (to D. W.). Part of this work was presented in abstract form in Abstracts of the 95th Meeting of the German Physiological Society, March 3-5, 2016, Lubeck, Germany (Wiemuth D., Lenzig P., and Grunder S. (2016) Acta Physiol 216, OS10-8 (Suppl. 707)). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi T, 2000, CHEM PHYS LIPIDS, V107, P93, DOI 10.1016/S0009-3084(00)00154-7; Alsop RJ, 2016, SOFT MATTER, V12, P6737, DOI 10.1039/c6sm00695g; Alsop RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22425; Alsop RJ, 2015, SOFT MATTER, V11, P4756, DOI 10.1039/c5sm00597c; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Barrett MA, 2015, MEMBRANES, V5, P824, DOI 10.3390/membranes5040824; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Boiko N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091326; Chen CC, 2013, J CELL MOL MED, V17, P337, DOI 10.1111/jcmm.12025; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Dies H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099124; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ilyaskin AV, 2016, J BIOL CHEM, V291, P19835, DOI 10.1074/jbc.M116.726471; Jalalvand E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10002; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Lefevre CMT, 2014, PFLUG ARCH EUR J PHY, V466, P253, DOI 10.1007/s00424-013-1310-4; Lin SH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11460; Madeja M, 1995, J NEUROSCI METH, V63, P211, DOI 10.1016/0165-0270(95)00094-1; Palmer LG, 2012, CLIN EXP NEPHROL, V16, P35, DOI 10.1007/s10157-011-0496-z; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Saugstad JA, 2004, J BIOL CHEM, V279, P55514, DOI 10.1074/jbc.M411849200; Schmidt A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111549; Schwartz V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18242; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Tang J, 2016, SOFT MATTER, V12, P3165, DOI 10.1039/c5sm02619a; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wiemuth D, 2014, PFLUG ARCH EUR J PHY, V466, P1725, DOI 10.1007/s00424-013-1403-0; Wiemuth D, 2014, CHANNELS, V8, P29, DOI 10.4161/chan.27493; Wiemuth D, 2013, CHANNELS, V7, P38, DOI 10.4161/chan.22406; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wiemuth D, 2010, J BIOL CHEM, V285, P30404, DOI 10.1074/jbc.M110.153064	48	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24551	24565		10.1074/jbc.M116.756437	http://dx.doi.org/10.1074/jbc.M116.756437			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27679529	Green Published, hybrid			2022-12-28	WOS:000388875500018
J	Huang, GC; Zhang, YF; Shan, YL; Yang, SZ; Chelliah, Y; Wang, H; Takahashi, JS				Huang, Guocun; Zhang, Yunfeng; Shan, Yongli; Yang, Shuzhang; Chelliah, Yogarany; Wang, Han; Takahashi, Joseph S.			Circadian Oscillations of NADH Redox State Using a Heterologous Metabolic Sensor in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosensor; cell metabolism; circadian; nicotinamide adenine dinucleotide (NADH); oxidation-reduction (redox); Rex; oscillation	DNA-BINDING; CLOCK; SIRT1; NAD(+); REX; TRANSCRIPTION; FLUORESCENCE; DEACETYLASE; EXPRESSION; BIOSENSOR	It is known that there are mechanistic links between circadian clocks and metabolic cycles. Reduced nicotinamide adenine dinucleotide (NADH) is a key metabolic cofactor in all living cells; however, it is not known whether levels of NADH oscillate or not. Here we employed REX, a bacterial NADH-binding protein, fused to the VP16 activator to convert intracellular endogenous redox balance into transcriptional readouts by a reporter gene in mammalian cells. EMSA results show that the DNA binding activity of both T- and S-REX::VP16 fusions is decreased with a reduced-to-oxidized cofactor ratio increase. Transient and stabilized cell lines bearing the REX::VP16 and the REX binding operator (ROP) exhibit two circadian luminescence cycles. Consistent with these results, NADH oscillations are observed in host cells, indicating REX can act as a NADH sensor to report intracellular dynamic redox homeostasis in mammalian cells in real time. NADH oscillations provide another metabolic signal for coupling the circadian clock and cellular metabolic states.	[Huang, Guocun; Shan, Yongli; Takahashi, Joseph S.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yang, Shuzhang; Chelliah, Yogarany; Takahashi, Joseph S.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Huang, Guocun; Zhang, Yunfeng; Wang, Han] Soochow Univ, Ctr Circadian Clocks, Suzhou 215123, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Soochow University - China	Huang, GC; Takahashi, JS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	guocun.huang@utsouthwestern.edu; joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Wang, Han/A-9774-2008	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Wang, Han/0000-0003-2420-3147; Shan, Yongli/0000-0002-5870-2107	National Natural Science Foundation of China [31571206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31571206 (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Blacker TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4936; Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Christensen CE, 2014, J BIOL CHEM, V289, P2344, DOI 10.1074/jbc.M113.498626; Du XH, 1999, NUCLEIC ACIDS RES, V27, P1690, DOI 10.1093/nar/27.7.1690; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Hong HK, 2007, PLOS GENET, V3, P324, DOI 10.1371/journal.pgen.0030033; Itoh TQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063113; Kumar V, 2010, CELL, V142, P841, DOI 10.1016/j.cell.2010.08.037; McLaughlin KJ, 2010, MOL CELL, V38, P563, DOI 10.1016/j.molcel.2010.05.006; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sickmier EA, 2005, STRUCTURE, V13, P43, DOI 10.1016/j.str.2004.10.012; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Stringari C, 2015, CELL REP, V10, P1, DOI 10.1016/j.celrep.2014.12.007; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	32	8	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23906	23914		10.1074/jbc.M116.728774	http://dx.doi.org/10.1074/jbc.M116.728774			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27645993	Green Published, hybrid			2022-12-28	WOS:000388498100006
J	Long, T; Li, J; Li, H; Zhou, M; Zhou, XL; Liu, RJ; Wang, ED				Long, Tao; Li, Jing; Li, Hao; Zhou, Mi; Zhou, Xiao-Long; Liu, Ru-Juan; Wang, En-Duo			Sequence-specific and Shape-selective RNA Recognition by the Human RNA 5-Methylcytosine Methyltransferase NSun6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5-methylcytosine; RNA methylation; RNA methyltransferase; S-adenosylmethionine (SAM); transfer RNA (tRNA); NSun family; methyltransferase; substrate recognition; tRNA modification	RECESSIVE INTELLECTUAL DISABILITY; CODON-BIASED TRANSLATION; ENZYMATIC FORMATION; CELLULAR STRESS; NONCODING RNA; METHYLATION; IDENTIFICATION; DNMT2; ANTICODON; PROLIFERATION	Human NSun6 is an RNA methyltransferase that catalyzes the transfer of the methyl group from S-adenosyl-l-methionine (SAM) to C72 of tRNA(Thr) and tRNA(Cys). In the current study, we used mass spectrometry to demonstrate that human NSun6 indeed introduces 5-methylcytosine (m(5)C) into tRNA, as expected. To further reveal the tRNA recognition mechanism of human NSun6, we measured the methylation activity of human NSun6 and its kinetic parameters for different tRNA substrates and their mutants. We showed that human NSun6 requires a well folded, full-length tRNA as its substrate. In the acceptor region, the CCA terminus, the target site C72, the discriminator base U73, and the second and third base pairs (2:71 and 3:70) of the acceptor stem are all important RNA recognition elements for human NSun6. In addition, two specific base pairs (11:24 and 12:23) in the D-stem of the tRNA substrate are involved in interacting with human NSun6. Together, our findings suggest that human NSun6 relies on a delicate network for RNA recognition, which involves both the primary sequence and tertiary structure of tRNA substrates.	[Long, Tao; Li, Jing; Li, Hao; Zhou, Mi; Zhou, Xiao-Long; Liu, Ru-Juan; Wang, En-Duo] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Long, Tao; Li, Jing; Li, Hao; Zhou, Mi; Wang, En-Duo] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Liu, RJ; Wang, ED (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	liurj@sibcb.ac.cn; edwang@sibcb.ac.cn	Li, Hao/GPS-9834-2022	Liu, Ru-Juan/0000-0001-7459-3126	National Natural Science Foundation of China [91440204, 31270775, 81471113]; National Key Basic Research Foundation of China [2012CB911000]; Youth Innovation Promotion Association (Chinese Academy of Sciences)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Youth Innovation Promotion Association (Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 91440204, 31270775, and 81471113 and National Key Basic Research Foundation of China Grant 2012CB911000. This work was also supported by the Youth Innovation Promotion Association (Chinese Academy of Sciences) (to R.-J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Cerrudo CS, 2014, FEBS J, V281, P74, DOI 10.1111/febs.12602; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Endres L, 2015, RNA BIOL, V12, P603, DOI 10.1080/15476286.2015.1031947; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Gillis D, 2014, J MED GENET, V51, P581, DOI 10.1136/jmedgenet-2014-102282; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; Grosjean H., 2009, DNA RNA MODIFICATION; Guy MP, 2015, HUM MUTAT, V36, P1176, DOI 10.1002/humu.22897; Haag S, 2015, RNA, V21, P1532, DOI 10.1261/rna.051524.115; Harris T, 2007, BIOL REPROD, V77, P376, DOI 10.1095/biolreprod.106.058669; Hazlewood J, 1989, Cancer Commun, V1, P29; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Hussain S, 2013, MOL CELL BIOL, V33, P1561, DOI 10.1128/MCB.01523-12; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Khosronezhad N, 2015, REPROD FERT DEVELOP, V27, P471, DOI 10.1071/RD13371; Kosi N, 2015, BRAIN RES, V1597, P65, DOI 10.1016/j.brainres.2014.11.040; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Lipman RSA, 1998, P NATL ACAD SCI USA, V95, P13495, DOI 10.1073/pnas.95.23.13495; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, P7489, DOI 10.1093/nar/gkv745; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; PUTZ J, 1994, NAT STRUCT BIOL, V1, P580, DOI 10.1038/nsb0994-580; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Roundtree IA, 2016, CURR OPIN CHEM BIOL, V30, P46, DOI 10.1016/j.cbpa.2015.10.024; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Shitivelband S, 2005, J MOL BIOL, V348, P513, DOI 10.1016/j.jmb.2005.02.023; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Yuan S, 2014, MOL CELL BIOL, V34, P3630, DOI 10.1128/MCB.00243-14; Zhang XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1692; Zhou M, 2015, RNA BIOL, V12, P900, DOI 10.1080/15476286.2015.1050576	60	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24293	24303		10.1074/jbc.M116.742569	http://dx.doi.org/10.1074/jbc.M116.742569			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703015	hybrid, Green Published			2022-12-28	WOS:000388498100040
J	Casu, B; Smart, J; Hancock, MA; Smith, M; Sygusch, J; Baron, C				Casu, Bastien; Smart, Jonathan; Hancock, Mark A.; Smith, Mark; Sygusch, Jurgen; Baron, Christian			Structural Analysis and Inhibition of TraE from the pKM101 Type IV Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial conjugation; membrane protein; plasmid; protein secretion; protein-protein interaction; type IV secretion	BRUCELLA-SUIS VIRB8; AGROBACTERIUM-TUMEFACIENS VIRB8; CONJUGAL TRANSFER SYSTEM; INCN PLASMID PKM101; DNA TRANSPORT PORE; PERIPLASMIC DOMAIN; ESCHERICHIA-COLI; CORE COMPLEX; PROTEINS; COMPLEMENTATION	Gram-negative bacteria use type IV secretion systems (T4SSs) for a variety of macromolecular transport processes that include the exchange of genetic material. The pKM101 plasmid encodes a T4SS similar to the well-studied model systems from Agrobacterium tumefaciens and Brucella suis. Here, we studied the structure and function of TraE, a homolog of VirB8 that is an essential component of all T4SSs. Analysis by X-ray crystallography revealed a structure that is similar to other VirB8 homologs but displayed an altered dimerization interface. The dimerization interface observed in the X-ray structure was corroborated using the bacterial two-hybrid assay, biochemical characterization of the purified protein, and in vivo complementation, demonstrating that there are different modes of dimerization among VirB8 homologs. Analysis of interactions using the bacterial two-hybrid and cross-linking assays showed that TraE and its homologs from Agrobacterium, Brucella, and Helicobacter pylori form heterodimers. They also interact with heterologous VirB10 proteins, indicating a significant degree of plasticity in the protein-protein interactions of VirB8-like proteins. To further assess common features of VirB8-like proteins, we tested a series of small molecules derived from inhibitors of Brucella VirB8 dimerization. These molecules bound to TraE in vitro, docking predicted that they bind to a structurally conserved surface groove of the protein, and some of them inhibited pKM101 plasmid transfer. VirB8-like proteins thus share functionally important sites, and these can be exploited for the design of specific inhibitors of T4SS function.	[Casu, Bastien; Smart, Jonathan; Smith, Mark; Sygusch, Jurgen; Baron, Christian] Univ Montreal, Dept Biochem & Mol Med, Fac Med, Pavillon Roger Gaudry,CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Hancock, Mark A.] McGill Univ, Fac Med, SPR MS Facil, Montreal, PQ H3G 1Y6, Canada	Universite de Montreal; McGill University	Baron, C (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Fac Med, Pavillon Roger Gaudry,CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	christian.baron@umontreal.ca		Baron, Christian/0000-0002-0132-2111; Sygusch, Jurgen/0000-0002-6629-2128; Casu, Bastien/0000-0003-3508-6804	Canadian Institutes of Health Research (CIHR) [MOP-84239]; Natural Sciences and Engineering Research Council (NSERC); NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes (CDMC); Bristol Myers Smith Research Chair in Molecular Biology at Universite de Montreal; Groupe d'etudes des proteines membranaires (GEPROM); Canada Foundation for Innovation (CFI); Fonds de recherche du Quebec-Sante (FRQ-S)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes (CDMC); Bristol Myers Smith Research Chair in Molecular Biology at Universite de Montreal; Groupe d'etudes des proteines membranaires (GEPROM); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de recherche du Quebec-Sante (FRQ-S)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-84239 and grants from the Natural Sciences and Engineering Research Council (NSERC), the NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes (CDMC), the Bristol Myers Smith Research Chair in Molecular Biology at Universite de Montreal, the Groupe d'etudes des proteines membranaires (GEPROM), the Canada Foundation for Innovation (CFI), and the Fonds de recherche du Quebec-Sante (FRQ-S) (to C. B.). The McGill SPR-MS facility receives infrastructure support from CFI. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Aguilar J, 2010, P NATL ACAD SCI USA, V107, P3758, DOI 10.1073/pnas.0914940107; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Bourg G, 2009, J BACTERIOL, V191, P2985, DOI 10.1128/JB.01426-08; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Das A, 2000, J BACTERIOL, V182, P758, DOI 10.1128/JB.182.3.758-763.2000; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Gillespie JJ, 2015, MBIO, V6, DOI 10.1128/mBio.01867-15; Giraldo AMV, 2015, FEBS LETT, V589, P1883, DOI 10.1016/j.febslet.2015.05.051; Giraldo AMV, 2012, BIOCHEMISTRY-US, V51, P3881, DOI 10.1021/bi300298v; Goessweiner-Mohr N, 2013, J BIOL CHEM, V288, P2018, DOI 10.1074/jbc.M112.428847; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kayama S, 2015, ANTIMICROB AGENTS CH, V59, P1356, DOI 10.1128/AAC.04759-14; Kumar RB, 2000, MOL MICROBIOL, V36, P608, DOI 10.1046/j.1365-2958.2000.01876.x; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Kumpar RB, 2001, J BACTERIOL, V183, P3636, DOI 10.1128/JB.183.12.3636-3641.2001; Kuroda T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10912; LANGER PJ, 1981, MOL GEN GENET, V182, P268, DOI 10.1007/BF00269669; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P979, DOI 10.1073/pnas.72.3.979; MORTELMANS KE, 1979, MOL GEN GENET, V167, P317, DOI 10.1007/BF00267425; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Paschos A, 2006, P NATL ACAD SCI USA, V103, P7252, DOI 10.1073/pnas.0600862103; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Patey G, 2006, INFECT IMMUN, V74, P4945, DOI 10.1128/IAI.00584-06; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; POHLMAN RF, 1994, MOL MICROBIOL, V14, P655, DOI 10.1111/j.1365-2958.1994.tb01304.x; Porter CJ, 2012, MOL MICROBIOL, V83, P275, DOI 10.1111/j.1365-2958.2011.07930.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Sivanesan D, 2011, J BACTERIOL, V193, P2097, DOI 10.1128/JB.00907-10; Sivanesan D, 2010, BIOCHEMISTRY-US, V49, P4483, DOI 10.1021/bi902201y; Smith MA, 2012, CHEM BIOL, V19, P1041, DOI 10.1016/j.chembiol.2012.07.007; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Trokter M, 2014, CURR OPIN STRUC BIOL, V27, P16, DOI 10.1016/j.sbi.2014.02.006; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Valdes R Jr, 1979, Methods Enzymol, V61, P125; WINANS SC, 1985, J BACTERIOL, V161, P402, DOI 10.1128/JB.161.1.402-410.1985; Winans SC, 1996, TRENDS MICROBIOL, V4, P64, DOI 10.1016/0966-842X(96)81513-7; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660	44	29	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23817	23829		10.1074/jbc.M116.753327	http://dx.doi.org/10.1074/jbc.M116.753327			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634044	hybrid, Green Published			2022-12-28	WOS:000387884400040
J	Doherty, CM; Visse, R; Dinakarpandian, D; Strickland, DK; Nagase, H; Troeberg, L				Doherty, Christine M.; Visse, Robert; Dinakarpandian, Deendayal; Strickland, Dudley K.; Nagase, Hideaki; Troeberg, Linda			Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; ADAMTS; extracellular matrix; glycosaminoglycan; osteoarthritis; receptor; tissue inhibitor of metalloproteinase (TIMP); low-density lipoprotein receptor-related protein 1	RECEPTOR-RELATED PROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ALPHA-CONVERTING-ENZYME; COAGULATION-FACTOR-VIII; BINDING-SITE; SULFATED GLYCOSAMINOGLYCANS; MATRIX-METALLOPROTEINASES; PROTEOLYTIC ACTIVITIES; EXTRACELLULAR-MATRIX; PENTOSAN POLYSULFATE	Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a central inhibitor of matrix-degrading and sheddase families of metalloproteinases. Extracellular levels of the inhibitor are regulated by the balance between its retention on the extracellular matrix and its endocytic clearance by the scavenger receptor low density lipoprotein receptor-related protein 1 (LRP1). Here, we used molecular modeling to predict TIMP-3 residues potentially involved in binding to LRP1 based on the proposed LRP1 binding motif of 2 lysine residues separated by about 21 and mutated the candidate lysine residues to alanine individually and in pairs. Of the 22 mutants generated, 13 displayed a reduced rate of uptake by HTB94 chondrosarcoma cells. The two mutants (TIMP-3 K26A/K45A and K42A/K110A) with lowest rates of uptake were further evaluated and found to display reduced binding to LRP1 and unaltered inhibitory activity against prototypic metalloproteinases. TIMP-3 K26A/K45A retained higher affinity for sulfated glycosaminoglycans than K42A/K110A and exhibited increased affinity for ADAMTS-5 in the presence of heparin. Both mutants inhibited metalloproteinase-mediated degradation of cartilage at lower concentrations and for longer than wild-type TIMP-3, indicating that their increased half-lives improved their ability to protect cartilage. These mutants may be useful in treating connective tissue diseases associated with increased metalloproteinase activity.	[Doherty, Christine M.; Visse, Robert; Nagase, Hideaki; Troeberg, Linda] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Arthrit Res UK Ctr Osteoarthrit Pathogenesis, Roosevelt Dr, Oxford OX3 7FY, England; [Dinakarpandian, Deendayal] Univ Missouri, Sch Comp & Engn, Kansas City, MO 64111 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University of Oxford; University of Missouri System; University of Missouri Kansas City; University System of Maryland; University of Maryland Baltimore	Troeberg, L (corresponding author), Univ Oxford, Arthrit Res UK Ctr Excellence Osteoarthrit Pathog, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England.	linda.troeberg@kennedy.ox.ac.uk		/0000-0003-0939-4651	Kennedy Trust for Rheumatology Research Doctoral Scholarship; Arthritis Research UK Career Development Fellowship [19466]; Arthritis Research UK Centre for Osteoarthritis Pathogenesis [20205]; NIAMS, National Institutes of Health [AR40994]; NHLBI, National Institutes of Health [HL114379, HL120388]; Versus Arthritis [19466] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120388, R01HL114379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	Kennedy Trust for Rheumatology Research Doctoral Scholarship; Arthritis Research UK Career Development Fellowship(Versus Arthritis); Arthritis Research UK Centre for Osteoarthritis Pathogenesis(Versus Arthritis); NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Versus Arthritis(Versus Arthritis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Kennedy Trust for Rheumatology Research Doctoral Scholarship (to C. D.) and an Arthritis Research UK Career Development Fellowship (Grant 19466) (to L. T.). The work was additionally supported by the Arthritis Research UK Centre for Osteoarthritis Pathogenesis (Grant 20205); NIAMS, National Institutes of Health, Grant AR40994 (to H. N.); and NHLBI, National Institutes of Health, Grants HL114379 and HL120388 (to D. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Black R.A., 2006, OSTEOARTHR CARTIL, V14, pS23, DOI [10.1016/S1063-4584(07)60467-1, DOI 10.1016/S1063-4584(07)60467-1, 10.1101/2020.08.25.266775, DOI 10.1101/2020.08.25.266775]; BLENIS J, 1983, P NATL ACAD SCI-BIOL, V80, P770, DOI 10.1073/pnas.80.3.770; Bond M, 2002, J BIOL CHEM, V277, P13787, DOI 10.1074/jbc.M111507200; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fedak PWM, 2004, CIRCULATION, V110, P2401, DOI 10.1161/01.CIR.0000134959.83967.2D; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Ismail HM, 2015, ARTHRITIS RHEUMATOL, V67, P1826, DOI 10.1002/art.39099; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Jin GX, 2002, ANAL BIOCHEM, V302, P269, DOI 10.1006/abio.2001.5549; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Krenn EC, 2008, BIOCHEM BIOPH RES CO, V375, P297, DOI 10.1016/j.bbrc.2008.07.144; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2002, FEBS LETT, V520, P102, DOI 10.1016/S0014-5793(02)02776-X; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Huynh MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.030; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Morris KJ, 2010, CONNECT TISSUE RES, V51, P478, DOI 10.3109/03008201003686958; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Neels JG, 2000, BLOOD, V96, P3459, DOI 10.1182/blood.V96.10.3459.h8003459_3459_3465; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Qi JH, 2015, APOPTOSIS, V20, P523, DOI 10.1007/s10495-014-1076-y; Rajalingam D, 2009, PROTEIN SCI, V18, P980, DOI 10.1002/pro.108; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; SAKAMOTO S, 1973, CALC TISS RES, V12, P247, DOI 10.1007/BF02013739; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2014, CHEM BIOL, V21, P1300, DOI 10.1016/j.chembiol.2014.07.014; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; Troeberg L, 2009, MATRIX BIOL, V28, P463, DOI 10.1016/j.matbio.2009.07.005; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; Wayne GJ, 2007, J BIOL CHEM, V282, P20991, DOI 10.1074/jbc.M610721200; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Westein E, 2002, J BIOL CHEM, V277, P2511, DOI 10.1074/jbc.M102293200; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Yamamoto K, 2013, FASEB J, V27, P511, DOI 10.1096/fj.12-216671; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	64	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22160	22172		10.1074/jbc.M116.733261	http://dx.doi.org/10.1074/jbc.M116.733261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27582494	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000386332600029
J	Nikolaienko, RM; Hammel, M; Dubreuil, V; Zalmai, R; Hall, DR; Mehzabeen, N; Karuppan, SJ; Harroch, S; Stella, SL; Bouyain, S				Nikolaienko, Roman M.; Hammel, Michal; Dubreuil, Veronique; Zalmai, Rana; Hall, David R.; Mehzabeen, Nurjahan; Karuppan, Sebastian J.; Harroch, Sheila; Stella, Salvatore L.; Bouyain, Samuel			Structural Basis for Interactions Between Contactin Family Members and Protein-tyrosine Phosphatase Receptor Type G in Neural Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell surface; crystal structure; protein phosphatase; retina; contactin; immunoglobulin|L-like domain	NUCLEOTIDE-GATED CHANNELS; EXTRACELLULAR REGION; CRYSTAL-STRUCTURE; RPTP-GAMMA; COMPLEX; SYSTEM; CELLS; CIS; SPECIFICITY; SUPERFAMILY	Protein-tyrosine phosphatase receptor type G (RPTP/PTPRG) interacts in vitro with contactin-3-6 (CNTN3-6), a group of glycophosphatidylinositol-anchored cell adhesion molecules involved in the wiring of the nervous system. In addition to PTPRG, CNTNs associate with multiple transmembrane proteins and signal inside the cell via cis-binding partners to alleviate the absence of an intracellular region. Here, we use comprehensive biochemical and structural analyses to demonstrate that PTPRGCNTN3-6 complexes share similar binding affinities and a conserved arrangement. Furthermore, as a first step to identifying PTPRGCNTN complexes in vivo, we found that PTPRG and CNTN3 associate in the outer segments of mouse rod photoreceptor cells. In particular, PTPRG and CNTN3 form cis-complexes at the surface of photoreceptors yet interact in trans when expressed on the surfaces of apposing cells. Further structural analyses suggest that all CNTN ectodomains adopt a bent conformation and might lie parallel to the cell surface to accommodate these cis and trans binding modes. Taken together, these studies identify a PTPRGCNTN complex in vivo and provide novel insights into PTPRG- and CNTN-mediated signaling.	[Nikolaienko, Roman M.; Zalmai, Rana; Hall, David R.; Mehzabeen, Nurjahan; Karuppan, Sebastian J.; Bouyain, Samuel] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, 5100 Rockhill Rd, Kansas City, MO 64110 USA; [Hammel, Michal] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Dubreuil, Veronique] Inst Pasteur Paris, Dept Neurosci, 25-28 Rue Dr Roux, F-75624 Paris, France; [Dubreuil, Veronique; Harroch, Sheila] Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Epigenet & Cell Fate,UMR 7216, Paris, France; [Stella, Salvatore L.] Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA; [Harroch, Sheila] NYU, Sch Med, Dept Psychiat, 550 First Ave, New York, NY 10016 USA; [Stella, Salvatore L.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, 500 Univ Dr, Hershey, PA 17033 USA	University of Missouri System; University of Missouri Kansas City; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Missouri System; University of Missouri Kansas City; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bouyain, S (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, 5100 Rockhill Rd, Kansas City, MO 64110 USA.	bouyains@umkc.edu		Dubreuil, Veronique/0000-0001-8060-3597; Hammel, Michal/0000-0002-5610-9289; Bouyain, Samuel/0000-0002-7499-738X	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; United States Department of Energy Program Integrated Diffraction Analysis Technologies (IDAT); National Institutes of Health [MINOS GM105404]; NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, P41GM103311, R01GM088806] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy Program Integrated Diffraction Analysis Technologies (IDAT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Brian Geisbrecht for helpful comments on the manuscript and assistance with circular dichroism. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Data were collected at Southeast Regional Collaborative Access Team beamlines at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found at www.ser-cat.org/members.html. X-ray scattering technologies at the Lawrence Berkeley National Laboratory SIBYLS beamline of the Advanced Light Source are supported in part by the United States Department of Energy Program Integrated Diffraction Analysis Technologies (IDAT) and National Institutes of Health Grant MINOS GM105404. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, National Institutes of Health, Grant P41-GM103311).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Ashrafi S, 2014, NEURON, V81, P120, DOI 10.1016/j.neuron.2013.10.060; BARNEA G, 1993, MOL CELL BIOL, V13, P1497, DOI 10.1128/MCB.13.3.1497; Bouyain S, 2007, PROTEIN SCI, V16, P654, DOI 10.1110/ps.062700307; Bouyain S, 2010, P NATL ACAD SCI USA, V107, P2443, DOI 10.1073/pnas.0911235107; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ensslen-Craig SE, 2004, DEV BIOL, V275, P12, DOI 10.1016/j.ydbio.2004.08.009; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guinier A., 1955, SMALL ANGLE SCATTERI; Hamaoka BY, 2004, P NATL ACAD SCI USA, V101, P11673, DOI 10.1073/pnas.0402559101; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Held W, 2011, CELL MOL LIFE SCI, V68, P3469, DOI 10.1007/s00018-011-0798-z; Horvat-Broecker A, 2008, NEUROSCIENCE, V152, P618, DOI 10.1016/j.neuroscience.2008.01.016; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kao TJ, 2011, NEURON, V71, P76, DOI 10.1016/j.neuron.2011.05.031; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulahin N, 2011, STRUCTURE, V19, P203, DOI 10.1016/j.str.2010.12.014; Lamprianou S, 2006, MOL CELL BIOL, V26, P5106, DOI 10.1128/MCB.00101-06; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lorenzetto E, 2014, BRAIN STRUCT FUNCT, V219, P875, DOI 10.1007/s00429-013-0541-7; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Molokanova E, 1999, J NEUROSCI, V19, P4786; Molokanova E, 1997, J NEUROSCI, V17, P9068; Nans A, 2011, J NEUROSCI RES, V89, P310, DOI 10.1002/jnr.22561; Osterfield M, 2008, DEVELOPMENT, V135, P1189, DOI 10.1242/dev.007401; Osterhout JA, 2015, NEURON, V86, P985, DOI 10.1016/j.neuron.2015.04.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parent AS, 2007, J NEUROENDOCRINOL, V19, P847, DOI 10.1111/j.1365-2826.2007.01597.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sakurai K, 2010, NEUROSCI LETT, V473, P102, DOI 10.1016/j.neulet.2010.02.027; Savchenko A, 2001, P NATL ACAD SCI USA, V98, P5880, DOI 10.1073/pnas.101524998; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Shimoda Y, 2012, NEUROSCI LETT, V510, P148, DOI 10.1016/j.neulet.2012.01.026; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stella SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043463; Tolbert WD, 2007, P NATL ACAD SCI USA, V104, P14592, DOI 10.1073/pnas.0704290104; Toyoshima M, 2009, DEV BIOL, V336, P192, DOI 10.1016/j.ydbio.2009.09.043; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939; YOSHIHARA Y, 1994, NEURON, V13, P415, DOI 10.1016/0896-6273(94)90357-3; Zayas-Santiago A, 2009, MOL VIS, V15, P1; Zuko A, 2011, ADV PROTEIN CHEM STR, V84, P143, DOI 10.1016/B978-0-12-386483-3.00001-X	61	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21335	21349		10.1074/jbc.M116.742163	http://dx.doi.org/10.1074/jbc.M116.742163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539848	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000385999200001
J	Shapiro, BA; Vu, NT; Shultz, MD; Shultz, JC; Mietla, JA; Gouda, MM; Yacoub, A; Dent, P; Fisher, PB; Park, MA; Chalfant, CE				Shapiro, Brian A.; Vu, Ngoc T.; Shultz, Michael D.; Shultz, Jacqueline C.; Mietla, Jennifer A.; Gouda, Mazen M.; Yacoub, Adly; Dent, Paul; Fisher, Paul B.; Park, Margaret A.; Chalfant, Charles E.			Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKC Signaling Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell death; cell signaling; RNA splicing; signal transduction; MDA-7; IL-24; Bcl-x; alternative splicing; non-small cell lung cancer	PROSTATE-CANCER CELLS; CHEMOTHERAPY-INDUCED APOPTOSIS; KINASE-C-DELTA; PROTEIN PHOSPHATASE-1; BREAST-CANCER; IN-VIVO; CARCINOMA-CELLS; ER STRESS; CASPASE 9; BCL-X(L)	Melanoma differentiation-associated gene 7 (MDA-7/IL-24) exhibits cytotoxic effects on tumor cells while sparing untransformed cells, and Bcl-x(L) is reported to efficiently block the induction of cell death by MDA-7/IL-24. The expression of Bcl-x(L) is regulated at the level of RNA splicing via alternative 5 splice site selection within exon 2 to produce either the pro-apoptotic Bcl-x(s) or the anti-apoptotic Bcl-x(L). Our laboratory previously reported that Bcl-x RNA splicing is dysregulated in a large percentage of human non-small cell lung cancer (NSCLC) tumors. Therefore, we investigated whether the alternative RNA splicing of Bcl-x pre-mRNA was modulated by MDA-7/IL-24, which would suggest that specific NSCLC tumors are valid targets for this cytokine therapy. Adenovirus-delivered MDA-7/IL-24 (Ad.mda-7) reduced the viability of NSCLC cells of varying oncogenotypes, which was preceded by a decrease in the ratio of Bcl-x(L)/Bcl-x(s) mRNA and Bcl-x(L) protein expression. Importantly, both the expression of Bcl-x(L) and the loss of cell viability were rescued in Ad.mda-7-treated cells incubated with Bcl-x(s) siRNA. In addition, NSCLC cells ectopically expressing Bcl-x(s) exhibited significantly reduced Bcl-x(L) expression, which was again restored by Bcl-x(s) siRNA, suggesting the existence of a novel mechanism by which Bcl-x(s) mRNA restrains the expression of Bcl-x(L). In additional mechanistic studies, inhibition of SRC and PKC completely ablated the ability of MDA-7/IL-24 to reduce the Bcl-x(L)/(s) mRNA ratio and cell viability. These findings show that Bcl-x(s) expression is an important mediator of MDA-7/IL-24-induced cytotoxicity requiring the SRC/PKC signaling axis in NSCLC cells.	[Shapiro, Brian A.; Shultz, Michael D.; Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA 23249 USA; [Shapiro, Brian A.; Vu, Ngoc T.; Shultz, Jacqueline C.; Mietla, Jennifer A.; Gouda, Mazen M.; Dent, Paul; Park, Margaret A.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Sch Med, Richmond, VA 23298 USA; [Yacoub, Adly] Virginia Commonwealth Univ, Sch Med, Dept Neurosurg, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Fisher, Paul B.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Dent, Paul; Fisher, Paul B.; Chalfant, Charles E.] Virginia Commonwealth Univ, Inst Mol Med, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Dent, Paul; Fisher, Paul B.; Park, Margaret A.; Chalfant, Charles E.] Virginia Commonwealth Univ, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Johnson Ctr Crit Care & Pulm Res, Med Coll Virginia Campus, Richmond, VA 23298 USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Fisher, PB (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, 1101 East Marshall St,POB 980033, Richmond, VA 23298 USA.; Park, MA; Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, 1101 East Marshall St,POB 980614, Richmond, VA 23298 USA.	paul.fisher@vcuhealth.org; margaret.park@vcuhealth.org; charles.chalfant@vcuhealth.org			National Institutes of Health, NCI Cancer Center Support Grant [P30 CA016059]; National Institutes of Health [NH1C06-RR17393]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD087198] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA104177, R01CA154314, R21CA201195, R01CA097318, P30CA016059, R01CA117950, R01CA127641, T32CA085159, R01CA192613] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	National Institutes of Health, NCI Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Services and products in support of this project were generated by the VCU Massey Cancer Center Shared supported, in part, with funding from National Institutes of Health, NCI Cancer Center Support Grant P30 CA016059. National Institutes of Health Grant NH1C06-RR17393 was provided to Virginia Commonwealth University for renovation.	Ban J, 1998, BIOCHEM BIOPH RES CO, V248, P147, DOI 10.1006/bbrc.1998.8907; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Boschelli DH, 2004, J MED CHEM, V47, P1599, DOI 10.1021/jm0499458; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chang WH, 2011, CANCER RES, V71, P383, DOI 10.1158/0008-5472.CAN-10-1037; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Coluccia AML, 2004, BLOOD, V103, P2787, DOI 10.1182/blood-2003-09-3144; DATTA R, 1995, CELL GROWTH DIFFER, V6, P363; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Deng G, 1998, MOL MED, V4, P158, DOI 10.1007/BF03401913; DOLE MG, 1995, CANCER RES, V55, P2576; Eto K, 2011, MOL CELL BIOCHEM, V355, P217, DOI 10.1007/s11010-011-0857-7; FANG W, 1994, J IMMUNOL, V153, P4388; Finch A, 2006, CANCER CELL, V10, P113, DOI 10.1016/j.ccr.2006.06.017; Hamed HA, 2013, CANCER BIOL THER, V14, P1039, DOI 10.4161/cbt.26110; Hamed HA, 2010, CANCER BIOL THER, V9, P526, DOI 10.4161/cbt.9.7.11116; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Hyer ML, 2000, MOL THER, V2, P348, DOI 10.1006/mthe.2000.0139; Inoue S, 2005, MOL THER, V12, P707, DOI 10.1016/j.ymthe.2005.05.015; Jiang HP, 1995, ONCOGENE, V11, P2477; Johnson BW, 2000, J BIOL CHEM, V275, P31546, DOI 10.1074/jbc.M001363200; Johnson RM, 2015, J BIOL CHEM, V290, P25717, DOI 10.1074/jbc.M115.671206; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kontny E, 2000, J LEUKOCYTE BIOL, V67, P249, DOI 10.1002/jlb.67.2.249; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Larroque-Cardoso P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.47; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; MEYN RE, 1995, ANTI-CANCER DRUG, V6, P443, DOI 10.1097/00001813-199506000-00013; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Mitra RS, 2001, NEOPLASIA, V3, P437, DOI 10.1038/sj.neo.7900181; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Nekrutenko A, 2006, TRENDS GENET, V22, P645, DOI 10.1016/j.tig.2006.09.012; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Peterman EE, 2004, J CARDIOVASC PHARM, V43, P645, DOI 10.1097/00005344-200405000-00006; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Piazzi M, 2013, MOL CELL PROTEOMICS, V12, P2220, DOI 10.1074/mcp.M113.029686; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Saeki T, 2002, ONCOGENE, V21, P4558, DOI 10.1038/sj.onc.1205553; Saeki T, 2000, GENE THER, V7, P2051, DOI 10.1038/sj.gt.3301330; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sauane M, 2010, J CELL PHYSIOL, V222, P546, DOI 10.1002/jcp.21969; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Shultz JC, 2012, MOL CANCER RES, V10, P660, DOI 10.1158/1541-7786.MCR-11-0363; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Sieger KA, 2004, MOL THER, V9, P355, DOI 10.1016/j.ymthe.2003.11.014; Su ZZ, 2006, ONCOGENE, V25, P2339, DOI 10.1038/sj.onc.1209271; Su ZZ, 2005, ONCOGENE, V24, P7552, DOI 10.1038/sj.onc.1208911; SUMANTRAN VN, 1995, CANCER RES, V55, P2507; Tanuma N, 2008, J BIOL CHEM, V283, P35805, DOI 10.1074/jbc.M805468200; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Wiederrecht G J, 1995, Prog Cell Cycle Res, V1, P53; Yang XF, 1997, IMMUNITY, V7, P629, DOI 10.1016/S1074-7613(00)80384-2	72	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21669	21681		10.1074/jbc.M116.737569	http://dx.doi.org/10.1074/jbc.M116.737569			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27519412	Green Published, hybrid			2022-12-28	WOS:000385999200032
J	Sathianathan, A; Ravichandran, P; Lippi, JM; Cohen, L; Messina, A; Shaju, S; Swede, MJ; Ginsburg, DS				Sathianathan, Anish; Ravichandran, Priyadarshini; Lippi, Jake M.; Cohen, Leah; Messina, Angelo; Shaju, Sherwin; Swede, Marci J.; Ginsburg, Daniel S.			The Eaf3/5/7 Subcomplex Stimulates NuA4 Interaction with Methylated Histone H3 Lys-36 and RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; ACETYLTRANSFERASE COMPLEX; TARGETED RECRUITMENT; MOLECULAR-BASIS; CODING REGIONS; CHROMO DOMAIN; YEAST NUA4; ACETYLATION; TRANSCRIPTION	NuA4 is the only essential lysine acetyltransferase complex in Saccharomyces cerevisiae, where it has been shown to stimulate transcription initiation and elongation. Interaction with nucleosomes is stimulated by histone H3 Lys-4 and Lys-36 methylation, but the mechanism of this interaction is unknown. Eaf3, Eaf5, and Eaf7 form a subcomplex within NuA4 that may also function independently of the lysine acetyltransferase complex. The Eaf3/5/7 complex and the Rpd3C(S) histone deacetylase complex have both been shown to bind di- and trimethylated histone H3 Lys-36 stimulated by Eaf3. Weinvestigated the role of the Eaf3/5/7 subcomplex in NuA4 binding to nucleosomes. Different phenotypes of eaf3/5/7 Delta mutants support functions for the complex as both part of and independent of NuA4. Further evidence for Eaf3/5/7 within NuA4 came from mutations in the subcomplex leading to similar to 40% reductions in H4 acetylation in bulk histones, probably caused by binding defects to both nucleosomes and RNA polymerase II. In vitro binding assays showed that Eaf3/5/7 specifically stimulates NuA4 binding to di- and trimethylated histone H3 Lys-36 and that this binding is important for NuA4 occupancy in transcribed ORFs. Consistent with the role of NuA4 in stimulating transcription elongation, loss of EAF5 or EAF7 resulted in a processivity defect. Overall, these results reveal the function of Eaf3/5/7 within NuA4 to be important for both NuA4 and RNA polymerase II binding.	[Sathianathan, Anish; Ravichandran, Priyadarshini; Lippi, Jake M.; Cohen, Leah; Messina, Angelo; Shaju, Sherwin; Ginsburg, Daniel S.] LIU Post, Dept Biomed Sci, Brookville, NY 11548 USA; [Swede, Marci J.] LIU Post, Dept Hlth Sci, Brookville, NY 11548 USA		Ginsburg, DS (corresponding author), Dept Biomed Sci, 720 Northern Blvd, Brookville, NY 11548 USA.	daniel.ginsburg@liu.edu	Swede, Marci/AAD-3921-2021	Swede, Marci/0000-0002-3003-4258	LIU Post Research Committee	LIU Post Research Committee	This work was funded by intramural grants from the LIU Post Research Committee. The authors declare that they have no conflicts of interest with the contents of this article.	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheng X, 2014, TRANSCR-AUSTIN, V5, DOI 10.1080/21541264.2014.995571; Chittuluru JR, 2011, NAT STRUCT MOL BIOL, V18, P1196, DOI 10.1038/nsmb.2128; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Eissenberg JC, 2012, GENE, V496, P69, DOI 10.1016/j.gene.2012.01.003; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ginsburg DS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.585588; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Morillo-Huesca M, 2006, FEBS J, V273, P756, DOI 10.1111/j.1742-4658.2005.05108.x; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Rasband W, 2014, IMAGEJ 1 48V; REID GA, 1982, J BIOL CHEM, V257, P3056; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rossetto D, 2014, EMBO J, V33, P1397, DOI 10.15252/embj.201386433; Ruan C, 2015, CELL REP, V10, P204, DOI 10.1016/j.celrep.2014.12.027; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	62	10	10	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21195	21207		10.1074/jbc.M116.718742	http://dx.doi.org/10.1074/jbc.M116.718742			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27535225	Green Published, hybrid			2022-12-28	WOS:000385406200033
J	Miravet, S; Piedra, J; Miro, F; Itarte, E; de Herreros, AG; Dunach, M				Miravet, Susana; Piedra, Jose; Miro, Francesc; Itarte, Emilio; de Herreros, Antonio Garcia; Dunach, Mireia			The transcriptional factor Tcf-4 contains different binding sites for beta 3-catenin and plakoglobin (vol 277, pg 1884, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Itarte, Emilio/Q-6246-2019; Miro-Mur, Francesc A./AAT-3013-2020	Miro-Mur, Francesc A./0000-0003-3936-2693				Miravet S, 2002, J BIOL CHEM, V277, P1884, DOI 10.1074/jbc.M110248200	1	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18854	18854		10.1074/jbc.A116.110248	http://dx.doi.org/10.1074/jbc.A116.110248			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27591254	Green Published, hybrid			2022-12-28	WOS:000383242300022
J	Mahapatra, G; Varughese, A; Ji, QQ; Lee, I; Liu, J; Vaishnav, A; Sinkler, C; Kapralov, AA; Moraes, CT; Sanderson, TH; Stemmler, TL; Grossman, LI; Kagan, VE; Brunzelle, JS; Salomon, AR; Edwards, BFP; Huttemanna, M				Mahapatra, Gargi; Varughese, Ashwathy; Ji, Qinqin; Lee, Icksoo; Liu, Jenney; Vaishnav, Asmita; Sinkler, Christopher; Kapralov, Alexandr A.; Moraes, Carlos T.; Sanderson, Thomas H.; Stemmler, Timothy L.; Grossman, Lawrence I.; Kagan, Valerian E.; Brunzelle, Joseph S.; Salomon, Arthur R.; Edwards, Brian F. P.; Huttemanna, Maik			Phosphorylation of Cytochrome c Threonine 28 Regulates Electron Transport Chain Activity in Kidney IMPLICATIONS FOR AMP KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDASE; MITOCHONDRIA; APOPTOSIS; LIVER; CARDIOLIPIN; RESPIRATION; SUPEROXIDE; MECHANISMS; PREDICTION; BINDING	Mammalian cytochrome c (Cytc) plays a key role in cellular life and death decisions, functioning as an electron carrier in the electron transport chain and as a trigger of apoptosis when released from the mitochondria. However, its regulation is not well understood. We show that the major fraction of Cytc isolated from kidneys is phosphorylated on Thr(28), leading to a partial inhibition of respiration in the reaction with cytochrome c oxidase. To further study the effect of Cytc phosphorylation in vitro, we generated T28E phosphomimetic Cytc, revealing superior behavior regarding protein stability and its ability to degrade reactive oxygen species compared with wild-type un-phosphorylated Cytc. Introduction of T28E phosphomimetic Cytc into Cytc knock-out cells shows that intact cell respiration, mitochondrial membrane potential (Delta Psi(m)), and ROS levels are reduced compared with wild type. As we show by high resolution crystallography of wild-type and T28E Cytc in combination with molecular dynamics simulations, Thr(28) is located at a central position near the heme crevice, the most flexible epitope of the protein apart from the N and C termini. Finally, in silico prediction and our experimental data suggest that AMP kinase, which phosphorylates Cytc on Thr(28) in vitro and colocalizes with Cytc to the mitochondrial intermembrane space in the kidney, is the most likely candidate to phosphorylate Thr(28) in vivo. We conclude that Cytc phosphorylation is mediated in a tissue-specific manner and leads to regulation of electron transport chain flux via "controlled respiration," preventing Delta Psi(m) hyperpolarization, a known cause of ROS and trigger of apoptosis.	[Mahapatra, Gargi; Varughese, Ashwathy; Lee, Icksoo; Liu, Jenney; Sinkler, Christopher; Grossman, Lawrence I.; Huttemanna, Maik] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Mahapatra, Gargi; Varughese, Ashwathy; Vaishnav, Asmita; Edwards, Brian F. P.; Huttemanna, Maik] Wayne State Univ, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Sanderson, Thomas H.] Wayne State Univ, Dept Emergency Med, Detroit, MI 48201 USA; [Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Ji, Qinqin] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Salomon, Arthur R.] Brown Univ, MCB Dept, Providence, RI 02912 USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 31116, Chungcheongnam, South Korea; [Kapralov, Alexandr A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Kapralov, Alexandr A.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Moraes, Carlos T.] Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA; [Brunzelle, Joseph S.] Northwestern Univ, Ctr Synchrotron Res, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Brown University; Brown University; Dankook University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; Northwestern University	Huttemanna, M (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu	Sanderson, Thomas H/K-6656-2012; Mahapatra, Gargi/ABC-9107-2020; Moraes, Carlos/AAT-3818-2021	Sanderson, Thomas H/0000-0003-0112-8164; Mahapatra, Gargi/0000-0003-2363-4092; Huttemann, Maik/0000-0001-6310-7081; Stemmler, Timothy/0000-0002-6298-088X; Kagan, Valerian E./0000-0002-7245-1885; Brunzelle, Joseph/0000-0001-9197-0018; Kapralov, Oleksandr/0000-0002-3006-916X	Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091242] Funding Source: NIH RePORTER	Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research used resources of the Advanced Photon Source, a United States Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation, the Michigan Technology Tri-Corridor (Grant 085P1000817), and Wayne State University Office of the Vice-President for Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cammack R., 1995, BIOENERGETICS PRACTI, P93; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Dickerson L., 2004, GALE ENCY SCI, P500; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FERGUSONMILLER S, 1976, J BIOL CHEM, V251, P1104; Firsov D, 2010, KIDNEY INT, V78, P640, DOI 10.1038/ki.2010.227; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garcia-Heredia JM, 2011, J BIOL INORG CHEM, V16, P1155, DOI 10.1007/s00775-011-0804-9; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; GOLDBERG E, 1977, SCIENCE, V196, P1010, DOI 10.1126/science.193188; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guerra-Castellano A, 2016, BBA-BIOENERGETICS, V1857, P387, DOI 10.1016/j.bbabio.2016.01.011; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e; Huttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Lempiainen J, 2012, BRIT J PHARMACOL, V166, P1905, DOI 10.1111/j.1476-5381.2012.01895.x; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Liu Z, 2006, P NATL ACAD SCI USA, V103, P8965, DOI 10.1073/pnas.0603327103; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pecina P, 2010, BIOCHEMISTRY-US, V49, P6705, DOI 10.1021/bi100486s; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Rajagopal BS, 2013, BIOCHEM J, V456, P441, DOI 10.1042/BJ20130758; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Sanderson TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078627; SANISHVILI R, 1995, STRUCTURE, V3, P707, DOI 10.1016/S0969-2126(01)00205-2; Satriano J, 2013, AM J PHYSIOL-RENAL, V305, pF727, DOI 10.1152/ajprenal.00293.2013; Sugitani R, 2009, BBA-BIOENERGETICS, V1787, P1140, DOI 10.1016/j.bbabio.2009.04.004; Takiyama Y, 2011, DIABETES, V60, P981, DOI 10.2337/db10-0655; Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299; Zhou MY, 2015, GENE DEV, V29, P2349, DOI 10.1101/gad.272278.115; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	56	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					64	79		10.1074/jbc.M116.744664	http://dx.doi.org/10.1074/jbc.M116.744664			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27758862	hybrid, Green Published			2022-12-28	WOS:000391578000006
J	Cisternas, P; Salazar, P; Silva-Alvarez, C; Barros, LF; Inestrosa, NC				Cisternas, Pedro; Salazar, Paulina; Silva-Alvarez, Carmen; Felipe Barros, L.; Inestrosa, Nibaldo C.			Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN PATHWAY; BRAIN ENERGY-METABOLISM; ALZHEIMERS-DISEASE; PROTEIN-KINASE; COMPETITIVE-INHIBITION; COGNITIVE FUNCTION; GLYCOGEN-SYNTHESIS; CEREBRAL GLUCOSE; SKELETAL-MUSCLE; HEXOKINASE	The Wnt signaling pathway is critical for a number of functions in the central nervous system, including regulation of the synaptic cleft structure and neuroprotection against injury. Deregulation of Wnt signaling has been associated with several brain pathologies, including Alzheimer's disease. In recent years, it has been suggested that the Wnt pathway might act as a central integrator of metabolic signals from peripheral organs to the brain, which would represent a new role for Wnt signaling in cell metabolism. Energy metabolism is critical for normal neuronal function, which mainly depends on glucose utilization. Brain energy metabolism is important in almost all neurological disorders, to which a decrease in the capacity of the brain to utilize glucose has been linked. However, little is known about the relationship between Wnt signaling and neuronal glucose metabolism in the cellular context. In the present study, we found that acute treatment with the Wnt3a ligand induced a large increase in glucose uptake, without changes in the expression or localization of glucose transporter type 3. In addition, we observed that Wnt3a treatment increased the activation of the metabolic sensor Akt. Moreover, we observed an increase in the activity of hexokinase and in the glycolytic rate, and both processes were dependent on activation of the Akt pathway. Furthermore, we did not observe changes in the activity of glucose-6-phosphate dehydrogenase or in the pentose phosphate pathway. The effect of Wnt3a was independent of both the transcription of Wnt target genes and synaptic effects of Wnt3a. Together, our results suggest that Wnt signaling stimulates glucose utilization in cortical neurons through glycolysis to satisfy the high energy demand of these cells.	[Cisternas, Pedro; Salazar, Paulina; Silva-Alvarez, Carmen; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE UC, Santiago 8330025, Chile; [Cisternas, Pedro] Univ Atacama, Fac Ciencias Nat, Dept Quim & Biol, Copayapu 485, Copiapo, Chile; [Felipe Barros, L.] Ctr Estudios Cient, Casilla 1469, Valdivia, Chile; [Inestrosa, Nibaldo C.] Univ New South Wales, Fac Med, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW 1235, Australia; [Inestrosa, Nibaldo C.] Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas 6200732, Chile	Pontificia Universidad Catolica de Chile; Universidad de Atacama; University of New South Wales Sydney; Universidad de Magallanes	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Biol Sci, CARE UC Biomed Res Ctr, A Bernardo OHiggins 340,POB 114-D, Santiago, Chile.	ninestrosa@bio.puc.cl			Sociedad Quimica y Minera de Chile (SQM); Basal Centers of Excellence Program (CONICYT-PFB)	Sociedad Quimica y Minera de Chile (SQM); Basal Centers of Excellence Program (CONICYT-PFB)	We thank the Sociedad Quimica y Minera de Chile (SQM) for the special grants "The role of K<SUP>+</SUP> on Hypertension and Cognition" and "The role of Lithium in Human Health and Disease." The Centro de Estudios Cientificos (CECs) is funded by the Basal Centers of Excellence Program (CONICYT-PFB).	Amado NG, 2012, CURR TOP MED CHEM, V12, P2103; Amato S, 2011, CELL CYCLE, V10, P3452, DOI 10.4161/cc.10.20.17953; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arrazola MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00166; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Avila ME, 2010, J BIOL CHEM, V285, P18939, DOI 10.1074/jbc.M110.103028; Babkin P, 2015, FEBS OPEN BIO, V5, P335, DOI 10.1016/j.fob.2015.04.006; Barros LF, 2009, J NEUROCHEM, V109, P94, DOI 10.1111/j.1471-4159.2009.05885.x; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benzler J, 2013, ENDOCRINOLOGY, V154, P4737, DOI 10.1210/en.2013-1746; Benzler J, 2012, BIOCHEM J, V447, P175, DOI 10.1042/BJ20120834; BERTONI JM, 1981, J NEUROCHEM, V37, P1523, DOI 10.1111/j.1471-4159.1981.tb06322.x; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; Ciani L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9302; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cisternas P, 2014, CURR MOL MED, V14, P510, DOI 10.2174/1566524014666140414210346; Cisternas P, 2014, J NEUROCHEM, V129, P663, DOI 10.1111/jnc.12663; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Dienel GA, 2017, NEUROSCI LETT, V637, P18, DOI 10.1016/j.neulet.2015.02.052; Euser SM, 2010, DIABETES, V59, P1601, DOI 10.2337/db09-0568; Falkowska A, 2015, INT J MOL SCI, V16, P25959, DOI 10.3390/ijms161125939; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Forlenza OV, 2014, ACS CHEM NEUROSCI, V5, P484, DOI 10.1021/cn5000315; Codocedo JF, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0071-x; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Godoy JA, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-23; Helfer G, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12368; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; JUNG CY, 1977, J BIOL CHEM, V252, P5456; Kadir A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.015; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Komiya Yuko, 2008, Organogenesis, V4, P68; Konagaya M, 1990, Rinsho Shinkeigaku, V30, P1078; LARRABEE MG, 1990, BIOCHEM J, V272, P127, DOI 10.1042/bj2720127; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu S, 2015, PAIN, V156, P2572, DOI 10.1097/j.pain.0000000000000366; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Lyssenko V, 2008, CURR OPIN CLIN NUTR, V11, P385, DOI 10.1097/MCO.0b013e328304d970; Ma T, 2011, J NEUROSCI, V31, P17537, DOI 10.1523/JNEUROSCI.4761-11.2011; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Mayeur S, 2013, AM J PHYSIOL-ENDOC M, V304, pE14, DOI 10.1152/ajpendo.00332.2012; McNay EC, 1998, J NEUROSCI, V18, P3853; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Moon JS, 2011, BIOCHEM J, V433, P225, DOI 10.1042/BJ20101104; Morris SAL, 2016, GENES DIS, V3, P41, DOI 10.1016/j.gendis.2015.12.003; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Murphy GG, 1999, J NEUROSCI, V19, P10595; Naujok Ortwin, 2014, BMC Res Notes, V7, P273, DOI 10.1186/1756-0500-7-273; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Niccoli T, 2016, CURR BIOL, V26, P2291, DOI [10.1016/j.cub.2016.07.017, 10.1016/j.cub.2016.09.018]; Nobrega MA, 2013, DIABETES, V62, P706, DOI 10.2337/db12-1418; Novellasdemunt L, 2013, J BIOL CHEM, V288, P10640, DOI 10.1074/jbc.M113.455998; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Oliva CA, 2015, EXP NEUROL, V269, P43, DOI 10.1016/j.expneurol.2015.03.027; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Ramirez VT, 2016, J BIOL CHEM, V291, P19092, DOI 10.1074/jbc.M116.722132; Ramirez VT, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4258171; Rios JA, 2014, PROG NEUROBIOL, V121, P125, DOI 10.1016/j.pneurobio.2014.07.004; Rosa J. C., 2016, CURR MOL PH IN PRESS; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Shao WJ, 2013, DIABETES, V62, P789, DOI 10.2337/db12-0365; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Tapia-Rojas C, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0057-0; Tapia-Rojas C, 2015, BIOCHEM J, V466, P415, DOI 10.1042/BJ20140207; Tian J, 2015, J HUAZHONG U SCI-MED, V35, P212, DOI 10.1007/s11596-015-1413-6; Tsai CS, 1998, BIOCHEM CELL BIOL, V76, P107, DOI 10.1139/bcb-76-1-107; VANNUCCI RC, 1994, J CEREBR BLOOD F MET, V14, P279, DOI 10.1038/jcbfm.1994.35; Varela-Nallar L., 2014, CELL NEUROSCI, V8, P17; Varela-Nallar L, 2012, NEURODEGENER DIS, V10, P23, DOI 10.1159/000333360; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Vargas JY, 2015, EXP NEUROL, V264, P14, DOI 10.1016/j.expneurol.2014.11.005; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; Verdile G, 2015, NEUROBIOL DIS, V84, P22, DOI 10.1016/j.nbd.2015.04.008; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Zeve D, 2012, CELL METAB, V15, P492, DOI 10.1016/j.cmet.2012.03.010	100	37	37	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25950	25964		10.1074/jbc.M116.735373	http://dx.doi.org/10.1074/jbc.M116.735373			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27703002	Green Published, hybrid			2022-12-28	WOS:000390345200017
J	Kehrli, K; Phelps, M; Lazarchuk, P; Chen, E; Monnat, R; Sidorova, JM				Kehrli, Keffy; Phelps, Michael; Lazarchuk, Pavlo; Chen, Eleanor; Monnat, Ray; Sidorova, Julia M.			Class I Histone Deacetylase HDAC1 and WRN RECQ Helicase Contribute Additively to Protect Replication Forks upon Hydroxyurea-induced Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; BLOOMS-SYNDROME; NASCENT DNA; HUMAN-CELLS; DEFICIENT CELLS; SYNDROME GENE; STRESS; PROGRESSION; RESTART; DAMAGE	The WRN helicase/exonuclease is mutated in Werner syndrome of genomic instability and premature aging. WRN-depleted fibroblasts, although remaining largely viable, have a reduced capacity to maintain replication forks active during a transient hydroxyurea-induced arrest. A strand exchange protein, RAD51, is also required for replication fork maintenance, and here we show that recruitment of RAD51 to stalled forks is reduced in the absence of WRN. We performed a siRNA screen for genes that are required for viability of WRN-depleted cells after hydroxyurea treatment, and identified HDAC1, a member of the class I histone deacetylase family. One of the functions of HDAC1, which it performs together with a close homolog HDAC2, is deacetylation of new histone H4 deposited at replication forks. We show that HDAC1 depletion exacerbates defects in fork reactivation and progression after hydroxyurea treatment observed in WRN- or RAD51-deficient cells. The additive WRN, HDAC1 loss-of-function phenotype is also observed with a catalytic mutant of HDAC1; however, it does not correlate with changes in histone H4 deacetylation at replication forks. On the other hand, inhibition of histone deacetylation by an inhibitor specific to HDACs 1-3, CI-994, correlates with increased processing of newly synthesized DNA strands in hydroxyurea-stalled forks. WRN co-precipitates with HDAC1 and HDAC2. Taken together, our findings indicate that WRN interacts with HDACs 1 and 2 to facilitate activity of stalled replication forks under conditions of replication stress.	[Kehrli, Keffy; Phelps, Michael; Lazarchuk, Pavlo; Chen, Eleanor; Monnat, Ray; Sidorova, Julia M.] Univ Washington, Dept Pathol, K-065,Box 357705,1959 NE Pacific St, Seattle, WA 98195 USA; [Monnat, Ray] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kehrli, Keffy] SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; [Lazarchuk, Pavlo] Adapt Biotechnol, Seattle, WA 98102 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sidorova, JM (corresponding author), Univ Washington, Dept Pathol, K-065,Box 357705,1959 NE Pacific St, Seattle, WA 98195 USA.	julias@uw.edu	Phelps, Michael/O-6686-2018; Kehrli, Keffy/ABA-3390-2020	Phelps, Michael/0000-0001-8246-0710; Kehrli, Keffy/0000-0002-6573-2216; Sidorova, Julia/0000-0001-5502-4323	National Institutes of Health [R01GM115482, P01CA77852, K08 AR063165-03, R01CA196882]; St. Baldrick's Scholar Award; Sarcoma Foundation; Rally Foundation; University of Washington Royalty Research Fund; Seattle Cancer Consortium Breast NCI SPORE; NATIONAL CANCER INSTITUTE [P01CA077852, R01CA196882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR063165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Scholar Award; Sarcoma Foundation; Rally Foundation; University of Washington Royalty Research Fund(University of Washington); Seattle Cancer Consortium Breast NCI SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM115482 (to J. M. S.), P01CA77852 (to R. M., Jr.), and K08 AR063165-03 and R01CA196882 (to E C.). This work was also supported by St. Baldrick's Scholar Award, Sarcoma Foundation and Rally Foundation grants (to E. C.), and by the University of Washington Royalty Research Fund and Seattle Cancer Consortium Breast NCI SPORE (to J. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Aranda S, 2014, NUCLEIC ACIDS RES, V42, P6972, DOI 10.1093/nar/gku374; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Fukuda T, 2015, CANCER SCI, V106, P1050, DOI 10.1111/cas.12717; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Iannascoli C, 2015, NUCLEIC ACIDS RES, V43, P9788, DOI 10.1093/nar/gkv836; Kehrli Keffy R M, 2014, Oncoscience, V1, P540; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Lauper JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059709; Leman AR, 2013, GENES-BASEL, V4, P1, DOI 10.3390/genes4010001; Leung KHT, 2013, BIOTECHNIQUES, V55, P204, DOI 10.2144/000114089; Magdalou I, 2014, SEMIN CELL DEV BIOL, V30, P154, DOI 10.1016/j.semcdb.2014.04.035; Mao FJ, 2010, CANCER RES, V70, P6548, DOI 10.1158/0008-5472.CAN-10-0475; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Moser MA, 2014, CHROMOSOMA, V123, P67, DOI 10.1007/s00412-013-0441-x; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Pathania S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6496; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028; Rodriguez-Lopez AM, 2002, AGING CELL, V1, P30, DOI 10.1046/j.1474-9728.2002.00002.x; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sidorova J. M., 2015, Advances in Genomics and Genetics, V5, P19; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Sidorova JM, 2013, DNA REPAIR, V12, P128, DOI 10.1016/j.dnarep.2012.11.005; Sidorova JM, 2009, NAT PROTOC, V4, P849, DOI 10.1038/nprot.2009.54; Sirbu BM, 2013, J BIOL CHEM, V288, P31458, DOI 10.1074/jbc.M113.511337; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Su FT, 2014, CELL REP, V9, P1387, DOI 10.1016/j.celrep.2014.10.025; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Yu CE, 1997, AM J HUM GENET, V60, P330; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356	54	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24487	24503		10.1074/jbc.M115.708594	http://dx.doi.org/10.1074/jbc.M115.708594			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27672210	Green Published, hybrid			2022-12-28	WOS:000388875500013
J	Lv, Y; Zhang, SY; Liang, XY; Zhang, H; Xu, Z; Liu, B; Xu, MJ; Jiang, CT; Shang, J; Wang, X				Lv, Ying; Zhang, Song-Yang; Liang, Xianyi; Zhang, Heng; Xu, Zhi; Liu, Bo; Xu, Ming-Jiang; Jiang, Changtao; Shang, Jin; Wang, Xian			Adrenomedullin 2 Enhances Beiging in White Adipose Tissue Directly in an Adipocyte-autonomous Manner and Indirectly through Activation of M2 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; energy metabolism; macrophage; obesity; uncoupling protein	GENE-RELATED PEPTIDE; P38 MAP KINASE; INSULIN-RESISTANCE; PROTEIN-KINASE; BROWN ADIPOCYTES; APOLIPOPROTEIN-E; FAT-CELL; IN-VIVO; MICE; INTERMEDIN	Adrenomedullin 2 (ADM2) is an endogenous bioactive peptide belonging to the calcitonin gene-related peptide family. Our previous studies showed that overexpression of ADM2 in mice reduced obesity and insulin resistance by increasing thermogenesis in brown adipose tissue. However, the effects of ADM2 in another type of thermogenic adipocyte, beige adipocytes, remain to be understood. The plasma ADM2 levels were inversely correlated with obesity in humans, and adipo-ADM2-transgenic (tg) mice displayed resistance to high-fat diet-induced obesity with increased energy expenditure. Beiging of subcutaneous white adipose tissues (WAT) was more noticeably induced in high-fat diet-fed transgenic mice with adipocyte-ADM2 overexpression (adipo-ADM2-tg mice) than in WT animals. ADM2 treatment in primary rat subcutaneous adipocytes induced beiging with up-regulation of UCP1 and beiging-related marker genes and increased mitochondrial uncoupling respiration, which was mainly mediated by activation of the calcitonin receptor-like receptor (CRLR)<bold>receptor activity</bold>-modifying protein 1 (RAMP1) complex and PKA and p38 MAPK signaling pathways. Importantly, this adipocyte-autonomous beiging effect by ADM2 was translatable to human primary adipocytes. In addition, M2 macrophage activation also contributed to the beiging effects of ADM2 through catecholamine secretion. Therefore, our study reveals that ADM2 enhances subcutaneous WAT beiging via a direct effect by activating the CRLR<bold>RAMP</bold>1-cAMP/PKA and p38 MAPK pathways in white adipocytes and via an indirect effect by stimulating alternative M2 polarization in macrophages. Through both mechanisms, beiging of WAT by ADM2 results in increased energy expenditure and reduced obesity, suggesting ADM2 as a novel anti-obesity target.	[Lv, Ying; Zhang, Song-Yang; Liang, Xianyi; Liu, Bo; Xu, Ming-Jiang; Jiang, Changtao; Wang, Xian] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Key Lab Mol Cardiovascular Sci,Minist Educ, Beijing 100191, Peoples R China; [Lv, Ying; Zhang, Song-Yang; Liang, Xianyi; Liu, Bo; Xu, Ming-Jiang; Jiang, Changtao; Wang, Xian] Beijing Key Lab Cardiovasc Receptors Res, Beijing 100191, Peoples R China; [Zhang, Heng] Capital Med Univ, Dept Endocrinol, Beijing Chao Yang Hosp, Beijing 100020, Peoples R China; [Xu, Zhi] Peking Univ, Hosp 3, Dept Gen Surg, Beijing 100191, Peoples R China; [Shang, Jin] Merck & Co Inc, Dept Cardiometabol Dis, Merck Res Labs, Kenilworth, NJ 07033 USA	Peking University; Capital Medical University; Peking University; Merck & Company	Jiang, CT (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Key Lab Mol Cardiovascular Sci,Minist Educ, Beijing 100191, Peoples R China.; Jiang, CT (corresponding author), Beijing Key Lab Cardiovasc Receptors Res, Beijing 100191, Peoples R China.; Shang, J (corresponding author), Merck & Co Inc, Dept Cardiometabol Dis, Merck Res Labs, Kenilworth, NJ 07033 USA.; Jiang, CT (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100191, Peoples R China.; Shang, J (corresponding author), Merck Res Labs, Dept Cardiometabol Dis, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	jiangchangtao@bjmu.edu.cn; jin_shang@merck.com		Jiang, Changtao/0000-0002-5206-2372; Song-Yang, Zhang/0000-0002-4356-897X	National Natural Science Foundation of the People's Republic of China [31230035, 91439206, 81522007, 81470554]; National Basic Research Program (973 Program) of the People's Republic of China [2012CB518002]; 111 Project of the Chinese Ministry of Education [B07001]; Merck Sharp & Dohme R&D China postdoctoral fellowship	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of the People's Republic of China(National Basic Research Program of China); 111 Project of the Chinese Ministry of Education; Merck Sharp & Dohme R&D China postdoctoral fellowship	This work was supported by National Natural Science Foundation of the People's Republic of China Grants 31230035 and 91439206 (to X. W.) and 81522007 and 81470554 (to C. J.), National Basic Research Program (973 Program) of the People's Republic of China Grant 2012CB518002 (to M. J. X.), 111 Project of the Chinese Ministry of Education Grant B07001, and a Merck Sharp & Dohme R&D China postdoctoral fellowship (to Y. L.). J. S. is an employee of Merck & Co., Inc.	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; COUSIN B, 1992, J CELL SCI, V103, P931; Dai XY, 2014, CARDIOVASC RES, V101, P297, DOI 10.1093/cvr/cvt254; Dai XY, 2012, J MOL CELL CARDIOL, V53, P509, DOI 10.1016/j.yjmcc.2012.07.006; Dunham-Snary KJ, 2014, REDOX BIOL, V2, P656, DOI 10.1016/j.redox.2014.04.005; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gustafson B, 2015, DIABETES, V64, P1670, DOI 10.2337/db14-1127; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Kuwasako K, 2004, MOL PHARMACOL, V65, P207, DOI 10.1124/mol.65.1.207; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Lu WW, 2015, J HYPERTENS, V33, P1676, DOI 10.1097/HJH.0000000000000597; Lyu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117536; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Morimoto R, 2007, PEPTIDES, V28, P1095, DOI 10.1016/j.peptides.2007.01.018; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Pang YL, 2016, J BIOL CHEM, V291, P12336, DOI 10.1074/jbc.M115.702654; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Qiao X, 2015, NEPHROLOGY, V20, P820, DOI 10.1111/nep.12520; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Shostak A, 2013, ADIPOCYTE, V2, P201, DOI 10.4161/adip.26007; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; TRASFORINI G, 1991, J CLIN ENDOCR METAB, V73, P945, DOI 10.1210/jcem-73-5-945; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Wang C, 2010, BIOMED ENVIRON SCI, V23, P173, DOI 10.1016/S0895-3988(10)60049-9; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Xiang XX, 2015, DIABETES, V64, P519, DOI 10.2337/db14-0427; Zhang H, 2016, INT J OBESITY, V40, P852, DOI 10.1038/ijo.2016.2; Zhang SY, 2016, DIABETES, V65, P2342, DOI 10.2337/db15-1626; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	50	30	31	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23390	23402		10.1074/jbc.M116.735563	http://dx.doi.org/10.1074/jbc.M116.735563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621315	Green Published, hybrid			2022-12-28	WOS:000387884400003
J	Katoh, T; Katayama, T; Tomabechi, Y; Nishikawa, Y; Kumada, J; Matsuzaki, Y; Yamamoto, K				Katoh, Toshihiko; Katayama, Takane; Tomabechi, Yusuke; Nishikawa, Yoshihide; Kumada, Jyunichi; Matsuzaki, Yuji; Yamamoto, Kenji			Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; COMPLEX-TYPE OLIGOSACCHARIDES; TRANSGLYCOSYLATION ACTIVITY; CHEMOENZYMATIC SYNTHESIS; GLYCOSYNTHASE MUTANTS; MOLECULAR-CLONING; ACETYLGLUCOSAMINIDASE-D; CAENORHABDITIS-ELEGANS; HUMAN LACTOFERRIN; HIGH-MANNOSE	Endo-beta-N-acetylglucosaminidase M (Endo-M), an endoglycosidase from the fungus Mucor hiemalis, is a useful tool for chemoenzymatic synthesis of glycoconjugates, including glycoprotein-based therapeutics having a precisely defined glycoform, by virtue of its transglycosylation activity. Although Endo-M has been known to act on various N-glycans, it does not act on core-fucosylated N-glycans, which exist widely in mammalian glycoproteins, thus limiting its application. Therefore, we performed site-directed mutagenesis on Endo-M to isolate mutant enzymes that are able to act on mammalian-type core-1,6-fucosylated glycans. Among the Endo-M mutant enzymes generated, those in which the tryptophan at position 251 was substituted with alanine or asparagine showed altered substrate specificities. Such mutant enzymes exhibited increased hydrolysis of a synthetic alpha 1,6-fucosylated trimannosyl core structure, whereas their activity on the afucosylated form decreased. In addition, among the Trp-251 mutants, the W251N mutant was most efficient in hydrolyzing the core-fucosylated substrate. W251N mutants could act on the immunoglobulin G-derived core-fucosylated glycopeptides and human lactoferrin glycoproteins. This mutant was also capable of transferring the sialyl glycan from an activated substrate intermediate (sialyl glycooxazoline) onto an alpha 1,6-fucosyl-N-acetylglucosaminyl biotin. Furthermore, the W251N mutant gained a glycosynthase-like activity when a N175Q substitution was introduced and it caused accumulation of the transglycosylation products. These findings not only give insights into the substrate recognition mechanism of glycoside hydrolase family 85 enzymes but also widen their scope of application in preparing homogeneous glycoforms of core-fucosylated glycoproteins for the production of potent glycoprotein-based therapeutics.	[Katoh, Toshihiko; Katayama, Takane] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Katayama, Takane] Ishikawa Prefectural Univ, Host Microbe Interact Res Lab, Nonoichi, Ishikawa 9218836, Japan; [Tomabechi, Yusuke; Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Nishikawa, Yoshihide; Kumada, Jyunichi; Matsuzaki, Yuji] Tokyo Chem Ind Co Ltd, Kita Ku, 6-15-9 Toshima, Tokyo 1140003, Japan	Kyoto University; Ishikawa Prefecture University; Ishikawa Prefecture University	Katoh, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Oiwake Cho, Kyoto 6068502, Japan.	tkatoh@lif.kyoto-u.ac.jp		Katayama, Takane/0000-0003-4009-7874	Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	We thank Dr. Yoshinobu Kimura (Okayama University) for valuable discussions. Part of this work was conducted in the Japan Advanced Institute of Science and Technology (JAIST), supported by the Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Allhorn M, 2010, BLOOD, V115, P5080, DOI 10.1182/blood-2009-08-239020; Andre S, 2007, BIOCHEMISTRY-US, V46, P6984, DOI 10.1021/bi7000467; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; BOCK K, 1973, TETRAHEDRON LETT, P1037; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Eshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132859; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Fujita K, 2004, BIOSCI BIOTECH BIOCH, V68, P1059, DOI 10.1271/bbb.68.1059; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Garbe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091035; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Giddens JP, 2016, J BIOL CHEM, V291, P9356, DOI 10.1074/jbc.M116.721597; Haneda K, 2006, CARBOHYD RES, V341, P181, DOI 10.1016/j.carres.2005.11.015; Huang CC, 2015, P NATL ACAD SCI USA, V112, P1398, DOI 10.1073/pnas.1414593112; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2011, CHEMBIOCHEM, V12, P932, DOI 10.1002/cbic.201000763; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; KADOWAKI S, 1991, J BIOCHEM-TOKYO, V110, P17, DOI 10.1093/oxfordjournals.jbchem.a123536; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 2007, J BIOL CHEM, V282, P22080, DOI 10.1074/jbc.M700805200; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Li TZ, 2016, J BIOL CHEM, V291, P16508, DOI 10.1074/jbc.M116.738765; Ling ZL, 2009, J MOL BIOL, V389, P1, DOI 10.1016/j.jmb.2009.03.050; Maeda M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00429; Murakami S, 2013, GLYCOBIOLOGY, V23, P736, DOI 10.1093/glycob/cwt012; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Nakamura K, 2009, BIOSCI BIOTECH BIOCH, V73, P461, DOI 10.1271/bbb.80889; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Parsons TB, 2016, ANGEW CHEM INT EDIT, V55, P2361, DOI 10.1002/anie.201508723; Sakaguchi K, 2016, BIOTECHNOL APPL BIOC, V63, P812, DOI 10.1002/bab.1433; Shang TQ, 2014, J PHARM SCI-US, V103, P1967, DOI 10.1002/jps.24004; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Umemura M, 2008, J MED CHEM, V51, P4496, DOI 10.1021/jm8000967; vanBerkel PHC, 1996, BIOCHEM J, V319, P117, DOI 10.1042/bj3190117; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72; Yamamoto S, 2005, GLYCOCONJUGATE J, V22, P35, DOI 10.1007/s10719-005-0847-7; Yin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004658; Yu TA, 2011, GLYCOBIOLOGY, V21, P206, DOI 10.1093/glycob/cwq151	55	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23305	23317		10.1074/jbc.M116.737395	http://dx.doi.org/10.1074/jbc.M116.737395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27629418	hybrid, Green Published			2022-12-28	WOS:000387224800038
J	Murphy, J; Kolandaivelu, S				Murphy, Joseph; Kolandaivelu, Saravanan			Palmitoylation of Progressive Rod-Cone Degeneration (PRCD) Regulates Protein Stability and Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINITIS-PIGMENTOSA; MUTATION; IDENTIFICATION; REVEALS; EXPRESSION; GENETICS; FAMILY; SITE; DOGS	Progressive rod-cone degeneration (PRCD) is a photoreceptor outer segment (OS) disc-specific protein with unknown function that is associated with retinitis pigmentosa (RP). The most common mutation in PRCD linked with severe RP phenotype is substitution of the only cysteine to tyrosine (C2Y). In this study, we find that PRCD is post-translationally modified by a palmitoyl lipid group at the cysteine residue linked with RP. Disrupting PRCD palmitoylation either chemically or by genetically eliminating the modified cysteine dramatically affects the stability of PRCD. Furthermore, in vivo electroporation of PRCD C2Y mutant in the mouse retina demonstrates that the palmitoylation of PRCD is important for its proper localization in the photoreceptor OS. Mutant PRCD C2Y was found in the inner segment in contrast to normal localization of WTPRCD in the OS. Our results also suggest that zDHHC3, a palmitoyl acyltransferase (PAT), catalyzes the palmitoylation of PRCD in the Golgi compartment. In conclusion, we find that the palmitoylation of PRCD is crucial for its trafficking to the photoreceptor OS and mislocalization of this protein likely leads to RP-related phenotypes.	[Murphy, Joseph; Kolandaivelu, Saravanan] West Virginia Univ, Inst Eye, Dept Ophthalmol, One Med Ctr Dr, Morgantown, WV 26506 USA	West Virginia University	Kolandaivelu, S (corresponding author), West Virginia Univ, Inst Eye, Dept Ophthalmol, One Med Ctr Dr, Morgantown, WV 26506 USA.	kolandaivelus@wvuhealthcare.com			West Virginia University (WVU); WVU internal Research Funding Development Grant (RFDG) [10018012.2.NT10076W]	West Virginia University (WVU); WVU internal Research Funding Development Grant (RFDG)	This work was supported by West Virginia University (WVU) startup funds (to S. K.) and WVU internal Research Funding Development Grant (RFDG) 10018012.2.NT10076W (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Addison JB, 2015, CANCER RES, V75, P344, DOI 10.1158/0008-5472.CAN-14-1561; AGUIRRE G, 1986, INVEST OPHTH VIS SCI, V27, P635; AGUIRRE G, 1982, INVEST OPHTH VIS SCI, V23, P610; Beltran WA, 2010, GENE THER, V17, P1162, DOI 10.1038/gt.2010.56; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Fahim A.T., 2000, GENEREVIEWS; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gelabert-Baldrich M, 2014, FASEB J, V28, P3023, DOI 10.1096/fj.13-241158; Gentilini F, 2009, J VET DIAGN INVEST, V21, P689, DOI 10.1177/104063870902100515; Goldstein O, 2006, GENOMICS, V88, P541, DOI 10.1016/j.ygeno.2006.05.013; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Guadagni V, 2015, PROG RETIN EYE RES, V48, P62, DOI 10.1016/j.preteyeres.2015.06.005; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kalloniatis M, 2016, EXP EYE RES, V150, P106, DOI 10.1016/j.exer.2015.10.019; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; Kohyama M, 2016, J VET MED SCI, V78, P481, DOI 10.1292/jvms.15-0279; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Majumder A, 2013, P NATL ACAD SCI USA, V110, P12468, DOI 10.1073/pnas.1222666110; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Maubaret C, 2005, J FR OPHTALMOL, V28, P71, DOI 10.1016/S0181-5512(05)81029-0; Murphy D, 2015, MOL CELL BIOL, V35, P1860, DOI 10.1128/MCB.00040-15; Nevet MJ, 2010, J MED GENET, V47, P533, DOI 10.1136/jmg.2009.073619; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; Pach J, 2013, MOL VIS, V19, P1350; Parmeggiani F, 2011, CURR GENOMICS, V12, P236, DOI 10.2174/138920211795860080; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Remez L, 2014, EXP EYE RES, V125, P217, DOI 10.1016/j.exer.2014.06.017; Roberts BJ, 2014, J CELL SCI, V127, P3782, DOI 10.1242/jcs.149849; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Skiba NP, 2013, J PROTEOME RES, V12, P3010, DOI 10.1021/pr4003678; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Yeste-Velasco M, 2015, BBA-REV CANCER, V1856, P107, DOI 10.1016/j.bbcan.2015.06.004; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007	46	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23036	23046		10.1074/jbc.M116.742767	http://dx.doi.org/10.1074/jbc.M116.742767			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613864	Green Published, hybrid			2022-12-28	WOS:000387224800016
J	Schuebel, F; Rocker, A; Edelmann, D; Schessner, J; Brieke, C; Meinhart, A				Schuebel, Felix; Rocker, Andrea; Edelmann, Daniel; Schessner, Julia; Brieke, Clara; Meinhart, Anton			3 '-NADP and 3 '-NAADP, Two Metabolites Formed by the Bacterial Type III Effector AvrRxo1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; PLANT IMMUNITY; MALIC ENZYME; PYRIDINE-NUCLEOTIDES; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CALCIUM-RELEASE; RESISTANCE	An arsenal of effector proteins is injected by bacterial pathogens into the host cell or its vicinity to increase virulence. The commonly used top-down approaches inferring the toxic mechanism of individual effector proteins from the host's phenotype are often impeded by multiple targets of different effectors as well as by their pleiotropic effects. Here we describe our bottom-up approach, showing that the bacterial type III effector AvrRxo1 of plant pathogens is an authentic phosphotransferase that produces two novel metabolites by phosphorylating nicotinamide/nicotinic acid adenine dinucleotide at the adenosine 3'-hydroxyl group. Both products of AvrRxo1, 3'-NADP and 3'-nicotinic acid adenine dinucleotide phosphate (3'-NAADP), are substantially different from the ubiquitous co-enzyme 2'-NADP and the calcium mobilizer 2'-NAADP. Interestingly, 3'-NADP and 3'-NAADP have previously been used as inhibitors or signaling molecules but were regarded as "artificial" compounds so far. Our findings now necessitate a shift in thinking about the biological importance of 3'-phosphorylated NAD derivatives.	[Schuebel, Felix; Rocker, Andrea; Edelmann, Daniel; Schessner, Julia; Brieke, Clara; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany; [Meinhart, Anton] CellNetworks, Heidelberg, Germany	Max Planck Society	Meinhart, A (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.; Meinhart, A (corresponding author), CellNetworks, Heidelberg, Germany.	Anton.Meinhart@mpimf-heidelberg.mpg.de	Schessner, Julia Patricia/AFQ-4383-2022	Schessner, Julia Patricia/0000-0003-3361-9830	Max Planck Society; Chica and Heinz Schaller Foundation, Heidelberg	Max Planck Society(Max Planck Society); Chica and Heinz Schaller Foundation, Heidelberg	A member of CellNetworks, Heidelberg and supported by the Max Planck Society and the Chica and Heinz Schaller Foundation, Heidelberg. To whom correspondence should be addressed. E-mail: Anton.Meinhart@mpimf-heidelberg.mpg.de.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; ATKINSON MM, 1990, PLANT PHYSIOL, V92, P215, DOI 10.1104/pp.92.1.215; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bahadur RP, 2014, J BIOMOL STRUCT DYN, V32, P669, DOI 10.1080/07391102.2013.787370; BATIE CJ, 1986, J BIOL CHEM, V261, P1214; BERGHAUSER J, 1975, BIOCHIM BIOPHYS ACTA, V397, P370, DOI 10.1016/0005-2744(75)90126-6; BERNOFSKY C, 1975, ANAL BIOCHEM, V67, P611, DOI 10.1016/0003-2697(75)90336-X; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; CHINI EN, 1995, J BIOL CHEM, V270, P3216, DOI 10.1074/jbc.270.7.3216; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Drincovich MF, 2001, FEBS LETT, V490, P1, DOI 10.1016/S0014-5793(00)02331-0; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; GALIONE A, 1994, MOL CELL ENDOCRINOL, V98, P125, DOI 10.1016/0303-7207(94)90130-9; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Han Q, 2015, STRUCTURE, V23, P1900, DOI 10.1016/j.str.2015.06.030; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; IMSANDE J, 1961, J BIOL CHEM, V236, P1494; Jacobson MK, 1999, TRENDS BIOCHEM SCI, V24, P415, DOI 10.1016/S0968-0004(99)01481-4; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawai S, 2001, EUR J BIOCHEM, V268, P4359, DOI 10.1046/j.1432-1327.2001.02358.x; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee HC, 1997, J BIOL CHEM, V272, P20378, DOI 10.1074/jbc.272.33.20378; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; LEE HJ, 1987, BIOCHEM J, V245, P407, DOI 10.1042/bj2450407; Liu HT, 2014, J CHINESE LINGUIST, V42, P1; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mutschler H, 2011, J MOL MED, V89, P1183, DOI 10.1007/s00109-011-0797-4; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Navazio L, 2000, P NATL ACAD SCI USA, V97, P8693, DOI 10.1073/pnas.140217897; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; OKUDA K, 1985, EUR J BIOCHEM, V147, P249, DOI 10.1111/j.1432-1033.1985.tb08744.x; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SHUSTER L, 1955, J BIOL CHEM, V215, P183; Singer AU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003121; SPAMPINATO CP, 1991, PHOTOSYNTH RES, V28, P69, DOI 10.1007/BF00033716; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yu S, 2014, PROTEINS, V82, P2910, DOI 10.1002/prot.24656; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao BY, 2004, THEOR APPL GENET, V109, P71, DOI 10.1007/s00122-004-1623-y; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	55	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22868	22880		10.1074/jbc.M116.751297	http://dx.doi.org/10.1074/jbc.M116.751297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27621317	hybrid, Green Published			2022-12-28	WOS:000387224800002
J	Shearer, AM; Rana, R; Austin, K; Baleja, JD; Nguyen, N; Bohm, A; Covic, L; Kuliopulos, A				Shearer, Andrew M.; Rana, Rajashree; Austin, Karyn; Baleja, James D.; Nguyen, Nga; Bohm, Andrew; Covic, Lidija; Kuliopulos, Athan			Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONALCOHOLIC FATTY LIVER; HEPATIC STELLATE CELLS; TISSUE FACTOR; PULMONARY-FIBROSIS; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; SQUID RHODOPSIN; INTERLEUKIN-6; PATHWAYS	Chronic liver inflammation and fibrosis in nonalcoholic steatohepatitis can lead to cirrhosis and liver failure for which there are currently no approved treatments. Protease-activated receptor-2 (PAR2) is an emerging new target expressed on liver stellate cells and hepatocytes that regulates the response to liver injury and inflammation. Here, we identified a pepducin to block the deleterious actions of PAR2 in promoting liver fibrosis. Non-alcoholic fatty liver disease and early fibrosis were induced by the methionine-choline-deficient diet in mice. Fibrotic liver disease was induced by administering carbon tetrachloride for 8 weeks. Mice were treated with the pepducin PZ-235 either from onset of the experiment or after fibrosis was established. Hepatic fibrosis, collagen content, inflammatory cytokines, steatosis, triglycerides, and NAFLD activity score were assessed as primary outcome parameters depending on the model. The activity of the PAR2 pepducin on cultured stellate cell activation and hepatocyte reactive oxygen species production was evaluated. PZ-235 significantly suppressed liver fibrosis, collagen deposition, inflammatory cytokines, NAFLD activity score, steatosis, triglycerides, aspartate transaminase, alanine transaminase, and stellate cell proliferation by up to 50-100%. The PAR2 inhibitor afforded significant protective effects against hepatocellular necrosis and attenuated PAR2-mediated reactive oxygen species production in hepatocytes. PZ-235 was distributed to liver and other mouse tissues and was found to form a well structured alpha-helix that closely resembles the juxtamembrane helical region of the analogous TM6 and third intracellular region of the intact receptor that is critical for coupling to internal G proteins. The ability of PZ-235 to effectively suppress fibrosis, hepatocellular necrosis, reactive oxygen species production, steatosis, and inflammation indicates the potential for PAR2 pepducin inhibitors to be broadly efficacious in the treatment of liver fibrosis.	[Shearer, Andrew M.; Rana, Rajashree; Austin, Karyn; Nguyen, Nga; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Ctr Hemostasis & Thrombosis Res, Mol Oncol Res Inst,Tufts Med Ctr, Boston, MA 02111 USA; [Shearer, Andrew M.; Austin, Karyn; Baleja, James D.; Bohm, Andrew; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Sch Grad Biomed Sci Biochem Dev Mol & Chem Biol, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Med Ctr, Box 7510,800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu		Shearer, Andrew/0000-0003-2039-0934	NIDDK, National Institutes of Health [DK101240]; NHLBI, National Institutes of Health Ruth L. Kirschstein National Research Service Award [F31HL132419]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL132419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R42DK101240, R44DK101240] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, National Institutes of Health Ruth L. Kirschstein National Research Service Award; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIDDK, National Institutes of Health Grant DK101240 (to A. K. and L. C.). Dr. Kuliopulos and Dr. Covic report serving as Scientific Founders of Oasis Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by NHLBI, National Institutes of Health Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship F31HL132419.r Supported by an American Heart Association postdoctoral fellowship.	Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Borensztajn K, 2010, AM J PATHOL, V177, P2753, DOI 10.2353/ajpath.2010.091107; Borensztajn K, 2010, J CELL MOL MED, V14, P143, DOI 10.1111/j.1582-4934.2009.00980.x; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Chung H, 2013, J BIOL CHEM, V288, P37319, DOI 10.1074/jbc.M113.492793; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Gurbel PA, 2016, ARTERIOSCL THROM VAS, V36, P189, DOI 10.1161/ATVBAHA.115.306777; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Klausen P, 2000, ONCOGENE, V19, P3675, DOI 10.1038/sj.onc.1203707; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Kuliopulos A, 2003, LIFE SCI, V74, P255, DOI 10.1016/j.lfs.2003.09.012; KULIOPULOS A, 1994, J BIOL CHEM, V269, P21364; LaBrecque D, 2012, WORLD GASTROENTEROLO; Machado MV, 2016, GASTROENTEROLOGY, V150, P1769, DOI 10.1053/j.gastro.2016.02.066; Mak KM, 2013, ANAT REC, V296, P953, DOI 10.1002/ar.22694; Marra F, 1998, AM J PATHOL, V152, P423; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Michael ES, 2013, AM J PHYSIOL-GASTR L, V304, pG516, DOI 10.1152/ajpgi.00296.2012; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Murakami M, 2011, J MOL BIOL, V413, P615, DOI 10.1016/j.jmb.2011.08.044; Novo E, 2015, HISTOL HISTOPATHOL, V30, P1011, DOI 10.14670/HH-11-623; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rautou PE, 2014, HEPATOLOGY, V60, P1793, DOI 10.1002/hep.27033; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Ruf W, 2015, HAMOSTASEOLOGIE, V35, P279, DOI 10.5482/HAMO-14-11-0068; Sauvant P, 2011, J PHYSIOL BIOCHEM, V67, P487, DOI 10.1007/s13105-011-0101-7; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Sevigny LM, 2011, P NATL ACAD SCI USA, V108, P8491, DOI 10.1073/pnas.1017091108; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Su Z, 2016, CELL DEATH DIFFER, V23, P748, DOI 10.1038/cdd.2016.8; Sullivan BP, 2013, BLOOD, V121, P1868, DOI 10.1182/blood-2012-09-455436; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Tsuji M, 2013, ORG BIOMOL CHEM, V11, P3030, DOI 10.1039/c3ob27445d; Wielders SJH, 2007, J THROMB HAEMOST, V5, P571, DOI 10.1111/j.1538-7836.2007.02364.x; Wieser V, 2017, GUT, V66, P930, DOI 10.1136/gutjnl-2015-310344; Wygrecka M, 2011, AM J RESP CRIT CARE, V183, P1703, DOI 10.1164/rccm.201009-1479OC; Zhang P, 2015, J BIOL CHEM, V290, P15785, DOI 10.1074/jbc.M115.636316; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918	60	33	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23188	23198		10.1074/jbc.M116.732743	http://dx.doi.org/10.1074/jbc.M116.732743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613872	hybrid, Green Published			2022-12-28	WOS:000387224800028
J	Eldeeb, MA; Fahlman, RP				Eldeeb, Mohamed A.; Fahlman, Richard P.			Phosphorylation Impacts N-end Rule Degradation of the Proteolytically Activated Form of BMX Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; phosphorylation; protein degradation; tyrosine-protein kinase (tyrosine kinase); ubiquitin ligase; BMX; Etk; N-end Rule	PROSTATE-CANCER CELLS; ETK/BMX TYROSINE KINASE; PROTEIN-FRAGMENTS; INDUCED APOPTOSIS; UBIQUITIN LIGASE; TEC FAMILY; PH-DOMAIN; PATHWAY; DEATH; DOCETAXEL	Cellular signaling leading to the initiation of apoptosis typically results in the activation of caspases, which in turn leads to the proteolytic generation of protein fragments with new or altered cellular functions. Increasing numbers of reports are demonstrating that the activity of many of these proteolytically activated protein fragments can be attenuated by their selective degradation by the N-end rule pathway. Here we report the first evidence that selective degradation of a caspase product by the N-end rule pathway can be modulated by phosphorylation. We demonstrate that the pro-apoptotic fragment of the bone marrow kinase on chromosome X (BMX) generated by caspase cleavage in the prostate cancer-derived PC3 cell line is metabolically unstable in cells because its N-terminal tryptophan targets it for proteasomal degradation via the N-end rule pathway. In addition, we have demonstrated that phosphorylation of tyrosine 566 relatively inhibits degradation of the C-terminal BMX catalytic fragment, and this phosphorylation is crucial for its pro-apoptotic function. Overall, our results demonstrate that cleaved BMX is a novel N-end rule substrate, and its degradation exhibits a novel interplay between substrate phosphorylation and N-end rule degradation, revealing an increasing complex regulatory network of apoptotic proteolytic signaling cascades.	[Eldeeb, Mohamed A.; Fahlman, Richard P.] Univ Alberta, Dept Biochem, Edmonton, AB T6J 2H7, Canada; [Fahlman, Richard P.] Univ Alberta, Dept Oncol, Edmonton, AB T6J 2H7, Canada	University of Alberta; University of Alberta	Fahlman, RP (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biochem, 474 Med Sci Bldg, Edmonton, AB T6J 2H7, Canada.	rfahlman@ualberta.ca	Eldeeb, Mohamed/H-5437-2019	A. Eldeeb, Mohamed/0000-0001-9671-9340	Natural Sciences and Engineering Research Council (NSERC) of Canada [341453-12]; Alberta Innovates Technology Futures Graduate Student Scholarship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Technology Futures Graduate Student Scholarship	This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant 341453-12 (to R. P. F.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by an Alberta Innovates Technology Futures Graduate Student Scholarship.	An JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037414; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Ekman N, 2000, ONCOGENE, V19, P4151, DOI 10.1038/sj.onc.1203763; Eldeeb M, 2016, PROTEIN PEPTIDE LETT, V23, P343, DOI 10.2174/0929866523666160108115809; Eldeeb MA, 2014, ONCOTARGET, V5, P2714, DOI 10.18632/oncotarget.1931; Fabbri F, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-6; Fox JL, 2015, CANCER RES, V75, P1345, DOI 10.1158/0008-5472.CAN-14-1340; Gan L, 2011, PROSTATE, V71, P1158, DOI 10.1002/pros.21331; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gottar-Guillier M, 2011, J IMMUNOL, V186, P6014, DOI 10.4049/jimmunol.1002813; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jiang SY, 2014, MOL CELL BIOL, V34, P3928, DOI 10.1128/MCB.00745-14; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim JW, 2000, ONCOGENE, V19, P4491, DOI 10.1038/sj.onc.1203796; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu YJ, 2016, J BIOL CHEM, V291, P7426, DOI 10.1074/jbc.M116.714964; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Polverino AJ, 1997, J BIOL CHEM, V272, P7013, DOI 10.1074/jbc.272.11.7013; Potter DS, 2014, NEOPLASIA, V16, P147, DOI 10.1593/neo.131376; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Roman-Hernandez G, 2009, P NATL ACAD SCI USA, V106, P8888, DOI 10.1073/pnas.0903614106; Sheng J, 2002, EMBO J, V21, P6061, DOI 10.1093/emboj/cdf626; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Sriram S, 2013, J MED CHEM, V56, P2540, DOI 10.1021/jm400046q; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wu YM, 2001, J BIOL CHEM, V276, P17672, DOI 10.1074/jbc.M010964200; Xu ZZ, 2012, J BIOL CHEM, V287, P7495, DOI 10.1074/jbc.M111.301002; Xue LY, 1999, ONCOGENE, V18, P3391, DOI 10.1038/sj.onc.1202687; Zhang ZH, 2011, CANCER BIOL THER, V11, P690, DOI 10.4161/cbt.11.7.15060	47	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22757	22768		10.1074/jbc.M116.737387	http://dx.doi.org/10.1074/jbc.M116.737387			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601470	Green Published, hybrid			2022-12-28	WOS:000386760600033
J	Beerepoot, P; Lam, VM; Salahpour, A				Beerepoot, Pieter; Lam, Vincent M.; Salahpour, Ali			Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; COPII; dopamine transporter; membrane protein; protein folding; DTDS; SEC24D; bupropion; ibogaine; pharmacological chaperone	SURFACE EXPRESSION; ENDOPLASMIC-RETICULUM; SEROTONIN TRANSPORTER; MEMBRANE-PROTEINS; BINDING-SITES; C-TERMINUS; COCAINE; AMPHETAMINE; RECEPTOR; EXPORT	A number of pathological conditions have been linked to mutations in the dopamine transporter gene, including hereditary dopamine transporter deficiency syndrome (DTDS). DTDS is a rare condition that is caused by autosomal recessive loss-of-function mutations in the dopamine transporter (DAT), which often affects transporter trafficking and folding. We examined the possibility of using pharmacological chaperones of DAT to rescue DTDS mutations. After screening a set of known DAT ligands for their ability to increase DAT surface expression, we found that bupropion and ibogaine increased DAT surface expression, whereas others, including cocaine and methylphenidate, had no effect. Bupropion and ibogaine increased wild type DAT protein levels and also promoted maturation of the endoplasmic reticulum (ER)-retained DAT mutant K590A. Rescue of K590A could be blocked by inhibiting ER to Golgi transport using brefeldin A. Furthermore, knockdown of coat protein complex II (COPII) component SEC24D, which is important in the ER export of wild type DAT, also blocked the rescue effects of bupropion and ibogaine. These data suggest that bupropion and ibogaine promote maturation of DAT by acting as pharmacological chaperones in the ER. Importantly, both drugs rescue DAT maturation and functional activity of the DTDS-associated mutations A314V and R445C. Together, these results are the first demonstration of pharmacological chaperoning of DAT and suggest this may be a viable approach to increase DAT levels in DTDS and other conditions associated with reduced DAT function.	[Beerepoot, Pieter; Lam, Vincent M.; Salahpour, Ali] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada	University of Toronto	Salahpour, A (corresponding author), Dept Pharmacol & Toxicol, Rm 4302,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	ali.salahpour@utoronto.ca	Beerepoot, Pieter/AAA-3156-2019	Beerepoot, Pieter/0000-0003-3721-3213	ERA/MRI (Early Research Award/Ministry of Research and Innovation) Ontario grant; OGS (Ontario Graduate Scholarship); CIHR (Canadian Institutes of Health Research); NSERC (Natural Science and Engineering Research Council)	ERA/MRI (Early Research Award/Ministry of Research and Innovation) Ontario grant; OGS (Ontario Graduate Scholarship)(Ontario Graduate Scholarship); CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); NSERC (Natural Science and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an ERA/MRI (Early Research Award/Ministry of Research and Innovation) Ontario grant (to A.S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by OGS (Ontario Graduate Scholarship) and CIHR (Canadian Institutes of Health Research) awards.; Supported by OGS and NSERC (Natural Science and Engineering Research Council) awards.	Alper K R, 2001, Alkaloids Chem Biol, V56, P1, DOI 10.1016/S0099-9598(01)56005-8; Beerepoot P., 2015, METHODS MOL BIOL, V1270, P107, DOI [10.1007/978-1-4939-2309-0_8, DOI 10.1007/978-1-4939-2309-0_8]; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Eshaq RS, 2010, BRAIN RES, V1346, P1, DOI 10.1016/j.brainres.2010.05.030; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fortin JP, 2006, MOL PHARMACOL, V69, P1146, DOI 10.1124/mol.105.019976; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gorentla BK, 2005, NEUROPHARMACOLOGY, V49, P759, DOI 10.1016/j.neuropharm.2005.08.011; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lam VM, 2013, TRAFFIC, V14, P778, DOI 10.1111/tra.12073; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pinsonneault JK, 2011, NEUROPSYCHOPHARMACOL, V36, P1644, DOI 10.1038/npp.2011.45; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Seibert FS, 1997, J BIOENERG BIOMEMBR, V29, P429, DOI 10.1023/A:1022478822214; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Vecchio LM, 2014, MOL CELL NEUROSCI, V61, P123, DOI 10.1016/j.mcn.2014.05.007	42	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22053	22062		10.1074/jbc.M116.749119	http://dx.doi.org/10.1074/jbc.M116.749119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27555326	hybrid, Green Published			2022-12-28	WOS:000386332600020
J	Sommese, RF; Sivaramakrishnan, S				Sommese, Ruth F.; Sivaramakrishnan, Sivaraj			Substrate Affinity Differentially Influences Protein Kinase C Regulation and Inhibitor Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); inhibitor; phosphorylation; protein kinase C (PKC); substrate specificity	STRUCTURAL BASIS; PHOSPHORYLATION; PKC; DOMAIN; MOTIFS; SPECIFICITY; MECHANISMS; DISORDER; PATHWAY; CANCER	The overlapping network of kinase-substrate interactions provides exquisite specificity in cell signaling pathways, but also presents challenges to our ability to understand the mechanistic basis of biological processes. Efforts to dissect kinase-substrate interactions have been particularly limited by their inherently transient nature. Here, we use a library of FRET sensors to monitor these transient complexes, specifically examining weak interactions between the catalytic domain of protein kinase C and 14 substrate peptides. Combining results from this assay platform with those from standard kinase activity assays yields four novel insights into the kinase-substrate interaction. First, preferential binding of non-phosphorylated versus phosphorylated substrates leads to enhanced kinase-specific activity. Second, kinase-specific activity is inversely correlated with substrate binding affinity. Third, high affinity substrates can suppress phosphorylation of their low affinity counterparts. Finally, the substrate-competitive inhibitor bisindolylmaleimide I displaces low affinity substrates more potently leading to substrate selective inhibition of kinase activity. Overall, our approach complements existing structural and biophysical approaches to provide generalizable insights into the regulation of kinase activity.	[Sommese, Ruth F.; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Sivaramakrishnan, S (corresponding author), Univ Minnesota, 4-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA.	sivaraj@umn.edu			American Heart Association [13SDG14270009]; National Institutes of Health [1DP2 CA186752-01, 1-R01-GM-105646-01-A1]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the American Heart Association Scientist Development Grant 13SDG14270009 and National Institutes of Health Grants 1DP2 CA186752-01 and 1-R01-GM-105646-01-A1 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; AMESS B, 1992, FEBS LETT, V297, P285; Autry JM, 2012, J BIOL CHEM, V287, P39070, DOI 10.1074/jbc.M112.404434; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Chen CH, 2015, ONCOTARGET, V6, P15194, DOI 10.18632/oncotarget.3827; de Oliveira PSL, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4016; DEKKER LV, 1993, FEBS LETT, V329, P129, DOI 10.1016/0014-5793(93)80208-C; DEKKER LV, 1993, J BIOL CHEM, V268, P19498; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Foda ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6939; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hirschi A, 2010, NAT STRUCT MOL BIOL, V17, P1051, DOI 10.1038/nsmb.1868; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Kim J, 2016, STRUCTURE, V24, P353, DOI 10.1016/j.str.2015.11.016; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lopez-Sanchez I, 2013, P NATL ACAD SCI USA, V110, P5510, DOI 10.1073/pnas.1303392110; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Schulz S, 2013, CELL SIGNAL, V25, P2485, DOI 10.1016/j.cellsig.2013.08.003; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P12072, DOI 10.1021/bi991109q; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Smith IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026338; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Verma SK, 2008, FEBS LETT, V582, P2270, DOI 10.1016/j.febslet.2008.05.028; WOODS A, 1992, J CELL SCI, V101, P277; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	46	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21963	21970		10.1074/jbc.M116.737601	http://dx.doi.org/10.1074/jbc.M116.737601			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27555323	Green Published, hybrid			2022-12-28	WOS:000386332600012
J	Mehmood, S; Corradi, V; Choudhury, HG; Hussain, R; Becker, P; Axford, D; Zirah, S; Rebuffat, S; Tieleman, DP; Robinson, CV; Beis, K				Mehmood, Shahid; Corradi, Valentina; Choudhury, Hassanul G.; Hussain, Rohanah; Becker, Patrick; Axford, Danny; Zirah, Severine; Rebuffat, Sylvie; Tieleman, D. Peter; Robinson, Carol V.; Beis, Konstantinos			Structural and Functional Basis for Lipid Synergy on the Activity of the Antibacterial Peptide ABC Transporter McjD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; circular dichroism (CD); lipid; membrane protein; membrane transport; molecular dynamics; structural biology; structure-function; delipidation; non-denaturing mass spectrometry	BACTERIAL RNA-POLYMERASE; DIAMOND LIGHT-SOURCE; MEMBRANE-PROTEIN; MOLECULAR-DYNAMICS; CIRCULAR-DICHROISM; MICROCIN J25; FORCE-FIELD; MACROMOLECULAR CRYSTALLOGRAPHY; MAXIMUM-LIKELIHOOD; MASS-SPECTROMETER	The lipid bilayer is a dynamic environment that consists of a mixture of lipids with different properties that regulate the function of membrane proteins; these lipids are either annular, masking the protein hydrophobic surface, or specific lipids, essential for protein function. In this study, using tandem mass spectrometry, we have identified specific lipids associated with the Escherichia coli ABC transporter McjD, which translocates the antibacterial peptide MccJ25. Using non-denaturing mass spectrometry, we show that McjD in complex with MccJ25 survives the gas phase. Partial delipidation of McjD resulted in reduced ATPase activity and thermostability as shown by circular dichroism, both of which could be restored upon addition of defined E. coli lipids. We have resolved a phosphatidylglycerol lipid associated with McjD at 3.4 angstrom resolution, whereas molecular dynamic simulations carried out in different lipid environments assessed the binding of specific lipids to McjD. Combined, our data show a synergistic effect of zwitterionic and negatively charged lipids on the activity of McjD; the zwitterionic lipids provide structural stability to McjD, whereas the negatively charged lipids are essential for its function.	[Mehmood, Shahid; Robinson, Carol V.] Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England; [Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Choudhury, Hassanul G.; Becker, Patrick; Beis, Konstantinos] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Choudhury, Hassanul G.; Becker, Patrick; Beis, Konstantinos] Harwell Sci & Innovat Campus, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Hussain, Rohanah; Axford, Danny] Harwell Sci & Innovat Campus, Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Choudhury, Hassanul G.; Becker, Patrick; Beis, Konstantinos] Res Complex Harwell, Rutherford Appleton Lab, Didcot OX11 0DE, Oxon, England; [Zirah, Severine; Rebuffat, Sylvie] Univ Paris 04, Museum Natl Hist Nat, CNRS, Commun Mol & Adaptat Microorganisms Lab MCAM,UMR, CP 54,57 Rue Cuvier, F-75005 Paris, France; [Choudhury, Hassanul G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Oxford; University of Calgary; University of Calgary; Imperial College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Queensland	Robinson, CV (corresponding author), Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England.; Beis, K (corresponding author), Imperial Coll London, Dept Life Sci, London SW7 2AZ, England.; Beis, K (corresponding author), Harwell Sci & Innovat Campus, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England.; Beis, K (corresponding author), Res Complex Harwell, Rutherford Appleton Lab, Didcot OX11 0DE, Oxon, England.	carol.robinson@chem.ox.ac.uk; kbeis@imperial.ac.uk	Corradi, Valentina/G-3937-2017; Rebuffat, Sylvie/AAE-4194-2021; Corradi, Valentina/N-9312-2019; Zirah, Severine/C-9193-2012; Rebuffat, Sylvie/AAO-2072-2020	Zirah, Severine/0000-0001-6082-8414; robinson, carol/0000-0001-7829-5505; Rebuffat, Sylvie/0000-0002-5257-5039; Beis, Konstantinos/0000-0001-5727-4721	Wellcome Trust [WT/099165/Z/12/Z]; ERC IMPRESS Grant [26851]; Medical Research Council [98101]; BBSRC [BB/H01778X/1] Funding Source: UKRI; MRC [MR/N020413/1, G1000819] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01778X/1] Funding Source: researchfish; Medical Research Council [MR/N020413/1, G1000819] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); ERC IMPRESS Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to NanoTemper Technologies GmbH and Dr. James Wilkinson for kindly providing the Prometheus NT.48 instrument for the nano-DSF measurements; we also thank Dr. Wilkinson for help with data analysis. We thank C. Bechara (University of Oxford) for help with the LC-MS experiments. We thank the Diamond Light Source for beam time allocation and access. We thank Dr. Gurpreet Singh, Department of Biological Sciences, University of Calgary, for suggestions and help with the programming component of the MD simulations analyses. MD simulations were carried out on WestGrid/Compute Canada facilities. Membrane Protein Lab is funded by Wellcome Trust Grant WT/099165/Z/12/Z (to Professor So Iwata). The Oxford University Mass Spectrometry facility is funded by ERC IMPRESS Grant 26851 and Medical Research Council Grant 98101.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bechara C, 2015, NAT CHEM, V7, P255, DOI [10.1038/NCHEM.2172, 10.1038/nchem.2172]; Benesch JLP, 2009, ANAL CHEM, V81, P1270, DOI 10.1021/ac801950u; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Corbalan N, 2013, J BACTERIOL, V195, P5352, DOI 10.1128/JB.00824-13; Dahlberg M, 2010, J CHEM THEORY COMPUT, V6, P1638, DOI 10.1021/ct900654e; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Haviv H, 2013, J BIOL CHEM, V288, P10073, DOI 10.1074/jbc.M112.446997; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hussain R, 2015, J SYNCHROTRON RADIAT, V22, P862, DOI 10.1107/S1600577515007602; Hussain R, 2012, J SYNCHROTRON RADIAT, V19, P132, DOI 10.1107/S0909049511038982; Javorfi T, 2010, CHIRALITY, V22, pE149, DOI 10.1002/chir.20924; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalli AC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004123; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Martens C, 2016, NAT STRUCT MOL BIOL, V23, P744, DOI 10.1038/nsmb.3262; Mathavan I, 2014, NAT CHEM BIOL, V10, P340, DOI [10.1038/nchembio.1499, 10.1038/NCHEMBIO.1499]; Mathavan I, 2012, BIOCHEM SOC T, V40, P1539, DOI 10.1042/BST20120176; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Picas L, 2010, BBA-BIOMEMBRANES, V1798, P291, DOI 10.1016/j.bbamem.2009.06.024; Reading E, 2015, CHEM BIOL, V22, P593, DOI 10.1016/j.chembiol.2015.04.016; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; Semenova E, 2005, J BACTERIOL, V187, P3859, DOI 10.1128/JB.187.11.3859-3863.2005; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Sonntag Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1307; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vincent PA, 2005, BIOCHEM BIOPH RES CO, V331, P549, DOI 10.1016/j.bbrc.2005.03.220; Vitrac H, 2013, J BIOL CHEM, V288, P5873, DOI 10.1074/jbc.M112.442988; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wilson KA, 2003, J AM CHEM SOC, V125, P12475, DOI 10.1021/JA036756q; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zirah S, 2011, J AM SOC MASS SPECTR, V22, P467, DOI 10.1007/s13361-010-0028-1	58	22	23	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21656	21668		10.1074/jbc.M116.732107	http://dx.doi.org/10.1074/jbc.M116.732107			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27555327	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000385999200031
J	Iyer, A; Roeters, SJ; Schilderink, N; Hommersom, B; Heeren, RMA; Woutersen, S; Claessens, MMAE; Subramaniam, V				Iyer, Aditya; Roeters, Steven J.; Schilderink, Nathalie; Hommersom, Bob; Heeren, Ron M. A.; Woutersen, Sander; Claessens, Mireille M. A. E.; Subramaniam, Vinod			The Impact of N-terminal Acetylation of alpha-Synuclein on Phospholipid Membrane Binding and Fibril Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFRARED-SPECTROSCOPY; AMYLOID FIBRILS; VIBRATIONAL SPECTROSCOPY; PARKINSONS-DISEASE; LIPID VESICLES; IN-VITRO; AGGREGATION; PROTEIN; CELLS; CONFORMATION	Human alpha-synuclein (alpha S) has been shown to be N terminally acetylated in its physiological state. This modification is proposed to modulate the function and aggregation of alpha S into amyloid fibrils. Using bacterially expressed acetylated-alpha S (NTAc-alpha S) and endogenous alpha S (Endo-alpha S) from human erythrocytes, we show that N-terminal acetylation has little impact on alpha S binding to anionic membranes and thus likely not relevant for regulating membrane affinity. N-terminal acetylation does have an effect on alpha S aggregation, resulting in a narrower distribution of the aggregation lag times and rates. 2D-IR spectra show that acetylation changes the secondary structure of alpha S in fibrils. This difference may arise from the slightly higher helical propensity of acetylated-alpha S in solution leading to a more homogenous fibril population with different fibril structure than non-acetylated alpha S. We speculate that N-terminal acetylation imposes conformational restraints on N-terminal residues in alpha S, thus predisposing alpha S toward specific interactions with other binding partners or alternatively decrease nonspecific interactions.	[Iyer, Aditya; Subramaniam, Vinod] FOM Inst AMOLF, Nanoscale Biophys Grp, Amsterdam, Netherlands; [Iyer, Aditya; Schilderink, Nathalie; Claessens, Mireille M. A. E.; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, Nanobiophys Grp, Enschede, Netherlands; [Roeters, Steven J.; Woutersen, Sander] Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Hommersom, Bob; Heeren, Ron M. A.] FOM Inst AMOLF, BioImaging MS Grp, Amsterdam, Netherlands; [Heeren, Ron M. A.] Maastricht Univ, Maastricht MultiModal Mol Imaging Inst, M4I, NL-6200 MD Maastricht, Netherlands; [Subramaniam, Vinod] Vrije Univ Amsterdam, De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands	AMOLF; University of Twente; University of Amsterdam; AMOLF; Maastricht University; Vrije Universiteit Amsterdam	Woutersen, S (corresponding author), Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.; Subramaniam, V (corresponding author), Vrije Univ Amsterdam, De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands.; Claessens, MMAE (corresponding author), Univ Twente, Nanobiophys, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.	s.woutersen@uva.nl; m.m.a.e.claessens@utwente.nl; v.subramaniam@vu.nl	Heeren, Ron/ABA-4858-2020; Subramaniam, Vinod/B-4197-2010; Iyer, Aditya/G-4839-2014; Roeters, Steven/Q-7088-2017	Heeren, Ron/0000-0002-6533-7179; Subramaniam, Vinod/0000-0001-6712-7266; Iyer, Aditya/0000-0002-3144-6385; Roeters, Steven/0000-0003-3238-2181	Stichting voor Fundamenteel Onderzoek der Materie (FOM) [127]; European Research Council (ERC) [210999]; Netherlands Organization for Scientific Research (NWO)	Stichting voor Fundamenteel Onderzoek der Materie (FOM)(FOM (The Netherlands)); European Research Council (ERC)(European Research Council (ERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was part of a project titled "A Single Molecule View on Protein Aggregation" (number 127) supported by the Stichting voor Fundamenteel Onderzoek der Materie (FOM), European Research Council (ERC) Grant 210999, and the Netherlands Organization for Scientific Research (NWO). The authors declare that they have no conflicts of interest with the contents of this article.	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Baiz C., 2013, INTRO PROTEIN 2D IR; Bartels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103727; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Baum J, 2012, PROTEIN SCI, V21, P61; Bellani Serena, 2010, Commun Integr Biol, V3, P106; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Buchanan L. E., 2011, EXAMINING AMYLOID ST; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; Cho M, 2012, NAT CHEM, V4, P339, DOI 10.1038/nchem.1336; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Dearborn AD, 2016, J BIOL CHEM, V291, P2310, DOI 10.1074/jbc.M115.698787; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Faas FGA, 2009, BIOPHYS J, V97, P1148, DOI 10.1016/j.bpj.2009.06.015; Fantini J, 2013, ADV EXP MED BIOL, V991, P15, DOI 10.1007/978-94-007-6331-9_2; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreira TM, 2013, PHYS CHEM CHEM PHYS, V15, P1976, DOI 10.1039/c2cp42738a; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Hellstrand E, 2013, ACS CHEM NEUROSCI, V4, P1339, DOI 10.1021/cn400066t; Huerta-Viga A, 2010, J PHYS CHEM B, V114, P15212, DOI 10.1021/jp105133r; Gallea JI, 2016, BBA-PROTEINS PROTEOM, V1864, P501, DOI 10.1016/j.bbapap.2016.01.011; JARVIS JA, 1995, J BIOL CHEM, V270, P1323, DOI 10.1074/jbc.270.3.1323; Jiang ZP, 2015, J PHYS CHEM B, V119, P4812, DOI 10.1021/jp512499r; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Karjalainen EL, 2011, J PHYS CHEM B, V115, P749, DOI 10.1021/jp109918c; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lindblom G, 2009, BBA-BIOMEMBRANES, V1788, P234, DOI 10.1016/j.bbamem.2008.08.016; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Manas ES, 2000, J AM CHEM SOC, V122, P9883, DOI 10.1021/ja001782z; Marsh D, 2009, BBA-BIOMEMBRANES, V1788, P2114, DOI 10.1016/j.bbamem.2009.08.004; Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/nchem.1293, 10.1038/NCHEM.1293]; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rabe M, 2013, ACS CHEM NEUROSCI, V4, P408, DOI 10.1021/cn3001312; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rossetti G, 2016, PHYS CHEM CHEM PHYS, V18, P5702, DOI 10.1039/c5cp04549e; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shvadchak VV, 2015, J PHYS CHEM B, V119, P1912, DOI 10.1021/jp5111604; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Shvadchak VV, 2011, J BIOL CHEM, V286, P13023, DOI 10.1074/jbc.M110.204776; Sidhu A, 2014, BBA-PROTEINS PROTEOM, V1844, P2127, DOI 10.1016/j.bbapap.2014.09.007; Smith B J, 1984, Methods Mol Biol, V1, P63, DOI 10.1385/0-89603-062-8:63; Sousa Alioscka A, 2013, Methods Mol Biol, V950, P195, DOI 10.1007/978-1-62703-137-0_12; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1987, ARCH BIOCHEM BIOPHYS, V258, P465, DOI 10.1016/0003-9861(87)90367-5; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; ZANNI M, 2011, CONCEPTS METHODS 2D; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	72	59	59	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21110	21122		10.1074/jbc.M116.726612	http://dx.doi.org/10.1074/jbc.M116.726612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27531743	Green Published, hybrid			2022-12-28	WOS:000385406200026
J	Pfister, JA; D'Mello, SR				Pfister, Jason A.; D'Mello, Santosh R.			Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cell death; Huntington's disease; neurodegeneration; neuron; neuroprotection; neuronal death; neuronal survival; nucleophosmin	CEREBELLAR GRANULE NEURONS; ACUTE MYELOID-LEUKEMIA; CELL-CYCLE REGULATION; NF-KAPPA-B; HUNTINGTONS-DISEASE; 3-NITROPROPIONIC ACID; POSTMITOTIC NEURONS; PROTEIN EXPRESSION; CENTROSOME DUPLICATION; INDEPENDENT MECHANISM	NPM1 (nucleophosmin 1) is a nucleolar phosphoprotein that regulates many cellular processes, including ribosome biogenesis, proliferation, and genomic integrity. Although its role in proliferating cell types and tissues has been extensively investigated, little is known about its function in neurons and in the brain where it is highly expressed. We report that NPM1 protein expression is increased selectively in the striatum in both the R6/2 transgenic and 3-nitropropionic acid-injected mouse models of Huntington's disease. Examination of the effect of ectopic expression on cultured neurons revealed that increasing NPM1 is toxic to otherwise healthy cerebellar granule and cortical neurons. Toxicity is dependent on its cytoplasmic localization and oligomerization status. Forced retention of NPM1 in the nucleus, as well as inhibiting its ability to oligomerize, not only neutralizes NPM1 toxicity but also renders it protective against apoptosis. Although not blocked by pharmacological inhibition of the pro-apoptotic molecules, JNK, glycogen synthase kinase 3 beta, or caspases, toxicity is blocked by compounds targeting cyclin-dependent kinases (CDKs), as well as by dominant-negative forms of CDK1 and CDK2 and the pan-CDK inhibitor, p21(Cip1/Waf1). Although induced in in vivo Huntington's disease models, NPM1 protein levels are unchanged in cultured cerebellar granule and cortical neurons induced to die by low potassium or homocysteic acid treatment, respectively. Moreover, and counterintuitively, knockdown of its expression or inhibition of endogenous NPM1 oligomerization in these cultured neurons is toxic. Taken together, our study suggests that although neurons need NPM1 for survival, an increase in its expression beyond physiological levels and its translocation to the cytoplasm leads to death through abortive cell cycle induction.	[Pfister, Jason A.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [D'Mello, Santosh R.] Southern Methodist Univ, Dept Biol Sci, Dedman Life Sci Bldg,6501 Airline Rd, Dallas, TX 75275 USA	University of Texas System; University of Texas Dallas; Southern Methodist University	D'Mello, SR (corresponding author), Southern Methodist Univ, Dept Biol Sci, Dedman Life Sci Bldg,6501 Airline Rd, Dallas, TX 75275 USA.	sdmello@smu.edu	D'Mello, Santosh/AAO-7192-2020; D'Mello, Santosh/AAM-3644-2020	D'Mello, Santosh/0000-0002-7652-1334; 	National Institutes of Health [R01 NS040408]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS040408 (to S. R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn JY, 2005, MOL CELL, V18, P435, DOI 10.1016/j.molcel.2005.04.010; Bardai FH, 2013, J NEUROSCI, V33, P11833, DOI 10.1523/JNEUROSCI.5831-12.2013; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Bates GP, 1997, HUM MOL GENET, V6, P1633, DOI 10.1093/hmg/6.10.1633; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Brady SN, 2009, ONCOGENE, V28, P3209, DOI 10.1038/onc.2009.178; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; Chen HM, 2008, EUR J NEUROSCI, V28, P2003, DOI 10.1111/j.1460-9568.2008.06491.x; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Cisbani G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.121; D'Mello SR, 2005, CNS NEUROL DISORD-DR, V4, P3, DOI 10.2174/1568007053005118; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dastidar SG, 2012, J NEUROSCI, V32, P2846, DOI 10.1523/JNEUROSCI.5841-11.2012; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; Duan-Porter WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115062; Erickson JD, 2013, CELL DEATH DIFFER, V20, P1435, DOI 10.1038/cdd.2013.107; Falini B, 2009, CURR OPIN ONCOL, V21, P573, DOI 10.1097/CCO.0b013e3283313dfa; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002; Jian Y, 2009, ONCOGENE, V28, P4201, DOI 10.1038/onc.2009.275; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Koulich E, 2001, J NEUROCHEM, V76, P1188, DOI 10.1046/j.1471-4159.2001.00134.x; Lee J, 2014, BBA-MOL BASIS DIS, V1842, P785, DOI 10.1016/j.bbadis.2013.09.017; Lee SB, 2012, J CELL BIOL, V199, P65, DOI 10.1083/jcb.201205015; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Lim ACB, 2003, J ALZHEIMERS DIS, V5, P329, DOI 10.3233/JAD-2003-5409; Maezawa I, 2002, PATHOL INT, V52, P551, DOI 10.1046/j.1440-1827.2002.01398.x; Mallick S, 2014, J BIOL CHEM, V289, P35409, DOI 10.1074/jbc.M114.597575; Marquez-Lona EM, 2012, BIOCHEM BIOPH RES CO, V417, P514, DOI 10.1016/j.bbrc.2011.11.152; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Neve RL, 2006, PHARMACOL THERAPEUT, V111, P99, DOI 10.1016/j.pharmthera.2005.09.005; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Okuwaki M, 2012, NUCLEIC ACIDS RES, V40, P4861, DOI 10.1093/nar/gks162; Pelegri C, 2008, INT J DEV NEUROSCI, V26, P665, DOI 10.1016/j.ijdevneu.2008.07.016; Pfister JA, 2015, EXP BIOL MED, V240, P774, DOI 10.1177/1535370215579168; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Prinos Panagiotis, 2011, Int J Biochem Mol Biol, V2, P24; RATAN RR, 1994, J NEUROSCI, V14, P4385; Rau R, 2009, HEMATOL ONCOL, V27, P171, DOI 10.1002/hon.904; Tsoi H, 2013, CEREBELLUM, V12, P310, DOI 10.1007/s12311-012-0447-6; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Verdaguer E, 2004, NEUROCHEM INT, V44, P251, DOI 10.1016/S0197-0186(03)00147-5; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Wang LL, 2010, J NEUROSCI RES, V88, P1970, DOI 10.1002/jnr.22352; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Yalcin A, 2003, J NEUROCHEM, V84, P397, DOI 10.1046/j.1471-4159.2003.01540.x; Ye KQ, 2005, CANCER BIOL THER, V4, P918, DOI 10.4161/cbt.4.9.2072; Yohe S, 2015, J CLIN MED, V4, P460, DOI 10.3390/jcm4030460; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	62	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20787	20797		10.1074/jbc.M116.723015	http://dx.doi.org/10.1074/jbc.M116.723015			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27510036	hybrid, Green Published			2022-12-28	WOS:000384574800039
J	Sun, YJ; Kaur, K; Kanayama, K; Morinaga, K; Park, S; Hokugo, A; Kozlowska, A; McBride, WH; Li, J; Jewett, A; Nishimura, I				Sun, Yujie; Kaur, Kawaljit; Kanayama, Keiichi; Morinaga, Kenzo; Park, Sil; Hokugo, Akishige; Kozlowska, Anna; McBride, William H.; Li, Jun; Jewett, Anahid; Nishimura, Ichiro			Plasticity of Myeloid Cells during Oral Barrier Wound Healing and the Development of Bisphosphonate-related Osteonecrosis of the Jaw	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; bone marrow; necrosis (necrotic death); neutrophil; wound healing	MEMORY T-CELLS; BONE-MARROW; IMMUNE-SYSTEM; IN-VIVO; NEUTROPHIL; INFLAMMATION; MACROPHAGES; DISEASE; INNATE; ZOLEDRONATE	Injury to the barrier tissue initiates a rapid distribution of myeloid immune cells from bone marrow, which guide sound wound healing. Bisphosphonates, a widely used anti-bone resorptive drug with minimal systemic side effects, have been linked to an abnormal wound healing in the oral barrier tissue leading to, in some cases, osteonecrosis of the jaw (ONJ). Here we report that the development of ONJ may involve abnormal phenotypic plasticity of Ly6G+/Gr1+ myeloid cells in the oral barrier tissue undergoing tooth extraction wound healing. A bolus intravenous zoledronate (ZOL) injection to female C57Bl/6 mice followed by maxillary first molar extraction resulted in the development of ONJ-like lesion during the second week of wound healing. The multiplex assay of dissociated oral barrier cells exhibited the secretion of cytokines and chemokines, which was significantly modulated in ZOL mice. Tooth extraction-induced distribution of Ly6G+/Gr1+ cells in the oral barrier tissue increased in ZOL mice at week 2. ONJ-like lesion in ZOL mice contained Ly6G+/Gr1+ cells with abnormal size and morphology as well as different flow cytometric staining intensity. When anti-Ly6G (Gr1) antibody was intraperitoneally injected for 5 days during the second week of tooth extraction, CD11b+GR1(hi) cells in bone marrow and Ly6G+ cells in the oral barrier tissue were depleted, and the development of ONJ-like lesion was significantly attenuated. This study suggests that local modulation of myeloid cell plasticity in the oral barrier tissue may provide the basis for pathogenesis and thus therapeutic as well as preventive strategy of ONJ.	[Sun, Yujie; Li, Jun] Capital Med Univ, Beijing Stomatol Hosp, Sch Stomatol, Dept Dent Implant Ctr, Beijing 100050, Peoples R China; [Sun, Yujie; Kaur, Kawaljit; Kanayama, Keiichi; Morinaga, Kenzo; Park, Sil; Hokugo, Akishige; Kozlowska, Anna; Jewett, Anahid; Nishimura, Ichiro] UCLA Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Box 951668, Los Angeles, CA 90095 USA; [Sun, Yujie; Park, Sil; Nishimura, Ichiro] UCLA Sch Dent, Div Adv Prosthodont, Los Angeles, CA 90095 USA; [Kaur, Kawaljit; Park, Sil; Kozlowska, Anna; Jewett, Anahid; Nishimura, Ichiro] UCLA Sch Dent, Div Oral Med & Biol, Los Angeles, CA 90095 USA; [Kanayama, Keiichi] Asahi Univ, Dept Periodontol, Sch Dent, Gifu 5010296, Japan; [Morinaga, Kenzo] Fukuoka Dent Coll, Dept Oral Rehabil, Fukuoka 8140175, Japan; [Hokugo, Akishige] Univ Calif Los Angeles, David Geffen Sch Med, Div Plast & Reconstruct Surg, Los Angeles, CA 90095 USA; [Kozlowska, Anna] Poznan Univ Med Sci, Dept Tumor Immunol, Chair Med Biotechnol, PL-61866 Poznan, Poland; [McBride, William H.] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol & Cellular Oncol, Los Angeles, CA 90095 USA	Capital Medical University; Asahi University; Fukuoka Dental College (FDC); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Poznan University of Medical Sciences; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, J (corresponding author), Capital Med Univ, Beijing Stomatol Hosp, Sch Stomatol, Dept Dent Implant Ctr, Beijing 100050, Peoples R China.; Jewett, A; Nishimura, I (corresponding author), UCLA Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Box 951668, Los Angeles, CA 90095 USA.; Jewett, A (corresponding author), UCLA Sch Dent, Div Oral Med & Biol, Los Angeles, CA 90095 USA.	lijun3021@aliyun.com; ajewett@dentistry.ucla.edu; inishimura@dentistry.ucla.edu	Kozlowska, Anna Karolina/P-1620-2015; Kozlowska, Anna Karolina/AAC-7248-2019	Kozlowska, Anna Karolina/0000-0003-2465-217X; Kozlowska, Anna Karolina/0000-0003-2465-217X	National Institutes of Health from National Center for Research Resources Research Improvement Program Grant [C06 RR014529]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022552, R21DE023410] Funding Source: NIH RePORTER	National Institutes of Health from National Center for Research Resources Research Improvement Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the Tissue Procurement Core Laboratory, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA for histopathological and immunohistochemical specimen preparation. We also thank Jessica Cook, UCLA, for excellent technical assistance. This work was conducted in part in a facility supported by National Institutes of Health Grant C06 RR014529 from the National Center for Research Resources Research Improvement Program Grant.	Ali Naveid, 2015, Small GTPases, V6, P202, DOI 10.1080/21541248.2015.1085485; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arora M, 2010, MUCOSAL IMMUNOL, V3, P578, DOI 10.1038/mi.2010.41; Ashhurst TM, 2014, CELL IMMUNOL, V291, P49, DOI 10.1016/j.cellimm.2014.07.002; Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Chiaramonte MG, 1999, J IMMUNOL, V162, P920; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cortes-Vieyra R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1396106; Didierlaurent A, 2005, CELL MOL LIFE SCI, V62, P1285, DOI 10.1007/s00018-005-5032-4; Failli A, 2014, HUM VACC IMMUNOTHER, V10, P3375, DOI 10.4161/hv.29416; Favot CL, 2013, INT J ORAL MAX SURG, V42, P619, DOI 10.1016/j.ijom.2012.12.011; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gatzka M, 2015, J DTSCH DERMATOL GES, V13, P647, DOI 10.1111/ddg.12677; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; Hoefert S, 2015, CLIN ORAL INVEST, V19, P1307, DOI 10.1007/s00784-014-1358-3; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Kagnoff MF, 2014, J CLIN INVEST, V124, P2841, DOI 10.1172/JCI75225; Kalyan S, 2014, CELL MOL LIFE SCI, V71, P2335, DOI 10.1007/s00018-013-1495-x; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Kuiper JWP, 2012, BRIT J PHARMACOL, V165, P532, DOI 10.1111/j.1476-5381.2011.01592.x; Lin A, 2010, CELL ADHES MIGR, V4, P396, DOI 10.4161/cam.4.3.11917; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; Matsui T, 2015, INT IMMUNOL, V27, P269, DOI 10.1093/intimm/dxv013; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Obregon-Henao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080669; Omenetti S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00639; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Park S, 2015, J BIOL CHEM, V290, P17349, DOI 10.1074/jbc.M115.652305; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217; Scott DA, 2012, FRONT ORAL BIOL, V15, P56; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Soumelis V, 2015, CURR OPIN IMMUNOL, V32, P42, DOI 10.1016/j.coi.2014.12.007; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Tseng HC, 2015, ONCOTARGET, V6, P20002, DOI 10.18632/oncotarget.4755; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Utreja A, 2013, Odontostomatol Trop, V36, P38; Wicks K, 2015, DIABETES, V64, P4184, DOI 10.2337/db14-1895; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yamazaki T, 2012, INT J ORAL MAX SURG, V41, P1397, DOI 10.1016/j.ijom.2012.06.020	58	18	19	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20602	20616		10.1074/jbc.M116.735795	http://dx.doi.org/10.1074/jbc.M116.735795			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514746	hybrid, Green Published			2022-12-28	WOS:000384574800025
J	Herve, G; Evans, HG; Fernado, R; Patel, C; Hachem, F; Evans, DR				Herve, Guy; Evans, Hedeel Guy; Fernado, Roshini; Patel, Chandni; Hachem, Fatme; Evans, David R.			Activation of Latent Dihydroorotase from Aquifex aeolicus by Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BISUBSTRATE ANALOG N-(PHOSPHONACETYL)-L-ASPARTATE; ASPARTATE CARBAMOYLTRANSFERASE; ESCHERICHIA-COLI; CARBAMOYL-PHOSPHATE; PYRIMIDINE BIOSYNTHESIS; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; HAMSTER-CELLS; METAL CENTER; TRANSCARBAMOYLASE	Elevated hydrostatic pressure was used to probe conformational changes of Aquifex aeolicus dihydroorotase (DHO), which catalyzes the third step in de novo pyrimidine biosynthesis. The isolated protein, a 45-kDa monomer, lacks catalytic activity but becomes active upon formation of a dodecameric complex with aspartate transcarbamoylase (ATC). X-ray crystallographic studies of the isolated DHO and of the complex showed that association induces several major conformational changes in the DHO structure. In the isolated DHO, a flexible loop occludes the active site blocking the access of substrates. The loop is mostly disordered but is tethered to the active site region by several electrostatic and hydrogen bonds. This loop becomes ordered and is displaced from the active site upon formation of DHO-ATC complex. The application of pressure to the complex causes its time-dependent dissociation and the loss of both DHO and ATC activities. Pressure induced irreversible dissociation of the obligate ATC trimer, and as a consequence the DHO is also inactivated. However, moderate hydrostatic pressure applied to the isolated DHO subunit mimics the complex formation and reversibly activates the isolated subunit in the absence of ATC, suggesting that the loop has been displaced from the active site. This effect of pressure is explained by the negative volume change associated with the disruption of ionic interactions and exposure of ionized amino acids to the solvent (electrostriction). The interpretation that the loop is relocated by pressure was validated by site-directed mutagenesis and by inhibition by small peptides that mimic the loop residues.	[Herve, Guy] Univ Paris 06, CNRS, Inst Biol Paris Seine, Lab BIOSIPE,Sorbonne Univ, F-75005 Paris, France; [Evans, Hedeel Guy; Fernado, Roshini] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA; [Evans, Hedeel Guy; Patel, Chandni; Hachem, Fatme; Evans, David R.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield St, Detroit, MI 48201 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Eastern Michigan University; Wayne State University	Evans, DR (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield St, Detroit, MI 48201 USA.; Herve, G (corresponding author), Univ Paris 06, Inst Biol Paris Seine, Lab BIOSIPE, Sorbonne Univ, 7 Quai St Bernard, F-75005 Paris, France.	guy.herve@upmc.fr; ab2285@wayne.edu			National Institute of Health [GM47399, GM/CA60371]; National Science Foundation [MCB9810325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047399, R01GM060371] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institute of Health Grants GM47399 and GM/CA60371 and National Science Foundation Grant MCB9810325. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja A, 2004, J BIOL CHEM, V279, P53136, DOI 10.1074/jbc.M403009200; Ahuja A, 2001, J BIOL CHEM, V276, P45694, DOI 10.1074/jbc.M106382200; CHRISTOPHERSON RI, 1980, J BIOL CHEM, V255, P1381; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DUFOUR E, 1995, BIOPOLYMERS, V35, P475, DOI 10.1002/bip.360350506; Edwards BFP, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-36; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Evans HG, 2014, PROTEIN SCI, V23, P100, DOI 10.1002/pro.2396; Fields C., 1999, PATHS PYRIMIDINES, V7, P49; GOUAUX JE, 1988, P NATL ACAD SCI USA, V85, P4205, DOI 10.1073/pnas.85.12.4205; Grande-Garcia A, 2014, STRUCTURE, V22, P185, DOI 10.1016/j.str.2013.10.016; HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245; HEREMANS L, 1989, BIOCHIM BIOPHYS ACTA, V999, P192, DOI 10.1016/0167-4838(89)90217-3; Herve G., 2010, CELL MECHANOCHEMISTR; HOA GHB, 1990, ANAL BIOCHEM, V187, P258; HONZATKO RB, 1982, J MOL BIOL, V160, P219, DOI 10.1016/0022-2836(82)90175-9; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; KANTROWITZ ER, 1988, SCIENCE, V241, P669, DOI 10.1126/science.3041592; Kornblatt JA, 1999, EUR J BIOCHEM, V265, P120, DOI 10.1046/j.1432-1327.1999.00695.x; KRAUSE KL, 1987, J MOL BIOL, V193, P527, DOI 10.1016/0022-2836(87)90265-8; KRAUSE KL, 1985, P NATL ACAD SCI USA, V82, P1643, DOI 10.1073/pnas.82.6.1643; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin PD, 2005, J MOL BIOL, V348, P535, DOI 10.1016/j.jmb.2005.03.015; MONACO HL, 1978, P NATL ACAD SCI USA, V75, P5276, DOI 10.1073/pnas.75.11.5276; Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R; PASTRALANDIS SC, 1981, ANAL BIOCHEM, V118, P358, DOI 10.1016/0003-2697(81)90594-7; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Purcarea C, 2003, J BIOL CHEM, V278, P52924, DOI 10.1074/jbc.M309383200; Purcarea C, 2002, ACTA CRYSTALLOGR D, V58, P154, DOI 10.1107/S0907444901017528; ROSENBUSCH JP, 1971, J BIOL CHEM, V246, P1644; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935; WILEY DC, 1968, NATURE, V218, P1119, DOI 10.1038/2181119a0; Xu Z, 2003, J BACTERIOL, V185, P4038, DOI 10.1128/JB.185.14.4038-4049.2003; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r	40	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					629	637		10.1074/jbc.M116.739862	http://dx.doi.org/10.1074/jbc.M116.739862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27746403	Green Published, hybrid			2022-12-28	WOS:000392316100018
J	Ma, J; Zhang, XF; Feng, YB; Zhang, H; Wang, XJ; Zheng, YH; Qiao, WT; Liu, XQ				Ma, Jing; Zhang, Xianfeng; Feng, Yanbin; Zhang, Hui; Wang, Xiaojun; Zheng, Yonghui; Qiao, Wentao; Liu, Xinqi			Structural and Functional Study of Apoptosis-linked Gene-2 center dot Heme-binding Protein 2 Interactions in HIV-1 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED ISOFORM; RETICULUM EXIT SITES; PROTEOME-SCALE MAP; CELL-DEATH; ALG-2; BINDING; MEMBRANE; PATHWAY; ALIX; GENE	In the HIV-1 replication cycle, the endosomal sorting complex required for transport (ESCRT) machinery promotes viral budding and release in the late stages. In this process, the ESCRT proteins, ALIX and TSG101, are recruited through interactions with HIV-1 Gag p6. ALG-2, also known as PDCD6, interacts with both ALIX and TSG101 and bridges ESCRT-III and ESCRT-I. In this study, we show that ALG-2 affects HIV-1 production negatively at both the exogenous and endogenous levels. Through a yeast two-hybrid screen, we identified HEBP2 as the binding partner of ALG-2, and we solved the crystal structure of the ALG-2 center dot HEBP2 complex. The function of ALG2 center dot HEBP2 complex in HIV-1 replication was further explored. ALG-2 inhibits HIV-1 production by affecting Gag expression and distribution, and HEBP2 might aid this process by tethering ALG-2 in the cytoplasm.	[Ma, Jing; Feng, Yanbin; Zhang, Hui; Qiao, Wentao; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhang, Xianfeng; Wang, Xiaojun; Zheng, Yonghui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, CAAS Michigan State Univ Joint Lab Innate Immun, Harbin 150069, Peoples R China; [Ma, Jing; Qiao, Wentao] Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Minist Educ, Tianjin 300071, Peoples R China	Nankai University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Nankai University	Qiao, WT; Liu, XQ (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Qiao, WT (corresponding author), Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Minist Educ, Tianjin 300071, Peoples R China.	wentaoqiao@nankai.edu.cn; liu2008@nankai.edu.cn	Ma, Jing/GQH-0676-2022; Zheng, Yong-Hui/AAP-4492-2021; zhang, xian/GYA-0290-2022	Ma, Jing/0000-0002-8096-4832; Zheng, Yong-Hui/0000-0002-1098-7385; Wang, Xiaojun/0000-0003-4521-4099	National Key Project on Major Infectious Diseases from the Ministry of Science and Technology [2012ZX10001008, 2012ZX10001-006]; National Natural Science Foundation of China [31370925, 31640024]	National Key Project on Major Infectious Diseases from the Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Project on Major Infectious Diseases from the Ministry of Science and Technology Grants 2012ZX10001008 and 2012ZX10001-006 and National Natural Science Foundation of China Grants 31370925 and 31640024. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrosi E, 2011, BIOCHEM J, V438, P291, DOI 10.1042/BJ20110257; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bregnard C, 2013, J VIROL, V87, P3729, DOI 10.1128/JVI.02477-12; Caillat C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9781; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Finzi A, 2013, CELL MICROBIOL, V15, P809, DOI 10.1111/cmi.12074; Furuta RA, 2006, MICROBES INFECT, V8, P520, DOI 10.1016/j.micinf.2005.08.004; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Inuzuka T, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-25; Jang IK, 2002, MOL CELL BIOL, V22, P4094, DOI 10.1128/MCB.22.12.4094-4100.2002; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Krebs J, 2000, BBA-MOL CELL RES, V1498, P153, DOI 10.1016/S0167-4889(00)00091-4; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; la Cour JM, 2008, MOL ONCOL, V1, P431, DOI 10.1016/j.molonc.2007.08.002; Lacana E, 1997, J IMMUNOL, V158, P5129; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Martin-Serrano J, 2007, CELL HOST MICROBE, V1, P5, DOI 10.1016/j.chom.2007.02.006; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Lopez-Huertas MR, 2013, J BIOL CHEM, V288, P7626, DOI 10.1074/jbc.M112.408294; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Su D, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-31; Subramanian L, 2004, BIOCHEMISTRY-US, V43, P11175, DOI 10.1021/bi048848d; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Suzuki K, 2012, CANCER SCI, V103, P1788, DOI 10.1111/j.1349-7006.2012.02362.x; Szigeti A, 2006, FEBS LETT, V580, P6447, DOI 10.1016/j.febslet.2006.10.067; Szigeti A, 2010, J BIOL CHEM, V285, P2140, DOI 10.1074/jbc.M109.015222; Takahashi T, 2015, INT J MOL SCI, V16, P3677, DOI 10.3390/ijms16023677; Takahashi T, 2012, INT J MOL SCI, V13, P7532, DOI 10.3390/ijms13067532; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Vlach J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00232; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zylka MJ, 1999, MOL BRAIN RES, V74, P175, DOI 10.1016/S0169-328X(99)00277-6	59	17	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26670	26685		10.1074/jbc.M116.752444	http://dx.doi.org/10.1074/jbc.M116.752444			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27784779	hybrid, Green Published			2022-12-28	WOS:000391571400008
J	Pan, L; Zhu, B; Hao, WJ; Zeng, XL; Vlahopoulos, SA; Hazra, TK; Hegde, ML; Radak, Z; Bacsi, A; Brasier, AR; Ba, XQ; Boldogh, I				Pan, Lang; Zhu, Bing; Hao, Wenjing; Zeng, Xianlu; Vlahopoulos, Spiros A.; Hazra, Tapas K.; Hegde, Muralidhar L.; Radak, Zsolt; Bacsi, Attila; Brasier, Allan R.; Ba, Xueqing; Boldogh, Istvan			Oxidized Guanine Base Lesions Function in 8-Oxoguanine DNA Glycosylase-1-mediated Epigenetic Regulation of Nuclear Factor B-driven Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-oxoguanine (8-oxoG); 8-oxoguanine glycosylase (OGG1); NF-B transcription factor; promoter; reactive oxygen species (ROS)	NF-KAPPA-B; EXCISION-REPAIR; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; OXIDATIVE DAMAGE; MAMMALIAN-CELLS; POTENTIAL ROLE; TNF-ALPHA; INFLAMMATION; OGG1	A large percentage of redox-responsive gene promoters contain evolutionarily conserved guanine-rich clusters; guanines are the bases most susceptible to oxidative modification(s). Consequently, 7,8-dihydro-8-oxoguanine (8-oxoG) is one of the most abundant base lesions in promoters and is primarily repaired via the 8-oxoguanine DNA glycosylase-1 (OOG1)-initiated base excision repair pathway. In view of a prompt cellular response to oxidative challenge, we hypothesized that the 8-oxoG lesion and the cognate repair protein OGG1 are utilized in transcriptional gene activation. Here, we document TNF-induced enrichment of both 8-oxoG and OGG1 in promoters of pro-inflammatory genes, which precedes interaction of NF-B with its DNA-binding motif. OGG1 bound to 8-oxoG upstream from the NF-B motif increased its DNA occupancy by promoting an on-rate of both homodimeric and heterodimeric forms of NF-B. OGG1 depletion decreased both NF-B binding and gene expression, whereas Nei-like glycosylase-1 and -2 had a marginal effect. These results are the first to document a novel paradigm wherein the DNA repair protein OGG1 bound to its substrate is coupled to DNA occupancy of NF-B and functions in epigenetic regulation of gene expression.	[Pan, Lang; Zhu, Bing; Vlahopoulos, Spiros A.; Radak, Zsolt; Bacsi, Attila; Ba, Xueqing; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA; [Hazra, Tapas K.; Brasier, Allan R.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA; [Hazra, Tapas K.; Brasier, Allan R.; Boldogh, Istvan] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Hao, Wenjing; Zeng, Xianlu; Ba, Xueqing] Northeast Normal Univ, Key Lab Mol Epigenet, Minist Educ, Inst Cytol & Genet, Changchun 130024, Peoples R China; [Hegde, Muralidhar L.] Methodist Res Inst, Dept Radiat Oncol & Neurol, Houston, TX 77030 USA; [Vlahopoulos, Spiros A.] Univ Athens, Dept Pediat 1, Horemeio Res Lab, Athens 11527, Greece; [Radak, Zsolt] Semmelweis Univ, H-1123 Budapest, Hungary; [Bacsi, Attila] Univ Debrecen, Dept Immunol, Fac Med, H-4012 Debrecen, Hungary	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Northeast Normal University - China; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; National & Kapodistrian University of Athens; Semmelweis University; University of Debrecen	Boldogh, I (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA.; Ba, XQ (corresponding author), NE Normal Univ, Key Lab Mol Epigenet, Inst Cytol & Genet, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.	baxq755@nenu.edu.cn; sboldogh@utmb.edu	Vlahopoulos, Spiros A/A-1186-2014; Vlahopoulos, Spiros/AAK-6362-2020	Vlahopoulos, Spiros A/0000-0001-6245-3863; Vlahopoulos, Spiros/0000-0001-6245-3863; Pan, Lang/0000-0003-2324-2144; Radak, Zsolt/0000-0003-1297-6804; Bacsi, Attila/0000-0002-2311-2975; Ba, Xueqing/0000-0002-1075-5496; Brasier, Allan/0000-0002-5012-4090; bing, zhu/0000-0002-8371-3182; Hegde, Muralidhar/0000-0001-7333-8123	National Institutes of Health from NIEHS [RO1 ES018948, P30 ES006676]; National Institutes of Health from NIAID [PO1-AI062885]; National Science Foundation of China [31571339]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948, P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088645] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant RO1 ES018948 from NIEHS (to I. B.), Grant PO1-AI062885 from NIAID (to A. R. B. and I. B.), Grant P30 ES006676 from NIEHS (to A. R. B. and I. B.), and National Science Foundation of China Grant 31571339 (to X. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Aguilera-Aguirre L, 2014, J IMMUNOL, V193, P4643, DOI 10.4049/jimmunol.1401625; Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Allgayer J, 2016, NUCLEIC ACIDS RES, V44, P7267, DOI 10.1093/nar/gkw473; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Ba X, 2014, INT J MOL SCI, V15, P16975, DOI 10.3390/ijms150916975; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bacsi A, 2007, MECH AGEING DEV, V128, P637, DOI 10.1016/j.mad.2007.09.005; Bacsi A, 2013, DNA REPAIR, V12, P18, DOI 10.1016/j.dnarep.2012.10.002; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Boldogh I, 2012, J BIOL CHEM, V287, P20769, DOI 10.1074/jbc.C112.364620; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Bravard A, 2006, MOL CELL BIOL, V26, P7430, DOI 10.1128/MCB.00624-06; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Chakraborty A, 2015, J BIOL CHEM, V290, P24636, DOI 10.1074/jbc.M115.658146; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; Donley N, 2015, ACS CHEM BIOL, V10, P2334, DOI 10.1021/acschembio.5b00452; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Ghosh R, 1999, NUCLEIC ACIDS RES, V27, P3213, DOI 10.1093/nar/27.15.3213; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Giese B, 2002, ANNU REV BIOCHEM, V71, P51, DOI 10.1146/annurev.biochem.71.083101.134037; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hailer-Morrison MK, 2003, BIOCHEMISTRY-US, V42, P9761, DOI 10.1021/bi034546k; Hajas G, 2013, FREE RADICAL BIO MED, V61, P384, DOI 10.1016/j.freeradbiomed.2013.04.011; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kaplan N, 2011, FREE RADICAL RES, V45, P1124, DOI 10.3109/10715762.2011.602073; Kaur S, 2016, J BIOL CHEM, V291, P22769, DOI 10.1074/jbc.M116.735696; Kim HS, 2016, FREE RADICAL BIO MED, V93, P12, DOI 10.1016/j.freeradbiomed.2015.10.415; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Luo JX, 2014, FREE RADICAL BIO MED, V73, P430, DOI 10.1016/j.freeradbiomed.2014.03.030; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Margolin Y, 2006, NAT CHEM BIOL, V2, P365, DOI 10.1038/nchembio796; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Mitra S, 1997, MOL CELLS, V7, P305; Mokkapati SK, 2004, BIOCHEMISTRY-US, V43, P11596, DOI 10.1021/bi049097i; Moore SPG, 2016, J BIOL CHEM, V291, P5452, DOI 10.1074/jbc.M115.672733; Morreall J, 2015, DNA REPAIR, V26, P15, DOI 10.1016/j.dnarep.2014.11.007; Nakajima H, 2004, J BIOL CHEM, V279, P42774, DOI 10.1074/jbc.M407923200; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Pastukh V, 2007, FREE RADICAL BIO MED, V43, P1616, DOI 10.1016/j.freeradbiomed.2007.08.027; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SCHRECK R, 1990, NUCLEIC ACIDS RES, V18, P6497, DOI 10.1093/nar/18.22.6497; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Tian B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1707-x; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Vlahopoulos SA, 2015, CYTOKINE GROWTH F R, V26, P389, DOI 10.1016/j.cytogfr.2015.06.001; Vraetz T, 1999, NEPHROL DIAL TRANSPL, V14, P2137, DOI 10.1093/ndt/14.9.2137; Wallace SS, 2013, ENVIRON MOL MUTAGEN, V54, P691, DOI 10.1002/em.21820; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	70	111	113	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25553	25566		10.1074/jbc.M116.751453	http://dx.doi.org/10.1074/jbc.M116.751453			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27756845	hybrid, Green Published			2022-12-28	WOS:000390095300023
J	Kurth, JM; Brito, JA; Reuter, J; Flegler, A; Koch, T; Franke, T; Klein, EM; Rowe, SF; Butt, JN; Denkmann, K; Pereira, IAC; Archer, M; Dahl, C				Kurth, Julia M.; Brito, Jose A.; Reuter, Jula; Flegler, Alexander; Koch, Tobias; Franke, Thomas; Klein, Eva-Maria; Rowe, Sam F.; Butt, Julea N.; Denkmann, Kevin; Pereira, Ines A. C.; Archer, Margarida; Dahl, Christiane			Electron Accepting Units of the Diheme Cytochrome c TsdA, a Bifunctional Thiosulfate Dehydrogenase/Tetrathionate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR PROTEIN HIPIP; STRUCTURE VALIDATION; MAXIMUM-LIKELIHOOD; IRON PROTEIN; OXIDATION; REDOX; BACTERIUM; COMPLEX; DEHYDROGENASE; REFINEMENT	The enzymes of the thiosulfate dehydrogenase (TsdA) family are wide-spread diheme c-type cytochromes. Here, redox carriers were studied mediating the flow of electrons arising from thiosulfate oxidation into respiratory or photosynthetic electron chains. In a number of organisms, including Thiomonas intermedia and Sideroxydans lithotrophicus, the tsdA gene is immediately preceded by tsdB encoding for another diheme cytochrome. Spectrophotometric experiments in combination with enzymatic assays in solution showed that TsdB acts as an effective electron acceptor of TsdA in vitro when TsdA and TsdB originate from the same source organism. Although TsdA covers a range from -300 to +150 mV, TsdB is redox active between -100 and +300 mV, thus enabling electron transfer between these hemoproteins. The three-dimensional structure of the TsdB-TsdA fusion protein from the purple sulfur bacterium Marichromatium purpuratum was solved by X-ray crystallography to 2.75 angstrom resolution providing insights into internal electron transfer. In the oxidized state, this tetraheme cytochrome c contains three hemes with axial His/Met ligation, whereas heme 3 exhibits the His/Cys coordination typical for TsdA active sites. Interestingly, thiosulfate is covalently bound to Cys(330) on heme 3. In several bacteria, including Allochromatium vinosum, TsdB is not present, precluding a general and essential role for electron flow. Both AvTsdA and theMpTsdBA fusion react efficiently in vitro with high potential iron-sulfur protein from A. vinosum (E-m + 350 mV). High potential ironsulfur protein not only acts as direct electron donor to the reaction center in anoxygenic phototrophs but can also be involved in aerobic respiratory chains.	[Kurth, Julia M.; Reuter, Jula; Flegler, Alexander; Koch, Tobias; Franke, Thomas; Klein, Eva-Maria; Denkmann, Kevin; Dahl, Christiane] Rheinische Friedrich Wilhelms Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany; [Brito, Jose A.; Pereira, Ines A. C.; Archer, Margarida] Univ Nova Lisboa ITQB UNL, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal; [Rowe, Sam F.; Butt, Julea N.] Univ East Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Rowe, Sam F.; Butt, Julea N.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Reuter, Jula] Rheinische Friedrich Wilhelms Univ Bonn, Inst Pharmazeut Mikrobiol, Meckenheimer Allee 168, D-53115 Bonn, Germany; [Klein, Eva-Maria] Rheinische Friedrich Wilhelms Univ Bonn, Inst Virol, Siegmund Freud Str 25, D-53127 Bonn, Germany; [Denkmann, Kevin] Dunn Labortech GmbH, Thelenberg 6, D-53567 Asbach, Germany	University of Bonn; Universidade Nova de Lisboa; University of East Anglia; University of East Anglia; University of Bonn; University of Bonn	Dahl, C (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany.; Archer, M (corresponding author), Univ Nova Lisboa ITQB UNL, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal.	archer@itqb.unl.pt; chdahl@uni-bonn.de	Dahl, Christiane/H-4786-2019; Kurth, Julia/AAE-7008-2021; Butt, Julea/E-2133-2011; Brito, Jose A./A-5605-2011; Pereira, Ines A. C./C-2748-2009	Dahl, Christiane/0000-0001-8288-7546; Butt, Julea/0000-0002-9624-5226; Brito, Jose A./0000-0002-8307-2282; Kurth, Julia/0000-0002-1221-1230; Pereira, Ines A. C./0000-0003-3283-4520; Archer, Margarida/0000-0001-8419-5420; Flegler, Alexander/0000-0002-3019-9597	Deutsche Forschungsgemeinschaft [Da 351/7-2]; Fundacao para a Ciencia e Tecnologia through iNOVA4Health Research Unit - Fundacao para a Ciencia e a Tecnologia do Ministerio para a Ciencia e Ensino Superior (FCT/MCES) [LISBOA-01-0145-FEDER-007344]; Fonds Europeen de Developpement Economique et Regional (FEDER) [UID/Multi/04551/2013]; MostMicro Unit - FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; National Funds through FCT; Aventis Foundation [700051]; Fonds der Chemischen Industrie; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/79224/2011]; Biotechnology and Biological Sciences Research Council, United Kingdom; Royal Society Leverhulme Trust Senior Research Fellowship;  [1493]; Biotechnology and Biological Sciences Research Council [1369608] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacao para a Ciencia e Tecnologia through iNOVA4Health Research Unit - Fundacao para a Ciencia e a Tecnologia do Ministerio para a Ciencia e Ensino Superior (FCT/MCES); Fonds Europeen de Developpement Economique et Regional (FEDER); MostMicro Unit - FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI); National Funds through FCT(Portuguese Foundation for Science and Technology); Aventis Foundation; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Leverhulme Trust Senior Research Fellowship; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft Grant Da 351/7-2; Fundacao para a Ciencia e Tecnologia through iNOVA4Health Research Unit, LISBOA-01-0145-FEDER-007344, co-funded by Fundacao para a Ciencia e a Tecnologia do Ministerio para a Ciencia e Ensino Superior (FCT/MCES) and Fonds Europeen de Developpement Economique et Regional (FEDER) under the PT2020 Partnership Agreement through the Research and Development Unit; UID/Multi/04551/2013 (GreenIT); Bio-Struct-X Proposal 1493; MostMicro Unit by Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI), and by National Funds through FCT.r Recipient of Scholarship 700051 funded by the Aventis Foundation and awarded by the Fonds der Chemischen Industrie.r Recipient of Fundacao para a Ciencia e a Tecnologia Fellowship SFRH/BPD/79224/2011.r Supported by a studentship from the Biotechnology and Biological Sciences Research Council, United Kingdom.r Supported by a Royal Society Leverhulme Trust Senior Research Fellowship.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Barco RA, 2015, APPL ENVIRON MICROB, V81, P5927, DOI 10.1128/AEM.01374-15; Bartsch R G, 1978, Methods Enzymol, V53, P329; BARTSCH RG, 1991, BIOCHIM BIOPHYS ACTA, V1058, P28, DOI 10.1016/S0005-2728(05)80262-2; Beckwith CR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00332; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bonora P, 1999, BBA-BIOENERGETICS, V1410, P51, DOI 10.1016/S0005-2728(98)00173-X; Bradley JM, 2012, J BIOL CHEM, V287, P40350, DOI 10.1074/jbc.M112.396192; Branca RMM, 2007, ARCH BIOCHEM BIOPHYS, V467, P174, DOI 10.1016/j.abb.2007.07.031; Brito JA, 2015, J BIOL CHEM, V290, P9222, DOI 10.1074/jbc.M114.623397; Bruser T, 1997, BBA-GENE STRUCT EXPR, V1352, P18, DOI 10.1016/S0167-4781(97)00033-X; Chang HY, 2010, BIOCHEMISTRY-US, V49, P7494, DOI 10.1021/bi1004574; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CUSANOVI.MA, 1969, BIOCHIM BIOPHYS ACTA, V189, P245, DOI 10.1016/0005-2728(69)90051-6; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Du J, 2011, COORDIN CHEM REV, V255, P700, DOI 10.1016/j.ccr.2011.01.029; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FUKUMORI Y, 1979, CURR MICROBIOL, V3, P117, DOI 10.1007/BF02602443; Grabarczyk DB, 2015, J BIOL CHEM, V290, P9209, DOI 10.1074/jbc.M114.618025; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOCHKOEPPLER A, 1995, J BACTERIOL, V177, P608, DOI 10.1128/jb.177.3.608-613.1995; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMPF C, 1980, ARCH MICROBIOL, V127, P125, DOI 10.1007/BF00428016; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KENNEL SJ, 1972, BIOPHYS J, V12, P882, DOI 10.1016/S0006-3495(72)86131-9; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Kurth JM, 2015, J AM CHEM SOC, V137, P13232, DOI 10.1021/jacs.5b08291; Lieutaud C, 2003, BBA-BIOENERGETICS, V1557, P83, DOI 10.1016/S0005-2728(02)00397-3; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marritt SJ, 2008, J AM CHEM SOC, V130, P8588, DOI 10.1021/ja802641a; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MILES CS, 1993, BIOCHIM BIOPHYS ACTA, V1202, P82, DOI 10.1016/0167-4838(93)90066-Z; Nagashima KVP, 2002, BIOCHEMISTRY-US, V41, P14028, DOI 10.1021/bi026511a; Nissum M, 1997, J BIOL INORG CHEM, V2, P302, DOI 10.1007/s007750050136; Ohmine M, 2009, BIOCHEMISTRY-US, V48, P9132, DOI 10.1021/bi901202m; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; Segel IH., 1993, ENZYME KINETICS BEHA; Taylor P, 1999, NAT STRUCT BIOL, V6, P1108; Vermeglio A, 2002, BIOCHEMISTRY-US, V41, P8868, DOI 10.1021/bi012037h; Visser JM, 1996, ARCH MICROBIOL, V166, P372, DOI 10.1007/BF01682982; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	56	21	24	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24804	24818		10.1074/jbc.M116.753863	http://dx.doi.org/10.1074/jbc.M116.753863			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27694441	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000388880100001
J	Goloviznina, NA; Verghese, SC; Yoon, YM; Taratula, O; Marks, DL; Kurre, P				Goloviznina, Natalya A.; Verghese, Santhosh Chakkaramakkil; Yoon, Young Me; Taratula, Oleh; Marks, Daniel L.; Kurre, Peter			Mesenchymal Stromal Cell-derived Extracellular Vesicles Promote Myeloid-biased Multipotent Hematopoietic Progenitor Expansion via Toll-Like Receptor Engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; INFLAMMATORY CYTOKINES; EXOSOMES; DIFFERENTIATION; TRAFFICKING; NICHE; MOUSE; HSC; MICROVESICLES; BIOGENESIS	Mesenchymal stromal cells (MSCs) present in the bone marrow microenvironment secrete cytokines and angiogenic factors that support the maintenance and regenerative expansion of hematopoietic stem and progenitor cells (HSPCs). Here, we tested the hypothesis that extracellular vesicles (EVs) released by MSCs contribute to the paracrine crosstalk that shapes hematopoietic function. We systematically characterized EV release by murine stromal cells and demonstrate that MSC-derived EVs prompt a loss of HSPC quiescence with concomitant expansion of murine myeloid progenitors. Our studies reveal that HSPC expansion by MSC EVs is mediated via the MyD88 adapter protein and is partially blocked by treatment with a TLR4 inhibitor. Imaging of fluorescence protein-tagged MSC EVs corroborated their cellular co-localization with TLR4 and endosomal Rab5 compartments in HSPCs. The dissection of downstream responses to TLR4 activation reveals that the mechanism by which MSC EVs impact HSPCs involves canonical NF-kappa B signaling and downstream activation of Htf-1a and CCL2 target genes. Our aggregate data identity a previously unknown role for MSC-derived EVs in the regulation of hematopoiesis through innate immune mechanisms and illustrate the expansive cell-cell crosstalk in the bone marrow microenvironment.	[Goloviznina, Natalya A.; Verghese, Santhosh Chakkaramakkil; Yoon, Young Me; Marks, Daniel L.; Kurre, Peter] Oregon Hlth & Sci Univ, Dept Pediat, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Verghese, Santhosh Chakkaramakkil; Yoon, Young Me; Marks, Daniel L.; Kurre, Peter] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Kurre, Peter] Oregon Hlth & Sci Univ, Pediat Canc Biol Program, Portland, OR 97239 USA; [Taratula, Oleh] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; [Goloviznina, Natalya A.] Univ Minnesota, Mol Cellular Dev Biol & Genet Program, Minneapolis, MN 55108 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon State University; University of Minnesota System; University of Minnesota Twin Cities	Kurre, P (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Kurre, P (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	kurrepe@ohsu.edu		Goloviznina, Natalya/0000-0001-6002-4125	National Center for Research Resources (NCRR) [P40RR017447]; National Institutes of Health [PSI OD011092]; NATIONAL CANCER INSTITUTE [R01CA184324] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM113846] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some of the materials employed in this work were provided by the Tulane Center for Gene Therapy through the National Center for Research Resources (NCRR) Grant P40RR017447. We gratefully acknowledge the assistance of Dr Stephanie Krasnow, Dr. Xinxia Zhu, Pete Levasseur, Dr. Claudia Lopez, John Butler, Dr. Shelton Viola, Ben Doron, and Merna Labib with select experiments. We also thank Dr. David W. Erikson at The Endocrine Technologies Support Core (ETSC) at the Oregon National Primate Research Center (ONPRC) for help with the Lominex experiment The ETSC at the ONPRC is supported by National Institutes of Health Grant PSI OD011092 awarded to ONPRC.	Anderson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076979; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Boettcher S, 2014, BLOOD, V124, P1393, DOI 10.1182/blood-2014-04-570762; Boiko JR, 2012, CYTOKINE, V57, P1, DOI 10.1016/j.cyto.2011.10.005; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806; Burberry A, 2014, CELL HOST MICROBE, V15, P779, DOI 10.1016/j.chom.2014.05.004; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Ciuculescu MF, 2014, METHODS MOL BIOL, V1185, P287, DOI 10.1007/978-1-4939-1133-2_20; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cosgun KN, 2014, CELL STEM CELL, V15, P227, DOI 10.1016/j.stem.2014.06.001; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Fiedler K, 2013, AM J BLOOD RES, V3, P124; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Grassinger J, 2012, CYTOKINE, V58, P218, DOI 10.1016/j.cyto.2012.01.014; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; He QP, 2015, BLOOD, V125, P1098, DOI 10.1182/blood-2014-09-601542; Huan J, 2015, LEUKEMIA, V29, P2285, DOI 10.1038/leu.2015.163; Huan J, 2013, CANCER RES, V73, P918, DOI 10.1158/0008-5472.CAN-12-2184; KAULEN DR, 1983, ZH MIKROB EPID IMMUN, P84; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Lai CP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8029; Lai RC, 2015, SEMIN CELL DEV BIOL, V40, P82, DOI 10.1016/j.semcdb.2015.03.001; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mercier FE, 2016, STEM CELL REP, V6, P985, DOI 10.1016/j.stemcr.2016.04.010; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nagamoto-Combs K, 2014, J NEUROSCI METH, V233, P187, DOI 10.1016/j.jneumeth.2014.05.021; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854; Purton L.E., 2008, STEMBOOK, DOI [10.3824/stembook.1.28.1, DOI 10.3824/STEMBOOK.1.28.1]; Sahoo S, 2014, CIRC RES, V114, P333, DOI 10.1161/CIRCRESAHA.114.300639; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Schuettpelz LG, 2014, LEUKEMIA, V28, P1851, DOI 10.1038/leu.2014.68; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Simon NC, 2014, INFECT IMMUN, V82, P21, DOI 10.1128/IAI.01059-13; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vicencio JM, 2015, J AM COLL CARDIOL, V65, P1525, DOI 10.1016/j.jacc.2015.02.026; Wilson AA, 2013, MOL THER, V21, P825, DOI 10.1038/mt.2013.19; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; Zhang HJ, 2016, STEM CELL REP, V6, P940, DOI 10.1016/j.stemcr.2016.05.002; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007; Zhou BO, 2015, ELIFE, V4, DOI 10.7554/eLife.05521; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504; Zielske SP, 2009, INT J RADIAT ONCOL, V75, P843, DOI 10.1016/j.ijrobp.2008.06.1953	58	40	40	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24607	24617		10.1074/jbc.M116.745653	http://dx.doi.org/10.1074/jbc.M116.745653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27758863	hybrid, Green Published			2022-12-28	WOS:000388875500022
J	Aydemir, TB; Troche, C; Kim, MH; Cousins, RJ				Aydemir, Tolunay Beker; Troche, Catalina; Kim, Min-Hyun; Cousins, Robert J.			Hepatic ZIP14-mediated Zinc Transport Contributes to Endosomal Insulin Receptor Trafficking and Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gluconeogenesis; glycogen; glycolysis; insulin; mitochondria; Insulin degrading enzyme	RAT HEPATOCYTES; HORMONAL-REGULATION; CATHEPSIN-D; BETA-CELL; LIVER; MICE; ASSOCIATION; RESISTANCE; INHIBITION; OBESITY	Zinc influences signaling pathways through controlled targeted zinc transport. Zinc transporter Zip14 KO mice display a phenotype that includes impaired intestinal barrier function with low grade chronic inflammation, hyperinsulinemia, and increased body fat, which are signatures of diet-induced diabetes (type 2 diabetes) and obesity in humans. Hyperglycemia in type 2 diabetes and obesity is caused by insulin resistance. Insulin resistance results in inhibition of glucose uptake by liver and other peripheral tissues, principally adipose and muscle and with concurrently higher hepatic glucose production. Therefore, modulation of hepatic glucose metabolism is an important target for antidiabetic treatment approaches. We demonstrate that during glucose uptake, cell surface abundance of zinc transporter ZIP14 and mediated zinc transport increases. Zinc is distributed to multiple sites in hepatocytes through sequential translocation of ZIP14 from plasma membrane to early and late endosomes. Endosomes from Zip14 KO mice were zinc-deficient because activities of the zinc-dependent insulin-degrading proteases insulin-degrading enzyme and cathepsin D were impaired; hence insulin receptor activity increased. Transient increases in cytosolic zinc levels are concurrent with glucose uptake and suppression of glycogen synthesis. In contrast, Zip14 KO mice exhibited greater hepatic glycogen synthesis and impaired gluconeogenesis and glycolysis related to low cytosolic zinc levels. We can conclude that ZIP14-mediated zinc transport contributes to regulation of endosomal insulin receptor activity and glucose homeostasis in hepatocytes. Therefore, modulation of ZIP14 transport activity presents a new target for management of diabetes and other glucose-related disorders.	[Aydemir, Tolunay Beker; Troche, Catalina; Kim, Min-Hyun; Cousins, Robert J.] Univ Florida, Coll Med, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA; [Aydemir, Tolunay Beker; Troche, Catalina; Kim, Min-Hyun; Cousins, Robert J.] Univ Florida, Coll Med, Ctr Nutrit Sci, Coll Agr & Life Sci, Gainesville, FL 32611 USA; [Cousins, Robert J.] Univ Florida, Dept Biochem & Mol Biol, Coll Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cousins, RJ (corresponding author), Univ Florida, 572 Newell Dr,POB 110370, Gainesville, FL 32611 USA.	cousins@ufl.edu	Aydemir, Tolunay Beker/I-5385-2019	Kim, Min-Hyun/0000-0001-5108-9816	National Institutes of Health [R01-DK-94244]; Boston Family Endowment of the University of Florida Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Family Endowment of the University of Florida Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-DK-94244 and the Boston Family Endowment of the University of Florida Foundation (to R.J.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARAKI N, 1995, EXP CELL RES, V217, P469, DOI 10.1006/excr.1995.1111; Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Aydemir TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048679; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Brand IA, 1996, J BIOL CHEM, V271, P1941, DOI 10.1074/jbc.271.4.1941; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Capdor J, 2013, J TRACE ELEM MED BIO, V27, P137, DOI 10.1016/j.jtemb.2012.08.001; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Clayton D. A., 2014, COLD SPRING HARBOR P, V2014; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; COWEN LA, 1986, BIOCHEM BIOPH RES CO, V134, P944, DOI 10.1016/S0006-291X(86)80511-3; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; Eisenberg ML, 2005, CELL PHYSIOL BIOCHEM, V15, P51, DOI 10.1159/000083638; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Elia Giuliano, 2012, Methods Mol Biol, V869, P361, DOI 10.1007/978-1-61779-821-4_29; ETZEL KR, 1983, J NUTR, V113, P1657, DOI 10.1093/jn/113.8.1657; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Grasso G, 2011, CHEM-EUR J, V17, P2752, DOI 10.1002/chem.201002809; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Huang LP, 2012, J BIOL CHEM, V287, P33883, DOI 10.1074/jbc.M111.309666; Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-13; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; KING JC, 1994, J NUTR, V124, P508, DOI 10.1093/jn/124.4.508; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Mannucci E, 2012, ACTA DIABETOL, V49, P307, DOI 10.1007/s00592-011-0355-0; Mitchell RK, 2016, MOL ENDOCRINOL, V30, P77, DOI 10.1210/me.2015-1227; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Murphy R. F., 1988, ADV MOL CELL BIOL, P159; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PEDROSA FO, 1977, P NATL ACAD SCI USA, V74, P2742, DOI 10.1073/pnas.74.7.2742; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; ROGNSTAD R, 1984, BIOCHEM BIOPH RES CO, V122, P726, DOI 10.1016/S0006-291X(84)80094-7; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SIPE DM, 1991, J BIOL CHEM, V266, P3469; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song YP, 2006, PROTEOMICS, V6, P5269, DOI 10.1002/pmic.200500893; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; Suski JM, 2014, NAT PROTOC, V9, P312, DOI 10.1038/nprot.2014.016; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Troche C, 2016, AM J PHYSIOL-ENDOC M, V310, pE258, DOI 10.1152/ajpendo.00421.2015; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0	54	26	27	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23939	23951		10.1074/jbc.M116.748632	http://dx.doi.org/10.1074/jbc.M116.748632			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703010	hybrid, Green Published			2022-12-28	WOS:000388498100011
J	Mulvaney, KM; Matson, JP; Siesser, PF; Tamir, TY; Goldfarb, D; Jacobs, TM; Cloer, EW; Harrison, JS; Vaziri, C; Cook, JG; Major, MB				Mulvaney, Kathleen M.; Matson, Jacob P.; Siesser, Priscila F.; Tamir, Tigist Y.; Goldfarb, Dennis; Jacobs, Timothy M.; Cloer, Erica W.; Harrison, Joseph S.; Vaziri, Cyrus; Cook, Jeanette G.; Major, Michael B.			Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; E3 ubiquitin ligase; nuclear factor 2; erythroid-derived 2-like factor; NFE2L2; Nrf2; oxidative stress; proteomics; KEAP1; MCM3	ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; UBIQUITIN LIGASE COMPLEX; DNA-REPLICATION; OXIDATIVE STRESS; NRF2-KEAP1 PATHWAY; PROTEOMICS REVEALS; ENDOPLASMIC-RETICULUM; NEGATIVE REGULATION; CYSTEINE RESIDUES	KEAP1 is a substrate adaptor protein for a CUL3-based E3 ubiquitin ligase. Ubiquitylation and degradation of the antioxidant transcription factor NRF2 is considered the primary function of KEAP1; however, few other KEAP1 substrates have been identified. Because KEAP1 is altered in a number of human pathologies and has been proposed as a potential therapeutic target therein, we sought to better understand KEAP1 through systematic identification of its substrates. Toward this goal, we combined parallel affinity capture proteomics and candidate-based approaches. Substrate-trapping proteomics yielded NRF2 and the related transcription factor NRF1 as KEAP1 substrates. Our targeted investigation of KEAP1-interacting proteins revealed MCM3, an essential subunit of the replicative DNA helicase, as a new substrate. We show that MCM3 is ubiquitylated by the KEAP1-CUL3-RBX1 complex in cells and in vitro. Using ubiquitin remnant profiling, we identify the sites of KEAP1-dependent ubiquitylation in MCM3, and these sites are on predicted exposed surfaces of the MCM2-7 complex. Unexpectedly, we determined that KEAP1 does not regulate total MCM3 protein stability or subcellular localization. Our analysis of a KEAP1 targeting motif in MCM3 suggests that MCM3 is a point of direct contact between KEAP1 and the MCM hexamer. Moreover, KEAP1 associates with chromatin in a cell cycle-dependent fashion with kinetics similar to the MCM2-7 complex. KEAP1 is thus poised to affect MCM2-7 dynamics or function rather than MCM3 abundance. Together, these data establish new functions for KEAP1 within the nucleus and identify MCM3 as a novel substrate of the KEAP1-CUL3-RBX1 E3 ligase.	[Mulvaney, Kathleen M.; Cloer, Erica W.; Major, Michael B.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Matson, Jacob P.; Harrison, Joseph S.; Cook, Jeanette G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Tamir, Tigist Y.; Major, Michael B.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Goldfarb, Dennis; Major, Michael B.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Vaziri, Cyrus] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Mulvaney, Kathleen M.; Siesser, Priscila F.; Tamir, Tigist Y.; Goldfarb, Dennis; Cloer, Erica W.; Harrison, Joseph S.; Vaziri, Cyrus; Cook, Jeanette G.; Major, Michael B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Jacobs, Timothy M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cook, JG (corresponding author), Dept Biochem & Biophys, 120 Mason Farm Rd,Campus Box 7260, Chapel Hill, NC 27599 USA.; Major, MB (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Lineberger Comprehens Canc Ctr, 450 West Dr,Lineberger Bldg,CB 7295, Chapel Hill, NC 27599 USA.	jgcook@email.unc.edu; benmajor@med.unc.edu		Harrison, Joseph/0000-0002-2118-6524; Cook, Jeanette/0000-0003-0849-7405; Matson, Jacob/0000-0002-9375-1676; Major, Michael/0000-0002-6753-8513; Tamir, Tigist/0000-0002-8194-8754	Sidney Kimmel Cancer Foundation; American Cancer Society [RSG-14-068-01-TBE]; National Science Foundation [DGE-1144081]; NIGMS, National Institutes of Health [R01GM102413]; NATIONAL CANCER INSTITUTE [T32CA071341, U54CA156733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040, R01GM102413] Funding Source: NIH RePORTER	Sidney Kimmel Cancer Foundation; American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Sidney Kimmel Cancer Foundation (to M. B. M.), by American Cancer Society Grant RSG-14-068-01-TBE (to M. B. M.), by National Science Foundation Graduate Research Fellowship DGE-1144081 (to J. P. M.), and by NIGMS, National Institutes of Health Grant R01GM102413 (to J. G. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baird L, 2013, BIOCHEM BIOPH RES CO, V433, P58, DOI 10.1016/j.bbrc.2013.02.065; Barone MC, 2011, DIS MODEL MECH, V4, P701, DOI 10.1242/dmm.007575; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Camp ND, 2012, J BIOL CHEM, V287, P6539, DOI 10.1074/jbc.M111.316471; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085744; Cheng IH, 2002, J BIOL CHEM, V277, P41706, DOI 10.1074/jbc.M205793200; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Deegan TD, 2016, CURR OPIN STRUC BIOL, V37, P145, DOI 10.1016/j.sbi.2016.01.014; Dewar JM, 2015, NATURE, V525, P345, DOI 10.1038/nature14887; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Drissi R, 2015, MOL CELL PROTEOMICS, V14, P2002, DOI 10.1074/mcp.M115.048991; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goldfarb D, 2014, J PROTEOME RES, V13, P5944, DOI 10.1021/pr5008416; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jiang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075076; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kim JH, 2012, FREE RADICAL BIO MED, V53, P629, DOI 10.1016/j.freeradbiomed.2012.04.019; Kim MS, 2016, MOL CELLS, V39, P258, DOI 10.14348/molcells.2016.2310; Kim TY, 2015, MOL CELL BIOL, V35, P167, DOI 10.1128/MCB.00857-14; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Lam SKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082177; Lecona E, 2016, NAT STRUCT MOL BIOL, V23, P270, DOI 10.1038/nsmb.3185; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Maculins T, 2015, CURR BIOL, V25, P2254, DOI 10.1016/j.cub.2015.07.012; Mann GE, 2009, CURR OPIN PHARMACOL, V9, P139, DOI 10.1016/j.coph.2008.12.012; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Mathew R, 2014, MOL CELL, V55, P916, DOI 10.1016/j.molcel.2014.07.019; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Musahl C, 1998, EXP CELL RES, V241, P260, DOI 10.1006/excr.1998.4041; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Siddiqui K., 2013, COLD SPRING HARB PER, V5, P9, DOI DOI 10.1101/CSHPERSPECT.A012930; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Takei Y, 2002, J BIOL CHEM, V277, P43121, DOI 10.1074/jbc.C200442200; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wei L, 2016, NAT STRUCT MOL BIOL, V23, P209, DOI 10.1038/nsmb.3173; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yankulov K, 1999, MOL CELL BIOL, V19, P6154; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725	77	50	53	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23719	23733		10.1074/jbc.M116.729418	http://dx.doi.org/10.1074/jbc.M116.729418			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621311	Green Published, hybrid			2022-12-28	WOS:000387884400032
J	Singh, Y; Zhou, YT; Shi, XL; Zhang, SQ; Umbach, AT; Salker, MS; Lang, KS; Lang, F				Singh, Yogesh; Zhou, Yuetao; Shi, Xiaolong; Zhang, Shaqiu; Umbach, Anja T.; Salker, Madhuri S.; Lang, Karl S.; Lang, Florian			Alkaline Cytosolic pH and High Sodium Hydrogen Exchanger 1 (NHE1) Activity in Th9 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cellular regulation; interleukin; pH regulation; T helper cells; NHE1; Th9 cells; iTregs	REGULATORY T-CELLS; NA+/H+ EXCHANGER; IN-VIVO; DENDRITIC CELLS; CANCER-CELLS; T(H)9 CELLS; HELPER 9; DIFFERENTIATION; IMMUNITY; ACTIVATION	CD4(+) T helper 9 (Th9) cells are a newly discovered Th cell subset that produce the pleiotropic cytokine IL-9. Th9 cells can protect against tumors and provide resistance against helminth infections. Given their pivotal role in the adaptive immune system, understanding Th9 cell development and the regulation of IL-9 production could open novel immunotherapeutic opportunities. The Na+/H+ exchanger 1 (NHE1; gene name Slc91)) is critically important for regulating intracellular pH (pH(i)), cell volume, migration, and cell survival. The pH(i) influences cytokine secretion, activities of membrane-associated enzymes, ion transport, and other effector signaling molecules such as ATP and Ca2+ levels. However, whether NHE1 regulates Th9 cell development or IL-9 secretion has not yet been defined. The present study explored the role of NHE1 in Th9 cell development and function. Th cell subsets were characterized by flow cytometry and pH(i) was measured using 2,7-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein-acetoxymethyl ester (BCECF-AM) dye. NHE1 functional activity was estimated from the rate of realkalinization following an ammonium pulse. Surprisingly, in Th9 cells pH(i) and NHE1 activity were significantly higher than in all other Th cell subsets (Th1/Th2/Th17 and induced regulatory T cells (iTregs)). NHE1 transcript levels and protein abundance were significantly higher in Th9 cells than in other Th cell subsets. Inhibition of NHE1 by siRNA-NHE1 or with cariporide in Th9 cells down-regulated IL-9 and ATP production. NHE1 activity, Th9 cell development, and IL-9 production were further blunted by pharmacological inhibition of protein kinase Akt1/Akt2. Our findings reveal that Akt1/Akt2 control of NHE1 could be an important physiological regulator of Th9 cell differentiation, IL-9 secretion, and ATP production.	[Singh, Yogesh; Zhou, Yuetao; Shi, Xiaolong; Zhang, Shaqiu; Umbach, Anja T.; Salker, Madhuri S.; Lang, Florian] Eberhard Karls Tubingen Univ, Dept Cardiol Cardiovasc Med & Physiol, Gmelinstr 5, D-72076 Tubingen, Germany; [Zhang, Shaqiu] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu 611130, Sichuan, Peoples R China; [Lang, Karl S.] Univ Duisburg Essen, Inst Immunol, Fac Med, Hufelandstr 55, D-45147 Essen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Sichuan Agricultural University; University of Duisburg Essen	Singh, Y; Lang, F (corresponding author), Eberhard Karls Tubingen Univ, Dept Cardiol Cardiovasc Med & Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	ysinghbt@gmail.com; florian.lang@uni-tuebingen.de	Singh, Yogesh/T-8230-2017; Zhou, Yuetao/U-9384-2019	Singh, Yogesh/0000-0001-6919-6273; Zhou, Yuetao/0000-0003-1870-3276; Salker, Madhuri Sonal/0000-0002-7939-289X; Lang, Karl/0000-0001-9783-7605	Deutsche Forschungsgemeinschaft [LA 315]; EMBO Long Term Postdoctoral Fellowship [ATLF 20-2013]; China Scholarship Council (CSC), China Ph.D. studentships	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO Long Term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); China Scholarship Council (CSC), China Ph.D. studentships(China Scholarship Council)	This work was supported by grants from Deutsche Forschungsgemeinschaft LA 315 (to F. L.), EMBO Long Term Postdoctoral Fellowship ATLF 20-2013 (to M. S. S.), and China Scholarship Council (CSC), China Ph.D. studentships (to Y. Z., X. S., and S. Z.). The authors declare that they have no conflicts of interest with the content of this article.	Abu Jawdeh BG, 2011, J BIOL CHEM, V286, P42435, DOI 10.1074/jbc.M110.212845; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; BOITEUX A, 1981, PHILOS T ROY SOC B, V293, P5, DOI 10.1098/rstb.1981.0056; Bruhn S, 2012, ALLERGY, V67, P33, DOI 10.1111/j.1398-9995.2011.02707.x; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cairns RA, 2015, CANCER J, V21, P56, DOI 10.1097/PPO.0000000000000106; Chang CP, 2010, J CELL PHYSIOL, V223, P679, DOI 10.1002/jcp.22070; Chatterjee S, 2014, FEBS LETT, V588, P1571, DOI 10.1016/j.febslet.2014.02.040; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Chien EJ, 2007, J CELL PHYSIOL, V211, P544, DOI 10.1002/jcp.20962; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dardalhon V, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.01.28; De, 2006, CELL IMMUNOL, V240, P69; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Harguindey S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-282; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Heinrich R, 1999, BIOCHEM SOC T, V27, P294, DOI 10.1042/bst0270294; Horka H, 2012, J IMMUNOL, V188, P2669, DOI 10.4049/jimmunol.1100529; Hosseinzadeh Z, 2015, CELL PHYSIOL BIOCHEM, V36, P727, DOI 10.1159/000430133; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Kara EE, 2013, J IMMUNOL, V191, P1110, DOI 10.4049/jimmunol.1203089; Kerzerho J, 2013, J ALLERGY CLIN IMMUN, V131, P1048, DOI 10.1016/j.jaci.2012.09.027; Kim IK, 2015, NAT MED, V21, P1010, DOI 10.1038/nm.3922; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kudo M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00263; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Liao W, 2014, P NATL ACAD SCI USA, V111, P3508, DOI 10.1073/pnas.1301138111; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; MILLS GB, 1986, J IMMUNOL, V136, P1150; Nagai S, 2013, ANN NY ACAD SCI, V1280, P30, DOI 10.1111/nyas.12059; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Niedbala W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5575; Odunewu A, 2013, AM J PHYSIOL-RENAL, V305, pF370, DOI 10.1152/ajprenal.00598.2012; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Pierau M, 2009, J IMMUNOL, V183, P6124, DOI 10.4049/jimmunol.0900246; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Putney LK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-46; Qadri SM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0134-7; Rotte A, 2010, CELL PHYSIOL BIOCHEM, V26, P553, DOI 10.1159/000322323; Salker MS, 2015, BIOCHEM BIOPH RES CO, V460, P845, DOI 10.1016/j.bbrc.2015.03.120; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Singh Y, 2016, IMMUNOLOGY, V149, P74, DOI 10.1111/imm.12631; Singh Y, 2015, J IMMUNOL, V195, P5667, DOI 10.4049/jimmunol.1401875; Singh Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17723; Singh Y, 2011, IMMUNOL LETT, V140, P21, DOI 10.1016/j.imlet.2011.05.011; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Vegran F, 2015, CANCER RES, V75, P475, DOI 10.1158/0008-5472.CAN-14-2748; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wang Y, 2016, IMMUNITY, V44, P1337, DOI 10.1016/j.immuni.2016.05.009; Xiao X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9266; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou YT, 2015, CELL PHYSIOL BIOCHEM, V36, P1237, DOI 10.1159/000430293; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	73	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23662	23671		10.1074/jbc.M116.730259	http://dx.doi.org/10.1074/jbc.M116.730259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27629415	Green Published, hybrid			2022-12-28	WOS:000387884400026
J	Garwain, O; Scarlata, S				Garwain, Osama; Scarlata, Suzanne			Phospholipase C beta-TRAX Association Is Required for PC12 Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; MEMBRANE INTERACTIONS; RNA INTERFERENCE; RISC ACTIVATION; FACTOR-X; PROTEIN; C-BETA-1; C3PO; COMPLEX; BINDING	When treated with nerve growth factor, PC12 cells will differentiate over the course of several days. Here, we have followed changes during differentiation in the cellular levels of phosphoinositide-specific phospholipase C beta (PLC beta) and its activator, G alpha(q), which together mediate Ca2+ release. We also followed changes in the level of the novel PLC beta binding partner TRAX (translin-associated factor X), which promotes RNA-induced gene silencing. We find that the level of PLC beta increases 4-fold within 24 h, whereas G alpha(q) increases only 1.4-fold, and this increase occurs similar to 24 h later than PLC beta. Alternately, the level of TRAX remains constant over the 72 h tested. When PLC beta 1 or TRAX is down-regulated, differentiation does not occur. The impact of PLC beta on differentiation appears independent of G alpha(q) as down-regulating G alpha(q) at constant PLC beta does not affect differentiation. Forster resonance energy transfer studies after PLC beta association with its partners indicate that PLC beta induced soon after nerve growth factor treatment associates with TRAX rather than G alpha(q). Functional measurements of Ca2+ signals to assess the activity of PLC beta-G alpha(q) complexes and measurements of the reversal of siRNA(GAPDH) to assess the activity of PLC beta-TRAX complexes additionally suggest that the newly synthesized PLC beta associates with TRAX to impact RNA-induced silencing. Taken together, our studies show that PLC beta, through its ability to bind TRAX and reverse RNA silencing of specific genes, plays a key role in switching PC12 cells to their differentiated state.	[Garwain, Osama; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			National Institutes of Health [RO1GM116187, RO172853]; Richard Whitcomb endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Whitcomb endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1GM116187 and RO172853. This work was also supported by the Richard Whitcomb endowment. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bortul R, 2002, J CELL BIOCHEM, V84, P56, DOI 10.1002/jcb.1266; Ciruela A, 2000, BIOCHEM J, V346, P587, DOI 10.1042/0264-6021:3460587; Cocco L, 2002, ADV ENZYME REGUL, V42, P181, DOI 10.1016/S0065-2571(01)00030-9; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Golebiewska U, 2011, BIOCHEMISTRY-US, V50, P2829, DOI 10.1021/bi101701x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hannan AJ, 1998, NEUROPHARMACOLOGY, V37, P593, DOI 10.1016/S0028-3908(98)00056-2; KIM UH, 1991, J BIOL CHEM, V266, P1359; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Marchetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113708; Philip F, 2016, FASEB J, V30, P1958, DOI 10.1096/fj.201500140; Philip Finly, 2013, Advances in Biological Regulation, V53, P319, DOI 10.1016/j.jbior.2013.07.002; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Sahu S, 2014, J BIOL CHEM, V289, P5134, DOI 10.1074/jbc.M113.531467; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Toni T, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.48; Weinstein H, 2011, BBA-BIOMEMBRANES, V1808, P2940, DOI 10.1016/j.bbamem.2011.08.028; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Yang SC, 2004, J BIOL CHEM, V279, P12605, DOI 10.1074/jbc.M313133200; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032	28	13	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22970	22976		10.1074/jbc.M116.744953	http://dx.doi.org/10.1074/jbc.M116.744953			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27624933	Green Published, hybrid			2022-12-28	WOS:000387224800010
J	Luczak, SET; Smits, SHJ; Decker, C; Nagel-Steger, L; Schmitt, L; Hegemann, JH				Luczak, Soeren E. T.; Smits, Sander H. J.; Decker, Christina; Nagel-Steger, Luitgard; Schmitt, Lutz; Hegemann, Johannes H.			The Chlamydia pneumoniae Adhesin Pmp21 Forms Oligomers with Adhesive Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; amyloid; bacterial adhesion; Chlamydia; oligomerization; Pmp	PROTEIN SECONDARY STRUCTURE; AMYLOID BETA-PROTEIN; POLYMORPHIC MEMBRANE-PROTEINS; ESCHERICHIA-COLI O157-H7; CURLI FIMBRIAE; BIOFILM FORMATION; SURFACE-PROTEINS; THIOFLAVIN T; BALB/C MICE; HOST-CELLS	Chlamydiae sp. are obligate intracellular pathogens that cause a variety of diseases in humans. The adhesion of Chlamydiae to the eukaryotic host cell is a pivotal step in pathogenesis. The adhesin family of polymorphic membrane proteins (Pmp) in Chlamydia pneumoniae consists of 21 members. Pmp21 binds to the epidermal growth factor receptor (EGFR). Pmps contain large numbers of FXXN (where X is any amino acid) and GGA(I/L/V) motifs. At least two of these motifs are crucial for adhesion by certain Pmp21 fragments. Here we describe how the two FXXN motifs in Pmp21-D (D-Wt), a domain of Pmp21, influence its self-interaction, folding, and adhesive capacities. Refolded D-Wt molecules form oligomers with high sedimentation values (8-85 S). These oligomers take the form of elongated protofibrils, which exhibit Thioflavin T fluorescence, like the amyloid protein fragment 42. A mutant version of Pmp21-D (D-Mt), with FXXN motifs replaced by SXXV, shows a markedly reduced capacity to form oligomers. Secondary-structure assays revealed that monomers of both variants exist predominantly as random coils, whereas the oligomers form predominantly -sheets. Adhesion studies revealed that oligomers of D-Wt (D-Wt-O) mediate significantly enhanced binding to human epithelial cells relative to D-Mt-O and monomeric protein species. Moreover, D-Wt-O binds EGFR more efficiently than D-Wt monomers. Importantly, pretreatment of human cells with D-Wt-O reduces infectivity upon subsequent challenge with C. pneumoniae more effectively than all other protein species. Hence, the FXXN motif in D-Wt induces the formation of -sheet-rich oligomeric protofibrils, which are important for adhesion to, and subsequent infection of human cells.	[Luczak, Soeren E. T.; Hegemann, Johannes H.] Univ Dusseldorf, Inst Funct Microbial Genom, Univ Str 1, D-40225 Dusseldorf, Germany; [Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany; [Decker, Christina; Nagel-Steger, Luitgard] Univ Dusseldorf, Inst Phys Biol, Univ Str 1, D-40225 Dusseldorf, Germany; [Nagel-Steger, Luitgard] ICS 6 Res Ctr Juelich, D-52425 Julich, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Hegemann, JH (corresponding author), Univ Dusseldorf, Inst Funct Microbial Genom, Univ Str 1, D-40225 Dusseldorf, Germany.	Johannes.hegemann@hhu.de	Nagel-Steger, Luitgard/H-6415-2013	Nagel-Steger, Luitgard/0000-0001-5232-2149	NRW Graduate School BioStruct-Biological Structures in Molecular Medicine and Biotechnology	NRW Graduate School BioStruct-Biological Structures in Molecular Medicine and Biotechnology	This work was supported in part by a Ph.D. fellowship from the NRW Graduate School BioStruct-Biological Structures in Molecular Medicine and Biotechnology (to S. E. T. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Boelen E, 2007, ACTA NEUROPATHOL, V114, P255, DOI 10.1007/s00401-007-0252-3; Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Campbell L. A., 2006, INTERACTIONS CHLAMYD, P505; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; D'Amico M, 2012, J PHYS CHEM LETT, V3, P1596, DOI 10.1021/jz300412v; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Epstein EA, 2009, J BACTERIOL, V191, P608, DOI 10.1128/JB.01244-08; Fernandez LA, 2000, FEMS MICROBIOL REV, V24, P21, DOI 10.1111/j.1574-6976.2000.tb00531.x; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Grimwood J, 2001, INFECT IMMUN, V69, P2383, DOI 10.1128/IAI.69.4.2383-2389.2001; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Harris SA, 2015, J ALZHEIMERS DIS, V48, P319, DOI 10.3233/JAD-142853; Hatch TP, 1999, CHLAMYDIA, P29; Hegemann JH, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P97, DOI 10.1128/9781555817329.ch5; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jantos CA, 1997, J CLIN MICROBIOL, V35, P620, DOI 10.1128/JCM.35.3.620-623.1997; Jonson Ann-Beth, 2005, V12, P67, DOI 10.1159/000081690; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kiselev AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005191; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Little CS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00304; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Longbottom D, 1998, INFECT IMMUN, V66, P1317, DOI 10.1128/IAI.66.4.1317-1324.1998; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nybo M, 1999, SCAND J IMMUNOL, V49, P219; Olsen A, 1998, INFECT IMMUN, V66, P944; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Pawar DM, 2005, J APPL MICROBIOL, V99, P418, DOI 10.1111/j.1365-2672.2005.02499.x; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pujol-Pina R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14809; Puolakkainen M, 2009, FEMS IMMUNOL MED MIC, V55, P167, DOI 10.1111/j.1574-695X.2008.00519.x; Rockey DD, 2000, INFECT IMMUN, V68, P5473, DOI 10.1128/IAI.68.10.5473-5479.2000; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryu JH, 2004, J FOOD PROTECT, V67, P2123, DOI 10.4315/0362-028X-67.10.2123; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Schachter J, 1999, CHLAMYDIA, P139; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Stallmann S, 2016, CELL MICROBIOL, V18, P761, DOI 10.1111/cmi.12549; Sulatskaya A, 2012, FEBS J, V279, P416; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Tan C, 2010, CELL MICROBIOL, V12, P174, DOI 10.1111/j.1462-5822.2009.01389.x; Tanford C., 1961, PHYSICAL CHEMISTRY M, P381; Tanzer RJ, 2001, INFECT IMMUN, V69, P2428, DOI 10.1128/IAI.69.4.2428-2434.2001; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Vandahl BB, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-36; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	82	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22806	22818		10.1074/jbc.M116.728915	http://dx.doi.org/10.1074/jbc.M116.728915			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27551038	hybrid, Green Published			2022-12-28	WOS:000386760600037
J	Tikoo, K; Sharma, E; Amara, VR; Pamulapati, H; Dhawale, VS				Tikoo, Kulbhushan; Sharma, Ekta; Amara, Venkateswara Rao; Pamulapati, Himani; Dhawale, Vaibhav Shrirang			Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); fibronectin; insulin resistance; kidney; metformin; Metabolic memory; diet reversal; high fat diet (HFD)	ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; ACID; EXPRESSION; NEPHROPATHY; MECHANISMS; PATHWAY; DISEASE; OBESITY; INJURY	Recently, we have shown that high fat diet (HFD) in vivo and in vitro generates metabolic memory by altering H3K36me2 and H3K27me3 on the promoter of FOXO1 (transcription factor of gluconeogenic genes) (Kumar, S., Pamulapati, H., and Tikoo, K. (2016) Mol. Cell. Endocrinol. 422, 233-242). Here we checked the hypothesis whether concomitant diet reversal and metformin could overcome HFD-induced metabolic memory and renal damage. Male adult Sprague-Dawley rats were rendered insulin-resistant by feeding high fat diet for 16 weeks. Then the rats were subjected to diet reversal alone and along with metformin for 8 weeks. Biochemical and histological markers of insulin resistance and kidney function were measured. Blood pressure and in vivo vascular reactivity to angiotensin II (200 mg kg(-1)) were also checked. Diet reversal could improve lipid profile but could not prevent renal complications induced by HFD. Interestingly, metformin along with diet reversal restored the levels of blood glucose, triglycerides, cholesterol, blood urea nitrogen, and creatinine. In kidney, metformin increased the activation of AMP-activated protein kinase (AMPK) and decreased inflammatory markers (COX-2 and IL-1) and apoptotic markers (poly(ADP-ribose) polymerase (PARP) and caspase 3). Metformin was effective in lowering elevated basal blood pressure and acute change in mean arterial pressure in response to angiotensin II (Ang II). It also attenuated tubulointerstitial fibrosis and glomerulosclerosis induced by HFD feeding in kidney. Here we report, for the first time, that metformin treatment overcomes metabolic memory and prevents HFD-induced renal damage.	[Tikoo, Kulbhushan; Sharma, Ekta; Amara, Venkateswara Rao; Pamulapati, Himani; Dhawale, Vaibhav Shrirang] Natl Inst Pharmaceut Educ & Res, Lab Epigenet & Dis, Dept Pharmacol & Toxicol, Sas Nagar Mohali 160062, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Tikoo, K (corresponding author), Natl Inst Pharmaceut Educ & Res, Lab Epigenet & Dis, Dept Pharmacol & Toxicol, Sect 67, Sas Nagar 160062, Punjab, India.	tikoo.k@gmail.com	Amara, Venkateswara Rao/AGJ-6417-2022; Amara, Venkateswara Rao/AGP-0388-2022; Amara, Venkateswara Rao/U-1081-2019	Amara, Venkateswara Rao/0000-0002-3061-0120; Tikoo, Kulbhushan/0000-0003-3061-9739	National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, India; Department of Science & Technology, Government of India	National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, India; Department of Science & Technology, Government of India(Department of Science & Technology (India))	This work was supported by grants from the National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, India and the Department of Science & Technology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Bendale DS, 2013, BRIT J PHARMACOL, V170, P779, DOI 10.1111/bph.12290; Crinigan C, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/157520; Decleves AE, 2011, J AM SOC NEPHROL, V22, P1846, DOI 10.1681/ASN.2011010026; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Drzewoski J, 2009, POL ARCH MED WEWN, V119, P493, DOI 10.20452/pamw.747; El-Atat FA, 2004, J AM SOC NEPHROL, V15, P2816, DOI 10.1097/01.ASN.0000133698.80390.37; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Karpe PA, 2014, DIABETES, V63, P1124, DOI 10.2337/db13-1267; Karpe PA, 2012, J HYPERTENS, V30, P132, DOI 10.1097/HJH.0b013e32834d9efe; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Kumar S, 2016, MOL CELL ENDOCRINOL, V422, P233, DOI 10.1016/j.mce.2015.12.019; Kumar S, 2015, BIOCHIMIE, V112, P73, DOI 10.1016/j.biochi.2015.02.009; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Lennon R, 2009, NEPHROL DIAL TRANSPL, V24, P3288, DOI 10.1093/ndt/gfp302; Majithiya JB, 2006, LIFE SCI, V78, P2615, DOI 10.1016/j.lfs.2005.10.020; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nayak BK, 2016, DIABETES, V65, P1387, DOI 10.2337/db15-0519; Peairs A, 2009, CLIN EXP IMMUNOL, V156, P542, DOI 10.1111/j.1365-2249.2009.03924.x; Peng JH, 2013, EXP BIOL MED, V238, P668, DOI 10.1177/1535370213480741; Piwkowska A, 2010, BIOCHEM BIOPH RES CO, V393, P268, DOI 10.1016/j.bbrc.2010.01.119; RANDLE PJ, 1965, ANN NY ACAD SCI, V131, P324, DOI 10.1111/j.1749-6632.1965.tb34800.x; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Sawicka KM, 2015, ADV WOUND CARE, V4, P469, DOI 10.1089/wound.2014.0616; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Tallapragada DSP, 2015, BRIT J PHARMACOL, V172, P4012, DOI 10.1111/bph.13145; Tikoo K, 2007, FEBS LETT, V581, P2027, DOI 10.1016/j.febslet.2007.04.036; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Wang Wei, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P170; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812; Zick Y, 2003, INT J OBESITY, V27, pS56, DOI 10.1038/sj.ijo.0802503	41	23	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21848	21856		10.1074/jbc.C116.732990	http://dx.doi.org/10.1074/jbc.C116.732990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27551045	hybrid, Green Published			2022-12-28	WOS:000386332600002
J	Sjolander, J; Byman, E; Kulak, K; Nilsson, SC; Zhang, EM; Krus, U; Westermark, GT; Storm, P; King, BC; Renstrom, E; Blom, AM				Sjolander, Jonatan; Byman, Elin; Kulak, Klaudia; Nilsson, Sara C.; Zhang, Enming; Krus, Ulrika; Westermark, Gunilla T.; Storm, Petter; King, Ben C.; Renstrom, Erik; Blom, Anna M.			C4b-binding Protein Protects -Cells from Islet Amyloid Polypeptide-induced Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; beta cell (B-cell); cell death; cholesterol; complement system	HEPARAN-SULFATE PROTEOGLYCANS; INSULIN-SECRETION; COMPLEMENT ACTIVATION; ALPHA-CHAIN; FACTOR-H; MEMBRANE; CHOLESTEROL; OLIGOMERS; MECHANISM; APOPTOSIS	C4BP (C4b-binding protein) is a polymer of seven identical chains and one unique chain synthesized in liver and pancreas. We showed previously that C4BP enhances islet amyloid polypeptide (IAPP) fibril formation in vitro. Now we report that polymeric C4BP strongly inhibited lysis of human erythrocytes incubated with monomeric IAPP, whereas no lysis was observed after incubation with preformed IAPP fibrils. In contrast, incubation with the monomeric -chain of C4BP was less effective. These data indicate that polymeric C4BP with multiple binding sites for IAPP neutralizes lytic activity of IAPP. Furthermore, addition of monomeric IAPP to a rat insulinoma cell line (INS-1) resulted in decreased cell viability, which was restored in the presence of physiological concentrations of C4BP. Treatment of INS-1 cells and primary rat islets with IAPP also diminished their ability to secrete insulin upon stimulation with glucose, which was reversed in the presence of C4BP. Further, C4BP was internalized together with IAPP into INS-1 cells. Pathway analyses of mRNA expression microarray data indicated that cells exposed to C4BP and IAPP in comparison with IAPP alone increased expression of genes involved in cholesterol synthesis. Depletion of cholesterol through methyl--cyclodextrin or cholesterol oxidase abolished the protective effect of C4BP on IAPP cytotoxicity of INS-1 cells. Also, inhibition of phosphoinositide 3-kinase but not NF-B had a similar effect. Taken together, C4BP protects -cells from IAPP cytotoxicity by modulating IAPP fibril formation extracellularly and also, after uptake by the cells, by enhancing cholesterol synthesis.	[Sjolander, Jonatan; Byman, Elin; Kulak, Klaudia; Nilsson, Sara C.; King, Ben C.; Blom, Anna M.] Lund Univ, Dept Translat Med, S-20502 Malmo, Sweden; [Zhang, Enming; Krus, Ulrika; Storm, Petter; Renstrom, Erik] Lund Univ, Dept Clin Sci, S-20502 Malmo, Sweden; [Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden	Lund University; Lund University; Uppsala University	Blom, AM (corresponding author), Lund Univ, Dept Translat Med, Sect Med Prot Chem, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; King, Benjamin/0000-0001-6776-8741; Storm, Petter/0000-0002-7655-3731; Zhang, Enming/0000-0002-0401-4608	Knut and Alice Wallenberg Foundation; Swedish Research Council [K2012-66X-14928-09-5]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Knut and Alice Wallenberg Foundation and by Swedish Research Council Grants K2012-66X-14928-09-5. The authors declare that they have no conflicts of interest with the contents of this article.	Blom AM, 2004, ARCH IMMUNOL THER EX, V52, P83; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Blom AM, 2008, J IMMUNOL, V180, P6385, DOI 10.4049/jimmunol.180.9.6385; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Caillon L, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5639875; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Cho WJ, 2008, METHOD CELL BIOL, V90, P267, DOI 10.1016/S0091-679X(08)00813-3; DAHLBACK B, 1983, BIOCHEM J, V209, P857, DOI 10.1042/bj2090857; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; HILLARP A, 1990, P NATL ACAD SCI USA, V87, P1183, DOI 10.1073/pnas.87.3.1183; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Jusko M, 2014, J INNATE IMMUN, V6, P31, DOI 10.1159/000351458; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Lin CY, 2005, J CLIN ENDOCR METAB, V90, P6678, DOI 10.1210/jc.2005-0079; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; MANDERS EMM, 1992, J CELL SCI, V103, P857; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mohlin FC, 2013, EUR J IMMUNOL, V43, P1617, DOI 10.1002/eji.201243196; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Olivar R, 2013, J IMMUNOL, V190, P2857, DOI 10.4049/jimmunol.1200503; Oskarsson ME, 2015, J BIOL CHEM, V290, P15121, DOI 10.1074/jbc.M114.631697; Paulsson JF, 2008, EXP DIABETES RES, DOI 10.1155/2008/865850; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Singh S, 2015, ADV EXP MED BIOL, V855, P95, DOI 10.1007/978-3-319-17344-3_4; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; Sjolander J, 2012, J BIOL CHEM, V287, P10824, DOI 10.1074/jbc.M111.244285; Spijkers PP, 2008, EUR J IMMUNOL, V38, P809, DOI 10.1002/eji.200737722; TENNER AJ, 1981, J IMMUNOL, V127, P648; Trikha S, 2011, J BIOL CHEM, V286, P36086, DOI 10.1074/jbc.M111.240762; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2008, MOL IMMUNOL, V45, P3649, DOI 10.1016/j.molimm.2008.04.025; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vrielink A, 2010, SUBCELL BIOCHEM, V51, P137, DOI 10.1007/978-90-481-8622-8_5	43	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21644	21655		10.1074/jbc.M116.731141	http://dx.doi.org/10.1074/jbc.M116.731141			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27566545	hybrid, Green Published			2022-12-28	WOS:000385999200030
J	Wang, D; Li, XR; Dong, DJ; Huang, H; Wang, JX; Zhao, XF				Wang, Di; Li, Xiang-Ru; Dong, Du-Juan; Huang, Hua; Wang, Jin-Xing; Zhao, Xiao-Fan			The Steroid Hormone 20-Hydroxyecdysone Promotes the Cytoplasmic Localization of Yorkie to Suppress Cell Proliferation and Induce Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell proliferation; Hippo pathway; insect; steroid hormone; 20-hydroxyecdysone; Yorkie; cytoplasmic localization	HIPPO-YAP PATHWAY; DROSOPHILA-MELANOGASTER; SIZE-CONTROL; DEATH; METAMORPHOSIS; FAMILY; GENES; PHOSPHORYLATION; BIOSYNTHESIS; EXPRESSION	The transcriptional co-activator Yki (Yorkie), a member of the Hippo pathway, regulates cell proliferation or apoptosis, depending on its nuclear or cytoplasmic location. However, the upstream factors regulating the subcellular localization of Yki are unclear. We found that the steroid hormone 20-hydroxyecdysone (20E) induces phosphorylation of Yki, causing it to remain in the cytoplasm, where it promotes apoptosis in the midgut of the lepidopteran insect Helicoverpa armigera. Yki is expressed in various tissues, with an increase in the epidermis and midgut during early metamorphic molting. Yki is localized mainly in the nucleus of feeding larval midgut cells but is mainly localized in the cytoplasm of metamorphic molting larval midgut cells. The knockdown of Yki in the feeding larvae promotes larval-pupal transition, midgut programmed cell death, and repressed IAP1 (inhibitor of apoptosis 1) expression. Knockdown of Yki in the epidermal cell line (HaEpi) induced increased activation of Caspase3/7. Overexpressed Yki in HaEpi cells was mainly localized in the nucleus and induced cell proliferation. 20E promotes the cytoplasmic localization of Yki, reducing the expression of the IAP1, resulting in apoptosis. 20E promotes cytoplasmic retention of Yki by increasing Yki phosphorylation levels and promoting the interaction between Yki and the adaptor protein 14-3-3-E. This regulation of Yki suppresses cell proliferation and induces cell apoptosis.	[Wang, Di; Li, Xiang-Ru; Dong, Du-Juan; Huang, Hua; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Zhao, Xiao-Fan/0000-0003-1809-4730; Dong, Dujuan/0000-0003-3416-5017; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31230067, 31372261]; Ph.D. Programs Foundation of the Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China Grants 31230067 and 31372261 and Ph.D. Programs Foundation of the Ministry of Education of China Grant 20120131110025. The authors declare that they have no conflicts of interest with the contents of this article.	Boo KH, 2010, BIOSCI BIOTECH BIOCH, V74, P2226, DOI 10.1271/bbb.100410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai MJ, 2012, APOPTOSIS, V17, P1327, DOI 10.1007/s10495-012-0761-y; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Dong DJ, 2015, J BIOL CHEM, V290, P24738, DOI 10.1074/jbc.M115.643783; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fraenkel G, 1935, PROC R SOC SER B-BIO, V118, P1, DOI 10.1098/rspb.1935.0044; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hsueh YJ, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.14; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liu CY, 2015, CELL CYCLE, V14, P3045, DOI 10.1080/15384101.2015.1053664; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nagashima S., 2016, CURR DRUG T IN PRESS; Ogawa S, 1967, Yakugaku Zasshi, V87, P325; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Orme M, 2009, APOPTOSIS, V14, P950, DOI 10.1007/s10495-009-0358-2; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Sui YP, 2009, INSECT MOL BIOL, V18, P443, DOI 10.1111/j.1365-2583.2009.00884.x; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tettamanti G, 2007, CELL TISSUE RES, V330, P345, DOI 10.1007/s00441-007-0449-8; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Yin VP, 2007, J CELL BIOL, V178, P85, DOI 10.1083/jcb.200703206; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao XF, 2005, ARCH INSECT BIOCHEM, V58, P39, DOI 10.1002/arch.20030	38	8	10	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21761	21770		10.1074/jbc.M116.719856	http://dx.doi.org/10.1074/jbc.M116.719856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551043	Green Published, hybrid			2022-12-28	WOS:000385999200040
J	Hacker, KE; Fahey, CC; Shinsky, SA; Chiang, YCJ; DiFiore, JV; Jha, DK; Vo, AH; Shavit, JA; Davis, IJ; Strahl, BD; Rathmell, WK				Hacker, Kathryn E.; Fahey, Catherine C.; Shinsky, Stephen A.; Chiang, Yun-Chen J.; DiFiore, Julia V.; Jha, Deepak Kumar; Vo, Andy H.; Shavit, Jordan A.; Davis, Ian J.; Strahl, Brian D.; Rathmell, W. Kimryn			Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LYSINE 36 TRIMETHYLATION; DNA MISMATCH REPAIR; I-TASSER SERVER; H3K36 METHYLATION; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; METHYLTRANSFERASE SETD2; BRANCHED EVOLUTION	The yeast Set2 histone methyltransferase is a critical enzyme that plays a number of key roles in gene transcription and DNA repair. Recently, the human homologue, SETD2, was found to be recurrently mutated in a significant percentage of renal cell carcinomas, raising the possibility that the activity of SETD2 is tumor-suppressive. Using budding yeast and human cell line model systems, we examined the functional significance of two evolutionarily conserved residues in SETD2 that are recurrently mutated in human cancers. Whereas one of these mutations (R2510H), located in the Set2 Rpb1 interaction domain, did not result in an observable defect in SETD2 enzymatic function, a second mutation in the catalytic domain of this enzyme (R1625C) resulted in a complete loss of histone H3 Lys-36 trimethylation (H3K36me3). This mutant showed unchanged thermal stability as compared with the wild type protein but diminished binding to the histone H3 tail. Surprisingly, mutation of the conserved residue in Set2 (R195C) similarly resulted in a complete loss of H3K36me3 but did not affect dimethylated histone H3 Lys-36 (H3K36me2) or functions associated with H3K36me2 in yeast. Collectively, these data imply a critical role for Arg-1625 in maintaining the protein interaction with H3 and specific H3K36me3 function of this enzyme, which is conserved from yeast to humans. They also may provide a refined biochemical explanation for how H3K36me3 loss leads to genomic instability and cancer.	[Hacker, Kathryn E.; Fahey, Catherine C.; DiFiore, Julia V.; Davis, Ian J.; Strahl, Brian D.; Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Hacker, Kathryn E.; Fahey, Catherine C.; Shinsky, Stephen A.; Chiang, Yun-Chen J.; Jha, Deepak Kumar; Davis, Ian J.; Strahl, Brian D.; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Shinsky, Stephen A.; DiFiore, Julia V.; Jha, Deepak Kumar; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Vo, Andy H.; Shavit, Jordan A.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Davis, Ian J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27514 USA; [Rathmell, W. Kimryn] Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Div Hematol & Oncol, Nashville, TN 37232 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University	Strahl, BD; Rathmell, WK (corresponding author), Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Strahl, BD; Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Strahl, BD (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.; Rathmell, WK (corresponding author), Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Div Hematol & Oncol, Nashville, TN 37232 USA.	brian_strahl@med.unc.edu; kimryn.rathmell@vanderbilt.edu	Chiang, Yun/GRJ-5251-2022; Ariel, Pablo/AGJ-4118-2022; Jha, Deepak/AAK-2279-2020; Strahl, Brian D/C-7601-2012	Jha, Deepak/0000-0002-6657-5662; Davis, Ian/0000-0002-1552-0960; Strahl, Brian D/0000-0002-4947-6259; Fahey, Catherine/0000-0003-4347-361X	V Foundation Translational Research Grant; National Institutes of Health (NIH) [R01 CA198482, K24 CA172355]; UNC Medical Scientist Training Program [T32 GM008719-12]; National Research Service Award (NRSA) [TR000085-05]; NRSA [F30 CA192643-02]; UNC Lineberger Cancer Center Postdoctoral Fellowship Award; NIGMS; NIH [5T32 GM007092, R01 HL124232]; NATIONAL CANCER INSTITUTE [K24CA172355, R01CA166447, T32CA009156, F30CA192643, R01CA198482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, T32GM007092] Funding Source: NIH RePORTER	V Foundation Translational Research Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Medical Scientist Training Program; National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Lineberger Cancer Center Postdoctoral Fellowship Award; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the V Foundation Translational Research Grant (to B. D. S., I. J. D., and W. K. R.), National Institutes of Health (NIH) Grants R01 CA198482 (to B. D. S., I. J. D., and W. K. R.) and K24 CA172355 (to W. K. R.), UNC Medical Scientist Training Program Grant T32 GM008719-12 (to K. E. H. and C. C. F.), National Research Service Award (NRSA) Training Grant TR000085-05 (to C. C. F.), NRSA Award F30 CA192643-02 (to C. C. F.), a UNC Lineberger Cancer Center Postdoctoral Fellowship Award (to S. A. S.), NIGMS, NIH, award 5T32 GM007092 (to J. V. D.), and NIH Grant R01 HL124232 (to J. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Sarakbi W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-290; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Awwad SW, 2015, BIOL OPEN, V4, P498, DOI 10.1242/bio.201410991; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Carvalho S, 2013, NUCLEIC ACIDS RES, V41, P2881, DOI 10.1093/nar/gks1472; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guo R, 2014, MOL CELL, V56, P298, DOI 10.1016/j.molcel.2014.08.022; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Lickwar CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004886; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Sorenson MR, 2016, RNA BIOL, V13, P412, DOI 10.1080/15476286.2016.1144009; Sun S, 2016, GENOME RES, V26, P670, DOI 10.1101/gr.192526.115; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	58	39	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21283	21295		10.1074/jbc.M116.739375	http://dx.doi.org/10.1074/jbc.M116.739375			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27528607	Green Published, hybrid			2022-12-28	WOS:000385406200040
J	Cai, XY; Zhou, YD; Nwokonko, RM; Loktionova, NA; Wang, XM; Xin, P; Trebak, M; Wang, YJ; Gill, DL				Cai, Xiangyu; Zhou, Yandong; Nwokonko, Robert M.; Loktionova, Natalia A.; Wang, Xianming; Xin, Ping; Trebak, Mohamed; Wang, Youjun; Gill, Donald L.			The Orai1 Store-operated Calcium Channel Functions as a Hexamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; SUBUNIT STOICHIOMETRY; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; CA2+ ENTRY; STIM1; ACTIVATION; PORE; DOMAIN; SELECTIVITY	Orai channels mediate store-operated Ca2+ signals crucial in regulating transcription in many cell types, and implicated in numerous immunological and inflammatory disorders. Despite their central importance, controversy surrounds the basic subunit structure of Orai channels, with several biochemical and biophysical studies suggesting a tetrameric structure yet crystallographic evidence indicating a hexamer. We systematically investigated the subunit configuration of the functional Orai1 channel, generating a series of tdTomato-tagged concatenated Orai1 channel constructs (dimers to hexamers) expressed in CRISPR-derived ORAI1 knock-out HEK cells, stably expressing STIM1-YFP. Surface biotinylation demonstrated that the full-length concatemers were surface membrane-expressed. Unexpectedly, Orai1 dimers, trimers, tetramers, pentamers, and hexamers all mediated similar and substantial store-operated Ca2+ entry. Moreover, each Orai1 concatemer mediated Ca2+ currents with inward rectification and reversal potentials almost identical to those observed with expressed Orai1 monomer. In Orai1 tetramers, subunit-specific replacement with Orai1 E106A "pore-inactive" subunits revealed that functional channels utilize only the N-terminal dimer from the tetramer. In contrast, Orai1 E106A replacement in Orai1 hexamers established that all the subunits can contribute to channel formation, indicating a hexameric channel configuration. The critical Ca2+ selectivity filter-forming Glu-106 residue may mediate Orai1 channel assembly around a central Ca2+ ion within the pore. Thus, multiple E106A substitutions in the Orai1 hexamer may promote an alternative "trimer-of-dimers" channel configuration in which the C-terminal E106A subunits are excluded from the hexameric core. Our results argue strongly against a tetrameric configuration for Orai1 channels and indicate that the Orai1 channel functions as a hexamer.	[Cai, Xiangyu; Zhou, Yandong; Nwokonko, Robert M.; Loktionova, Natalia A.; Wang, Xianming; Xin, Ping; Trebak, Mohamed; Gill, Donald L.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Wang, Youjun] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resources & Mol Dev, Beijing 100875, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Beijing Normal University	Zhou, YD; Gill, DL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	zhouyd@psu.edu; dongill@psu.edu	Wang, Youjun/H-4016-2013; Nwokonko, Robert/ABH-3833-2020; zhou, Yandong/AAN-3947-2021	Wang, Youjun/0000-0003-0961-1716; Nwokonko, Robert/0000-0002-0793-7379; zhou, Yandong/0000-0003-3503-0296	National Institute of Health [R01 GM120783, R01 GM109279]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123364, R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109279, R01GM120783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050072] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in whole or part by National Institute of Health Grants R01 GM120783 and R01 GM109279. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amcheslavsky A, 2015, BIOPHYS J, V108, P237, DOI 10.1016/j.bpj.2014.11.3473; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; Hogan PG, 2015, CELL CALCIUM, V58, P357, DOI 10.1016/j.ceca.2015.07.001; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kar P, 2013, CHANNELS, V7, P374, DOI 10.4161/chan.25298; Li PY, 2016, MOL BIOL CELL, V27, P2542, DOI 10.1091/mbc.E16-03-0163; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Mancarella S, 2011, J BIOL CHEM, V286, P44788, DOI 10.1074/jbc.M111.303081; Mancarella S, 2011, NAT CHEM BIOL, V7, P344, DOI 10.1038/nchembio.587; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Perni S, 2015, P NATL ACAD SCI USA, V112, pE5533, DOI 10.1073/pnas.1515606112; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Thompson JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01961; Thompson JL, 2009, J BIOL CHEM, V284, P6620, DOI 10.1074/jbc.M808346200; Tirado-Lee L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128622; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2014, MOL BIOL CELL, V25, P3672, DOI 10.1091/mbc.E14-06-1107; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhou Y., 2016, NAT COMMUN IN PRESS; Zhou YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9395; Zhou YD, 2015, MOL CELL, V58, P197, DOI 10.1016/j.molcel.2015.04.003; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	45	74	75	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25764	25775		10.1074/jbc.M116.758813	http://dx.doi.org/10.1074/jbc.M116.758813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780862	Green Published, hybrid			2022-12-28	WOS:000390345200001
J	Liu, X; Cai, XL; Hu, B; Mei, ZC; Zhang, DW; Ouyang, G; Wang, J; Zhang, W; Xiao, WH				Liu, Xing; Cai, Xiaolian; Hu, Bo; Mei, Zhichao; Zhang, Dawei; Ouyang, Gang; Wang, Jing; Zhang, Wei; Xiao, Wuhan			Forkhead Transcription Factor 3a (FOXO3a) Modulates Hypoxia Signaling via Up-regulation of the von Hippel-Lindau Gene (VHL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FOXO; hypoxia; hypoxia-inducible factor (HIF); stress; transcription regulation; zebrafish; pVHL	HIGH-ALTITUDE ADAPTATION; CELL RENAL-CARCINOMA; OXIDATIVE STRESS; HIF-ALPHA; PROTEASOMAL DEGRADATION; INDUCIBLE FACTORS; BETA-CATENIN; PVHL; PROTEIN; PATHWAY	FOXO3a, a member of the forkhead homeobox type O (FOXO) family of transcriptional factors, regulates cell survival in response to DNA damage, caloric restriction, and oxidative stress. The von Hippel-Lindau (VHL) tumor suppressor gene encodes a component of the E3 ubiquitin ligase complex that mediates hypoxia-inducible factor degradation under aerobic conditions, thus acting as one of the key regulators of hypoxia signaling. However, whether FOXO3a impacts cellular hypoxia stress remains unknown. Here we show that FOXO3a directly binds to the VHL promoter and up-regulates VHL expression. Using a zebrafish model, we confirmed the up-regulation of vhl by foxo3b, an ortholog of mammalian FOXO3a. Furthermore, by employing the clustered regularly interspaced short palindromic repeats (CRISPR)-associated RNA-guided endonuclease Cas9 (CRISPR/Cas9) technology, we deleted foxo3b in zebrafish and determined that expression of hypoxia-inducible genes was affected under hypoxia. Moreover, foxo3b-null zebrafish exhibited impaired acute hypoxic tolerance, resulting in death. In conclusion, our findings suggest that, by modulating hypoxia-inducible factor activity via up-regulation of VHL, FOXO3a (foxo3b) plays an important role in survival in response to hypoxic stress.	[Liu, Xing; Cai, Xiaolian; Hu, Bo; Mei, Zhichao; Zhang, Dawei; Ouyang, Gang; Wang, Jing; Zhang, Wei; Xiao, Wuhan] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan 430072, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Zhang, Wei/I-1481-2017; Xiao, Wuhan/GLU-7352-2022; hu, bo/ABC-3810-2021	hu, bo/0000-0001-5656-9632	National Natural Science Foundation in China (NSFC) [31401072]; Chinese Academy of Sciences Major Scientific and Technological Project [XDA08010208]; NSFC [31461163003, 91631102, 31671315]	National Natural Science Foundation in China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Major Scientific and Technological Project; NSFC(National Natural Science Foundation of China (NSFC))	Supported by National Natural Science Foundation in China (NSFC) Grant 31401072.; Supported by Chinese Academy of Sciences Major Scientific and Technological Project XDA08010208 and NSFC Grants 31461163003, 91631102, and 31671315.	Asikainen TM, 2005, P NATL ACAD SCI USA, V102, P10212, DOI 10.1073/pnas.0504520102; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham AW, 2014, GENE DEV, V28, P2189, DOI 10.1101/gad.250167.114; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen JX, 2015, CELL SIGNAL, V27, P2314, DOI 10.1016/j.cellsig.2015.08.011; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; Du J, 2015, J IMMUNOL, V195, P1782, DOI 10.4049/jimmunol.1500588; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; Gerez J, 2015, ONCOGENE, V34, P4855, DOI 10.1038/onc.2014.407; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Ji W, 2014, BIOCHEM J, V457, P185, DOI 10.1042/BJ20130793; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kim JJ, 2015, GENE DEV, V29, P2244, DOI 10.1101/gad.268128.115; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu D, 2014, J GENET GENOMICS, V41, P43, DOI 10.1016/j.jgg.2013.11.004; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nunez-O'Mara A, 2015, J CELL SCI, V128, P40, DOI 10.1242/jcs.151514; Okumura F, 2016, MOL CELL BIOL, V36, P1803, DOI 10.1128/MCB.00067-16; Onnis B, 2013, J CLIN INVEST, V123, P1615, DOI 10.1172/JCI59623; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Petousi N, 2014, J APPL PHYSIOL, V116, P875, DOI 10.1152/japplphysiol.00605.2013; Putker M, 2013, MOL CELL, V49, P730, DOI 10.1016/j.molcel.2012.12.014; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Song D, 2014, J BIOL CHEM, V289, P14656, DOI 10.1074/jbc.M113.541227; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang J, 2014, MOL ENDOCRINOL, V28, P239, DOI 10.1210/me.2013-1258; Xie XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024469; Yang F, 2015, NEUROSCIENCE, V304, P250, DOI 10.1016/j.neuroscience.2015.07.051; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439	62	17	21	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25692	25705		10.1074/jbc.M116.745471	http://dx.doi.org/10.1074/jbc.M116.745471			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27777301	Green Published, hybrid			2022-12-28	WOS:000390095300034
J	Chintapalli, SV; Jayanthi, S; Mallipeddi, PL; Gundampati, R; Kumar, TKS; van Rossum, DB; Anishkin, A; Adams, SH				Chintapalli, Sree V.; Jayanthi, Srinivas; Mallipeddi, Prema L.; Gundampati, Ravikumar; Kumar, Thallapuranam Krishnaswamy Suresh; van Rossum, Damian B.; Anishkin, Andriy; Adams, Sean H.			Novel Molecular Interactions of Acylcarnitines and Fatty Acids with Myoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE INSULIN-RESISTANCE; BINDING-PROTEIN; SKELETAL-MUSCLE; 3-DIMENSIONAL STRUCTURE; X-RAY; AUTOMATED DOCKING; SPERM WHALE; DYNAMICS; MITOCHONDRIAL; OXYMYOGLOBIN	Previous research has indicated that long-chain fatty acids can bind myoglobin (Mb) in an oxygen-dependent manner. This suggests that oxy-Mb may play an important role in fuel delivery in Mb-rich muscle fibers (e.g. type I fibers and cardiomyocytes), and raises the possibility that Mb also serves as an acylcarnitine-binding protein. We report for the first time the putative interaction and affinity characteristics for different chain lengths of both fatty acids and acylcarnitines with oxy-Mb using molecular dynamic simulations and isothermal titration calorimetry experiments. We found that short-to medium-chain fatty acids or acylcarnitines (ranging from C2:0 to C10:0) fail to achieve a stable conformation with oxy-Mb. Furthermore, our results indicate that C12:0 is the minimum chain length essential for stable binding of either fatty acids or acylcarnitines with oxy-Mb. Importantly, the empirical lipid binding studies were consistent with structural modeling. These results reveal that: (i) the lipid binding affinity for oxy-Mb increases as the chain length increases (i.e. C12:0 to C18:1), (ii) the binding affinities of acylcarnitines are higher when compared with their respective fatty acid counterparts, and (iii) both fatty acids and acylcarnitines bind to oxy-Mb in 1:1 stoichiometry. Taken together, our results support a model in which oxy-Mb is a novel regulator of long-chain acylcarnitine and fatty acid pools in Mb-rich tissues. This has important implications for physiological fuel management during exercise, and relevance to pathophysiological conditions (e.g. fatty acid oxidation disorders and cardiac ischemia) where long-chain acylcarnitine accumulation is evident.	[Chintapalli, Sree V.; Adams, Sean H.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Chintapalli, Sree V.; Adams, Sean H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA; [Jayanthi, Srinivas; Gundampati, Ravikumar; Kumar, Thallapuranam Krishnaswamy Suresh] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Mallipeddi, Prema L.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [van Rossum, Damian B.] Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA; [van Rossum, Damian B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Anishkin, Andriy] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Mallipeddi, Prema L.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Houston System; University of Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas Southwestern Medical Center Dallas	Adams, SH (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA.; Adams, SH (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA.; Chintapalli, SV (corresponding author), Arkansas Childrens Nutr Ctr, 15 Childrens Way, Little Rock, AR 72202 USA.	svchintapalli@uams.edu; shadams@uams.edu	Kumar, Dr Suresh/HHZ-2615-2022; Gundampati, Ravi Kumar/AAL-7624-2020; KUMAR, P. SURESH/AAT-8951-2020; Kumar, Suresh Thallapuranam/R-5606-2016; Jayanthi, Srinivas/AAD-2808-2019; ADAMS, SEAN/N-9262-2018	Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Suresh Thallapuranam/0000-0001-7262-1373; van Rossum, Damian/0000-0003-1011-2586; Jayanthi, Srinivas/0000-0001-7357-760X; ADAMS, SEAN/0000-0002-9515-2319	U.S. Department of Agriculture, Agricultural Research Service [6026-51000-010-05S]; Arkansas Children's Research Institute; National Institutes of Health [R01DK078328-01]; Sturgis Diabetes Research Funds; Arkansas Bioscience Institute, National Institutes of Health, NCI Grant [1 RO1 CA 172631]; NATIONAL CANCER INSTITUTE [R01CA172631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Arkansas Children's Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sturgis Diabetes Research Funds; Arkansas Bioscience Institute, National Institutes of Health, NCI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. Department of Agriculture, Agricultural Research Service Project 6026-51000-010-05S and support from the Arkansas Children's Research Institute and National Institutes of Health NIDDK Grant R01DK078328-01 (to S. H. A.), pilot award funding from Sturgis Diabetes Research Funds (to S. H. A. and S. V. C.), and Arkansas Bioscience Institute, National Institutes of Health, NCI Grant 1 RO1 CA 172631 (to T. K. S. K.). The authors declare that they have no conflict of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; Aon MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00282; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Chintapalli SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128496; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Dube JJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE882, DOI 10.1152/ajpendo.00769.2007; Dutta-Roy AK, 2000, CELL MOL LIFE SCI, V57, P1360, DOI 10.1007/PL00000621; EISERT WG, 1979, BIOPHYS J, V25, P455, DOI 10.1016/S0006-3495(79)85315-1; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GLATZ JFC, 1990, MOL CELL BIOCHEM, V98, P231, DOI 10.1007/BF00231389; GLATZ JFC, 1990, MOL CELL BIOCHEM, V98, P237, DOI 10.1007/BF00231390; GLOSTER J, 1977, BIOCHEM BIOPH RES CO, V74, P506, DOI 10.1016/0006-291X(77)90333-3; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; GOTZ FM, 1994, BIOL CHEM H-S, V375, P387, DOI 10.1515/bchm3.1994.375.6.387; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; Hersleth HP, 2007, J BIOL CHEM, V282, P23372, DOI 10.1074/jbc.M701948200; Hodsdon ME, 1996, J MOL BIOL, V264, P585, DOI 10.1006/jmbi.1996.0663; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAIKAUS RM, 1990, EXPERIENTIA, V46, P617, DOI 10.1007/BF01939701; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; LASSEN D, 1995, EUR J BIOCHEM, V230, P266, DOI 10.1111/j.1432-1033.1995.tb20560.x; Liepinsh E, 2016, BIOCHEM J, V473, P1191, DOI 10.1042/BCJ20160164; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nelson DL, 2000, LEHNINGER PRINCIPLES; OCKNER RK, 1990, MOL CELL BIOCHEM, V98, P3; Ory JJ, 1999, BIOPHYS J, V77, P1107, DOI 10.1016/S0006-3495(99)76961-4; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PHILLIPS SEV, 1980, J MOL BIOL, V142, P531, DOI 10.1016/0022-2836(80)90262-4; Postnikova GB, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1211, DOI 10.1134/S0006297909110054; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; SACCHETTINI JC, 1989, P NATL ACAD SCI USA, V86, P7736, DOI 10.1073/pnas.86.20.7736; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Sharma Shruti, 2009, Drug Discov Today Dis Mech, V6, pe31; Shih L, 2015, CHEM PHYS LIPIDS, V191, P115, DOI 10.1016/j.chemphyslip.2015.07.010; Shih L, 2014, BBA-GEN SUBJECTS, V1840, P656, DOI 10.1016/j.bbagen.2013.10.028; SPENER F, 1990, MOL CELL BIOCHEM, V98, P57; Sriram R, 2008, FEBS LETT, V582, P3643, DOI 10.1016/j.febslet.2008.09.047; Steele RA, 1998, PROTEIN SCI, V7, P1332, DOI 10.1002/pro.5560070609; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; TAKANO T, 1977, J MOL BIOL, V110, P537, DOI 10.1016/S0022-2836(77)80111-3; TAKANO T, 1977, J MOL BIOL, V110, P569, DOI 10.1016/S0022-2836(77)80112-5; Terjung R. L., 1995, SPORTS SCI EXCHANGE, V8, P1; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; VINOGRADOV SN, 1993, COMP BIOCHEM PHYS B, V106, P1, DOI 10.1016/0305-0491(93)90002-M; Yamada T, 2013, J APPL PHYSIOL, V114, P490, DOI 10.1152/japplphysiol.00789.2012; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541; Zhang J, 2017, EXP PHYSIOL, V102, P48, DOI 10.1113/EP086019	58	18	19	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					251133	251143		10.1074/jbc.M116.754978	http://dx.doi.org/10.1074/jbc.M116.754978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758871	Green Published, hybrid			2022-12-28	WOS:000388880100028
J	Li, LM; Qian, GH; Zuo, YB; Yuan, YK; Cheng, Q; Guo, TT; Liu, J; Liu, C; Zhang, LT; Zheng, H				Li, Lemin; Qian, Guanghui; Zuo, Yibo; Yuan, Yukang; Cheng, Qiao; Guo, Tingting; Liu, Jin; Liu, Chang; Zhang, Liting; Zheng, Hui			Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; RECEPTOR; VIRUSES; ALPHA; ELIMINATION; MAINTENANCE; SUPPRESSION; MUTATIONS; INDUCTION; SYSTEM	Adenosine deaminase acting on RNA 1 (ADAR1) catalyzes RNA editing of cellular and viral RNAs. Besides RNA editing, ADAR1 has recently been shown to play important roles in maintaining the body balance, including tissue homoeostasis, organ development, and autoimmune regulations, by inhibiting both IFN production and subsequent IFN-activated pathways. Accordingly, the question was raised how IFN signaling induced by viral infections overcomes the inhibitory effect of constitutively expressed ADAR1 (ADAR1-P110) to execute efficient antiviral activity. Here we unexpectedly found that IFN signaling promoted Lys(48)-linked ubiquitination and degradation of ADAR1-P110. Furthermore, we identified the E3 ligase beta transducin repeat-containing protein responsible for IFN-mediated ADAR1-P110 down-regulation. IFN signaling promoted the interaction between beta transducin repeat-containing protein and ADAR1-P110 as well as protein turnover of ADAR1-P110. Moreover, we found that both lysine 574 and 576 are essential for ADAR1-P110 ubiquitination. Critically, we demonstrated that down-regulation of ADAR1-P110 is required for IFN signaling to execute efficient antiviral activity during viral infections. These findings renew the understanding of the mechanisms by which IFN signaling acts to achieve antiviral functions and may provide potential targets for IFN-based antiviral therapy.	[Li, Lemin; Zuo, Yibo; Yuan, Yukang; Cheng, Qiao; Guo, Tingting; Liu, Jin; Liu, Chang; Zhang, Liting; Zheng, Hui] Soochow Univ, Jiangsu Key Lab Infect & Immun, Inst Biol, Suzhou 215123, Peoples R China; [Li, Lemin; Zuo, Yibo; Yuan, Yukang; Cheng, Qiao; Guo, Tingting; Liu, Jin; Liu, Chang; Zhang, Liting; Zheng, Hui] Soochow Univ, Jiangsu Key Lab Infect & Immun, Inst Med Sci, Suzhou 215123, Peoples R China; [Qian, Guanghui] Soochow Univ, Childrens Hosp, Pediat Res Inst, Suzhou 215025, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zheng, H (corresponding author), Soochow Univ, Inst Biol, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Zheng, H (corresponding author), Soochow Univ, Inst Med Sci, 199 Ren Ai Rd, Suzhou 215123, Jiangsu, Peoples R China.	huizheng@suda.edu.cn	Zheng, Hui/ABD-6141-2021		Program of 1000 Young Talents; National Natural Science Foundation of China [31370873, 31570865, 31600695]; Jiangsu Provincial Distinguished Young Scholars Grant [BK20130004]; Jiangsu Provincial Innovative Research Team; Changjiang Scholars and Innovative Research Team, University of Ministry of Education of China [PCSIRT-IRT1075]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Program of 1000 Young Talents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Distinguished Young Scholars Grant; Jiangsu Provincial Innovative Research Team; Changjiang Scholars and Innovative Research Team, University of Ministry of Education of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported in part by Program of 1000 Young Talents; National Natural Science Foundation of China Grants 31370873, 31570865, and 31600695; Jiangsu Provincial Distinguished Young Scholars Grant BK20130004; Jiangsu Provincial Innovative Research Team; Changjiang Scholars and Innovative Research Team, University of Ministry of Education of China Grant PCSIRT-IRT1075; and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Bhattacharya S, 2011, BLOOD, V118, P4179, DOI 10.1182/blood-2010-12-325373; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Coccia EM, 2006, CELL MOL BIOL, V52, P77, DOI 10.1170/T701; Davis G L, 2001, Rev Gastroenterol Disord, V1, P59; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Kumar KGS, 2003, EMBO J, V22, P5480; Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026; Liddicoat BJ, 2016, WIRES RNA, V7, P157, DOI 10.1002/wrna.1322; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Qiu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.125; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ren Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005764; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Wang GL, 2015, AM J PATHOL, V185, P3224, DOI 10.1016/j.ajpath.2015.08.002; Zheng H, 2011, J BIOL CHEM, V286, P35733, DOI 10.1074/jbc.M111.263608; Zheng H, 2011, BLOOD, V118, P4003, DOI 10.1182/blood-2011-06-359745; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	31	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24974	24985		10.1074/jbc.M116.737098	http://dx.doi.org/10.1074/jbc.M116.737098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27729454	Green Published, hybrid			2022-12-28	WOS:000388880100016
J	Ng, T; Hor, CHH; Chew, B; Zhao, J; Zhong, Z; Ryu, JR; Goh, ELK				Ng, Teclise; Hor, Catherine H. H.; Chew, Benjamin; Zhao, Jing; Zhong, Zhong; Ryu, Jae Ryun; Goh, Eyleen L. K.			Neuropilin 2 Signaling Is Involved in Cell Positioning of Adult-born Neurons through Glycogen Synthase Kinase-3 beta (GSK3 beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY GENERATED NEURONS; SYNAPTIC INTEGRATION; REGULATES MIGRATION; NEUROGENESIS; HIPPOCAMPUS; GSK-3; PATHWAY; SEMA3A; BRAIN	Proper positioning of neurons is fundamental for brain functions. However, little is known on how adult-born neurons generated in the hilar side of hippocampal dentate gyrus migrate into the granular cell layer. Because class 3 Semaphorins (Sema3) are involved in dendritic growth of these newborn neurons, we examined whether they are essential for cell positioning. We disrupted Sema3 signaling by silencing neuropilin 1 (NRP1) or 2 (NRP2), the main receptors for Sema3A and Sema3F, in neural progenitors of adult mouse dentate gyrus. Silencing of NRP2, but not NRP1, affected cell positioning of adult newborn neurons. Glycogen synthase kinase-3 beta (GSK3 beta) knockdown phenocopied this NRP2 silencing-mediated cell positioning defect, but did not affect dendritic growth. Furthermore, GSK3 beta is activated upon stimulation with Sema3F, and GSK3 beta overexpression rescued the cell positioning phenotypes seen in NRP2-deficient neurons. These results point to a new role for NRP2 in the positioning of neurons during adult hippocampal neurogenesis, acting via the GSK3 beta signaling pathway.	[Ng, Teclise; Chew, Benjamin; Ryu, Jae Ryun; Goh, Eyleen L. K.] Duke NUS Med Sch, Programme Neurosci & Behav Disorder, Singapore 169857, Singapore; [Hor, Catherine H. H.; Goh, Eyleen L. K.] Duke NUS Med Sch, Neurosci Acad Clin Programme, 8 Coll Rd, Singapore 169857, Singapore; [Hor, Catherine H. H.; Goh, Eyleen L. K.] Natl Neurosci Inst, Dept Res, Singapore 308433, Singapore; [Zhao, Jing; Zhong, Zhong] GlaxoSmithKline China R&D Co Ltd, Shanghai 201203, Peoples R China; [Goh, Eyleen L. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Goh, Eyleen L. K.] KK Womens & Childrens Hosp, KK Res Ctr, Singapore 229899, Singapore	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); GlaxoSmithKline; National University of Singapore; KK Women's & Children's Hospital	Ryu, JR; Goh, ELK (corresponding author), Duke NUS Med Sch, Neurosci Acad Clin Programme, 8 Coll Rd, Singapore 169857, Singapore.	jaeryunryu@gmail.com; eyleen.goh@duke-nus.edu.sg		Goh, Eyleen/0000-0002-8244-6959; Hor, Catherine/0000-0002-7467-2243	Abbott Nutrition; Academic Center of Excellence (ACE) research award from GlaxoSmithKline (GSK); National Research Foundation Singapore under its Competitive Research Program [NRF 2008 NRF-CRP 002-082]	Abbott Nutrition(Abbott Laboratories); Academic Center of Excellence (ACE) research award from GlaxoSmithKline (GSK); National Research Foundation Singapore under its Competitive Research Program(National Research Foundation, Singapore)	This work was supported by Abbott Nutrition, the Academic Center of Excellence (ACE) research award from GlaxoSmithKline (GSK), and the National Research Foundation Singapore under its Competitive Research Program (Grant NRF 2008 NRF-CRP 002-082) (to E. L. K. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bagri A, 2002, DEVELOPMENT, V129, P4249; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chew B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00158; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Duveau V, 2011, EUR J NEUROSCI, V34, P362, DOI 10.1111/j.1460-9568.2011.07782.x; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fitzsimons CP, 2013, MOL PSYCHIATR, V18, P993, DOI 10.1038/mp.2012.123; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ito K, 2008, J NEUROSCI, V28, P4414, DOI 10.1523/JNEUROSCI.0372-08.2008; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Koga T, 2015, J BIOL CHEM, V290, P30366, DOI 10.1074/jbc.M115.664169; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Larimer P, 2010, NAT NEUROSCI, V13, P213, DOI 10.1038/nn.2458; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Manning EE, 2012, HIPPOCAMPUS, V22, P309, DOI 10.1002/hipo.20900; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Namba T, 2011, J NEUROCHEM, V118, P34, DOI 10.1111/j.1471-4159.2011.07282.x; Ng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065572; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Shivaraj MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042935; Su CTE, 2015, JOVE-J VIS EXP, DOI 10.3791/52408; Tamamaki N, 2003, J COMP NEUROL, V455, P238, DOI 10.1002/cne.10476; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Whissell PD, 2013, ANN NEUROL, V74, P611, DOI 10.1002/ana.23941; Zhao N, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00158; Zhou MO, 2013, NEURON, V77, P647, DOI 10.1016/j.neuron.2012.12.033	40	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25088	25095		10.1074/jbc.M116.755215	http://dx.doi.org/10.1074/jbc.M116.755215			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27687730	Green Published, hybrid			2022-12-28	WOS:000388880100024
J	Torres, MA; Hoffarth, E; Eugenio, L; Savtchouk, J; Chen, X; Morris, JS; Facchini, PJ; Ng, KKS				Torres, Miguel A.; Hoffarth, Elesha; Eugenio, Luiz; Savtchouk, Julia; Chen, Xue; Morris, Jeremy S.; Facchini, Peter J.; Ng, Kenneth K. -S.			Structural and Functional Studies of Pavine N-Methyltransferase from Thalictrum flavum Reveal Novel Insights into Substrate Recognition and Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; protein structure; secondary metabolism; x-ray crystallography; Benzylisoquinoline alkaloid biosynthesis	ALKALOID BIOSYNTHESIS; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; BINDING-PROTEINS; METABOLISM	Benzylisoquinoline alkaloids (BIAs) are produced in a wide variety of plants and include many common analgesic, antitussive, and anticancer compounds. Several members of a distinct family of S-adenosylmethionine (SAM)-dependent N-methyltransferases (NMTs) play critical roles in BIA biosynthesis, but the molecular basis of substrate recognition and catalysis is not known for NMTs involved in BIA metabolism. To address this issue, the crystal structure of pavine NMT from Thalictrum flavum was solved using selenomethionine-substituted protein (d(min) = 2.8 ). Additional structures were determined for the native protein (d(min) = 2.0 ) as well as binary complexes with SAM (d(min) = 2.3 ) or the reaction product S-adenosylhomocysteine (d(min) = 1.6 ). The structure of a complex with S-adenosylhomocysteine and two molecules of tetrahydropapaverine (THP; one as the S conformer and a second in the R configuration) (d(min) = 1.8 ) revealed key features of substrate recognition. Pavine NMT converted racemic THP to laudanosine, but the enzyme showed a preference for (+/-)-pavine and (S)-reticuline as substrates. These structures suggest the involvement of highly conserved residues at the active site. Mutagenesis of three residues near the methyl group of SAM and the nitrogen atom of the alkaloid acceptor decreased enzyme activity without disrupting the structure of the protein. The binding site for THP provides a framework for understanding substrate specificity among numerous NMTs involved in the biosynthesis of BIAs and other specialized metabolites. This information will facilitate metabolic engineering efforts aimed at producing medicinally important compounds in heterologous systems, such as yeast.	[Torres, Miguel A.; Hoffarth, Elesha; Eugenio, Luiz; Savtchouk, Julia; Chen, Xue; Morris, Jeremy S.; Facchini, Peter J.; Ng, Kenneth K. -S.] Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Torres, Miguel A.; Hoffarth, Elesha; Eugenio, Luiz; Savtchouk, Julia; Ng, Kenneth K. -S.] Univ Calgary, Alberta Glyc Ctr, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.; Ng, KKS (corresponding author), Univ Calgary, Alberta Glyc Ctr, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca		Ng, Kenneth K.S./0000-0001-7280-8445; Torres, Megan/0000-0001-6126-709X	Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Some of the X-ray diffraction data were measured at beamline 08ID-1 of the Canadian Light Source (CLS), which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Some of the diffraction data were also measured at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS (including P41GM103393) and the National Center for Research Resources (P41RR001209). We thank Dr. Jillian Hagel for assistance with the chiral analysis of THP.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Drinkwater N, 2009, BIOCHEM J, V422, P463, DOI 10.1042/BJ20090702; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facchini PJ, 2003, PHYTOCHEMISTRY, V64, P177, DOI 10.1016/S0031-9422(03)00292-9; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; Farrow SC, 2012, PHYTOCHEMISTRY, V77, P79, DOI 10.1016/j.phytochem.2012.02.014; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; Gana R, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-6; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Jain A, 2008, ACTA CRYSTALLOGR F, V64, P1066, DOI 10.1107/S1744309108033046; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Komoto J, 2004, BIOCHEMISTRY-US, V43, P14385, DOI 10.1021/bi0486785; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Morris JS, 2016, J BIOL CHEM, V291, P23416, DOI 10.1074/jbc.M116.750893; Ropivia J, 2010, MOLECULES, V15, P6476, DOI 10.3390/molecules15096476; Saen-oon S, 2014, J BIOL CHEM, V289, P33815, DOI 10.1074/jbc.M114.611319; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Wu Q, 2013, ARCH BIOCHEM BIOPHYS, V539, P1, DOI 10.1016/j.abb.2013.08.019; Zhang JY, 2016, J AM CHEM SOC, V138, P9158, DOI 10.1021/jacs.6b03462; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	33	20	21	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23403	23415		10.1074/jbc.M116.747261	http://dx.doi.org/10.1074/jbc.M116.747261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27573242	hybrid, Green Published			2022-12-28	WOS:000387884400004
J	Fan, Y; He, JJ				Fan, Yan; He, Johnny J.			HIV-1 Tat Promotes Lysosomal Exocytosis in Astrocytes and Contributes to Astrocyte-mediated Tat Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; cathepsin B (CTSB); exocytosis; glial cell; human immunodeficiency virus (HIV); neuron	HUMAN-IMMUNODEFICIENCY-VIRUS; FIBRILLARY ACIDIC PROTEIN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TERMINAL REPEAT PROMOTER; CATHEPSIN-B INHIBITOR; NEURONAL CELL-DEATH; IN-VITRO; ALPHA PRODUCTION; TRANSGENIC MICE; AIDS DEMENTIA	Tat interaction with astrocytes has been shown to be important for Tat neurotoxicity and HIV/neuroAIDS. We have recently shown that Tat expression leads to increased glial fibrillary acidic protein (GFAP) expression and aggregation and activation of unfolded protein response/endoplasmic reticulum (ER) stress in astrocytes and causes neurotoxicity. However, the exact molecular mechanism of astrocyte-mediated Tat neurotoxicity is not defined. In this study, we showed that neurotoxic factors other than Tat protein itself were present in the supernatant of Tat-expressing astrocytes. Two-dimensional gel electrophoresis and mass spectrometry revealed significantly elevated lysosomal hydrolytic enzymes and plasma membrane-associated proteins in the supernatant of Tat-expressing astrocytes. We confirmed that Tat expression and infection of pseudotyped HIV.GFP led to increased lysosomal exocytosis from mouse astrocytes and human astrocytes. We found that Tat-induced lysosomal exocytosis was tightly coupled to astrocyte-mediated Tat neurotoxicity. In addition, we demonstrated that Tat-induced lysosomal exocytosis was astrocyte-specific and required GFAP expression and was mediated by ER stress. Taken together, these results show for the first time that Tat promotes lysosomal exocytosis in astrocytes and causes neurotoxicity through GFAP activation and ER stress induction in astrocytes and suggest a common cascade through which aberrant astrocytosis/GFAP up-regulation potentiates neurotoxicity and contributes to neurodegenerative diseases.	[Fan, Yan; He, Johnny J.] Univ North Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center	He, JJ (corresponding author), Univ North Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu	Fan, Yan/F-5107-2018		NINDS, National Institutes of Health [R01NS065785, R01094108, R01MH092673]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094108, R01NS065785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043162] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NINDS, National Institutes of Health Grants R01NS065785, R01094108, and R01MH092673 (to J. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopova I, 2012, PURINERG SIGNAL, V8, P59, DOI 10.1007/s11302-011-9259-2; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; ATWOOD WJ, 1993, ANN NY ACAD SCI, V693, P324, DOI 10.1111/j.1749-6632.1993.tb26298.x; Banks WA, 2005, EXP NEUROL, V193, P218, DOI 10.1016/j.expneurol.2004.11.019; Bastow ER, 2012, BIOL OPEN, V1, P318, DOI 10.1242/bio.2012547; Benelli R, 2000, J INFECT DIS, V182, P1643, DOI 10.1086/317597; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; BUMA P, 1983, CELL TISSUE RES, V233, P143; Cantres-Rosario Y, 2013, AIDS, V27, P347, DOI 10.1097/QAD.0b013e32835b3e47; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Cohen RA, 2009, NEUROLOGY, V73, P338, DOI 10.1212/WNL.0b013e3181b1220d; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Del Valle L, 2006, FRONT BIOSCI-LANDMRK, V11, P718, DOI 10.2741/1830; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fan Y, 2016, J BIOL CHEM, V291, P22819, DOI 10.1074/jbc.M116.731828; Fan Y, 2015, CURR HIV RES, V13, P55, DOI 10.2174/1570162X13666150121115804; Fan Y, 2011, J NEUROIMMUNE PHARM, V6, P121, DOI 10.1007/s11481-010-9217-8; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Fitting S, 2013, BIOL PSYCHIAT, V73, P443, DOI 10.1016/j.biopsych.2012.09.026; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hudson L, 2000, J NEUROVIROL, V6, P145, DOI 10.3109/13550280009013158; Hui L, 2012, ASN NEURO, V4, P243, DOI 10.1042/AN20120017; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jin JJ, 2012, AM J TRANSL RES, V4, P302; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Jung J, 2016, NEUROSCIENCE, V313, P10, DOI 10.1016/j.neuroscience.2015.11.028; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; KLAVER B, 1994, J VIROL, V68, P3830, DOI 10.1128/JVI.68.6.3830-3840.1994; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; KOLSON DL, 1993, AIDS RES HUM RETROV, V9, P677, DOI 10.1089/aid.1993.9.677; Lafrenie RM, 1996, J IMMUNOL, V157, P974; Lawrence CP, 2006, J IMMUNOL, V177, P3827, DOI 10.4049/jimmunol.177.6.3827; LEE SC, 1993, ANN NY ACAD SCI, V693, P314, DOI 10.1111/j.1749-6632.1993.tb26295.x; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; Liang QL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-37; Lieuallen K, 2001, HUM MOL GENET, V10, P1867, DOI 10.1093/hmg/10.18.1867; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu ZQ, 2014, J NEUROVIROL, V20, P278, DOI 10.1007/s13365-014-0245-7; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Mayne M, 2000, J IMMUNOL, V164, P6538, DOI 10.4049/jimmunol.164.12.6538; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; PAPAGAPIOU MP, 1990, J CEREBR BLOOD F MET, V10, P270, DOI 10.1038/jcbfm.1990.44; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Parks A, 2015, PEERJ, V3, DOI 10.7717/peerj.1314; PRICE RW, 1988, J INFECT DIS, V158, P1079, DOI 10.1093/infdis/158.5.1079; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; REMPEL SA, 1994, CANCER RES, V54, P6027; Rivera LE, 2014, CURR HIV RES, V12, P111, DOI 10.2174/1570162X12666140526120249; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rodriguez-Franco EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036571; SABATIER JM, 1991, J VIROL, V65, P961, DOI 10.1128/JVI.65.2.961-967.1991; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Schotte P, 2001, J BIOL CHEM, V276, P21153, DOI 10.1074/jbc.M102239200; Shute AA, 2005, NEUROSCIENCE, V131, P349, DOI 10.1016/j.neuroscience.2004.11.025; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Sun L, 2010, BIOCHEM BIOPH RES CO, V399, P391, DOI 10.1016/j.bbrc.2010.07.084; Tsuchiya K, 1999, EXP NEUROL, V155, P187, DOI 10.1006/exnr.1998.6988; Turchan-Cholewo J, 2009, J NEUROCHEM, V108, P202, DOI 10.1111/j.1471-4159.2008.05756.x; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005709; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zhou BY, 2004, NEUROSCI LETT, V359, P155, DOI 10.1016/j.neulet.2004.02.012; Zou W, 2007, AM J PATHOL, V171, P1923, DOI 10.2353/ajpath.2007.070333; Zou W, 2010, GLIA, V58, P1640, DOI 10.1002/glia.21038	84	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22830	22840		10.1074/jbc.M116.731836	http://dx.doi.org/10.1074/jbc.M116.731836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609518	hybrid, Green Published			2022-12-28	WOS:000386760600039
J	Makita, N; Sato, T; Yajima-Shoji, Y; Sato, J; Manaka, K; Eda-Hashimoto, M; Ootaki, M; Matsumoto, N; Nangaku, M; Iiri, T				Makita, Noriko; Sato, Tomohiko; Yajima-Shoji, Yuki; Sato, Junichiro; Manaka, Katsunori; Eda-Hashimoto, Makiko; Ootaki, Masanori; Matsumoto, Naoki; Nangaku, Masaomi; Iiri, Taroh			Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); membrane trafficking; molecular chaperone; receptor regulation; signal transduction	FUNCTIONAL-CHARACTERIZATION; PHARMACOLOGICAL CHAPERONES; BIASED AGONISM; MUTANT; ACTIVATION; G(S-ALPHA); RESCUE; IDENTIFICATION; DEFECT	Disease-causing mutations in G protein-coupled receptor (GPCR) genes, including the V2 vasopressin receptor (V2R) gene, often cause misfolded receptors, leading to a defect in plasma membrane trafficking. A novel V2R mutation, T273M, identified in a boy with partial nephrogenic diabetes insipidus (NDI), shows intracellular localization and partial defects similar to the two mutants we described previously (10). Although non-peptide V2R antagonists have been shown to rescue the membrane localization of V2R mutants, their level of functional rescue is weak. Interestingly, it has been reported that a non-peptide agonist, OPC51803, activates misfolded V2R mutants intracellularly without degradation, thus potentially serving as a therapeutic agent against NDI (14). In our current experiments, however, a peptide antagonist blocked arginine vasopressin (AVP)- or OPC51803-stimulated cAMP accumulation both in COS-7 and MDCK cells, suggesting that OPC51803 mainly stimulates cell surface V2R mutants. In addition, our analyses revealed that OPC51803 works not only as a non-peptide agonist that causes activation/-arrestin-dependent desensitization of V2R mutants expressed at the plasma membrane but also as a pharmacochaperone that promotes the endoplasmic reticulum-retained mutant maturation and trafficking to the plasma membrane. The ratio of the pharmacochaperone effect to the desensitization effect likely correlates negatively with the residual function of the tested mutants, suggesting that OPC5 has a more favorable effect on the V2R mutants with a less residual function. We speculated that the canceling of the desensitization effect of OPC51803 by the pharmacochaperone effect after long-term treatment may produce sustainable signaling, and thus pharmacochaperone agonists such as OPC51803 may serve as promising therapeutics for NDI caused by misfolded V2R mutants.	[Makita, Noriko; Yajima-Shoji, Yuki; Sato, Junichiro; Manaka, Katsunori; Eda-Hashimoto, Makiko; Nangaku, Masaomi; Iiri, Taroh] Univ Tokyo, Dept Endocrinol & Nephrol, Tokyo 1138655, Japan; [Sato, Tomohiko] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori 0368562, Japan; [Ootaki, Masanori; Matsumoto, Naoki; Iiri, Taroh] St Marianna Univ, Dept Pharmacol, Sch Med, Kawasaki, Kanagawa 2168511, Japan	University of Tokyo; Hirosaki University; Saint Marianna University	Makita, N (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.; Iiri, T (corresponding author), 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	norimaki-tky@umin.ac.jp; tiiri-tky@umin.ac.jp	Makita, Noriko/GQY-8175-2022		Ministry of Education, Science, Sports, and Culture, Japan	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Ala Y, 1998, J AM SOC NEPHROL, V9, P1861; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Bichet DG, 2016, BEST PRACT RES CL EN, V30, P263, DOI 10.1016/j.beem.2016.02.010; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; Bockenhauer D, 2015, NAT REV NEPHROL, V11, P576, DOI 10.1038/nrneph.2015.89; Bockenhauer D, 2010, NEPHRON PHYSIOL, V114, P1, DOI 10.1159/000245059; Chen CH, 2002, J HUM GENET, V47, P66, DOI 10.1007/s100380200002; Faerch M, 2008, CLIN ENDOCRINOL, V68, P395, DOI 10.1111/j.1365-2265.2007.03054.x; Faerch M, 2009, AM J PHYSIOL-RENAL, V297, pF1518, DOI 10.1152/ajprenal.00331.2009; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Huang CY, 2016, ACTA CRYSTALLOGR D, V72, P93, DOI 10.1107/S2059798315021683; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Inaba S, 2001, J CLIN ENDOCR METAB, V86, P381, DOI 10.1210/jc.86.1.381; Jean-Alphonse F, 2009, J AM SOC NEPHROL, V20, P2190, DOI 10.1681/ASN.2008121289; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Macion-Dazard R, 2006, J PHARMACOL EXP THER, V316, P564, DOI 10.1124/jpet.105.095554; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; Makita N, 2014, ENDOCR J, V61, P303, DOI 10.1507/endocrj.EJ13-0453; Makita N, 2013, CIRC RES, V112, P327, DOI 10.1161/CIRCRESAHA.112.277665; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Neocleous V, 2012, METABOLISM, V61, P922, DOI 10.1016/j.metabol.2012.01.005; Oishi A, 2012, J BIOL CHEM, V287, P38705, DOI 10.1074/jbc.M112.401547; Pasel K, 2000, J CLIN ENDOCR METAB, V85, P1703, DOI 10.1210/jc.85.4.1703; Robben JH, 2007, AM J PHYSIOL-RENAL, V292, pF253, DOI 10.1152/ajprenal.00247.2006; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Sadeghi H, 1997, MOL ENDOCRINOL, V11, P1806, DOI 10.1210/me.11.12.1806; Sahakitrungruang T, 2010, HORM RES PAEDIAT, V73, P349, DOI 10.1159/000308167; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]	35	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22460	22471		10.1074/jbc.M116.733220	http://dx.doi.org/10.1074/jbc.M116.733220			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601473	Green Published, hybrid			2022-12-28	WOS:000386760600009
J	Oho, M; Nakano, R; Nakayama, R; Sakurai, W; Miyamoto, A; Masuhiro, Y; Hanazawa, S				Oho, Michitaka; Nakano, Risa; Nakayama, Ryutarou; Sakurai, Wataru; Miyamoto, Azusa; Masuhiro, Yoshikazu; Hanazawa, Shigemasa			TIPE2 (Tumor Necrosis Factor -induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-penetrating peptide (CPP); immunology; inflammation; signal transduction; tumor necrosis factor (TNF)	NF-KAPPA-B; CELL-CYCLE PROGRESSION; KINASE KINASE KINASE; MAP KINASE; TRANSCRIPTIONAL ACTIVITY; TNFAIP8 FAMILY; ACTIVATION; TRAF6; BETA; IL-1	TIPE2 (TNF--induced protein 8-like 2) is a novel death effector domain protein and is a negative regulator of the innate and adaptive immune response. Although it has been demonstrated that caspase-8 contributes to the negative regulation of TIPE2, the negative regulatory mechanism is not entirely understood. Here, we demonstrate that TIPE2 interacts with TGF--activated kinase 1 (TAK1), a crucial regulatory molecule of inflammatory and immune signals, and consequently acts as a powerful negative regulator of TAK1. The interaction between endogenous TIPE2 and TAK1 was observed in RAW264.7 macrophage-like cells and mouse primary cells derived from spleen and thymus. The TIPE2 amino acid 101-140 region interacted with TAK1 by binding to the amino acid 200-291 region of the internal kinase domain of TAK1. TIPE2 interfered with the formation of the TAK1-TAB1-TAB2 complex and subsequently inhibited activation of TAK1 and its downstream molecules. Importantly, silencing TIPE2 through RNA interference attenuated the inhibitory action of TIPE2 on LPS- and TNF--stimulated TAK1 activity. Exogenous TIPE2 101-140, the region that interacts with TAK1, also inhibited LPS- and TNF--stimulated NF-B reporter activity. Interestingly, cell-permeable TIPE2 protein maintained its binding ability with TAK1 and exhibited the same inhibitory action of native TIPE2 on TLR4 signaling in vitro. Thus, cell-permeable TIPE2 protein is a potential candidate for intracellular protein therapy for TAK1-related diseases. The present study demonstrates that TIPE2 acts as a novel negative regulator of inflammatory and immune responses through TAK1 signaling.	[Oho, Michitaka; Nakano, Risa; Nakayama, Ryutarou; Sakurai, Wataru; Miyamoto, Azusa; Masuhiro, Yoshikazu; Hanazawa, Shigemasa] Nihon Univ, Dept Appl Biol Sci, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Nihon University	Hanazawa, S (corresponding author), Nihon Univ, Dept Appl Biol Sci, Coll Bioresource Sci, Lab Mol & Cell Physiol, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	hanazawa@brs.nihon-u.ac.jp			ministry of Education, Culture, Sports, Science and Technology of Japan	ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for science research from the ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Cao XL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-149; Choi JM, 2010, P NATL ACAD SCI USA, V107, P18575, DOI 10.1073/pnas.1000400107; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Fan YH, 2012, CELL SIGNAL, V24, P1381, DOI 10.1016/j.cellsig.2012.02.017; Goswami M, 2001, DEV BIOL, V236, P259, DOI 10.1006/dbio.2001.0338; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Ha JY, 2014, J NEUROCHEM, V129, P527, DOI [10.1111/jnc.12643, 10.1111/j.1471-4159.2013.12643.x]; Ishida H, 2005, J BIOL CHEM, V280, P24642, DOI 10.1074/jbc.M500189200; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kim SY, 2014, MOL CELL BIOL, V34, P510, DOI 10.1128/MCB.01225-13; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lou YW, 2013, J IMMUNOL, V191, P4849, DOI 10.4049/jimmunol.1300053; Lou YW, 2011, MOL IMMUNOL, V49, P4, DOI 10.1016/j.molimm.2011.08.006; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Masuhiro Y, 2008, J BIOL CHEM, V283, P31575, DOI 10.1074/jbc.M800328200; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Munoz-Sanjuan I, 2002, DEVELOPMENT, V129, P5529, DOI 10.1242/dev.00097; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Ray DM, 2010, BIOCHEM CELL BIOL, V88, P947, DOI 10.1139/O10-148; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Shi TY, 2013, CARCINOGENESIS, V34, P770, DOI 10.1093/carcin/bgt001; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Woodward MJ, 2010, CELL DEATH DIFFER, V17, P316, DOI 10.1038/cdd.2009.125; Zhang SY, 2010, BBA-MOL BASIS DIS, V1802, P1078, DOI 10.1016/j.bbadis.2010.08.003; Zhang Y, 2012, J BIOL CHEM, V287, P32546, DOI 10.1074/jbc.M112.348755; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037846; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	43	23	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22650	22660		10.1074/jbc.M116.733451	http://dx.doi.org/10.1074/jbc.M116.733451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601471	Green Published, hybrid			2022-12-28	WOS:000386760600025
J	Martin, GM; Rex, EA; Devaraneni, P; Denton, JS; Boodhansingh, KE; DeLeon, DD; Stanley, CA; Shyng, SL				Martin, Gregory M.; Rex, Emily A.; Devaraneni, Prasanna; Denton, Jerod S.; Boodhansingh, Kara E.; DeLeon, Diva D.; Stanley, Charles A.; Shyng, Show-Ling			Pharmacological Correction of Trafficking Defects in ATP-sensitive Potassium Channels Caused by Sulfonylurea Receptor 1 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; ATP-binding cassette transporter subfamily C member 8 (ABCC8); chaperone; gating; hypoglycemia; insulin secretion; intracellular trafficking; potassium channel; protein misfolding; protein processing	PANCREATIC BETA-CELLS; CONGENITAL HYPERINSULINISM; INSULIN-SECRETION; FAMILIAL HYPERINSULINISM; K+ CHANNELS; INFANCY; DIAGNOSIS; DISEASES; ABCC8; RESCUE	ATP-sensitive potassium (K-ATP) channels play a key role in mediating glucose-stimulated insulin secretion by coupling metabolic signals to -cell membrane potential. Loss of K-ATP channel function due to mutations in ABCC8 or KCNJ11, genes encoding the sulfonylurea receptor 1 (SUR1) or the inwardly rectifying potassium channel Kir6.2, respectively, results in congenital hyperinsulinism. Many SUR1 mutations prevent trafficking of channel proteins from the endoplasmic reticulum to the cell surface. Channel inhibitors, including sulfonylureas and carbamazepine, have been shown to correct channel trafficking defects. In the present study, we identified 13 novel SUR1 mutations that cause channel trafficking defects, the majority of which are amenable to pharmacological rescue by glibenclamide and carbamazepine. By contrast, none of the mutant channels were rescued by K-ATP channel openers. Cross-linking experiments showed that K-ATP channel inhibitors promoted interactions between the N terminus of Kir6.2 and SUR1, whereas channel openers did not, suggesting the inhibitors enhance intersubunit interactions to overcome channel biogenesis and trafficking defects. Functional studies of rescued mutant channels indicate that most mutants rescued to the cell surface exhibited WT-like sensitivity to ATP, MgADP, and diazoxide. In intact cells, recovery of channel function upon trafficking rescue by reversible sulfonylureas or carbamazepine was facilitated by the K-ATP channel opener diazoxide. Our study expands the list of K-ATP channel trafficking mutations whose function can be recovered by pharmacological ligands and provides further insight into the structural mechanism by which channel inhibitors correct channel biogenesis and trafficking defects.	[Martin, Gregory M.; Rex, Emily A.; Devaraneni, Prasanna; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Denton, Jerod S.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37232 USA; [Boodhansingh, Kara E.; DeLeon, Diva D.; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Philadelphia, PA 19104 USA	Oregon Health & Science University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu	De Leon, Diva D./V-8626-2019	De Leon, Diva D./0000-0003-1225-8087	National Institutes of Health [R01DK066485, F31DK105800, R01DK098517, R37DK056268]; Goldsmith Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066485, F31DK105800, R01DK098517, R37DK056268, R01DK057699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldsmith Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DK066485 (to S.-L. S.), F31DK105800 (to G. M. M.), R01DK098517 (to D. D. D. L.), and R37DK056268 (to C. A. S.) and a grant from the Goldsmith Foundation (to D. D. D. L. and C. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2001, RECENT PROG HORM RES, V56, P47, DOI 10.1210/rp.56.1.47; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chen PC, 2013, J BIOL CHEM, V288, P20942, DOI 10.1074/jbc.M113.470948; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Convertino M, 2016, ACS CHEM BIOL, V11, P1471, DOI 10.1021/acschembio.6b00195; Cosgrove KE, 2004, EUR J PHARMACOL, V486, P133, DOI 10.1016/j.ejphar.2003.12.017; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; De Vroede M, 2004, PEDIATRICS, V114, pE520, DOI 10.1542/peds.2003-1180-L; Devaraneni PK, 2015, J BIOL CHEM, V290, P7980, DOI 10.1074/jbc.M114.634576; Fernandez-Marmiesse A, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9401; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Greer RM, 2007, PEDIATR DEVEL PATHOL, V10, P25, DOI 10.2350/06-04-0083.1; Hardy OT, 2007, J PEDIATR-US, V150, P140, DOI 10.1016/j.jpeds.2006.08.028; Leidenheimer NJ, 2014, PHARMACOL RES, V83, P10, DOI 10.1016/j.phrs.2014.01.005; MacMullen CM, 2011, DIABETES, V60, P1797, DOI 10.2337/db10-1631; Martin GM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00386; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nielsen FE, 2006, J MED CHEM, V49, P4127, DOI 10.1021/jm060042j; Otonkoski T, 2006, DIABETES, V55, P13, DOI 10.2337/diabetes.55.01.06.db05-1128; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pratt EB, 2009, J BIOL CHEM, V284, P7951, DOI 10.1074/jbc.M807012200; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Raphemot R, 2014, MOL PHARMACOL, V85, P858, DOI 10.1124/mol.114.091884; Sampson HM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-11; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Snider KE, 2013, J CLIN ENDOCR METAB, V98, pE355, DOI 10.1210/jc.2012-2169; Stanley CA, 2016, J CLIN ENDOCR METAB, V101, P815, DOI 10.1210/jc.2015-3651; Suchi M, 2006, MODERN PATHOL, V19, P122, DOI 10.1038/modpathol.3800497; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; Tornovsky S, 2004, J CLIN ENDOCR METAB, V89, P6224, DOI 10.1210/jc.2004-1233; Verheul JC, 2011, NED TIJDSCHR GENEES, V155, pA3343; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou Q, 2014, CHANNELS, V8, P376, DOI 10.4161/chan.29117	47	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21971	21983		10.1074/jbc.M116.749366	http://dx.doi.org/10.1074/jbc.M116.749366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573238	Green Published, hybrid			2022-12-28	WOS:000386332600013
J	Smith, CA; Nossoni, Z; Toth, M; Stewart, NK; Frase, H; Vakulenko, SB				Smith, Clyde A.; Nossoni, Zahra; Toth, Marta; Stewart, Nichole K.; Frase, Hilary; Vakulenko, Sergei B.			Role of the Conserved Disulfide Bridge in Class A Carbapenemases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; crystal structure; disulfide; enzyme kinetics; hydrogen bond; carbapenemase; enzyme stability	BETA-LACTAMASES; ESCHERICHIA-COLI; STRUCTURAL BASIS; ACTIVE-SITE; CRYSTALLOGRAPHY; RESISTANCE; CEPHALOSPORINASE; REQUIREMENTS; HYDROLYSIS; RESOLUTION	Some members of the class A -lactamase family are capable of conferring resistance to the last resort antibiotics, carbapenems. A unique structural feature of these clinically important enzymes, collectively referred to as class A carbapenemases, is a disulfide bridge between invariant Cys(69) and Cys(238) residues. It was proposed that this conserved disulfide bridge is responsible for their carbapenemase activity, but this has not yet been validated. Here we show that disruption of the disulfide bridge in the GES-5 carbapenemase by the C69G substitution results in only minor decreases in the conferred levels of resistance to the carbapenem imipenem and other -lactams. Kinetic and circular dichroism experiments with C69G-GES-5 demonstrate that this small drop in antibiotic resistance is due to a decline in the enzyme activity caused by a marginal loss of its thermal stability. The atomic resolution crystal structure of C69G-GES-5 shows that two domains of this disulfide bridge-deficient enzyme are held together by an intensive hydrogen-bonding network. As a result, the protein architecture and imipenem binding mode remain unchanged. In contrast, the corresponding hydrogen-bonding networks in NMCA, SFC-1, and SME-1 carbapenemases are less intensive, and as a consequence, disruption of the disulfide bridge in these enzymes destabilizes them, which causes arrest of bacterial growth. Our results demonstrate that the disulfide bridge is essential for stability but does not play a direct role in the carbapenemase activity of the GES family of -lactamases. This would likely apply to all other class A carbapenemases given the high degree of their structural similarity.	[Smith, Clyde A.] Stanford Univ, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Nossoni, Zahra; Toth, Marta; Stewart, Nichole K.; Frase, Hilary; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA	Stanford University; University of Notre Dame	Vakulenko, SB (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.; Smith, CA (corresponding author), Stanford Synchrotron Radiat Lightsource, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	csmith@slac.stanford.edu; svakulen@nd.edu			National Institutes of Health [R01AI089726]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01AI089726 (to S. B. V.). The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Copeland R. A., 2004, ENZYMES PRACTICAL IN; DELAIRE M, 1992, J BIOL CHEM, V267, P20600; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fonseca F, 2012, J AM CHEM SOC, V134, P18275, DOI 10.1021/ja304460j; Frase H, 2009, J BIOL CHEM, V284, P29509, DOI 10.1074/jbc.M109.011262; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Helfand MS, 2002, J BIOL CHEM, V277, P47719, DOI 10.1074/jbc.M207271200; JAURIN B, 1981, P NATL ACAD SCI-BIOL, V78, P4897, DOI 10.1073/pnas.78.8.4897; JELSCH C, 1992, FEBS LETT, V299, P135, DOI 10.1016/0014-5793(92)80232-6; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Majiduddin FK, 2003, ANTIMICROB AGENTS CH, V47, P1062, DOI 10.1128/AAC.47.3.1062-1067.2003; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; OUELLETTE M, 1987, P NATL ACAD SCI USA, V84, P7378, DOI 10.1073/pnas.84.21.7378; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Raquet X, 1997, PROTEINS, V27, P47, DOI 10.1002/(SICI)1097-0134(199701)27:1<47::AID-PROT6>3.0.CO;2-K; Russi S, 2016, J APPL CRYSTALLOGR, V49, P622, DOI 10.1107/S1600576716000649; Smith CA, 2007, ACTA CRYSTALLOGR D, V63, P982, DOI 10.1107/S0907444907036955; Smith CA, 2012, J AM CHEM SOC, V134, P19512, DOI 10.1021/ja308197j; Smith Clyde A, 2008, JALA Charlottesv Va, V13, P335, DOI 10.1016/j.jala.2008.08.008; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Sougakoff W, 2002, ACTA CRYSTALLOGR D, V58, P267, DOI 10.1107/S0907444901019606; Stewart NK, 2015, BIOCHEMISTRY-US, V54, P588, DOI 10.1021/bi501052t; Swaren P, 1998, J BIOL CHEM, V273, P26714, DOI 10.1074/jbc.273.41.26714; Tondi D, 2016, CURR DRUG TARGETS, V17, P983, DOI 10.2174/1389450116666151001104448; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22196	22206		10.1074/jbc.M116.749648	http://dx.doi.org/10.1074/jbc.M116.749648			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27590339	Green Published, hybrid			2022-12-28	WOS:000386332600031
J	Woodall, BP; Woodall, MC; Luongo, TS; Grisanti, LA; Tilley, DG; Elrod, JW; Koch, WJ				Woodall, Benjamin P.; Woodall, Meryl C.; Luongo, Timothy S.; Grisanti, Laurel A.; Tilley, Douglas G.; Elrod, John W.; Koch, Walter J.			Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adrenergic receptor; Akt PKB; G protein-coupled receptor (GPCR); mouse; muscle hypertrophy; muscle physiology	MYOCARDIAL CONTRACTILE FUNCTION; CARDIAC-FUNCTION; INSULIN-RESISTANCE; HEART; EXPRESSION; THERAPY; INHIBITION; NORMALIZES; FAILURE; GROWTH	GRK2, a G protein-coupled receptor kinase, plays a critical role in cardiac physiology. Adrenergic receptors are the primary target for GRK2 activity in the heart; phosphorylation by GRK2 leads to desensitization of these receptors. As such, levels of GRK2 activity in the heart directly correlate with cardiac contractile function. Furthermore, increased expression of GRK2 after cardiac insult exacerbates injury and speeds progression to heart failure. Despite the importance of this kinase in both the physiology and pathophysiology of the heart, relatively little is known about the role of GRK2 in skeletal muscle function and disease. In this study we generated a novel skeletal muscle-specific GRK2 knock-out (KO) mouse (MLC-Cre:GRK2(fl/fl)) to gain a better understanding of the role of GRK2 in skeletal muscle physiology. In isolated muscle mechanics testing, GRK2 ablation caused a significant decrease in the specific force of contraction of the fast-twitch extensor digitorum longus muscle yet had no effect on the slow-twitch soleus muscle. Despite these effects in isolated muscle, exercise capacity was not altered in MLC-Cre:GRK2(fl/fl) mice compared with wild-type controls. Skeletal muscle hypertrophy stimulated by clenbuterol, a (2)-adrenergic receptor ((2)AR) agonist, was significantly enhanced in MLC-Cre:GRK2(fl/fl) mice; mechanistically, this seems to be due to increased clenbuterol-stimulated pro-hypertrophic Akt signaling in the GRK2 KO skeletal muscle. In summary, our study provides the first insights into the role of GRK2 in skeletal muscle physiology and points to a role for GRK2 as a modulator of contractile properties in skeletal muscle as well as (2)AR-induced hypertrophy.	[Woodall, Benjamin P.; Woodall, Meryl C.; Luongo, Timothy S.; Grisanti, Laurel A.; Tilley, Douglas G.; Elrod, John W.; Koch, Walter J.] Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Koch, WJ (corresponding author), Temple Univ, Dept Pharmacol, Ctr Translat Med, 3500 N Broad St,941 MERB, Philadelphia, PA 19140 USA.	walter.koch@temple.edu	Luongo, Timothy/AAY-1073-2020	Tilley, Douglas/0000-0002-9681-3377; Elrod, John/0000-0003-3925-2224; Luongo, Timothy/0000-0001-7621-7992	National Institutes of Health [P01 HL091799, R37 HL061690, R01 HL085503, P01 HL075443, P01 HL108806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL061690, P01HL091799, R01HL123966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA037830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grant P01 HL091799. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; The W. W. Smith Chair in Cardiovascular Medicine at the Lewis Katz School of Medicine at Temple University. Supported by National Institutes of Health Grants R37 HL061690, R01 HL085503, P01 HL075443 (Project 2), and P01 HL108806 (Project 3). To whom correspondence should be addressed: Dept. of Pharmacology, Center for Translational Medicine, Temple University, 3500 N. Broad St., 941 MERB, Philadelphia, PA 19140-4106. Tel.: 215-707-9820; Fax: 215-707-9890; E-mail: walter.koch@temple.edu.	Akhter SA, 1999, CIRCULATION, V100, P648, DOI 10.1161/01.CIR.100.6.648; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; BENSON DW, 1991, J SURG RES, V50, P1; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Cairns SP, 2015, J PHYSIOL-LONDON, V593, P4713, DOI 10.1113/JP270909; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Ciccarelli M, 2011, CIRCULATION, V123, P1953, DOI 10.1161/CIRCULATIONAHA.110.988642; Garcia-Guerra L, 2010, DIABETES, V59, P2407, DOI 10.2337/db10-0771; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; MALTIN CA, 1986, BIOSCIENCE REP, V6, P293, DOI 10.1007/BF01115158; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Petrofski JA, 2003, J MOL CELL CARDIOL, V35, P1167, DOI 10.1016/S0022-2828(03)00243-8; Raake PW, 2012, CIRCULATION, V125, P2108, DOI 10.1161/CIRCULATIONAHA.111.044255; Raake PWJ, 2013, EUR HEART J, V34, P1437, DOI 10.1093/eurheartj/ehr447; Rengo G, 2009, CIRCULATION, V119, P89, DOI 10.1161/CIRCULATIONAHA.108.803999; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Sato PY, 2015, J MOL CELL CARDIOL, V89, P360, DOI 10.1016/j.yjmcc.2015.10.002; Sato PY, 2015, PHYSIOL REV, V95, P377, DOI 10.1152/physrev.00015.2014; Schumacher SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0154; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Shah AS, 2001, CIRCULATION, V103, P1311; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Woo AYH, 2012, ACTA PHARMACOL SIN, V33, P335, DOI 10.1038/aps.2011.201; Woodall MC, 2014, CIRC RES, V114, P1661, DOI 10.1161/CIRCRESAHA.114.300513; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; ZEMAN RJ, 1988, AM J PHYSIOL, V254, pE726, DOI 10.1152/ajpendo.1988.254.6.E726	35	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21913	21924		10.1074/jbc.M116.721282	http://dx.doi.org/10.1074/jbc.M116.721282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27566547	hybrid, Green Published			2022-12-28	WOS:000386332600008
J	Hexnerova, R; Krizkova, K; Fabry, M; Sieglova, I; Kedrova, K; Collinsova, M; Ullrichova, P; Srb, P; Williams, C; Crump, MP; Tosner, Z; Jiracek, J; Veverka, V; Zakova, L				Hexnerova, Rozalie; Krizkova, Kvetoslava; Fabry, Milan; Sieglova, Irena; Kedrova, Katerina; Collinsova, Michaela; Ullrichova, Pavlina; Srb, Pavel; Williams, Christopher; Crump, Matthew P.; Tosner, Zdenek; Jiracek, Jiri; Veverka, Vaclav; Zakova, Lenka			Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; IGF-II; LIGAND-BINDING; 3-DIMENSIONAL STRUCTURE; 6-PHOSPHATE RECEPTOR; PROTEIN INTERACTIONS; ECTODOMAIN REVEALS; TYROSINE RESIDUES; CRYSTAL-STRUCTURE; HYBRID RECEPTORS	Insulin and insulin-like growth factors I and II are closely related protein hormones. Their distinct evolution has resulted in different yet overlapping biological functions with insulin becoming a key regulator of metabolism, whereas insulin-like growth factors (IGF)-I/II are major growth factors. Insulin and IGFs cross-bind with different affinities to closely related insulin receptor isoforms A and B (IR-A and IR-B) and insulin-like growth factor type I receptor (IGF-1R). Identification of structural determinants in IGFs and insulin that trigger their specific signaling pathways is of increasing importance in designing receptor-specific analogs with potential therapeutic applications. Here, we developed a straightforward protocol for production of recombinant IGF-II and prepared six IGF-II analogs with IGF-I-like mutations. All modified molecules exhibit significantly reduced affinity toward IR-A, particularly the analogs with a Pro-Gln insertion in the C-domain. Moreover, one of the analogs has enhanced binding affinity for IGF-1R due to a synergistic effect of the Pro-Gln insertion and S29N point mutation. Consequently, this analog has almost a 10-fold higher IGF1R/IR-A binding specificity in comparison with native IGF-II. The established IGF-II purification protocol allowed for cost-effective isotope labeling required for a detailedNMRstructural characterization of IGF-II analogs that revealed a link between the altered binding behavior of selected analogs and conformational rearrangement of their C-domains.	[Hexnerova, Rozalie; Krizkova, Kvetoslava; Fabry, Milan; Sieglova, Irena; Kedrova, Katerina; Collinsova, Michaela; Srb, Pavel; Jiracek, Jiri; Veverka, Vaclav; Zakova, Lenka] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic; [Hexnerova, Rozalie; Krizkova, Kvetoslava; Kedrova, Katerina; Tosner, Zdenek] Charles Univ Prague, Fac Sci, Albertov 6, Prague 12843, Czech Republic; [Ullrichova, Pavlina] Univ Chem & Technol, Dept Analyt Chem, Tech 5, Prague 16628 6, Czech Republic; [Fabry, Milan] Acad Sci Czech Republic, Inst Mol Genet, Vvi, Videnska 1083, CR-14220 Prague 4, Czech Republic; [Williams, Christopher; Crump, Matthew P.] Univ Bristol, Sch Chem, Dept Organ & Biol Chem, Cantocks Close, Bristol BS8 1TS, Avon, England	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Bristol	Veverka, V; Zakova, L (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.	vaclav.veverka@uochb.cas.cz; zakova@uochb.cas.cz	Zakova, Lenka/A-7119-2008; Zakova, Lenka/Y-6234-2019; Tosner, Zdenek/G-6736-2014; Veverka, Vaclav/P-5251-2019; Wiliams, Christopher/P-4904-2015; Hexnerová, Rozálie/O-6968-2017; Mlčochová, Květoslava/L-6979-2017; Srb, Pavel/C-5202-2014; Jiracek, Jiri/Y-6703-2019; Fabry, Milan/G-3602-2014; Machackova, Katerina/G-5608-2014; Veverka, Vaclav/G-9174-2014; Jiracek, Jiri/A-7124-2008	Zakova, Lenka/0000-0001-6439-2574; Tosner, Zdenek/0000-0003-2741-9154; Veverka, Vaclav/0000-0003-3782-5279; Wiliams, Christopher/0000-0001-5806-9842; Hexnerová, Rozálie/0000-0002-3537-8439; Mlčochová, Květoslava/0000-0002-6226-8067; Srb, Pavel/0000-0002-4562-578X; Jiracek, Jiri/0000-0003-3848-2773; Machackova, Katerina/0000-0003-4980-9460; Veverka, Vaclav/0000-0003-3782-5279; Jiracek, Jiri/0000-0003-3848-2773; Crump, Matthew/0000-0002-7868-5818	Czech Science Foundation [15-19018S]; Medical Research Council [MR/K000179/1]; Ministry of Education of the Czech Republic Programs "NAVRAT" [LK11205]; NPU I [LO1304]; Charles University Grant Agency [227020]; Specific University Research (Ministry of Education of the Czech Republic) [20/2013, A1_FCHI_2014_003]; Research Project of the Academy of Sciences of the Czech Republic [RVO:61388963]; MRC [MR/K000179/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1237655] Funding Source: researchfish	Czech Science Foundation(Grant Agency of the Czech Republic); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education of the Czech Republic Programs "NAVRAT"; NPU I; Charles University Grant Agency; Specific University Research (Ministry of Education of the Czech Republic); Research Project of the Academy of Sciences of the Czech Republic(Czech Academy of Sciences); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Czech Science Foundation Grant 15-19018S, Medical Research Council Grant MR/K000179/1, Ministry of Education of the Czech Republic Programs "NAVRAT" LK11205 and "NPU I" LO1304, Charles University Grant Agency Grant 227020, Specific University Research (Ministry of Education of the Czech Republic Grant 20/2013, A1_FCHI_2014_003), and Research Project of the Academy of Sciences of the Czech Republic RVO:61388963. The authors declare that they have no conflicts of interest with the contents of this article.	Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Alvino CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027488; Alvino CL, 2009, J BIOL CHEM, V284, P7656, DOI 10.1074/jbc.M808061200; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; Bedinger DH, 2015, MOL CELL ENDOCRINOL, V415, P143, DOI 10.1016/j.mce.2015.08.013; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Boucher J, 2010, J BIOL CHEM, V285, P17235, DOI 10.1074/jbc.M110.118620; Brandt J, 2001, J BIOL CHEM, V276, P12378, DOI 10.1074/jbc.M009402200; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; De, 2015, BIOESSAYS, V37, P389; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; DeWolf E, 1996, PROTEIN SCI, V5, P2193; Dynkevich Y, 2013, ENDOCR REV, V34, P798, DOI 10.1210/er.2012-1033; Esposito DL, 1997, ENDOCRINOLOGY, V138, P2979, DOI 10.1210/en.138.7.2979; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; FRANCIS GL, 1992, J MOL ENDOCRINOL, V8, P213, DOI 10.1677/jme.0.0080213; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gill R, 1999, PROTEIN ENG, V12, P297, DOI 10.1093/protein/12.4.297; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; GURSKY O, 1992, BIOPHYS J, V61, P604, DOI 10.1016/S0006-3495(92)81865-9; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; HASHIMOTO R, 1995, J BIOL CHEM, V270, P18013, DOI 10.1074/jbc.270.30.18013; Henderson ST, 2015, GROWTH HORM IGF RES, V25, P20, DOI 10.1016/j.ghir.2014.09.004; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KING GL, 1982, J BIOL CHEM, V257, P869; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kosinova L, 2014, BIOCHEMISTRY-US, V53, P3392, DOI 10.1021/bi500073z; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Krizkova K, 2016, BIOCHEMISTRY-US, V55, P2903, DOI 10.1021/acs.biochem.6b00140; Laajoki LG, 2000, J BIOL CHEM, V275, P10009, DOI 10.1074/jbc.275.14.10009; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; MALY P, 1988, J BIOL CHEM, V263, P7068; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Pascual-Lucas M, 2014, EMBO MOL MED, V6, P1246, DOI 10.15252/emmm.201404228; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SATO A, 1993, INT J PEPT PROT RES, V41, P433; SCHAEFER EM, 1990, J BIOL CHEM, V265, P13248; Schaffer ML, 2003, BIOCHEMISTRY-US, V42, P9324, DOI 10.1021/bi034386c; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Siwanowicz I, 2005, STRUCTURE, V13, P155, DOI 10.1016/j.str.2004.11.009; Slaaby R, 2008, GROWTH HORM IGF RES, V18, P267, DOI 10.1016/j.ghir.2007.09.003; Slaaby R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07911; Sohma Y, 2008, ANGEW CHEM INT EDIT, V47, P1102, DOI 10.1002/anie.200703521; TERASAWA H, 1994, EMBO J, V13, P5590, DOI 10.1002/j.1460-2075.1994.tb06896.x; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Vikova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19431; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; Williams C, 2012, SCIENCE, V338, P1209, DOI 10.1126/science.1228633; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; Yun CH, 2005, BIOCHEM BIOPH RES CO, V326, P52, DOI 10.1016/j.bbrc.2004.10.203; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; Zeslawski W, 2001, EMBO J, V20, P3638, DOI 10.1093/emboj/20.14.3638; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6; Ziegler AN, 2014, J BIOL CHEM, V289, P4626, DOI 10.1074/jbc.M113.537597	87	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21234	+		10.1074/jbc.M116.741041	http://dx.doi.org/10.1074/jbc.M116.741041			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27510031	hybrid, Green Published			2022-12-28	WOS:000385406200036
J	Rapanelli, M; Frick, LR; Horn, KD; Schwarcz, RC; Pogorelov, V; Nairn, AC; Pittenger, C				Rapanelli, Maximiliano; Frick, Luciana R.; Horn, Kyla D.; Schwarcz, Rivka C.; Pogorelov, Vladimir; Nairn, Angus C.; Pittenger, Christopher			The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-3 RECEPTOR; HISTIDINE-DECARBOXYLASE; TOURETTE SYNDROME; REPETITIVE BEHAVIOR; S6 PHOSPHORYLATION; DOPAMINE D-1; PATHWAYS; MICE; NEUROBIOLOGY; COCAINE	The basal ganglia have a central role in motor patterning, habits, motivated behaviors, and cognition as well as in numerous neuropsychiatric disorders. Receptors for histamine, especially the H3 receptor (H3R), are highly expressed in the striatum, the primary input nucleus of the basal ganglia, but their effects on this circuitry have been little explored. H3R interacts with dopamine (DA) receptors ex vivo; the nature and functional importance of these interactions in vivo remain obscure. We found H3R activation with the agonist R-(-)-alpha-methylhistamine to produce a unique time-and cell type-dependent profile of molecular signaling events in the striatum. H3 agonist treatment did not detectably alter extracellular DA levels or signaling through the cAMP/DARPP-32 signaling pathway in either D1- or D2-expressing striatal medium spiny neurons (MSNs). In D1-MSNs, H3 agonist treatment transiently activated MAPK signaling and phosphorylation of rpS6 and led to phosphorylation of GSK3 beta-Ser(9), a novel effect. Consequences of H3 activation in D2-MSNs were completely different. MAPK signaling was unchanged, and GSK3 beta-Ser(9) phosphorylation was reduced. At the behavioral level, two H3 agonists had no significant effect on locomotion or stereotypy, but they dramatically attenuated the locomotor activation produced by the D1 agonist SKF82958. H3 agonist co-administration blocked the activation of MAPK signaling and the phosphorylation of rpS6 produced by D1 activation in D1-MSNs, paralleling behavioral effects. In contrast, GSK3 beta-Ser(9) phosphorylation was seen only after H3 agonist treatment, with no interactive effects. H3R signaling has been neglected in models of basal ganglia function and has implications for a range of pathophysiologies.	[Rapanelli, Maximiliano; Frick, Luciana R.; Pogorelov, Vladimir; Nairn, Angus C.; Pittenger, Christopher] Yale Univ, Dept Psychiat, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Dept Psychol, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Ctr Child Study, New Haven, CT 06519 USA; [Horn, Kyla D.; Pittenger, Christopher] Yale Univ, Interdept Neurosci Program, New Haven, CT 06519 USA; [Schwarcz, Rivka C.] Yale Univ, Grad Program Cell Biol, New Haven, CT 06519 USA; [Pogorelov, Vladimir] Duke Univ, 469 Sands Bldg, Durham, NC 27710 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Duke University	Nairn, AC; Pittenger, C (corresponding author), 34 Pk St,3rd Floor, New Haven, CT 06519 USA.	angus.nairn@yale.edu; christopher.pittenger@yale.edu	rapanelli, maximiliano/P-3141-2016	rapanelli, maximiliano/0000-0001-7329-2364; Nairn, Angus/0000-0002-7075-0195; Pittenger, Christopher/0000-0003-2117-9321	Allison Family Foundation; Tourette Syndrome Association; National Institutes of Health [R01MH091861, DA10044, MH090963]; State of Connecticut through Ribicoff Research Facilities at the Connecticut Mental Health Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091861, P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	Allison Family Foundation; Tourette Syndrome Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut through Ribicoff Research Facilities at the Connecticut Mental Health Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Allison Family Foundation (to C. P.), the Tourette Syndrome Association (to L. F.), National Institutes of Health Grants R01MH091861 (to C. P.) and DA10044 and MH090963 (to A. C. N.), and the State of Connecticut through its support of the Ribicoff Research Facilities at the Connecticut Mental Health Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; Banks ML, 2009, PHARMACOLOGY, V83, P164, DOI 10.1159/000191473; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biever A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00075; Bolam JP, 2016, NEUROPHARMACOLOGY, V106, P74, DOI 10.1016/j.neuropharm.2015.08.013; Bongers G, 2007, J NEUROCHEM, V103, P248, DOI 10.1111/j.1471-4159.2007.04752.x; Brabant C, 2010, PROG NEUROBIOL, V92, P421, DOI 10.1016/j.pneurobio.2010.07.002; Brabant C, 2009, PSYCHOPHARMACOLOGY, V202, P673, DOI 10.1007/s00213-008-1345-y; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chan CS, 2012, J NEUROSCI, V32, P9124, DOI 10.1523/JNEUROSCI.0229-12.2012; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Desai RI, 2005, PHARMACOL BIOCHEM BE, V81, P843, DOI 10.1016/j.pbb.2005.06.006; Ellenbroek BA, 2013, BRIT J PHARMACOL, V170, P46, DOI 10.1111/bph.12221; Ellender TJ, 2011, J NEUROSCI, V31, P15340, DOI 10.1523/JNEUROSCI.3144-11.2011; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Ferrada C, 2008, NEUROPHARMACOLOGY, V55, P190, DOI 10.1016/j.neuropharm.2008.05.008; Ferrada C, 2009, BRIT J PHARMACOL, V157, P64, DOI 10.1111/j.1476-5381.2009.00152.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Girault JA, 2012, ADV EXP MED BIOL, V970, P407, DOI 10.1007/978-3-7091-0932-8_18; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Greengard P, 2001, BIOSCIENCE REP, V21, P247, DOI 10.1023/A:1013205230142; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Karagiannidis I, 2013, J MED GENET, V50, P760, DOI 10.1136/jmedgenet-2013-101637; Krusong K, 2011, NEUROSCI LETT, V495, P110, DOI 10.1016/j.neulet.2011.03.050; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P356, DOI 10.1016/j.neubiorev.2010.02.005; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P345, DOI 10.1016/j.neubiorev.2010.02.004; Macpherson T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01301; Mahmood D, 2012, PHARMACOL REP, V64, P191; Mariottini C, 2009, J NEUROCHEM, V110, P1469, DOI 10.1111/j.1471-4159.2009.06249.x; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; Moreno E, 2011, J BIOL CHEM, V286, P5846, DOI 10.1074/jbc.M110.161489; Moreno E, 2014, J NEUROSCI, V34, P3545, DOI 10.1523/JNEUROSCI.4147-13.2014; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Park HY, 2014, J NEUROSCI, V34, P11744, DOI 10.1523/JNEUROSCI.0864-14.2014; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pende Mario, 2006, Bull Cancer, V93, pE39; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; Rapanelli M, 2016, NEUROPHARMACOLOGY, V106, P85, DOI 10.1016/j.neuropharm.2015.08.019; Rapanelli M, 2014, EUR NEUROPSYCHOPHARM, V24, P1896, DOI 10.1016/j.euroneuro.2014.10.007; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; SCHLICKER E, 1994, FUND CLIN PHARMACOL, V8, P128, DOI 10.1111/j.1472-8206.1994.tb00789.x; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; SHARP T, 1987, BRAIN RES, V401, P322, DOI 10.1016/0006-8993(87)91416-8; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Torrent A, 2005, MOL PHARMACOL, V67, P195, DOI 10.1124/mol.104.005652; Vanhanen J, 2015, PSYCHOPHARMACOLOGY, V232, P1143, DOI 10.1007/s00213-014-3751-7; Webb IC, 2009, J BIOL RHYTHM, V24, P465, DOI 10.1177/0748730409346657; Xu MY, 2015, NEUROSCI LETT, V595, P50, DOI 10.1016/j.neulet.2015.03.067	59	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21042	21052		10.1074/jbc.M116.731406	http://dx.doi.org/10.1074/jbc.M116.731406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27510032	hybrid, Green Published			2022-12-28	WOS:000385406200020
J	Watanabe, K; Hirata, M; Tominari, T; Matsumoto, C; Fujita, H; Yonekura, K; Murphy, G; Nagase, H; Miyaura, C; Inada, M				Watanabe, Kenta; Hirata, Michiko; Tominari, Tsukasa; Matsumoto, Chiho; Fujita, Hidenori; Yonekura, Kazuhiko; Murphy, Gillian; Nagase, Hideaki; Miyaura, Chisato; Inada, Masaki			The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; BREAST-CANCER; LIGAND; COMBINATION; MOUSE; MICROENVIRONMENT; INFLAMMATION; METASTASIS; ACTIVATION; PATHWAYS	The tyrosine kinase inhibitor TAS-115 that blocks VEGF receptor and hepatocyte growth factor receptor MET signaling exhibits antitumor properties in xenografts of human gastric carcinoma. In this study, we have evaluated the efficacy of TAS-115 in preventing prostate cancer metastasis to the bone and bone destruction using the PC3 cell line. When PC3 cells were injected into proximal tibiae in nude mouse, severe trabecular and cortical bone destruction and subsequent tumor growths were detected. Oral administration of TAS-115 almost completely inhibited both PC3-induced bone loss and PC3 cell proliferation by suppressing osteoclastic bone resorption. In an ex vivo bone organ culture, PC3 cells induced osteoclastic bone resorption when co-cultured with calvarial bone, but TAS-115 effectively suppressed the PC3-induced bone destruction. We found that macrophage colony-stimulating factor-dependent macrophage differentiation and subsequent receptor activator of NF-kappa B ligand-induced osteoclast formation were largely suppressed by adding TAS-115. The phosphorylation of the macrophage colony-stimulating factor receptor FMS and osteoclast related kinases such as ERK and Akt were also suppressed by the presence of TAS-115. Gene expression profiling showed that FMS expression was only seen in macrophage and in the osteoclast cell lineage. Our study indicates that tyrosine kinase signaling in host pre-osteoclasts/osteoclasts is critical for bone destruction induced by tumor cells and that targeting of MET/VEGF receptor/FMS activity makes it a promising therapeutic candidate for the treatment of prostate cancer patients with bone metastasis.	[Watanabe, Kenta; Hirata, Michiko; Matsumoto, Chiho; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan; [Tominari, Tsukasa; Nagase, Hideaki; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Global Innovat Res Org, Koganei, Tokyo 1848588, Japan; [Fujita, Hidenori; Yonekura, Kazuhiko] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Ibaraki 3002611, Japan; [Murphy, Gillian] Univ Cambridge, Dept Oncol, Canc Res UK, Cambridge Inst,Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Nagase, Hideaki] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford OX3 7FY, England	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Taiho Pharmaceutical; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Oxford	Inada, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	m-inada@cc.tuat.ac.jp	Tominari, Tsukasa/B-6054-2015; Hirata, Michiko/D-2351-2013; miyaura, chisato/D-1864-2013; inada, masaki/D-1581-2013	Hirata, Michiko/0000-0002-5291-6112; miyaura, chisato/0000-0002-2548-8191; inada, masaki/0000-0002-5066-8506; Tominari, Tsukasa/0000-0001-5683-8951	National Institute of Health [AR40994]; Global Innovation Research Organization in Tokyo University of Agriculture and Technology; Japan Society for the Promotion of Science Bilateral Joint Research Projects;  [23590069];  [25460062]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Innovation Research Organization in Tokyo University of Agriculture and Technology; Japan Society for the Promotion of Science Bilateral Joint Research Projects(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is partly supported by Grants-in-Aid for Scientific Research 25460062 (to C. M.) and 23590069 (to M. I.), National Institute of Health Grant AR40994 (to H. N.), and Global Innovation Research Organization in Tokyo University of Agriculture and Technology (to M. I. and H. N.). This project was also supported by Open Partnership Joint Projects of Japan Society for the Promotion of Science Bilateral Joint Research Projects. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai A, 2012, J CELL SCI, V125, P2910, DOI 10.1242/jcs.099986; Bergh J, 2012, J CLIN ONCOL, V30, P921, DOI 10.1200/JCO.2011.35.7376; Bhatia V, 2013, EXP CELL RES, V319, P1419, DOI 10.1016/j.yexcr.2013.03.003; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Dai JL, 2014, CLIN CANCER RES, V20, P617, DOI 10.1158/1078-0432.CCR-13-0839; Danks L, 2013, J BIOCHEM, V154, P29, DOI 10.1093/jb/mvt049; Eswaraka J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-742; Feng X, 2013, BONE RES, V1, DOI 10.4248/BR201301003; Fujita H, 2013, MOL CANCER THER, V12, P2685, DOI 10.1158/1535-7163.MCT-13-0459; Gartrell BA, 2014, NAT REV CLIN ONCOL, V11, P335, DOI 10.1038/nrclinonc.2014.70; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Inada M, 2015, J BIOL CHEM, V290, P29781, DOI 10.1074/jbc.M115.669481; Israeli Ron S, 2008, Rev Urol, V10, P99; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XT, 2003, ENDOCRINOLOGY, V144, P4999, DOI 10.1210/en.2003-0166; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Morony S, 2001, CANCER RES, V61, P4432; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Ohshiba T, 2003, BRIT J CANCER, V88, P1318, DOI 10.1038/sj.bjc.6600858; Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645; Ongkeko WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085803; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sulpice E, 2009, BIOL CELL, V101, P525, DOI 10.1042/BC20080221; Suzu S, 2007, J CELL PHYSIOL, V212, P519, DOI 10.1002/jcp.21045; Teoh D, 2012, INT J GYNECOL CANCER, V22, P348, DOI 10.1097/IGC.0b013e31823c6efd; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	32	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20891	20899		10.1074/jbc.M116.727875	http://dx.doi.org/10.1074/jbc.M116.727875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27539855	Green Published, hybrid			2022-12-28	WOS:000385406200008
J	Vidal-Martinez, G; Vargas-Medrano, J; Gil-Tommee, C; Medina, D; Garza, NT; Yang, B; Segura-Ulate, I; Dominguez, SJ; Perez, RG				Vidal-Martinez, Guadalupe; Vargas-Medrano, Javier; Gil-Tommee, Carolina; Medina, David; Garza, Nathan T.; Yang, Barbara; Segura-Ulate, Ismael; Dominguez, Samantha J.; Perez, Ruth G.			FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (aSyn); neurodegenerative disease; neuroprotection; Parkinson disease; pathology; gut; preclinical assessment; synucleinopathy	TYROSINE-HYDROXYLASE PHOSPHORYLATION; ENTERIC DOPAMINERGIC-NEURONS; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; UP-REGULATION; SUBSTANTIA-NIGRA; NERVOUS-SYSTEM; RAT MODEL; IN-VITRO; FINGOLIMOD	Patients with Parkinson's disease (PD) often have aggregated -synuclein (aSyn) in enteric nervous system (ENS) neurons, which may be associated with the development of constipation. This occurs well before the onset of classic PD motor symptoms. We previously found that aging A53T transgenic (Tg) mice closely model PD-like ENS aSyn pathology, making them appropriate for testing potential PD therapies. Here we show that Tg mice overexpressing mutant human aSyn develop ENS pathology by 4 months. We then evaluated the responses of Tg mice and their WT littermates to the Food and Drug Administration-approved drug FTY720 (fingolimod, Gilenya) or vehicle control solution from 5 months of age. Long term oral FTY720 in Tg mice reduced ENS aSyn aggregation and constipation, enhanced gut motility, and increased levels of brain-derived neurotrophic factor (BDNF) but produced no significant change in WT littermates. A role for BDNF was directly assessed in a cohort of young A53T mice given vehicle, FTY720, the Trk-B receptor inhibitor ANA-12, or FTY720 + ANA-12 from 1 to 4 months of age. ANA-12-treated Tg mice developed more gut aSyn aggregation as well as constipation, whereas FTY720-treated Tg mice had reduced aSyn aggregation and less constipation, occurring in part by increasing both pro-BDNF and mature BDNF levels. The data from young and old Tg mice revealed FTY720-associated neuroprotection and reduced aSyn pathology, suggesting that FTY720 may also benefit PD patients and others with synucleinopathy. Another finding was a loss of tyrosine hydroxylase immunoreactivity in gut neurons with aggregated aSyn, comparable with our prior findings in the CNS.	[Vidal-Martinez, Guadalupe; Vargas-Medrano, Javier; Gil-Tommee, Carolina; Medina, David; Garza, Nathan T.; Yang, Barbara; Segura-Ulate, Ismael; Dominguez, Samantha J.; Perez, Ruth G.] Texas Tech Univ, Grad Sch Biomed Sci, Paul L Foster Sch Med, Ctr Emphasis Neurosci,Hlth Sci Ctr El Paso, 5001 El Paso Dr,MSB 1,Suite 4002, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Perez, RG (corresponding author), Texas Tech Univ, Grad Sch Biomed Sci, Paul L Foster Sch Med, Ctr Emphasis Neurosci,Hlth Sci Ctr El Paso, 5001 El Paso Dr,MSB 1,Suite 4002, El Paso, TX 79905 USA.	ruth.g.perez@ttuhsc.edu	Vargas Medrano, Javier/AAW-4666-2021; Perez, Ruth G./AAK-9844-2020	Vargas Medrano, Javier/0000-0002-5424-4225; 	NINDS, National Institutes of Health [NS42094]; Texas Tech University Health Sciences Center El Paso; Lizanell and Colbert Coldwell Foundation; Multiple System Atrophy Coalition; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042094] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Texas Tech University Health Sciences Center El Paso; Lizanell and Colbert Coldwell Foundation; Multiple System Atrophy Coalition; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health, Grant NS42094; the Texas Tech University Health Sciences Center El Paso (startup funds); the Lizanell and Colbert Coldwell Foundation; the Multiple System Atrophy Coalition; and gifts from Anna Mae Doyle and Hoy Family Research. R. P. filed a patent for FTY720 and FTY720-based compounds (US 14/435,346). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn M, 2006, BIOCHEM BIOPH RES CO, V346, P1142, DOI 10.1016/j.bbrc.2006.05.213; Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Ashraf W, 1997, MOVEMENT DISORD, V12, P946, DOI 10.1002/mds.870120617; Baba M, 1998, AM J PATHOL, V152, P879; Beach TG, 2013, J NEUROPATH EXP NEUR, V72, P130, DOI 10.1097/NEN.0b013e3182805c72; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chauhan A, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/345285; Chen F, 2014, ACTA PHYSIOL, V212, P226, DOI 10.1111/apha.12374; Chun HS, 2000, NEUROREPORT, V11, P511, DOI 10.1097/00001756-200002280-00017; Cipriani R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0308-6; Coulie B, 2000, GASTROENTEROLOGY, V119, P41, DOI 10.1053/gast.2000.8553; Cronin KD, 2009, HUM MOL GENET, V18, P3274, DOI 10.1093/hmg/ddp265; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Di Menna L, 2013, PHARMACOL RES, V67, P1, DOI 10.1016/j.phrs.2012.10.004; Di Pardo A, 2014, HUM MOL GENET, V23, P2251, DOI 10.1093/hmg/ddt615; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Farrell KF, 2014, J NEUROCHEM, V128, P536, DOI 10.1111/jnc.12481; Fredriksson A, 2011, J NEURAL TRANSM, V118, P407, DOI 10.1007/s00702-010-0474-8; Fukumoto K, 2014, BEHAV BRAIN RES, V268, P88, DOI 10.1016/j.bbr.2014.03.046; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hoglinger GU, 2001, EXP NEUROL, V167, P148, DOI 10.1006/exnr.2000.7546; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Iwatsubo T, 2003, J NEUROL, V250, P11, DOI 10.1007/s00415-003-1303-x; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Karamohamed S, 2005, NEUROLOGY, V65, P1823, DOI 10.1212/01.wnl.0000187075.81589.fd; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Krismer F, 2014, PARKINSONISM RELAT D, V20, P793, DOI 10.1016/j.parkreldis.2014.05.005; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuo YM, 2010, HUM MOL GENET, V19, P1633, DOI 10.1093/hmg/ddq038; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Miguez A, 2015, HUM MOL GENET, V24, P4958, DOI 10.1093/hmg/ddv218; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nakamura K, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0208-0; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Nishimura H, 2010, J HISTOCHEM CYTOCHEM, V58, P847, DOI 10.1369/jhc.2010.956409; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Pellicano Clelia, 2007, Neuropsychiatr Dis Treat, V3, P145, DOI 10.2147/nedt.2007.3.1.145; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Salawu F K, 2010, Niger J Med, V19, P126; Savica R, 2009, NEUROLOGY, V73, P1752, DOI 10.1212/WNL.0b013e3181c34af5; Schapira AHV, 2003, ANN NEUROL, V53, pS149, DOI 10.1002/ana.10514; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shannon KM, 2012, MOVEMENT DISORD, V27, P716, DOI 10.1002/mds.25020; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; SINGARAM C, 1995, LANCET, V346, P861, DOI 10.1016/S0140-6736(95)92707-7; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sun M, 2005, BRAIN RES, V1052, P119, DOI 10.1016/j.brainres.2005.05.072; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Tome CML, 2013, MOL NEUROBIOL, V47, P561, DOI 10.1007/s12035-012-8267-8; Varendi K, 2015, CELL MOL LIFE SCI, V72, P1779, DOI 10.1007/s00018-015-1836-z; Vargas-Medrano J, 2014, ACS MED CHEM LETT, V5, P782, DOI 10.1021/ml500128g; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Visanji Naomi P, 2013, Acta Neuropathol Commun, V1, P2, DOI 10.1186/2051-5960-1-2; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Weinreb O, 2007, ANN NY ACAD SCI, V1122, P155, DOI 10.1196/annals.1403.011; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; Wu J, 2012, NEUROSCIENCE, V207, P288, DOI 10.1016/j.neuroscience.2012.01.028; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang L., 2011, PROTOC EXCH, DOI [10.1038/protex.2011.236, DOI 10.1038/PROTEX.2011.236]	87	50	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20811	20821		10.1074/jbc.M116.744029	http://dx.doi.org/10.1074/jbc.M116.744029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27528608	Green Published, hybrid			2022-12-28	WOS:000384574800041
J	Marino, JS; Stechschulte, LA; Stec, DE; Nestor-Kalinoski, A; Coleman, S; Hinds, TD				Marino, Joseph S.; Stechschulte, Lance A.; Stec, David E.; Nestor-Kalinoski, Andrea; Coleman, Sydni; Hinds, Terry D., Jr.			Glucocorticoid Receptor beta Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; FATTY LIVER-DISEASE; GLYCOGEN-SYNTHASE KINASE-3-BETA; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GENE-EXPRESSION; METABOLIC SYNDROME; MICE LACKING; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM	Glucocorticoids (GCs) regulate energy supply in response to stress by increasing hepatic gluconeogenesis during fasting. Long-term GC treatment induces hepatic steatosis and weight gain. GC signaling is coordinated via the GC receptor (GR) GR alpha, as the GR beta isoform lacks a ligand-binding domain. The roles of the GR isoforms in the regulation of lipid accumulation is unknown. The purpose of this study was to determine whether GR beta inhibits the actions of GCs in the liver, or enhances hepatic lipid accumulation. We show that GR beta expression is increased in adipose and liver tissues in obese high-fat fed mice. Adenovirus-mediated delivery of hepatic GR beta overexpression (GR beta-Ad) resulted in suppression of gluconeogenic genes and hyperglycemia in mice on a regular diet. Furthermore, GR beta-Ad mice had increased hepatic lipid accumulation and serum triglyceride levels possibly due to the activation of NF-kappa B signaling and increased tumor necrosis factor alpha (TNF alpha) and inducible nitric-oxide synthase expression, indicative of enhanced M1 macrophages and the development of steatosis. Consequently, GR beta-Ad mice had increased glycogen synthase kinase 3 beta (GSK3 beta) activity and reduced hepatic PPAR alpha and fibroblast growth factor 21 (FGF21) expression and lower serum FGF21 levels, which are two proteins known to increase during fasting to enhance the burning of fat by activating the beta-oxidation pathway. In conclusion, GR beta antagonizes the GC-induced signaling during fasting via GR alpha and the PPAR alpha-FGF21 axis that reduces fat burning. Furthermore, hepatic GR beta increases inflammation, which leads to hepatic lipid accumulation.	[Marino, Joseph S.] Univ N Carolina, Dept Kinesiol, Lab Syst Physiol, Charlotte, NC 28223 USA; [Stechschulte, Lance A.] Univ Toledo, Coll Med, Dept Orthoped, Toledo, OH 43614 USA; [Nestor-Kalinoski, Andrea] Univ Toledo, Coll Med, Adv Microscopy & Imaging Ctr, Dept Surg, Toledo, OH 43614 USA; [Hinds, Terry D., Jr.] Univ Toledo, Coll Med, Ctr Hypertens & Personalized Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Stec, David E.] Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Dept Physiol & Biophys,Mississippi Ctr Obes Res, Jackson, MS 39216 USA; [Coleman, Sydni] Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA	University of North Carolina; University of North Carolina Charlotte; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Mississippi; University of Mississippi Medical Center; University System of Ohio; University of Cincinnati	Hinds, TD (corresponding author), Univ Toledo, Coll Med, 3000 Arlington Ave,Mail Stop 1008, Toledo, OH 43614 USA.	Terry.Hinds@utoledo.edu	; Hinds, Terry/B-8495-2015	Marino, Joseph/0000-0002-6207-5986; Hinds, Terry/0000-0002-7599-1529; Stechschulte, Lance/0000-0001-9783-6194	University of Toledo deArce-Memorial Endowment Fund; National Institutes of Health [L32MD009154]; NHLBI [K01HL-125445, PO1HL-051971, HL088421]; NIGMS [P20GM-104357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971, K01HL125445, R01HL088421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	University of Toledo deArce-Memorial Endowment Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Toledo deArce-Memorial Endowment Fund (to T. D. H), National Institutes of Health Grant L32MD009154 (to T. D. H.), NHLBI Grants K01HL-125445 (to T. D. H.), PO1HL-051971, and HL088421 (to D. E. S.), and NIGMS Grant P20GM-104357 (to D. E. S.). The authors declare that they have no conflict of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bozzetto L, 2016, NUTR METAB CARDIOVAS, V26, P623, DOI 10.1016/j.numecd.2016.01.011; Camporez JPG, 2015, J ENDOCRINOL, V226, P207, DOI 10.1530/JOE-15-0136; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Christodoulopoulos P, 2000, J ALLERGY CLIN IMMUN, V106, P479; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DuBois DC, 2013, STEROIDS, V78, P312, DOI 10.1016/j.steroids.2012.11.014; Dunderski J, 2009, J MED BIOCHEM, V28, P248, DOI 10.2478/v10011-009-0022-y; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Goecke A, 2006, IMMUNOBIOLOGY, V211, P85, DOI 10.1016/j.imbio.2005.11.002; Goyal R, 2012, N AM J MED SCI, V4, P180, DOI 10.4103/1947-2714.94944; He B, 2016, MOL CELL BIOL, V36, P714, DOI 10.1128/MCB.00908-15; Hinds TD, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020232; Hinds TD, 2014, OBESITY, V22, P705, DOI 10.1002/oby.20559; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Kimura R, 2011, BIOCHEM BIOPH RES CO, V410, P1, DOI 10.1016/j.bbrc.2011.05.057; Komatsu M, 2015, BBA-MOL BASIS DIS, V1852, P473, DOI 10.1016/j.bbadis.2014.12.011; Lee SJ, 2008, GASTROENTEROLOGY, V135, P2084, DOI 10.1053/j.gastro.2008.08.007; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; McBeth L, 2016, ONCOTARGET, V7, P27313, DOI 10.18632/oncotarget.8430; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Moon YS, 2004, METABOLISM, V53, P863, DOI 10.1016/j.metabol.2004.02.007; Nandan D, 2012, J IMMUNOL, V188, P367, DOI 10.4049/jimmunol.1100076; Nwaneri Assumpta C, 2016, Cancer Cell Microenviron, V3; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; Paschos P, 2009, HIPPOKRATIA, V13, P9; Patel R, 2015, MOL ENDOCRINOL, V29, P213, DOI 10.1210/me.2014-1259; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Ramakrishnan SK, 2016, J BIOL CHEM, V291, P8121, DOI 10.1074/jbc.M116.714014; Rando G, 2016, ELIFE, V5, DOI 10.7554/eLife.11853; Robert O, 2016, J HEPATOL, V64, P916, DOI 10.1016/j.jhep.2015.11.023; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Samms RJ, 2016, ENDOCRINOLOGY, V157, P1467, DOI 10.1210/en.2015-1722; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Sharma M, 2015, J CLIN EXP HEPATOL, V5, P147, DOI 10.1016/j.jceh.2015.02.002; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shulman GI, 2014, NEW ENGL J MED, V371, P2237; Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521; Stec DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153427; Stechschulte LA, 2016, ENDOCRINOLOGY, V157, P3888, DOI 10.1210/en.2015-1996; Stechschulte LA, 2014, J BIOL CHEM, V289, P17885, DOI 10.1074/jbc.M113.544072; Tipoe GL, 2009, HISTOL HISTOPATHOL, V24, P1161, DOI 10.14670/HH-24.1161; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Vazquez-Tello A, 2013, J CLIN IMMUNOL, V33, P466, DOI 10.1007/s10875-012-9828-3; Wang Y, 2011, ONCOGENE, V30, P4327, DOI 10.1038/onc.2011.144; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Wuescher L, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.7; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10222	66	47	51	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25776	25788		10.1074/jbc.M116.752311	http://dx.doi.org/10.1074/jbc.M116.752311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27784782	Green Published, hybrid			2022-12-28	WOS:000390345200002
J	Sun, B; Guo, WT; Tian, XX; Yao, JJ; Zhang, L; Wang, RW; Chen, SRW				Sun, Bo; Guo, Wenting; Tian, Xixi; Yao, Jinjing; Zhang, Lin; Wang, Ruiwu; Chen, S. R. Wayne			The Cytoplasmic Region of Inner Helix S6 Is an Important Determinant of Cardiac Ryanodine Receptor Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CA2+ RELEASE; CRYSTAL-STRUCTURES; VENTRICULAR-TACHYCARDIA; DISEASE MUTATIONS; ACTIVATION; THRESHOLD; PROTEINS; MYOCYTES; DOMAINS; FORMS	The ryanodine receptor (RyR) channel pore is formed by four S6 inner helices, with its intracellular gate located at the S6 helix bundle crossing region. The cytoplasmic region of the extended S6 helix is held by the U motif of the central domain and is thought to control the opening and closing of the S6 helix bundle. However, the functional significance of the S6 cytoplasmic region in channel gating is unknown. Here we assessed the role of the S6 cytoplasmic region in the function of cardiac RyR (RyR2) via structure-guided site-directed mutagenesis. We mutated each residue in the S6 cytoplasmic region of the mouse RyR2 ((4876)QQEQVKEDM(4884)) and characterized their functional impact. We found that mutations Q4876A, V4880A, K4881A, and M4884A, located mainly on one side of the S6 helix that faces the U motif, enhanced basal channel activity and the sensitivity to Ca2+ or caffeine activation, whereas mutations Q4877A, E4878A, Q4879A, and D4883A, located largely on the opposite side of S6, suppressed channel activity. Furthermore, V4880A, a cardiac arrhythmia-associated mutation, markedly enhanced the frequency of spontaneous openings and the sensitivity to cytosolic and luminal Ca2+ activation of single RyR2 channels. V4880A also increased the propensity and reduced the threshold for arrhythmogenic spontaneous Ca2+ release in HEK293 cells. Collectively, our data suggest that interactions between the cytoplasmic region of S6 and the U motif of RyR2 are important for stabilizing the closed state of the channel. Mutations in the S6/U motif domain interface likely destabilize the closed state of RyR2, resulting in enhanced basal channel activity and sensitivity to activation and increased propensity for spontaneous Ca2+ release and cardiac arrhythmias.	[Sun, Bo; Guo, Wenting; Tian, Xixi; Yao, Jinjing; Zhang, Lin; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	Chen, SRW (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca			Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS); AIHS Graduate Studentship Award; University of Calgary; Alberta Innovates [201300501, 201500221] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS); AIHS Graduate Studentship Award; University of Calgary; Alberta Innovates	This work was supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research (to S. R. W. C.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of the Heart and Stroke Foundation of Canada Junior Fellowship Award and the Alberta Innovates-Health Solutions (AIHS) Fellowship Award.r Recipients of the AIHS Graduate Studentship Award.r Recipient of the University of Calgary Eyes High Postdoctoral Fellowship Award.	Amador F. J., 2013, J MOL BIOL; Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bagattin A, 2004, CLIN CHEM, V50, P1148, DOI 10.1373/clinchem.2003.030734; Bai XC, 2016, CELL RES; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Diaz ME, 1997, J PHYSIOL-LONDON, V501, P3, DOI 10.1111/j.1469-7793.1997.003bo.x; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Guo WT, 2016, J BIOL CHEM, V291, P2150, DOI 10.1074/jbc.M115.693325; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6397; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang RW, 2003, BIOPHYS J, V84, p427A; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	39	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26024	26034		10.1074/jbc.M116.758821	http://dx.doi.org/10.1074/jbc.M116.758821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27789712	Green Published, hybrid			2022-12-28	WOS:000390345200022
J	Charpentier, TH; Waldo, GL; Lowery-Gionta, EG; Krajewski, K; Strahl, BD; Kash, TL; Harden, TK; Sondek, J				Charpentier, Thomas H.; Waldo, Gary L.; Lowery-Gionta, Emily G.; Krajewski, Krzysztof; Strahl, Brian D.; Kash, Thomas L.; Harden, T. Kendall; Sondek, John			Potent and Selective Peptide-based Inhibition of the G Protein G(q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; inhibitor; p63; peptide interaction; phospholipase C	HETEROTRIMERIC G-PROTEIN; PHOSPHOLIPASE-C-BETA; GUANINE-NUCLEOTIDE EXCHANGE; CHROMOBACTERIUM SP QS3666; REAL-TIME VISUALIZATION; COUPLED RECEPTORS; GAMMA-SUBUNITS; G-ALPHA; ACTIVATION; COMPLEX	In contrast to G protein-coupled receptors, for which chemical and peptidic inhibitors have been extensively explored, few compounds are available that directly modulate heterotrimeric G proteins. Active G(q) binds its two major classes of effectors, the phospholipase C (PLC)- isozymes and Rho guanine nucleotide exchange factors (RhoGEFs) related to Trio, in a strikingly similar fashion: a continuous helix-turn-helix of the effectors engages G(q) within its canonical binding site consisting of a groove formed between switch II and helix 3. This information was exploited to synthesize peptides that bound active G(q)in vitro with affinities similar to full-length effectors and directly competed with effectors for engagement of G(q). A representative peptide was specific for active G(q) because it did not bind inactive G(q) or other classes of active G subunits and did not inhibit the activation of PLC-3 by G(12). In contrast, the peptide robustly prevented activation of PLC-3 or p63RhoGEF by G(q); it also prevented G protein-coupled receptor-promoted neuronal depolarization downstream of G(q) in the mouse prefrontal cortex. Moreover, a genetically encoded form of this peptide flanked by fluorescent proteins inhibited G(q)-dependent activation of PLC-3 at least as effectively as a dominant-negative form of full-length PLC-3. These attributes suggest that related, cell-penetrating peptides should effectively inhibit active G(q) in cells and that these and genetically encoded sequences may find application as molecular probes, drug leads, and biosensors to monitor the spatiotemporal activation of G(q) in cells.	[Charpentier, Thomas H.; Waldo, Gary L.; Lowery-Gionta, Emily G.; Kash, Thomas L.; Harden, T. Kendall; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Krajewski, Krzysztof; Strahl, Brian D.; Sondek, John] Univ N Carolina, Sch Med, Dept Biochem & Biophys, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Krajewski, Krzysztof; Strahl, Brian D.] Univ N Carolina, Sch Med, High Throughput Peptide Synth & Array Facil, Chapel Hill, NC 27599 USA; [Charpentier, Thomas H.; Sondek, John] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Sondek, J (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	sondek@med.unc.edu	Kash, Thomas/G-9625-2013; Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259; Krajewski, Krzysztof/0000-0001-7159-617X	National Institutes of Health [R01-GM057391, R01-AA019454, U01-AA020911, AA022549]; Melanoma Research Foundation; American Cancer Society [PF-12-153-01-DMC]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391, R01GM120291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019454, U01AA020911, F32AA022549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants R01-GM057391 (to J.S. and T.K.H), R01-AA019454 and U01-AA020911 (to T.L.K.), and AA022549 (to E.G.L.G.) and by a Melanoma Research Foundation grant (to J.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the American Cancer Society (PF-12-153-01-DMC).	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; JHON DY, 1993, J BIOL CHEM, V268, P6654; Johnston CA, 2005, FEBS LETT, V579, P5746, DOI 10.1016/j.febslet.2005.09.059; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Johnston CA, 2008, COMB CHEM HIGH T SCR, V11, P370, DOI 10.2174/138620708784534798; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li C, 2012, BIOL PSYCHIAT, V71, P725, DOI 10.1016/j.biopsych.2011.11.015; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; MIYAMAE A, 1989, J CHEM SOC PERK T 1, P873, DOI 10.1039/p19890000873; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Prevost GP, 2006, CANCER RES, V66, P9227, DOI 10.1158/0008-5472.CAN-05-4205; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schmitz AL, 2014, CHEM BIOL, V21, P890, DOI 10.1016/j.chembiol.2014.06.003; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Taniguchi M, 2004, BIOORGAN MED CHEM, V12, P3125, DOI 10.1016/j.bmc.2004.04.006; Taniguchi M, 2003, J ANTIBIOT, V56, P358, DOI 10.7164/antibiotics.56.358; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0	41	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25608	25616		10.1074/jbc.M116.740407	http://dx.doi.org/10.1074/jbc.M116.740407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27742837	Green Published, hybrid			2022-12-28	WOS:000390095300027
J	Zalewski, JK; Mo, JH; Heber, S; Heroux, A; Gardner, RG; Hildebrand, JD; VanDemark, AP				Zalewski, Jenna K.; Mo, Joshua H.; Heber, Simone; Heroux, Annie; Gardner, Richard G.; Hildebrand, Jeffrey D.; VanDemark, Andrew P.			Structure of the Shroom-Rho Kinase Complex Reveals a Binding Interface with Monomeric Shroom That Regulates Cell Morphology and Stimulates Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; Ras homolog gene family; member A (RhoA); serine; threonine protein kinase; structural biology; X-ray crystallography; Rho-kinase; RhoA; Shroom; coiled-coil	SMOOTH-MUSCLE CONTRACTION; NEURAL-TUBE MORPHOGENESIS; APICAL CONSTRICTION; MYOSIN PHOSPHATASE; PROTEIN-KINASE; ROK-ALPHA; ACTIN; PHOSPHORYLATION; ROCK; DOMAIN	Shroom-mediated remodeling of the actomyosin cytoskeleton is a critical driver of cellular shape and tissue morphology that underlies the development of many tissues including the neural tube, eye, intestines, and vasculature. Shroom uses a conserved SD2 domain to direct the subcellular localization of Rho-associated kinase (Rock), which in turn drives changes in the cytoskeleton and cellular morphology through its ability to phosphorylate and activate non-muscle myosin II. Here, we present the structure of the human Shroom-Rock binding module, revealing an unexpected stoichiometry for Shroom in which two Shroom SD2 domains bind independent surfaces on Rock. Mutation of interfacial residues impaired Shroom-Rock binding in vitro and resulted in altered remodeling of the cytoskeleton and loss of Shroom-mediated changes in cellular morphology. Additionally, we provide the first direct evidence that Shroom can function as a Rock activator. These data provide molecular insight into the Shroom-Rock interface and demonstrate that Shroom directly participates in regulating cytoskeletal dynamics, adding to its known role in Rock localization.	[Zalewski, Jenna K.; Mo, Joshua H.; Heber, Simone; Hildebrand, Jeffrey D.; VanDemark, Andrew P.] Univ Pittsburgh, Dept Biol Sci, 4249 Fifth Ave, Pittsburgh, PA 15260 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Washington; University of Washington Seattle	VanDemark, AP (corresponding author), Univ Pittsburgh, Dept Biol Sci, 4249 Fifth Ave, Pittsburgh, PA 15260 USA.	andyv@pitt.edu		Heber, Simone/0000-0002-7702-9798; VanDemark, Andrew/0000-0003-3424-4831; Gardner, Richard/0000-0003-2162-6275	Department of Energy, Office of Basic Energy Sciences - National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097204] Funding Source: NIH RePORTER	Department of Energy, Office of Basic Energy Sciences - National Institutes of Health(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Andrea Berman, Dr. Joel Rosenbaum, and Ryan Corbo for helpful discussions and advice and Doowon Lee for technical assistance. Operations at the National Synchrotron Light Source are supported by the Department of Energy, Office of Basic Energy Sciences, and by the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano M, 2015, J CELL BIOL, V209, P895, DOI 10.1083/jcb.201412008; Araki S, 2001, PFLUG ARCH EUR J PHY, V441, P596, DOI 10.1007/s004240000462; Bolinger C, 2010, DEV DYNAM, V239, P2078, DOI 10.1002/dvdy.22326; Brandt R, 2001, CELL TISSUE RES, V305, P255, DOI 10.1007/s004410000334; Chen XQ, 2002, J BIOL CHEM, V277, P12680, DOI 10.1074/jbc.M109839200; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Craft JW, 2013, J MOL GRAPH MODEL, V46, P74, DOI 10.1016/j.jmgm.2013.09.009; Das D, 2014, BIOL OPEN, V3, P850, DOI 10.1242/bio.20147450; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DENT P, 1992, EUR J BIOCHEM, V210, P1037, DOI 10.1111/j.1432-1033.1992.tb17509.x; Dickson HM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0171-5; Dietz ML, 2006, J BIOL CHEM, V281, P20542, DOI 10.1074/jbc.M512463200; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Dye DE, 2009, CELL MOL LIFE SCI, V66, P681, DOI 10.1007/s00018-009-8645-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairbank PD, 2006, DEVELOPMENT, V133, P4109, DOI 10.1242/dev.02563; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Hagens O, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-18; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leung T, 1996, MOL CELL BIOL, V16, P5313; Malinova D, 2016, J LEUKOCYTE BIOL, V99, P699, DOI 10.1189/jlb.2A0215-050RR; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mohan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081075; Mohan S, 2012, MOL BIOL CELL, V23, P2131, DOI 10.1091/mbc.E11-11-0937; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plageman TF, 2011, DEV BIOL, V357, P227, DOI 10.1016/j.ydbio.2011.06.027; Plageman TF, 2010, DEVELOPMENT, V137, P405, DOI 10.1242/dev.045369; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; Riento K, 2006, METHOD ENZYMOL, V406, P533, DOI 10.1016/S0076-6879(06)06041-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; SELLERS JR, 1982, J BIOL CHEM, V257, P3880; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Truebestein L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10029; Tu DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018080; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Yoder M, 2007, CELL MOTIL CYTOSKEL, V64, P49, DOI 10.1002/cm.20167	65	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25364	25374		10.1074/jbc.M116.738559	http://dx.doi.org/10.1074/jbc.M116.738559			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27758857	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000390095300008
J	Dennis, EA				Dennis, Edward A.			Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COBRA VENOM PHOSPHOLIPASE-A2; EXCHANGE MASS-SPECTROMETRY; ARACHIDONIC-ACID MOBILIZATION; MACROPHAGE-LIKE CELLS; LINKED SUBSTRATES SIBLINKS; NUCLEAR-MAGNETIC-RESONANCE; LOW-DENSITY-LIPOPROTEIN; CYTOSOLIC GROUP-IV; ACTIVATED P388D(1) MACROPHAGES; OXIDIZED CHOLESTERYL ESTERS	In 1970, it was well accepted that the central role of lipids was in energy storage and metabolism, and it was assumed that amphipathic lipids simply served a passive structural role as the backbone of biological membranes. As a result, the scientific community was focused on nucleic acids, proteins, and carbohydrates as information-containing molecules. It took considerable effort until scientists accepted that lipids also "encode" specific and unique biological information and play a central role in cell signaling. Along with this realization came the recognition that the enzymes that act on lipid substrates residing in or on membranes and micelles must also have important signaling roles, spurring curiosity into their potentially unique modes of action differing from those acting on water-soluble substrates. This led to the creation of the concept of "surface dilution kinetics" for describing the mechanism of enzymes acting on lipid substrates, as well as the demonstration that lipid enzymes such as phospholipase A(2) (PLA(2)) contain allosteric activator sites for specific phospholipids as well as for membranes. As our understanding of phospholipases advanced, so did the understanding that many of the lipids released by these enzymes are chiral information containing signaling molecules; for example, PLA(2) regulates the generation of precursors for the biosynthesis of eicosanoids and other bioactive lipid mediators of inflammation and resolution underlying disease progression. The creation of the LIPID MAPS initiative in 2003 and the ensuing development of the lipidomics field have revealed that lipid metabolites are central to human metabolism. Today lipids are recognized as key mediators of health and disease as we enter a new era of biomarkers and personalized medicine. This article is my personal "reflection" on these scientific advances.	[Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Dennis, EA (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	edennis@ucsd.edu	Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140	National Institute of General Medical Sciences (NIGMS) [RO1 GM20501-40, U54 GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM020501] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The NIH, NSF, and Lilly Research Laboratories and numerous other non-profit organizations and for-profit companies have provided the essential support for my laboratory. I want to explicitly express my appreciation to the National Institute of General Medical Sciences (NIGMS) for continuous individual predoctoral and postdoctoral fellowships, RO1 support for over 40 years (RO1 GM20501-40), and over 10 years of support for the LIPID MAPS "Glue" grant (U54 GM069338). I especially thank the Journal of Biological Chemistry, a journal in which over 70 publications on my work have appeared, for inviting me to write this Reflection.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; ADAMICH M, 1978, J BIOL CHEM, V253, P5121; ADAMICH M, 1979, BIOCHEMISTRY-US, V18, P3308, DOI 10.1021/bi00582a017; Andreyev AY, 2010, J LIPID RES, V51, P2785, DOI 10.1194/jlr.M008748; Andreyev AY, 2010, MOL CELL PROTEOMICS, V9, P388, DOI 10.1074/mcp.M900432-MCP200; ASMIS R, 1994, BIOCHEM J, V298, P543, DOI 10.1042/bj2980543; Baker PRS, 2014, J LIPID RES, V55, P2432, DOI 10.1194/jlr.D051581; BALBOA MA, 1995, J BIOL CHEM, V270, P11738, DOI 10.1074/jbc.270.20.11738; Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Balboa MA, 1999, J BIOL CHEM, V274, P522, DOI 10.1074/jbc.274.1.522; Balboa MA, 1999, J BIOL CHEM, V274, P36764, DOI 10.1074/jbc.274.51.36764; Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 2000, J BIOL CHEM, V275, P22544, DOI 10.1074/jbc.M910163199; Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; Balsinde J, 1999, J BIOL CHEM, V274, P25967, DOI 10.1074/jbc.274.37.25967; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; BARBOUR SE, 1993, J BIOL CHEM, V268, P21875; BARDEN RE, 1980, BIOCHEMISTRY-US, V19, P1621, DOI 10.1021/bi00549a015; BARLOW PN, 1988, J BIOL CHEM, V263, P12954; Baskakis C, 2008, J MED CHEM, V51, P8027, DOI 10.1021/jm800649q; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Boegeman SC, 2004, BIOCHEMISTRY-US, V43, P3907, DOI 10.1021/bi035921b; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Bradshaw R. A., 2003, HDB CELL SIGNALING, V3; Bradshaw R. A., 2003, HDB CELL SIGNALING, V2; Bradshaw R. A., 2003, HDB CELL SIGNALING, V1, P1; BRADSHAW RA, 2003, HDB CELL SIGNALING, V1; Bucher D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003156; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Buczynski MW, 2010, J NEUROCHEM, V114, P981, DOI 10.1111/j.1471-4159.2010.06815.x; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Cao J, 2013, J BIOL CHEM, V288, P1806, DOI 10.1074/jbc.R112.421909; Cao J, 2013, J LIPID RES, V54, P127, DOI 10.1194/jlr.M030221; Cao J, 2011, BIOCHEMISTRY-US, V50, P5314, DOI 10.1021/bi101916w; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Changeux JP, 2013, J BIOL CHEM, V288, P26969, DOI 10.1074/jbc.X113.503375; Choi SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083145; Christianson CA, 2011, PAIN, V152, P2881, DOI 10.1016/j.pain.2011.09.020; CondeFrieboes K, 1996, J AM CHEM SOC, V118, P5519, DOI 10.1021/ja953553w; DAVIDSON FF, 1987, J BIOL CHEM, V262, P1698; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; DAVIDSON FF, 1989, BIOCHEM PHARMACOL, V38, P3645, DOI 10.1016/0006-2952(89)90567-4; DAVIDSON FF, 1990, J BIOL CHEM, V265, P5602; DEBONY J, 1981, BIOCHEMISTRY-US, V20, P5256, DOI 10.1021/bi00521a025; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DENNIS E A, 1973, Journal of Supramolecular Structure, V1, P165, DOI 10.1002/jss.400010302; Dennis E. A, 1991, PHOSPHOLIPASES METHO, V197; DENNIS EA, 1987, BIO-TECHNOL, V5, P1294, DOI 10.1038/nbt1287-1294; DENNIS EA, 1972, J LIPID RES, V13, P263; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; DENNIS EA, 1973, J LIPID RES, V14, P152; DENNIS EA, 1966, J AM CHEM SOC, V88, P3432, DOI 10.1021/ja00966a046; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Dennis EA, 2015, J LIPID RES, V56, P1245, DOI 10.1194/jlr.E061101; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Dennis EA, 2009, P NATL ACAD SCI USA, V106, P2089, DOI 10.1073/pnas.0812636106; Dove A, 2015, SCIENCE, V347, P788, DOI 10.1126/science.347.6223.788; Dumlao DS, 2012, J NUTR, V142, P1582, DOI 10.3945/jn.112.157883; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; EATON BR, 1976, ARCH BIOCHEM BIOPHYS, V176, P604, DOI 10.1016/0003-9861(76)90204-6; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Fang LH, 2010, J BIOL CHEM, V285, P32343, DOI 10.1074/jbc.M110.137257; FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342; GLASER KB, 1990, J BIOL CHEM, V265, P8658; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Gregus AM, 2013, FASEB J, V27, P1939, DOI 10.1096/fj.12-217414; Gregus AM, 2012, P NATL ACAD SCI USA, V109, P6721, DOI 10.1073/pnas.1110460109; Grkovich A, 2006, J BIOL CHEM, V281, P32978, DOI 10.1074/jbc.M605935200; Gupta S, 2016, J PHYS CHEM B, V120, P8346, DOI 10.1021/acs.jpcb.6b02036; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Harkewicz R, 2008, J BIOL CHEM, V283, P10241, DOI 10.1074/jbc.M709006200; Harkewicz R, 2007, J BIOL CHEM, V282, P2899, DOI 10.1074/jbc.M610067200; Harkewicz R, 2012, J BIOL CHEM, V287, P11469, DOI 10.1074/jbc.M111.256073; Harkewicz R, 2011, ANNU REV BIOCHEM, V80, P301, DOI 10.1146/annurev-biochem-060409-092612; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; HAZLETT TL, 1985, BIOCHEMISTRY-US, V24, P6152, DOI 10.1021/bi00343a018; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5734; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5740; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2013, J AM CHEM SOC, V135, P1330, DOI 10.1021/ja306490g; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; JARVIS AA, 1984, J BIOL CHEM, V259, P5188; Jiao J, 2014, MOL CANCER RES, V12, P1677, DOI 10.1158/1541-7786.MCR-14-0397-T; Jiao J, 2014, CARCINOGENESIS, V35, P1310, DOI 10.1093/carcin/bgu020; Johnson CA, 1999, J BIOL CHEM, V274, P27689, DOI 10.1074/jbc.274.39.27689; Kalyvas A, 2009, BRAIN, V132, P1221, DOI 10.1093/brain/awp002; KELLEY MJ, 1992, BIOCHIM BIOPHYS ACTA, V1118, P107, DOI 10.1016/0167-4838(92)90136-2; Kennedy EP, 2001, J BIOL CHEM, V276, P42619, DOI 10.1074/jbc.R100051200; KENSIL CR, 1981, BIOCHEMISTRY-US, V20, P6079, DOI 10.1021/bi00524a025; KENSIL CR, 1979, J BIOL CHEM, V254, P5843; Kessen UA, 2005, J LIPID RES, V46, P2488, DOI 10.1194/jlr.M500325-JLR200; Kihara Y, 2014, BIOPHYS J, V106, P966, DOI 10.1016/j.bpj.2014.01.015; Kokotos G, 2004, J MED CHEM, V47, P3615, DOI 10.1021/jm030485c; Kokotos G, 2002, J MED CHEM, V45, P2891, DOI 10.1021/jm025538p; Kokotos G, 2014, J MED CHEM, V57, P7523, DOI 10.1021/jm500192s; Kokotos G, 2010, J MED CHEM, V53, P3602, DOI 10.1021/jm901872v; Lefkowitz LJ, 1999, BIOCHEMISTRY-US, V38, P14174, DOI 10.1021/bi991432t; Leibundgut G, 2013, J LIPID RES, V54, P2815, DOI 10.1194/jlr.M040733; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7; Lio YC, 1996, BBA-LIPID LIPID MET, V1302, P55, DOI 10.1016/0005-2760(96)00002-1; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; LISTER MD, 1988, J BIOL CHEM, V263, P7506; LISTER MD, 1989, J BIOL CHEM, V264, P8520; LOMBARDO D, 1986, J BIOL CHEM, V261, P1663; LOMBARDO D, 1985, J BIOL CHEM, V260, P7234; Loo RW, 1997, J BIOL CHEM, V272, P19214, DOI 10.1074/jbc.272.31.19214; Loomba R, 2015, J LIPID RES, V56, P185, DOI 10.1194/jlr.P055640; Lopez-Vales R, 2008, BRAIN, V131, P2620, DOI 10.1093/brain/awn188; Lopez-Vales R, 2011, FASEB J, V25, P4240, DOI 10.1096/fj.11-183186; Lucas KK, 2005, BRIT J PHARMACOL, V144, P940, DOI 10.1038/sj.bjp.0706116; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Mouchlis VD, 2016, BIOORGAN MED CHEM, V24, P4801, DOI 10.1016/j.bmc.2016.05.009; Mouchlis VD, 2016, J MED CHEM, V59, P4403, DOI 10.1021/acs.jmedchem.6b00377; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; Norris PC, 2012, P NATL ACAD SCI USA, V109, P8517, DOI 10.1073/pnas.1200189109; Norris PC, 2011, J LEUKOCYTE BIOL, V90, P563, DOI 10.1189/jlb.0311153; Pang XY, 2012, J BIOL CHEM, V287, P35260, DOI 10.1074/jbc.M112.398859; PLESNIAK LA, 1995, BIOCHEMISTRY-US, V34, P4943, DOI 10.1021/bi00015a005; PLESNIAK LA, 1993, BIOCHEMISTRY-US, V32, P5009, DOI 10.1021/bi00070a006; PLUCKTHUN A, 1981, J PHYS CHEM-US, V85, P678; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1750, DOI 10.1021/bi00537a008; PLUCKTHUN A, 1985, BIOCHEMISTRY-US, V24, P4201, DOI 10.1021/bi00336a058; PLUCKTHUN A, 1985, J BIOL CHEM, V260, P1099; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Quehenberger O, 2011, BBA-MOL CELL BIOL L, V1811, P648, DOI 10.1016/j.bbalip.2011.07.006; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Ravandi A, 2014, J AM COLL CARDIOL, V63, P1961, DOI 10.1016/j.jacc.2014.01.055; REYNOLDS LJ, 1991, J BIOL CHEM, V266, P16512; REYNOLDS LJ, 1995, BIOPHYS J, V68, P2108, DOI 10.1016/S0006-3495(95)80390-5; REYNOLDS LJ, 1988, J AM CHEM SOC, V110, P5172, DOI 10.1021/ja00223a044; RIBEIRO AA, 1975, BIOCHEMISTRY-US, V14, P3746, DOI 10.1021/bi00688a005; ROBERTS GCK, 1969, P NATL ACAD SCI USA, V62, P1151, DOI 10.1073/pnas.62.4.1151; ROBERTS MF, 1977, J AM CHEM SOC, V99, P6142, DOI 10.1021/ja00460a071; ROBERTS MF, 1978, BIOCHEMISTRY-US, V17, P935, DOI 10.1021/bi00598a030; ROBERTS MF, 1978, J BIOL CHEM, V253, P1252; ROBERTS MF, 1977, J BIOL CHEM, V252, P6011; ROBERTS MF, 1979, BIOCHEMISTRY-US, V18, P3301, DOI 10.1021/bi00582a016; ROBERTS MF, 1977, P NATL ACAD SCI USA, V74, P1950, DOI 10.1073/pnas.74.5.1950; ROBSON RJ, 1983, ACCOUNTS CHEM RES, V16, P251, DOI 10.1021/ar00091a003; ROBSON RJ, 1977, J PHYS CHEM-US, V81, P1075, DOI 10.1021/j100526a010; ROSS MI, 1985, ARCH BIOCHEM BIOPHYS, V238, P247, DOI 10.1016/0003-9861(85)90162-6; Sabido E, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014746; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Segelke BW, 1998, J MOL BIOL, V279, P223, DOI 10.1006/jmbi.1998.1759; Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Shirai Y, 2005, BBA-MOL CELL BIOL L, V1735, P119, DOI 10.1016/j.bbalip.2005.05.005; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Six DA, 2007, J MED CHEM, V50, P4222, DOI 10.1021/jm0613673; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stephens D, 2006, J MED CHEM, V49, P2821, DOI 10.1021/jm050993h; Svensson CI, 2005, NEUROSCIENCE, V133, P543, DOI 10.1016/j.neuroscience.2005.01.024; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Wang AJ, 1997, J BIOL CHEM, V272, P22030, DOI 10.1074/jbc.272.35.22030; Wang AJ, 1997, J BIOL CHEM, V272, P12723, DOI 10.1074/jbc.272.19.12723; Wang Y, 2014, J CHROMATOGR A, V1359, P60, DOI 10.1016/j.chroma.2014.07.006; WARNER TG, 1973, J LIPID RES, V14, P595; WARNER TG, 1975, J BIOL CHEM, V250, P8004; WASHBURN WN, 1990, J AM CHEM SOC, V112, P2042, DOI 10.1021/ja00161a083; WASHBURN WN, 1990, J AM CHEM SOC, V112, P2040, DOI 10.1021/ja00161a082; WASHBURN WN, 1991, J BIOL CHEM, V266, P5042; Westheimer FH, 2003, J BIOL CHEM, V278, P11729, DOI 10.1074/jbc.X300001200; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Yaksh TL, 2006, J PHARMACOL EXP THER, V316, P466, DOI 10.1124/jpet.105.091686; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x; YU L, 1993, BIOCHEMISTRY-US, V32, P10185, DOI 10.1021/bi00089a039; YU L, 1991, P NATL ACAD SCI USA, V88, P9325, DOI 10.1073/pnas.88.20.9325; YU L, 1992, J AM CHEM SOC, V114, P8757, DOI 10.1021/ja00049a001; YU L, 1990, J BIOL CHEM, V265, P2657; ZHANG Y, 1988, J BIOL CHEM, V263, P9965	203	32	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24431	24448		10.1074/jbc.X116.723791	http://dx.doi.org/10.1074/jbc.X116.723791			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27555328	Green Published, hybrid			2022-12-28	WOS:000388875500009
J	Stechschulte, LA; Ge, CX; Hinds, TD; Sanchez, ER; Franceschi, RT; Lecka-Czernik, B				Stechschulte, Lance A.; Ge, Chunxi; Hinds, Terry D.; Sanchez, Edwin R.; Franceschi, Renny T.; Lecka-Czernik, Beata			RETRACTED: Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPAR gamma (Peroxisome Proliferator-activated Receptor gamma) and RUNX2 (Runt-related Transcription Factor 2) (Retracted article. See vol. 293, pg. 8314, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							TETRATRICOPEPTIDE REPEAT; OSTEOBLAST DIFFERENTIATION; GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; KINASE; PHOSPHORYLATION; MICE; IDENTIFICATION; LOCALIZATION; PPAR-GAMMA-2	Peroxisome proliferator-activated receptor gamma (PPAR gamma) and runt-related transcription factor 2 (RUNX2) are key regulators of mesenchymal stem cell (MSC) differentiation toward adipocytes and osteoblasts, respectively. Post-translational modifications of these factors determine their activities. Dephosphorylation of PPAR gamma at Ser-112 is required for its adipocytic activity, whereas phosphorylation of RUNX2 at serine 319 (Ser319) promotes its osteoblastic activity. Here we show that protein phosphatase 5 (PP5) reciprocally regulates each receptor by targeting each serine. Mice deficient in PP5 phosphatase have increased osteoblast numbers and high bone formation, which results in high bone mass in the appendicular and axial skeleton. This is associated with a substantial decrease in lipid-containing marrow adipocytes. Indeed, in the absence of PP5 the MSC lineage allocation is skewed toward osteoblasts and away from lipid accumulating adipocytes, although an increase in beige adipocyte gene expression is observed. In the presence of rosiglitazone, PP5 translocates to the nucleus, binds to PPAR gamma and RUNX2, and dephosphorylates both factors, resulting in activation of PPAR gamma adipocytic and suppression of RUNX2 osteoblastic activities. Moreover, shRNA knockdown of PP5 results in cells refractory to rosiglitazone treatment. Lastly, mice deficient in PP5 are resistant to the negative effects of rosiglitazone on bone, which in wild type animals causes a 50% decrease in trabecular bone mass. In conclusion, PP5 is a unique phosphatase reciprocally regulating PPAR gamma and RUNX2 activities in marrow MSC.	[Stechschulte, Lance A.] Univ Toledo Hlth Sci Campus, Dept Orthopaed Surg, Toledo, OH 43614 USA; [Hinds, Terry D.; Sanchez, Edwin R.; Lecka-Czernik, Beata] Univ Toledo Hlth Sci Campus, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Stechschulte, Lance A.; Sanchez, Edwin R.; Lecka-Czernik, Beata] Univ Toledo Hlth Sci Campus, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Ge, Chunxi; Franceschi, Renny T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University of Michigan System; University of Michigan	Lecka-Czernik, B (corresponding author), Univ Toledo Hlth Sci Campus, MS1008,3000 Arlington Ave, Toledo, OH 43614 USA.	beata.leckaczernik@utoledo.edu	FRANCESCHI, RENNY/K-3533-2019; Hinds, Terry/B-8495-2015	Stechschulte, Lance/0000-0001-9783-6194; Hinds, Terry/0000-0002-7599-1529	National Institutes of Health [DK105825, DE11723, DK70127]; American Diabetes Association [7-13-BS-089]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070127, R01DK105825, R24DK092759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK105825 (to B. L.-C.), DE11723 (to R. T. F.), and DK70127 (to E. R. S.). This work was also supported by the American Diabetes Association Grant 7-13-BS-089 (to B. L.-C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Banerjee A, 2008, BIOCHEMISTRY-US, V47, P10471, DOI 10.1021/bi8011862; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Borthwick EB, 2001, FEBS LETT, V491, P279, DOI 10.1016/S0014-5793(01)02177-9; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Camp HS, 1997, J BIOL CHEM, V272, P10811; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Ge CX, 2016, J CELL PHYSIOL, V231, P587, DOI 10.1002/jcp.25102; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kang H, 2001, BIOCHEMISTRY-US, V40, P10485, DOI 10.1021/bi010999i; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Li Y, 2012, J BONE MINER RES, V27, P1263, DOI 10.1002/jbmr.1574; Liu LC, 2012, CALCIFIED TISSUE INT, V91, P139, DOI 10.1007/s00223-012-9623-4; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; McGee-Lawrence ME, 2013, J BIOL CHEM, V288, P5291, DOI 10.1074/jbc.M112.414995; PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x; Rahman S, 2013, ENDOCRINOLOGY, V154, P2687, DOI 10.1210/en.2012-2162; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Skinner J, 1997, J BIOL CHEM, V272, P22464, DOI 10.1074/jbc.272.36.22464; Stechschulte LA, 2016, EBIOMEDICINE, V10, P174, DOI 10.1016/j.ebiom.2016.06.040; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	35	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24475	24486		10.1074/jbc.M116.752493	http://dx.doi.org/10.1074/jbc.M116.752493			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27687725	Green Published, hybrid			2022-12-28	WOS:000388875500012
J	Kanemura, S; Okumura, M; Yutani, K; Ramming, T; Hikima, T; Appenzeller-Herzog, C; Akiyama, S; Inaba, K				Kanemura, Shingo; Okumura, Masaki; Yutani, Katsuhide; Ramming, Thomas; Hikima, Takaaki; Appenzeller-Herzog, Christian; Akiyama, Shuji; Inaba, Kenji			Human ER Oxidoreductin-1 alpha (Ero1 alpha) Undergoes Dual Regulation through Complementary Redox Interactions with Protein-Disulfide Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; endoplasmic reticulum (ER); hydrogen peroxide; protein-disulfide isomerase; redox regulation	X-RAY-SCATTERING; ENDOPLASMIC-RETICULUM; BOND FORMATION; PDI FAMILY; HYDROGEN-PEROXIDE; OXIDATION; PEROXIREDOXIN; PATHWAY; MECHANISMS; REDUCTION	In the mammalian endoplasmic reticulum, oxidoreductin-1 (Ero1) generates protein disulfide bonds and transfers them specifically to canonical protein-disulfide isomerase (PDI) to sustain oxidative protein folding. This oxidative process is coupled to the reduction of O-2 to H2O2 on the bound flavin adenine dinucleotide cofactor. Because excessive thiol oxidation and H2O2 generation cause cell death, Ero1 activity must be properly regulated. In addition to the four catalytic cysteines (Cys(94), Cys(99), Cys(104), and Cys(131)) that are located in the flexible active site region, the Cys(208)-Cys(241) pair located at the base of another flexible loop is necessary for Ero1 regulation, although the mechanistic basis is not fully understood. The present study revealed that the Cys(208)-Cys(241) disulfide was reduced by PDI and other PDI family members during PDI oxidation. Differential scanning calorimetry and small angle X-ray scattering showed that mutation of Cys(208) and Cys(241) did not grossly affect the thermal stability or overall shape of Ero1, suggesting that redox regulation of this cysteine pair serves a functional role. Moreover, the flexible loop flanked by Cys(208) and Cys(241) provides a platform for functional interaction with PDI, which in turn enhances the oxidative activity of Ero1 through reduction of the Cys(208)-Cys(241) disulfide. We propose a mechanism of dual Ero1 regulation by dynamic redox interactions between PDI and the two Ero1 flexible loops that harbor the regulatory cysteines.	[Kanemura, Shingo; Okumura, Masaki; Inaba, Kenji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan; [Okumura, Masaki; Yutani, Katsuhide; Hikima, Takaaki; Akiyama, Shuji] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Ramming, Thomas; Appenzeller-Herzog, Christian] Univ Basel, Div Mol & Syst Toxicol, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland; [Appenzeller-Herzog, Christian] Berufsfachschule Gesundheit Baselland, CH-4142 Munchenstein, Switzerland; [Akiyama, Shuji] Res Ctr Integrat Mol Syst CIMoS, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Akiyama, Shuji] Grad Univ Adv Studies, SOKENDAI, Dept Funct Mol Sci, Kanagawa 2400193, Japan; [Inaba, Kenji] Japan Sci & Technol Agcy JST, CREST, Tokyo 1020076, Japan	Tohoku University; RIKEN; University of Basel; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Inaba, K (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	kinaba@tagen.tohoku.ac.jp	okumura, masaki/AAO-3454-2020; Appenzeller-Herzog, Christian/A-2894-2014	okumura, masaki/0000-0001-8130-2470; Appenzeller-Herzog, Christian/0000-0001-7430-294X; AKIYAMA, Shuji/0000-0002-7184-189X; Kanemura, Shingo/0000-0002-7012-8179; Inaba, Kenji/0000-0001-8229-0467	Core Research for Evolutional Science and Technology program of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [26116005, 15641922]; Takeda Science Foundation; Japan Society for the Promotion of Science [15J06349, 13J04030]; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [15J06349] Funding Source: KAKEN	Core Research for Evolutional Science and Technology program of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Core Research for Evolutional Science and Technology program of Japan Science and Technology Agency (to K. I.), a Grant-in-Aid for Scientific Research B (to K. I.), Grants-in-Aid 26116005 (to K. I.) and 15641922 (to M. O.) for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Takeda Science Foundation (to K. I.), Fellowships 15J06349 (to S. K.) and 13J04030 (to M. O.) from the Japan Society for the Promotion of Science, funds from the Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. A. and M. O.), and funds from the Uehara Memorial Foundation (to M. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama S, 2010, J APPL CRYSTALLOGR, V43, P237, DOI 10.1107/S002188981000138X; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Hansen HG, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405050; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; KUROKI R, 1992, BIOCHEMISTRY-US, V31, P8323, DOI 10.1021/bi00150a028; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Okumura M., 2014, CURR PROTOC PROTEIN, V76; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; Okumura M, 2014, J BIOL CHEM, V289, P27004, DOI 10.1074/jbc.M114.564104; Okumura M, 2011, FEBS J, V278, P1137, DOI 10.1111/j.1742-4658.2011.08039.x; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; POLAND DC, 1965, BIOPOLYMERS, V3, P379, DOI 10.1002/bip.1965.360030404; Ramming T, 2016, REDOX BIOL, V7, P14, DOI 10.1016/j.redox.2015.11.004; Ramming T, 2015, FREE RADICAL BIO MED, V83, P361, DOI 10.1016/j.freeradbiomed.2015.02.011; Ramming T, 2014, FREE RADICAL BIO MED, V70, P106, DOI 10.1016/j.freeradbiomed.2014.01.018; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; SCHELLMAN JOHN A., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P230; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	42	11	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23952	23964		10.1074/jbc.M116.735662	http://dx.doi.org/10.1074/jbc.M116.735662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703014	Green Published, hybrid			2022-12-28	WOS:000388498100012
J	Oliva, CR; Markert, T; Ross, LJ; White, EL; Rasmussen, L; Zhang, W; Everts, M; Moellering, DR; Bailey, SM; Suto, MJ; Griguer, CE				Oliva, Claudia R.; Markert, Tahireh; Ross, Larry J.; White, E. Lucile; Rasmussen, Lynn; Zhang, Wei; Everts, Maaike; Moellering, Douglas R.; Bailey, Shannon M.; Suto, Mark J.; Griguer, Corinne E.			Identification of Small Molecule Inhibitors of Human Cytochrome c Oxidase That Target Chemoresistant Glioma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemoresistance; cytochrome c oxidase (complex IV); glioblastoma; inhibitor; metabolism; mitochondria; small molecule; stem cells	MITOCHONDRIAL ELECTRON-TRANSPORT; CULTURED-CELLS; CAPACITY; GLUTATHIONE; CYANIDE; GLIOBLASTOMA; TEMOZOLOMIDE; METABOLISM; TISSUES; CHAIN	The enzyme cytochrome c oxidase (CcO) or complex IV (EC 1.9.3.1) is a large transmembrane protein complex that serves as the last enzyme in the respiratory electron transport chain of eukaryotic mitochondria. CcO promotes the switch from glycolytic to oxidative phosphorylation (OXPHOS) metabolism and has been associated with increased self-renewal characteristics in gliomas. Increased CcO activity in tumors has been associated with tumor progression after chemotherapy failure, and patients with primary glioblastoma multiforme and high tumor CcO activity have worse clinical outcomes than those with low tumor CcO activity. Therefore, CcO is an attractive target for cancer therapy. We report here the characterization of a CcO inhibitor (ADDA 5) that was identified using a high throughput screening paradigm. ADDA 5 demonstrated specificity for CcO, with no inhibition of other mitochondrial complexes or other relevant enzymes, and biochemical characterization showed that this compound is a non-competitive inhibitor of cytochrome c. When tested in cellular assays, ADDA 5 dose-dependently inhibited the proliferation of chemosensitive and chemoresistant glioma cells but did not display toxicity against non-cancer cells. Furthermore, treatment with ADDA 5 led to significant inhibition of tumor growth in flank xenograft mouse models. Importantly, ADDA 5 inhibited CcO activity and blocked cell proliferation and neurosphere formation in cultures of glioma stem cells, the cells implicated in tumor recurrence and resistance to therapy in patients with glioblastoma. In summary, we have identified ADDA 5 as a lead CcO inhibitor for further optimization as a novel approach for the treatment of glioblastoma and related cancers.	[Oliva, Claudia R.; Markert, Tahireh; Griguer, Corinne E.] Univ Alabama Birmingham, Div Infect Dis, Dept Neurosurg, Birmingham, AL 35294 USA; [Griguer, Corinne E.] Univ Alabama Birmingham, Div Infect Dis, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [Everts, Maaike] Univ Alabama Birmingham, Div Infect Dis, Dept Pediat, Birmingham, AL 35294 USA; [Ross, Larry J.; White, E. Lucile; Rasmussen, Lynn; Zhang, Wei; Suto, Mark J.] Southern Res, Drug Discovery Div, Birmingham, AL 35205 USA; [Bailey, Shannon M.] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, Birmingham, AL 35294 USA; [Moellering, Douglas R.] Univ Alabama Birmingham, Diabet Res Ctr BARB Core, UAB Nutr Sci Dept, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Griguer, CE (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Dept Neurosurg, Birmingham, AL 35294 USA.	cegriguer@uabmc.edu		, Corinne/0000-0003-3877-5031; Bailey, Shannon/0000-0003-0002-3424; Oliva, Claudia/0000-0003-0624-5490; Moellering, Douglas/0000-0003-2040-4187; Everts, Maaike/0000-0001-7421-4691	National Institutes of Health [R01CA160821, P30 DK079626]; Alabama Drug Discovery Alliance (ADDA); University of Alabama at Birmingham; Southern Research Institute; National Center for Advancing Translational Sciences of the National Institutes of Health (National Institutes of Health) [UL1TR00165]; NATIONAL CANCER INSTITUTE [R01CA160821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165, UL1TR001417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alabama Drug Discovery Alliance (ADDA); University of Alabama at Birmingham; Southern Research Institute; National Center for Advancing Translational Sciences of the National Institutes of Health (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01CA160821 and P30 DK079626. Work reported in this publication was supported by the Alabama Drug Discovery Alliance (ADDA) and collaboration between the University of Alabama at Birmingham and Southern Research Institute as well as the National Center for Advancing Translational Sciences of the National Institutes of Health (National Institutes of Health) under award UL1TR00165. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balaban RS, 1996, ANAL BIOCHEM, V237, P274, DOI 10.1006/abio.1996.0239; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Bryant NL, 2011, J NEURO-ONCOL, V101, P179, DOI 10.1007/s11060-010-0245-2; Campian JL, 2004, J BIOL CHEM, V279, P46580, DOI 10.1074/jbc.M406685200; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7; Darley-Usmar V. M., 1987, MITOCHONDRIA PRACTIC; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Eng J, 2013, ACAD RADIOL, V20, P795, DOI 10.1016/j.acra.2013.05.001; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Griguer CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061035; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Gunasekar PG, 1998, J PHARMACOL EXP THER, V285, P236; HARRIS SI, 1981, J BIOL CHEM, V256, P319; JONES MG, 1984, BIOCHEM J, V220, P57, DOI 10.1042/bj2200057; LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171; Melendez-Ferro M, 2013, J NEUROSCI METH, V214, P156, DOI 10.1016/j.jneumeth.2013.01.010; Oliva CR, 2015, ONCOTARGET, V6, P4330, DOI 10.18632/oncotarget.3015; Oliva CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024665; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Partridge MA, 2007, CANCER RES, V67, P5239, DOI 10.1158/0008-5472.CAN-07-0074; Ragan C, 1987, MITOCHONDRIA PRACTIC; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321; Sancho P, 2016, BRIT J CANCER, V114, P1305, DOI 10.1038/bjc.2016.152; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp Roger, 2005, Curr Neurol Neurosci Rep, V5, P198, DOI 10.1007/s11910-005-0047-7; SUN AS, 1980, CANCER RES, V40, P4677; SUN AS, 1981, LAB INVEST, V44, P13; Sun Wenqing G, 2010, Cancers (Basel), V2, P68, DOI 10.3390/cancers2010068; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; WAY JL, 1984, ANNU REV PHARMACOL, V24, P451, DOI 10.1146/annurev.pa.24.040184.002315; WAY JL, 1988, CIBA F SYMP, V140, P232; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24188	24199		10.1074/jbc.M116.749978	http://dx.doi.org/10.1074/jbc.M116.749978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679486	Green Published, hybrid			2022-12-28	WOS:000388498100033
J	Yano, N; Muramoto, K; Shimada, A; Takemura, S; Baba, J; Fujisawa, H; Mochizuki, M; Shinzawa-Itoh, K; Yamashita, E; Tsukihara, T; Yoshikawa, S				Yano, Naomine; Muramoto, Kazumasa; Shimada, Atsuhiro; Takemura, Shuhei; Baba, Junpei; Fujisawa, Hidenori; Mochizuki, Masao; Shinzawa-Itoh, Kyoko; Yamashita, Eiki; Tsukihara, Tomitake; Yoshikawa, Shinya			The Mg2+-containing Water Cluster of Mammalian Cytochrome c Oxidase Collects Four Pumping Proton Equivalents in Each Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; copper; cytochrome c oxidase (Complex IV); heme; membrane protein; mitochondrial membrane potential; proton pump; x-ray crystallography	O-2 REDUCTION; MECHANISM; REFINEMENT; RESOLUTION; MUTATIONS; MOLECULES; PATHWAY; ROLES; HEME; IONS	Bovine heart cytochrome c oxidase (CcO) pumps four proton equivalents per catalytic cycle through the H-pathway, a proton-conducting pathway, which includes a hydrogen bond network and a water channel operating in tandem. Protons are transferred by H3O+ through the water channel from the N-side into the hydrogen bond network, where they are pumped to the P-side by electrostatic repulsion between protons and net positive charges created at heme a as a result of electron donation to O-2 bound to heme a(3). To block backward proton movement, the water channel remains closed after O-2 binding until the sequential four-proton pumping process is complete. Thus, the hydrogen bond network must collect four proton equivalents before O-2 binding. However, a region with the capacity to accept four proton equivalents was not discernable in the x-ray structures of the hydrogen bond network. The present x-ray structures of oxidized/reduced bovine CcO are improved from 1.8/1.9 to 1.5/1.6 angstrom resolution, increasing the structural information by 1.7/1.6 times and revealing that a large water cluster, which includes a Mg2+ ion, is linked to the H-pathway. The cluster contains enough proton acceptor groups to retain four proton equivalents. The redox-coupled x-ray structural changes in Glu(198), which bridges the Mg2+ and Cu-A (the initial electron acceptor from cytochrome c) sites, suggest that the Cu-A-Glu(198)-Mg2+ system drives redox-coupled transfer of protons pooled in the water cluster to the H-pathway. Thus, these x-ray structures indicate that the Mg2+-containing water cluster is the crucial structural element providing the effective proton pumping in bovine CcO.	[Yano, Naomine; Shimada, Atsuhiro; Takemura, Shuhei; Baba, Junpei; Fujisawa, Hidenori; Mochizuki, Masao; Shinzawa-Itoh, Kyoko; Tsukihara, Tomitake; Yoshikawa, Shinya] Univ Hyogo, Picobiol Inst, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan; [Muramoto, Kazumasa] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan; [Yamashita, Eiki; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Tsukihara, Tomitake] CREST, JSJT, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	University of Hyogo; University of Hyogo; Osaka University; Japan Science & Technology Agency (JST)	Yoshikawa, S (corresponding author), Univ Hyogo, Picobiol Inst, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan.	yoshi@sci.u-hyogo.ac.jp	Yamashita, Eiki/V-6758-2019	Yamashita, Eiki/0000-0002-4278-0039	Academia Sinica; National Synchrotron Radiation Research Center; Grants-in-Aid for Scientific Research [26291033] Funding Source: KAKEN	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We sincerely thank Prof. Masaru Tateno (University of Hyogo) and Dr. Minoru Kubo for important comments and advice regarding the mechanism of CcO. We thank Kazunori Maeda and Wataru Ido for preliminary x-ray diffraction experiments and structural analyses. Diffraction data were collected in the SPring-8 facility at BL44XU under the proposals 2006B6500, 2008A6500, 2008B6500, 2009A6500, 2009B6500, and 2010A6500 and at BL41XU 2008B1001, 2008B1015, 2009A1012, 2009A1013, 2009B1001, and 2009B1031. Use of the MX225HE CCD detector was financially supported by Academia Sinica and the National Synchrotron Radiation Research Center.	Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; Braden BC, 1995, J MOL RECOGNIT, V8, P317, DOI 10.1002/jmr.300080505; BRICOGNE G, 1974, ACTA CRYSTALLOGR A, VA 30, P395, DOI 10.1107/S0567739474010722; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Chan SI, 2010, P NATL ACAD SCI USA, V107, P8505, DOI 10.1073/pnas.1004050107; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Egawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063669; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Goyal P, 2015, CHEM SCI, V6, P826, DOI 10.1039/c4sc01674b; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/NMETH.2962, 10.1038/nmeth.2962]; Isaacs N. S., 1995, PHYS ORGANIC CHEM, P235; Kamiya K, 2007, J AM CHEM SOC, V129, P9663, DOI 10.1021/ja070464y; Katz AK, 1998, J PHYS CHEM B, V102, P6342, DOI 10.1021/jp9815412; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Lee HM, 2000, BIOCHEMISTRY-US, V39, P2989, DOI 10.1021/bi9924821; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rich PR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0183; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Sharma V, 2015, P NATL ACAD SCI USA, V112, P2040, DOI 10.1073/pnas.1409543112; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Tomizaki T, 1999, ACTA CRYSTALLOGR D, V55, P31, DOI 10.1107/S0907444998006362; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; von Ballmoos C, 2011, P NATL ACAD SCI USA, V108, P11057, DOI 10.1073/pnas.1104103108; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WILLIAMS RJP, 1995, NATURE, V376, P643, DOI 10.1038/376643a0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341	35	55	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23882	23894		10.1074/jbc.M115.711770	http://dx.doi.org/10.1074/jbc.M115.711770			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27605664	Green Published, hybrid			2022-12-28	WOS:000388498100004
J	Akhter, N; Takeda, Y; Nara, H; Araki, A; Ishii, N; Asao, N; Asao, H				Akhter, Nasrin; Takeda, Yuji; Nara, Hidetoshi; Araki, Akemi; Ishii, Naoto; Asao, Naoki; Asao, Hironobu			Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; dendritic cell; differentiation; redox regulation; T helper cells; Ape1; Ref-1; IL-12; antigen presenting cell	DNA-REPAIR; INTERLEUKIN-6 RECEPTOR; PROTEIN APE1/REF-1; IL-12; PROLIFERATION; MACROPHAGES; EXPRESSION; DOMAIN; ALPHA; APE1	Apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape1/Ref-1) is a multifunctional protein possessing DNA repair, redox control, and transcriptional regulatory activities. Although Ape1/Ref-1 plays multiple roles in the immune system, its functions in helper T (Th) cell activation and differentiation are largely unknown. In this study, the function of Ape1/Ref-1 in Th cell activation was analyzed using an Ape1/Ref-1 redox-specific inhibitor, E3330. When splenocytes from OT-II mice, which are ovalbumin (OVA)-specific T-cell receptor transgenic mice, were activated with OVA in the presence of E3330, the induction of IFN--producing OT-II T cells was significantly increased. In contrast, E3330 did not enhance IFN- production from plate-bound anti-CD3 antibody-stimulated CD4(+) T cells in the absence of antigen presenting cells (APCs). Furthermore, E3330-pretreated and OVA-pulsed APCs also enhanced the IFN- production from OT-II T cells. These results suggested that E3330 enhances Th1 responses by modifying APC function. E3330 did not alter the surface expression of MHC-II or the co-stimulatory molecules CD80 and CD86 on APCs. On the other hand, E3330 up-regulated the IL-12 p35 and p40 gene expression, and IL-12 surface retention, but decreased the IL-12 secretion from Toll-like receptor (TLR) ligand-stimulated APCs. These results were confirmed with Ape1/Ref-1 knockdown experiments. Taken together, our findings indicated that the suppression of Ape1/Ref-1 redox function leads to an increased cell surface retention of IL-12 and enhances Th1 responses. This is the first study to demonstrate that Ape1/Ref-1 modulates the IL-12 production and secretion from APCs and controls Th1 immune responses.	[Akhter, Nasrin; Takeda, Yuji; Nara, Hidetoshi; Araki, Akemi; Asao, Hironobu] Yamagata Univ, Dept Immunol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan; [Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808075, Japan; [Asao, Naoki] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Yamagata University; Tohoku University; Tohoku University	Asao, H (corresponding author), Yamagata Univ, Dept Immunol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	asao-h@med.id.yamagata-u.ac.jp		Ishii, Naoto/0000-0002-0549-8245	Seizankai Medical Welfare Group; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan;  [22590432]	Seizankai Medical Welfare Group; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; 	This work was supported in part by Grant-in-Aid for Scientific Research (C) 22590432 and a grant from the Seizankai Medical Welfare Group and the Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Araki A, 2013, CYTOKINE, V62, P262, DOI 10.1016/j.cyto.2013.03.006; Asao H, 2000, J BIOL CHEM, V275, P867, DOI 10.1074/jbc.275.2.867; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Chakrabarti R, 2004, VACCINE, V22, P1199, DOI 10.1016/j.vaccine.2003.09.023; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Fan XH, 1996, BIOCHEM BIOPH RES CO, V225, P1063, DOI 10.1006/bbrc.1996.1295; Feng GJ, 1999, J IMMUNOL, V163, P6403; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; Ji JF, 2004, J GENE MED, V6, P777, DOI 10.1002/jgm.547; Juliana FM, 2012, BIOCHEM BIOPH RES CO, V420, P628, DOI 10.1016/j.bbrc.2012.03.051; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; Lee HM, 2009, J IMMUNOL, V183, P6839, DOI 10.4049/jimmunol.0901856; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liu Jianguo, 2005, Curr Immunol Rev, V1, P119, DOI 10.2174/1573395054065115; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Merluzzi S, 2004, J BIOL CHEM, V279, P1777, DOI 10.1074/jbc.M305418200; Onoda T, 2007, INT IMMUNOL, V19, P1191, DOI 10.1093/intimm/dxm090; Quinones M, 2000, J EXP MED, V192, P507, DOI 10.1084/jem.192.4.507; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Takeda Y, 2013, INFLAMM RES, V62, P951, DOI 10.1007/s00011-013-0650-z; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Zhu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041260; Zou GM, 2007, BLOOD, V109, P1917, DOI 10.1182/blood-2006-08-044172	31	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23672	23680		10.1074/jbc.M116.742353	http://dx.doi.org/10.1074/jbc.M116.742353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27637330	hybrid, Green Published			2022-12-28	WOS:000387884400027
J	Campos, BM; Liberato, MV; Alvarez, TM; Zanphorlin, LM; Ematsu, GC; Barud, H; Polikarpov, I; Ruller, R; Gilbert, HJ; Zeri, ACD; Squina, FM				Campos, Bruna Medeia; Liberato, Marcelo Vizona; Alvarez, Thabata Maria; Zanphorlin, Leticia Maria; Ematsu, Gabriela Cristina; Barud, Hernane; Polikarpov, Igor; Ruller, Roberto; Gilbert, Harry J.; de Mattos Zeri, Ana Carolina; Squina, Fabio Marcio			A Novel Carbohydrate-binding Module from Sugar Cane Soil Metagenome Featuring Unique Structural and Carbohydrate Affinity Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; cellulose; glycoside hydrolase; metagenomics; X-ray crystallography	CELLULOSE-BINDING; ENZYMATIC-HYDROLYSIS; X-RAY; CRYSTALLINITY; RECOGNITION; SPECIFICITY; CHITINASE; XYLANASE; QUALITY; DOMAIN	Carbohydrate-binding modules (CBMs) are appended to glycoside hydrolases and can contribute to the degradation of complex recalcitrant substrates such as the plant cell wall. For application in bioethanol production, novel enzymes with high catalytic activity against recalcitrant lignocellulosic material are being explored and developed. In this work, we report the functional and structural study of CBM_E1, which was discovered through a metagenomics approach and is the founding member of a novel CBM family, CBM81. CBM_E1, which is linked to an endoglucanase, displayed affinity for mixed linked 1,3-1,4-glucans, xyloglucan, Avicel, and cellooligosaccharides. The crystal structure of CBM_E1 in complex with cellopentaose displayed a canonical -sandwich fold comprising two -sheets. The planar ligand binding site, observed in a parallel orientation with the -strands, is a typical feature of type A CBMs, although the expected affinity for bacterial crystalline cellulose was not detected. Conversely, the binding to soluble glucans was enthalpically driven, which is typical of type B modules. These unique properties of CBM_E1 are at the interface between type A and type B CBMs.	[Campos, Bruna Medeia] CNPEM, Lab Nacl Biociencias LNBio, BR-13083970 Sao Paulo, Brazil; [Liberato, Marcelo Vizona; Alvarez, Thabata Maria; Zanphorlin, Leticia Maria; Ematsu, Gabriela Cristina; Ruller, Roberto; Squina, Fabio Marcio] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CNBE, Postal 6192, BR-13083970 Sao Paulo, Brazil; [de Mattos Zeri, Ana Carolina] CNPEM, Lab Nacl Luz Sincrotron LNLS, BR-13083970 Sao Paulo, Brazil; [Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13566590 Sao Paulo, Brazil; [Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE 4HH, Tyne & Wear, England; [Barud, Hernane] BioPolMat, Ctr Univ Araraquara UNIARA, BR-14801340 Araraquara, SP, Brazil	Universidade de Sao Paulo; Newcastle University - UK	Squina, FM (corresponding author), CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CNBE, Postal 6192, BR-13083970 Sao Paulo, Brazil.	fabio.squina@bioetanol.org.br	Squina, Fabio/J-8130-2012; Polikarpov, Igor/D-2575-2012; Zeri, Ana/AAY-4799-2021; Liberato, Marcelo V/J-3606-2014	Squina, Fabio/0000-0002-8154-7459; Zeri, Ana/0000-0003-4169-4523; Liberato, Marcelo V/0000-0002-7609-7844; Ruller, Roberto/0000-0001-7501-5176; Polikarpov, Igor/0000-0001-9496-4174	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Process [2013/06336-0, 2014/04105-4, 2010/11469-1, 2008/58037-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Process; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Process Grants 2013/06336-0, 2014/04105-4, 2010/11469-1, and 2008/58037-9 and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083635; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P46, DOI 10.1016/j.abb.2006.05.006; Campos BM, 2014, ACTA CRYSTALLOGR F, V70, P1232, DOI 10.1107/S2053230X14015520; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malecki PH, 2013, ACTA CRYSTALLOGR D, V69, P821, DOI 10.1107/S0907444913002011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2008, J MOL BIOL, V381, P670, DOI 10.1016/j.jmb.2008.06.006; Okazaki F, 2002, J BACTERIOL, V184, P2399, DOI 10.1128/JB.184.9.2399-2403.2002; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Petkun S, 2015, PEERJ, V3, DOI 10.7717/peerj.1126; Pinto ERP, 2015, J MATER CHEM C, V3, P11581, DOI 10.1039/c5tc02359a; Ponyi T, 2000, BIOCHEMISTRY-US, V39, P985, DOI 10.1021/bi9921642; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	41	13	14	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23734	23743		10.1074/jbc.M116.744383	http://dx.doi.org/10.1074/jbc.M116.744383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621314	Green Published, hybrid			2022-12-28	WOS:000387884400033
J	Woo, MS; Yang, J; Beltran, C; Cho, S				Woo, Moon-Sook; Yang, Jiwon; Beltran, Cesar; Cho, Sunghee			Cell Surface CD36 Protein in Monocyte/Macrophage Contributes to Phagocytosis during the Resolution Phase of Ischemic Stroke in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; macrophage; monocyte; phagocytosis; stroke; CD36; ischemic stroke; resolution	SCAVENGER RECEPTOR CD36; BRAIN-INJURY; PPAR-GAMMA; ACID TRANSLOCASE; OXIDIZED LDL; IDENTIFICATION; ACTIVATION; EXPRESSION; MICROGLIA; DIFFERENTIATION	Infiltrating monocyte-derived macrophages (M-M-phi) influence stroke-induced brain injury. Although the inflammatory nature of M-M-phi in acute stroke has been well documented, their role during the resolution phase of stroke is less clear. With emerging evidence for the involvement of scavenger receptors in innate immunity, this study addresses an M-M-phi CD36 role in mediating phagocytosis during the recovery phase of stroke. Stroke increases CD36 and TSP-1/2 mRNA levels in the ipsilateral hemisphere at acute (3-day (d)) and recovery (7d) periods. Quantification of total, intracellular, and cell surface CD36 protein levels showed relatively unchanged expression at 3d post-ischemia. At 7d, there was a significant increase in cell surface CD36 (p < 0.05) with a concurrent reduction of intracellular CD36 (p < 0.05) in the ipsilateral hemisphere. Both cell surface and intracellular CD36 were found in whole brain lysates, whereas cell surface CD36 was predominantly detected in isolated brain mononuclear cells, blood monocytes, and peritoneal macrophages, suggesting that cell surface CD36 expressed in the post-ischemic brain originates from the periphery. The stroke-induced CD36 mRNA level correlated with increased expression of lysosomal acid lipase, an M2 macrophage marker. Functionally, higher CD36 expression in M-M-phi is correlated with higher phagocytic indices in post-ischemic brain immune cells. Moreover, pharmacological inhibition of CD36 attenuated phagocytosis in peritoneal macrophages and brain M-M-phi. These findings demonstrate that cell surface CD36 on M-M-phi mediates phagocytosis during the recovery phase in post-stroke brains and suggests that CD36 plays a reparative role during the resolution of inflammation in ischemic stroke.	[Cho, Sunghee] Burke Cornell Med Res Inst, White Plains, NY 10605 USA; Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Cornell University	Cho, S (corresponding author), Burke Med Res Inst, Weill Cornell Med, Feil Family Brain & Mind Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	suc2002@med.cornell.edu			National Institutes of Health [R01HL82511, R01NS077897, R01NS095359]; Burke Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095359, R01NS077897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01HL82511, R01NS077897, and R01NS095359 (to S. C.) and the Burke Foundation (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JC, 2004, INT J BIOCHEM CELL B, V36, P1102, DOI 10.1016/j.biocel.2004.01.022; Alessio M, 1996, J BIOL CHEM, V271, P1770, DOI 10.1074/jbc.271.3.1770; Ballesteros I, 2014, J LEUKOCYTE BIOL, V95, P587, DOI 10.1189/jlb.0613326; Bao Y, 2012, ATHEROSCLEROSIS, V223, P152, DOI 10.1016/j.atherosclerosis.2012.05.006; Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Bohlson SS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00402; BORDESSOULE D, 1993, BRIT J HAEMATOL, V83, P370, DOI 10.1111/j.1365-2141.1993.tb04659.x; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Cho S, 2009, J NEUROCHEM, V109, P126, DOI 10.1111/j.1471-4159.2009.05801.x; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; De Haas AH, 2007, GLIA, V55, P1374, DOI 10.1002/glia.20554; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Garcia-Bonilla L, 2015, J NEUROSCI, V35, P14783, DOI 10.1523/JNEUROSCI.2980-15.2015; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; KIEFFER N, 1988, BIOCHIM BIOPHYS ACTA, V967, P408, DOI 10.1016/0304-4165(88)90104-3; Kim E, 2008, J NEUROSCI, V28, P4661, DOI 10.1523/JNEUROSCI.0982-08.2008; Kim E, 2014, J CEREBR BLOOD F MET, V34, P1411, DOI 10.1038/jcbfm.2014.101; Kim E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-83; Kim E, 2012, ANN NEUROL, V71, P753, DOI 10.1002/ana.23569; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Navazo MDP, 1996, J BIOL CHEM, V271, P15381, DOI 10.1074/jbc.271.26.15381; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; TALLE MA, 1983, CELL IMMUNOL, V78, P83, DOI 10.1016/0008-8749(83)90262-9; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; VANNIEUWENHOVEN FA, 1995, BIOCHEM BIOPH RES CO, V207, P747, DOI 10.1006/bbrc.1995.1250; Woo MS, 2012, ANN NEUROL, V72, P961, DOI 10.1002/ana.23727; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zhao XR, 2015, J NEUROCHEM, V133, P144, DOI 10.1111/jnc.12974	37	70	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23654	23661		10.1074/jbc.M116.750018	http://dx.doi.org/10.1074/jbc.M116.750018			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27646002	Green Published, hybrid			2022-12-28	WOS:000387884400025
J	Hoover, AR; Dozmorov, I; MacLeod, J; Du, QM; de la Morena, MT; Forbess, J; Guleserian, K; Cleaver, OB; van Oers, NSC				Hoover, Ashley R.; Dozmorov, Igor; MacLeod, Jessica; Du, Qiumei; de la Morena, M. Teresa; Forbess, Joseph; Guleserian, Kristine; Cleaver, Ondine B.; van Oers, Nicolai S. C.			MicroRNA-205 Maintains T Cell Development following Stress by Regulating Forkhead Box N1 and Selected Chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC EPITHELIAL-CELLS; AGED THYMUS; EXPRESSION; GENE; TOLERANCE; MIGRATION; FOXN1; MICROENVIRONMENTS; DIFFERENTIATION; REGENERATION	The thymus, an organ responsible for T cell development, is one of the more stress-sensitive tissues in the body. Stress, in the form of infections, radiation exposure, and steroids, impairs thymic epithelial cell (TEC) functions and induces the programmed cell death of immature thymocytes. MicroRNAs are small noncoding RNAs involved in tissue repair and homeostasis, with several supporting T cell development. We report that miR-205, an epithelial-specific miR, maintains thymopoiesis following inflammatory perturbations. Thus, the activation of diverse pattern recognition receptors in mice causes a more severe thymic hypoplasia and delayed T cell recovery when miR-205 is conditionally ablated in TECs. Gene expression comparisons in the TECs with/without miR-205 revealed a significant differential regulation of chemokine/chemokine receptor pathways, antigen processing components, and changes in the Wnt signaling system. This was partly a consequence of reduced expression of the transcriptional regulator of epithelial cell function, Forkhead Box N1 (Foxn1), and its two regulated targets, stem cell factor and ccl25, following stress. miR-205 mimics supplemented into miR-205-deficient fetal thymic organ cultures restored Foxn1 expression along with ccl25 and stem cell factor. A number of putative targets of miR-205 were up-regulated in TECs lacking miR-205, consistent with an important role for this miR in supporting T cell development in response to stress.	[Hoover, Ashley R.; Dozmorov, Igor; MacLeod, Jessica; Du, Qiumei; van Oers, Nicolai S. C.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, NA2-200,6000 Harry Hines Blvd, Dallas, TX 75390 USA; [de la Morena, M. Teresa; van Oers, Nicolai S. C.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [de la Morena, M. Teresa; Forbess, Joseph; Guleserian, Kristine] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Cleaver, Ondine B.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [de la Morena, M. Teresa; Forbess, Joseph; Guleserian, Kristine] Childrens Hlth, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	van Oers, NSC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, NA2-200,6000 Harry Hines Blvd, Dallas, TX 75390 USA.	nicolai.vanoers@utsouthwestern.edu	Van+Oers, Nicolai/ABA-2437-2021	van Oers, Nicolai/0000-0002-6545-8405	National Institutes of Health [R01 AI114523, F31 AI110140]; Children's Medical Center Research Foundation; University of Texas Southwestern Medical Center; Jeffery Model Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114523, F31AI110140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Center Research Foundation; University of Texas Southwestern Medical Center; Jeffery Model Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI114523 (to N. v. O.) and F31 AI110140 (to A. H.), and grants from the Children's Medical Center Research Foundation (to N. v. O., and M. d. l. M.), the Beecherl Grant from the University of Texas Southwestern Medical Center (to N. v. O.), and the Jeffery Model Foundation (to M. d. l. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Belkaya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085274; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Belkaya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027580; Berki T, 2002, INT IMMUNOL, V14, P463, DOI 10.1093/intimm/14.5.463; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; Birling MC, 2012, GENESIS, V50, P482, DOI 10.1002/dvg.20826; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Bunting MD, 2014, IMMUNOL CELL BIOL, V92, P489, DOI 10.1038/icb.2014.14; Bunting MD, 2011, IMMUNOL CELL BIOL, V89, P185, DOI 10.1038/icb.2010.142; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Dixit VD, 2010, CURR OPIN IMMUNOL, V22, P521, DOI 10.1016/j.coi.2010.06.010; Dooley J, 2012, EUR J IMMUNOL, V42, P1073, DOI 10.1002/eji.201142305; Dozmorov I, 2009, NUCLEIC ACIDS RES, V37, P6323, DOI 10.1093/nar/gkp706; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Farmer DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076634; Gennery AR, 2012, CELL MOL LIFE SCI, V69, P17, DOI 10.1007/s00018-011-0842-z; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; Hagman Z, 2013, BRIT J CANCER, V108, P1668, DOI 10.1038/bjc.2013.131; Halkias J, 2014, CELL MOL LIFE SCI, V71, P3101, DOI 10.1007/s00018-014-1607-2; Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Khan IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135440; Khan IS, 2014, EUR J IMMUNOL, V44, P1313, DOI 10.1002/eji.201344079; Li B, 2011, CLIN IMMUNOL, V140, P244, DOI 10.1016/j.clim.2011.04.004; Liang CC, 2013, IMMUNOL CELL BIOL, V91, P511, DOI 10.1038/icb.2013.34; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Olsen NJ, 2001, ENDOCRINOLOGY, V142, P1278, DOI 10.1210/en.142.3.1278; Otero DC, 2013, J IMMUNOL, V190, P3289, DOI 10.4049/jimmunol.1203086; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Romano R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00187; Seach N, 2012, J IMMUNOL METHODS, V385, P23, DOI 10.1016/j.jim.2012.07.023; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Varecza Z, 2011, MECH AGEING DEV, V132, P249, DOI 10.1016/j.mad.2011.04.007; Vidalain PO, 2002, J VIROL, V76, P6415, DOI 10.1128/JVI.76.13.6415-6424.2002; Wallin J, 1996, DEVELOPMENT, V122, P23; Williams KM, 2009, CTS-CLIN TRANSL SCI, V2, P279, DOI 10.1111/j.1752-8062.2009.00128.x; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Zuklys S, 2012, J IMMUNOL, V189, P3894, DOI 10.4049/jimmunol.1200783	47	16	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23237	23247		10.1074/jbc.M116.744508	http://dx.doi.org/10.1074/jbc.M116.744508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27646003	Green Published, hybrid			2022-12-28	WOS:000387224800032
J	Welinder, KG; Hansen, R; Overgaard, MT; Brohus, M; Sonderkaer, M; von Bergen, M; Rolle-Kampczyk, U; Otto, W; Lindahl, TL; Arinell, K; Evans, AL; Swenson, JE; Revsbech, IG; Frobert, O				Welinder, Karen Gjesing; Hansen, Rasmus; Overgaard, Michael Toft; Brohus, Malene; Sonderkaer, Mads; von Bergen, Martin; Rolle-Kampczyk, Ulrike; Otto, Wolfgang; Lindahl, Tomas L.; Arinell, Karin; Evans, Alina L.; Swenson, Jon E.; Revsbech, Inge G.; Frobert, Ole			Biochemical Foundations of Health and Energy Conservation in Hibernating Free-ranging Subadult Brown Bear Ursus arctos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; complement system; metabolomics; protein turnover; proteomics; antimicrobial proteins; blood constituents; hibernation physiology; sex hormone-binding globulin (SHBG)	HORMONE-BINDING GLOBULIN; BLACK BEARS; BODY-TEMPERATURE; PROTEIN-SYNTHESIS; GENE-EXPRESSION; AMERICANUS; PLASMA; TESTOSTERONE; GENOMICS; HAPTOGLOBIN	Brown bears (Ursus arctos) hibernate for 5-7 months without eating, drinking, urinating, and defecating at a metabolic rate of only 25% of the summer activity rate. Nonetheless, they emerge healthy and alert in spring. We quantified the biochemical adaptations for hibernation by comparing the proteome, metabolome, and hematological features of blood from hibernating and active free-ranging subadult brown bears with a focus on conservation of health and energy. We found that total plasma protein concentration increased during hibernation, even though the concentrations of most individual plasma proteins decreased, as did the white blood cell types. Strikingly, antimicrobial defense proteins increased in concentration. Central functions in hibernation involving the coagulation response and protease inhibition, as well as lipid transport and metabolism, were upheld by increased levels of very few key or broad specificity proteins. The changes in coagulation factor levels matched the changes in activity measurements. A dramatic 45-fold increase in sex hormone-binding globulin levels during hibernation draws, for the first time, attention to its significant but unknown role in maintaining hibernation physiology. We propose that energy for the costly protein synthesis is reduced by three mechanisms as follows: (i) dehydration, which increases protein concentration without de novo synthesis; (ii) reduced protein degradation rates due to a 6 degrees C reduction in body temperature and decreased protease activity; and (iii) a marked redistribution of energy resources only increasing de novo synthesis of a few key proteins. The comprehensive global data identified novel biochemical strategies for bear adaptations to the extreme condition of hibernation and have implications for our understanding of physiology in general.	[Welinder, Karen Gjesing; Hansen, Rasmus; Overgaard, Michael Toft; Brohus, Malene; Sonderkaer, Mads; von Bergen, Martin] Aalborg Univ, Sect Biotechnol, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark; [von Bergen, Martin; Rolle-Kampczyk, Ulrike] UFZ Helmholtz Ctr Environm Res, Dept Metabol, Permoserstr 15, D-04318 Leipzig, Germany; [von Bergen, Martin; Otto, Wolfgang] UFZ Helmholtz Ctr Environm Res, Dept Prote, Permoserstr 15, D-04318 Leipzig, Germany; [Lindahl, Tomas L.] Linkoping Univ, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Arinell, Karin; Frobert, Ole] Univ Orebro, Fac Hlth, Dept Cardiol, S-70185 Orebro, Sweden; [Evans, Alina L.] Hedmark Univ Coll, Dept Forestry & Wildlife Management, Campus Evenstrand, N-2411 Elverum, Norway; [Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, Postbox 5014, N-1432 As, Norway; [Swenson, Jon E.] Norwegian Inst Nat Res, Tungasletta 2, N-7485 Trondheim, Norway; [Revsbech, Inge G.] Aarhus Univ, Zoophysiol, Dept Biosci, CF Mollers Alle 3, DK-8000 Aarhus C, Denmark; [Hansen, Rasmus] Wellspring Biosci LLC, 11119 N Torrey Pines Rd,Ste 125, La Jolla, CA 92037 USA	Aalborg University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Linkoping University; Orebro University; Inland Norway University of Applied Sciences; Norwegian University of Life Sciences; Norwegian Institute Nature Research; Aarhus University	Welinder, KG (corresponding author), Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark.	kgw@bio.aau.dk	Overgaard, Michael Toft/E-1354-2011; Lindahl, Tomas L/H-5150-2012; von Bergen, Martin/D-7960-2011; Swenson, Jon/AAE-2890-2019; Rolle-Kampczyk, Ulrike E./D-4786-2015; Evans, Alina/AAH-8881-2019	Overgaard, Michael Toft/0000-0002-1423-2481; Lindahl, Tomas L/0000-0003-0174-8152; von Bergen, Martin/0000-0003-2732-2977; Rolle-Kampczyk, Ulrike E./0000-0002-7728-6284; Welinder, Karen Gjesing/0000-0002-5409-0131; Sonderkaer, Mads/0000-0002-9309-7459; Frobert, Ole/0000-0002-5846-345X	Lundbech Foundation [R126-2012-12408]; Aalborg University; Lundbeck Foundation [R194-2015-1108, R126-2012-12408] Funding Source: researchfish	Lundbech Foundation; Aalborg University; Lundbeck Foundation(Lundbeckfonden)	This work was supported by Grant R126-2012-12408 from the Lundbech Foundation (to F. O. and M. T. O.) and by Aalborg University (to K. G. W. and R. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Arinell K, 2012, CTS-CLIN TRANSL SCI, V5, P269, DOI 10.1111/j.1752-8062.2011.00370.x; Banerjee S, 2012, FREE RADICAL BIO MED, V53, P1317, DOI 10.1016/j.freeradbiomed.2012.07.023; Blumenthal S, 2011, AM J PHYSIOL-ENDOC M, V301, pE628, DOI 10.1152/ajpendo.00082.2011; BOCCHINFUSO WP, 1992, ENDOCRINOLOGY, V131, P2331, DOI 10.1210/en.131.5.2331; Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345; Canoy D, 2014, EUR J ENDOCRINOL, V170, P863, DOI 10.1530/EJE-13-1046; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chauhan V, 2002, BIOCHIMIE, V84, P1031, DOI 10.1016/S0300-9084(02)00006-8; Chow BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066119; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040520; Fedorov VB, 2014, MOL ECOL, V23, P5524, DOI 10.1111/mec.12963; Fedorov VB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-171; Friebe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101410; Fuster G, 2007, CLIN NUTR, V26, P658, DOI 10.1016/j.clnu.2007.07.003; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Graesli AR, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0615-2; GUSTAFSON AW, 1985, BIOL REPROD, V33, P1126, DOI 10.1095/biolreprod33.5.1126; Harlow HJ, 2002, J MAMMAL, V83, P1020, DOI 10.1644/1545-1542(2002)083&lt;1020:BMALCB&gt;2.0.CO;2; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Iaizzo PA, 2012, INTEGR ZOOL, V7, P48, DOI [10.1111/j.1749-4877.2012.00275.x, 10.1111/j.1749-4877.2011.00280.x]; Jorgensen PG, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-36; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Lohuis TD, 2007, COMP BIOCHEM PHYS B, V147, P20, DOI 10.1016/j.cbpb.2006.12.020; Villanueva-Canas JL, 2014, INTEGR COMP BIOL, V54, P452, DOI 10.1093/icb/icu048; MCMILLIN JM, 1976, BIOL REPROD, V15, P163, DOI 10.1095/biolreprod15.2.163; Mominoki K, 2005, COMP BIOCHEM PHYS A, V142, P472, DOI 10.1016/j.cbpa.2005.09.017; Nelson OL, 2010, J COMP PHYSIOL B, V180, P465, DOI 10.1007/s00360-009-0421-x; PALMER SS, 1988, BIOL REPROD, V38, P1044, DOI 10.1095/biolreprod38.5.1044; PANNEVIS MC, 1992, J COMP PHYSIOL B, V162, P393; RCoreTeam, 2014, R LANG ENV STAT COMP; Revsbech IG, 2013, AM J PHYSIOL-REG I, V304, pR43, DOI 10.1152/ajpregu.00440.2012; Ritchie RF, 2004, J CLIN LAB ANAL, V18, P139, DOI 10.1002/jcla.20012; Rosner W, 2010, MOL CELL ENDOCRINOL, V316, P79, DOI 10.1016/j.mce.2009.08.009; SABOUREAU M, 1982, GEN COMP ENDOCR, V47, P59, DOI 10.1016/0016-6480(82)90084-3; Sahdo B, 2013, INT J MED SCI, V10, P508, DOI 10.7150/ijms.4476; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sheikh AM, 2003, BIOCHIMIE, V85, P1027, DOI 10.1016/S0300-9084(03)00133-0; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Sommer F, 2016, CELL REP, V14, P1655, DOI 10.1016/j.celrep.2016.01.026; Stenvinkel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072934; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; Tomasi TE, 1998, GEN COMP ENDOCR, V109, P192, DOI 10.1006/gcen.1997.7018; Vestergaard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021483; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vos MJ, 2014, J CLIN ENDOCR METAB, V99, pE1798, DOI 10.1210/jc.2014-2055; Wallace IR, 2013, CLIN ENDOCRINOL, V78, P321, DOI 10.1111/cen.12086; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zedrosser A, 2007, J ANIM ECOL, V76, P368, DOI 10.1111/j.1365-2656.2006.01203.x; Zhao S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-201	54	24	24	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22509	22523		10.1074/jbc.M116.742916	http://dx.doi.org/10.1074/jbc.M116.742916			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609515	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000386760600013
J	Desfougeres, Y; Gerasimaite, R; Jessen, HJ; Mayer, A				Desfougeres, Yann; Gerasimaite, Ruta; Jessen, Henning Jacob; Mayer, Andreas			Vtc5, a Novel Subunit of the Vacuolar Transporter Chaperone Complex, Regulates Polyphosphate Synthesis and Phosphate Homeostasis in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homeostasis; inositol phosphate; plant physiology; vacuole; yeast; polyphosphate; acidocalcisome; phosphate homeostasis	CYCLIN-CDK COMPLEX; SACCHAROMYCES-CEREVISIAE; INORGANIC POLYPHOSPHATE; V-ATPASE; SOLUBLE EXOPOLYPHOSPHATASE; TRYPANOSOMA-CRUZI; MEMBRANE-FUSION; AMINO-ACID; PROTEIN; GENE	SPX domains control phosphate homeostasis in eukaryotes. Ten genes in yeast encode SPX-containing proteins, among which YDR089W is the only one of unknown function. Here, we show that YDR089W encodes a novel subunit of the vacuole transporter chaperone (VTC) complex that produces inorganic polyphosphate (polyP). The polyP synthesis transfers inorganic phosphate (P-i) from the cytosol into the acidocalcisome- and lysosome-related vacuoles of yeast, where it can be released again. It was therefore proposed for buffer changes in cytosolic P-i concentration (Thomas, M. R., and O'Shea, E. K. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 9565-9570). Vtc5 physically interacts with the VTC complex and accelerates the accumulation of polyP synthesized by it. Deletion of VTC5 reduces polyP accumulation in vivo and in vitro. Its overexpression hyperactivates polyP production and triggers the phosphate starvation response via the PHO pathway. Because this Vtc5-induced starvation response can be reverted by shutting down polyP synthesis genetically or pharmacologically, we propose that polyP synthesis rather than Vtc5 itself is a regulator of the PHO pathway. Our observations suggest that polyP synthesis not only serves to establish a buffer for transient drops in cytosolic P-i levels but that it can actively decrease or increase the steady state of cytosolic P-i.	[Desfougeres, Yann; Gerasimaite, Ruta; Mayer, Andreas] Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland; [Jessen, Henning Jacob] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany; [Desfougeres, Yann] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of Lausanne; University of Freiburg; University of London; University College London	Mayer, A (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	andreas.mayer@unil.ch	Gerasimaitė, Rūta/GLV-5402-2022; Mayer, Andreas/AAE-4315-2020; Desfougères, Yann/AAC-9244-2019; Jessen, Henning/O-1157-2019; Jessen, Henning/F-5108-2014	Mayer, Andreas/0000-0001-6131-313X; Desfougères, Yann/0000-0002-6450-5863; Jessen, Henning/0000-0002-1025-9484; Jessen, Henning/0000-0002-1025-9484	European Research Council [233458]; Schweizerischer Nationalfonds zur Forderung der Wissenschaften [144258, 163477/1, PP00P2-157607]	European Research Council(European Research Council (ERC)European Commission); Schweizerischer Nationalfonds zur Forderung der Wissenschaften	This work was supported by European Research Council Grant 233458 and Schweizerischer Nationalfonds zur Forderung der Wissenschaften Grants 144258 and 163477/1 (to A. M.) and PP00P2-157607 (to H. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bru S, 2016, MOL MICROBIOL, V101, P367, DOI 10.1111/mmi.13396; BunYa M, 1996, CURR GENET, V29, P344, DOI 10.1007/s002940050055; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Desfougeres Y, 2016, J CELL SCI, V129, P2817, DOI 10.1242/jcs.184382; DURR M, 1979, ARCH MICROBIOL, V121, P169, DOI 10.1007/BF00689982; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Gerasimaite R, 2014, J CELL SCI, V127, P5093, DOI 10.1242/jcs.159772; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Han BK, 2005, GENE DEV, V19, P2606, DOI 10.1101/gad.1361505; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JONES EW, 1982, GENETICS, V102, P665; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; Lau WTW, 2000, P NATL ACAD SCI USA, V97, P1107, DOI 10.1073/pnas.97.3.1107; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Li ZH, 2011, J BIOL CHEM, V286, P43959, DOI 10.1074/jbc.M111.311530; Liu C, 2000, J BIOL CHEM, V275, P31972, DOI 10.1074/jbc.M003055200; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Michaillat L, 2012, MOL BIOL CELL, V23, P881, DOI 10.1091/mbc.E11-08-0703; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Pinson B, 2004, J BIOL CHEM, V279, P35273, DOI 10.1074/jbc.M405398200; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Secco D, 2012, FEBS LETT, V586, P289, DOI 10.1016/j.febslet.2012.01.036; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shirahama K, 1996, PLANT CELL PHYSIOL, V37, P1090, DOI 10.1093/oxfordjournals.pcp.a029058; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; SPAIN BH, 1995, J BIOL CHEM, V270, P25435, DOI 10.1074/jbc.270.43.25435; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; UEDA Y, 1975, J BACTERIOL, V122, P911, DOI 10.1128/JB.122.3.911-922.1975; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; Vardi N, 2014, CELL REP, V9, P1122, DOI 10.1016/j.celrep.2014.10.002; Vardi N, 2013, CURR BIOL, V23, P2051, DOI 10.1016/j.cub.2013.08.043; Vaughan AE, 2012, J VIROL, V86, P1661, DOI 10.1128/JVI.06073-11; Werner TP, 2005, ARCH MICROBIOL, V184, P129, DOI 10.1007/s00203-005-0031-2; WIEMKEN A, 1970, Archiv fuer Mikrobiologie, V70, P89, DOI 10.1007/BF00412200; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; WURST H, 1994, J BIOL CHEM, V269, P10996; Wykoff DD, 2001, GENETICS, V159, P1491	61	45	45	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22262	22275		10.1074/jbc.M116.746784	http://dx.doi.org/10.1074/jbc.M116.746784			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27587415	Green Published, hybrid			2022-12-28	WOS:000386332600037
J	Boskovic, J; Martinez-Gago, J; Mendez-Pertuz, M; Buscato, A; Martinez-Torrecuadrada, JL; Blasco, MA				Boskovic, Jasminka; Martinez-Gago, Jaime; Mendez-Pertuz, Marinela; Buscato, Alberto; Luis Martinez-Torrecuadrada, Jorge; Blasco, Maria A.			Molecular Architecture of Full-length TRF1 Favors Its Interaction with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; electron microscopy (EM); protein structure; shelterin; telomere; telomeric repeat-binding factor 1 (TERF1); protein structure; electron microscopy (EM); telomere; telomeric repeat binding factor1 (TRF1)	TELOMERIC PROTEINS TRF1; COMPLEX; SHELTERIN; RAP1; TANKYRASE; GENE; TIN2; EXPRESSION; PROTECTION; REGULATOR	Telomeres are specific DNA-protein structures found at both ends of eukaryotic chromosomes that protect the genome from degradation and from being recognized as double-stranded breaks. In vertebrates, telomeres are composed of tandem repeats of the TTAGGG sequence that are bound by a six-subunit complex called shelterin. Molecular mechanisms of telomere functions remain unknown in large part due to lack of structural data on shelterins, shelterin complex, and its interaction with the telomeric DNA repeats. TRF1 is one of the best studied shelterin components; however, the molecular architecture of the full-length protein remains unknown. We have used single-particle electron microscopy to elucidate the structure of TRF1 and its interaction with telomeric DNA sequence. Our results demonstrate that full-length TRF1 presents a molecular architecture that assists its interaction with telometic DNA and at the same time makes TRFH domains accessible to other TRF1 binding partners. Furthermore, our studies suggest hypothetical models on how other proteins as TIN2 and tankyrase contribute to regulate TRF1 function.	[Boskovic, Jasminka; Buscato, Alberto] Spanish Natl Canc Res Ctr CNIO, Electron Microscopy Unit, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Martinez-Gago, Jaime; Luis Martinez-Torrecuadrada, Jorge] Spanish Natl Canc Res Ctr CNIO, Crystallog & Prot Engn Unit, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Mendez-Pertuz, Marinela; Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Telomeres & Telomerase Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Boskovic, J (corresponding author), Spanish Natl Canc Res Ctr CNIO, Electron Microscopy Unit, Struct Biol & Biocomp Programme, Madrid 28029, Spain.; Blasco, MA (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Telomeres & Telomerase Grp, Madrid 28029, Spain.	jboskovic@cnio.es; mblasco@cnio.es	Martinez-Torrecuadrada, Jorge L./AAG-1090-2019; Blasco, Maria A./M-1694-2014; boskovic, jasminka/L-5117-2018	Blasco, Maria A./0000-0002-4211-233X; boskovic, jasminka/0000-0001-6135-0686; Martinez-Torrecuadrada, Jorge Luis/0000-0002-8240-6623	Spanish Ministry of Economy and Competitiveness [SAF2013-45111RETOS]; Fundacion Botin	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Botin	The M. A. B laboratory is supported by the Spanish Ministry of Economy and Competitiveness Project SAF2013-45111RETOS and the Fundacion Botin. We thank Oscar Llorca and Santiago Ramon for valuable comments and Maria Moreno for critical reading of the manuscript.	Bainbridge MN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju384; Calvete O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9383; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; De Boeck G, 2009, J PATHOL, V217, P327, DOI 10.1002/path.2500; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Diotti R, 2011, NUCLEUS-PHILA, V2, P119, DOI 10.4161/nucl.2.2.15135; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Garcia-Beccaria M, 2015, EMBO MOL MED, V7, P930, DOI 10.15252/emmm.201404497; Gaullier G, 2016, NUCLEIC ACIDS RES, V44, P1962, DOI 10.1093/nar/gkv1531; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kim SH, 2003, EMBO REP, V4, P685, DOI 10.1038/sj.embor.embor872; Li B, 2016, ACTA CRYSTALLOGR F, V72, P320, DOI 10.1107/S2053230X16004131; Martinez P, 2013, CELL REP, V3, P2059, DOI 10.1016/j.celrep.2013.05.030; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Martinez-Torrecuadrada JL, 2005, J BIOTECHNOL, V115, P23, DOI 10.1016/j.jbiotec.2004.07.011; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Walker JR, 2012, MECH AGEING DEV, V133, P421, DOI 10.1016/j.mad.2012.05.002; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Yokoyama N, 2000, BBA-GENE STRUCT EXPR, V1493, P119, DOI 10.1016/S0167-4781(00)00170-6; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	38	4	4	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21829	21835		10.1074/jbc.M116.744896	http://dx.doi.org/10.1074/jbc.M116.744896			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27563064	Green Published, hybrid			2022-12-28	WOS:000385999200045
J	Higuchi, T; Todaka, H; Sugiyama, Y; Ono, M; Tamaki, N; Hatano, E; Takezaki, Y; Hanazaki, K; Miwa, T; Lai, S; Morisawa, K; Tsuda, M; Taniguchi, T; Sakamoto, S				Higuchi, Takuma; Todaka, Hiroshi; Sugiyama, Yasunori; Ono, Masafumi; Tamaki, Nobuyuki; Hatano, Etsuro; Takezaki, Yuka; Hanazaki, Kazuhiro; Miwa, Takeshi; Lai, Sylvia; Morisawa, Keiko; Tsuda, Masayuki; Taniguchi, Taketoshi; Sakamoto, Shuji			Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; LUNG-CANCER; NEGATIVE REGULATOR; GENE-EXPRESSION; PROTEIN; RNA; MECHANISM; GLIOBLASTOMA; METASTASIS; INHIBITOR	MicroRNA-7 (miR-7) has been characterized as an anti-oncogenic microRNA (miRNA) in several cancers, including hepatocellular carcinoma (HCC). However, the mechanism for the regulation of miR-7 production in tumors remains unclear. Here, we identified nuclear factor 90 (NF90) and NF45 complex (NF90-NF45) as negative regulators of miR-7 processing in HCC. Expression of NF90 and NF45 was significantly elevated in primary HCC tissues compared with adjacent non-tumor tissues. To examine which miRNAs are controlled by NF90-NF45, we performed an miRNA microarray and quantitative RT-PCR analyses of HCC cell lines. Depletion of NF90 resulted in elevated levels of mature miR-7, whereas the expression of primary miR-7-1 (pri-miR-7-1) was decreased in cells following knockdown of NF90. Conversely, the levels of mature miR-7 were reduced in cells overexpressing NF90 and NF45, although primiR- 7-1 was accumulated in the same cells. Furthermore, NF90-NF45 was found to bind pri-miR-7-1 in vitro. These results suggest that NF90-NF45 inhibits the pri-miR-7-1 processing step through the binding of NF90-NF45 to pri-miR-7-1. We also found that levels of the EGF receptor, an oncogenic factor that is a direct target of miR-7, and phosphorylation of AKT were significantly decreased in HCC cell lines depleted of NF90 or NF45. Of note, knockdown of NF90 or NF45 caused a reduction in the proliferation rate ofHCCcells. Taken together, NF90-NF45 stimulates an elevation of EGF receptor levels via the suppression of miR-7 biogenesis, resulting in the promotion of cell proliferation in HCC.	[Higuchi, Takuma; Todaka, Hiroshi; Sugiyama, Yasunori; Miwa, Takeshi; Lai, Sylvia; Morisawa, Keiko; Taniguchi, Taketoshi; Sakamoto, Shuji] Kochi Med Sch, Ctr Sci Res, Mol Biol Lab, Kochi 7838505, Japan; [Ono, Masafumi] Kochi Med Sch, Ctr Sci Res, Dept Gastroenterol & Hepatol, Kochi 7838505, Japan; [Takezaki, Yuka; Hanazaki, Kazuhiro] Kochi Med Sch, Ctr Sci Res, Dept Surg, Kochi 7838505, Japan; [Tsuda, Masayuki] Kochi Med Sch, Ctr Sci Res, Div Lab Anim Sci, Kochi 7838505, Japan; [Tamaki, Nobuyuki; Hatano, Etsuro] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068501, Japan	Kochi University; Kochi University; Kochi University; Kochi University; Kyoto University	Sakamoto, S (corresponding author), Kochi Univ, Kochi Med Sch, Ctr Sci Res, Mol Biol Lab, Oko Cho, Nankoku, Kochi 7838505, Japan.	sshuji@kochi-u.ac.jp	Hatano, Etsuro/AAX-2407-2020	Hatano, Etsuro/0000-0003-3407-1918	Japan Society for the Promotion of Science [12J10660, 25460371, 16K08590]; Grants-in-Aid for Scientific Research [16K08590, 26750372] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science Grant-in-aid for JSPS Fellows 12J10660 and Grants-in-aid for Scientific Research (C) 25460371 and 16K08590. The authors declare that they have no conflicts of interest with the contents of this article.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Guo Y, 2012, ONCOL REP, V27, P286, DOI 10.3892/or.2011.1483; Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Hu Q, 2013, ONCOGENE, V32, P3933, DOI 10.1038/onc.2012.414; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jiang W, 2015, ONCOGENE, V34, P4460, DOI 10.1038/onc.2014.373; Kalinowski FC, 2014, INT J BIOCHEM CELL B, V54, P312, DOI 10.1016/j.biocel.2014.05.040; Kalinowski FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047067; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Normanno N, 2003, J CELL PHYSIOL, V194, P13, DOI 10.1002/jcp.10194; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Papp G, 2014, GENE CHROMOSOME CANC, V53, P168, DOI 10.1002/gcc.22128; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sakamoto S, 2001, J BIOL CHEM, V276, P37237, DOI 10.1074/jbc.M105543200; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shin S, 2012, BIOCHIMIE, V94, P1431, DOI 10.1016/j.biochi.2012.03.023; Song DM, 2002, BIOCHEMISTRY-US, V41, P929, DOI 10.1021/bi015669c; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Todaka H, 2015, MOL CELL BIOL, V35, P2295, DOI 10.1128/MCB.01297-14; Tominaga-Yamanaka K, 2012, AGING-US, V4, P695, DOI 10.18632/aging.100497; Wang YL, 2013, MOL CELL BIOL, V33, P1233, DOI 10.1128/MCB.01604-12; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wu DG, 2011, CHINESE MED J-PEKING, V124, P2616, DOI 10.3760/cma.j.issn.0366-6999.2011.17.010; Wu L, 2012, J HUAZHONG U SCI-MED, V32, P601, DOI 10.1007/s11596-012-1004-8; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	51	53	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21074	21084		10.1074/jbc.M116.748210	http://dx.doi.org/10.1074/jbc.M116.748210			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27519414	Green Published, hybrid			2022-12-28	WOS:000385406200023
J	Petrvalska, O; Kosek, D; Kukacka, Z; Tosner, Z; Man, P; Vecer, J; Herman, P; Obsilova, V; Obsil, T				Petrvalska, Olivia; Kosek, Dalibor; Kukacka, Zdenek; Tosner, Zdenek; Man, Petr; Vecer, Jaroslav; Herman, Petr; Obsilova, Veronika; Obsil, Tomas			Structural Insight into the 14-3-3 Protein-dependent Inhibition of Protein Kinase ASK1 (Apoptosis Signal-regulating kinase 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 protein; apoptosis signal-regulating kinase 1 (ASK1); fluorescence; nuclear magnetic resonance (NMR); protein cross-linking; small-angle x-ray scattering (SAXS)	SMALL-ANGLE SCATTERING; NEUTRAL TREHALASE NTH1; X-RAY-SCATTERING; CRYSTAL-STRUCTURE; FAMILY PROTEINS; LIGAND-BINDING; CELL-DEATH; ACTIVATION; COMPLEX; PHOSPHORYLATION	Apoptosis signal-regulating kinase 1 (ASK1, also known as MAP3K5), a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, regulates diverse physiological processes. The activity of ASK1 is triggered by various stress stimuli and is involved in the pathogenesis of cancer, neurodegeneration, inflammation, and diabetes. ASK1 forms a high molecular mass complex whose activity is, under non-stress conditions, suppressed through interaction with thioredoxin and the scaffolding protein 14-3-3. The 14-3-3 protein binds to the phosphorylated Ser-966 motif downstream of the ASK1 kinase domain. The role of 14-3-3 in the inhibition of ASK1 has yet to be elucidated. In this study we performed structural analysis of the complex between the ASK1 kinase domain phosphorylated at Ser-966 (pASK1-CD) and the 14-3-3 protein. Small angle x-ray scattering (SAXS) measurements and chemical cross-linking revealed that the pASK1-CD14-3-3 complex is dynamic and conformationally heterogeneous. In addition, structural analysis coupled with the results of phosphorus NMR and time-resolved tryptophan fluorescence measurements suggest that 14-3-3 interacts with the kinase domain of ASK1 in close proximity to its active site, thus indicating this interaction might block its accessibility and/or affect its conformation.	[Petrvalska, Olivia; Kosek, Dalibor; Tosner, Zdenek; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Man, Petr] Charles Univ Prague, Dept Biochem, Fac Sci, Prague 12843, Czech Republic; [Petrvalska, Olivia; Kosek, Dalibor; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republic, Inst Physiol, Prague 14220, Czech Republic; [Kukacka, Zdenek; Man, Petr] Acad Sci Czech Republic, Inst Microbiol, Prague 14220, Czech Republic; [Vecer, Jaroslav; Herman, Petr] Charles Univ Prague, Inst Phys, Fac Math & Phys, Prague 12116, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic.; Obsilova, V; Obsil, T (corresponding author), Acad Sci Czech Republic, Inst Physiol, Prague 14220, Czech Republic.	veronika.obsilova@fgu.cas.cz; obsil@natur.cuni.cz	Man, Petr/H-2451-2014; Kukacka, Zdenek/J-8816-2014; Obsil, Tomas/B-7142-2012; Košek, Dalibor/AAD-4715-2021; Tosner, Zdenek/G-6736-2014; Petrvalska, Olivia/O-6572-2017; Herman, Petr/A-2626-2008; Obsilova, Veronika/B-7116-2012	Man, Petr/0000-0002-1485-2197; Kukacka, Zdenek/0000-0001-7569-843X; Obsil, Tomas/0000-0003-4602-1272; Tosner, Zdenek/0000-0003-2741-9154; Petrvalska, Olivia/0000-0002-9855-1913; Herman, Petr/0000-0001-6918-2576; Obsilova, Veronika/0000-0003-4887-0323	EU [CZ.1.05/1.1.00/02.0109]	EU(European Commission)	We thank Petr Novak for assistance with MS, Martin Dracinsky for assistance with NMR, and Daniel Steiner for critical reading of the manuscript. Access to the MS facility was enabled by the EU project CZ.1.05/1.1.00/02.0109 and by the Czech Infrastructure for Integrative Structural Biology (LM2015043).	BOCK JL, 1975, BIOCHEM BIOPH RES CO, V66, P24, DOI 10.1016/S0006-291X(75)80289-0; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Carter L, 2015, BIOPHYS J, V109, P793, DOI 10.1016/j.bpj.2015.06.065; Cockrell LM, 2010, ONCOGENE, V29, P822, DOI 10.1038/onc.2009.382; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hari SB, 2013, CHEM BIOL, V20, P806, DOI 10.1016/j.chembiol.2013.05.005; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson ML, 2008, METHOD CELL BIOL, V84, P781, DOI 10.1016/S0091-679X(07)84024-6; Kacirova M, 2015, J BIOL CHEM, V290, P16246, DOI 10.1074/jbc.M115.636563; Kawarazaki Y, 2014, EXPERT OPIN THER TAR, V18, P651, DOI 10.1517/14728222.2014.896903; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Klein DC, 2003, J NEUROENDOCRINOL, V15, P370, DOI 10.1046/j.1365-2826.2003.01000.x; Kleppe R, 2014, MOL CELL PROTEOMICS, V13, P2017, DOI 10.1074/mcp.M113.035709; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kopecka M, 2014, J BIOL CHEM, V289, P13948, DOI 10.1074/jbc.M113.544551; Kosek D, 2014, J BIOL CHEM, V289, P24463, DOI 10.1074/jbc.M114.583807; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P129; Macakova E, 2013, BBA-GEN SUBJECTS, V1830, P4491, DOI 10.1016/j.bbagen.2013.05.025; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Raveh B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000295; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Shiizaki Shigeru, 2013, Advances in Biological Regulation, V53, P135, DOI 10.1016/j.jbior.2012.09.006; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vecer J, 2011, J FLUORESC, V21, P873, DOI 10.1007/s10895-009-0589-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	50	33	38	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20753	20765		10.1074/jbc.M116.724310	http://dx.doi.org/10.1074/jbc.M116.724310			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514745	Green Published, hybrid			2022-12-28	WOS:000384574800036
J	Qiao, YC; He, H; Jonsson, P; Sinha, I; Zhao, CY; Dahlman-Wright, K				Qiao, Yichun; He, Huan; Jonsson, Philip; Sinha, Indranil; Zhao, Chunyan; Dahlman-Wright, Karin			AP-1 is a key regulator of proinflammatory cytokine TNF alpha-mediated triple-negative breast cancer progression (vol 291, pg 5068, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Jonsson, Philip] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Jonsson, Philip] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Jonsson, Philip] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	University of Houston System; University of Houston; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center			Qiao, yichun/Q-6498-2018; He, Huan/AAF-9644-2019					Qiao YC, 2016, J BIOL CHEM, V291, P5068, DOI 10.1074/jbc.M115.702571	1	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18309	18309		10.1074/jbc.A115.702571	http://dx.doi.org/10.1074/jbc.A115.702571			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27566813	Green Published, hybrid			2022-12-28	WOS:000383241800023
J	Das, DK; Mallis, RJ; Duke-Cohan, JS; Hussey, RE; Tetteh, PW; Hilton, M; Wagner, G; Lang, MJ; Reinherz, EL				Das, Dibyendu Kumar; Mallis, Robert J.; Duke-Cohan, Jonathan S.; Hussey, Rebecca E.; Tetteh, Paul W.; Hilton, Mark; Wagner, Gerhard; Lang, Matthew J.; Reinherz, Ellis L.			Pre-T Cell Receptors (Pre-TCRs) Leverage V Complementarity Determining Regions (CDRs) and Hydrophobic Patch in Mechanosensing Thymic Self-ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cell differentiation; cell surface receptor; crystallography; major histocompatibility complex (MHC); nuclear magnetic resonance (NMR); optical tweezers; mechanobiology; pre-T cell receptor; structural transition	BETA FG LOOP; THYMOCYTE DEVELOPMENT; MECHANICAL FORCE; STRUCTURAL BASIS; ANTIGEN RECEPTOR; FAB FRAGMENT; PEPTIDE-MHC; IN-VITRO; COMPLEX; SELECTION	The pre-T cell receptor (pre-TCR) is a pT- heterodimer functioning in early T cell development. Although once thought to be ligand-autonomous, recent studies show that pre-TCRs participate in thymic repertoire formation through recognition of peptides bound to major histocompatibility molecules (pMHC). Using optical tweezers, we probe pre-TCR bonding with pMHC at the single molecule level. Like the TCR, the pre-TCR is a mechanosensor undergoing force-based structural transitions that dynamically enhance bond lifetimes and exploiting allosteric control regulated via the C FG loop region. The pre-TCR structural transitions exhibit greater reversibility than TCR and ordered force-bond lifetime curves. Higher piconewton force requires binding through both complementarity determining region loops and hydrophobic V patch apposition. This patch functions in the pre-TCR as a surrogate V domain, fostering ligand promiscuity to favor development of chains with self-reactivity but is occluded by subunit replacement of pT upon TCR formation. At the double negative 3 thymocyte stage where the pre-TCR is first expressed, pre-TCR interaction with self-pMHC ligands imparts growth and survival advantages as revealed in thymic stromal cultures, imprinting fundamental self-reactivity in the T cell repertoire. Collectively, our data imply the existence of sequential mechanosensor TCR repertoire tuning via the pre-TCR.	[Das, Dibyendu Kumar; Hilton, Mark; Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Mallis, Robert J.; Wagner, Gerhard] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Duke-Cohan, Jonathan S.; Tetteh, Paul W.; Reinherz, Ellis L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Duke-Cohan, Jonathan S.; Hussey, Rebecca E.; Tetteh, Paul W.; Reinherz, Ellis L.] Dana Farber Canc Inst, Immunobiol Lab, Dept Med Oncol, Boston, MA 02115 USA; [Lang, Matthew J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University	Lang, MJ (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.; Reinherz, EL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Reinherz, EL (corresponding author), Dana Farber Canc Inst, Immunobiol Lab, Dept Med Oncol, Boston, MA 02115 USA.; Lang, MJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA.	matt.lang@vanderbilt.edu; ellis_reinherz@dfci.harvard.edu	Duke-Cohan, Jonathan/A-5812-2010	Duke-Cohan, Jonathan/0000-0002-9478-9609; Das, Dibyendu Kumar/0000-0002-8450-9298	National Institutes of Health [R01AI100643, R01AI37581, P01GM047467]; National Science Foundation [MCB-1330792]; Singapore-Massachusetts Institute of Technology Alliance for Research and Technology (SMART) Program; American Association for Cancer Research [SU2C-AACR-DT-13-14]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100643, R01AI037581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; Direct For Biological Sciences [1330792] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Singapore-Massachusetts Institute of Technology Alliance for Research and Technology (SMART) Program; American Association for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health Grants R01AI100643, R01AI37581, and P01GM047467; National Science Foundation Grant MCB-1330792; the Singapore-Massachusetts Institute of Technology Alliance for Research and Technology (SMART) Program; and American Association for Cancer Research Grant SU2C-AACR-DT-13-14. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; Castro CE, 2011, BIOPHYS J, V101, P439, DOI 10.1016/j.bpj.2011.06.016; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; Choi YI, 2014, P NATL ACAD SCI USA, V111, P379, DOI 10.1073/pnas.1314209111; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; Dai BB, 2009, STEM CELLS DEV, V18, P235, DOI 10.1089/scd.2008.0021; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Hoerter JAH, 2013, J EXP MED, V210, P1807, DOI 10.1084/jem.20122528; Hu KH, 2016, J CELL BIOL, V213, P535, DOI 10.1083/jcb.201511053; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; IMARAI M, 1995, CELL IMMUNOL, V160, P33, DOI 10.1016/0008-8749(95)80006-5; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kim ST, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00076; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu J, 1996, J BIOL CHEM, V271, P33639, DOI 10.1074/jbc.271.52.33639; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Ma ZY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00217; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Pyzocha NK, 2014, METHODS MOL BIOL, V1114, P269, DOI 10.1007/978-1-62703-761-7_17; R Core Team, 2015, LANG ENV STAT COMP V; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Smelty P, 2010, P NATL ACAD SCI USA, V107, P19991, DOI 10.1073/pnas.1010166107; STALLCUP KC, 1981, J IMMUNOL, V127, P923; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; von Boehmer H, 2014, CANCER IMMUNOL RES, V2, P592, DOI 10.1158/2326-6066.CIR-14-0070; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Zhou B, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00005; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	57	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25292	25305		10.1074/jbc.M116.752865	http://dx.doi.org/10.1074/jbc.M116.752865			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27707880	Green Published, hybrid			2022-12-28	WOS:000390095300002
J	Esser, L; Zhou, F; Zhou, YH; Xiao, YM; Tang, WK; Yu, CA; Qin, ZH; Xia, D				Esser, Lothar; Zhou, Fei; Zhou, Yihui; Xiao, Yumei; Tang, Wai-Kwan; Yu, Chang-An; Qin, Zhaohai; Xia, Di			Hydrogen Bonding to the Substrate Is Not Required for Rieske Iron-Sulfur Protein Docking to the Quinol Oxidation Site of Complex III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; C REDUCTASE; Q-CYCLE; MITOCHONDRIAL; INHIBITORS; BINDING	Complex III or the cytochrome (cyt) bc(1) complex constitutes an integral part of the respiratory chain of most aerobic organisms and of the photosynthetic apparatus of anoxygenic purple bacteria. The function of cyt bc(1) is to couple the reaction of electron transfer from ubiquinol to cytochrome c to proton pumping across the membrane. Mechanistically, the electron transfer reaction requires docking of its Rieske iron-sulfur protein (ISP) subunit to the quinol oxidation site (Q(P)) of the complex. Formation of an H-bond between the ISP and the bound substrate was proposed to mediate the docking. Here we show that the binding of oxazolidinedione-type inhibitors famoxadone, jg144, and fenamidone induces docking of the ISP to the QP site in the absence of the H-bond formation both in mitochondrial and bacterial cyt bc(1) complexes, demonstrating that ISP docking is independent of the proposed direct ISP-inhibitor interaction. The binding of oxazolidinedione-type inhibitors to cyt bc(1) of different species reveals a toxophore that appears to interact optimally with residues in the Q(P) site. The effect of modifications or additions to the toxophore on the binding to cyt bc(1) from different species could not be predicted from structure-based sequence alignments, as demonstrated by the altered binding mode of famoxadone to bacterial cyt bc(1).	[Esser, Lothar; Zhou, Fei; Zhou, Yihui; Xiao, Yumei; Tang, Wai-Kwan; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA; [Zhou, Yihui; Xiao, Yumei; Qin, Zhaohai] China Agr Univ, Coll Sci, Beijing 100193, Peoples R China; [Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); China Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater	Xia, D (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	xiad@mail.nih.gov	Tang, Wai Kwan/A-6158-2012		Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Basic Research Science Foundation of China [2010CB126100]; NATIONAL CANCER INSTITUTE [ZIABC010319] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Basic Research Science Foundation of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and a grant from the National Basic Research Science Foundation of China (2010CB126100) (to Z. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Berry EA, 2003, FEBS LETT, V555, P13, DOI 10.1016/S0014-5793(03)01099-8; Berry EA, 2011, BBA-BIOENERGETICS, V1807, P1349, DOI 10.1016/j.bbabio.2011.04.005; BRANDT U, 1988, EUR J BIOCHEM, V173, P499, DOI 10.1111/j.1432-1033.1988.tb14026.x; BRANDT U, 1991, EUR J BIOCHEM, V195, P163, DOI 10.1111/j.1432-1033.1991.tb15690.x; Brandt U, 1997, BBA-BIOENERGETICS, V1321, P238, DOI 10.1016/S0005-2728(97)00060-1; Chen WJ, 2007, APPL ENVIRON MICROB, V73, P5162, DOI 10.1128/AEM.00507-07; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Fernandez-Ortuno D, 2008, PEST MANAG SCI, V64, P694, DOI 10.1002/ps.1544; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan DB, 1999, PESTIC SCI, V55, P105, DOI 10.1002/(SICI)1096-9063(199902)55:2&lt;105::AID-PS879&gt;3.0.CO;2-D; Keilin D, 1925, P R SOC LOND B-CONTA, V98, P312, DOI 10.1098/rspb.1925.0039; Kleinschroth T, 2011, BBA-BIOENERGETICS, V1807, P1606, DOI 10.1016/j.bbabio.2011.09.017; LINK TA, 1993, J BIOENERG BIOMEMBR, V25, P221, DOI 10.1007/BF00762584; LJUNGDAHL O, 1987, BIOCHIM BIOPHYS ACTA, V891, P227; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHNISHI T, 1988, EUR J BIOCHEM, V176, P385, DOI 10.1111/j.1432-1033.1988.tb14293.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Steinfeld U, 2001, PEST MANAG SCI, V57, P787, DOI 10.1002/ps.356; Sternberg JA, 2001, PEST MANAG SCI, V57, P143, DOI 10.1002/1526-4998(200102)57:2<143::AID-PS282>3.0.CO;2-8; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Willis R. J., 2007, HIST ALLELOPATHY; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008; Xiao YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093765; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	44	13	13	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25019	25031		10.1074/jbc.M116.744391	http://dx.doi.org/10.1074/jbc.M116.744391			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27758861	Green Published, hybrid			2022-12-28	WOS:000388880100019
J	Speen, AM; Kim, HYH; Bauer, RN; Meyer, M; Gowdy, KM; Fessler, MB; Duncan, KE; Liu, W; Porter, NA; Jaspers, I				Speen, Adam M.; Kim, Hye-Young H.; Bauer, Rebecca N.; Meyer, Megan; Gowdy, Kymberly M.; Fessler, Michael B.; Duncan, Kelly E.; Liu, Wei; Porter, Ned A.; Jaspers, Ilona			Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; BIOLOGICALLY-ACTIVE OXYSTEROLS; BRONCHOALVEOLAR LAVAGE FLUID; LEMLI-OPITZ SYNDROME; NF-KAPPA-B; OZONATION PRODUCTS; LUNG SURFACTANT; INNATE IMMUNITY; INFLAMMATORY MEDIATORS; OXIDIZED PHOSPHOLIPIDS	When inhaled, ozone (O-3) interacts with cholesterols of airway epithelial cell membranes or the lung-lining fluid, generating chemically reactive oxysterols. The mechanism by which O-3-derived oxysterols affect molecular function is unknown. Our data show that in vitro exposure of human bronchial epithelial cells to O-3 results in the formation of oxysterols, epoxy-cholesterol-alpha and -beta and secosterol A and B (Seco A and Seco B), in cell lysates and apical washes. Similarly, bronchoalveolar lavage fluid obtained from human volunteers exposed to O-3 contained elevated levels of these oxysterol species. As expected, O-3-derived oxysterols have a pro-inflammatory effect and increase NF-kappa B activity. Interestingly, expression of the cholesterol efflux pump ATP-binding cassette transporter 1 (ABCA1), which is regulated by activation of the liver X receptor (LXR), was suppressed in epithelial cells exposed to O-3. Additionally, exposure of LXR knock-out mice to O-3 enhanced pro-inflammatory cytokine production in the lung, suggesting LXR inhibits O-3-induced inflammation. Using alkynyl surrogates of O-3-derived oxysterols, our data demonstrate adduction of LXR with Seco A. Similarly, supplementation of epithelial cells with alkynyl-tagged cholesterol followed by O-3 exposure causes observable lipid-LXR adduct formation. Experiments using Seco A and the LXR agonist T0901317 (T09) showed reduced expression of ABCA1 as compared with stimulation with T0901317 alone, indicating that Seco A-LXR protein adduct formation inhibits LXR activation by traditional agonists. Overall, these data demonstrate that O-3-derived oxysterols have pro-inflammatory functions and form lipid-protein adducts with LXR, thus leading to suppressed cholesterol regulatory gene expression and providing a biochemical mechanism mediating O-3-derived formation of oxidized lipids in the airways and subsequent adverse health effects.	[Speen, Adam M.; Bauer, Rebecca N.; Meyer, Megan; Duncan, Kelly E.; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Dept Pediat, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Speen, Adam M.; Bauer, Rebecca N.; Meyer, Megan; Duncan, Kelly E.; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Dept Microbiol & Immunol, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Kim, Hye-Young H.; Liu, Wei; Porter, Ned A.] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA; [Kim, Hye-Young H.; Liu, Wei; Porter, Ned A.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA; [Gowdy, Kymberly M.] East Carolina Univ, Brody Sch Med, Dept Pharmacol & Toxicol, Greenville, NC 27834 USA; [Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Vanderbilt University; University of North Carolina; East Carolina University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jaspers, I (corresponding author), Univ North Carolina Chapel Hill, Dept Pediat Microbiol & Immunol, 104 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Jaspers, I (corresponding author), Univ North Carolina Chapel Hill, Environm Sci & Engn, 104 Mason Farm Rd, Chapel Hill, NC 27599 USA.	ilona_jaspers@med.unc.edu	Jaspers, Ilona/AAZ-5035-2020; Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613; Jaspers, Ilona/0000-0001-8728-0305; Gowdy, Kymberly/0000-0002-7227-0697	United States Environmental Protection Agency [CR83346301]; Center for Environmental Medicine, Asthma and Lung Biology at the University of North Carolina at Chapel Hill; National Institutes of Health [T32ES007126, R21ES024666]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211, R01HD064727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024666, ZIAES102005, T32ES007126] Funding Source: NIH RePORTER	United States Environmental Protection Agency(United States Environmental Protection Agency); Center for Environmental Medicine, Asthma and Lung Biology at the University of North Carolina at Chapel Hill; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the United States Environmental Protection Agency through cooperative agreement CR83346301 with the Center for Environmental Medicine, Asthma and Lung Biology at the University of North Carolina at Chapel Hill (to I. J. and K. E. D.) and National Institutes of Health Grants T32ES007126 (to A. M. S. and R. N. B.) and R21ES024666 (to H. Y. K., N. A. P., and I. J.). The authors declare that they have no conflicts of interest with the contents of this article. This article has not been formally reviewed by EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexis NE, 2010, INHAL TOXICOL, V22, P593, DOI 10.3109/08958371003596587; Almstrand AC, 2015, ANAL BIOCHEM, V474, P50, DOI 10.1016/j.ab.2014.12.018; Azzam KM, 2012, TRENDS ENDOCRIN MET, V23, P169, DOI 10.1016/j.tem.2012.02.001; Bauer RN, 2015, AM J RESP CELL MOL, V52, P285, DOI 10.1165/rcmb.2014-0035OC; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bjorkhem I, 2013, BIOCHIMIE, V95, P448, DOI 10.1016/j.biochi.2012.02.029; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Bochem AE, 2015, ARTERIOSCL THROM VAS, V35, P1663, DOI 10.1161/ATVBAHA.114.304959; Connor RE, 2011, CHEM RES TOXICOL, V24, P1275, DOI 10.1021/tx200157t; Crisafulli C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-19; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; Devlin RB, 1996, TOXICOL APPL PHARM, V138, P176, DOI 10.1006/taap.1996.0111; Draper DW, 2012, J IMMUNOL, V188, P5327, DOI 10.4049/jimmunol.1101605; Fessler MB, 2008, CURR SIGNAL TRANSD T, V3, P75, DOI 10.2174/157436208784223170; Fessler MB, 2009, AM J RESP CRIT CARE, V180, P1031, DOI 10.1164/ajrccm.180.10.1031; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Gong HBA, 2009, J BIOL CHEM, V284, P30113, DOI 10.1074/jbc.M109.047753; Gowdy KM, 2013, PULM PHARMACOL THER, V26, P430, DOI 10.1016/j.pupt.2012.06.002; Hemming JM, 2015, BIOCHEMISTRY-US, V54, P5185, DOI 10.1021/acs.biochem.5b00308; Hollingsworth John W, 2007, Proc Am Thorac Soc, V4, P240, DOI 10.1513/pats.200701-023AW; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jaspers I, 2005, TOXICOL SCI, V85, P990, DOI 10.1093/toxsci/kfi141; Jaspers I, 1997, AM J PHYSIOL-LUNG C, V272, pL504, DOI 10.1152/ajplung.1997.272.3.L504; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Jorres RA, 2000, AM J RESP CRIT CARE, V161, P1855; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kafoury RM, 2007, ENVIRON TOXICOL, V22, P159, DOI 10.1002/tox.20246; Kafoury RM, 1999, AM J RESP CRIT CARE, V160, P1934, DOI 10.1164/ajrccm.160.6.9902025; Kafoury RM, 1998, TOXICOL APPL PHARM, V150, P338, DOI 10.1006/taap.1998.8418; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; Kim HYH, 2009, MOL CELL PROTEOMICS, V8, P2080, DOI 10.1074/mcp.M900121-MCP200; Kim HJ, 2013, J LEUKOCYTE BIOL, V94, P99, DOI 10.1189/jlb.1112601; Kirichenko A, 1996, TOXICOL APPL PHARM, V141, P416, DOI 10.1006/taap.1996.0307; Liu W, 2013, J LIPID RES, V54, P244, DOI 10.1194/jlr.M031732; Lopez-Souza N, 2003, IN VITRO CELL DEV-AN, V39, P266; Madenspacher JH, 2013, J EXP MED, V210, P891, DOI 10.1084/jem.20121674; Miyata R, 2013, CHEST, V143, P452, DOI 10.1378/chest.12-1237; Muller L, 2013, AM J PHYSIOL-LUNG C, V304, pL332, DOI 10.1152/ajplung.00256.2012; Murphy RC, 2008, J BIOL CHEM, V283, P15521, DOI 10.1074/jbc.R700049200; Nieva J, 2008, BIOCHEMISTRY-US, V47, P7695, DOI 10.1021/bi800333s; O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023; OOSTING RS, 1991, AM J PHYSIOL, V261, pL77, DOI 10.1152/ajplung.1991.261.2.L77; Ostro B, 2014, ENVIRON RES, V132, P168, DOI 10.1016/j.envres.2014.03.042; PRYOR WA, 1992, BIOCHEM BIOPH RES CO, V188, P618, DOI 10.1016/0006-291X(92)91101-U; Pulfer MK, 2005, J PHARMACOL EXP THER, V312, P256, DOI 10.1124/jpet.104.073437; Pulfer MK, 2004, J BIOL CHEM, V279, P26331, DOI 10.1074/jbc.M403581200; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SMITH LL, 1989, FREE RADICAL BIO MED, V7, P285, DOI 10.1016/0891-5849(89)90136-6; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Solan PD, 2011, SHOCK, V35, P367, DOI 10.1097/SHK.0b013e3181f7d742; Stewart CR, 2007, BIOCHEMISTRY-US, V46, P5552, DOI 10.1021/bi602554z; Tal TL, 2010, TOXICOL APPL PHARM, V243, P46, DOI 10.1016/j.taap.2009.11.011; Tang CR, 2016, J LIPID RES, V57, P848, DOI 10.1194/jlr.M065797; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Uhlson C, 2002, CHEM RES TOXICOL, V15, P896, DOI 10.1021/tx010183i; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; United States Environmental Protection Agency, 2014, NAT AMB AIR QUAL STA; UPPU RM, 1995, ARCH BIOCHEM BIOPHYS, V319, P257, DOI 10.1006/abbi.1995.1290; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Wentworth AD, 2009, CHEM COMMUN, P3098, DOI 10.1039/b821584g; Windsor K, 2014, CHEM RES TOXICOL, V27, P1757, DOI 10.1021/tx500229h; Windsor K, 2013, J LIPID RES, V54, P2842, DOI 10.1194/jlr.M041061; Wu CH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0524-8; Zanobetti A, 2004, EPIDEMIOLOGY, V15, pS22, DOI 10.1097/00001648-200407000-00042; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	76	19	19	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25192	25206		10.1074/jbc.M116.732362	http://dx.doi.org/10.1074/jbc.M116.732362			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27703007	hybrid, Green Published			2022-12-28	WOS:000388880100033
J	Warren, KJ; Fang, X; Gowda, NM; Thompson, JJ; Heller, NM				Warren, Kristi J.; Fang, Xi; Gowda, Nagaraj M.; Thompson, Joshua J.; Heller, Nicola M.			The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; MTOR; ACTIVATION; GROWTH; IRS-2; DEGRADATION; EXPRESSION; RAPAMYCIN; KINASE	Lung M2 macrophages are regulators of airway inflammation, associated with poor lung function in allergic asthma. Previously, we demonstrated that IL-4-induced M2 gene expression correlated with tyrosine phosphorylation of the insulin receptor substrate-2 (IRS-2) in macrophages. We hypothesized that negative regulation of IRS-2 activity after IL-4 stimulation is dependent upon serine phosphorylation of IRS-2. Herein, we describe an inverse relationship between tyrosine phosphorylation (Tyr(P)) and serine phosphorylation (Ser(P)) of IRS-2 after IL-4 stimulation. Inhibiting serine phosphatase activity increased Ser(P)-IRS-2 and decreased Tyr(P)-IRS-2 leading to reduced M2 gene expression (CD200R, CCL22, MMP12, andTGM2). We found that inhibition of p70S6K, downstream of TORC1, resulted in diminished Ser(P)-IRS-2 and prolonged Tyr(P)IRS-2 as well. Inhibition of p70S6K increased expression of CD200R and CCL22 indicating that p70S6K negatively regulates some, but not all, human M2 genes. Knocking down GRB10, another negative regulatory protein downstream of TORC1, enhanced both Tyr(P)-IRS-2 and increased expression of all four M2 genes. Furthermore, GRB10 associated with IRS-2, NEDD4.2 (an E3-ubiquitin ligase), IL-4R alpha, and gamma C after IL-4 stimulation. Both IL-4R alpha and gamma C were ubiquitinated after 30 min of IL-4 treatment, suggesting that GRB10 may regulate degradation of the IL-4 receptor-signaling complex through interactions with NEDD4.2. Taken together, these data highlight two novel regulatory proteins that could be therapeutically manipulated to limit IL-4-induced IRS-2 signaling and polarization of M2 macrophages in allergic inflammation.	[Warren, Kristi J.; Fang, Xi; Gowda, Nagaraj M.; Thompson, Joshua J.; Heller, Nicola M.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University	Heller, NM (corresponding author), Johns Hopkins Univ, Sch Med, Dept ACCM, Div Allergy & Clin Immunol, 720 Rutland Ave,Ross 367, Baltimore, MD 21205 USA.	nheller@jhmi.edu			National Institutes of Health [K99/R00 HL096897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096897, R00HL096897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant K99/R00 HL096897 (NHLBI; to N. M. H.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Binia A, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13612; Boura-Halfon S, 2009, VITAM HORM, V80, P313, DOI 10.1016/S0083-6729(08)00612-2; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chen D, 1999, MOL CELL BIOL, V19, P4684; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Dasgupta P, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6724; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Festuccia WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095432; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, pE824, DOI 10.1152/ajpendo.00409.2010; Genuneit J, 2009, CLIN EXP ALLERGY, V39, P1875, DOI 10.1111/j.1365-2222.2009.03364.x; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Hallowell R. W., 2013, RESP CRITICAL CARE M, pA4128; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Heller NM, 2012, J BIOL CHEM, V287, P31948, DOI 10.1074/jbc.M112.348896; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Malarde V, 2009, BIOCHEM BIOPH RES CO, V387, P409, DOI 10.1016/j.bbrc.2009.07.041; Melgert BN, 2011, J ALLERGY CLIN IMMUN, V127, P831, DOI 10.1016/j.jaci.2010.10.045; Mercalli A, 2013, IMMUNOLOGY, V140, P179, DOI 10.1111/imm.12126; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pozuelo-Rubio M, 2010, CELL BIOCHEM BIOPHYS, V58, P147, DOI 10.1007/s12013-010-9101-4; Robert H., 2012, C92 CONTROL MACROPHA, pA5061; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; St-Laurent J, 2009, J ASTHMA, V46, P1, DOI 10.1080/02770900802444211; SUN XJ, 1992, J BIOL CHEM, V267, P22662; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Vercelli D, 2008, J ALLERGY CLIN IMMUN, V122, P267, DOI 10.1016/j.jaci.2008.06.008; Viksman MY, 2002, CLIN IMMUNOL, V104, P77, DOI 10.1006/clim.2002.5233; Wang HY, 1998, J BIOL CHEM, V273, P9898, DOI 10.1074/jbc.273.16.9898; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	44	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24922	24930		10.1074/jbc.M116.756791	http://dx.doi.org/10.1074/jbc.M116.756791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27742835	Green Published, hybrid			2022-12-28	WOS:000388880100012
J	Cabukusta, B; Kohlen, JA; Richter, CP; You, C; Holthuis, JCM				Cabukusta, Birol; Kohlen, Jan A.; Richter, Christian P.; You, Changjiang; Holthuis, Joost C. M.			Monitoring Changes in the Oligomeric State of a Candidate Endoplasmic Reticulum (ER) Ceramide Sensor by Single-molecule Photobleaching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-INDUCED APOPTOSIS; SPHINGOLIPID BIOSYNTHESIS; SPHINGOMYELIN SYNTHASES; PROTEIN SMSR; CANCER CELLS; DYNAMICS; CURCUMIN; PHOSPHORYLATION; IDENTIFICATION; STOICHIOMETRY	Single-molecule photobleaching has emerged as a powerful non-invasive approach to extract the stoichiometry of multimeric membrane proteins in their native cellular environment. However, this method has mainly been used to determine the subunit composition of ion channels and receptors at the plasma membrane. Here, we applied single-molecule photobleaching to analyze the oligomeric state of an endoplasmic reticulum (ER) resident candidate ceramide sensor protein, SMSr/SAMD8. Co-immunoprecipitation and chemical cross-linking studies previously revealed that the N-terminal sterile alpha motif (or SAM) domain of SMSr drives self-assembly of the protein into oligomers and that SMSr oligomerization is promoted by curcumin, a drug known to perturb ER ceramide and calcium homeostasis. Application of cell spreading surface-active coating materials in combination with total internal reflection fluorescence (TIRF) microscopy allowed us to image GFP-tagged SMSr proteins as single fluorescent spots in the ER of He La cells in which expression of endogenous SMSr was abolished. In line with our biochemical analysis, we find that the number of bleaching steps in SMSr-GFP-positive spots displays a substantial drop after removal of the SAM domain. In contrast, treatment of cells with curcumin increased the number of bleaching steps. Our results document the first successful application of single-molecule photobleaching to resolve drug-induced and domain-dependent changes in the oligomeric state of an ER-resident membrane protein, hence establishing a complementary method to unravel the mechanism by which SMSr controls ceramide levels in the ER.	[Cabukusta, Birol; Kohlen, Jan A.; Holthuis, Joost C. M.] Univ Osnabruck, Mol Cell Biol Div, Barbarastr 13, D-49076 Osnabruck, Germany; [Richter, Christian P.; You, Changjiang] Univ Osnabruck, Div Biophys, Fac Biol Chem, D-49076 Osnabruck, Germany; [Holthuis, Joost C. M.] Univ Utrecht, Membrane Biochem & Biophys, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands; [Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	University Osnabruck; University Osnabruck; Utrecht University; Utrecht University	Holthuis, JCM (corresponding author), Univ Osnabruck, Mol Cell Biol Div, Barbarastr 13, D-49076 Osnabruck, Germany.	holthuis@uos.de	Holthuis, Joost/AAL-9157-2020; You, Changjiang/AFK-2816-2022; You, Changjiang/L-3901-2014	You, Changjiang/0000-0002-7839-6397; You, Changjiang/0000-0002-7839-6397; Cabukusta, Birol/0000-0002-1187-3048; Holthuis, Joost/0000-0001-8912-1586	European Union 7th FP Marie-Curie ITN "Sphingonet" Grant [289278]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich/SFB944-P14]	European Union 7th FP Marie-Curie ITN "Sphingonet" Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the European Union 7th FP Marie-Curie ITN "Sphingonet" Grant 289278 and by Deutsche Forschungsgemeinschaft Sonderforschungsbereich/SFB944-P14 (to J. C. M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal V, 2014, BIOESSAYS, V36, P1109, DOI 10.1002/bies.201400090; Arant RJ, 2014, CHEMPHYSCHEM, V15, P600, DOI 10.1002/cphc.201301092; Bernard K, 2009, J BIOL CHEM, V284, P30754, DOI 10.1074/jbc.M109.056010; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dolgachev V, 2004, J BIOL CHEM, V279, P23238, DOI 10.1074/jbc.M311974200; Fricke F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14072; Fricke F, 2015, CHEMPHYSCHEM, V16, P713, DOI 10.1002/cphc.201402765; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Hertel F, 2016, CELL REP, V14, P390, DOI 10.1016/j.celrep.2015.12.036; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Jha NS, 2015, ELECTROCHIM ACTA, V151, P574, DOI 10.1016/j.electacta.2014.11.026; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kol M, 2016, J LIPID RES, V57, P1273, DOI 10.1194/jlr.M068692; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Liesche C, 2015, BIOPHYS J, V109, P2352, DOI 10.1016/j.bpj.2015.10.035; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Moussavi M, 2006, CARCINOGENESIS, V27, P1636, DOI 10.1093/carcin/bgi371; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Segui B, 2006, BBA-BIOMEMBRANES, V1758, P2104, DOI 10.1016/j.bbamem.2006.05.024; Shuang B, 2014, J PHYS CHEM LETT, V5, P3157, DOI 10.1021/jz501435p; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tafesse FG, 2014, J CELL SCI, V127, P445, DOI 10.1242/jcs.138933; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625; Wedeking T, 2015, NANO LETT, V15, P3610, DOI 10.1021/acs.nanolett.5b01153; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang XF, 2009, CANCER BIOL THER, V8, P1117, DOI 10.4161/cbt.8.12.8374	45	8	8	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24735	24746		10.1074/jbc.M116.749812	http://dx.doi.org/10.1074/jbc.M116.749812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27729449	Green Published, hybrid			2022-12-28	WOS:000388875500031
J	Mitra, S; Ghosh, B; Gayen, N; Roy, J; Mandal, AK				Mitra, Shahana; Ghosh, Baijayanti; Gayen, Nilanjan; Roy, Joydeep; Mandal, Atin K.			Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; MOLECULAR CHAPERONE; IN-VIVO; CO-CHAPERONE; RAF KINASE; STEROID-RECEPTOR; TYROSINE KINASE; QUALITY-CONTROL; ATPASE ACTIVITY; SRC-KINASE	GRAF kinase maintains cell viability, growth, and proliferation by participating in the MAPK pathway. Unlike BRAF, CRAF requires continuous chaperoning by Hsp90 to retain MAPK signaling. However, the reason behind the continuous association of Hsp90 with CRAF is still elusive. In this study, we have identified the bipartite role of Hsp90 in chaperoning CRAF kinase. Hsp90 facilitates Ser-621 phosphorylation of CRAF and prevents the kinase from degradation. Co-chaperone Cdc37 assists in this phosphorylation event. However, after folding, the stability of the kinase becomes insensitive to Hsp90 inhibition, although the physical association between Hsp90 and CRAF remains intact. We observed that overexpression of Hsp90 stimulates MAPK signaling by activating CRAF. The interaction between Hsp90 and CRAF is substantially increased under an elevated level of cellular Hsp90 and in the presence of either active Ras (Ras(V12)) or EGF. Surprisingly, enhanced binding of Hsp90 to CRAF occurs prior to the Ras-CRAF association and facilitates actin recruitment to CRAF for efficient Ras-CRAF interaction, which is independent of the ATPase activity of Hsp90. However, monomeric CRAF (CRAF(R401H)) shows abrogated interaction with both Hsp90 and actin, thereby affecting Hsp90-dependent CRAF activation. This finding suggests that stringent assemblage of Hsp90 keeps CRAF kinase equipped for participating in the MAPK pathway. Thus, the role of Hsp90 in GRAF maturation and activation acts as a limiting factor to maintain the function of a strong client like CRAF kinase.	[Mitra, Shahana; Ghosh, Baijayanti; Gayen, Nilanjan; Roy, Joydeep; Mandal, Atin K.] Bose Inst, Div Mol Med, P-1-12 CIT Scheme VIIM, Kolkata 700054, India	Department of Science & Technology (India); Bose Institute	Mandal, AK (corresponding author), Bose Inst, Div Mol Med, P-1-12 CIT Scheme VIIM, Kolkata 700054, India.	mandalak@jcbose.ac.in		Mitra, Sahana/0000-0001-8339-1307	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR6544/BRB/10/1151/2012]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by Department of Biotechnology, Ministry of Science and Technology, Government of India Grant BT/PR6544/BRB/10/1151/2012 (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allanson JE, 2011, AM J MED GENET C, V157C, P129, DOI 10.1002/ajmg.c.30295; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Baljuls A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194167; Bandhakavi S, 2003, J BIOL CHEM, V278, P2829, DOI 10.1074/jbc.M206662200; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bijlmakers MJJE, 2000, MOL BIOL CELL, V11, P1585, DOI 10.1091/mbc.11.5.1585; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chavany C, 1996, J BIOL CHEM, V271, P4974; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dasgupta G, 1997, EXP CELL RES, V237, P29, DOI 10.1006/excr.1997.3766; Dey B, 1996, MOL BIOL CELL, V7, P1405, DOI 10.1091/mbc.7.9.1405; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Dhillon AS, 2003, MOL CELL BIOL, V23, P1983, DOI 10.1128/MCB.23.6.1983-1993.2003; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; FABIAN JR, 1993, J CELL BIOL, V122, P645, DOI 10.1083/jcb.122.3.645; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X; Keramisanou D, 2016, MOL CELL, V62, P260, DOI 10.1016/j.molcel.2016.04.005; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Luo ZJ, 1997, MOL CELL BIOL, V17, P46, DOI 10.1128/MCB.17.1.46; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Marais R, 1996, CANCER SURV, V27, P101; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; MORRISON DK, 1995, MOL REPROD DEV, V42, P507, DOI 10.1002/mrd.1080420420; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Muller P, 2005, J BIOL CHEM, V280, P6682, DOI 10.1074/jbc.M412767200; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prince T, 2005, BIOCHEM BIOPH RES CO, V338, P1447, DOI 10.1016/j.bbrc.2005.10.100; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Pullen L, 2011, J BIOL CHEM, V286, P11091, DOI 10.1074/jbc.M111.223131; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Roering Michael, 2012, Critical Reviews in Oncogenesis, V17, P97; Roy J, 2015, MOL BIOL CELL, V26, P1583, DOI 10.1091/mbc.E14-08-1262; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Schwarze SR, 2003, CANCER RES, V63, P4614; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith JR, 2015, ONCOGENE, V34, P15, DOI 10.1038/onc.2013.519; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Soga S, 1998, J BIOL CHEM, V273, P822, DOI 10.1074/jbc.273.2.822; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; Weber CK, 2001, CANCER RES, V61, P3595; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	115	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24579	24593		10.1074/jbc.M116.746420	http://dx.doi.org/10.1074/jbc.M116.746420			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703006	Green Published, hybrid			2022-12-28	WOS:000388875500020
J	Maruyama, K; Kawasaki, T; Hamaguchi, M; Hashimoto, M; Furu, M; Ito, H; Fujii, T; Takemura, N; Karuppuchamy, T; Kondo, T; Kawasaki, T; Fukasaka, M; Misawa, T; Saitoh, T; Suzuki, Y; Martino, MM; Kumagai, Y; Akira, S				Maruyama, Kenta; Kawasaki, Takahiko; Hamaguchi, Masahide; Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Takemura, Naoki; Karuppuchamy, Thangaraj; Kondo, Takeshi; Kawasaki, Takumi; Fukasaka, Masahiro; Misawa, Takuma; Saitoh, Tatsuya; Suzuki, Yutaka; Martino, Mikael M.; Kumagai, Yutaro; Akira, Shizuo			Bone-protective Functions of Netrin 1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arthritis; interleukin 17A (IL-17 or IL-17A); osteoblast; osteoclast; osteoporosis; netrin 1; cell fusion; rheumatoid arthritis	NF-KAPPA-B; OSTEOCLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; RHEUMATOID-ARTHRITIS; AXON GUIDANCE; CELL-FUSION; IN-VITRO; DC-STAMP; ACTIVATION	Netrin 1 was initially identified as an axon guidance factor, and recent studies indicate that it inhibits chemokine-directed monocyte migration. Despite its importance as a neuroimmune guidance cue, the role of netrin 1 in osteoclasts is largely unknown. Here we detected high netrin 1 levels in the synovial fluid of rheumatoid arthritis patients. Netrin 1 is potently expressed in osteoblasts and synovial fibroblasts, and IL-17 robustly enhances netrin 1 expression in these cells. The binding of netrin 1 to its receptor UNC5b on osteoclasts resulted in activation of SHP1, which inhibited VAV3 phosphorylation and RAC1 activation. This significantly impaired the actin polymerization and fusion, but not the differentiation of osteoclast. Strikingly, netrin 1 treatment prevented bone erosion in an autoimmune arthritis model and age-related bone destruction. Therefore, the netrin 1-UNC5b axis is a novel therapeutic target for bone-destructive diseases.	[Maruyama, Kenta; Karuppuchamy, Thangaraj; Kondo, Takeshi; Kawasaki, Takumi; Fukasaka, Masahiro; Misawa, Takuma; Saitoh, Tatsuya; Martino, Mikael M.; Kumagai, Yutaro; Akira, Shizuo] Osaka Univ, WPI, Immunol Frontier Res Ctr IFReC, Lab Host Def, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Hamaguchi, Masahide] Osaka Univ, WPI, Immunol Frontier Res Ctr IFReC, Lab Expt Immunol, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Osaka 5650871, Japan; [Kawasaki, Takahiko] Natl Inst Genet, Div Brain Funct, 1111 Yata, Mishima, Shizuoka 4118540, Japan; [Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto 6068507, Japan; [Takemura, Naoki] Univ Tokyo, Div Innate Immune Regulat, Int Res & Dev Ctr Mucosal Vaccine, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Saitoh, Tatsuya] Univ Tokushima, Dept Inflammat Biol, Inst Enzyme Res, 3-18-15 Kuramoto Cho, Tokushima, Tokushima 7708503, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Funct Genom & Med Genome Sci, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan; [Martino, Mikael M.] Monash Univ, European Mol Biol Lab, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia	Osaka University; Osaka University; Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; University of Tokyo; Tokushima University; University of Tokyo; Australian Regenerative Medicine Institute; European Molecular Biology Laboratory (EMBL); Monash University	Maruyama, K; Akira, S (corresponding author), Osaka Univ, WPI, Immunol Frontier Res Ctr IFReC, Lab Host Def, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	maruyama@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Martino, Mikaël M/N-9345-2013; Karuppuchamy, Thangaraj/O-2123-2017; Kumagai, Yutaro/L-7732-2018; KONDO, Takeshi/AGV-4963-2022; Akira, Shizuo/C-3134-2009	Martino, Mikaël M/0000-0002-5012-4605; Karuppuchamy, Thangaraj/0000-0002-7537-1530; Kumagai, Yutaro/0000-0002-5039-3979; Hamaguchi, Masahide/0000-0002-8651-4445; Kawasaki, Takahiko/0000-0001-9939-8407	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); JSPS for the Promotion of Science for Young Scientists; Osaka University MEET project; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation Natural Science; Takeda Science Foundation; Japan Intractable Diseases Research Foundation; SENSHIN Medical Research Foundation; Senri Life Science Foundation Kishimoto; Nouchi Shitagau; Japan Prize Foundation; Mochida Memorial; Japan Rheumatism Foundation	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS for the Promotion of Science for Young Scientists; Osaka University MEET project; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation Natural Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Intractable Diseases Research Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Senri Life Science Foundation Kishimoto; Nouchi Shitagau; Japan Prize Foundation(Japan Prize Foundation); Mochida Memorial; Japan Rheumatism Foundation(Japan Rheumatism Foundation)	This research was supported by the Cabinet Office, Government of Japan, and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), a research fellowship from the JSPS for the Promotion of Science for Young Scientists, a grant from the Osaka University MEET project, a grant from the Astellas Foundation for Research on Metabolic Disorders, a scholarship from the Naito Foundation Natural Science, a visionary research grant from Takeda Science Foundation, a KAKENHI grant-in-aid for Challenging Exploratory Research, a KAKENHI grant-in-aid for Young Scientists A, grants from the Japan Intractable Diseases Research Foundation and the SENSHIN Medical Research Foundation, a Senri Life Science Foundation Kishimoto grant, and grants from Nouchi Shitagau, Japan Prize Foundation, Mochida Memorial, and Japan Rheumatism Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Enoki Y, 2014, FEBS LETT, V588, P2262, DOI 10.1016/j.febslet.2014.05.009; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Gerszten RE, 2012, NEW ENGL J MED, V366, P1734, DOI 10.1056/NEJMcibr1200164; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Guo XK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/462152; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Maruyama K, 2013, J EXP MED, V210, P1947, DOI 10.1084/jem.20130512; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; Mediero A, 2015, J BONE MINER RES, V30, P837, DOI 10.1002/jbmr.2421; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mori Y, 2008, J IMMUNOL, V181, P4742, DOI 10.4049/jimmunol.181.7.4742; Okamoto K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3323; Paradisi A, 2013, EMBO MOL MED, V5, P1821, DOI 10.1002/emmm.201302654; Paradisi A, 2009, P NATL ACAD SCI USA, V106, P17146, DOI 10.1073/pnas.0901767106; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Ranganathan P, 2013, AM J PHYSIOL-RENAL, V304, pF1187, DOI 10.1152/ajprenal.00702.2012; Reginster JY, 2013, EXPERT OPIN DRUG SAF, V12, P507, DOI 10.1517/14740338.2013.793669; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Togari A, 2000, BRAIN RES, V878, P204, DOI 10.1016/S0006-8993(00)02700-1; van Beek EM, 2009, FASEB J, V23, P4081, DOI 10.1096/fj.09-131557; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Zhang RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020780; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815	53	19	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23854	23868		10.1074/jbc.M116.738518	http://dx.doi.org/10.1074/jbc.M116.738518			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27681594	hybrid, Green Published			2022-12-28	WOS:000388498100002
J	Prajapati, RK; Sur, R; Mukhopadhyay, J				Prajapati, Ranjit Kumar; Sur, Runa; Mukhopadhyay, Jayanta			A Novel Function of Factor from Bacillus subtilis as a Transcriptional Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; bacterial transcription; gene regulation; repressor protein; sporulation	RNA-POLYMERASE; DELTA-SUBUNIT; STREPTOCOCCUS-MUTANS; PROMOTER SELECTIVITY; GENE; EXPRESSION; INITIATION; SIGMA; SPORULATION; PURIFICATION	delta , a small protein found in most Gram-positive bacteria was, for a long time, thought to be a subunit of RNA polymerase (RNAP) and was shown to be involved in recycling of RNAP at the end of each round of transcription. However, how participates in both up-regulation and down-regulation of genes in vivo remains unclear. We have recently shown, in addition to the recycling of RNAP, functions as a transcriptional activator by binding to an A-rich sequence located immediately upstream of the -35 element, consequently facilitating the open complex formation. The result had explained the mechanism of up-regulation of the genes by . Here, we show that Bacillus subtilis could also function as a transcriptional repressor. Our results demonstrate that binds to an A-rich sequence located near the -35 element of the spo0B promoter, the gene involved in the regulatory cascade of bacterial sporulation and inhibits the open complex formation due to steric clash with sigma region 4.2. We observed a significant increase in the mRNA level of the spo0B gene in a -knock-out strain of B. subtilis compared with the wild-type. Thus, the results report a novel function of , and suggest the mechanism of down-regulation of genes in vivo by the protein.	[Prajapati, Ranjit Kumar; Mukhopadhyay, Jayanta] Univ Calcutta, Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India; [Sur, Runa] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, 93-1 APC Rd, Kolkata 700009, India	Department of Science & Technology (India); Bose Institute; University of Calcutta; University of Calcutta	Mukhopadhyay, J (corresponding author), Univ Calcutta, Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India.	jayanta@jcbose.ac.in		Prajapati, Ranjit/0000-0002-9294-3537	Department of Biotechnology, India Research Grants [BT/PR 5345/MED/29/648/2012, BT/PR 5270/BRB/10/1066/2012]	Department of Biotechnology, India Research Grants	This work was supported in part by Department of Biotechnology, India Research Grants BT/PR 5345/MED/29/648/2012 and BT/PR 5270/BRB/10/1066/2012. The authors declare no conflicts of interest with the contents of this article.	ACHBERGER EC, 1981, J BIOL CHEM, V256, P7424; Banerjee R, 2015, J BACTERIOL, V197, P646, DOI 10.1128/JB.02445-14; BOUVIER J, 1984, P NATL ACAD SCI-BIOL, V81, P7012, DOI 10.1073/pnas.81.22.7012; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; de Saro FJL, 1999, J BIOL CHEM, V274, P15953, DOI 10.1074/jbc.274.22.15953; DESARO FJL, 1995, J MOL BIOL, V252, P189, DOI 10.1006/jmbi.1995.0487; DICKEL CD, 1980, BIOCHEM BIOPH RES CO, V95, P1789, DOI 10.1016/S0006-291X(80)80106-9; DOBINSON KF, 1987, BIOCHEMISTRY-US, V26, P8206, DOI 10.1021/bi00399a028; Gao HC, 2004, CURR MICROBIOL, V48, P401, DOI 10.1007/s00284-003-4229-8; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HOLMBERG C, 1991, MOL MICROBIOL, V5, P2891, DOI 10.1111/j.1365-2958.1991.tb01849.x; HYDE EI, 1986, J BIOL CHEM, V261, P6565; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; LAMPE M, 1988, GENE, V67, P13, DOI 10.1016/0378-1119(88)90003-0; Prajapati RK, 2016, J BIOL CHEM, V291, P1064, DOI 10.1074/jbc.M115.686170; Rabatinova A, 2013, J BACTERIOL, V195, P2603, DOI 10.1128/JB.00188-13; Sambrook J., 2001, MOL CLONING LAB MANU; SAXILD HH, 1995, MICROBIOL-SGM, V141, P2211, DOI 10.1099/13500872-141-9-2211; Seepersaud R, 2006, J BACTERIOL, V188, P2096, DOI 10.1128/JB.188.6.2096-2105.2006; Shafikhani SH, 2002, J BACTERIOL, V184, P564, DOI 10.1128/JB.184.2.564-571.2002; Sonenshein AL, 2000, CURR OPIN MICROBIOL, V3, P561, DOI 10.1016/S1369-5274(00)00141-7; TJIAN R, 1977, EUR J BIOCHEM, V74, P149, DOI 10.1111/j.1432-1033.1977.tb11376.x; Weiss A, 2014, INFECT IMMUN, V82, P1424, DOI 10.1128/IAI.01508-14; WILLIAMSON VM, 1979, MOL GEN GENET, V174, P47, DOI 10.1007/BF00433304; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Xue XL, 2012, MICROBIOL-SGM, V158, P191, DOI 10.1099/mic.0.047936-0; Xue XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020075; Xue XL, 2010, J BACTERIOL, V192, P5081, DOI 10.1128/JB.00653-10; Yang X, 2008, PROTEIN EXPRES PURIF, V59, P86, DOI 10.1016/j.pep.2008.01.006	30	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24029	24035		10.1074/jbc.M116.746065	http://dx.doi.org/10.1074/jbc.M116.746065			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679485	hybrid, Green Published			2022-12-28	WOS:000388498100019
J	Webb, BA; White, KA; Grillo-Hill, BK; Schonichen, A; Choi, C; Barber, DL				Webb, Bradley A.; White, Katharine A.; Grillo-Hill, Bree K.; Schoenichen, Andre; Choi, Changhoon; Barber, Diane L.			A Histidine Cluster in the Cytoplasmic Domain of the Na-H Exchanger NHE1 Confers pH-sensitive Phospholipid Binding and Regulates Transporter Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; focal adhesions; pH regulation; phospholipid; sodium-proton exchange	NA+/H+ EXCHANGER; ALZHEIMERS-DISEASE; INTRACELLULAR PH; FYVE DOMAIN; ACTIVATION; PHOSPHORYLATION; GROWTH; ISOFORM-1; KINASE; CANCER	The Na-H exchanger NHE1 contributes to intracellular pH (pH(i)) homeostasis in normal cells and the constitutively increased pH(i) in cancer. NHE1 activity is allosterically regulated by intracellular protons, with greater activity at lower pH(i). However, the molecular mechanism for pH-dependent NHE1 activity remains incompletely resolved. We report that an evolutionarily conserved cluster of histidine residues located in the C-terminal cytoplasmic domain between two phosphatidylinositol 4,5-bisphosphate binding sites (PI(4,5)P-2) of NHE1 confers pH-dependent PI(4,5)P-2 binding and regulates NHE1 activity. A GST fusion of the wild type C-terminal cytoplasmic domain of NHE1 showed increased maximum PI(4,5)P-2 binding at pH 7.0 compared with pH 7.5. However, pH-sensitive binding is abolished by substitutions of the His-rich cluster to arginine (RXXR3) or alanine (AXXA3), mimicking protonated and neutral histidine residues, respectively, and the RXXR3 mutant had significantly greater PI(4,5)P-2 binding than AXXA3. When expressed in cells, NHE1 activity and pH(i) were significantly increased with NHE1-RXXR3 and decreased with NHE1-AXXA3 compared with wild type NHE1. Additionally, fibroblasts expressing NHE1-RXXR3 had significantly more contractile actin filaments and focal adhesions compared with fibroblasts expressing wild type NHE1, consistent with increased pH(i) enabling cytoskeletal remodeling. These data identify a molecular mechanism for pH-sensitive PI(4,5)P-2 binding regulating NHE1 activity and suggest that the evolutionarily conserved cluster of four histidines in the proximal cytoplasmic domain of NHE1 may constitute a proton modifier site. Moreover, a constitutively activated NHE1-RXXR3 mutant is a new tool that will be useful for studying how increased pH(i) contributes to cell behaviors, most notably the biology of cancer cells.	[Webb, Bradley A.; White, Katharine A.; Grillo-Hill, Bree K.; Schoenichen, Andre; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave,HSW618,Box 0512, San Francisco, CA 94143 USA; [Choi, Changhoon] Samsung Med Ctr, Dept Radiat Oncol, Seoul 06351, South Korea	University of California System; University of California San Francisco; Sungkyunkwan University (SKKU); Samsung Medical Center	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave,HSW618,Box 0512, San Francisco, CA 94143 USA.	diane.barber@ucsf.edu	Webb, Bradley/F-6946-2013; Webb, Bradley/HDO-7820-2022; White, Katharine A./X-9101-2019	Webb, Bradley/0000-0002-5299-2852; White, Katharine A./0000-0002-5831-1886; Grillo-Hill, Bree/0000-0001-6471-7025; Choi, Changhoon/0000-0002-2847-1168	National Institutes of Health F32 NRSA (National Research Service Award) Postdoctoral Fellowship [CA177085, R01 GM116384]; Canadian Institutes of Health research postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG) Postdoctoral Fellowship SCHO [1410/1-1]; NATIONAL CANCER INSTITUTE [F32CA177085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116384] Funding Source: NIH RePORTER	National Institutes of Health F32 NRSA (National Research Service Award) Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft (DFG) Postdoctoral Fellowship SCHO(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health F32 NRSA (National Research Service Award) Postdoctoral Fellowship CA177085 (to K.A.W.) and Grant R01 GM116384 (to D.L.B.). This work was also supported in whole or part by Canadian Institutes of Health research postdoctoral fellowship (to B.A.W.) and Deutsche Forschungsgemeinschaft (DFG) Postdoctoral Fellowship SCHO 1410/1-1 (to A.S.).The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.	Abu Jawdeh BG, 2011, J BIOL CHEM, V286, P42435, DOI 10.1074/jbc.M110.212845; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cha B, 2003, J MEMBRANE BIOL, V191, P49, DOI 10.1007/s00232-002-1044-2; Choi CH, 2013, J CELL BIOL, V202, P849, DOI 10.1083/jcb.201302131; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Dibrov P, 2000, BIOSCIENCE REP, V20, P185, DOI 10.1023/A:1005567519792; Fang BY, 2010, INT J NEUROSCI, V120, P591, DOI 10.3109/00207454.2010.505353; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Grillo-Hill BK, 2015, ELIFE, V4, DOI 10.7554/eLife.03270; Harguindey S, 2007, CURR ALZHEIMER RES, V4, P53, DOI 10.2174/156720507779939841; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Hong JH, 2013, P NATL ACAD SCI USA, V110, P4105, DOI 10.1073/pnas.1221410110; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Khan S, 2014, J CLIN INVEST, V124, P1057, DOI 10.1172/JCI71863; Krump E, 1997, J BIOL CHEM, V272, P17303, DOI 10.1074/jbc.272.28.17303; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Schonichen A, 2013, ANNU REV BIOPHYS, V42, P289, DOI 10.1146/annurev-biophys-050511-102349; Shimada-Shimizu N, 2014, MOL PHARMACOL, V85, P18, DOI 10.1124/mol.113.089268; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; Wakabayashi S, 2010, J BIOL CHEM, V285, P26652, DOI 10.1074/jbc.M110.130120; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200	41	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24096	24104		10.1074/jbc.M116.736215	http://dx.doi.org/10.1074/jbc.M116.736215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27650500	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000388498100026
J	Ferrari, AR; Rozeboom, HJ; Dobruchowska, JM; van Leeuwen, SS; Vugts, ASC; Koetsier, MJ; Visser, J; Fraaije, MW				Ferrari, Alessandro R.; Rozeboom, Henriette J.; Dobruchowska, Justyna M.; van Leeuwen, Sander S.; Vugts, Aniek S. C.; Koetsier, Martijn J.; Visser, Jaap; Fraaije, Marco W.			Discovery of a Xylooligosaccharide Oxidase from Myceliophthora thermophila C1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; crystal structure; flavin adenine dinucleotide (FAD); oligosaccharide; oxidase; CAZy; xylan; xylose; oxidase; carbohydrate processing	GLUCOOLIGOSACCHARIDE OXIDASE; CHITOOLIGOSACCHARIDE OXIDASE; CELLOBIOSE DEHYDROGENASE; ACCEPTOR OXIDOREDUCTASE; FUSARIUM-GRAMINEARUM; CRYSTAL-STRUCTURE; LACTOBIONIC ACID; OXIDATION; CARBOHYDRATE; PURIFICATION	By inspection of the predicted proteome of the fungus Myceliophthora thermophila C1 for vanillyl-alcohol oxidase (VAO)-type flavoprotein oxidases, a putative oligosaccharide oxidase was identified. By homologous expression and subsequent purification, the respective protein could be obtained. The protein was found to contain a bicovalently bound FAD cofactor. By screening a large number of carbohydrates, several mono- and oligosaccharides could be identified as substrates. The enzyme exhibits a strong substrate preference toward xylooligosaccharides; hence it is named xylooligosaccharide oxidase (XylO). Chemical analyses of the product formed upon oxidation of xylobiose revealed that the oxidation occurs at C1, yielding xylobionate as product. By elucidation of several XylO crystal structures (in complex with a substrate mimic, xylose, and xylobiose), the residues that tune the unique substrate specificity and regioselectivity could be identified. The discovery of this novel oligosaccharide oxidase reveals that the VAO-type flavoprotein family harbors oxidases tuned for specific oligosaccharides. The unique substrate profile of XylO hints at a role in the degradation of xylan-derived oligosaccharides by the fungus M. thermophila C1.	[Ferrari, Alessandro R.; Rozeboom, Henriette J.; Fraaije, Marco W.] Univ Groningen, Mol Enzymol Grp, NL-9747 AG Groningen, Netherlands; [Dobruchowska, Justyna M.; van Leeuwen, Sander S.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Microbial Physiol Grp, NL-9747 AG Groningen, Netherlands; [Vugts, Aniek S. C.; Koetsier, Martijn J.] Dupont Ind Biosci, NL-6709 PA Wageningen, Netherlands; [Visser, Jaap] Fungal Genet & Technol Consultancy, NL-6700 AJ Wageningen, Netherlands	University of Groningen; University of Groningen	Fraaije, MW (corresponding author), Univ Groningen, Mol Enzymol Grp, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl	DOBRUCHOWSKA, JUSTYNA/AAY-1409-2021; van Leeuwen, Sander/C-7140-2012	van Leeuwen, Sander/0000-0003-0017-2841; Rozeboom, Henriette/0000-0002-1656-6477; Fraaije, Marco/0000-0001-6346-5014	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organisation for Scientific Research (NWO) in the framework of the Technology Areas for Sustainable Chemistry (TASC) Technology Area Biomass. The authors declare that they have no conflicts of interest with the contents of this article.	Baminger U, 2001, APPL ENVIRON MICROB, V67, P1766, DOI 10.1128/AEM.67.4.1766-1774.2001; Baumann MJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-45; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniel B, 2015, J BIOL CHEM, V290, P18770, DOI 10.1074/jbc.M115.659631; Dijkman WP, 2014, APPL ENVIRON MICROB, V80, P1082, DOI 10.1128/AEM.03740-13; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferrari AR, 2015, BIOTECHNOL BIOENG, V112, P1074, DOI 10.1002/bit.25532; Ferrari AR, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-37; Foumani M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125398; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Heuts DPHM, 2007, FEBS LETT, V581, P4905, DOI 10.1016/j.febslet.2007.09.019; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; HUANG CH, 2008, J BIOL CHEM, V0283; Huang TH, 2012, ACTA CRYSTALLOGR D, V68, P1303, DOI 10.1107/S0907444912027552; Jain I, 2015, INDIAN J EXP BIOL, V53, P131; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karnaouri A, 2013, PEERJ, V1, DOI 10.7717/peerj.46; KASPRZAK AA, 1983, BIOCHEM J, V211, P535, DOI 10.1042/bj2110535; Kiryu T, 2008, BIOSCI BIOTECH BIOCH, V72, P833, DOI 10.1271/bbb.70701; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Kolbusz MA, 2014, FUNGAL GENET BIOL, V72, P10, DOI 10.1016/j.fgb.2014.05.006; Kopacz MM, 2014, BIOORGAN MED CHEM, V22, P5621, DOI 10.1016/j.bmc.2014.05.051; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee MH, 2005, APPL ENVIRON MICROB, V71, P8881, DOI 10.1128/AEM.71.12.8881-8887.2005; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; LIN SF, 1991, BIOCHIM BIOPHYS ACTA, V1118, P41, DOI 10.1016/0167-4838(91)90439-7; Ludwig R, 2004, APPL MICROBIOL BIOT, V64, P213, DOI 10.1007/s00253-003-1501-6; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NISHIKIMI M, 1977, FEBS LETT, V81, P323, DOI 10.1016/0014-5793(77)80545-0; Nordkvist M, 2007, BIOTECHNOL BIOENG, V97, P694, DOI 10.1002/bit.21273; Parikka K, 2010, J AGR FOOD CHEM, V58, P262, DOI 10.1021/jf902930t; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qing Q, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-18; ROYER JC, 1991, EUR J BIOCHEM, V202, P521, DOI 10.1111/j.1432-1033.1991.tb16404.x; Samanta A. K., 2015, Bioactive Carbohydrates and Dietary Fibre, V5, P62; Schallmey M, 2013, CHEMBIOCHEM, V14, P870, DOI 10.1002/cbic.201300005; Schou C, 1998, BIOCHEM J, V330, P565, DOI 10.1042/bj3300565; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; THEANDER O, 1989, ANIM FEED SCI TECH, V23, P205, DOI 10.1016/0377-8401(89)90098-9; Topakas E, 2012, APPL MICROBIOL BIOT, V94, P399, DOI 10.1007/s00253-011-3612-9; van Gool MP, 2012, BIORESOURCE TECHNOL, V119, P123, DOI 10.1016/j.biortech.2012.05.117; van Hellemond EW, 2006, ADV APPL MICROBIOL, V60, P17, DOI 10.1016/S0065-2164(06)60002-6; Verdoes J.C., 2007, IND BIOTECHNOL, V3, P48, DOI [10.1089/ind.2007.3.048, DOI 10.1089/IND.2007.3.048]; Verdoes J. C., 2010, Patent, Patent No. [WO 2010107 303 A2, 2010107303]; Visser H., 2011, IND BIOTECHNOL, V7, P214, DOI [10.1089/ind.2011.7.214, DOI 10.1089/IND.2011.7.214]; Vuong TV, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-148; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Xu F, 2001, EUR J BIOCHEM, V268, P1136, DOI 10.1046/j.1432-1327.2001.01982.x; Zafred D, 2015, FEBS J, V282, P3060, DOI 10.1111/febs.13212	56	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23709	23718		10.1074/jbc.M116.741173	http://dx.doi.org/10.1074/jbc.M116.741173			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27629413	hybrid, Green Published			2022-12-28	WOS:000387884400031
J	Li, J; Wang, RP; Gannon, OJ; Rezey, AC; Jiang, SX; Gerlach, BD; Liao, GN; Tang, DD				Li, Jia; Wang, Ruping; Gannon, Olivia J.; Rezey, Alyssa C.; Jiang, Sixin; Gerlach, Brennan D.; Liao, Guoning; Tang, Dale D.			Polo-like Kinase 1 Regulates Vimentin Phosphorylation at Ser-56 and Contraction in Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; excitation-contraction coupling (E-C coupling); intermediate filament; phosphorylation; signal transduction; smooth muscle	CRK-ASSOCIATED SUBSTRATE; P21-ACTIVATED KINASE; AIRWAY HYPERRESPONSIVENESS; ACTIN POLYMERIZATION; STRUCTURAL BASIS; TYROSINE KINASE; ACTIVATION; CELLS; ABL; CYTOSKELETON	Polo-like kinase 1 (Plk1) is a serine/threonine-protein kinase that has been implicated in mitosis, cytokinesis, and smooth muscle cell proliferation. The role of Plk1 in smooth muscle contraction has not been investigated. Here, stimulation with acetylcholine induced Plk1 phosphorylation at Thr-210 (an indication of Plk1 activation) in smooth muscle. Contractile stimulation also activated Plk1 in live smooth muscle cells as evidenced by changes in fluorescence resonance energy transfer signal of a Plk1 sensor. Moreover, knockdown of Plk1 in smooth muscle attenuated force development. Smooth muscle conditional knock-out of Plk1 also diminished contraction of mouse tracheal rings. Plk1 knockdown inhibited acetylcholine-induced vimentin phosphorylation at Ser-56 without affecting myosin light chain phosphorylation. Expression of T210A Plk1 inhibited the agonist-induced vimentin phosphorylation at Ser-56 and contraction in smooth muscle. However, myosin light chain phosphorylation was not affected by T210A Plk1. Ste20-like kinase (SLK) is a serine/threonine-protein kinase that has been implicated in spindle orientation and microtubule organization during mitosis. In this study knockdown of SLK inhibited Plk1 phosphorylation at Thr-210 and activation. Finally, asthma is characterized by airway hyperresponsiveness, which largely stems from airway smooth muscle hyperreactivity. Here, smooth muscle conditional knock-out of Plk1 attenuated airway resistance and airway smooth muscle hyperreactivity in a murine model of asthma. Taken together, these findings suggest that Plk1 regulates smooth muscle contraction by modulating vimentin phosphorylation at Ser-56. Plk1 activation is regulated by SLK during contractile activation. Plk1 contributes to the pathogenesis of asthma.	[Li, Jia; Wang, Ruping; Gannon, Olivia J.; Rezey, Alyssa C.; Jiang, Sixin; Gerlach, Brennan D.; Liao, Guoning; Tang, Dale D.] Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave,MC-8, Albany, NY 12208 USA	Albany Medical College	Tang, DD (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave,MC-8, Albany, NY 12208 USA.	tangd@mail.amc.edu	T, Dale/AAE-9643-2020	T, Dale/0000-0002-7339-9249; Wang, Ruping/0000-0003-4233-7755	National Institutes of Health [HL-110951, HL-113208, HL-130304]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130304, R01HL110951, R01HL113208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-110951, HL-113208, and HL-130304 (NHLBI; to D. D. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amrani Y, 2004, CURR OPIN PHARMACOL, V4, P230, DOI 10.1016/j.coph.2004.02.004; Anfinogenova Y, 2007, CIRC RES, V101, P420, DOI 10.1161/CIRCRESAHA.107.156463; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Cleary RA, 2014, AM J PHYSIOL-CELL PH, V306, pC753, DOI 10.1152/ajpcell.00327.2013; Cleary RA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-105; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jia L, 2010, AM J PHYSIOL-CELL PH, V299, pC630, DOI 10.1152/ajpcell.00095.2010; Jiang SX, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0257-8; Johnson TM, 2008, BIOCHEMISTRY-US, V47, P3688, DOI 10.1021/bi702134c; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Lee KY, 2012, J CELL PHYSIOL, V227, P739, DOI 10.1002/jcp.22782; Li J, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0415-7; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC1424, DOI 10.1152/ajpcell.00324.2009; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC299, DOI 10.1152/ajpcell.00037.2009; Liu TG, 2014, J CELL PHYSIOL, V229, P1484, DOI 10.1002/jcp.24590; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Tang DD, 2009, J CARDIOVASC PHARM T, V14, P89, DOI 10.1177/1074248409333490; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tliba O, 2003, BRIT J PHARMACOL, V140, P1159, DOI 10.1038/sj.bjp.0705558; VANDERLOOP FTL, 1995, EUR J CELL BIOL, V68, P62; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang RP, 2014, J BIOL CHEM, V289, P14157, DOI 10.1074/jbc.M114.548099; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; Wang T, 2015, J BIOL CHEM, V290, P8913, DOI 10.1074/jbc.M114.621003; Wang T, 2014, AM J RESP CELL MOL, V51, P652, DOI 10.1165/rcmb.2014-0125OC; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Wu YD, 2015, J BIOL CHEM, V290, P11403, DOI 10.1074/jbc.M115.645788; Xu J, 2013, NAT STRUCT MOL BIOL, V20, P1047, DOI 10.1038/nsmb.2623; Zhapparova ON, 2013, MOL BIOL CELL, V24, P3205, DOI 10.1091/mbc.E13-03-0137	47	32	34	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23693	23703		10.1074/jbc.M116.749341	http://dx.doi.org/10.1074/jbc.M116.749341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27662907	Green Published, hybrid			2022-12-28	WOS:000387884400029
J	Lykken, EA; Li, QJ				Lykken, Erik Allen; Li, Qi-Jing			The MicroRNA miR-191 Supports T Cell Survival Following Common Chain Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; cytokine induction; homeostasis; immunodeficiency; microRNA mechanism; T cell biology	INSULIN-RECEPTOR SUBSTRATE-1; NORMAL IMMUNE FUNCTION; IN-VIVO; HOMEOSTATIC PROLIFERATION; TH1 RESPONSES; C-ELEGANS; MEMORY; STAT5; NAIVE; EXPRESSION	To ensure lifelong immunocompetency, naive and memory T cells must be adequately maintained in the peripheral lymphoid tissues. Homeostatic maintenance of T cells is controlled by tonic signaling through T cell antigen receptors and common chain cytokine receptors. In this study, we identify the highly expressed microRNA miR-191 as a key regulator of naive, memory, and regulatory T cell homeostasis. Conditional deletion of miR-191 using LckCre resulted in preferential loss of peripheral CD4(+) regulatory T cells as well as naive and memory CD8(+) T cells. This preferential loss stemmed from reduced survival following deficient cytokine signaling and STAT5 activation. Mechanistically, insulin receptor substrate 1 (Irs1) is a direct target of miR-191, and dysregulated IRS1 expression antagonizes STAT5 activation. Our study identifies a novel role for microRNAs in fine-tuning immune homeostasis and thereby maintaining the lymphocyte reservoir necessary to mount productive immune responses.	[Lykken, Erik Allen; Li, Qi-Jing] Duke Univ, Dept Immunol, Med Ctr, Box 3010, Durham, NC 27710 USA	Duke University	Li, QJ (corresponding author), Duke Univ, Dept Immunol, Med Ctr, Box 3010, Durham, NC 27710 USA.	qi-jing.li@dm.duke.edu		Lykken, Erik/0000-0002-1458-5885	American Diabetes Association [1-10-JF-28]; National Institutes of Health [R01AI091878]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091878, T32AI052077] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Diabetes Association Grant 1-10-JF-28 and National Institutes of Health Grant R01AI091878 (to Q. J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Buckley RH, 2000, IMMUNOL RES, V22, P237, DOI 10.1385/IR:22:2-3:237; Cerwenka A, 1998, J IMMUNOL, V161, P97; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Decaluwe H, 2010, P NATL ACAD SCI USA, V107, P9311, DOI 10.1073/pnas.0913729107; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; Kang JS, 2004, J IMMUNOL, V173, P2307, DOI 10.4049/jimmunol.173.4.2307; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lin R, 2014, J CLIN INVEST, V124, P5352, DOI 10.1172/JCI76561; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Masuda K, 2007, J IMMUNOL, V179, P3699, DOI 10.4049/jimmunol.179.6.3699; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Metz HE, 2016, P NATL ACAD SCI USA, V113, P8795, DOI 10.1073/pnas.1601989113; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Mitchell DM, 2013, J IMMUNOL, V190, P3390, DOI 10.4049/jimmunol.1202674; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sharfe N, 1997, J IMMUNOL, V159, P1107; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Snow JW, 2003, J IMMUNOL, V171, P5042, DOI 10.4049/jimmunol.171.10.5042; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zou T, 2012, J IMMUNOL, V189, P28, DOI 10.4049/jimmunol.1200507	49	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23532	23544		10.1074/jbc.M116.741264	http://dx.doi.org/10.1074/jbc.M116.741264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634043	Green Published, hybrid			2022-12-28	WOS:000387884400015
J	Qi, ST; Ma, JY; Wang, ZB; Guo, L; Hou, Y; Sun, QY				Qi, Shu-Tao; Ma, Jun-Yu; Wang, Zhen-Bo; Guo, Lei; Hou, Yi; Sun, Qing-Yuan			N-6-Methyladenosine Sequencing Highlights the Involvement of mRNA Methylation in Oocyte Meiotic Maturation and Embryo Development by Regulating Translation in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC POLYADENYLATION; GENOME ACTIVATION; DNA-REPLICATION; ZYGOTIC GENOME; NUCLEAR-RNA; PROTEIN; MOS; CPEB; N6-METHYLADENOSINE; PHOSPHORYLATION	During the oogenesis of Xenopus laevis, oocytes accumulate maternal materials for early embryo development. As the transcription activity of the oocyte is silenced at the fully grown stage and the global genome is reactivated only by the mid-blastula embryo stage, the translation of maternal mRNAs accumulated during oocyte growth should be accurately regulated. Previous evidence has illustrated that the poly(A) tail length and RNA binding elements mediate RNA translation regulation in the oocyte. Recently, RNA methylation has been found to exist in various systems. In this study, we sequenced the N-6-methyladenosine (m(6)A) modified mRNAs in fully grown germinal vesicle-stage and metaphase II-stage oocytes. As a result, we identified 4207 mRNAs with m(6)A peaks in germinal vesicle-stage or metaphase II-stage oocytes. When we integrated the mRNA methylation data with transcriptome and proteome data, we found that the highly methylated mRNAs showed significantly lower protein levels than those of the hypomethylated mRNAs, although the RNA levels showed no significant difference. We also found that the hypomethylated mRNAs were mainly enriched in the cell cycle and translation pathways, whereas the highly methylated mRNAs were mainly associated with protein phosphorylation. Our results suggest that oocyte mRNA methylation can regulate cellular translation and cell division during oocyte meiotic maturation and early embryo development.	[Qi, Shu-Tao; Wang, Zhen-Bo; Guo, Lei; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Ma, Jun-Yu; Sun, Qing-Yuan] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao 266109, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Qingdao Agricultural University	Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.	sunqy@ioz.ac.cn		Qi, Shutao/0000-0002-4073-1161; Sun, Qing-Yuan/0000-0002-0148-2414	Ministry of Science and Technology of China [JFYS2016ZY05001886]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work is supported by Ministry of Science and Technology of China Grant JFYS2016ZY05001886. The authors declare that they have no conflicts of interest with the contents of this article.	Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bellier S, 1997, MOL CELL BIOL, V17, P1434, DOI 10.1128/MCB.17.3.1434; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Charlier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-560; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Miyara F, 2003, MOL REPROD DEV, V64, P458, DOI 10.1002/mrd.10233; Narasimhachar Y, 2009, J BIOL CHEM, V284, P27235, DOI 10.1074/jbc.M109.008854; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Peshkin L, 2015, DEV CELL, V35, P383, DOI 10.1016/j.devcel.2015.10.010; Peter M, 2002, DEVELOPMENT, V129, P2129; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Prather R. S., 2010, MOL REPROD DEV, V77; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Smits AH, 2014, NUCLEIC ACIDS RES, V42, P9880, DOI 10.1093/nar/gku661; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Yoshitome S, 2012, BIOCHEM BIOPH RES CO, V422, P770, DOI 10.1016/j.bbrc.2012.05.080; Yu C, 2016, NAT STRUCT MOL BIOL, V23, P387, DOI 10.1038/nsmb.3204; Yu C, 2016, CELL RES, V26, P275, DOI 10.1038/cr.2016.20; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	42	44	47	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23020	23026		10.1074/jbc.M116.748889	http://dx.doi.org/10.1074/jbc.M116.748889			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613873	Green Published, hybrid			2022-12-28	WOS:000387224800014
J	Wigington, CP; Morris, KJ; Newman, LE; Corbett, AH				Wigington, Callie P.; Morris, Kevin J.; Newman, Laura E.; Corbett, Anita H.			The Polyadenosine RNA-binding Protein, Zinc Finger Cys(3)His Protein 14 (ZC3H14), Regulates the Pre-mRNA Processing of a Key ATP Synthase Subunit mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; post-transcriptional regulation; RNA; RNA-binding protein; RNA processing; RNA splicing; MSUT2; Nab2; ZC3H14	POLY(A) TAIL LENGTH; NUCLEAR POLY(A)-BINDING PROTEIN; BROWN ADIPOSE-TISSUE; GENE-EXPRESSION; CYTOCHROME-C; MITOCHONDRIAL MORPHOLOGY; SACCHAROMYCES-CEREVISIAE; SPECIFICITY FACTOR; CELL VIABILITY; APOPTOSIS	Polyadenosine RNA-binding proteins (Pabs) regulate multiple steps in gene expression. This protein family includes the well studied Pabs, PABPN1 and PABPC1, as well as the newly characterized Pab, zinc finger CCCH-type containing protein 14 (ZC3H14). Mutations in ZC3H14 are linked to a form of intellectual disability. To probe the function of ZC3H14, we performed a transcriptome-wide analysis of cells depleted of either ZC3H14 or the control Pab, PABPN1. Depletion of PABPN1 affected approximate to 17% of expressed transcripts, whereas ZC3H14 affected only approximate to 1% of expressed transcripts. To assess the function of ZC3H14 in modulating target mRNAs, we selected the gene encoding the ATP synthase F-0 subunit C (ATP5G1) transcript. Knockdown of ZC3H14 significantly reduced ATP5G1 steady-state mRNA levels. Consistent with results suggesting that ATP5G1 turnover increases upon depletion of ZC3H14, double knockdown of ZC3H14 and the nonsense-mediated decay factor, UPF1, rescues ATP5G1 transcript levels. Furthermore, fractionation reveals an increase in the amount of ATP5G1 pre-mRNA that reaches the cytoplasm when ZC3H14 is depleted and that ZC3H14 binds to ATP5G1 pre-mRNA in the nucleus. These data support a role for ZC3H14 in ensuring proper nuclear processing and retention of ATP5G1 pre-mRNA. Consistent with the observation that ATP5G1 is a rate-limiting component for ATP synthase activity, knockdown of ZC3H14 decreases cellular ATP levels and causes mitochondrial fragmentation. These data suggest that ZC3H14 modulates pre-mRNA processing of select mRNA transcripts and plays a critical role in regulating cellular energy levels, observations that have broad implications for proper neuronal function.	[Wigington, Callie P.; Morris, Kevin J.; Newman, Laura E.; Corbett, Anita H.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Wigington, Callie P.; Morris, Kevin J.; Newman, Laura E.; Corbett, Anita H.] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021	Corbett, Anita/0000-0002-0461-6895; Newman, Laura/0000-0001-5559-713X	National Institutes of Health [P30NS055077]; NATIONAL CANCER INSTITUTE [F31CA168321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM058728, R01GM090158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the members of the Corbett and Kahn laboratories for helpful discussions and contributions to this work. The HEK293-T17 and HeLa cells were a generous gift from the Kahn laboratory at Emory University. The MB-231 and D556 cells were a generous gift from the Vertino and Read laboratories, respectively, at the Winship Cancer Institute. The Emory Neuroscience Microscopy Core facilities was a recipient of National Institutes of Health Grant P30NS055077.	Abouantoun TJ, 2009, MOL CANCER THER, V8, P1137, DOI 10.1158/1535-7163.MCT-08-0889; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Andersson U, 1997, BIOCHEM J, V323, P379, DOI 10.1042/bj3230379; Apponi LH, 2007, MOL CELL BIOL, V27, P6569, DOI 10.1128/MCB.00881-07; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Aschrafi A, 2012, CELL MOL LIFE SCI, V69, P4017, DOI 10.1007/s00018-012-1064-8; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; Banerjee A, 2013, FEBS J, V280, P4230, DOI 10.1111/febs.12294; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Blackinton JG, 2014, SEMIN CELL DEV BIOL, V34, P44, DOI 10.1016/j.semcdb.2014.05.014; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chan YA, 2014, TRENDS GENET, V30, P245, DOI 10.1016/j.tig.2014.03.005; CHANCE B, 1963, J BIOL CHEM, V238, P418; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; De Grassi A, 2006, GENE, V371, P224, DOI 10.1016/j.gene.2005.11.022; Duborjal H, 2002, GENOME RES, V12, P1901, DOI 10.1101/gr.194102; DYER MR, 1989, BIOCHEM J, V260, P249, DOI 10.1042/bj2600249; DYER MR, 1993, BIOCHEM J, V293, P51, DOI 10.1042/bj2930051; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Guthrie CR, 2011, HUM MOL GENET, V20, P1989, DOI 10.1093/hmg/ddr079; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689; HURWITZ J, 1962, P NATL ACAD SCI USA, V48, P1222, DOI 10.1073/pnas.48.7.1222; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; KAPUT J, 1989, J CELL BIOL, V109, P101, DOI 10.1083/jcb.109.1.101; Karam R, 2013, BBA-GENE REGUL MECH, V1829, P624, DOI 10.1016/j.bbagrm.2013.03.002; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kelly SM, 2014, RNA, V20, P681, DOI 10.1261/rna.043984.113; Kelly SM, 2012, RNA BIOL, V9, P555, DOI 10.4161/rna.20187; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Kramarova TV, 2008, FASEB J, V22, P55, DOI 10.1096/fj.07-8581com; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhlmann SI, 2014, NUCLEIC ACIDS RES, V42, P672, DOI 10.1093/nar/gkt876; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; Kurosaki T, 2014, GENE DEV, V28, P1900, DOI 10.1101/gad.245506.114; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Lenzken SC, 2014, WIRES RNA, V5, P565, DOI 10.1002/wrna.1231; Leung SW, 2009, GENE, V439, P71, DOI 10.1016/j.gene.2009.02.022; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nagaoka K, 2006, BBA-GENE STRUCT EXPR, V1759, P132, DOI 10.1016/j.bbaexp.2006.04.004; Natera-Naranjo O, 2012, MOL CELL NEUROSCI, V49, P263, DOI 10.1016/j.mcn.2011.12.006; Pak C, 2011, P NATL ACAD SCI USA, V108, P12390, DOI 10.1073/pnas.1107103108; Phillips T., 2008, NAT ED, V1, P199; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Romano M, 2013, J BIOMOL SCREEN, V18, P967, DOI 10.1177/1087057113497256; Roth KM, 2005, MOL CELL BIOL, V25, P1577, DOI 10.1128/MCB.25.5.1577-1585.2005; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Sangawa H, 1997, J BIOL CHEM, V272, P6034, DOI 10.1074/jbc.272.9.6034; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Silver I, 1998, ADV EXP MED BIOL, V454, P7; SINGH B, 1990, BIOCHEM BIOPH RES CO, V169, P391, DOI 10.1016/0006-291X(90)90344-M; Soucek S., 2016, MOL BIOL CELL, DOI [10.1128/MCB.00402-16, DOI 10.1128/MCB.00402-16]; Soucek S, 2012, BBA-GENE REGUL MECH, V1819, P546, DOI 10.1016/j.bbagrm.2012.03.006; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; St-Sauveur VG, 2013, MOL CELL BIOL, V33, P4718, DOI 10.1128/MCB.00887-13; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Viphakone N, 2008, NUCLEIC ACIDS RES, V36, P2418, DOI 10.1093/nar/gkn080; Vives-Bauza C, 2010, MOL BIOL CELL, V21, P131, DOI 10.1091/mbc.E09-06-0483; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wigington CP, 2014, WIRES RNA, V5, P601, DOI 10.1002/wrna.1233; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; YAN WL, 1994, GENOMICS, V24, P375, DOI 10.1006/geno.1994.1631; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	93	11	12	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22442	22459		10.1074/jbc.M116.754069	http://dx.doi.org/10.1074/jbc.M116.754069			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27563065	Green Published, hybrid			2022-12-28	WOS:000386760600008
J	Topalovski, M; Hagopian, M; Wang, M; Brekken, RA				Topalovski, Mary; Hagopian, Michelle; Wang, Miao; Brekken, Rolf A.			Hypoxia and Transforming Growth Factor beta Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; extracellular matrix; hypoxia; pancreatic cancer; TGF-beta; fibulin-5	TGF-BETA; TUMOR MICROENVIRONMENT; MATRICELLULAR PROTEINS; CELL-PROLIFERATION; IMMUNE CELLS; ANGIOGENESIS; ELASTIN; INVASION; BINDING; FIBRONECTIN	The deposition of extracellular matrix (ECM) is a defining feature of pancreatic ductal adenocarcinoma (PDA), where ECM signaling can promote cancer cell survival and epithelial plasticity programs. However, ECM signaling can also limit PDA tumor growth by producing cytotoxic levels of reactive oxygen species. For example, excess fibronectin stimulation of 51 integrin on stromal cells in PDA results in reduced angiogenesis and increased tumor cell apoptosis because of oxidative stress. Fibulin-5 (Fbln5) is a matricellular protein that blocks fibronectin-integrin interaction and thus directly limits ECM-driven reactive oxygen species production and supports PDA progression. Compared with normal pancreatic tissue, Fbln5 is expressed abundantly in the stroma of PDA; however, the mechanisms underlying the stimulation of Fbln5 expression in PDA are undefined. Using in vitro and in vivo approaches, we report that hypoxia triggers Fbln5 expression in a TGF-- and PI3K-dependent manner. Pharmacologic inhibition of TGF- receptor, PI3K, or protein kinase B (AKT) was found to block hypoxia-induced Fbln5 expression in mouse embryonic fibroblasts and 3T3 fibroblasts. Moreover, tumor-associated fibroblasts from mouse PDA were also responsive to TGF- receptor and PI3K/AKT inhibition with regard to suppression of Fbln5. In genetically engineered mouse models of PDA, therapy-induced hypoxia elevated Fbln5 expression, whereas pharmacologic inhibition of TGF- signaling reduced Fbln5 expression. These findings offer insight into the signaling axis that induces Fbln5 expression in PDA and a potential strategy to block its production.	[Topalovski, Mary; Wang, Miao; Brekken, Rolf A.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Topalovski, Mary; Brekken, Rolf A.] Univ Texas Southwestern Med Ctr Dallas, Canc Biol Grad Program, Dallas, TX 75390 USA; [Hagopian, Michelle; Brekken, Rolf A.] Univ Texas Southwestern Med Ctr Dallas, Div Surg Oncol, Dept Surg, Dallas, TX 75390 USA; [Brekken, Rolf A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brekken, RA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	rolf.brekken@utsouthwestern.edu			American Cancer Society [RSG-10-244-01-CSM]; Joe and Jessie Crump Medical Research Foundation; National Institutes of Health [R01 CA118240, T32 GM008203]; Effie Marie Cain Scholarship in Angiogenesis Research; NATIONAL CANCER INSTITUTE [R01CA118240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Joe and Jessie Crump Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Effie Marie Cain Scholarship in Angiogenesis Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Cancer Society Grant RSG-10-244-01-CSM (to R. A. B.), the Joe and Jessie Crump Medical Research Foundation (to R. A. B.), National Institutes of Health Grants R01 CA118240 (to R. A. B.) and T32 GM008203 (to M. T.), and the Effie Marie Cain Scholarship in Angiogenesis Research (to R. A. B.). R. A. B. is a co-founder of Tuevol Therapeutics, a company that is developing therapeutics that target the tumor microenvironment. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera KY, 2014, CANCER RES, V74, P1032, DOI 10.1158/0008-5472.CAN-13-2800; Albig Allan R, 2005, Future Oncol, V1, P23, DOI 10.1517/14796694.1.1.23; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Buchler P, 2004, J SURG RES, V120, P295, DOI 10.1016/j.jss.2004.02.014; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; Dineen SP, 2010, CANCER RES, V70, P2852, DOI 10.1158/0008-5472.CAN-09-3892; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hwang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084218; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Kuang PP, 2007, AM J PHYSIOL-LUNG C, V292, pL944, DOI 10.1152/ajplung.00184.2006; Kuang PP, 2006, AM J PHYSIOL-CELL PH, V291, pC1412, DOI 10.1152/ajpcell.00087.2006; Kuang PP, 2003, AM J PHYSIOL-LUNG C, V285, pL1147, DOI 10.1152/ajplung.00098.2003; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Miyazaki S, 2014, INT J CANCER, V135, P295, DOI 10.1002/ijc.28686; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ostapoff KT, 2014, CANCER RES, V74, P4996, DOI 10.1158/0008-5472.CAN-13-1807; Ostapoff KT, 2013, MOL CANCER THER, V12, P1190, DOI 10.1158/1535-7163.MCT-12-1123; Phillips P., 2012, PANCREATIC CANC TUMO, P1; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Schluterman MK, 2010, DIS MODEL MECH, V3, P333, DOI 10.1242/dmm.003707; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; Shi XY, 2014, ASIAN PAC J TROP MED, V7, P787, DOI 10.1016/S1995-7645(14)60137-1; Shibaji T, 2003, ANTICANCER RES, V23, P4721; Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594; Sullivan LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012031; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Wang M, 2015, CANCER RES, V75, P5058, DOI 10.1158/0008-5472.CAN-15-0744; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wong GS, 2013, BRIT J CANCER, V108, P755, DOI 10.1038/bjc.2012.592; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zheng Q, 2006, J INVEST DERMATOL, V126, P2707, DOI 10.1038/sj.jid.5700501	52	28	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22244	22252		10.1074/jbc.M116.730945	http://dx.doi.org/10.1074/jbc.M116.730945			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27531748	Green Published, hybrid			2022-12-28	WOS:000386332600035
J	Syson, K; Stevenson, CEM; Miah, F; Barclay, JE; Tang, MH; Gorelik, A; Rashid, AM; Lawson, DM; Bornemann, S				Syson, Karl; Stevenson, Clare E. M.; Miah, Farzana; Barclay, J. Elaine; Tang, Minhong; Gorelik, Andrii; Rashid, Abdul M.; Lawson, David M.; Bornemann, Stephen			Ligand-bound Structures and Site-directed Mutagenesis Identify the Acceptor and Secondary Binding Sites of Streptomyces coelicolor Maltosyltransferase GlgE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; crystal structure; glycosyltransferase; oligosaccharide; site-directed mutagenesis	MYCOBACTERIUM-TUBERCULOSIS GLGE; VALIDATED ANTITUBERCULOSIS TARGET; ALPHA-MALTOSE 1-PHOSPHATE; MOLECULAR-GRAPHICS; AMYLASE FAMILY; PATHWAY; GLUCAN; TRANSFERASE; INHIBITORS; TREHALOSE	GlgE is a maltosyltransferase involved in -glucan biosynthesis in bacteria that has been genetically validated as a target for tuberculosis therapies. Crystals of the Mycobacterium tuberculosis enzyme diffract at low resolution so most structural studies have been with the very similar Streptomyces coelicolor GlgE isoform 1. Although the donor binding site for -maltose 1-phosphate had been previously structurally defined, the acceptor site had not. Using mutagenesis, kinetics, and protein crystallography of the S. coelicolor enzyme, we have now identified the +1 to +6 subsites of the acceptor/product, which overlap with the known cyclodextrin binding site. The sugar residues in the acceptor subsites +1 to +5 are oriented such that they disfavor the binding of malto-oligosaccharides that bear branches at their 6-positions, consistent with the known acceptor chain specificity of GlgE. A secondary binding site remote from the catalytic center was identified that is distinct from one reported for the M. tuberculosis enzyme. This new site is capable of binding a branched -glucan and is most likely involved in guiding acceptors toward the donor site because its disruption kinetically compromises the ability of GlgE to extend polymeric substrates. However, disruption of this site, which is conserved in the Streptomyces venezuelae GlgE enzyme, did not affect the growth of S. venezuelae or the structure of the polymeric product. The acceptor subsites +1 to +4 in the S. coelicolor enzyme are well conserved in the M. tuberculosis enzyme so their identification could help inform the design of inhibitors with therapeutic potential.	[Syson, Karl; Stevenson, Clare E. M.; Miah, Farzana; Barclay, J. Elaine; Tang, Minhong; Gorelik, Andrii; Rashid, Abdul M.; Lawson, David M.; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bornemann, S (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stephen.bornemann@jic.ac.uk	Bornemann, Stephen/K-2938-2012	Bornemann, Stephen/0000-0001-5930-9473; Gorelik, Andrii/0000-0001-5354-4042	United Kingdom Biotechnology and Biological Sciences Research Council Responsive Mode Grant [BB/I012850/1]; United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant [BB/J004561/1]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BB/I012850/1, BBS/E/J/000C0647] Funding Source: researchfish; BBSRC [BBS/E/J/000C0647, BB/I012850/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council Responsive Mode Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Responsive Mode Grant BB/I012850/1 and Institute Strategic Programme Grant BB/J004561/1 and by the John Innes Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Billones J.B., 2014, ORIENT J CHEM, V30, P1137; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Damager I, 2010, CHEM REV, V110, P2049, DOI 10.1021/cr900227t; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraga J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08026; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koliwer-Brandl H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005768; Leiba J, 2013, J BIOL CHEM, V288, P16546, DOI 10.1074/jbc.M112.398503; Lindenberger JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12830; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mendes V, 2015, SCI REP-UK, V5, DOI 10.1038/srep17144; Miah F, 2016, MICROBIOL-SGM, V162, P1208, DOI 10.1099/mic.0.000296; Miah F, 2013, CHEM BIOL, V20, P487, DOI 10.1016/j.chembiol.2013.02.014; Mizuno M, 2004, EUR J BIOCHEM, V271, P2530, DOI 10.1111/j.1432-1033.2004.04183.x; Moller MS, 2015, J MOL BIOL, V427, P1263, DOI 10.1016/j.jmb.2014.12.019; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Sullivan AC, 1999, BIOPOLYMERS, V50, P381, DOI 10.1002/(SICI)1097-0282(19991005)50:4<381::AID-BIP4>3.0.CO;2-W; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rashid AM, 2016, BIOCHEMISTRY-US, V55, P3270, DOI 10.1021/acs.biochem.6b00209; Sengupta S, 2015, J BIOMOL STRUCT DYN, V33, P2655, DOI 10.1080/07391102.2014.1003602; Sengupta S, 2014, MOL BIOL REP, V41, P3549, DOI 10.1007/s11033-014-3068-y; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; SOGAARD M, 1993, CARBOHYD POLYM, V21, P137, DOI 10.1016/0144-8617(93)90008-R; Syson K, 2014, BIOCHEMISTRY-US, V53, P2494, DOI 10.1021/bi500183c; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; TAKUSAGAWA F, 1978, ACTA CRYSTALLOGR B, V34, P213, DOI 10.1107/S0567740878002630; Thanna S, 2015, ORG BIOMOL CHEM, V13, P7542, DOI 10.1039/c5ob00867k; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Veleti SK, 2014, J ORG CHEM, V79, P9444, DOI 10.1021/jo501481r; Veleti SK, 2014, BIOORGAN MED CHEM, V22, P1404, DOI 10.1016/j.bmc.2013.12.058; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	44	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21531	21540		10.1074/jbc.M116.748160	http://dx.doi.org/10.1074/jbc.M116.748160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531751	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000385999200020
J	Yoshida, A; Tomita, T; Atomi, H; Kuzuyama, T; Nishiyama, M				Yoshida, Ayako; Tomita, Takeo; Atomi, Haruyuki; Kuzuyama, Tomohisa; Nishiyama, Makoto			Lysine Biosynthesis of Thermococcus kodakarensis with the Capacity to Function as an Ornithine Biosynthetic System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; archaea; biosynthesis; crystal structure; evolution; protein complex; carrier protein	COMPLETE GENOME SEQUENCE; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; ARGININE-BIOSYNTHESIS; CARRIER PROTEIN; EVOLUTION; PATHWAYS; ACID; BACTERIUM; SYNTHASE	We recently discovered a biosynthetic system using a novel amino group carrier protein called LysW for lysine biosynthesis via -aminoadipate (AAA), and revealed that this system is also utilized in the biosynthesis of arginine by Sulfolobus. In the present study, we focused on the biosynthesis of lysine and ornithine in the hyperthermophilic archaeon Thermococcus kodakarensis, and showed that their biosynthesis is accomplished by a single set of metabolic enzymes. We also determined the crystal structure of the LysX family protein from T. kodakarensis, which catalyzes the conjugation of LysW with either AAA or glutamate, in a complex with LysW--AAA. This crystal structure is the first example to show how LysX recognizes AAA as a substrate and provides a structural basis for the bifunctionality of the LysX family protein from T. kodakarensis. Based on comparisons with other LysX family proteins, we propose a mechanism for substrate recognition and its relationship with molecular evolution among LysX family proteins, which have different substrate specificities.	[Yoshida, Ayako; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Atomi, Haruyuki] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, 7 Gobancho, Tokyo 1020076, Japan	University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Atomi, Haruyuki/0000-0001-9687-6426; Kuzuyama, Tomohisa/0000-0002-7221-5858; Yoshida, Ayako/0000-0002-3668-9001	Japan Society for the Promotion of Science KAKENHI [24228001]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 24228001 (to M.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Baetens M, 1998, MICROBIOL-SGM, V144, P479, DOI 10.1099/00221287-144-2-479; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Irvin SD, 1998, J MOL EVOL, V46, P401, DOI 10.1007/PL00006319; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Jung JH, 2014, J BIOTECHNOL, V174, P14, DOI 10.1016/j.jbiotec.2014.01.022; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Lazcano A, 1996, CELL, V85, P793, DOI 10.1016/S0092-8674(00)81263-5; LEISINGER T, 1975, J BIOL CHEM, V250, P1690; MARTIN PR, 1992, J BACTERIOL, V174, P2694, DOI 10.1128/jb.174.8.2694-2701.1992; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouchi T, 2013, NAT CHEM BIOL, V9, P277, DOI [10.1038/NCHEMBIO.1200, 10.1038/nchembio.1200]; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Velasco AM, 2002, J MOL EVOL, V55, P445, DOI 10.1007/s00239-002-2340-2; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06; YASUKAWA T, 1995, J BIOL CHEM, V270, P25328, DOI 10.1074/jbc.270.43.25328; Yoshida A, 2015, J BIOL CHEM, V290, P435, DOI 10.1074/jbc.M114.595983	34	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21630	21643		10.1074/jbc.M116.743021	http://dx.doi.org/10.1074/jbc.M116.743021			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27566549	Green Published, hybrid			2022-12-28	WOS:000385999200029
J	Li, A; Li, JW; Johnson, KA				Li, An; Li, Jiawen; Johnson, Kenneth A.			HIV-1 Reverse Transcriptase Polymerase and RNase H (Ribonuclease H) Active Sites Work Simultaneously and Independently	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-POLYMERASE; SECONDARY STRUCTURE; AVIAN-MYELOBLASTOSIS; DRUG-RESISTANCE; RNA/DNA HYBRID; KINETIC-DATA; CLEAVAGE; DOMAIN; SPECIFICITY	HIV reverse transcriptase plays a central role in viral replication and requires coordination of both polymerase and RNase H activities. Although this coordination is crucial in viral replication, whether a DNA/RNA hybrid can simultaneously engage both active sites has yet to be determined as structural and kinetic analyses have provided contradictory results. Single nucleotide incorporation and RNase H cleavage were examined using presteady-state kinetics with global data analysis. The results revealed three interconverting reverse transcriptase-DNA/RNA species; 43% were active for both sites simultaneously, 27% showed only polymerase activity, and the remaining 30% were nonproductive. Our data clearly demonstrated that the DNA/RNA hybrid could contact both active sites simultaneously, although the single nucleotide incorporation (105 s(-1)) was similar to 5-fold faster than the cleavage (23 s(-1)). By using a series of primers with different lengths, we found that a string of at least 4-6 nucleotides downstream of the cleaving site was required for efficient RNA cleavage. This was corroborated by our observations that during processive nucleotide incorporation, sequential rounds of RNA cleavage occurred each time after similar to 6 nucleotides were incorporated. More importantly, during processive primer extension, pyrophosphate (PPi) release was ratelimiting so that the average rate of nucleotide incorporation (similar to 28 s(-1)) was comparable with that of net RNA cleavage (similar to 27 nucleotides(s)). Although polymerization is efficient and processive, RNase H is inefficient and periodic. This combination allows the two catalytic centers of HIVRT to work simultaneously at similar speeds without being tightly coupled.	[Li, An; Li, Jiawen; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), 2500 Speedway MBB3-122, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [R01 GM084741]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084741. This work was also supported by a grant from the Welch Foundation (F-1604). K. A. J. is the president of KinTek Corp., which provided the AutoSF-200x stopped flow and RQF-3 quench-flow instruments and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Beilhartz GL, 2010, VIRUSES-BASEL, V2, P900, DOI 10.3390/v2040900; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; Das K, 2014, NUCLEIC ACIDS RES, V42, P8125, DOI 10.1093/nar/gku487; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; DESTEFANO JJ, 1994, NUCLEIC ACIDS RES, V22, P3793, DOI 10.1093/nar/22.18.3793; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P24295; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; EVANS DB, 1991, J BIOL CHEM, V266, P20583; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gao HQ, 1998, J MOL BIOL, V277, P559, DOI 10.1006/jmbi.1998.1624; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; HOSTOMSKY Z, 1991, P NATL ACAD SCI USA, V88, P1148, DOI 10.1073/pnas.88.4.1148; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KATI WM, 1992, J BIOL CHEM, V267, P25988; KECK JL, 1995, P NATL ACAD SCI USA, V92, P2740, DOI 10.1073/pnas.92.7.2740; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14056, DOI 10.1021/bi971385+; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; KRUG MS, 1989, P NATL ACAD SCI USA, V86, P3539, DOI 10.1073/pnas.86.10.3539; Lapkouski M, 2013, NAT STRUCT MOL BIOL, V20, P230, DOI 10.1038/nsmb.2485; Li A, 2016, J BIOL CHEM, V291, P26554, DOI 10.1074/jbc.M116.753152; Mandal D, 2006, NUCLEIC ACIDS RES, V34, P2853, DOI 10.1093/nar/gkl360; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Powell MD, 1999, J BIOL CHEM, V274, P19885, DOI 10.1074/jbc.274.28.19885; Purohit V, 2007, J BIOL CHEM, V282, P12598, DOI 10.1074/jbc.M700043200; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schultz SJ, 2010, J MOL BIOL, V397, P161, DOI 10.1016/j.jmb.2010.01.059; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; SMITH JS, 1993, J VIROL, V67, P4037, DOI 10.1128/JVI.67.7.4037-4049.1993; STAHL SJ, 1994, PROTEIN ENG, V7, P1103, DOI 10.1093/protein/7.9.1103; STAMMERS DK, 1991, FEBS LETT, V283, P298, DOI 10.1016/0014-5793(91)80613-8; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12468, DOI 10.1021/bi971218+; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P14778, DOI 10.1021/bi971963m; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057	46	16	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26566	26585		10.1074/jbc.M116.753160	http://dx.doi.org/10.1074/jbc.M116.753160			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27777303	Green Published, hybrid			2022-12-28	WOS:000391568200028
J	Grabe, GJ; Zhang, Y; Przydacz, M; Rolhion, N; Yang, Y; Pruneda, JN; Komander, D; Holden, DW; Hare, SA				Grabe, Grzegorz J.; Zhang, Yue; Przydacz, Michal; Rolhion, Nathalie; Yang, Yi; Pruneda, Jonathan N.; Komander, David; Holden, David W.; Hare, Stephen A.			The Salmonella Effector SpvD Is a Cysteine Hydrolase with a Serovar-specific Polymorphism Influencing Catalytic Activity, Suppression of Immune Responses, and Bacterial Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECISION-MAKING; PLASMID; MECHANISM; UBIQUITIN; DUBLIN; PHENIX; TYPHIMURIUM; REFINEMENT; BINDING; SYSTEM	Many bacterial pathogens secrete virulence (effector) proteins that interfere with immune signaling in their host. SpvD is a Salmonella enterica effector protein that we previously demonstrated to negatively regulate the NF-kappa B signaling pathway and promote virulence of S. enterica serovar Typhimurium in mice. To shed light on the mechanistic basis for these observations, we determined the crystal structure of SpvD and show that it adopts a papa-in-like fold with a characteristic cysteine-histidine-aspartate catalytic triad comprising Cys-73, His-162, and Asp-182. SpvD possessed an in vitro deconjugative activity on aminoluciferin-linked peptide and protein substrates in vitro. A C73A mutation abolished SpvD activity, demonstrating that an intact catalytic triad is required for its function. Taken together, these results strongly suggest that SpvD is a cysteine protease. The amino acid sequence of SpvD is highly conserved across different S. enterica serovars, but residue 161, located close to the catalytic triad, is variable, with serovar Typhimurium SpvD havingan arginine and serovar Enteritidis a glycine at this position. This variation affected hydrolytic activity of the enzyme on artificial substrates and can be explained by substrate accessibility to the active site. Interestingly, the SpvD(G161) variant more potently inhibited NF-kappa B-mediated immune responses in cells in vitro and increased virulence of serovar Typhimurium in mice. In summary, our results explain the biochemical basis for the effect of virulence protein SpvD and demonstrate that a single amino acid polymorphism can affect the overall virulence of a bacterial pathogen in its host.	[Grabe, Grzegorz J.; Rolhion, Nathalie; Holden, David W.] Imperial Coll London, Microbiol Sect, London SW7 2AZ, England; [Zhang, Yue; Przydacz, Michal; Yang, Yi; Hare, Stephen A.] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, London SW7 2AZ, England; [Pruneda, Jonathan N.; Komander, David] MRC Lab Mol Biol, Div Prot & Nucle Acid Chem, Cambridge CB2 OQH, England; [Zhang, Yue] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Rolhion, Nathalie] Inst Pasteur, Unite Interact Bacteries Cellules, F-75724 Paris, France	Imperial College London; Imperial College London; University of Cambridge; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Holden, DW (corresponding author), Imperial Coll London, Microbiol Sect, London SW7 2AZ, England.; Hare, SA (corresponding author), Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, London SW7 2AZ, England.	d.holden@imperial.ac.uk; s.hare@imperial.ac.uk	Grabe, Grzegorz/CAG-9633-2022	Grabe, Grzegorz/0000-0002-0419-491X; Pruneda, Jonathan/0000-0002-0304-4418; Holden, David/0000-0002-8369-5105; Hare, Stephen/0000-0003-2951-1595; ROLHION, nathalie/0000-0002-2946-4808	Medical Research Council [MR/K027077/1, G1100332]; Wellcome Trust [095484/Z/11/Z, 093617/Z/10/Z]; Medical Research Council [MC_U105192732] Funding Source: researchfish; MRC [MR/K027077/1, MC_U105192732] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants MR/K027077/1 (to D. H.) and G1100332 (to S. H.), Wellcome Trust Grant 095484/Z/11/Z (to D. H.), and Wellcome Trust Fellowship 093617/Z/10/Z (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bauerfeind R, 2001, BERL MUNCH TIERARZTL, V114, P404; BENINGER PR, 1988, J CLIN INVEST, V81, P1341, DOI 10.1172/JCI113461; Bhaskaran SS, 2012, ACTA CRYSTALLOGR D, V68, P1613, DOI 10.1107/S0907444912039042; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Filipek R, 2005, J BIOL CHEM, V280, P14669, DOI 10.1074/jbc.M411792200; GULIG PA, 1988, INFECT IMMUN, V56, P3262, DOI 10.1128/IAI.56.12.3262-3271.1988; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JONES GW, 1982, INFECT IMMUN, V38, P476, DOI 10.1128/IAI.38.2.476-486.1982; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KRAUSE M, 1992, J BACTERIOL, V174, P4482, DOI 10.1128/JB.174.13.4482-4489.1992; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Libby SJ, 1997, INFECT IMMUN, V65, P1786, DOI 10.1128/IAI.65.5.1786-1792.1997; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; Mirkovic B, 2011, CHEMMEDCHEM, V6, P1351, DOI 10.1002/cmdc.201100098; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Nishide A, 2013, J MOL BIOL, V425, P2623, DOI 10.1016/j.jmb.2013.02.037; PICKERSGILL RW, 1992, ACTA CRYSTALLOGR B, V48, P59, DOI 10.1107/S0108768191006572; Pruneda JN, 2016, MOL CELL, V63, P261, DOI 10.1016/j.molcel.2016.06.015; Rolhion N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005653; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thornbrough JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045245; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wong CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10172; Yang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138529; Zhang Z, 2006, J APPL CRYSTALLOGR, V39, P112, DOI 10.1107/S0021889805040677; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100; Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011	41	21	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25853	25863		10.1074/jbc.M116.752782	http://dx.doi.org/10.1074/jbc.M116.752782			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27789710	Green Published, hybrid			2022-12-28	WOS:000390345200009
J	Rosati, R; Patki, M; Chari, V; Dakshnamurthy, S; McFall, T; Saxton, J; Kidder, BL; Shaw, PE; Ratnam, M				Rosati, Rayna; Patki, Mugdha; Chari, Venkatesh; Dakshnamurthy, Selvakumar; McFall, Thomas; Saxton, Janice; Kidder, Benjamin L.; Shaw, Peter E.; Ratnam, Manohar			The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX-FORMATION; TRANSCRIPTION FACTOR; MAP KINASES; PROGRESSION; TARGETS; BINDING; SURFACE; PHOSPHORYLATION; OVEREXPRESSION; PROLIFERATION	The ETS domain transcription factor ELK1 is in a repressive association with growth genes and is transiently activated through phosphorylation by ERK1/2. In prostate cancer (PCa) cells the androgen receptor (AR) is recruited by ELK1, via its amino-terminal domain (A/B), as a transcriptional co-activator, without ELK1 hyper-phosphorylation. Here we elucidate the structural basis of the interaction of AR with ELK1. The ELK1 polypeptide motifs required for co-activation by AR versus those required for activation of ELK1 by ERK were systematically mapped using a mammalian two-hybrid system and confirmed using a co-immunoprecipitation assay. The mapping precisely identified the two ERK-docking sites in ELK1, the D-box and the DEF (docking site for ERK, FXFP) motif, as the essential motifs for its cooperation with AR(A/B) or WTAR. In contrast, the transactivation domain in ELK1 was only required for activation by ERK. ELK1-mediated transcriptional activity of AR(A/B) was optimal in the absence of ELK1 binding partners, ERK1/2 and serum-response factor. Purified ELK1 and AR bound with a dissociation constant of 1.9 x 10(-8) M. A purified mutant ELK1 in which the D-box and DEF motifs were disrupted did not bind AR. An ELK1 mutant with deletion of the D-box region had a dominant-negative effect on androgen-dependent growth of PCa cells that were insensitive to MEK inhibition. This novel mechanism in which a nuclear receptor impinges on a signaling pathway by co-opting protein kinase docking sites to constitutively activate growth genes could enable rational design of a new class of targeted drug interventions.	[Rosati, Rayna; Patki, Mugdha; Chari, Venkatesh; Dakshnamurthy, Selvakumar; McFall, Thomas; Kidder, Benjamin L.; Ratnam, Manohar] Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Rosati, Rayna; Patki, Mugdha; Chari, Venkatesh; Dakshnamurthy, Selvakumar; McFall, Thomas; Kidder, Benjamin L.; Ratnam, Manohar] Dept Oncol, Detroit, MI 48201 USA; [Rosati, Rayna; Patki, Mugdha; McFall, Thomas; Kidder, Benjamin L.; Ratnam, Manohar] Wayne State Univ, Sch Med, Detroit, MI 48201 USA; [Saxton, Janice; Shaw, Peter E.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England	Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Nottingham	Ratnam, M (corresponding author), 4100 John R,HWCRC840-1, Detroit, MI 48201 USA.	ratnamm@karmanos.org		SHAW, Peter/0000-0002-2598-4283	National Institutes of Health NRSA [5T32CA009531]; Biotechnology and Biological Sciences Research Council [BB/D019117/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009531, P30CA022453] Funding Source: NIH RePORTER; BBSRC [BB/D019117/1] Funding Source: UKRI	National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Institutes of Health NRSA-T32 Training Grant 5T32CA009531 (to R. R.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Evans EL, 2011, NUCLEIC ACIDS RES, V39, P6390, DOI 10.1093/nar/gkr266; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gonit M, 2011, MOL ENDOCRINOL, V25, P621, DOI 10.1210/me.2010-0409; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kawahara T, 2015, AM J CANCER RES, V5, P2959; Kawahara T, 2015, ONCOTARGET, V6, P29860, DOI 10.18632/oncotarget.5007; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Liao RS, 2013, TRANSL ANDROL UROL, V2, P187, DOI 10.3978/j.issn.2223-4683.2013.09.07; Linja MJ, 2001, CANCER RES, V61, P3550; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Patki M, 2013, J BIOL CHEM, V288, P11047, DOI 10.1074/jbc.M112.438473; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ratnam M, 2013, ANDROGEN RESPONSIVE, P85; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Selvakumar D, 2013, J BIOL CHEM, V288, P7215, DOI 10.1074/jbc.M112.443226; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; SHAW PE, 1989, EMBO J, V8, P2567, DOI 10.1002/j.1460-2075.1989.tb08395.x; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Toren P, 2014, INT J ONCOL, V45, P1793, DOI 10.3892/ijo.2014.2601; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zarif JC, 2016, CELL SIGNAL, V28, P348, DOI 10.1016/j.cellsig.2016.01.013; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099; Zhang J, 2010, ONCOGENE, V29, P723, DOI 10.1038/onc.2009.373; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	63	10	10	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25983	25998		10.1074/jbc.M116.745596	http://dx.doi.org/10.1074/jbc.M116.745596			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27793987	Green Published, hybrid			2022-12-28	WOS:000390345200019
J	Sorrenson, B; Cognard, E; Lee, KL; Dissanayake, WC; Fu, YY; Han, WP; Hughes, WE; Shepherd, PR				Sorrenson, Brie; Cognard, Emmanuelle; Lee, Kathryn L.; Dissanayake, Waruni C.; Fu, Yanyun; Han, Weiping; Hughes, William E.; Shepherd, Peter R.			A Critical Role for beta-Catenin in Modulating Levels of Insulin Secretion from beta-Cells by Regulating Actin Cytoskeleton and Insulin Vesicle Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULE EXOCYTOSIS; SYNAPTIC VESICLES; SIGNALING PATHWAY; GLUCOSE; TCF7L2; MECHANISMS; CADHERIN; GENE; ASSOCIATION; ACTIVATION	The processes regulating glucose-stimulated insulin secretion (GSIS) and its modulation by incretins in pancreatic beta-cells are only partly understood. Here we investigate the involvement of beta-catenin in these processes. Reducing beta-catenin levels using siRNA knockdown attenuated GSIS in a range of beta-cell models and blocked the ability of GLP-1 agonists and the depolarizing agent KCl to potentiate this. This could be mimicked in both beta-cell models and isolated islets by short-term exposure to the beta-catenin inhibitory drug pyrvinium. In addition, short-term treatment with a drug that increases beta-catenin levels results in an increase in insulin secretion. The timing of these effects suggests that beta-catenin is required for the processes regulating trafficking and/or release of pre-existing insulin granules rather than for those regulated by gene expression. This was supported by the finding that the overexpression of the transcriptional coactivator of beta-catenin, transcription factor 7-like 2 (TCF7L2), attenuated insulin secretion, consistent with the extra TCF7L2 translocating beta-catenin from the plasma membrane pool to the nucleus. We show that beta-catenin depletion disrupts the intracellular actin cytoskeleton, and by using total internal reflectance fluorescence (TIRF) microscopy, we found that beta-catenin is required for the glucose-and incretin-induced depletion of insulin vesicles from near the plasma membrane. In conclusion, we find that beta-catenin levels modulate Ca2+-dependent insulin exocytosis under conditions of glucose, GLP-1, or KCl stimulation through a role in modulating insulin secretory vesicle localization and/or fusion via actin remodeling. These findings also provide insights as to how the overexpression of TCF7L2 may attenuate insulin secretion.	[Sorrenson, Brie; Cognard, Emmanuelle; Lee, Kathryn L.; Dissanayake, Waruni C.; Shepherd, Peter R.] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Private Bag 92019, Auckland 1142, New Zealand; [Sorrenson, Brie; Shepherd, Peter R.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1142, New Zealand; [Fu, Yanyun; Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Singapore 138667, Singapore; [Hughes, William E.] St Vincents Hosp, Dept Med, Victoria St, Sydney, NSW 2010, Australia; [Hughes, William E.] Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia	University of Auckland; University of Auckland; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); St Vincents Hospital Sydney; Garvan Institute of Medical Research	Shepherd, PR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Private Bag 92019, Auckland 1142, New Zealand.; Shepherd, PR (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1142, New Zealand.	peter.shepherd@auckland.ac.nz		Hughes, William/0000-0002-7149-3987; Sorrenson, Brie/0000-0002-0938-7585	Health Research Council of New Zealand; University of Auckland; New Zealand Heart Foundation	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland; New Zealand Heart Foundation	This work was supported by a project grant from the Health Research Council of New Zealand and a PJ Smith Traveling Fellowship from the University of Auckland. This work was also supported by a New Zealand Heart Foundation Research Fellowship (to B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bertera S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/856386; Bian S., 2011, PLOS ONE, V6; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Cognard E, 2013, BIOCHEM J, V449, P803, DOI 10.1042/BJ20121454; Dabernat S, 2009, DIABETOLOGIA, V52, P1608, DOI 10.1007/s00125-009-1411-y; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; Elghazi L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00693; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Gujral TS, 2013, CHEM BIOL, V20, P816, DOI 10.1016/j.chembiol.2013.04.021; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; He H, 2008, BBA-MOL CELL RES, V1783, P1943, DOI 10.1016/j.bbamcr.2008.04.016; Heaslip AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109082; Hodgkin MN, 2007, PANCREAS, V34, P170, DOI 10.1097/01.mpa.0000240616.28098.55; Jacobson DA, 2010, J PHYSIOL-LONDON, V588, P3525, DOI 10.1113/jphysiol.2010.190207; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Kalwat MA, 2013, BIOCHEM PHARMACOL, V85, P808, DOI 10.1016/j.bcp.2012.12.003; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krutzfeldt J, 2010, DIABETOLOGIA, V53, P123, DOI 10.1007/s00125-009-1578-2; Lesage F, 2004, P NATL ACAD SCI USA, V101, P671, DOI 10.1073/pnas.0307681100; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Meloni AR, 2013, DIABETES OBES METAB, V15, P15, DOI 10.1111/j.1463-1326.2012.01663.x; Mitchell RK, 2015, HUM MOL GENET, V24, P1390, DOI 10.1093/hmg/ddu553; Mourad NI, 2010, AM J PHYSIOL-CELL PH, V299, pC389, DOI 10.1152/ajpcell.00138.2010; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Parnaud G, 2015, DIABETES, V64, P887, DOI 10.2337/db14-0257; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Rutter GA, 2014, DIABETIC MED, V31, P1480, DOI 10.1111/dme.12579; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tsang SW, 2010, MOL CELL ENDOCRINOL, V315, P263, DOI 10.1016/j.mce.2009.11.007; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Yang SY, 2016, BIOCHEM J, V473, P1791, DOI 10.1042/BCJ20160137; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294	59	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25888	25900		10.1074/jbc.M116.758516	http://dx.doi.org/10.1074/jbc.M116.758516			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777306	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000390345200012
J	Huang, SC; Zhou, AY; Nguyen, DT; Zhang, HS; Benz, EJ				Huang, Shu-Ching; Zhou, Anyu; Nguyen, Dan T.; Zhang, Henry S.; Benz, Edward J., Jr.			Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; myogenesis; protein degradation; protein stability; ubiquitylation (ubiquitination); myogenin; protein 4; 1R; von Hippel Lindau	TUMOR-SUPPRESSOR PROTEIN; MYOD MESSENGER-RNA; NONERYTHROID ISOFORM; EXPRESSION; GENE; IDENTIFICATION; DEGRADATION; CELLS; PATHOGENESIS; DISTINCT	Protein 4.1R (4.1R) isoforms are expressed in both cardiac and skeletal muscle. 4.1R is a component of the contractile apparatus. It is also associated with dystrophin at the sarcolemma in skeletal myofibers. However, the expression and function of 4.1R during myogenesis have not been characterized. We now report that 4.1R expression increases during C2C12 myoblast differentiation into myotubes. Depletion of 4.1R impairs skeletal muscle differentiation and is accompanied by a decrease in the levels of myosin heavy and light chains and caveolin-3. Furthermore, the expression of myogenin at the protein, but not mRNA, level is drastically decreased in 4.1R knockdown myocytes. Similar results were obtained using MyoD-induced differentiation of 4.1R(-/-) mouse embryonic fibroblast cells. von Hippel-Lindau (VHL) protein is known to destabilize myogenin via the ubiquitin-proteasome pathway. We show that 4.1R associates with VHL and, when overexpressed, reverses myogenin ubiquitination and stability. This suggests that 4.1R may influence myogenesis by preventing VHL-mediated myogenin degradation. Together, our results define a novel biological function for 4.1R in muscle differentiation and provide a molecular mechanism by which 4.1R promotes myogenic differentiation.	[Huang, Shu-Ching; Zhou, Anyu; Nguyen, Dan T.; Zhang, Henry S.; Benz, Edward J., Jr.] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA; [Huang, Shu-Ching; Benz, Edward J., Jr.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Huang, Shu-Ching; Benz, Edward J., Jr.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Benz, Edward J., Jr.] Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Huang, SC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	shu-ching_huang@dfci.harvard.edu			National Institutes of Health [HL24385, HL44985, HL61295]; Claudia Barr Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024385, R29HL061295, R01HL061295, R01HL044985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Barr Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL24385 and HL44985 (to E.J.B.) and National Institutes of Health Grant HL61295 and the Claudia Barr Award (to S.C.H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; AURADE F, 1994, DIFFERENTIATION, V55, P185, DOI 10.1046/j.1432-0436.1994.5530185.x; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; Delhommeau F, 2005, CR BIOL, V328, P43, DOI 10.1016/j.crvi.2004.11.003; Doucet Christine, 2005, BMC Biochem, V6, P27, DOI 10.1186/1471-2091-6-27; EDMONDSON DG, 1991, J BIOL CHEM, V266, P21343; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Gutmann DH, 2000, HUM MOL GENET, V9, P1495, DOI 10.1093/hmg/9.10.1495; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Infante JP, 1999, MOL CELL BIOCHEM, V195, P155, DOI 10.1023/A:1006972315739; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kontrogianni-Konstantopoulos A, 2000, MOL BIOL CELL, V11, P3805, DOI 10.1091/mbc.11.11.3805; Krauss SW, 2003, P NATL ACAD SCI USA, V100, P10752, DOI 10.1073/pnas.1934680100; Kuns R, 2005, ONCOGENE, V24, P6502, DOI 10.1038/sj.onc.1208813; Lallena MJ, 1998, J CELL SCI, V111, P1963; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Na X, 2003, EMBO J, V22, P4249, DOI 10.1093/emboj/cdg410; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Olguin HC, 2011, BIOL RES, V44, P323, DOI /S0716-97602011000400002; Pecina-Slaus N, 2013, PATHOL ONCOL RES, V19, P365, DOI 10.1007/s12253-013-9644-y; Perry A, 2004, J NEURO-ONCOL, V70, P183, DOI 10.1007/s11060-004-2749-0; Pinder JC, 2012, EXP CELL RES, V318, P1467, DOI 10.1016/j.yexcr.2012.03.003; Rajaram V, 2005, MODERN PATHOL, V18, P991, DOI 10.1038/modpathol.3800390; Reinstein E, 2006, ANN INTERN MED, V145, P676, DOI 10.7326/0003-4819-145-9-200611070-00010; Robb VA, 2003, NEUROBIOL DIS, V13, P191, DOI 10.1016/S0969-9961(03)00071-8; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Shiraishi S, 2007, J BIOL CHEM, V282, P9017, DOI 10.1074/jbc.M611513200; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; Sussman Michael, 2002, J Am Acad Orthop Surg, V10, P138; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Taylor-Harris PM, 2005, MAMM GENOME, V16, P137, DOI 10.1007/s00335-004-2436-7; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Wong SY, 2007, P NATL ACAD SCI USA, V104, P12784, DOI 10.1073/pnas.0705499104; Yageta M, 2002, CANCER RES, V62, P5129; YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zatyka M, 2002, CANCER RES, V62, P3803	68	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25591	25607		10.1074/jbc.M116.761296	http://dx.doi.org/10.1074/jbc.M116.761296			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27780863	Green Published, hybrid			2022-12-28	WOS:000390095300026
J	Xie, J; Cai, K; Hu, HX; Jiang, YL; Yang, F; Hu, PF; Cao, DD; Li, WF; Chen, YX; Zhou, CZ				Xie, Jin; Cai, Kun; Hu, Hai-Xi; Jiang, Yong-Liang; Yang, Feng; Hu, Peng-Fei; Cao, Dong-Dong; Li, Wei-Fang; Chen, Yuxing; Zhou, Cong-Zhao			Structural Analysis of the Catalytic Mechanism and Substrate Specificity of Anabaena Alkaline Invertase InvA Reveals a Novel Glucosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; cyanobacteria; enzyme catalysis; glycoside hydrolase; substrate specificity; GH100; alkaline; neutral invertases; glucosidase; sucrose metabolism	NEUTRAL INVERTASE; CYTOSOLIC INVERTASE; SUCROSE METABOLISM; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; CELL-DEVELOPMENT; NORMAL GROWTH; SOLUBLE ACID; PURIFICATION; COMPLEX	Invertases catalyze the hydrolysis of sucrose to glucose and fructose, thereby playing a key role in primary metabolism and plant development. According to the optimum pH, invertases are classified into acid invertases (Ac-Invs) and alkaline/neutral invertases (A/N-Invs), which share no sequence homology. Compared with Ac-Invs that have been extensively studied, the structure and catalytic mechanism of A/N-Invs remain unknown. Here we report the crystal structures of Anabaena alkaline invertase InvA, which was proposed to be the ancestor of modern plant A/N-Invs. These structures are the first in the GH100 family. InvA exists as a hexamer in both crystal and solution. Each subunit consists of an (/)(6) barrel core structure in addition to an insertion of three helices. A couple of structures in complex with the substrate or products enabled us to assign the subsites -1 and +1 specifically binding glucose and fructose, respectively. Structural comparison combined with enzymatic assays indicated that Asp-188 and Glu-414 are putative catalytic residues. Further analysis of the substrate binding pocket demonstrated that InvA possesses a stringent substrate specificity toward the 1,2-glycosidic bond of sucrose. Together, we suggest that InvA and homologs represent a novel family of glucosidases.	[Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chen, YX; Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Chen, Yuxing/P-4156-2014; Zhou, Cong-Zhao/E-9174-2011	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Jiang, YongLiang/0000-0001-5441-4936; Cao, Dongdong/0000-0002-2031-9321	National Natural Science Foundation of China [31630001, 31370757, 31621002, 31500598]; Ministry of Education of China [20133402110023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 31630001 and 31370757, 31621002, and 31500598 and Ministry of Education of China Grant 20133402110023. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; Barker MK, 2013, J BIOL CHEM, V288, P13563, DOI 10.1074/jbc.M113.460436; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; CHEN JQ, 1992, ARCH BIOCHEM BIOPHYS, V295, P61, DOI 10.1016/0003-9861(92)90488-I; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallagher JA, 1998, J EXP BOT, V49, P789, DOI 10.1093/jexbot/49.322.789; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; HAMAZAKI H, 1980, EUR J BIOCHEM, V111, P587, DOI 10.1111/j.1432-1033.1980.tb04975.x; Hertel S, 2000, CARBOHYD RES, V326, P264, DOI 10.1016/S0008-6215(00)00008-2; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hussain A, 2009, PLANT PHYSIOL BIOCH, V47, P188, DOI 10.1016/j.plaphy.2008.11.001; Jia LQ, 2008, PLANTA, V228, P51, DOI 10.1007/s00425-008-0718-0; Kim D, 2010, J INTEGR PLANT BIOL, V52, P536, DOI 10.1111/j.1744-7909.2010.00937.x; Kim HS, 2004, J BACTERIOL, V186, P411, DOI 10.1128/JB.186.2.411-418.2004; Kim MI, 2008, J MOL BIOL, V380, P636, DOI 10.1016/j.jmb.2008.05.046; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Kolman Maria A., 2015, Life-Basel, V5, P102, DOI 10.3390/life5010102; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Lee HS, 1996, PLANT PHYSIOL, V112, P1513, DOI 10.1104/pp.112.4.1513; Lin CL, 1999, NEW PHYTOL, V142, P427, DOI 10.1046/j.1469-8137.1999.00416.x; Liu CC, 2006, FOOD CHEM, V96, P621, DOI 10.1016/j.foodchem.2005.02.044; Liu SJ, 2015, NEW PHYTOL, V206, P709, DOI 10.1111/nph.13257; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lou Y, 2007, PLANT CELL, V19, P163, DOI 10.1105/tpc.106.045658; MASUDA H, 1987, AGR BIOL CHEM TOKYO, V51, P2309; MASUDA H, 1988, PLANT PHYSIOL, V86, P312, DOI 10.1104/pp.86.1.312; MITSUISHI Y, 1980, CARBOHYD RES, V83, P303, DOI 10.1016/S0008-6215(00)84542-5; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Omori T, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi XP, 2007, PLANT MOL BIOL, V64, P575, DOI 10.1007/s11103-007-9177-4; Reca IB, 2008, BIOCHIMIE, V90, P1611, DOI 10.1016/j.biochi.2008.04.019; Reddy A, 1996, J BIOL CHEM, V271, P13953, DOI 10.1074/jbc.271.24.13953; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Salerno GL, 2003, TRENDS PLANT SCI, V8, P63, DOI 10.1016/S1360-1385(02)00029-8; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sturm A, 1999, PHYSIOL PLANTARUM, V107, P159, DOI 10.1034/j.1399-3054.1999.100202.x; Sturm A, 1999, PLANT PHYSIOL, V121, P1, DOI 10.1104/pp.121.1.1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDENENDE W, 1995, PHYSIOL PLANTARUM, V93, P241, DOI 10.1111/j.1399-3054.1995.tb02223.x; Vargas W, 2003, PLANTA, V216, P951, DOI 10.1007/s00425-002-0943-x; Vargas WA, 2007, PLANTA, V226, P1535, DOI 10.1007/s00425-007-0590-3; Vargas WA, 2011, PLANTA, V233, P153, DOI 10.1007/s00425-010-1288-5; Vargas WA, 2010, PLANT SCI, V178, P1, DOI 10.1016/j.plantsci.2009.09.015; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207; Wang LT, 2005, J AGR FOOD CHEM, V53, P3672, DOI 10.1021/jf0480851; Welham T, 2009, J EXP BOT, V60, P3353, DOI 10.1093/jxb/erp169; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069	67	20	21	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25667	25677		10.1074/jbc.M116.759290	http://dx.doi.org/10.1074/jbc.M116.759290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27777307	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000390095300032
J	Koga, T; Yao, PL; Goudarzi, M; Murray, IA; Balandaram, G; Gonzalez, FJ; Perdew, GH; Fornace, AJ; Peters, JM				Koga, Takayuki; Yao, Pei-Li; Goudarzi, Maryam; Murray, Iain A.; Balandaram, Gayathri; Gonzalez, Frank J.; Perdew, Gary H.; Fornace, Albert J., Jr.; Peters, Jeffrey M.			Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-beta/delta Modulation of SP1 Promoter Occupancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; PPAR-DELTA AGONIST; NUCLEAR TRANSLOCATION; LIGAND ACTIVATION; CELLS; DISEASE; ALPHA; CAR; MICE; GENE	Alcoholic liver disease is a pathological condition caused by overconsumption of alcohol. Because of the high morbidity and mortality associated with this disease, there remains a need to elucidate the molecular mechanisms underlying its etiology and to develop new treatments. Because peroxisome proliferator-activated receptor-beta/delta (PPAR beta/delta) modulates ethanol-induced hepatic effects, the present study examined alterations in gene expression that may contribute to this disease. Chronic ethanol treatment causes increased hepatic CYP2B10 expression in Ppar beta/delta(+/+) mice but not in Ppar beta/delta(-/-) mice. Nuclear and cytosolic localization of the constitutive androstane receptor (CAR), a transcription factor known to regulate Cyp2b10 expression, was not different between genotypes. PPAR gamma co-activator 1 alpha, a co-activator of both CAR and PPAR beta/delta, was up-regulated in Ppar beta/delta(+/+) liver following ethanol exposure, but not in Ppar beta/delta(-/-) liver. Functional mapping of the Cyp2b10 promoter and ChIP assays revealed that PPAR beta/delta-dependent modulation of SP1 promoter occupancy up-regulated Cyp2b10 expression in response to ethanol. These results suggest that PPAR beta/delta regulates Cyp2b10 expression indirectly by modulating SP1 and PPAR gamma co-activator 1 alpha expression and/or activity independent of CAR activity. Ligand activation of PPAR beta/delta attenuates ethanol-induced Cyp2b10 expression in Ppar beta/delta(+/+) liver but not in Ppar beta/delta(-/-) liver. Strikingly, Cyp2b10 suppression by ligand activation of PPAR beta/delta following ethanol treatment occurred in hepatocytes and was mediated by paracrine signaling from Kupffer cells. Combined, results from the present study demonstrate a novel regulatory role of PPAR beta/delta in modulating CYP2B10 that may contribute to the etiology of alcoholic liver disease.	[Koga, Takayuki; Yao, Pei-Li; Murray, Iain A.; Balandaram, Gayathri; Perdew, Gary H.; Peters, Jeffrey M.] Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA; [Koga, Takayuki; Yao, Pei-Li; Murray, Iain A.; Balandaram, Gayathri; Perdew, Gary H.; Peters, Jeffrey M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, 312 Life Sci Bldg, University Pk, PA 16802 USA; [Goudarzi, Maryam; Fornace, Albert J., Jr.] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peters, JM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA.; Peters, JM (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, 312 Life Sci Bldg, University Pk, PA 16802 USA.	jmp21@psu.edu	Goudarzi, Maryam/O-9472-2015	Goudarzi, Maryam/0000-0003-4961-3935; Koga, Takayuki/0000-0001-9782-6746; Yao, Pei-Li/0000-0003-0832-3771; Peters, Jeffrey/0000-0003-2782-2998	National Institute of Alcohol Abuse and Alcoholism [CA124533, CA141029, AA018863]; National Institutes of Health NCI Intramural Research Program [ZIABC005561, ZIABC005562, ZIABC005708]; NATIONAL CANCER INSTITUTE [ZIABC005561, ZIABC005562, R01CA141029, ZIABC005708, R01CA124533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018863] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health NCI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute of Alcohol Abuse and Alcoholism Grants CA124533 and CA141029 (to J. M. P.) and AA018863 (to A. J. F. and J. M. P.) and National Institutes of Health NCI Intramural Research Program Grants ZIABC005561, ZIABC005562, and ZIABC005708 (to F. J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balandaram G, 2016, TOXICOLOGY, V363, P1, DOI 10.1016/j.tox.2016.07.010; Bale SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25329; Bogdanowicz DR, 2013, BIOTECHNOL J, V8, P395, DOI 10.1002/biot.201300054; Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Borland MG, 2014, CARCINOGENESIS, V35, P1602, DOI 10.1093/carcin/bgu067; Chacko KR, 2016, CLIN LIVER DIS, V20, P419, DOI 10.1016/j.cld.2016.02.002; Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68; Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Dunn W, 2016, CLIN LIVER DIS, V20, P445, DOI 10.1016/j.cld.2016.02.004; Goers L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0065; Goudarzi M, 2013, TOXICOLOGY, V311, P87, DOI 10.1016/j.tox.2013.07.002; Goyak KMO, 2008, TOXICOL APPL PHARM, V231, P216, DOI 10.1016/j.taap.2008.04.024; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855; HAWKSWORTH GM, 1994, HUM EXP TOXICOL, V13, P568, DOI 10.1177/096032719401300811; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Khozoie C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-665; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; Moriya T, 2009, J OCCUP HEALTH, V51, P391, DOI 10.1539/joh.K9001; Muangmoonchai R, 2001, BIOCHEM J, V355, P71, DOI 10.1042/0264-6021:3550071; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; NAKAJIMA T, 1994, BIOCHEM PHARMACOL, V48, P637; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Pang MY, 2009, J HEPATOL, V50, P1192, DOI 10.1016/j.jhep.2009.01.021; Peters JM, 2011, CANCER METAST REV, V30, P619, DOI 10.1007/s10555-011-9320-1; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; Salatino S, 2016, MOL ENDOCRINOL, V30, P809, DOI 10.1210/me.2016-1036; Shan W, 2008, TOXICOL SCI, V105, P418, DOI 10.1093/toxsci/kfn142; Shan WW, 2008, HEPATOLOGY, V47, P225, DOI 10.1002/hep.21925; Shin SW, 2015, INT J ONCOL, V46, P1328, DOI 10.3892/ijo.2015.2834; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Yao PL, 2015, ONCOTARGET, V6, P36319, DOI 10.18632/oncotarget.5415; Yao PL, 2015, J BIOL CHEM, V290, P23416, DOI 10.1074/jbc.M115.664508; Yao PL, 2014, MOL CANCER THER, V13, P1008, DOI 10.1158/1535-7163.MCT-13-0836; Yao PL, 2011, BIOL REPROD, V85, P1203, DOI 10.1095/biolreprod.111.093484; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245	42	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25255	25263		10.1074/jbc.M116.755447	http://dx.doi.org/10.1074/jbc.M116.755447			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27765815	hybrid, Green Published			2022-12-28	WOS:000388880100039
J	Bao, L; Chen, SJ; Conrad, K; Keefer, K; Abraham, T; Lee, JP; Wang, J; Zhang, XQ; Hirschler-Laszkiewicz, I; Wang, HG; Dovat, S; Gans, B; Madesh, M; Cheung, JY; Miller, BA				Bao, Lei; Chen, Shu-Jen; Conrad, Kathleen; Keefer, Kerry; Abraham, Thomas; Lee, John P.; Wang, JuFang; Zhang, Xue-Qian; Hirschler-Laszkiewicz, Iwona; Wang, Hong-Gang; Dovat, Sinisa; Gans, Brian; Madesh, Muniswamy; Cheung, Joseph Y.; Miller, Barbara A.			Depletion of the Human Ion Channel TRPM2 in Neuroblastoma Demonstrates Its Key Role in Cell Survival through Modulation of Mitochondrial Reactive Oxygen Species and Bioenergetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE-SUPEROXIDE-DISMUTASE; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; ADP-RIBOSE; CATION CHANNEL; CANCER-CELLS; HYDROGEN-PEROXIDE; INTRACELLULAR CALCIUM; INDUCIBLE FACTOR-1; GENE-EXPRESSION	Transient receptor potential melastatin 2 (TRPM2) ion channel has an essential function in modulating cell survival following oxidant injury and is highly expressed in many cancers including neuroblastoma. Here, in xenografts generated from neuroblastoma cells in which TRPM2 was depleted with CRISPR/Cas9 technology and in in vitro experiments, tumor growth was significantly inhibited and doxorubicin sensitivity increased. The hypoxia-inducible transcription factor 1/2 alpha (HIF-1/2 alpha) signaling cascade including proteins involved in oxidant stress, glycolysis, and mitochondrial function was suppressed by TRPM2 depletion. TRPM2-depleted SH-SYSY neuroblastoma cells demonstrated reduced oxygen consumption and ATP production after doxorubicin, confirming impaired cellular bioenergetics. In cells in which TRPM2 was depleted, mitochondrial superoxide production was significantly increased, particularly following doxorubicin. Ectopic expression of superoxide dismutase 2 (SOD2) reduced ROS and preserved viability of TRPM2-depleted cells, however, failed to restore ATP levels. Mitochondrial reactive oxygen species (ROS) were also significantly increased in cells in which TRPM2 function was inhibited by TRPM2-S, and pretreatment of these cells with the antioxidant MitoTEMPO significantly reduced ROS levels in response to doxorubicin and protected cell viability. Expression of the TRPM2 pore mutant E960D, in which calcium entry through TRPM2 is abolished, also resulted in significantly increased mitochondrial ROS following doxorubicin treatment, showing the critical role of TRPM2-mediated calcium entry. These findings demonstrate the important function of TRPM2 in modulation of cell survival through mitochondrial ROS, and the potential of targeted inhibition of TRPM2 as a therapeutic approach to reduce cellular bioenergetics, tumor growth, and enhance susceptibility to chemotherapeutic agents.	[Bao, Lei; Chen, Shu-Jen; Conrad, Kathleen; Keefer, Kerry; Lee, John P.; Hirschler-Laszkiewicz, Iwona; Wang, Hong-Gang; Dovat, Sinisa; Gans, Brian; Miller, Barbara A.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Coll Med, Microscopy Imaging Facil, Hershey, PA 17033 USA; [Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Dovat, Sinisa; Miller, Barbara A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Wang, JuFang; Zhang, Xue-Qian; Cheung, Joseph Y.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA; [Madesh, Muniswamy] Temple Univ, Sch Med, Dept Mol Genet & Med Biochem, Philadelphia, PA 19140 USA; [Zhang, Xue-Qian; Madesh, Muniswamy; Cheung, Joseph Y.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Miller, BA (corresponding author), Milton S Hershey Med Ctr, Dept Pediat, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu	Abraham, Thomas/AAJ-7950-2020; Wang, Hong-Gang/A-3018-2015; Abraham, Thomas/J-7080-2014	Wang, Hong-Gang/0000-0003-0551-0571; Dovat, Sinisa/0000-0003-3906-6165; Abraham, Thomas/0000-0003-0750-8774	National Institutes of Health [RO1-GM117014, RO1-DK46778, RO1-HL-58672, RO1-HL74854, RO1-HL123093, R01GM109882, R01HL086699, R01HL119306, 1S10RR027327]; Hyundai Hope on Wheels; Four Diamonds Fund of the Pennsylvania State University; American Heart Association [15GRNT25680042]; PA CURE Grant [4100062220]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123093, R01HL058672, R01HL119306, R01HL086699, R01HL074854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117014, R01GM109882] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010756, S10OD018124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels; Four Diamonds Fund of the Pennsylvania State University; American Heart Association(American Heart Association); PA CURE Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants RO1-GM117014 and RO1-DK46778 (to B. A. M.), RO1-HL-58672, RO1-HL74854, and RO1-HL123093 (to J. Y. C.), R01GM109882, R01HL086699, R01HL119306, and 1S10RR027327 (to M. M.), grants from the Hyundai Hope on Wheels, the Four Diamonds Fund of the Pennsylvania State University, American Heart Association (Great Rivers Affiliate) Grant-in-aid 15GRNT25680042, and PA CURE Grant (Project 5) SAP#4100062220. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen SJ, 2014, J BIOL CHEM, V289, P36284, DOI 10.1074/jbc.M114.620922; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Csanady L, 2010, J PHYSIOL-LONDON, V588, P1661, DOI 10.1113/jphysiol.2010.190223; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Duncan LM, 1998, CANCER RES, V58, P1515; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Fredlund E, 2008, BIOCHEM BIOPH RES CO, V366, P1054, DOI 10.1016/j.bbrc.2007.12.074; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hoffman NE, 2015, AM J PHYSIOL-HEART C, V308, pH637, DOI 10.1152/ajpheart.00720.2014; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Klumpp D, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8026702; Knowles H, 2011, P NATL ACAD SCI USA, V108, P11578, DOI 10.1073/pnas.1010678108; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kornmann B, 2013, CURR OPIN CELL BIOL, V25, P443, DOI 10.1016/j.ceb.2013.02.010; Lackner LL, 2013, P NATL ACAD SCI USA, V110, pE458, DOI 10.1073/pnas.1215232110; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Miller BA, 2014, J BIOL CHEM, V289, P7615, DOI 10.1074/jbc.M113.533851; Miller BA, 2013, AM J PHYSIOL-HEART C, V304, pH1010, DOI 10.1152/ajpheart.00906.2012; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Mohlin S, 2013, NEOPLASIA, V15, P328, DOI 10.1593/neo.121706; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Noguera R, 2009, CLIN CANCER RES, V15, P7130, DOI 10.1158/1078-0432.CCR-09-0223; O-Uchi J, 2014, ANTIOXID REDOX SIGN, V21, P863, DOI 10.1089/ars.2013.5394; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Park JH, 2016, CELL REP, V14, P2154, DOI 10.1016/j.celrep.2016.02.004; Park YR, 2016, CANCER GENOM PROTEOM, V13, P83; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shaw AT, 2011, P NATL ACAD SCI USA, V108, P8773, DOI 10.1073/pnas.1105941108; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Toth B, 2015, J GEN PHYSIOL, V145, P419, DOI 10.1085/jgp.201511377; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsavaler L, 2001, CANCER RES, V61, P3760; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang JF, 2011, AM J PHYSIOL-HEART C, V300, pH859, DOI 10.1152/ajpheart.00894.2010; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	84	42	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24449	24464		10.1074/jbc.M116.747147	http://dx.doi.org/10.1074/jbc.M116.747147			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27694440	hybrid, Green Published			2022-12-28	WOS:000388875500010
J	Benoit, SL; Maier, RJ				Benoit, Stephane L.; Maier, Robert J.			Helicobacter Catalase Devoid of Catalytic Activity Protects the Bacterium against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; bacterial metabolism; bacterial pathogenesis; infectious disease; microbiology; multifunctional enzyme; oxidative stress	METHIONINE SULFOXIDE REDUCTASE; PYLORI-CATALASE; IN-VIVO; PROTEINS; GASTRITIS; RESIDUES; STRAINS; ENZYMES; ACID; KAPA	Catalase, a conserved and abundant enzyme found in all domains of life, dissipates the oxidant hydrogen peroxide (H2O2). The gastric pathogen Helicobacter pylori undergoes host-mediated oxidant stress exposure, and its catalase contains oxidizable methionine (Met) residues. We hypothesized catalase may play a large stress-combating role independent of its classical catalytic one, namely quenching harmful oxidants through its recyclable Met residues, resulting in oxidant protection to the bacterium. Two Helicobacter mutant strains (katA(H56A) and katA(Y339A)) containing catalase without enzyme activity but that retain all Met residues were created. These strains were much more resistant to oxidants than a catalase-deletion mutant strain. The quenching ability of the altered versions was shown, whereby oxidant-stressed (HOCl-exposed) Helicobacter retained viability even upon extracellular addition of the inactive versions of catalase, in contrast to cells receiving HOCl alone. The importance of the methionine-mediated quenching to the pathogen residing in the oxidant-rich gastric mucus was studied. In contrast to a catalase-null strain, both site-change mutants proficiently colonized the murine gastric mucosa, suggesting that the amino acid composition-dependent oxidant-quenching role of catalase is more important than the well described H2O2-dissipating catalytic role. Over 100 years after the discovery of catalase, these findings reveal a new non-enzymatic protective mechanism of action for the ubiquitous enzyme.	[Benoit, Stephane L.; Maier, Robert J.] Univ Georgia, Dept Microbiol, 807 Biological Sci Bldg,100 Cedar St, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Maier, RJ (corresponding author), Univ Georgia, Dept Microbiol, 807 Biological Sci Bldg,100 Cedar St, Athens, GA 30602 USA.	rmaier@uga.edu		Benoit, Stephane/0000-0002-9314-8586	National Institutes of Health [1R21AI121181]; University of Georgia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 1R21AI121181 and by the University of Georgia Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achilli C, 2015, BIOFACTORS, V41, P135, DOI 10.1002/biof.1214; Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Alamuri P, 2006, J BACTERIOL, V188, P5839, DOI 10.1128/JB.00430-06; Alfonso-Prieto M, 2012, ARCH BIOCHEM BIOPHYS, V525, P121, DOI 10.1016/j.abb.2012.04.004; ARUOMA OI, 1987, BIOCHEM J, V248, P973, DOI 10.1042/bj2480973; Bagchi D, 1996, FREE RADICAL RES, V24, P439, DOI 10.3109/10715769609088043; Benoit SL, 2007, MICROBIOL-SGM, V153, P1474, DOI 10.1099/mic.0.2006/003228-0; Benoit SL, 2014, MBIO, V5, DOI 10.1128/mBio.01016-13; Benoit SL, 2013, J BACTERIOL, V195, P5396, DOI 10.1128/JB.01001-13; BLASER MJ, 1995, ALIMENT PHARM THERAP, V9, P27; Booniakuakul JK, 2004, J INFECT DIS, V190, P946, DOI 10.1086/423142; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; Handa O, 2010, INFLAMM RES, V59, P997, DOI 10.1007/s00011-010-0245-x; Harris AG, 2003, FEMS MICROBIOL LETT, V229, P283, DOI 10.1016/S0378-1097(03)00850-4; Harris AG, 2003, MICROBIOL-SGM, V149, P665, DOI 10.1099/mic.0.26012-0; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HAZELL SL, 1991, J GEN MICROBIOL, V137, P57, DOI 10.1099/00221287-137-1-57; Johnson William M, 2015, Ther Targets Neurol Dis, V2; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Kleanthous H, 2001, VACCINE, V19, P4883, DOI 10.1016/S0264-410X(01)00248-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Loew O, 1900, SCIENCE, V11, P701, DOI 10.1126/science.11.279.701; Loewen PC, 2004, BIOCHEMISTRY-US, V43, P3089, DOI 10.1021/bi035663i; Mahawar M, 2011, J BIOL CHEM, V286, P19159, DOI 10.1074/jbc.M111.223677; MASTERS C, 1995, PEROXISOME VITAL ORG; Miyashita M, 2002, VACCINE, V20, P2336, DOI 10.1016/S0264-410X(02)00104-4; Radcliff FJ, 1997, INFECT IMMUN, V65, P4668, DOI 10.1128/IAI.65.11.4668-4674.1997; Ramarao N, 2000, MOL MICROBIOL, V38, P103, DOI 10.1046/j.1365-2958.2000.02114.x; Sipponen P, 1998, ALIMENT PHARM THER, V12, P61, DOI 10.1111/j.1365-2036.1998.00005.x; Smith TG, 2007, PROTEOMICS, V7, P2240, DOI 10.1002/pmic.200600875; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wang G, 2004, J BIOL CHEM, V279, P51908, DOI 10.1074/jbc.M408450200; WEISS SJ, 1989, NEW ENGL J MED, V320, P365	36	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23366	23373		10.1074/jbc.M116.747881	http://dx.doi.org/10.1074/jbc.M116.747881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27605666	Green Published, hybrid			2022-12-28	WOS:000387884400001
J	Matsukawa, K; Hashimoto, T; Matsumoto, T; Ihara, R; Chihara, T; Miura, M; Wakabayashi, T; Iwatsubo, T				Matsukawa, Koji; Hashimoto, Tadafumi; Matsumoto, Taisei; Ihara, Ryoko; Chihara, Takahiro; Miura, Masayuki; Wakabayashi, Tomoko; Iwatsubo, Takeshi			Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); Drosophila; fused in sarcoma (FUS); neurodegeneration; neurodegenerative disease; profilin; TAR DNA-binding protein 43 (TDP-43) (TARDBP)	FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; STRESS GRANULE DYNAMICS; HEXANUCLEOTIDE REPEAT; VCP MUTATIONS; GENE; ALS; DISEASE; RNA; DEMENTIA	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive and selective loss of motor neurons. Causative genes for familial ALS (fALS), e.g. TARDBP or FUS/TLS, have been found, among which mutations within the profilin 1 (PFN1) gene have recently been identified in ALS18. To elucidate the mechanism whereby PFN1 mutations lead to neuronal death, we generated transgenic Drosophila melanogaster overexpressing human PFN1 in the retinal photoreceptor neurons. Overexpression of wild-type or fALS mutant PFN1 caused no degenerative phenotypes in the retina. Double overexpression of fALS mutant PFN1 and human TDP-43 markedly exacerbated the TDP-43-induced retinal degeneration, i.e. vacuolation and thinning of the retina, whereas co-expression of wild-type PFN1 did not aggravate the degenerative phenotype. Notably, co-expression of TDP-43 with fALS mutant PFN1 increased the cytoplasmic localization of TDP-43, the latter remaining in nuclei upon co-expression with wild-type PFN1, whereas co-expression of TDP-43 lacking the nuclear localization signal with the fALS mutant PFN1 did not aggravate the retinal degeneration. Knockdown of endogenous Drosophila PFN1 did not alter the degenerative phenotypes of the retina in flies overexpressing wild-type TDP-43. These data suggest that ALS-linked PFN1 mutations exacerbate TDP-43-induced neurodegeneration in a gain-of-function manner, possibly by shifting the localization of TDP-43 from nuclei to cytoplasm.	[Matsukawa, Koji; Hashimoto, Tadafumi; Matsumoto, Taisei; Ihara, Ryoko; Wakabayashi, Tomoko; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Matsumoto, Taisei; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Chihara, Takahiro; Miura, Masayuki] Univ Tokyo, Dept Genet, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.; Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.; Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@m.u-tokyo.ac.jp	Chihara, Takahiro/G-7639-2019; Wakabayashi, Tomoko/GSD-1544-2022	Chihara, Takahiro/0000-0001-9989-3619; Hashimoto, Tadafumi/0000-0001-5442-4800	Nakabayashi Trust for ALS Research; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [15H04375] Funding Source: KAKEN	Nakabayashi Trust for ALS Research; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Nakabayashi Trust for ALS Research (to T. H.) and Grants-in-Aid for Scientific Research (C) (to T. H.) and for JSPS Fellows (to K. M.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; BRAND AH, 1993, DEVELOPMENT, V118, P401; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; De Conti L, 2015, NUCLEIC ACIDS RES, V43, P8990, DOI 10.1093/nar/gkv814; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Figley MD, 2014, J NEUROSCI, V34, P8083, DOI 10.1523/JNEUROSCI.0543-14.2014; Fratta P, 2014, J NEUROL NEUROSUR PS, V85, P506, DOI 10.1136/jnnp-2013-306761; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gitcho MA, 2009, J BIOL CHEM, V284, P12384, DOI 10.1074/jbc.M900992200; Ihara R, 2013, HUM MOL GENET, V22, P4474, DOI 10.1093/hmg/ddt296; Ingre C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.009; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853; Kobayashi Z, 2010, J NEUROL SCI, V293, P6, DOI 10.1016/j.jns.2010.03.029; Kullmann JA, 2012, EMBO REP, V13, P75, DOI 10.1038/embor.2011.211; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Miguel L, 2011, NEUROBIOL DIS, V41, P398, DOI 10.1016/j.nbd.2010.10.007; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; Shao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032802; Smith BN, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.10.032; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tanaka Y, 2016, HUM MOL GENET, V25, P1420, DOI 10.1093/hmg/ddw024; van Blitterswijk M, 2013, AMYOTROPH LAT SCL FR, V14, P463, DOI 10.3109/21678421.2013.787630; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	49	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23464	23476		10.1074/jbc.M116.729152	http://dx.doi.org/10.1074/jbc.M116.729152			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634045	hybrid, Green Published			2022-12-28	WOS:000387884400009
J	Morris, JS; Facchini, PJ				Morris, Jeremy S.; Facchini, Peter J.			Isolation and Characterization of Reticuline N-Methyltransferase Involved in Biosynthesis of the Aporphine Alkaloid Magnoflorine in Opium Poppy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; enzyme catalysis; functional genomics; plant biochemistry; secondary metabolism; N-methyltransferase; aporphine alkaloid; benzylisoquinoline alkaloid; biochemical genomics; magnoflorine	ADENOSYL-L-METHIONINE; COPTIS-JAPONICA CELLS; MOLECULAR-CLONING; O-METHYLTRANSFERASES; TINOSPORA-CORDIFOLIA; PARTIAL-PURIFICATION; DENSITY-LIPOPROTEIN; GENE-EXPRESSION; CULTURED-CELLS; RHIZOMA	Benzylisoquinoline alkaloids are a large group of plant-specialized metabolites displaying an array of biological and pharmacological properties associated with numerous structural scaffolds and diverse functional group modification. N-Methylation is one of the most common tailoring reactions, yielding tertiary and quaternary pathway intermediates and products. Two N-methyltransferases accepting (i) early 1-benzylisoquinoline intermediates possessing a secondary amine and leading to the key branch-point intermediate (S)-reticuline and (ii) downstream protoberberines containing a tertiary amine and forming quaternary intermediates destined for phthalideisoquinolines and antimicrobial benzo[c]phenanthridines were previously characterized. We report the isolation and characterization of a phylogenetically related yet functionally distinct N-methyltransferase (NMT) from opium poppy (Papaver somniferum) that primarily accepts 1-benzylisoquinoline and aporphine substrates possessing a tertiary amine. The preferred substrates were the R and S conformers of reticuline and the aporphine (S)-corytuberine, which are proposed intermediates in the biosynthesis of magnoflorine, a quaternary aporphine alkaloid common in plants. Suppression of the gene encoding reticuline N-methyltransferase (RNMT) using virus-induced gene silencing in opium poppy resulted in a significant decrease in magnoflorine accumulation and a concomitant increase in corytuberine levels in roots. RNMT transcript levels were also most abundant in roots, in contrast to the distribution of transcripts encoding other NMTs, which occur predominantly in aerial plant organs. The characterization of a third functionally unique NMT involved in benzylisoquinoline alkaloid metabolism will facilitate the establishment of structure-function relationships among a large group of related enzymes.	[Morris, Jeremy S.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to P. J. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Austin RS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-191; BHAKUNI DS, 1980, TETRAHEDRON, V36, P2525, DOI 10.1016/0040-4020(80)80233-X; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chen JH, 2009, ARCH PHARM RES, V32, P3, DOI 10.1007/s12272-009-1111-7; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Choi KB, 2001, PHYTOCHEMISTRY, V56, P649, DOI 10.1016/S0031-9422(00)00481-7; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; de la Pena JBI, 2013, J NAT MED-TOKYO, V67, P814, DOI 10.1007/s11418-013-0754-3; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; Farrow SC, 2012, PHYTOCHEMISTRY, V77, P79, DOI 10.1016/j.phytochem.2012.02.014; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRENZEL T, 1990, PHYTOCHEMISTRY, V29, P3491, DOI 10.1016/0031-9422(90)85263-F; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Hagel JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0596-0; Hagel JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0594-2; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2012, J BIOL CHEM, V287, P42972, DOI 10.1074/jbc.M112.420414; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; HIBI N, 1994, PLANT CELL, V6, P723, DOI 10.1105/tpc.6.5.723; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Hung TM, 2007, PLANTA MED, V73, P1281, DOI 10.1055/s-2007-981615; Hung TM, 2007, BIOL PHARM BULL, V30, P1157, DOI 10.1248/bpb.30.1157; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Kato M, 2000, NATURE, V406, P956, DOI 10.1038/35023072; Khamidov II, 1997, CHEM NAT COMPD, V33, p323 , DOI DOI 10.1007/BF02234886; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lam KC, 2007, GENOME, V50, P1001, DOI 10.1139/G07-077; Levac D, 2016, PLANT PHYSIOL, V170, P1935, DOI 10.1104/pp.15.01813; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liscombe DK, 2010, P NATL ACAD SCI USA, V107, P18793, DOI 10.1073/pnas.1009003107; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEFFLER S, 1995, PHYTOCHEMISTRY, V38, P1387, DOI 10.1016/0031-9422(94)00813-9; Marques JV, 2014, MOL BIOSYST, V10, P2838, DOI 10.1039/c4mb00403e; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; McCarthy AA, 2007, PLANT PHYSIOL, V144, P879, DOI 10.1104/pp.106.094854; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Patel MB, 2012, PHYTOTHER RES, V26, P1342, DOI 10.1002/ptr.3721; Priestap HA, 2012, BIOCHEM SYST ECOL, V40, P126, DOI 10.1016/j.bse.2011.10.006; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RUEFFER M, 1990, PHYTOCHEMISTRY, V29, P3727, DOI 10.1016/0031-9422(90)85321-6; Shulgin A.T., 2002, SIMPLE PLANT ISOQUIN; Torres MA, 2016, J BIOL CHEM, V291, P23403, DOI 10.1074/jbc.M116.747261; WAT CK, 1986, Z NATURFORSCH C, V41, P126; Willaman JJ, 1961, ALKALOID BEARING PLA; Winzer T, 2015, SCIENCE, V349, P309, DOI 10.1126/science.aab1852	51	25	29	6	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23416	23427		10.1074/jbc.M116.750893	http://dx.doi.org/10.1074/jbc.M116.750893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634038	Green Published, hybrid			2022-12-28	WOS:000387884400005
J	Farache, D; Jauneau, A; Chemin, C; Chartrain, M; Remy, MH; Merdes, A; Haren, L				Farache, Dorian; Jauneau, Alain; Chemin, Cecile; Chartrain, Marine; Remy, Marie-Helene; Merdes, Andreas; Haren, Laurence			Functional Analysis of gamma-Tubulin Complex Proteins Indicates Specific Lateral Association via Their N-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE NUCLEATION; RING COMPLEX; CENTRIOLE DUPLICATION; CENTROSOME; TURC; RECRUITMENT; COMPONENTS; GCP6; ORGANIZATION; SUBUNIT	Microtubules are nucleated from multiprotein complexes containing gamma-tubulin and associated gamma-tubulin complex proteins (GCPs). Small complexes (gamma TuSCs) comprise two molecules of gamma-tubulin bound to the C-terminal domains of GCP2 and GCP3. gamma TuSCs associate laterally into helical structures, providing a structural template for microtubule nucleation. In most eukaryotes gamma TuSCs associate with additional GCPs (4, 5, and 6) to form the core of the so-called gamma-tubulin ring complex (gamma TuRC). GCPs2-6 constitute a family of homologous proteins. Previous structural analysis and modeling of GCPs suggest that all family members can potentially integrate into the helical structure. Here we provide experimental evidence for this model. Using chimeric proteins in which the N- and C-terminal domains of different GCPs are swapped, we show that the N-terminal domains define the functional identity of GCPs, whereas the C-terminal domains are exchangeable. FLIM-FRET experiments indicate that GCP4 and GCP5 associate laterally within the complex, and their interaction is mediated by their N-terminal domains as previously shown for gamma TuSCs. Our results suggest that all GCPs are incorporated into the helix via lateral interactions between their N-terminal domains, whereas the C-terminal domains mediate longitudinal interactions with gamma-tubulin. Moreover, we show that binding to gamma-tubulin is not essential for integrating into the helical complex.	[Farache, Dorian; Chemin, Cecile; Chartrain, Marine; Remy, Marie-Helene; Merdes, Andreas; Haren, Laurence] Univ Toulouse III, CNRS, Ctr Biol Dev, 118 Route Narbonne, F-31062 Toulouse, France; [Jauneau, Alain] FR 3450 Pole Biotechnol Vegetale, Plateforme Imagerie Microscopie, F-31326 Castanet Tolosan, France; [Chartrain, Marine] Oncopole, Syntivia, F-31106 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Merdes, A; Haren, L (corresponding author), Univ Toulouse III, CNRS, Ctr Biol Dev, 118 Route Narbonne, F-31062 Toulouse, France.	andreas.merdes@univ-tlse3.fr; laurence.haren@univ-tlse3.fr		CHEMIN, Cecile/0000-0002-5483-8103; farache, dorian/0000-0003-3715-9739	Agence Nationale de la Recherche (ANR, France) [08-BLAN-0281, 13-BSV8-0007-01]; Fondation ARC pour la Recherche sur le Cancer [SFI20121205511]	Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by Agence Nationale de la Recherche (ANR, France) Grants 08-BLAN-0281 and 13-BSV8-0007-01 and Fondation ARC pour la Recherche sur le Cancer Grant SFI20121205511. The authors declare that they have no conflicts of interest with the contents of this article.	Anders A, 2006, MOL BIOL CELL, V17, P5075, DOI 10.1091/mbc.E05-11-1009; Bahtz R, 2012, J CELL SCI, V125, P486, DOI 10.1242/jcs.093930; Cala O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063908; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chinen T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9722; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Choy RM, 2009, J STRUCT BIOL, V168, P571, DOI 10.1016/j.jsb.2009.08.012; Dhani DK, 2013, MOL BIOL CELL, V24, P3337, DOI 10.1091/mbc.E13-05-0253; Erlemann S, 2012, J CELL BIOL, V197, P59, DOI 10.1083/jcb.201111123; Fava F, 1999, J CELL BIOL, V147, P857, DOI 10.1083/jcb.147.4.857; Greenberg CH, 2016, J STRUCT BIOL, V194, P303, DOI 10.1016/j.jsb.2016.03.006; Guillet V, 2011, NAT STRUCT MOL BIOL, V18, P915, DOI 10.1038/nsmb.2083; Gunawardane RN, 2003, MOL BIOL CELL, V14, P1017, DOI 10.1091/mbc.E02-01-0034; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Izumi N, 2008, J BIOL CHEM, V283, P12981, DOI 10.1074/jbc.M710282200; Janski N, 2012, PLANT CELL, V24, P1171, DOI 10.1105/tpc.111.094904; JULIAN M, 1993, J CELL SCI, V105, P145; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2015, NAT STRUCT MOL BIOL, V22, P132, DOI 10.1038/nsmb.2953; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Lin TC, 2014, ELIFE, V3, DOI 10.7554/eLife.02208; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Lyon AS, 2016, MOL BIOL CELL, V27, P2245, DOI 10.1091/mbc.E16-02-0072; Masuda H, 2016, MOL BIOL CELL, V27, P1753, DOI 10.1091/mbc.E15-08-0577; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Oriolo AS, 2007, MOL BIOL CELL, V18, P781, DOI 10.1091/mbc.E06-03-0201; Remy MH, 2013, PROG MOL BIOL TRANSL, V117, P511, DOI 10.1016/B978-0-12-386931-9.00019-2; Scheidecker S, 2015, AM J HUM GENET, V96, P666, DOI 10.1016/j.ajhg.2015.02.011; Suri C, 2015, PROTEINS, V83, P827, DOI 10.1002/prot.24773; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Xiong Y, 2009, J CELL SCI, V122, P4218, DOI 10.1242/jcs.059196; Zhang LJ, 2000, J CELL BIOL, V151, P1525, DOI 10.1083/jcb.151.7.1525; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	41	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23112	23125		10.1074/jbc.M116.744862	http://dx.doi.org/10.1074/jbc.M116.744862			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27660388	Green Published, hybrid			2022-12-28	WOS:000387224800022
J	Jadhav, S; Russo, S; Cottier, S; Schneiter, R; Cowart, A; Greenberg, ML				Jadhav, Shyamalagauri; Russo, Sarah; Cottier, Stephanie; Schneiter, Roger; Cowart, Ashley; Greenberg, Miriam L.			Valproate Induces the Unfolded Protein Response by Increasing Ceramide Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; fatty acid metabolism; lipid metabolism; sphingolipid; unfolded protein response (UPR); inositol	ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; BIPOLAR DISORDER; INOSITOL-BIOSYNTHESIS; STRESS-RESPONSE; SPHINGOLIPID HOMEOSTASIS; PHOSPHATASE SAC1P; GENE-EXPRESSION; FUMONISIN B-1; YEAST	Bipolar disorder (BD), which is characterized by depression and mania, affects 1-2% of the world population. Current treatments are effective in only 40-60% of cases and cause severe side effects. Valproate (VPA) is one of the most widely used drugs for the treatment of BD, but the therapeutic mechanism of action of this drug is not understood. This knowledge gap has hampered the development of effective treatments. To identify candidate pathways affected by VPA, we performed a genome-wide expression analysis in yeast cells grown in the presence or absence of the drug. VPA caused up-regulation of FEN1 and SUR4, encoding fatty acid elongases that catalyze the synthesis of very long chain fatty acids (C24 to C26) required for ceramide synthesis. Interestingly, fen1 and sur4 mutants exhibited VPA sensitivity. In agreement with increased fatty acid elongase gene expression, VPA increased levels of phytoceramide, especially those containing C24-C26 fatty acids. Consistent with an increase in ceramide, VPA decreased the expression of amino acid transporters, increased the expression of ER chaperones, and activated the unfolded protein response element (UPRE), suggesting that VPA induces the UPR pathway. These effects were rescued by supplementation of inositol and similarly observed in inositol-starved ino1 cells. Starvation of ino1 cells increased expression of FEN1 and SUR4, increased ceramide levels, decreased expression of nutrient transporters, and induced the UPR. These findings suggest that VPA-mediated inositol depletion induces the UPR by increasing the de novo synthesis of ceramide.	[Jadhav, Shyamalagauri; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Russo, Sarah; Cowart, Ashley] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Russo, Sarah; Cowart, Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Cottier, Stephanie; Schneiter, Roger] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	Wayne State University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Fribourg	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu		Schneiter, Roger/0000-0002-9102-8396; Jadhav, Shyamalagauri/0000-0003-4302-6713	National Institutes of Health [DK081367]; Swiss National Science Foundation; Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK081367 (to M. L. G.), the Swiss National Science Foundation (to R. S.), and the Graduate School of Wayne State University (to S. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; BERRIDGE MJ, 1989, PROC R SOC SER B-BIO, V238, P235, DOI 10.1098/rspb.1989.0079; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Cheng RSY, 2005, MED SCI LAW, V45, P317, DOI 10.1258/rsmmsl.45.4.317; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Deranieh RM, 2009, BIOCHEM SOC T, V37, P1099, DOI 10.1042/BST0371099; Epstein S, 2012, J LIPID RES, V53, P412, DOI 10.1194/jlr.M022186; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Fu Yu, 2006, Methods Mol Biol, V313, P257; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Goodwin GM, 2007, EVID-BASED MENT HEAL, V10, P82, DOI 10.1136/ebmh.10.3.82; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hayashi A, 2009, INT J NEUROPSYCHOPH, V12, P33, DOI 10.1017/S1461145708009358; He QR, 2006, TOXICOL SCI, V94, P388, DOI 10.1093/toxsci/kfl102; Henry CA, 2003, J CHILD ADOL PSYCHOP, V13, P523, DOI 10.1089/104454603322724913; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; Johnson SS, 2010, J BIOL CHEM, V285, P35792, DOI 10.1074/jbc.M110.162883; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Knodler A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-16; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Mayinger P, 2009, SEMIN CELL DEV BIOL, V20, P793, DOI 10.1016/j.semcdb.2009.03.016; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Parthasarathy RN, 2013, MOL CELL BIOCHEM, V378, P83, DOI 10.1007/s11010-013-1597-7; Payet LA, 2013, TRAFFIC, V14, P1257, DOI 10.1111/tra.12117; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; So J, 2007, BIOL PSYCHIAT, V62, P141, DOI 10.1016/j.biopsych.2006.10.014; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; Ye CQ, 2015, J NEUROCHEM, V133, P273, DOI 10.1111/jnc.12978	55	16	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22253	22261		10.1074/jbc.M116.752634	http://dx.doi.org/10.1074/jbc.M116.752634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27590340	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000386332600036
J	Li, YX; Erickson, JW; Stalnecker, CA; Katt, WP; Huang, QQ; Cerione, RA; Ramachandran, S				Li, Yunxing; Erickson, Jon W.; Stalnecker, Clint A.; Katt, William P.; Huang, Qingqiu; Cerione, Richard A.; Ramachandran, Sekar			Mechanistic Basis of Glutaminase Activation A KEY ENZYME THAT PROMOTES GLUTAMINE METABOLISM IN CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-TYPE GLUTAMINASE; PHOSPHATE ACTIVATION; INHIBITION; EXPRESSION; BIOLOGY; PROTEIN; GROWTH; LYSINE	Glutamine-derived carbon becomes available for anabolic biosynthesis in cancer cells via the hydrolysis of glutamine to glutamate, as catalyzed by GAC, a splice variant of kidney-type glutaminase (GLS). Thus, there is significant interest in understanding the regulation of GAC activity, with the suggestion being that higher order oligomerization is required for its activation. We used x-ray crystallography, together with site-directed mutagenesis, to determine the minimal enzymatic unit capable of robust catalytic activity. Mutagenesis of the helical interface between the two pairs of dimers comprising a GAC tetramer yielded a non-active, GAC dimer whose x-ray structure displays a stationary loop ("activation loop") essential for coupling the binding of allosteric activators like inorganic phosphate to catalytic activity. Further mutagenesis that removed constraints on the activation loop yielded a constitutively active dimer, providing clues regarding how the activation loop communicates with the active site, as well as with a peptide segment that serves as a "lid" to close off the active site following substrate binding. Our studies show that the formation of large GAC oligomers is not a pre-requisite for full enzymatic activity. They also offer a mechanism by which the binding of activators like inorganic phosphate enables the activation loop to communicate with the active site to ensure maximal rates of catalysis, and promotes the opening of the lid to achieve optimal product release. Moreover, these findings provide new insights into how other regulatory events might induce GAC activation within cancer cells.	[Li, Yunxing; Erickson, Jon W.; Stalnecker, Clint A.; Cerione, Richard A.; Ramachandran, Sekar] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Katt, William P.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Huang, Qingqiu] Cornell Univ, Cornell Lab Accelerator Based Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020	Ramachandran, Sekar/0000-0002-2243-1368; Stalnecker, Clint/0000-0002-0570-4416; Katt, William/0000-0001-5104-7667	MacCHESS (National Institutes of Health) [P41 GM103485]; NATIONAL CANCER INSTITUTE [R01CA163255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R35GM122575, R01GM040654, P41GM103485] Funding Source: NIH RePORTER	MacCHESS (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cindy Westmiller for excellent secretarial assistance and David J. Schuller and MacCHESS (National Institutes of Health Grant P41 GM103485) for help with x-ray data analysis.	Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GODFREY S, 1977, J BIOL CHEM, V252, P1927; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; HART MJ, 1994, J BIOL CHEM, V269, P62; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Kim CU, 2006, ACTA CRYSTALLOGR D, V62, P687, DOI 10.1107/S0907444906014727; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Lukey MJ, 2013, FUTURE MED CHEM, V5, P1685, DOI 10.4155/fmc.13.130; McDonald CJ, 2015, NEUROCHEM INT, V88, P10, DOI 10.1016/j.neuint.2014.12.003; Moller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074783; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056	31	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20900	20910		10.1074/jbc.M116.720268	http://dx.doi.org/10.1074/jbc.M116.720268			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542409	hybrid, Green Published			2022-12-28	WOS:000385406200009
J	Zhou, XL; Chen, Y; Fang, ZP; Ruan, ZR; Wang, Y; Liu, RJ; Xue, MQ; Wang, ED				Zhou, Xiao-Long; Chen, Yun; Fang, Zhi-Peng; Ruan, Zhi-Rong; Wang, Yong; Liu, Ru-Juan; Xue, Mei-Qin; Wang, En-Duo			Translational Quality Control by Bacterial Threonyl-tRNA Synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-CODE; PROTEIN-BIOSYNTHESIS; AMINOACYLATION; DOMAIN; MISTRANSLATION; TRNA(LEU); COMPLEX; YEAST; DISCRIMINATION; RECOGNITION	Translational fidelity mediated by aminoacyl-tRNA synthetases ensures the generation of the correct aminoacyl-tRNAs, which is critical for most species. Threonyl-tRNA synthetase (ThrRS) contains multiple domains, including an N2 editing domain. Of the ThrRS domains, N1 is the last to be assigned a function. Here, we found that ThrRSs from Mycoplasma species exhibit differences in their domain composition and editing active sites compared with the canonical ThrRSs. The Mycoplasma mobile ThrRS, the first example of a ThrRS naturally lacking the N1 domain, displays efficient post-transfer editing activity. In contrast, the Mycoplasma capricolum ThrRS, which harbors an N1 domain and a degenerate N2 domain, is editing-defective. Only editing-capable ThrRSs were able to support the growth of a yeast thrS deletion strain (Sc Delta thrS), thus suggesting that Sc Delta thrS is an excellent tool for studying the in vivo editing of introduced bacterial ThrRSs. On the basis of the presence or absence of an N1 domain, we further revealed the crucial importance of the only absolutely conserved residue within the N1 domain in regulating editing by mediating an N1-N2 domain interaction in Escherichia coli ThrRS. Our results reveal the translational quality control of various ThrRSs and the role of the N1 domain in translational fidelity.	[Zhou, Xiao-Long; Chen, Yun; Fang, Zhi-Peng; Ruan, Zhi-Rong; Liu, Ru-Juan; Xue, Mei-Qin; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Ctr Excellence Mol Cell Sc, Shanghai 200031, Peoples R China; [Wang, Yong; Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Ctr Excellence Mol Cell Sc, Shanghai 200031, Peoples R China.; Wang, ED (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China.	edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Fang, Zhipeng/0000-0001-5720-1709; Ruan, Zhi-Rong/0000-0002-1806-2942; , Yong/0000-0002-3698-123X; Liu, Ru-Juan/0000-0001-7459-3126	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai [12JC1409700, 15ZR1446500]; Shanghai Rising-Star Program Grant [16QA1404400]; Youth Innovation Promotion Association of the Chinese Academy of Sciences	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee); Shanghai Rising-Star Program Grant; Youth Innovation Promotion Association of the Chinese Academy of Sciences	This work was supported by Grant 2012CB911000 from the National Key Basic Research Foundation of China, Grants 31130064 and 91440204 from the Natural Science Foundation of China, and Grants 12JC1409700, 15ZR1446500 from the Committee of Science and Technology in Shanghai. This work was also sponsored by Shanghai Rising-Star Program Grant 16QA1404400 and funds from the Youth Innovation Promotion Association of the Chinese Academy of Sciences (to X.-L. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Dwivedi S, 2005, NAT STRUCT MOL BIOL, V12, P556, DOI 10.1038/nsmb943; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ji QQ, 2016, J BIOL CHEM, V291, P3613, DOI 10.1074/jbc.M115.699777; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; Ling JQ, 2012, P NATL ACAD SCI USA, V109, P3281, DOI 10.1073/pnas.1200109109; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Ruan ZR, 2015, J BIOL CHEM, V290, P1664, DOI 10.1074/jbc.M114.599886; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Tan M, 2012, BIOCHEM J, V443, P477, DOI 10.1042/BJ20111925; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Wang Y, 2016, J BIOL CHEM, V291, P6507, DOI 10.1074/jbc.M115.700849; Yadavalli SS, 2013, NUCLEIC ACIDS RES, V41, P1104, DOI 10.1093/nar/gks1240; YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1; Zhou XL, 2014, NUCLEIC ACIDS RES, V42, P13873, DOI 10.1093/nar/gku1218; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P9825, DOI 10.1093/nar/gkt741; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	36	12	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21208	21221		10.1074/jbc.M116.740472	http://dx.doi.org/10.1074/jbc.M116.740472			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542414	hybrid, Green Published			2022-12-28	WOS:000385406200034
J	Dolezal, M; Hadravova, R; Kozisek, M; Bednarova, L; Langerova, H; Ruml, T; Rumlova, M				Dolezal, Michal; Hadravova, Romana; Kozisek, Milan; Bednarova, Lucie; Langerova, Hana; Ruml, Tomas; Rumlova, Michaela			Functional and Structural Characterization of Novel Type of Linker Connecting Capsid and Nucleocapsid Protein Domains in Murine Leukemia Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circular dichroism (CD); electron microscopy (EM); nuclear magnetic resonance (NMR); retrovirus; virus assembly; capsid protein (CA); charged assembly helix (CAH); murine leukemia virus (MLV); single alpha-helix (SAH); spacer peptide (SP)	HUMAN-IMMUNODEFICIENCY-VIRUS; PFIZER MONKEY VIRUS; CIRCULAR-DICHROISM SPECTRA; SINGLE ALPHA-HELICES; SPACER PEPTIDE; IN-VITRO; CRYOELECTRON MICROSCOPY; SECONDARY STRUCTURE; POTENTIAL ROLE; NMR	The assembly of immature retroviral particles is initiated in the cytoplasm by the binding of the structural polyprotein precursor Gag with viral genomic RNA. The protein interactions necessary for assembly are mediated predominantly by the capsid (CA) and nucleocapsid (NC) domains, which have conserved structures. In contrast, the structural arrangement of the CA-NC connecting region differs between retroviral species. In HIV-1 and Rous sarcoma virus, this region forms a rod-like structure that separates the CA and NC domains, whereas in Mason-Pfizer monkey virus, this region is densely packed, thus holding the CA and NC domains in close proximity. Interestingly, the sequence connecting the CA and NC domains in gammaretroviruses, such as murine leukemia virus (MLV), is unique. The sequence is called a charged assembly helix (CAH) due to a high number of positively and negatively charged residues. Although both computational and deletion analyses suggested that the MLV CAH forms a helical conformation, no structural or biochemical data supporting this hypothesis have been published. Using an in vitro assembly assay, alanine scanning mutagenesis, and biophysical techniques (circular dichroism, NMR, microcalorimetry, and electrophoretic mobility shift assay), we have characterized the structure and function of the MLV CAH. We provide experimental evidence that the MLV CAH belongs to a group of charged, E(R/K)-rich, single -helices. This is the first single -helix motif identified in viral proteins.	[Dolezal, Michal; Hadravova, Romana; Kozisek, Milan; Bednarova, Lucie; Rumlova, Michaela] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Flemingovo Namesti 2, Prague 16610 6, Czech Republic; [Langerova, Hana; Ruml, Tomas] Univ Chem & Technol, Dept Biochem & Microbiol, Tech 3, Prague 16628 6, Czech Republic; [Rumlova, Michaela] Univ Chem & Technol, Dept Biotechnol, Tech 5, Prague 16628 6, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Chemistry & Technology, Prague; University of Chemistry & Technology, Prague	Rumlova, M (corresponding author), Univ Chem & Technol, Dept Biotechnol, Tech 5, Prague 16628 6, Czech Republic.	michaela.rumlova@vscht.cz	Bednarova, Lucie/E-7622-2012; Ruml, Tomas/R-2543-2017; Rumlova, Michaela/G-9142-2018; Dolezal, Michal/G-5895-2014; Kozisek, Milan/D-4234-2013	Ruml, Tomas/0000-0002-5698-4366; Rumlova, Michaela/0000-0002-5645-8227; Dolezal, Michal/0000-0001-8814-7805; Kozisek, Milan/0000-0002-9476-3409	Grant Agency of the Czech Republic [14-15326S]; "National Program of Sustainability I" (NPU I) [LO 1302]; "Operational Programme Prague - Competitiveness" [CZ.2.16/3.1.00/24503]; NPU I LO1601 Grant [MSMT-43760/ 2015]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); "National Program of Sustainability I" (NPU I); "Operational Programme Prague - Competitiveness"; NPU I LO1601 Grant	This work was supported by the Grant Agency of the Czech Republic Grant 14-15326S (to M. R.), by "National Program of Sustainability I" (NPU I) projects LO 1302, by the "Operational Programme Prague - Competitiveness" (Grant CZ.2.16/3.1.00/24503), and by NPU I LO1601 Grant MSMT-43760/ 2015. The authors declare that they have no conflicts of interest with the contents of this article.	Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Baker EG, 2015, NAT CHEM BIOL, V11, P221, DOI 10.1038/nchembio.1739; Bharat TAM, 2014, P NATL ACAD SCI USA, V111, P8233, DOI 10.1073/pnas.1401455111; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Bohmova K, 2010, J VIROL, V84, P1977, DOI 10.1128/JVI.02022-09; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Bush DL, 2014, J VIROL, V88, P5617, DOI 10.1128/JVI.02659-13; Cheslock SR, 2003, J VIROL, V77, P7058, DOI 10.1128/JVI.77.12.7058-7066.2003; Datta SAK, 2011, J VIROL, V85, P4111, DOI 10.1128/JVI.00006-11; de Marco A, 2010, J VIROL, V84, P11729, DOI 10.1128/JVI.01423-10; England MR, 2014, J VIROL, V88, P7170, DOI 10.1128/JVI.00309-14; Fuzik T, 2016, J VIROL, V90, P4593, DOI 10.1128/JVI.03197-15; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hadravova R, 2012, J VIROL, V86, P1297, DOI 10.1128/JVI.05564-11; Han Y, 2013, J AM CHEM SOC, V135, P17793, DOI 10.1021/ja406907h; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Keller PW, 2008, J VIROL, V82, P6788, DOI 10.1128/JVI.00213-08; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; KRAUSSLICH HG, 1995, J VIROL, V69, P3407; Machara A, 2016, J MED CHEM, V59, P545, DOI 10.1021/acs.jmedchem.5b01089; Melamed D, 2004, J VIROL, V78, P9675, DOI 10.1128/JVI.78.18.9675-9688.2004; Morellet N, 2005, PROTEIN SCI, V14, P375, DOI 10.1110/ps.041087605; Noviello CM, 2011, J VIROL, V85, P4730, DOI 10.1128/JVI.00099-11; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Rumlova M, 2003, VIROLOGY, V310, P310, DOI 10.1016/S0042-6822(03)00128-4; Schur FKM, 2016, SCIENCE, V353, P506, DOI 10.1126/science.aaf9620; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strohalmova-Bohmova K, 2014, J VIROL, V88, P14148, DOI 10.1128/JVI.02286-14; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WANG CLA, 1991, J BIOL CHEM, V266, P13958; Wang MQ, 2003, J VIROL, V77, P3339, DOI 10.1128/JVI.77.5.3339-3344.2003; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	45	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20630	20642		10.1074/jbc.M116.746461	http://dx.doi.org/10.1074/jbc.M116.746461			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514744	Green Published, hybrid			2022-12-28	WOS:000384574800027
J	Steffan, JJ; Koul, S; Meacham, RB; Koul, HK				Steffan, Joshua J.; Koul, Sweaty; Meacham, Randall B.; Koul, Hari K.			The transcription factor SPDEF suppresses prostate tumor metastasis (vol 287, pg 29968, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Steffan JJ, 2012, J BIOL CHEM, V287, P29968, DOI 10.1074/jbc.M112.379396	1	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20826	20826		10.1074/jbc.A112.379396	http://dx.doi.org/10.1074/jbc.A112.379396			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27664067	Green Published, hybrid			2022-12-28	WOS:000384574800046
J	Zhang, G; Park, MA; Mitchell, C; Walker, T; Hamed, H; Studer, E; Graf, M; Rahmani, M; Gupta, S; Hylemon, PB; Fisher, PB; Grant, S; Dent, P				Zhang, Guo; Park, Margaret A.; Mitchell, Clint; Walker, Teneille; Hamed, Hossein; Studer, Elaine; Graf, Martin; Rahmani, Mohamed; Gupta, Seema; Hylemon, Philip B.; Fisher, Paul B.; Grant, Steven; Dent, Paul			Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling (vol 283, pg 24343, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													ZHANG, GUO/D-2556-2014					Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200	1	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20823	20823		10.1074/jbc.A116.803444	http://dx.doi.org/10.1074/jbc.A116.803444			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27664064	Green Published, hybrid			2022-12-28	WOS:000384574800043
J	Weston, C; Winfield, I; Harris, M; Hodgson, R; Shah, A; Dowell, SJ; Mobarec, JC; Woodlock, DA; Reynolds, CA; Poyner, DR; Watkins, HA; Ladds, G				Weston, Cathryn; Winfield, Ian; Harris, Matthew; Hodgson, Rose; Shah, Archna; Dowell, Simon J.; Mobarec, Juan Carlos; Woodlock, David A.; Reynolds, Christopher A.; Poyner, David R.; Watkins, Harriet A.; Ladds, Graham			Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); molecular dynamics; molecular modeling; signal transduction; yeast; adrenomedullin; adrenomedullin 2; CGRP; RAMP; signal bias	COUPLED RECEPTORS; CGRP RECEPTOR; ADRENOMEDULLIN; PHARMACOLOGY; DYNAMICS; ACTIVATION; INTERMEDIN; PATHWAYS; AMYLIN; CELLS	The calcitonin gene-related peptide (CGRP) family of G protein-coupled receptors (GPCRs) is formed through the association of the calcitonin receptor-like receptor (CLR) and one of three receptor activity-modifying proteins (RAMPs). Binding of one of the three peptide ligands, CGRP, adrenomedullin (AM), and intermedin/adrenomedullin 2 (AM2), is well known to result in a G(s)-mediated increase in cAMP. Here we used modified yeast strains that couple receptor activation to cell growth, via chimeric yeast/G subunits, and HEK-293 cells to characterize the effect of different RAMP and ligand combinations on this pathway. We not only demonstrate functional couplings to both G(s) and G(q) but also identify a G(i) component to CLR signaling in both yeast and HEK-293 cells, which is absent in HEK-293S cells. We show that the CGRP family of receptors displays both ligand- and RAMP-dependent signaling bias among the G(s), G(i), and G(q/11) pathways. The results are discussed in the context of RAMP interactions probed through molecular modeling and molecular dynamics simulations of the RAMP-GPCR-G protein complexes. This study further highlights the importance of RAMPs to CLR pharmacology and to bias in general, as well as identifying the importance of choosing an appropriate model system for the study of GPCR pharmacology.	[Weston, Cathryn; Winfield, Ian; Hodgson, Rose; Shah, Archna] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Winfield, Ian; Harris, Matthew; Ladds, Graham] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England; [Dowell, Simon J.] GlaxoSmithkline, Dept Platform Technol & Sci, Stevenage SG1 2NY, Herts, England; [Mobarec, Juan Carlos; Woodlock, David A.; Reynolds, Christopher A.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Poyner, David R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Watkins, Harriet A.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Watkins, Harriet A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand	University of Warwick; University of Cambridge; GlaxoSmithKline; University of Essex; Aston University; University of Auckland; University of Auckland	Ladds, G (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	grl30@cam.ac.uk	Harris, Matt/AAV-1471-2021; Reynolds, Christopher/G-1036-2010	Harris, Matt/0000-0002-7918-5735; Dowell, Simon/0000-0001-6499-7573; Reynolds, Christopher/0000-0001-9267-5141; Mobarec, Juan Carlos/0000-0001-9482-4294; Ladds, Graham/0000-0001-7320-9612; Poyner, David R/0000-0003-1590-112X	National Heart Foundation of New Zealand; School of Biological Sciences, University of Auckland [BB/M00015X/1, BB/M000176/1, BB/M006883/1]; BBSRC; BBSRC Doctoral Training Partnership Grant [BB/JO14540/1]; MRC Doctoral Training Partnership [MR/J003964/1]; Warwick Impact Fund; Warwick Research Development Fund [RD13301]; Warwick Undergraduate Research Scholarship Scheme; Biotechnology and Biological Sciences Research Council [BB/M00015X/1, BB/M007529/1, BB/M000176/1, BB/M00015X/2, BB/M006883/1, 1643678] Funding Source: researchfish; Medical Research Council [1361423] Funding Source: researchfish; BBSRC [1643678, BB/M00015X/1, BB/M00015X/2, BB/M007529/1, BB/M006883/1, BB/M000176/1] Funding Source: UKRI	National Heart Foundation of New Zealand; School of Biological Sciences, University of Auckland(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Doctoral Training Partnership Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Doctoral Training Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Warwick Impact Fund; Warwick Research Development Fund; Warwick Undergraduate Research Scholarship Scheme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Heart Foundation of New Zealand (to H. A. W.), the School of Biological Sciences, University of Auckland seed fund (to H. A. W.), Grants BB/M00015X/1 (to G. L.), BB/M000176/1 (to D. R. P.), and BB/M006883/1 (to C. A. R.) from the BBSRC, BBSRC Doctoral Training Partnership Grant BB/JO14540/1 (to M. H.), MRC Doctoral Training Partnership MR/J003964/1 (to I. W.), the Warwick Impact Fund (to C. W. and G. L.), Grant RD13301 from the Warwick Research Development Fund (to C. W. and G. L.), and the Warwick Undergraduate Research Scholarship Scheme (to A. S. and R. H). The authors declare they have no conflicts of interest with the contents of this article.	Aiyar N, 1999, MOL CELL BIOCHEM, V197, P179, DOI 10.1023/A:1006962221332; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Case D. A., 2016, AMBER 2016; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Disa J, 2000, NEUROPEPTIDES, V34, P229, DOI 10.1054/npep.2000.0810; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Edvinsson L, 2013, CURR PROTEIN PEPT SC, V14, P386, DOI 10.2174/13892037113149990055; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gingell JJ, 2010, PEPTIDES, V31, P1400, DOI 10.1016/j.peptides.2010.03.027; Harikumar KG, 2009, BIOCHEMISTRY-US, V48, P11773, DOI 10.1021/bi901326k; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hay DL, 2016, BIOCHEM SOC T, V44, P568, DOI 10.1042/BST20150237; Hay DL, 2003, REGUL PEPTIDES, V112, P139, DOI 10.1016/S0167-0115(03)00032-6; Hoang HN, 2015, J MED CHEM, V58, P4080, DOI 10.1021/acs.jmedchem.5b00166; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Holmes D, 2013, CURR PROTEIN PEPT SC, V14, P294, DOI 10.2174/13892037113149990049; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kataoka Y, 2010, J CARDIOVASC PHARM, V56, P413, DOI 10.1097/FJC.0b013e3181f15b45; Kato J, 2015, EUR J PHARMACOL, V764, P140, DOI 10.1016/j.ejphar.2015.06.061; KIM DH, 1991, PFLUG ARCH EUR J PHY, V418, P338, DOI 10.1007/BF00550871; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kuwasako K, 2010, BIOCHEM BIOPH RES CO, V392, P380, DOI 10.1016/j.bbrc.2010.01.030; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Ladds G, 2003, MOL MICROBIOL, V47, P781, DOI 10.1046/j.1365-2958.2003.03336.x; Ladds G, 2009, EUR J PHARMACOL, V610, P23, DOI 10.1016/j.ejphar.2009.03.042; Li Y, 2016, PHYS CHEM CHEM PHYS, V18, P12642, DOI 10.1039/c6cp00798h; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Main MJ, 1998, FEBS LETT, V441, P6, DOI 10.1016/S0014-5793(98)01507-5; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miret JJ, 2002, J BIOL CHEM, V277, P6881, DOI 10.1074/jbc.M107384200; Perez-Castells J, 2012, BIOPOLYMERS, V97, P45, DOI 10.1002/bip.21700; Permpoonputtana K, 2016, LIFE SCI, V144, P19, DOI 10.1016/j.lfs.2015.11.015; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Qi T, 2013, BRIT J PHARMACOL, V168, P644, DOI 10.1111/j.1476-5381.2012.02197.x; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; SHIMEKAKE Y, 1995, J BIOL CHEM, V270, P4412, DOI 10.1074/jbc.270.9.4412; Singh R, 2015, J PHYS CHEM B, V119, P2806, DOI 10.1021/jp509814n; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Smillie SJ, 2011, NEUROPEPTIDES, V45, P93, DOI 10.1016/j.npep.2010.12.002; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Walker R. C., 2014, 248 NAT M AM CHEM SO; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Watkins HA, 2016, J BIOL CHEM, V291, P11657, DOI 10.1074/jbc.M115.688218; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Weston C, 2015, J BIOL CHEM, V290, P23009, DOI 10.1074/jbc.M114.624601; WILEY JW, 1992, J PHYSIOL-LONDON, V455, P367, DOI 10.1113/jphysiol.1992.sp019306; Woolley MJ, 2013, CURR PROTEIN PEPT SC, V14, P358, DOI 10.2174/13892037113149990053; Wootten D, 2013, BRIT J PHARMACOL, V168, P822, DOI 10.1111/j.1476-5381.2012.02202.x; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Yang DH, 2016, J BIOL CHEM, V291, P12991, DOI 10.1074/jbc.M116.721977; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859	72	55	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21925	21944		10.1074/jbc.M116.751362	http://dx.doi.org/10.1074/jbc.M116.751362			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27913664	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000386332600009
